PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dakin, SG; Smith, RKW; Heinegard, D; Onnerfjord, P; Khabut, A; Dudhia, J				Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Heinegard, Dick; Onnerfjord, Patrik; Khabut, Areej; Dudhia, Jayesh			Proteomic Analysis of Tendon Extracellular Matrix Reveals Disease Stage- specific Fragmentation and Differential Cleavage of COMP ( Cartilage Oligomeric Matrix Protein)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Inflammation; Mass Spectrometry (MS); Peptides; Proteomics; Tendon	DIGITAL FLEXOR TENDON; SHEATH SYNOVIAL-FLUID; ACHILLES-TENDON; PROTEIN COMP; DEGRADATION; METALLOPROTEINASE; COLLAGEN; INTERLEUKIN-1; PROTEOGLYCAN; EXERCISE	Background: Tendon disease is characterized by extensive remodeling of the extracellular matrix. Results: Novel COMP cleavage fragments were identified in both an in vitro inflammatory model and natural disease. Conclusion: Inflammatory mediators drive distinct COMP fragmentation at different stages of tendon disease. Significance: Novel COMP neo-terminal fragments provide opportunities for developing markers for tendon injury. During inflammatory processes the extracellular matrix (ECM) is extensively remodeled, and many of the constituent components are released as proteolytically cleaved fragments. These degradative processes are better documented for inflammatory joint diseases than tendinopathy even though the pathogenesis has many similarities. The aims of this study were to investigate the proteomic composition of injured tendons during early and late disease stages to identify disease-specific cleavage patterns of the ECM protein cartilage oligomeric matrix protein (COMP). In addition to characterizing fragments released in naturally occurring disease, we hypothesized that stimulation of tendon explants with proinflammatory mediators in vitro would induce fragments of COMP analogous to natural disease. Therefore, normal tendon explants were stimulated with IL-1 and prostaglandin E-2, and their effects on the release of COMP and its cleavage patterns were characterized. Analyses of injured tendons identified an altered proteomic composition of the ECM at all stages post injury, showing protein fragments that were specific to disease stage. IL-1 enhanced the proteolytic cleavage and release of COMP from tendon explants, whereas PGE(2) had no catabolic effect. Of the cleavage fragments identified in early stage tendon disease, two fragments were generated by an IL-1-mediated mechanism. These fragments provide a platform for the development of neo-epitope assays specific to injury stage for tendon disease.	[Dakin, Stephanie Georgina; Smith, Roger Kenneth Whealands; Dudhia, Jayesh] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Heinegard, Dick; Onnerfjord, Patrik; Khabut, Areej] Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden	University of London; University of London Royal Veterinary College; Lund University	Dakin, SG (corresponding author), Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Nuffield Orthopaed Ctr, Windmill Rd, Oxford OX3 7LD, England.	stephanie.dakin@ndorms.ox.ac.uk	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Dudhia, Jayesh/0000-0002-2503-697X; Dakin, Stephanie Georgina/0000-0003-2470-1031	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Ceva (France) [BB/F018258/1]; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ceva (France); European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) UK and Ceva (France) Grant BB/F018258/1. Part of this work was supported by the European Commission 7th Framework Program for Research, NanoDiaRa, and Anamar Medical.	Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; ARNER EC, 1989, ARTHRITIS RHEUM, V32, P288, DOI 10.1002/anr.1780320310; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dakin SG, 2011, EQUINE VET J, V43, P418, DOI 10.1111/j.2042-3306.2010.00303.x; Dakin S. G., 2012, PLOS ONE, V7; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Ganu V, 1998, ARTHRITIS RHEUM, V41, P2143, DOI 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; JOZSA L, 1989, ACTA ORTHOP SCAND, V60, P469, DOI 10.3109/17453678909149322; Ker RF, 2000, J EXP BIOL, V203, P1317; KNUDSEN PJ, 1986, J IMMUNOL, V137, P3189; Kozaci LD, 1997, ARTHRITIS RHEUM-US, V40, P164, DOI 10.1002/art.1780400121; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Ley C, 2011, CONNECT TISSUE RES, V52, P290, DOI 10.3109/03008207.2010.523803; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Miyatake S, 2008, J BIOMECH, V41, P884, DOI 10.1016/j.jbiomech.2007.10.018; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Murphy R. J., 2013, BR J SPORTS MED, DOI 10.1136/bjsports-2013-092459.51; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Perez-Castro AV, 1999, J ORTHOP RES, V17, P139, DOI 10.1002/jor.1100170120; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 1996, ANN RHEUM DIS, V55, P109, DOI 10.1136/ard.55.2.109; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Shohani Behnaz, 2010, Iranian Biomedical Journal, V14, P158; Smith MRW, 2011, VET SURG, V40, P54, DOI 10.1111/j.1532-950X.2010.00751.x; Smith R K, 1999, Equine Vet J Suppl, P201; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Smith RKW, 2002, COMP BIOCHEM PHYS A, V133, P1039, DOI 10.1016/S1095-6433(02)00148-4; Smith RKW, 2002, EQUINE VET J, V34, P726, DOI 10.2746/042516402776250423; Smith RKW, 2000, EQUINE VET J, V32, P52, DOI 10.2746/042516400777612053; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Sztrolovics R, 1999, BIOCHEM J, V339, P571, DOI 10.1042/0264-6021:3390571; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a	51	23	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4919	4927		10.1074/jbc.M113.511972	http://dx.doi.org/10.1074/jbc.M113.511972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398684	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000331607900038
J	Dalvi, P; Wang, K; Mermis, J; Zeng, RX; Sanderson, M; Johnson, S; Dai, YQ; Sharma, G; Ladner, AO; Dhillon, NK				Dalvi, Pranjali; Wang, Kun; Mermis, Joel; Zeng, Ruoxi; Sanderson, Miles; Johnson, Sara; Dai, Yuqiao; Sharma, Garima; Ladner, Amy O'Brien; Dhillon, Navneet K.			HIV-1/Cocaine Induced Oxidative Stress Disrupts Tight Junction Protein-1 in Human Pulmonary Microvascular Endothelial Cells: Role of Ras/ERK1/2 Pathway	PLOS ONE			English	Article							HIV-1 TAT PROTEIN; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; IMMUNODEFICIENCY-VIRUS; ARTERIAL-HYPERTENSION; HYDROGEN-PEROXIDE; H2O2-MEDIATED PERMEABILITY; TYROSINE PHOSPHORYLATION; KINASE-ACTIVITY; NADPH OXIDASE	Intravenous drug use (IVDU) is the major risk factor in the development of HIV-related pulmonary arterial hypertension (HRPAH); however, the pathogenesis of HRPAH in association with IVDU has yet to be characterized. Endothelial injury is considered to be an initiating factor for pulmonary vascular remodeling in animal models of PAH. Our previous study shows that simultaneous exposure to HIV-Trans-activator of transcription (Tat) and cocaine exacerbates both disruption of tight junction proteins and permeability of human pulmonary artery endothelial cells compared with either treatment alone. We here now demonstrate that this HIV-Tat and cocaine mediated endothelial dysfunction accompanies with increase in hydrogen peroxide and superoxide radicals generation and involves redox sensitive signaling pathway. Pretreatment with antioxidant cocktail attenuated the cocaine and Tat mediated disassembly of Zonula Occludens (ZO)-1 and enhancement of endothelial monolayer permeability. Furthermore, inhibition of NADPH oxidase by apocynin or siRNA-mediated knockdown of gp-91(phox) abolished the Tat/cocaine-induced reactive oxygen species (ROS) production, suggesting the NADPH oxidase mediated generation of oxidative radicals. In addition, ROS dependent activation of Ras and ERK1/2 Kinase was observed to be mediating the TJP-1 disassembly, and endothelial dysfunction in response to cocaine and Tat exposure. In conclusion, our findings demonstrate that Tat/cocaine-mediated production of ROS activate Ras/Raf/ERK1/2 pathway that contributes to disruption of tight junction protein leading to pulmonary endothelial dysfunction associated with pulmonary vascular remodeling.	[Dalvi, Pranjali; Wang, Kun; Mermis, Joel; Zeng, Ruoxi; Sanderson, Miles; Johnson, Sara; Dai, Yuqiao; Sharma, Garima; Ladner, Amy O'Brien; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Div Pulm & Crit Care Med, Kansas City, KS 66103 USA; [Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dhillon, NK (corresponding author), Univ Kansas, Med Ctr, Div Pulm & Crit Care Med, Kansas City, KS 66103 USA.	ndhillon@kumc.edu	Wang, Kun/H-5227-2016; Dalvi, Pranjali/GRF-1132-2022	Dalvi, Pranjali/0000-0002-5247-9645	NIH [1R01DA034542, 1R03DA031589]; American Heart Association [11SDG7500016]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA031589, R01DA034542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants: 1R01DA034542 and 1R03DA031589 and American Heart Association's Scientist Development grant: 11SDG7500016 awarded to N. K. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barillari G, 1999, BLOOD, V94, P663; Barillari G, 2002, CLIN MICROBIOL REV, V15, P310, DOI 10.1128/CMR.15.2.310-326.2002; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; CHALIFOUX LV, 1992, LAB INVEST, V67, P338; Chang R, 2008, AM J PHYSIOL-LUNG C, V295, pL688, DOI 10.1152/ajplung.00504.2007; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Dhillon NK, 2008, J NEUROIMMUNE PHARM, V3, P52, DOI 10.1007/s11481-007-9091-1; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Foltin RW, 2003, DRUG ALCOHOL DEPEN, V70, P149, DOI 10.1016/S0376-8716(02)00343-5; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Gumbiner BM, 1998, ANNU REV PHYSIOL, V60, P121; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hughes A, 2008, NSDUH SERIES H; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1940, DOI 10.1152/ajpcell.2001.281.6.C1940; Klings ES, 2003, ADV CARDIOL, V40, P71; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lederman MM, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000327509.30385.3b; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Marecki J, 2005, CHEST, V128, p621S, DOI 10.1378/chest.128.6_suppl.621S-a; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Matsumoto RR, 2003, EUR J PHARMACOL, V469, P1, DOI 10.1016/S0014-2999(03)01723-0; MATSUMOTO T, 2001, SCI STKE; Mermis J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-103; Mitola S, 1997, BLOOD, V90, P1365, DOI 10.1182/blood.V90.4.1365.1365_1365_1372; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Opravil M, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327514.60879.47; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Saez CG, 2011, THROMB RES, V128, pE18, DOI 10.1016/j.thromres.2011.04.019; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; STADDON JM, 1995, J CELL SCI, V108, P609; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wang W, 1996, AM J PHYSIOL-CELL PH, V271, pC1973, DOI 10.1152/ajpcell.1996.271.6.C1973; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wong CM, 2012, ANTIOXID REDOX SIGNA; YAKEL DL, 1995, AM HEART J, V130, P398, DOI 10.1016/0002-8703(95)90459-X; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yu WF, 2012, P NATL ACAD SCI USA, V109, P6680, DOI 10.1073/pnas.1116800109	70	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85246	10.1371/journal.pone.0085246	http://dx.doi.org/10.1371/journal.pone.0085246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409324	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500048
J	Wang, YZ; Dai, MS; Zhang, SJ; Shi, ZB				Wang, Yue-zhi; Dai, Mei-song; Zhang, Shu-jun; Shi, Ze-bin			Exploring Candidate Genes for Pericarp Russet Pigmentation of Sand Pear (Pyrus pyrifolia) via RNA-Seq Data in Two Genotypes Contrasting for Pericarp Color	PLOS ONE			English	Article							TRANSPIRATION BARRIER PROPERTIES; TIME QUANTITATIVE PCR; CELL-WALL FORMATION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTOR; LIGNIN BIOSYNTHESIS; XANTHINE DEHYDROGENASE; ARABIDOPSIS-THALIANA; WATER PERMEATION; CUTICULAR WAXES	Sand pear (Pyrus pyrifolia) russet pericarp is an important trait affecting both the quality and stress tolerance of fruits. This trait is controlled by a relative complex genetic process, with some fundamental biological questions such as how many and which genes are involved in the process remaining elusive. In this study, we explored differentially expressed genes between the russet-and green-pericarp offspring from the sand pear (Pyrus pyrifolia) cv. 'Qingxiang' x 'Cuiguan' F1 group by RNA-seq-based bulked segregant analysis (BSA). A total of 29,100 unigenes were identified and 206 of which showed significant differences in expression level (log(2)fold values>1) between the two types of pericarp pools. Gene Ontology (GO) analyses detected 123 unigenes in GO terms related to 'cellular_component' and 'biological_process', suggesting developmental and growth differentiations between the two types. GO categories associated with various aspects of 'lipid metabolic processes', 'transport', 'response to stress', 'oxidation-reduction process' and more were enriched with genes with divergent expressions between the two libraries. Detailed examination of a selected set of these categories revealed repressed expressions of candidate genes for suberin, cutin and wax biosynthesis in the russet pericarps. Genes encoding putative cinnamoyl-CoA reductase (CCR), cinnamyl alcohol dehydrogenase (CAD) and peroxidase (POD) that are involved in the lignin biosynthesis were suggested to be candidates for pigmentation of sand pear russet pericarps. Nine differentially expressed genes were analyzed for their expressions using qRT-PCR and the results were consistent with those obtained from Illumina RNA-sequencing. This study provides a comprehensive molecular biology insight into the sand pear pericarp pigmentation and appearance quality formation.	[Wang, Yue-zhi; Dai, Mei-song; Zhang, Shu-jun; Shi, Ze-bin] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Shi, ZB (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	shizb@mail.zaas.ac.cn			Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement [2011AA10020602]; Special Funds for China Agriculture Research System [CARS-29-04]; Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences	Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement; Special Funds for China Agriculture Research System; Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences	This study was supported by the Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement (2011AA10020602), the Special Funds for China Agriculture Research System (CARS-29-04), and the Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Albouyeh R, 2010, TREE GENET GENOMES, V6, P601, DOI 10.1007/s11295-010-0275-0; Anai T, 2003, PLANT CELL REP, V21, P988, DOI 10.1007/s00299-003-0609-6; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; ATTAURRAHMAN, 1995, PHYTOCHEMISTRY, V40, P427, DOI 10.1016/0031-9422(95)00195-D; Beisson F, 2012, CURR OPIN PLANT BIOL, V15, P329, DOI 10.1016/j.pbi.2012.03.003; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bernards MA, 2002, CAN J BOT, V80, P227, DOI [10.1139/B02-017, 10.1139/b02-017]; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Carlsbecker A, 2005, CURR OPIN PLANT BIOL, V8, P512, DOI 10.1016/j.pbi.2005.07.001; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Fu Y, 1995, P 13 ANN C FRUIT TRE; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Gou JY, 2009, P NATL ACAD SCI USA, V106, P18855, DOI 10.1073/pnas.0905555106; Inoue E, 2006, SCI HORTIC-AMSTERDAM, V107, P254, DOI 10.1016/j.scienta.2005.07.009; Ito Y, 2011, PLANT J, V66, P680, DOI 10.1111/j.1365-313X.2011.04530.x; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jung JH, 2011, PLANT CELL REP, V30, P1881, DOI 10.1007/s00299-011-1095-x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kaur H, 2012, PLANT PHYSIOL, V159, P1545, DOI 10.1104/pp.112.196717; Kim D, 2005, ACTA HORTIC, P315, DOI 10.17660/ActaHortic.2005.671.45; Kim H, 2002, J BIOL CHEM, V277, P47412, DOI 10.1074/jbc.M208860200; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Kurdyukov S, 2006, PLANTA, V224, P315, DOI 10.1007/s00425-005-0215-7; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; Lemaire-Chamley M, 2005, PLANT PHYSIOL, V139, P750, DOI 10.1104/pp.105.063719; LEYDECKER MT, 1995, PLANT PHYSIOL, V107, P1427, DOI 10.1104/pp.107.4.1427; Li XiaoFeng, 2012, Acta Horticulturae Sinica, V39, P828; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Li-Beisson Y, 2009, P NATL ACAD SCI USA, V106, P22008, DOI 10.1073/pnas.0909090106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malnoy M, 2005, PLANT CELL REP, V23, P632, DOI 10.1007/s00299-004-0855-2; MARSTON A, 1995, J NAT PRODUCTS, V58, P128, DOI 10.1021/np50115a019; Matas AJ, 2010, J EXP BOT, V61, P3321, DOI 10.1093/jxb/erq153; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; PEREIRA H, 1988, WOOD SCI TECHNOL, V22, P211, DOI 10.1007/BF00386015; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sagi M, 1999, PLANT PHYSIOL, V120, P571, DOI 10.1104/pp.120.2.571; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Sartorelli P, 1998, PHYTOCHEMISTRY, V47, P1003, DOI 10.1016/S0031-9422(97)00605-5; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Serra O, 2009, J EXP BOT, V60, P697, DOI 10.1093/jxb/ern314; Shani Z, 2006, PLANT CELL REP, V25, P1067, DOI 10.1007/s00299-006-0167-9; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Sibout R, 2012, CURR BIOL, V22, pR533, DOI 10.1016/j.cub.2012.05.005; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Soler M, 2011, PLANTA, V233, P933, DOI 10.1007/s00425-011-1350-y; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Szepesi A, 2009, J PLANT PHYSIOL, V166, P914, DOI 10.1016/j.jplph.2008.11.012; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wagner A, 2013, PLANT MOL BIOL, V81, P105, DOI 10.1007/s11103-012-9985-z; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yan W, 2009, J SHANXI AGR U NAT S, V29, P32; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang HuaYun, 1996, Acta Horticulturae Sinica, V23, P23; Zhang SJ, 2011, J HORTIC SCI BIOTECH, V86, P595, DOI 10.1080/14620316.2011.11512809; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270	92	33	37	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83675	10.1371/journal.pone.0083675	http://dx.doi.org/10.1371/journal.pone.0083675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400075	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700009
J	Del Turco, D; Schlaudraff, J; Bonin, M; Deller, T				Del Turco, Domenico; Schlaudraff, Jessica; Bonin, Michael; Deller, Thomas			Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ENTORHINAL CORTEX LESION; BETA-SECRETASE ACTIVITY; RAT FASCIA-DENTATA; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; REACTIVE ASTROCYTES; TRANSGENIC MICE; FAMILY-MEMBERS	The disintegrin and metalloproteinases ADAM10 and ADAM17 are regarded as the most important alpha-secretases involved in the physiological processing of amyloid precursor protein (APP) in brain. Since it has been suggested that processing of APP by alpha-secretases could be involved in the reorganization of the brain following injury, we studied mRNA expression of the two alpha-secretases Adam10 and Adam17, the beta-secretase Bace1, and the App-gene family (App, Aplp1, Aplp2) in the dentate gyrus of the mouse following entorhinal denervation. Using laser microdissection, tissue was harvested from the outer molecular layer and the granule cell layer of the denervated dentate gyrus. Expression levels of candidate genes were assessed using Affymetrix GeneChip Mouse Gene 1.0 ST arrays and reverse transcription-quantitative PCR, revealing an upregulation of Adam10 mRNA and Adam17 mRNA in the denervated outer molecular layer and an upregulation of Adam10 mRNA and App mRNA in the dentate granule cell layer. Immunolabeling for ADAM10 or ADAM17 in combination with markers for astro- and microglia revealed an increased labeling of ADAM10 and ADAM17 in the denervated outer molecular layer that was associated with reactive astrocytes but not with microglia. Collectively, these data show that denervation affects the expression level of APP and its two most important alpha-secretases. This suggests that APP-processing could be shifted towards the non-amyloidogenic pathway in denervated areas of the brain and, thus, towards the formation of neuroprotective APP cleavage products, such as APPs alpha.	[Del Turco, Domenico; Schlaudraff, Jessica; Deller, Thomas] Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany	Goethe University Frankfurt; Eberhard Karls University of Tubingen	Del Turco, D (corresponding author), Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany.	DelTurco@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [DE 551/11-1, DE 551/11-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The grant sponsor was Deutsche Forschungsgemeinschaft (http://www.dfg.de), Grant number: DE 551/11-1; DE 551/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Burbach GJ, 2003, J NEUROSCI METH, V131, P83, DOI 10.1016/S0165-0270(03)00232-2; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Fahrenholz F, 2010, NEURODEGENER DIS, V7, P190, DOI 10.1159/000295662; Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001; Finsen B, 1999, ADV EXP MED BIOL, V468, P157; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Haas CA, 1999, J NEUROSCI, V19, P9953; Heber S, 2000, J NEUROSCI, V20, P7951; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mattson MP, 1999, J NEUROCHEM, V73, P532, DOI 10.1046/j.1471-4159.1999.0730532.x; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nielsen HH, 2006, GLIA, V54, P105, DOI 10.1002/glia.20357; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Ramirez MJ, 2001, BRAIN RES, V907, P222, DOI 10.1016/S0006-8993(01)02580-X; Reeves TM, 2003, J NEUROSCI, V23, P10182; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; STEWARD O, 1994, EXP NEUROL, V129, P103, DOI 10.1006/exnr.1994.1151; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; Steward O., 1991, CEREB CORTEX, V9, P81; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	73	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84962	10.1371/journal.pone.0084962	http://dx.doi.org/10.1371/journal.pone.0084962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404197	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800076
J	Feng, MC; Xiao, LJ; Zhang, MJ; Yang, WD; Ding, GW				Feng, Mei-chen; Xiao, Lu-jie; Zhang, Mei-jun; Yang, Wu-de; Ding, Guang-wei			Integrating Remote Sensing and GIS for Prediction of Winter Wheat (Triticum aestivum) Protein Contents in Linfen (Shanxi), China	PLOS ONE			English	Article							GRAIN-YIELD; NITROGEN STATUS	In this study, relationships between normalized difference vegetation index (NDVI) and plant (winter wheat) nitrogen content (PNC) and between PNC and grain protein content (GPC) were investigated using multi-temporal moderate-resolution imaging spectroradiometer (MODIS) data at the different stages of winter wheat in Linfen (Shanxi, P. R. China). The anticipating model for GPC of winter wheat was also established by the approach of NDVI at the different stages of winter wheat. The results showed that the spectrum models of PNC passed F test. The NDVI4.14 regression effect of PNC model of irrigated winter wheat was the best, and that in dry land was NDVI4.30. The PNC of irrigated and dry land winter wheat were significantly (P<0.01) and positively correlated to GPC. Both of protein spectral anticipating model of irrigated and dry land winter wheat passed a significance test (P<0.01). Multiple anticipating models (MAM) were established by NDVI from two periods of irrigated and dry land winter wheat and PNC to link GPC anticipating model. The coefficient of determination R-2 (R) of MAM was greater than that of the other two single-factor models. The relative root mean square error (R-RMSE) and relative error (RE) of MAM were lower than those of the other two single-factor models. Therefore, test effects of multiple proteins anticipating model were better than those of single-factor models. The application of multiple anticipating models for predication of protein content (PC) of irrigated and dry land winter wheat was more accurate and reliable. The regionalization analysis of GPC was performed using inverse distance weighted function of GIS, which is likely to provide the scientific basis for the reasonable winter wheat planting in Linfen city, China.	[Feng, Mei-chen; Xiao, Lu-jie; Zhang, Mei-jun; Yang, Wu-de] Shanxi Agr Univ, Inst Dryland Farming Engn, Taigu, Peoples R China; [Ding, Guang-wei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi Agricultural University; Northern State University	Yang, WD (corresponding author), Shanxi Agr Univ, Inst Dryland Farming Engn, Taigu, Peoples R China.	sxauywd@126.com; guangwei.ding@northern.edu		Meichen, Feng/0000-0002-0338-7963	Key Technologies R&D Program of Shanxi Province, China [20060311140, 20110311038, 201203110012]; Scientific Research Starting Foundation of Shanxi Agricultural University [XB2009016]; Sci-tech Innovation Foundation of Shanxi Agricultural University [201222]	Key Technologies R&D Program of Shanxi Province, China; Scientific Research Starting Foundation of Shanxi Agricultural University; Sci-tech Innovation Foundation of Shanxi Agricultural University	This work was supported by grants from the Key Technologies R&D Program of Shanxi Province, China (20060311140, 20110311038, and 201203110012), the Scientific Research Starting Foundation of Shanxi Agricultural University (XB2009016), and the Sci-tech Innovation Foundation of Shanxi Agricultural University (201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEAS STAT, V648, P651, DOI [10.1007/springerreference_61039, DOI 10.1007/SPRINGERREFERENCE_61039]; Agrawal G, 2011, INT J ADV ENG SCI TE, V4, P178; Apan A., 2006, INT J GEOINFORMATICS, V2, P93; Boken VK, 2002, INT J REMOTE SENS, V23, P4155, DOI 10.1080/014311602320567955; BURT PJ, 1983, ACM T GRAPHIC, V2, P217, DOI 10.1145/245.247; Cohen Y., 2002, International Journal of Applied Earth Observation and Geoinformation, V4, P75, DOI 10.1016/S0303-2434(02)00003-X; DAUGHTRY CST, 1992, REMOTE SENS ENVIRON, V39, P141, DOI 10.1016/0034-4257(92)90132-4; Diago MP, 2012, SENSORS-BASEL, V12, P16988, DOI 10.3390/s121216988; Freeman KW, 2003, COMMUN SOIL SCI PLAN, V34, P1837, DOI 10.1081/CSS-120023219; Girodo M, 2006, SOL ENERGY, V80, P1145, DOI 10.1016/j.solener.2005.09.005; Gitelson AA, 1998, REMOTE SENS ENVIRON, V66, P343, DOI 10.1016/S0034-4257(98)00065-0; Guiarati DN, 1995, BASIC ECONOMETRICS; Hansen PM, 2002, J AGR SCI-CAMBRIDGE, V139, P307, DOI 10.1017/S0021859602002320; Huang WJ, 2008, INT FED INFO PROC, V259, P1299; Liu LY, 2006, INT J REMOTE SENS, V27, P737, DOI 10.1080/01431160500296867; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Manjunath KR, 2002, INT J REMOTE SENS, V23, P3023, DOI 10.1080/01431160110104692; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Matsunaka T, 1997, SOIL SCI PLANT NUTR, V43, P127, DOI 10.1080/00380768.1997.10414721; Otis DL., 1982, CAPTURE RECAPTURE RE; Reyniers M, 2006, INT J REMOTE SENS, V27, P549, DOI 10.1080/01431160500117907; Reyniers M, 2006, EUR J AGRON, V24, P87, DOI 10.1016/j.eja.2005.05.002; Rouse J.W., 1973, 3 EARTH RESOURCES TE, DOI DOI 10.1002/MRM.26868; SAHRAWAT KL, 1995, GEODERMA, V68, P219, DOI 10.1016/0016-7061(95)00031-I; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; SHEWRY P. R, 2006, IMPACTS AGR HUMAN HL; SHIH SF, 1994, SOIL CROP SCI SOC FL, V53, P19; Shum HY, 2000, INT J COMPUT VISION, V36, P101, DOI 10.1023/A:1008195814169; Stark J, 2001, AM SOC AGR ANN M CHA; Stone ML, 1996, T ASAE, V39, P1623, DOI 10.13031/2013.27678; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; TERMAN GL, 1969, AGRON J, V61, P755, DOI 10.2134/agronj1969.00021962006100050031x; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Wang ZJ, 2004, FIELD CROP RES, V90, P311, DOI 10.1016/j.fcr.2004.04.004; Wright D.L., 2004, GISCI REMOTE SENS, V41, P287, DOI 10.2747/1548-1603.41.4.287; Zhao CJ, 2005, INT J APPL EARTH OBS, V7, P1, DOI 10.1016/j.jag.2004.10.002; Zribi M, 2003, INT J REMOTE SENS, V24, P1335, DOI 10.1080/01431160210146668	37	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e80989	10.1371/journal.pone.0080989	http://dx.doi.org/10.1371/journal.pone.0080989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404124	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800003
J	Guo, H; Peng, D; Yang, XG; Wang, Y; Xu, BC; Ni, JS; Meng, W; Jiang, YF				Guo, Hui; Peng, Di; Yang, Xi-Ge; Wang, Ye; Xu, Bing-Chuan; Ni, Jin-Song; Meng, Wei; Jiang, Yan-Fang			A Higher Frequency of Circulating IL-22(+)CD4(+) T Cells in Chinese Patients with Newly Diagnosed Hashimoto's Thyroiditis	PLOS ONE			English	Article							INTERLEUKIN 22; DISTINCT; LINEAGE	Background: IL-22 and IL-17A are implicated in the pathogenesis of autoimmune diseases. However, the role of IL-22(+) and IL-17A(+) CD4(+) T cells in the pathogenesis of Hashimoto's thyroiditis (HT) is not fully understood. This study investigates serum IL-22 and IL-17A levels and determines the frequency of circulating IL-22(+) CD4(+) T cells in HT patients to understand their roles in the pathogenesis of HT. Methods: The levels of serum IL-22, IL-17A and IFN-gamma and the frequency of circulating IL-22(+)D4(+) and IL-17A(+)CD4(+) T cells in 17 HT patients and 17 healthy controls (HC) were determined by enzyme-linked immunosorbent assay (ELISA) and flow cytometry. The levels of serum free triiodothyronine (FT4), free thyroxine (FT3), thyroid stimulating hormone (TSH), antithyroid peroxidase (TPO) and anti-thyroglobulin antibodies (TgAb) by chemiluminescent enzyme immunoassay and radioimmunoassay. Results: The percentages of circulating IL-22(+)CD4(+) and IL-17(+)CD4(+) T cells (p<0.0001, p<0.0001) and the levels of serum IL-22, IL-17A and IFN-gamma (p<0.0001, p<0.0001, p = 0.0210) in the HT patients were significantly higher than that in the HC. The percentages of IL-22(+)CD4(+) T cells were positively correlated with Th17 cells (r = 0.8815, p<0.0001) and IL-17A(+)IL-22(+)CD4(+) T cells (r = 0.8914, p<0.0001), but were negatively correlated with Th1 cells (r = -0.6110, p<0.0092) in the HT patients. The percentages of Th22 cells, Th17 cells and IL-17A(+)IL-22(+)CD4(+) T cells were negatively correlated with the levels of serum TSH in the HT patients (r = -0.8402, p<0.0001; r = -0.8589, p<0.0001; r = -0.8289 p<0.0001, respectively). Conclusions: A higher frequency of circulating IL-22(+)CD4(+) and IL-17A(+)CD4(+) T cells may be associated with the development of HT in Chinese patients.	[Peng, Di; Wang, Ye; Xu, Bing-Chuan; Jiang, Yan-Fang] Jilin Univ, Hosp 1, Dept Cent Lab, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Guo, Hui; Peng, Di; Wang, Ye; Xu, Bing-Chuan] Jilin Univ, Part Hosp 1 2, Dept Endocrinol, Changchun 130023, Peoples R China; [Yang, Xi-Ge] Jilin Univ, Hosp 1, Dept Anesthesiol, Changchun 130023, Peoples R China; [Ni, Jin-Song] Jilin Univ, Part Hosp 1 2, Dept Pathol, Changchun 130023, Peoples R China; [Meng, Wei] Jilin Univ, Hosp 1, Dept Thyroid Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Dept Cent Lab, Key Lab Zoonosis Res, Changchun 130023, Peoples R China.	yanfangjiang@hotmail.com	Wang, Ye/GWQ-7482-2022					Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Bossowski Artur, 2012, Pediatr Endocrinol Diabetes Metab, V18, P89; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kallmann BA, 1997, DIABETES, V46, P237, DOI 10.2337/diabetes.46.2.237; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pavuk M, 2003, ANN EPIDEMIOL, V13, P335, DOI 10.1016/S1047-2797(02)00422-2; Peng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068446; Qin Q, 2012, BRAZ J MED BIOL RES, V45, P1202, DOI 10.1590/S0100-879X2012007500168; Qin WZ, 2011, CLIN EXP MED, V11, P245, DOI 10.1007/s10238-011-0134-9; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Watanabe M, 2002, THYROID, V12, P801, DOI 10.1089/105072502760339370; Xu W, 2013, J NEUROIMMUNOL; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8	19	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84545	10.1371/journal.pone.0084545	http://dx.doi.org/10.1371/journal.pone.0084545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404171	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800050
J	Herrero-Fresno, A; Wallrodt, I; Leekitcharoenphon, P; Olsen, JE; Aarestrup, FM; Hendriksen, RS				Herrero-Fresno, Ana; Wallrodt, Inke; Leekitcharoenphon, Pimlapas; Olsen, John Elmerdahl; Aarestrup, Frank M.; Hendriksen, Rene S.			The Role of the st313-td Gene in Virulence of Salmonella Typhimurium ST313	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INVASIVE NONTYPHOIDAL SALMONELLA; MULTIDRUG-RESISTANCE; CHROMOSOMAL GENES; BIOFILM FORMATION; BACTEREMIA; CHILDREN; INFECTIONS; DUBLIN; CELLS	Multidrug-resistant Salmonella enterica serovar Typhimurium ST313 has emerged in sub-Saharan Africa causing severe infections in humans. Therefore, it has been speculated that this specific sequence type, ST313, carries factors associated with increased pathogenicity. We assessed the role in virulence of a gene with a yet unknown function, st313-td, detected in ST313 through comparative genomics. Additionally, the structure of the genomic island ST313-GI, harbouring the gene was determined. The gene st313-td was cloned into wild type S. Typhimurium 4/74 (4/74-C) as well as knocked out in S. Typhimurium ST313 02-03/002 (Delta st313-td) followed by complementation (02-03/002-C). Delta st313-td was less virulent in mice following i.p. challenge than the wild type and this phenotype could be partly complemented in trans, indicating that st313td plays a role during systemic infection. The gene st313-td was shown not to affect invasion of cultured epithelial cells, while the absence of the gene significantly affects uptake and intracellular survival within macrophages. The gene st313-td was proven to be strongly associated to invasiveness, harboured by 92.5% of S. Typhimurium blood isolates (n = 82) and 100% of S. Dublin strains (n = 50) analysed. On the contrary, S. Typhimurium isolates of animal and food origin (n = 82) did not carry st313-td. Six human, non-blood isolates of S. Typhimurium from Belarus, China and Nepal harboured the gene and belonged to sequence types ST398 and ST19. Our data showed a global presence of the st313-td gene and in other sequence types than ST313. The gene st313-td was shown to be expressed during logarithmic phase of growth in 14 selected Salmonella strains carrying the gene. This study reveals that st313-td plays a role in S. Typhimurium ST313 pathogenesis and adds another chapter to understanding of the virulence of S. Typhimurium and in particular of the emerging sequence type ST313.	[Herrero-Fresno, Ana; Wallrodt, Inke; Olsen, John Elmerdahl] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Herrero-Fresno, Ana; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Herrero-Fresno, Ana; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Herrero-Fresno, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	ahefr@sund.ku.dk	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Herrero Fresno, Ana/GLU-6728-2022; Olsen, John Elmerdahl/N-9271-2019	Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723; Hendriksen, Rene S./0000-0003-2934-8214; Olsen, John Elmerdahl/0000-0001-6225-6587; Herrero-Fresno, Ana/0000-0001-5026-7852	Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	This work was funded by the Center for Genomic Epidemiology (www.genomicepidemiology.org) and by the World Health Organization Global Foodborne Infections Network (www.who.int/gfn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bhatta DR, 2007, LETT APPL MICROBIOL, V44, P588, DOI 10.1111/j.1472-765X.2007.02133.x; Bolton AJ, 1999, MICROBIOL-SGM, V145, P2431, DOI 10.1099/00221287-145-9-2431; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Goh YS, 2013, J IMMUNOL METHODS, V387, P121, DOI 10.1016/j.jim.2012.10.005; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holzer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033220; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Issack MI, 2009, FOODBORNE PATHOG DIS, V6, P739, DOI 10.1089/fpd.2009.0283; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Krauland MG, 2009, EMERG INFECT DIS, V15, P388, DOI 10.3201/eid1503.081131; Kundinger MM, 2008, J RAPID METH AUT MIC, V16, P273, DOI 10.1111/j.1745-4581.2008.00133.x; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Laupland KB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-95; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; Leekitcharoenphon P, 2013, J INFECT DE IN PRESS; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Msefula CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042085; Nyirenda TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013667; OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Tapalski D, 2007, CLIN MICROBIOL INFEC, V13, P1030, DOI 10.1111/j.1469-0691.2007.01795.x; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; Vandenberg O, 2010, PEDIATR INFECT DIS J, V29, P504, DOI 10.1097/INF.0b013e3181cd615a; Wain J, 2013, J INFECT DEV COUNTR, V7, P1, DOI 10.3855/jidc.3080; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995; Wallrodt I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070829; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou QH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-729	57	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84566	10.1371/journal.pone.0084566	http://dx.doi.org/10.1371/journal.pone.0084566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404174	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800053
J	Orr, MT; Beebe, EA; Hudson, TE; Moon, JJ; Fox, CB; Reed, SG; Coler, RN				Orr, Mark T.; Beebe, Elyse A.; Hudson, Thomas E.; Moon, James J.; Fox, Christopher B.; Reed, Steven G.; Coler, Rhea N.			A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93	PLOS ONE			English	Article							INDUCED INTERLEUKIN-12P70 SECRETION; T-CELL RESPONSES; DENDRITIC CELLS; EXPRESSION; PATHWAYS; LIGANDS; FORMULATION; FREQUENCY; CORRELATE; LIGATION	With over eight million cases of tuberculosis each year there is a pressing need for the development of new vaccines against Mycobacterium tuberculosis. Subunit vaccines consisting of recombinant proteins are an attractive vaccine approach due to their inherent safety compared to attenuated live vaccines and the uniformity of manufacture. Addition of properly formulated TLR agonist-containing adjuvants to recombinant protein vaccines enhances the antigen-specific CD4(+) T cell response characterized by IFN-gamma and TNF, both of which are critical for the control of TB. We have developed a clinical stage vaccine candidate consisting of a recombinant fusion protein ID93 adjuvanted with the TLR4 agonist GLA-SE. Here we examine whether ID93+GLA-SE can be improved by the addition of a second TLR agonist. Addition of CpG containing DNA to ID93+GLA-SE enhanced the magnitude of the multi-functional T(H)1 response against ID93 characterized by co-production of IFN-gamma, TNF, and IL-2. Addition of CpG also improved the protective efficacy of ID93+GLA-SE. Finally we demonstrate that this adjuvant synergy between GLA and CpG is independent of TRIF signaling, whereas TRIF is necessary for the adjuvant activity of GLA-SE in the absence of CpG.	[Orr, Mark T.; Beebe, Elyse A.; Hudson, Thomas E.; Fox, Christopher B.; Reed, Steven G.; Coler, Rhea N.] Infect Dis Res Inst, Seattle, WA USA; [Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Moon, James J.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Charlestown, MA USA; [Moon, James J.] Harvard Univ, Sch Med, Charlestown, MA USA; [Coler, Rhea N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Washington; University of Washington Seattle	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	rhea.coler@idri.org	; moon, james/F-1031-2014	Orr, Mark/0000-0003-2684-4722; Fox, Christopher/0000-0002-4644-2619; moon, james/0000-0001-8071-1491	National Institute Of Allergy And Infectious Diseases [U01AI078054, HHSN272200800045C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078054, U19AI095261] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant No. U01AI078054 and Contract No. HHSN272200800045C from the National Institute Of Allergy And Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Coler RN, 2012, J INFECT DIS; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Matthews K, 2012, J IMMUNOL, V189, P5729, DOI 10.4049/jimmunol.1200601; Meyer J, 2013, EXPERT REV VACCINES, V12, P443, DOI [10.1586/ERV.13.19, 10.1586/erv.13.19]; Mitchell D, 2010, J INFECT DIS, V202, P318, DOI 10.1086/653499; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Orr MT, 2013, EUR J IMMUNOL, V43, P2398, DOI 10.1002/eji.201243124; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Rowland R, 2011, EXPERT REV VACCINES, V10, P645, DOI [10.1586/ERV.11.28, 10.1586/erv.11.28]; Schreibelt G, 2010, BLOOD, V116, P564, DOI 10.1182/blood-2009-11-251884; Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293	44	55	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83884	10.1371/journal.pone.0083884	http://dx.doi.org/10.1371/journal.pone.0083884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404140	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800019
J	Sattar, Z; Saberi, MR; Chamani, J				Sattar, Zohreh; Saberi, Mohammad Reza; Chamani, Jamshidkhan			Determination of LMF Binding Site on a HSA-PPIX Complex in the Presence of Human Holo Transferrin from the Viewpoint of Drug Loading on Proteins	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; PROTOPORPHYRIN-IX; 4TH-DERIVATIVE SPECTROPHOTOMETRY; 3-DIMENSIONAL EXCITATION; FLUORESCENCE; RECEPTOR; LOMEFLOXACIN; BEHAVIOR; CELLS; ACID	Holo transferrin (TF) and the natural complex of human serum albumin and protoporphyrin IX (HSA-PPIX) are two serum carrier proteins that can interact with each other. Such an interaction may alter their binding sites. In this study, fluorescence spectroscopy, as well as zeta potential and molecular modeling techniques, have been used to compare the complexes (HSA-PPIX)-LMF and [(HSA-PPIX)-TF]-LMF. The K-a1, K-a2, values of (HSA-PPIX)-LMF and [(HSA-PPIX)-TF]-LMF were 1.1x10(5) M-1, 9.7x10(6) M-1, and 2.0x10(4) M-1, 1.8x10(5) M-1, respectively, and the n(1), n(2) values were respectively 1.19, 1.53 and 1.17, 1.65. The second derivative of the Trp emission scan of (HSA-PPIX)-LMF exhibited one negative band at 310 nm, whereas for the [(HSA-PPIX)-TF]-LMF system, we observed one negative band at 316 nm indicating an increase in polarity around Trp. The effect of TF on the conformation of (HSA-PPIX)-TF was analyzed using three-dimensional fluorescence spectroscopy. The phase diagram indicated that the presence of a second binding site on HSA and TF was due to the existence of intermediate structures. Zeta potential analysis showed that the presence of TF increased the positive charges of the HSA-PPIX system. Site marker experiments revealed that the binding site of LMF to HSA-PPIX changed from Sudlow's site IIA to Sudlow's site IIIB in the presence of TF. Moreover, molecular modeling studies suggested the sub-domain IIIB in HSA as the candidate place for the formation of the binding site of LMF on the (HSA-PPIX)-TF complex.	[Sattar, Zohreh; Chamani, Jamshidkhan] Islamic Azad Univ, Mashhad Branch, Dept Biochem & Biophys, Fac Sci, Mashhad, Iran; [Saberi, Mohammad Reza] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Iran	Islamic Azad University; Mashhad University Medical Science	Chamani, J (corresponding author), Islamic Azad Univ, Mashhad Branch, Dept Biochem & Biophys, Fac Sci, Mashhad, Iran.	chamani@ibb.ut.ac.ir	Chamani, Jamshidkhan/AAC-7481-2019	Chamani, Jamshidkhan/0000-0003-2562-2458	Research Council of the Islamic Azad University Mashhad Branch	Research Council of the Islamic Azad University Mashhad Branch(Islamic Azad University)	The financial support of the Research Council of the Islamic Azad University Mashhad Branch is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhosale SV, 2011, SUPRAMOL CHEM, V23, P263, DOI 10.1080/10610278.2010.523115; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; De Luca G, 2006, J PHYS CHEM B, V110, P7309, DOI 10.1021/jp0530348; De Luca G, 2005, J PHYS CHEM B, V109, P7149, DOI 10.1021/jp0448797; Ding F, 2010, J LUMIN, V130, P2013, DOI 10.1016/j.jlumin.2010.05.019; DUNACH M, 1983, EUR J BIOCHEM, V134, P123, DOI 10.1111/j.1432-1033.1983.tb07540.x; Gallegos ER, 1999, ARCH MED RES, V30, P163, DOI 10.1016/S0188-0128(99)00013-5; Gardner SF, 2003, ANN PHARMACOTHER, V37, P99; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2004, BIOCHEMISTRY-US, V41, P13127; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Liu T, 2011, WATER RES, V45, P2111, DOI 10.1016/j.watres.2010.12.023; Malhotra A, 2004, FOOD HYDROCOLLOID, V18, P101, DOI 10.1016/S0268-005X(03)00047-X; Nanda RK, 2007, J PHOTOCH PHOTOBIO A, V192, P152, DOI 10.1016/j.jphotochem.2007.05.018; Natarajan P, 2004, EUR POLYM J, V40, P2291, DOI 10.1016/j.eurpolymj.2004.06.003; Neault JF, 1998, BBA-PROTEIN STRUCT M, V1384, P153, DOI 10.1016/S0167-4838(98)00011-9; Oliveira AC, 2009, ACTA BIOMATER, V5, P2142, DOI 10.1016/j.actbio.2009.02.019; Ouameur AA, 2004, BIOPOLYMERS, V73, P503, DOI 10.1002/bip.10557; PADROS E, 1984, TRENDS BIOCHEM SCI, V9, P508, DOI 10.1016/0968-0004(84)90272-X; Peng LC, 2010, COLLOID SURFACE A, V370, P136, DOI 10.1016/j.colsurfa.2010.08.060; Purcell M, 2000, BBA-PROTEIN STRUCT M, V1478, P61, DOI 10.1016/S0167-4838(99)00251-4; Quamer AA, 2005, BIOPOLYMERS, V77, P129; Ragi C, 2005, BIOPOLYMERS, V78, P231, DOI 10.1002/bip.20281; Ruilope L, 1997, J HYPERTENS, V15, pS15; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P187, DOI 10.1016/j.jphotobiol.2008.01.001; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; Subramanian B, 2008, INT IMMUNOPHARMACOL, V8, P1533, DOI 10.1016/j.intimp.2008.06.009; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; Visser CC, 2004, J DRUG TARGET, V12, P145, DOI 10.1080/10611860410001701706; Wang J, 2008, SPECTROCHIM ACTA A, V69, P956, DOI 10.1016/j.saa.2007.05.057; Wang YQ, 2008, J MOL STRUCT, V886, P77, DOI 10.1016/j.molstruc.2007.10.039; Wang ZW, 2009, WATER RES, V43, P1533, DOI 10.1016/j.watres.2008.12.033; Yuan JL, 2007, J PHOTOCH PHOTOBIO A, V191, P104, DOI 10.1016/j.jphotochem.2007.04.010; Zhang DY, 2010, J HAZARD MATER, V175, P359, DOI 10.1016/j.jhazmat.2009.10.011; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002; Zhang MX, 2004, J AM SOC MASS SPECTR, V15, P1658, DOI 10.1016/j.jasms.2004.08.009; Zhang Y, 2005, J PHYS CHEM A, V109, P7442, DOI 10.1021/jp050516a; Zhao Y, 2009, J COLLOID INTERF SCI, V332, P345, DOI 10.1016/j.jcis.2008.12.048	47	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84045	10.1371/journal.pone.0084045	http://dx.doi.org/10.1371/journal.pone.0084045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392106	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100030
J	Nakimuli, A; Elliott, AM; Kaleebu, P; Moffett, A; Mirembe, F				Nakimuli, Annettee; Elliott, Alison M.; Kaleebu, Pontiano; Moffett, Ashley; Mirembe, Florence			Hypertension Persisting after Pre-Eclampsia: A Prospective Cohort Study at Mulago Hospital, Uganda	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; FETAL HLA-C; RISK-FACTORS; CARDIOVASCULAR SEQUELAE; MATERNAL KIR; PREGNANCY; WOMEN; MORTALITY; MOTHERS; POPULATION	Background: Pre-eclampsia/eclampsia usually resolves after delivery but sometimes hypertension persists and cardiovascular disease develops later. Our objective was to determine the incidence and maternal socio-demographic and obstetric risk factors for persistence of hypertension in women with pre-eclampsia/eclampsia. Methods: This was a prospective cohort study conducted from July 2009 to June 2011 at Mulago Hospital labour ward and postnatal clinics. We followed up 188 women admitted with pre-eclampsia/eclampsia until 3 months after delivery. Data was collected using interviewer-administered questionnaires, examination of participants and review of medical records. Stata (version12) software was used for data analysis. Univariable analysis was used to compute the relative risk of persistent hypertension at the 95% confidence level. This was followed by multivariable logistic regression analysis to determine factors independently associated with persistence of hypertension. Results: 64 (34%) out of the 188 women analysed had persistent hypertension three months after delivery. Maternal age, gestational age at delivery and parity were predictors of persistent hypertension. Conclusion: The proportion of women with pre-eclampsia/eclampsia at risk of persistent hypertension at three months after delivery was high, with nearly one of three mothers remaining hypertensive. Follow up of mothers who develop pre-eclampsia is important so that early diagnosis and management of chronic hypertension can be made to avoid long term morbidity and mortality.	[Nakimuli, Annettee; Mirembe, Florence] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Kampala, Uganda; [Elliott, Alison M.; Kaleebu, Pontiano] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Elliott, Alison M.] London Sch Hyg & Trop Med, London WC1, England; [Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Moffett, Ashley] Ctr Trophoblast Res, Cambridge, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Cambridge	Nakimuli, A (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Kampala, Uganda.	annettee.nakimuli@gmail.com		Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; Wellcome Trust Strategic Award [084344]; Centre for Trophoblast Research at the University of Cambridge	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; Wellcome Trust Strategic Award(Wellcome Trust); Centre for Trophoblast Research at the University of Cambridge	This work was funded by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by Annettee Nakimuli, funded by a Wellcome Trust Strategic Award, grant number 084344 and by the Centre for Trophoblast Research at the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Berg CJ, 2003, OBSTET GYNECOL, V101, P289, DOI 10.1016/S0029-7844(02)02587-5; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Carr DB, 2009, HYPERTENS PREGNANCY, V28, P435, DOI 10.3109/10641950802629675; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cunningham G.F., 2005, WILLIAMS OBSTET, V22nd ed., DOI [10.1097/00001888-193609000-00027, DOI 10.1097/00001888-193609000-00027]; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Drost JT, 2010, MATURITAS, V67, P321, DOI 10.1016/j.maturitas.2010.08.002; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; FRIEDMAN SA, 1995, AM J OBSTET GYNECOL, V172, P1785, DOI 10.1016/0002-9378(95)91412-9; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Haapanen N, 1997, AM J EPIDEMIOL, V145, P762, DOI 10.1093/aje/145.8.762; Hannaford P, 1997, HEART, V77, P154, DOI 10.1136/hrt.77.2.154; Harskamp RE, 2007, AM J MED SCI, V334, P291, DOI 10.1097/MAJ.0b013e3180a6f094; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; IRWIN DE, 1994, AM J PUBLIC HEALTH, V84, P1508, DOI 10.2105/AJPH.84.9.1508; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Kaye D, 2003, East Afr Med J, V80, P144; Kelsey JL., 1996, METHODS OBSERVATIONA; Kestenbaum B, 2003, AM J KIDNEY DIS, V42, P982, DOI 10.1016/j.ajkd.2003.07.001; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klungsoyr K, 2012, PAEDIATR PERINAT EP, V26, P190, DOI 10.1111/j.1365-3016.2012.01260.x; Knuist M, 1998, OBSTET GYNECOL, V92, P174, DOI 10.1016/S0029-7844(98)00143-4; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lazzarin N, 2012, PREGNANCY HYPERTENS, V2, P393, DOI 10.1016/j.preghy.2012.02.002; Libby G, 2007, DIABETOLOGIA, V50, P523, DOI 10.1007/s00125-006-0558-z; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Mittendorf R, 1996, J REPROD MED, V41, P491; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett A, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P92; Mostello D, 2002, AM J OBSTET GYNECOL, V187, P425, DOI 10.1067/mob.2002.123608; Mufunda J, 2006, ETHNIC DIS, V16, P521; Nakimuli A, 2013, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2013.10.879, DOI 10.1016/J.AJ0G.2013.10.879]; Ndayambagye EB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-12; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P114, DOI [10.1038/ncpneph0035, DOI 10.1038/NCPNEPH0035.PUBMED:16932375]; North RA, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P243; Norwitz ER, 1999, CLIN OBSTET GYNECOL, V42, P436, DOI 10.1097/00003081-199909000-00003; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Redman C, 2007, PREECLAMPSIA, P114; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1991, AM J OBSTET GYNECOL, V165, P1408; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Williams B, 2010, OXFORD TXB MED; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; World Health Organization, 2005, WORLD HLTH REP 2005	59	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85273	10.1371/journal.pone.0085273	http://dx.doi.org/10.1371/journal.pone.0085273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392003	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000329323900146
J	Won, YJ; Park, JW; Han, SH; Cho, HG; Kang, LH; Lee, SG; Ryu, SR; Paik, SY				Won, Yu-Jung; Park, Jeong-Woong; han, Sang-ha; Cho, Han-Gil; Kang, Lae-Hyung; Lee, Sung-Geun; Ryu, Sang-Ryeol; Paik, Soon-Young			Full-Genomic Analysis of a Human Norovirus Recombinant GII.12/13 Novel Strain Isolated from South Korea	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; RT-PCR; OUTBREAKS; CHILDREN; EMERGENCE; SEQUENCE; VARIANT; INFECTIONS	Norovirus (NoV) genogroups I and II are frequently recognized as the main causes of acute gastroenteritis and outbreaks of non-bacterial foodborne diseases. Furthermore, variants and recombinant strains of this virus are continuously emerging worldwide. The aim of this study was to identify NoV strains and to investigate and characterize rare genotypes. Stool samples (n = 500) were collected from patients with symptoms of acute gastroenteritis in Korea between December 2004 and November 2007. For analysis of the samples, rapid genotype screening was performed using reverse transcriptase-polymerase chain reaction. Full sequencing, using a newly designed set of 12 primers, revealed GII-12/13 strain. The partial sequence of GII-12/13 strain was compared with published NoV (GII-1 - 14) sequences targeting RdRp and capsid regions using phylogenetic analysis with the SimPlot program, which could evaluate recombination breakpoints. SimPlot analysis was also performed with the strain GII-12/Gifu-96/JPN (AB045603) for the RdRp region and with GII-13/G5175B-83/AUS(DQ379714) for the capsid region. NoV was detected in 19 of the 500 stool samples (3.8%). Genogroup GII-4 was found most frequently (n = 9, 1.8%), followed by GII-3 (n = 4, 0.8%), GII-6 (n = 3, 0.6%), GI-6 (n = 2, 0.4%), and GII-12/13 (n = 1, 0.2%). Importantly, we identified a novel NoV recombinant strain, C9-439 (KF289337), indicating potential risks, which suggested that, recombination occurred in the region between open reading frames 1 and 2 of the GII-12/13 strain and that breakpoints occurred in the polymerase region.	[Won, Yu-Jung; han, Sang-ha; Kang, Lae-Hyung; Paik, Soon-Young] Catholic Univ Korea, Dept Microbiol, Coll Med, Seoul, South Korea; [Park, Jeong-Woong; Ryu, Sang-Ryeol] Seoul Natl Univ, Dept Food & Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea; [Park, Jeong-Woong; Ryu, Sang-Ryeol] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Cho, Han-Gil] Gyeonggi Prov Res Inst Publ Hlth & Environm, Div Virol, Suwon, South Korea; [Lee, Sung-Geun] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Jeonju, South Korea	Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Jeonbuk National University	Paik, SY (corresponding author), Catholic Univ Korea, Dept Microbiol, Coll Med, Seoul, South Korea.	paik@catholic.ac.kr			Mid-career Researcher Program from the Environmental Industry & Technology Institute [2012R1A2A2A01045078]; GAIA project from the Environmental Industry & Technology Institute [2013000550009]	Mid-career Researcher Program from the Environmental Industry & Technology Institute; GAIA project from the Environmental Industry & Technology Institute	This work was supported by the Mid-career Researcher Program (2012R1A2A2A01045078) and GAIA project (2013000550009) from the Environmental Industry & Technology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Buesa J, 2002, J CLIN MICROBIOL, V40, P2854, DOI 10.1128/JCM.40.8.2854-2859.2002; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chhabra P, 2010, INFECT GENET EVOL, V10, P1101, DOI 10.1016/j.meegid.2010.07.007; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fretz R, 2005, EPIDEMIOL INFECT, V133, P429, DOI 10.1017/S0950268804003619; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Hohne M, 2004, J MED VIROL, V72, P312, DOI 10.1002/jmv.10573; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; Kim SH, 2005, J CLIN MICROBIOL, V43, P4836, DOI 10.1128/JCM.43.9.4836-4839.2005; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Kostela J, 2008, J VIROL METHODS, V149, P226, DOI 10.1016/j.jviromet.2008.02.001; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Lee SG, 2011, APPL ENVIRON MICROB, V77, P1466, DOI 10.1128/AEM.01996-10; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Nataraju SM, 2011, INT J MOL EPIDEMIOL, V2, P130; Park JW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-167; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07; Yun SI, 2010, VIRUS RES, V152, P137, DOI 10.1016/j.virusres.2010.06.018; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; 함희진, 2012, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V38, P57	37	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85063	10.1371/journal.pone.0085063	http://dx.doi.org/10.1371/journal.pone.0085063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391985	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900128
J	Luo, SL; Zhangsun, DT; Schroeder, CI; Zhu, XP; Hu, YY; Wu, Y; Weltzin, MM; Eberhard, S; Kaas, Q; Craik, DJ; McIntosh, JM; Whiteaker, P				Luo, Sulan; Zhangsun, Dongting; Schroeder, Christina I.; Zhu, Xiaopeng; Hu, Yuanyan; Wu, Yong; Weltzin, Maegan M.; Eberhard, Spencer; Kaas, Quentin; Craik, David J.; McIntosh, J. Michael; Whiteaker, Paul			A novel alpha 4/7-conotoxin LvIA from Conus lividus that selectively blocks alpha 3 beta 2 vs. alpha 6/alpha 3 beta 2 beta 3 nicotinic acetylcholine receptors	FASEB JOURNAL			English	Article						nuclear magnetic resonance spectroscopy; cholinergic; ligand-gated ion channel receptor; molecular modeling	SPIN COUPLING-CONSTANTS; DISULFIDE BOND ISOMERS; ALPHA-CONOTOXIN-MII; SUBUNIT COMPOSITION; PROTEIN; ALPHA-9-ALPHA-10; BINDING; PEPTIDES; TARGETS; TOOLS	This study was performed to discover and characterize the first potent alpha 3 beta 2-subtype-selective nicotinic acetylcholine receptor (nAChR) ligand. A novel alpha 4/7-conotoxin, alpha-CTxLvIA, was cloned from Conus lividus. Its pharmacological profile at Xenopus laevis oocyte-expressed rat nAChR subtypes was determined by 2-electrode voltage-clamp electrophysiology, and its 3-dimensional (3D) structure was determined by NMR spectroscopy. alpha-CTx LvIA is a 16-aa C-terminally-amidated peptide with 2-disulfide bridges. Using rat subunits expressed in Xenopus oocytes, we found the highest affinity of alpha-CTxLvIA was for alpha 3 beta 2 nAChRs (IC50 8.7 nM), where blockade was reversible within 2 min. IC50 values were > 100 nM at alpha 6/alpha 3 beta 2 beta 3, alpha 6/alpha 3 beta 4, and alpha 3 beta 4 nAChRs, and >= 3 mu M at all other subtypes tested. alpha 3 beta 2 vs. alpha 6 beta 2 subtype selectivity was confirmed for human-subunit nAChRs with much greater preference (300-fold) for alpha 3 beta 2 over alpha 6 beta 2 nAChRs. This is the first alpha-CTx reported to show high selectivity for human alpha 3 beta 2 vs. alpha 6 beta 2 nAChRs. alpha-CTxLvIA adopts two similarly populated conformations water: one (assumed to be bioactive) is highly structured, whereas the other is mostly random coil in nature. Selectivity differences with the similarly potent, but less selective, alpha 3 beta 2 nAChR antagonist alpha-CTx PeIA probably reside within the three residues, which differ in loop 2, given their otherwise similar 3D structures. alpha 4/7-CTx LvIA is a new, potent, selective alpha 3 beta 2 nAChR antagonist, which will enable detailed studies of alpha 3 beta 2 nAChR structure, function, and physiological roles.-Luo, S., Zhangsun, D., Schroeder, C. I., Zhu, X., Hu, Y., Wu, Y., Weltzin, M. M., Eberhard, S., Kaas, Q., Craik, D. J., McIntosh, J. M., Whiteaker, P. A novel alpha 4/7-conotoxin LvIA from Conus lividus that selectively blocks alpha 3 beta 2 vs. alpha 6/alpha 3 beta 2 beta 3 nicotinic acetylcholine receptors.	[Luo, Sulan; Zhangsun, Dongting; Zhu, Xiaopeng; Hu, Yuanyan; Wu, Yong] Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Key Lab Marine Drug Haikou, Haikou 570228, Hainan, Peoples R China; [Schroeder, Christina I.; Kaas, Quentin; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Weltzin, Maegan M.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Eberhard, Spencer] Brigham Young Univ, Dept Biol, Rexburg, ID USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA	Hainan University; University of Queensland; Barrow Neurological Institute; Brigham Young University; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Luo, SL (corresponding author), Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Haikou 570228, Hainan, Peoples R China.	luosulan2003@163.com	Craik, David/B-1695-2010; Schroeder, Cristina I./K-2042-2014; Kaas, Quentin/J-8727-2014	Craik, David/0000-0003-0007-6796; Schroeder, Cristina I./0000-0002-6737-6374; Kaas, Quentin/0000-0001-9988-6152	National Natural Science Foundation of China [81160503, 41366002]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; Program for International Science and Technology Cooperation Program of China [2011DFR31210]; Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1123]; U.S. National Institutes of Health [DA012242, GM103801, GM48677]; Australian Research Council [1093115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012242] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; Program for International Science and Technology Cooperation Program of China; Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by the National Natural Science Foundation of China, grants 81160503 and 41366002; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China, grant 2012AA021706; Program for International Science and Technology Cooperation Program of China, grant 2011DFR31210; and Changjiang Scholars and Innovative Research Team in University, grants PCSIRT and IRT1123. This work was also supported by U.S. National Institutes of Health grants DA012242, GM103801, and GM48677, and Australian Research Council grant 1093115. D.J.C. is an Australian National Health and Medical Research Council Professorial Fellow (APP1026501). A preliminary account of some of this work was presented in the patent literature (76).	Armishaw CJ, 2010, BIOPOLYMERS, V94, P307, DOI 10.1002/bip.21360; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Daly NL, 2011, J BIOL CHEM, V286, P10233, DOI 10.1074/jbc.M110.196170; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dowell C, 2003, J NEUROSCI, V23, P8445; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jacobsen RB, 1999, BIOCHEMISTRY-US, V38, P13310, DOI 10.1021/bi9907476; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kasheverov IE, 2009, CURR PHARM DESIGN, V15, P2430, DOI 10.2174/138161209788682316; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Luo S., 2012, Chinese Pat. Lit. CN, Patent No. [201210347966. 3, 2012103479663]; Luo Su-lan, 2004, Zhongguo Haiyang Yaowu, V23, P21; Luo SL, 2013, J BIOL CHEM, V288, P894, DOI 10.1074/jbc.M112.427898; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; McClure-Begley TD, 2012, J NEUROCHEM, V122, P48, DOI 10.1111/j.1471-4159.2012.07759.x; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Nicke A, 2004, EUR J BIOCHEM, V271, P2305, DOI 10.1111/j.1432-1033.2004.04145.x; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Peng C, 2009, ACTA BIOCH BIOPH SIN, V41, P858, DOI 10.1093/abbs/gmp077; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Teichert RW, 2006, BIOCHEMISTRY-US, V45, P1304, DOI 10.1021/bi052016d; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Young T, 2008, BRAIN RES, V1229, P118, DOI 10.1016/j.brainres.2008.06.086; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011; [郑晓冬 ZHENG Xiaodong], 2011, [生物技术, Biotechnology], V21, P40	80	47	53	1	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1842	1853		10.1096/fj.13-244103	http://dx.doi.org/10.1096/fj.13-244103			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24398291	Green Published			2022-12-25	WOS:000335344300029
J	Neill, T; Torres, A; Buraschi, S; Owens, RT; Hoek, JB; Baffa, R; Iozzo, RV				Neill, Thomas; Torres, Annabel; Buraschi, Simone; Owens, Rick T.; Hoek, Jan B.; Baffa, Raffaele; Iozzo, Renato V.			Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator- activated Receptor gamma Coactivator-1 alpha ( PGC-1 alpha) and Mitostatin*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Extracellular Matrix; Mitochondria; Proteoglycan; Receptor-tyrosine Kinase; Beclin 1; Mitochondrial Membrane Potential; Mitochondrial Respiratory Chain Complexes; Small Leucine-rich Proteoglycan	LEUCINE-RICH PROTEOGLYCANS; EPIDERMAL-GROWTH-FACTOR; CANCER GROWTH; COLLAGEN FIBRILLOGENESIS; TUMOR MICROENVIRONMENT; ANDROGEN RECEPTOR; METABOLISM; GENE; INHIBITION; THROMBOSPONDIN-1	Background: Decorin functions as a soluble tumor repressor via binding receptor-tyrosine kinases, such as Met, to curb rampant tumor neovascularization. Results: Decorin evokes tumor cell mitophagy through dynamic co-regulation of PGC-1 and mitostatin via physical interactions between PGC-1 and mitostatin Conclusion: Decorin requires mitostatin to evoke mitophagy as the underlying basis for angiogenic attenuation. Significance: We have identified mitostatin as a novel mitophagic effector. Tumor cell mitochondria are key biosynthetic hubs that provide macromolecules for cancer progression and angiogenesis. Soluble decorin protein core, hereafter referred to as decorin, potently attenuated mitochondrial respiratory complexes and mitochondrial DNA (mtDNA) in MDA-MB-231 breast carcinoma cells. We found a rapid and dynamic interplay between peroxisome proliferator-activated receptor coactivator-1 (PGC-1) and the decorin-induced tumor suppressor gene, mitostatin. This interaction stabilized mitostatin mRNA with concurrent accumulation of mitostatin protein. In contrast, siRNA-mediated abrogation of PGC-1-blocked decorin-evoked stabilization of mitostatin. Mechanistically, PGC-1 bound MITOSTATIN mRNA to achieve rapid stabilization. These processes were orchestrated by the decorin/Met axis, as blocking the Met-tyrosine kinase or knockdown of Met abrogated these responses. Furthermore, depletion of mitostatin blocked decorin- or rapamycin-evoked mitophagy, increased vascular endothelial growth factor A (VEGFA) production, and compromised decorin-evoked VEGFA suppression. Collectively, our findings underscore the complexity of PGC-1-mediated mitochondrial homeostasis and establish mitostatin as a key regulator of tumor cell mitophagy and angiostasis.	[Neill, Thomas; Torres, Annabel; Buraschi, Simone; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Neill, Thomas; Torres, Annabel; Buraschi, Simone; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Baffa, Raffaele] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Buraschi, Simone/0000-0002-4233-7627; Hoek, Jan/0000-0001-7127-4218	National Institutes of Health Grants [RO1 CA39481, RO1 CA47282, RO1 CA164462]; National Institutes of Health Training Grant [T32 AA07463]; Diversity Research Supplement National Institutes of Health Grant [CA39481-26S1]; NATIONAL CANCER INSTITUTE [R01CA047282, P30CA056036, R01CA164462, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity Research Supplement National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). This work is in partial fulfillment of the doctoral theses of T. Neill and A. Torres in Cell and Developmental Biology, Thomas Jefferson University.; Supported by National Institutes of Health Training Grant T32 AA07463.; Supported by a Diversity Research Supplement National Institutes of Health Grant CA39481-26S1.	Araki K, 2009, ONCOLOGY-BASEL, V77, P92, DOI 10.1159/000228253; Baghy K, 2013, FEBS J, V280, P2150, DOI 10.1111/febs.12215; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; Buraschi S, 2012, PLOS ONE, V7; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dunkman AA, 2013, MATRIX BIOL, V32, P3, DOI 10.1016/j.matbio.2012.11.005; Fassan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019771; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jarvinen TAH, 2010, P NATL ACAD SCI USA, V107, P21671, DOI 10.1073/pnas.1016233107; Kalas W, 2005, CANCER RES, V65, P8878, DOI 10.1158/0008-5472.CAN-05-1479; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Murphy-Ullrich JE, 2012, MATRIX BIOL, V31, P152, DOI 10.1016/j.matbio.2012.01.002; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nikitovic D, 2012, J BIOL CHEM, V287, P33926, DOI 10.1074/jbc.R112.379602; Perdomo G, 2008, J BIOL CHEM, V283, P13700, DOI 10.1074/jbc.M707551200; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; SCHMIDT B, 1983, J CELL BIOL, V96, P248, DOI 10.1083/jcb.96.1.248; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Shintani K, 2008, ONCOL REP, V19, P1533; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	78	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4952	4968		10.1074/jbc.M113.512566	http://dx.doi.org/10.1074/jbc.M113.512566			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403067	Green Published, hybrid			2022-12-25	WOS:000331607900041
J	Marino, JL; Moore, VM; Willson, KJ; Rumbold, A; Whitrow, MJ; Giles, LC; Davies, MJ				Marino, Jennifer L.; Moore, Vivienne M.; Willson, Kristyn J.; Rumbold, Alice; Whitrow, Melissa J.; Giles, Lynne C.; Davies, Michael J.			Perinatal Outcomes by Mode of Assisted Conception and Sub-Fertility in an Australian Data Linkage Cohort	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; LOW-BIRTH-WEIGHT; REPRODUCTIVE TECHNOLOGIES; SINGLETON PREGNANCIES; CRYOPRESERVED EMBRYOS; PRETERM DELIVERY; GESTATIONAL-AGE; CHILDREN BORN; TWIN BIRTHS; INFERTILITY	Background: Fertility treatment is associated with increased risk of major birth defects, which varies between in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), and is significantly reduced by embryo freezing. We therefore examined a range of additional perinatal outcomes for these exposures. Methods: All patients in South Australia receiving assisted conception between Jan 1986-Dec 2002 were linked to the state-wide perinatal collection (all births/stillbirths >= 20 weeks gestation or 400 g birth weight, n = 306 995). We examined stillbirth, mean birth weight, low birth weight (, 2500 g, <1500 g), small size for gestational age (<10th percentile, <3rd percentile), large size for gestational age (>90th percentile), preterm birth (32-<37 weeks, <32 weeks gestation), postterm birth (>= 41 weeks gestation), Apgar <7 at 5 minutes and neonatal death. Results: Relative to spontaneous conceptions, singletons from assisted conception were more likely to be stillborn (OR = 1.82, 95% Confidence Interval (CI) 1.34-2.48), while survivors as a group were comprehensively disadvantaged at birth, including lower birth weight (2109 g, CI -129--89), very low birth weight (OR = 2.74, CI 2.19-3.43), very preterm birth (OR = 2.30, CI 1.82-2.90) and neonatal death (OR = 2.04, CI 1.27-3.26). Outcomes varied by type of assisted conception. Very low and low birth weight, very preterm and preterm birth, and neonatal death were markedly more common in singleton births from IVF and to a lesser degree, in births from ICSI. Using frozen-embryos eliminated all significant adverse outcomes associated with ICSI but not with IVF. However, frozen-embryo cycles were also associated with increased risk of macrosomia for IVF and ICSI singletons (OR = 1.36, CI 1.02-1.82; OR = 1.55, CI 1.05-2.28). Infertility status without treatment was also associated with adverse outcomes. Conclusions: Births after assisted conception show an extensive range of compromised outcomes that vary by treatment modality, that are substantially reduced after embryo freezing, but which co-occur with an increased risk of macrosomia.	[Marino, Jennifer L.] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Moore, Vivienne M.; Willson, Kristyn J.; Whitrow, Melissa J.; Giles, Lynne C.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Moore, Vivienne M.; Rumbold, Alice; Whitrow, Melissa J.; Giles, Lynne C.; Davies, Michael J.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Rumbold, Alice; Davies, Michael J.] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	University of Melbourne; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Davies, MJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	michael.davies@adelaide.edu.au	Davies, Michael John/Y-3542-2018; Davies, Michael/GWV-2527-2022; Marino, Jennifer L/O-2909-2017	Davies, Michael John/0000-0003-1526-0801; Marino, Jennifer L/0000-0001-6742-1940; Giles, Lynne/0000-0001-9054-9088	National Health and Medical Research Council [349475, 349548, 453556, 465455]; Australian Research Council [FT100101018]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by grants from the National Health and Medical Research Council (349475, 349548, 453556, and 465455) and the Australian Research Council (FT100101018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addor V, 1998, FERTIL STERIL, V69, P210, DOI 10.1016/S0015-0282(97)00468-8; Ananth CV, 2005, ANN EPIDEMIOL, V15, P293, DOI 10.1016/j.annepidem.2004.08.007; Axmon A, 2005, FERTIL STERIL, V84, P966, DOI 10.1016/j.fertnstert.2005.04.030; Barnhart KT, 2013, FERTIL STERIL, V99, P299, DOI 10.1016/j.fertnstert.2012.12.032; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Boulet SL, 2008, HUM REPROD, V23, P1941, DOI 10.1093/humrep/den169; Bower C, 2005, REPROD FERT DEVELOP, V17, P329, DOI 10.1071/RD04095; Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; De Geyter C, 2006, HUM REPROD, V21, P705, DOI 10.1093/humrep/dei378; Fujii M, 2010, FERTIL STERIL, V94, P2113, DOI 10.1016/j.fertnstert.2009.12.031; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jaques AM, 2010, FERTIL STERIL, V94, P2674, DOI 10.1016/j.fertnstert.2010.02.043; Kallen B, 2005, FERTIL STERIL, V84, P611, DOI 10.1016/j.fertnstert.2005.02.038; Kallen B, 2010, BJOG-INT J OBSTET GY, V117, P676, DOI 10.1111/j.1471-0528.2010.02517.x; Kallen B, 2010, HUM REPROD, V25, P1026, DOI 10.1093/humrep/deq003; Klemetti R, 2010, FERTIL STERIL, V93, P1157, DOI 10.1016/j.fertnstert.2008.12.025; Macaldowie A, 2012, ASSISTED REPROD TECH; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; Marino JL, 2011, HUM REPROD, V26, P473, DOI 10.1093/humrep/deq305; Myers E, 2008, 167 AG HEALTHC RES Q; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Roberts CL, 1999, J PAEDIATR CHILD H, V35, P278, DOI 10.1046/j.1440-1754.1999.00354.x; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Shebl O, 2008, J REPROD MED, V53, P798; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; South Australian Council on Reproductive Technology, 2007, ANN REP MIN HLTH; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; WADA I, 1994, HUM REPROD, V9, P543, DOI 10.1093/oxfordjournals.humrep.a138542; WANG JX, 1994, HUM REPROD, V9, P141, DOI 10.1093/oxfordjournals.humrep.a138304; Wang YA, 2005, FERTIL STERIL, V83, P1650, DOI 10.1016/j.fertnstert.2004.12.033; Wennerholm UB, 2013, HUM REPROD, V28, P2545, DOI 10.1093/humrep/det272; Wennerholm UB, 2009, ACTA OBSTET GYN SCAN, V88, P6, DOI 10.1080/00016340802555948; Wisborg K, 2010, HUM REPROD, V25, P1312, DOI 10.1093/humrep/deq023; Wisborg K, 2010, FERTIL STERIL, V94, P2102, DOI 10.1016/j.fertnstert.2010.01.014; Zhu JL, 2007, OBSTET GYNECOL, V110, P1326, DOI 10.1097/01.AOG.0000290330.80256.97	45	91	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e80398	10.1371/journal.pone.0080398	http://dx.doi.org/10.1371/journal.pone.0080398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416127	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500007
J	Meng, J; Li, Y; Camarillo, C; Yao, Y; Zhang, YN; Xu, C; Jiang, LH				Meng, Jia; Li, Yan; Camarillo, Cynthia; Yao, Yue; Zhang, Yina; Xu, Chun; Jiang, Lihong			The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERACTION NETWORKS; CASCADE HYPOTHESIS; PROTEIN; THERAPEUTICS; VISUALIZATION; MECHANISMS; EXPRESSION; CYTOSCAPE	With the trend of an increasing aged population worldwide, Alzheimer's disease (AD), an age-related neurodegenerative disorder, as one of the major causes of dementia in elderly people is of growing concern. Despite the many hard efforts attempted during the past several decades in trying to elucidate the pathological mechanisms underlying AD and putting forward potential therapeutic strategies, there is still a lack of effective treatments for AD. The efficacy of many potential therapeutic drugs for AD is of main concern in clinical practice. For example, large bodies of evidence show that the antitumor histone deacetylase (HDAC) inhibitor, suberoylanilidehydroxamic acid (SAHA), may be of benefit for the treatment of AD; however, its extensive inhibition of HDACs makes it a poor therapeutic. Moreover, the natural flavonoid, curcumin, may also have a potential therapeutic benefit against AD; however, it is plagued by low bioavailability. Therefore, the integrative effects of SAHA and curcumin were investigated as a protection against amyloid-beta neurotoxicity in vitro. We hypothesized that at low doses their synergistic effect would improve therapeutic selectivity, based on experiments that showed that at low concentrations SAHA and curcumin could provide comprehensive protection against A beta(25-35)-induced neuronal damage in PC12 cells, strongly implying potent synergism. Furthermore, network analysis suggested that the possible mechanism underlying their synergistic action might be derived from restoration of the damaged functional link between Akt and the CBP/p300 pathway, which plays a crucial role in the pathological development of AD. Thus, our findings provided a feasible avenue for the application of a synergistic drug combination, SAHA and curcumin, in the treatment of AD.	[Meng, Jia; Yao, Yue; Zhang, Yina; Jiang, Lihong] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Heilongjiang, Peoples R China; [Li, Yan] Harbin Med Univ, Affiliated Hosp 4, Dept Pharm, Harbin, Heilongjiang, Peoples R China; [Camarillo, Cynthia; Xu, Chun] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Neurosci, El Paso, TX USA	Harbin Medical University; Harbin Medical University; Texas Tech University System; Texas Tech University	Zhang, YN (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Heilongjiang, Peoples R China.	yinazhlu@163.com; jianglihong2006@163.com			Heilongjiang Province Foundation for Returnees [LC2009C13]; Foundation of Heilongjiang Educational Committee [12521z019]	Heilongjiang Province Foundation for Returnees; Foundation of Heilongjiang Educational Committee	This study was supported by Heilongjiang Province Foundation for Returnees (LC2009C13) and Foundation of Heilongjiang Educational Committee (12521z019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bajda M, 2011, CURR MED CHEM, V18, P4949, DOI 10.2174/092986711797535245; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain S, 2010, NEURON, V68, P207, DOI 10.1016/j.neuron.2010.10.010; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Korzus E, 2010, NAT NEUROSCI, V13, P405, DOI 10.1038/nn0410-405; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu RG, 2012, NEUROBIOL DIS, V45, P902, DOI 10.1016/j.nbd.2011.12.007; Lopez Oscar L, 2011, Am J Manag Care, V17 Suppl 13, pS339; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Patel L, 2011, DRUG AGING, V28, P539, DOI 10.2165/11591860-000000000-00000; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Sabbagh M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-21; Satoh J, 2009, DIS MARKERS, V27, P239, DOI [10.1155/2009/618619, 10.3233/DMA-2009-0670]; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; de la Torre AV, 2013, PHARMACOL RES, V70, P116, DOI 10.1016/j.phrs.2013.01.007; Vlasblom J, 2006, BIOINFORMATICS, V22, P2178, DOI 10.1093/bioinformatics/btl356; Wang YL, 2013, AM J CHINESE MED, V41, P59, DOI 10.1142/S0192415X13500055; Xu K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/143269; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	42	30	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85570	10.1371/journal.pone.0085570	http://dx.doi.org/10.1371/journal.pone.0085570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409332	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500056
J	Williams, DM; Quinn, ACD; Porter, WF				Williams, David M.; Quinn, Amy C. Dechen; Porter, William F.			Informing Disease Models with Temporal and Spatial Contact Structure among GPS-Collared Individuals in Wild Populations	PLOS ONE			English	Article							WHITE-TAILED DEER; FACIAL TUMOR DISEASE; SARCOPHILUS-HARRISII; RABIES SPREAD; HOME RANGES; RATES; TRANSMISSION; DYNAMICS; BEHAVIOR; SEASONALITY	Contacts between hosts are essential for transmission of many infectious agents. Understanding how contacts, and thus transmission rates, occur in space and time is critical to effectively responding to disease outbreaks in free-ranging animal populations. Contacts between animals in the wild are often difficult to observe or measure directly. Instead, one must infer contacts from metrics such as proximity in space and time. Our objective was to examine how contacts between white-tailed deer (Odocoileus virginianus) vary in space and among seasons. We used GPS movement data from 71 deer in central New York State to quantify potential direct contacts between deer and indirect overlap in space use across time and space. Daily probabilities of direct contact decreased from winter (0.05-0.14), to low levels post-parturition through summer (0.00-0.02), and increased during the rut to winter levels. The cumulative distribution for the spatial structure of direct and indirect contact probabilities around a hypothetical point of occurrence increased rapidly with distance for deer pairs separated by 1,000 m - 7,000 m. Ninety-five percent of the probabilities of direct contact occurred among deer pairs within 8,500 m of one another, and 99% within 10,900 m. Probabilities of indirect contact accumulated across greater spatial extents: 95% at 11,900 m and 99% at 49,000 m. Contacts were spatially consistent across seasons, indicating that although contact rates differ seasonally, they occur proportionally across similar landscape extents. Distributions of contact probabilities across space can inform management decisions for assessing risk and allocating resources in response.	[Williams, David M.; Quinn, Amy C. Dechen; Porter, William F.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Williams, DM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	dmwill@msu.edu			New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project [W-173-G]; United States Geological Survey; McIntire-Stennis Foundation at SUNY-ESF	New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project; United States Geological Survey(United States Geological Survey); McIntire-Stennis Foundation at SUNY-ESF	Funding for this project was provided by the New York State Department of Environmental Conservation (NYSDEC) with partial support from the United States Federal Aid in Wildlife Restoration Project W-173-G. Additional support was provided by the United States Geological Survey and the McIntire-Stennis Foundation at SUNY-ESF. The NYSDEC assisted in the selection of the study areas and provided technicians to assist in deer-trapping efforts. The NYSDEC had no role in additional data collection, analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Aycrigg JL, 1997, J MAMMAL, V78, P468, DOI 10.2307/1382899; Bertrand MR, 1996, J WILDLIFE MANAGE, V60, P899, DOI 10.2307/3802391; Bolker BM, 1995, ECOLOGY INFECT DIS N, P384; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Courtenay O, 2001, VET MICROBIOL, V81, P9, DOI 10.1016/S0378-1135(01)00326-1; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; JORGENSEN CD, 1968, J MAMMAL, V49, P104, DOI 10.2307/1377732; Kauhala K, 2006, ANN ZOOL FENN, V43, P348; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Long ES, 2008, BEHAV ECOL, V19, P1235, DOI 10.1093/beheco/arn082; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NELSON ME, 1992, J MAMMAL, V73, P891, DOI 10.2307/1382212; NYS Streets-Public, NYS STREETS PUBL; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P1, DOI 10.2307/3808402; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Quinn ACD, 2012, J MAMMAL, V93, P456, DOI 10.1644/10-MAMM-A-422.1; R Development Core Team, 2009, R FDN STAT COMP; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Swinton J., 2002, P83; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; TIERSON WC, 1985, J WILDLIFE MANAGE, V49, P760, DOI 10.2307/3801708; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; United States Monthly Surface Data, US MONTHL SURF DAT; White PCL, 1995, J APPL ECOL, V32, P693, DOI 10.2307/2404809; White PCL, 2003, WILDLIFE RES, V30, P49, DOI 10.1071/WR01106; Williams DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048439	37	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84368	10.1371/journal.pone.0084368	http://dx.doi.org/10.1371/journal.pone.0084368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409293	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500017
J	Wotton, KR; Jimenez-Guri, E; Matheu, BG; Jaeger, J				Wotton, Karl R.; Jimenez-Guri, Eva; Garcia Matheu, Belen; Jaeger, Johannes			A Staging Scheme for the Development of the Scuttle Fly Megaselia abdita	PLOS ONE			English	Article							TRIBOLIUM EMBRYOGENESIS; DROSOPHILA; EXPRESSION; DIPTERA; SPECIFICATION; GASTRULATION; CYTOSKELETON; VARIABILITY; AMNIOSEROSA; BLASTODERM	Model organisms, such as Drosophila melanogaster, provide powerful experimental tools for the study of development. However, approaches using model systems need to be complemented by comparative studies for us to gain a deeper understanding of the functional properties and evolution of developmental processes. New model organisms need to be established to enable such comparative work. The establishment of new model system requires a detailed description of its life cycle and development. The resulting staging scheme is essential for providing morphological context for molecular studies, and allows us to homologise developmental processes between species. In this paper, we provide a staging scheme and morphological characterisation of the life cycle for an emerging non-drosophilid dipteran model system: the scuttle fly Megaselia abdita. We pay particular attention to early embryogenesis (cleavage and blastoderm stages up to gastrulation), the formation and retraction of extraembryonic tissues, and the determination and formation of germ (pole) cells. Despite the large evolutionary distance between the two species (approximately 150 million years), we find that M. abdita development is remarkably similar to D. melanogaster in terms of developmental landmarks and their relative timing.	[Wotton, Karl R.; Jimenez-Guri, Eva; Garcia Matheu, Belen; Jaeger, Johannes] UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Jaeger, J (corresponding author), UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain.	yogi.jaeger@crg.eu		Wotton, Karl/0000-0002-8672-9948; Jaeger, Johannes/0000-0002-2568-2103; jimenez-guri, eva/0000-0002-9592-1077	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR [406]; MINECO [BFU2009-10184, BFU2012-33775]; ERANet: ERASysBio+ grant [EUI2009-04045]	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR; MINECO(Spanish Government); ERANet: ERASysBio+ grant	The laboratory of Johannes Jaeger and this study in particular was funded by the MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology, by SGR grant 406 from the Catalan funding agency AGAUR, by grants BFU2009-10184 & BFU2012-33775 from the Spanish Ministry of Science (MICINN, now called MINECO), and by ERANet: ERASysBio+ grant EUI2009-04045 (MODHEART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Becker K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003281; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Boehme P, 2010, INT J LEGAL MED, V124, P577, DOI 10.1007/s00414-010-0429-5; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; Dawkins R., 2004, ANCESTORS TALE PILGR; Disney RHL, 2005, MED VET ENTOMOL, V19, P489, DOI 10.1111/j.1365-2915.2005.00593.x; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Fritsch C, 2010, DEV GENES EVOL, V220, P235, DOI 10.1007/s00427-010-0341-5; Greenberg B, 1998, J MED ENTOMOL, V35, P205, DOI 10.1093/jmedent/35.3.205; Handel K, 2005, DEV GENES EVOL, V215, P13, DOI 10.1007/s00427-004-0446-9; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Janssens H, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-1; Janssens H, 2013, DEV BIOL, V377, P305, DOI 10.1016/j.ydbio.2013.01.010; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Jimenez-Guri E, 2013, PLOS ONE IN PRESS; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lemke S, 2008, EVOL DEV, V10, P413, DOI 10.1111/j.1525-142X.2008.00252.x; Manlove JD, 2008, FORENSIC SCI INT, V175, P83, DOI 10.1016/j.forsciint.2007.08.001; Marshall SA, 2012, FLIES NATURAL HIST D; Rafiqi A.M., 2011, COLD SPRING HARBOR P, P2011, DOI [10.1101/pdb.prot5600, DOI 10.1101/PDB.PR0T5600]; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rafiqi Ab Matteen, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5602; Rafiqi AM, 2012, DEVELOPMENT, V139, P3373, DOI 10.1242/dev.083873; Rafiqi AM, 2010, DEV BIOL, V341, P282, DOI 10.1016/j.ydbio.2010.01.040; Rafiqi AM, 2011, COLD SPRING HARBOR P, DOI [10.1101/pdb.emo143, DOI 10.1101/PDB.EM0143]; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schmidt-Ott U, 2000, DEV GENES EVOL, V210, P373, DOI 10.1007/s004270000068; Schmidt-Ott U, 2010, ADV EXP MED BIOL, V689, P133; SCHMIDTOTT U, 1994, ROUX ARCH DEV BIOL, V203, P298, DOI 10.1007/BF00457800; Sommer RJ, 2009, NAT REV GENET, V10, P416, DOI 10.1038/nrg2567; STANLEY MSM, 1970, ANN ENTOMOL SOC AM, V63, P1248, DOI 10.1093/aesa/63.5.1248; Stauber M, 2000, P NATL ACAD SCI USA, V97, P10844, DOI 10.1073/pnas.190095397; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84421	10.1371/journal.pone.0084421	http://dx.doi.org/10.1371/journal.pone.0084421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409295	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500019
J	Bartlett, TE; Olhede, SC; Zaikin, A				Bartlett, Thomas E.; Olhede, Sofia C.; Zaikin, Alexey			A DNA Methylation Network Interaction Measure, and Detection of Network Oncomarkers	PLOS ONE			English	Article							GENOME; CELL; CANCER; LOCALIZATION; LANDSCAPE; SUBUNITS; RECEPTOR; BIOLOGY	Epigenetic processes-including DNA methylation-are increasingly seen as having a fundamental role in chronic diseases like cancer. DNA methylation patterns offer a route to develop prognostic measures based directly on DNA measurements, rather than less-stable RNA measurements. A novel DNA methylation-based measure of the co-ordinated interactive behaviour of genes is developed, in a network context. It is shown that this measure reflects well the co-regulatory behaviour linked to gene expression (at the mRNA level) over the same network interactions. This measure, defined for pairs of genes in a single patient/sample, associates with overall survival outcome independent of known prognostic clinical features, in several independent data sets relating to different cancer types. In total, more than half a billion CpGs in over 1600 samples, taken from nine different cancer entities, are analysed. It is found that groups of gene-pair interactions which associate significantly with survival identify statistically significant subnetwork modules. Many of these subnetwork modules are shown to be biologically relevant by strong correlation with pre-defined gene sets, such as immune function, wound healing, mitochondrial function and MAP-kinase signalling. In particular, the wound healing module corresponds to an increase in co-ordinated interactive behaviour between genes for worse prognosis, and the immune module corresponds to a decrease in co-ordinated interactive behaviour between genes for worse prognosis. This measure has great potential for defining DNA-based cancer biomarkers. Such biomarkers could naturally be developed further, by drawing on the rapidly expanding knowledge base of network science.	[Bartlett, Thomas E.; Zaikin, Alexey] UCL, Dept Math, London, England; [Olhede, Sofia C.] UCL, Dept Stat Sci, London, England; [Bartlett, Thomas E.; Olhede, Sofia C.] UCL, CoMPLEX, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Bartlett, TE (corresponding author), UCL, Dept Math, London, England.	thomas.bartlett.10@ucl.ac.uk	Zaikin, Alexey/T-7171-2019; Zaikin, Alexey/K-6581-2017	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Olhede, Sofia/0000-0003-0061-227X; Bartlett, Thomas/0000-0003-0831-9713	UCL CoMPLEX; Medical Research Council; Engineering and Physical Sciences Research Council (ESPRC); EPSRC [EP/I005250/1]; CR-UK; Eve Appeal [PROMISE-2016]; Engineering and Physical Sciences Research Council [EP/I005250/1] Funding Source: researchfish; Medical Research Council [1297534] Funding Source: researchfish	UCL CoMPLEX; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (ESPRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CR-UK(Cancer Research UK); Eve Appeal; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded via UCL CoMPLEX, by the Medical Research Council and the Engineering and Physical Sciences Research Council (ESPRC). SCO acknowledges funding from EPSRC grant no. EP/I005250/1. AZ acknowledges financial support from CR-UK and Eve Appeal (PROMISE-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartlett TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068285; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonetta L, 2006, NAT METHODS, V3, P141, DOI 10.1038/nmeth0206-141; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; COUGHLIN SR, 1992, J CLIN INVEST, V89, P351, DOI 10.1172/JCI115592; Cox P R, 2001, BMC Genomics, V2, P7, DOI 10.1186/1471-2164-2-7; Davies PCW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; LOVEJOY B, 1993, J MOL BIOL, V234, P640, DOI 10.1006/jmbi.1993.1617; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Mimuro J, 1991, Rinsho Ketsueki, V32, P487; OWREN PA, 1947, LANCET, V252, P446; R Core Team, 2021, R LANG ENV STAT COMP; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; TRAGARDH L, 1980, P NATL ACAD SCI-BIOL, V77, P1129, DOI 10.1073/pnas.77.2.1129; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84573	10.1371/journal.pone.0084573	http://dx.doi.org/10.1371/journal.pone.0084573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400102	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700036
J	Dhamdhere, GR; Fang, MY; Jiang, J; Lee, K; Cheng, D; Olveda, RC; Liu, B; Mulligan, KA; Carlson, JC; Ransom, RC; Weis, WI; Helms, JA				Dhamdhere, Girija R.; Fang, Mark Y.; Jiang, Jie; Lee, Katherine; Cheng, Du; Olveda, Rebecca C.; Liu, Bo; Mulligan, Kimberley A.; Carlson, Jeffery C.; Ransom, Ryan C.; Weis, William I.; Helms, Jill A.			Drugging a Stem Cell Compartment Using Wnt3a Protein as a Therapeutic	PLOS ONE			English	Article							DIFFERENTIATION; PROLIFERATION; IDENTIFICATION; SIGNALS; GROWTH	The therapeutic potential of Wnt proteins has long been recognized but challenges associated with in vivo stability and delivery have hindered their development as drug candidates. By exploiting the hydrophobic nature of the protein we provide evidence that exogenous Wnt3a can be delivered in vivo if it is associated with a lipid vesicle. Recombinant Wnt3a associates with the external surface of the lipid membrane; this association stabilizes the protein and leads to prolonged activation of the Wnt pathway in primary cells. We demonstrate the consequences of Wnt pathway activation in vivo using a bone marrow engraftment assay. These data provide validation for the development of WNT3A as a therapeutic protein.	[Dhamdhere, Girija R.; Fang, Mark Y.; Jiang, Jie; Lee, Katherine; Cheng, Du; Olveda, Rebecca C.; Liu, Bo; Carlson, Jeffery C.; Ransom, Ryan C.; Helms, Jill A.] Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Mulligan, Kimberley A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, HHMI,Dept Dev Biol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Sch Med, Dept Biol Struct, Stanford, CA USA; [Weis, William I.] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Helms, JA (corresponding author), Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	jhelms@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Jiang, Jie/0000-0001-6619-1936; Cheng, Du/0000-0002-7851-1244; Helms, Jill/0000-0002-0463-396X; Ransom, Ryan/0000-0001-6696-1793	California Institute of Regenerative Medicine [TR1-01249]; National Institutes of Health (NIH) [AG39420]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039420] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by California Institute of Regenerative Medicine grant TR1-01249 (to J.A.H.) and National Institutes of Health (NIH) AG39420 grant (to W.I.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2010, J BONE MINER RES, V25, P2412, DOI 10.1002/jbmr.135; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Das Soumyashree, 2012, Front Biol (Beijing), V7, P587; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giacomelli CE, 2000, LANGMUIR, V16, P4853, DOI 10.1021/la9913708; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gross JC, 2012, NAT CELL BIOL; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175, DOI 10.1016/S0940-2993(96)80039-X; Immordino ML, 2006, INT J NANOMED, V1, P297; Janda CY, 2012, SCIENCE; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kunisaki Y, 2012, NAT MED, V18, P864, DOI 10.1038/nm.2825; Lee Y, 2011, J BIOL CHEM, V286, P7033, DOI 10.1074/jbc.M110.207217; Lewis RNAH, 2004, STRUCTURE BIOL MEMBR; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Manjila SB, 2013, INT J PHARM INVESTIG, V3, P1, DOI 10.4103/2230-973X.108958; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Norkin M, 2012, BONE MARROW TRANSPLA; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Polakis P, 2000, GENE DEV, V14, P1837; Popelut A, 2010, BIOMATERIALS, V31, P9173, DOI 10.1016/j.biomaterials.2010.08.045; Qin XG, 2011, J PHYS CHEM B, V115, P1991, DOI 10.1021/jp108694v; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tokumasu F, 2002, J ELECTRON MICROSC, V51, P1, DOI 10.1093/jmicro/51.1.1; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Whyte JL, 2012, COLD SPRING HARB PER; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5; Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]	54	41	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83650	10.1371/journal.pone.0083650	http://dx.doi.org/10.1371/journal.pone.0083650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400074	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700008
J	Eini, R; Stoop, H; Gillis, AJM; Biermann, K; Dorssers, LCJ; Looijenga, LHJ				Eini, Ronak; Stoop, Hans; Gillis, Ad J. M.; Biermann, Katharina; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.			Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; STEM-CELLS; BREAST-CANCER; GERM-CELLS; DIFFERENTIATION; EXPRESSION; ONCOGENE; PROLIFERATION; INHIBITION; OCT3/4	The transcription factor SOX2, associated with amongst others OCT3/4, is essential for maintenance of pluripotency and self-renewal of embryonic stem cells. SOX2 is highly expressed in embryonal carcinoma (EC), the stem cell component of malignant nonseminomatous germ cell tumors, referred to as germ cell cancer (GCC). In fact, OCT3/4 together with SOX2 is an informative diagnostic tool for EC in a clinical setting. Several studies support the hypothesis that SOX2 is a relevant oncogenic factor in various cancers and recently, SOX2 has been suggested as a putative therapeutic target for early stage EC. We demonstrate the presence of genomic amplification of SOX2 in an EC cell line, NCCIT, using array comparative genome hybridization and fluorescence in situ hybridization. Down-regulation of SOX2 by targeted siRNA provokes NCCIT cells towards apoptosis, while inhibition of OCT3/4 expression induced differentiation, with retained SOX2 levels. Mice pluripotent xenografts from NCCIT (N-NCCIT and N2-NCCIT) show a consistent SOX2 expression, in spite of loss of the expression of OCT3/4, and differentiation, with retained presence of genomic amplification. No SOX2 amplification has been identified in primary pure and mixed EC in vivo patient samples so far. The data presented in this study are based on a single EC cell line with a SOX2 amplification, with NT2 as control EC cell line, showing no profound induction of apoptosis upon SOX2 downregulation. The findings are of relevance to identify mechanisms involved in the pathogenesis of EC tumors, and support the model of SOX2-oncogene dependency of EC, which however, does not exclude induction of differentiation. This finding is likely related to the presence of wild type p53 in GCC, resulting in expression of downstream target genes, amongst others miR-34a, miR-145 and SOX2, associated to the unique sensitivity of GCC to DNA damaging agents.	[Eini, Ronak; Stoop, Hans; Gillis, Ad J. M.; Biermann, Katharina; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Looijenga, LHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911	Dutch Cancer Society [KWF: 2006-3607]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by a grant from the Dutch Cancer Society (KWF: 2006-3607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1994, LAB INVEST, V71, P243; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1987, INT J ANDROL, V10, P95, DOI 10.1111/j.1365-2605.1987.tb00170.x; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; DAMJANOV I, 1983, CANCER RES, V43, P2190; DAMJANOV I, 1993, LAB INVEST, V68, P220; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Eini R, 2013, INT J DEV BIOL, V57, P319, DOI 10.1387/ijdb.130020re; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Honecker F, 2006, J PATHOL, V208, P395, DOI 10.1002/path.1872; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Lim JH, 2012, AM J VET RES, V73, P1963, DOI 10.2460/ajvr.73.12.1963; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Looijenga LHJ, 2003, CANCER RES, V63, P2244; LOOIJENGA LHJ, 1990, CYTOGENET CELL GENET, V53, P216, DOI 10.1159/000132934; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Masters JR, 2003, BJU INT, V92, P661, DOI 10.1046/j.1464-410X.2003.04481.x; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Park SW, 2012, FEBS LETT, V586, P3529, DOI 10.1016/j.febslet.2012.08.013; Preston SL, 2003, J CLIN PATHOL-MOL PA, V56, P86, DOI 10.1136/mp.56.2.86; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TESHIMA S, 1988, LAB INVEST, V59, P328; ULBRIGHT TM, 1993, AM J SURG PATHOL, V17, P1075, DOI 10.1097/00000478-199311000-00001; Ushida H, 2012, J UROLOGY, V187, P1876, DOI 10.1016/j.juro.2011.12.058; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Woodward PJ, 2004, WHO CLASSIFICATION T; Xu XL, 2010, CARCINOGENESIS, V31, P167, DOI 10.1093/carcin/bgp232; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Yang S, 2012, CELL PROLIFERAT, V45, P299, DOI 10.1111/j.1365-2184.2012.00827.x; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhang Y, 2012, J BIOL CHEM; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	65	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83585	10.1371/journal.pone.0083585	http://dx.doi.org/10.1371/journal.pone.0083585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404135	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800014
J	Delobel, P; Tesniere, C				Delobel, Pierre; Tesniere, Catherine			A Simple FCM Method to Avoid Misinterpretation in Saccharomyces cerevisiae Cell Cycle Assessment between G0 and Sub-G1	PLOS ONE			English	Article							YEAST; BIOCONDUCTOR; APOPTOSIS	Extensively developed for medical and clinical applications, flow cytometry is now being used for diverse applications in food microbiology. Most uses of flow cytometry for yeast cells are derived from methods for mammalian cells, but yeast cells can present specificities that must be taken into account for rigorous analysis of the data output to avoid any misinterpretation. We report an analysis of Saccharomyces cerevisiae cell cycle progression that highlights possible errors. The cell cycle was analyzed using an intercalating fluorochrome to assess cell DNA content. In analyses of yeast cultures, the presence of a sub-G1 peak in the fluorescent signal is often interpreted as a loss of DNA due to its fragmentation associated with apoptosis. However, the cell wall and its stucture may interfere with the fluorescent signal recorded. These observations indicate that misinterpretation of yeast DNA profiles is possible in analyses based on some of the most common probes: cells in G0 appeared to have a lower DNA content and may have been mistaken as a sub-G1 population. However, careful selection of the fluorochrome for DNA quantification allowed a direct discrimination between G0 and G1 yeast cell cycle steps, without additional labeling. We present and discuss results obtained with five current fluorochromes. These observations led us to recommend to use SYTOX Green for cycle analysis of living cells and SYBR Green I for the identification of the apoptosis sub-G1 population identification or the DNA ploidy application.	[Delobel, Pierre; Tesniere, Catherine] INRA, UMR1083, F-34060 Montpellier, France; [Delobel, Pierre; Tesniere, Catherine] SupAgro Montpellier, UMR1083, Montpellier, France; [Delobel, Pierre; Tesniere, Catherine] Univ Montpellier I, UMR1083, Montpellier, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier	Tesniere, C (corresponding author), INRA, UMR1083, F-34060 Montpellier, France.	tesniere@supagro.inra.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229; Delobel, pierre/0000-0002-8770-3192				Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Brachmann CB, 1998, YEAST, V14, P115; Darzynkiewicz Z, 2001, METHOD CELL BIOL, V63, P527; Ellis B, OWCORE BASIC STRUCTU; Ellis B, OWVIZ VISUALIZATION; Gagneur J, 2012, CELLGROWTH FITTING C; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Malka Y, 2011, CYTOM PART A, V79A, P243, DOI 10.1002/cyto.a.21051; Martani F, 2013, YEAST, V30, P365, DOI 10.1002/yea.2969; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nunez R, 2001, Curr Issues Mol Biol, V3, P39; R Core Team, 2021, R LANG ENV STAT COMP; SLATER ML, 1977, P NATL ACAD SCI USA, V74, P3850, DOI 10.1073/pnas.74.9.3850; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107	17	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84645	10.1371/journal.pone.0084645	http://dx.doi.org/10.1371/journal.pone.0084645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392149	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100072
J	Herr, L; Friedrich, T; Durante, M; Scholz, M				Herr, Lisa; Friedrich, Thomas; Durante, Marco; Scholz, Michael			A Model of Photon Cell Killing Based on the Spatio-Temporal Clustering of DNA Damage in Higher Order Chromatin Structures	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; STRUCTURE-DEPENDENT REPAIR; HUMAN-TUMOR-CELLS; LOW-DOSE-RATE; IONIZING-RADIATION; H2AX PHOSPHORYLATION; GAMMA-RADIATION; HISTONE H2AX; CHO-CELLS; LINES	We present a new approach to model dose rate effects on cell killing after photon radiation based on the spatio-temporal clustering of DNA double strand breaks (DSBs) within higher order chromatin structures of approximately 1-2 Mbp size, so called giant loops. The main concept of this approach consists of a distinction of two classes of lesions, isolated and clustered DSBs, characterized by the number of double strand breaks induced in a giant loop. We assume a low lethality and fast component of repair for isolated DSBs and a high lethality and slow component of repair for clustered DSBs. With appropriate rates, the temporal transition between the different lesion classes is expressed in terms of five differential equations. These allow formulating the dynamics involved in the competition of damage induction and repair for arbitrary dose rates and fractionation schemes. Final cell survival probabilities are computable with a cell line specific set of three parameters: The lethality for isolated DSBs, the lethality for clustered DSBs and the half-life time of isolated DSBs. By comparison with larger sets of published experimental data it is demonstrated that the model describes the cell line dependent response to treatments using either continuous irradiation at a constant dose rate or to split dose irradiation well. Furthermore, an analytic investigation of the formulation concerning single fraction treatments with constant dose rates in the limiting cases of extremely high or low dose rates is presented. The approach is consistent with the Linear-Quadratic model extended by the Lea-Catcheside factor up to the second moment in dose. Finally, it is shown that the model correctly predicts empirical findings about the dose rate dependence of incidence probabilities for deterministic radiation effects like pneumonitis and the bone marrow syndrome. These findings further support the general concepts on which the approach is based.	[Herr, Lisa; Friedrich, Thomas; Durante, Marco; Scholz, Michael] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany; [Herr, Lisa; Durante, Marco] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Technical University of Darmstadt	Scholz, M (corresponding author), GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany.	m.scholz@gsi.de	Friedrich, Thomas/K-6748-2013; Durante, Marco/L-4795-2017; Durante, Marco/K-1315-2014	Friedrich, Thomas/0000-0003-0074-6390; Durante, Marco/0000-0002-4615-553X; Durante, Marco/0000-0002-4615-553X; Scholz, Michael/0000-0002-6382-6737	GSI; Studienstiftung des deutschen Volkes; HGS-HIRe	GSI(Helmholtz Association); Studienstiftung des deutschen Volkes; HGS-HIRe	Funding was provided by GSI (http://www.gsi.de/), Studienstiftung des deutschen Volkes (http://www.studienstiftung.de/), and HGS-HIRe (http://hgs-hire.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448; Catcheside DG, 1946, J GENET, V47, P137, DOI 10.1007/BF02986783; CURTIS SB, 1986, RADIAT RES, V106, P252, DOI 10.2307/3576798; DahmDaphi J, 1996, INT J RADIAT BIOL, V69, P615, DOI 10.1080/095530096145625; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; Edwards A. A., 1998, Journal of Radiological Protection, V18, P175, DOI 10.1088/0952-4746/18/3/004; EGUCHIKASAI K, 1991, INT J RADIAT BIOL, V59, P97, DOI 10.1080/09553009114550091; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Fowler JF, 2004, INT J RADIAT ONCOL, V59, P242, DOI 10.1016/j.ijrobp.2004.01.004; Friedland W, 2006, RADIAT PROT DOSIM, V122, P116, DOI 10.1093/rpd/ncl451; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Fry RJM, 2001, HEALTH PHYS, V80, P338, DOI 10.1097/00004032-200104000-00009; Gauter B, 2002, RADIAT RES, V157, P721, DOI 10.1667/0033-7587(2002)157[0721:RORIDD]2.0.CO;2; HOLMES A, 1990, BRIT J CANCER, V62, P791, DOI 10.1038/bjc.1990.381; Johnston PJ, 1997, RADIAT RES, V148, P561, DOI 10.2307/3579731; Johnston PJ, 1998, RADIAT RES, V149, P533, DOI 10.2307/3579899; JOHNSTON PJ, 1994, INT J RADIAT BIOL, V66, P531, DOI 10.1080/09553009414551571; Johnston PJ, 1998, RADIAT RES, V149, P455, DOI 10.2307/3579785; KELLAND LR, 1986, RADIOTHER ONCOL, V7, P259, DOI 10.1016/S0167-8140(86)80037-8; Lea DA, 1946, ACTIONS RAD LIVING C; Ling CC, 2010, RADIOTHER ONCOL, V95, P261, DOI 10.1016/j.radonc.2010.03.014; Little MP, 2003, BRIT MED BULL, V68, P259, DOI 10.1093/bmb/ldg031; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Menegakis A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; NUNEZ MI, 1995, BRIT J CANCER, V71, P311, DOI 10.1038/bjc.1995.62; OLIVER R, 1964, INT J RADIAT BIOL RE, V8, P475, DOI 10.1080/09553006414550581; Orton CG, 2001, INT J RADIAT ONCOL, V49, P183, DOI 10.1016/S0360-3016(00)00810-5; Ostashevsky J, 1998, MOL BIOL CELL, V9, P3031, DOI 10.1091/mbc.9.11.3031; OTTOLENGHI A, 1995, RADIAT ENVIRON BIOPH, V34, P239, DOI 10.1007/BF01209749; PEACOCK JH, 1988, INT J RADIAT BIOL, V54, P945, DOI 10.1080/09553008814552341; Pop LAM, 2000, RADIOTHER ONCOL, V55, P301, DOI 10.1016/S0167-8140(00)00205-X; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Solovjeva L, 1998, CHROMOSOME RES, V6, P595, DOI 10.1023/A:1009293108736; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; STEEL GG, 1987, RADIOTHER ONCOL, V9, P299; STEPHENS TC, 1987, INT J RADIAT BIOL, V52, P157, DOI 10.1080/09553008714551581; Stisova V, 2011, RADIAT RES, V176, P217, DOI 10.1667/RR2490.1; Stuben G, 1997, RADIOTHER ONCOL, V42, P189, DOI 10.1016/S0167-8140(96)01869-5; Supe Sanjay S, 2006, J Cancer Res Ther, V2, P105; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; THAMES HD, 1982, INT J RADIAT ONCOL, V8, P219, DOI 10.1016/0360-3016(82)90517-X; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; VANDYK J, 1989, RADIOTHER ONCOL, V14, P55, DOI 10.1016/0167-8140(89)90009-1; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WELLS RL, 1983, RADIAT RES, V94, P105, DOI 10.2307/3575868; YANG X, 1990, RADIOTHER ONCOL, V19, P49, DOI 10.1016/0167-8140(90)90165-S; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83923	10.1371/journal.pone.0083923	http://dx.doi.org/10.1371/journal.pone.0083923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392100	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100024
J	Arenas, CD; Lehman, N				Arenas, Carolina Diaz; Lehman, Niles			Partitioning the Fitness Components of RNA Populations Evolving In Vitro	PLOS ONE			English	Article							CATALYTIC RNA; TEST-TUBE; EVOLUTION; SELECTION; MUTATION; RIBOZYMES; SURVIVAL; FLATTEST; ENZYMES	All individuals in an evolving population compete for resources, and their performance is measured by a fitness metric. The performance of the individuals is relative to their abilities and to the biotic surroundings -the conditions under which they are competing -and involves many components. Molecules evolving in a test tube can also face complex environments and dynamics, and their fitness measurements should reflect the complexity of various contributing factors as well. Here, the fitnesses of a set of ligase ribozymes evolved by the continuous in vitro evolution system were measured. During these evolution cycles there are three different catalytic steps, ligation, reverse transcription, and forward transcription, each with a potential differential influence on the total fitness of each ligase. For six distinct ligase ribozyme genotypes that resulted from continuous evolution experiments, the rates of reaction were measured for each catalytic step by tracking the kinetics of enzymes reacting with their substrates. The reaction products were analyzed for the amount of product formed per time. Each catalytic step of the evolution cycle was found to have a differential incidence in the total fitness of the ligases, and therefore the total fitness of any ligase cannot be inferred from only one catalytic step of the evolution cycle. Generally, the ribozyme-directed ligation step tends to impart the largest effect on overall fitness. Yet it was found that the ligase genotypes have different absolute fitness values, and that they exploit different stages of the overall cycle to gain a net advantage. This is a new example of molecular niche partitioning that may allow for coexistence of more than one species in a population. The dissection of molecular events into multiple components of fitness provides new insights into molecular evolutionary studies in the laboratory, and has the potential to explain heretofore counterintuitive findings.	[Arenas, Carolina Diaz; Lehman, Niles] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Portland State University	Lehman, N (corresponding author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.	niles@pdx.edu	Lehman, Niles/ABF-7609-2021; DiazArenas, Carolina/H-2396-2015	Lehman, Niles/0000-0002-9056-6600; DiazArenas, Carolina/0000-0002-2308-8717	National Science Foundation [DEB-0315286]; National Aeronautics and Space Administration [NNX07-AU05G]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was funded by the National Science Foundation (grant DEB-0315286 to NL) and the National Aeronautics and Space Administration (grant NNX07-AU05G to NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-80; Arenas CD, 2009, INT J BIOCHEM CELL B, V41, P266, DOI 10.1016/j.biocel.2008.08.034; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI 10.1111/j.1558-5646.1984.tb00344.x; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; Bisswanger H., 2008, ENZYME KINETICS PRIN; Burton AS, 2009, ANAL BIOCHEM, V388, P351, DOI 10.1016/j.ab.2009.02.010; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Diaz Arenas C, 2010, CURRENT PROTOCOLS NU; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Falconer D. S., 1981, INTRO QUANTITATIVE G; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; LAZCANO A, 1992, J MOL EVOL, V35, P524, DOI 10.1007/BF00160213; Lehman N, 2004, ARTIF LIFE, V10, P1, DOI 10.1162/106454604322875887; Lehman N, 2000, J MOL EVOL, V50, P481, DOI 10.1007/s002390010051; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; Pearson K, 1903, PHILOS T R SOC LOND, V200, P1, DOI 10.1098/rsta.1903.0001; Preston BD, 1996, P NATL ACAD SCI USA, V93, P7427, DOI 10.1073/pnas.93.15.7427; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Schmitt T, 1999, CHEM BIOL, V6, P857, DOI 10.1016/S1074-5521(00)80005-8; Soll SJ, 2007, GENETICS, V175, P267, DOI 10.1534/genetics.106.066142; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Vartanian JP, 1999, J GEN VIROL, V80, P1983, DOI 10.1099/0022-1317-80-8-1983; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614	34	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84454	10.1371/journal.pone.0084454	http://dx.doi.org/10.1371/journal.pone.0084454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391957	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900100
J	Humily, F; Partensky, F; Six, C; Farrant, GK; Ratin, M; Marie, D; Garczarek, L				Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence			A Gene Island with Two Possible Configurations Is Involved in Chromatic Acclimation in Marine Synechococcus	PLOS ONE			English	Article							PHOTOSYNTHESIS GENES; UNICELLULAR CYANOBACTERIA; WATER COLUMN; PROCHLOROCOCCUS; PHYCOERYTHRIN; PROTEIN; SEQUENCE; PHYCOBILISOME; ADAPTATION; ECOTYPES	Synechococcus, the second most abundant oxygenic phototroph in the marine environment, harbors the largest pigment diversity known within a single genus of cyanobacteria, allowing it to exploit a wide range of light niches. Some strains are capable of Type IV chromatic acclimation (CA4), a process by which cells can match the phycobilin content of their phycobilisomes to the ambient light quality. Here, we performed extensive genomic comparisons to explore the diversity of this process within the marine Synechococcus radiation. A specific gene island was identified in all CA4-performing strains, containing two genes (fciA/b) coding for possible transcriptional regulators and one gene coding for a phycobilin lyase. However, two distinct configurations of this cluster were observed, depending on the lineage. CA4-A islands contain the mpeZ gene, encoding a recently characterized phycoerythrobilin lyase-isomerase, and a third, small, possible regulator called fciC. In CA4-B islands, the lyase gene encodes an uncharacterized relative of MpeZ, called MpeW. While mpeZ is expressed more in blue light than green light, this is the reverse for mpeW, although only small phenotypic differences were found among chromatic acclimaters possessing either CA4 island type. This study provides novel insights into understanding both diversity and evolution of the CA4 process.	[Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence] Univ Paris 06, Stn Biol, Roscoff, France; [Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence] CNRS, UMR 7144, Ocean Plankton Grp, Marine Phototroph Prokaryotes Team, Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Garczarek, L (corresponding author), Univ Paris 06, Stn Biol, Roscoff, France.	laurence.garczarek@sb-roscoff.fr	Farrant, Gregory/K-3394-2015; Partensky, Frédéric/AAH-1170-2021; Partensky, Frédéric/B-9194-2018	Farrant, Gregory/0000-0002-3774-3743; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Six, Christophe/0000-0002-8506-1149; Garczarek, Laurence/0000-0002-8191-8395	French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN) [ANR-09-GENM-030]; European Union [287589]; MaCumba [311975]	French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN)(French National Research Agency (ANR)); European Union(European Commission); MaCumba	This work was supported by the French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN, ANR-09-GENM-030), the European Union's Seventh Framework Programmes FP7 MicroB3 (grant agreement 287589, http://www.microb3.eu) and MaCumba (grant agreement 311975, http://www.macumbaproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Ahlgren NA, 2006, APPL ENVIRON MICROB, V72, P7193, DOI 10.1128/AEM.00358-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Buitenhuis ET, 2012, EARTH SYST SCI DATA, V4, P37, DOI 10.5194/essd-4-37-2012; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Coste F, 2005, LECT NOTES ARTIF INT, V3720, P522, DOI 10.1007/11564096_50; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Garczarek L, 2008, ISME J, V2, P937, DOI 10.1038/ismej.2008.46; Guindon S, 2009, INFECT GENET EVOL, V9, P384; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Haverkamp T, 2008, ENVIRON MICROBIOL, V10, P174, DOI 10.1111/j.1462-2920.2007.01442.x; Huang SJ, 2012, ISME J, V6, P285, DOI 10.1038/ismej.2011.106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kolowrat C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-204; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu H, 1998, DEEP-SEA RES PT II, V45, P2327, DOI 10.1016/S0967-0645(98)00073-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; MARIE D, 1999, CURRENT PROTOCOLS CY, V10; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; Morimoto K, 2003, J BIOCHEM, V134, P211, DOI 10.1093/jb/mvg131; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1984, SCIENCE, V224, P80, DOI 10.1126/science.224.4644.80; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; SIDLER WA, 1994, MOL BIOL CYANOBACTER, P1999; Six C, 2005, J BACTERIOL, V187, P1685, DOI 10.1128/JB.187.5.1685-1694.2005; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Six C, 2007, PHOTOSYNTH RES, V92, P75, DOI 10.1007/s11120-007-9170-4; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049; Wickstrum JR, 2010, J BACTERIOL, V192, P225, DOI 10.1128/JB.00829-08; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025	73	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84459	10.1371/journal.pone.0084459	http://dx.doi.org/10.1371/journal.pone.0084459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391958	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900101
J	Mattsson, N; Insel, P; Tosun, D; Zhang, J; Jack, CR; Galasko, D; Weiner, M				Mattsson, Niklas; Insel, Philip; Tosun, Duygu; Zhang, Jing; Jack, Clifford R., Jr.; Galasko, Douglas; Weiner, Michael		Alzheimer's Dis Neuroimaging	Effects of Baseline CSF alpha-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							LEWY BODIES; CEREBROSPINAL-FLUID; FOCAL ATROPHY; DEMENTIA; MRI; BIOMARKERS; PATTERNS; ADNI; TAU	Background: Cerebrospinal fluid (CSF) alpha-synuclein is reduced in synucleinopathies, including dementia with Lewy bodies, and some studies have found increased CSF alpha-synuclein in Alzheimer's disease (AD). No study has explored effects of CSF alpha-synuclein on brain atrophy. Here we tested if baseline CSF alpha-synuclein affects brain atrophy rates and if these effects vary across brain regions, and across the cognitive spectrum from healthy elders (NL), to patients with mild cognitive impairment (MCI) and AD. Methods: Baseline CSF alpha-synuclein measurements and longitudinal structural brain magnetic resonance imaging was performed in 74 NL, 118 MCI patients and 55 AD patients. Effects of baseline CSF alpha-synuclein on regional atrophy rates were tested in 1) four pre-hoc defined regions possibly associated with Lewy body and/or AD pathology (amygdala, caudate, hippocampus, brainstem), and 2) all available regions of interest. Differences across diagnoses were tested by assessing the interaction of CSF alpha-synuclein and diagnosis (testing NL versus MCI, and NL versus AD). Results: The effects of CSF alpha-synuclein on longitudinal atrophy rates were not significant after correction for multiple comparisons. There were tendencies for effects in AD in caudate (higher atrophy rates in subjects with higher CSF alpha-synuclein, P=0.046) and brainstem (higher atrophy rates in subjects with lower CSF alpha-synuclein, P=0.063). CSF alpha-synuclein had significantly different effects on atrophy rates in NL and AD in brainstem (P=0.037) and caudate (P=0.006). Discussion: With the possible exception of caudate and brainstem, the overall weak effects of CSF alpha-synuclein on atrophy rates in NL, MCI and AD argues against CSF alpha-synuclein as a biomarker related to longitudinal brain atrophy in these diagnostic groups. Any effects of CSF alpha-synuclein may be attenuated by possible simultaneous occurrence of AD-related neuronal injury and concomitant Lewy body pathology, which may elevate and reduce CSF alpha-synuclein levels, respectively.	[Mattsson, Niklas; Insel, Philip; Tosun, Duygu; Weiner, Michael] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Mattsson, Niklas] Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden; [Mattsson, Niklas; Tosun, Duygu; Weiner, Michael] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Zhang, Jing] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Galasko, Douglas] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of Gothenburg; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Mayo Clinic; University of California System; University of California San Diego	Mattsson, N (corresponding author), Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA.	niklas.mattsson@neuro.gu.se	Hsiung, Robin/AAT-1661-2021; Levey, Allan/F-2104-2011; Preda, Adrian/K-8889-2013; Jack, Clifford R/F-2508-2010; Mattsson-Carlgren, Niklas/H-7597-2019	Hsiung, Robin/0000-0002-8017-0856; Levey, Allan/0000-0002-3153-502X; Preda, Adrian/0000-0003-3373-2438; Jack, Clifford R/0000-0001-7916-622X; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Ponto, Laura/0000-0003-1197-6714; Tosun, Duygu/0000-0001-8644-7724	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Northern California Institute for Research and Education; National Institutes of Health (NIH) [P30 AG010129, K01 AG030514]; NIH [R01-AG011378, RO1-AG041851, RO1-AG037551, U01-HL096917, U01-AG032438, U01-AG024904, PO1 AGO5131, U01 AG1048, P01AG020206]; Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation; Michael J. Fox Foundation; Alzheimer's Drug Discovery Foundation; Swedish Research Council; Goteborgs Lakaresallskap; Svenska Lakaresallskapet; Sahlgrenska Universitetssjukhuset; Carl-Bertil Laurells fond; Klinisk Biokemi i Norden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004696, P30ES007033, R01ES016873, R01ES019277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684, R01NS057567, U01NS082137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206, P50AG005131, U24AG021886, R01AG041851, R01AG037551, R01AG011378, P30AG013846, R01AG033398, P30AG010129, U01AG024904, P50AG008702, K01AG030514] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Northern California Institute for Research and Education; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation; Michael J. Fox Foundation; Alzheimer's Drug Discovery Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Goteborgs Lakaresallskap; Svenska Lakaresallskapet; Sahlgrenska Universitetssjukhuset; Carl-Bertil Laurells fond; Klinisk Biokemi i Norden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health (NIH) grants P30 AG010129 and K01 AG030514. MW receives research funding from the NIH (R01-AG011378, RO1-AG041851, RO1-AG037551, U01-HL096917, U01-AG032438, U01-AG024904), and the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation. DG receives research funding from Michael J. Fox Foundation, Alzheimer's Drug Discovery Foundation, and the NIH (PO1 AGO5131; U01 AG1048; P01AG020206). JZ receives research funding from Michael J. Fox Foundation as well as NIH grants (ES004696-5897, ES007033-6364, AG033398, ES016873, ES019277, NS057567, NS062684-6221 and NS082137). NM receives research funding from the Swedish Research Council, Goteborgs Lakaresallskap, Svenska Lakaresallskapet, Sahlgrenska Universitetssjukhuset, Carl-Bertil Laurells fond, and Klinisk Biokemi i Norden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bozzali M, 2005, BRAIN, V128, P1595, DOI 10.1093/brain/awh493; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kantarci K, 2012, NEUROLOGY, V79, P553, DOI 10.1212/WNL.0b013e31826357a5; Korff A, 2013, J ALZHEIMERS DIS, V36, P679, DOI 10.3233/JAD-130458; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Mattsson N, 2014, NEUROBIOL AGING, V35, P614, DOI 10.1016/j.neurobiolaging.2013.08.027; Mollenhauer B, 2008, EXP NEUROL; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P683, DOI 10.1007/s00401-013-1148-z; Tosun D, 2011, J ALZHEIMERS DIS, V26, P77, DOI 10.3233/JAD-2011-0006; Watson R, 2012, INT PSYCHOGERIATR, V24, P532, DOI 10.1017/S1041610211002171; Wennstrom M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053250, 10.1371/journal.pone.0109387]; Whitwell JL, 2007, BRAIN, V130, P708, DOI 10.1093/brain/awl388; Zaccai J, 2008, NEUROLOGY, V70, P1042, DOI 10.1212/01.wnl.0000306697.48738.b6	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85443	10.1371/journal.pone.0085443	http://dx.doi.org/10.1371/journal.pone.0085443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392009	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900153
J	Baussano, I; Elfstrom, KM; Lazzarato, F; Gillio-Tos, A; De Marco, L; Carozzi, F; Del Mistro, A; Dillner, J; Franceschi, S; Ronco, G				Baussano, Iacopo; Elfstrom, K. Miriam; Lazzarato, Fulvio; Gillio-Tos, Anna; De Marco, Laura; Carozzi, Francesca; Del Mistro, Annarosa; Dillner, Joakim; Franceschi, Silvia; Ronco, Guglielmo			Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; CERVICAL-CANCER; GLOBAL BURDEN; HPV TYPES; VACCINATION; IMPACT; WOMEN; INFECTIONS; TRANSMISSION; RISK	Infection with high-risk (hr) human papillomavirus (HPV) is considered the necessary cause of cervical cancer. Vaccination against HPV16 and 18 types, which are responsible of about 75% of cervical cancer worldwide, is expected to have a major global impact on cervical cancer occurrence. Valid estimates of the parameters that regulate the natural history of hrHPV infections are crucial to draw reliable projections of the impact of vaccination. We devised a mathematical model to estimate the probability of infection transmission, the rate of clearance, and the patterns of immune response following the clearance of infection of 13 hrHPV types. To test the validity of our estimates, we fitted the same transmission model to two large independent datasets from Italy and Sweden and assessed finding consistency. The two populations, both unvaccinated, differed substantially by sexual behaviour, age distribution, and study setting (screening for cervical cancer or Chlamydia trachomatis infection). Estimated transmission probability of hrHPV types (80% for HPV16, 73%-82% for HPV18, and above 50% for most other types); clearance rates decreasing as a function of time since infection; and partial protection against re-infection with the same hrHPV type (approximately 20% for HPV16 and 50% for the other types) were similar in the two countries. The model could accurately predict the HPV16 prevalence observed in Italy among women who were not infected three years before. In conclusion, our models inform on biological parameters that cannot at the moment be measured directly from any empirical data but are essential to forecast the impact of HPV vaccination programmes.	[Baussano, Iacopo; Franceschi, Silvia] Int Agcy Res Canc, F-69372 Lyon, France; [Elfstrom, K. Miriam; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lazzarato, Fulvio; Gillio-Tos, Anna; De Marco, Laura] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Carozzi, Francesca] Inst Canc Study & Prevent ISPO, Florence, Italy; [Del Mistro, Annarosa] Venetian Oncol Inst IOV, Padua, Italy; [Ronco, Guglielmo] Ctr Canc Prevent, Canc Epidemiol Unit, Turin, Italy	World Health Organization; International Agency for Research on Cancer (IARC); Karolinska Institutet; University of Turin; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Istituto Oncologico Veneto (IOV)	Baussano, I (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	baussanoi@iarc.fr	franceschi, silvia/M-2452-2014; Carozzi, Francesca Maria/K-4739-2016; DEL MISTRO, ANNAROSA/E-9352-2014; De Marco, Laura/J-7254-2016; Carozzi, Francesca/AAB-4985-2019; SANI, CRISTINA/J-8722-2016	franceschi, silvia/0000-0003-4181-8071; Carozzi, Francesca Maria/0000-0002-7162-8781; DEL MISTRO, ANNAROSA/0000-0001-7201-9374; De Marco, Laura/0000-0003-2167-9270; Carozzi, Francesca/0000-0002-6980-8011; SANI, CRISTINA/0000-0001-8955-8913; Gillio-Tos, Anna/0000-0001-6553-5362	European Community [242061]; Bill & Melinda Gates Foundation [OPP1053353]	European Community(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the European Community's Seventh Framework programme (FP7/2007-2013) under grant agreement No. 242061 (acronym PREHDICT) and by the Bill & Melinda Gates Foundation (grant number OPP1053353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2011, VACCINE, V29, P1270, DOI 10.1016/j.vaccine.2010.11.082; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Garnett GP, 2002, SEX TRANSM INFECT, V78, pI14, DOI 10.1136/sti.78.suppl_1.i14; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; LEWIN B, 2000, SEX SWEDEN SWEDISH S; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Olsen J, 2010, INT J TECHNOL ASSESS, V26, P183, DOI 10.1017/S0266462310000085; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco Guglielmo, 2012, Epidemiol Prev, V36, P39; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Ryding J, 2008, VACCINE, V26, P5263, DOI 10.1016/j.vaccine.2008.07.041; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; SERGEEV R, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003815; Signorelli C, 2006, EUR J PUBLIC HEALTH, V16, P498, DOI 10.1093/eurpub/ckl024; Soderlund-Strand A, 2013, CANCER EPIDEM BIOMAR, V22, P242, DOI 10.1158/1055-9965.EPI-12-1003; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Vanni T, 2012, VACCINE, V30, P4866, DOI 10.1016/j.vaccine.2012.04.087; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; Zechmeister I, 2009, VACCINE, V27, P5133, DOI 10.1016/j.vaccine.2009.06.039	49	21	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81171	10.1371/journal.pone.0081171	http://dx.doi.org/10.1371/journal.pone.0081171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24400036	Green Published, Green Submitted, gold			2022-12-25	WOS:000327670300027
J	Lauer, ME; Aytekin, M; Comhair, SA; Loftis, J; Tian, LP; Farver, CF; Hascall, VC; Dweik, RA				Lauer, Mark E.; Aytekin, Metin; Comhair, Suzy A.; Loftis, Jacqueline; Tian, Liping; Farver, Carol F.; Hascall, Vincent C.; Dweik, Raed A.			Modification of Hyaluronan by Heavy Chains of Inter-alpha-Inhibitor in Idiopathic Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Extracellular Matrix; Glycobiology; Hyaluronate; Lung; Proteoglycan; TSG-6; Heavy Chain; Hyaluronan; Inter--inhibitor; Tumor Necrosis Factor-stimulated Gene 6	TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; LEUKOCYTE ADHESION; EXPRESSION; CD44; BIND	Background: Hyaluronan metabolism is altered in idiopathic pulmonary arterial hypertension lung tissue. Results: This hyaluronan is of a pathological form covalently modified by heavy chains from inter--inhibitor. Conclusion: The distribution of this matrix in regions of abnormal vascular remodeling implies a mechanistic role. Significance: Pathological hyaluronan matrices may direct inflammatory events and vascular changes in this disease. We previously reported an altered hyaluronan (HA) metabolism in idiopathic pulmonary arterial hypertension (IPAH) lung tissue and cultured smooth muscle cells. Hyaluronan was present in the smooth muscle cell layer surrounding the pulmonary vasculature and in plexigenic lesions. Additionally, cultured pulmonary artery smooth muscle cells produced spontaneous HA cable structures, without additional stimuli, that were leukocyte-adhesive. We now present evidence that the HA that accumulates in IPAH plexigenic lesions is a pathological form of HA in which heavy chains (HCs) from the serum-derived proteoglycan inter--inhibitor are covalently attached to the HA backbone to form a pathological HC-HA complex. CD45-positive leukocytes were identified within these HC-HA matrices. Elevated mRNA levels of the enzyme that transfers HCs to HA, known as tumor necrosis factor-stimulated gene 6, were detected in IPAH lung tissue.	[Lauer, Mark E.; Loftis, Jacqueline; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Aytekin, Metin] Erciyes Univ, Dept Med Biol, Fac Med, TR-38039 Kayseri, Turkey; [Aytekin, Metin] Erciyes Univ, Genome Stem Cell Ctr, TR-38039 Kayseri, Turkey; [Comhair, Suzy A.; Tian, Liping; Dweik, Raed A.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Farver, Carol F.] Cleveland Clin, Dept Pathol, Cleveland, OH 44195 USA; [Dweik, Raed A.] Cleveland Clin, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Erciyes University; Erciyes University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dweik, RA (corresponding author), Cleveland Clin, Dept Pulm & Crit Care Med, Desk A-90, Cleveland, OH 44195 USA.	dweikr@ccf.org			National Institutes of Health from the NHLBI [P01HL107147, HL081064, HL103453, HL060917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, R37HL060917, P01HL103453, P01HL081064, P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL107147, HL081064, HL103453, and HL060917 from the NHLBI.	Aytekin M, 2008, AM J PHYSIOL-LUNG C, V295, pL789, DOI 10.1152/ajplung.90306.2008; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; El Chami H, 2012, PROG CARDIOVASC DIS, V55, P218, DOI 10.1016/j.pcad.2012.07.006; Kalay N, 2013, TOHOKU J EXP MED, V230, P7, DOI 10.1620/tjem.230.7; Kida D, 1999, J RHEUMATOL, V26, P1230; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEEPERWOODFORD SK, 1991, AM REV RESPIR DIS, V143, P1076, DOI 10.1164/ajrccm/143.5_Pt_1.1076; Lei Ye, 2002, Asian J Surg, V25, P203, DOI 10.1016/S1015-9584(09)60176-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Ohta-Ogo K, 2012, PATHOL INT, V62, P219, DOI 10.1111/j.1440-1827.2011.02779.x; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wilkins MR, 2012, EUR RESPIR REV, V21, P19, DOI 10.1183/09059180.00008411; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	21	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6791	6798		10.1074/jbc.M113.512491	http://dx.doi.org/10.1074/jbc.M113.512491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24403074	Green Published, hybrid			2022-12-25	WOS:000332389400039
J	Purushothaman, A; Toole, BP				Purushothaman, Anurag; Toole, Bryan P.			Serglycin Proteoglycan Is Required for Multiple Myeloma Cell Adhesion, in Vivo Growth, and Vascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Chondroitin Sulfate; Glycosaminoglycan; Multiple Myeloma; Proteoglycan	AGGRESSIVE TUMOR PHENOTYPE; ENDOTHELIAL-CELLS; HEMATOPOIETIC-CELLS; SECRETORY GRANULE; PLASMA-CELLS; EXPRESSION; SYNDECAN-1; SULFATE; CD44; COMPLEXES	Background: Contribution of serglycin in myeloma pathobiology remains undefined. Results: Serglycin promotes myeloma cell adhesion to bone marrow components and serglycin knockdown in myeloma cells dramatically diminish tumor growth. Conclusion: Serglycin plays a crucial role in myeloma pathogenesis. Significance: Targeting serglycin may provide a novel therapeutic approach for multiple myeloma. Recently, it was discovered that serglycin, a hematopoietic cell proteoglycan, is the major proteoglycan expressed and constitutively secreted by multiple myeloma (MM) cells. High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly diagnosed MM patients. However, its contribution to the pathophysiology of MM is unknown. Here, we show that serglycin knockdown (by approximate to 85% compared with normal levels), using lentiviral shRNA, dramatically attenuated MM tumor growth in mice with severe combined immunodeficiency. Tumors formed from cells deficient in serglycin exhibited diminished levels of hepatocyte growth factor expression and impaired development of blood vessels, indicating that serglycin may affect tumor angiogenesis. Furthermore, knockdown of serglycin significantly decreased MM cell adhesion to bone marrow stromal cells and collagen I. Even though serglycin proteoglycan does not have a transmembrane domain, flow cytometry showed that serglycin is present on the MM cell surface, and attachment to the cell surface is, at least in part, dependent on its chondroitin sulfate side chains. Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression. Finally, we demonstrate that serglycin mRNA expression in MM cells is up-regulated by activin, a predominant cytokine among those increased in MM patients with osteolytic lesions. These studies provide direct evidence for a critical role for serglycin in MM pathogenesis and show that targeting serglycin may provide a novel therapeutic approach for MM.	[Purushothaman, Anurag] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Toole, Bryan P.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Toole, Bryan P.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Medical University of South Carolina	Purushothaman, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Wallace Tumor Inst, 1824 6th Ave S,Room 602A, Birmingham, AL 35294 USA.	anuragp@uab.edu			National Institutes of Health [P30 AR48311, P30 AI027767, P30 AR46031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Ralph D. Sanderson (UAB) for his excellent support and discussions throughout this work. We also thank Dr. Erming Tian (University of Arkansas at Little Rock) for providing OPM-1, Delta 47, OCIMy5, and KMS-11 cell lines. We acknowledge Enid Keyser from the University of Alabama at Birmingham for assistance with flow analysis and the RDCC-CFCC core (supported by National Institutes of Health Grant P30 AR48311 and P30 AI027767). We also thank Ed Phillips (University of Alabama at Birmingham, High Resolution Imaging Facility) for assistance with fluorescence microscopy. Histology services were performed by the University of Alabama at Birmingham Center for Metabolic Bone Diseases Histomorphometry and Molecular Analysis Core Laboratory (supported by National Institutes of Health Grant P30 AR46031).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Andersen NF, 2005, BRIT J HAEMATOL, V128, P210, DOI 10.1111/j.1365-2141.2004.05299.x; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Falkowska-Hansen B, 2006, MOL CELL BIOCHEM, V287, P43, DOI 10.1007/s11010-005-9024-3; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Holt RU, 2008, HAEMATOLOGICA, V93, P619, DOI 10.3324/haematol.11867; HUMPHRIES DE, 1992, J BIOL CHEM, V267, P13558; Iwasaki T, 2002, BRIT J HAEMATOL, V116, P796, DOI 10.1046/j.0007-1048.2002.03364.x; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Malla N, 2013, FEBS J, V280, P2870, DOI 10.1111/febs.12291; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Neri P, 2012, CURR CANCER DRUG TAR, V12, P776, DOI 10.2174/156800912802429337; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2012, J BIOL CHEM, V287, P41288, DOI 10.1074/jbc.M112.391417; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; RIDLEY RC, 1993, BLOOD, V81, P767; SALI A, 1993, J BIOL CHEM, V268, P9023; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; Schick BP, 2010, PROG MOL BIOL TRANSL, V93, P235, DOI [10.1016/S1S77-1173(10)93011-1, 10.1016/S1877-1173(10)93011-1]; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; SCHICK BP, 1992, BIOCHEM J, V282, P651, DOI 10.1042/bj2820651; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Seidel C, 1998, BLOOD, V91, P806, DOI 10.1182/blood.V91.3.806.806_806_812; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; SERAFIN WE, 1986, J BIOL CHEM, V261, P5017; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	46	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5499	5509		10.1074/jbc.M113.532143	http://dx.doi.org/10.1074/jbc.M113.532143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403068	Green Published, hybrid			2022-12-25	WOS:000332015500014
J	Li, M; Chang, S; Yang, LJ; Shi, JY; McFarland, K; Yang, X; Moller, A; Wang, CG; Zou, XQ; Chi, CW; Cui, JM				Li, Min; Chang, Shan; Yang, Longjin; Shi, Jingyi; McFarland, Kelli; Yang, Xiao; Moller, Alyssa; Wang, Chunguang; Zou, Xiaoqin; Chi, Chengwu; Cui, Jianmin			Conopeptide Vt3.1 Preferentially Inhibits BK Potassium Channels Containing beta 4 Subunits via Electrostatic Interactions*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Molecular Modeling; Peptide Interactions; Potassium Channels; Toxins; 4 Subunit; BK Channel; Activation; Conopeptide; Electrostatic Interaction	SCORPION PEPTIDE BLOCKER; LARGE-CONDUCTANCE; K+ CHANNELS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CALCIUM; VOLTAGE; VENOM; CHARYBDOTOXIN; INACTIVATION	Background: BK channel function is differentially modulated by tissue-specific (1-4) subunits. Results: Conopeptide Vt3.1 preferentially inhibits neuronal BK channels containing the 4 subunit. Conclusion: Electrostatic interactions between Vt3.1 and the extracellular loop of 4 decrease voltage-dependent activation of the channel. Significance: Vt3.1 is an excellent tool for studying the structure, function, and roles in neurophysiology of BK channels. BK channel subunits (1-4) modulate the function of channels formed by slo1 subunits to produce tissue-specific phenotypes. The molecular mechanism of how the homologous subunits differentially alter BK channel functions and the role of different BK channel functions in various physiologic processes remain unclear. By studying channels expressed in Xenopus laevis oocytes, we show a novel disulfide-cross-linked dimer conopeptide, Vt3.1 that preferentially inhibits BK channels containing the 4 subunit, which is most abundantly expressed in brain and important for neuronal functions. Vt3.1 inhibits the currents by a maximum of 71%, shifts the G-V relation by 45 mV approximately half-saturation concentrations, and alters both open and closed time of single channel activities, indicating that the toxin alters voltage dependence of the channel. Vt3.1 contains basic residues and inhibits voltage-dependent activation by electrostatic interactions with acidic residues in the extracellular loops of the slo1 and 4 subunits. These results suggest a large interaction surface between the slo1 subunit of BK channels and the 4 subunit, providing structural insight into the molecular interactions between slo1 and 4 subunits. The results also suggest that Vt3.1 is an excellent tool for studying subunit modulation of BK channels and for understanding the physiological roles of BK channels in neurophysiology.	[Li, Min; Yang, Longjin; Wang, Chunguang; Chi, Chengwu] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Li, Min; Shi, Jingyi; McFarland, Kelli; Yang, Xiao; Moller, Alyssa; Cui, Jianmin] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Chang, Shan; Zou, Xiaoqin] Univ Missouri, Dept Phys & Astron, Dept Biochem, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Chang, Shan; Zou, Xiaoqin] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Chi, Chengwu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Cui, Jianmin] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China	Tongji University; Washington University (WUSTL); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Chi, CW (corresponding author), Tongji Univ, Inst Prot Res, 1239 Siping Rd, Shanghai 200092, Peoples R China.	zwqi@sibs.ac.cn; jcui@wustl.edu		Chang, Shan/0000-0001-7169-9398	National Institutes of Health [R01-HL70393, R01-NS060706]; Chinese Ministry of Science and Technology [2010CB529802]; National Science Foundation of China [31271143]; National Science Foundation [DBI-0953839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL70393 and R01-NS060706. This work was also supported by Chinese Ministry of Science and Technology Grant 2010CB529802 (to M. L.), National Science Foundation of China Grant 31271143 (to J. C.), and National Science Foundation Career Award Grant DBI-0953839 (to X. Z.).	Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Duray H., 1997, SCI MED, V4, P6; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Fan CX, 2003, J BIOL CHEM, V278, P12624, DOI 10.1074/jbc.M210200200; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garcia-Valdes J, 2001, FEBS LETT, V505, P369, DOI 10.1016/S0014-5793(01)02791-0; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee US, 2009, J PHYSIOL-LONDON, V587, P1481, DOI 10.1113/jphysiol.2009.169243; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi J, 2008, BIOPHYS J, V94, P3706, DOI 10.1529/biophysj.107.122150; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Tao J., 2011, PLOS ONE, V6; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Windley MJ, 2011, MOL PHARMACOL, V80, P1, DOI 10.1124/mol.110.070540; Wu XC, 2010, PEPTIDES, V31, P1001, DOI 10.1016/j.peptides.2010.03.010; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yao J, 2005, J BIOL CHEM, V280, P14819, DOI 10.1074/jbc.M412735200; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	51	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4735	4742		10.1074/jbc.M113.535898	http://dx.doi.org/10.1074/jbc.M113.535898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398688	Green Published, hybrid			2022-12-25	WOS:000331607900020
J	Rafikov, R; Dimitropoulou, C; Aggarwal, S; Kangath, A; Gross, C; Pardo, D; Sharma, S; Jezierska-Drutel, A; Patel, V; Snead, C; Lucas, R; Verin, A; Fulton, D; Catravas, JD; Black, SM				Rafikov, Ruslan; Dimitropoulou, Christiana; Aggarwal, Saurabh; Kangath, Archana; Gross, Christine; Pardo, Daniel; Sharma, Shruti; Jezierska-Drutel, Agnieszka; Patel, Vijay; Snead, Connie; Lucas, Rudolf; Verin, Alexander; Fulton, David; Catravas, John D.; Black, Stephen M.			Lipopolysaccharide- induced Lung Injury Involves the Nitration- mediated Activation of RhoA*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lung Injury; Post-translational Modification; Protein Structure; Recombinant Protein Expression; Redox Regulation; Superoxide Ion; Enzymology	MICROVASCULAR ENDOTHELIAL-CELLS; TYROSINE NITRATION; CRYSTAL-STRUCTURE; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; PROTEIN NITRATION; BARRIER FUNCTION; AIRWAY DISEASE; CDC42; PEROXYNITRITE	Background: The activation of RhoA is a critical event in acute lung injury (ALI), but the role of nitration in this process is unresolved. Results: The nitration of RhoA at Tyr(34) produced GEF-like conformational changes that stimulate RhoA by decreasing GDP binding. Conclusion: We have identified a new mechanism of RhoA activation. Significance: Preventing RhoA nitration may be useful for the management of ALI. Acute lung injury (ALI) is characterized by increased endothelial hyperpermeability. Protein nitration is involved in the endothelial barrier dysfunction in LPS-exposed mice. However, the nitrated proteins involved in this process have not been identified. The activation of the small GTPase RhoA is a critical event in the barrier disruption associated with LPS. Thus, in this study we evaluated the possible role of RhoA nitration in this process. Mass spectroscopy identified a single nitration site, located at Tyr(34) in RhoA. Tyr(34) is located within the switch I region adjacent to the nucleotide-binding site. Utilizing this structure, we developed a peptide designated NipR1 (nitration inhibitory peptide for RhoA 1) to shield Tyr(34) against nitration. TAT-fused NipR1 attenuated RhoA nitration and barrier disruption in LPS-challenged human lung microvascular endothelial cells. Further, treatment of mice with NipR1 attenuated vessel leakage and inflammatory cell infiltration and preserved lung function in a mouse model of ALI. Molecular dynamics simulations suggested that the mechanism by which Tyr(34) nitration stimulates RhoA activity was through a decrease in GDP binding to the protein caused by a conformational change within a region of Switch I, mimicking the conformational shift observed when RhoA is bound to a guanine nucleotide exchange factor. Stopped flow kinetic analysis was used to confirm this prediction. Thus, we have identified a new mechanism of nitration-mediated RhoA activation involved in LPS-mediated endothelial barrier dysfunction and show the potential utility of shielding peptides to prevent RhoA nitration in the management of ALI.	[Rafikov, Ruslan; Dimitropoulou, Christiana; Aggarwal, Saurabh; Kangath, Archana; Gross, Christine; Pardo, Daniel; Sharma, Shruti; Jezierska-Drutel, Agnieszka; Snead, Connie; Lucas, Rudolf; Verin, Alexander; Fulton, David; Catravas, John D.; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Program Pulm Vasc Dis, Augusta, GA 30912 USA; [Patel, Vijay] Georgia Regents Univ, Dept Surg, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, 1459 Laney Walker Blvd,CB 3210-B, Augusta, GA 30912 USA.	sblack@gru.edu	Lucas, Rudolf/ABA-3011-2020; Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076; Sharma, Shruti/0000-0001-8200-108X; Lucas, Rudolf/0000-0003-3805-8868	National Institutes of Health [P01HL0101902]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL0101902.	Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Budge PJ, 2004, J VIROL, V78, P5015, DOI 10.1128/JVI.78.10.5015-5022.2004; Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Carbajal JM, 1999, AM J PHYSIOL-CELL PH, V277, pC955, DOI 10.1152/ajpcell.1999.277.5.C955; Catravas JD, 2010, VASC PHARMACOL, V52, P175, DOI 10.1016/j.vph.2009.12.009; Choi JC, 2008, J KOREAN MED SCI, V23, P288, DOI 10.3346/jkms.2008.23.2.288; Ckless K, 2008, J IMMUNOL, V181, P4255, DOI 10.4049/jimmunol.181.6.4255; Dechend R, 2003, CIRCULATION, V108, P261, DOI 10.1161/01.CIR.0000083367.93022.78; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; Groshaus HE, 2004, CRIT CARE, V8, P234, DOI 10.1186/cc2875; Guilgen G, 2011, BLOOD PURIFICAT, V32, P296, DOI 10.1159/000330327; Harrington EO, 2004, AM J PHYSIOL-LUNG C, V287, pL1091, DOI 10.1152/ajplung.00421.2003; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kallet Richard H, 2004, Respir Care, V49, P793; Knapp LT, 2001, BIOCHEM BIOPH RES CO, V286, P764, DOI 10.1006/bbrc.2001.5448; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Lucas R, 2012, P NATL ACAD SCI USA, V109, P2084, DOI 10.1073/pnas.1121075109; Magder S, 2006, J VASC RES, V43, P447, DOI 10.1159/000095162; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McNichol BA, 2006, MOL MICROBIOL, V60, P939, DOI 10.1111/j.1365-2958.2006.05157.x; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sugiura H, 2004, FREE RADICAL RES, V38, P49, DOI 10.1080/10715760310001633817; Visvikis O, 2010, BIOL CELL, V102, P377, DOI 10.1042/BC20090151; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728	45	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4710	4722		10.1074/jbc.M114.547596	http://dx.doi.org/10.1074/jbc.M114.547596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398689	Green Published, hybrid			2022-12-25	WOS:000331607900018
J	Yang, W; Park, IJ; Yun, H; Im, DU; Ock, S; Kim, J; Seo, SM; Shin, HY; Viollet, B; Kang, I; Choe, W; Kim, SS; Ha, J				Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Ock, Sangmi; Kim, Jaetaek; Seo, Seon-Mi; Shin, Ha-Yeon; Viollet, Benoit; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun			AMP-activated Protein Kinase 2 and E2F1 Transcription Factor Mediate Doxorubicin-induced Cytotoxicity by Forming a Positive Signal Loop in Mouse Embryonic Fibroblasts and Non-carcinoma Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Anticancer Drug; Cell Death; E2F Transcription Factor; Resveratrol; Doxorubicin	INDUCED CARDIOMYOCYTE APOPTOSIS; DNA-DAMAGE; GENOTOXIC STRESS; IN-VITRO; MICE; PHOSPHORYLATION; CARDIOTOXICITY; ADRIAMYCIN; INHIBITION; SUBUNIT	Background: Despite the central position in chemotherapy, the clinical application of doxorubicin is compromised by severe adverse effect in different organs. Results: Doxorubicin induces AMPK2 transcription, and AMPK2 in turn stabilizes E2F1 in non-carcinoma cells. Conclusion: AMPK2 and E2F1 mediate cytotoxicity of doxorubicin. Significance: AMPK2 might serve as a novel target for alleviating the cytotoxicity of doxorubicin. Doxorubicin is one of the most widely used anti-cancer drugs, but its clinical application is compromised by severe adverse effects in different organs including cardiotoxicity. In the present study we explored mechanisms of doxorubicin-induced cytotoxicity by revealing a novel role for the AMP-activated protein kinase 2 (AMPK2) in mouse embryonic fibroblasts (MEFs). Doxorubicin robustly induced the expression of AMPK2 in MEFs but slightly reduced AMPK1 expression. Our data support the previous notion that AMPK1 harbors survival properties under doxorubicin treatment. In contrast, analyses of Ampk2(-/-) MEFs, gene knockdown of AMPK2 by shRNA, and inhibition of AMPK2 activity with an AMPK inhibitor indicated that AMPK2 functions as a pro-apoptotic molecule under doxorubicin treatment. Doxorubicin induced AMPK2 at the transcription level via E2F1, a transcription factor that regulates apoptosis in response to DNA damage. E2F1 directly transactivated the Ampk2 gene promoter. In turn, AMPK2 significantly contributed to stabilization and activation of E2F1 by doxorubicin, forming a positive signal amplification loop. AMPK2 directly interacted with and phosphorylated E2F1. This signal loop was also detected in H9c2, C2C12, and ECV (human epithelial cells) cells as well as mouse liver under doxorubicin treatment. Resveratrol, which has been suggested to attenuate doxorubicin-induced cytotoxicity, significantly blocked induction of AMPK2 and E2F1 by doxorubicin, leading to protection of these cells. This signal loop appears to be non-carcinoma-specific because AMPK2 was not induced by doxorubicin in five different tested cancer cell lines. These results suggest that AMPK2 may serve as a novel target for alleviating the cytotoxicity of doxorubicin.	[Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Seo, Seon-Mi; Shin, Ha-Yeon; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, Seoul 130701, South Korea; [Yang, Wookyeom; Park, In-Ja; Yun, Hee; Im, Dong-Uk; Seo, Seon-Mi; Shin, Ha-Yeon; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun] Kyung Hee Univ, Sch Med, Inst Biomed Sci, Seoul 130701, South Korea; [Ock, Sangmi; Kim, Jaetaek] Chung Ang Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul 156755, South Korea; [Viollet, Benoit] Univ Paris 05, UMR8104, CNRS, INSERM,U1016,Inst Cochin, F-75014 Paris, France	Kyung Hee University; Kyung Hee University; Chung Ang University; Chung Ang University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ha, J (corresponding author), Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Med Res Ctr, 1 Hoegi Dong, Seoul 130701, South Korea.	hajh@khu.ac.kr	Yang, Wookyeom/X-3939-2019; Viollet, Benoit/O-6927-2017; Kim, Jaetaek/AAE-7147-2020; Viollet, Benoit/N-2397-2019; Kim, Sung Soo/S-2540-2017	Yang, Wookyeom/0000-0002-3970-7973; Viollet, Benoit/0000-0002-0121-0224; Kim, Jaetaek/0000-0001-5247-0408; Viollet, Benoit/0000-0002-0121-0224; Kim, Sung Soo/0000-0002-6817-7668	National Research Foundation of Korea grant; Korea government (MSIP) [2012009447, 20120009381]	National Research Foundation of Korea grant(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MSIP; 2012009447 and 20120009381).	Arcamone F, 2000, BIOTECHNOL BIOENG, V67, P704, DOI 10.1002/(SICI)1097-0290(20000320)67:6<704::AID-BIT8>3.0.CO;2-L; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Gu J, 2012, CARDIOVASC TOXICOL, V12, P341, DOI 10.1007/s12012-012-9178-7; HA J, 1994, J BIOL CHEM, V269, P22162; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hamlaoui S, 2012, J PHYSIOL PHARMACOL, V63, P293; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lin WC, 2001, GENE DEV, V15, P1833; Lv X., 2012, PLOS ONE, V7; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhu Q, 2010, MOL CELL BIOCHEM, V340, P275, DOI 10.1007/s11010-010-0428-3	52	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4839	4852		10.1074/jbc.M113.496315	http://dx.doi.org/10.1074/jbc.M113.496315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398673	hybrid, Green Published			2022-12-25	WOS:000331607900031
J	Yueh, MF; Chen, SJ; Nguyen, N; Tukey, RH				Yueh, Mei-Fei; Chen, Shujuan; Nghia Nguyen; Tukey, Robert H.			Developmental Onset of Bilirubin-induced Neurotoxicity Involves Toll-like Receptor 2-dependent Signaling in Humanized UDP-glucuronosyltransferase1 Mice*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Glia; Neuroinflammation; Oxidative Stress; Toll-like Receptors (TLR); UDP-glucuronosyltransferase	PATTERN-RECOGNITION RECEPTORS; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; NADPH OXIDASE; UGT1 LOCUS; CLINICAL-IMPLICATIONS; OXIDATIVE STRESS; CRIGLER-NAJJAR; LUNG INJURY; DISEASE	Background: Neonatal jaundice with dangerously high levels of serum bilirubin leads to neurological toxicity. Results: Toll-like receptor 2 signaling is essential for regulation of glia activation, neuroinflammation, and oxidative stress when neonatal mice experience severe hyperbilirubinemia. Conclusion: Toll-like receptor 2 signaling is linked to a protection mode against serum bilirubin-induced brain toxicity. Significance: Understanding how signaling from innate immunity contributes to bilirubin-induced pathology. Biological and signaling events that connect developmentally induced hyperbilirubinemia to bilirubin-induced neurological dysfunction (BIND) and CNS toxicity in humans are poorly understood. In mammals, UDP-glucuronosyltransferase 1A1 (UGT1A1) is the sole enzyme responsible for bilirubin glucuronidation, a rate-limiting step necessary for bilirubin metabolism and clearance. Humanized mice that express the entire UGT1 locus (hUGT1) and the UGT1A1 gene, develop neonatal hyperbilirubinemia, with 8-10% of hUGT1 mice succumbing to CNS damage, a phenotype that is presented by uncontrollable seizures. We demonstrate that neuroinflammation and reactive gliosis are prominent features of bilirubin brain toxicity, and a disturbed redox status resulting from activation of NADPH oxidase is an important contributing mechanism found in BIND. Using knock-out mice and primary brain cells, we connect a key pattern recognition receptor, Toll-like receptor 2 (TLR2), to hyperbilirubinemia-induced signaling. We illustrate a requirement for TLR2 signaling in regulating gliosis, proinflammatory mediators, and oxidative stress when neonatal mice encounter severe hyperbilirubinemia. TLR2-mediated gliosis strongly correlates with pronounced neuroinflammation in the CNS with up-regulation of TNF, IL-1, and IL-6, creating a pro-inflammatory CNS environment. Gene expression and immunohistochemistry staining show that hUGT1/Tlr2(-/-) mice fail to activate glial cells, proinflammatory cytokines, and stress response genes. In addition, bilirubin-induced apoptosis was significantly enhanced by blocking TLR2 signaling indicating its anti-apoptotic property. Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was observed when compared with hUGT1 mice (8.7%). These results suggest that TLR2 signaling and microglia neuroinflammation are linked to a repair and/or protection mode against BIND.	[Tukey, Robert H.] Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Tukey, RH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA.	rtukey@ucsd.edu		Chen, Shujuan/0000-0002-1068-195X	National Institutes of Health from the United States Public Health Service [P42ES010337, GM100481, GM086713]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086713, R01GM100481] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P42ES010337, GM100481, and GM086713 from the United States Public Health Service.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen SJ, 2012, HEPATOLOGY, V56, P658, DOI 10.1002/hep.25671; Chen SJ, 2005, J BIOL CHEM, V280, P37547, DOI 10.1074/jbc.M506683200; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gaddis DE, 2013, J LEUKOCYTE BIOL, V93, P21, DOI 10.1189/jlb.0512220; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2006, FASEB J, V20, P750, DOI 10.1096/fj.05-5234fje; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hansen TWR, 2002, CLIN PERINATOL, V29, P765, DOI 10.1016/S0095-5108(02)00053-2; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ionita MG, 2010, J INNATE IMMUN, V2, P307, DOI 10.1159/000314270; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson L, 2011, SEMIN PERINATOL, V35, P101, DOI 10.1053/j.semperi.2011.02.003; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; M Ni, 2010, CURR PROTOC TOXICOL, V43; Millar NL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/436203; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Vartanian KB, 2010, TRANSL STROKE RES, V1, P252, DOI 10.1007/s12975-010-0033-5; Yueh MF, 2011, MOL PHARMACOL, V79, P1053, DOI 10.1124/mol.110.070649; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005	50	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4699	4709		10.1074/jbc.M113.518613	http://dx.doi.org/10.1074/jbc.M113.518613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403077	Green Published, hybrid			2022-12-25	WOS:000331607900017
J	Burchett, KM; Yan, Y; Ouellette, MM				Burchett, Katrina M.; Yan, Ying; Ouellette, Michel M.			Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR-GROWTH; DNA; ADENOCARCINOMA; SHELTERIN; MAINTENANCE; TANKYRASE-1; ANTAGONIST; TISSUES	Telomerase is required for the unlimited lifespan of cancer cells. The vast majority of pancreatic adenocarcinomas overexpress telomerase activity and blocking telomerase could limit their lifespan. GRN163L (Imetelstat) is a lipid-conjugated N39RP59 thio-phosphoramidate oligonucleotide that blocks the template region of telomerase. The aim of this study was to define the effects of long-term GRN163L exposure on the maintenance of telomeres and lifespan of pancreatic cancer cells. Telomere size, telomerase activity, and telomerase inhibition response to GRN163L were measured in a panel of 10 pancreatic cancer cell lines. The cell lines exhibited large differences in levels of telomerase activity (46-fold variation), but most lines had very short telomeres (2-3 kb in size). GRN163L inhibited telomerase in all 10 pancreatic cancer cell lines, with IC50 ranging from 50 nM to 200 nM. Continuous GRN163L exposure of CAPAN1 (IC50 = 75 nM) and CD18 cells (IC50 = 204 nM) resulted in an initial rapid shortening of the telomeres followed by the maintenance of extremely short but stable telomeres. Continuous exposure to the drug eventually led to crisis and to a complete loss of viability after 47 (CAPAN1) and 69 (CD18) doublings. Crisis In these cells was accompanied by activation of a DNA damage response (gamma-H2AX) and evidence of both senescence (SA-b-galactosidase activity) and apoptosis (sub-G1 DNA content, PARP cleavage). Removal of the drug after long-term GRN163L exposure led to a reactivation of telomerase and re-elongation of telomeres in the third week of cultivation without GRN163L. These findings show that the lifespan of pancreatic cancer cells can be limited by continuous telomerase inhibition. These results should facilitate the design of future clinical trials of GRN163L in patients with pancreatic cancer.	[Burchett, Katrina M.; Yan, Ying; Ouellette, Michel M.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Ouellette, Michel M.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Ouellette, MM (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.	mouellet@unmc.edu			National Cancer Institute (NCI) [P50 CA127297]; NCI [T32 CA09476]; NATIONAL CANCER INSTITUTE [P50CA127297, T32CA009476] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Cancer Institute (NCI) SPORE grant (P50 CA127297) and NCI training grant (T32 CA09476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Choi KH, 2009, ROLE TELOMERASE CANC; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Djojosubroto MW, 2005, HEPATOLOGY, V42, P1127, DOI 10.1002/hep.20822; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gellert GC, 2006, BREAST CANCER RES TR, V96, P73, DOI 10.1007/s10549-005-9043-5; Gryaznov S, 2001, NUCLEOS NUCLEOT NUCL, V20, P401, DOI 10.1081/NCN-100002314; Gryaznov SM, 2010, CHEM BIODIVERS, V7, P477, DOI 10.1002/cbdv.200900187; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hiyama E, 1997, CANCER RES, V57, P326; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Iwamura T, 1999, HUMAN CELL CULTURE, V1, P107; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Lau LMS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks781; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Nakamura T, 2007, CANCER RES, V67, P139, DOI 10.1158/0008-5472.CAN-06-2563; Norton JC, 1996, NAT BIOTECHNOL, V14, P615, DOI 10.1038/nbt0596-615; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pearson AS, 2000, INT J ONCOL, V17, P381; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2008, CLIN CANCER RES, V14, P4971, DOI 10.1158/1078-0432.CCR-08-0473; Shay JW, 2005, CANCER CELL, V7, P1, DOI 10.1016/j.ccr.2004.12.012; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shea-Herbert B, 2002, ONCOGENE, V21, P638, DOI 10.1038/sj.onc.1205064; Siegel R, 2012, CANC FACTS FIGURES; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; Tsutsumi M, 1997, JPN J CANCER RES, V88, P971, DOI 10.1111/j.1349-7006.1997.tb00317.x; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; White LK, 2001, TRENDS BIOTECHNOL, V19, P114, DOI 10.1016/S0167-7799(00)01541-9; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Wright WE, 1996, DEV GENET, V18, P173; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020	61	49	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85155	10.1371/journal.pone.0085155	http://dx.doi.org/10.1371/journal.pone.0085155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409321	Green Submitted, gold, Green Published			2022-12-25	WOS:000329463500045
J	Benabdellah, K; Gutierrez-Guerrero, A; Cobo, M; Munoz, P; Martin, F				Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Munoz, Pilar; Martin, Francisco			A Chimeric HS4-SAR Insulator (IS2) That Prevents Silencing and Enhances Expression of Lentiviral Vectors in Pluripotent Stem Cells	PLOS ONE			English	Article							SCAFFOLD ATTACHMENT REGION; TRANSGENE EXPRESSION; GENE-THERAPY; CHROMATIN INSULATOR; CHS4 INSULATOR; RETROVIRAL VECTORS; METHYLATION; DIFFERENTIATION; SEQUENCES; DESIGN	Chromatin insulators, such as the chicken beta-globin locus control region hypersensitive site 4 (HS4), and scaffold/matrix attachment regions (SARs/MARs) have been incorporated separately or in combination into retroviral vectors (RVs) in order to increase transgene expression levels, avoid silencing and reduce expression variability. However, their incorporation into RVs either produces a reduction on titer and/or expression levels or do not have sufficient effect on stem cells. In order to develop an improved insulator we decided to combine SAR elements with HS4 insulators. We designed several synthetic shorter SAR elements containing 4 or 5 MAR/SARs recognition signatures (MRS) and studied their effects on a lentiviral vector (LV) expressing eGFP through the SFFV promoter (SE). A 388 bp SAR element containing 5 MRS, named SAR2, was as efficient or superior to the other SARs analyzed. SAR2 enhanced transgene expression and reduced silencing and variability on human embryonic stem cells (hESCs). We next compared the effect of different HS4-based insulators, the HS4-Core (250 bp), the HS4-Ext (400 bp) and the HS4-650 (650 bp). All HS4 elements reduced silencing and expression variability but they also had a negative effect on transgene expression levels and titer. In general, the HS4-650 element had a better overall effect. Based on these data we developed a chimeric insulator, IS2, combining the SAR2 and the HS4-650. When incorporated into the 3' LTR of the SE LV, the IS2 element was able to enhance expression, avoid silencing and reduce variability of expression on hESCs. Importantly, these effects were maintained after differentiation of the transduced hESCs toward the hematopoietic linage. Neither the HS4-650 nor the SAR2 elements had these effects. The IS2 element is therefore a novel insulator that confers expression stability and enhances expression of LVs on stem cells.	[Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Munoz, Pilar; Martin, Francisco] Univ Granada, PTS Granada, Pfizer, GENYO Ctr Genom & Oncol Res,Human DNA Variabil De, Granada, Spain	Pfizer; University of Granada	Benabdellah, K (corresponding author), Univ Granada, PTS Granada, Pfizer, GENYO Ctr Genom & Oncol Res,Human DNA Variabil De, Granada, Spain.	Karim.benabdel@genyo.es; francisco.martin@genyo.es	Munoz, Pilar/N-2277-2016; Martin, Francisco/K-8763-2014; Benabdellah, karim/F-4209-2016; Benabdellah, karim/L-4569-2014	Munoz, Pilar/0000-0002-7985-9859; Martin, Francisco/0000-0003-1961-8612; Benabdellah, karim/0000-0003-2790-562X; Benabdellah, karim/0000-0003-4673-2111	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PS09/00340]; Consejeria de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejeria de Salud from the Junta de Andalucia [PI0001/2009]; FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - ISCIII	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Consejeria de Innovacion Ciencia y Empresa; Consejeria de Salud from the Junta de Andalucia(Junta de Andalucia); FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia)(Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - ISCIII(Instituto de Salud Carlos III)	This work has been financed by Fondo de Investigaciones Sanitarias ISCIII (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [grant number PS09/00340], by the Consejeria de Innovacion Ciencia y Empresa [grant numbers P09-CTS-04532 and PAIDI-Bio-326] and by the Consejeria de Salud [grant number PI0001/2009] from the Junta de Andalucia and FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia 2007-2013 to F.M., M.C. and F.M. are funded by Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia). K.B. is financed by the Consejeria de Innovacion Ciencia y Empresa [grant number P09-CTS-04532]. P.M. has a Sara Borrell contract from the Fondo de Investigaciones Sanitarias (FIS) - ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 1998, J VIROL, V72, P3720, DOI 10.1128/JVI.72.5.3720-3728.1998; Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Arumugam PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006995; Barkess G, 2012, EPIGENOMICS-UK, V4, P67, DOI [10.2217/EPI.11.112, 10.2217/epi.11.112]; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Dang Q, 2000, J VIROL, V74, P2671, DOI 10.1128/JVI.74.6.2671-2678.2000; Dravid G, 2011, MOL THER, V19, P768, DOI 10.1038/mt.2010.281; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Giannakopoulos A, 2009, J MOL BIOL, V387, P1239, DOI 10.1016/j.jmb.2009.02.043; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hawley Robert G., 2001, Current Gene Therapy, V1, P1, DOI 10.2174/1566523013348904; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Ji JF, 2008, STEM CELLS, V26, P2485, DOI 10.1634/stemcells.2008-0642; KLEHR D, 1992, BIOCHEMISTRY-US, V31, P3222, DOI 10.1021/bi00127a025; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Mok HP, 2007, GENE THER, V14, P741, DOI 10.1038/sj.gt.3302923; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Munoz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039091; Neff T, 1997, STEM CELLS, V15, P265; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Park F, 2001, MOL THER, V4, P164, DOI 10.1006/mthe.2001.0450; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Rincon-Arano H, 2007, P NATL ACAD SCI USA, V104, P14044, DOI 10.1073/pnas.0704999104; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Senigl F, 2012, NUCLEIC ACIDS RES, V40, P5298, DOI 10.1093/nar/gks197; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Stein S, 2008, HUM GENE THER, V19, P1097; Toscano MG, 2008, HUM GENE THER, V19, P179, DOI 10.1089/hum.2007.098; Uchida N, 2011, MOL THER, V19, P133, DOI 10.1038/mt.2010.218; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; van Drunen CM, 1999, NUCLEIC ACIDS RES, V27, P2924, DOI 10.1093/nar/27.14.2924; Wei GH, 2005, CELL RES, V15, P292, DOI 10.1038/sj.cr.7290298; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582	44	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84268	10.1371/journal.pone.0084268	http://dx.doi.org/10.1371/journal.pone.0084268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400083	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700017
J	Cheron, G; Leroy, A; Palmero-Soler, E; De Saedeleer, C; Bengoetxea, A; Cebolla, AM; Vidal, M; Dan, B; Berthoz, A; McIntyre, J				Cheron, Guy; Leroy, Axelle; Palmero-Soler, Ernesto; De Saedeleer, Caty; Bengoetxea, Ana; Cebolla, Ana-Maria; Vidal, Manuel; Dan, Bernard; Berthoz, Alain; McIntyre, Joseph			Gravity Influences Top-Down Signals in Visual Processing	PLOS ONE			English	Article							REFERENCE FRAMES; PARIETAL CORTEX; WORKING-MEMORY; PERCEPTION; MOTION; OSCILLATIONS; MODULATION; ATTENTION; ALPHA; SYNCHRONIZATION	Visual perception is not only based on incoming visual signals but also on information about a multimodal reference frame that incorporates vestibulo-proprioceptive input and motor signals. In addition, top-down modulation of visual processing has previously been demonstrated during cognitive operations including selective attention and working memory tasks. In the absence of a stable gravitational reference, the updating of salient stimuli becomes crucial for successful visuo-spatial behavior by humans in weightlessness. Here we found that visually-evoked potentials triggered by the image of a tunnel just prior to an impending 3D movement in a virtual navigation task were altered in weightlessness aboard the International Space Station, while those evoked by a classical 2D-checkerboard were not. Specifically, the analysis of event-related spectral perturbations and inter-trial phase coherency of these EEG signals recorded in the frontal and occipital areas showed that phase-locking of theta-alpha oscillations was suppressed in weightlessness, but only for the 3D tunnel image. Moreover, analysis of the phase of the coherency demonstrated the existence on Earth of a directional flux in the EEG signals from the frontal to the occipital areas mediating a top-down modulation during the presentation of the image of the 3D tunnel. In weightlessness, this fronto-occipital, top-down control was transformed into a diverging flux from the central areas toward the frontal and occipital areas. These results demonstrate that gravity-related sensory inputs modulate primary visual areas depending on the affordances of the visual scene.	[Cheron, Guy; Leroy, Axelle; Palmero-Soler, Ernesto; De Saedeleer, Caty; Bengoetxea, Ana; Cebolla, Ana-Maria; Dan, Bernard] Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Biomech Movement, Brussels, Belgium; [Cheron, Guy; De Saedeleer, Caty] Univ Mons, Lab Electrophysiol, B-7000 Mons, Belgium; [Vidal, Manuel; Berthoz, Alain] CNRS, Coll France, Lab Physiol Percept & Act, Paris, France; [McIntyre, Joseph] Univ Paris 05, CNRS, Inst Neurosci & Cognit, Ctr Etude Sensorimotricite,UMR 8194, Paris, France	Universite Libre de Bruxelles; University of Mons; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Cheron, G (corresponding author), Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Biomech Movement, Brussels, Belgium.	gcheron@ulb.ac.be	McIntyre, Joseph/K-6395-2015	McIntyre, Joseph/0000-0003-4974-4257; Dan, Bernard/0000-0002-2051-9876; , Ana/0000-0002-8885-796X; Vidal, Manuel/0000-0002-8504-1500	Belgian Federal Science Policy Office; European Space Agency [AO-2004,118]; Belgian National Fund for Scientific Research (FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Centre National d'Etudes Spatiales (CNES)	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004,118), the Belgian National Fund for Scientific Research (FNRS), the research funds of the Universite Libre de Bruxelles and of the Universite de Mons (Belgium) and the Centre National d'Etudes Spatiales (CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Bartsch T, 2010, SCIENCE, V328, P1412, DOI 10.1126/science.1188160; Berthoz A, 1991, BRAIN SPACE, P82; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Cardin V, 2011, CEREB CORTEX, V21, P550, DOI 10.1093/cercor/bhq122; Cheron G, 2006, BRAIN RES, V1121, P104, DOI 10.1016/j.brainres.2006.08.098; Cheron G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-75; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; De Saedeleer C, 2013, EXP BRAIN RES, V226, P95, DOI 10.1007/s00221-013-3414-7; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deutschlander A, 2008, BRAIN, V131, P1025, DOI 10.1093/brain/awn035; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Freunberger R, 2008, EUR J NEUROSCI, V27, P2330, DOI 10.1111/j.1460-9568.2008.06190.x; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Harris LR, 2010, J VESTIBUL RES-EQUIL, V20, P25, DOI 10.3233/VES-2010-0352; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Kovacs G, 2010, NEUROIMAGE, V51, P329, DOI 10.1016/j.neuroimage.2010.02.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lipshits M, 2005, PERCEPTION, V34, P545, DOI 10.1068/p5358; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Michel Christoph M, 2004, Suppl Clin Neurophysiol, V57, P617; MOCKS J, 1984, ELECTROEN CLIN NEURO, V57, P571, DOI 10.1016/0013-4694(84)90093-2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Patai EZ, 2012, J COGNITIVE NEUROSCI, V24, P2281, DOI 10.1162/jocn_a_00294; PAVARD B, 1977, PERCEPTION, V6, P529, DOI 10.1068/p060529; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Pollen DA, 2011, CEREB CORTEX, V21, P1941, DOI 10.1093/cercor/bhq285; Ramalingam N, 2013, J NEUROSCI, V33, P1773, DOI 10.1523/JNEUROSCI.3825-12.2013; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Steve Luck, 2005, INTRO EVENT RELATED; Stokes MG, 2012, P NATL ACAD SCI USA, V109, pE360, DOI 10.1073/pnas.1108555108; Summerfield JJ, 2011, J NEUROSCI, V31, P14952, DOI 10.1523/JNEUROSCI.5541-10.2011; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TURETSKY BI, 1988, ELECTROEN CLIN NEURO, V71, P310, DOI 10.1016/0168-5597(88)90032-9; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal M, 2006, PERCEPT PSYCHOPHYS, V68, P1338, DOI 10.3758/BF03193732; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	58	44	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e82371	10.1371/journal.pone.0082371	http://dx.doi.org/10.1371/journal.pone.0082371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400069	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700003
J	Chong, PM; Lynch, T; McCorrister, S; Kibsey, P; Miller, M; Gravel, D; Westmacott, GR; Mulvey, MR				Chong, Patrick M.; Lynch, Tarah; McCorrister, Stuart; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Westmacott, Garrett R.; Mulvey, Michael R.		CNISP	Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole	PLOS ONE			English	Article							UPTAKE REGULATOR FUR; HELICOBACTER-PYLORI; 5-NITROIMIDAZOLE RESISTANCE; REDUCED SUSCEPTIBILITY; ESCHERICHIA-COLI; RECA PROTEIN; NIM GENES; STRAINS; OXIDOREDUCTASE; INVOLVEMENT	Background: Clostridium difficile is an anaerobic, Gram-positive bacterium that has been implicated as the leading cause of antibiotic-associated diarrhea. Metronidazole is currently the first-line treatment for mild to moderate C. difficile infections. Our laboratory isolated a strain of C. difficile with a stable resistance phenotype to metronidazole. A shotgun proteomics approach was used to compare differences in the proteomes of metronidazole-resistant and -susceptible isolates. Methodology/Principal Findings: NAP1 C. difficile strains CD26A54_R (Met-resistant), CD26A54_S (reduced-susceptibility), and VLOO13 (Met-susceptible) were grown to mid-log phase, and spiked with metronidazole at concentrations 2 doubling dilutions below the MIC. Peptides from each sample were labeled with iTRAQ and subjected to 2D-LC-MS/MS analysis. In the absence of metronidazole, higher expression was observed of some proteins in C. difficile strains CD26A54_S and CD26A54_R that may be involved with reduced susceptibility or resistance to metronidazole, including DNA repair proteins, putative nitroreductases, and the ferric uptake regulator (Fur). After treatment with metronidazole, moderate increases were seen in the expression of stress-related proteins in all strains. A moderate increase was also observed in the expression of the DNA repair protein RecA in CD26A54_R. Conclusions/Significance: This study provided an in-depth proteomic analysis of a stable, metronidazole-resistant C. difficile isolate. The results suggested that a multi-factorial response may be associated with high level metronidazole-resistance in C. difficile, including the possible roles of altered iron metabolism and/or DNA repair.	[Chong, Patrick M.; Lynch, Tarah; McCorrister, Stuart; Gravel, Denise; Westmacott, Garrett R.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kibsey, Pamela] Victoria Gen Hosp, Victoria, BC, Canada; [Miller, Mark] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Public Health Agency of Canada; University of Victoria; McGill University	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Winnipeg, MB, Canada.	Michael_mulvey@phac-aspc.gc.ca	Quach, Caroline/AAT-6987-2021; Evans, Gerald/J-9229-2019; McGeer, Allison/AAB-6885-2020	Quach, Caroline/0000-0002-1170-9475; Evans, Gerald/0000-0003-2557-0897; McGeer, Allison/0000-0001-5647-6137; Forgie, Sarah/0000-0001-8073-5389; Langley, Joanne/0000-0003-3270-7345				Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Alauzet C, 2010, ANTIMICROB AGENTS CH, V54, P60, DOI 10.1128/AAC.01003-09; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 1999, ANTIMICROB AGENTS CH, V43, P2607, DOI 10.1128/AAC.43.11.2607; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Brazier JS, 2001, J ANTIMICROB CHEMOTH, V48, P741, DOI 10.1093/jac/48.5.741; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Carlier JP, 1997, ANTIMICROB AGENTS CH, V41, P1495, DOI 10.1128/AAC.41.7.1495; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Choi SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018236; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Diniz CG, 2004, J ANTIMICROB CHEMOTH, V54, P100, DOI 10.1093/jac/dkh256; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P9, DOI 10.1093/jac/31.1.9; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P988, DOI 10.1093/jac/dki357; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Gancz H, 2011, J MICROBIOL, V49, P294, DOI 10.1007/s12275-011-0396-7; Goldstein EJC, 2010, ANAEROBE, V16, P220, DOI 10.1016/j.anaerobe.2009.12.002; HAGGOUD A, 1994, ANTIMICROB AGENTS CH, V38, P1047, DOI 10.1128/AAC.38.5.1047; Hoffman PS, 1996, J BACTERIOL, V178, P4822, DOI 10.1128/jb.178.16.4822-4829.1996; Huang HH, 2010, ANAEROBE, V16, P633, DOI 10.1016/j.anaerobe.2010.09.002; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Johnson S, 2000, CLIN INFECT DIS, V31, P625, DOI 10.1086/313955; Jorgensen MA, 2001, ARCH BIOCHEM BIOPHYS, V392, P180, DOI 10.1006/abbi.2001.2427; Kaakoush NO, 2009, ANTIMICROB AGENTS CH, V53, P1884, DOI 10.1128/AAC.01449-08; Kaihovaara P, 1998, J ANTIMICROB CHEMOTH, V41, P171, DOI 10.1093/jac/41.2.171; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kwon DH, 2000, FEMS MICROBIOL LETT, V188, P197, DOI 10.1111/j.1574-6968.2000.tb09193.x; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Land KM, 1999, DRUG RESIST UPDATE, V2, P289, DOI 10.1054/drup.1999.0104; Leffler DA, 2009, GASTROENTEROLOGY, V136, P1899, DOI 10.1053/j.gastro.2008.12.070; Leitsch D, 2011, J ANTIMICROB CHEMOTH, V66, P1756, DOI 10.1093/jac/dkr192; Lofmark S, 2005, ANTIMICROB AGENTS CH, V49, P1253, DOI 10.1128/AAC.49.3.1253-1256.2005; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Lynch T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053757; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Moura I, 2013, J ANTIMICROB CHEMOTH, V68, P362, DOI 10.1093/jac/dks420; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; O'Connor J, 2009, GEOJOURNAL LIB, V98, P1, DOI 10.1007/978-1-4020-9949-6_1; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Proctor RA, 1998, DRUG RESIST UPDATE, V1, P227, DOI 10.1016/S1368-7646(98)80003-4; Reysset G, 1996, ANAEROBE, V2, P59, DOI 10.1006/anae.1996.0008; REYSSET G, 1993, CLIN INFECT DIS, V16, pS401, DOI 10.1093/clinids/16.Supplement_4.S401; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Roggenkamp A, 2004, INFECT IMMUN, V72, P2254, DOI 10.1128/IAI.72.4.2254-2262.2004; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schapiro JM, 2004, J CLIN MICROBIOL, V42, P4127, DOI 10.1128/JCM.42.9.4127-4129.2004; Schaumann R, 2005, INFECTION, V33, P368, DOI 10.1007/s15010-005-5061-9; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; THOMPSON SA, 1995, INFECT IMMUN, V63, P2185, DOI 10.1128/IAI.63.6.2185-2193.1995; TOCHER JH, 1994, BIOCHEM PHARMACOL, V48, P1089, DOI 10.1016/0006-2952(94)90144-9; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wong SSY, 1999, DIAGN MICR INFEC DIS, V34, P1, DOI 10.1016/S0732-8893(98)00139-4	72	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e82622	10.1371/journal.pone.0082622	http://dx.doi.org/10.1371/journal.pone.0082622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400070	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700004
J	Bai, L; Kiyama, T; Li, HY; Wang, SW				Bai, Ling; Kiyama, Takae; Li, Hongyan; Wang, Steven W.			Birth of Cone Bipolar Cells, but Not Rod Bipolar Cells, Is Associated with Existing RGCs	PLOS ONE			English	Article							RETINAL GANGLION-CELL; DOMAIN FACTOR BRN-3B; HOMEOBOX GENE VSX1; FATE SPECIFICATION; PROGENITOR CELLS; MOUSE RETINA; MATH5; DIFFERENTIATION; PROLIFERATION; COMPETENCE	Retinal ganglion cells (RGCs) play important roles in retinogenesis. They are required for normal retinal histogenesis and retinal cell number balance. Developmental RGC loss is typically characterized by initial retinal neuronal number imbalance and subsequent loss of retinal neurons. However, it is not clear whether loss of a specific non-RGC cell type in the RGC-depleted retina is due to reduced cell production or subsequent degeneration. Taking advantage of three knockout mice with varying degrees of RGC depletion, we re-examined bipolar cell production in these retinas from various aspects. Results show that generation of the cone bipolar cells is correlated with the existing number of RGCs. However, generation of the rod bipolar cells is unaffected by RGC shortage. Results report the first observation that RGCs selectively influence the genesis of subsequent retinal cell types.	[Kiyama, Takae; Li, Hongyan; Wang, Steven W.] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Sch Med, Houston, TX 77030 USA; [Bai, Ling] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Ophthalmol, Xian, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Xi'an Jiaotong University	Wang, SW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Sch Med, Houston, TX 77030 USA.	Steven.Wang@uth.tmc.edu			National Institutes of Health National Eye Institute (NEI) [EY018352]; NEI [P30EY10608]; E. Matilda Ziegler Foundation for the Blind; Research to Prevent Blindness; Hermann Eye Fund; Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China; NATIONAL EYE INSTITUTE [R01EY018352, P30EY010608] Funding Source: NIH RePORTER	National Institutes of Health National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Ziegler Foundation for the Blind; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources: National Institutes of Health National Eye Institute (NEI) EY018352 to SWW, NEI core grant P30EY10608, E. Matilda Ziegler Foundation for the Blind (http://emzfoundation.com) to SWW, Research to Prevent Blindness (http://www.rpbusa.org), and the Hermann Eye Fund (http://www.cizikeye.org/hermann_eye_fund.htm). Dr. Ling Bai's visiting scholar position was partially supported by the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China. All mentioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Chow RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Fu XY, 2009, DEV DYNAM, V238, P2309, DOI 10.1002/dvdy.21974; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; Hassan BA, 2000, GENE DEV, V14, P1852; Inoue T, 2002, DEVELOPMENT, V129, P831; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kiyama T, 2011, VISION RES, V51, P251, DOI 10.1016/j.visres.2010.10.016; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Moshiri A, 2004, J NEUROSCI, V24, P229, DOI 10.1523/JNEUROSCI.2980-03.2004; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Ohtoshi A, 2004, CURR BIOL, V14, P530, DOI 10.1016/j.cub.2004.02.027; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; WAID DK, 1995, NEURON, V14, P117, DOI 10.1016/0896-6273(95)90245-7; Waid DK, 1998, DEVELOPMENT, V125, P1059; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83686	10.1371/journal.pone.0083686	http://dx.doi.org/10.1371/journal.pone.0083686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392091	gold, Green Submitted, Green Published			2022-12-25	WOS:000329460100015
J	Suteu, D; Bacila, I; Has, V; Has, I; Miclaus, M				Suteu, Dana; Bacila, Ioan; Has, Voichita; Has, Ioan; Miclaus, Mihai			Romanian Maize (Zea mays) Inbred Lines as a Source of Genetic Diversity in SE Europe, and Their Potential in Future Breeding Efforts	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; BALSAS RIVER VALLEY; POPULATIONS; INFERENCE; TRAITS; INTROGRESSION; INDIVIDUALS; METHIONINE; NUMBER; GENOME	Maize has always been under constant human selection ever since it had been domesticated. Intensive breeding programs that resulted in the massive use of hybrids nowadays have started in the 60s. That brought significant yield increases but reduced the genetic diversity at the same time. Consequently, breeders and researchers alike turned their attention to national germplasm collections established decades ago in many countries, as they may hold allelic variations that could prove useful for future improvements. These collections are mainly composed of inbred lines originating from well-adapted local open pollinated varieties. However, there is an overall lack of data in the literature about the genetic diversity of maize in SE Europe, and its potential for future breeding efforts. There are no data, whatsoever, on the nutritional quality of the grain, primarily dictated by the zein proteins. We therefore sought to use the Romanian maize germplasm as an entry point in understanding the molecular make-up of maize in this part of Europe. By using 80 SSR markers, evenly spread throughout the genome, on 82 inbred lines from various parts of the country, we were able to decipher population structure and the existing relationships between those and the eight international standards used, including the reference sequenced genome B73. Corroborating molecular data with a standardized morphological, physiological, and biochemical characterization of all 90 inbred lines, this is the first comprehensive such study on the existing SE European maize germplasm. The inbred lines we present here are an important addition to the ever-shrinking gene pool that the breeding programs are faced-with, because of the allelic richness they hold. They may serve as parental lines in crosses that will lead to new hybrids, characterized by a high level of heterosis, nationwide and beyond, due to their existing relationship with the international germplasm.	[Suteu, Dana; Bacila, Ioan; Miclaus, Mihai] Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania; [Has, Voichita; Has, Ioan] Agr Res & Dev Stn, Turda, Romania; [Has, Ioan] Univ Agr Sci & Vet Med, Cluj Napoca, Romania	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Miclaus, M (corresponding author), Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania.	mihai.miclaus@icbcluj.ro	Miclăuș, Mihai/L-1340-2019; Suteu, Dana/A-1719-2017; Miclaus, Mihai/G-5571-2011; Bacila, Ioan/B-8867-2012	Miclăuș, Mihai/0000-0001-7969-2393; Miclaus, Mihai/0000-0001-7969-2393; 	Romanian National Authority for Scientific Research, CNDI-UEFISCDI [PN-II-PT-PCCA-2011-3.1-0511-103/2012]	Romanian National Authority for Scientific Research, CNDI-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a grant of the Romanian National Authority for Scientific Research, CNDI-UEFISCDI (http://uefiscdi.gov.ro/), project number PN-II-PT-PCCA-2011-3.1-0511-103/2012 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bioversity International, 2007, BIOV TECHN B SER; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; BRANDOLINI A., 1970, Maydica, V15, P5; Cristea M, 1977, ROMANIAN MAIZE RACES; Dubreuil P, 2006, MAYDICA, V51, P281; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartings H, 2008, THEOR APPL GENET, V117, P831, DOI 10.1007/s00122-008-0823-2; Holding D, 2013, SEED GENOMICS; Holding David R., 2009, V63, P269; Ionescu-Sisesti G, 1955, MAIZE CULTURE; Krishnan HB, 2010, J AGR FOOD CHEM, V58, P7323, DOI 10.1021/jf100927u; LENG ER, 1962, EUPHYTICA, V11, P263; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Madgearu V, 1931, OFFICIAL PUBLICATION, V2, P18; Nuss ET, 2011, ADV NUTR, V2, P217, DOI 10.3945/an.110.000182; Pascovschi V, 1957, MAIZE MONOGRAPH ROMA, P19; PHILLIPS RL, 1985, CEREAL CHEM, V62, P213; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pritchard JK, 2000, GENETICS, V155, P945; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Rebourg C, 2001, HEREDITY, V86, P574, DOI 10.1046/j.1365-2540.2001.00869.x; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Scott MP, 2006, MAYDICA, V51, P417; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; SWARUP S, 1995, PLANT J, V8, P359, DOI 10.1046/j.1365-313X.1995.08030359.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wang LZ, 2008, J CEREAL SCI, V48, P387, DOI 10.1016/j.jcs.2007.09.014; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Xu JH, 2008, P NATL ACAD SCI USA, V105, P14330, DOI 10.1073/pnas.0807026105; Xu JH, 2012, MOL BIOL EVOL, V29, P861, DOI 10.1093/molbev/msr261; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9; Zhang PF, 2003, PLANT MOL BIOL, V52, P1, DOI 10.1023/A:1023942819106	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85501	10.1371/journal.pone.0085501	http://dx.doi.org/10.1371/journal.pone.0085501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392016	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900160
J	Kwon, SJ; Park, JH; Park, EJ; Lee, SA; Lee, HS; Kang, SW; Kwon, J				Kwon, S-J; Park, J-H; Park, E-J; Lee, S-A; Lee, H-S; Kang, S. W.; Kwon, J.			ATM-mediated phosphorylation of the chromatin remodeling enzyme BRG1 modulates DNA double-strand break repair	ONCOGENE			English	Article						BRG1 chromatin remodeling enzyme; DNA double-strand break repair; ATM phosphorylation; gamma-H2AX	DAMAGE RESPONSE; INO80 COMPLEX; SWI/SNF; REPLICATION; GAMMA-H2AX; RSC; CANCER; SITES; RECRUITMENT; TRANSCRIPTION	ATP-dependent chromatin remodeling complexes such as SWI/SNF (SWItch/Sucrose NonFermentable) have been implicated in DNA double-strand break (DSB) repair and damage responses. However, the regulatory mechanisms that control the function of chromatin remodelers in DNA damage response are largely unknown. Here, we show that ataxia telangiectasia mutated (ATM) mediates the phosphorylation of BRG1, the catalytic ATPase of the SWI/SNF complex that contributes to DSB repair by binding g-H2AX-containing nucleosomes via interaction with acetylated histone H3 and stimulating gamma-H2AX formation, at Ser-721 in response to DNA damage. ATM-mediated phosphorylation of BRG1 occurs rapidly and transiently after DNA damage. Phosphorylated BRG1 binds g-H2AX-containing nucleosomes to form the repair foci. The Ser-721 phosphorylation of BRG1 is critical for binding g-H2AX-containing nucleosomes and stimulating g-H2AX formation and DSB repair. BRG1 binds to acetylated H3 peptides much better after phosphorylation at Ser-721 by DNA damage. However, the phosphorylation of Ser-721 does not significantly affect the ATPase and transcriptional activities of BRG1. These results, establishing BRG1 as a novel and functional ATM substrate, suggest that the ATM-mediated phosphorylation of BRG1 facilitates DSB repair by stimulating the association of this remodeler with g-H2AX nucleosomes via enhancing the affinity to acetylated H3. Our work also suggests that the mechanism of BRG1 stimulation of DNA repair is independent of the remodeler's enzymatic or transcriptional activities.	[Kwon, S-J; Park, J-H; Park, E-J; Lee, S-A; Lee, H-S; Kang, S. W.; Kwon, J.] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Coll Nat Sci, Dept Life Sci, Seoul 120750, South Korea	Ewha Womans University	Kwon, J (corresponding author), Ewha Womans Univ, Res Ctr Cellular Homeostasis, Coll Nat Sci, Dept Life Sci, Daehyun Dong 11-1,Sci Bld C 308, Seoul 120750, South Korea.	jongkwon@ewha.ac.kr			National Research Foundation (NRF) - Korea Ministry of Education and Science (MEST) [2012R1A2A2A01003744]; MEST [2012R1A5A1048236]; Ewha Global Top5 Grant; Ewha Womans University	National Research Foundation (NRF) - Korea Ministry of Education and Science (MEST)(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ewha Global Top5 Grant; Ewha Womans University	We thank Rho H Seong (Seoul National University) for kindly providing the plasmids pREP4-p53RE-luc and flag-p53, and Seul-Ki Lee and Shin-Kyoung Hur for technical assistance. This work was supported by the National Research Foundation (NRF) grant funded by the Korea Ministry of Education and Science (MEST) (2012R1A2A2A01003744 to JK); the NRF grant funded by the MEST (2012R1A5A1048236); Ewha Global Top5 Grant 2013 and RP-Grant 2009 (to J-HP) funded by Ewha Womans University.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chambers AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032016; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohen SM, 2010, NUCLEIC ACIDS RES, V38, P6906, DOI 10.1093/nar/gkq559; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kashiwaba S, 2010, BIOCHEM BIOPH RES CO, V402, P619, DOI 10.1016/j.bbrc.2010.10.066; Kato D, 2012, BIOCHEM BIOPH RES CO, V417, P433, DOI 10.1016/j.bbrc.2011.11.134; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Zhang L, 2009, CELL CYCLE, V8, P3953, DOI 10.4161/cc.8.23.10115; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	54	42	42	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					351	361		10.1038/onc.2013.556	http://dx.doi.org/10.1038/onc.2013.556			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24413084				2022-12-25	WOS:000348145500009
J	Rahme, GJ; Israel, MA				Rahme, G. J.; Israel, M. A.			Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function	ONCOGENE			English	Article						Id4; glioma; invasion; MMP2; Twist1; helix-loop-helix	EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; HEPATOCELLULAR-CARCINOMA; PROMOTER METHYLATION; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; CANCER; GROWTH; DIFFERENTIATION	Tumor cell invasion is a major contributor to cancer morbidity, and is of particular importance in patients with glioblastoma multiforme (GBM), the highest grade and most aggressive primary brain tumor. Tumor cell invasion and the expression of matrix metalloproteinases (MMPs), which are required for GBM invasion, are enhanced by inhibitor of DNA binding (Id) gene family members, Id1, Id2 and Id3, which can be highly expressed in glioma. Id4 is expressed in GBM at more variable levels than these other family members and we sought to determine its role in invasion. We found, unexpectedly, that invasion was dramatically inhibited in cells expressing Id4 as a result of decreased MMP2, a secreted proteinase key for brain tumor invasion. We demonstrate that Id4 decreased MMP2 expression by a direct inhibitory interaction with Twist1, a basic helix-loop-helix transcription factor known to increase MMP2 expression. Importantly, using data from The Cancer Genome Atlas, we show that Id4 expression correlates with survival of glioblastoma patients and inversely correlates with MMP2 expression. These data suggest that the upregulation of MMP2 resulting from decreased Id4 expression in GBM may contribute to the morbidity and mortality of GBM patients.	[Rahme, G. J.; Israel, M. A.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Israel, M. A.] Geisel Sch Med Dartmouth, Dept Pediat, Hanover, NH USA; [Rahme, G. J.; Israel, M. A.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Hanover, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Israel, MA (corresponding author), Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Mark.A.Israel@dartmouth.edu		Rahme, Gilbert/0000-0001-6060-1279	Hitchcock Foundation; Jordan and Kyra Memorial Foundation; Theodora B. Betz Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	Hitchcock Foundation; Jordan and Kyra Memorial Foundation; Theodora B. Betz Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Constance Brinckerhoff for assisting in the development of the project and for providing antibodies to MMP1, 3 and 13. We are grateful for all the Israel Laboratory members for stimulating discussion, especially Dr Zhonghua Zhang for his expert opinions. We thank Dr Constance Brinckerhoff, Dr Zhonghua Zhang, Pranam Chatterjee and Henna Jones for their help on preparing the manuscript. We would like to thank Kenneth A Orndorff from the shared fluorescence imaging core at the Norris Cotton Cancer Center for his expert advice on confocal images. We thank Dr Christopher Dant and Ms Tabatha Richardson at Dartmouth for their editorial advice. This work is supported by the Hitchcock Foundation (GJR), the Jordan and Kyra Memorial Foundation (MAI) and the Theodora B. Betz Foundation (MAI).	Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chen BB, 1997, NUCLEIC ACIDS RES, V25, P423, DOI 10.1093/nar/25.2.423; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Choe GY, 2002, CLIN CANCER RES, V8, P2894; Clark I. M., 2001, MATRIX METALLOPROTEI; COMA A, 2010, CIRC FARM, V68, P5; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Garcia-Baquero R, 2013, J UROLOGY, V190, P723, DOI 10.1016/j.juro.2013.01.105; Itahana Y, 2003, CANCER RES, V63, P7098; Kappert K, 2009, INT J BIOCHEM CELL B, V41, P1511, DOI 10.1016/j.biocel.2009.01.004; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Ling YX, 2011, EUR J CANCER PREV, V20, P9, DOI 10.1097/CEJ.0b013e32833ebaa0; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Meng YG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-75; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Murad JM, 2010, J BIOL CHEM, V285, P24164, DOI 10.1074/jbc.M110.128744; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Paolella BR, 2011, STEM CELLS, V29, P1090, DOI 10.1002/stem.660; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Sawaya RE, 1996, CLIN EXP METASTAS, V14, P35, DOI 10.1007/BF00157684; Sharma P, 2012, CANCER MED-US, V1, P176, DOI 10.1002/cam4.16; Shelton EL, 2008, DEV BIOL, V317, P282, DOI 10.1016/j.ydbio.2008.02.037; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Soroceanu L, 2013, CANCER RES, V73, P1559, DOI 10.1158/0008-5472.CAN-12-1943; Sun T, 2010, HEPATOLOGY, V51, P545, DOI 10.1002/hep.23311; Tatenhorst L, 2005, BRAIN PATHOL, V15, P46; Tsunedomi R, 2008, CLIN CANCER RES, V14, P1025, DOI 10.1158/1078-0432.CCR-07-1116; Umetani N, 2004, CLIN CANCER RES, V10, P7475, DOI 10.1158/1078-0432.CCR-04-0689; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Maode, 2003, Brain Tumor Pathol, V20, P65, DOI 10.1007/BF02483449; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Zeng WF, 2010, J CANCER, V1, P1; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x	58	46	50	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					53	62		10.1038/onc.2013.531	http://dx.doi.org/10.1038/onc.2013.531			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24413082				2022-12-25	WOS:000349740100005
J	Yao, C; Yao, GQ; Sun, BH; Zhang, CQ; Tommasini, SM; Insogna, K				Yao, Chen; Yao, Gang-Qing; Sun, Ben-hua; Zhang, Changqing; Tommasini, Steven M.; Insogna, Karl			The Transcription Factor T-box 3 Regulates Colony-stimulating Factor 1-dependent Jun Dimerization Protein 2 Expression and Plays an Important Role in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Osteoclast; Promoters; Signal Transduction; Transcription Factors	ULNAR-MAMMARY SYNDROME; TBX3; DIFFERENTIATION; CELLS; GENE; JDP2; BINDING; AP-1; BONE; SURVIVAL	Background: Colony-stimulating factor 1 (CSF1) and Jun dimerization protein 2 (JDP2) regulate osteoclastogenesis, but a molecular interaction between the two has not been reported. Results: CSF1 up-regulates JDP2 by inducing T-box 3 (Tbx3) binding to the JDP2 promoter, and suppressing Tbx3 expression impairs osteoclastogenesis. Conclusion: Tbx3 is a target for CSF1 in osteoclasts. Significance: Novel molecular targets for CSF1 in modulating osteoclastogenesis are described. Colony-stimulating factor 1 (CSF1) is known to promote osteoclast progenitor survival, but its roles in osteoclast differentiation and mature osteoclast function are less well understood. In a microarray screen, Jun dimerization protein 2 (JDP2) was identified as significantly induced by CSF1. Recent reports indicate that JDP2 is required for normal osteoclastogenesis and skeletal metabolism. Because there are no reports on the transcriptional regulation of this gene, the DNA sequence from -2612 to +682 bp (relative to the transcription start site) of the JDP2 gene was cloned, and promoter activity was analyzed. The T box-binding element (TBE) between -191 and -141 bp was identified as the cis-element responsible for CSF1-dependent JDP2 expression. Using degenerate PCR, Tbx3 was identified as the major isoform binding the TBE. Overexpression of Tbx3 induced JDP2 promoter activity, whereas suppressing Tbx3 expression substantially attenuated CSF1-induced transcription. Suppressing Tbx3 in osteoclast precursors reduced JDP2 expression and significantly impaired RANKL/CSF1-induced osteoclastogenesis. A MEK1/2-specific inhibitor was found to block CSF1-induced JDP2 expression. Consistent with these data, JDP2(-/-) mice were found to have increased bone mass. In summary, CSF1 up-regulates JDP2 expression by inducing Tbx3 binding to the JDP2 promoter. The downstream signaling cascade from activated c-Fms involves the MEK1/2-ERK1/2 pathway. Tbx3 plays an important role in osteoclastogenesis at least in part by regulating CSF1-dependent expression of JDP2.	[Yao, Chen; Sun, Ben-hua; Insogna, Karl] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Yao, Gang-Qing] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Tommasini, Steven M.] Yale Univ, Sch Med, Dept Orthoped, New Haven, CT 06520 USA; [Yao, Chen; Zhang, Changqing] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 6, Shanghai 200233, Peoples R China	Yale University; Yale University; Yale University; Shanghai Jiao Tong University	Insogna, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	karl.insogna@yale.edu		Tommasini, Steven/0000-0001-5118-5867; Insogna, Karl/0000-0001-6973-5679; zhang, changqing/0000-0002-7408-4126	National Institutes of Health [DE12459, DK45228]; Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD) [AR46032]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12459 and DK45228. This work was also supported by the Yale Core Center for Musculoskeletal Disorders, a National Institutes of Health (NIAMD)-funded P30 Core Center (Grant AR46032).	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Aziz N, 1999, MOL CELL BIOL, V19, P1101; Bouyer P, 2007, ENDOCRINOLOGY, V148, P831, DOI 10.1210/en.2006-0547; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Deepak V, 2011, CELL BIOCHEM FUNCT, V29, P348, DOI 10.1002/cbf.1753; Deng HW, 2002, J CLIN ENDOCR METAB, V87, P5151, DOI 10.1210/jc.2002-020474; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Ghebranious N, 2008, J BONE MINER RES, V23, P1576, DOI 10.1359/JBMR.080503; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Govoni KE, 2009, J CELL BIOCHEM, V106, P482, DOI 10.1002/jcb.22035; Govoni KE, 2006, AM J PHYSIOL-ENDOC M, V291, pE128, DOI 10.1152/ajpendo.00592.2005; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jaworowski A, 1999, J BIOL CHEM, V274, P15127, DOI 10.1074/jbc.274.21.15127; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rallis C, 2005, DEVELOPMENT, V132, P1961, DOI 10.1242/dev.01787; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; ROHRSCHNEIDER LR, 1989, ONCOGENE, V4, P1015; Sakai H, 2006, BONE, V39, P1290, DOI 10.1016/j.bone.2006.06.012; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; TAKAHASHI N, 1991, ENDOCRINOLOGY, V128, P1792, DOI 10.1210/endo-128-4-1792; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yano T, 2011, J CELL BIOL, V193, P319, DOI 10.1083/jcb.201009100; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	48	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6775	6790		10.1074/jbc.M113.499210	http://dx.doi.org/10.1074/jbc.M113.499210			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24394418	hybrid, Green Published			2022-12-25	WOS:000332389400038
J	Haines, E; Saucier, C; Claing, A				Haines, Eric; Saucier, Caroline; Claing, Audrey			The Adaptor Proteins p66Shc and Grb2 Regulate the Activation of the GTPases ARF1 and ARF6 in Invasive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; ARF; Breast Cancer; Epidermal Growth Factor Receptor (EGFR); GTPase	EPIDERMAL-GROWTH-FACTOR; GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; EGF RECEPTOR; SHC; RAS; P66(SHC); PATHWAY	Background: ADP-ribosylation factors (ARF) 1 and 6 play an important role in breast cancer cell proliferation, migration, and invasion. Results: In invasive breast cancer cells, EGF-mediated ARF1 and ARF6 activation is regulated by p66Shc and Grb2. Conclusion: Adaptor proteins are required to promote ARF activation. Significance: Understanding the signaling mechanisms leading to ARF activation may identify novel therapeutic targets for the treatment of breast cancer. Signals downstream of growth factor receptors play an important role in mammary carcinogenesis. Recently, we demonstrated that the small GTPases ARF1 and ARF6 were shown to be activated downstream of the epidermal growth factor receptor (EGFR) and act as a key regulator of growth, migration, and invasion of breast cancer cells. However, the mechanism via which the EGFR recruits and activates ARF1 and ARF6 to transmit signals has yet to be fully elucidated. Here, we identify adaptor proteins Grb2 and p66Shc as important regulators mediating ARF activation. We demonstrate that ARF1 can be found in complex with Grb2 and p66Shc upon EGF stimulation of the basal-like breast cancer MDA-MB-231 cell line. However, we report that these two adaptors regulate ARF1 activation differently, with Grb2 promoting ARF1 activation and p66Shc blocking this response. Furthermore, we show that Grb2 is essential for the recruitment of ARF1 to the EGFR, whereas p66Shc hindered ARF1 receptor recruitment. We demonstrate that the negative regulatory role of p66Shc stemmed from its ability to block the recruitment of Grb2/ARF1 to the EGFR. Conversely, p66Shc potentiates ARF6 activation as well as the recruitment of this ARF isoform to the EGFR. Interestingly, we demonstrate that Grb2 is also required for the activation and receptor recruitment of ARF6. Additionally, we show an important role for p66Shc in modulating ARF activation, cell growth, and migration in HER2-positive breast cancer cells. Together, our results highlight a central role for adaptor proteins p66Shc and Grb2 in the regulation of ARF1 and ARF6 activation in invasive breast cancer cells.	[Haines, Eric; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Saucier, Caroline] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1E 4K8, Canada	Universite de Montreal; University of Sherbrooke	Claing, A (corresponding author), Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Saucier, Caroline/Q-9250-2019	Saucier, Caroline/0000-0001-7678-9886	Canadian Institutes of Health Research [MOP-106596]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-106596 (to A. C.).; Recipient of the Canadian Institutes of Health Research Fredrick Banting and Charles Best Doctoral Award.; Supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Beltrami E, 2013, CURR PHARM DESIGN, V19, P2708, DOI 10.2174/1381612811319150005; Borkowska A, 2012, EUR J NUTR, V51, P817, DOI 10.1007/s00394-011-0260-x; BORRELLO MG, 1994, ONCOGENE, V9, P1661; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; Cohen S, 1974, Recent Prog Horm Res, V30, P533; Cooke T, 2001, EUR J CANCER, V37, pS3, DOI 10.1016/S0959-8049(00)00402-0; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DALY RJ, 1994, ONCOGENE, V9, P2723; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Davol PA, 2003, CANCER RES, V63, P6772; Debnath J, 2010, ONCOGENE, V29, P5556, DOI 10.1038/onc.2010.347; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grossman SR, 2007, CLIN CANCER RES, V13, P5798, DOI 10.1158/1078-0432.CCR-07-0073; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hawley SP, 2011, DEV DYNAM, V240, P221, DOI 10.1002/dvdy.22506; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Jones N, 2007, MOL CELL BIOL, V27, P4759, DOI 10.1128/MCB.00184-07; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kirmani D, 2013, J RECEPT SIG TRANSD, V33, P107, DOI 10.3109/10799893.2013.770527; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Ma Z, 2010, ONCOGENE, V29, P5559, DOI 10.1038/onc.2010.326; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Rajendran M, 2010, CANCER METAST REV, V29, P207, DOI 10.1007/s10555-010-9213-8; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sabe H, 2008, CELL ADHES MIGR, V2, P71, DOI 10.4161/cam.2.2.6191; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUEN KL, 1993, MOL CELL BIOL, V13, P5500, DOI 10.1128/MCB.13.9.5500; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Veeramani S, 2012, FREE RADICAL BIO MED, V53, P95, DOI 10.1016/j.freeradbiomed.2012.03.024; Verbeek BS, 1997, J PATHOL, V183, P195; Walker RA, 1999, BREAST CANCER RES TR, V53, P167, DOI 10.1023/A:1006194700667; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2010, ENDOCRINOLOGY, V151, P3611, DOI 10.1210/en.2010-0242; Xiao D, 2010, CANCER RES, V70, P3150, DOI 10.1158/0008-5472.CAN-09-4451; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559	69	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5687	5703		10.1074/jbc.M113.516047	http://dx.doi.org/10.1074/jbc.M113.516047			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407288	Green Published, hybrid			2022-12-25	WOS:000332015500031
J	Yang, CD; Harrison, C; Jin, ES; Chuang, DT; Sherry, AD; Malloy, CR; Merritt, ME; DeBerardinis, RJ				Yang, Chendong; Harrison, Crystal; Jin, Eunsook S.; Chuang, David T.; Sherry, A. Dean; Malloy, Craig R.; Merritt, Matthew E.; DeBerardinis, Ralph J.			Simultaneous Steady-state and Dynamic C-13 NMR Can Differentiate Alternative Routes of Pyruvate Metabolism in Living Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Imaging; Metabolism; Nuclear Magnetic Resonance; Pyruvate; Anaplerosis; Hyperpolarization	ISOTOPE-RESOLVED METABOLOMICS; TRICARBOXYLIC-ACID CYCLE; BAYESIAN-ANALYSIS; SUBSTRATE OXIDATION; AEROBIC GLYCOLYSIS; SIGNAL-DETECTION; LUNG-CANCER; MUTATIONS; COMPLEX; MODEL	Background: C-13 hyperpolarization sensitively and non-destructively detects pyruvate-lactate exchanges in cancer cells. Results: Combining C-13 hyperpolarization with isotopomer analysis allowed many pyruvate-dependent pathways to be quantified simultaneously. Conclusion: Monitoring H[C-13]O-3(-) production from hyperpolarized [1-C-13]pyruvate yielded a quantitative readout of oncogene-regulated pyruvate dehydrogenase activity. Significance: This approach might enable a broader quantitative assessment of metabolic activity in tumors. Metabolic reprogramming facilitates cancer cell growth, so quantitative metabolic flux measurements could produce useful biomarkers. However, current methods to analyze flux in vivo provide either a steady-state overview of relative activities (infusion of C-13 and analysis of extracted metabolites) or a dynamic view of a few reactions (hyperpolarized C-13 spectroscopy). Moreover, although hyperpolarization has successfully quantified pyruvate-lactate exchanges, its ability to assess mitochondrial pyruvate metabolism is unproven in cancer. Here, we combined C-13 hyperpolarization and isotopomer analysis to quantify multiple fates of pyruvate simultaneously. Two cancer cell lines with divergent pyruvate metabolism were incubated with thermally polarized [3-C-13]pyruvate for several hours, then briefly exposed to hyperpolarized [1-C-13]pyruvate during acquisition of NMR spectra using selective excitation to maximize detection of H[C-13]O-3(-) and [1-C-13]lactate. Metabolites were then extracted and subjected to isotopomer analysis to determine relative rates of pathways involving [3-C-13]pyruvate. Quantitation of hyperpolarized H[C-13]O-3(-) provided a single definitive metabolic rate, which was then used to convert relative rates derived from isotopomer analysis into quantitative fluxes. This revealed that H[C-13]O-3(-) appearance reflects activity of pyruvate dehydrogenase rather than pyruvate carboxylation followed by subsequent decarboxylation reactions. Glucose substantially altered [1-C-13]pyruvate metabolism, enhancing exchanges with [1-C-13]lactate and suppressing H[C-13]O-3(-) formation. Furthermore, inhibiting Akt, an oncogenic kinase that stimulates glycolysis, reversed these effects, indicating that metabolism of pyruvate by both LDH and pyruvate dehydrogenase is subject to the acute effects of oncogenic signaling on glycolysis. The data suggest that combining C-13 isotopomer analyses and dynamic hyperpolarized C-13 spectroscopy may enable quantitative flux measurements in living tumors.	[Yang, Chendong; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Harrison, Crystal; Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Mol Biophys, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Biomed Engn, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs North Texas Healthcare Syst, Lancaster, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merritt, ME (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthew.merritt@utsouthwestern.edu	Harrison, Crystal/F-2295-2011; Sherry, Dean/P-2348-2018	Harrison, Crystal/0000-0002-8884-2805; Malloy, Craig/0000-0001-5077-0642; Merritt, Matthew/0000-0003-4617-9651; Sherry, Dean/0000-0001-7150-8301	National Institutes of Health [P41-EB015908, RR-02584, CA157996, R37-HL34557]; Cancer Prevention and Research Institute of Texas [RP101243]; Robert A. Welch Foundation [I-1733]; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-EB015908, RR-02584, CA157996, and R37-HL34557. This work was also supported by a multi-investigator award from the Cancer Prevention and Research Institute of Texas (RP101243).r Supported by grants from the Robert A. Welch Foundation (I-1733) and Damon Runyon Cancer Research Foundation. To whom correspondence may be addressed: Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8502. Tel.: 214-633-1804; Fax: 214-648-5515; E-mail: Ralph.deberardinis@utsouthwestern.edu.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BRETTHORST GL, 1990, J MAGN RESON, V88, P533, DOI 10.1016/0022-2364(90)90287-J; BRETTHORST GL, 1990, J MAGN RESON, V88, P571, DOI 10.1016/0022-2364(90)90289-L; BRETTHORST GL, 1990, J MAGN RESON, V88, P552, DOI 10.1016/0022-2364(90)90288-K; BRETTHORST GL, 1991, J MAGN RESON, V93, P369, DOI 10.1016/0022-2364(91)90013-J; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Larson PEZ, 2008, J MAGN RESON, V194, P121, DOI 10.1016/j.jmr.2008.06.010; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RACKER E, 1985, P NATL ACAD SCI USA, V82, P3535, DOI 10.1073/pnas.82.11.3535; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sherry AD, 2004, METAB ENG, V6, P12, DOI 10.1016/j.ymben.2003.10.007; Swisher CL, 2014, MAGN RESON MED, V71, P1, DOI 10.1002/mrm.24634; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; von Morze C, 2012, MAGN RESON IMAGING, V20, P305, DOI 10.1016/j.mri.2011.09.026; WARBURG O, 1956, SCIENCE, V124, P269; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	50	39	41	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6212	6224		10.1074/jbc.M113.543637	http://dx.doi.org/10.1074/jbc.M113.543637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415759	Green Published, hybrid			2022-12-25	WOS:000332015500074
J	Brinkman, DL; Konstantakopoulos, N; McInerney, BV; Mulvenna, J; Seymour, JE; Isbister, GK; Hodgson, WC				Brinkman, Diane L.; Konstantakopoulos, Nicki; McInerney, Bernie V.; Mulvenna, Jason; Seymour, Jamie E.; Isbister, Geoffrey K.; Hodgson, Wayne C.			Chironex fleckeri ( Box Jellyfish) Venom Proteins EXPANSION OF A CNIDARIAN TOXIN FAMILY THAT ELICITS VARIABLE CYTOLYTIC AND CARDIOVASCULAR EFFECTS*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Cardiovascular; Endotoxin; Protein Purification; Toxins; Cubozoa; Cytolytic; Jellyfish Toxin; Nematocyst; Venom	BACILLUS-THURINGIENSIS; PARTIAL-PURIFICATION; SEA WASP; MOLECULAR CHARACTERIZATION; INSECTICIDAL TOXIN; CRYSTAL-STRUCTURE; DELTA-ENDOTOXIN; CARYBDEA-ALATA; HABU-KURAGE; PREDICTION	Background: Box jellyfish produce a unique family of toxic venom proteins. Results: The toxins are structurally similar, yet two subgroups confer different cytolytic activities in red blood cells and cardiovascular effects in rats. Conclusion: Diversification within the toxin family may influence toxin function/specificity. Significance: Characterization of the toxins provides new insight into their potential roles in human envenoming. The box jellyfish Chironex fleckeri produces extremely potent and rapid-acting venom that is harmful to humans and lethal to prey. Here, we describe the characterization of two C. fleckeri venom proteins, CfTX-A (approximate to 40 kDa) and CfTX-B (approximate to 42 kDa), which were isolated from C. fleckeri venom using size exclusion chromatography and cation exchange chromatography. Full-length cDNA sequences encoding CfTX-A and -B and a third putative toxin, CfTX-Bt, were subsequently retrieved from a C. fleckeri tentacle cDNA library. Bioinformatic analyses revealed that the new toxins belong to a small family of potent cnidarian pore-forming toxins that includes two other C. fleckeri toxins, CfTX-1 and CfTX-2. Phylogenetic inferences from amino acid sequences of the toxin family grouped CfTX-A, -B, and -Bt in a separate clade from CfTX-1 and -2, suggesting that the C. fleckeri toxins have diversified structurally and functionally during evolution. Comparative bioactivity assays revealed that CfTX-1/2 (25 g kg(-1)) caused profound effects on the cardiovascular system of anesthetized rats, whereas CfTX-A/B elicited only minor effects at the same dose. Conversely, the hemolytic activity of CfTX-A/B (HU50 = 5 ng ml(-1)) was at least 30 times greater than that of CfTX-1/2. Structural homology between the cubozoan toxins and insecticidal three-domain Cry toxins (-endotoxins) suggests that the toxins have a similar pore-forming mechanism of action involving -helices of the N-terminal domain, whereas structural diversification among toxin members may modulate target specificity. Expansion of the cnidarian toxin family therefore provides new insights into the evolutionary diversification of box jellyfish toxins from a structural and functional perspective.	[Brinkman, Diane L.] Townsville Mail Ctr, Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Konstantakopoulos, Nicki; Isbister, Geoffrey K.; Hodgson, Wayne C.] Monash Univ, Dept Pharmacol, Monash Venom Grp, Melbourne, Vic 3800, Australia; [McInerney, Bernie V.] Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia; [Mulvenna, Jason] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Seymour, Jamie E.] James Cook Univ, Fac Med Hlth & Mol Sci, Cairns 4870, Australia; [Isbister, Geoffrey K.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia	Australian Institute of Marine Science; Monash University; Macquarie University; QIMR Berghofer Medical Research Institute; James Cook University; University of Newcastle	Brinkman, DL (corresponding author), Townsville Mail Ctr, Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	d.brinkman@aims.gov.au	Brinkman, Diane L/A-1084-2010; Isbister, Geoffrey K/G-8052-2015; Mulvenna, Jason/H-7110-2014	Brinkman, Diane L/0000-0002-6954-7667; Isbister, Geoffrey K/0000-0003-1519-7419; Mulvenna, Jason/0000-0003-3521-8061; McInerney, Bernie/0000-0002-2097-4393; Hodgson, Wayne/0000-0002-9919-0144	Herman Slade Foundation; National Health and Medical Research Council Clinical Career Development Fellowship	Herman Slade Foundation; National Health and Medical Research Council Clinical Career Development Fellowship	This research project was funded by a grant from the Herman Slade Foundation and facilitated by access to the Australian Proteome Analysis Facility supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS).; Supported by a National Health and Medical Research Council Clinical Career Development Fellowship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderluh G, 2000, BBA-PROTEIN STRUCT M, V1476, P372, DOI 10.1016/S0167-4838(99)00237-X; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Bravo A, 2002, J BIOL CHEM, V277, P23985, DOI 10.1074/jbc.C200263200; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047866; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Chung JJ, 2001, TOXICON, V39, P981, DOI 10.1016/S0041-0101(00)00237-3; Currie BJ, 2005, MED J AUSTRALIA, V183, P631, DOI 10.5694/j.1326-5377.2005.tb00062.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Frazao B, 2012, MAR DRUGS, V10, P1812, DOI 10.3390/md10081812; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gershwin L., 2005, Memoirs of the Queensland Museum, V51, P501; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Guo SY, 2009, J STRUCT BIOL, V168, P259, DOI 10.1016/j.jsb.2009.07.004; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Konstantakopoulos Nicki, 2009, Journal of Pharmacological and Toxicological Methods, V59, P166, DOI 10.1016/j.vascn.2009.02.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis C, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2030.1.5; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; McClounan S, 2012, TOXICON, V60, P1335, DOI 10.1016/j.toxicon.2012.08.020; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Nagai H, 2003, J HEALTH SCI, V49, P337, DOI 10.1248/jhs.49.337; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; Nugent T, 2011, BIOINFORMATICS, V27, P1438, DOI 10.1093/bioinformatics/btr096; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saggiomo SLA, 2012, TOXICON, V60, P391, DOI 10.1016/j.toxicon.2012.03.025; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tang B, 2003, BIOCHEM BIOPH RES CO, V301, P1093, DOI 10.1016/S0006-291X(03)00084-6; Uechi G, 2010, TOXICON, V56, P1470, DOI 10.1016/j.toxicon.2010.09.002; Wong E. S., 2013, PLOS ONE, V8; Yanagihara AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051368	43	50	53	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4798	4812		10.1074/jbc.M113.534149	http://dx.doi.org/10.1074/jbc.M113.534149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403082	Green Published, hybrid			2022-12-25	WOS:000331607900026
J	Colon-Lopez, V; Ortiz, AP; Del Toro-Mejias, L; Clatts, MC; Palefsky, JM				Colon-Lopez, Vivian; Ortiz, Ana Patricia; Del Toro-Mejias, Lizbeth; Clatts, Michael Craig; Palefsky, Joel M.			Epidemiology of Anal HPV Infection in High-Risk Men Attending a Sexually Transmitted Infection Clinic in Puerto Rico	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; PREVALENCE; CANCER; WOMEN; SEX	Purpose: Recent studies in Puerto Rico have reported an increasing incidence of anal cancer in Puerto Rican men. The objective of this study was to determine the prevalence, genotype distribution and risk factors associated with anal HPV infection among men attending an STI clinic in Puerto Rico. Methods: We conducted a cross-sectional study among 205 men 18 years and older. A comprehensive survey was administered that included a demographic and a behavioral assessment. Separate logistic regression models were performed to determine factors associated with any, high-risk (HR), and multiple anal HPV infection. Results: The mean age of the study sample was 38.0+/-13.5 years. The most common HR types were 58, 51 and 31. Overall, HR anal HPV infection was found in 53.5% of the participants. Multiple HPV types in the anal canal were found in 47.6% of the sample. A third (29.8%) of participants reported being men who had sex with men (MSM). MSM had a significantly higher prevalence of any, HR and multiple HPV infection (p-value<0.05). Separate multivariate logistic regression analyses showed that being MSM was associated with any (OR = 4.5; [95%CI: 1.9-10.7]), HR (OR = 3.4; [95%CI: 1.1-10.3) and multiple anal HPV infection (OR = 3.6; [95%CI: 1.5-9.1). HIV was marginally associated with multiple anal HPV infection in multivariate analysis (OR = 3.3; 95%CI = 1.0-11.0). Conclusions: Anal HPV is common among sexually active men attending this STI clinic, with higher likelihood of anal HPV infection among MSM.	[Colon-Lopez, Vivian; Ortiz, Ana Patricia] Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA; [Colon-Lopez, Vivian] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, San Juan, PR 00936 USA; [Ortiz, Ana Patricia; Del Toro-Mejias, Lizbeth] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, San Juan, PR 00936 USA; [Clatts, Michael Craig] Univ Puerto Rico, Grad Sch Publ Hlth, Ctr Res Global Hlth, San Juan, PR 00936 USA; [Palefsky, Joel M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Francisco	Colon-Lopez, V (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA.	vivian.colon@upr.edu			National Institutes of Health [R03 DA027939-01]; AIDS-Science Track Award for Research Transition A-START from NIDA [1R03DA031590-01]; National Center for Research Resources [U54 RR026139]; National Institute on Minority Health and Health Disparities [8U54MD 007587-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027939, R03DA031590] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS-Science Track Award for Research Transition A-START from NIDA; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was fully supported by National Institutes of Health R03 DA027939-01, and AIDS-Science Track Award for Research Transition A-START 1R03DA031590-01 from NIDA. The project was also partially supported by Award Number U54 RR026139 from the National Center for Research Resources, and the Award Number 8U54MD 007587-03 from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the PR Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2012, INT J CANCER, V131, P1969, DOI 10.1002/ijc.27650; Clatts MC, 2011, P R HEALTH SCI J, V30, P101; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P76; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P8; Colon-Lopez V, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-346; Colon-Lopez V, 2012, P R HEALTH SCI J, V31, P227; Colon-Lopez V, 2011, P R HEALTH SCI J, V30, P65; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Alvarez-Arguelles ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054375; Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026; IARC, 2012, IARC MON EV CARC R B, V100B; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Machalek DA, 2012, SEX HEALTH, V9, P527, DOI 10.1071/SH12043; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Orlando G, 2008, JAIDS-J ACQ IMM DEF, V47, P129, DOI 10.1097/QAI.0b013e318156ec7b; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Ramirez-Marrero FA, 2010, P R HEALTH SCI J, V29, P256; STRAND A, 1993, GENITOURIN MED, V69, P446; Svare EI, 2002, SEX TRANSM INFECT, V78, P215, DOI 10.1136/sti.78.3.215; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	21	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83209	10.1371/journal.pone.0083209	http://dx.doi.org/10.1371/journal.pone.0083209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400071	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700005
J	Gross, R; Bellamy, SL; Chapman, J; Han, XY; O'Duor, J; Strom, BL; Houts, PS; Palmer, SC; Coyne, JC				Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.; Houts, Peter S.; Palmer, Steven C.; Coyne, James C.			The Effects of a Problem Solving-Based Intervention on Depressive Symptoms and HIV Medication Adherence Are Independent	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ANTIDEPRESSANT TREATMENT; CANCER-PATIENTS; DISORDERS; RISK; METAANALYSIS; HIV/AIDS; PROJECT; ANXIETY; TRIAL	Depression and depressive symptoms predict poor adherence to medical therapy, but the association is complex, nonspecific, and difficult to interpret. Understanding this association may help to identify the mechanism explaining the results of interventions that improve both medical therapy adherence and depressive symptoms as well as determine the importance of targeting depression in adherence interventions. We previously demonstrated that Managed Problem Solving (MAPS) focused on HIV medication adherence improved adherence and viral load in patients initiating a new antiretroviral regimen. Here, we assessed whether MAPS improved depressive symptoms and in turn, whether changes in depressive symptoms mediated changes in adherence and treatment outcomes. We compared MAPS to usual care with respect to presence of depressive symptoms during the trial using logistic regression. We then assessed whether MAPS' effect on depressive symptoms mediated the relationship between MAPS and adherence and virologic outcomes using linear and logistic regression, respectively. Mediation was defined by the disappearance of the mathematical association between MAPS and the outcomes when the proposed mediator was included in regression models. Although MAPS participants had a lower rate of depressive symptoms (OR = 0.45, 95% confidence interval 0.21-0.93), there was no evidence of mediation of the effects of MAPS on adherence and virological outcome by improvements in depression. Thus, interventions for medication adherence may not need to address depressive symptoms in order to impact both adherence and depression; this remains to be confirmed, however, in other data.	[Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gross, Robert; Strom, Brian L.] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA; [Gross, Robert] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Gross, Robert] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Houts, Peter S.] Penn State Univ, Coll Med, Hershey, PA USA; [Palmer, Steven C.; Coyne, James C.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Medicine; University of Groningen	Gross, R (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	grossr@mail.med.upenn.edu	han, xiao/HDN-9782-2022	Bellamy, Scarlett/0000-0002-2906-4046; Chapman, Jennifer/0000-0001-7065-311X	National Institute Of Mental Health [R01 MH080701, R01 MH067498]; National Center for Research Resources [UL1 RR024134]; National Institute of Allergy and Infectious Diseases; Penn Center for AIDS Research [P30 AI045008]; Philadelphia Veterans Affairs Medical Center; Bristol-Myers Squibb; Abbott Laboratories; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH097488, R01MH067498, R01MH080701] Funding Source: NIH RePORTER	National Institute Of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Center for AIDS Research; Philadelphia Veterans Affairs Medical Center(US Department of Veterans Affairs); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute Of Mental Health under Award Numbers R01 MH080701 and R01 MH067498, by the National Center for Research Resources under Award Number UL1 RR024134, by the National Institute of Allergy and Infectious Diseases via core services and support from the Penn Center for AIDS Research under Award Number P30 AI045008 and career support (RG) from the Philadelphia Veterans Affairs Medical Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the course of this study, Dr. Gross received research support via contracts with Bristol-Myers Squibb and Abbott Laboratories for work related to HIV and its treatment, but not for work on this study. Dr. Strom was supported in part by contracts with and received payment for consulting with numerous pharmaceutical companies, none of which was related to HIV or this study.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cruess DG, 2012, ANN BEHAV MED, V43, P189, DOI 10.1007/s12160-011-9322-9; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037/0022-006X.62.3.550; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gross R, 2013, JAMA INTERN MED, V173, P300, DOI 10.1001/jamainternmed.2013.2152; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Klinkman MS, 1997, ARCH FAM MED, V6, P567, DOI 10.1001/archfami.6.6.567; Kumar V, 2009, PSYCHIAT QUART, V80, P131, DOI 10.1007/s11126-009-9100-z; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Palmer SC, 2012, CANCER-AM CANCER SOC, V118, P2735, DOI 10.1002/cncr.26603; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Safren SA, 2012, J CONSULT CLIN PSYCH, V80, P404, DOI 10.1037/a0028208; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Tsai AC, 2012, AM J PUBLIC HLTH; Walkup J, 2008, PSYCHIAT QUART, V79, P43, DOI 10.1007/s11126-007-9055-x; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84952	10.1371/journal.pone.0084952	http://dx.doi.org/10.1371/journal.pone.0084952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IW	24400124	Green Submitted, gold, Green Published			2022-12-25	WOS:000329462700058
J	Sekiguchi, A; Sugiura, M; Taki, Y; Kotozaki, Y; Nouchi, R; Takeuchi, H; Araki, T; Hanawa, S; Nakagawa, S; Miyauchi, CM; Sakuma, A; Kawashima, R				Sekiguchi, Atsushi; Sugiura, Motoaki; Taki, Yasuyuki; Kotozaki, Yuka; Nouchi, Rui; Takeuchi, Hikaru; Araki, Tsuyoshi; Hanawa, Sugiko; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Sakuma, Atsushi; Kawashima, Ryuta			White Matter Microstructural Changes as Vulnerability Factors and Acquired Signs of Post-Earthquake Distress	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE CORTEX; MRI REVEALS; INTEGRITY; BRAIN; AMYGDALA; ANXIETY; VOLUME; ACTIVATIONS; EARTHQUAKE	Many survivors of severe disasters need psychological support, even those not suffering post-traumatic stress disorder (PTSD). The critical issue in understanding the psychological response after experiencing severe disasters is to distinguish neurological microstructural underpinnings as vulnerability factors from signs of emotional distress acquired soon after the stressful life event. We collected diffusion-tensor magnetic resonance imaging (DTI) data from a group of healthy adolescents before the Great East Japan Earthquake and re-examined the DTIs and anxiety levels of 30 non-PTSD subjects from this group 3-4 months after the earthquake using voxel-based analyses in a longitudinal DTI study before and after the earthquake. We found that the state anxiety level after the earthquake was negatively associated with fractional anisotropy (FA) in the right anterior cingulum (Cg) before the earthquake (r = -0.61, voxel level p<0.0025, cluster level p<0.05 corrected), and positively associated with increased FA changes from before to after the earthquake in the left anterior Cg (r = 0.70, voxel level p<0.0025, cluster level p<0.05 corrected) and uncinate fasciculus (Uf) (r = 0.65, voxel level p<0.0025, cluster level p<0.05 corrected). The results demonstrated that lower FA in the right anterior Cg was a vulnerability factor and increased FA in the left anterior Cg and Uf was an acquired sign of state anxiety after the earthquake. We postulate that subjects with dysfunctions in processing fear and anxiety before the disaster were likely to have higher anxiety levels requiring frequent emotional regulation after the disaster. These findings provide new evidence of psychophysiological responses at the neural network level soon after a stressful life event and might contribute to the development of effective methods to prevent PTSD.	[Sekiguchi, Atsushi; Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Sugiura, Motoaki; Hanawa, Sugiko; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Sakuma, Atsushi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Takeuchi, Hikaru] Tohoku Univ, IDAC, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 980, Japan; [Kotozaki, Yuka; Nouchi, Rui; Araki, Tsuyoshi; Kawashima, Ryuta] Tohoku Univ, IDAC, Smart Ageing Int Res Ctr, Dept Adv Brain Sci, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Japanese Soc Promot Sci, Tokyo, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Schools Law & Polit, Tokyo, Japan; [Sakuma, Atsushi] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Society for the Promotion of Science; University of Tokyo; Tohoku University	Sekiguchi, A (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan.	asekiguchi@idac.tohoku.ac.jp	Nouchi, Rui/GQH-1608-2022; Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Sakuma, Atsushi/0000-0002-9290-5311; xing zhi, shi zhi/0000-0003-3289-5681; Nouchi, Rui/0000-0002-2078-9518; Takeuchi, Hikaru/0000-0002-8022-9694	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 24790653]; Ministry of Health, Labor and Welfare in Japan [H24-seishin-wakate014]	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	A.S. was supported by a Grant for Special Project Research from the International Research Institute of Disaster Science, a Grant-in-Aid for Young Scientists (B) (KAKENHI 24790653) from the Ministry of Education, Culture, Sports, Science and Technology, and Grants-in-Aid for Scientific Research (H24-seishin-wakate014) from the Ministry of Health, Labor and Welfare in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Albrecht J, 2007, J NEUROL NEUROSUR PS, V78, P964, DOI 10.1136/jnnp.2006.112987; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-4; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Carrion VG, 2010, BIOL PSYCHIAT, V68, P491, DOI 10.1016/j.biopsych.2010.05.010; Chen L, 2013, HUM BRAIN MAPP, V34, P367, DOI 10.1002/hbm.21438; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Furukawa K, 2011, LANCET, V377, P1652, DOI 10.1016/S0140-6736(11)60671-5; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Hamner M B, 1999, Depress Anxiety, V9, P1; Hettema JM, 2012, DEPRESS ANXIETY, V29, P202, DOI 10.1002/da.20901; *JAP I HLTH PSYCH, 1996, LAZ TYP STRESS COP I; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lazarus R.S., 1984, STRESS APPRAISAL COP; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McCurry J, 2011, LANCET, V378, P1061, DOI 10.1016/S0140-6736(11)61466-9; Nakazato K, 1982, USE STAI; Nishizono-Maher A., 1998, JAPANESE VERSION CLI; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shima S, 1985, SEISHIN IGAKU, V27, P717; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tabachnick G.B., 1996, USING MULTIVARIATE S; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	52	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83967	10.1371/journal.pone.0083967	http://dx.doi.org/10.1371/journal.pone.0083967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400079	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700013
J	Zhao, GD; Guo, S; Somel, M; Khaitovich, P				Zhao, Guodong; Guo, Song; Somel, Mehmet; Khaitovich, Philipp			Evolution of Human Longevity Uncoupled from Caloric Restriction Mechanisms	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; GENE-EXPRESSION; DIETARY RESTRICTION; OXIDATIVE STRESS; INCREASE LONGEVITY; RHESUS-MONKEYS; HUMAN-BEINGS; RESVERATROL; DISEASE; METABOLISM	Caloric restriction (CR) and chemical agents, such as resveratrol and rapamycin that partially mimic the CR effect, can delay morbidity and mortality across a broad range of species. In humans, however, the effects of CR or other life-extending agents have not yet been investigated systematically. Human maximal lifespan is already substantially greater compared to that of closely related primate species. It is therefore possible that humans have acquired genetic mutations that mimic the CR effect. Here, we tested this notion by comparing transcriptome differences between humans and other primates, with the transcriptome changes observed in mice subjected to CR. We show that the human transcriptome state, relative to other primate transcriptomes, does not match that of the CR mice or mice treated with resveratrol, but resembles the transcriptome state of ad libitum fed mice. At the same time, the transcriptome changes induced by CR in mice are enriched among genes showing age-related changes in primates, concentrated in specific expression patterns, and can be linked with specific functional pathways, including insulin signalling, cancer, and the immune response. These findings indicate that the evolution of human longevity was likely independent of CR-induced lifespan extension mechanisms. Consequently, application of CR or CR-mimicking agents may yet offer a promising direction for the extension of healthy human lifespan.	[Zhao, Guodong; Guo, Song; Somel, Mehmet; Khaitovich, Philipp] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Zhao, Guodong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Khaitovich, Philipp] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Somel, Mehmet] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Max Planck Society; Middle East Technical University	Somel, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	somel.mehmet@gmail.com; khaitovich@eva.mpg.de	Guo, Song/F-7572-2016; Khaitovich, Philipp/HGC-8520-2022; Somel, Mehmet/B-1471-2016	Guo, Song/0000-0002-7150-8528; Somel, Mehmet/0000-0002-3138-1307	Ministry of Science and Technology of the People's Republic of China [2012DFG31940]; National Natural Science Fund of China [31171232, 31050110128]; Max Planck-Society; Bundesministerum fuer Bildung und Forschung; 1000 Plan for Foreign Experts; Chinese Academy of Sciences [2009Y2BS12]; European Molecular Biology Organization [EMBO ALTF 1475-2010]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Max Planck-Society(Max Planck SocietyFoundation CELLEX); Bundesministerum fuer Bildung und Forschung; 1000 Plan for Foreign Experts; Chinese Academy of Sciences(Chinese Academy of Sciences); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the Ministry of Science and Technology of the People's Republic of China (grant no. 2012DFG31940), National Natural Science Fund of China (grants no. 31171232 and 31050110128), the Max Planck-Society, and the Bundesministerum fuer Bildung und Forschung for financial support. PK was supported by 1000 Plan for Foreign Experts; MS was supported by fellowships from the Chinese Academy of Sciences (2009Y2BS12) and the European Molecular Biology Organization (EMBO ALTF 1475-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, AM J HUM BIOL, V17, P673, DOI 10.1002/ajhb.20439; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chouliaras L, 2011, BRAIN BEHAV IMMUN, V25, P616, DOI 10.1016/j.bbi.2010.11.016; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; CUTLER RG, 1979, MECH AGEING DEV, V9, P337, DOI 10.1016/0047-6374(79)90110-6; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Magalhaes JP, 2002, EXP GERONTOL, V37, P769, DOI 10.1016/S0531-5565(02)00008-6; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONES M L, 1992, In Vivo (Attiki), V6, P363; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; KRITCHEVSKY D, 1979, FED PROC, V38, P2001; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Lane MA, 2000, MECH AGEING DEV, V112, P185, DOI 10.1016/S0047-6374(99)00087-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bourg E, 2006, BIOGERONTOLOGY, V7, P149, DOI 10.1007/s10522-006-9014-1; Le Bourg E, 2006, BIOGERONTOLOGY, V7, P123, DOI 10.1007/s10522-006-9010-5; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lefevre M, 2009, ATHEROSCLEROSIS, V203, P206, DOI 10.1016/j.atherosclerosis.2008.05.036; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; MCCAY CM, 1989, NUTRITION, V5, P155; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Newton IG, 2008, NEUROBIOL AGING, V29, P1308, DOI 10.1016/j.neurobiolaging.2007.03.009; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Phelan JP, 2006, BIOGERONTOLOGY, V7, P161, DOI 10.1007/s10522-006-9005-2; Plank M, 2012, MOL BIOSYST, V8, P1339, DOI 10.1039/c2mb05255e; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; ROBERTST.IC, 1974, LANCET, V2, P368; Rohrbach S, 2008, BIOGERONTOLOGY, V9, P169, DOI 10.1007/s10522-008-9126-x; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Smith DL, 2010, EUR J CLIN INVEST, V40, P440, DOI 10.1111/j.1365-2362.2010.02276.x; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Team. RDC, 2007, R LANG ENV STAT COMP; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Videan EN, 2009, COMPARATIVE MED, V59, P287; Walker ARP, 2003, NUTRITION, V19, P169, DOI 10.1016/S0899-9007(02)00948-6; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Walker R, 2006, J HUM EVOL, V51, P480, DOI 10.1016/j.jhevol.2006.06.002; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5; Wu X, 2009, BIOINFORMATICS, V25, P832, DOI 10.1093/bioinformatics/btp059; Yuan Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-347	82	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84117	10.1371/journal.pone.0084117	http://dx.doi.org/10.1371/journal.pone.0084117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400080	Green Published, gold			2022-12-25	WOS:000329462700014
J	Adler, C; Corbalan, NS; Peralta, DR; Pomares, MF; de Cristobal, RE; Vincent, PA				Adler, Conrado; Corbalan, Natalia S.; Peralta, Daiana R.; Fernanda Pomares, Maria; de Cristobal, Ricardo E.; Vincent, Paula A.			The Alternative Role of Enterobactin as an Oxidative Stress Protector Allows Escherichia coli Colony Development	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; NONCULTURABLE STATE; DESFERRIOXAMINE-E; OUTER-MEMBRANE; IRON-TRANSPORT; SIDEROPHORES; BACTERIA; SYSTEM; GROWTH; PROTEINS	Numerous bacteria have evolved different iron uptake systems with the ability to make use of their own and heterologous siderophores. However, there is growing evidence attributing alternative roles for siderophores that might explain the potential adaptive advantages of microorganisms having multiple siderophore systems. In this work, we show the requirement of the siderophore enterobactin for Escherichia coli colony development in minimal media. We observed that a strain impaired in enterobactin production (entE mutant) was unable to form colonies on M9 agar medium meanwhile its growth was normal on LB agar medium. Given that, neither iron nor citrate supplementation restored colony growth, the role of enterobactin as an iron uptake-facilitator would not explain its requirement for colony development. The absence of colony development was reverted either by addition of enterobactin, the reducing agent ascorbic acid or by incubating in anaerobic culture conditions with no additives. Then, we associated the enterobactin requirement for colony development with its ability to reduce oxidative stress, which we found to be higher in media where the colony development was impaired (M9) compared with media where the strain was able to form colonies (LB). Since oxyR and soxS mutants (two major stress response regulators) formed colonies in M9 agar medium, we hypothesize that enterobactin could be an important piece in the oxidative stress response repertoire, particularly required in the context of colony formation. In addition, we show that enterobactin has to be hydrolyzed after reaching the cell cytoplasm in order to enable colony development. By favoring iron release, hydrolysis of the enterobactin-iron complex, not only would assure covering iron needs, but would also provide the cell with a molecule with exposed hydroxyl groups (hydrolyzed enterobactin). This molecule would be able to scavenge radicals and therefore reduce oxidative stress.	[Adler, Conrado; Corbalan, Natalia S.; Peralta, Daiana R.; Fernanda Pomares, Maria; de Cristobal, Ricardo E.; Vincent, Paula A.] INSIBIO Consejo Nacl Invest Cient & Tecn Univ Nac, Dept Bioquim Nutr, San Miguel De Tucuman, Argentina		Vincent, PA (corresponding author), INSIBIO Consejo Nacl Invest Cient & Tecn Univ Nac, Dept Bioquim Nutr, San Miguel De Tucuman, Argentina.	pvincent@fbqf.unt.edu.ar		Corbalan, Natalia/0000-0002-3588-3099	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2107, 1939]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112]; Consejo de Investigaciones de la U.N.T. [CIUNT 26/D439]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigaciones de la U.N.T.; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by grants PICT 2107 and 1939 from the Agencia Nacional de Promocion Cientifica y Tecnologica, PIP 112 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, CIUNT 26/D439 from the Consejo de Investigaciones de la U.N.T. Conrado Adler, Daiana R. Peralta and Natalia S. Corbalan were recipients of a fellowship from CONICET. Ricardo de Cristobal, Maria Fernanda Pomares and Paula Andrea Vincent are Career Investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Achard ME, 2013, BIOCH J; Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; Al-Azemi A, 2011, J APPL MICROBIOL, V110, P1307, DOI 10.1111/j.1365-2672.2011.04983.x; Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; CARRANO CJ, 1979, J AM CHEM SOC, V101, P5401, DOI 10.1021/ja00512a047; CHENAULT SS, 1991, MOL MICROBIOL, V5, P1405, DOI 10.1111/j.1365-2958.1991.tb00787.x; Chi Z, 2011, BIOMETALS; Clarke Teresa E., 2001, Current Topics in Medicinal Chemistry, V1, P7, DOI 10.2174/1568026013395623; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Ishida S, 2011, BIOL PHARM BULL, V34, P917, DOI 10.1248/bpb.34.917; Jeong JM, 2007, J PHARM PHARM SCI, V10, P537, DOI 10.18433/J3KW2Z; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Ma L, 2012, J BACTERIOL, V194, P6748, DOI 10.1128/JB.01574-12; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Narten M, 2011, CURR MICROBIOL; Negre VL, 2004, INFECT IMMUN, V72, P1216, DOI 10.1128/IAI.72.2.1216-1220.2004; NEILANDS JB, 1992, CAN J MICROBIOL, V38, P728, DOI 10.1139/m92-119; NEILANDS JB, 1982, ANNU REV MICROBIOL, V36, P285, DOI 10.1146/annurev.mi.36.100182.001441; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; Pazos M, 2006, J AGR FOOD CHEM, V54, P10215, DOI 10.1021/jf062134n; Povie G, CHEM COMMUN CAMB, V46, P803; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; Sorsa LJ, 2003, INFECT IMMUN, V71, P3285, DOI 10.1128/IAI.71.6.3285-3293.2003; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang WL, 2009, BIORESOURCE TECHNOL, V100, P2639, DOI 10.1016/j.biortech.2008.12.010; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	48	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84734	10.1371/journal.pone.0084734	http://dx.doi.org/10.1371/journal.pone.0084734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392154	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100077
J	Axpe, E; Lopez-Euba, T; Castellanos-Rubio, A; Merida, D; Garcia, JA; Plaza-Izurieta, L; Fernandez-Jimenez, N; Plazaola, F; Bilbao, JR				Axpe, Eneko; Lopez-Euba, Tamara; Castellanos-Rubio, Ainara; Merida, David; Angel Garcia, Jose; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Plazaola, Fernando; Ramon Bilbao, Jose			Detection of Atomic Scale Changes in the Free Volume Void Size of Three-Dimensional Colorectal Cancer Cell Culture Using Positron Annihilation Lifetime Spectroscopy	PLOS ONE			English	Article							SKIN	Positron annihilation lifetime spectroscopy (PALS) provides a direct measurement of the free volume void sizes in polymers and biological systems. This free volume is critical in explaining and understanding physical and mechanical properties of polymers. Moreover, PALS has been recently proposed as a potential tool in detecting cancer at early stages, probing the differences in the subnanometer scale free volume voids between cancerous/healthy skin samples of the same patient. Despite several investigations on free volume in complex cancerous tissues, no positron annihilation studies of living cancer cell cultures have been reported. We demonstrate that PALS can be applied to the study in human living 3D cell cultures. The technique is also capable to detect atomic scale changes in the size of the free volume voids due to the biological responses to TGF-beta. PALS may be developed to characterize the effect of different culture conditions in the free volume voids of cells grown in vitro.	[Axpe, Eneko; Plazaola, Fernando] Univ Basque Country UPV EHU, Dept Elect & Elect, Leioa, Basque Country, Spain; [Lopez-Euba, Tamara; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Ramon Bilbao, Jose] BioCruces Res Inst, Immunogenet Res Lab, Baracaldo, Basque Country, Spain; [Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Ramon Bilbao, Jose] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Basque Country, Spain; [Merida, David; Angel Garcia, Jose] Univ Basque Country UPV EHU, Dept Appl Phys 2, Leioa, Basque Country, Spain	University of Basque Country; University of Basque Country; University of Basque Country	Axpe, E (corresponding author), Univ Basque Country UPV EHU, Dept Elect & Elect, Leioa, Basque Country, Spain.	eneko.axpe@ehu.es	Castellanos-Rubio, Ainara/AAB-9700-2022; Bilbao, Jose Ramon/A-9177-2008; Fernandez-Jimenez, Nora/T-1535-2019	Bilbao, Jose Ramon/0000-0002-3176-501X; Plazaola Muguruza, Fernando/0000-0002-0081-8131; Castellanos Rubio, Ainara/0000-0003-3192-9544; Axpe, Eneko/0000-0002-9114-5306; Fernandez-Jimenez, Nora/0000-0001-6307-0880	Basque Department of Industry [SAI11/263 - PRODETEC]; Basque Department of Education, Universities and Research [IT/443/10]	Basque Department of Industry; Basque Department of Education, Universities and Research	Basque Department of Industry grant no. SAI11/263 - PRODETEC and Basque Department of Education, Universities and Research grant no. IT/443/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HM, 2012, DEFECT DIFFUS FORUM, V331, P275, DOI 10.4028/www.scientific.net/DDF.331.275; ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; JEAN YC, 1990, MICROCHEM J, V42, P72, DOI 10.1016/0026-265X(90)90027-3; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Kansy J, 1996, NUCL INSTRUM METH A, V374, P235, DOI 10.1016/0168-9002(96)00075-7; Liu G, 2008, APPL SURF SCI, V255, P115, DOI 10.1016/j.apsusc.2008.05.241; Liu G, 2007, PHYS STATUS SOLIDI C, V4, P3912, DOI 10.1002/pssc.200675736; Nakanishi H., 1988, POSITRON ANNIHILATIO; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Sane P, 2010, BBA-BIOMEMBRANES, V1798, P958, DOI 10.1016/j.bbamem.2010.01.011; Sane P, 2009, J PHYS CHEM B, V113, P1810, DOI 10.1021/jp809308j; Siles S, 1999, J RADIOANAL NUCL CH, V240, P529, DOI 10.1007/BF02349408; TAO SJ, 1972, J CHEM PHYS, V56, P5499, DOI 10.1063/1.1677067; Yang S, 2009, AIP CONF PROC, V1099, P948, DOI 10.1063/1.3120199	15	27	27	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83838	10.1371/journal.pone.0083838	http://dx.doi.org/10.1371/journal.pone.0083838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392097	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100021
J	Su, YC; Guo, JL; Ling, H; Chen, SS; Wang, SS; Xu, LP; Allan, AC; Que, YX				Su, Yachun; Guo, Jinlong; Ling, Hui; Chen, Shanshan; Wang, Shanshan; Xu, Liping; Allan, Andrew C.; Que, Youxiong			Isolation of a Novel Peroxisomal Catalase Gene from Sugarcane, Which Is Responsive to Biotic and Abiotic Stresses	PLOS ONE			English	Article							MOLECULAR-CLONING; CELL-DEATH; EXPRESSION ANALYSIS; RESISTANCE; SALT; DISEASE; PROTEIN; SMUT; H2O2; IDENTIFICATION	Catalase is an iron porphyrin enzyme, which serves as an efficient scavenger of reactive oxygen species (ROS) to avoid oxidative damage. In sugarcane, the enzymatic activity of catalase in a variety (Yacheng05-179) resistant to the smut pathogen Sporisorium scitamineum was always higher than that of the susceptible variety (Liucheng03-182), suggesting that catalase activity may have a positive correlation with smut resistance in sugarcane. To understand the function of catalase at the molecular level, a cDNA sequence of ScCAT1 (GenBank Accession No. KF664183), was isolated from sugarcane infected by S. scitamineum. ScCAT1 was predicted to encode 492 amino acid residues, and its deduced amino acid sequence shared a high degree of homology with other plant catalases. Enhanced growth of ScCAT1 in recombinant Escherichia coli Rosetta cells under the stresses of CuCl2, CdCl2 and NaCl indicated its high tolerance. Q-PCR results showed that ScCAT1 was expressed at relatively high levels in the bud, whereas expression was moderate in stem epidermis and stem pith. Different kinds of stresses, including S. scitamineum challenge, plant hormones (SA, MeJA and ABA) treatments, oxidative (H2O2) stress, heavy metal (CuCl2) and hyper-osmotic (PEG and NaCl) stresses, triggered a significant induction of ScCAT1. The ScCAT1 protein appeared to localize in plasma membrane and cytoplasm. Furthermore, histochemical assays using DAB and trypan blue staining, as well as conductivity measurement, indicated that ScCAT1 may confer the sugarcane immunity. In conclusion, the positive response of ScCAT1 to biotic and abiotic stresses suggests that ScCAT1 is involved in protection of sugarcane against reactive oxidant-related environmental stimuli.	[Su, Yachun; Guo, Jinlong; Ling, Hui; Chen, Shanshan; Wang, Shanshan; Xu, Liping; Que, Youxiong] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China; [Allan, Andrew C.] New Zealand Inst Plant & Food Res, Auckland, New Zealand	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; New Zealand Institute for Plant & Food Research Ltd	Xu, LP (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China.	xlpmail@126.com; queyouxiong@hotmail.com	Allan, Andrew C/L-3253-2016	Allan, Andrew C/0000-0003-1944-7067; Que, Youxiong/0000-0003-1111-5834; Su, Yachun/0000-0002-3893-2909; Guo, Jin long/0000-0001-5537-3152	National Natural Science Foundation of China [31101196]; earmarked fund for the Modern Agriculture Technology of China (CARS-20); Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University [xjq201202]; National High Technology Research and Development Program of China (863 Program) Project [2013AA102604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China (CARS-20); Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University; National High Technology Research and Development Program of China (863 Program) Project(National High Technology Research and Development Program of China)	This research was supported by National Natural Science Foundation of China (No. 31101196), the earmarked fund for the Modern Agriculture Technology of China (CARS-20), Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University (xjq201202), National High Technology Research and Development Program of China (863 Program) Project (2013AA102604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri VP, 1990, DIS SUGARCANE SUGARB, P72; Alexander K.C., 1980, P INT SOC SUGARCANE, V17, P1452; Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen HJ, 2012, J PLANT PHYSIOL, V169, P86, DOI 10.1016/j.jplph.2011.08.002; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; DRORY A, 1992, PLANT PHYSIOL, V100, P1605, DOI 10.1104/pp.100.3.1605; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Dussle CM, 2003, THEOR APPL GENET, V106, P485, DOI 10.1007/s00122-002-1107-x; Fawcett GL, 1942, CIRCULAR ESTACION EX, P114; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Guan LM, 2000, FREE RADICAL BIO MED, V28, P1182, DOI 10.1016/S0891-5849(00)00212-4; GUAN LQ, 1995, P NATL ACAD SCI USA, V92, P5930, DOI 10.1073/pnas.92.13.5930; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guan ZQ, 2009, CHEMOSPHERE, V76, P623, DOI 10.1016/j.chemosphere.2009.04.047; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Guo JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/904769; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hao JJ, 2001, PLANT PHYSL EXPT TEC, P53; HOY JW, 1986, PLANT DIS, V70, P59, DOI 10.1094/PD-70-59; Huckelhoven R, 2000, PLANTA, V212, P16, DOI 10.1007/s004250000385; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Kwon SI, 2001, PLANT SCI, V160, P961, DOI 10.1016/S0168-9452(01)00332-6; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li YZ, 2010, PLANT PHYSIOL, V153, P1425, DOI 10.1104/pp.110.156240; Lin YanQuan, 1996, Journal of Fujian Agricultural University, V25, P271; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi L, 2005, PLANT SCI, V168, P797, DOI 10.1016/j.plantsci.2004.10.012; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Moosawi-Jorf S. A., 2007, Journal of Applied Sciences, V7, P3768; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Purev M, 2010, PLANT PHYSIOL BIOCH, V48, P451, DOI 10.1016/j.plaphy.2010.02.005; [阙友雄 Que Youxiong], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P274; Rezaee F, 2013, S AFR J BOT, V84, P13, DOI 10.1016/j.sajb.2012.09.006; SANDMANN G, 1980, PLANT PHYSIOL, V66, P797, DOI 10.1104/pp.66.5.797; Scandalios JG, 2000, PLANT SCI, V156, P103, DOI 10.1016/S0168-9452(00)00235-1; Singh N, 2004, PLANT SCI, V167, P987, DOI 10.1016/j.plantsci.2004.05.006; Skadsen RW, 1995, PLANT MOL BIOL, V29, P1005, DOI 10.1007/BF00014973; Solas M. T., 1999, Sugar Cane, P14; [宋新华 SONG Xinhua], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P9824; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Sundar A.R., 2012, BOTANY, DOI [10.5772/34116, DOI 10.5772/34116]; Takken FLW, 2000, EUR J PLANT PATHOL, V106, P699, DOI 10.1023/A:1026571130477; WALLER JM, 1970, T BRIT MYCOL SOC, V54, P405, DOI 10.1016/S0007-1536(70)80155-3; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang C, 2013, FISH SHELLFISH IMMUN, V34, P91, DOI 10.1016/j.fsi.2012.10.013; WILLEKENS H, 1994, FEBS LETT, V352, P79, DOI 10.1016/0014-5793(94)00923-6; WILLIAMSON JD, 1992, PLANT J, V2, P351; Xu L. P., 1994, SUGARCANE, V3, P13; [Xu Liping 徐莉萍], 2004, [热带作物学报, Chinese Journal of Tropical Crops], V25, P33	55	69	79	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84426	10.1371/journal.pone.0084426	http://dx.doi.org/10.1371/journal.pone.0084426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392135	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100058
J	Heim, D; Cornils, K; Schulze, K; Fehse, B; Lohse, AW; Brummendorf, TH; Wege, H				Heim, D.; Cornils, K.; Schulze, K.; Fehse, B.; Lohse, A. W.; Bruemmendorf, T. H.; Wege, H.			Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis	ONCOGENE			English	Article						Hepatocarcinogenesis; hepatocellular carcinoma; retroviral insertional mutagenesis; telomerase	NF-KAPPA-B; HEMATOPOIETIC STEM-CELLS; PRECANCEROUS HEPATIC NODULES; HUMAN FETAL HEPATOCYTES; HEPATOCELLULAR-CARCINOMA; GENE-TRANSFER; INDUCED APOPTOSIS; LIVER-CANCER; PLAG1; PROTEIN	Carcinogenesis is a multistep process involving alterations in various cellular pathways. The critical genetic events driving the evolution of primary liver cancer, specifically hepatoblastoma and hepatocellular carcinoma (HCC), are still poorly understood. However, telomere stabilization is acknowledged as prerequisite for cancer progression in humans. In this project, human fetal hepatocytes were utilized as a cell culture model for untransformed, proliferating human liver cells, with telomerase activation as first oncogenic hit. To elucidate critical downstream genetic events driving further transformation of immortalized liver cells, we used retroviral insertional mutagenesis as an unbiased approach to induce genetic alterations. Following isolation of hyperproliferating, provirus-bearing cell clones, we monitored cancer-associated growth properties and characterized changes toward a malignant phenotype. Three transformed clones with the ability to form colonies in soft agar were expanded. As proof-ofprinciple for our experimental setup, we identified a transforming insertion on chromosome 8 within the pleiomorphic adenoma gene 1 (PLAG1), resulting in a 20-fold increase in PLAG1 expression. Upregulation of PLAG1 has already been described to promote human hepatoblastoma development. In a separate clone, a transforming insertion was detected in close proximity to the receptorinteracting serine-threonine kinase 4 (RIPK4) with an approximately eightfold suppression in RIPK4 expression. As validation for this currently unknown driver in hepatocarcinogenesis, we examined RIPK4 expression in human HCC samples and confirmed a significant suppression of RIPK4 in 80% of the samples. Furthermore, overexpression of RIPK4 in transformed human fetal hepatocytes resulted in an almost complete elimination of anchorage-independent growth. On the basis of these data, we propose RIPK4 as a novel putative tumor suppressor in human hepatocarcinogenesis.	[Heim, D.; Schulze, K.; Lohse, A. W.; Wege, H.] Univ Med Ctr Hamburg Eppendorf, Dept Gastroenterol & Hepatol, D-20246 Hamburg, Germany; [Cornils, K.; Fehse, B.] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, D-20246 Hamburg, Germany; [Bruemmendorf, T. H.] Rhein Westfal TH Aachen, Univ Med Ctr, Dept Hematol & Oncol, D-52062 Aachen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; RWTH Aachen University; RWTH Aachen University Hospital	Heim, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gastroenterol & Hepatol, Martinistr 52, D-20246 Hamburg, Germany.	dheim@uke.de	Fehse, Boris/A-8721-2012	Fehse, Boris/0000-0001-9780-7211	Deutsche Forschungsgemeinschaft [SFB 841, C5, C7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge the valuable technical assistance provided by N Knuth, J Polke, P Zemke-Trautmann and the FACS Core Unit of the UMC Hamburg-Eppendorf. We are grateful for the financial support by the Deutsche Forschungsgemeinschaft (SFB 841, projects C5 and C7).	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Astrom AK, 2000, INT J ONCOL, V16, P1107; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; Declercq J, 2005, CANCER RES, V65, P4544, DOI 10.1158/0008-5472.CAN-04-4041; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Greider CW, 1991, CURR OPIN CELL BIOL, V3, P444, DOI 10.1016/0955-0674(91)90072-7; Haker B, 2007, CANCER LETT, V256, P120, DOI 10.1016/j.canlet.2007.06.007; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; Hibbard MK, 2000, CANCER RES, V60, P4869; Hoshida Yujin, 2009, Expert Rev Gastroenterol Hepatol, V3, P101, DOI 10.1586/egh.09.5; Hytiroglou P, 1998, CANCER, V82, P1831, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1831::AID-CNCR4>3.0.CO;2-Q; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SW, 2008, BLOOD, V111, P1644, DOI 10.1182/blood-2007-05-088591; KING W, 1985, SCIENCE, V228, P554, DOI 10.1126/science.3838595; Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303; Komine F, 2000, J HEPATOL, V32, P235, DOI 10.1016/S0168-8278(00)80068-9; Kuhlcke K, 2002, MOL THER, V5, P473, DOI 10.1006/mthe.2002.0566; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Oh BK, 2003, J HEPATOL, V39, P786, DOI 10.1016/S0168-8278(03)00395-7; Ranzani M, 2013, NAT METHODS, V10, P155, DOI [10.1038/nmeth.2331, 10.1038/NMETH.2331]; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Takaishi H, 2000, CANCER, V88, P312, DOI 10.1002/(SICI)1097-0142(20000115)88:2<312::AID-CNCR10>3.3.CO;2-I; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Wege H, 2011, MOL CANCER RES, V9, P1222, DOI 10.1158/1541-7786.MCR-10-0474; Zatkova A, 2004, GENE CHROMOSOME CANC, V39, P126, DOI 10.1002/gcc.10307	52	22	25	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					385	393		10.1038/onc.2013.551	http://dx.doi.org/10.1038/onc.2013.551			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24413083				2022-12-25	WOS:000348145500012
J	Dowling, JK; Becker, CE; Bourke, NM; Corr, SC; Connolly, DJ; Quinn, SR; Pandolfi, PP; Mansell, A; O'Neill, LAJ				Dowling, Jennifer K.; Becker, Christine E.; Bourke, Nollaig M.; Corr, Sinead C.; Connolly, Dympna J.; Quinn, Susan R.; Pandolfi, Paolo P.; Mansell, Ashley; O'Neill, Luke A. J.			Promyelocytic Leukemia Protein Interacts with the Apoptosis-associated Speck-like Protein to Limit Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cytokine; Inflammation; Innate Immunity; Nod-like Receptors (NLR); Inflammasome	HOST-DEFENSE; ASC; PML; RECOGNITION; ADAPTER; NLRP3; DNA	Background: ASC is the common adaptor of caspase-1 activation in several inflammasomes. Results: A novel interaction between PML and ASC is identified. PML-deficient macrophages display enhanced levels of IL-1 secretion and higher levels of ASC in the cytosol. Conclusion: PML retains ASC in the nucleus limiting inflammasome activation. Significance: Understanding the regulation of inflammasome components will aid in the development of therapeutics to alleviate IL-1-mediated diseases. The apoptosis-associated speck-like protein containing a caspase-activating recruitment domain (ASC) is an essential component of several inflammasomes, multiprotein complexes that regulate caspase-1 activation and inflammation. We report here an interaction between promyelocytic leukemia protein (PML) and ASC. We observed enhanced formation of ASC dimers in PML-deficient macrophages. These macrophages also display enhanced levels of ASC in the cytosol. Furthermore, IL-1 production was markedly enhanced in these macrophages in response to both NLRP3 and AIM2 inflammasome activation and following bone marrow-derived macrophage infection with herpes simplex virus-1 (HSV-1) and Salmonella typhimurium. Collectively, our data indicate that PML limits ASC function, retaining ASC in the nucleus.	[Dowling, Jennifer K.; Becker, Christine E.; Corr, Sinead C.; Connolly, Dympna J.; Quinn, Susan R.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Pandolfi, Paolo P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Genet Program,Dept Med,Med Sch, Boston, MA 01605 USA; [Bourke, Nollaig M.; Mansell, Ashley] Monash Univ, Ctr Innate Immun & Infect Dis, MIMR PHI Inst Med Res, Clayton, Vic 3168, Australia	Trinity College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Monash University; Prince Henry's Institute of Medical Research	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Inflammat Res Grp, 152-160 Pearse St, Dublin 2, Ireland.	laoneill@tcd.ie	Bourke, Nollaig M/A-9840-2017; Bourke, Nollaig/AAE-7279-2019; Dowling, Jennifer/ABA-6670-2020; Mansell, Ashley/B-9553-2008	Bourke, Nollaig M/0000-0003-4313-6859; Bourke, Nollaig/0000-0003-4313-6859; Mansell, Ashley/0000-0002-6540-1281; Dowling, Jennifer/0000-0003-2842-1504; O'Neill, Luke/0000-0002-4333-2748; Corr, Sinead/0000-0001-9930-5039; Pandolfi, Pier Paolo/0000-0002-5352-5295	Victorian Government's Operational Infrastructure Support Program; Science Foundation Ireland	Victorian Government's Operational Infrastructure Support Program; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Victorian Government's Operational Infrastructure Support Program along with Science Foundation Ireland.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arlehamn CSL, 2011, CELL MICROBIOL, V13, P388, DOI 10.1111/j.1462-5822.2010.01541.x; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan NB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-23; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Conway KE, 2000, CANCER RES, V60, P6236; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026264; Lo YH, 2013, BLOOD, V121, P3185, DOI 10.1182/blood-2012-05-432104; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Matsushita K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/287387; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Salomoni P, 2007, HISTOL HISTOPATHOL, V22, P937, DOI 10.14670/HH-22.937; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	31	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6429	6437		10.1074/jbc.M113.539692	http://dx.doi.org/10.1074/jbc.M113.539692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407287	Green Published, hybrid			2022-12-25	WOS:000332389400011
J	Yoo, JE; Park, YN; Oh, BK				Yoo, Jeong Eun; Park, Young Nyun; Oh, Bong-Kyeong			PinX1, a Telomere Repeat-binding Factor 1 (TRF1)-interacting Protein, Maintains Telomere Integrity by Modulating TRF1 Homeostasis, the Process in Which Human Telomerase Reverse Transcriptase (hTERT) Plays Dual Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage Response; Telomerase; Telomeres; Tumor Cell Biology; Tumor Suppressor Gene; DNA Damage Response; TERT; Chromosomal Instability; Telomere Deficiency; Telomeric Repeat-binding Factor 1	IMMORTAL CELLS; CANCER; FIBROBLASTS; STABILIZES; ACTIVATION; COMPLEX; LENGTH	Background: PinX1 interacts with TRF1 and hTERT, but the significance of the physical association is not fully understood. Results: PinX1 is involved in chromosome stability by regulating TRF1 protein stability, and the function of PinX1 is linked to hTERT. Conclusion: PinX1 is functionally connected with hTERT to maintain TRF1 stability. Significance: These findings suggest that a TRF1 turnover mechanism is linked to telomerase. TRF1, a telomere-binding protein, is important for telomere protection and homeostasis. PinX1 interacts with TRF1, but the physiological consequences of their interaction in telomere protection are not yet understood. Here we investigated PinX1 function on TRF1 stability in HeLa cells. PinX1 overexpression stabilized TRF1, but PinX1 depletion by siRNA led to TRF1 degradation, TRF1 ubiquitination, and less TRF1 telomere association. The depletion also induced DNA damage responses at telomeres and chromosome instability. These telomere dysfunctional phenotypes were in fact due to TRF1 deficiency. We also report that hTERT, a catalytic component of telomerase, plays dual roles in the TRF1 steady state pathway. PinX1-mediated TRF1 stability was not observed in hTERT-negative immortal cells, but was pronounced when hTERT was ectopically expressed in the cells, suggesting that hTERT may be needed in the PinX1-mediated TRF1 stability pathway. Interestingly, the knockdown of both PinX1 and hTERT in HeLa cells stabilized TRF1, suppressed DNA damage response activation, and restored chromosome stability. In summary, our findings suggested that PinX1 may maintain telomere integrity by regulating TRF1 stability and that hTERT may act as both a positive and a negative regulator of TRF1 homeostasis in a PinX1-dependent manner.	[Yoo, Jeong Eun; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Oh, Bong-Kyeong] Hanyang Univ, Coll Med, Inst Med Sci, Dept Obstet & Gynecol, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Brain Korea PLUS Project Med Sci 21, 250 Seongsan Ro, Seoul 120752, South Korea.	young0608@yuhs.ac; bongoh0401@hanyang.ac.kr		Park, Young Nyun/0000-0003-0357-7967	National Research Foundation of Korea [2013R1A2A2A05005990, 2012M3A9B6055350, 2011-0030086, 2010-0008254, 2011-0015638]; Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 2013R1A2A2A05005990, 2012M3A9B6055350, and 2011-0030086 (to Y.N.P.) and 2010-0008254 and 2011-0015638 (to B.K.O.) funded by the Ministry of Education, Science and Technology.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)90128-0; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen GM, 2011, GASTROENTEROLOGY, V140, P332, DOI 10.1053/j.gastro.2010.08.046; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Jung AR, 2013, ANTICANCER RES, V33, P821; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lackner DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021407; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Soohoo CY, 2011, J BIOL CHEM, V286, P3894, DOI 10.1074/jbc.M110.180174; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11; Yoo JE, 2009, J MOL BIOL, V388, P928, DOI 10.1016/j.jmb.2009.02.051; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	32	14	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6886	6898		10.1074/jbc.M113.506006	http://dx.doi.org/10.1074/jbc.M113.506006			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415760	Green Published, hybrid			2022-12-25	WOS:000332389400049
J	Bojjireddy, N; Botyanszki, J; Hammond, G; Creech, D; Peterson, R; Kemp, DC; Snead, M; Brown, R; Morrison, A; Wilson, S; Harrison, S; Moore, C; Balla, T				Bojjireddy, Naveen; Botyanszki, Janos; Hammond, Gerald; Creech, Donald; Peterson, Richard; Kemp, Daniel C.; Snead, Mark; Brown, Randy; Morrison, Alastair; Wilson, Steve; Harrison, Steve; Moore, Chris; Balla, Tamas			Pharmacological and Genetic Targeting of the PI4KA Enzyme Reveals Its Important Role in Maintaining Plasma Membrane Phosphatidylinositol 4-Phosphate and Phosphatidylinositol 4,5-Bisphosphate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; G Protein-coupled Receptors; Phosphatidylinositol; Phosphatidylinositol Kinase; Phospholipase C	C VIRUS-REPLICATION; III-ALPHA; 4-KINASE; PHOSPHOINOSITIDES; DOMAINS; KINASE; POOLS; PTDINS(4,5)P-2; TRAFFICKING; ACTIVATION	Background: PI4KA is a critical host factor for replication of hepatitis C virus in liver and a potential therapeutic target. Results: PI4KA inhibitors prevent the maintenance of PtdIns(4,5)P-2 pools during strong PLC activation. Conclusion: PI4KA plays a critical role in maintaining plasma membrane phosphoinositide pools. Significance: Safe pharmacological targeting of PI4KA is not feasible. Phosphatidylinositol 4-kinase type III (PI4KA) is a host factor essential for hepatitis C virus replication and hence is a target for drug development. PI4KA has also been linked to endoplasmic reticulum exit sites and generation of plasma membrane phosphoinositides. Here, we developed highly specific and potent inhibitors of PI4KA and conditional knock-out mice to study the importance of this enzyme in vitro and in vivo. Our studies showed that PI4KA is essential for the maintenance of plasma membrane phosphatidylinositol 4,5-bisphosphate pools but only during strong stimulation of receptors coupled to phospholipase C activation. Pharmacological blockade of PI4KA in adult animals leads to sudden death closely correlating with the drug's ability to induce phosphatidylinositol 4,5-bisphosphate depletion after agonist stimulation. Genetic inactivation of PI4KA also leads to death; however, the cause in this case is due to severe intestinal necrosis. These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.	[Bojjireddy, Naveen; Hammond, Gerald; Balla, Tamas] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA; [Botyanszki, Janos; Creech, Donald; Moore, Chris] GlaxoSmithKline, Infect Dis Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Peterson, Richard; Kemp, Daniel C.; Brown, Randy] GlaxoSmithKline, Safety Assessment, Res Triangle Pk, NC 27709 USA; [Snead, Mark; Morrison, Alastair; Wilson, Steve; Harrison, Steve] GlaxoSmithKline, Lab Anim Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Moore, C (corresponding author), GlaxoSmithKline, Infect Dis Discovery Performance Unit, Rm 3-3245,5 Moore Dr, Res Triangle Pk, NC 27709 USA.	christopher.b.moore@gsk.com; ballat@mail.nih.gov	Hammond, Gerald R/A-5759-2016	Hammond, Gerald R/0000-0002-6660-3272; Balla, Tamas/0000-0002-9077-3335	National Institutes of Health from the Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program of the Eunice Kennedy Shriver NICHD (to N. B., G. H., and T. B.).	Adams N. D., 2008, PCT International Patent Application, Patent No. [WO 2008157191 A2, 201287938A1]; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Banka A. L., 2012, PCT International Patent Application, Patent No. [WO 201287938 A1, 201287938A1]; Bengtsson M. L., 2006, PCT International Patent Application, Patent No. [WO 2006051270 A1, 201287938A1]; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Botyanszki J., 2012, PCT International Patent Application, Patent No. [WO 2012174312 A2, 2012174312A2]; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo Giovanni, 2012, Subcell Biochem, V59, P255, DOI 10.1007/978-94-007-3015-1_8; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Leivers A.L., 2013, J MED CHEM; Minogue Shane, 2012, Subcell Biochem, V58, P1, DOI 10.1007/978-94-007-3012-0_1; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2012, J VIROL, V86, P11595, DOI 10.1128/JVI.01320-12; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236	43	99	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6120	6132		10.1074/jbc.M113.531426	http://dx.doi.org/10.1074/jbc.M113.531426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415756	Green Published, hybrid			2022-12-25	WOS:000332015500066
J	Maxson, JE; Luty, SB; MacManiman, JD; Abel, ML; Druker, BJ; Tyner, JW				Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Abel, Melissa L.; Druker, Brian J.; Tyner, Jeffrey W.			Ligand Independence of the T618I Mutation in the Colony-stimulating Factor 3 Receptor (CSF3R) Protein Results from Loss of O-Linked Glycosylation and Increased Receptor Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Glycoprotein; Leukemia; Neutrophil; Receptor Modification; GCSFR T595I; Myeloproliferative Neoplasm	SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOID-LEUKEMIA; CHRONIC NEUTROPHILIC LEUKEMIA; SRC KINASE LYN; ACTIVATING MUTATION; GRANULOCYTE; INTERNALIZATION; DOMAIN; GENE; MICE	Background: We recently identified CSF3R mutations in chronic neutrophilic leukemia. The most common mutation, T618I, signals without ligand through an undefined mechanism. Results: CSF3R T618I abrogates an O-glycosylation event and increases receptor dimerization. Conclusion: The constitutive activity of CSF3R T618I may be explained by loss of O-glycosylation. Significance: This study illustrates the role of O-linked glycosylation in protein function and oncogenesis. Mutations in the CSF3 granulocyte colony-stimulating factor receptor CSF3R have recently been found in a large percentage of patients with chronic neutrophilic leukemia and, more rarely, in other types of leukemia. These CSF3R mutations fall into two distinct categories: membrane-proximal mutations and truncation mutations. Although both classes of mutation have exhibited the capacity for cellular transformation, several aspects of this transformation, including the kinetics, the requirement for ligand, and the dysregulation of downstream signaling pathways, have all been shown to be discrepant between the mutation types, suggesting distinct mechanisms of activation. CSF3R truncation mutations induce overexpression and ligand hypersensitivity of the receptor, likely because of the removal of motifs necessary for endocytosis and degradation. In contrast, little is known about the mechanism of activation of membrane-proximal mutations, which are much more commonly observed in chronic neutrophilic leukemia. In contrast with CSF3R truncation mutations, membrane-proximal mutations do not exhibit overexpression and are capable of signaling in the absence of ligand. We show that the Thr-615 and Thr-618 sites of membrane-proximal mutations are part of an O-linked glycosylation cluster. Mutation at these sites prevents O-glycosylation of CSF3R and increases receptor dimerization. This increased dimerization explains the ligand-independent activation of CSF3R membrane-proximal mutations. Cytokine receptor activation through loss of O-glycosylation represents a novel avenue of aberrant signaling. Finally, the combination of the CSF3R membrane proximal and truncation mutations, as has been reported in some patients, leads to enhanced cellular transformation when compared with either mutation alone, underscoring their distinct mechanisms of action.	[Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Abel, Melissa L.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Maxson, Julia E.; Luty, Samuel B.; MacManiman, Jason D.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Abel, Melissa L.; Druker, Brian J.] Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute	Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Mailcode L592, Portland, OR 97239 USA.	tynerj@ohsu.edu		Druker, Brian/0000-0001-8331-8206; Tyner, Jeffrey/0000-0002-2133-0960	Howard Hughes Medical Institute; Training Program in Molecular Hematology, National Institutes of Health [5T32HL007781]; Leukemia and Lymphoma Society Fellow award; Medical Research Foundation; V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; Gabrielle's Angel Foundation for Cancer Research; NCI, National Institutes of Health [4 R00CA151457-03]; NATIONAL CANCER INSTITUTE [R01CA183974, R00CA151457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Training Program in Molecular Hematology, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Fellow award(Leukemia and Lymphoma Society); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); V Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; Gabrielle's Angel Foundation for Cancer Research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (to B. J. D.).; Supported by Training Program in Molecular Hematology, National Institutes of Health Grant 5T32HL007781, by a Leukemia and Lymphoma Society Fellow award, and by a Medical Research Foundation Early Clinical Investigator award.; Supported by the V Foundation for Cancer Research, by the William Lawrence and Blanche Hughes Fund, by the Gabrielle's Angel Foundation for Cancer Research, and by NCI, National Institutes of Health Grant 4 R00CA151457-03. To whom correspondence should be addressed: Dept. of Cell and Developmental Biology, Mailcode L592, Oregon Health and Science University, Portland, OR 97239. Tel.: 503-346-0603; Fax: 503-494-3688; E-mail: tynerj@ohsu.edu.	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; Beekman R, 2013, HAEMATOLOGICA, V98, pE62, DOI 10.3324/haematol.2013.085050; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Forbes LV, 2002, ONCOGENE, V21, P5981, DOI 10.1038/sj.onc.1205767; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Haniu M, 1996, BIOCHEMISTRY-US, V35, P13040, DOI 10.1021/bi960213u; Kimura A, 2004, J BIOL CHEM, V279, P6905, DOI 10.1074/jbc.C300496200; KODAMA S, 1993, EUR J BIOCHEM, V211, P903, DOI 10.1111/j.1432-1033.1993.tb17624.x; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Mehta HM, 2013, LEUKEMIA, V27, P2407, DOI 10.1038/leu.2013.164; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; NISSEN C, 1994, EUR J CANCER, V30A, pS12; Pardanani A, 2013, LEUKEMIA, V27, P1870, DOI 10.1038/leu.2013.122; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; TIAN SS, 1994, BLOOD, V84, P1760; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	25	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5820	5827		10.1074/jbc.M113.508440	http://dx.doi.org/10.1074/jbc.M113.508440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403076	Green Published, hybrid			2022-12-25	WOS:000332015500041
J	Nakamoto, H; Fujita, K; Ohtaki, A; Watanabe, S; Narumi, S; Maruyama, T; Suenaga, E; Misono, TS; Kumar, PKR; Goloubinoff, P; Yoshikawa, H				Nakamoto, Hitoshi; Fujita, Kensaku; Ohtaki, Aguru; Watanabe, Satoru; Narumi, Shoichi; Maruyama, Takahiro; Suenaga, Emi; Misono, Tomoko S.; Kumar, Penmetcha K. R.; Goloubinoff, Pierre; Yoshikawa, Hirofumi			Physical Interaction between Bacterial Heat Shock Protein (Hsp) 90 and Hsp70 Chaperones Mediates Their Cooperative Action to Refold Denatured Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Heat Shock Protein; Hsp90; Molecular Chaperone; Protein Aggregation; DnaJ; DnaK; Hsp70; HtpG	MOLECULAR CHAPERONE; ESCHERICHIA-COLI; CONFORMATIONAL DYNAMICS; MULTIGENE FAMILY; HTPG; DNAK; STABILIZES; PROTECTION; SYSTEM; GENE	Background: HtpG, a bacterial heat shock protein 90 (Hsp90), is essential for thermotolerance in some prokaryotes. Results: HtpG functions with DnaK2/DnaJ2/GrpE to assist unfolding/folding of denatured proteins in both ATP-dependent and -independent fashions. Conclusion: The cooperative action of HtpG and DnaK2 might play a key role under stress. Significance: This might be the first sign of a prokaryotic Hsp90 foldosome. In eukaryotes, heat shock protein 90 (Hsp90) is an essential ATP-dependent molecular chaperone that associates with numerous client proteins. HtpG, a prokaryotic homolog of Hsp90, is essential for thermotolerance in cyanobacteria, and in vitro it suppresses the aggregation of denatured proteins efficiently. Understanding how the non-native client proteins bound to HtpG refold is of central importance to comprehend the essential role of HtpG under stress. Here, we demonstrate by yeast two-hybrid method, immunoprecipitation assays, and surface plasmon resonance techniques that HtpG physically interacts with DnaJ2 and DnaK2. DnaJ2, which belongs to the type II J-protein family, bound DnaK2 or HtpG with submicromolar affinity, and HtpG bound DnaK2 with micromolar affinity. Not only DnaJ2 but also HtpG enhanced the ATP hydrolysis by DnaK2. Although assisted by the DnaK2 chaperone system, HtpG enhanced native refolding of urea-denatured lactate dehydrogenase and heat-denatured glucose-6-phosphate dehydrogenase. HtpG did not substitute for DnaJ2 or GrpE in the DnaK2-assisted refolding of the denatured substrates. The heat-denatured malate dehydrogenase that did not refold by the assistance of the DnaK2 chaperone system alone was trapped by HtpG first and then transferred to DnaK2 where it refolded. Dissociation of substrates from HtpG was either ATP-dependent or -independent depending on the substrate, indicating the presence of two mechanisms of cooperative action between the HtpG and the DnaK2 chaperone system.	[Nakamoto, Hitoshi; Fujita, Kensaku; Ohtaki, Aguru; Narumi, Shoichi; Maruyama, Takahiro] Saitama Univ, Dept Biochem & Mol Biol, Saitama 3388570, Japan; [Nakamoto, Hitoshi] Saitama Univ, Inst Environm Sci & Technol, Saitama 3388570, Japan; [Watanabe, Satoru; Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Suenaga, Emi; Misono, Tomoko S.; Kumar, Penmetcha K. R.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Goloubinoff, Pierre] Univ Lausanne, Fac Biol & Med, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Yoshikawa, Hirofumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	Saitama University; Saitama University; Tokyo University of Agriculture; National Institute of Advanced Industrial Science & Technology (AIST); University of Lausanne; Japan Science & Technology Agency (JST)	Nakamoto, H (corresponding author), Saitama Univ, Dept Biochem & Mol Biol, Saitama 3388570, Japan.	nakamoto@mail.saitama-u.ac.jp	Nakamoto, Hitoshi/H-5315-2012; Penmetcha, Kumar/K-8834-2017	Penmetcha, Kumar/0000-0002-3512-704X; Goloubinoff, Pierre/0000-0002-4802-0807	Ministry of Education, Science, Sports and Culture of Japan [24580102]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (C) 24580102 (to H. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Dang W, 2011, VET MICROBIOL, V152, P394, DOI 10.1016/j.vetmic.2011.05.030; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Garcia-Descalzo L, 2011, CELL STRESS CHAPERON, V16, P203, DOI 10.1007/s12192-010-0233-7; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Hossain MM, 2002, CURR MICROBIOL, V44, P291, DOI 10.1007/s00284-001-0005-9; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Motojima-Miyazaki Y, 2010, BIOCHEM BIOPH RES CO, V400, P241, DOI 10.1016/j.bbrc.2010.08.047; Nimura K, 2001, J BACTERIOL, V183, P1320, DOI 10.1128/JB.183.4.1320-1328.2001; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rowland JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010511; Roy SK, 1999, EUR J BIOCHEM, V262, P406, DOI 10.1046/j.1432-1327.1999.00380.x; Sato M, 2007, BIOSCI BIOTECH BIOCH, V71, P1021, DOI 10.1271/bbb.60691; Sato T, 2010, MOL MICROBIOL, V76, P576, DOI 10.1111/j.1365-2958.2010.07139.x; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Tanaka N, 1999, FEBS LETT, V458, P117, DOI 10.1016/S0014-5793(99)01134-5; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Versteeg S, 1999, MOL GEN GENET, V261, P582, DOI 10.1007/s004380051004; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P279, DOI 10.1271/bbb.60647; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V352, P36, DOI 10.1016/j.bbrc.2006.10.144; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0	35	53	53	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6110	6119		10.1074/jbc.M113.524801	http://dx.doi.org/10.1074/jbc.M113.524801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415765	Green Published, hybrid			2022-12-25	WOS:000332015500065
J	Sobierajska, K; Skurzynski, S; Stasiak, M; Kryczka, J; Cierniewski, CS; Swiatkowska, M				Sobierajska, Katarzyna; Skurzynski, Szymon; Stasiak, Marta; Kryczka, Jakub; Cierniewski, Czeslaw S.; Swiatkowska, Maria			Protein Disulfide Isomerase Directly Interacts with beta-Actin Cys(374) and Regulates Cytoskeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adhesion; Cytoskeleton; Disulfide; Thiol	S-GLUTATHIONYLATION; REDOX REGULATION; CELL-ADHESION; POLYMERIZATION; ISOMERIZATION; ASSOCIATION; ACTIVATION; OXIDATION; INTEGRIN; SURFACE	Background: PDI regulates cytoskeleton reorganization by the thiol-disulfide exchange in -actin. Results: PDI directly binds to Cys(374) of -actin during cell adhesion and spreading. Conclusion: Interaction of PDI with -actin is induced by integrin-mediated cell adhesion and promotes cytoskeleton reorganization. Significance: PDI is a new regulator of the intramolecular disulfide-thiol rearrangement of -actin in response to IIb3 integrin engagement. Recent studies support the role of cysteine oxidation in actin cytoskeleton reorganization during cell adhesion. The aim of this study was to explain whether protein disulfide isomerase (PDI) is responsible for the thiol-disulfide rearrangement in the -actin molecule of adhering cells. First, we showed that PDI forms a disulfide-bonded complex with -actin with a molecular mass of 110 kDa. Specific interaction of both proteins was demonstrated by a solid phase binding assay, surface plasmon resonance analysis, and immunoprecipitation experiments. Second, using confocal microscopy, we found that both proteins colocalized when spreading MEG-01 cells on fibronectin. Colocalization of PDI and -actin could be abolished by the membrane-permeable sulfhydryl blocker, N-ethylmaleimide, by the RGD peptide, and by anti-IIb3 antibodies. Consequently, down-regulation of PDI expression by antisense oligonucleotides impaired the spreading of cells and initiated reorganization of the cytoskeleton. Third, because of transfection experiments followed by immunoprecipitation and confocal analysis, we provided evidence that PDI binds to the -actin Cys(374) thiol. Formation of the -actin-PDI complex was mediated by integrin-dependent signaling in response to the adhesion of cells to the extracellular matrix. Our data suggest that PDI is released from subcellular compartments to the cytosol and translocated toward the periphery of the cell, where it forms a disulfide bond with -actin when MEG-01 cells adhere via the IIb3 integrin to fibronectin. Thus, PDI appears to regulate cytoskeletal reorganization by the thiol-disulfide exchange in -actin via a redox-dependent mechanism.	[Sobierajska, Katarzyna; Skurzynski, Szymon; Stasiak, Marta; Kryczka, Jakub; Cierniewski, Czeslaw S.; Swiatkowska, Maria] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Kryczka, Jakub; Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-93232 Lodz, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Swiatkowska, M (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	maria.swiatkowska@umed.lodz.pl	Sobierajska, Katarzyna/S-6650-2016	Sobierajska, Katarzyna/0000-0003-3510-0098; Kryczka, Jakub/0000-0002-5719-4139	Polish National Science Center [N401 140939]; National Science Center [2011/02/A/NZ3/00068]	Polish National Science Center; National Science Center(National Science Centre, Poland)	This work was supported by Project N401 140939 from the Polish National Science Center (to M. S.).; Supported by Project 2011/02/A/NZ3/00068 from the National Science Center.	Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Dalle-Donne I, 2005, FREE RADICAL BIO MED, V38, P1501, DOI 10.1016/j.freeradbiomed.2005.02.019; Dalle-Donne I, 2003, FREE RADICAL BIO MED, V34, P23, DOI 10.1016/S0891-5849(02)01182-6; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FARWELL AP, 1990, J BIOL CHEM, V265, P18546; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; HINSHAW DB, 1991, ARCH BIOCHEM BIOPHYS, V288, P311, DOI 10.1016/0003-9861(91)90200-3; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; OGURA M, 1985, BLOOD, V66, P1384; OMANN GM, 1994, ARCH BIOCHEM BIOPHYS, V308, P407, DOI 10.1006/abbi.1994.1057; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; RUOPPOLO M, 1995, BIOCHEMISTRY-US, V34, P9380, DOI 10.1021/bi00029a014; Ruoppolo M, 1996, BIOCHEMISTRY-US, V35, P13636, DOI 10.1021/bi960755b; SAFRAN M, 1992, ENDOCRINOLOGY, V131, P2413, DOI 10.1210/en.131.5.2413; STOURNARAS C, 1990, ANTICANCER RES, V10, P1651; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	33	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5758	5773		10.1074/jbc.M113.479477	http://dx.doi.org/10.1074/jbc.M113.479477			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415753	Green Published, hybrid			2022-12-25	WOS:000332015500036
J	Wolfram, F; Kitova, EN; Robinson, H; Walvoort, MTC; Codee, JDC; Klassen, JS; Howell, PL				Wolfram, Francis; Kitova, Elena N.; Robinson, Howard; Walvoort, Marthe T. C.; Codee, Jeroen D. C.; Klassen, John S.; Howell, P. Lynne			Catalytic Mechanism and Mode of Action of the Periplasmic Alginate Epimerase AlgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofilm; Crystal Structure; Enzyme Catalysis; Polysaccharide; Pseudomonas aeruginosa; Alginate; Epimerase	VINELANDII MANNURONAN C-5-EPIMERASE; PSEUDOMONAS-AERUGINOSA ALGG; BIOSYNTHETIC GENE-CLUSTER; C-5 EPIMERASE; C5-MANNURONAN EPIMERASE; ERWINIA-CHRYSANTHEMI; PECTIN LYASE; ACID; PROTEIN; SEQUENCE	Background: The alginate epimerase AlgG converts mannuronate to its C5 epimer guluronate at the polymer level. Results: The structure of Pseudomonas syringae AlgG has been determined, and the protein has been functionally characterized. Conclusion: His(319) acts as the catalytic base, whereas Arg(345) neutralizes the negative charge of the carboxylate group during catalysis. Significance: This is the first structural characterization of a periplasmic alginate epimerase. Pseudomonas aeruginosa is an opportunistic pathogen that forms chronic biofilm infections in the lungs of cystic fibrosis patients. A major component of the biofilm during these infections is the exopolysaccharide alginate, which is synthesized at the inner membrane as a homopolymer of 1-4-linked -d-mannuronate. As the polymer passages through the periplasm, 22-44% of the mannuronate residues are converted to -l-guluronate by the C5-epimerase AlgG to produce a polymer of alternating -d-mannuronate and -l-guluronate blocks and stretches of polymannuronate. To understand the molecular basis of alginate epimerization, the structure of Pseudomonas syringae AlgG has been determined at 2.1- resolution, and the protein was functionally characterized. The structure reveals that AlgG is a long right-handed parallel -helix with an elaborate lid structure. Functional analysis of AlgG mutants suggests that His(319) acts as the catalytic base and that Arg(345) neutralizes the acidic group during the epimerase reaction. Water is the likely catalytic acid. Electrostatic surface potential and residue conservation analyses in conjunction with activity and substrate docking studies suggest that a conserved electropositive groove facilitates polymannuronate binding and contains at least nine substrate binding subsites. These subsites likely align the polymer in the correct register for catalysis to occur. The presence of multiple subsites, the electropositive groove, and the non-random distribution of guluronate in the alginate polymer suggest that AlgG is a processive enzyme. Moreover, comparison of AlgG and the extracellular alginate epimerase AlgE4 of Azotobacter vinelandii provides a structural rationale for the differences in their Ca2+ dependence.	[Wolfram, Francis; Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Walvoort, Marthe T. C.; Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Alberta; United States Department of Energy (DOE); Brookhaven National Laboratory; Leiden University; Leiden University - Excl LUMC; University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca	Walvoort, Marthe/AAE-4468-2019; Walvoort, Marthe/ABE-8335-2020	Walvoort, Marthe/0000-0003-1101-2659; Klassen, John/0000-0002-3389-7112	National Center for Research Resources [P41RR012408]; National Institute of General Medical Sciences from the National Institutes of Health [P41GM103473]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103473] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ana Mirela Neculai for substantial contributions to the initial studies on P. aeruginosa AlgG; Laura Riley, Joel Weadge, John C. C. Whitney, and Perrin Baker for helpful discussions; and Dustin J. Little and Jason Koo for technical assistance. Beam line X29 at the National Synchrotron Light Source is supported by the United States Department of Energy and by National Center for Research Resources Grant P41RR012408 and National Institute of General Medical Sciences Grant P41GM103473 from the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts B., 2002, MOL BIOL CELL, P1091; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boyd CD, 2012, J BACTERIOL, V194, P4406, DOI 10.1128/JB.00642-12; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; CASWELL RC, 1989, GENE, V75, P127, DOI 10.1016/0378-1119(89)90389-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P59, DOI 10.1016/S0968-0004(01)02046-1; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 1998, J BIOL CHEM, V273, P30927, DOI 10.1074/jbc.273.47.30927; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; GORIN PAJ, 1966, CAN J CHEMISTRY, V44, P993, DOI 10.1139/v66-147; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hoidal HK, 1999, J BIOL CHEM, V274, P12316, DOI 10.1074/jbc.274.18.12316; Holtan S, 2006, BIOCHEM J, V395, P319, DOI 10.1042/BJ20051804; Jerga A, 2006, BIOCHEMISTRY-US, V45, P552, DOI 10.1021/bi051862l; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitova EN, 2012, J AM SOC MASS SPECTR, V23, P431, DOI 10.1007/s13361-011-0311-9; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSEN B, 1971, CARBOHYD RES, V20, P225, DOI 10.1016/S0008-6215(00)81375-0; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Morea A, 2001, GENE, V278, P107, DOI 10.1016/S0378-1119(01)00685-0; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; PREISS J, 1962, J BIOL CHEM, V237, P309; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ramstad MV, 2001, ENZYME MICROB TECH, V28, P57, DOI 10.1016/S0141-0229(00)00273-8; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; SHERBROCKCOX V, 1984, CARBOHYD RES, V135, P147, DOI 10.1016/0008-6215(84)85012-0; SIMPSON JA, 1988, J GEN MICROBIOL, V134, P29; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; SKJAKBRAEK G, 1986, INT J BIOL MACROMOL, V8, P330, DOI 10.1016/0141-8130(86)90051-6; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun JX, 2006, ANAL CHEM, V78, P3010, DOI 10.1021/ac0522005; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tonon T, 2008, J PHYCOL, V44, P1250, DOI 10.1111/j.1529-8817.2008.00580.x; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Valla S, 2001, BIOCHIMIE, V83, P819, DOI 10.1016/S0300-9084(01)01313-X; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Walvoort MTC, 2012, ANGEW CHEM INT EDIT, V51, P4393, DOI 10.1002/anie.201108744; Wang WJ, 2003, ANAL CHEM, V75, P4945, DOI 10.1021/ac034300l; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	84	26	30	2	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6006	6019		10.1074/jbc.M113.533158	http://dx.doi.org/10.1074/jbc.M113.533158			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398681	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000332015500056
J	Zimmerman, MW; McQueeney, KE; Isenberg, JS; Pitt, BR; Wasserloos, KA; Homanics, GE; Lazo, JS				Zimmerman, Mark W.; McQueeney, Kelley E.; Isenberg, Jeffrey S.; Pitt, Bruce R.; Wasserloos, Karla A.; Homanics, Gregg E.; Lazo, John S.			Protein-tyrosine Phosphatase 4A3 (PTP4A3) Promotes Vascular Endothelial Growth Factor Signaling and Enables Endothelial Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cancer; Endothelial Cell; Endothelium; Phosphatase; Src; Vascular Endothelial Growth Factor (VEGF); PTP4A3 (PRL-3); Vascular Permeability	NITRIC-OXIDE; PRL-3; EXPRESSION; MIGRATION; INVASION; ANGIOGENESIS; METASTASIS; ACTIVATION; BEVACIZUMAB; DENSITY	Background: The Ptp4a gene family encodes cancer-associated phosphatases with poorly understood in vivo functions. Results: Mice deficient for PTP4A3 exhibit reduced tumor angiogenesis and decreased VEGF-mediated endothelial cell motility and vascular permeability. Conclusion: PTP4A3 has an important role in endothelial cell response to proangiogenic VEGF signaling. Significance: PTP4A3 appears to be an attractive molecular target for impeding angiogenesis in addition to tumor progression. Protein-tyrosine phosphatase 4A3 (PTP4A3) is highly expressed in multiple human cancers and is hypothesized to have a critical, albeit poorly defined, role in the formation of experimental tumors in mice. PTP4A3 is broadly expressed in many tissues so the cellular basis of its etiological contributions to carcinogenesis may involve both tumor and stromal cells. In particular, PTP4A3 is expressed in the tumor vasculature and has been proposed to be a direct target of vascular endothelial growth factor (VEGF) signaling in endothelial cells. We now provide the first in vivo experimental evidence that PTP4A3 participates in VEGF signaling and contributes to the process of pathological angiogenesis. Colon tumor tissue isolated from Ptp4a3-null mice revealed reduced tumor microvessel density compared with wild type controls. Additionally, vascular cells derived from Ptp4a3-null tissues exhibited decreased invasiveness in an ex vivo wound healing assay. When primary endothelial cells were isolated and cultured in vitro, Ptp4a3-null cells displayed greatly reduced migration compared with wild type cells. Exposure to VEGF led to an increase in Src phosphorylation in wild type endothelial cells, a response that was completely ablated in Ptp4a3-null cells. In loss-of-function studies, reduced VEGF-mediated migration was also observed when human endothelial cells were treated with a small molecule inhibitor of PTP4A3. VEGF-mediated in vivo vascular permeability was significantly attenuated in PTP4A3-deficient mice. These findings strongly support a role for PTP4A3 as an important contributor to endothelial cell function and as a multimodal target for cancer therapy and mitigating VEGF-regulated angiogenesis.	[Zimmerman, Mark W.; Pitt, Bruce R.; Homanics, Gregg E.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [McQueeney, Kelley E.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15260 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Pitt, Bruce R.; Wasserloos, Karla A.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Virginia, Dept Pharmacol, POB 800793, Charlottesville, VA 22908 USA.	lazo@virginia.edu		Homanics, Gregg/0000-0003-3641-8153	National Institute of Alcohol Abuse and Alcoholism [R37AA10422, F31AA019597]; National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship [T32GM007055]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010422, F31AA019597] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute of Alcohol Abuse and Alcoholism Grant R37AA10422 and Fellowship F31AA019597 and National Institutes of Health Pharmacological Sciences Training Grant Predoctoral Fellowship T32GM007055.	Ahn JH, 2006, BIOORG MED CHEM LETT, V16, P2996, DOI 10.1016/j.bmcl.2006.02.060; Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Fiordalisi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064309; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Lian SY, 2013, BIOCHEM BIOPH RES CO, V430, P196, DOI 10.1016/j.bbrc.2012.11.036; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-80; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Min G, 2013, BIOORG MED CHEM LETT, V23, P3769, DOI 10.1016/j.bmcl.2013.04.092; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Nagy J. A., 2012, COLD SPRING HARB PER, V2; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Preusser M, 2006, CANCER-AM CANCER SOC, V107, P162, DOI 10.1002/cncr.21973; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; St Croix B, 2000, SCIENCE, V289, P1197; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Sun ZY, 2012, J EXP MED, V209, P1363, DOI 10.1084/jem.20111343; Thompson HJ, 2002, CARCINOGENESIS, V23, P847, DOI 10.1093/carcin/23.5.847; Tyurina YY, 2011, RADIAT RES, V175, P610, DOI 10.1667/RR2297.1; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Xu J, 2011, PLOS ONE, V6; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	39	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5904	5913		10.1074/jbc.M113.480038	http://dx.doi.org/10.1074/jbc.M113.480038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403062	Green Published, hybrid			2022-12-25	WOS:000332015500047
J	Fritz, C; Lamers, LPM; Riaz, M; van den Berg, LJL; Elzenga, TJTM				Fritz, Christian; Lamers, Leon P. M.; Riaz, Muhammad; van den Berg, Leon J. L.; Elzenga, Theo J. T. M.			Sphagnum Mosses - Masters of Efficient N-Uptake while Avoiding Intoxication	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; NITRATE REDUCTASE-ACTIVITY; VASCULAR PLANTS; PHYSIOLOGICAL-RESPONSES; OMBROTROPHIC BOGS; WATER-TABLE; AMMONIUM; GROWTH; ACCUMULATION; BRYOPHYTES	Peat forming Sphagnum mosses are able to prevent the dominance of vascular plants under ombrotrophic conditions by efficiently scavenging atmospherically deposited nitrogen (N). N-uptake kinetics of these mosses are therefore expected to play a key role in differential N availability, plant competition, and carbon sequestration in Sphagnum peatlands. The interacting effects of rain N concentration and exposure time on moss N-uptake rates are, however, poorly understood. We investigated the effects of N-concentration (1, 5, 10, 50, 100, 500 mu M), N-form (N-15 - ammonium or nitrate) and exposure time (0.5, 2, 72 h) on uptake kinetics for Sphagnum magellanicum from a pristine bog in Patagonia (Argentina) and from a Dutch bog exposed to decades of N-pollution. Uptake rates for ammonium were higher than for nitrate, and N-binding at adsorption sites was negligible. During the first 0.5 h, N-uptake followed saturation kinetics revealing a high affinity (K-m 3.5-6.5 mu M). Ammonium was taken up 8 times faster than nitrate, whereas over 72 hours this was only 2 times. Uptake rates decreased drastically with increasing exposure times, which implies that many short-term N-uptake experiments in literature may well have overestimated long-term uptake rates and ecosystem retention. Sphagnum from the polluted site (i.e. long-term N exposure) showed lower uptake rates than mosses from the pristine site, indicating an adaptive response. Sphagnum therefore appears to be highly efficient in using short N pulses (e. g. rainfall in pristine areas). This strategy has important ecological and evolutionary implications: at high N input rates, the risk of N-toxicity seems to be reduced by lower uptake rates of Sphagnum, at the expense of its long-term filter capacity and related competitive advantage over vascular plants. As shown by our conceptual model, interacting effects of N-deposition and climate change (changes in rainfall) will seriously alter the functioning of Sphagnum peatlands.	[Fritz, Christian; Lamers, Leon P. M.; van den Berg, Leon J. L.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Riaz, Muhammad] GC Univ, Dept Environm Sci, Faisalabad, Pakistan; [Fritz, Christian] Univ Groningen, Ctr Energy & Environm Studies, Groningen, Netherlands; [Riaz, Muhammad] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Elzenga, Theo J. T. M.] Univ Groningen, Lab Plant Physiol, Groningen, Netherlands	Radboud University Nijmegen; Government College University Faisalabad; University of Groningen; University of York - UK; University of Groningen	Fritz, C (corresponding author), Radboud Univ Nijmegen, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	f.c@gmx.li	Fritz, Christian/C-5501-2011; Lamers, Leon P.M./A-8718-2012	Fritz, Christian/0000-0003-2687-9749; Lamers, Leon P.M./0000-0003-3769-2154; Riaz, Muhammad/0000-0001-8074-3063; Elzenga, J. Theo M./0000-0003-4556-2093	ESF [EG/2835, EG/3356]	ESF(European Commission)	Muhammed Riaz received two ESF exchange grants 'NinE' to participate in this research (EG/2835 & EG/3356). We did not require further external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, ECOLOGY, V80, P2170, DOI 10.1890/0012-9658(1999)080[2170:PMCONC]2.0.CO;2; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Aldous AR, 2002, NEW PHYTOL, V156, P241, DOI 10.1046/j.1469-8137.2002.00518.x; Aldous AR, 2002, CAN J BOT, V80, P721, DOI [10.1139/B02-054, 10.1139/b02-054]; Arroniz-Crespo M, 2008, NEW PHYTOL, V180, P864, DOI 10.1111/j.1469-8137.2008.02617.x; BAXTER R, 1992, NEW PHYTOL, V120, P265, DOI 10.1111/j.1469-8137.1992.tb05663.x; BAYLEY SE, 1987, CAN J FISH AQUAT SCI, V44, P194; Beijk R, 2007, JAAROVERZICHT LUCHTK, P1; Berendse F, 2001, GLOBAL CHANGE BIOL, V7, P591, DOI 10.1046/j.1365-2486.2001.00433.x; Blodau C, 2006, SCI TOTAL ENVIRON, V364, P215, DOI 10.1016/j.scitotenv.2005.06.002; Bragazza L, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002267; Bragazza L, 2004, NEW PHYTOL, V163, P609, DOI 10.1111/j.1469-8137.2004.01154.x; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; Bragazza L, 2012, GLOBAL CHANGE BIOL, V18, P1163, DOI 10.1111/j.1365-2486.2011.02585.x; BREHM K, 1968, PLANTA, V79, P324, DOI 10.1007/BF00386916; BREUER K, 1990, OECOLOGIA, V82, P461, DOI 10.1007/BF00319786; Cagampan JP, 2008, HYDROL PROCESS, V22, P1776, DOI 10.1002/hyp.6802; CLYMO RS, 1973, J ECOL, V61, P849, DOI 10.2307/2258654; Curtis CJ, 2005, J APPL ECOL, V42, P507, DOI 10.1111/j.1365-2664.2005.01029.x; Fritz C, 2012, PLANT BIOLOGY, V14, P491, DOI 10.1111/j.1438-8677.2011.00527.x; Fritz C, 2008, HYDROL PROCESS, V22, P3264, DOI 10.1002/hyp.6912; Fritz C, 2011, NEW PHYTOL, V190, P398, DOI 10.1111/j.1469-8137.2010.03604.x; GIGNAC LD, 1990, BRYOLOGIST, V93, P7, DOI 10.2307/3243541; Granath G, 2009, OECOLOGIA, V161, P481, DOI 10.1007/s00442-009-1406-x; Grootjans A, 2010, MIRES PEAT, V6; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Gunnarsson U, 2000, NEW PHYTOL, V147, P527, DOI 10.1046/j.1469-8137.2000.00717.x; Gunnarsson U, 2008, GLOBAL CHANGE BIOL, V14, P2152, DOI 10.1111/j.1365-2486.2008.01638.x; Heeschen V, 1996, PHYSIOL PLANTARUM, V97, P402, DOI 10.1034/j.1399-3054.1996.970227.x; Holden J, 2002, EUR J SOIL SCI, V53, P675, DOI 10.1046/j.1365-2389.2002.00486.x; Holden J, 2009, J HYDROL, V364, P342, DOI 10.1016/j.jhydrol.2008.11.010; Jauhiainen J, 1998, NEW PHYTOL, V138, P287, DOI 10.1046/j.1469-8137.1998.00110.x; Joosten H, 2002, WISE USE MIRES PEATL; Kahl S, 1997, PHYSIOL PLANTARUM, V101, P86, DOI 10.1111/j.1399-3054.1997.tb01823.x; Kielland K, 1997, ECOSCIENCE, V4, P75, DOI 10.1080/11956860.1997.11682379; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kleinebecker T, 2007, FOLIA GEOBOT, V42, P363, DOI 10.1007/BF02861700; KOCHIAN LV, 1982, PLANT PHYSIOL, V70, P1723, DOI 10.1104/pp.70.6.1723; Lafleur PM, 2005, HYDROL PROCESS, V19, P3533, DOI 10.1002/hyp.5842; Lamers LPM, 2000, GLOB CHANGE BIOL, V6, P583, DOI 10.1046/j.1365-2486.2000.00342.x; Limpens J, 2003, NEW PHYTOL, V157, P339, DOI 10.1046/j.1469-8137.2003.00667.x; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Limpens J, 2011, NEW PHYTOLOGIST, DOI j.1469-8137.2011.03680.x; Lindo Z, 2010, ECOSYSTEMS, V13, P612, DOI 10.1007/s10021-010-9336-3; Malmer N, 2003, OIKOS, V100, P469, DOI 10.1034/j.1600-0706.2003.12170.x; Marschall M, 1998, J BRYOL, V20, P273, DOI 10.1179/jbr.1998.20.2.273; Melzer A, 1989, OKOPHYSIOLOGISCHE UN, P1; Moore T, 2005, GLOBAL CHANGE BIOL, V11, P356, DOI 10.1111/j.1365-2486.2004.00882.x; Nakamura T, 2012, OECOLOGIA, V168, P913, DOI 10.1007/s00442-011-2161-3; Pearce ISK, 2003, NEW PHYTOL, V160, P145, DOI 10.1046/j.1469-8137.2003.00875.x; Pilkington MG, 2005, ENVIRON POLLUT, V135, P29, DOI 10.1016/j.envpol.2004.10.016; Pinheiro J., 2006, NLME R PACKAGE FITTI; R Team DC, 2009, LANG ENV STAT COMP; Robroek BJM, 2007, PLANT ECOL, V190, P97, DOI 10.1007/s11258-006-9193-5; Robroek BJM, 2009, GLOBAL CHANGE BIOL, V15, P680, DOI 10.1111/j.1365-2486.2008.01724.x; Rudolph H, 1993, ADV BRYOL, V5, P79; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Schipperges B, 1998, NEW PHYTOL, V140, P677, DOI 10.1046/j.1469-8137.1998.00311.x; Shaw AJ, 2010, MOL PHYLOGENET EVOL, V55, P1139, DOI 10.1016/j.ympev.2010.01.020; Sheppard L, 2012, BIOGEOSCIENCES DISCU, V9, P8141; Smolders AJP, 2001, NEW PHYTOL, V152, P325, DOI 10.1046/j.0028-646X.2001.00261.x; Soares A, 1997, WATER AIR SOIL POLL, V93, P225, DOI 10.1007/BF02404758; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; Turetsky MR, 2010, CAN J FOREST RES, V40, P1237, DOI 10.1139/X10-072; Turetsky MR, 1999, ECOSCIENCE, V6, P587, DOI 10.1080/11956860.1999.11682559; TWENHOVEN FL, 1992, J BRYOL, V17, P71, DOI 10.1179/jbr.1992.17.1.71; Twenhoven FL, 1992, MITTEILUNGEN ARBEITS, V44, P1; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Vergeer P, 2008, NEW PHYTOL, V179, P129, DOI 10.1111/j.1469-8137.2008.02445.x; Wanek W, 2005, NEW PHYTOL, V166, P577, DOI 10.1111/j.1469-8137.2005.01319.x; Wanek W, 2008, FUNCT PLANT BIOL, V35, P51, DOI 10.1071/FP07191; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Wiedermann MM, 2009, OIKOS, V118, P449, DOI 10.1111/j.1600-0706.2008.17129.x; Wiedermann MM, 2009, NEW PHYTOL, V181, P208, DOI 10.1111/j.1469-8137.2008.02628.x; WOODIN S, 1985, NEW PHYTOL, V99, P381, DOI 10.1111/j.1469-8137.1985.tb03666.x; WOODIN SJ, 1987, ENVIRON POLLUT, V45, P61, DOI 10.1016/0269-7491(87)90016-9; Xing YP, 2011, BIOGEOCHEMISTRY, V103, P281, DOI 10.1007/s10533-010-9463-0; Yazaki T, 2006, J HYDROL, V319, P312, DOI 10.1016/j.jhydrol.2005.06.037; Zuur AF, 2007, STAT BIOL HEALTH, P163	80	60	60	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e79991	10.1371/journal.pone.0079991	http://dx.doi.org/10.1371/journal.pone.0079991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416125	Green Published, gold			2022-12-25	WOS:000329866300003
J	Gossmann, TI; Waxman, D; Eyre-Walker, A				Gossmann, Toni I.; Waxman, David; Eyre-Walker, Adam			Fluctuating Selection Models and Mcdonald-Kreitman Type Analyses	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; NATURAL-SELECTION; POPULATION-SIZE; FREQUENCY; REVEAL; DRIFT	It is likely that the strength of selection acting upon a mutation varies through time due to changes in the environment. However, most population genetic theory assumes that the strength of selection remains constant. Here we investigate the consequences of fluctuating selection pressures on the quantification of adaptive evolution using McDonald-Kreitman (MK) style approaches. In agreement with previous work, we show that fluctuating selection can generate evidence of adaptive evolution even when the expected strength of selection on a mutation is zero. However, we also find that the mutations, which contribute to both polymorphism and divergence tend, on average, to be positively selected during their lifetime, under fluctuating selection models. This is because mutations that fluctuate, by chance, to positive selected values, tend to reach higher frequencies in the population than those that fluctuate towards negative values. Hence the evidence of positive adaptive evolution detected under a fluctuating selection model by MK type approaches is genuine since fixed mutations tend to be advantageous on average during their lifetime. Never-the-less we show that methods tend to underestimate the rate of adaptive evolution when selection fluctuates.	[Gossmann, Toni I.; Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Gossmann, Toni I.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Waxman, David] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	University of Sussex; University of Sheffield; Fudan University	Eyre-Walker, A (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011; Gossmann, Toni/H-6579-2013	Eyre-Walker, Adam/0000-0001-5527-8729; Gossmann, Toni/0000-0001-6609-4116				Bell G, 2010, PHILOS T R SOC B, V365, P87, DOI 10.1098/rstb.2009.0150; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fay JC, 2001, GENETICS, V158, P1227; FISHER RA, 1947, HEREDITY, V1, P143, DOI 10.1038/hdy.1947.11; Gillespie J, 1991, CAUSES MOL EVOLUTION, V2; GILLESPIE JH, 1973, GENET RES, V21, P115, DOI 10.1017/S001667230001329X; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Huerta-Sanchez E, 2008, GENETICS, V178, P325, DOI 10.1534/genetics.107.073361; JENSEN L, 1973, GENET RES, V21, P215, DOI 10.1017/S0016672300013409; KARLIN S, 1974, THEOR POPUL BIOL, V6, P383, DOI 10.1016/0040-5809(74)90017-3; KIMURA M, 1954, GENETICS, V39, P280; LYNCH M, 1987, GENETICS, V115, P657; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MUELLER LD, 1985, GENETICS, V111, P517; O'Hara RB, 2005, P ROY SOC B-BIOL SCI, V272, P211, DOI 10.1098/rspb.2004.2929; Schneider A, 2011, GENETICS, V189, P1427, DOI 10.1534/genetics.111.131730; Slotte T, 2010, MOL BIOL EVOL, V27, P1813, DOI 10.1093/molbev/msq062; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Strasburg JL, 2011, MOL BIOL EVOL, V28, P1569, DOI 10.1093/molbev/msq270; TAKAHATA N, 1975, P NATL ACAD SCI USA, V72, P4541, DOI 10.1073/pnas.72.11.4541; Waxman D, 2011, GENETICS, V188, P907, DOI 10.1534/genetics.111.129288; Zhang LQ, 2005, MOL BIOL EVOL, V22, P2504, DOI 10.1093/molbev/msi240	26	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84540	10.1371/journal.pone.0084540	http://dx.doi.org/10.1371/journal.pone.0084540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409303	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000329463500027
J	Liao, JQ; Qian, F; Tchabo, N; Mhawech-Fauceglia, P; Beck, A; Qian, ZK; Wang, XH; Huss, WJ; Lele, SB; Morrison, CD; Odunsi, K				Liao, Jianqun; Qian, Feng; Tchabo, Nana; Mhawech-Fauceglia, Paulette; Beck, Amy; Qian, Zikun; Wang, Xinhui; Huss, Wendy J.; Lele, Shashikant B.; Morrison, Carl D.; Odunsi, Kunle			Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism	PLOS ONE			English	Article							CARCINOMA ASCITES SPHEROIDS; IN-VITRO MODEL; PROSTATE-CANCER; PROSPECTIVE IDENTIFICATION; INITIATING CELLS; PROGENITOR CELLS; MASS ISOTOPOMER; GENE-EXPRESSION; INVASION; GROWTH	Cells with sphere forming capacity, spheroid cells, are present in the malignant ascites of patients with epithelial ovarian cancer (EOC) and represent a significant impediment to efficacious treatment due to their putative role in progression, metastasis and chemotherapy resistance. The exact mechanisms that underlie EOC metastasis and drug resistance are not clear. Understanding the biology of sphere forming cells may contribute to the identification of novel therapeutic opportunities for metastatic EOC. Here we generated spheroid cells from human ovarian cancer cell lines and primary ovarian cancer. Xenoengraftment of as few as 2000 dissociated spheroid cells into immune-deficient mice allowed full recapitulation of the original tumor, whereas > 10(5) parent tumor cells remained non-tumorigenic. The spheroid cells were found to be enriched for cells with cancer stem cell-like characteristics such as upregulation of stem cell genes, self-renewal, high proliferative and differentiation potential, and high aldehyde dehydrogenase (ALDH) activity. Furthermore, spheroid cells were more aggressive in growth, migration, invasion, scratch recovery, clonogenic survival, anchorage-independent growth, and more resistant to chemotherapy in vitro. C-13-glucose metabolic studies revealed that spheroid cells route glucose predominantly to anaerobic glycolysis and pentose cycle to the detriment of re-routing glucose for anabolic purposes. These metabolic properties of sphere forming cells appear to confer increased resistance to apoptosis and contribute to more aggressive tumor growth. Collectively, we demonstrated that spheroid cells with cancer stem cell-like characteristics contributed to tumor generation, progression and chemotherapy resistance. This study provides insight into the relationship between tumor dissemination and metabolic attributes of human cancer stem cells and has clinical implications for cancer therapy.	[Liao, Jianqun; Lele, Shashikant B.; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Qian, Feng; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Qian, Feng; Beck, Amy; Wang, Xinhui; Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Liao, Jianqun] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Urol Oncol, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette; Morrison, Carl D.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Wang, Xinhui] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg Oncol, Boston, MA USA; [Tchabo, Nana] Womens Canc Ctr, Atlant Hlth Syst Morristown Overlook Med Ctr, Morristown, NJ USA; Womens Canc Ctr, Atlant Hlth Syst Morristown Overlook Med Ctr, Summit, NJ USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Atlantic Health System; Atlantic Health System	Odunsi, K (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	kunle.odunsi@roswellpark.org			Cancer Research Institute Ovarian Cancer; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; Roswell Park Cancer Institute Alliance Foundation [NIH P30 CA016056, NIH R01CA158318-01A1]; RPCI-UPCI Ovarian Cancer [SPORE P50CA159981-01A1]; NATIONAL CANCER INSTITUTE [P50CA159981, P30CA016056, R01CA158318] Funding Source: NIH RePORTER	Cancer Research Institute Ovarian Cancer; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; Roswell Park Cancer Institute Alliance Foundation; RPCI-UPCI Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Cancer Research Institute Ovarian Cancer Working Group Grant, Cancer Vaccine Collaborative Grant of the Cancer Research Institute and Ludwig Institute for Cancer Research, Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute (to KO), Roswell Park Cancer Institute Alliance Foundation, NIH P30 CA016056; NIH R01CA158318-01A1 and RPCI-UPCI Ovarian Cancer SPORE P50CA159981-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2013, INT J CLIN EXP PATHO, V6, P546; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALLEN HJ, 1987, EXP CELL BIOL, V55, P194; Armstrong Deborah, 2010, Clin Adv Hematol Oncol, V8, P675; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Boros LG, 2001, PANCREAS, V23, P141, DOI 10.1097/00006676-200108000-00004; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Charafe-Jauffret E., 2013, CANC RES; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kasho VN, 1996, ALIMENT PHARM THERAP, V10, P985, DOI 10.1046/j.1365-2036.1996.99271000.x; KATZ J, 1989, J BIOL CHEM, V264, P12994; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIU PP, 2013, CELL DEATH DIFFER; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Lyssiotis CA, 2012, CELL DEATH DIS, V3, DOI [10.1038/cddis.2012.41, 10.1038/cddis.2012.75]; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Nakano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027222; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	59	262	268	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84941	10.1371/journal.pone.0084941	http://dx.doi.org/10.1371/journal.pone.0084941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409314	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500038
J	Reischl, S; Li, LX; Walkinshaw, G; Flippin, LA; Marti, HH; Kunze, R				Reischl, Stefan; Li, Lexiao; Walkinshaw, Gail; Flippin, Lee A.; Marti, Hugo H.; Kunze, Reiner			Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROLYL HYDROXYLASES; ALZHEIMERS-DISEASE; VASCULAR LEAKAGE; NERVOUS-SYSTEM; MOUSE-BRAIN; VEGF; NEUROPROTECTION	Ischemic stroke results in disruption of the blood-brain barrier (BBB), edema formation and neuronal cell loss. Some neuroprotective factors such as vascular endothelial growth factor (VEGF) favor edema formation, while others such as erythropoietin (Epo) can mitigate it. Both factors are controlled by hypoxia inducible transcription factors (HIF) and the activity of prolyl hydroxylase domain proteins (PHD). We hypothesize that activation of the adaptive hypoxic response by inhibition of PHD results in neuroprotection and prevention of vascular leakage. Mice, subjected to cerebral ischemia, were pre- or post-treated with the novel PHD inhibitor FG-4497. Inhibition of PHD activity resulted in HIF-1 alpha stabilization, increased expression of VEGF and Epo, improved outcome from ischemic stroke and reduced edema formation by maintaining BBB integrity. Additional in vitro studies using brain endothelial cells and primary astrocytes confirmed that FG-4497 induces the HIF signaling pathway, leading to increased VEGF and Epo expression. In an in vitro ischemia model, using combined oxygen and glucose deprivation, FG-4497 promoted the survival of neurons. Furthermore, FG-4497 prevented the ischemia-induced rearrangement and gap formation of the tight junction proteins zonula occludens 1 and occludin, both in cultured endothelial cells and in infarcted brain tissue in vivo. These results indicate that FG-4497 has the potential to prevent cerebral ischemic damage by neuroprotection and prevention of vascular leakage.	[Reischl, Stefan; Li, Lexiao; Marti, Hugo H.; Kunze, Reiner] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Walkinshaw, Gail; Flippin, Lee A.] FibroGen Inc, San Francisco, CA USA	Ruprecht Karls University Heidelberg; FibroGen	Kunze, R (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	reiner.kunze@physiologie.uni-heidelberg.de	Kunze, Reiner/K-8048-2019; Li, Lexiao/AAD-9166-2022; Li, Lexiao/GNP-5634-2022; Li, Lexiao/GQQ-6558-2022	Kunze, Reiner/0000-0002-8428-1027; Li, Lexiao/0000-0002-3693-5452; Reischl, Stefan/0000-0001-7341-4296; Marti, Hugo/0000-0002-8456-334X	Else Kroner-Fresenius-Stiftung [2012_A171]; B. Braun-Stiftung; Friedrich Fischer Nachlass (University of Heidelberg)	Else Kroner-Fresenius-Stiftung; B. Braun-Stiftung; Friedrich Fischer Nachlass (University of Heidelberg)	This work was supported by grants from Else Kroner-Fresenius-Stiftung (2012_A171; RK, HHM), B. Braun-Stiftung (HHM, RK) and Friedrich Fischer Nachlass (University of Heidelberg; RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Chen RL, 2012, J PHYSIOL-LONDON, V590, P4079, DOI 10.1113/jphysiol.2012.232884; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Erez N, 2004, FEBS LETT, V567, P311, DOI 10.1016/j.febslet.2004.05.003; Esser S, 1998, J CELL SCI, V111, P1853; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liu K, 2013, J MOL NEUROSCI, V49, P369, DOI 10.1007/s12031-012-9883-5; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sagare AP, 2013, J ALZHEIMERS DIS, V33, pS87, DOI 10.3233/JAD-2012-129037; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schneider C, 2009, BRAIN RES, V1280, P43, DOI 10.1016/j.brainres.2009.05.023; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027798; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	45	83	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84767	10.1371/journal.pone.0084767	http://dx.doi.org/10.1371/journal.pone.0084767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409307	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500031
J	Gupta, A; Miegueu, P; Lapointe, M; Poirier, P; Martin, J; Bastien, M; Tiwari, S; Cianflone, K				Gupta, Abhishek; Miegueu, Pierre; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Tiwari, Sunita; Cianflone, Katherine			Acute Post-Bariatric Surgery Increase in Orexin Levels Associates with Preferential Lipid Profile Improvement	PLOS ONE			English	Article							WEIGHT-LOSS; A LEVELS; PLASMA; OBESITY; LEPTIN; INSULIN; GLUCOSE; SLEEP; HYPOTHALAMUS; NEUROPEPTIDE	Context: Orexin is a recently identified neuropeptide hormone. Objectives: Acute and long-term post-bariatric changes in Orexin and relationship to post-operative metabolic outcomes. Design and Participants: Men and women undergoing biliopancreatic diversion with duodenal switch bariatric surgery (n = 76, BMI >= 35 kg/m(2)) were evaluated for body composition and plasma parameters at baseline, acutely (1 and 5 days) and long-term (6 and 12 months) post-surgery. Setting: University Hospital Centre, Canada. Interventions and Main Outcome Measures: Groups were subdivided based on acute (average 1 and 5 day) changes in Orexin prior to weight loss: (i). 10% Orexin decrease (n = 33, OrexinDEC) and (ii). 10% Orexin increase (n = 20, OrexinINC), to evaluate impact on long-term changes. Results: Both groups had comparable preoperative Orexin levels, BMI, age, sex distribution, diabetes and lipid lowering medication, plasma glucose and lipid parameters except for apolipoproteinB (p < 0.007). Orexin increase was rapid and maintained throughout one year, while OrexinDEC subjects remained significantly lower throughout. Over 12 months, changes in BMI, fat mass, and % fat mass were comparable. Fasting glucose and insulin increased immediately 1-day post-operatively, decreasing rapidly (5-day) and declining thereafter with the OrexinINC group remaining lower than the OrexinDEC group throughout (p = 0.001). Similarly, plasma cholesterol, triglyceride, LDL-C and HDL-C decreased at 1-day, increased slightly (5-day), except HDL-C, then decreased over 1 year, with greater decreases in OrexinINC group relative to OrexinDEC group. Conclusion: Rapid postoperative increases in plasma Orexin are associated with better improvement of glucose and lipid profiles following bariatric surgery.	[Gupta, Abhishek; Miegueu, Pierre; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Gupta, Abhishek; Tiwari, Sunita] King Georges Med Univ, Dept Physiol, Lucknow, Uttar Pradesh, India; [Poirier, Paul; Martin, Julie; Bastien, Marjorie] Univ Laval, Fac Pharm, Quebec City, PQ, Canada	Laval University; King George's Medical University; Laval University	Cianflone, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca		Lapointe, Marc/0000-0003-0461-2576	CIHR [77532]; Canadian Institutes for Health Research (CIHR); Obesity Network; CIHR Training Program in Obesity/Healthy Body Weight Research; Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Obesity Network; CIHR Training Program in Obesity/Healthy Body Weight Research(Canadian Institutes of Health Research (CIHR)); Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ)	This study was supported by a grant from CIHR (#77532 to KC). K. Cianflone holds a Canada Research Chair in Adipose Tissue. PP is a senior clinical researcher of the Fonds de recherche du Quebec - Sante (FRQS). AG is supported by a Postdoctoral HOPE-scholarship from the Canadian Institutes for Health Research (CIHR). PM was supported by a training scholarship (Obesity Network). JM received a scholarship from the CIHR Training Program in Obesity/Healthy Body Weight Research and from the Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JA, 2002, INT J OBESITY, V26, P274, DOI 10.1038/sj.ijo.0801868; Adeghate E, 2012, VITAM HORM, V89, P111, DOI 10.1016/B978-0-12-394623-2.00007-X; Baranowska B, 2005, NEUROENDOCRINOL LETT, V26, P293; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Bronsky J, 2007, PHYSIOL RES, V56, P89, DOI 10.33549/physiolres.930860; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cai XJ, 1999, DIABETES, V48, P2132, DOI 10.2337/diabetes.48.11.2132; Campfield LA, 1999, BEST PRACT RES CL EN, V13, P13, DOI 10.1053/beem.1999.0004; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Cussons AJ, 2006, ATHEROSCLEROSIS, V185, P227, DOI 10.1016/j.atherosclerosis.2005.10.007; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 1999, CELL MOL LIFE SCI, V56, P473, DOI 10.1007/s000180050446; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ganjavi H, 2007, J NEUROPSYCH CLIN N, V19, P413, DOI 10.1176/appi.neuropsych.19.4.413; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Haynes AC, 1999, PEPTIDES, V20, P1099, DOI 10.1016/S0196-9781(99)00105-9; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Igarashi N, 2003, CHEST, V124, P1381, DOI 10.1378/chest.124.4.1381; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Komaki G, 2001, EUR J ENDOCRINOL, V144, P645, DOI 10.1530/eje.0.1440645; Kotz C, 2012, ANN NY ACAD SCI, V1264, P72, DOI 10.1111/j.1749-6632.2012.06585.x; Martin J, 2013, CAN J CARDIOL; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; Shen J, 2008, NEUROSCI LETT, V444, P166, DOI 10.1016/j.neulet.2008.08.031; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Skrzypski M, 2011, DIABETOLOGIA, V54, P1841, DOI 10.1007/s00125-011-2152-2; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Tsuneki H, 2010, ACTA PHYSIOL, V198, P335, DOI 10.1111/j.1748-1716.2009.02008.x; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Zhu LY, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/754847	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84803	10.1371/journal.pone.0084803	http://dx.doi.org/10.1371/journal.pone.0084803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400115	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700049
J	Haddick, PCG; Tom, I; Luis, E; Quinones, G; Wranik, BJ; Ramani, SR; Stephan, JP; Tessier-Lavigne, M; Gonzalez, LC				Haddick, Patrick C. G.; Tom, Irene; Luis, Elizabeth; Quinones, Gabriel; Wranik, Bernd J.; Ramani, Sree R.; Stephan, Jean-Philippe; Tessier-Lavigne, Marc; Gonzalez, Lino C.			Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor	PLOS ONE			English	Article							COMMISSURAL AXON GUIDANCE; NETRIN RECEPTOR; CBLN FAMILY; SIGNALING PATHWAYS; NERVOUS-SYSTEM; PROTEINS; CUES; MIDLINE; UNC5; IDENTIFICATION	The growth and guidance of many axons in the developing nervous system require Netrin-mediated activation of Deleted in Colorectal Cancer (DCC) and other still unknown signaling cues. Commissural axon guidance defects are more severe in DCC mutant mice than Netrin-1 mutant mice, suggesting additional DCC activating signals besides Netrin-1 are involved in proper axon growth. Here we report that interaction screens on extracellular protein microarrays representing over 1,000 proteins uniquely identified Cerebellin 4 (CBLN4), a member of the C1q-tumor necrosis factor (TNF) family, and Netrin-1 as extracellular DCC-binding partners. Immunofluorescence and radio-ligand binding studies demonstrate that Netrin-1 competes with CBLN4 binding at an overlapping site within the membrane-proximal fibronectin domains (FN) 4-6 of DCC and binds with similar to 5-fold higher affinity. CBLN4 also binds to the DCC homolog, Neogenin-1 (NEO1), but with a lower affinity compared to DCC. CBLN4-null mice did not show a defect in commissural axons of the developing spinal cord but did display a transient increase in the number of wandering axons in the brachial plexus, consistent with a role in axon guidance. Overall, the data solidifies CBLN4 as a bona fide DCC ligand and strengthens its implication in axon guidance.	[Haddick, Patrick C. G.; Tessier-Lavigne, Marc] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Tom, Irene; Luis, Elizabeth; Quinones, Gabriel; Wranik, Bernd J.; Ramani, Sree R.; Stephan, Jean-Philippe; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Gonzalez, LC (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	gonzalez.lino@gene.com			Genentech, a member of the Roche group	Genentech, a member of the Roche group	All funding for this research was provided by Genentech, a member of the Roche group. The funder did have roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Chen Q, 2012, J CELL SCI; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Gonzalez LC, 2012, METHODS, V57, P448, DOI 10.1016/j.ymeth.2012.06.004; Gu WXW, 2010, DEV DYNAM, V239, P2246, DOI 10.1002/dvdy.22357; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Joo JY, 2011, BIOCHEM BIOPH RES CO, V406, P627, DOI 10.1016/j.bbrc.2011.02.108; Karaulanov E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005742; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Lobito AA, 2011, J BIOL CHEM, V286, P18969, DOI 10.1074/jbc.M111.224626; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; MUNSON PJ, 1983, SCIENCE, V220, P979, DOI 10.1126/science.6302842; Nawabi H, 2011, CELL MOL LIFE SCI, V68, P2539, DOI 10.1007/s00018-011-0691-9; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Rong YQ, 2012, J NEUROCHEM, V120, P528, DOI 10.1111/j.1471-4159.2011.07604.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tom Irene, 2013, Curr Protoc Protein Sci, VChapter 27, DOI 10.1002/0471140864.ps2703s72; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhang SB, 2010, NEUROSCI RES, V66, P53, DOI 10.1016/j.neures.2009.09.1710; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	41	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84823	10.1371/journal.pone.0084823	http://dx.doi.org/10.1371/journal.pone.0084823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400119	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700053
J	Hohna, S				Hohna, Sebastian			Likelihood Inference of Non-Constant Diversification Rates with Incomplete Taxon Sampling	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MOLECULAR PHYLOGENIES; EXTINCTION RATES; MODEL; SPECIATION; RADIATIONS; DIVERSITY; INSIGHTS; ORIGINS; CHOICE	Large-scale phylogenies provide a valuable source to study background diversification rates and investigate if the rates have changed over time. Unfortunately most large-scale, dated phylogenies are sparsely sampled (fewer than 5% of the described species) and taxon sampling is not uniform. Instead, taxa are frequently sampled to obtain at least one representative per subgroup (e. g. family) and thus to maximize diversity (diversified sampling). So far, such complications have been ignored, potentially biasing the conclusions that have been reached. In this study I derive the likelihood of a birth-death process with non-constant (time-dependent) diversification rates and diversified taxon sampling. Using simulations I test if the true parameters and the sampling method can be recovered when the trees are small or medium sized (fewer than 200 taxa). The results show that the diversification rates can be inferred and the estimates are unbiased for large trees but are biased for small trees (fewer than 50 taxa). Furthermore, model selection by means of Akaike's Information Criterion favors the true model if the true rates differ sufficiently from alternative models (e. g. the birth-death model is recovered if the extinction rate is large and compared to a pure-birth model). Finally, I applied six different diversification rate models - ranging from a constant-rate pure birth process to a decreasing speciation rate birth-death process but excluding any rate shift models - on three large-scale empirical phylogenies (ants, mammals and snakes with respectively 149, 164 and 41 sampled species). All three phylogenies were constructed by diversified taxon sampling, as stated by the authors. However only the snake phylogeny supported diversified taxon sampling. Moreover, a parametric bootstrap test revealed that none of the tested models provided a good fit to the observed data. The model assumptions, such as homogeneous rates across species or no rate shifts, appear to be violated.	Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden	Stockholm University	Hohna, S (corresponding author), Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden.	Sebastian.Hoehna@gmail.com	Höhna, Sebastian/ABE-9933-2020	Höhna, Sebastian/0000-0001-6519-6292				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Bollback JP, 2002, MOL BIOL EVOL, V19, P1171, DOI 10.1093/oxfordjournals.molbev.a004175; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Condamine FL, 2013, ECOLOGY LETT; Cusimano N, 2012, SYST BIOL, V61, P785, DOI 10.1093/sysbio/sys031; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Heath TA, 2012, MOL BIOL EVOL, V29, P939, DOI 10.1093/molbev/msr255; Hohna S, 2013, BIOINFORMATICS, V29, P1367, DOI 10.1093/bioinformatics/btt153; Hohna S, 2011, MOL BIOL EVOL, V28, P2577, DOI 10.1093/molbev/msr095; Huelsenbeck John P., 1996, P19; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Lambert A, 2010, ANN PROBAB, V38, P348, DOI 10.1214/09-AOP485; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Pennell MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043348; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stadler T, 2013, SYST BIOL, V62, P220, DOI 10.1093/sysbio/sys087; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Thompson E.A., 1975, HUMAN EVOLUTIONARY T; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	42	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84184	10.1371/journal.pone.0084184	http://dx.doi.org/10.1371/journal.pone.0084184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400082	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700016
J	Wrede, KH; Dammann, P; Monninghoff, C; Johst, S; Maderwald, S; Sandalcioglu, IE; Muller, O; Ozkan, N; Ladd, ME; Forsting, M; Schlamann, MU; Sure, U; Umutlu, L				Wrede, Karsten H.; Dammann, Philipp; Moenninghoff, Christoph; Johst, Soeren; Maderwald, Stefan; Sandalcioglu, I. Erol; Mueller, Oliver; Oezkan, Neriman; Ladd, Mark E.; Forsting, Michael; Schlamann, Marc U.; Sure, Ulrich; Umutlu, Lale			Non-Enhanced MR Imaging of Cerebral Aneurysms: 7 Tesla versus 1.5 Tesla	PLOS ONE			English	Article							TIME-OF-FLIGHT; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; INITIAL-EXPERIENCE; FOLLOW-UP; COMPLICATIONS; AGREEMENT; COILS; 3.0-T	Purpose: To prospectively evaluate 7 Tesla time-of-flight (TOF) magnetic resonance angiography (MRA) in comparison to 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced magnetization-prepared rapid acquisition gradient-echo (MPRAGE) for delineation of unruptured intracranial aneurysms (UIA). Material and Methods: Sixteen neurosurgical patients (male n = 5, female n = 11) with single or multiple UIA were enrolled in this trial. All patients were accordingly examined at 7 Tesla and 1.5 Tesla MRI utilizing dedicated head coils. The following sequences were obtained: 7 Tesla TOF MRA, 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced MPRAGE. Image analysis was performed by two radiologists with regard to delineation of aneurysm features (dome, neck, parent vessel), presence of artifacts, vessel-tissue-contrast and overall image quality. Interobserver accordance and intermethod comparisons were calculated by kappa coefficient and Lin's concordance correlation coefficient. Results: A total of 20 intracranial aneurysms were detected in 16 patients, with two patients showing multiple aneurysms (n = 2, n = 4). Out of 20 intracranial aneurysms, 14 aneurysms were located in the anterior circulation and 6 aneurysms in the posterior circulation. 7 Tesla MPRAGE imaging was superior over 1.5 and 7 Tesla TOF MRA in the assessment of all considered aneurysm and image quality features (e. g. image quality: mean MPRAGE7T: 5.0; mean TOF7T: 4.3; mean TOF1.5T: 4.3). Ratings for 7 Tesla TOF MRA were equal or higher over 1.5 Tesla TOF MRA for all assessed features except for artifact delineation (mean TOF7T: 4.3; mean TOF1.5T 4.4). Interobserver accordance was good to excellent for most ratings. Conclusion: 7 Tesla MPRAGE imaging demonstrated its superiority in the detection and assessment of UIA as well as overall imaging features, offering excellent interobserver accordance and highest scores for all ratings. Hence, it may bear the potential to serve as a high-quality diagnostic tool for pretherapeutic assessment and follow-up of untreated UIA.	[Wrede, Karsten H.; Dammann, Philipp; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.; Dammann, Philipp; Sandalcioglu, I. Erol; Mueller, Oliver; Oezkan, Neriman; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Moenninghoff, Christoph; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Forsting, Michael; Schlamann, Marc U.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Wrede, KH (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	karsten.wrede@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Maderwald, Stefan/B-4241-2011; Ladd, Mark E./B-3285-2011; Mueller, Oliver Marcus/E-3419-2014; Müller, Oliver/GQZ-2967-2022	Wrede, Karsten/0000-0001-7076-3503; Mueller, Oliver Marcus/0000-0003-4690-370X; Ladd, Mark/0000-0002-4128-9440	IFORES grant from the University Duisburg-Essen	IFORES grant from the University Duisburg-Essen	An IFORES grant to KHW from the University Duisburg-Essen supported the research [http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2000, AM J NEURORADIOL, V21, P1618; Chung TS, 1999, AM J NEURORADIOL, V20, P229; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Ferre JC, 2009, EUR J RADIOL, V72, P365, DOI 10.1016/j.ejrad.2008.08.005; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Gaa J, 2004, ACTA RADIOL, V45, P327, DOI 10.1080/02841850410004229; Gibbs GF, 2004, AM J NEURORADIOL, V25, P84; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Johst S, 2012, INVEST RADIOL, V47, P445, DOI 10.1097/RLI.0b013e31824ef21f; Kashiwazaki D, 2013, STROKE; Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawson MF, 2013, WORLD NEUROSURG, V79, P472, DOI 10.1016/j.wneu.2012.01.038; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN L I K, 1989, BIOMETRICS, V43, P255; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; Nakiri GS, 2011, CLINICS, V66, P641, DOI 10.1590/S1807-59322011000400020; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR.0000019510.32145.A9; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Shahzad R, 2011, JCPSP-J COLL PHYSICI, V21, P325, DOI 07.2011/JCPSP.325329; Steinberg GK, 2013, STROKE, V44, pS97, DOI 10.1161/STROKEAHA.113.001786; Umutlu L, 2013, EUR RADIOL; Umutlu L, 2012, J MAGN RESON IMAGING; Umutlu L, 2013, ACAD RADIOL; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; White PM, 2001, J NEUROL NEUROSUR PS, V71, P322, DOI 10.1136/jnnp.71.3.322; Willinek WA, 2003, RADIOLOGY, V229, P913, DOI 10.1148/radiol.2293020782; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071; Wrede KH, 2012, ACAD RADIOL, V19, P172, DOI 10.1016/j.acra.2011.10.004; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	36	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84562	10.1371/journal.pone.0084562	http://dx.doi.org/10.1371/journal.pone.0084562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400100	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700034
J	Zhao, Z; Zhong, LL; Elrod, E; Struble, E; Ma, L; Yan, HL; Harman, C; Deng, L; Virata-Theimer, ML; Liu, P; Alter, H; Grakoui, A; Zhang, P				Zhao, Zhong; Zhong, Lilin; Elrod, Elizabeth; Struble, Evi; Ma, Li; Yan, Hailing; Harman, Christine; Deng, Lu; Virata-Theimer, Maria Luisa; Liu, Peter; Alter, Harvey; Grakoui, Arash; Zhang, Pei			A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; VIRAL ENTRY; ANTIBODIES; BINDING; PARTICLES; INFECTION; PLASMA; GENOTYPES; RECEPTOR; PROGRESS	The identification of a specific immunogenic candidate that will effectively activate the appropriate pathway for neutralizing antibody production is fundamental for vaccine design. By using a monoclonal antibody (1H8) that neutralizes HCV in vitro, we have demonstrated here that 1H8 recognized an epitope mapped between residues A524 and W529 of the E2 protein. We also found that the epitope residues A524, P525, Y527 and W529 were crucial for antibody binding, while the residues T526, Y527 and W529 within the same epitope engaged in the interaction with the host entry factor CD81. Furthermore, we detected "1H8-like" antibodies, defined as those with amino acid-specificity similar to 1H8, in the plasma of patients with chronic HCV infection. The time course study of plasma samples from Patient H, a well-characterized case of post-transfusion hepatitis C, showed that "1H8-like" antibodies could be detected in a sample collected almost two years after the initial infection, thus confirming the immunogenicity of this epitope in vivo. The characterization of this neutralization epitope with a function in host entry factor CD81 interaction should enhance our understanding of antibody-mediated neutralization of HCV infections.	[Zhao, Zhong; Zhong, Lilin; Struble, Evi; Ma, Li; Yan, Hailing; Harman, Christine; Deng, Lu; Virata-Theimer, Maria Luisa; Liu, Peter; Zhang, Pei] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Off Blood Res & Review, Bethesda, MD 20892 USA; [Elrod, Elizabeth; Grakoui, Arash] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Alter, Harvey] NIH, Warren Grant Magnuson Clin Ctr, Dept Transfus Med, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Emory University; National Institutes of Health (NIH) - USA	Zhang, P (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Hematol, Off Blood Res & Review, Bethesda, MD 20892 USA.	pei.zhang@fda.hhs.gov	Deng, Lu/AAE-1635-2021		Modernizing Science Funds of the Food and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002078, ZIACL002068] Funding Source: NIH RePORTER	Modernizing Science Funds of the Food and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	This study was supported by the Modernizing Science Funds of the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2012, ANN INTERN MED, V156, P317, DOI 10.7326/0003-4819-156-4-201202210-00014; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Centers for Disease Control and Prevention, 2012, CDC HLTH INF INT TRA; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Heile JM, 2000, J VIROL, V74, P6885, DOI 10.1128/JVI.74.15.6885-6892.2000; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Meyer K, 2002, J VIROL, V76, P2150, DOI 10.1128/JVI.76.5.2150-2158.2002; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stoll-Keller F, 2009, EXPERT REV VACCINES, V8, P333, DOI 10.1586/14760584.8.3.333; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; YEI S, 1992, TRANSFUSION, V32, P824, DOI 10.1046/j.1537-2995.1992.32993110753.x; Yu MYW, 2004, P NATL ACAD SCI USA, V101, P7705, DOI 10.1073/pnas.0402458101; Zhang P, 2006, P NATL ACAD SCI USA, V103, P9214, DOI 10.1073/pnas.0603316103; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zhong L, 2009, BIOCHEM BIOPH RES CO, V390, P1056, DOI 10.1016/j.bbrc.2009.10.115	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84346	10.1371/journal.pone.0084346	http://dx.doi.org/10.1371/journal.pone.0084346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400084	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700018
J	Coustham, V; Vlad, D; Deremetz, A; Gy, I; Cubillos, FA; Kerdaffrec, E; Loudet, O; Bouche, N				Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas			SHOOT GROWTH1 Maintains Arabidopsis Epigenomes by Regulating IBM1	PLOS ONE			English	Article							DNA METHYLATION; JMJC DOMAIN; HISTONE DEMETHYLASE; THALIANA; MUTANTS; METHYLTRANSFERASE; HETEROCHROMATIN; BINDING; PROTEIN; PATTERNS	Maintaining correct DNA and histone methylation patterns is essential for the development of all eukaryotes. In Arabidopsis, we identified SHOOT GROWTH1 (SG1), a novel protein involved in the control of gene methylation. SG1 contains both a Bromo-Adjacent Homology (BAH) domain found in several chromatin regulators and an RNA-Recognition Motif (RRM). The sg1 mutations are associated with drastic pleiotropic phenotypes. The mutants degenerate after few generations and are similar to mutants of the histone demethylase INCREASE IN BONSAI METHYLATION1 (IBM1). A methylome analysis of sg1 mutants revealed a large number of gene bodies hypermethylated in the cytosine CHG context, associated with an increase in di-methylation of lysine 9 on histone H3 tail (H3K9me2), an epigenetic mark normally found in silenced transposons. The sg1 phenotype is suppressed by mutations in genes encoding the DNA methyltransferase CHROMOMETHYLASE3 (CMT3) or the histone methyltransferase KRYPTONITE (KYP), indicating that SG1 functions antagonistically to CMT3 or KYP. We further show that the IBM1 transcript is not correctly processed in sg1, and that the functional IBM1 transcript complements sg1. Altogether, our results suggest a function for SG1 in the maintenance of genome integrity by regulating IBM1.	[Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas] INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France; [Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas] AgroParisTech, Inst Jean Pierre Bourgin, RD10, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Loudet, O (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France.	Olivier.Loudet@versailles.inra.fr; Nicolas.Bouche@versailles.inra.fr	Coustham, Vincent/C-1836-2014; Coustham, Vincent/GON-4976-2022; Loudet, Olivier/K-8266-2012; Loudet, Olivier/CAF-7559-2022; Cubillos, Francisco/G-5195-2019	Coustham, Vincent/0000-0002-5399-2723; Coustham, Vincent/0000-0002-5399-2723; Loudet, Olivier/0000-0003-3717-0137; Kerdaffrec, Envel/0000-0001-8667-6850; Bouche, Nicolas/0000-0002-3800-2613; Cubillos, Francisco/0000-0003-3022-469X	BAP INRA division; Marie Curie European Reintegration Grant [FP7-PERG08-GA-2010-277068]; ANR [11-JSV7-0013]; European Commission ['AGRON-OMICS'/LSHG-CT-2006-037704, 'ARABRAS'/ANR-06-ERAPG-003-01]; European Commission Framework Programme 7, ERC Starting Grant ['DECODE'/ERC-2009-StG-243359]	BAP INRA division; Marie Curie European Reintegration Grant(European Commission); ANR(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission Framework Programme 7, ERC Starting Grant	VC was supported by the BAP INRA division and a Marie Curie European Reintegration Grant (FP7-PERG08-GA-2010-277068) to NB and OL. The authors acknowledge funding from ANR (Project 11-JSV7-0013) to NB. DV was supported by funding from the European Commission Framework Programme 6, Integrated Project 'AGRON-OMICS'/LSHG-CT-2006-037704 to OL. EK was supported by funding from ANR grant 'ARABRAS'/ANR-06-ERAPG-003-01 to OL. FC was supported by funding from the European Commission Framework Programme 7, ERC Starting Grant 'DECODE'/ERC-2009-StG-243359 to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Fan D, 2012, NUCLEIC ACIDS RES, V40, P8905, DOI 10.1093/nar/gks647; Huff JT, 2012, CURR OPIN GENET DEV, V22, P132, DOI 10.1016/j.gde.2012.01.007; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kankel MW, 2003, GENETICS, V163, P1109; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Sasaki T, 2012, PLANT J, V70, P750, DOI 10.1111/j.1365-313X.2012.04911.x; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Schiex T., 2001, LNCS, P111, DOI [10.1007/3-540-45727-5_10, DOI 10.1007/3-540-45727-5_10]; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	29	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84687	10.1371/journal.pone.0084687	http://dx.doi.org/10.1371/journal.pone.0084687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404182	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800061
J	Nunes, ERD; Zukurov, JP; Maricato, JT; Sucupira, MCA; Diaz, RS; Janini, LMR				De Morais Nunes, Edsel Renata; Zukurov, Jean Paulo; Maricato, Juliana Terzi; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Ramos Janini, Luiz Mario			Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in Sao Paulo and Santos, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUAL INFECTIONS; SUBTYPE-C; GENOME SEQUENCES; RAKAI DISTRICT; SEX WORKERS; VIRAL LOAD; SUPERINFECTION; IDENTIFICATION; EPIDEMIC	The present study investigated the prevalence of HIV-1 multiple infections in a population composed by 47 patients under HAART failure and enrolled at the National DST/AIDS, Program, Ministry of Health, Brazil. Detection of multiple infections was done using a previously published RFLP assay for the HIV-1 protease gene, which is able of distinguishing between infections caused by a single or multiple HIV-1 subtypes. Samples with multiple infections were cloned, and sequence data submitted to phylogenetic analysis. We were able to identify 17 HIV-1 multiple infections out of 47 samples. Multiple infections were mostly composed by a mixture of recombinant viruses (94%), with only one case in which protease gene pure subtypes B and F were recovered. This is the first study that reports the prevalence of multiple infections and intersubtype recombinants in a population undergoing HAART in Brazil. Based on the data there was a steep increase of multiple infections after the introduction of the combined antiretroviral therapy in Brazil. Cases of multiple infections may be associated with HIV-1 genetic diversity through recombination allowing for the generation of viruses showing a combination of resistance mutations.	[De Morais Nunes, Edsel Renata; Zukurov, Jean Paulo; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Ramos Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [Maricato, Juliana Terzi; Ramos Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Nunes, ERD (corresponding author), Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil.	edselmorais@gmail.com	Maricato, Juliana/F-1608-2012; Araripe Sucupira, Maria Cecilia/K-1931-2012	Janini, Luiz Mario/0000-0002-6186-6284; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo) [2009/10915-0, 2009/11216-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo; grant numbers 2009/10915-0 and 2009/11216-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Becker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P1099, DOI 10.1089/088922200414938; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Brenner B, 2004, AIDS, V18, P1653, DOI 10.1097/01.aids.0000131377.28694.04; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Campbell MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005690; Chakraborty B, 2004, AIDS, V18, P132, DOI 10.1097/01.aids.0000096893.73209.0e; Chohan B, 2005, J VIROL, V79, P10701, DOI 10.1128/JVI.79.16.10701-10708.2005; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Fonjungo PN, 2002, J CLIN MICROBIOL, V40, P837, DOI 10.1128/JCM.40.3.837-845.2002; Fung ICH, 2010, MATH BIOSCI, V224, P1, DOI 10.1016/j.mbs.2009.11.007; Gale CV, 2006, AIDS RES HUM RETROV, V22, P985, DOI 10.1089/aid.2006.22.985; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guimaraes ML, 2010, INFECT GENET EVOL, V10, P1094, DOI 10.1016/j.meegid.2010.07.001; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Hu DJ, 2005, AIDS, V19, P303; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Janini LM, 1996, VIRUS GENES, V13, P69, DOI 10.1007/BF00576981; JANINI LMR, 1995, 2 NAT C HUM RETR REL; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Jurriaans S, 2008, JAIDS-J ACQ IMM DEF, V47, P69, DOI 10.1097/QAI.0b013e3181582d6f; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Masciotra S, 2000, AIDS RES HUM RETROV, V16, P1007, DOI 10.1089/08892220050058425; NDEMBI N, 2011, J ACQ IMMUN DEF SYND, V57, P2; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58; Peeters M, 2000, AIDS, V14, pS129; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Sa DJ, 2003, J CLIN VIROL, V28, P186, DOI 10.1016/S1386-6532(03)00007-6; SAMPATHKUMAR R, 2012, ADV VIROL, V2012, P1; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Santos AF, 2006, AIDS, V20, P2011; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith DM, 2004, JAMA-J AM MED ASSOC, V292, P1177, DOI 10.1001/jama.292.10.1177; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; UNAIDS, 2013, REP GLOB AIDS EP; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; van der Kuyl AC, 2011, AIDS RES HUM RETROV, V27, P429, DOI 10.1089/aid.2010.0175; VANDERKUYL AC, 2005, NEW ENGL J MED, V352, P24; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Yerly S, 2004, AIDS, V18, P1413, DOI 10.1097/01.aids.0000131330.28762.0c; 2013, HIV SEQ DAT	72	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84066	10.1371/journal.pone.0084066	http://dx.doi.org/10.1371/journal.pone.0084066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404149	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800028
J	Dhar, P; Sharma, VK; Hota, KB; Das, SK; Hota, SK; Srivastava, RB; Singh, SB				Dhar, Priyanka; Sharma, Vijay K.; Hota, Kalpana B.; Das, Saroj K.; Hota, Sunil K.; Srivastava, Ravi B.; Singh, Shashi B.			Autonomic Cardiovascular Responses in Acclimatized Lowlanders on Prolonged Stay at High Altitude: A Longitudinal Follow Up Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DENSITY-LIPOPROTEIN CHOLESTEROL; EDUCATION-PROGRAM RECOMMENDATIONS; BLOOD-PRESSURE; INTERMITTENT HYPOXIA; NERVOUS-SYSTEM; NITRIC-OXIDE; SYMPATHETIC ACTIVATION; PLASMA HOMOCYSTEINE; ARTERIAL STIFFNESS	Acute exposure to hypobaric hypoxia at high altitude is reported to cause sympathetic dominance that may contribute to the pathophysiology of high altitude illnesses. The effect of prolonged stay at high altitude on autonomic functions, however, remains to be explored. Thus, the present study aimed at investigating the effect of high altitude on autonomic neural control of cardiovascular responses by monitoring heart rate variability (HRV) during chronic hypobaric hypoxia. Baseline electrocardiography (ECG) data was acquired from the volunteers at mean sea level (MSL) (<250 m) in Rajasthan. Following induction of the study population to high altitude (4500-4800 m) in Ladakh region, ECG data was acquired from the volunteers after 6 months (ALL 6) and 18 months of induction (ALL 18). Out of 159 volunteers who underwent complete investigation during acquisition of baseline data, we have only included the data of 104 volunteers who constantly stayed at high altitude for 18 months to complete the final follow up after 18 months. HRV parameters, physiological indices and biochemical changes in serum were investigated. Our results show sympathetic hyperactivation along with compromise in parasympathetic activity in ALL 6 and ALL 18 when compared to baseline data. Reduction of sympathetic activity and increased parasympathetic response was however observed in ALL 18 when compared to ALL 6. Our findings suggest that autonomic response is regulated by two distinct mechanisms in the ALL 6 and ALL 18. While the autonomic alterations in the ALL 6 group could be attributed to increased sympathetic activity resulting from increased plasma catecholamine concentration, the sympathetic activity in ALL 18 group is associated with increased concentration of serum coronary risk factors and elevated homocysteine. These findings have important clinical implications in assessment of susceptibility to cardio-vascular risks in acclimatized lowlanders staying for prolonged duration at high altitude.	[Dhar, Priyanka; Sharma, Vijay K.; Hota, Kalpana B.; Das, Saroj K.; Hota, Sunil K.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Singh, Shashi B.] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Singh, SB (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Lucknow Rd, Delhi, India.	sbs_1958@yahoo.co.in	Das, Saroj Kumar/W-5452-2019; Singh, Shashi Bala/AAS-9889-2021	Das, Saroj Kumar/0000-0002-5717-5333; Srivastava, Rakesh/0000-0002-0065-4069; Sharma, Vijay Kumar/0000-0002-9327-0397; Srivastava, Rakesh/0000-0003-3112-4252	Defence Research and Development Organisation, Ministry of Defence, Govt of India	Defence Research and Development Organisation, Ministry of Defence, Govt of India	The research was financially supported by Defence Research and Development Organisation, Ministry of Defence, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampa M, 2011, CLIN TRANSPLANT, V25, P119, DOI 10.1111/j.1399-0012.2009.01126.x; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALLEN R H, 1981, Ligand Quarterly, V4, P37; Amitabh, 2009, INDIAN J MED RES, V129, P138; Ashraf H M, 2006, J Coll Physicians Surg Pak, V16, P71; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; BACHORIK PS, 1995, CLIN CHEM, V41, P1414; BAHRKE MS, 1993, SPORTS MED, V16, P97, DOI 10.2165/00007256-199316020-00003; Baker F, 2002, CIRCULATION, V106, P741; Beall C M, 2000, High Alt Med Biol, V1, P25, DOI 10.1089/152702900320658; Beall CM, 2001, ANNU REV ANTHROPOL, V30, P423, DOI 10.1146/annurev.anthro.30.1.423; Beall CM, 2012, FREE RADICAL BIO MED, V52, P1123, DOI 10.1016/j.freeradbiomed.2011.12.028; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernardi L, 2001, EUR HEART J, V22, P879, DOI 10.1053/euhj.2000.2466; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; Bernardi L, 2007, P ANN INT IEEE EMBS, P6679; Billett H. H., 1990, CLIN METHODS HIST PH; BOWERS LD, 1980, CLIN CHEM, V26, P555; Brito J, 2007, HIGH ALT MED BIOL, V8, P236, DOI 10.1089/ham.2007.8310; Calbet JAL, 2003, J PHYSIOL-LONDON, V551, P379, DOI 10.1113/jphysiol.2003.045112; Chao WH, 1999, J NUTR, V129, P2009, DOI 10.1093/jn/129.11.2009; Chen YC, 2008, AM J MED SCI, V336, P248, DOI 10.1097/MAJ.0b013e3181629a32; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Coello SD, 2000, INT J EPIDEMIOL, V29, P65, DOI 10.1093/ije/29.1.65; Cornolo J, 2004, J APPL PHYSIOL, V97, P935, DOI 10.1152/japplphysiol.00239.2004; DEMENDOZA S, 1979, ARCH ENVIRON HEALTH, V34, P308, DOI 10.1080/00039896.1979.10667422; Dumont Lionel, 2005, Travel Med Infect Dis, V3, P183, DOI 10.1016/j.tmaid.2004.12.001; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; Fagan K A, 2001, Respir Res, V2, P306, DOI 10.1186/rr74; FARINELLI CCJ, 1994, EUR J APPL PHYSIOL O, V69, P502, DOI 10.1007/BF00239867; FEREZOU J, 1988, EUR J APPL PHYSIOL O, V57, P740, DOI 10.1007/BF01075997; Forslund L, 2002, HEART, V87, P415, DOI 10.1136/heart.87.5.415; FOSTER LB, 1971, CLIN CHEM, V17, P921; Gargya, 1999, INDIAN J MED SCI, V53, P471; Guasti L, 2001, ACTA CARDIOL, V56, P289, DOI 10.2143/AC.56.5.2005689; Guger C, 2008, NEUROSCI LETT, V442, P123, DOI 10.1016/j.neulet.2008.06.075; Guyton AC., 2006, TXB MED PHYSL; Hainsworth R, 2007, CLIN AUTON RES, V17, P13, DOI 10.1007/s10286-006-0395-7; HAMILTON AJ, 1991, AVIAT SPACE ENVIR MD, V62, P759; HAMMILL SC, 1979, CIRC RES, V44, P569, DOI 10.1161/01.RES.44.4.569; Hansen J, 2003, J PHYSIOL-LONDON, V546, P921, DOI 10.1113/jphysiol.2002.031765; HARTLEY LH, 1974, J APPL PHYSIOL, V36, P362, DOI 10.1152/jappl.1974.36.3.362; Hashimoto F, 1997, WILD ENVIRON MED, V8, P214, DOI 10.1580/1080-6032(1997)008[0214:PVFDIP]2.3.CO;2; Hopkins SR, 2003, J PHYSIOL-LONDON, V550, P605, DOI 10.1113/jphysiol.2003.040568; Huang HH, 2010, CLIN J SPORT MED, V20, P58, DOI 10.1097/JSM.0b013e3181cae6ba; HUGHSON RL, 1994, J APPL PHYSIOL, V77, P2537; Kanai M, 2001, WILD ENVIRON MED, V12, P8, DOI 10.1580/1080-6032(2001)012[0008:AIANCO]2.0.CO;2; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KLAIN GJ, 1968, P SOC EXP BIOL MED, V129, P646; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; KOLLER EA, 1988, EUR J APPL PHYSIOL O, V57, P163, DOI 10.1007/BF00640657; Kriemler S, 2008, EUR RESPIR J, V32, P664, DOI 10.1183/09031936.00166407; Lanfranchi PA, 2005, AM J PHYSIOL-HEART C, V289, pH2364, DOI 10.1152/ajpheart.00004.2005; LIPSITZ LA, 1995, BRIT HEART J, V74, P390; Liu X X, 2001, Space Med Med Eng (Beijing), V14, P328; Long Min, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P1195; LOUHIJA A, 1969, EXPERIENTIA, V25, P248, DOI 10.1007/BF02034371; Lusina SJC, 2006, J PHYSIOL-LONDON, V575, P961, DOI 10.1113/jphysiol.2006.114660; MALHOTRA MS, 1976, AVIAT SPACE ENVIR MD, V47, P1076; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; MAZZEO RS, 1991, AM J PHYSIOL, V261, pE419, DOI 10.1152/ajpendo.1991.261.4.E419; McNeely MDD, 1984, CLIN CHEM, P1402; Mindicino H J, 2002, Clin Lab, V48, P493; Moller S, 2010, AM J PHYSIOL-GASTR L, V299, pG784, DOI 10.1152/ajpgi.00078.2010; Muntzel MS, 2006, ATHEROSCLEROSIS, V184, P290, DOI 10.1016/j.atherosclerosis.2005.04.009; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Napoli AM, 2009, AM J EMERG MED, V27, P1081, DOI 10.1016/j.ajem.2008.09.025; Niermeyer S, 2003, HIGH ALT MED BIOL, V4, P225, DOI 10.1089/152702903322022820; Nishihara F, 1998, INT ARCH OCC ENV HEA, V71, P520, DOI 10.1007/s004200050317; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Panjwani Usha, 2006, Indian J Physiol Pharmacol, V50, P250; Passino Claudio, 1996, Clinical Science (London), V91, P81; Penaloza D, 2008, HIGH ALT MED BIOL, V9, P199, DOI 10.1089/ham.2008.1004; Perini R, 1996, EUR J APPL PHYSIOL O, V73, P521, DOI 10.1007/BF00357674; PONCHIA A, 1994, EUR HEART J, V15, P1463, DOI 10.1093/oxfordjournals.eurheartj.a060415; Povea C, 2005, HIGH ALT MED BIOL, V6, P215, DOI 10.1089/ham.2005.6.215; Prabhakaran P, 2011, AVIAT SPACE ENVIR MD, V82, P863, DOI 10.3357/ASEM.2135.2011; Pugh L G, 1964, Sci Basis Med Annu Rev, P32; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Rhodes HL, 2011, J ROY ARMY MED CORPS, V157, P110, DOI 10.1136/jramc-157-01-18; Richalet JP, 1985, 4 HYP S LAK LOUIS CA; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roche F, 2002, CLIN PHYSIOL FUNCT I, V22, P301, DOI 10.1046/j.1475-097X.2002.00434.x; Rostrup M, 1998, ACTA PHYSIOL SCAND, V162, P389, DOI 10.1046/j.1365-201X.1998.00335.x; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Sevre K, 2001, ACTA PHYSIOL SCAND, V173, P409, DOI 10.1046/j.1365-201X.2001.00925.x; Sharma VS, 2003, BIOCHEMISTRY-US, V42, P8900, DOI 10.1021/bi034469t; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Siques P, 2009, HIGH ALT MED BIOL, V10, P329, DOI 10.1089/ham.2008.1103; Smith JD, 2011, WILD ENVIRON MED, V22, P107, DOI 10.1016/j.wem.2011.01.003; Stanger O, 2003, CLIN CHEM LAB MED, V41, P1444, DOI 10.1515/CCLM.2003.222; Strain JJ, 2004, P NUTR SOC, V63, P597, DOI 10.1079/PNS2004390; Syed V S, 2010, Med J Armed Forces India, V66, P261, DOI 10.1016/S0377-1237(10)80052-8; Tannheimer M, 2010, SLEEP BREATH, V14, P193, DOI 10.1007/s11325-009-0284-0; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; Temte JL, 1996, WILD ENVIRON MED, V7, P216, DOI 10.1580/1080-6032(1996)007[0216:EOSCAH]2.3.CO;2; Thomas L., 1998, CLIN LAB DIAGNOSTICS, P55; UELAND PM, 1989, J LAB CLIN MED, V114, P473; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vearrier D, 2011, CLIN TOXICOL, V49, P629, DOI 10.3109/15563650.2011.607169; Vigo DE, 2010, WILD ENVIRON MED, V21, P4, DOI 10.1016/j.wem.2009.12.022; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WARD MP, 2000, HIGH ALTITUDE MED PH; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Weil JV, 2004, HIGH ALT MED BIOL, V5, P180, DOI 10.1089/1527029041352162; WERNER M, 1981, CLIN CHEM, V27, P268; Windsor JS, 2010, HIGH ALT MED BIOL, V11, P51, DOI 10.1089/ham.2009.1065; Woods DR, 2008, CARDIOLOGY, V111, P239, DOI 10.1159/000127445; World Health Organization Switzerland, 2008, WHO STEPS SURV; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323; Wu JT, 2007, J BIOMED LAB SCI, V19, P107; Xie AL, 2001, J APPL PHYSIOL, V91, P1555, DOI 10.1152/jappl.2001.91.4.1555; Zubieta-Calleja GR, 2007, J PHYSIOL PHARMACOL, V58, P811; Zuzewicz K, 1999, Int J Occup Saf Ergon, V5, P337	119	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84274	10.1371/journal.pone.0084274	http://dx.doi.org/10.1371/journal.pone.0084274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404157	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800036
J	Stoll, S; Kail, J; Lorenz, AW; Sundermann, A; Haase, P				Stoll, Stefan; Kail, Jochem; Lorenz, Armin W.; Sundermann, Andrea; Haase, Peter			The Importance of the Regional Species Pool, Ecological Species Traits and Local Habitat Conditions for the Colonization of Restored River Reaches by Fish	PLOS ONE			English	Article							HYDROMORPHOLOGICAL RESTORATION; STREAM HABITAT; LAND-USE; DIVERSITY; RECOVERY; REHABILITATION; FRAGMENTATION; HETEROGENEITY; COMMUNITIES; ASSEMBLAGES	It is commonly assumed that the colonization of restored river reaches by fish depends on the regional species pools; however, quantifications of the relationship between the composition of the regional species pool and restoration outcome are lacking. We analyzed data from 18 German river restoration projects and adjacent river reaches constituting the regional species pools of the restored reaches. We found that the ability of statistical models to describe the fish assemblages established in the restored reaches was greater when these models were based on 'biotic' variables relating to the regional species pool and the ecological traits of species rather than on 'abiotic' variables relating to the hydromorphological habitat structure of the restored habitats and descriptors of the restoration projects. For species presence in restored reaches, 'biotic' variables explained 34% of variability, with the occurrence rate of a species in the regional species pool being the most important variable, while 'abiotic' variables explained only the negligible amount of 2% of variability. For fish density in restored reaches, about twice the amount of variability was explained by 'biotic' (38%) compared to 'abiotic' (21%) variables, with species density in the regional species pool being most important. These results indicate that the colonization of restored river reaches by fish is largely determined by the assemblages in the surrounding species pool. Knowledge of species presence and abundance in the regional species pool can be used to estimate the likelihood of fish species becoming established in restored reaches.	[Stoll, Stefan; Sundermann, Andrea; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Stoll, Stefan; Sundermann, Andrea; Haase, Peter] Nat Hist Museum, Gelnhausen, Germany; [Stoll, Stefan; Haase, Peter] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Kail, Jochem] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Kail, Jochem; Lorenz, Armin W.] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Duisburg Essen	Stoll, S (corresponding author), Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany.	stefan.stoll@senckenberg.de	Stoll, Stefan/D-5278-2011; Haase, Peter/A-5644-2011; Sundermann, Andrea/A-2938-2009	Stoll, Stefan/0000-0002-3656-417X; Sundermann, Andrea/0000-0003-2304-1967	Deutsche Bundesstiftung Umwelt [FK 25032-33/2]; Hesse's Ministry of Environment [FK III 2-79i 02]; Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum)	Deutsche Bundesstiftung Umwelt; Hesse's Ministry of Environment; Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum)	This study was financially supported by Deutsche Bundesstiftung Umwelt (FK 25032-33/2), Hesse's Ministry of Environment (FK III 2-79i 02), and the research funding program 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese B, 2009, FRESHWATER BIOL, V54, P1444, DOI 10.1111/j.1365-2427.2009.02194.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], [No title captured]; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Clewell A, 1997, RESTOR ECOL, V5, P350, DOI 10.1046/j.1526-100X.1997.00548.x; COPP GH, 1989, ENVIRON BIOL FISH, V26, P1, DOI 10.1007/BF00002472; COPP GH, 1992, ENVIRON BIOL FISH, V33, P181, DOI 10.1007/BF00002563; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; DETENBECK NE, 1992, ENVIRON MANAGE, V16, P33, DOI 10.1007/BF02393907; Donaldson JA, 2013, FRESHWATER BIOL, V58, P1038, DOI 10.1111/fwb.12107; Dussling U, 2009, HDB FIBS; Dussling U, 2004, VERBUNDPROJEKT ERFOR; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; GORE JA, 1990, ENVIRON MANAGE, V14, P737, DOI 10.1007/BF02394722; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; Grenouillet G., 2006, FISH INDICATOR DATAB; Haase P, 2013, HYDROBIOLOGIA, V704, P475, DOI 10.1007/s10750-012-1255-1; Hamilton J. B., 1989, PRACTICAL APPROACHES, P149; Hanski I, 1999, METAPOPULATION ECOLO; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Jahnig SC, 2011, ECOL APPL, V21, P2007, DOI 10.1890/10-0618.1; Jahnig SC, 2013, HYDROBIOLOGIA, V712, P89, DOI 10.1007/s10750-012-1264-0; Kail J, 2007, J APPL ECOL, V44, P1145, DOI 10.1111/j.1365-2664.2007.01401.x; Kail J, 2009, RIVER RES APPL, V25, P537, DOI 10.1002/rra.1238; Kamp U, 2007, ENVIRON MONIT ASSESS, V127, P209, DOI 10.1007/s10661-006-9274-x; KONDOLF GM, 1995, RESTOR ECOL, V3, P133, DOI 10.1111/j.1526-100X.1995.tb00086.x; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Kucera-Hirzinger V, 2009, AQUAT SCI, V71, P94, DOI 10.1007/s00027-008-8110-5; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Leavy TR, 2009, N AM J FISH MANAGE, V29, P72, DOI 10.1577/M07-040.1; Lepori F, 2005, ECOL APPL, V15, P2060, DOI 10.1890/04-1372; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Lorenz AW, ECOLOGICAL ENG; Louca V, 2009, ECOL FRESHW FISH, V18, P60, DOI 10.1111/j.1600-0633.2008.00323.x; Neumann RM, 2002, ECOL FRESHW FISH, V11, P240, DOI 10.1034/j.1600-0633.2002.00016.x; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Pretty JL, 2003, J APPL ECOL, V40, P251, DOI 10.1046/j.1365-2664.2003.00808.x; R Development Core Team, 2011, LANG ENV STAT COMP; Radinger J., 2013, FISH FISH, P1; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Reynolds James B., 1996, P221; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; SCHLOSSER IJ, 1995, ECOLOGY, V76, P908, DOI 10.2307/1939356; Starrs D, 2011, FISHERIES MANAG ECOL, V18, P360, DOI 10.1111/j.1365-2400.2011.00788.x; Stoll S, 2008, J FISH BIOL, V72, P1001, DOI 10.1111/j.1095-8649.2007.01780.x; Stoll S, 2013, FRESHWATER BIOL, V58, P664, DOI 10.1111/fwb.12068; Sundermann A, 2011, ECOL APPL, V21, P1962, DOI 10.1890/10-0607.1; Sundermann A, 2011, FRESHWATER BIOL, V56, P1689, DOI 10.1111/j.1365-2427.2011.02599.x; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; Vitt P, 2009, TRENDS ECOL EVOL, V24, P473, DOI 10.1016/j.tree.2009.05.007; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; Weber C, 2009, RIVER RES APPL, V25, P687, DOI 10.1002/rra.1176; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z	58	52	52	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84741	10.1371/journal.pone.0084741	http://dx.doi.org/10.1371/journal.pone.0084741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404187	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800066
J	Tang, HL; Wang, ZY; Liu, Q; Liu, XP; Wu, MH; Li, GY				Tang, Hailin; Wang, Zeyou; Liu, Qing; Liu, Xiaoping; Wu, Minghua; Li, Guiyuan			Disturbing miR-182 and-381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROLIFERATION; CELLS; EXPRESSION; PROTEIN; APOPTOSIS; MIGRATION; PATHWAYS; INVASION; CLUSTER	Inactivated LRRC4 has been clinically detected in gliomas, and promoter hypermethylation has been implicated as the mechanism of inactivation in some of those tumors. Our previous researches indicated that LRRC4 is a target gene of miR-381, the interaction of miR-381 and LRRC4 is involved in glioma growth. In this study, we demonstrate that LRRC4 is a target gene of the other microRNA, miR-182. We found that the high expression of miR-182 and miR-381 in gliomas are involved in pathological malignant progression. The silencing of miR-182 and miR-381 inhibited the proliferation in vitro and growth of glioma cell with in vivo magnetic resonance imaging by intracranial transplanted tumor model in rats. We also demonstrated that BRD7, a transcriptional cofactor for p53, is highly expressed and negatively correlated with LRRC4 expression in gliomas. Disturbing miR-182 and miR-381 affected transcriptional regulation of the BRD7 gene. This finding was verified by ectopic overexpression of LRRC4 or restoration of endogenous LRRC4 expression by treatment with the DNA demethylating agent 5-Aza-dC. Taken together, miR-182 and miR-381 may be a useful therapeutic target for treatment of glioma.	[Tang, Hailin; Wang, Zeyou; Liu, Xiaoping; Wu, Minghua; Li, Guiyuan] Cent S Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Minist Educ,Key Lab Carcinogenesis,Minist Hlth, Changsha, Hunan, Peoples R China; [Tang, Hailin; Liu, Xiaoping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Qing; Wu, Minghua] Ctr Skull Base Surg & Neurooncol, Changsha, Hunan, Peoples R China	Central South University; State Key Lab Oncology South China; Sun Yat Sen University	Wu, MH (corresponding author), Cent S Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Minist Educ,Key Lab Carcinogenesis,Minist Hlth, Changsha, Hunan, Peoples R China.	wuminghua554@aliyun.com; ligy@xysm.net			National Natural Science Foundation of China [81272297, 81171932, 31100935]; Hunan Province Natural Sciences Foundations [11JJ1013]; Research Fund for the Doctoral Program of Higher Education of China [20110162110037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Natural Sciences Foundations; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from National Natural Science Foundation of China (81272297, 81171932, 31100935) and Hunan Province Natural Sciences Foundations (11JJ1013); Research Fund for the Doctoral Program of Higher Education of China (20110162110037). There are no financial or other relationships that might lead to a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; Hulleman E, 2005, ADV CANCER RES, V94, P1, DOI 10.1016/S0065-230X(05)94001-3; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Mantovani F, 2010, CELL CYCLE, V9, P2777; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Nagadia R, 2013, CELL ONCOL, V36, P1, DOI 10.1007/s13402-012-0122-4; Rossi S, 2013, ADV EXP MED BIOL, V774, P21, DOI 10.1007/978-94-007-5590-1_2; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Tang H, 2013, CLIN CANC RES, V19, P5602; Tang H, 2013, CANC LETT; Tang HL, 2013, CURR CANCER DRUG TAR, V13, P221, DOI 10.2174/1568009611313020010; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Wang Jie-Ru, 2003, Ai Zheng, V22, P897; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Wu MH, 2008, J CELL PHYSIOL, V214, P65, DOI 10.1002/jcp.21163; Wu MH, 2007, ACTA BIOCH BIOPH SIN, V39, P731, DOI 10.1111/j.1745-7270.2007.00338.x; Wu MH, 2006, MOL BIOL CELL, V17, P3534, DOI 10.1091/mbc.E05-11-1082; Wu MH, 2009, CURR GENOMICS, V10, P216, DOI 10.2174/138920209788488481; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhang QH, 2005, FEBS LETT, V579, P3674, DOI 10.1016/j.febslet.2005.05.058; Zhang ZP, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-99; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013; Zhou M, 2006, MOL CELL BIOCHEM, V292, P205, DOI 10.1007/s11010-006-9233-4	27	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84146	10.1371/journal.pone.0084146	http://dx.doi.org/10.1371/journal.pone.0084146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404152	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800031
J	Mallet, D; Wantiez, L; Lemouellic, S; Vigliola, L; Pelletier, D				Mallet, Delphine; Wantiez, Laurent; Lemouellic, Soazig; Vigliola, Laurent; Pelletier, Dominique			Complementarity of Rotating Video and Underwater Visual Census for Assessing Species Richness, Frequency and Density of Reef Fish on Coral Reef Slopes	PLOS ONE			English	Article							ARTIFICIAL REEFS; RELATIVE DENSITY; SIZE STRUCTURE; DIVERS; COMMUNITIES; ABUNDANCE; TRANSECT; ACCURACY; SYSTEM; CAMERA	Estimating diversity and abundance of fish species is fundamental for understanding community structure and dynamics of coral reefs. When designing a sampling protocol, one crucial step is the choice of the most suitable sampling technique which is a compromise between the questions addressed, the available means and the precision required. The objective of this study is to compare the ability to sample reef fish communities at the same locations using two techniques based on the same stationary point count method: one using Underwater Visual Census (UVC) and the other rotating video (STAVIRO). UVC and STAVIRO observations were carried out on the exact same 26 points on the reef slope of an intermediate reef and the associated inner barrier reefs. STAVIRO systems were always deployed 30 min to 1 hour after UVC and set exactly at the same place. Our study shows that; (i) fish community observations by UVC and STAVIRO differed significantly; (ii) species richness and density of large species were not significantly different between techniques; (iii) species richness and density of small species were higher for UVC; (iv) density of fished species was higher for STAVIRO and (v) only UVC detected significant differences in fish assemblage structure across reef type at the spatial scale studied. We recommend that the two techniques should be used in a complementary way to survey a large area within a short period of time. UVC may census reef fish within complex habitats or in very shallow areas such as reef flat whereas STAVIRO would enable carrying out a large number of stations focused on large and diver-averse species, particularly in the areas not covered by UVC due to time and depth constraints. This methodology would considerably increase the spatial coverage and replication level of fish monitoring surveys.	[Mallet, Delphine; Pelletier, Dominique] IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia; [Mallet, Delphine; Wantiez, Laurent; Lemouellic, Soazig] Univ Nouvelle Caledonie, EA LIVE 4243, Noumea, New Caledonia; [Vigliola, Laurent] IRD, UMR CoReUS 227, Lab Excellence LABEX Corail, Noumea, New Caledonia	Ifremer; Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Mallet, D (corresponding author), IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia.	Delphine.Mallet@ifremer.fr	Wantiez, Laurent/L-3343-2013; Vigliola, Laurent/J-7107-2016; Pelletier, Dominique/A-1649-2011	Wantiez, Laurent/0000-0001-5024-2057; Vigliola, Laurent/0000-0003-4715-7470; Mallet, Delphine/0000-0002-7636-6450; Pelletier, Dominique/0000-0003-2420-1942	French Institute for the Exploitation of the Sea (IFREMER); Agence des Aires Marines Protegees; Environment Department of the South Province of New Caledonia; University of New Caledonia	French Institute for the Exploitation of the Sea (IFREMER); Agence des Aires Marines Protegees; Environment Department of the South Province of New Caledonia; University of New Caledonia	This work is part of a PhD Thesis jointly funded by the French Institute for the Exploitation of the Sea (IFREMER) and the Agence des Aires Marines Protegees. This survey was also funded by the Environment Department of the South Province of New Caledonia and the University of New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEVIZON WS, 1975, B MAR SCI, V25, P482; Assis J., 2007, Journal of Coastal Conservation, V11, P153, DOI 10.1007/s11852-008-0015-x; BARNES H., 1953, DEUTSCHE HYDROGR ZEITSCHR, V6, P123, DOI 10.1007/BF02020044; Barnes H., 1952, Nature London, V169, P477, DOI 10.1038/169477a0; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Burge EJ, 2012, B MAR SCI, V88, P15, DOI 10.5343/bms.2010.1079; Burke L., 2011, REEFS RISK REVISITED; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Chabanet P, 2012, J EXP MAR BIOL ECOL, V430, P10, DOI 10.1016/j.jembe.2012.06.024; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chateau O, 2005, CYBIUM, V29, P159; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooke SJ, 2002, ENVIRON MONIT ASSESS, V73, P109, DOI 10.1023/A:1013099430900; CROSSLAND J, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P511; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Drelon J., 2010, EVALUATION VIDEO ROT; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; ELLIS DM, 1995, FISH B-NOAA, V93, P67; FEDRA K, 1979, MAR BIOL, V55, P239, DOI 10.1007/BF00396824; FRANCOUR P, 1999, NAT SICIL, V23, P155; GREENE LE, 1989, B MAR SCI, V44, P899; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, MAR TECHNOL SOC J, V36, P38, DOI 10.4031/002533202787914106; Harvey E, 2001, FISH B-NOAA, V99, P72; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey E, 2001, FISH B-NOAA, V99, P63; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; JOHNSTON CS, 1969, J ECOL, V57, P453, DOI 10.2307/2258391; JONES RS, 1978, B MAR SCI, V28, P159; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1988, CORRELATION CATCH DA, P305; Lam K, 2006, J EXP MAR BIOL ECOL, V333, P115, DOI 10.1016/j.jembe.2005.12.009; Langlois T., 2006, FISH NEWSL S PAC COM, P53; Le Grand Y, 1968, LIGHT COLOUR VISION; LEBART L, 1997, STAT EXPLORATOIRE MU; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEONARD GH, 1993, MAR ECOL PROG SER, V101, P203, DOI 10.3354/meps101203; Lessios HA, 1996, DIVING SCI 1996 METH, P9; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Longo GO, 2012, J FISH BIOL, V81, P1773, DOI 10.1111/j.1095-8649.2012.03441.x; Lowry M, 2012, J EXP MAR BIOL ECOL, V416, P243, DOI 10.1016/j.jembe.2012.01.013; MACHAN R, 1975, MAR BIOL, V33, P75, DOI 10.1007/BF00395004; MICHALOPOULOS C, 1992, MAR TECHNOL SOC J, V26, P27; MILLER RJ, 1987, B MAR SCI, V40, P484; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; Pelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030536; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; RICHARD JD, 1968, J FISH RES BOARD CAN, V25, P1441, DOI 10.1139/f68-125; Rogers CS, 2001, B MAR SCI, V69, P459; Rotherham D, 2007, ICES J MAR SCI, V64, P1512, DOI 10.1093/icesjms/fsm096; Sarramegna S, 2000, THESIS U NEW CALEDON; Sigler MF, 2000, CAN J FISH AQUAT SCI, V57, P1270, DOI 10.1139/cjfas-57-6-1270; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; Sokal R. R, 1981, BIOMETRY; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Tessier A, 2013, AQUAT BIOL, V18, P229, DOI 10.3354/ab00506; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; WALLACE JH, 1984, S AFR J ZOOL, V19, P164; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Winhold L, 2008, NORTHEAST NAT, V15, P263, DOI 10.1656/1092-6194(2008)15[263:NSFBIT]2.0.CO;2; [No title captured]	75	24	24	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84344	10.1371/journal.pone.0084344	http://dx.doi.org/10.1371/journal.pone.0084344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392126	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100049
J	Yin, SY; Kim, HJ; Kim, HJ				Yin, Sun Young; Kim, Hyoung Jin; Kim, Hong-Jin			Protective Effect of Dietary Xylitol on Influenza A Virus Infection	PLOS ONE			English	Article							KOREAN RED GINSENG; POLYSACCHARIDE; VACCINATION; OSELTAMIVIR; CHILDREN	Xylitol has been used as a substitute for sugar to prevent cavity-causing bacteria, and most studies have focused on its benefits in dental care. Meanwhile, the constituents of red ginseng (RG) are known to be effective in ameliorating the symptoms of influenza virus infection when they are administered orally for 14 days. In this study, we investigated the effect of dietary xylitol on influenza A virus infection (H1N1). We designed regimens containing various fractions of RG (RGs: whole extract, water soluble fraction, saponin and polysaccharide) and xylitol, and combination of xylitol with the RG fractions. Mice received the various combinations orally for 5 days prior to lethal influenza A virus infection. Almost all the mice died post challenge when xylitol or RGs were administered separately. Survival was markedly enhanced when xylitol was administered along with RGs, pointing to a synergistic effect. The effect of xylitol plus RG fractions increased with increasing dose of xylitol. Moreover, dietary xylitol along with the RG water soluble fraction significantly reduced lung virus titers after infection. Therefore, we suggest that dietary xylitol is effective in ameliorating influenza-induced symptoms when it is administered with RG fractions, and this protective effect of xylitol should be considered in relation to other diseases.	[Yin, Sun Young; Kim, Hyoung Jin; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea.	hongjink@cau.ac.kr			Chung-Ang University grant	Chung-Ang University grant	Chung-Ang University grant supported the authors' work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bardsley-Elliot A, 1999, DRUGS, V58, P851, DOI 10.2165/00003495-199958050-00007; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/732860; Converti A, 1999, APPL BIOCHEM BIOTECH, V82, P141, DOI 10.1385/ABAB:82:2:141; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Frejnagel Slawomir S., 2003, Polish Journal of Food and Nutrition Sciences, V12, P32; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Kim JY, 2011, J GINSENG RES, V35, P104, DOI 10.5142/jgr.2011.35.1.104; KIM Y S, 1990, Archives of Pharmacal Research (Seoul), V13, P330, DOI 10.1007/BF02858168; Kwak YS, 2010, BIOL PHARM BULL, V33, P468, DOI 10.1248/bpb.33.468; Li C, 2012, INT J BIOL MACROMOL, V51, P968, DOI 10.1016/j.ijbiomac.2012.06.031; Makinen K K, 1978, Experientia Suppl, P1; MAKINEN KK, 1989, CARIES RES, V23, P261; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Murphy Frederick A., 1996, P15; NEVINS DJ, 1967, PLANT PHYSIOL, V42, P900, DOI 10.1104/pp.42.7.900; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renko M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-45; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; Sato H, 2011, ODONTOLOGY, V99, P28, DOI 10.1007/s10266-010-0143-2; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Website of Centers for Disease Control and Prevention, 1976, MORBIDITY MORTALITY; Website of Centers for Disease Control and Prevention, 2012, SEAS FLU ANT DRUG RE; Wee JJ, 2011, HERBAL MED BIOMOLECU; Wikipedia the free encyclopedia, XYL; Wikipedia the free encyclopedia, 2013, INFL PAND; Wina E, 2005, J AGR FOOD CHEM, V53, P8093, DOI 10.1021/jf048053d; Yin SY, 2013, BIOL PHARM BULL, V36, P1002, DOI 10.1248/bpb.b13-00123; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84633	10.1371/journal.pone.0084633	http://dx.doi.org/10.1371/journal.pone.0084633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392148	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100071
J	Saha, A; Tan, AC; Kang, J				Saha, Ashis; Tan, Aik Choon; Kang, Jaewoo			Automatic Context-Specific Subnetwork Discovery from Large Interaction Networks	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; EXPRESSION; CANCER; GENE; CLASSIFICATION; MARKERS; PREDICTION; ALGORITHM; TARGETS	Genes act in concert via specific networks to drive various biological processes, including progression of diseases such as cancer. Under different phenotypes, different subsets of the gene members of a network participate in a biological process. Single gene analyses are less effective in identifying such core gene members (subnetworks) within a gene set/network, as compared to gene set/network-based analyses. Hence, it is useful to identify a discriminative classifier by focusing on the subnetworks that correspond to different phenotypes. Here we present a novel algorithm to automatically discover the important subnetworks of closely interacting molecules to differentiate between two phenotypes (context) using gene expression profiles. We name it COSSY (COntext-Specific Subnetwork discoverY). It is a non-greedy algorithm and thus unlikely to have local optima problems. COSSY works for any interaction network regardless of the network topology. One added benefit of COSSY is that it can also be used as a highly accurate classification platform which can produce a set of interpretable features.	[Saha, Ashis; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Tan, Aik Choon] Univ Colorado, Dept Med Med Oncol, Aurora, CO USA; [Kang, Jaewoo] Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea	Korea University; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University	Kang, J (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	kangj@korea.ac.kr	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	National Research Foundation of Korea (NRF); Korean government (MSIP) [2012R1A2A2A01014729]; Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [2012M3C4A7033341]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2012R1A2A2A01014729); and Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3C4A7033341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Chowdhury SA, 2010, BIOCOMPUT-PAC SYM, P133; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geman D., 2004, STAT APPL GENETICS M, V3; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lin X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-256; Magis AT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-227; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Oellerich T, 2013, BLOOD, V121, P3889, DOI 10.1182/blood-2012-09-457887; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shipp MA, 2002, 1 HARV MED SCH DAN F; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Su J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Wang HY, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S3; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Welsh JB, 2001, CANCER RES, V61, P5974	35	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2014	9	1							e84227	10.1371/journal.pone.0084227	http://dx.doi.org/10.1371/journal.pone.0084227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285EK	24392115	Green Published, Green Submitted, gold			2022-12-25	WOS:000329375900001
J	Abu El-Asrar, AM; Mohammad, G; Nawaz, MI; Siddiquei, MM; Van den Eynde, K; Mousa, A; De Hertogh, G; Opdenakker, G				Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj; Van den Eynde, Kathleen; Mousa, Ahmed; De Hertogh, Gert; Opdenakker, Ghislain			Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							TIMP-FREE MMP-9; GELATINASE B; VEGF-A; ANGIOGENESIS; CELLS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; RECEPTOR-1; NEUTROPHILS; METASTASIS	To investigate which matrix metalloproteinases (MMPs) are more likely to be involved in the angiogenic process in proliferative diabetic retinopathy (PDR), we measured the levels of MMPs in the vitreous fluid from patients with PDR and controls and correlated these levels with the levels of vascular endothelial growth factor (VEGF). Vitreous samples from 32 PDR and 24 nondiabetic patients were studied by mosaic multiplex MMPs enzyme-linked immunosorbent assay (ELISA), single ELISA, Western blot and zymography analysis. Epiretinal membranes from 11 patients with PDR were studied by immunohistochemistry. MMP-8 and MMP-13 were not detected. ELISA, Western blot and gelatin ymography assays revealed significant increases in the expression levels of MMP-1, MMP-7, MMP-9 and VEGF in vitreous samples from PDR patients compared to nondiabetic controls, whereas MMP-2 and MMP-3 were not upregulated in vitreous samples from PDR patients. Significant correlations existed between ELISA and zymography assays for the quantitation of MMP-2 (r=0.407; p=0.039) and MMP-9 (r=0.711; p < 0.001). Significant correlations were observed between levels of VEGF and levels of MMP-1 (r=0.845; P < 0.001) and MMP-9 (r=0.775; p < 0.001), and between levels of MMP-1 and MMP-9 (r=0.857; p < 0.001). In epiretinal membranes, cytoplasmic immunoreactivity for MMP-9 was present in vascular endothelial cells and stromal monocytes/macrophages and neutrophils. Our findings suggest that among the MMPs measured, MMP-1 and MMP-9 may contribute to the angiogenic switch in PDR.	[Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj; Mousa, Ahmed] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Van den Eynde, Kathleen; De Hertogh, Gert] Katholieke Univ Leuven, Univ Leuven, Lab Histochem & Cytochem, Louvain, Belgium; [Opdenakker, Ghislain] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium	King Saud University; KU Leuven; KU Leuven	Abu El-Asrar, AM (corresponding author), King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia.	abuasrar@KSU.edu.sa	Abu El-Asrar, Ahmed/AAX-5055-2021; Mousa, Ahmed Amin/AAH-2827-2019; NAWAZ, MOHD IMTIAZ/G-5193-2011; Opdenakker, Ghislain/Q-3130-2017; Mohammad, Ghulam/F-5623-2011; Opdenakker, Ghislain/V-8562-2019	NAWAZ, MOHD IMTIAZ/0000-0002-7040-9405; Opdenakker, Ghislain/0000-0003-1714-2294; Mohammad, Ghulam/0000-0002-6418-4772; Opdenakker, Ghislain/0000-0003-1714-2294	Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA); Geconcerteerde OnderzoeksActies [GOA 2013-2017]; Fund For Scientific Research of Flanders (FWO-Vlaanderen)	Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA); Geconcerteerde OnderzoeksActies; Fund For Scientific Research of Flanders (FWO-Vlaanderen)(FWO)	This work was supported by Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA). Research in Leuven was supported by the Geconcerteerde OnderzoeksActies (GOA 2013-2017) and the Fund For Scientific Research of Flanders (FWO-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/863036; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Alexandrakis MG, 2007, CLIN CHIM ACTA, V379, P31, DOI 10.1016/j.cca.2006.11.024; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Descamps FJ, 2006, EXP EYE RES, V83, P401, DOI 10.1016/j.exer.2006.01.017; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huo N, 2002, CANCER LETT, V177, P95, DOI 10.1016/S0304-3835(01)00772-8; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Jin M, 2001, RETINA-J RET VIT DIS, V21, P28, DOI 10.1097/00006982-200102000-00005; Kim KS, 2011, RHEUMATOL INT, V31, P543, DOI 10.1007/s00296-010-1592-1; Kosano H, 1999, LIFE SCI, V64, P2307, DOI 10.1016/S0024-3205(99)00184-8; Noda K, 2003, INVEST OPHTH VIS SCI, V44, P2163, DOI 10.1167/iovs.02-0662; Paemen L, 1995, EUR J BIOCHEM, V234, P759, DOI 10.1111/j.1432-1033.1995.759_a.x; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Pulukuri SMK, 2008, INT J ONCOL, V32, P757; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shirasawa M, 2011, GRAEF ARCH CLIN EXP, V249, P1805, DOI 10.1007/s00417-011-1795-5; Sier CFM, 2008, MATRIX BIOL, V27, P267, DOI 10.1016/j.matbio.2007.10.006; Spranger J, 2001, EXP CLIN ENDOCR DIAB, V109, pS438, DOI 10.1055/s-2001-18601; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Zaman K, 2006, INT J CANCER, V118, P755, DOI 10.1002/ijc.21408	34	60	60	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85857	10.1371/journal.pone.0085857	http://dx.doi.org/10.1371/journal.pone.0085857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392031	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900175
J	Alanazi, M; Pathan, AAK; Arifeen, Z; Shaik, JP; Alabdulkarim, HA; Semlali, A; Bazzi, MD; Parine, NR				Alanazi, Mohammad; Pathan, Akbar Ali Khan; Arifeen, Zainul; Shaik, Jilani P.; Alabdulkarim, Huda A.; Semlali, Abdelhabib; Bazzi, Mohammad D.; Parine, Narasimha Reddy			Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population	PLOS ONE			English	Article							EXCISION-REPAIR PATHWAY; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; WEB SERVER; RISK; SEQUENCE; TUMORIGENESIS; EXPRESSION; MUTATIONS; BINDING	Genetic aberrations of DNA repair enzymes are known to be common events and to be associated with different cancer entities. Aim of the following study was to analyze the genetic association of rs1136410 (Val762Ala) in PARP1 gene with the risk of breast cancer using genotypic assays and insilico structural predictions. Genotypic analysis of individual locus showed statistically significant association of Val762Ala with increased susceptibility to breast cancer. Protein structural analysis was performed with Val762Ala variant allele and compared with the predicted native protein structure. Protein prediction analysis showed that this nsSNP may cause changes in the protein structure and it is associated with the disease. In addition to the native and mutant 3D structures of PARP1 were also analyzed using solvent accessibility models for further protein stability confirmation. Taken together, this the first study that confirmed Val762Ala variant has functional effect and structural impact on the PARP1 and may play an important role in breast cancer progression in Saudi population.	[Alanazi, Mohammad; Pathan, Akbar Ali Khan; Arifeen, Zainul; Shaik, Jilani P.; Semlali, Abdelhabib; Bazzi, Mohammad D.; Parine, Narasimha Reddy] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Arifeen, Zainul] Umm Al Qura Univ, Dept Med Genet, Sci & Technol Unit, Mecca, Saudi Arabia; [Alabdulkarim, Huda A.] Comprehens Canc Ctr King Fahad Med City, Riyadh, Saudi Arabia	King Saud University; Umm Al Qura University; King Fahad Medical City	Parine, NR (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	reddyparine@gmail.com	Semlali, Abdelhabib/AAP-7043-2020; Parine, Narasimha Reddy/B-7975-2011; PATHAN, AKBAR ALI KHAN/ABC-8189-2021	Semlali, Abdelhabib/0000-0002-1643-0377; Parine, Narasimha Reddy/0000-0002-0765-9022; PATHAN, AKBAR ALI KHAN/0000-0002-6516-7587	National Science, Technology, and Innovation Plan strategic technologies program in the Kingdom [10-BIO897-2]	National Science, Technology, and Innovation Plan strategic technologies program in the Kingdom	This study was financially supported by a grant from National Science, Technology, and Innovation Plan strategic technologies program number 10-BIO897-2 in the Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Alanazi M, 2013, ASIAN PAC J CANCER P, V14, P3051, DOI 10.7314/APJCP.2013.14.5.3051; [Anonymous], [No title captured]; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bi FF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-90; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Ferlay J, 2010, IARC CANCERBASE, V2; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jo S, 2013, J CHEM INF MODEL, V53, P267, DOI 10.1021/ci300505n; Johnson-Thompson MC, 2000, CANCER, V88, P1224, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H; Khan W, 2013, GENE, V522, P75, DOI 10.1016/j.gene.2013.03.037; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumari SR, 1998, CANCER RES, V58, P5075; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Masutani M, 2003, GENE CHROMOSOME CANC, V38, P339, DOI 10.1002/gcc.10250; Milani L, 2007, EUR J CLIN INVEST, V37, P80; PERO RW, 1990, CANCER DETECT PREV, V14, P555; Prlic A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-333; Rajaee-Behbahani N, 2002, INT J CANCER, V98, P780, DOI 10.1002/ijc.10234; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Saudi National Cancer Registry, 2011, CANC INC SURV REP SA; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tong WM, 2007, ONCOGENE, V26, P3857, DOI 10.1038/sj.onc.1210156; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Tong WM, 2002, CANCER RES, V62, P6990; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037446; Yu HP, 2012, GENET EPIDEMIOL, V36, P56, DOI 10.1002/gepi.20663; Zhang XM, 2005, CANCER RES, V65, P722	43	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85541	10.1371/journal.pone.0085541	http://dx.doi.org/10.1371/journal.pone.0085541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392019	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900163
J	Ferrario, C; Ricci, G; Milani, C; Lugli, GA; Ventura, M; Eraclio, G; Borgo, F; Fortina, MG				Ferrario, Chiara; Ricci, Giovanni; Milani, Christian; Lugli, Gabriele Andrea; Ventura, Marco; Eraclio, Giovanni; Borgo, Francesca; Fortina, Maria Grazia			Lactococcus garvieae: Where Is It From? A First Approach to Explore the Evolutionary History of This Emerging Pathogen	PLOS ONE			English	Article							GENOME SEQUENCE; RAINBOW-TROUT; ITALIAN CHEESE; STRAINS; FISH; IDENTIFICATION; REVEALS; LACTOSE; DISEASE; DAIRY	The population structure and diversity of Lactococcus garvieae, an emerging pathogen of increasing clinical significance, was determined at both gene and genome level. Selected lactococcal isolates of various origins were analyzed by a multi locus sequence typing (MLST). This gene-based analysis was compared to genomic characteristics, estimated through the complete genome sequences available in database. The MLST identified two branches containing the majority of the strains and two branches bearing one strain each. One strain was particularly differentiated from the other L. garvieae strains, showing a significant genetic distance. The genomic characteristics, correlated to the MLST-based phylogeny, indicated that this "separated strain" appeared first and could be considered the evolutionary intermediate between Lactococcus lactis and L. garvieae main clusters. A preliminary genome analysis of L. garvieae indicated a pan-genome constituted of about 4100 genes, which included 1341 core genes and 2760 genes belonging to the dispensable genome. A total of 1491 Clusters of Orthologous Genes (COGs) were found to be specific to the 11 L. garvieae genomes, with the genome of the `` separated strain'' showing the highest presence of unique genes.	[Ferrario, Chiara; Ricci, Giovanni; Eraclio, Giovanni; Borgo, Francesca; Fortina, Maria Grazia] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Div Food Microbiol & Bioproc, Milan, Italy; [Milani, Christian; Lugli, Gabriele Andrea; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy	University of Milan; University of Parma	Fortina, MG (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Div Food Microbiol & Bioproc, Milan, Italy.	grazia.fortina@unimi.it	Lugli, Gabriele Andrea/AAV-5150-2021; Milani, Christian/ABA-8160-2020; BORGO, FRANCESCA CLAUDIA/AAM-7200-2020; ventura, marco/M-8230-2015; Lugli, Gabriele Andrea/GRX-2617-2022	Lugli, Gabriele Andrea/0000-0002-3024-0537; BORGO, FRANCESCA CLAUDIA/0000-0001-9685-1069; Lugli, Gabriele Andrea/0000-0002-3024-0537; Milani, Christian/0000-0002-5062-3164; FORTINA, MARIA GRAZIA/0000-0002-3275-6000; Ventura, Marco/0000-0002-4875-4560	Lombardy Region, Italy; Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti"	Lombardy Region, Italy(Regione Lombardia); Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti"	This work was carried out with the financial support of the Lombardy Region, Italy, under the Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Urda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040119; Aguado-Urda M, 2011, J BACTERIOL, V193, P4263, DOI 10.1128/JB.05326-11; Aguado-Urda M, 2011, J BACTERIOL, V193, P4033, DOI 10.1128/JB.05090-11; Aguado-Urda M, 2010, INT MICROBIOL, V13, P189, DOI 10.2436/20.1501.01.125; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubin GG, 2011, J CLIN MICROBIOL, V49, P2074, DOI 10.1128/JCM.00065-11; Baeck GW, 2006, J VET SCI, V7, P53, DOI 10.4142/jvs.2006.7.1.53; Baker GC, 2006, J MICROBIOL METH, V55, P541; Barnes AC, 2002, FISH SHELLFISH IMMUN, V12, P155, DOI 10.1006/fsim.2001.0361; Florez AB, 2012, J BACTERIOL, V194, P5118, DOI 10.1128/JB.00975-12; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Chen SC, 2001, DIS AQUAT ORGAN, V45, P45, DOI 10.3354/dao045045; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donkor ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-569; Eldar A, 1999, APPL ENVIRON MICROB, V65, P1005; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Evans JJ, 2009, J FISH DIS, V32, P943, DOI 10.1111/j.1365-2761.2009.01075.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez E, 2010, INT DAIRY J, V20, P142, DOI 10.1016/j.idairyj.2009.11.004; Ferrario C, 2012, FEMS MICROBIOL LETT, V332, P153, DOI 10.1111/j.1574-6968.2012.02591.x; Fihman V, 2006, J INFECTION, V52, P3; Fortina MG, 2009, J FOOD PROTECT, V72, P1248, DOI 10.4315/0362-028X-72.6.1248; Fortina MG, 2003, FOOD MICROBIOL, V20, P397, DOI 10.1016/S0740-0020(02)00149-1; Gabrielsen C, 2012, J BACTERIOL, V194, P6976, DOI 10.1128/JB.01864-12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Milani C, 2013, APPL ENVIRON MICROB, V79, P4304, DOI 10.1128/AEM.00984-13; Mira A, 2010, INT MICROBIOL, V13, P45, DOI 10.2436/20.1501.01.110; Miyauchi Eiji, 2012, Int J Microbiol, V2012, P728276, DOI 10.1155/2012/728276; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Pearson W R, 2000, Methods Mol Biol, V132, P185; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Ravelo C, 2003, J CLIN MICROBIOL, V41, P751, DOI 10.1128/JCM.41.2.751-756.2003; Reimundo P, 2011, MICROBIOL-SGM, V157, P2106, DOI 10.1099/mic.0.047969-0; Reimundo P, 2011, J BACTERIOL, V193, P3684, DOI 10.1128/JB.05210-11; Ricci G, 2013, GENOME ANNOUNC, V1; Ricci G, 2012, J BACTERIOL, V194, P1249, DOI 10.1128/JB.06655-11; Russo G, 2012, NEW MICROBIOL, V35, P495; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidtke LM, 2003, B EUR ASSOC FISH PAT, V23, P206; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	59	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84796	10.1371/journal.pone.0084796	http://dx.doi.org/10.1371/journal.pone.0084796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391975	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900118
J	Halberg, KA; Jorgensen, A; Mobjerg, N				Halberg, Kenneth Agerlin; Jorgensen, Aslak; Mobjerg, Nadja			Desiccation Tolerance in the Tardigrade Richtersius coronifer Relies on Muscle Mediated Structural Reorganization	PLOS ONE			English	Article							HALOBIOTUS-CRISPAE EUTARDIGRADA; BDELLOID ROTIFER; ANHYDROBIOSIS; CYCLOMORPHOSIS; DEHYDRATION; TREHALOSE; ANABIOSIS; LIFE	Life unfolds within a framework of constraining abiotic factors, yet some organisms are adapted to handle large fluctuations in physical and chemical parameters. Tardigrades are microscopic ecdysozoans well known for their ability to endure hostile conditions, such as complete desiccation - a phenomenon called anhydrobiosis. During dehydration, anhydrobiotic animals undergo a series of anatomical changes. Whether this reorganization is an essential regulated event mediated by active controlled processes, or merely a passive result of the dehydration process, has not been clearly determined. Here, we investigate parameters pivotal to the formation of the so-called "tun", a state that in tardigrades and rotifers marks the entrance into anhydrobiosis. Estimation of body volume in the eutardigrade Richtersius coronifer reveals an 87 % reduction in volume from the hydrated active state to the dehydrated tun state, underlining the structural stress associated with entering anhydrobiosis. Survival experiments with pharmacological inhibitors of mitochondrial energy production and muscle contractions show that i) mitochondrial energy production is a prerequisite for surviving desiccation, ii) uncoupling the mitochondria abolishes tun formation, and iii) inhibiting the musculature impairs the ability to form viable tuns. We moreover provide a comparative analysis of the structural changes involved in tun formation, using a combination of cytochemistry, confocal laser scanning microscopy and 3D reconstructions as well as scanning electron microscopy. Our data reveal that the musculature mediates a structural reorganization vital for anhydrobiotic survival, and furthermore that maintaining structural integrity is essential for resumption of life following rehydration.	[Halberg, Kenneth Agerlin; Jorgensen, Aslak; Mobjerg, Nadja] Univ Copenhagen, August Krogh Ctr, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Mobjerg, N (corresponding author), Univ Copenhagen, August Krogh Ctr, Dept Biol, Copenhagen, Denmark.	nmobjerg@bio.ku.dk	Møbjerg, Nadja/AAT-4788-2021; Møbjerg, Nadja/M-2646-2014	Møbjerg, Nadja/0000-0002-5845-9047; Møbjerg, Nadja/0000-0002-5845-9047; Halberg, Kenneth/0000-0002-5903-7196; Jorgensen, Aslak/0000-0001-7191-3796	Carlsberg Foundation; Freja-Programme at Faculty of Science, University of Copenhagen	Carlsberg Foundation(Carlsberg Foundation); Freja-Programme at Faculty of Science, University of Copenhagen	The study was funded by the Carlsberg Foundation (www.carlsbergfondet.dk/) and the Freja-Programme at Faculty of Science, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; CROWE JH, 1974, T AM MICROSC SOC, V93, P513, DOI 10.2307/3225155; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Goldstein B, 2002, CURR BIOL, V12, pR475, DOI 10.1016/S0960-9822(02)00959-4; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Halberg KA, 2013, J EXP BIOL, V216, P1235, DOI 10.1242/jeb.075531; Halberg KA, 2012, J EXP BIOL, V215, P497, DOI 10.1242/jeb.065987; Halberg KA, 2009, J EXP BIOL, V212, P2803, DOI 10.1242/jeb.029413; Halberg KA, 2009, J MORPHOL, V270, P996, DOI 10.1002/jmor.10734; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jorgensen A, 2007, J LIMNOL, V66, P77, DOI 10.4081/jlimnol.2007.s1.77; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Mobjerg N, 2007, J LIMNOL, V66, P132, DOI 10.4081/jlimnol.2007.s1.132; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Persson DK, 2012, J MORPHOL, V273, P1227, DOI 10.1002/jmor.20054; Ramazzotti G., 1983, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V41, P1; Reuner A, 2010, CELL STRESS CHAPERON, V15, P423, DOI 10.1007/s12192-009-0158-1; Ricci C, 2003, J MORPHOL, V257, P246, DOI 10.1002/jmor.10120; Ricci C, 2008, J MORPHOL, V269, P233, DOI 10.1002/jmor.10579; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Schmidt-Rhaesa A, 2007, ZOOMORPHOLOGY, V126, P265, DOI 10.1007/s00435-007-0046-0; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2002, J EXP BIOL, V205, P2799; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; WHARTON DA, 1985, TISSUE CELL, V17, P79, DOI 10.1016/0040-8166(85)90017-5; WRIGHT JC, 1989, TISSUE CELL, V21, P263, DOI 10.1016/0040-8166(89)90071-2; WRIGHT JC, 1989, J EXP BIOL, V142, P267	37	40	40	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85091	10.1371/journal.pone.0085091	http://dx.doi.org/10.1371/journal.pone.0085091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391987	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900130
J	Timucin, E; Sezerman, OU				Timucin, Emel; Sezerman, O. Ugur			The Conserved Lid Tryptophan, W211, Potentiates Thermostability and Thermoactivity in Bacterial Thermoalkalophilic Lipases	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS L1; MOLECULAR-DYNAMICS SIMULATIONS; HUMICOLA-LANUGINOSA LIPASE; THERMAL-STABILITY; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; EXTREME THERMOPHILE; LIGHT-SCATTERING; FORCE-FIELD; AGGREGATION	We hypothesize that aggregation of thermoalkalophilic lipases could be a thermostability mechanism. The conserved tryptophans (W211, W234) in the lid are of particular interest owing to their previous involvements in aggregation and thermostability mechanisms in many other proteins. The thermoalkalophilic lipase from Bacillus thermocatenulatus (BTL2) and its mutants (W211A, W234A) were expressed and purified to homogeneity. We found that, when aggregated, BTL2 is more thermostable than its non-aggregating form, showing that aggregation potentiates thermostability in the thermoalkalophilic lipase. Among the two lid mutants, the W211A lowered aggregation tendency drastically and resulted in a much less thermostable variant of BTL2, which indicated that W211 stabilizes the intermolecular interactions in BTL2 aggregates. Further thermoactivity and CD spectroscopy analyses showed that W211A also led to a strong decrease in the optimal and the melting temperature of BTL2, implying stabilization by W211 also to the intramolecular interactions. The other lid mutant W234A had no effects on these properties. Finally, we analyzed the molecular basis of these experimental findings in-silico using the dimer (PDB ID: 1KU0) and the monomer (PDB ID: 2W22) lipase structures. The computational analyses confirmed that W211 stabilized the intermolecular interactions in the dimer lipase and it is critical to the stability of the monomer lipase. Explicitly W211 confers stability to the dimer and the monomer lipase through distinct aromatic interactions with Y273-Y282 and H87-P232 respectively. The insights revealed by this work shed light not only on the mechanism of thermostability and its relation to aggregation but also on the particular role of the conserved lid tryptophan in the thermoalkalophilic lipases.	[Timucin, Emel; Sezerman, O. Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Timucin, E (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	emeld@sabanciuniv.edu	Timucin, Emel/N-7446-2017; Timucin, Emel/AHE-5258-2022; SEZERMAN, OSMAN U/X-6441-2018	Timucin, Emel/0000-0003-0048-0668; Timucin, Emel/0000-0003-0048-0668; Sezerman, Osman Ugur/0000-0003-0905-6783	State Planning Organization of Turkey [EACF-06-00422]	State Planning Organization of Turkey(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This work was supported by the State Planning Organization of Turkey [EACF-06-00422]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott MA, 2000, J MOL BIOL, V304, P657, DOI 10.1006/jmbi.2000.4240; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Attanasio F, 2013, CHEMBIOCHEM, V14, P583, DOI 10.1002/cbic.201200704; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; Carrasco-Lopez C, 2009, J BIOL CHEM, V284, P4365, DOI 10.1074/jbc.M808268200; Castro-Ochoa LD, 2005, ENZYME MICROB TECH, V37, P648, DOI 10.1016/j.enzmictec.2005.06.003; Cecchini P, 2012, PROTEIN ENG DES SEL, V25, P199, DOI 10.1093/protein/gzs005; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Cho AR, 2000, FEMS MICROBIOL LETT, V186, P235, DOI 10.1016/S0378-1097(00)00150-6; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Cygler M, 1997, METHOD ENZYMOL, V284, P3; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; DEREWENDA U, 1994, J LIPID RES, V35, P524; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; DUNHAUPT A, 1992, BIOTECHNOL LETT, V14, P953, DOI 10.1007/BF01020636; Durmaz E, 2013, PROTEIN ENG DES SEL, V26, P325, DOI 10.1093/protein/gzt004; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Hayakawa IK J, 1992, J FOOD SCI, V57; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jeong ST, 2002, J BIOL CHEM, V277, P17041, DOI 10.1074/jbc.M200640200; Jeong ST, 2001, ACTA CRYSTALLOGR D, V57, P1300, DOI 10.1107/S0907444901010332; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Kayser V, 2011, MABS-AUSTIN, V3, P408, DOI 10.4161/mabs.3.4.15677; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Kumari A, 2012, BIOTECHNOL LETT, V34, P1733, DOI 10.1007/s10529-012-0958-8; Littlechild JA, 2007, BIOCHEM SOC T, V35, P1558, DOI 10.1042/BST0351558; Lookene A, 1997, J BIOL CHEM, V272, P766, DOI 10.1074/jbc.272.2.766; Lorber B, 2012, BIOCHEM MOL BIOL EDU, V40, P372, DOI 10.1002/bmb.20644; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maithal K, 2002, PROTEIN ENG, V15, P575, DOI 10.1093/protein/15.7.575; Martinelle M, 1996, PROTEIN ENG, V9, P519, DOI 10.1093/protein/9.6.519; Matsumura H, 2008, PROTEINS, V70, P592, DOI 10.1002/prot.21799; MERKLER DJ, 1988, BIOCHIM BIOPHYS ACTA, V952, P101, DOI 10.1016/0167-4838(88)90106-9; Pedersen S, 2006, BIOPOLYMERS, V83, P619, DOI 10.1002/bip.20598; Peters GH, 1996, BIOPHYS J, V71, P119, DOI 10.1016/S0006-3495(96)79207-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quyen DT, 2003, PROTEIN EXPRES PURIF, V28, P102, DOI 10.1016/S1046-5928(02)00679-4; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Robb FT, 2008, THERMOPHILES BIOL TE, pxiii; Rua ML, 1997, J BIOTECHNOL, V56, P89, DOI 10.1016/S0168-1656(97)00079-5; Ruslan R, 2012, INT J MOL SCI, V13, P943, DOI 10.3390/ijms13010943; Salameh Moh'd A, 2010, Open Biochem J, V4, P22, DOI 10.2174/1874091X01004010022; Schlieben NH, 2004, PROTEIN EXPRES PURIF, V34, P103, DOI 10.1016/j.pep.2003.11.014; Schmid RD, 1998, ANGEW CHEM INT EDIT, V37, P1609; SCHMIDTDANNERT C, 1994, BBA-LIPID LIPID MET, V1214, P43, DOI 10.1016/0005-2760(94)90008-6; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; TAKAGI H, 1990, J BIOL CHEM, V265, P6874; TANAKA S, 2005, BMC BIOCH, V6, DOI DOI 10.1186/1471-2091-6-1; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tyndall JDA, 2002, J MOL BIOL, V323, P859, DOI 10.1016/S0022-2836(02)01004-5; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Zhu K, 2001, BBA-PROTEIN STRUCT M, V1547, P329, DOI 10.1016/S0167-4838(01)00198-4	62	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85186	10.1371/journal.pone.0085186	http://dx.doi.org/10.1371/journal.pone.0085186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391996	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900139
J	Zhu, QH; Fan, LJ; Liu, Y; Xu, H; Llewellyn, D; Wilson, I				Zhu, Qian-Hao; Fan, Longjiang; Liu, Yang; Xu, Hao; Llewellyn, Danny; Wilson, Iain			miR482 Regulation of NBS-LRR Defense Genes during Fungal Pathogen Infection in Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; GENOME-WIDE ANALYSIS; SMALL RNAS; FIBER DEVELOPMENT; SIRNA BIOGENESIS; STRESS RESPONSES; MICRORNAS; RESISTANCE; MIRNA; ARABIDOPSIS	In this study, we characterized the miR482 family in cotton using existing small RNA datasets and the recently released draft genome sequence of Gossypium raimondii, a diploid cotton species whose progenitor is the putative contributor of the Dt (representing the D genome of tetraploid) genome of the cultivated tetraploid cotton species G. hirsutum and G. barbadense. Of the three ghr-miR482 members reported in G. hirsutum, ghr-miR482a has no homolog in G. raimondii, ghrmiR482b and ghr-miR482c each has a single homolog in G. raimondii. Gra-miR482d has five homologous loci (gra-miR482d, f-i) in G. raimondii and also exists in G. hirsutum (ghr-miR482d). A variant, miR482.2 that is a homolog of miR2118 in other species, is produced from several GHR-MIR482 loci in G. hirsutum. Approximately 12% of the G. raimondii NBS-LRR genes were predicted targets of various members of the gra-miR482 family. Based on the rationale that the regulatory relationship between miR482 and NBS-LRR genes will be conserved in G. raimondii and G. hirsutum, we investigated this relationship using G. hirsutum miR482 and G. raimondii NBS-LRR genes, which are not currently available in G. hirsutum. Ghr-miR482/miR482.2-mediated cleavage was confirmed for three of the four NBS-LRR genes analysed. As in tomato, miR482-mediated cleavage of NBS-LRR genes triggered production of phased secondary small RNAs in cotton. In seedlings of the susceptible cultivar Sicot71 (G. hirsutum) infected with the fungal pathogen Verticillium dahliae, the expression levels of ghr-miR482b/miR482b. 2, ghr-miR482c and ghr-miR482d. 2 were down-regulated, and several NBS-LRR targets of ghr-miR482c and ghrmiR482d were up-regulated. These results imply that, like tomato plants infected with viruses or bacteria, cotton plants are able to induce expression of NBS-LRR defence genes by suppression of the miRNA-mediated gene silencing pathway upon fungal pathogen attack.	[Zhu, Qian-Hao; Llewellyn, Danny; Wilson, Iain] CSIRO Plant Ind, Canberra, ACT, Australia; [Fan, Longjiang; Liu, Yang; Xu, Hao] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zhejiang University	Zhu, QH (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	Qianhao.Zhu@csiro.au; Iain.Wilson@csiro.au	wei, jiang/GRX-7907-2022; Llewellyn, Danny J/D-5230-2009; Zhu, Qian-Hao/A-1298-2010; yang, liu/GVU-8760-2022; Wilson, Iain/D-4839-2009	Llewellyn, Danny J/0000-0001-9535-8707; Zhu, Qian-Hao/0000-0002-6505-7417; Wilson, Iain/0000-0002-4626-8059; Fan, Longjiang/0000-0003-4846-0500	Cotton Breeding Australia	Cotton Breeding Australia	This work was supported by Cotton Breeding Australia, a joint venture between CSIRO and Cotton Seed Distributors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar MT, 2011, EUPHYTICA, V178, P351, DOI 10.1007/s10681-010-0310-0; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai X, 2011, PLOS ONE, V39, pw155; Gao YL, 2006, SCI CHINA SER C, V49, P530, DOI 10.1007/s11427-006-2017-y; He LM, 2004, MOL PLANT MICROBE IN, V17, P1234, DOI 10.1094/MPMI.2004.17.11.1234; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liu Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25079; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	39	114	125	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84390	10.1371/journal.pone.0084390	http://dx.doi.org/10.1371/journal.pone.0084390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391949	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900092
J	Dumont, M; Stack, C; Elipenahli, C; Jainuddin, S; Launay, N; Gerges, M; Starkova, N; Starkov, AA; Calingasan, NY; Tampellini, D; Pujol, A; Beal, MF				Dumont, Magali; Stack, Cliona; Elipenahli, Ceyhan; Jainuddin, Shari; Launay, Nathalie; Gerges, Meri; Starkova, Natalia; Starkov, Anatoly A.; Calingasan, Noel Y.; Tampellini, Davide; Pujol, Aurora; Beal, M. Flint			PGC-1 alpha overexpression exacerbates beta-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						cell death; mitochondria; behavior; Tg19959 mice	GAMMA COACTIVATOR 1-ALPHA; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; NEURODEGENERATIVE DISORDERS; TRANSCRIPTIONAL COACTIVATOR; PARKINSONS-DISEASE; MUSCLE ATROPHY; A-BETA; EXPRESSION	The peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) interacts with various transcription factors involved in energy metabolism and in the regulation of mitochondrial biogenesis. PGC-1 alpha mRNA levels are reduced in a number of neurodegenerative diseases and contribute to disease pathogenesis, since increased levels ameliorate behavioral defects and neuropathology of Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. PGC-1 alpha and its downstream targets are reduced both in postmortem brain tissue of patients with Alzheimer's disease (AD) and in transgenic mouse models of AD. Therefore, we investigated whether increased expression of PGC-1 alpha would exert beneficial effects in the Tg19959 transgenic mouse model of AD; Tg19959 mice express the human amyloid precursor gene (APP) with 2 familial AD mutations and develop increased beta-amyloid levels, plaque deposition, and memory deficits by 2-3 mo of age. Rather than an improvement, the cross of the Tg19959 mice with mice overexpressing human PGC-1 alpha exacerbated amyloid and tau accumulation. This was accompanied by an impairment of proteasome activity. PGC-1 alpha overexpression induced mitochondrial abnormalities, neuronal cell death, and an exacerbation of behavioral hyperactivity in the Tg19959 mice. These findings show that PGC-1 alpha overexpression exacerbates the neuropathological and behavioral deficits that occur in transgenic mice with mutations in APP that are associated with human AD.-Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Launay, N., Gerges, M., Starkova, N., Starkov, A. A., Calingasan, N. Y., Tampellini, D., Pujol, A., Beal, M. F. PGC-1 alpha overexpression exacerbates beta-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.	[Dumont, Magali; Stack, Cliona; Elipenahli, Ceyhan; Jainuddin, Shari; Gerges, Meri; Starkova, Natalia; Starkov, Anatoly A.; Calingasan, Noel Y.; Beal, M. Flint] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Launay, Nathalie; Pujol, Aurora] Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Inst Neuropathol, Neurometabol Dis Lab, Barcelona, Spain; [Launay, Nathalie; Pujol, Aurora] ISCIII, Ctr Biomed Res Rare Dis CIBERER, U579, Valencia, Spain; [Tampellini, Davide] Univ Paris Sud, Hosp Kremlin Bicetre, INSERM, UMR 788, F-94275 Le Kremlin Bicetre, France; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Cornell University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; ICREA	Dumont, M (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, 525 East 68th St,Rm A569A, New York, NY 10065 USA.	mad2138@med.cornell.edu	Pujol, Aurora/N-4990-2014; Starkov, Anatoly/B-2688-2012; Launay, Nathalie/G-1387-2016	Pujol, Aurora/0000-0002-9606-0600; Starkov, Anatoly/0000-0002-1334-4828; Tampellini, Davide/0000-0003-3188-0293; Launay, Nathalie/0000-0002-7498-217X; DUMONT, MAGALI/0000-0001-9990-6512	U.S. National Institutes of Health (NIH) [5P01 (AG14930)]; Spanish National Institute of Health Carlos III [FIS PI11/01043]; Catalan Government Group of Excellence [2009SGR85]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), an initiative of Instituto de Salud Carlos III (ISCIII); NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish National Institute of Health Carlos III(Instituto de Salud Carlos III); Catalan Government Group of Excellence; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), an initiative of Instituto de Salud Carlos III (ISCIII); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ICREA(ICREA)	This work was supported by the U.S. National Institutes of Health (NIH), grant 5P01 (AG14930). The work performed at the Neurometabolic Diseases Laboratory was carried out thanks to grants from the Spanish National Institute of Health Carlos III (FIS PI11/01043) and the Catalan Government Group of Excellence (2009SGR85) to A.P. N.L. holds a postdoctoral fellowship from Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), an initiative of Instituto de Salud Carlos III (ISCIII). The authors thank Peter Davies (Albert Einstein College of Medicine, New York, NY, USA), Rakez Kayed (University of Texas Medical Branch, Galveston, TX, USA), and Wenjie Luo (Weill Cornell Medical College, New York, NY, USA) for providing the tau (CP13 and DA9), amyloid (OC), and PS1 antibodies, respectively. The authors declare no conflicts of interest.	ARRIGONI O, 1962, NATURE, V193, P1256, DOI 10.1038/1931256a0; Beal MF, 2009, PARKINSONISM RELAT D, V15, pS189, DOI 10.1016/S1353-8020(09)70812-0; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Dumont M., NEUROCHEM INT, V56, P345; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541; Katsouri L, 2011, J ALZHEIMERS DIS, V25, P151, DOI 10.3233/JAD-2011-101356; Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Launay N, 2013, BRAIN, V136, P891, DOI 10.1093/brain/aws370; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Ren QG, 2007, FEBS LETT, V581, P1521, DOI 10.1016/j.febslet.2007.02.065; Rona-Voros K, 2010, CURR DRUG TARGETS, V11, P1262, DOI 10.2174/1389450111007011262; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsunemi T., SCI TRANSL MED, V4; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	61	34	34	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1745	1755		10.1096/fj.13-236331	http://dx.doi.org/10.1096/fj.13-236331			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24398293	Green Published			2022-12-25	WOS:000335344300021
J	Koorella, C; Nair, JR; Murray, ME; Carlson, LM; Watkins, SK; Lee, KP				Koorella, Chandana; Nair, Jayakumar R.; Murray, Megan E.; Carlson, Louise M.; Watkins, Stephanie K.; Lee, Kelvin P.			Novel Regulation of CD80/CD86-induced Phosphatidylinositol 3-Kinase Signaling by NOTCH1 Protein in Interleukin-6 and Indoleamine 2,3-Dioxygenase Production by Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cells; Interleukin; NOTCH Pathway; PI 3-Kinase (PI3K); Signal Transduction; Indoleamine 2; 3-Dioxygenase	NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; MALIGNANT PLASMA-CELLS; TRANSCRIPTION FACTOR; TRYPTOPHAN CATABOLISM; DEPENDENT PATHWAY; STROMAL CELLS; CD28 FUNCTION; IN-VITRO; PTEN	Background: Engagement of CD80/CD86 on dendritic cells by CD28 on T cells induces dendritic cell production of IL-6 and IDO. Results: The NOTCH pathway modulates activation of the PI3K pathway downstream of CD80/CD86 ligation and regulates IL-6 and IDO production. Conclusion: Cross-talk between NOTCH and PI3K pathways modulates dendritic cell production of IL-6 and IDO. Significance: Elucidating the molecular mechanism of NOTCH-PI3K cross-talk will have broad implications in human disease. Dendritic cells (DC) play a critical role in modulating antigen-specific immune responses elicited by T cells via engagement of the prototypic T cell costimulatory receptor CD28 by the cognate ligands CD80/CD86, expressed on DC. Although CD28 signaling in T cell activation has been well characterized, it has only recently been shown that CD80/CD86, which have no demonstrated binding domains for signaling proteins in their cytoplasmic tails, nonetheless also transduce signals to the DC. Functionally, CD80/CD86 engagement results in DC production of the pro-inflammatory cytokine IL-6, which is necessary for full T cell activation. However, ligation of CD80/CD86 by CTLA4 also induces DC production of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), which depletes local pools of the essential amino acid tryptophan, resulting in blockade of T cell activation. Despite the significant role of CD80/CD86 in immunological processes and the seemingly opposing roles they play by producing IL-6 and IDO upon their activation, how CD80/CD86 signal remains poorly understood. We have now found that cross-linking CD80/CD86 in human DC activates the PI3K/AKT pathway. This results in phosphorylation/inactivation of its downstream target, FOXO3A, and alleviates FOXO3A-mediated suppression of IL-6 expression. A second event downstream of AKT phosphorylation is activation of the canonical NF-B pathway, which induces IL-6 expression. In addition to these downstream pathways, we unexpectedly found that CD80/CD86-induced PI3K signaling is regulated by previously unrecognized cross-talk with NOTCH1 signaling. This cross-talk is facilitated by NOTCH-mediated up-regulation of the expression of prolyl isomerase PIN1, which in turn increases enzyme activity of casein kinase II. Subsequently, phosphatase and tensin homolog (which suppresses PI3K activity) is inactivated via phosphorylation by casein kinase II. This results in full activation of PI3K signaling upon cross-linking CD80/CD86. Similar to IL-6, we have found that CD80/CD86-induced IDO production by DC at late time points is also dependent upon the PI3K AKT NF-B pathway and requires cross-talk with NOTCH signaling. These data further suggest that the same signaling pathways downstream of DC CD80/CD86 cross-linking induce early IL-6 production to enhance T cell activation, followed by later IDO production to self-limit this activation. In addition to characterizing the pathways downstream of CD80/CD86 in IL-6 and IDO production, identification of a novel cross-talk between NOTCH1 and PI3K signaling may provide new insights in other biological processes where PI3K signaling plays a major role.	[Koorella, Chandana; Nair, Jayakumar R.; Murray, Megan E.; Carlson, Louise M.; Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Watkins, Stephanie K.] NCI, Natl Inst Hlth, Frederick, MD 21702 USA	Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, KP (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	Kelvin.Lee@roswellpark.org	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [R01 CA140622, R01 CA121044, R01 AI10015, T32 CA085183]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [T32CA085183, R01CA140622, R01CA121044, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100157, F32AI010015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA140622, R01 CA121044, R01 AI10015, and T32 CA085183. This work was also supported by the Multiple Myeloma Research Foundation.	Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Bahlis NJ, 2007, BLOOD, V109, P5002, DOI 10.1182/blood-2006-03-012542; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cejas PJ, 2005, J BIOL CHEM, V280, P28412, DOI 10.1074/jbc.M500345200; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Han EKH, 2008, ANTICANCER RES, V28, P957; HOLSTI MA, 1994, J IMMUNOL, V152, P1618; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kim KY, 2004, J PHARMACOL EXP THER, V308, P97, DOI 10.1124/jpet.103.058768; Kin NW, 2006, J IMMUNOL, V176, P6727, DOI 10.4049/jimmunol.176.11.6727; LANIER LL, 1995, J IMMUNOL, V154, P97; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Lu LN, 1996, J IMMUNOL, V157, P3577; Lucas CR, 2013, J IMMUNOL, V190, P723, DOI 10.4049/jimmunol.1201646; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Nair JR, 2011, J IMMUNOL, V187, P1243, DOI 10.4049/jimmunol.1100016; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Paolucci C, 2003, J LEUKOCYTE BIOL, V73, P253, DOI 10.1189/jlb.0902447; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; UCHIYAMA H, 1993, BLOOD, V82, P3712; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	51	54	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7747	7762		10.1074/jbc.M113.519686	http://dx.doi.org/10.1074/jbc.M113.519686			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24415757	Green Published, hybrid			2022-12-25	WOS:000332761500042
J	Prosdocimo, DA; Anand, P; Liao, XD; Zhu, H; Shelkay, S; Artero-Calderon, P; Zhang, LL; Kirsh, J; Moore, D; Rosca, MG; Vazquez, E; Kerner, J; Akat, KM; Williams, Z; Zhao, JH; Fujioka, H; Tuschl, T; Bai, XD; Schulze, PC; Hoppel, CL; Jain, MK; Haldar, SM				Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Moore, D'Vesharronne; Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Akat, Kemal M.; Williams, Zev; Zhao, Jihe; Fujioka, Hisashi; Tuschl, Thomas; Bai, Xiaodong; Schulze, P. Christian; Hoppel, Charles L.; Jain, Mukesh K.; Haldar, Saptarsi M.			Kruppel-like Factor 15 Is a Critical Regulator of Cardiac Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Metabolism; Cardiovascular; Kruppel-like Factor (KLF); Lipid Metabolism; Transcription Factors	FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; HISTONE ACETYLTRANSFERASE ACTIVITY; GENE-EXPRESSION; TRANSPORT PROTEIN-1; INSULIN-RESISTANCE; ACTIVATION DOMAIN; FAILING HEART; PPAR-ALPHA; RECEPTOR	Background: Metabolic homeostasis is central to normal cardiac function. The molecular mechanisms underlying metabolic plasticity in the heart remain poorly understood. Results: Kruppel-like factor 15 (KLF15) is a direct and independent regulator of myocardial lipid flux. Conclusion: KLF15 is a core component of the transcriptional circuitry that governs cardiac metabolism. Significance: This work is the first to implicate the KLF transcription factor family in cardiac metabolism. The mammalian heart, the body's largest energy consumer, has evolved robust mechanisms to tightly couple fuel supply with energy demand across a wide range of physiologic and pathophysiologic states, yet, when compared with other organs, relatively little is known about the molecular machinery that directly governs metabolic plasticity in the heart. Although previous studies have defined Kruppel-like factor 15 (KLF15) as a transcriptional repressor of pathologic cardiac hypertrophy, a direct role for the KLF family in cardiac metabolism has not been previously established. We show in human heart samples that KLF15 is induced after birth and reduced in heart failure, a myocardial expression pattern that parallels reliance on lipid oxidation. Isolated working heart studies and unbiased transcriptomic profiling in Klf15-deficient hearts demonstrate that KLF15 is an essential regulator of lipid flux and metabolic homeostasis in the adult myocardium. An important mechanism by which KLF15 regulates its direct transcriptional targets is via interaction with p300 and recruitment of this critical co-activator to promoters. This study establishes KLF15 as a key regulator of myocardial lipid utilization and is the first to implicate the KLF transcription factor family in cardiac metabolism.	[Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Jain, Mukesh K.; Haldar, Saptarsi M.] Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Hoppel, Charles L.; Jain, Mukesh K.; Haldar, Saptarsi M.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Fujioka, Hisashi; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Fujioka, Hisashi; Hoppel, Charles L.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Akat, Kemal M.; Williams, Zev; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Moore, D'Vesharronne; Schulze, P. Christian] Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10032 USA; [Williams, Zev] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Program Early & Recurrent Pregnancy Loss, New York, NY 10461 USA; [Bai, Xiaodong] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; State University System of Florida; University of Central Florida; Howard Hughes Medical Institute; Rockefeller University; Columbia University; Yeshiva University; Case Western Reserve University	Jain, MK (corresponding author), Case Cardiovasc Res Inst, 2103 Cornell Rd,Rm 4-522, Cleveland, OH 44106 USA.	mukesh.jain2@case.edu; saptarsi.haldar@case.edu	Rosca, Mariana/ABH-7847-2020; Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Zhu, Han/0000-0002-2751-7814; Rosca, Mariana/0000-0003-3605-9787	National Institutes of Health [T32HL105338, F32HL110538, HL086614, DK093821, HL072952, HL084154, CA043703, HL074237, HL095742, HL101272, CA132977, UL1RR024143]; American Heart Association [12SDG12070077]; Hartwell Foundation; German Research Foundation [AK137/1-1]; Genome and Transcriptome Sequencing Core at Case Western Reserve University; Visconsi Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA132977] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072952, K08HL086614, P01HL074237, K23HL095742, R01HL119195, P30HL101272, R01HL084154, T32HL105338, R01HL112486, F32HL110538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hartwell Foundation; German Research Foundation(German Research Foundation (DFG)); Genome and Transcriptome Sequencing Core at Case Western Reserve University; Visconsi Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32HL105338 and F32HL110538 (to D. A. P.), HL086614 and DK093821 (to S. M. H.), HL072952 and HL084154 (to M. K. J.), CA043703 and HL074237 (to C. L. H.), HL095742 and HL101272 (to P. C. S.), CA132977 (to J. Z.), and UL1RR024143 (National Center for Research Resources) (to K. M. A. and T. T.). This work was also supported by American Heart Association Grant 12SDG12070077 (to X. L.), the Hartwell Foundation (to S. M. H.), German Research Foundation Fellowship Grant AK137/1-1 (to K. M. A.), the Genome and Transcriptome Sequencing Core at Case Western Reserve University (to X. B.), and the Visconsi Research Scholar Fund (to S. M. H.).	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Barth AS, 2009, CIRC-CARDIOVASC GENE, V2, P371, DOI 10.1161/CIRCGENETICS.108.832345; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ingwall JS, 2009, CIRC-HEART FAIL, V2, P275, DOI 10.1161/CIRCHEARTFAILURE.109.885301; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mallipattu SK, 2012, J BIOL CHEM, V287, P19122, DOI 10.1074/jbc.M112.345983; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Masuno K, 2011, AM J RESP CELL MOL, V45, P642, DOI 10.1165/rcmb.2010-0369OC; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Randle P J, 1978, Biochem Soc Symp, P47; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Teshigawara K, 2005, BIOCHEM BIOPH RES CO, V327, P920, DOI 10.1016/j.bbrc.2004.12.096; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Zhang J, 2011, J MOL BIOL, V411, P537, DOI 10.1016/j.jmb.2011.06.011; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	59	84	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5914	5924		10.1074/jbc.M113.531384	http://dx.doi.org/10.1074/jbc.M113.531384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407292	Green Published, hybrid			2022-12-25	WOS:000332015500048
J	Bakele, M; Joos, M; Burdi, S; Allgaier, N; Poschel, S; Fehrenbacher, B; Schaller, M; Marcos, V; Kummerle-Deschner, J; Rieber, N; Borregaard, N; Yazdi, A; Hector, A; Hartl, D				Bakele, Martina; Joos, Melanie; Burdi, Sofia; Allgaier, Nicolas; Poeschel, Simone; Fehrenbacher, Birgit; Schaller, Martin; Marcos, Veronica; Kuemmerle-Deschner, Jasmin; Rieber, Nikolaus; Borregaard, Niels; Yazdi, Amir; Hector, Andreas; Hartl, Dominik			Localization and Functionality of the Inflammasome in Neutrophils*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; Innate Immunity; Pathogen-associated Molecular Pattern (PAMP); Toll-like Receptor (TLR); Immunity; Neutrophils	SECRETORY VESICLES; ACTIVE IL-1-BETA; SERINE PROTEASES; GENERATION; INTERLEUKIN-1-BETA; ACTIVATION; GRANULES; CLEAVAGE; IMMUNITY; IL-1-SS	Background: The inflammasome generates IL-1 family proteins, but its role in neutrophils is poorly understood. Results: Neutrophils store key inflammasome components in distinct intracellular compartments and release IL-1 and IL-18, but not IL-1 or IL-33. Conclusion: Neutrophils store inflammasome components in intracellular compartments. Significance: Targeting the inflammasome in neutrophils represents a future anti-inflammatory strategy. Neutrophils represent the major fraction of circulating immune cells and are rapidly recruited to sites of infection and inflammation. The inflammasome is a multiprotein complex that regulates the generation of IL-1 family proteins. The precise subcellular localization and functionality of the inflammasome in human neutrophils are poorly defined. Here we demonstrate that highly purified human neutrophils express key components of the NOD-like receptor family, pyrin domain containing 3 (NLRP3), and absent in melanoma 2 (AIM2) inflammasomes, particularly apoptosis-associated speck-like protein containing a CARD (ASC), AIM2, and caspase-1. Subcellular fractionation and microscopic analyses further showed that inflammasome components were localized in the cytoplasm and also noncanonically in secretory vesicle and tertiary granule compartments. Whereas IL-1 and IL-18 were expressed at the mRNA level and released as protein, highly purified neutrophils neither expressed nor released IL-1 at baseline or upon stimulation. Upon inflammasome activation, highly purified neutrophils released substantially lower levels of IL-1 protein compared with partially purified neutrophils. Serine proteases and caspases were differentially involved in IL-1 release, depending on the stimulus. Spontaneous activation of the NLRP3 inflammasome in neutrophils in vivo affected IL-1, but not IL-18 release. In summary, these studies show that human neutrophils express key components of the inflammasome machinery in distinct intracellular compartments and release IL-1 and IL-18, but not IL-1 or IL-33 protein. Targeting the neutrophil inflammasome may represent a future therapeutic strategy to modulate neutrophilic inflammatory diseases, such as cystic fibrosis, rheumatoid arthritis, or sepsis.	[Bakele, Martina; Joos, Melanie; Burdi, Sofia; Allgaier, Nicolas; Poeschel, Simone; Kuemmerle-Deschner, Jasmin; Rieber, Nikolaus; Hector, Andreas; Hartl, Dominik] Univ Tubingen, Dept Pediat, D-72076 Tubingen, Germany; [Fehrenbacher, Birgit; Schaller, Martin; Yazdi, Amir] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Marcos, Veronica] Univ Munich, Dept Pediat, D-80539 Munich, Germany; [Borregaard, Niels] Natl Univ Hosp, Granulocyte Res Lab, Dept Hematol, Finsen Ctr, DK-2100 Copenhagen, Denmark	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Hartl, D (corresponding author), Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany.	dominik.hartl@med.uni-tuebingen.de		Hector, Andreas/0000-0002-5745-4746	German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme [HA 5274/3-1]; Fritz-Thyssen-Foundation; German Society of Pediatric Pneumology; PINA e. V.; Novartis Foundation;  [CRC/SFB685]	German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme(German Research Foundation (DFG)); Fritz-Thyssen-Foundation; German Society of Pediatric Pneumology; PINA e. V.; Novartis Foundation(Novartis); 	This work was supported by the German Research Foundation Deutsche Forschungsgemeinschaft Emmy Noether Programme HA 5274/3-1 to D. H.), the Fritz-Thyssen-Foundation (to A. H. and D. H.) the CRC/SFB685 at Tubingen, the German Society of Pediatric Pneumology (to D. H. and V. M.), PINA e. V. (to D. H.), and the Novartis Foundation (to D. H.).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Basran A, 2013, J LEUKOCYTE BIOL, V93, P7, DOI 10.1189/jlb.0512250; Berger M, 2012, J BIOL CHEM, V287, P19409, DOI 10.1074/jbc.M112.353557; BLACK RA, 1988, J BIOL CHEM, V263, P9437; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Dahlgren C, 2001, J LEUKOCYTE BIOL, V69, P57; Gross O, 2012, METHODS MOL BIOL, V844, P199, DOI 10.1007/978-1-61779-527-5_15; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; KJELDSEN L, 1993, BLOOD, V82, P3183; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kono H, 2012, J IMMUNOL, V189, P3734, DOI 10.4049/jimmunol.1200136; Kuemmerle-Deschner JB, 2011, ARTHRITIS RHEUM-US, V63, P840, DOI 10.1002/art.30149; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Mollinedo F, 1999, IMMUNOL TODAY, V20, P535, DOI 10.1016/S0167-5699(99)01500-5; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Parker Lisa C., 2009, V517, P191, DOI 10.1007/978-1-59745-541-1_12; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Tamassia N, 2012, EUR J IMMUNOL, V42, P565, DOI 10.1002/eji.201242399; Udby Lene, 2007, V412, P35, DOI 10.1007/978-1-59745-467-4_4	41	101	103	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5320	5329		10.1074/jbc.M113.505636	http://dx.doi.org/10.1074/jbc.M113.505636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398679	Green Published, hybrid			2022-12-25	WOS:000331607900072
J	Liu, X; Huang, Y; Yang, DH; Li, XH; Liang, JK; Lin, L; Zhang, M; Zhong, KB; Liang, B; Li, JL				Liu, Xiao; Huang, Yu; Yang, Dinghua; Li, Xianghong; Liang, Jiankun; Lin, Liang; Zhang, Meng; Zhong, Kebo; Liang, Bo; Li, Jialu			Overexpression of TRIM24 Is Associated with the Onset and Progress of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							ACTIVATION FUNCTION AF-2; CYCLIN D1; TIF1 ALPHA; TRANSCRIPTION; TIF1-ALPHA; EPITHELIA; RECEPTORS; MEDIATOR; PROTEIN; CANCER	The survival and colonization of tumor cells at new locations involve a variety of complex genetic, epigenetic, and microenvironmental factors. TRIM24 was originally named transcription intermediary factor 1-alpha (TIF1a), which was associated with cellular proliferation and was an oncogene in tumor development. Here we provide the first evidence of the expression profile and clinicopathological significance of TRIM24 in patients with hepatocellular carcinoma (HCC). Immunohistochemistry was employed to determine the expression level of TRIM24 in HCC tissues and noncancerous liver tissues. Elevated TRIM24 level was found in 61.4% HCC samples (51/83) correlating with AFP (P = 0.036), poor differentiation (P = 0.004), intrahepatic metastasis (P = 0.004), recurrence (P = 0.000006), and shorter tumor-free survival time (P = 0.002). Small interfering RNA induced down-regulation of TRIM24 promoted apoptosis in HCC cell line HepG2. Moreover, western blotting analysis revealed that knockdown of TRIM24 increased the protein levels of p53, Bax, and Caspase-8, and decreased Bcl-2, Survivin, Cyclin D1, and CDK4. Depletion of TRIM24 decreased Snail, Slug, b-catenin, and Vimentin, and increased Ecadherin expression, which suggested the involvement of TRIM24 in EMT. These results indicated that TRIM24 plays an important role in the pathogenesis of human HCC.	[Liu, Xiao; Huang, Yu; Yang, Dinghua; Li, Xianghong; Liang, Jiankun; Lin, Liang; Zhang, Meng; Zhong, Kebo; Liang, Bo; Li, Jialu] Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Yang, DH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	dhyang5810@yahoo.com	li, jia/GVT-7587-2022		Guangdong Natural Science Foundation [10151051501000120]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by Guangdong Natural Science Foundation, NUM: 10151051501000120 (URL:http://gdsf.gdstc.gov.cn/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Belloni E, 2005, GENE CHROMOSOME CANC, V42, P320, DOI 10.1002/gcc.20144; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Khetchoumian K, 2008, CELL CYCLE, V7, P3647, DOI 10.4161/cc.7.23.7123; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Le Douarin B, 1998, J STEROID BIOCHEM, V65, P43, DOI 10.1016/S0960-0760(97)00175-1; LeDouarin B, 1997, BIOCHEM SOC T, V25, P605, DOI 10.1042/bst0250605; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Mann CD, 2007, EUR J CANCER, V43, P979, DOI 10.1016/j.ejca.2007.01.004; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; Ratschiller D, 2003, J CLIN ONCOL, V21, P2085, DOI 10.1200/JCO.2003.03.103; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zimmerman MA, 2008, ARCH SURG-CHICAGO, V143, P182, DOI 10.1001/archsurg.2007.39	27	42	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85462	10.1371/journal.pone.0085462	http://dx.doi.org/10.1371/journal.pone.0085462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409330	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500054
J	Zhang, ZL; Nix, CA; Ercan, UK; Gerstenhaber, JA; Joshi, SG; Zhong, YH				Zhang, Zhiling; Nix, Camilla A.; Ercan, Utku K.; Gerstenhaber, Jonathan A.; Joshi, Suresh G.; Zhong, Yinghui			Calcium Binding-Mediated Sustained Release of Minocycline from Hydrophilic Multilayer Coatings Targeting Infection and Inflammation	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RESISTANT STAPHYLOCOCCUS-AUREUS; BIOMEDICAL APPLICATIONS; NITRIC-OXIDE; PH; BIOCOMPATIBILITY; TETRACYCLINES; ANTIBODIES; SURFACES; BIOFILMS	Infection and inflammation are common complications that seriously affect the functionality and longevity of implanted medical implants. Systemic administration of antibiotics and anti-inflammatory drugs often cannot achieve sufficient local concentration to be effective, and elicits serious side effects. Local delivery of therapeutics from drug-eluting coatings presents a promising solution. However, hydrophobic and thick coatings are commonly used to ensure sufficient drug loading and sustained release, which may limit tissue integration and tissue device communications. A calcium-mediated drug delivery mechanism was developed and characterized in this study. This novel mechanism allows controlled, sustained release of minocycline, an effective antibiotic and anti-inflammatory drug, from nanoscale thin hydrophilic polyelectrolyte multilayers for over 35 days at physiologically relevant concentrations. pH-responsive minocycline release was observed as the chelation between minocycline and Ca2+ is less stable at acidic pH, enabling 'smart' drug delivery in response to infection and/or inflammation-induced tissue acidosis. The release kinetics of minocycline can be controlled by varying initial loading, Ca2+ concentration, and Ca2+ incorporation into different layers, enabling facile development of implant coatings with versatile release kinetics. This drug delivery platform can potentially be used for releasing any drug that has high Ca2+ binding affinity, enabling its use in a variety of biomedical applications.	[Zhang, Zhiling; Nix, Camilla A.; Ercan, Utku K.; Gerstenhaber, Jonathan A.; Zhong, Yinghui] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Joshi, Suresh G.] Drexel Univ, Coll Med, Surg Infect Program, Dept Surg, Philadelphia, PA 19104 USA; [Joshi, Suresh G.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	Zhong, YH (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	yz348@drexel.edu	Ercan, Utku Kürşat/A-1658-2012; Ercan, Utku Kursat/AAX-1924-2020; Joshi, Suresh G./AAT-1354-2021	Ercan, Utku Kürşat/0000-0002-9762-2265; Joshi, Suresh G./0000-0002-7838-4898; Gerstenhaber, Jonathan/0000-0002-8162-7977	Drexel University	Drexel University	This work was supported by the startup fund from Drexel University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Bernier C, 2001, ANN DERMATOL VENER, V128, P627; Bhatia S, 2010, STEREOT FUNCT NEUROS, V88, P147, DOI 10.1159/000303528; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Burke SE, 2004, MACROMOLECULES, V37, P5375, DOI 10.1021/ma049445o; Carlotti B, 2012, PHYS CHEM CHEM PHYS, V14, P823, DOI 10.1039/c1cp22703c; Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dejugnat C., 2006, FUNCTIONAL COATINGS, P67; Del Pace S, 2010, INTERN EMERG MED, V5, P121, DOI 10.1007/s11739-010-0350-4; Dunston CR, 2011, PROTEOMICS, V11, P42, DOI 10.1002/pmic.201000273; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057; Huster D, 1998, BIOPHYS J, V75, P909, DOI 10.1016/S0006-3495(98)77579-4; Jin LH, 2007, BIOPHYS CHEM, V128, P185, DOI 10.1016/j.bpc.2007.04.005; Johnson MD, 2007, J NEUROSCI METH, V160, P276, DOI 10.1016/j.jneumeth.2006.09.023; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; LIEDBERG H, 1989, SCAND J UROL NEPHROL, P2; Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Menkin V, 1937, AM J PATHOL, V13, P25; Nieman GF, 2001, CURR MED CHEM, V8, P317, DOI 10.2174/0929867013373570; Novak MT, 2010, ANAL BIOANAL CHEM, V398, P1695, DOI 10.1007/s00216-010-4097-6; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Page J, 2000, ARCH INTERN MED, V160, P777, DOI 10.1001/archinte.160.6.777; Pautke C, 2011, ORAL ONCOL, V47, P425, DOI 10.1016/j.oraloncology.2011.03.022; PIRSON Y, 1986, AM J KIDNEY DIS, V8, P338, DOI 10.1016/S0272-6386(86)80108-1; Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069; Reis CP, 2008, J PHARM SCI-US, V97, P5290, DOI 10.1002/jps.21347; Satpute MG, 2011, AM J INFECT CONTROL, V39, pE21, DOI 10.1016/j.ajic.2010.10.034; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Shukla A, 2011, J CONTROL RELEASE, V155, P159, DOI 10.1016/j.jconrel.2011.06.011; Shukla A, 2010, SMALL, V6, P2392, DOI 10.1002/smll.201001150; Soliman GM, 2010, MACROMOL BIOSCI, V10, P278, DOI 10.1002/mabi.200900259; Telang NV, 2010, AM J INFECT CONTROL, V38, P165, DOI 10.1016/j.ajic.2009.07.007; Tendeloo HJC, 1936, J BIOL CHEM, V113, P333; THE TH, 1970, IMMUNOLOGY, V18, P865; Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	47	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84360	10.1371/journal.pone.0084360	http://dx.doi.org/10.1371/journal.pone.0084360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409292	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500016
J	Jain, HV; Richardson, A; Meyer-Hermann, M; Byrne, HM				Jain, Harsh Vardhan; Richardson, Alan; Meyer-Hermann, Michael; Byrne, Helen M.			Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas	PLOS ONE			English	Article							BCL-X-L; PERIODIC CHEMOTHERAPY; MATHEMATICAL-MODEL; DRUG-RESISTANCE; LOGISTIC MODEL; CANCER CELLS; CISPLATIN; BCL-X(L); THERAPY; CHEMORESISTANCE	Platinum drug-resistance in ovarian cancers mediated by anti-apoptotic proteins such as Bcl-xL is a major factor contributing to the chemotherapeutic resistance of recurrent disease. Consequently, concurrent inhibition of Bcl-xL in combination with chemotherapy may improve treatment outcomes for patients. Here, we develop a mathematical model to investigate the potential of combination therapy with ABT-737, a small molecule inhibitor of Bcl-xL, and carboplatin, a platinum-based drug, on a simulated tumor xenograft. The model is calibrated against in vivo experimental data, wherein xenografts established in mice were treated with ABT-737 and/or carboplatin on a fixed periodic schedule. The validated model is used to predict the minimum drug load that will achieve a predetermined level of tumor growth inhibition, thereby maximizing the synergy between the two drugs. Our simulations suggest that the infusion-duration of each carboplatin dose is a critical parameter, with an 8-hour infusion of carboplatin given weekly combined with a daily bolus dose of ABT-737 predicted to minimize residual disease. The potential of combination therapy to prevent or delay the onset of carboplatin-resistance is also investigated. When resistance is acquired as a result of aberrant DNA-damage repair in cells treated with carboplatin, drug delivery schedules that induce tumor remission with even low doses of combination therapy can be identified. Intrinsic resistance due to pre-existing cohorts of resistant cells precludes tumor regression, but dosing strategies that extend disease-free survival periods can still be identified. These results highlight the potential of our model to accelerate the development of novel therapeutics such as BH3 mimetics.	[Jain, Harsh Vardhan] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Richardson, Alan] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig, Germany; [Meyer-Hermann, Michael] Braunschweig Univ Technol, Bio Ctr Life Sci, Braunschweig, Germany; [Byrne, Helen M.] Univ Oxford, Inst Math, Oxford Ctr Collaborat & Appl Math, Oxford OX1 3LB, England; [Byrne, Helen M.] Univ Oxford, Dept Comp Sci, Oxford OX1 3LB, England	State University System of Florida; Florida State University; Keele University; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; University of Oxford; University of Oxford	Jain, HV (corresponding author), Florida State Univ, Dept Math, Tallahassee, FL 32306 USA.	hjain@fsu.edu	Richardson, Alan/I-4631-2015	Richardson, Alan/0000-0003-1825-3375; Byrne, Helen/0000-0003-1771-5910	National Science Foundation [DMS 0931642]; King Abdullah University of Science and Technology (KAUST) [KUK-C1-013-04]	National Science Foundation(National Science Foundation (NSF)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Funding came from a National Science Foundation grant DMS 0931642 and Award No. KUK-C1-013-04 made by the King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Bonate PL, 2011, PHARMACOKINETICS IN DRUG DEVELOPMENT, VOL 3: ADVANCES AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7937-7_1; Bookman MA, 2010, ANN ONCOL, V21, P211, DOI 10.1093/annonc/mdq368; Brotin E, 2010, INT J CANCER, V126, P885, DOI 10.1002/ijc.24787; Bukowski RM, 2007, SEMIN ONCOL, V34, pS1, DOI 10.1053/j.seminoncol.2007.03.012; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; El-Kareh AW, 2008, AAPS J, V10, P15, DOI 10.1208/s12248-007-9003-6; El-Kareh AW, 2003, NEOPLASIA, V5, P161, DOI 10.1016/S1476-5586(03)80008-8; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Jain HV, 2008, B MATH BIOL, V70, P89, DOI 10.1007/s11538-007-9242-9; Jain HV, 2012, APPL MATH LETT, V25, P2132, DOI 10.1016/j.aml.2012.04.024; Jain HV, 2011, CANCER RES, V71, P705, DOI 10.1158/0008-5472.CAN-10-3174; Jain HV, 2009, MOL CANCER THER, V8, P2926, DOI 10.1158/1535-7163.MCT-08-1223; Keyfitz BL, 1997, MATH COMPUT MODEL, V26, P1, DOI 10.1016/S0895-7177(97)00165-9; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; LUKAS G, 1971, J PHARMACOL EXP THER, V178, P562; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; PANETTA JC, 1995, APPL MATH LETT, V8, P83, DOI 10.1016/0893-9659(95)00053-S; Panetta JC, 1997, APPL MATH LETT, V10, P123, DOI 10.1016/S0893-9659(96)00123-1; PANETTA JC, 1995, MATH COMPUT MODEL, V22, P67, DOI 10.1016/0895-7177(95)00112-F; Roett MA, 2009, AM FAM PHYSICIAN, V80, P609; SIDDIK ZH, 1987, BIOCHEM PHARMACOL, V36, P1925, DOI 10.1016/0006-2952(87)90490-4; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Stamelos VA, 2013, GYNECOL ONCOL, V128, P377, DOI 10.1016/j.ygyno.2012.11.019; Tan DSP, 2008, ADV EXP MED BIOL, V622, P153, DOI 10.1007/978-0-387-68969-2_13; Vasey PA, 2003, BRIT J CANCER, V89, pS23, DOI 10.1038/sj.bjc.6601497; Villedieu M, 2007, GYNECOL ONCOL, V105, P31, DOI 10.1016/j.ygyno.2006.12.011; Whitecross KF, 2009, BLOOD, V113, P1982, DOI 10.1182/blood-2008-05-156851; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362	35	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e81582	10.1371/journal.pone.0081582	http://dx.doi.org/10.1371/journal.pone.0081582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400068	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000329462700002
J	Alves, FHF; Crestani, CC; Resstel, LBM; Correa, FMA				Alves, Fernando H. F.; Crestani, Carlos C.; Resstel, Leonardo B. M.; Correa, Fernando M. A.			Both alpha(1)- and alpha(2)-adrenoceptors in the Insular Cortex Are Involved in the Cardiovascular Responses to Acute Restraint Stress in Rats	PLOS ONE			English	Article							FREELY MOVING CATS; COERULEUS NEURONAL-ACTIVITY; MEDIAL PREFRONTAL CORTEX; NEUROENDOCRINE RESPONSES; LOCUS-COERULEUS; BED NUCLEUS; PHYSIOLOGICAL MANIPULATIONS; PARAVENTRICULAR NUCLEUS; SYMPATHETIC RESPONSES; BEHAVIORAL-RESPONSES	The insular cortex (IC) is a limbic structure involved in cardiovascular responses observed during aversive threats. However, the specific neurotransmitter mediating IC control of cardiovascular adjustments to stress is yet unknown. Therefore, in the present study we investigated the role of local IC adrenoceptors in the cardiovascular responses elicited by acute restraint stress in rats. Bilateral microinjection of different doses (0.3, 5, 10 and 15 nmol/100 nl) of the selective alpha(1)-adrenoceptor antagonist WB4101 into the IC reduced both the arterial pressure and heart rate increases elicited by restraint stress. However, local IC treatment with different doses (0.3, 5, 10 and 15 nmol/100 nl) of the selective alpha(2)-adrenoceptor antagonist RX821002 reduced restraint-evoked tachycardia without affecting the pressor response. The present findings are the first direct evidence showing the involvement of IC adrenoceptors in cardiovascular adjustments observed during aversive threats. Our findings indicate that IC noradrenergic neurotransmission acting through activation of both alpha(1)- and alpha(2)-adrenoceptors has a facilitatory influence on pressor response to acute restraint stress. Moreover, IC alpha(1)-adrenoceptors also play a facilitatory role on restraint-evoked tachycardiac response.	[Alves, Fernando H. F.; Resstel, Leonardo B. M.; Correa, Fernando M. A.] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Crestani, Carlos C.] Univ Estudual Paulista UNESP, Dept Nat Act Principles & Toxicol, Sch Pharmaceut Sci Araraquara, Araraquara, SP, Brazil	Universidade de Sao Paulo	Alves, FHF (corresponding author), Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	fer_farmacia@yahoo.com.br	Correa, Fernando/D-1614-2012; Crestani, Carlos C/E-4161-2012; Resstel, Leonardo/C-6100-2012	Correa, Fernando/0000-0003-4067-9524; Crestani, Carlos C/0000-0002-1942-858X; 	FAPESP [2010/09462-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial agency: FAPESP - Grant number 2010/09462-9, URL - www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1987, J NEUROSCI, V7, P2837; Alves FHF, 2013, EUR J NEUROSCI, V38, P2300, DOI 10.1111/ejn.12210; Alves FHF, 2011, AUTON NEUROSCI-BASIC, V160, P90, DOI 10.1016/j.autneu.2010.11.002; Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; Alves FHF, 2009, BRAIN RES, V1295, P119, DOI 10.1016/j.brainres.2009.08.013; Alves FHF, 2009, AUTON NEUROSCI-BASIC, V147, P56, DOI 10.1016/j.autneu.2008.12.015; BARRON BA, 1989, J AUTONOM NERV SYST, V28, P179, DOI 10.1016/0165-1838(89)90090-8; Baudrie V, 1997, J AUTON PHARMACOL, V17, P303, DOI 10.1046/j.1365-2680.1997.00465.x; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; BUTCHER KS, 1995, AM J PHYSIOL-REG I, V268, pR214, DOI 10.1152/ajpregu.1995.268.1.R214; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; Carrive P, 2002, AUTON NEUROSCI-BASIC, V98, P90, DOI 10.1016/S1566-0702(02)00039-5; Carrive P, 2006, CLIN EXP PHARMACOL P, V33, P1251, DOI 10.1111/j.1440-1681.2006.04519.x; Cecchi M, 2002, NEUROSCIENCE, V112, P13, DOI 10.1016/S0306-4522(02)00062-3; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; CECHETTO DF, 1992, AM J PHYSIOL, V263, pR544, DOI 10.1152/ajpregu.1992.263.3.R544; Crestani CC, 2008, BRIT J PHARMACOL, V153, P583, DOI 10.1038/sj.bjp.0707591; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; Crestani CC, 2010, STRESS, V13, P61, DOI 10.3109/10253890902927950; Dampney RAL, 2008, AUTON NEUROSCI-BASIC, V142, P3, DOI 10.1016/j.autneu.2008.07.005; Daubert DL, 2012, J PHYSIOL-LONDON, V590, P4881, DOI 10.1113/jphysiol.2012.232314; Deolindo MV, 2013, EUR J NEUROSCI, V38, P2374, DOI 10.1111/ejn.12246; Fornari RV, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00010; Hatton DC, 1997, AM J PHYSIOL-REG I, V272, pR1588, DOI 10.1152/ajpregu.1997.272.5.R1588; Irvine RJ, 1997, J PHARMACOL TOXICOL, V38, P157, DOI 10.1016/S1056-8719(97)00081-6; IWATA J, 1988, BEHAV NEUROSCI, V102, P66, DOI 10.1037/0735-7044.102.1.66; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; KRETZ R, 1984, J NEUROSCI METH, V11, P129, DOI 10.1016/0165-0270(84)90030-X; KRIEMAN MJ, 1992, NEUROPHARMACOLOGY, V31, P33, DOI 10.1016/0028-3908(92)90157-K; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Ma S, 2005, J NEUROENDOCRINOL, V17, P761, DOI 10.1111/j.1365-2826.2005.01372.x; Mayorov DN, 2002, AUTON NEUROSCI-BASIC, V98, P20, DOI 10.1016/S1566-0702(02)00024-3; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; MORILAK DA, 1987, BRAIN RES, V422, P24, DOI 10.1016/0006-8993(87)90536-1; MORILAK DA, 1987, BRAIN RES, V422, P32, DOI 10.1016/0006-8993(87)90537-3; MORRISON JH, 1978, J COMP NEUROL, V181, P17, DOI 10.1002/cne.901810103; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Nosaka S, 1996, JPN J PHYSIOL, V46, P271, DOI 10.2170/jjphysiol.46.271; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; PAGE ME, 1992, NEUROSCIENCE, V51, P555, DOI 10.1016/0306-4522(92)90295-D; Pardon MC, 2002, NEUROSCIENCE, V115, P229, DOI 10.1016/S0306-4522(02)00364-0; Resstel LBM, 2006, AUTON NEUROSCI-BASIC, V126, P130, DOI 10.1016/j.autneu.2006.02.022; SAAD MAA, 1989, J AUTONOM NERV SYST, V27, P165, DOI 10.1016/0165-1838(89)90098-2; Saleh TM, 1998, AM J PHYSIOL-REG I, V274, pR1417, DOI 10.1152/ajpregu.1998.274.5.R1417; SANDKUHLER J, 1987, EXP BRAIN RES, V68, P168; SARA SJ, 1991, PROG BRAIN RES, V88, P571; SCHENBERG LC, 1993, BRAIN RES, V621, P50, DOI 10.1016/0006-8993(93)90296-Y; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALENTINO RJ, 1993, ANN NY ACAD SCI, V697, P173, DOI 10.1111/j.1749-6632.1993.tb49931.x; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83900	10.1371/journal.pone.0083900	http://dx.doi.org/10.1371/journal.pone.0083900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404141	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800020
J	Bai, YT; Xu, ZG; Zhang, J; Mao, DQ; Luo, C; He, YY; Liang, GD; Lu, B; Bisesi, MS; Sun, QH; Xu, XY; Yang, WZ; Liu, QY				Bai, Yuntao; Xu, Zhiguang; Zhang, Jing; Mao, Deqiang; Luo, Chao; He, Yuanyuan; Liang, Guodong; Lu, Bo; Bisesi, Michael S.; Sun, Qinghua; Xu, Xinyi; Yang, Weizhong; Liu, Qiyong			Regional Impact of Climate on Japanese Encephalitis in Areas Located near the Three Gorges Dam	PLOS ONE			English	Article							RESERVOIR AREA; SCHISTOSOMIASIS TRANSMISSION; MAINLAND CHINA; ANDHRA-PRADESH; MOLECULAR CHARACTERIZATION; WEATHER VARIABLES; KURNOOL DISTRICT; SOUTHEAST-ASIA; YANGTZE-RIVER; VIRUS	Background: In this study, we aim to identify key climatic factors that are associated with the transmission of Japanese encephalitis virus in areas located near the Three Gorges Dam, between 1997 and 2008. Methods: We identified three geographical regions of Chongqing, based on their distance from the Three Gorges Dam. Collectively, the three regions consisted of 12 districts from which study information was collected. Zero-Inflated Poisson Regression models were run to identify key climatic factors of the transmission of Japanese encephalitis virus for both the whole study area and for each individual region; linear regression models were conducted to examine the fluctuation of climatic variables over time during the construction of the Three Gorges Dam. Results: Between 1997 and 2008, the incidence of Japanese encephalitis decreased throughout the entire city of Chongqing, with noticeable variations taking place in 2000, 2001 and 2006. The eastern region, which is closest to the Three Gorges Dam, suffered the highest incidence of Japanese encephalitis, while the western region experienced the lowest incidence. Linear regression models revealed that there were seasonal fluctuations of climatic variables during this period. Zero-Inflated Poisson Regression models indicated a significant positive association between temperature (with a lag of 1 and 3 months) and Japanese encephalitis incidence, and a significant negative association between rainfall (with a lag of 0 and 4 months) and Japanese encephalitis incidence. Conclusion: The spatial and temporal trends of Japanese encephalitis incidence that occurred in the City of Chongqing were associated with temperature and rainfall. Seasonal fluctuations of climatic variables during this period were also observed. Additional studies that focus on long-term data collection are needed to validate the findings of this study and to further explore the effects of the Three Gorges Dam on Japanese encephalitis and other related diseases.	[Bai, Yuntao; Bisesi, Michael S.; Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Xu, Zhiguang; Xu, Xinyi] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Zhang, Jing; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Mao, Deqiang] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Luo, Chao] Wanzhou Dist Control Dis Prevent & Control, Chongqing, Peoples R China; [He, Yuanyuan] Yichang Ctr Dis Control & Prevent, Yichang, Hubei Province, Peoples R China; [Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lu, Bo] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, XY (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	xinyi@stat.osu.edu; yangwz@chinacdc.cn; liuqiyong@icdc.cn	Bai, Yuntao/S-8408-2016; Yang, Wei/HIA-0360-2022		Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation [DMS-12-09194]; Division Of Mathematical Sciences [1209194] Funding Source: National Science Foundation	Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by The Ohio State University Office of International Affairs Gateway Research Seed Grant (2011) to Qinghua Sun, and in part by the National Science Foundation under award number DMS-12-09194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P678, DOI 10.4269/ajtmh.1959.8.678; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chai C, 2009, SCI TOTAL ENVIRON, V407, P4687, DOI 10.1016/j.scitotenv.2009.05.011; Dutta Kallol, 2011, Infectious Disorders - Drug Targets, V11, P300; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149; Hu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052687; Huang Liuqin, 2011, Weishengwu Xuebao, V51, P83; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; MOGI M, 1983, AM J TROP MED HYG, V32, P170, DOI 10.4269/ajtmh.1983.32.170; Murty US, 2010, J VECTOR DIS, V47, P26; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; REISEN W K, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P61; Richards EE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-32; RODRIGUES FM, 1981, T ROY SOC TROP MED H, V75, P258, DOI 10.1016/0035-9203(81)90330-8; Sabchareon A, 1998, ANN TROP PAEDIATR, V18, pS67, DOI 10.1080/02724936.1998.11747983; Sarkar A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-368; Sleigh AC, 2001, LANCET, V357, P570, DOI 10.1016/S0140-6736(00)04072-1; Teng M, 2012, VIRUS GENES; Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586; Tian LW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-110; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Upadhyayula SM, 2012, ASIAN PAC J TROP MED, V5, P337, DOI 10.1016/S1995-7645(12)60054-6; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wang JX, 2009, CHEMOSPHERE, V75, P1119, DOI 10.1016/j.chemosphere.2009.01.016; Wang Y M, 1985, Zhonghua Yi Xue Za Zhi, V65, P648; Xu LJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-101; Xu X J, 1999, Southeast Asian J Trop Med Public Health, V30, P549; Xu XB, 2011, SCI TOTAL ENVIRON, V409, P4656, DOI 10.1016/j.scitotenv.2011.08.004; Zeng H, 2011, ACTA TROP, V120, P238, DOI 10.1016/j.actatropica.2011.09.003; Zhang Ding-lin, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P95; Zhang Hui-juan, 2007, Zhonghua Yufang Yixue Zazhi, V41, P138; Zhang L, 2012, BIOMED ENVIRON SCI, V25, P297, DOI 10.3967/0895-3988.2012.03.007; Zhang Sheng, 2008, Huanjing Kexue, V29, P7; Zhang Sheng, 2007, Huanjing Kexue, V28, P500; Zheng H, 2013, J VET SCI, V14, P27, DOI 10.4142/jvs.2013.14.1.27; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710; Zhou GJ, 2011, ENVIRON MONIT ASSESS, V176, P125, DOI 10.1007/s10661-010-1571-8; Zhu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-43; Zhu Ze-rong, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P258	50	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84326	10.1371/journal.pone.0084326	http://dx.doi.org/10.1371/journal.pone.0084326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404159	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800038
J	Fedigan, LM; Melin, AD; Addicott, JF; Kawamura, S				Fedigan, Linda M.; Melin, Amanda D.; Addicott, John F.; Kawamura, Shoji			The Heterozygote Superiority Hypothesis for Polymorphic Color Vision Is Not Supported by Long-Term Fitness Data from Wild Neotropical Monkeys	PLOS ONE			English	Article							WHITE-FACED CAPUCHINS; MARMOSETS CALLITHRIX-GEOFFROYI; CEBUS-CAPUCINUS; REPRODUCTIVE SUCCESS; TRICHROMATIC VISION; FORAGING ADVANTAGE; MALE DISPERSAL; OPSIN ALLELES; PRIMATE; EVOLUTION	The leading explanatory model for the widespread occurrence of color vision polymorphism in Neotropical primates is the heterozygote superiority hypothesis, which postulates that trichromatic individuals have a fitness advantage over other phenotypes because red-green chromatic discrimination is useful for foraging, social signaling, or predator detection. Alternative explanatory models predict that dichromatic and trichromatic phenotypes are each suited to distinct tasks. To conclusively evaluate these models, one must determine whether proposed visual advantages translate into differential fitness of trichromatic and dichromatic individuals. We tested whether color vision phenotype is a significant predictor of female fitness in a population of wild capuchins, using long-term (26 years) survival and fertility data. We found no advantage to trichromats over dichromats for three fitness measures (fertility rates, offspring survival and maternal survival). This finding suggests that a selective mechanism other than heterozygote advantage is operating to maintain the color vision polymorphism. We propose that attention be directed to field testing the alternative mechanisms of balancing selection proposed to explain opsin polymorphism: niche-divergence, frequency-dependence and mutual benefit of association. This is the first in-depth, long-term study examining the effects of color vision variation on survival and reproductive success in a naturally-occurring population of primates.	[Fedigan, Linda M.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Addicott, John F.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Kawamura, Shoji] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Calgary; Washington University (WUSTL); University of Calgary; University of Tokyo	Fedigan, LM (corresponding author), Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada.	fedigan@ucalgary.ca		Melin, Amanda/0000-0002-0612-2514	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Wenner-Gren Foundation; Leakey Foundation; Japan Society for the Promotion of Science [A22247036]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Wenner-Gren Foundation; Leakey Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (LMF, ADM, JFA) http://www.nserc-crsng.gc.ca, The Canada Research Chairs Program (LMF) http://www.chairs-chaires.gc.ca/, the Wenner-Gren and Leakey Foundations (ADM) http://www.wennergren.org/, http://leakeyfoundation.org, and a Grant-in-Aid for Scientific Research (A22247036) from the Japan Society for the Promotion of Science (SK) http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley BJ, 2011, EVOL ANTHROPOL, V20, P104, DOI 10.1002/evan.20306; Brown D., 1988, REPROD SUCCESS, P439; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Caine NG, 2002, EAT OR BE EATEN, P58, DOI 10.1017/CBO9780511610233.005; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Clutton-Brock T.H., 1988, P325; Cropp S, 2002, J MOL EVOL, V54, P734, DOI 10.1007/s0023901-0073-2; DEEB SS, 1992, AM J HUM GENET, V51, P687; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Fedigan Linda M., 2012, P165; Fedigan LM, 2008, AM J PHYS ANTHROPOL, V137, P82, DOI 10.1002/ajpa.20848; Fedigan LM, 2011, AM J PHYS ANTHROPOL, V144, P317, DOI 10.1002/ajpa.21414; Fedigan LM, 2004, BEHAVIOUR, V141, P755, DOI 10.1163/1568539042245178; Fedigan LM, 2003, INT J PRIMATOL, V24, P723, DOI 10.1023/A:1024620620454; Freitag FB, 2012, J OPT SOC AM A, V29, pA216, DOI 10.1364/JOSAA.29.00A216; HARTL DL, 2007, PRINCIPLES POPULATIO, P4; Hiramatsu C, 2005, AM J PRIMATOL, V67, P447, DOI 10.1002/ajp.20199; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; Hiramatsu C, 2009, ANIM BEHAV, V77, P1421, DOI 10.1016/j.anbehav.2009.02.012; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Jack KM, 2004, ANIM BEHAV, V67, P771, DOI 10.1016/j.anbehav.2003.06.015; Jack KM, 2004, ANIM BEHAV, V67, P761, DOI 10.1016/j.anbehav.2003.04.015; Jack KM, 2009, BEHAVIOUR, V146, P437; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; Jones JH, 2010, J ANIM ECOL, V79, P1262, DOI 10.1111/j.1365-2656.2010.01687.x; Kamilar JM, 2013, AM J PRIMATOL, V75, P740, DOI 10.1002/ajp.22099; Kawamura Shoji, 2012, P93; Melin AD, 2014, INT J PRIMATOL, V35, P258, DOI 10.1007/s10764-013-9730-8; Melin AD, 2013, VISION RES, V86, P87, DOI 10.1016/j.visres.2013.04.013; Melin A. D., 2012, EVOLUTIONARY BIOL ME, P225, DOI [DOI 10.1007/978-3-642-30425-5_13, 10.1007/978-3-642-30425-5_13]; Melin AD, 2008, BEHAV ECOL SOCIOBIOL, V62, P659, DOI 10.1007/s00265-007-0490-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Melin AD, 2010, CURR ZOOL, V56, P300, DOI 10.1093/czoolo/56.3.300; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Montague MJ, 2014, INT J PRIMATOL, V35, P169, DOI 10.1007/s10764-013-9723-7; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Pusey Anne, 2012, P343; R Core Team, 2012, R LANG ENV STAT COMP; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Riba-Hernandez P, 2007, J EXP BIOL, V207, P2465; Rowe MP, 2004, VISUAL NEUROSCI, V21, P217, DOI 10.1017/S0952523804213104; Saito A, 2005, AM J PRIMATOL, V67, P471, DOI 10.1002/ajp.20201; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Sharpe L.T., 1999, COLOR VISION GENES P, P3; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith AC, 2003, AM J PRIMATOL, V61, P145, DOI 10.1002/ajp.10117; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; STRIER KB, 2004, PRIMATOLOGIA BRASIL, V8, P53; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Surridge AK, 2005, AM J PRIMATOL, V67, P463, DOI 10.1002/ajp.20200; Surridge AK, 2005, BIOL LETTERS, V1, P465, DOI 10.1098/rsbl.2005.0367; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Surridge AK, 2002, MOL ECOL, V11, P2157, DOI 10.1046/j.1365-294X.2002.01597.x; Therneau T, 2012, PACKAGE SURVIVAL ANA; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; Yamashita N, 2005, BEHAV ECOL SOCIOBIOL, V58, P618, DOI 10.1007/s00265-005-0936-4	61	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84872	10.1371/journal.pone.0084872	http://dx.doi.org/10.1371/journal.pone.0084872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404195	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800074
J	Witz, N; Zhou, JW; Hess, RF				Witz, Nirel; Zhou, Jiawei; Hess, Robert F.			Similar Mechanisms Underlie the Detection of Horizontal and Vertical Disparity Corrugations	PLOS ONE			English	Article							ORIENTATION CHANNELS; SENSITIVITY; SUMMATION; THRESHOLD	Our aim was to compare sensitivity for horizontal and vertical disparity corrugations and to resolve whether these stimuli are processed by similar or radically different underlying mechanisms. We measure global disparity sensitivity as a function of carrier spatial frequency for equi-detectable carriers and found a similar optimal carrier relationship for vertical and horizontal stimuli. Sensitivity as a function of corrugation spatial frequency for stimuli of comparable spatial summation and composed of optimal, equi-detectable narrowband carriers did not significantly differ for vertical and horizontal stimuli. A small anisotropy was revealed when fixed, high contrast broadband carriers were used. In a separate discrimination-at-threshold experiment, multiple mechanisms of similar tuning were revealed to underlie the detection of both vertical and horizontal disparity corrugations. We conclude that the processing of the horizontal and vertical disparity corrugations occurs along similar lines.	[Witz, Nirel; Zhou, Jiawei; Hess, Robert F.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	McGill University	Hess, RF (corresponding author), McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada.	robert.hess@mcgill.ca	Zhou, Jiawei/AGN-8024-2022	Zhou, Jiawei/0000-0003-4220-344X	NSERC [46528]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC grant(http://www.nserc-crsng.gc.ca/index_eng.asp) to RFH (#46528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw MF, 1999, VISION RES, V39, P3049, DOI 10.1016/S0042-6989(99)00015-2; Chen CC, 2006, VISION RES, V46, P2691, DOI 10.1016/j.visres.2006.02.009; Ellemberg D, 2006, VISION RES, V46, P2798, DOI 10.1016/j.visres.2006.01.028; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Hess RF, 1999, VISION RES, V39; Hibbard PB, 2002, J EXP PSYCHOL HUMAN, V28, P469, DOI 10.1037//0096-1523.28.2.469; HOWELL ER, 1978, VISION RES, V18, P369, DOI 10.1016/0042-6989(78)90045-7; Lee B, 1997, VISION RES, V37, P1769, DOI 10.1016/S0042-6989(96)00274-X; Pulliam K., 1982, VISUAL SIMULATION IM, VII, DOI [10.1117/12.932660, DOI 10.1117/12.932660]; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; SCHUMER R, 1979, VISION RES, V19, P1303, DOI 10.1016/0042-6989(79)90202-5; Serrano-Pedraza I, 2010, J VISION, V10, DOI 10.1167/10.12.10; THOMAS JP, 1979, J OPT SOC AM, V69, P652, DOI 10.1364/JOSA.69.000652; TYLER CW, 1975, VISION RES, V15, P583, DOI 10.1016/0042-6989(75)90306-5; Tyler CW, 2001, VISION RES, V41, P2235, DOI 10.1016/S0042-6989(00)00261-3; van der Willigen RF, 2010, J VISION, V10, DOI 10.1167/10.1.10; WATSON AB, 1981, VISION RES, V21, P1115, DOI 10.1016/0042-6989(81)90014-6; Witz N, 2013, VISION RES, V87, P10, DOI 10.1016/j.visres.2013.05.003	18	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84846	10.1371/journal.pone.0084846	http://dx.doi.org/10.1371/journal.pone.0084846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404193	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800072
J	Morishita, S; Oku, H; Horie, T; Tonari, M; Kida, T; Okubo, A; Sugiyama, T; Takai, S; Hara, H; Ikeda, T				Morishita, Seita; Oku, Hidehiro; Horie, Taeko; Tonari, Masahiro; Kida, Teruyo; Okubo, Akiko; Sugiyama, Tetsuya; Takai, Shinji; Hara, Hideaki; Ikeda, Tsunehiko			Systemic Simvastatin Rescues Retinal Ganglion Cells from Optic Nerve Injury Possibly through Suppression of Astroglial NF-kappa B Activation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; RAT RETINA; REACTIVE ASTROCYTES; MULTIPLE-SCLEROSIS; ADULT-RATS; IN-VIVO; EXPRESSION; NEURONS	Neuroinflammation is involved in the death of retinal ganglion cells (RGCs) after optic nerve injury. The purpose of this study was to determine whether systemic simvastatin can suppress neuroinflammation in the optic nerve and rescue RGCs after the optic nerve is crushed. Simvastatin or its vehicle was given through an osmotic minipump beginning one week prior to the crushing. Immunohistochemistry and real-time PCR were used to determine the degree of neuroinflammation on day 3 after the crushing. The density of RGCs was determined in Tuj-1 stained retinal flat mounts on day 7. The effect of simvastain on the TNF-alpha-induced NF-kappa B activation was determined in cultured optic nerve astrocytes. On day 3, CD68-positive cells, most likely microglia/macrophages, were accumulated at the crushed site. Phosphorylated NF-kB was detected in some astrocytes at the border of the lesion where the immunoreactivity to MCP-1 was intensified. There was an increase in the mRNA levels of the CD68 (11.4-fold), MCP-1 (22.6-fold), ET-1 (2.3-fold), GFAP (1.6-fold), TNF-alpha (7.0-fold), and iNOS (14.8-fold) genes on day 3. Systemic simvastatin significantly reduced these changes. The mean +/- SD number of RGCs was 1816.3 +/- 232.6/mm(2) (n = 6) in the sham controls which was significantly reduced to 831.4 +/- 202.5/mm(2) (n = 9) on day 7 after the optic nerve was crushed. This reduction was significantly suppressed to 1169.2 +/- 201.3/mm(2) (P = 0.01, Scheffe; n = 9) after systemic simvastatin. Simvastatin (1.0 mu M) significantly reduced the TNF-a-induced NF-kB activation in cultured optic nerve astrocytes. We conclude that systemic simvastatin can reduce the death of RGCs induced by crushing the optic nerve possibly by suppressing astroglial NF-kappa B activation.	[Morishita, Seita; Oku, Hidehiro; Horie, Taeko; Tonari, Masahiro; Kida, Teruyo; Okubo, Akiko; Sugiyama, Tetsuya; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan; [Takai, Shinji] Osaka Med Coll, Dept Pharmacol, Osaka, Japan; [Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Osaka Medical College; Osaka Medical College; Gifu Pharmaceutical University	Oku, H (corresponding author), Osaka Med Coll, Dept Ophthalmol, Osaka, Japan.	hidehirooku@aol.com	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Hara, Hideaki/0000-0003-2046-9001	Japanese Ministry of Education Grant [225919739]; Osaka Community Foundation grant	Japanese Ministry of Education Grant; Osaka Community Foundation grant	This study was supported by Japanese Ministry of Education Grant 225919739 (HO) and Osaka Community Foundation grant ( HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bian ZM, 2001, EXP EYE RES, V73, P111, DOI 10.1006/exer.2001.1019; Brambilla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-213; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Kawaji T, 2007, CURR EYE RES, V32, P991, DOI 10.1080/02713680701649603; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Ko ML, 2011, EXP EYE RES, V93, P580, DOI 10.1016/j.exer.2011.07.003; Krempler K, 2011, INVEST OPHTH VIS SCI, V52, P2606, DOI 10.1167/iovs.10-6005; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Pazman C, 2000, DEVELOPMENT, V127, P1715; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Rattan R, 2003, FREE RADICAL BIO MED, V35, P1037, DOI 10.1016/S0891-5849(03)00459-3; ROSENMAN SJ, 1995, J IMMUNOL, V154, P1888; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859	39	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84387	10.1371/journal.pone.0084387	http://dx.doi.org/10.1371/journal.pone.0084387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392131	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100054
J	Shi, XQ; Fu, YJ; Liao, DQ; Chen, YF; Liu, J				Shi, Xianqing; Fu, Yongjian; Liao, Daqing; Chen, Yanfang; Liu, Jin			Alterations of Voltage-Dependent Calcium Channel Currents in Basilar Artery Smooth Muscle Cells at Early Stage of Subarachnoid Hemorrhage in a Rabbit Model	PLOS ONE			English	Article							CEREBRAL VASOSPASM; CA2+ CHANNELS; ION CHANNELS; INJECTION; MYOCYTES; DISEASE; TONE	Objective: To investigate the changes in the currents of voltage-dependent calcium channels (VDCCs) in smooth muscle cells of basilar artery in a rabbit model of subarachnoid hemorrhage (SAH). Methods: New Zealand white rabbits were randomly divided into five groups: sham (C), normal (N), 24 hours (S1), 48 hours (S2) and 72 hours (S3) after SAH. Non-heparinized autologous arterial blood (1ml/kg) was injected into the cisterna magna to create SAH after intravenous anesthesia, and 1 ml/kg of saline was injected into cisterna magna in the sham group. Rabbits in group N received no injections. Basilar artery in S1, S2, S3 group were isolated at 24, 48, 72 hours after SAH. Basilar artery in group C was isolated at 72 hours after physiological saline injection. Basilar artery smooth muscle cells were isolated for all groups. Whole-cell patch-clamp technique was utilized to record cell membrane capacitance and VDCCs currents. The VDCCs antagonist nifedipine was added to the bath solution to block the Ca++ channels currents. Results: There were no significant differences in the number of cells isolated, the cell size and membrane capacitance among all the five groups. VDCC currents in the S1-S3 groups had higher amplitudes than those in control and sham groups. The significant change of current amplitude was observed at 72 hours after SAH, which was higher than those of 24 and 48 hours. The VDCCs were shown to expression in human artery smooth muscle cells. Conclusions: The changes of activation characteristics and voltage-current relationship at 72 hours after SAH might be an important event which leads to a series of molecular events in the microenvironment of the basilar artery smooth muscle cells. This may be the key time point for potential therapeutic intervention against subarachnoid hemorrhage.	[Shi, Xianqing; Fu, Yongjian] Guizhou Prov Peoples Hosp, Intens Care Unit, Guiyang, Peoples R China; [Liao, Daqing; Chen, Yanfang; Liu, Jin] Sichuan Univ, West China Hosp, Lab Anesthesia & Crit Med, Chengdu, Peoples R China	Sichuan University	Liu, J (corresponding author), Sichuan Univ, West China Hosp, Lab Anesthesia & Crit Med, Chengdu, Peoples R China.	sculiujin@gmail.com		Liu, Jin/0000-0002-2026-2513	Department of Science and Technology of Guizhou province [J20072118]	Department of Science and Technology of Guizhou province	This study was supported by a grant from the Department of Science and Technology of Guizhou province (Grant No. J20072118). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORCH E, 1995, PHARMACOL THERAPEUT, V68, P1, DOI 10.1016/0163-7258(95)00025-9; Bevan JA, 1997, INT J MICROCIRC, V17, P248, DOI 10.1159/000179237; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Fu ZJ, 2005, SHENG LI XUE BAO, V57, P27; Fukumori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069718; Furutani H, 2002, J CARDIOVASC PHARM, V40, P265, DOI 10.1097/00005344-200208000-00012; He J, 1998, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V20, P95; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Ishiguro M, 2008, ACTA NEUROCHIR SUPPL, V104, P99; Ishiguro M, 2005, CIRC RES, V96, P419, DOI 10.1161/01.RES.0000157670.49936.da; Kang S, 2013, J MED CHEM, V56, P4786, DOI 10.1021/jm4005048; Koide M, 2011, J CEREBR BLOOD F MET, V31, P3, DOI 10.1038/jcbfm.2010.143; Koide M, 2011, ACTA NEUROCHIR SUPPL, V110, P145, DOI 10.1007/978-3-7091-0353-1_25; Kovacic S, 2006, AUTON NEUROSCI-BASIC, V130, P28, DOI 10.1016/j.autneu.2006.05.002; Kuo IYT, 2011, J PHYSIOL-LONDON, V589, P783, DOI 10.1113/jphysiol.2010.199497; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Mizuno T, 2003, AM J NEURORADIOL, V24, P608; NAKAYAMA S, 1993, J PHYSIOL-LONDON, V471, P107, DOI 10.1113/jphysiol.1993.sp019893; Navarro-Gonzalez MF, 2009, CLIN EXP PHARMACOL P, V36, P55, DOI 10.1111/j.1440-1681.2008.05035.x; Nikitina E, 2010, J NEUROSURG, V113, P870, DOI 10.3171/2010.2.JNS091038; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Quignard JF, 1997, J CLIN INVEST, V99, P185, DOI 10.1172/JCI119146; Satoh M, 2001, STROKE, V32, P225, DOI 10.1161/01.STR.32.1.225; Shi HC, 2006, THESIS SICHUAN U; Simard JM, 1998, CIRC RES, V82, P1330, DOI 10.1161/01.RES.82.12.1330; STORNELLI SA, 1964, J NEUROSURG, V21, P769, DOI 10.3171/jns.1964.21.9.0769; Sviri GE, 2004, STROKE, V35, P1867, DOI 10.1161/01.STR.0000133397.44528.f8; Tani Eiichi, 2004, Current Vascular Pharmacology, V2, P13, DOI 10.2174/1570161043476492; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Wellman GC, 2002, STROKE, V33, P802, DOI 10.1161/hs0302.104089; Wellman GC, 2006, NEUROL RES, V28, P690, DOI 10.1179/016164106X151972; WILDE DW, 1994, HYPERTENSION, V24, P739, DOI 10.1161/01.HYP.24.6.739; Xie A, 2007, J CEREBR BLOOD F MET, V27, P1692, DOI 10.1038/sj.jcbfm.9600471	34	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84129	10.1371/journal.pone.0084129	http://dx.doi.org/10.1371/journal.pone.0084129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392110	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100034
J	Stone, MD; Harvey, SB; Nelsestuen, GL; Reilly, C; Hertz, MI; Wendt, CH				Stone, Matthew D.; Harvey, Stephen B.; Nelsestuen, Gary L.; Reilly, Cavan; Hertz, Marshall I.; Wendt, Chris H.			Elevated Peptides in Lung Lavage Fluid Associated with Bronchiolitis Obliterans Syndrome	PLOS ONE			English	Article							UNOPPOSED NEUTROPHIL ELASTASE; BRONCHOALVEOLAR LAVAGE; TRANSPLANT RECIPIENTS; DATABASE	Objective: The objective of this discovery-level investigation was to use mass spectrometry to identify low mass compounds in bronchoalveolar lavage fluid from lung transplant recipients that associate with bronchiolitis obliterans syndrome. Experimental Design: Bronchoalveolar lavage fluid samples from lung transplant recipients were evaluated for small molecules using ESI-TOF mass spectrometry and correlated to the development of bronchiolitis obliterans syndrome. Peptides associated with samples from persons with bronchiolitis obliterans syndrome and controls were identified separately by MS/MS analysis. Results: The average bronchoalveolar lavage fluid MS spectrum profile of individuals that developed bronchiolitis obliterans syndrome differed greatly compared to controls. Controls demonstrated close inter-sample correlation (R = 0.97+/-0.02, average+/-SD) while bronchiolitis obliterans syndrome showed greater heterogeneity (R = 0.86+/-0.09, average+/-SD). We identified 89 features that were predictive of developing BOS grade 1 and 66 features predictive of developing BOS grade 2 or higher. Fractions from MS analysis were pooled and evaluated for peptide content. Nearly 10-fold more peptides were found in bronchiolitis obliterans syndrome relative to controls. C-terminal residues suggested trypsin-like specificity among controls compared to elastase-type enzymes among those with bronchiolitis obliterans syndrome. Conclusions: Bronchoalveolar lavage fluid from individuals with bronchiolitis obliterans syndrome has an increase in low mass components detected by mass spectrometry. Many of these features were peptides that likely result from elevated neutrophil elastase activity.	[Stone, Matthew D.] Waters Corp, Milford, MA USA; [Stone, Matthew D.; Harvey, Stephen B.; Nelsestuen, Gary L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Reilly, Cavan] Univ Minnesota, Dept Biostat, Minneapolis, MN USA; [Hertz, Marshall I.; Wendt, Chris H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wendt, Chris H.] Univ Minnesota, Dept Med, Vet Adm Med Ctr, Minneapolis, MN 55455 USA	Waters Corporation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Wendt, CH (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	wendt005@umn.edu			National Institutes of Health [HL080041]; NIH; NSF; Hatch funds; College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences; Office of the Vice President for Research, University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741, R01HL080041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Hatch funds; College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences; Office of the Vice President for Research, University of Minnesota(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant HL080041 from the National Institutes of Health. Instruments used for metabolome and peptide analysis were in the Center for Mass Spectrometry and Proteomics (CMSP), University of Minnesota and were purchased with partial support from the NIH, NSF and from Hatch funds and the CMSP receives operational support from the College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences and from the Office of the Vice President for Research, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Boehler A, 1998, CHEST, V114, P1411, DOI 10.1378/chest.114.5.1411; DiGiovine B, 1996, J IMMUNOL, V157, P4194; Elssner A, 2001, Transpl Infect Dis, V3, P168, DOI 10.1034/j.1399-3062.2001.003003168.x; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Henke JA, 1999, CHEST, V115, P403, DOI 10.1378/chest.115.2.403; Hubner RH, 2005, EUR RESPIR J, V25, P494, DOI 10.1183/09031936.05.00091804; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Meyer KC, 2001, AM J RESP CRIT CARE, V164, P97, DOI 10.1164/ajrccm.164.1.2006096; Nelsestuen GL, 2005, PROTEOMICS, V5, P1705, DOI 10.1002/pmic.200401036; Nunley D, 1999, AM J RESP CRIT CARE, V159, P258, DOI 10.1164/ajrccm.159.1.9712068; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Riise GC, 1999, EUR RESPIR J, V14, P1123, DOI 10.1183/09031936.99.14511239; Riise GC, 1998, EUR RESPIR J, V12, P82, DOI 10.1183/09031936.98.12010082; Smith GN, 2007, AM J TRANSPLANT, V7, P1856, DOI 10.1111/j.1600-6143.2007.01850.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Zhang Y, 2005, PROTEOMIS IN PRESS; Zheng L, 2000, THORAX, V55, P53, DOI 10.1136/thorax.55.1.53	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84471	10.1371/journal.pone.0084471	http://dx.doi.org/10.1371/journal.pone.0084471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392140	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100063
J	Wang, BW; Wu, GJ; Cheng, WP; Shyu, KG				Wang, Bao-Wei; Wu, Gong-Jhe; Cheng, Wen-Ping; Shyu, Kou-Gi			MicroRNA-208a Increases Myocardial Fibrosis via Endoglin in Volume Overloading Heart	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; CARDIAC-HYPERTROPHY; MECHANICAL STRETCH; EXPRESSION; ATORVASTATIN; SURVIVAL; FIBROBLASTS; INFARCTION; PRESSURE; FAILURE	MicroRNA-208a (mir-208a) is essential for cardiac hypertrophy and fibrosis. Endoglin, a co-receptor of transforming growth factor-beta is also essential for cardiac fibrosis. Endoglin has been shown to be a target of mir-208a in the in vitro mechanical stress model. Volume overload can lead to heart failure and cardiac fibrosis. The role of mir-208a and endoglin in volume overload heart failure is well known. We sought to investigate the mechanism of regulation of mir-208a and endoglin in volume overload-induced heart failure. Aorta-caval (AV) shunt was performed in adult Sprague-Dawley rats to induce volume overload. Heart weight and heart weight/body weight ratio significantly increased in AV shunt animals. AV shunt significantly increased left ventricular end-diastolic dimension as compared to sham group. Mir-208a was significantly induced by AV shunt from 3 to 14 days. Endoglin, myosin heavy chain-beta and brain natriuretic peptide were significantly induced by AV shunt from 3 to 14 days. Overexpression of mir-208a in the sham group without AV shunt significantly increased endoglin expression similar to the AV shunt group. Antagomir-208a attenuated the endoglin expression induced by AV shunt. Pretreatment with atorvastatin also attenuated the endoglin expression induced by AV shunt. AV shunt significantly increased myocardial fibrosis as compared to sham group. Overexpression of mir-208a in the sham group significantly increased myocardial fibrosis. Antagomir-208a and atorvastatin significantly attenuated the myocardial fibrosis induced by AV shunt. In conclusion, mir-208a increased endoglin expression to induce myocardial fibrosis in volume overloaded heart failure. Treatment with atorvastatin can attenuate the myocardial fibrosis induced by volume overload through inhibition of endoglin expression.	[Wang, Bao-Wei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Wang, Bao-Wei; Cheng, Wen-Ping; Shyu, Kou-Gi] Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan; [Wu, Gong-Jhe] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Wu, Gong-Jhe] Shin Kong Wu Ho Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan	Fu Jen Catholic University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University	Shyu, KG (corresponding author), Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Executive Yuan, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This study was sponsored in part from National Science Council, Executive Yuan, Taiwan and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamin IJ, 2012, CIRCULATION, V125, P2689, DOI 10.1161/CIRCULATIONAHA.112.108282; Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen J, 2006, AM J PHYSIOL-HEART C, V291, pH1738, DOI 10.1152/ajpheart.00341.2006; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chiu CZ, 2012, ACTA CARDIOL SIN, V28, P286; Dubey G, 2013, J APPL PHARM SCI, V3, P52; Fonsatti E, 2003, CURR DRUG TARGETS, V4, P291, DOI 10.2174/1389450033491073; Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; Kapur NK, 2010, AM J CARDIOL, V106, P1770, DOI 10.1016/j.amjcard.2010.08.018; Khush KK, 2007, CIRCULATION, V115, P576, DOI 10.1161/CIRCULATIONAHA.106.625574; Kurata T, 2011, BRAIN RES, V1371, P161, DOI 10.1016/j.brainres.2010.11.067; Lambert V, 2010, J THORAC CARDIOV SUR, V139, P1197, DOI 10.1016/j.jtcvs.2009.11.028; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Nachtigal P, 2007, CAN J PHYSIOL PHARM, V85, P767, DOI 10.1139/Y07-068; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pospisilova N, 2006, J PHARM PHARM SCI, V9, P388; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Shyu KG, 2005, J CARD FAIL, V11, P152, DOI 10.1016/j.cardfail.2004.06.433; Shyu KG, 2013, EUR J HEART FAIL, V15, P36, DOI 10.1093/eurjhf/hfs143; Shyu KG, 2010, EUR J HEART FAIL, V12, P219, DOI 10.1093/eurjhf/hfq011; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang BW, 2013, J FORMOS MED ASSOC, V112, P635, DOI 10.1016/j.jfma.2013.01.002; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5	33	45	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84188	10.1371/journal.pone.0084188	http://dx.doi.org/10.1371/journal.pone.0084188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392114	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100038
J	Griffin, AS; Guez, D; Lermite, F; Patience, M				Griffin, Andrea S.; Guez, David; Lermite, Francoise; Patience, Madeleine			Tracking Changing Environments: Innovators Are Fast, but Not Flexible Learners	PLOS ONE			English	Article							PROBLEM-SOLVING PERFORMANCE; BEHAVIORAL FLEXIBILITY; BRAIN SIZE; SERIAL DISCRIMINATION; ACRIDOTHERES-TRISTIS; INDIVIDUAL VARIATION; INVASION SUCCESS; INDIAN MYNAHS; BIRDS; EVOLUTION	Behavioural innovations are increasingly thought to provide a rich source of phenotypic plasticity and evolutionary change. Innovation propensity shows substantial variation across avian taxa and provides an adaptive mechanism by which behaviour is flexibly adjusted to changing environmental conditions. Here, we tested for the first time the prediction that inter-individual variation in innovation propensity is equally a measure of behavioural flexibility. We used Indian mynas, Sturnus tristis, a highly successful worldwide invader. Results revealed that mynas that solved an extractive foraging task more quickly learnt to discriminate between a cue that predicted food, and one that did not more quickly. However, fast innovators were slower to change their behaviour when the significance of the food cues changed. This unexpected finding appears at odds with the well-established view that avian taxa with larger brains relative to their body size, and therefore greater neural processing power, are both faster, and more flexible learners. We speculate that the existence of this relationship across taxa can be reconciled with its absence within species by assuming that fast, innovative learners and non innovative, slow, flexible learners constitute two separate individual strategies, which are both underpinned by enhanced neural processing power. This idea is consistent with the recent proposal that individuals may differ consistently in 'cognitive style', differentially trading off speed against accuracy in cognitive tasks.	[Griffin, Andrea S.; Guez, David; Lermite, Francoise; Patience, Madeleine] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia	University of Newcastle	Griffin, AS (corresponding author), Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia.	andrea.griffin@newcastle.edu.au	Guez, David/B-6502-2009; Galef, Bennett G/A-5678-2008; Griffin, Andrea S/GWM-8557-2022; Guez, David/O-2740-2015	Guez, David/0000-0002-6322-5237; Griffin, Andrea S/0000-0003-4624-9904; Guez, David/0000-0002-6322-5237	University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants	University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants	The research was supported by two University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants (2011, Griffin & Dayas; 2012, Griffin, Dayas and Guez). Internal grants are not attributed grant numbers. The University of Newcastle, Faculty of Science and Information Technology had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brust V, 2013, ETHOLOGY, V119, P559, DOI 10.1111/eth.12095; Byrne R., 1995, THINKING APE EVOLUTI; Cauchard L, 2013, ANIM BEHAV, V85, P19, DOI 10.1016/j.anbehav.2012.10.005; Christidis L, 2008, SYSTEMATICS TAXONOMY; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Cole EF, 2011, ANIM BEHAV, V81, P491, DOI 10.1016/j.anbehav.2010.11.025; Diquelou M., 2010, THESIS U PARIS, P13; Feare C.J., 2010, CONSERV EVIDENCE, V7, P52; GOSSETTE RL, 1969, PERCEPT MOTOR SKILL, V29, P803, DOI 10.2466/pms.1969.29.3.803; Gould JL, 2004, CURR BIOL, V14, pR372, DOI 10.1016/j.cub.2004.05.008; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2011, ANIM BEHAV, V81, P1163, DOI 10.1016/j.anbehav.2011.02.022; Griffin AS, 2009, ANIM BEHAV, V78, P79, DOI 10.1016/j.anbehav.2009.03.012; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Soler JJ, 2012, NATURWISSENSCHAFTEN, V99, P111, DOI 10.1007/s00114-011-0875-z; Kamil A C, 1987, Nebr Symp Motiv, V35, P257; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Keagy J, 2012, BEHAV ECOL, V23, P448, DOI 10.1093/beheco/arr211; Keagy J, 2009, ANIM BEHAV, V78, P809, DOI 10.1016/j.anbehav.2009.07.011; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lefebvre L, 2011, BIOL LETTERS, V7, P631, DOI 10.1098/rsbl.2010.0556; Lermite F., 2012, THESIS U PARIS 13, P13; LEVINE BA, 1974, J COMP PHYSIOL PSYCH, V86, P730, DOI 10.1037/h0036163; Macphail EM, 2001, BIOL REV, V76, P341; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Nicolakakis N, 2003, ANIM BEHAV, V65, P445, DOI 10.1006/anbe.2003.2085; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; RAJALAKSHMI R, 1965, ANIM BEHAV, V13, P203, DOI 10.1016/0003-3472(65)90035-7; Reader SM, 2007, BEHAV BRAIN SCI, V30, P420, DOI 10.1017/S0140525X07002518; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; SCHUSTER.RJ, 1966, J EXP ANAL BEHAV, V9, P593, DOI 10.1901/jeab.1966.9-593; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2012, OECOLOGIA, V169, P553, DOI 10.1007/s00442-011-2203-x; Sol D, 2012, ANIM BEHAV, V83, P179, DOI 10.1016/j.anbehav.2011.10.024; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344	50	58	58	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84907	10.1371/journal.pone.0084907	http://dx.doi.org/10.1371/journal.pone.0084907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391981	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329323900124
J	Kurrle, N; Vollner, F; Eming, R; Hertl, M; Banning, A; Tikkanen, R				Kurrle, Nina; Voellner, Frauke; Eming, Ruediger; Hertl, Michael; Banning, Antje; Tikkanen, Ritva			Flotillins Directly Interact with gamma-Catenin and Regulate Epithelial Cell-Cell Adhesion	PLOS ONE			English	Article							LIPID RAFTS; E-CADHERIN; ALPHA-CATENIN; N-CADHERIN; DESMOSOMAL CADHERINS; PLAKOGLOBIN DOMAINS; BINDING-SITES; BETA-CATENIN; ASSOCIATION; MEMBRANE	Flotillin-1 and flotillin-2 are two homologous, membrane raft associated proteins. Although it has been reported that flotillins are involved in cell adhesion processes and play a role during breast cancer progression, thus making them interesting future therapeutic targets, their precise function has not been well elucidated. The present study investigates the function of these proteins in cell-cell adhesion in non-malignant cells. We have used the non-malignant epithelial MCF10A cells to study the interaction network of flotillins within cell-cell adhesion complexes. RNA interference was used to examine the effect of flotillins on the structure of adherens junctions and on the association of core proteins, such as Ecadherin, with membrane rafts. We here show that the cadherin proteins of the adherens junction associate with flotillin-2 in MCF10A cells and in various human cell lines. In vitro, flotillin-1 and flotillin-2 directly interact with c-catenin which is so far the only protein known to be present both in the adherens junction and the desmosome. Mapping of the interaction domain within the c-catenin sequence identified the Armadillo domains 6-8, especially ARM domain 7, to be important for the association with flotillins. Furthermore, depletion of flotillins significantly influenced the morphology of the adherens junction in human epithelial MCF10A cells and altered the association of E-cadherin and c-catenin with membrane rafts. Taken together, these observations suggest a functional role for flotillins, especially flotillin-2, in cell-cell adhesion in nonmalignant epithelial cells.	[Kurrle, Nina; Voellner, Frauke; Banning, Antje; Tikkanen, Ritva] Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany; [Eming, Ruediger; Hertl, Michael] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany	Justus Liebig University Giessen; Philipps University Marburg	Tikkanen, R (corresponding author), Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de		Tikkanen, Ritva/0000-0002-8393-1825	Behring-Rontgen Foundation [59-0012]; Deutsche Forschungsgemeinschaft (DFG) [Ti291/6-2]	Behring-Rontgen Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study has been financially supported by a grant from the von Behring-Rontgen Foundation to RT (Grant 59-0012) and by the Deutsche Forschungsgemeinschaft (DFG) grant Ti291/6-2 to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Banning A, 2014, CELL SIGNAL, V26, P198, DOI 10.1016/j.cellsig.2013.11.001; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Berger T, 2012, ONCOGENE; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; BOUKAMP P, 1982, JNCI-J NATL CANCER I, V68, P415; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chartier NT, 2011, EXP CELL RES, V317, P1422, DOI 10.1016/j.yexcr.2011.03.009; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Chitaev NA, 1998, J CELL SCI, V111, P1941; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Deininger SO, 2003, MOL CELL NEUROSCI, V22, P544, DOI 10.1016/S1044-7431(03)00028-9; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRANKE WW, 1983, EMBO J, V2, P2211, DOI 10.1002/j.1460-2075.1983.tb01725.x; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Guillaume E, 2013, J CELL SCI; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hazarika P, 1999, J CELL BIOCHEM, V75, P147, DOI 10.1002/(SICI)1097-4644(19991001)75:1<147::AID-JCB15>3.0.CO;2-D; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Misra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049766; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Obama H, 1997, J BIOL CHEM, V272, P11017; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pust S, 2013, ONCOGENE, V32, P3443, DOI 10.1038/onc.2012.357; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; SCHROEDER WT, 1994, J BIOL CHEM, V269, P19983; Schulte T, 1997, DEVELOPMENT, V124, P577; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; SOULE HD, 1990, CANCER RES, V50, P6075; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; Wahl JK, 1996, J CELL SCI, V109, P1143; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	71	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84393	10.1371/journal.pone.0084393	http://dx.doi.org/10.1371/journal.pone.0084393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391950	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900093
J	Toth, R; Meszaros, I; Stefancsik, R; Bartha, D; Balint, A; Zadori, Z				Toth, Renata; Meszaros, Istvan; Stefancsik, Rajmund; Bartha, Daniel; Balint, Adam; Zadori, Zoltan			CpG Distribution and Methylation Pattern in Porcine Parvovirus	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; DNA METHYLATION; MUTATION-RATE; CYTOSINE METHYLATION; VIRAL PERSISTENCE; VIRUS-INFECTION; BINDING-SITES; PROTEIN; FREQUENCY; CHROMATIN	Based on GC content and the observed/expected CpG ratio (oCpGr), we found three major groups among the members of subfamily Parvovirinae: Group I parvoviruses with low GC content and low oCpGr values, Group II with low GC content and high oCpGr values and Group III with high GC content and high oCpGr values. Porcine parvovirus belongs to Group I and it features an ascendant CpG distribution by position in its coding regions similarly to the majority of the parvoviruses. The entire PPV genome remains hypomethylated during the viral lifecycle independently from the tissue of origin. In vitro CpG methylation of the genome has a modest inhibitory effect on PPV replication. The in vitro hypermethylation disappears from the replicating PPV genome suggesting that beside the maintenance DNMT1 the de novo DNMT3a and DNMT3b DNA methyltransferases can't methylate replicating PPV DNA effectively either, despite that the PPV infection does not seem to influence the expression, translation or localization of the DNA methylases. SNP analysis revealed high mutability of the CpG sites in the PPV genome, while introduction of 29 extra CpG sites into the genome has no significant biological effects on PPV replication in vitro. These experiments raise the possibility that beyond natural selection mutational pressure may also significantly contribute to the low level of the CpG sites in the PPV genome.	[Toth, Renata; Meszaros, Istvan; Bartha, Daniel; Zadori, Zoltan] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Stefancsik, Rajmund] Univ Cambridge, Div Genet, FlyBase, Cambridge, England; [Balint, Adam] Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Cambridge	Toth, R (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	tothrenata@vmri.hu		Stefancsik, Ray/0000-0001-8314-2140	OTKA; NKTH [Mobilitas 08-C OTKA 81187]; Hungarian Academy of Sciences [BO/00414/10]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NKTH(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by OTKA and NKTH (Mobilitas 08-C OTKA 81187), the Janos Bolyai Fellowship from the Hungarian Academy of Sciences (BO/00414/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambinder RF, 1999, SEMIN CANCER BIOL, V9, P369, DOI 10.1006/scbi.1999.0137; Ballestar E, 2011, ADV EXP MED BIOL, V711, P1; BERGERON J, 1993, VIROLOGY, V197, P86, DOI 10.1006/viro.1993.1569; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonvicini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033316; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; BURNETT TS, 1984, NUCLEIC ACIDS RES, V12, P8847, DOI 10.1093/nar/12.23.8847; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; CHORBA T, 1986, J INFECT DIS, V154, P383, DOI 10.1093/infdis/154.3.383; COOPER DN, 1985, CELL DIFFER DEV, V17, P199, DOI 10.1016/0045-6039(85)90488-9; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; DANOS O, 1980, EUR J BIOCHEM, V109, P457, DOI 10.1111/j.1432-1033.1980.tb04815.x; Davison AJ, 2006, J GEN VIROL, V87, P3509, DOI 10.1099/vir.0.82291-0; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; DUNNE HW, 1965, AM J VET RES, V26, P1284; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Filipovska-Naumovska E, 2010, J AM ASSOC LAB ANIM, V49, P443; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; FORD JP, 1980, J BIOL CHEM, V255, P7544; Foulongne V, 2006, EMERG INFECT DIS, V12, P862, DOI 10.3201/eid1205.051523; Gagnon CA, 2007, CAN VET J, V48, P811; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRADIL CM, 1990, J VET MED B, V37, P309, DOI 10.1111/j.1439-0450.1990.tb01063.x; GUNTHERT U, 1976, P NATL ACAD SCI USA, V73, P3923, DOI 10.1073/pnas.73.11.3923; Harte RA, 2012, TRACKING COORDINATIN; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; KISARY J, 1978, AVIAN PATHOL, V7, P397, DOI 10.1080/03079457808418293; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Leger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020881; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Luo Juan, 2012, Frontiers in Genetics, V3, P20, DOI 10.3389/fgene.2012.00020; Lyko F, 2001, TRENDS GENET, V17, P169, DOI 10.1016/S0168-9525(01)02234-X; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mattei LM, 2013, J VIROL, V87, P3605, DOI 10.1128/JVI.03155-12; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MOLITOR TW, 1984, VIROLOGY, V137, P241, DOI 10.1016/0042-6822(84)90216-2; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nachman MW, 2000, GENETICS, V156, P297; Penaud-Budloo M, 2008, J VIROL, V82, P7875, DOI 10.1128/JVI.00649-08; Pringle IA, 2005, GENE THER, V12, P1206, DOI 10.1038/sj.gt.3302518; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rothenfusser S, 2001, EUR J IMMUNOL, V31, P3525, DOI 10.1002/1521-4141(200112)31:12<3525::AID-IMMU3525>3.0.CO;2-5; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shao G, 2013, IN VITRO CELL DEV-AN, V49, P386, DOI 10.1007/s11626-013-9619-z; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Stucker KM, 2012, J VIROL, V86, P1514, DOI 10.1128/JVI.06222-11; Takahashi M, 2013, BIOCHEM BIOPH RES CO, V434, P873, DOI 10.1016/j.bbrc.2013.04.041; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Tattersall P., 2006, PARVOVIRUSES, P5; VANLEENGOED LA, 1983, VET QUART, V5, P131, DOI 10.1080/01652176.1983.9693887; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIENHUES U, 1985, J VIROL, V56, P320, DOI 10.1128/JVI.56.1.320-324.1985; WINOCOUR E, 1965, VIROLOGY, V27, P156, DOI 10.1016/0042-6822(65)90155-8; Xia JF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S7; Zadori Z, 2005, J VIROL, V79, P13129, DOI 10.1128/JVI.79.20.13129-13138.2005; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zeisberg EM, 2013, J PATHOL, V229, P264, DOI 10.1002/path.4120	76	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85986	10.1371/journal.pone.0085986	http://dx.doi.org/10.1371/journal.pone.0085986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392033	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900177
J	Collen, PN; Jeudy, A; Sassi, JF; Groisillier, A; Czjzek, M; Coutinho, PM; Helbert, W				Collen, Pi Nyvall; Jeudy, Alexandra; Sassi, Jean-Francois; Groisillier, Agnes; Czjzek, Mirjam; Coutinho, Pedro M.; Helbert, William			A Novel Unsaturated beta-Glucuronyl Hydrolase Involved in Ulvan Degradation Unveils the Versatility of Stereochemistry Requirements in Family GH105	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biodegradation; Crystal Structure; Enzyme Catalysis; Glycoside Hydrolases; Polysaccharide; GH105; Ulvan	ASYMMETRIC INTERLACED PCR; CELL-WALL POLYSACCHARIDES; CHEMICAL-STRUCTURE; PERSICIVIRGA-ULVANIVORANS; RHEOLOGICAL PROPERTIES; SP NOV.; CHLOROPHYTA; GLYCOSAMINOGLYCAN; OLIGOSACCHARIDES; SEQUENCE	Background: Biodegradation of green algal cell wall requires specialized enzymatic machinery, which is not yet well characterized. Results: Structural and biochemical characterization of a new -glucuronyl hydrolase belonging to family GH105 active on oligo-ulvans. Conclusion: The GH105 family encompasses enzymes cleaving both - and -linked glycosides. Significance: Investigations of enzymatic degradation of marine polysaccharides reveals enzymes with unique characteristics. Ulvans are cell wall matrix polysaccharides in green algae belonging to the genus Ulva. Enzymatic degradation of the polysaccharide by ulvan lyases leads to the production of oligosaccharides with an unsaturated -glucuronyl residue located at the non-reducing end. Exploration of the genomic environment around the Nonlabens ulvanivorans (previously Percicivirga ulvanivorans) ulvan lyase revealed a gene highly similar to known unsaturated uronyl hydrolases classified in the CAZy glycoside hydrolase family 105. The gene was cloned, the protein was overexpressed in Escherichia coli, and enzymology experiments demonstrated its unsaturated -glucuronyl activity. Kinetic analysis of purified oligo-ulvans incubated with the new enzyme showed that the full substrate specificity is attained by three subsites that preferentially bind anionic residues (sulfated rhamnose, glucuronic/iduronic acid). The three-dimensional crystal structure of the native enzyme reveals that a trimeric organization is required for substrate binding and recognition at the +2 binding subsite. This novel unsaturated -glucuronyl hydrolase is part of a previously uncharacterized subgroup of GH105 members and exhibits only a very limited sequence similarity to known unsaturated -glucuronyl sequences previously found only in family GH88. Clan-O formed by families GH88 and GH105 was singular in the fact that it covered families acting on both axial and equatorial glycosidic linkages, respectively. The overall comparison of active site structures between enzymes from these two families highlights how that within family GH105, and unlike for classical glycoside hydrolysis, the hydrolysis of vinyl ether groups from unsaturated saccharides occurs independently of the or configuration of the cleaved linkage.	[Collen, Pi Nyvall; Jeudy, Alexandra; Groisillier, Agnes; Czjzek, Mirjam; Helbert, William] Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France; [Sassi, Jean-Francois] Ctr Etud & Valorisat Algues, F-22610 Pleubian, France; [Coutinho, Pedro M.] Aix Marseille Univ, CNRS, Unite Mixte Rech 7257, F-13288 Marseille, France; [Helbert, William] Univ Grenoble 1, Ctr Rech Macromol Vegetales, UPR CNRS 5301, Grenoble 9, France; [Helbert, William] Inst Chim Mol Grenoble, FR CNRS 2607, Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Helbert, W (corresponding author), CERMAV CNRS, Rue Chim,BP53x, F-38041 Grenoble 9, France.	helbert@cermav.cnrs.fr	SASSI, Jean Francois/D-4076-2013		French National Research Agency (ANR; Recherche et Innovation en Biotechnologie) [ANR-07-RIB-019]; Pole Mer Bretagne competitiveness cluster; CNRS; Brittany Regional Council	French National Research Agency (ANR; Recherche et Innovation en Biotechnologie)(French National Research Agency (ANR)); Pole Mer Bretagne competitiveness cluster(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); Brittany Regional Council(Region Bretagne)	This work was supported in part by the French National Research Agency (ANR; Recherche et Innovation en Biotechnologie, Grant ANR-07-RIB-019 for the Ulvoligo Project), the Pole Mer Bretagne competitiveness cluster, the CNRS, and the Brittany Regional Council.	Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Boutachfaiti R., 2009, Method for enzyme cleavage of polysaccharides derived from algae, Patent No. [WO 2009/016275 A2, 2009016275A2]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han C, 2009, STAND GENOMIC SCI, V1, P54, DOI 10.4056/sigs.22138; Hashimoto W, 2007, INT MICROBIOL, V10, P233, DOI 10.2436/20.1501.01.32; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korf U, 2005, PROTEOMICS, V5, P3571, DOI 10.1002/pmic.200401195; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Percival E., 1967, CHEM ENZYMOLOGY MARI, DOI DOI 10.1002/ANGE; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3; Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020; Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023; Robic A, 2009, J PHYCOL, V45, P962, DOI 10.1111/j.1529-8817.2009.00699.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yi H, 2012, SYST APPL MICROBIOL, V35, P150, DOI 10.1016/j.syapm.2011.12.002; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	40	33	34	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6199	6211		10.1074/jbc.M113.537480	http://dx.doi.org/10.1074/jbc.M113.537480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407291	Green Published, hybrid			2022-12-25	WOS:000332015500073
J	Mitsunobu, H; Zhu, B; Lee, SJ; Tabor, S; Richardson, CC				Mitsunobu, Hitoshi; Zhu, Bin; Lee, Seung-Joo; Tabor, Stanley; Richardson, Charles C.			Flap Endonuclease Activity of Gene 6 Exonuclease of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Damage; DNA Repair; DNA Replication; DNA-Protein Interaction; RNA Processing; Bacteriophage T7; Gene 6 Exonuclease; Okazaki Fragment; Flap Endonuclease	SINGLE-STRANDED-DNA; DEOXYRIBONUCLEIC-ACID; ESCHERICHIA-COLI; BINDING-PROTEIN; STRUCTURAL BASIS; DISPLACEMENT SYNTHESIS; SUBSTRATE-SPECIFICITY; REPLICATION FORK; 3'-FLAP POCKET; I-TASSER	Background: Flap endonucleases remove 5-single-stranded DNA termini. Results: T7 gene 6 exonuclease is a flap endonuclease that cleaves 5-single-stranded termini one nucleotide into the duplex. Conclusion: The flap endonuclease activity catalyzes the removal 5-single-stranded tails arising from duplex DNA. Significance: The specificity of gene 6 protein identifies it as a flap endonuclease that can remove unusual structures of recombination and replication. Flap endonucleases remove flap structures generated during DNA replication. Gene 6 protein of bacteriophage T7 is a 5-3-exonuclease specific for dsDNA. Here we show that gene 6 protein also possesses a structure-specific endonuclease activity similar to known flap endonucleases. The flap endonuclease activity is less active relative to its exonuclease activity. The major cleavage by the endonuclease activity occurs at a position one nucleotide into the duplex region adjacent to a dsDNA-ssDNA junction. The efficiency of cleavage of the flap decreases with increasing length of the 5-overhang. A 3-single-stranded tail arising from the same end of the duplex as the 5-tail inhibits gene 6 protein flap endonuclease activity. The released flap is not degraded further, but the exonuclease activity then proceeds to hydrolyze the 5-terminal strand of the duplex. T7 gene 2.5 single-stranded DNA-binding protein stimulates the exonuclease and also the endonuclease activity. This stimulation is attributed to a specific interaction between the two proteins because Escherichia coli single-stranded DNA binding protein does not produce this stimulatory effect. The ability of gene 6 protein to remove 5-terminal overhangs as well as to remove nucleotides from the 5-termini enables it to effectively process the 5-termini of Okazaki fragments before they are ligated.	[Mitsunobu, Hitoshi; Zhu, Bin; Lee, Seung-Joo; Tabor, Stanley; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.)	Alberts B., 1980, MECH STUDIES DNA REP; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; CENTER MS, 1970, P NATL ACAD SCI USA, V65, P242, DOI 10.1073/pnas.65.1.242; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHASE JW, 1974, J BIOL CHEM, V249, P4545; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garforth SJ, 1997, NUCLEIC ACIDS RES, V25, P3801, DOI 10.1093/nar/25.19.3801; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KERR C, 1972, J BIOL CHEM, V247, P311; KERR C, 1972, J BIOL CHEM, V247, P305; KERR C, 1975, VIROLOGY, V65, P281, DOI 10.1016/0042-6822(75)90031-8; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Kong DC, 1997, J BIOL CHEM, V272, P8380; KONG DC, 1994, J BACTERIOL, V176, P5904, DOI 10.1128/jb.176.19.5904-5911.1994; Kornberg A., 1992, DNA REPLICATION, P403; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; LEE M, 1974, J VIROL, V14, P1040, DOI 10.1128/JVI.14.5.1040-1048.1974; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MASAMUNE Y, 1971, J BIOL CHEM, V246, P2692; MASKER W, 1992, J BACTERIOL, V174, P155, DOI 10.1128/jb.174.1.155-160.1992; MILLER RC, 1976, J MOL BIOL, V101, P223, DOI 10.1016/0022-2836(76)90374-0; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; POWLING A, 1974, MOL GEN GENET, V134, P173, DOI 10.1007/BF00268418; Rezende LF, 2003, J BIOL CHEM, V278, P29098, DOI 10.1074/jbc.M303374200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; ROBERTS L, 1982, BIOCHEMISTRY-US, V21, P6000, DOI 10.1021/bi00266a042; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SADOWSKI PD, 1970, J VIROL, V6, P149, DOI 10.1128/JVI.6.2.149-155.1970; SADOWSKI PD, 1971, J BIOL CHEM, V246, P200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SERWER P, 1990, J MOL BIOL, V215, P287, DOI 10.1016/S0022-2836(05)80347-X; SHINOZAKI K, 1978, NUCLEIC ACIDS RES, V5, P4245, DOI 10.1093/nar/5.11.4245; SHINOZAKI K, 1977, MOL GEN GENET, V154, P263, DOI 10.1007/BF00571281; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; STUDIER FW, 1969, VIROLOGY, V39, P562, DOI 10.1016/0042-6822(69)90104-4; TABOR S, 1987, J BIOL CHEM, V262, P15330; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; WHITE JH, 1987, J BIOL CHEM, V262, P8851; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu B, 2012, P NATL ACAD SCI USA, V109, P8050, DOI 10.1073/pnas.1205990109	69	7	7	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5860	5875		10.1074/jbc.M113.538611	http://dx.doi.org/10.1074/jbc.M113.538611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394415	Green Published, hybrid			2022-12-25	WOS:000332015500044
J	Ziegler, AN; Chidambaram, S; Forbes, BE; Wood, TL; Levison, SW				Ziegler, Amber N.; Chidambaram, Shravanthi; Forbes, Briony E.; Wood, Teresa L.; Levison, Steven W.			Insulin- like Growth Factor- II ( IGF- II) and IGF- II Analogs with Enhanced Insulin Receptor- a Binding Affinity Promote Neural Stem Cell Expansion*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Insulin; Neurodevelopment; Receptor Tyrosine Kinase; Stem Cells; Central Nervous System; Insulin Receptor; Self-renewal	CEREBROSPINAL-FLUID; EXPRESSION; PROTEINS; ISOFORM; SITE; DETERMINANTS; MECHANISM; NEURONS; FLOW	Background: IGF-II promotes neural stem cell (NSC) proliferation and self-renewal. Results: IGF-II analogs are useful for elucidating the receptors responsible for NSC expansion. Conclusion: F19A expands NSCs via IR-A. Significance: IGF-II promotes stemness of NSCs via the IR-A and not through activation of either the IGF-1R or the IGF-2R. The objective of this study was to employ genetically engineered IGF-II analogs to establish which receptor(s) mediate the stemness promoting actions of IGF-II on mouse subventricular zone neural precursors. Neural precursors from the subventricular zone were propagated in vitro in culture medium supplemented with IGF-II analogs. Cell growth and identity were analyzed using sphere generation and further analyzed by flow cytometry. F19A, an analog of IGF-II that does not bind the IGF-2R, stimulated an increase in the proportion of neural stem cells (NSCs) while decreasing the proportion of the later stage progenitors at a lower concentration than IGF-II. V43M, which binds to the IGF-2R with high affinity but which has low binding affinity to the IGF-1R and to the A isoform of the insulin receptor (IR-A) failed to promote NSC growth. The positive effects of F19A on NSC growth were unaltered by the addition of a functional blocking antibody to the IGF-1R. Altogether, these data lead to the conclusion that IGF-II promotes stemness of NSCs via the IR-A and not through activation of either the IGF-1R or the IGF-2R.	[Ziegler, Amber N.; Chidambaram, Shravanthi; Wood, Teresa L.; Levison, Steven W.] Rutgers Biomed & Hlth Sci, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Forbes, Briony E.] Flinders Univ S Australia, Discipline Med Biochem, Ctr Neurosci, Adelaide, SA 5001, Australia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Flinders University South Australia	Levison, SW (corresponding author), Rutgers Biomed & Hlth Sci, Dept Neurol & Neurosci, Canc Ctr H1226, 205 S Orange Ave, Newark, NJ 07103 USA.	steve.levison@Rutgers.edu	Forbes, Briony/R-1838-2019; Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Chidambaram, Shravanthi/0000-0001-8746-3101; Wood, Teresa/0000-0002-4480-660X; Forbes, Briony/0000-0003-4360-9927	National Institutes of Health [R21 NS076874, F31 NS065607]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076874, F31NS065607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS076874 (to S. W. L. and T. L. W.) and F31 NS065607 (to A. N. Z.).	Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Blum G, 2000, BIOCHEMISTRY-US, V39, P15705, DOI 10.1021/bi001516y; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Brown J, 2009, TRENDS BIOCHEM SCI, V34, P612, DOI 10.1016/j.tibs.2009.07.003; Buono KD, 2012, DEV NEUROSCI-BASEL, V34, P449, DOI 10.1159/000345155; Carrick FE, 2001, J BIOL CHEM, V276, P27120, DOI 10.1074/jbc.M101317200; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jung S, 2010, STEM CELLS DEV, V19, P831, DOI 10.1089/scd.2009.0093; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Liang L, 2010, ENDOCRINOLOGY, V151, P741, DOI 10.1210/en.2009-0705; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Owen-Lynch PJ, 2003, BRAIN, V126, P623, DOI 10.1093/brain/awg058; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Ziegler AN, 2012, STEM CELLS, V30, P1265, DOI 10.1002/stem.1095	38	34	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4626	4633		10.1074/jbc.M113.537597	http://dx.doi.org/10.1074/jbc.M113.537597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398690	Green Published, hybrid			2022-12-25	WOS:000331607900010
J	Hasmats, J; Green, H; Orear, C; Validire, P; Huss, M; Kaller, M; Lundeberg, J				Hasmats, Johanna; Green, Henrik; Orear, Cedric; Validire, Pierre; Huss, Mikael; Kaller, Max; Lundeberg, Joakim			Assessment of Whole Genome Amplification for Sequence Capture and Massively Parallel Sequencing	PLOS ONE			English	Article							EXOME CAPTURE; AMPLIFIED DNA; MUTATION; CANCER; METAGENOMES; DISCOVERY; VIRUSES; SAMPLES; TUMOR	Exome sequence capture and massively parallel sequencing can be combined to achieve inexpensive and rapid global analyses of the functional sections of the genome. The difficulties of working with relatively small quantities of genetic material, as may be necessary when sharing tumor biopsies between collaborators for instance, can be overcome using whole genome amplification. However, the potential drawbacks of using a whole genome amplification technology based on random primers in combination with sequence capture followed by massively parallel sequencing have not yet been examined in detail, especially in the context of mutation discovery in tumor material. In this work, we compare mutations detected in sequence data for unamplified DNA, whole genome amplified DNA, and RNA originating from the same tumor tissue samples from 16 patients diagnosed with non-small cell lung cancer. The results obtained provide a comprehensive overview of the merits of these techniques for mutation analysis. We evaluated the identified genetic variants, and found that most (74%) of them were observed in both the amplified and the unamplified sequence data. Eighty-nine percent of the variations found by WGA were shared with unamplified DNA. We demonstrate a strategy for avoiding allelic bias by including RNA-sequencing information.	[Hasmats, Johanna; Green, Henrik; Kaller, Max; Lundeberg, Joakim] Royal Inst Technol, Div Gene Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Green, Henrik] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Green, Henrik] Linkoping Univ, Dept Hlth & Med Sci, Linkoping, Sweden; [Orear, Cedric] Inst Gustave Roussy, Genom Unit, Villejuif, France; [Validire, Pierre] Inst Mutualiste Montsouris, Dept Pathol, Paris, France; [Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden	Royal Institute of Technology; Swedish National Board of Forensic Medicine; Linkoping University; UNICANCER; Gustave Roussy; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Stockholm University	Green, H (corresponding author), Royal Inst Technol, Div Gene Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden.	henrik.green@rmv.se	Green, Henrik/D-1401-2012	Green, Henrik/0000-0002-8015-5728; Huss, Mikael/0000-0003-0839-2451	European Commission [CHEMORES LSHC-CT-2007-037665]; Swedish Cancer Society; Swedish Cancer Foundation; Swedish Research Council; Fondkistan; Stiftelsen Sigurd och Elsa Goljes Minne; Markus Borgstroms stiftelse	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Cancer Society(Swedish Cancer Society); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Fondkistan; Stiftelsen Sigurd och Elsa Goljes Minne; Markus Borgstroms stiftelse	This work was financially supported by grants from the European Commission (CHEMORES LSHC-CT-2007-037665), the Swedish Cancer Society, the Swedish Cancer Foundation, the Swedish Research Council, Fondkistan, Stiftelsen Sigurd och Elsa Goljes Minne and Markus Borgstroms stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent, 2012, SURESELECT TARG ENR; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Forster M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks836; Hannemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026362; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Illumina, 2012, TRUS EX ENR KIT DAT; Indap AR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-468; Jiang T, 2011, SCI CHINA LIFE SCI, V54, P945, DOI 10.1007/s11427-011-4232-4; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee JC, 2012, MED SCI LAW; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Murphy SJ, 2012, DNA RES, V19, P395, DOI 10.1093/dnares/dss021; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nimblegen, 2011, SEQCAP EZ HUM EX LIB; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Siu WK, 2012, DIAGN MOL PATHOL, V21, P184, DOI 10.1097/PDM.0b013e31825554d0; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; Stahl PL, 2012, ANNU REV BIOCHEM, V81, P359, DOI 10.1146/annurev-biochem-060410-094158; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	28	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84785	10.1371/journal.pone.0084785	http://dx.doi.org/10.1371/journal.pone.0084785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409309	Green Submitted, gold, Green Published			2022-12-25	WOS:000329463500033
J	Naya, L; Paul, S; Valdes-Lopez, O; Mendoza-Soto, AB; Nova-Franco, B; Sosa-Valencia, G; Reyes, JL; Hernandez, G				Naya, Loreto; Paul, Sujay; Valdes-Lopez, Oswaldo; Mendoza-Soto, Ana B.; Nova-Franco, Barbara; Sosa-Valencia, Guadalupe; Reyes, Jose L.; Hernandez, Georgina			Regulation of Copper Homeostasis and Biotic Interactions by MicroRNA 398b in Common Bean	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; PHASEOLUS-VULGARIS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; SCLEROTINIA-SCLEROTIORUM; DIFFERENTIAL REGULATION; PLANT MICRORNAS; DOWN-REGULATION; ARABIDOPSIS; IDENTIFICATION	MicroRNAs are recognized as important post-transcriptional regulators in plants. Information about the roles of miRNAs in common bean (Phaseolus vulgaris L.), an agronomically important legume, is yet scant. The objective of this work was to functionally characterize the conserved miRNA: miR398b and its target Cu/Zn Superoxide Dismutase 1 (CSD1) in common bean. We experimentally validated a novel miR398 target: the stress up-regulated Nodulin 19 (Nod19). Expression analysis of miR398b and target genes -CSD1 and Nod19- in bean roots, nodules and leaves, indicated their role in copper (Cu) homeostasis. In bean plants under Cu toxicity miR398b was decreased and Nod19 and CSD1, that participates in reactive oxygen species (ROS) detoxification, were up-regulated. The opposite regulation was observed in Cu deficient bean plants; lower levels of CSD1 would allow Cu delivery to essential Cu-containing proteins. Composite common bean plants with transgenic roots over-expressing miR398 showed ca. 20-fold higher mature miR398b and almost negligible target transcript levels as well as increased anthocyanin content and expression of Cu-stress responsive genes, when subjected to Cu deficiency. The down-regulation of miR398b with the consequent up-regulation of its targets was observed in common bean roots during the oxidative burst resulting from short-time exposure to high Cu. A similar response occurred at early stage of bean roots inoculated with Rhizobium tropici, where an increase in ROS was observed. In addition, the miR398b down-regulation and an increase in CSD1 and Nod19 were observed in bean leaves challenged with Sclerotinia scleortiorum fungal pathogen. Transient over-expression of miR398b in Nicotiana benthamiana leaves infected with S. sclerotiorum resulted in enhanced fungal lesions. We conclude that the miR398b-mediated up-regulation of CSD and Nod19 is relevant for common bean plants to cope with oxidative stress generated in abiotic and biotic stresses.	[Naya, Loreto; Paul, Sujay; Valdes-Lopez, Oswaldo; Mendoza-Soto, Ana B.; Nova-Franco, Barbara; Hernandez, Georgina] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Valdes-Lopez, Oswaldo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Lab Bioquim, Tlalnepantla, Estado Mexico, Mexico; [Sosa-Valencia, Guadalupe; Reyes, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez, G (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	gina@ccg.unam.mx	Paul, Sujay/R-7572-2019; Reyes, Jose/D-7331-2013; Valdés-López, Oswaldo/K-8695-2019; SOSA-VALENCIA, GUADALUPE/F-8071-2019	Valdés-López, Oswaldo/0000-0002-4760-048X; Mendoza Soto, Ana Belen/0000-0002-9184-1424; Reyes, Jose L./0000-0001-5129-9741; Paul, Sujay/0000-0001-5024-7261; SOSA-VALENCIA, GUADALUPE/0000-0002-7178-3271	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [PAPIIT IN202213]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM. Grant no. PAPIIT IN202213 and Postdoctoral Scholarships to LN and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio-Fabre R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-26; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Baron C, 1995, ANNU REV GENET, V29, P107, DOI 10.1146/annurev.ge.29.120195.000543; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; BONGUEBARTELSMAN M, 1995, PLANT PHYSIOL BIOCH, V33, P539; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bouazizi H, 2010, ECOTOX ENVIRON SAFE, V73, P1304, DOI 10.1016/j.ecoenv.2010.05.014; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cuypers A, 2005, J PLANT PHYSIOL, V162, P383, DOI 10.1016/j.jplph.2004.07.018; Cuypers A, 2000, PHYSIOL PLANTARUM, V110, P512, DOI 10.1111/j.1399-3054.2000.1100413.x; De Luis A, 2012, PLANT PHYSIOL, V160, P2137, DOI 10.1104/pp.112.204883; Doss RP, 2005, PLANT PHYSIOL BIOCH, V43, P225, DOI 10.1016/j.plaphy.2005.01.016; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; ELNENNAH M, 1982, PLANT SOIL, V65, P289, DOI 10.1007/BF02374660; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; FERNANDES JC, 1991, BOT REV, V57, P246, DOI 10.1007/BF02858564; FRANCO AA, 1982, PLANT SOIL, V66, P149, DOI 10.1007/BF02183974; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Ganesan V, 2001, PLANT SCI, V160, P1095, DOI 10.1016/S0168-9452(01)00327-2; Giusti M.M., 2001, CURR PROTOC FOOD ANA, V00, pF1.1.1, DOI [10.1002/0471142913.faf0102s00, DOI 10.1002/0471142913.FAF0102S00]; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guan QM, 2013, PLANT J, V74, P840, DOI 10.1111/tpj.12169; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kuo HF, 2011, PLANT PHYSIOL, V156, P1016, DOI 10.1104/pp.111.175265; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048951; Mandon K, 2009, SIGNAL COMMUN PLANTS, P135, DOI 10.1007/978-3-642-00390-5_8; Marschner H., 2002, MINERAL NUTR HIGHER; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; OLDENKAM.L, 1966, PLANT SOIL, V25, P150, DOI 10.1007/BF01347969; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Paul S, 2014, J INTEGR PLANT BIOL, V56, P15, DOI 10.1111/jipb.12115; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Perea-Garcia A, 2013, PLANT PHYSIOL, V162, P180, DOI 10.1104/pp.112.212407; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sgherri C, 2007, J PLANT PHYSIOL, V164, P1152, DOI 10.1016/j.jplph.2006.05.020; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Valdes Lopez O, 2011, PLANT PHYSIOL, V157, P1975; Valdes-Lopez O, 2008, PLANT CELL ENVIRON, V31, P1834, DOI 10.1111/j.1365-3040.2008.01883.x; Valdes-Lopez O, 2010, NEW PHYTOL, V187, P805, DOI 10.1111/j.1469-8137.2010.03320.x; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou J, 2013, J EXP BOT, V64, P3261, DOI 10.1093/jxb/ert166; Zhou ZS, 2008, CHEMOSPHERE, V70, P1500, DOI 10.1016/j.chemosphere.2007.08.028; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	79	81	86	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84416	10.1371/journal.pone.0084416	http://dx.doi.org/10.1371/journal.pone.0084416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400089	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700023
J	Campagnolo, L; Costanza, G; Francesconi, A; Arcuri, G; Moscatelli, I; Orlandi, A				Campagnolo, Luisa; Costanza, Gaetana; Francesconi, Arianna; Arcuri, Gaetano; Moscatelli, Ilana; Orlandi, Augusto			Sortilin Expression Is Essential for Pro-Nerve Growth Factor-Induced Apoptosis of Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY INFLUENCES; MARKER EXPRESSION; IN-VITRO; ATHEROSCLEROSIS; NEUROTROPHIN; PROLIFERATION; NGF; SUSCEPTIBILITY; MECHANISMS; SURVIVAL	Background: Sortilin, a member of the Vps10p-domain receptor family, has been demonstrated a key regulator in mediating cellular response to pro-neurotrophins. In the present study, we investigated the role of sortilin in the apoptotic pathway of vascular smooth muscle cells. Methods and Principal Findings: Immunohistochemistry revealed that sortilin was barely detectable in human and rat normal young vessels, while its expression was increased in human fibroatheromatous plaques. Sortilin immunodetection was also marked in the neointima of the rat aorta fifteen days after ballooning. In vitro, rat aortic intimal cells expressed higher sortilin levels than normal media SMCs; sortilin was distributed in the cytoplasm and in correspondence of the cell membrane. After 48 h, pro-nerve growth factor (proNGF) induced the strong dose-dependent increase of intimal cell apoptosis and the accumulation of sortilin protein. ProNGF was a more potent apoptotic inducer than equimolar or even higher concentration of NGF, whereas brain derived neutrotrophic factor was ineffective. Targeted interfering RNA-mediated sortilin reduction counteracted proNGF-induced apoptosis without affecting p75(NTR) expression. ProNGF-induced apoptosis was associated to NF-kappa B down-regulation and bax increase. Inhibition of NF-kappa B activity increased intimal cell apoptosis that did not further increase with the addition of proNGF. Conclusions: Our results indicate that sortilin expression characterizes human atheromatous lesions and rat aortic post-injury neointima, and suggest that sortilin represents an important regulator of proNGF-induced SMC apoptosis and arterial remodeling.	[Campagnolo, Luisa; Costanza, Gaetana; Francesconi, Arianna; Arcuri, Gaetano; Moscatelli, Ilana; Orlandi, Augusto] Univ Roma Tor Vergata, Dept Biomed & Prevent, Inst Pathol Anat, Rome, Italy; [Moscatelli, Ilana] Lund Univ, Dept Mol Med & Gene Therapy, Lund Stem Cell Ctr, Lund, Sweden	University of Rome Tor Vergata; Lund University	Orlandi, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Inst Pathol Anat, Rome, Italy.	orlandi@uniroma2.it	Campagnolo, Luisa/K-3520-2018; Orlandi, Augusto/AHE-8753-2022; Costanza, Gaetana (Tania)/GXV-4686-2022; costanza, gaetana/J-5171-2018	Campagnolo, Luisa/0000-0003-3928-0276; costanza, gaetana/0000-0002-1115-4270; orlandi, augusto/0000-0001-7202-5854	AIFA [MRAR08L007]	AIFA	This work has been partially funded by a grant from AIFA (2008, MRAR08L007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BENNETT MR, 1994, CIRC RES, V74, P525, DOI 10.1161/01.RES.74.3.525; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Bono F, 1997, FEBS LETT, V416, P243, DOI 10.1016/S0014-5793(97)01215-5; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; CLOWES AW, 1983, LAB INVEST, V49, P327; CLOWES AW, 1983, LAB INVEST, V49, P208; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Ferlosio A, 2012, ATHEROSCLEROSIS, V224, P51, DOI 10.1016/j.atherosclerosis.2012.07.016; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; KOCHER O, 1984, LAB INVEST, V50, P645; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Kraemer R, 1999, ARTERIOSCL THROM VAS, V19, P1041, DOI 10.1161/01.ATV.19.4.1041; Kraemer R, 2002, CIRC RES, V91, P494, DOI 10.1161/01.RES.0000035245.83233.2A; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Orlandi A, 2005, EXP CELL RES, V311, P317, DOI 10.1016/j.yexcr.2005.10.008; ORLANDI A, 1994, EXP CELL RES, V214, P528, DOI 10.1006/excr.1994.1290; Orlandi A, 2001, ARTERIOSCL THROM VAS, V21, P1118, DOI 10.1161/hq0701.092144; ORLANDI A, 1994, ARTERIOSCLER THROMB, V14, P982, DOI 10.1161/01.ATV.14.6.982; Orlandi A, 2007, J BIOL CHEM, V282, P4932, DOI 10.1074/jbc.M606148200; Orlandi A, 2010, CARDIOVASC RES, V85, P214, DOI 10.1093/cvr/cvp288; Orlandi A, 2008, CELL CYCLE, V7, P3889, DOI 10.4161/cc.7.24.7323; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perlman H, 1997, CIRCULATION, V95, P981; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Urban D, 2013, J BIOCHEM, V153, P197, DOI 10.1093/jb/mvs137; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x	41	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84969	10.1371/journal.pone.0084969	http://dx.doi.org/10.1371/journal.pone.0084969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404198	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800077
J	Gajjar, K; Ahmadzai, AA; Valasoulis, G; Trevisan, J; Founta, C; Nasioutziki, M; Loufopoulos, A; Kyrgiou, M; Stasinou, SM; Karakitsos, P; Paraskevaidis, E; Da Gama-Rose, B; Martin-Hirsch, PL; Martin, FL				Gajjar, Ketan; Ahmadzai, Abdullah A.; Valasoulis, George; Trevisan, Julio; Founta, Christina; Nasioutziki, Maria; Loufopoulos, Aristotelis; Kyrgiou, Maria; Stasinou, Sofia Melina; Karakitsos, Petros; Paraskevaidis, Evangelos; Da Gama-Rose, Bianca; Martin-Hirsch, Pierre L.; Martin, Francis L.			Histology Verification Demonstrates That Biospectroscopy Analysis of Cervical Cytology Identifies Underlying Disease More Accurately than Conventional Screening: Removing the Confounder of Discordance	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; RAMAN-SPECTROSCOPY; MULTIVARIATE-ANALYSIS; INTRAEPITHELIAL NEOPLASIA; COMPUTATIONAL ANALYSIS; DISCRIMINANT-ANALYSIS; SQUAMOUS EPITHELIUM; DIAGNOSTIC-APPROACH; STRUCTURAL-CHANGES; FTIR SPECTROSCOPY	Background: Subjective visual assessment of cervical cytology is flawed, and this can manifest itself by inter- and intra-observer variability resulting ultimately in the degree of discordance in the grading categorisation of samples in screening vs. representative histology. Biospectroscopy methods have been suggested as sensor-based tools that can deliver objective assessments of cytology. However, studies to date have been apparently flawed by a corresponding lack of diagnostic efficiency when samples have previously been classed using cytology screening. This raises the question as to whether categorisation of cervical cytology based on imperfect conventional screening reduces the diagnostic accuracy of biospectroscopy approaches; are these latter methods more accurate and diagnose underlying disease? The purpose of this study was to compare the objective accuracy of infrared (IR) spectroscopy of cervical cytology samples using conventional cytology vs. histology-based categorisation. Methods: Within a typical clinical setting, a total of n = 322 liquid-based cytology samples were collected immediately before biopsy. Of these, it was possible to acquire subsequent histology for n = 154. Cytology samples were categorised according to conventional screening methods and subsequently interrogated employing attenuated total reflection Fourier-transform IR (ATR-FTIR) spectroscopy. IR spectra were pre-processed and analysed using linear discriminant analysis. Dunn's test was applied to identify the differences in spectra. Within the diagnostic categories, histology allowed us to determine the comparative efficiency of conventional screening vs. biospectroscopy to correctly identify either true atypia or underlying disease. Results: Conventional cytology-based screening results in poor sensitivity and specificity. IR spectra derived from cervical cytology do not appear to discriminate in a diagnostic fashion when categories were based on conventional screening. Scores plots of IR spectra exhibit marked crossover of spectral points between different cytological categories. Although, significant differences between spectral bands in different categories are noted, crossover samples point to the potential for poor specificity and hampers the development of biospectroscopy as a diagnostic tool. However, when histology-based categories are used to conduct analyses, the scores plot of IR spectra exhibit markedly better segregation. Conclusions: Histology demonstrates that ATR-FTIR spectroscopy of liquid-based cytology identifies the presence of underlying atypia or disease missed in conventional cytology screening. This study points to an urgent need for a future biospectroscopy study where categories are based on such histology. It will allow for the validation of this approach as a screening tool.	[Gajjar, Ketan; Ahmadzai, Abdullah A.; Trevisan, Julio; Martin, Francis L.] Univ Lancaster, Lancaster Environm Ctr, Ctr Biophoton, Lancaster, England; [Gajjar, Ketan; Founta, Christina; Da Gama-Rose, Bianca; Martin-Hirsch, Pierre L.] Lancashire Teaching Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Preston, Lancs, England; [Valasoulis, George; Founta, Christina; Stasinou, Sofia Melina; Paraskevaidis, Evangelos] Univ Hosp Ioannina, Dept Obstet & Gynaecol, Ioannina, Greece; [Nasioutziki, Maria; Loufopoulos, Aristotelis] Aristotle Univ Thessaloniki, Hippokrat Hosp Thessaloniki, Dept Obstet & Gynaecol 2, GR-54006 Thessaloniki, Greece; [Kyrgiou, Maria; Stasinou, Sofia Melina] Imperial Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, London, England; [Kyrgiou, Maria] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Karakitsos, Petros] Univ Athens, Attikon Hosp, Dept Cytopathol, Athens, Greece	Lancaster University; University Hospital Ioannina; Aristotle University of Thessaloniki; Imperial College London; National & Kapodistrian University of Athens; University Hospital Attikon	Gajjar, K (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Ctr Biophoton, Lancaster, England.	gajjarkb@gmail.com; f.martin@lancaster.ac.uk	NASIOUTZIKI, MARIA/HDM-7116-2022; Valasoulis, George/AAR-2795-2021; Paraskevaidis, Evangelos/ABH-4990-2020; Martin, Francis L/J-4585-2019	Valasoulis, George/0000-0003-4444-3711; Martin, Francis L/0000-0001-8562-4944	EPSRC [EP/K023349/1]; Engineering and Physical Sciences Research Council [EP/K023349/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding from EPSRC (grant number EP/K023349/1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar BS, 2003, AM FAM PHYSICIAN, V68, P1992; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Baker MJ, 2008, BRIT J CANCER, V99, P1859, DOI 10.1038/sj.bjc.6604753; Baldwin P, 2003, NAT REV CANCER, V3, P217, DOI 10.1038/nrc1010; Castanon A, 2012, CYTOPATHOLOGY, V23, P13, DOI 10.1111/j.1365-2303.2011.00948.x; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chiriboga L, 1998, BIOSPECTROSCOPY, V4, P55, DOI 10.1002/(SICI)1520-6343(1998)4:1<55::AID-BSPY6>3.0.CO;2-R; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Daniel W. W., 1990, APPL NONPARAMETRIC S, V2nd; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Duraipandian S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.067007; El-Tawil SG, 2008, PATHOLOGY, V40, P600, DOI 10.1080/00313020802320622; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Gajjar K, 2013, ANALYST, V138, P3917, DOI 10.1039/c3an36654e; Gajjar K, 2013, ANAL METHODS-UK, V5, P89, DOI 10.1039/c2ay25544h; ISMAIL SM, 1989, BRIT MED J, V298, P707, DOI 10.1136/bmj.298.6675.707; Kanter EM, 2009, J BIOPHOTONICS, V2, P81, DOI 10.1002/jbio.200910001; Kelly JG, 2011, J PROTEOME RES, V10, P1437, DOI 10.1021/pr101067u; Kelly JG, 2010, ANAL BIOANAL CHEM, V398, P2191, DOI 10.1007/s00216-010-4179-5; Kelly JG, 2010, CLIN CHIM ACTA, V411, P1027, DOI 10.1016/j.cca.2010.03.029; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Llabjani V, 2010, ENVIRON SCI TECHNOL, V44, P3992, DOI 10.1021/es100206f; Llabjani V, 2009, ENVIRON SCI TECHNOL, V43, P3356, DOI 10.1021/es8036127; Mahadevan-Jansen A, 1998, PHOTOCHEM PHOTOBIOL, V68, P427, DOI 10.1562/0031-8655(1998)068<0427:DOAFOP>2.3.CO;2; Mahadevan-Jansen A, 1998, PHOTOCHEM PHOTOBIOL, V68, P123, DOI 10.1111/j.1751-1097.1998.tb03262.x; Martin FL, 2007, J COMPUT BIOL, V14, P1176, DOI 10.1089/cmb.2007.0057; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCrory D C, 1999, Evid Rep Technol Assess (Summ), P1; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Mohlenhoff B, 2005, BIOPHYS J, V88, P3635, DOI 10.1529/biophysj.104.057950; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Njoroge Erick, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5338; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Price GJ, 2003, HUM PATHOL, V34, P1193, DOI 10.1016/S0046-8177(03)00421-0; Purandare NC, 2013, BIOANALYSIS, V5, P2697, DOI [10.4155/BIO.13.233, 10.4155/bio.13.233]; Purandare NC, 2013, ANALYST, V138, P3909, DOI 10.1039/c3an36527a; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sindhuphak R, 2003, GYNECOL ONCOL, V90, P10, DOI 10.1016/S0090-8258(03)00196-3; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Taylor SE, 2011, BRIT J CANCER, V104, P790, DOI 10.1038/sj.bjc.6606094; Trevisan J, 2013, BIOINFORMATICS, V29, P1095, DOI 10.1093/bioinformatics/btt084; Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; Walsh MJ, 2007, BIOCHEM BIOPH RES CO, V352, P213, DOI 10.1016/j.bbrc.2006.11.005; Walsh MJ, 2008, BIOMARK INSIGHTS, V3, P179; Wong PTT, 2002, BIOPOLYMERS, V67, P376, DOI 10.1002/bip.10166; WONG PTT, 1991, P NATL ACAD SCI USA, V88, P10988, DOI 10.1073/pnas.88.24.10988; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Wright TC, 2012, BEST PRACT RES CL OB, V26, P197, DOI 10.1016/j.bpobgyn.2011.11.004; Yazdi HM, 1996, ACTA CYTOL, V40, P664	54	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82416	10.1371/journal.pone.0082416	http://dx.doi.org/10.1371/journal.pone.0082416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404130	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000329460800009
J	Jers, C; Michalak, M; Larsen, DM; Kepp, KP; Li, HY; Guo, Y; Kirpekar, F; Meyer, AS; Mikkelsen, JD				Jers, Carsten; Michalak, Malwina; Larsen, Dorte M.; Kepp, Kasper P.; Li, Haiying; Guo, Yao; Kirpekar, Finn; Meyer, Anne S.; Mikkelsen, Jorn D.			Rational Design of a New Trypanosoma rangeli Trans-Sialidase for Efficient Sialylation of Glycans	PLOS ONE			English	Article							CATALYTIC MECHANISM; LIQUID WATER; CRUZI; OLIGOSACCHARIDES; ACID; EXPRESSION; ENZYME; ASSAY	This paper reports rational engineering of Trypanosoma rangeli sialidase to develop an effective enzyme for a potentially important type of reactivity: production of sialylated prebiotic glycans. The Trypanosoma cruzi trans-sialidase and the homologous T. rangeli sialidase has previously been used to investigate the structural requirements for trans-sialidase activity. We observed that the T. cruzi trans-sialidase has a seven-amino-acid motif (197-203) at the border of the substrate binding cleft. The motif differs substantially in chemical properties and substitution probability from the homologous sialidase, and we hypothesised that this motif is important for trans-sialidase activity. The 197-203 motif is strongly positively charged with a marked change in hydrogen bond donor capacity as compared to the sialidase. To investigate the role of this motif, we expressed and characterised a T. rangeli sialidase mutant, Tr13. Conditions for efficient trans-sialylation were determined, and Tr13's acceptor specificity demonstrated promiscuity with respect to the acceptor molecule enabling sialylation of glycans containing terminal galactose and glucose and even monomers of glucose and fucose. Sialic acid is important in association with human milk oligosaccharides, and Tr13 was shown to sialylate a number of established and potential prebiotics. Initial evaluation of prebiotic potential using pure cultures demonstrated, albeit not selectively, growth of Bifidobacteria. Since the 197-203 motif stands out in the native trans-sialidase, is markedly different from the wild-type sialidase compared to previous mutants, and is shown here to confer efficient and broad trans-sialidase activity, we suggest that this motif can serve as a framework for future optimization of trans-sialylation towards prebiotic production.	[Jers, Carsten; Michalak, Malwina; Larsen, Dorte M.; Guo, Yao; Meyer, Anne S.; Mikkelsen, Jorn D.] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, DK-2800 Lyngby, Denmark; [Kepp, Kasper P.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Li, Haiying; Kirpekar, Finn] Southern Univ Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Technical University of Denmark; Technical University of Denmark; University of Southern Denmark	Mikkelsen, JD (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, DK-2800 Lyngby, Denmark.	jdm@kt.dtu.dk	Meyer, Anne S/AAN-2157-2020; Kepp, Kasper P./AAA-4626-2021; Kepp, Kasper Planeta/G-1748-2013	Meyer, Anne S/0000-0001-8910-9931; Kepp, Kasper P./0000-0002-6754-7348; Kepp, Kasper Planeta/0000-0002-6754-7348; Kirpekar, Finn/0000-0003-1901-2266	Strategic Research Council in Denmark [09-067134]	Strategic Research Council in Denmark	This work was supported by the Strategic Research Council in Denmark, http://fivu.dk; The project number is 09-067134, The title is:"Enzymatic production of human milk oligosaccharides". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; DENNY PC, 1983, CLIN CHIM ACTA, V131, P333, DOI 10.1016/0009-8981(83)90103-1; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HUMMER G, 1995, J PHYS CHEM-US, V99, P14188, DOI 10.1021/j100038a062; Koliwer-Brandl H, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-39; Kuhne TD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2459; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Michalak M, 2012, ENZYME MICROB TECH, V50, P121, DOI 10.1016/j.enzmictec.2011.11.001; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Onumpai C, 2011, APPL ENVIRON MICROB, V77, P5747, DOI 10.1128/AEM.00179-11; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; Pereira MEA, 1996, INFECT IMMUN, V64, P3884, DOI 10.1128/IAI.64.9.3884-3892.1996; Ribeirao M, 1997, GLYCOBIOLOGY, V7, P1237, DOI 10.1093/glycob/7.8.1237; SAITO T, 1992, J DAIRY SCI, V75, P1768, DOI 10.3168/jds.S0022-0302(92)77936-3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; Schmidt D, 2000, J ORG CHEM, V65, P8518, DOI 10.1021/jo000871r; Schrader S, 2003, ANAL BIOCHEM, V322, P139, DOI 10.1016/j.ab.2003.07.016; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Silva IR, 2011, ENZYME MICROB TECH, V49, P160, DOI 10.1016/j.enzmictec.2011.04.015; Singh S, 2000, CHEM COMMUN, P1013, DOI 10.1039/b002302g; SKOZA L, 1976, BIOCHEM J, V159, P457, DOI 10.1042/bj1590457; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Walters DM, 1999, J BACTERIOL, V181, P4526, DOI 10.1128/JB.181.15.4526-4532.1999; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138	33	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83902	10.1371/journal.pone.0083902	http://dx.doi.org/10.1371/journal.pone.0083902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404142	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800021
J	Klein, JD; Sano, D; Sen, M; Myers, JN; Grandis, JR; Kim, S				Klein, Jonah D.; Sano, Daisuke; Sen, Malabika; Myers, Jeffrey N.; Grandis, Jennifer R.; Kim, Seungwon			STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONSTITUTIVE ACTIVATION; DECOY OLIGONUCLEOTIDE; NECK-CANCER; IN-VIVO; IMMUNODEFICIENT MICE; SIGNALING PATHWAY; HEAD; THERAPY; TRANSDUCER	Purpose: Signal transducer and activator of transcription 3 (STAT3) has shown to play a critical role in head and neck squamous cell carcinoma (HNSCC) and we have recently completed clinical trials of STAT3 decoy oligonucleotide in patients with recurrent or metastatic HNSCC. However, there is limited understanding of the role of STAT3 in modulating other aspects of tumorigenesis such as angiogenesis. In this study, we aimed to examine the effects of STAT3 decoy oligonucleotide on tumor angiogenesis. Experimental Design: A STAT3 decoy oligonucleotide and small interfering RNA (siRNA) were used to inhibit STAT3 in endothelial cells in vitro and in vivo. The biochemical effects of STAT3 inhibition were examined in conjunction with the consequences on proliferation, migration, apoptotic staining, and tubule formation. Additionally, we assessed the effects of STAT3 inhibition on tumor angiogenesis using murine xenograft models. Results: STAT3 decoy oligonucleotide decreased proliferation, induces apoptosis, decreased migration, and decreased tubule formation of endothelial cells in vitro. The STAT3 decoy oligonucleotide also inhibited tumor angiogenesis in murine tumor xenografts. Lastly, our data suggest that the antiangiogenic effects of STAT3 decoy oligonucleotide were mediated through the inhibition of both STAT3 and STAT1. Conclusions: The STAT3 decoy oligonucleotide was found to be an effective antiangiogenic agent, which is likely to contribute to the overall antitumor effects of this agent in solid tumors. Taken together with the previously demonstrated antitumor activity of this agent, STAT3 decoy oligonucleotide represents a promising single agent approach to targeting both the tumor and vascular compartments in various malignancies.	[Klein, Jonah D.; Sen, Malabika; Grandis, Jennifer R.; Kim, Seungwon] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Sano, Daisuke] Yokohama City Univ, Grad Sch Med, Dept Biol & Funct Head & Neck, Yokohama, Kanagawa 232, Japan; [Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA; [Grandis, Jennifer R.; Kim, Seungwon] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yokohama City University; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	kimsw2@upmc.edu	Sano, Daisuke/R-6591-2018	Sano, Daisuke/0000-0002-7686-4724	NIH [K08 DE019201]; American College of Surgeons/Triological Society Clinician Scientist Career Development Grant; NATIONAL CANCER INSTITUTE [P50CA097190] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019201, R01DE023685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons/Triological Society Clinician Scientist Career Development Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by the NIH grant K08 DE019201 and American College of Surgeons/Triological Society Clinician Scientist Career Development Grant. The funders have no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Bartoli M, 2000, J BIOL CHEM, V275, P33189, DOI 10.1074/jbc.C000318200; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; Duan WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057941; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lui VWY, 2007, MOL PHARMACOL, V71, P1435, DOI 10.1124/mol.106.032284; Ni CW, 2004, AM J PHYSIOL-CELL PH, V287, pC771, DOI 10.1152/ajpcell.00532.2003; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Polverini PJ, 2003, METH MOLEC MED, V78, P161; Sano D, 2007, ONCOL REP, V17, P289; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Sen M, 2010, AM ASS CANC RES ANN; Sen M, 2010, DEV STAT3 DECOY SYST; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Sen M, 2009, CANCER CHEMOTH PHARM, V63, P983, DOI 10.1007/s00280-008-0823-6; Sriuranpong V, 2003, CANCER RES, V63, P2948; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Sun ZK, 2006, IMMUNOBIOLOGY, V211, P199, DOI 10.1016/j.imbio.2005.11.004; Van Tubergen E, 2011, CANCER; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yigitbasi OG, 2004, CANCER RES, V64, P7977, DOI 10.1158/0008-5472.CAN-04-1477; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004; Zhang XL, 2007, ONCOL REP, V17, P1377	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e81819	10.1371/journal.pone.0081819	http://dx.doi.org/10.1371/journal.pone.0081819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404126	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000329460800005
J	Kemp, A; Preen, DB; Saunders, C; Boyle, F; Bulsara, M; Holman, CDJ; Malacova, E; Roughead, EE				Kemp, Anna; Preen, David B.; Saunders, Christobel; Boyle, Frances; Bulsara, Max; Holman, C. D'Arcy J.; Malacova, Eva; Roughead, Elizabeth E.			Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice	PLOS ONE			English	Article								Background: Australian clinical guidelines recommend endocrine therapy for all women with hormone-dependent early breast cancer. Guidelines specify tamoxifen as first-line therapy for pre-menopausal women, and tamoxifen or an aromatase inhibitor (AI) for post-menopausal women depending on the risk of recurrence based on tumour characteristics including size. Therapies have different side effect profiles; therefore comorbidity may also influence choice. We examined comorbidity, and the clinical and demographic characteristics of women commencing different therapies. Patients and Methods: We identified the first dispensing of tamoxifen, anastrozole or letrozole for women diagnosed with invasive breast cancer in the 45 and Up Study from 2004-2009 (N=1266). Unit-level pharmacy and medical service claims, hospital, Cancer Registry, and self-reported data were linked to determine menopause status at diagnosis, tumour size, age, comorbidities, and change in subsidy restrictions. Chi-square tests and generalised regression models were used to compare the characteristics of women commencing different therapies. Results: Most pre-menopausal women commenced therapy with tamoxifen (91%). Anastrozole was the predominant therapy for post-menopausal women (57%), followed by tamoxifen (28%). Women with osteoporosis were less likely to commence anastrozole compared with tamoxifen (anastrozole RR=0.7, 95% CI=0.5-0.9). Women with arthritis were 1.6-times more likely to commence letrozole than anastrozole (95% CI=1.1-2.1). Tamoxifen was more often initiated in women with tumours >1 cm, who were also >= 75 years. Subsidy restriction changes were associated with substantial increases in the proportion of women commencing AIs (anastrozole RR=4.3, letrozole RR=8.3). Conclusions: The findings indicate interplay of comorbidity and therapy choice for women with invasive breast cancer. Most post-menopausal women commenced therapy with anastrozole; however, letrozole and tamoxifen were more often initiated for women with comorbid arthritis and osteoporosis, respectively. Tamoxifen was also more common for women with tumours >1 cm and aged >= 75 years. Subsidy restrictions appear to have strongly influenced therapy choice.	[Kemp, Anna; Preen, David B.; Holman, C. D'Arcy J.; Malacova, Eva] Univ Western Australia, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [Saunders, Christobel] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Boyle, Frances] Mater Hosp, Patricia Richie Ctr Canc Care & Res, Sydney, NSW, Australia; [Bulsara, Max] Univ Notre Dame, Inst Hlth Res, Perth, WA, Australia; [Holman, C. D'Arcy J.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Western Australia; University of Western Australia; University of Notre Dame Australia; University of South Australia	Kemp, A (corresponding author), Univ Western Australia, Ctr Hlth Serv Res, Perth, WA 6009, Australia.	anna.kemp@uwa.edu.au	Saunders, Christobel M/H-5779-2014; Roughead, Elizabeth E/G-4431-2010; Kemp-Casey, Anna/F-1283-2013; Kemp-Casey, Anna/AAU-7292-2021; Preen, David B/H-5663-2014	Saunders, Christobel M/0000-0003-2281-9829; Roughead, Elizabeth E/0000-0002-6811-8991; Kemp-Casey, Anna/0000-0002-0018-962X; Kemp-Casey, Anna/0000-0002-0018-962X; Preen, David B/0000-0002-2982-2169	Cancer Australia; National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme] [1011488]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Australia; National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme]; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was jointly-funded by Cancer Australia and the National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme 1011488 to AK, DBP, CS, MB, CDJH, and EER]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2006, BREAST, V15, pS30, DOI 10.1016/j.breast.2006.01.005; ALBAIN K, 2002, LANCET, V359, P1925; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; *AUSTR GOB DEP HLT, 2006, GOV FUNDS NEW BREAST; *AUSTR GOV DEP HLT, 2013, AB PBS; *AUSTR GOV DEP HLT, 2013, FEES PAT CONTR SAF N; *AUSTR GOV DEP HLT, 2005, PUBL SUMM DOC AN TAB; *AUSTR POP MIGR RE, 2013, ACC REM IND AUSTR AR; Australian Bureau of Statistics, 2003, INF PAP CENS POP HOU; Australian Government Department of Health and Ageing, 2013, SCHED PHARM BEN; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Briot K, 2010, BREAST CANCER RES TR, V120, P127, DOI 10.1007/s10549-009-0692-7; *CANC I NEW S WAL, 2013, LAT PUBL; Cancer Institute New South Wales, 2013, NSW CENTR CANC REG D; *CHEREL, 2009, INF RES; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Chlebowski RT, 2008, BREAST, V17, pS9, DOI 10.1016/j.breast.2007.12.003; Clarke M, 1998, LANCET, V351, P1451; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; DEVOS FYF, CRIT REV ONCOL HEMAT, V84, P252; Hernandez RK, 2008, CANCER EPIDEM BIOMAR, V17, P2509, DOI 10.1158/1055-9965.EPI-08-0570; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; KEMP A, 2013, BMC MED RES METHODOL, V13, DOI DOI 10.1186/1471-2288-1113-1117; National Breast Cancer Centre (NBCC), 2001, CLIN PRACT GUID MAN; *NBCC, 2006, REC AR INH ADJ END T; Niravath P, 2013, ANN ONCOL, V24, P1443, DOI 10.1093/annonc/mdt037; *SAX I, 2013, RES TOOLK; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; World Health Organization, 2001, INT CLASS DIS ONC; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84835	10.1371/journal.pone.0084835	http://dx.doi.org/10.1371/journal.pone.0084835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392158	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329460100081
J	Schilcher, G; Schlagenhauf, A; Schneditz, D; Scharnagl, H; Ribitsch, W; Krause, R; Rosenkranz, AR; Stojakovic, T; Horina, JH				Schilcher, Gernot; Schlagenhauf, Axel; Schneditz, Daniel; Scharnagl, Hubert; Ribitsch, Werner; Krause, Robert; Rosenkranz, Alexander R.; Stojakovic, Tatjana; Horina, Joerg H.			Ethanol Causes Protein Precipitation-New Safety Issues for Catheter Locking Techniques	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; HEPARIN LOCK; THERAPY; PREVENTION; CITRATE; COMPLICATIONS; COMPATIBILITY; ERADICATION	Objective: The ethanol lock technique has shown great potential to eradicate organisms in biofilms and to treat or prevent central venous catheter related infections. Following instillation of ethanol lock solution, however, the inherent density gradient between blood and ethanol causes gravity induced seepage of ethanol out of the catheter and blood influx into the catheter. Plasma proteins so are exposed to highly concentrated ethanol, which is a classic agent for protein precipitation. We aimed to investigate the precipitating effect of ethanol locks on plasma proteins as a possible cause for reported catheter occlusions. Methods: Plasma samples were exposed in-vitro to ethanol (concentrations ranging from 7 to 70 v/v%) and heparin lock solutions. In catheter studies designed to mimic different in-vivo situations, the catheter tip was placed in a plasma reservoir and the material contained within the catheter was analyzed after ethanol lock instillation. The samples underwent standardized investigation for protein precipitation. Results: Protein precipitation was observed in plasma samples containing ethanol solutions above a concentration of 28%, as well as in material retrieved from vertically positioned femoral catheters and jugular (subclavian) catheters simulating recumbent or head down tilt body positions. Precipitates could not be re-dissolved by dilution with plasma, urokinase or alteplase. Plasma samples containing heparin lock solutions showed no signs of precipitation. Conclusions: Our in-vitro results demonstrate that ethanol locks may be associated with plasma protein precipitation in central venous catheters. This phenomenon could be related to occlusion of vascular access devices locked with ethanol, as has been reported. Concerns should be raised regarding possible complications upon injection or spontaneous gravity induced leakage of such irreversibly precipitated protein particles into the systemic circulation. We suggest limiting the maximum advisable concentration of ethanol to 28 v/v% in catheter lock solutions.	[Schilcher, Gernot; Ribitsch, Werner; Rosenkranz, Alexander R.; Horina, Joerg H.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Schlagenhauf, Axel] Med Univ Graz, Dept Gen Pediat & Adolescent Med, Graz, Austria; [Schneditz, Daniel] Med Univ Graz, Inst Physiol, Graz, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Krause, Robert] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Schilcher, G (corresponding author), Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria.	gernot.schilcher@medunigraz.at	Schneditz, Daniel/E-6580-2010; Schlagenhauf, Axel/AAK-9598-2021	Schneditz, Daniel/0000-0002-0124-1012; Schlagenhauf, Axel/0000-0003-3408-6415				Agharazii M, 2005, NEPHROL DIAL TRANSPL, V20, P1238, DOI 10.1093/ndt/gfh841; ARONSON JK, 1981, BRIT MED J, V282, P288, DOI 10.1136/bmj.282.6260.288; Balestrino D, 2009, NEPHROL DIAL TRANSPL, V24, P3204, DOI 10.1093/ndt/gfp187; Blackwood RA, 2011, PEDIATR INFECT DIS J, V30, P1105, DOI 10.1097/INF.0b013e31822c84a4; Broom J, 2008, SCAND J INFECT DIS, V40, P399, DOI 10.1080/00365540701756953; Burrows PE, 2004, J VASC INTERV RADIOL, V15, P431, DOI 10.1097/01.RVI.0000124949.24134.CF; Chambers ST, 2007, J ANTIMICROB CHEMOTH, V59, P779, DOI 10.1093/jac/dkl542; CHI LM, 1991, BIOCHIM BIOPHYS ACTA, V1062, P46, DOI 10.1016/0005-2736(91)90333-4; Cober MP, 2011, JPEN-PARENTER ENTER, V35, P67, DOI 10.1177/0148607110362758; COHN EJ, 1947, J AM CHEM SOC, V69, P1753, DOI 10.1021/ja01199a051; Dannenberg C, 2003, J PEDIAT HEMATOL ONC, V25, P616, DOI 10.1097/00043426-200308000-00006; Davenport A, 2012, NEPHROL DIAL TRANSPL, V27, P2621, DOI 10.1093/ndt/gfs274; Doorenbos CJ, 2006, NEPHROL DIAL TRANSPL, V21, P543, DOI 10.1093/ndt/gfi331; Dotson B, 2010, AM J HEALTH-SYST PH, V67, P1195, DOI 10.2146/ajhp090505; Droste JC, 2003, J ANTIMICROB CHEMOTH, V51, P849, DOI 10.1093/jac/dkg179; HINGHOFERSZALKAY H, 1980, BIOMED TECH, V25, P151, DOI 10.1515/bmte.1980.25.6.151; Hoang V, 2008, PEDIATRICS, V121, pE1152, DOI 10.1542/peds.2007-1962; Huang EY, 2011, J PEDIATR SURG, V46, P2000, DOI 10.1016/j.jpedsurg.2011.06.017; JOHNSTON DA, 1992, CLIN NUTR, V11, P97, DOI 10.1016/0261-5614(92)90018-L; Kanji S, 2010, CRIT CARE MED, V38, P1890, DOI 10.1097/CCM.0b013e3181e8adcc; Karaaslan H, 2001, NEPHROL DIAL TRANSPL, V16, P2072, DOI 10.1093/ndt/16.10.2072; Kayton ML, 2010, J PEDIATR SURG, V45, P1961, DOI 10.1016/j.jpedsurg.2010.05.014; Laird J, 2005, J INFECTION, V51, P338, DOI 10.1016/j.jinf.2005.02.009; Maiefski M, 2009, INFECT CONT HOSP EP, V30, P1096, DOI 10.1086/606162; Mellanby J, 1907, J PHYSIOL-LONDON, V36, P288; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; Mouw E, 2008, J PEDIATR SURG, V43, P1025, DOI 10.1016/j.jpedsurg.2008.02.026; Niyyar VD, 2012, SEMIN DIALYSIS, V25, P693, DOI 10.1111/j.1525-139X.2011.00991.x; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Opilla MT, 2007, JPEN-PARENTER ENTER, V31, P302, DOI 10.1177/0148607107031004302; ORourke MF., 1990, MCDONALDS BLOOD FLOW, P12; PENNINGTON CR, 1987, JPEN-PARENTER ENTER, V11, P507, DOI 10.1177/0148607187011005507; Polaschegg HD, 2008, BLOOD PURIFICAT, V26, P255, DOI 10.1159/000123706; Polaschegg HD, 2012, ARTIF ORGANS, V36, P824, DOI 10.1111/j.1525-1594.2012.01466.x; Polaschegg HD, 2005, ASAIO J, V51, P230, DOI 10.1097/01.MAT.0000159742.15560.93; Qu Y, 2009, J MED MICROBIOL, V58, P442, DOI 10.1099/jmm.0.006387-0; Rajpurkar M, 2009, HAEMOPHILIA, V15, P1267, DOI 10.1111/j.1365-2516.2009.02075.x; Rasmussen RL, 2010, SEMIN DIALYSIS, V23, P648, DOI 10.1111/j.1525-139X.2010.00802.x; Rayner HC, 2010, SEMIN DIALYSIS, V23, P6, DOI 10.1111/j.1525-139X.2009.00675.x; Rimon U, 2004, EUR J RADIOL, V52, P283, DOI 10.1016/j.ejrad.2003.09.010; Rosenblatt J, 2013, ANTIMICROB AGENTS CH; Saad TF, 1999, AM J KIDNEY DIS, V34, P1114, DOI 10.1016/S0272-6386(99)70018-1; Sanders J, 2008, J ANTIMICROB CHEMOTH, V62, P809, DOI 10.1093/jac/dkn284; Schilcher G, 2012, NEPHROL DIAL TRANSPL, V27, P2953, DOI 10.1093/ndt/gfs048; Scopes RK, 1994, PROTEIN PURIFICATION, P85; Sherertz RJ, 2006, ANTIMICROB AGENTS CH, V50, P1865, DOI 10.1128/AAC.50.5.1865-1868.2006; Slobbe L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010840; Sovinz P, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e104; Thomson PC, 2011, CLIN NEPHROL, V75, P212, DOI 10.5414/CN106460; Wales PW, 2011, J PEDIATR SURG, V46, P951, DOI 10.1016/j.jpedsurg.2011.02.036; Weast R.C, 1974, HDB CHEM PHYS, V55; Willicombe MK, 2010, AM J KIDNEY DIS, V55, P348, DOI 10.1053/j.ajkd.2009.06.037; Wolf J, 2013, PEDIATR BLOOD CANCER, V60, P18, DOI 10.1002/pbc.24249; Wong T, 2012, JPEN-PARENTER ENTER, V36, P358, DOI 10.1177/0148607111414713; Yevzlin AS, 2007, SEMIN DIALYSIS, V20, P351, DOI 10.1111/j.1525-139X.2007.00294.x	57	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84869	10.1371/journal.pone.0084869	http://dx.doi.org/10.1371/journal.pone.0084869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391979	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900122
J	Tsai, HJ; Wu, CC; Tsai, CR; Lin, SF; Chen, LT; Chang, JS				Tsai, Hui-Jen; Wu, Chun-Chieh; Tsai, Chia-Rung; Lin, Sheng-Fung; Chen, Li-Tzong; Chang, Jeffrey. S.			Second Cancers in Patients with Neuroendocrine Tumors	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CARCINOID-TUMORS; RISK; GROWTH; CHEMOTHERAPY; MORTALITY; RADIOTHERAPY; EXPRESSION; MALIGNANCY; RECEPTORS	Background: Second cancers have been reported to occur in 10-20% of patients with neuroendocrine tumors (NETs). However, most published studies used data from a single institution or focused only on specific sites of NETs. In addition, most of these studies included second cancers diagnosed concurrently with NETs, making it difficult to assess the temporality and determine the exact incidence of second cancers. In this nationwide population-based study, we used data recorded by the Taiwan Cancer Registry (TCR) to analyze the incidence and distribution of second cancers after the diagnosis of NETs. Methods: NET cases diagnosed from January 1, 1996 to December 31, 2006 were identified from the TCR. The data on the occurrence of second cancers were ascertained up to December 31, 2008. Standardized incidence ratios (SIRs) of second cancers were calculated based on the cancer incidence rates of the general population. Cox-proportional hazards regression analysis was performed to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the risk of second cancers associated with sex, age, and primary NET sites. Results: A total of 1,350 newly diagnosed NET cases were identified according to the selection criteria. Among the 1,350 NET patients, 49 (3.63%) developed a second cancer >3 months after the diagnosis of NET. The risk of second cancer following NETs was increased compared to the general population (SIR = 1.48, 95% CI: 1.09-1.96), especially among those diagnosed at age 70 or older (HR = 5.08, 95% CI = 1.69-15.22). There appeared to be no preference of second cancer type according to the primary sites of NETs. Conclusions: Our study showed that the risk of second cancer following NETs is increased, especially among those diagnosed at age 70 or older. Close monitoring for the occurrence of second cancers after the diagnosis of NETs is warranted.	[Tsai, Hui-Jen; Tsai, Chia-Rung; Chen, Li-Tzong; Chang, Jeffrey. S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Tsai, Hui-Jen; Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Tsai, Hui-Jen; Lin, Sheng-Fung; Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Hui-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Chun-Chieh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University	Lin, SF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	shlin@cc.kmu.edu.tw; leochen@nhri.org.tw; jeffreychang@nhri.org.tw	Tsai, Hui-Jen/G-9361-2011; Chang, Jeffrey Shu-Ming/B-1092-2010; Chen, Li-Tzong/D-2071-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205	Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-004]; National Health Research Institutes [CA-102-PP-07, CA-102-PP-17]	Department of Health, Executive Yuan, Taiwan; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by the Establishment of Cancer Research System Excellence Program [DOH102-TD-C-111-004], Department of Health, Executive Yuan, Taiwan. In addition, HJT and JSC were supported by the National Health Research Institutes (CA-102-PP-07 and CA-102-PP-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2012, ENDOCR-RELAT CANCER, V19, P381, DOI 10.1530/ERC-11-0392; Bold RJ, 1998, ANTICANCER RES, V18, P4051; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CHAUDHRY A, 1993, ACTA ONCOL, V32, P107, DOI 10.3109/02841869309083898; Cote ML, 2006, LUNG CANCER, V52, P273, DOI 10.1016/j.lungcan.2006.02.004; Curtis RE, 2004, JNCI-J NATL CANCER I, V96, P70, DOI 10.1093/jnci/djh007; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ferme C, 2006, BLOOD, V107, P4636, DOI 10.1182/blood-2005-11-4429; Flannery J T, 1985, Natl Cancer Inst Monogr, V68, P13; Habal N, 2000, J SURG ONCOL, V75, P301; Hemminki K, 2001, INT J CANCER, V94, P444, DOI 10.1002/ijc.1473; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KOBAYASHI Y, 1991, JPN J CLIN ONCOL, V21, P233; Krausch M, 2013, ENDOCRINE, V44, P510, DOI 10.1007/s12020-013-9911-4; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lee DH, 2013, OTOLARYNG HEAD NECK, V149, P579, DOI 10.1177/0194599813496373; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Lo J, 2002, CELL BIOL INT, V26, P319, DOI 10.1006/cbir.2001.0858; MOERTEL CG, 1961, CANCER, V14, P901, DOI 10.1002/1097-0142(196109/10)14:5<901::AID-CNCR2820140502>3.0.CO;2-Q; Momota H, 2010, PEDIATR BLOOD CANCER, V55, P577, DOI 10.1002/pbc.22542; Moser EC, 2006, HAEMATOLOGICA, V91, P1481; Neyns B, 2008, J CLIN ONCOL, V26, P4518, DOI 10.1200/JCO.2008.18.8177; Niederle MB, 2011, ONCOLOGIST, V16, P602, DOI 10.1634/theoncologist.2011-0002; Perez EA, 2007, WORLD J SURG, V31, P1022, DOI 10.1007/s00268-005-0774-6; Prommegger R, 2004, ANTICANCER RES, V24, P1049; Sharma A, 2009, PEDIATR BLOOD CANCER, V53, P661, DOI 10.1002/pbc.22090; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Taeger D, 2000, EPIDEMIOLOGY, V11, P607, DOI 10.1097/00001648-200009000-00019; TAJIKA M, 2013, J GASTROENTEROL, P93380; Tichansky DS, 2002, DIS COLON RECTUM, V45, P91, DOI 10.1007/s10350-004-6119-y; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; Travis LB, 2013, NAT REV CLIN ONCOL, V10, P289, DOI 10.1038/nrclinonc.2013.41; Tsai HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062487; Wang QMJ, 1996, INT J CANCER, V68, P528, DOI 10.1002/(SICI)1097-0215(19961115)68:4<528::AID-IJC20>3.3.CO;2-Q; Wolanska M, 2006, BIOCHIMIE, V88, P141, DOI 10.1016/j.biochi.2005.07.014; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e86414	10.1371/journal.pone.0086414	http://dx.doi.org/10.1371/journal.pone.0086414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392036	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900180
J	Bezawork-Geleta, A; Saiyed, T; Dougan, DA; Truscott, KN				Bezawork-Geleta, Ayenachew; Saiyed, Tamanna; Dougan, David A.; Truscott, Kaye N.			Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA	FASEB JOURNAL			English	Article						organelle; assembly factor; protein degradation; AAA+ protease; succinate dehydrogenase	SUCCINATE-DEHYDROGENASE; COMPLEX-II; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; GENE; MUTATIONS; MEMBRANE; CELLS; ELECTROPHORESIS	Mutations in succinate dehydrogenase (SDH) subunits and assembly factors cause a range of clinical conditions. One such condition, hereditary paraganglioma 2 (PGL2), is caused by a G78R mutation in the assembly factor SDH5. Although SDH5(G78R) is deficient in its ability to promote SDHA flavinylation, it has remained unclear whether impairment to its import, structure, or stability contributes to its loss of function. Using import-chase analysis in human mitochondria isolated from HeLa cells, we found that the import and maturation of human SDH5(G78R) was normal, while its stability was reduced significantly, with similar to 25% of the protein remaining after 180 min compared to similar to 85% for the wild-type protein. Notably, the metabolic stability of SDH5(G78R) was restored to wild-type levels by depleting mitochondrial LON (LONM). Degradation of SDH5(G78R) by LONM was confirmed in vitro; however, in contrast to the in organello analysis, wild-type SDH5 was also rapidly degraded by LONM. SDH5 instability was confirmed in SDHA-depleted mitochondria. Blue native PAGE showed that imported SDH5(G78R) formed a transient complex with SDHA; however, this complex was stabilized in LONM depleted mitochondria. These data demonstrate that SDH5 is protected from LONM-mediated degradation in mitochondria by its stable interaction with SDHA, a state that is dysregulated in PGL2.-Bezawork-Geleta, A., Saiyed, T., Dougan, D. A., Truscott, K. N. Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA.	[Bezawork-Geleta, Ayenachew; Saiyed, Tamanna; Dougan, David A.; Truscott, Kaye N.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia	La Trobe University	Truscott, KN (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia.	d.dougan@latrobe.edu.au; k.truscott@latrobe.edu.au	dougan, david/B-3359-2010	dougan, david/0000-0001-9313-1904; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093; Bezawork-Geleta, Ayenachew/0000-0003-2739-8023; Truscott, Kaye/0000-0002-5352-9835	Australian Research Council [DP110103936, FT0992033]; La Trobe University; Cooperative Research Centre	Australian Research Council(Australian Research Council); La Trobe University; Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by Australian Research Council fellowships to D.A.D (DP110103936) and K.N.T. (FT0992033), a La Trobe University postgraduate research scholarship to A.B-G., and a Cooperative Research Centre postgraduate award to T.S. Protein sequencing was performed by the Australian Proteome Analysis Facility (North Ryde, NSW, Australia). The authors thank N. Hoogenraad and M. Ryan (La Trobe University) for anti-HSP60 and anti-NDUFA9 antisera, respectively.	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Gur Eyal, 2013, Subcell Biochem, V66, P3, DOI 10.1007/978-94-007-5940-4_1; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Lowth BR, 2012, J STRUCT BIOL, V179, P193, DOI 10.1016/j.jsb.2012.06.001; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tatsuta Takashi, 2007, Methods Mol Biol, V372, P343, DOI 10.1007/978-1-59745-365-3_25; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Voos Wolfgang, 2013, Subcell Biochem, V66, P223, DOI 10.1007/978-94-007-5940-4_9; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	37	33	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1794	1804		10.1096/fj.13-242420	http://dx.doi.org/10.1096/fj.13-242420			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24414418				2022-12-25	WOS:000335344300025
J	Gelinas, AD; Davies, DR; Edwards, TE; Rohloff, JC; Carter, JD; Zhang, C; Gupta, S; Ishikawa, Y; Hirota, M; Nakaishi, Y; Jarvis, TC; Janjic, N				Gelinas, Amy D.; Davies, Douglas R.; Edwards, Thomas E.; Rohloff, John C.; Carter, Jeffrey D.; Zhang, Chi; Gupta, Shashi; Ishikawa, Yuichi; Hirota, Masao; Nakaishi, Yuichiro; Jarvis, Thale C.; Janjic, Nebojsa			Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aptamers; DNA Structure; Drug Discovery; Interleukin; Molecular Evolution; Nucleic Acid Chemistry; Protein-Nucleic Acid Interaction; G-quartet; SELEX	SIGNAL TRANSDUCER; HIGH-AFFINITY; DNA APTAMER; RECEPTOR; BINDING; IL-6; ASSOCIATION; EXPRESSION; RNA	Background: Traditional aptamers favor polar interactions with protein binding partners. Results: The IL-6SOMAmer structure reveals an interface rich in hydrophobic interactions that overlap the binding sites of IL-6 receptors. Conclusion: Hydrophobic modifications on DNA scaffolds generate diverse and novel structural motifs. Significance: Synthetic SOMAmers are potent, specific, and chemically versatile ligands with distinct binding properties compared with conventional aptamers. IL-6 is a secreted cytokine that functions through binding two cell surface receptors, IL-6R and gp130. Because of its involvement in the progression of several chronic inflammatory diseases, IL-6 is a target of pharmacologic interest. We have recently identified a novel class of ligands called SOMAmers (S low Off-rate Modified Aptamers) that bind IL-6 and inhibit its biologic activity. SOMAmers exploit the chemical diversity of protein-like side chains assembled on flexible nucleic acid scaffolds, resulting in an expanded repertoire of intra- and intermolecular interactions not achievable with conventional aptamers. Here, we report the co-crystal structure of a high affinity SOMAmer (K-d = 0.20 nm) modified at the 5-position of deoxyuridine in a complex with IL-6. The SOMAmer, comprised of a G-quartet domain and a stem-loop domain, engages IL-6 in a clamp-like manner over an extended surface exhibiting close shape complementarity with the protein. The interface is characterized by substantial hydrophobic interactions overlapping the binding surfaces of the IL-6R and gp130 receptors. The G-quartet domain retains considerable binding activity as a disconnected autonomous fragment (K-d = 270 nm). A single substitution from our diversely modified nucleotide library leads to a 37-fold enhancement in binding affinity of the G-quartet fragment (K-d = 7.4 nm). The ability to probe ligand surfaces in this manner is a powerful tool in the development of new therapeutic reagents with improved pharmacologic properties. The SOMAmerIL-6 structure also expands our understanding of the diverse structural motifs achievable with modified nucleic acid libraries and elucidates the nature with which these unique ligands interact with their protein targets.	[Gelinas, Amy D.; Rohloff, John C.; Carter, Jeffrey D.; Zhang, Chi; Gupta, Shashi; Jarvis, Thale C.; Janjic, Nebojsa] SomaLog Inc, Boulder, CO 80301 USA; [Davies, Douglas R.; Edwards, Thomas E.] Emerald Bio, Bainbridge Isl, WA 98110 USA; [Ishikawa, Yuichi; Hirota, Masao; Nakaishi, Yuichiro] Otsuka Pharmaceut Co Ltd, Kawaguchi, Tokushima 7710192, Japan	Otsuka Pharmaceutical	Janjic, N (corresponding author), SomaLog Inc, 2945 Wilderness Pl, Boulder, CO 80301 USA.	njanjic@somalogic.com		Edwards, Thomas/0000-0002-0474-8003				Ataie-Kachoie P, 2013, CYTOKINE GROWTH F R, V24, P163, DOI 10.1016/j.cytogfr.2012.09.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Silva MW, 2007, CHEM-EUR J, V13, P9738, DOI 10.1002/chem.200701255; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gao YG, 1997, J AM CHEM SOC, V119, P1496, DOI 10.1021/ja963793r; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gupta S, 2014, J BIOL CHEM, V289, P8706, DOI 10.1074/jbc.M113.532580; HEINEMANN U, 1992, J BIOL CHEM, V267, P7332; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1990, INT J CELL CLONING, V8, P155, DOI 10.1002/stem.5530080714; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MOTT HR, 1995, CURR OPIN STRUC BIOL, V5, P114, DOI 10.1016/0959-440X(95)80016-T; Nomura Y, 2010, NUCLEIC ACIDS RES, V38, P7822, DOI 10.1093/nar/gkq615; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	36	67	68	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8720	8734		10.1074/jbc.M113.532697	http://dx.doi.org/10.1074/jbc.M113.532697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24415767	hybrid, Green Published			2022-12-25	WOS:000333157500060
J	Mukherjee, P; Wilson, RC; Lahiri, I; Pata, JD				Mukherjee, Purba; Wilson, Ryan C.; Lahiri, Indrajit; Pata, Janice D.			Three Residues of the Interdomain Linker Determine the Conformation and Single-base Deletion Fidelity of Y-family Translesion Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Replication; Enzyme Mutation; Kinetics; Protein Conformation; Structural Biology; Fidelity; Translesion Synthesis; Y-family Polymerase	DNA-POLYMERASE; CRYSTAL-STRUCTURE; ERROR-PRONE; BYPASS; MECHANISM; KAPPA; DINB; DOMAIN; IOTA; ETA	Background: Dpo4 and Dbh translesion polymerases show distinct mutagenic signatures and lesion bypass abilities. Results: Three residues in the interdomain linker are major determinants of polymerase conformation and nucleotide incorporation rate. Conclusion: Residues remote from the active site strongly influence single-base deletion and mispair extension efficiency by controlling polymerase conformation. Significance: This work suggests new possibilities for regulating translesion synthesis activity through altered conformation. Dpo4 and Dbh are from two closely related Sulfolobus species and are well studied archaeal homologues of pol IV, an error prone Y-family polymerase from Escherichia coli. Despite sharing 54% amino acid identity, these polymerases display distinct mutagenic and translesion specificities. Structurally, Dpo4 and Dbh adopt different conformations because of the difference in relative orientation of their N-terminal catalytic and C-terminal DNA binding domains. Using chimeric constructs of these two polymerases, we have previously demonstrated that the interdomain linker is a major determinant of polymerase conformation, base-substitution fidelity, and abasic-site translesion synthesis. Here we find that the interdomain linker also affects the single-base deletion frequency and the mispair extension efficiency of these polymerases. Exchanging just three amino acids in the linkers of Dbh and Dpo4 is sufficient to change the fidelity by up to 30-fold, predominantly by altering the rate of correct (but not incorrect) nucleotide incorporation. Additionally, from a 2.4 resolution crystal structure, we have found that the three linker amino acids from Dpo4 are sufficient to allow Dbh to adopt the standard conformation of Dpo4. Thus, a small region of the interdomain linker, located more than 11 away from the catalytic residues, determines the fidelity of these Y-family polymerases, by controlling the alignment of substrates at the active site.	[Mukherjee, Purba; Wilson, Ryan C.; Lahiri, Indrajit; Pata, Janice D.] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Mukherjee, Purba; Lahiri, Indrajit; Pata, Janice D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Pata, JD (corresponding author), SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	jpata@wadsworth.org	Mukherjee, Purba/Q-6811-2019	Mukherjee, Purba/0000-0001-9869-6509; Lahiri, Indrajit/0000-0002-5633-7978; Pata, Janice/0000-0001-5999-5442	National Institutes of Health [R01-GM080573]; Wadsworth Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM080573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM080573 (to J. D. P.). This work was also supported by fellowship support from the Wadsworth Center (to P. M. and I. L.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foti JJ, 2011, J BACTERIOL, V193, P2637, DOI 10.1128/JB.00005-11; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Mukherjee P, 2013, NUCLEIC ACIDS RES, V41, P5024, DOI 10.1093/nar/gkt179; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pata JD, 2010, BBA-PROTEINS PROTEOM, V1804, P1124, DOI 10.1016/j.bbapap.2010.01.020; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wilson RC, 2013, STRUCTURE, V21, P20, DOI 10.1016/j.str.2012.11.005; Wu YF, 2011, J BACTERIOL, V193, P2630, DOI 10.1128/JB.00012-11; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	30	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6323	6331		10.1074/jbc.M113.537860	http://dx.doi.org/10.1074/jbc.M113.537860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415763	Green Published, hybrid			2022-12-25	WOS:000332389400001
J	Bruge, F; Tiano, L; Astolfi, P; Emanuelli, M; Damiani, E				Bruge, Francesca; Tiano, Luca; Astolfi, Paola; Emanuelli, Monica; Damiani, Elisabetta			Prevention of UVA-Induced Oxidative Damage in Human Dermal Fibroblasts by New UV Filters, Assessed Using a Novel In Vitro Experimental System	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; LIPID-PEROXIDATION; PHOTOSTABILITY; MATRIX; ABSORPTION; SUNSCREENS; EFFICACY; METALLOPROTEINASES; PHOTOPROTECTION; RADIATION	Background: UVA rays present in sunlight are able to reach the dermal skin layer generating reactive oxygen species (ROS) responsible for oxidative damage, alterations in gene expression, DNA damage, leading to cell inflammation, photoageing/-carcinogenesis. Sunscreens contain UV filters as active ingredients that absorb/reflect/dissipate UV radiation: their efficiency depends on their spectral profile and photostability which should then be reflected in biological protection of underlying skin. Methods: A set of new UV filters was synthesized, and the most photostable one was compared to BMDBM, a widely used UVA filter. Cultured human dermal fibroblasts were exposed to UVA radiation which was filtered by a base cream containing or not UV filters placed above cell culture wells. The endpoints measured were: cell viability (MTT assay), ROS generation (DCFH-DA assay), mitochondrial function (JC-1 assay), DNA integrity (Comet assay) and gene expression (MMP-1, COL1A1) by RT-qPCR. Results: The new UV filter resulted more efficient than BMDBM in preserving cell viability, mitochondrial functionality and oxidative DNA damage, despite similar inhibition levels of intracellular ROS. Moreover, expression of genes involved in dermal photoageing were positively affected by the filtering action of the tested molecules. Conclusions: The experimental model proposed was able to validate the efficacy of the new UV filter, taking into account important cellular events related to UV-induced intracellular oxidative stress, often underestimated in the assessments of these compounds. General Significance: The model may be used to compare the actual biological protection of commercial sunscreens and suncare products aside from their SPF and UVA-PF values.	[Bruge, Francesca; Tiano, Luca; Emanuelli, Monica] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Astolfi, Paola] Univ Politecn Marche, Dipartimento Sci Ingn Mat Ambiente & Urbanist, Ancona, Italy; [Damiani, Elisabetta] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Damiani, E (corresponding author), Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.	e.damiani@univpm.it	Astolfi, Paola/C-5953-2008; Tiano, Luca/ABC-2341-2020	Astolfi, Paola/0000-0003-3226-082X; Tiano, Luca/0000-0002-7519-7106; Damiani, Elisabetta/0000-0002-7885-1783	Universita Politecnica delle Marche	Universita Politecnica delle Marche	Funding was provided by the Universita Politecnica delle Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, TETRAHEDRON, V67, P6889, DOI 10.1016/j.tet.2011.06.094; Andrae I, 1997, J PHOTOCH PHOTOBIO B, V37, P147, DOI 10.1016/S1011-1344(96)07330-7; BATTISTONI P, 1983, J HETEROCYCLIC CHEM, V20, P451, DOI 10.1002/jhet.5570200235; Behbahani H, 2006, J NEUROSCI RES, V84, P891, DOI 10.1002/jnr.20990; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bonda C.A., 2005, SUNSCREENS REGULATIO, P321; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Buechner N, 2008, EXP GERONTOL, V43, P633, DOI 10.1016/j.exger.2008.04.009; Cantrell A, 2001, J PHOTOCH PHOTOBIO B, V64, P117, DOI 10.1016/S1011-1344(01)00226-3; COLIPA, 2006, COLIPA GUID INT SUN; Collins AR, 1996, ENVIRON HEALTH PERSP, V104, P465, DOI 10.2307/3432805; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Couteau C, 2007, PHARMAZIE, V62, P449, DOI 10.1691/ph.2007.6.6247; Damiani E, 1999, FREE RADICAL BIO MED, V26, P809, DOI 10.1016/S0891-5849(98)00292-5; Damiani E, 2006, J PHOTOCH PHOTOBIO B, V82, P204, DOI 10.1016/j.jphotobiol.2005.03.011; Damiani E, 2006, FREE RADICAL RES, V40, P485, DOI 10.1080/10715760600590065; Damiani E, 2007, J PHOTOCH PHOTOBIO B, V87, P95, DOI 10.1016/j.jphotobiol.2007.03.003; Damiani E, 2010, FREE RADICAL RES, V44, P304, DOI 10.3109/10715760903486065; Diffey BL, 1997, EUR J DERMATOL, V7, P226; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; Goslinski T, 2002, J MED CHEM, V45, P5052, DOI 10.1021/jm020827z; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jean C, 2011, PHOTODERMATOL PHOTO, V27, P318, DOI 10.1111/j.1600-0781.2011.00627.x; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Lhiaubet-Vallet V, 2010, PHOTOCH PHOTOBIO SCI, V9, P552, DOI 10.1039/b9pp00158a; Maines M.D., 1998, CURRENT PROTOCOLS TO; Marrot L, 2004, BRIT J DERMATOL, V151, P1234, DOI 10.1111/j.1365-2133.2004.06173.x; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Palm MD, 2007, DERMATOL THER, V20, P360, DOI 10.1111/j.1529-8019.2007.00150.x; Pelizzo Maria, 2012, ISRN Dermatol, V2012, P352135, DOI 10.5402/2012/352135; Pescia AC, 2012, INT J PHARMACEUT, V427, P217, DOI 10.1016/j.ijpharm.2012.02.001; Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003; Puglia C, 2012, J PHARM SCI-US, V101, P301, DOI 10.1002/jps.22741; ROSCHER NM, 1994, J PHOTOCH PHOTOBIO A, V80, P417, DOI 10.1016/1010-6030(94)01043-9; Routaboul C, 1999, EUR J DERMATOL, V9, P95; SABITHA G, 1987, SYNTHETIC COMMUN, V17, P341, DOI 10.1080/00397918708077315; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Sayre RM, 2005, PHOTOCHEM PHOTOBIOL, V81, P452, DOI 10.1562/2004-02-12-RA-083.1; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; SCHWACK W, 1995, J PHOTOCH PHOTOBIO B, V28, P229, DOI 10.1016/1011-1344(95)07118-L; Seite S, 1998, J PHOTOCH PHOTOBIO B, V44, P69, DOI 10.1016/S1011-1344(98)00122-5; Tarras-Wahlberg N, 1999, J INVEST DERMATOL, V113, P547, DOI 10.1046/j.1523-1747.1999.00721.x; Tiano L, 2010, FREE RADICAL BIO MED, V49, P408, DOI 10.1016/j.freeradbiomed.2010.04.032; Venditti E, 2008, FREE RADICAL BIO MED, V45, P345, DOI 10.1016/j.freeradbiomed.2008.04.025; Vielhaber G, 2006, PHOTOCH PHOTOBIO SCI, V5, P275, DOI 10.1039/b516702g; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wendel V., 2001, SOFW-J, V127, P12; Wondrak GT, 2003, J INVEST DERMATOL, V121, P578, DOI 10.1046/j.1523-1747.2003.12414.x	50	24	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83401	10.1371/journal.pone.0083401	http://dx.doi.org/10.1371/journal.pone.0083401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409282	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500006
J	Fuchs, S; Behrends, V; Bundy, JG; Crisanti, A; Nolan, T				Fuchs, Silke; Behrends, Volker; Bundy, Jacob G.; Crisanti, Andrea; Nolan, Tony			Phenylalanine Metabolism Regulates Reproduction and Parasite Melanization in the Malaria Mosquito	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; EGG DEVELOPMENT; AEDES-AEGYPTI; MELANOTIC ENCAPSULATION; DOPA DECARBOXYLASE; GENES; INFUSION; HYDROXYLASE; OCTOPAMINE; CULICIDAE	The blood meal of the female malaria mosquito is a pre-requisite to egg production and also represents the transmission route for the malaria parasite. The proper and rapid assimilation of proteins and nutrients in the blood meal creates a significant metabolic challenge for the mosquito. To better understand this process we generated a global profile of metabolite changes in response to blood meal of Anopheles gambiae, using Gas Chromatography-Mass Spectrometry (GCMS). To disrupt a key pathway of amino acid metabolism we silenced the gene phenylalanine hydroxylase (PAH) involved in the conversion of the amino acid phenylalanine into tyrosine. We observed increased levels of phenylalanine and the potentially toxic metabolites phenylpyruvate and phenyllactate as well as a reduction in the amount of tyrosine available for melanin synthesis. This in turn resulted in a significant impairment of the melanotic encapsulation response against the rodent malaria parasite Plasmodium berghei. Furthermore silencing of PAH resulted in a significant impairment of mosquito fertility associated with reduction of laid eggs, retarded vitellogenesis and impaired melanisation of the chorion. Carbidopa, an inhibitor of the downstream enzyme DOPA decarboxylase that coverts DOPA into dopamine, produced similar effects on egg melanization and hatching rate suggesting that egg chorion maturation is mainly regulated via dopamine. This study sheds new light on the role of amino acid metabolism in regulating reproduction and immunity.	[Fuchs, Silke; Crisanti, Andrea; Nolan, Tony] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Behrends, Volker; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Nolan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	t.nolan@imperial.ac.uk	Nolan, Tony/I-4925-2012; Bundy, Jacob G/C-2131-2008	Nolan, Tony/0000-0002-2982-8333; Bundy, Jacob G/0000-0002-1164-8465; Behrends, Volker/0000-0003-4855-5497; Crisanti, Andrea/0000-0002-2406-4426	European Community [242095]; INFRAVEC; Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative	European Community(European Commission); INFRAVEC; Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative	Funded by grants from European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement Nu 242095 and INFRAVEC and the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida M., 1990, P239; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Behrends V, 2011, ANAL BIOCHEM, V415, P206, DOI 10.1016/j.ab.2011.04.009; BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P105; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clements A. N., 1992, BIOL MOSQUITOES, V1; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; DIMOND J. B., 1956, CANADIAN ENT, V88, P57; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; FERDIG MT, 1993, AM J TROP MED HYG, V49, P756, DOI 10.4269/ajtmh.1993.49.756; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fukumitsu Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-92; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Infanger LC, 2004, INSECT BIOCHEM MOLEC, V34, P1329, DOI 10.1016/j.ibmb.2004.09.004; Isoe J, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0101; Johnson JK, 2003, INSECT BIOCHEM MOLEC, V33, P345, DOI 10.1016/S0965-1748(02)00257-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; LEA AO, 1956, SCIENCE, V123, P890, DOI 10.1126/science.123.3203.890; LI JY, 1994, INSECT BIOCHEM MOLEC, V24, P1043, DOI 10.1016/0965-1748(94)90142-2; LI JY, 1994, COMP BIOCHEM PHYS A, V109, P835, DOI 10.1016/0300-9629(94)90231-3; LI JY, 1993, INSECT BIOCHEM MOLEC, V23, P739, DOI 10.1016/0965-1748(93)90048-W; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; PORTER CC, 1962, BIOCHEM PHARMACOL, V11, P1067, DOI 10.1016/0006-2952(62)90166-1; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; SINDEN RE, 1996, MOL BIOL INSECT DIS, P67; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Turner EH, 2006, PHARMACOL THERAPEUT, V109, P325, DOI 10.1016/j.pharmthera.2005.06.004; Uchida K, 1998, J INSECT PHYSIOL, V44, P525, DOI 10.1016/S0022-1910(98)00033-X; Uchida K, 2001, J MED ENTOMOL, V38, P572, DOI 10.1603/0022-2585-38.4.572; UCHIDA K, 1992, J INSECT PHYSIOL, V38, P953, DOI 10.1016/0022-1910(92)90003-V; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029	50	40	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84865	10.1371/journal.pone.0084865	http://dx.doi.org/10.1371/journal.pone.0084865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409310	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500034
J	Gan, SW; Surya, W; Vararattanavech, A; Torres, J				Gan, Siok Wan; Surya, Wahyu; Vararattanavech, Ardcharaporn; Torres, Jaume			Two Different Conformations in Hepatitis C Virus p7 Protein Account for Proton Transport and Dye Release	PLOS ONE			English	Article							ION-CHANNEL; SECONDARY STRUCTURE; TOPOLOGY; DETERMINANTS; FORMS; MODEL; POLYPEPTIDE; MUTATIONS; PEPTIDES; SINGLE	The p7 protein from the hepatitis C virus (HCV) is a 63 amino acid long polypeptide that is essential for replication, and is involved in protein trafficking and proton transport. Therefore, p7 is a possible target for antivirals. The consensus model for the channel formed by p7 protein is a hexameric or heptameric oligomer of alpha-helical hairpin monomers, each having two transmembrane domains, TM1 and TM2, where the N-terminal TM1 would face the lumen of this channel. A reported high-throughput functional assay to search for p7 channel inhibitors is based on carboxyfluorescein (CF) release from liposomes after p7 addition. However, the rationale for the dual ability of p7 to serve as an ion or proton channel in the infected cell, and to permeabilize membranes to large molecules like CF is not clear. We have recreated both activities in vitro, examining the conformation present in these assays using infrared spectroscopy. Our results indicate that an alpha-helical form of p7, which can transport protons, is not able to elicit CF release. In contrast, membrane permeabilization to CF is observed when p7 contains a high percentage of beta-structure, or when using a C-terminal fragment of p7, encompassing TM2. We propose that the reported inhibitory effect of some small compounds, e. g., rimantadine, on both CF release and proton transport can be explained via binding to the membrane-inserted C-terminal half of p7, increasing its rigidity, in a similar way to the influenza A M2-rimantadine interaction.	[Gan, Siok Wan; Surya, Wahyu; Vararattanavech, Ardcharaporn; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	jtorres@ntu.edu.sg	Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020	Torres, Jaume/0000-0002-1282-9727; Surya, Wahyu/0000-0001-9240-371X	National Research Foundation [NRF-CRP4-2008-02]; AcRF [RG 38/08]	National Research Foundation; AcRF	J.T. acknowledges the funding of the National Research Foundation grant NRF-CRP4-2008-02 and AcRF Tier 1 grant RG 38/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFMANN HA, 1977, BIOPOLYMERS, V16, P1815, DOI 10.1002/bip.1977.360160815; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Chew CF, 2009, BIOPHYS J, V96, pL10, DOI 10.1016/j.bpj.2008.10.004; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Cook G. A., 2010, BIOCHIM BIOPHYS ACTA, V1808, P1448; Cook GA, 2009, EUR BIOPHYS J, V39; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P554, DOI 10.1016/j.bbamem.2010.08.005; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Gan SW, 2012, J BIOL CHEM, V287, P24671, DOI 10.1074/jbc.M111.332791; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Gervais C, 2011, J BIOMOL SCREEN, V16, P363, DOI 10.1177/1087057110396215; Griffin S, 2005, J VIROL, V79, P15525, DOI 10.1128/JVI.79.24.15525-15536.2005; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Haqshenas G, 2007, VIROLOGY, V360, P17, DOI 10.1016/j.virol.2006.10.014; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; HUANG CH, 1971, J BIOL CHEM, V246, P2555; Isherwood BJ, 2005, J GEN VIROL, V86, P667, DOI 10.1099/vir.0.80737-0; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Li H, 2012, VIROLOGY, V423, P30, DOI 10.1016/j.virol.2011.11.011; LITMAN BJ, 1973, BIOCHEMISTRY-US, V12, P2545, DOI 10.1021/bi00737a028; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; McGinnes LW, 2003, J VIROL, V77, P1951, DOI 10.1128/JVI.77.3.1951-1963.2003; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; MUTTER M, 1985, BIOPOLYMERS, V24, P1057, DOI 10.1002/bip.360240610; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; PARSEGIAN VA, 1979, P NATL ACAD SCI USA, V76, P2750, DOI 10.1073/pnas.76.6.2750; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Perez-Berna AJ, 2008, J BIOL CHEM, V283, P8089, DOI 10.1074/jbc.M709413200; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; REYNOLDS JA, 1985, METHOD ENZYMOL, V117, P41; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Tedbury P, 2011, J GEN VIROL, V92, P819, DOI 10.1099/vir.0.027441-0; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Torres J, 2000, BIOPHYS J, V79, P3139, DOI 10.1016/S0006-3495(00)76547-7; Torres J, 2000, J MOL BIOL, V300, P677, DOI 10.1006/jmbi.2000.3885; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Whitfield T, 2011, MOL MEMBR BIOL, V28, P254, DOI 10.3109/09687688.2011.581253; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	52	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e78494	10.1371/journal.pone.0078494	http://dx.doi.org/10.1371/journal.pone.0078494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409277	gold, Green Published			2022-12-25	WOS:000329463500001
J	Pan, Y; Bhattarai, S; Modestou, M; Drack, AV; Chetkovich, DM; Baker, SA				Pan, Yuan; Bhattarai, Sajag; Modestou, Modestos; Drack, Arlene V.; Chetkovich, Dane M.; Baker, Sheila A.			TRIP8b Is Required for Maximal Expression of HCN1 in the Mouse Retina	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; ROD PHOTORECEPTORS; BIPOLAR CELLS; GANGLION-CELLS; ION CHANNELS; RAT RETINA; TRAFFICKING; LOCALIZATION; SUBUNIT; PROTEINS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are cation-selective channels present in retina, brain and heart. The activity of HCN channels contributes to signal integration, cell excitability and pacemaker activity. HCN1 channels expressed in photoreceptors participate in keeping light responses transient and are required for normal mesopic vision. The subcellular localization of HCN1 varies among cell types. In photoreceptors HCN1 is concentrated in the inner segments while in other retinal neurons, HCN1 is evenly distributed though the cell. This is in contrast to hippocampal neurons where HCN1 is concentrated in a subset of dendrites. A key regulator of HCN1 trafficking and activity is tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b). Multiple splice isoforms of TRIP8b are expressed throughout the brain and can differentially regulate the surface expression and activity of HCN1. The purpose of the present study was to determine which isoforms of TRIP8b are expressed in the retina and to test if loss of TRIP8b alters HCN1 expression or trafficking. We found that TRIP8b colocalizes with HCN1 in multiple retina neurons and all major splice isoforms of TRIP8b are expressed in the retina. Photoreceptors express three different isoforms. In TRIP8b knockout mice, the ability of HCN1 to traffic to the surface of retinal neurons is unaffected. However, there is a large decrease in the total amount of HCN1. We conclude that TRIP8b in the retina is needed to achieve maximal expression of HCN1.	[Pan, Yuan; Modestou, Modestos; Baker, Sheila A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bhattarai, Sajag; Drack, Arlene V.; Baker, Sheila A.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Chetkovich, Dane M.] Northwestern Univ, Ken & Ruth Davee Dept Neurol & Clin Neurosci, Feinberg Sch Med, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	University of Iowa; University of Iowa; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Baker, SA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	sheila-baker@uiowa.edu	Chetkovich, Dane/AAV-5457-2021	Drack, Arlene/0000-0002-8195-8426; Baker, Sheila/0000-0002-0259-0652; Pan, Yuan/0000-0002-9465-8289	Research to Prevent Blindness; National Institutes of Health [NS059934, EY020542]; NATIONAL EYE INSTITUTE [R01EY020542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from Research to Prevent Blindness (A. V. D.) and the National Institutes of Health: NS059934 (D. M. C) and EY020542 (S. A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050442; Barbuti A, 2012, J MOL CELL CARDIOL, V53, P187, DOI 10.1016/j.yjmcc.2012.05.013; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; Braun AP, 2009, CHANNELS, V3, P217, DOI 10.4161/chan.3.4.9620; Bucchi A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00240; Della Santina L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029812; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; Demontis GC, 2009, INVEST OPHTH VIS SCI, V50, P1948, DOI 10.1167/iovs.08-2659; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Eldstrom J, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002092; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; Huang Z, 2012, J NEUROSCI, V32, P14835, DOI 10.1523/JNEUROSCI.1544-12.2012; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Kim IB, 2003, J COMP NEUROL, V467, P389, DOI 10.1002/cne.10957; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Koizumi A, 2004, MOL VIS, V10, P328; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Oi H, 2008, VISUAL NEUROSCI, V25, P95, DOI 10.1017/S095252380808005X; Partida GJ, 2012, INVEST OPHTH VIS SCI, V53, P1696, DOI 10.1167/iovs.11-9307; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Reiners J, 2005, MOL VIS, V11, P347; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Savelieva I, 2008, DRUG SAFETY, V31, P95, DOI 10.2165/00002018-200831020-00001; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Stradleigh TW, 2011, J COMP NEUROL, V519, P2546, DOI 10.1002/cne.22638; Tanimoto N, 2012, ADV EXP MED BIOL, V723, P807, DOI 10.1007/978-1-4614-0631-0_103; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wilkars W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032181; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009; Ying SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042756; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85850	10.1371/journal.pone.0085850	http://dx.doi.org/10.1371/journal.pone.0085850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409334	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500058
J	Alwan, NA; Cade, JE; Greenwood, DC; Deanfield, J; Lawlor, DA				Alwan, Nisreen A.; Cade, Janet E.; Greenwood, Darren C.; Deanfield, John; Lawlor, Debbie A.			Associations of Maternal Iron Intake and Hemoglobin in Pregnancy with Offspring Vascular Phenotypes and Adiposity at Age 10: Findings from the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							BLOOD-PRESSURE; FETAL; COPPER; DEFICIENCY; ANEMIA; RAT; POPULATION; ABSORPTION; CHILDHOOD; WEIGHT	Background: Iron deficiency is common during pregnancy. Experimental animal studies suggest that it increases cardiovascular risk in the offspring. Objective: To examine the relationship between maternal pregnancy dietary and supplement iron intake and hemoglobin, with offspring's arterial stiffness (measured by carotid-radial pulse wave velocity), endothelial function (measured by brachial artery flow mediated dilatation), blood pressure, and adiposity (measured by body mass index), test for mediation by cord ferritin, birth weight, gestational age, and child dietary iron intake, and for effect modification by maternal vitamin C intake and offspring sex. Design: Prospective data from 2958 mothers and children pairs at 10 years of age enrolled in an English birth cohort, the Avon Longitudinal Study for Parents and Children (ALSPAC), was analysed. Results: 2639 (89.2%) mothers reported dietary iron intake in pregnancy below the UK reference nutrient intake of 14.8 mg/day. 1328 (44.9%) reported taking iron supplements, and 129 (4.4%) were anemic by 18 weeks gestation. No associations were observed apart from maternal iron intake from supplements with offspring systolic blood pressure (20.8 mmHg, 99% CI 21.7 to 0, P = 0.01 in the sample with all relevant data observed, and 20.7 mmHg, 99% CI 21.3 to 0, P = 0.008 in the sample with missing data imputed). Conclusion: There was no evidence of association between maternal pregnancy dietary iron intake, or maternal hemoglobin concentration (which is less likely to be biased by subjective reporting) with offspring outcomes. There was a modest inverse association between maternal iron supplement intake during pregnancy with offspring systolic blood pressure at 10 years.	[Alwan, Nisreen A.; Cade, Janet E.] Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds, W Yorkshire, England; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Hlth Genet & Therapeut, Div Epidemiol & Biostat, Leeds, W Yorkshire, England; [Deanfield, John] UCL, Inst Cardiovasc Sci, Vasc Physiol Unit, London, England; [Lawlor, Debbie A.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Leeds; University of Leeds; University of London; University College London; University of Bristol; University of Bristol	Alwan, NA (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds, W Yorkshire, England.	N.Alwan@leeds.ac.uk	Alwan, Nisreen A./AFP-0662-2022; Greenwood, Darren C/C-3220-2008; Cade, Janet E/G-4250-2016	Alwan, Nisreen A./0000-0002-4134-8463; Greenwood, Darren C/0000-0001-7035-3096; Cade, Janet E/0000-0003-3421-0121; Deanfield, John/0000-0001-8806-6052; Lawlor, Debbie A/0000-0002-6793-2262	British Heart Foundation; Wellcome Trust [WT87789]; UK Medical Research Council [MC_UU_12013/5]; MRC [MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [MC_PC_15018, MC_UU_12013/5] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Core support for ALSPAC is provided by the UK Medical Research Council, the Wellcome Trust and the University of Bristol. Funding for the vascular measurements used in this study was obtained from the British Heart Foundation. NAA is funded by a Wellcome Trust research fellowship [WT87789] and DAL works in a Unit that receives funding from the UK Medical Research Council [grant number MC_UU_12013/5]. The study funders had no role in study design, analysis and interpretation of data, the writing of the article or the decision to submit for publication. The views expressed in this paper are those of the authors and not necessarily any of the funding agencies that have supported this work.	AGRAWAL RMD, 1983, ACTA PAEDIATR SCAND, V72, P545, DOI 10.1111/j.1651-2227.1983.tb09768.x; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; [Anonymous], 2001, IRON DEFICIENCY ANAE; Baker PN, 2009, AM J CLIN NUTR, V89, P1114, DOI 10.3945/ajcn.2008.27097; Belfort MB, 2008, INT J EPIDEMIOL, V37, P301, DOI 10.1093/ije/dyn002; Bergel E, 2000, AM J EPIDEMIOL, V151, P594, DOI 10.1093/oxfordjournals.aje.a010247; Bergmann RL, 2002, EUR J OBSTET GYN R B, V102, P155, DOI 10.1016/S0301-2115(01)00609-1; Boyd A., 2012, INT J EPIDEMIOLOGY, DOI 10.1093/ije/dys064; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brion MJA, 2008, AM J CLIN NUTR, V88, P1126, DOI 10.1093/ajcn/88.4.1126; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Donald AE, 2010, EUR HEART J, V31, P1502, DOI 10.1093/eurheartj/ehq062; Fraser A, 2012, INT J EPIDEMIOLOGY; FSA, 2003, NAT DIET NUTR SURV A, V3; Gambling L, 2004, P NUTR SOC, V63, P553, DOI 10.1079/PNS2004385; Gambling L, 2004, J NUTR BIOCHEM, V15, P366, DOI 10.1016/j.jnutbio.2003.12.009; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Gambling L, 2008, BIOCHEM SOC T, V36, P1258, DOI 10.1042/BST0361258; Gibney M, 2004, PUBLIC HLTH NUTR; GODFREY KM, 1994, BRIT J OBSTET GYNAEC, V101, P398, DOI 10.1111/j.1471-0528.1994.tb11911.x; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Holland B, 1991, ROYAL SOC CHEM; KANESHIGE E, 1981, OBSTET GYNECOL, V57, P238; Kelleher SL, 2006, J NUTR, V136, P1185; LAW CM, 1991, ARCH DIS CHILD, V66, P1291, DOI 10.1136/adc.66.11.1291; Lisle SJM, 2003, BRIT J NUTR, V90, P33, DOI 10.1079/BJN2003881; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Singla PN, 1996, ACTA PAEDIATR, V85, P1327, DOI 10.1111/j.1651-2227.1996.tb13919.x; TAMURA T, 2002, OBSTET GYNECOL SURV, V57, P493, DOI DOI 10.1097/00006254-200208000-00008; WHINCUP P, 1994, J HUM HYPERTENS, V8, P337; WHO, 2010, MICR DEF; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	44	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84684	10.1371/journal.pone.0084684	http://dx.doi.org/10.1371/journal.pone.0084684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400110	Green Published, gold, Green Accepted			2022-12-25	WOS:000329462700044
J	Jiang, CX; Zhang, LJ; Zou, C; Long, XJ; Liu, X; Zheng, HR; Liao, WQ; Diao, YJ				Jiang, Chunxiang; Zhang, Lijuan; Zou, Chao; Long, Xiaojing; Liu, Xin; Zheng, Hairong; Liao, Weiqi; Diao, Yanjun			Diurnal Microstructural Variations in Healthy Adult Brain Revealed by Diffusion Tensor Imaging	PLOS ONE			English	Article							WHITE-MATTER CHANGES; FRACTIONAL ANISOTROPY; WATER DIFFUSION; SLEEP; COEFFICIENT; VOLUME; MRI; ASYMMETRY; GRAY; FACE	Biorhythm is a fundamental property of human physiology. Changes in the extracellular space induced by cell swelling in response to the neural activity enable the in vivo characterization of cerebral microstructure by measuring the water diffusivity using diffusion tensor imaging (DTI). To study the diurnal microstructural alterations of human brain, fifteen right-handed healthy adult subjects were recruited for DTI studies in two repeated sessions (8: 30 AM and 8: 30 PM) within a 24-hour interval. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial (lambda(//)) and radial diffusivity (lambda(perpendicular to)) were compared pixel by pixel between the sessions for each subject. Significant increased morning measurements in FA, ADC, lambda(//) and lambda(perpendicular to) were seen in a wide range of brain areas involving frontal, parietal, temporal and occipital lobes. Prominent evening dominant lambda(perpendicular to) (18.58%) was detected in the right inferior temporal and ventral fusiform gyri. AM-PM variation of lambda(perpendicular to) was substantially left side hemisphere dominant (p<0.05), while no hemispheric preference was observed for the same analysis for ADC (p = 0.77), lambda(//) (p = 0.08) or FA (p = 0.25). The percentage change of ADC, lambda(//), lambda(perpendicular to), and FA were 1.59%, 2.15%, 1.20% and 2.84%, respectively, for brain areas without diurnal diffusivity contrast. Microstructural variations may function as the substrates of the phasic neural activities in correspondence to the environment adaptation in a light-dark cycle. This research provided a baseline for researches in neuroscience, sleep medicine, psychological and psychiatric disorders, and necessitates that diurnal effect should be taken into account in following up studies using diffusion tensor quantities.	[Jiang, Chunxiang; Zhang, Lijuan; Zou, Chao; Long, Xiaojing; Liu, Xin; Zheng, Hairong; Liao, Weiqi; Diao, Yanjun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhang, LJ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	lj.zhang@siat.ac.cn		Liao, Weiqi/0000-0002-8605-3749	Basic Research Program of Shenzhen [JCYJ20120615124706404]	Basic Research Program of Shenzhen	This study was partially sponsored by Basic Research Program of Shenzhen (Grant number JCYJ20120615124706404). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; BACHYRITA P, 1993, NEUROREPORT, V4, P343, DOI 10.1097/00001756-199304000-00001; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Buckley DL, 1999, MAGNET RESON MED, V42, P603, DOI 10.1002/(SICI)1522-2594(199909)42:3<603::AID-MRM25>3.0.CO;2-Q; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Clark CA, 2000, MAGN RESON MED, V43, P133, DOI 10.1002/(SICI)1522-2594(200001)43:1<133::AID-MRM16>3.0.CO;2-X; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Flint J, 2009, NEUROIMAGE, V46, P411, DOI 10.1016/j.neuroimage.2009.02.003; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Habib J, 2010, MAGN RESON MED, V63, P1098, DOI 10.1002/mrm.22232; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Hsiao JH, 2013, J COGNITIVE NEUROSCI, V25, P998, DOI 10.1162/jocn_a_00377; Ivry R.B., 1998, 2 SIDES PERCEPTION; Jean-Louis Girardin, 2005, J Circadian Rhythms, V3, P13, DOI 10.1186/1740-3391-3-13; Johnson C.H., 1990, ATLAS PHASE RESPONSE; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kolaj M, 2012, J NEUROPHYSIOL, V107, P1835, DOI 10.1152/jn.00974.2011; Kumar R, 2012, J NEUROSCI RES, V90, P346, DOI 10.1002/jnr.22757; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Li F, 2011, RADIOLOGY, V260, P216, DOI 10.1148/radiol.11101971; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Long X., 2012, HUMAN BRAIN MAPPING; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; MILLARCRAIG MW, 1978, LANCET, V1, P795; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; O'Donnell LJ, 2010, LECT NOTES COMPUT SC, V6362, P225; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; PIERPAOLI C, 2003, P 11 ANN M ISMRM; Rocklage M, 2009, SLEEP, V32, P1100, DOI 10.1093/sleep/32.8.1100; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sheth BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005496; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stadlbauer A, 2010, RADIOLOGY, V257, P846, DOI 10.1148/radiol.10100343; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taubert M, 2012, NEUROSCIENTIST, V18, P320, DOI 10.1177/1073858411419048; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Weis S., 2000, NEUROIMAGE, V11, pS10, DOI [10.1016/S1053-8119(00)90945-5, DOI 10.1016/S1053-8119(00)90945-5]; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965	70	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84822	10.1371/journal.pone.0084822	http://dx.doi.org/10.1371/journal.pone.0084822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400118	gold, Green Submitted, Green Published			2022-12-25	WOS:000329462700052
J	Gonzalez, E; Piva, M; Rodriguez-Suarez, E; Gil, D; Royo, F; Elortza, F; Falcon-Perez, JM; Vivanco, MD				Gonzalez, Esperanza; Piva, Marco; Rodriguez-Suarez, Eva; Gil, David; Royo, Felix; Elortza, Felix; Falcon-Perez, Juan M.; Vivanco, Maria Dm			Human Mammospheres Secrete Hormone-Regulated Active Extracellular Vesicles	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; HUMAN-MILK; EXOSOMES; GROWTH; TUMOR; MICROVESICLES; MEDIATE; HETEROGENEITY; PROTEINS	Breast cancer is a leading cause of cancer-associated death worldwide. One of the most important prognostic factors for survival is the early detection of the disease. Recent studies indicate that extracellular vesicles may provide diagnostic information for cancer management. We demonstrate the secretion of extracellular vesicles by primary breast epithelial cells enriched for stem/progenitor cells cultured as mammospheres, in non-adherent conditions. Using a proteomic approach we identified proteins contained in these vesicles whose expression is affected by hormonal changes in the cellular environment. In addition, we showed that these vesicles are capable of promoting changes in expression levels of genes involved in epithelial-mesenchymal transition and stem cell markers. Our findings suggest that secreted extracellular vesicles could represent potential diagnostic and/or prognostic markers for breast cancer and support a role for extracellular vesicles in cancer progression.	[Gonzalez, Esperanza; Royo, Felix; Falcon-Perez, Juan M.] Metabol CIBERehd, Derio, Spain; [Piva, Marco; Vivanco, Maria Dm] CIBERehd, Cell Biol & Stem Cells Unit, Derio, Spain; [Rodriguez-Suarez, Eva; Elortza, Felix] CIBERehd, ProteoRed ISCIII, Derio, Spain; [Gil, David] CIC BioGUNE, Derio, Spain; [Falcon-Perez, Juan M.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Basque Foundation for Science	Falcon-Perez, JM (corresponding author), Metabol CIBERehd, Derio, Spain.	jfalcon@cicbiogune.es; mdmvivanco@cicbiogune.es	Carton, David Gil/G-2404-2011; Elortza, Felix/D-5058-2011; Vivanco, Maria/G-2393-2011; Carton, David Gil/M-9332-2019; Piva, Marco/F-2748-2019; Elortza, Felix/ABG-4183-2020; González, Esperanza/AAK-4097-2020; Royo, Felix/ABE-8064-2021; Royo, Felix/A-7198-2015; Falcon-Perez, Juan M/F-5920-2011; González, Esperanza/H-5450-2015	Carton, David Gil/0000-0003-4241-1302; Vivanco, Maria/0000-0002-9540-247X; Carton, David Gil/0000-0003-4241-1302; González, Esperanza/0000-0002-3831-4596; Royo, Felix/0000-0001-9769-4165; Royo, Felix/0000-0001-9769-4165; González, Esperanza/0000-0002-3831-4596; Elortza, Felix/0000-0001-8839-5438; Piva, Marco/0000-0001-6906-6065; Falcon-Perez, Juan M/0000-0003-3133-0670	Foundation La Caixa; Foundation for Science and Technology of the Portuguese Ministry of Science; Institute of Health Carlos III [06/0621, 09/00526, PI081877]; program Ramon y Cajal; Department of Education of the Government of the Autonomous Community of the Basque Country; Department of Health of the Government of the Autonomous Community of the Basque Country; Department of Industry, Tourism and Trade (Etortek)	Foundation La Caixa(La Caixa Foundation); Foundation for Science and Technology of the Portuguese Ministry of Science; Institute of Health Carlos III(Instituto de Salud Carlos III); program Ramon y Cajal(Spanish Government); Department of Education of the Government of the Autonomous Community of the Basque Country; Department of Health of the Government of the Autonomous Community of the Basque Country; Department of Industry, Tourism and Trade (Etortek)	This work was supported by grants from: Foundation La Caixa (MP), Foundation for Science and Technology of the Portuguese Ministry of Science (BS), the Institute of Health Carlos III (06/0621 & 09/00526 to JMFP and PI081877 to MdMV), the program Ramon y Cajal (JMFP), the Departments of Education and Health of the Government of the Autonomous Community of the Basque Country (MdMV) and the Department of Industry, Tourism and Trade (Etortek). Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Cho JA, 2011, GYNECOL ONCOL, V123, P379, DOI 10.1016/j.ygyno.2011.08.005; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Kato K, 2010, AM J PATHOL, V176, P381, DOI 10.2353/ajpath.2010.090056; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; LAROCCA D, 1991, CANCER RES, V51, P4994; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mossuz P, 1998, LEUKEMIA RES, V22, P1063, DOI 10.1016/S0145-2126(98)00101-5; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Pasquier J, 2012, J BIOL CHEM, V287, P7374, DOI 10.1074/jbc.M111.312157; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez I, 2009, HEAD NECK-J SCI SPEC, V31, P1335, DOI 10.1002/hed.21099; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saitoh Y, 2006, BIOL PHARM BULL, V29, P709, DOI 10.1248/bpb.29.709; Seli E, 2001, FERTIL STERIL, V75, P1172, DOI 10.1016/S0015-0282(01)01779-4; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Simoes B.M., 2010, BREAST CANC RES TREA; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Teranishi J, 2008, PROSTATE, V68, P1666, DOI 10.1002/pros.20835; Vivanco MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001215; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	42	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83955	10.1371/journal.pone.0083955	http://dx.doi.org/10.1371/journal.pone.0083955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404144	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800023
J	Johns, N; Hatakeyama, S; Stephens, NA; Degen, M; Degen, S; Frieauff, W; Lambert, C; Ross, JA; Roubenoff, R; Glass, DJ; Jacobi, C; Fearon, KCH				Johns, Neil; Hatakeyama, Shinji; Stephens, Nathan A.; Degen, Martin; Degen, Simone; Frieauff, Wilfried; Lambert, Christian; Ross, James A.; Roubenoff, Ronenn; Glass, David J.; Jacobi, Carsten; Fearon, Kenneth C. H.			Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; STEM-CELL FUNCTION; PROTEIN-SYNTHESIS; MYOSIN ISOFORMS; ATROPHY; MASS; DEGRADATION; ACTIVATION; EXPRESSION; GENE	Background: Cachexia affects the majority of patients with advanced cancer and is associated with a reduction in treatment tolerance, response to therapy, and duration of survival. One impediment towards the effective treatment of cachexia is a validated classification system. Methods: 41 patients with resectable upper gastrointestinal (GI) or pancreatic cancer underwent characterisation for cachexia based on weight-loss (WL) and/or low muscularity (LM). Four diagnostic criteria were used >5% WL,>10% WL, LM, and LM+>2% WL. All patients underwent biopsy of the rectus muscle. Analysis included immunohistochemistry for fibre size and type, protein and nucleic acid concentration, Western blots for markers of autophagy, SMAD signalling, and inflammation. Findings: Compared with non-cachectic cancer patients, patients with LM or LM+>2% WL, mean muscle fibre diameter was reduced by about 25% (p = 0.02 and p = 0.001 respectively). No significant difference in fibre diameter was observed if patients had WL alone. Regardless of classification, there was no difference in fibre number or proportion of fibre type across all myosin heavy chain isoforms. Mean muscle protein content was reduced and the ratio of RNA/DNA decreased in patients with either >5% WL or LM+>2% WL. Compared with non-cachectic patients, SMAD3 protein levels were increased in patients with >5% WL (p = 0.022) and with >10% WL, beclin (p = 0.05) and ATG5 (p = 0.01) protein levels were increased. There were no differences in phospho-NFkB or phospho-STAT3 levels across any of the groups. Conclusion: Muscle fibre size, biochemical composition and pathway phenotype can vary according to whether the diagnostic criteria for cachexia are based on weight loss alone, a measure of low muscularity alone or a combination of the two. For intervention trials where the primary end-point is a change in muscle mass or function, use of combined diagnostic criteria may allow identification of a more homogeneous patient cohort, reduce the sample size required and enhance the time scale within which trials can be conducted.	[Johns, Neil; Stephens, Nathan A.; Ross, James A.; Fearon, Kenneth C. H.] Univ Edinburgh, Dept Clin & Surg Sci, Edinburgh, Midlothian, Scotland; [Hatakeyama, Shinji; Degen, Martin; Degen, Simone; Frieauff, Wilfried; Lambert, Christian; Jacobi, Carsten] Novartis Pharma AG, Novartis Inst BioMed Res Basel, Basel, Switzerland; [Roubenoff, Ronenn; Glass, David J.] Novartis Inst Biomed Res, Cambridge, MA USA	University of Edinburgh; Novartis; Novartis	Fearon, KCH (corresponding author), Univ Edinburgh, Dept Clin & Surg Sci, Edinburgh, Midlothian, Scotland.	k.fearon@ed.ac.uk	Glass, David/AAI-3910-2021; Hatakeyama, Shinji/I-8873-2019; Glass, David/C-4782-2012	Hatakeyama, Shinji/0000-0002-0166-2773; Glass, David/0000-0001-6187-4164; Roubenoff, Ronenn/0000-0002-3959-3179; Degen, Martin/0000-0002-4356-3714	Royal College of Surgeons	Royal College of Surgeons	The authors' received a small grant from Royal College of Surgeons: http://www.rcsed.ac.uk/fellows-members/awards-and-grants/grants/small-research-grants.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Aulino P, 2010, BMC CANCER, V10, P363; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Basu R, 2002, J Nutr Health Aging, V6, P336; Bhogal AS, 2006, ANTICANCER RES, V26, P4149; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2011, J EXP MED, V208, P2449, DOI 10.1084/jem.20111020; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; D'Orlando C, 2013, MUSCLE NERVE; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Eley HL, 2008, BRIT J CANCER, V98, P443, DOI 10.1038/sj.bjc.6604150; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Gallagher I. J., 2012, CLIN CANC RES; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; GOLDBERG AL, 1969, J PHYSIOL-LONDON, V200, P655, DOI 10.1113/jphysiol.1969.sp008714; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; LOPES MN, 1989, BIOCHEM J, V264, P713, DOI 10.1042/bj2640713; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ryan AS, 2011, STROKE, V42, P416, DOI 10.1161/STROKEAHA.110.602441; Samuels SE, 2001, AM J PHYSIOL-REG I, V281, pR133, DOI 10.1152/ajpregu.2001.281.1.R133; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; SCIOTE JJ, 1994, J NEUROL SCI, V126, P15, DOI 10.1016/0022-510X(94)90089-2; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Stephens NA, 2012, CLIN NUTR; Stephens NA, 2010, GENOME MED, V2, DOI 10.1186/gm122; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Weber MA, 2007, J MOL MED, V85, P887, DOI 10.1007/s00109-007-0220-3; Weber MA, 2009, ACTA ONCOL, V48, P116, DOI 10.1080/02841860802130001; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708	52	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83618	10.1371/journal.pone.0083618	http://dx.doi.org/10.1371/journal.pone.0083618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404136	gold, Green Submitted, Green Published			2022-12-25	WOS:000329460800015
J	Kuijper, DPJ; Verwijmeren, M; Churski, M; Zbyryt, A; Schmidt, K; Jedrzejewska, B; Smit, C				Kuijper, Dries P. J.; Verwijmeren, Mart; Churski, Marcin; Zbyryt, Adam; Schmidt, Krzysztof; Jedrzejewska, Bogumila; Smit, Chris			What Cues Do Ungulates Use to Assess Predation Risk in Dense Temperate Forests?	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; YELLOWSTONE-NATIONAL-PARK; MEDIATED TROPHIC CASCADE; TEMPORAL VARIATION; EURASIAN LYNX; RED DEER; ANTIPREDATOR RESPONSE; NORTHERN YELLOWSTONE; BEHAVIORAL-RESPONSES; WOLF REINTRODUCTION	Anti-predator responses by ungulates can be based on habitat features or on the near-imminent threat of predators. In dense forest, cues that ungulates use to assess predation risk likely differ from half-open landscapes, as scent relative to sight is predicted to be more important. We studied, in the Bialowieza Primeval Forest (Poland), whether perceived predation risk in red deer (Cervus elaphus) and wild boar (Sus scrofa) is related to habitat visibility or olfactory cues of a predator. We used camera traps in two different set-ups to record undisturbed ungulate behavior and fresh wolf (Canis lupus) scats as olfactory cue. Habitat visibility at fixed locations in deciduous old growth forest affected neither vigilance levels nor visitation rate and cumulative visitation time of both ungulate species. However, red deer showed a more than two-fold increase of vigilance level from 22% of the time present on control plots to 46% on experimental plots containing one wolf scat. Higher vigilance came at the expense of time spent foraging, which decreased from 32% to 12% while exposed to the wolf scat. These behavioral changes were most pronounced during the first week of the experiment but continuous monitoring of the plots suggested that they might last for several weeks. Wild boar did not show behavioral responses indicating higher perceived predation risk. Visitation rate and cumulative visitation time were not affected by the presence of a wolf scat in both ungulate species. The current study showed that perceived predation risk in red deer and wild boar is not related to habitat visibility in a dense forest ecosystem. However, olfactory cues of wolves affected foraging behavior of their preferred prey species red deer. We showed that odor of wolves in an ecologically equivalent dose is sufficient to create fine-scale risk factors for red deer.	[Kuijper, Dries P. J.; Churski, Marcin; Schmidt, Krzysztof; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Verwijmeren, Mart] Univ Utrecht, Copernicus Inst, Dept Environm Sci, Utrecht, Netherlands; [Zbyryt, Adam] Polish Soc Bird Protect, Bialystok, Poland; [Smit, Chris] Univ Groningen, Ctr Evolutionary & Ecol Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Utrecht University; University of Groningen	Kuijper, DPJ (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	dkuijper@ibs.bialowieza.pl	Churski, Marcin/Y-5361-2019; Schmidt, Krzysztof/L-6437-2013; smit, christian/B-9817-2008	Churski, Marcin/0000-0001-8727-0203; Kuijper, Dries/0000-0002-0324-5893; Verwijmeren, Mart/0000-0002-8051-0697; smit, christian/0000-0002-4044-9473; Zbyryt, Adam/0000-0003-1490-5700; Schmidt, Krzysztof/0000-0002-9043-291X	Marie Curie European Reintegration Grant under the 7th framework program [PERG06-GA-2009-256444]; National Science Center, Poland [2011/01/B/NZ8/04337, 2012/05/B/NZ8/01010]; Polish Ministry of Science and Higher Education [N309 137 335]; European Union [245737]	Marie Curie European Reintegration Grant under the 7th framework program; National Science Center, Poland(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	Part of the work of DPJK was supported by a Marie Curie European Reintegration Grant under the 7th framework program (project PERG06-GA-2009-256444) and funding by the National Science Center, Poland (grants no.: 2011/01/B/NZ8/04337 and 2012/05/B/NZ8/01010). Additionally MC received funding by the Polish Ministry of Science and Higher Education (grants no.: N309 137 335). BJ and KS received funding from the European Union 7th Framework Programme under project Research Potential in Conservation and Sustainable Management of Biodiversity - BIOCONSUS (grant agreement no. 245737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Arnould C, 1998, J CHEM ECOL, V24, P559, DOI 10.1023/A:1022321104758; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; Barja I, 2008, CAN J ZOOL, V86, P170, DOI 10.1139/Z07-129; Barja I, 2005, FOLIA ZOOL, V54, P21; Bernadzki E, 1998, J VEG SCI, V9, P229, DOI 10.2307/3237122; Beschta RL, 2013, ECOLOGY, V94, P1420, DOI 10.1890/11-0063.1; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2009, ECOLOGY, V90, P2454, DOI 10.1890/08-2017.1; Falinski J.B., 1986, VEGETATION DYNAMICS; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Halofsky J, 2008, FORESTRY, V81, P195, DOI 10.1093/forestry/cpm044; Halofsky JS, 2008, OECOLOGIA, V155, P869, DOI 10.1007/s00442-007-0956-z; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JEDRZEJEWSKA B, 1994, J APPL ECOL, V31, P664, DOI 10.2307/2404157; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Kamler JF, 2008, AM MIDL NAT, V159, P75, DOI 10.1674/0003-0031(2008)159[75:HRORDI]2.0.CO;2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; Kuijper DPJ, 2013, ECOGRAPHY, V36, P1263, DOI 10.1111/j.1600-0587.2013.00266.x; Kuijper DPJ, 2009, FOREST ECOL MANAG, V258, P1528, DOI 10.1016/j.foreco.2009.07.010; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Kuijper DPJ, 2010, J ECOL, V98, P888, DOI 10.1111/j.1365-2745.2010.01656.x; Kweczlich I., 2004, Sylwan, V148, P18; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LEWIS MA, 1993, NATURE, V366, P738, DOI 10.1038/366738a0; Li CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023623; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; Mech DL, 1977, SCIENCE, V198, P320, DOI 10.1126/science.198.4314.320; MELCHIORS MA, 1985, J WILDLIFE MANAGE, V49, P358, DOI 10.2307/3801531; Michalczuk C., 2001, PHYTOCOENOSIS, V13; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Parsons MH, 2010, ETHOLOGY, V116, P972, DOI 10.1111/j.1439-0310.2010.01810.x; PETERS RP, 1975, AM SCI, V63, P628; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Samojlik T, 2007, ACADEMIA, V4, P36; Schmidt K, 2009, ECOL RES, V24, P207, DOI 10.1007/s11284-008-0496-y; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; SWIHART RK, 1991, J CHEM ECOL, V17, P767, DOI 10.1007/BF00994199; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; UNDERWOOD R, 1982, BEHAVIOUR, V79, P82; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Winnie JA, 2012, ECOLOGY, V93, P2600, DOI 10.1890/11-1990.1; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zar JH., 1999, BIOSTAT ANAL; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	68	76	79	2	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84607	10.1371/journal.pone.0084607	http://dx.doi.org/10.1371/journal.pone.0084607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404177	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800056
J	Qian, YJ; Zhang, J; Jung, YS; Chen, XB				Qian, Yingjuan; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin			DEC1 Coordinates with HDAC8 to Differentially Regulate TAp73 and Delta Np73 Expression	PLOS ONE			English	Article							DAMAGE RESPONSE PATHWAY; P53 FAMILY; DNA-DAMAGE; TRANSCRIPTION FACTORS; PROXIMAL PROMOTER; PROTEIN STABILITY; CELL-SURVIVAL; FEEDBACK LOOP; TARGET GENES; C-TERMINUS	P73, a member of the p53 family, plays a critical role in neural development and tumorigenesis. Due to the usage of two different promoters, p73 is expressed as two major isoforms, TAp73 and Delta Np73, often with opposing functions. Here, we reported that transcriptional factor DEC1, a target of the p53 family, exerts a distinct control of TAp73 and Delta Np73 expression. In particular, we showed that DEC1 was able to increase TAp73 expression via transcriptional activation of the TAp73 promoter. By contrast, Np73 transcription was inhibited by DEC1 via transcriptional repression of the Delta Np73 promoter. To further explore the underlying mechanism, we showed that DEC1 was unable to increase TAp73 expression in the absence of HDAC8, suggesting that HDAC8 is required for DEC1 to enhance TAp73 expression. Furthermore, we found that DEC1 was able to interact with HDAC8 and recruit HDAC8 to the TAp73, but not the Delta Np73, promoter. Together, our data provide evidence that DEC1 and HDAC8 in differentially regulate TAp73 and Delta Np73 expression, suggesting that this regulation may lay a foundation for a therapeutic strategy to enhance the chemosensitivity of tumor cells.	[Qian, Yingjuan; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [RO1 CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by a National Institutes of Health grant (RO1 CA081237). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Jung YS, 2008, J BIOL CHEM, V283, P1018, DOI 10.1074/jbc.M707722200; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhang J, 2013, J BIOL CHEM, V288, P7727, DOI 10.1074/jbc.M112.429522; Zheng XJ, 2001, FEBS LETT, V489, P4, DOI 10.1016/S0014-5793(00)02437-6	40	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84015	10.1371/journal.pone.0084015	http://dx.doi.org/10.1371/journal.pone.0084015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404147	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800026
J	Walker, GE; Ricotti, R; Roccio, M; Moia, S; Bellone, S; Prodam, F; Bona, G				Walker, Gillian E.; Ricotti, Roberta; Roccio, Marta; Moia, Stefania; Bellone, Simonetta; Prodam, Flavia; Bona, Gianni			Pediatric Obesity and Vitamin D Deficiency: A Proteomic Approach Identifies Multimeric Adiponectin as a Key Link between These Conditions	PLOS ONE			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; VISCERAL ADIPOSITY INDEX; METABOLIC SYNDROME; D-RECEPTOR; CARDIOVASCULAR-DISEASE; DSBA-L; CARDIOMETABOLIC RISK; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; 3T3-L1 CELLS	Key circulating molecules that link vitamin D (VD) to pediatric obesity and its co-morbidities remain unclear. Using a proteomic approach, our objective was to identify key molecules in obese children dichotomized according to 25OH-vitamin D (25OHD) levels. A total of 42 obese children (M/F = 18/24) were divided according to their 25OHD3 levels into 25OHD3 deficient (VDD; n = 18; 25OHD<15 ng/ml) or normal subjects (NVD; n = 24;>30 ng/ml). Plasma proteomic analyses by two dimensional (2D)-electrophoresis were performed at baseline in all subjects. VDD subjects underwent a 12mo treatment with 3000 IU vitamin D3 once a week to confirm the proteomic analyses. The proteomic analyses identified 53 "spots" that differed between VDD and NVD (p<0.05), amongst which adiponectin was identified. Adiponectin was selected for confirmational studies due to its tight association with obesity and diabetes mellitus. Western Immunoblot (WIB) analyses of 2D-gels demonstrated a downregulation of adiponectin in VDD subjects, which was confirmed in the plasma from VDD with respect to NVD subjects (p<0.035) and increased following 12mo vitamin D3 supplementation in VDD subjects (p<0.02). High molecular weight (HMW) adiponectin, a surrogate indicator of insulin sensitivity, was significantly lower in VDD subjects (p<0.02) and improved with vitamin D3 supplementation (p<0.042). A direct effect in vitro of 1 alpha, 25-(OH)2D3 on adipocyte adiponectin synthesis was demonstrated, with adiponectin and its multimeric forms upregulated, even at low pharmacological doses (10(-9) M) of 1 alpha, 25-(OH)2D3. This upregulation was paralleled by the adiponectin interactive protein, DsbA-L, suggesting that the VD regulation of adiponectin involves post-transciptional events. Using a proteomic approach, multimeric adiponectin has been identified as a key plasma protein that links VDD to pediatric obesity.	[Walker, Gillian E.; Roccio, Marta; Moia, Stefania] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Lab Clin Pediat, Novara, Italy; [Bellone, Simonetta; Prodam, Flavia; Bona, Gianni] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Walker, GE (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Lab Clin Pediat, Novara, Italy.	gillian.walker@med.unipmn.it	Bellone, Simonetta/K-2196-2016	Prodam, Flavia/0000-0001-9660-5335	Research Projects of National Interest(PRIN) [prot. 20082P8CCE]; Regione Piemonte Grant [prot. 2827]	Research Projects of National Interest(PRIN); Regione Piemonte Grant(Regione Piemonte)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support for the research reported was provided by Research Projects of National Interest(PRIN) 2008 (prot. 20082P8CCE) and Regione Piemonte Grant (2008, prot. 2827).	Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Ashraf A, 2009, J CLIN ENDOCR METAB, V94, P3200, DOI 10.1210/jc.2009-0445; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Breslavsky A., 2013, CLIN NUTR; BUFFINGTON C, 1993, OBES SURG, V3, P421, DOI 10.1381/096089293765559142; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; de Roos B, 2008, J PROTEOME RES, V7, P2280, DOI 10.1021/pr700714x; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Gao D, 2013, INT J OBESITY, V37, P357, DOI 10.1038/ijo.2012.53; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gueugnon C, 2012, APPL PHYSIOL NUTR ME, V37, P672, DOI [10.1139/h2012-045, 10.1139/H2012-045]; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Hillman JB, 2011, DISCOV MED, V11, P521; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; Martos-Moreno GA, 2010, OBESITY, V18, P2288, DOI 10.1038/oby.2010.68; Meerza D, 2012, J DIABETES COMPLICAT, V26, P363, DOI 10.1016/j.jdiacomp.2012.05.013; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Prodam F, 2011, EUROPEAN E J CLIN NU, V6, P109; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sergeev Igor N., 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P153; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Song Q, 2012, NUTR RES REV, V16, P1; Sun X, 2007, OBESITY, V15, P340, DOI 10.1038/oby.2007.540; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Walker GE, 2008, OBESITY, V16, P1983, DOI 10.1038/oby.2008.326; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu-Wong JR, 2009, BRIT J PHARMACOL, V158, P395, DOI 10.1111/j.1476-5381.2009.00171.x; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zhou P, 2011, J PEDIATR-US, V158, P930, DOI 10.1016/j.jpeds.2010.11.034; Zunigaa S, 2011, CLIN RES HEPATOL GAS, V35, P295, DOI 10.1016/j.clinre.2011.02.003	58	36	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83685	10.1371/journal.pone.0083685	http://dx.doi.org/10.1371/journal.pone.0083685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404137	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800016
J	Lu, LM; Zou, GY; Zeng, Z; Han, L; Guo, Y; Ling, L				Lu, Liming; Zou, Guanyang; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li			Health-Related Quality of Life and Its Correlates among Chinese Migrants in Small- and Medium-Sized Enterprises in Two Cities of Guangdong	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BEHAVIORAL-MODEL; OCCUPATIONAL-HEALTH; WORKERS; SF-12; SERVICES; VALIDITY; POPULATION; VALIDATION; CHALLENGES	Objectives: To explore the relationship between health-related quality of life (HRQOL) status and associated factors among rural-to-urban migrants in China. Methods: A cross-sectional survey was conducted with 856 rural-to-urban migrants working at small- and medium-size enterprises (SMEs) in Shenzhen and Zhongshan City in 2012. Andersen's behavioral model was used as a theoretical framework to exam the relationships among factors affecting HRQOL. Analysis was performed using structural equation modeling (SEM). Results: Workers with statutory working hours, higher wages and less migrant experience had higher HRQOL scores. Need (contracting a disease in the past two weeks and perception of needing health service) had the greatest total effect on HRQOL (beta = -0.78), followed by enabling (labor contract, insurance purchase, income, physical examination during work and training) (beta = 0.40), predisposing (age, family separation, education) (beta = 0.22) and health practices and use of health service (physical exercise weekly, health check-up and use of protective equipments) (beta = -0.20). Conclusions: Priority should be given to satisfy the needs of migrant workers, and improve the enabling resources.	[Lu, Liming; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Liming; Zou, Guanyang; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Guanyang] Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh, Midlothian, Scotland	Sun Yat Sen University; Sun Yat Sen University; Queen Margaret University	Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Han, Lu/K-4614-2015		China Medical Board [09-984, 12-111]	China Medical Board	This research was funded by the China Medical Board (Grant No. 09-984 and No. 12-111). The funder had no further role in the study design, data collection, analysis and interpretation of data, writing of the report, or decision to submit the paper for publication.	amCham-China, 2011, SMALL MED SIZ ENT; Andersen R, 1996, CHANGING US HLTH CAR; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andrews G, 2002, AUST NZ J PUBL HEAL, V26, P508, DOI 10.1111/j.1467-842X.2002.tb00357.x; [Anonymous], 2011, COMM MAJ DAT 6 NAT C; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Baker SR, 2009, COMMUNITY DENT ORAL, V37, P485, DOI 10.1111/j.1600-0528.2009.00495.x; Brown Timothy A, 2006, CONFIRMATORY FACTOR; Chen YS, 2007, QUAL LIFE RES, V16, P1289, DOI 10.1007/s11136-007-9248-7; Chen YW, 2010, J OCCUP HEALTH, V52, P82, DOI 10.1539/joh.O9005; Comer JS, 2011, J CLIN PSYCHIAT, V72, P43, DOI 10.4088/JCP.09m05094blu; Conner NE, 2012, AM J HOSP PALLIAT ME, V29, P368, DOI 10.1177/1049909111425227; Downey RG, 1998, J GEN PSYCHOL, V125, P175, DOI 10.1080/00221309809595542; Finlayson TL, 2010, J PUBLIC HEALTH DENT, V70, P292, DOI 10.1111/j.1752-7325.2010.00184.x; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Guangdong Statistical Bureau, 2012, GUANGD STAT YB 2012; Guo Q, 2004, HDB SAMPLING RES; Hobart JC, 2002, STROKE, V33, P1348, DOI 10.1161/01.STR.0000015030.59594.B3; Huang Y.X, 2003, CHINA W CEREALS OILS, V5, P13; Kontodimopoulos N, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-55; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; Liang YX, 2004, TOXICOLOGY, V198, P45, DOI 10.1016/j.tox.2004.01.018; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Ma CH, 2012, J N CHINA I AEROSP E, V22, P61; Michalos AC, 2000, SOC INDIC RES, V51, P245, DOI 10.1023/A:1007010401301; Montazeri A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-12; Montazeri A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-341; Mou J, 2011, J COMMUNITY PSYCHOL, V39, P212, DOI 10.1002/jcop.20428; Nordin NM., 2010, GLOBAL J HLTH SCI, V2, P104, DOI [10.5539/gjhs.v2n2p104, DOI 10.5539/GJHS.V2N2P104]; People's Government of Guangdong Province, 2011, COMM MAJ DAT 6 NAT C; Phillips KA, 1998, HEALTH SERV RES, V33, P571; Qian S, 2008, CHINA J HLTH PSYCHOL, V16, P459; Researching Group of National Bureau of Statistics (RGNBS), 2007, STAT RES, V24, P3; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Service Management Division of the National Population and Family Planning Commission for the Migrant Population, 2012, REP CHIN MIGR POP DE; Service Management Division of the National Population and Family Planning Commission for the Migrant Population, 2011, REP CHIN MIGR POP DE; Smith DR, 2004, J OCCUP HLTH SAF, V20, P441; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; The People's Republic of China Ministry of Industry, 2012, NOT ISS SME PROGR ST; Wang W, 2010, CHIN J PUBLIC HLTH, V26, P317; Wang XR, 2011, ARCH ENVIRON OCCUP H, V66, P3, DOI 10.1080/19338244.2010.486424; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wu M., 2010, 3 INT I STAT MAN ENG, V2; XIAO Y, 2008, J OCCUP HLTH SAF AUS, V24, P455; Yan Z, 2010, CHIN J PUBLIC HLTH, V3, P317; Yu W., 2012, OCCUPATIONAL HLTH SA; Zhang JT, 2009, QUAL LIFE RES, V18, P291, DOI 10.1007/s11136-009-9454-6; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3	49	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83315	10.1371/journal.pone.0083315	http://dx.doi.org/10.1371/journal.pone.0083315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392084	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100008
J	Luksys, G; Ackermann, S; Coynel, D; Fastenrath, M; Gschwind, L; Heck, A; Rasch, B; Spalek, K; Vogler, C; Papassotiropoulos, A; de Quervain, D				Luksys, Gediminas; Ackermann, Sandra; Coynel, David; Fastenrath, Matthias; Gschwind, Leo; Heck, Angela; Rasch, Bjoern; Spalek, Klara; Vogler, Christian; Papassotiropoulos, Andreas; de Quervain, Dominique			BAIAP2 Is Related to Emotional Modulation of Human Memory Strength	PLOS ONE			English	Article							EPISODIC MEMORY; COGNITIVE NEUROSCIENCE; DECISION-MAKING; ASSOCIATION; GENES; METAANALYSIS; EXPERIENCE; PREDICTS; IRSP53; STRESS	Memory performance is the result of many distinct mental processes, such as memory encoding, forgetting, and modulation of memory strength by emotional arousal. These processes, which are subserved by partly distinct molecular profiles, are not always amenable to direct observation. Therefore, computational models can be used to make inferences about specific mental processes and to study their genetic underpinnings. Here we combined a computational model-based analysis of memory-related processes with high density genetic information derived from a genome-wide study in healthy young adults. After identifying the best-fitting model for a verbal memory task and estimating the best-fitting individual cognitive parameters, we found a common variant in the gene encoding the brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) that was related to the model parameter reflecting modulation of verbal memory strength by negative valence. We also observed an association between the same genetic variant and a similar emotional modulation phenotype in a different population performing a picture memory task. Furthermore, using functional neuroimaging we found robust genotype-dependent differences in activity of the parahippocampal cortex that were specifically related to successful memory encoding of negative versus neutral information. Finally, we analyzed cortical gene expression data of 193 deceased subjects and detected significant BAIAP2 genotype-dependent differences in BAIAP2 mRNA levels. Our findings suggest that model-based dissociation of specific cognitive parameters can improve the understanding of genetic underpinnings of human learning and memory.	[Luksys, Gediminas; Ackermann, Sandra; Coynel, David; Gschwind, Leo; Heck, Angela; Rasch, Bjoern; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland; [Luksys, Gediminas; Coynel, David; Fastenrath, Matthias; Rasch, Bjoern; Spalek, Klara; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland; [Ackermann, Sandra; Rasch, Bjoern] Univ Zurich, Dept Psychol, Dept Psychol, Zurich, Switzerland; [Papassotiropoulos, Andreas; de Quervain, Dominique] Univ Basel, Psychiat Univ Clin, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland	University of Basel; University of Basel; University of Zurich; University of Basel; University of Basel	Luksys, G (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.	gedi.luksys@unibas.ch; andreas.papas@unibas.ch; dominique.dequervain@unibas.ch	Coynel, David/H-9189-2019; Rasch, Björn/A-3119-2015	Coynel, David/0000-0001-5028-5807; Rasch, Björn/0000-0001-7607-3415; Papassotiropoulos, Andreas/0000-0002-2210-9651; Heck, Angela/0000-0002-1543-3197; Vogler, Christian/0000-0003-3922-109X; de Quervain, Dominique/0000-0001-7131-2464; Spalek, Klara/0000-0002-4244-6495	Swiss National Science Foundation [CRSIK0_122691, CRSI33_130080, CRSII1_136227]; 7th framework programme of the European Union (ADAMS project) [HEALTH-F4-2009-242257]; National Center for Competence in Research SYNAPSY	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th framework programme of the European Union (ADAMS project); National Center for Competence in Research SYNAPSY	This work was funded by the Swiss National Science Foundation (Sinergia grants CRSIK0_122691, CRSI33_130080, CRSII1_136227 to DQ and AP), by the 7th framework programme of the European Union (ADAMS project, HEALTH-F4-2009-242257) and by the National Center for Competence in Research SYNAPSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Hager W, 1994, HDB DEUTSCHSPRACHIGE; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kolsch H, 2009, J NEURAL TRANSM, V116, P897, DOI 10.1007/s00702-009-0238-5; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang PJ, 2008, INT AFFECTIVE PICTUR; Luksys G, 2011, CURR OPIN NEUROBIOL, V21, P502, DOI 10.1016/j.conb.2011.03.003; Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nassar MR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003015; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Press W. H., 1992, ART SCI COMPUTING; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ribases M, 2009, BIOL PSYCHIAT, V66, P926, DOI 10.1016/j.biopsych.2009.06.024; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Toma C, 2011, J PSYCHIATR RES, V45, P280, DOI 10.1016/j.jpsychires.2010.09.001; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83707	10.1371/journal.pone.0083707	http://dx.doi.org/10.1371/journal.pone.0083707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392092	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000329460100016
J	Stauffer, ME; Fan, T				Stauffer, Melissa E.; Fan, Tao			Prevalence of Anemia in Chronic Kidney Disease in the United States	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; GLOMERULAR-FILTRATION-RATE; CKD; EPIDEMIOLOGY; POPULATION; DIALYSIS; ILLNESS; BURDEN; ADULTS	Anemia is one of the many complications of chronic kidney disease (CKD). However, the current prevalence of anemia in CKD patients in the United States is not known. Data from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008 and 2009-2010 were used to determine the prevalence of anemia in subjects with CKD. The analysis was limited to adults aged >18 who participated in both the interview and exam components of the survey. Three outcomes were assessed: the prevalence of CKD, the prevalence of anemia in subjects with CKD, and the self-reported treatment of anemia. CKD was classified into 5 stages based on the glomerular filtration rate and evidence of kidney damage, in accordance with the guidelines of the National Kidney Foundation. Anemia was defined as serum hemoglobin levels <= 12 g/dL in women and <= 13 g/dL in men. We found that an estimated 14.0% of the US adult population had CKD in 2007-2010. Anemia was twice as prevalent in people with CKD (15.4%) as in the general population (7.6%). The prevalence of anemia increased with stage of CKD, from 8.4% at stage 1 to 53.4% at stage 5. A total of 22.8% of CKD patients with anemia reported being treated for anemia within the previous 3 months-14.6% of patients at CKD stages 1-2 and 26.4% of patients at stages 3-4. These results update our knowledge of the prevalence and treatment of anemia in CKD in the United States.	[Stauffer, Melissa E.] SCRIBCO, Effort, PA 18330 USA; [Fan, Tao] Merck & Co Inc, Whitehouse Stn, NJ USA	Merck & Company	Stauffer, ME (corresponding author), SCRIBCO, Effort, PA 18330 USA.	melstauff@charter.net			Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	This study was funded by Merck & Co., Inc. Web site: http://www.merck.com/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2006, J AM MED DIR ASSOC, V7, pS7, DOI 10.1016/j.jamda.2006.09.005; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; *CDCP, 2007, MMWR-MORBID MORTAL W, V58, P161, DOI DOI 10.1053/AJKD.2003.50007; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Clase CM, 2007, NEPHRON CLIN PRACT, V105, pC178, DOI 10.1159/000100489; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Herzog CA, 2004, J CARD FAIL, V10, P467, DOI 10.1016/j.cardfail.2004.03.003; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Lawler EV, 2010, NEPHROL DIAL TRANSPL, V25, P2237, DOI 10.1093/ndt/gfp758; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Moossavi S, 2009, ARCH INTERN MED, V169, P1100, DOI 10.1001/archinternmed.2009.159; National Anemia Action Council, AN KIDN DIS; National Kidney Foundation, FREQ ASK QUEST GFR E; Nissenson Allen R, 2005, J Manag Care Pharm, V11, P565; Rasu RS, 2007, CLIN THER, V29, P1524, DOI 10.1016/j.clinthera.2007.07.016; Robinson B, 2007, J AM GERIATR SOC, V55, P1566, DOI 10.1111/j.1532-5415.2007.01389.x; Smith RE, 2010, AM J MANAG CARE, V16, pS59; Snyder JJ, 2009, AM J KIDNEY DIS, V53, P218, DOI 10.1053/j.ajkd.2008.07.034; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2010, AM J KIDNEY DIS, V55, pS23, DOI 10.1053/j.ajkd.2009.09.035; van Nooten Floortje E, 2010, J Med Econ, V13, P241, DOI 10.3111/13696998.2010.484307; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	29	280	292	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84943	10.1371/journal.pone.0084943	http://dx.doi.org/10.1371/journal.pone.0084943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392162	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100085
J	Vilardi, F; Stephan, M; Clancy, A; Janshoff, A; Schwappach, B				Vilardi, Fabio; Stephan, Milena; Clancy, Anne; Janshoff, Andreas; Schwappach, Blanche			WRB and CAML Are Necessary and Sufficient to Mediate Tail-Anchored Protein Targeting to the ER Membrane	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INSERTION; BINDING; IDENTIFICATION; EXPRESSION; PATHWAYS; RECEPTOR; COMPLEX; SITES; CELLS	Tail-Anchored (TA) proteins are inserted into the endoplasmic reticulum (ER) membrane of yeast cells via the posttranslational Guided Entry of Tail-Anchored protein (GET) pathway. The key component of this targeting machinery is the ATPase Get3 that docks to the ER membrane by interacting with a receptor complex formed by the proteins Get1 and Get2. A conserved pathway is present in higher eukaryotes and is mediated by TRC40, homolog of Get3, and the recently identified membrane receptors WRB and CAML. Here, we used yeast lacking the GET1 and GET2 genes and substituted them with WRB and CAML. This rescued the growth phenotypes of the GET receptor mutant. We demonstrate that WRB and CAML efficiently recruit Get3 to the ER membrane and promote the targeting of the TA proteins in vivo. Our results show that the membrane spanning segments of CAML are essential to create a functional receptor with WRB and to ensure TA protein membrane insertion. Finally, we determined the binding parameters of TRC40 to the WRB/CAML receptor. We conclude that together, WRB and CAML are not only necessary but also sufficient to create a functional membrane receptor complex for TRC40. The yeast complementation assay can be used to further dissect the structure-function relationship of the WRB/CAML heteromultimer in the absence of endogenous receptor proteins.	[Vilardi, Fabio; Clancy, Anne; Schwappach, Blanche] Univ Gottingen, Inst Mol Biol, D-37073 Gottingen, Germany; [Stephan, Milena; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Schwappach, B (corresponding author), Univ Gottingen, Inst Mol Biol, D-37073 Gottingen, Germany.	blanche.schwappach@med.uni-goettingen.de	Janshoff, Andreas/B-8711-2009	Clancy, Anne/0000-0001-8873-0849; Janshoff, Andreas/0000-0002-0773-2963; Schwappach, Blanche/0000-0003-0225-6432	University Medicine Gottingen	University Medicine Gottingen	The project was funded by core support to BS and FV provided by University Medicine Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Bryda EC, 2012, MAMM GENOME, V23, P270, DOI 10.1007/s00335-011-9381-z; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Dodd CE, 2008, BIOINTERPHASES, V3, pFA59, DOI 10.1116/1.2896113; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Hassdenteufel S, 2011, FEBS LETT, V585, P3485, DOI 10.1016/j.febslet.2011.10.008; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Maniatis T., 1982, MOL CLONING LAB MANU; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Powis K, 2013, J CELL SCI, V126, P473, DOI 10.1242/jcs.112151; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tram DD, 2005, IMMUNITY, V23, P139, DOI 10.1016/j.immuni.2005.06.006; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002; Zane NA, 2012, J IMMUNOL, V188, P3009, DOI 10.4049/jimmunol.1101641	31	45	45	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85033	10.1371/journal.pone.0085033	http://dx.doi.org/10.1371/journal.pone.0085033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392163	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100086
J	Wang, Y; Liu, L; Chen, LN; Chen, T; Sun, FZ				Wang, Ying; Liu, Lin; Chen, Lina; Chen, Ting; Sun, Fengzhu			Comparison of Metatranscriptomic Samples Based on k-Tuple Frequencies	PLOS ONE			English	Article							STATISTICAL MEASURES; SEQUENCE; ALIGNMENT	Background: The comparison of samples, or beta diversity, is one of the essential problems in ecological studies. Next generation sequencing (NGS) technologies make it possible to obtain large amounts of metagenomic and metatranscriptomic short read sequences across many microbial communities. De novo assembly of the short reads can be especially challenging because the number of genomes and their sequences are generally unknown and the coverage of each genome can be very low, where the traditional alignment-based sequence comparison methods cannot be used. Alignment-free approaches based on k-tuple frequencies, on the other hand, have yielded promising results for the comparison of metagenomic samples. However, it is not known if these approaches can be used for the comparison of metatranscriptome datasets and which dissimilarity measures perform the best. Results: We applied several beta diversity measures based on k-tuple frequencies to real metatranscriptomic datasets from pyrosequencing 454 and Illumina sequencing platforms to evaluate their effectiveness for the clustering of metatranscriptomic samples, including three d(2) - type dissimilarity measures, one dissimilarity measure in CVTree, one relative entropy based measure S2 and three classical l(p) - norm distances. Results showed that the measure d(2)(S) can achieve superior performance on clustering metatranscriptomic samples into different groups under different sequencing depths for both 454 and Illumina datasets, recovering environmental gradients affecting microbial samples, classifying coexisting metagenomic and metatranscriptomic datasets, and being robust to sequencing errors. We also investigated the effects of tuple size and order of the background Markov model. A software pipeline to implement all the steps of analysis is built and is available at http://code.google.com/p/d2-tools/. Conclusions: The k-tuple based sequence signature measures can effectively reveal major groups and gradient variation among metatranscriptomic samples from NGS reads. The d(2)(S) dissimilarity measure performs well in all application scenarios and its performance is robust with respect to tuple size and order of the Markov model.	[Wang, Ying; Liu, Lin; Chen, Lina] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Chen, Ting; Sun, Fengzhu] Univ So Calif, Los Angeles, CA USA	Xiamen University; University of Southern California	Wang, Y (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China.	wangying@xmu.edu.cn; fsun@usc.edu	Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X	National Natural Science Foundation of China [61203282, 61202144]; US NIH [R21HG006199]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006199] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The research is supported by: 1. National Natural Science Foundation of China (61203282, 61202144) http://www.nsfc.gov.cn/Portal0/default166.htm. 2. US NIH (R21HG006199) http://www.nih.gov/. 3. NSF [DMS-1043075, OCE 1136818] http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson M. J., 2003, PCO FORTRAN COMPUTER; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436; Dai Q, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-394; Dalevi D, 2006, BIOINFORMATICS, V22, P517, DOI 10.1093/bioinformatics/btk029; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Dick GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P6517, DOI 10.1016/j.gca.2009.07.039; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Ghosh TS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S9; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P183, DOI 10.4056/sigs.1202536; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Hide W, 1994, J Comput Biol, V1, P199, DOI 10.1089/cmb.1994.1.199; Jiang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-730; Kantorovitz MR, 2007, BIOINFORMATICS, V23, pI249, DOI 10.1093/bioinformatics/btm211; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Miller RT, 1999, GENOME RES, V9, P1143, DOI 10.1101/gr.9.11.1143; Mou XZ, 2011, ENV MICROBIOL REP, V3, P798, DOI 10.1111/j.1758-2229.2011.00289.x; Murtagh F, 1984, COMPUT STAT Q, V1, P101; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Song K, 2013, J COMPUT BIOL, V20, P64, DOI 10.1089/cmb.2012.0228; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Wan L, 2010, J COMPUT BIOL, V17, P1467, DOI 10.1089/cmb.2010.0056; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Zeng F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt372	37	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84348	10.1371/journal.pone.0084348	http://dx.doi.org/10.1371/journal.pone.0084348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392128	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100051
J	Li, SJ; Qin, XB; Guo, X; Cui, AR; He, YZ; Wei, S; Wang, XL; Shan, BE				Li, Shujun; Qin, Xuebo; Guo, Xin; Cui, Airong; He, Yuzheng; Wei, Sen; Wang, Xiaolu; Shan, Baoen			Dickkopf-1 Is Oncogenic and Involved in Invasive Growth in Non Small Cell Lung Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BETA-CATENIN/TCF; STEM-CELLS; WNT; DKK1; PATHWAY; CHINA; PROLIFERATION; ANTAGONIST; EXPRESSION	Dickkopf-1 (DKK1) is an inhibitor of the Wnt/beta-catenin signaling pathway. However, the role of DKK1 in the progression of non small cell lung cancer (NSCLC) is not fully understood. In this study, RT-PCR and Western blot were used to examine the expression of DKK1 in a panel of ten human NSCLC cell lines and NSCLC tissues. DKK1 expression was highly transactivated in the great majority of these cancer lines. The expression of DKK1 was upregulated on both mRNA and protein levels in NSCLC tissues compared with the adjacent normal lung tissues. Immunohistochemistry and immunofluoresence revealed that DKK1 was mainly distributed in the cytoplasm in both carcinoma tissues and cell lines. DKK1 protein expression was also evaluated in paraffin sections from 102 patients with NSCLC by immunohistochemistry, and 65(63.73%) tumors were DKK1 positive. Relative analysis showed a significant relationship between DKK1 positive expression and lymph node metastasis(P< 0.05). Patients with DKK1positive tumors had poorer DFS than those with negative ESCC (5-year DFS; 15.4% versus 27%, P = 0.007). To further explore the biological effects of DKK1 in NSCLC cells, we over-expressed DKK1 in NSCLC 95C cell using eukaryotic expression vector pCMV-Tab-2b and performed a knockdown of DKK1 in LTEP-a-2 cell using a short hairpin RNA expression vector pSilencer 5.1. DKK1 did not have any effect on proliferation, but seemed to play a role in migration and invasion capability. Overexpression of DKK1 promotes migratory and invasive activity of 95C, while DKK1 knockdown resulted in the suppression of migration and invasion potentials of LTEP-a-2 cell. Taken together, these results indicate that DKK1 may be a crucial regulator in the progression of NSCLC. DKK1 might be a potential therapeutic target in NSCLC.	[Li, Shujun; Guo, Xin; Cui, Airong; He, Yuzheng; Wang, Xiaolu] Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China; [Qin, Xuebo] Hebei Chest Hosp, Shijiazhuang, Peoples R China; [Wei, Sen] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin, Peoples R China; [Shan, Baoen] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Hebei Medical University; Tianjin Medical University; Hebei Medical University	Wang, XL (corresponding author), Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China.	thoracic20081069@126.com; shanbaoen_1962@163.com		, Shujun/0000-0001-5959-3160				Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chen WQ, 2011, THORAC CANCER, V2, P149, DOI 10.1111/j.1759-7714.2011.00062.x; Chen WQ, 2013, THORAC CANCER, V4, P102, DOI 10.1111/1759-7714.12025; Darlavoix T, 2009, VIRCHOWS ARCH, V454, P629, DOI 10.1007/s00428-009-0769-z; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Hall CL, 2008, PROSTATE, V68, P1396, DOI 10.1002/pros.20805; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Makino T, 2009, ANN SURG ONCOL, V16, P2058, DOI 10.1245/s10434-009-0476-7; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sheng SL, 2009, CLIN CHEM, V55, P1656, DOI 10.1373/clinchem.2009.125641; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Takahashi N, 2010, INT J CANCER, V126, P1611, DOI 10.1002/ijc.24865; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yao XA, 2010, BIOMARKERS, V15, P128, DOI 10.3109/13547500903325662; You L, 2004, CANCER RES, V64, P3474, DOI 10.1158/0008-5472.CAN-04-0115; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zeng HM, 2013, THORAC CANCER, V4, P53, DOI 10.1111/j.1759-7714.2012.00160.x; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	30	11	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84944	10.1371/journal.pone.0084944	http://dx.doi.org/10.1371/journal.pone.0084944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391982	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900125
J	Azzaz, AM; Vitalini, MW; Thomas, AS; Price, JP; Blacketer, MJ; Cryderman, DE; Zirbel, LN; Woodcock, CL; Elcock, AH; Wallrath, LL; Shogren-Knaak, MA				Azzaz, Abdelhamid M.; Vitalini, Michael W.; Thomas, Andrew S.; Price, Jason P.; Blacketer, Melissa J.; Cryderman, Diane E.; Zirbel, Luka N.; Woodcock, Christopher L.; Elcock, Adrian H.; Wallrath, Lori L.; Shogren-Knaak, Michael A.			Human Heterochromatin Protein 1 alpha Promotes Nucleosome Associations That Drive Chromatin Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Structure; Chromosomes; DNA Binding Protein; Heterochromatin; Histone Modification	POSITION-EFFECT VARIEGATION; HISTONE H3; LYSINE 9; PERICENTRIC HETEROCHROMATIN; GENE-EXPRESSION; CORE PARTICLE; HP1 SUGGESTS; DROSOPHILA; METHYLATION; DOMAIN	Background: Heterochromatin is enriched for di- and tri-methylated lysine 9 of histone H3 (H3K9Me2/3) and heterochromatin protein 1 (HP1(Hs .)). Results: The association of HP1(Hs) with H3K9Me3-containing nucleosome arrays facilitated array compaction and cross-array interactions. Conclusion: HP1(Hs) association caused intra- and inter-array associations, leading to chromatin condensation and looping. Significance: An understanding of HP1(Hs)-nucleosome interactions provides insights on the structure and functions of heterochromatin. HP1(Hs)-containing heterochromatin is located near centric regions of chromosomes and regulates DNA-mediated processes such as DNA repair and transcription. The higher-order structure of heterochromatin contributes to this regulation, yet the structure of heterochromatin is not well understood. We took a multidisciplinary approach to determine how HP1(Hs)-nucleosome interactions contribute to the structure of heterochromatin. We show that HP1(Hs) preferentially binds histone H3K9Me3-containing nucleosomal arrays in favor of non-methylated nucleosomal arrays and that nonspecific DNA interactions and pre-existing chromatin compaction promote binding. The chromo and chromo shadow domains of HP1(Hs) play an essential role in HP1(Hs)-nucleosome interactions, whereas the hinge region appears to have a less significant role. Electron microscopy of HP1(Hs)-associated nucleosomal arrays showed that HP1(Hs) caused nucleosome associations within an array, facilitating chromatin condensation. Differential sedimentation of HP1(Hs)-associated nucleosomal arrays showed that HP1(Hs) promotes interactions between arrays. These strand-to-strand interactions are supported by in vivo studies where tethering the Drosophila homologue HP1a to specific sites promotes interactions with distant chromosomal sites. Our findings demonstrate that HP1(Hs)-nucleosome interactions cause chromatin condensation, a process that regulates many chromosome events.	[Azzaz, Abdelhamid M.; Blacketer, Melissa J.; Shogren-Knaak, Michael A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Vitalini, Michael W.; Thomas, Andrew S.; Price, Jason P.; Cryderman, Diane E.; Zirbel, Luka N.; Elcock, Adrian H.; Wallrath, Lori L.] Univ Iowa, Dept Biochem, Iowa City, IA 52241 USA; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Iowa State University; University of Iowa; University of Massachusetts System; University of Massachusetts Amherst	Wallrath, LL (corresponding author), Dept Biochem, 3136 MERF,375 Newton Rd, Iowa City, IA 52241 USA.	lori-wallrath@uiowa.edu; knaak@iastate.edu		Wallrath, Lori/0000-0002-4391-7199; Elcock, Adrian/0000-0003-2820-1376	National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061513, T34GM008574, R01GM079663] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. Gadhok and A. Peterson are acknowledged for technical assistance with Drosophila experiments. K. Wakeland is acknowledged for help with the statistical analysis of the EM images. Computational time on the TACC supercomputing resource Ranger provided through the National Science Foundation funded TeraGrid and XSEDE programs is acknowledged.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Cryderman DE, 1998, CHROMOSOMA, V107, P277, DOI 10.1007/s004120050309; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Honda S, 2012, NAT STRUCT MOL BIOL, V19, P471, DOI 10.1038/nsmb.2274; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Munari F, 2012, J BIOL CHEM, V287, P33756, DOI 10.1074/jbc.M112.390849; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Norwood LE, 2004, GENE, V336, P37, DOI 10.1016/j.gene.2004.04.003; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Seum C, 2000, CHROMOSOMA, V109, P453, DOI 10.1007/s004120000101; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Zhao T, 2000, J BIOL CHEM, V275, P28332	46	63	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6850	6861		10.1074/jbc.M113.512137	http://dx.doi.org/10.1074/jbc.M113.512137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415761	hybrid, Green Published			2022-12-25	WOS:000332389400046
J	Bialkowska, AB; Liu, Y; Nandan, MO; Yang, VW				Bialkowska, Agnieszka B.; Liu, Yang; Nandan, Mandayam O.; Yang, Vincent W.			A Colon Cancer-derived Mutant of Kruppel-like Factor 5 (KLF5) Is Resistant to Degradation by Glycogen Synthase Kinase 3 beta (GSK3 beta) and the E3 Ubiquitin Ligase F-box and WD Repeat Domain-containing 7 alpha (FBW7 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cyclin d1; Mutant; Promoters; Protein Stability; Transcription Factors	TRANSCRIPTION FACTOR; COLORECTAL CANCERS; EPITHELIAL-CELLS; BETA-CATENIN; CHROMOSOMAL INSTABILITY; MUTATIONS; KRUPPEL-LIKE-FACTOR-5; TUMORIGENESIS; INACTIVATION; ACETYLATION	Background: Stability of KLF5 is regulated by GSK3- and FBW7-mediated proteasomal degradation. Results: Colon cancer-derived P301S KLF5 mutant is degradation-resistant due to the inability to interact with FBW7. Conclusion: Residue 301 of KLF5 is critical for the proper recognition by FBW7 that is involved in the degradation of KLF5. Significance: Our results suggest that the P301S KLF5 mutant is potentially oncogenic in colon cancer. Kruppel-like factor 5 (KLF5) is a zinc finger transcription factor that is highly expressed in the crypt epithelial cells of the intestine and plays a critical role in regulating proliferation of both normal intestinal epithelial cells and colorectal cancer cells. Stability of the KLF5 is mediated by proteasomal degradation via phosphorylation by glycogen synthase kinase 3 (GSK3) and recognition by F-box and WD repeat domain-containing 7 (FBW7) of a phosphodegron sequence surrounding serine 303 in KLF5. A genomic analysis of colorectal cancer tissues identified a somatic mutation (P301S) in KLF5 within the phosphodegron sequence. We hypothesized that due to its close proximity to the phosphodegron sequence, the P301S mutation may affect signaling that is involved in proper KLF5 degradation. We demonstrated that the P301S KLF5 mutant has a longer half-life than wild type (WT) KLF5. Furthermore, P301S KLF5 has a higher transcriptional activity than WT KLF5 as demonstrated by luciferase assays using cyclin D1 and CDC2 promoter constructs. In contrast to WT KLF5, P301S KLF5 does not physically interact with FBW7. Concomitantly, the P301S KLF5 mutant displays reduced levels of phosphorylation at serine 303 in comparison with WT KLF5. These results of our study indicate that amino acid residue 301 of KLF5 is critical for proper recognition of the phosphodegron sequence by FBW7 and that the P301S mutation inhibits this recognition, leading to a degradation-resistant protein with elevated levels and enhanced transcriptional activity. These findings raise a potentially oncogenic role for the P301S KLF5 mutant in colorectal cancer.	[Bialkowska, Agnieszka B.; Liu, Yang; Nandan, Mandayam O.; Yang, Vincent W.] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Yang, Vincent W.] SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Yang, VW (corresponding author), SUNY Stony Brook, Sch Med, Dept Med, HSC T-16,Rm 020, Stony Brook, NY 11794 USA.	vincent.yang@stonybrookmedicine.edu		Mandayam, Nandan/0000-0002-4061-9348	National Institutes of Health [DK052230, CA084197]; NATIONAL CANCER INSTITUTE [R01CA084197, R01CA172113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052230, R01DK093680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052230 and CA084197 (to V. W. Y.).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Davis H., 2013, GUT; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Ekstrand AI, 2010, FAM CANCER, V9, P125, DOI 10.1007/s10689-009-9293-1; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Mori D, 2003, GENE, V304, P163, DOI 10.1016/S0378-1119(02)01203-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	35	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5997	6005		10.1074/jbc.M113.508549	http://dx.doi.org/10.1074/jbc.M113.508549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398687	Green Published, hybrid			2022-12-25	WOS:000332015500055
J	Suzuki, H; Raska, M; Yamada, K; Moldoveanu, Z; Julian, BA; Wyatt, RJ; Tomino, Y; Gharavi, AG; Novak, J				Suzuki, Hitoshi; Raska, Milan; Yamada, Koshi; Moldoveanu, Zina; Julian, Bruce A.; Wyatt, Robert J.; Tomino, Yasuhiko; Gharavi, Ali G.; Novak, Jan			Cytokines Alter IgA1 O- Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Immunology; Kidney; Mucosal Immunology; Nephrology; IgA Nephropathy; IgA1; O-Glycans	GALACTOSE-DEFICIENT IGA1; HUMAN MESANGIAL CELLS; HENOCH-SCHONLEIN PURPURA; IGA1-CONTAINING IMMUNE-COMPLEXES; RESONANCE MASS-SPECTROMETRY; HUMAN SERUM IGA1; MURINE B-CELLS; HINGE REGION; TNF-ALPHA; CARBOHYDRATE-COMPOSITION	Background: IgA1-producing cells of IgA nephropathy patients secrete IgA1 with galactose-deficient O-glycans; these IgA1 molecules form nephritogenic immune complexes. Results: Cytokines IL-6 and IL-4 accentuate IgA1 galactose deficiency via modulation of key glycosyltransferases. Conclusion: Some cytokines alter IgA1 O-glycosylation and increase production of nephritogenic IgA1 glycoforms. Significance: These data provide a mechanism explaining increased immune-complex formation in IgA nephropathy patients. IgA nephropathy (IgAN), the most common primary glomerulonephritis, is characterized by renal immunodeposits containing IgA1 with galactose-deficient O-glycans (Gd-IgA1). These immunodeposits originate from circulating immune complexes consisting of anti-glycan antibodies bound to Gd-IgA1. As clinical disease onset and activity of IgAN often coincide with mucosal infections and dysregulation of cytokines, we hypothesized that cytokines may affect IgA1 O-glycosylation. We used IgA1-secreting cells derived from the circulation of IgAN patients and healthy controls and assessed whether IgA1 O-glycosylation is altered by cytokines. Of the eight cytokines tested, only IL-6 and, to a lesser degree, IL-4 significantly increased galactose deficiency of IgA1; changes in IgA1 O-glycosylation were robust for the cells from IgAN patients. These cytokines reduced galactosylation of the O-glycan substrate directly via decreased expression of the galactosyltransferase C1GalT1 and, indirectly, via increased expression of the sialyltransferase ST6GalNAc-II, which prevents galactosylation by C1GalT1. These findings were confirmed by siRNA knockdown of the corresponding genes and by in vitro enzyme reactions. In summary, IL-6 and IL-4 accentuated galactose deficiency of IgA1 via coordinated modulation of key glycosyltransferases. These data provide a mechanism explaining increased immune-complex formation and disease exacerbation during mucosal infections in IgAN patients.	[Suzuki, Hitoshi; Raska, Milan; Yamada, Koshi; Moldoveanu, Zina; Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Suzuki, Hitoshi; Yamada, Koshi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Tokyo 1138421, Japan; [Raska, Milan] Palacky Univ, Olomouc 77900, Czech Republic; [Wyatt, Robert J.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38103 USA; [Gharavi, Ali G.] Columbia Univ, New York, NY 10032 USA	University of Alabama System; University of Alabama Birmingham; Juntendo University; Palacky University Olomouc; University of Tennessee System; University of Tennessee Health Science Center; Columbia University	Novak, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 761A, Birmingham, AL 35294 USA.	jannovak@uab.edu	Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Wyatt, Robert/0000-0001-6077-0259	National Institutes of Health [DK082753, DK078244, DK083663, GM098539]; IGA Nephropathy Foundation of America; European Social Fund [CZ.1.07/2.3.00/20.0164]; Ministry of School, Youth, and Sport [LH11046]; Czech Science Foundation [GAP302/10/1055]; Grant Agency of the Ministry of Health, Czech Republic [NT11081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, R56DK078244, R21DK083663, R01DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IGA Nephropathy Foundation of America; European Social Fund(European Social Fund (ESF)); Ministry of School, Youth, and Sport; Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Ministry of Health, Czech Republic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082753, DK078244, DK083663, and GM098539. This work was also supported by a grant from the IGA Nephropathy Foundation of America and by Grants CZ.1.07/2.3.00/20.0164 (European Social Fund), LH11046 (Ministry of School, Youth, and Sport), GAP302/10/1055 (Czech Science Foundation), and NT11081 (Grant Agency of the Ministry of Health, Czech Republic).	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; ANDRE PM, 1990, J CLIN LAB ANAL, V4, P115, DOI 10.1002/jcla.1860040208; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Beerman I, 2007, NAT CLIN PRACT NEPHR, V3, P325, DOI 10.1038/ncpneph0492; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; BENNETT WM, 1983, KIDNEY INT, V23, P393, DOI 10.1038/ki.1983.32; BERGER J, 1968, J UROL NEPHROL, V74, P694; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Chintalacharuvu SR, 1997, J IMMUNOL, V159, P2327; Chintalacharuvu SR, 2000, CYTOKINE, V12, P1182, DOI 10.1006/cyto.2000.0699; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Emancipator S.N., 1998, HEPTINSTALLS PATHOLO, P479; EMANCIPATOR SN, 1989, LAB INVEST, V60, P168; Emancipator SN, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1579, DOI 10.1016/B978-012491543-5/50096-6; EVANS SS, 1993, J CELL BIOL, V123, P1889, DOI 10.1083/jcb.123.6.1889; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; FIELD MC, 1989, BIOCHEM SOC T, V17, P1034, DOI 10.1042/bst0171034; FUJIHASHI K, 1991, J CLIN INVEST, V88, P248, DOI 10.1172/JCI115284; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Glassock RJ, 2008, CLEV CLIN J MED, V75, P569, DOI 10.3949/ccjm.75.8.569; Glassock RJ, 2011, CURR OPIN NEPHROL HY, V20, P153, DOI 10.1097/MNH.0b013e3283436f5c; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Goodrich ME, 1999, IMMUNOL LETT, V67, P11, DOI 10.1016/S0165-2478(98)00112-6; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HOLAN V, 1992, IMMUNOLOGY, V75, P176; Huston MM, 1996, J IMMUNOL, V156, P1392; ITOH K, 1995, J IMMUNOL, V154, P4341; Iwase H, 1998, J CHROMATOGR B, V709, P145, DOI 10.1016/S0378-4347(98)00050-4; JENNETTE JC, 1988, AM J KIDNEY DIS, V12, P348, DOI 10.1016/S0272-6386(88)80022-2; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julian BA, 2007, CONTRIB NEPHROL, V157, P19, DOI 10.1159/000102284; Julian BA, 2009, PROTEOM CLIN APPL, V3, P1029, DOI 10.1002/prca.200800243; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; KISHIMOTO T, 1992, CIBA F SYMP, V167, P5; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Lau KK, 2007, PEDIATR NEPHROL, V22, P2067, DOI 10.1007/s00467-007-0623-y; Leung JCK, 2003, NEPHROL DIAL TRANSPL, V18, P36, DOI 10.1093/ndt/18.1.36; Leung JCK, 2002, J LAB CLIN MED, V140, P398, DOI 10.1067/mlc.2002.129338; Leung JCK, 2002, J CLIN LAB ANAL, V16, P11, DOI 10.1002/jcla.2035; Leung JCK, 2000, J AM SOC NEPHROL, V11, P241, DOI 10.1681/ASN.V112241; Leung JCK, 2008, NEPHROL DIAL TRANSPL, V23, P72, DOI 10.1093/ndt/gfm581; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Moura IC, 2004, J AM SOC NEPHROL, V15, P622, DOI 10.1097/01.ASN.0000115401.07980.0C; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2007, CONTRIB NEPHROL, V157, P134; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Novak J, 2011, NEPHROL DIAL TRANSPL, V26, P3451, DOI 10.1093/ndt/gfr448; Raska M, 2007, J MOL BIOL, V369, P69, DOI 10.1016/j.jmb.2007.03.002; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Rostoker G, 1998, CLIN EXP IMMUNOL, V114, P468; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Smith AC, 2006, J AM SOC NEPHROL, V17, P1192, DOI 10.1681/ASN.2005101115; Smith AC, 2006, J AM SOC NEPHROL, V17, P3520, DOI 10.1681/ASN.2006060658; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; TAKAGI M, 1995, J EXP MED, V181, P889, DOI 10.1084/jem.181.3.889; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tarelli E, 2004, CARBOHYD RES, V339, P2329, DOI 10.1016/j.carres.2004.07.011; TOMANA M, 1978, ANAL BIOCHEM, V89, P110, DOI 10.1016/0003-2697(78)90731-5; TOMANA M, 1972, IMMUNOCHEMISTRY, V9, P933, DOI 10.1016/0019-2791(72)90166-8; TOMANA M, 1976, IMMUNOCHEMISTRY, V13, P325, DOI 10.1016/0019-2791(76)90342-6; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; TUCCI A, 1992, J IMMUNOL, V148, P2778; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	96	98	107	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5330	5339		10.1074/jbc.M113.512277	http://dx.doi.org/10.1074/jbc.M113.512277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398680	hybrid, Green Published			2022-12-25	WOS:000331607900073
J	Landry, AP; Ding, HG				Landry, Aaron P.; Ding, Huangen			Redox Control of Human Mitochondrial Outer Membrane Protein MitoNEET [2Fe-2S] Clusters by Biological Thiols and Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Hydrogen Peroxide; Iron-Sulfur Protein; Redox Regulation; Thioredoxin	IRON-SULFUR CLUSTER; DRUG TARGET MITONEET; THIOREDOXIN REDUCTASE; DISULFIDE INTERCHANGE; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-SITE; IDENTIFICATION; OXIDATION	Background: MitoNEET is a target of the type II diabetes drug pioglitazone and contains a [2Fe-2S] cluster. Results: The mitoNEET [2Fe-2S] cluster can be reduced by biological thiols and reversibly oxidized by hydrogen peroxide. Conclusion: The redox state of mitoNEET [2Fe-2S] clusters can be regulated by thiols and oxidative signals. Significance: MitoNEET may act as a redox sensor to modulate mitochondrial functions. The human mitochondrial outer membrane protein mitoNEET is a novel target of the type II diabetes drug pioglitazone. The C-terminal cytosolic domain of mitoNEET hosts a redox-active [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine residues and one histidine residue. Here we report that human mitoNEET [2Fe-2S] clusters are fully reduced when expressed in Escherichia coli cells. In vitro studies show that purified mitoNEET [2Fe-2S] clusters can be partially reduced by monothiols such as reduced glutathione, l-cysteine or N-acetyl-l-cysteine and fully reduced by dithiothreitol or the E. coli thioredoxin/thioredoxin reductase system under anaerobic conditions. Importantly, thiol-reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen peroxide without disruption of the clusters in vitro and in E. coli cells, indicating that mitoNEET may act as a sensor of oxidative signals to regulate mitochondrial functions via its [2Fe-2S] clusters. Furthermore, the binding of the type II diabetes drug pioglitazone in mitoNEET effectively inhibits the thiol-mediated reduction of [2Fe-2S] clusters, suggesting that pioglitazone may modulate the function of mitoNEET by blocking the thiol-mediated reduction of [2Fe-2S] clusters in the protein.	[Landry, Aaron P.; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	NCI, National Institutes of Health [R01CA107494]; American Heart Association [13GRNT16890014]; Louisiana Board of Regents graduate scholarship; NATIONAL CANCER INSTITUTE [R01CA107494] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Louisiana Board of Regents graduate scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA107494. This work was also supported by American Heart Association Grant 13GRNT16890014 and by a Louisiana Board of Regents graduate scholarship.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Arif W, 2011, BIOCHEMISTRY-US, V50, P5806, DOI 10.1021/bi200546s; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Baxter EL, 2012, P NATL ACAD SCI USA, V109, P1955, DOI 10.1073/pnas.1116369109; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Chang NC, 2012, AUTOPHAGY, V8, P856, DOI 10.4161/auto.20054; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Geldenhuys WJ, 2013, CURR MED CHEM, V20, P1662; Geldenhuys WJ, 2011, BIOORG MED CHEM LETT, V21, P5498, DOI 10.1016/j.bmcl.2011.06.111; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026977; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Tan GQ, 2012, BIOMETALS, V25, P1177, DOI 10.1007/s10534-012-9580-4; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Walters EM, 2009, BIOCHEMISTRY-US, V48, P1016, DOI 10.1021/bi802074p; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yonutas HM, 2013, CURR DRUG TARGETS, V14, P733, DOI 10.2174/1389450111314070003; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zschauer TC, 2013, ANTIOXID REDOX SIGN, V18, P1053, DOI 10.1089/ars.2012.4822; Zuris JA, 2012, J BIOL CHEM, V287, P11649, DOI 10.1074/jbc.M111.319731; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	57	46	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4307	4315		10.1074/jbc.M113.542050	http://dx.doi.org/10.1074/jbc.M113.542050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24403080	hybrid, Green Published			2022-12-25	WOS:000331403800041
J	He, WY; Sun, XF; Liu, L; Li, M; Jin, H; Wang, WH				He, Wenyin; Sun, Xiaofang; Liu, Lian; Li, Man; Jin, Hua; Wang, Wei-Hua			The Prevalence of Chromosomal Deletions Relating to Developmental Delay and/or Intellectual Disability in Human Euploid Blastocysts	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; INTRACYTOPLASMIC SPERM INJECTION; ADVANCED MATERNAL AGE; COPY NUMBER VARIATION; ARRAY CGH; OLIGONUCLEOTIDE MICROARRAYS; SINGLETON PREGNANCIES; ANEUPLOIDY; MICRODELETIONS	Chromosomal anomalies in human embryos produced by in vitro fertilization are very common, which include numerical (aneuploidy) and structural (deletion, duplication or others) anomalies. Our previous study indicated that chromosomal deletion(s) is the most common structural anomaly accounting for approximately 8% of euploid blastocysts. It is still unknown if these deletions in human euploid blastocysts have clinical significance. In this study, we analyzed 15 previously diagnosed euploid blastocysts that had chromosomal deletion(s) using Agilent oligonucleotide DNA microarray platform and localized the gene location in each deletion. Then, we used OMIM gene map and phenotype database to investigate if these deletions are related with some important genes that cause genetic diseases, especially developmental delay or intellectual disability. As results, we found that the detectable chromosomal deletion size with Agilent microarray is above 2.38 Mb, while the deletions observed in human blastocysts are between 11.6 to 103 Mb. With OMIM gene map and phenotype database information, we found that deletions can result in loss of 81-464 genes. Out of these genes, 34-149 genes are related with known genetic problems. Furthermore, we found that 5 out of 15 samples lost genes in the deleted region, which were related to developmental delay and/or intellectual disability. In conclusion, our data indicates that all human euploid blastocysts with chromosomal deletion(s) are abnormal and transfer of these embryos may cause birth defects and/or developmental and intellectual disabilities. Therefore, the embryos with chromosomal deletion revealed by DNA microarray should not be transferred to the patients, or further gene map and/or phenotype seeking is necessary before making a final decision.	[He, Wenyin; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Liu, Lian; Li, Man; Jin, Hua] Pacgenomics Inc, Village Med Ctr, Thousand Oaks, CA USA; [Wang, Wei-Hua] New Houston Hlth, Houston, TX USA; [Wang, Wei-Hua] Vivere Hlth, Franklin, TN USA	Guangzhou Medical University	Wang, WH (corresponding author), New Houston Hlth, Houston, TX USA.	wangweihua11@yahoo.com			Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China [81270745]	Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The Third Affiliated Hospital of Guangzhou Medical University and the National Natural Science Foundation of China (81270745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Apantaku O, 2008, J OBSTET GYNAECOL, V28, P398, DOI 10.1080/01443610802091792; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; De Neubourg D, 2006, HUM REPROD, V21, P1041, DOI 10.1093/humrep/dei424; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Fujii M, 2010, FERTIL STERIL, V94, P2113, DOI 10.1016/j.fertnstert.2009.12.031; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Girardet A, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.07.1305; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Halliday J, 2007, BEST PRACT RES CL OB, V21, P67, DOI 10.1016/j.bpobgyn.2006.08.004; Harper JC, 2010, FERTIL STERIL, V94, P1173, DOI 10.1016/j.fertnstert.2010.04.064; Harper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hehir-Kwa JY, 2007, DNA RES, V14, P1, DOI 10.1093/dnares/dsm002; Heilstedt HA, 2003, CLIN GENET, V64, P310, DOI 10.1034/j.1399-0004.2003.00126.x; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Li XM, 2008, CURR GENOMICS, V9, P466, DOI 10.2174/138920208786241199; Liang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061838; Liu JQ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103192; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Manning M, 2010, AM J HUM GENET, V86, P749; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Miller DT, 2010, GENET MED, V12, P742; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pober BR, 2010, NEW ENGL J MED, V362, P2142; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Poongothai J, 2009, SINGAP MED J, V50, P336; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Ren Z, 2009, FERTIL STERIL, V91, P359, DOI 10.1016/j.fertnstert.2007.11.044; Rius M, 2011, FERTIL STERIL, V95, P413, DOI 10.1016/j.fertnstert.2010.07.1051; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Schoolcraft WB, 2010, FERTIL STERIL, V94, pS23, DOI 10.1016/j.fertnstert.2010.07.090; Shen XT, 2011, J ASSIST REPROD GEN, V28, P957, DOI 10.1007/s10815-011-9598-5; Shoukier M, 2013, CLIN GENET, V83, P53, DOI 10.1111/j.1399-0004.2012.01850.x; Song NH, 2005, CHINESE MED J-PEKING, V118, P1462; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sykulski Maciej, 2013, J Clin Bioinforma, V3, P12, DOI 10.1186/2043-9113-3-12; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Vanneste Evelyne, 2012, Frontiers in Genetics, V3, P44, DOI 10.3389/fgene.2012.00044; Wang ZB, 2011, PHYSIOLOGY, V26, P314, DOI 10.1152/physiol.00020.2011; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85207	10.1371/journal.pone.0085207	http://dx.doi.org/10.1371/journal.pone.0085207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409323	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500047
J	Li, HH; Huang, ZY; Ye, SP; Lu, CY; Cheng, PC; Chen, SH; Chen, CS				Li, Hsing-Hui; Huang, Zi-Yu; Ye, Shih-Png; Lu, Chi-Yu; Cheng, Pai-Chiao; Chen, Shu-Hwa; Chen, Chii-Shiarng			Membrane Labeling of Coral Gastrodermal Cells by Biotinylation: The Proteomic Identification of Surface Proteins Involving Cnidaria-Dinoflagellate Endosymbiosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALGAL SYMBIONTS; ACTIN; GENE; ZOOXANTHELLAE; ENDOCYTOSIS; RESPONSES; ANEMONE; BINDING	The cellular and molecular-scale processes underlying the stability of coral-Symbiodinium endosymbioses remain unclear despite decades of investigation. As the coral gastroderm is the only tissue layer characterized by this unique symbiotic association, the membranes of these symbiotic gastrodermal cells (SGCs) may play important roles in the initiation and maintenance of the endosymbiosis. In order to elucidate the interactions between the endosymbiotic dinoflagellates and their coral hosts, a thorough characterization of SGC membranes is therefore required. Cell surface proteins of isolated SGCs were biotinylated herein by a cell impermeant agent, biotin-XX sulfosuccinimidyl ester. The in situ distribution of these biotinylated proteins was uncovered by both fluorescence and transmission electron microscopic imaging of proteins bound to Alexa Fluor (R) 488-conjugated streptavidin. The identity of these proteins was then determined by two-dimensional gel electrophoresis followed by liquid chromatography-tandem mass spectrometry. Nineteen (19) proteins were identified, and they are known to be involved in the molecular chaperone/stress response, cytoskeletal remodeling, and energy metabolism. These results not only reveal the molecular characters of the host SGC membrane, but also provide critical insight into understanding the possible role of host membranes in this ecologically important endosymbiotic association.	[Li, Hsing-Hui; Huang, Zi-Yu; Ye, Shih-Png; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Li, Hsing-Hui; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Cheng, Pai-Chiao] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Shu-Hwa] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; Kaohsiung Medical University; National Cheng Kung University; Academia Sinica - Taiwan; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan.	cchen@nmmba.gov.tw			National Science Council of Taiwan (NSC) [101-2311-B-291-002-MY3]; National Museum of Marine Biology and Aquarium	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Museum of Marine Biology and Aquarium	This work was supported by the National Science Council of Taiwan (NSC 101-2311-B-291-002-MY3 to C.-S. Chen) and intramural funds from the National Museum of Marine Biology and Aquarium (to H.-H. Li and C.-S. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANKS PR, 1995, BIOCONJUGATE CHEM, V6, P447, DOI 10.1021/bc00034a015; Birkeland CR, 1997, LIFE DEATH CORAL REE, P1; Chen CS, 2012, SCI CHINA LIFE SCI, V55, P599, DOI 10.1007/s11427-012-4345-4; Chen CS, 2005, PROTOPLASMA, V226, P175, DOI 10.1007/s00709-005-0116-4; Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Dunn SR, 2007, BIOL BULL-US, V212, P250, DOI 10.2307/25066607; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FITT WK, 1983, J CELL SCI, V64, P195; GRANIER F, 1988, ELECTROPHORESIS, V9, P712, DOI 10.1002/elps.1150091106; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; HOHMAN TC, 1982, J CELL BIOL, V94, P56, DOI 10.1083/jcb.94.1.56; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lin KL, 2000, ZOOL STUD, V39, P172; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MUSCATINE L, 1975, T AM MICROSC SOC, V94, P450, DOI 10.2307/3225518; Nakamura M, 2002, ANAL BIOCHEM, V304, P231, DOI 10.1006/abio.2002.5595; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; VANDERMEULEN JH, 1972, MAR BIOL, V16, P185; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; Weston AJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015487	35	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85119	10.1371/journal.pone.0085119	http://dx.doi.org/10.1371/journal.pone.0085119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409319	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500043
J	Mangrud, OM; Waalen, R; Gudlaugsson, E; Dalen, I; Tasdemir, I; Janssen, EAM; Baak, JPA				Mangrud, Ok Malfrid; Waalen, Rune; Gudlaugsson, Einar; Dalen, Ingvild; Tasdemir, Ilker; Janssen, Emiel A. M.; Baak, Jan P. A.			Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder	PLOS ONE			English	Article							ORGANIZATION INTERNATIONAL SOCIETY; UROLOGIC-PATHOLOGY CLASSIFICATION; NEOPLASMS; WHO/ISUP; RISK; PROGRESSION; CANCER; TUMORS	Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highly on stage and WHO1973-grade but grading reproducibility is wanting. The newer WHO2004 grading system is still debated and both systems are currently used. Aims: To compare reproducibility and prognostic value (of stage progression) of the WHO1973 and WHO2004. Methods: One hundred and ninety-three primary urothelial carcinomas were reviewed. Follow-up data were retrieved from the patient records. Kappa statistics and Harrell's C-index were used. Results: Median follow-up was 75 months (range 1-127). 17 patients (9%) progressed, 82% of these within and 18% after 60 months. The distribution of WHO73-grades 1, 2 and 3 was 23%, 51% and 26%, interobserver agreement for each individual grade was 66% (kappa = 0.68), while for grades 1&2 versus 3 89% (kappa = 0.68). Intraobserver reproducibility was 68-63% for WHO73 and 88-89% for WHO73 as 1&2 vs. 3. Progression free survival rates at 5 years were 95% (grade 1), 98% (grade 2) and 82% (grade 3) and 96% and 82% for grades 1&2 versus 3 (Hazard Ratio, HR, 5.4, p = 0.003). Using WHO2004, 62% were low grade and 38% high grade, inter-observer agreement 87% (kappa = 0.70), intraobserver reproducibility 93%, and progression free 5-year survival rates 97% and 85% (HR 6.6, p = 0.004). Positive and negative predictive values for stage progression within 5 years for the WHO73 (12 vs. 3) were 18% and 96%, and 15% and 97% for the WHO04. Using Harrell's C-index, none of the grading systems was prognostically superior. Conclusion: None of the grading systems is prognostically stronger than the others. Most importantly, inter-observer reproducibility and sensitivities for stage progression of both systems are low and need improvement for optimal treatment.	[Mangrud, Ok Malfrid; Gudlaugsson, Einar; Janssen, Emiel A. M.; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Mangrud, Ok Malfrid; Gudlaugsson, Einar; Baak, Jan P. A.] Univ Bergen, Clin Inst 1, Bergen, Norway; [Waalen, Rune] Innlandet Hosp Trust, Dept Pathol, Lillehammer, Norway; [Dalen, Ingvild] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Tasdemir, Ilker] Stavanger Univ Hosp, Dept Urol, Stavanger, Norway	Stavanger University Hospital; University of Bergen; Innlandet Hospital Trust; Stavanger University Hospital; Stavanger University Hospital	Baak, JPA (corresponding author), Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway.	jpabaak47@yahoo.com	Janssen, Emiel A.M./AAM-2357-2020					[Anonymous], 2004, KIDNEY TUMORS CHILDR; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Bol MGW, 2003, J UROLOGY, V169, P1291, DOI 10.1097/01.ju.0000055471.78783.ae; Chen ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047199; Cheng L, 1999, CANCER, V86, P2102, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.3.CO;2-L; Cheng L, 2012, HUM PATHOL, V43, P2097, DOI 10.1016/j.humpath.2012.01.008; Eble JN, 2004, PATHOLOGY GENETICS T; Engers R, 2007, WORLD J UROL, V25, P595, DOI 10.1007/s00345-007-0209-0; Epstein JI, 2003, CRIT REV ONCOL HEMAT, V47, P83, DOI 10.1016/S1040-8428(03)00073-8; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fujii Y, 2003, BJU INT, V92, P559, DOI 10.1046/j.1464-410X.2003.04415.x; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Haldorsen T, 2011, CANC NORWAY 2009; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOLMANG S, 1995, J UROLOGY, V153, P1823, DOI 10.1016/S0022-5347(01)67321-X; Larsson P, 2003, SCAND J UROL NEPHROL, V37, P195, DOI 10.1080/00365590310008037; MacLennan GT, 2007, EUR UROL, V51, P889, DOI 10.1016/j.eururo.2006.10.037; Mostofi FK, 1973, HISTOLOGICAL TYPING; Murphy WM, 2002, J UROLOGY, V168, P968, DOI 10.1016/S0022-5347(05)64553-3; Pan CC, 2010, AM J CLIN PATHOL, V133, P788, DOI 10.1309/AJCP12MRVVHTCKEJ; Samaratunga H, 2002, UROLOGY, V60, P315, DOI 10.1016/S0090-4295(02)01705-3; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; van Rhijn BWG, 2010, EUR UROL, V58, P433, DOI 10.1016/j.eururo.2010.05.043; Rhijn BWG, 2010, EUR UROL, V57, P1052, DOI 10.1016/j.eururo.2009.09.022; Yin H, 2004, AM J CLIN PATHOL, V121, P679, DOI 10.1039/0KATYHQBJD5XHQ8J; Yorukoglu K, 2003, VIRCHOWS ARCH, V443, P734, DOI 10.1007/s00428-003-0905-0	26	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83192	10.1371/journal.pone.0083192	http://dx.doi.org/10.1371/journal.pone.0083192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409280	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500004
J	Asztalos, A; Sreenivasan, S; Szymanski, BK; Korniss, G				Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy			Cascading Failures in Spatially-Embedded Random Networks	PLOS ONE			English	Article							COMPLEX; SYNCHRONIZATION	Cascading failures constitute an important vulnerability of interconnected systems. Here we focus on the study of such failures on networks in which the connectivity of nodes is constrained by geographical distance. Specifically, we use random geometric graphs as representative examples of such spatial networks, and study the properties of cascading failures on them in the presence of distributed flow. The key finding of this study is that the process of cascading failures is non-self-averaging on spatial networks, and thus, aggregate inferences made from analyzing an ensemble of such networks lead to incorrect conclusions when applied to a single network, no matter how large the network is. We demonstrate that this lack of self-averaging disappears with the introduction of a small fraction of long-range links into the network. We simulate the well studied preemptive node removal strategy for cascade mitigation and show that it is largely ineffective in the case of spatial networks. We introduce an altruistic strategy designed to limit the loss of network nodes in the event of a cascade triggering failure and show that it performs better than the preemptive strategy. Finally, we consider a real-world spatial network viz. a European power transmission network and validate that our findings from the study of random geometric graphs are also borne out by simulations of cascading failures on the empirical network.	[Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy] Rensselaer Polytech Inst, Acad Res Ctr, Social Network, Troy, NY 12180 USA; [Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy] Rensselaer Polytech Inst, Acad Res Ctr, Cognit Network, Troy, NY USA; [Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Asztalos, Andrea; Sreenivasan, Sameet; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Sreenivasan, S (corresponding author), Rensselaer Polytech Inst, Acad Res Ctr, Social Network, Troy, NY 12180 USA.	sreens@rpi.edu	Szymanski, Boleslaw Karol/O-1374-2017; Szymanski, Boleslaw K/A-9121-2009; Korniss, Gyorgy/A-7360-2011	Szymanski, Boleslaw Karol/0000-0002-0307-6743; Szymanski, Boleslaw K/0000-0002-0307-6743; 	DTRA [HDTRA1-09-1-0049]; Army Research Laboratory [W911NF-09-2-0053]; NSF [DMR-1246958]; Direct For Mathematical & Physical Scien [1246958] Funding Source: National Science Foundation	DTRA(United States Department of DefenseDefense Threat Reduction Agency); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by DTRA Award No. HDTRA1-09-1-0049, by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 and by NSF Grant No. DMR-1246958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UPDATED UCTE DATA; Asztalos A, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30122-3; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bernstein A, 2011, 20110506 COL U EL EN; Bollobas B., 2001, RANDOM GRAPHS, DOI 10.1017/CBO9780511814068.008; Brandes U, 2005, LECT NOTES COMPUT SC, V3404, P533; Colak S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113037; Diaz J, 2001, PARALLEL PROCESSING, V10, P2000; Diaz-Guilera A, 2009, INT J BIFURCAT CHAOS, V19, P687, DOI 10.1142/S0218127409023044; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Ercsey-Ravasz M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.038701; Hernandez V, 2005, ACM T MATH SOFTWARE, V31, P351, DOI 10.1145/1089014.1089019; Herrmann C, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026128; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Kong ZN, 2010, IEEE T INFORM THEORY, V56, P5533, DOI 10.1109/TIT.2010.2068910; Korniss G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051121; Korniss G, 2006, PHYS LETT A, V350, P324, DOI 10.1016/j.physleta.2005.09.081; Korniss G, 2012, SPRINGER SER OPTIM A, V58, P61, DOI 10.1007/978-1-4614-0857-4_3; Krapivsky PL, 2000, PHYS REV E, V61, pR993, DOI 10.1103/PhysRevE.61.R993; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Lopez E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248701; Lu Q, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016111; Mendes GA, 2012, PHYSICA A, V391, P362, DOI 10.1016/j.physa.2011.07.046; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Penrose M, 2003, OXFORD STUDIES PROBA, V5; Rahnamay-Naeini M, 2013, IEEE T POWE IN PRESS; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Sachs JD., 2009, SCI AM, V300, P34; Scala A, 2012, ARXIV12093733V2; Simonsen I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218701; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Verma T, 2013, ARXIV13045402PHYSICS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zaslavsky A, 2013, ARXIV13010159CSCY; Zhou Q, 2005, IEEE T POWER SYST, V20, P782, DOI 10.1109/TPWRS.2005.846178; Zhou Q, 2013, IEEE POWERT IN PRESS; Zimmerman RD, 2011, IEEE T POWER SYST, V26, P12, DOI 10.1109/TPWRS.2010.2051168	45	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84563	10.1371/journal.pone.0084563	http://dx.doi.org/10.1371/journal.pone.0084563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400101	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700035
J	Berg, RK; Rahbek, SH; Kofod-Olsen, E; Holm, CK; Melchjorsen, J; Jensen, DG; Hansen, AL; Jorgensen, LB; Ostergaard, L; Tolstrup, M; Larsen, CS; Paludan, SR; Jakobsen, MR; Mogensen, TH				Berg, Randi K.; Rahbek, Stine H.; Kofod-Olsen, Emil; Holm, Christian K.; Melchjorsen, Jesper; Jensen, David G.; Hansen, Anne Louise; Jorgensen, Louise B.; Ostergaard, Lars; Tolstrup, Martin; Larsen, Carsten S.; Paludan, Soren R.; Jakobsen, Martin R.; Mogensen, Trine H.			T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: Implications for Restriction of HIV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE RECOGNITION; SINGLE-STRANDED RNA; SAMHD1 RESTRICTS; INTERFERON-ALPHA; INFECTION; SENSOR; LYMPHOCYTES; RETROVIRUS	HIV infects key cell types of the immune system, most notably macrophages and CD4+ T cells. Whereas macrophages represent an important viral reservoir, activated CD4+ T cells are the most permissive cell types supporting high levels of viral replication. In recent years, it has been appreciated that the innate immune system plays an important role in controlling HIV replication, e. g. via interferon (IFN)-inducible restriction factors. Moreover, innate immune responses are involved in driving chronic immune activation and the pathogenesis of progressive immunodeficiency. Several pattern recognition receptors detecting HIV have been reported, including Toll-like receptor 7 and Retinoic-inducible gene-I, which detects viral RNA. Here we report that human primary T cells fail to induce strong IFN responses, despite the fact that this cell type does express key molecules involved in DNA signaling pathways. We demonstrate that the DNA sensor IFI16 migrates to sites of foreign DNA localization in the cytoplasm and recruits the signaling molecules stimulator of IFN genes and Tank-binding kinase, but this does not result in expression of IFN and IFN-stimulated genes. Importantly, we show that cytosolic DNA fails to affect HIV replication. However, exogenous treatment of activated T cells with type I IFN has the capacity to induce expression of IFN-stimulated genes and suppress HIV replication. Our data suggest the existence of an impaired DNA signaling machinery in T cells, which may prevent this cell type from activating cell-autonomous anti-HIV responses. This phenomenon could contribute to the high permissiveness of CD4+ T cells for HIV-1.	[Berg, Randi K.; Kofod-Olsen, Emil; Melchjorsen, Jesper; Jensen, David G.; Ostergaard, Lars; Tolstrup, Martin; Larsen, Carsten S.; Mogensen, Trine H.] Aarhus Univ, Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Rahbek, Stine H.; Kofod-Olsen, Emil; Holm, Christian K.; Hansen, Anne Louise; Paludan, Soren R.; Jakobsen, Martin R.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Rahbek, Stine H.; Holm, Christian K.; Paludan, Soren R.; Jakobsen, Martin R.; Mogensen, Trine H.] Aarhus Res Ctr Innate Immunol, Aarhus, Denmark; [Jorgensen, Louise B.] State Serum Inst, Dept Virol, Copenhagen, Denmark	Aarhus University; Aarhus University; Statens Serum Institut	Mogensen, TH (corresponding author), Aarhus Univ, Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	Trinmoge@rm.dk	Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Tolstrup, Martin/0000-0001-7020-5173; Mogensen, Trine Hyrup/0000-0002-1853-9704; Ostergaard, Lars/0000-0002-7619-605X; Hansen, Anne Louise/0000-0002-3741-8705; Holm, Christian/0000-0002-2655-3362; , Martin/0000-0001-8847-9201	Danish Medical Research Council [09-066031, 12-124330, 10-081986]; Kong Christian IX og Dronning Louises Jubilaeumslegat; Aase og Ejnar Danielsens Fond; Foundation for the Advancement of Medical Sciences; Faculty of Health Sciences, Aarhus University; Lundbeck Foundation [R83-2011-7598] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kong Christian IX og Dronning Louises Jubilaeumslegat; Aase og Ejnar Danielsens Fond; Foundation for the Advancement of Medical Sciences; Faculty of Health Sciences, Aarhus University; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council (grant numbers 09-066031 (THM), 12-124330 (SRP), and 10-081986 (MRJ)). In addition, the work was supported by Kong Christian IX og Dronning Louises Jubilaeumslegat, Aase og Ejnar Danielsens Fond and The Foundation for the Advancement of Medical Sciences. RKB is recipient of a PhD fellowship from the Faculty of Health Sciences, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Dobson-Belaire WN, 2010, CELL MICROBIOL, V12, P1703, DOI 10.1111/j.1462-5822.2010.01502.x; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Equils O, 2001, J IMMUNOL, V166, P2342, DOI 10.4049/jimmunol.166.4.2342; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Freed EO, 2007, FIELDS VIROLOGY; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gao D, 2013, SCIENCE; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Gougeon ML, 2012, EXP CELL RES, V318, P1260, DOI 10.1016/j.yexcr.2012.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Hayashi T, 2010, MICROBES INFECT, V12, P937, DOI 10.1016/j.micinf.2010.06.003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Holm CK, 2009, J IMMUNOL, V183, P4422, DOI 10.4049/jimmunol.0804318; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Isegawa Y, 2007, ACTA VIROL, V51, P13; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jakobsen MR, 2013, P NATL ACAD SCI US; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LATHEY JL, 1994, VIROLOGY, V199, P98, DOI 10.1006/viro.1994.1101; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Ploquin MJY, 2012, AIDS, V26, P1269, DOI 10.1097/QAD.0b013e328353e46b; Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Wei W, 2003, HISTOCHEM CELL BIOL, V119, P45, DOI 10.1007/s00418-002-0485-0; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84513	10.1371/journal.pone.0084513	http://dx.doi.org/10.1371/journal.pone.0084513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404168	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800047
J	Labno, A; Warrier, A; Wang, S; Zhang, X				Labno, Anna; Warrier, Ajithkumar; Wang, Sheng; Zhang, Xiang			Local Plasticity of Dendritic Excitability Can Be Autonomous of Synaptic Plasticity and Regulated by Activity-Based Phosphorylation of Kv4.2	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; POTASSIUM CHANNELS; K+ CHANNELS; KINASE-II; EXPRESSION; MEMORY; HIPPOCAMPUS; CURRENTS	While plasticity is typically associated with persistent modifications of synaptic strengths, recent studies indicated that modulations of dendritic excitability may form the other part of the engram and dynamically affect computational processing and output of neuronal circuits. However it remains unknown whether modulation of dendritic excitability is controlled by synaptic changes or whether it can be distinct from them. Here we report the first observation of the induction of a persistent plastic decrease in dendritic excitability decoupled from synaptic stimulation, which is localized and purely activity-based. In rats this local plasticity decrease is conferred by CamKII mediated phosphorylation of A-type potassium channels upon interaction of a back propagating action potential (bAP) with dendritic depolarization.	[Labno, Anna; Warrier, Ajithkumar; Wang, Sheng; Zhang, Xiang] Nanoscale Sci & Engn Ctr, Berkeley, CA USA; [Labno, Anna] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhang, X (corresponding author), Nanoscale Sci & Engn Ctr, Berkeley, CA USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011	Zhang, Xiang/0000-0002-3272-894X	National Institutes of Health through the NIH Roadmap for Medical Research [PN2 EY018228]; National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM) [CMMI-0751621]; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY018228) and the National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM) (Grant No. CMMI-0751621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chi XX, 2000, J NEUROPHYSIOL, V84, P2834, DOI 10.1152/jn.2000.84.6.2834; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Debanne Dominique, 2010, Front Synaptic Neurosci, V2, P21, DOI 10.3389/fnsyn.2010.00021; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Gollo LL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000402; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Isaac JTR, 2009, J NEUROSCI, V29, P6840, DOI 10.1523/JNEUROSCI.0731-09.2009; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; Lei ZG, 2008, J NEUROCHEM, V106, P182, DOI 10.1111/j.1471-4159.2008.05356.x; Li CY, 2004, NEURON, V41, P257, DOI 10.1016/S0896-6273(03)00847-X; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nestor MW, 2012, HIPPOCAMPUS, V22, P969, DOI 10.1002/hipo.20899; Niehusmann P, 2010, J NEUROSCI, V30, P6225, DOI 10.1523/JNEUROSCI.6411-09.2010; Ribeiro MJ, 2005, LEARN MEMORY, V12, P538, DOI 10.1101/lm.8305; Rosenkranz JA, 2009, J PHYSIOL-LONDON, V587, P115, DOI 10.1113/jphysiol.2008.158816; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Sharma SK, 2004, LEARN MEMORY, V11, P373, DOI 10.1101/lm.81104; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Truchet B, 2012, LEARN MEMORY, V19, P282, DOI 10.1101/lm.025411.111; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yuan LL, 2006, PROG NEUROBIOL, V78, P374, DOI 10.1016/j.pneurobio.2006.03.003; Zarayskiy VV, 2005, TOXICON, V45, P431, DOI 10.1016/j.toxicon.2004.11.015; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CP, 2011, HIPPOCAMPUS, V21, P288, DOI 10.1002/hipo.20748; Zou BD, 2005, BRAIN RES, V1033, P78, DOI 10.1016/j.brainres.2004.11.023	52	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84086	10.1371/journal.pone.0084086	http://dx.doi.org/10.1371/journal.pone.0084086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404150	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800029
J	Oliveira, FTP; Hickey, C; McDonald, JJ				Oliveira, Flavio T. P.; Hickey, Clayton; McDonald, John J.			Proactive and Reactive Processes in the Medial Frontal Cortex: An Electrophysiological Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-DETECTION; PREFRONTAL CORTEX; RESPONSE CONFLICT; ERP COMPONENTS; FUNCTIONAL-SIGNIFICANCE; INTEGRATIVE THEORY; NEURAL SYSTEM; INHIBITION; ATTENTION	The posterior medial frontal cortex (pMFC) is known to be involved in adaptive goal-directed behavior, but its specific function is not yet clear. Most theories have proposed that the pMFC monitors performance in a reactive manner only, but it is possible that the pMFC also contributes to performance monitoring in a proactive manner. To date, the evidence for proactive pMFC activity is equivocal. Here, we investigated pMFC activity before, during and after the performance of a challenging motor task. Participants navigated a cursor through narrow and wide mazes in randomly intermixed trials. On each trial, participants saw previews of the actual maze display prior to gaining control of the cursor. Event-related potentials (ERPs) to the preview displays were compared to ERPs elicited by no-go signals and errors. Compared to the wider maze, the preview display for the more challenging narrow maze elicited a medial-frontal negativity (MFN) similar to the ERP components elicited by no-go signals and errors. Like these known ERP components, the preview-elicited MFN appeared to be generated from a source in pMFC. This is consistent with the hypothesis that the pMFC participates in adaptive behavior whenever there is a need for increased effort to maintain successful task performance.	[Oliveira, Flavio T. P.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Oliveira, Flavio T. P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Hickey, Clayton] Vrije Univ Amsterdam, Amsterdam, Netherlands; [McDonald, John J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Vrije Universiteit Amsterdam; Simon Fraser University	Oliveira, FTP (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	oflavio@gmail.com	McDonald, John/P-6966-2015; Hickey, Clayton/ABA-6126-2021	Hickey, Clayton/0000-0002-4162-5643	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canada Foundation for Innovation; Canadian Institutes of Health Research; Netherlands Organization for Scientific Research VENI grant [016-125-283]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research VENI grant	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the Canada Research Chairs program (http://www.chairs-chaires.gc.ca), the Canada Foundation for Innovation (http://www.innovation.ca), and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). CH is supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl) VENI grant 016-125-283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Baird A, 2006, BRAIN COGNITION, V60, P166, DOI 10.1016/j.bandc.2005.11.003; Botvinick M., 2004, COGNIT NEUROSCI ATTE, P91; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bush G., 2004, COGNITIVE NEUROSCIEN, P207; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gomez-Herrero G, 2006, 2006 7TH NORDIC SIGNAL PROCESSING SYMPOSIUM, P130; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hoechstetter K., 2010, BESA RES TUTORIAL; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Luck S. J., 2004, EVENT RELATED POTENT, P17, DOI [DOI 10.1371/JOURNAL.PCBI.0020012, 10.1371/journal.pcbi.0020012]; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Mathalon DH, 2003, BIOL PSYCHOL, V64, P119, DOI 10.1016/S0301-0511(03)00105-4; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Mulert C, 2007, NEUROPSYCHOLOGIA, V45, P2294, DOI 10.1016/j.neuropsychologia.2007.02.020; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Ochsner KN, 2001, NEUROPSYCHOLOGIA, V39, P219, DOI 10.1016/S0028-3932(00)00114-7; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schweimer J, 2005, BEHAV NEUROSCI, V119, P1687, DOI 10.1037/0735-7044.119.6.1687; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; THALER D, 1995, EXP BRAIN RES, V102, P445; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009	90	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84351	10.1371/journal.pone.0084351	http://dx.doi.org/10.1371/journal.pone.0084351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404160	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800039
J	Tian, F; Zhang, YJ; Li, Y; Xie, Y				Tian, Feng; Zhang, Ya Jie; Li, Yu; Xie, Ying			Celecoxib Ameliorates Non-Alcoholic Steatohepatitis in Type 2 Diabetic Rats via Suppression of the Non-Canonical Wnt Signaling Pathway Expression	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NF-KAPPA-B; INSULIN-RESISTANCE; COLON-CANCER; PPAR-GAMMA; ACTIVATION; BETA; MICE; OBESITY; COX-2	Our aim was to test whether pharmacological inhibition of cycloxygenase-2 (COX-2) reverses non-alcoholic steatohepatitis (NASH) in type 2 diabetes mellitus (T2DM) rats via suppression of the non-canonical Wnt signaling pathway expression. Twenty-four male Sprague-Dawley rats were randomly distributed to two groups and were fed with a high fat and sucrose (HF-HS) diet or a normal chow diet, respectively. After four weeks, rats fed with a HF-HS diet were made diabetic with low-dose streptozotocin. At the 9th week the diabetic rats fed with a HF-HS diet or the non-diabetic rats fed with a normal chow diet were further divided into two subgroups treated with vehicle or celecoxib (a selective COX-2 inhibitor, 10 mg/Kg/day, gavage) for the last 4 weeks, respectively. At the end of the 12th week, rats were anesthetized. NASH was assessed by histology. Related cytokine expression was measured at both the protein and gene levels through immunohistochemistry (IHC), Western blot and real-time PCR. T2DM rats fed with a HF-HS diet developed steatohepatitis and insulin resistance associated with elevated serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), insulin levels and the nonalcoholic fatty liver disease (NAFLD) activity score (NAS). The expression of Wnt5a, JNK1, NF-kappa B p65, and COX-2 were all significantly increased in the T2DM-NASH group compared with the control and control-cele group. Hepatic injury was improved by celecoxib in T2DM-NASH-Cele group indicated by reduced serum ALT and AST levels and hepatic inflammation was reduced by celecoxib showed by histology and the NAFLD activity score (NAS). Serum related metabolic parameters, HOMA-IR and insulin sensitivity index were all improved by celecoxib. The expression of Wnt5a, JNK1, NF-kappa B p65, and COX-2 expression were all suppressed by celecoxib in T2DM-NASH-Cele group. The results of the present study indicated that celecoxib ameliorated NASH in T2DM rats via suppression of the non-canonical Wnt5a/JNK1 signaling pathway expression.	[Tian, Feng; Zhang, Ya Jie; Xie, Ying] China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Li, Yu] Third Peoples Hosp Dalian City, Dept Gastroenterol, Dalian, Liaoning Provin, Peoples R China	China Medical University	Tian, F (corresponding author), China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	tianfeng@sj-hospital.org			Science and Technology Program of Liaoning Province [2010225034]	Science and Technology Program of Liaoning Province	The article was supported by Science and Technology Program of Liaoning Province(2010225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chatrath H, 2012, SEMIN LIVER DIS, V32, P22, DOI 10.1055/s-0032-1306423; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Lu SY, 2007, EXP BIOL MED, V232, P643; Morris EM, 2011, ANTIOXID REDOX SIGN, V15, P485, DOI 10.1089/ars.2010.3795; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Rivera Chantal A, 2008, Pathophysiology, V15, P109, DOI 10.1016/j.pathophys.2008.04.003; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Vaish V, 2010, TUMOR BIOL, V31, P427, DOI 10.1007/s13277-010-0051-7; Vandoros GP, 2006, J CANCER RES CLIN, V132, P76, DOI 10.1007/s00432-005-0042-z; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wu HT, 2010, HORM METAB RES, V42, P775, DOI 10.1055/s-0030-1261952; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	37	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83819	10.1371/journal.pone.0083819	http://dx.doi.org/10.1371/journal.pone.0083819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404139	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800018
J	Chi, YK; Han, JW; Jeong, H; Park, JY; Kim, TH; Lee, JJ; Lee, SB; Park, JH; Yoon, JC; Kim, JL; Ryu, SH; Jhoo, JH; Lee, DY; Kim, KW				Chi, Yeon Kyung; Han, Ji Won; Jeong, Hyeon; Park, Jae Young; Kim, Tae Hui; Lee, Jung Jae; Lee, Seok Bum; Park, Joon Hyuk; Yoon, Jong Chul; Kim, Jeong Lan; Ryu, Seung-Ho; Jhoo, Jin Hyeong; Lee, Dong Young; Kim, Ki Woong			Development of a Screening Algorithm for Alzheimer's Disease Using Categorical Verbal Fluency	PLOS ONE			English	Article							MENTAL STATUS EXAMINATION; KOREAN VERSION; PERFORMANCE; DEMENTIA; TIME; DISSOCIATION; REGRESSION; RETRIEVAL; MEMORY; SCALE	We developed a weighted composite score of the categorical verbal fluency test (CVFT) that can more easily and widely screen Alzheimer's disease (AD) than the mini-mental status examination (MMSE). We administered the CVFT using animal category and MMSE to 423 community-dwelling mild probable AD patients and their age-and gender-matched cognitively normal controls. To enhance the diagnostic accuracy for AD of the CVFT, we obtained a weighted composite score from subindex scores of the CVFT using a logistic regression model: logit (case) = 1.160+0.4746 x gender + 0.003 x age + 0.226 x education level -0.089 x first-half score -0.516 x switching score -0.303 x clustering score + 0.534 x perseveration score. The area under the receiver operating curve (AUC) for AD of this composite score AD was 0.903 (95% CI = 0.883 - 0.923), and was larger than that of the age-, gender-and education-adjusted total score of the CVFT (p < 0.001). In 100 bootstrapped resamples, the composite score consistently showed better diagnostic accuracy, sensitivity and specificity for AD than the total score. Although AUC for AD of the CVFT composite score was slightly smaller than that of the MMSE (0.930, p = 0.006), the CVFT composite score may be a good alternative to the MMSE for screening AD since it is much briefer, cheaper, and more easily applicable over phone or internet than the MMSE.	[Chi, Yeon Kyung; Han, Ji Won; Jeong, Hyeon; Park, Jae Young; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Lee, Jung Jae] Kyungbook Natl Univ Hosp, Dept Psychiat, Taegu, South Korea; [Lee, Seok Bum] Dankook Univ Hosp, Dept Psychiat, Cheonan, South Korea; [Park, Joon Hyuk] Jeju Natl Univ Hosp, Dept Neuropsychiat, Cheju, South Korea; [Yoon, Jong Chul] Kyunggi Prov Hosp Elderly, Dept Neuropsychiat, Yongin, South Korea; [Kim, Jeong Lan] Chungnam Natl Univ Hosp, Dept Psychiat, Taejon, South Korea; [Ryu, Seung-Ho] Konkuk Univ Hosp, Dept Neuropsychiat, Seoul, South Korea; [Jhoo, Jin Hyeong] Kangwon Natl Univ Hosp, Dept Neuropsychiat, Chunchon, South Korea; [Lee, Dong Young] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Lee, Dong Young; Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Dankook University; Dankook University Hospital; Jeju National University; Chungnam National University; Chungnam National University Hospital; Konkuk University; Konkuk University Medical Center; Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea.	kwkimmd@snu.ac.kr	Kim, Tae Hui/AAR-9213-2020; Kim, Ki Woong/D-5801-2012	Kim, Ki Woong/0000-0002-1103-3858; PARK, JOON HYUK/0000-0002-0396-5284; Kim, Tae Hui/0000-0003-0133-5227; Kim, Jeong Lan/0000-0002-6554-4637	Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea [A092077]; National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0018262]	Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea (Grant No. A092077), and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; Grant No. 2011-0018262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Fagundo AB, 2008, INT J GERIATR PSYCH, V23, P1007, DOI 10.1002/gps.2025; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kim KW, 2011, J ALZHEIMERS DIS, V23, P279, DOI 10.3233/JAD-2010-101221; Kim KW, 2005, DEMENT GERIATR COGN, V19, P324, DOI 10.1159/000084558; Kim KW, 2011, NATIONWIDE SURVEY DE, P347; Kim KW, 2009, NATIONWIDE SURVEY EP, P131; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Lacruz M, 2012, INT J GERIATR PSYCHI; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Li CP, 2012, CHINESE MED J-PEKING, V125, P851, DOI 10.3760/cma.j.issn.0366-6999.2012.05.022; March EG, 2006, J CLIN EXP NEUROPSYC, V28, P549, DOI 10.1080/13803390590949502; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Park J, 2006, COMMUNICATION SCI DI, V11, P99; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Raboutet C, 2010, J CLIN EXP NEUROPSYC, V32, P268, DOI 10.1080/13803390902984464; Reckess GZ, 2013, J ALZHEIMERS DIS; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Scott AJ, 1997, BIOMETRIKA, V84, P57, DOI 10.1093/biomet/84.1.57; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8	28	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84111	10.1371/journal.pone.0084111	http://dx.doi.org/10.1371/journal.pone.0084111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392109	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100033
J	George, AA; Hayden, S; Holzhausen, LC; Ma, EY; Suzuki, SC; Brockerhoff, SE				George, Ashley A.; Hayden, Sara; Holzhausen, Lars C.; Ma, Eva Y.; Suzuki, Sachihiro C.; Brockerhoff, Susan E.			Synaptojanin 1 Is Required for Endolysosomal Trafficking of Synaptic Proteins in Cone Photoreceptor Inner Segments	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; IN-VIVO; ZEBRAFISH; RAB7; ROD; NEURODEGENERATION; TRANSMISSION; LIGHT; CONSTRUCTION; MATURATION	Highly polarized cells such as photoreceptors require precise and efficient strategies for establishing and maintaining the proper subcellular distribution of proteins. The signals and molecular machinery that regulate trafficking and sorting of synaptic proteins within cone inner segments is mostly unknown. In this study, we show that the polyphosphoinositide phosphatase Synaptojanin 1 (SynJ1) is critical for this process. We used transgenic markers for trafficking pathways, electron microscopy, and immunocytochemistry to characterize trafficking defects in cones of the zebrafish mutant, nrc(a14), which is deficient in phosphoinositide phosphatase, SynJ1. The outer segments and connecting cilia of nrc(a14) cone photoreceptors are normal, but RibeyeB and VAMP2/synaptobrevin, which normally localize to the synapse, accumulate in the nrc(a14) inner segment. The structure of the Endoplasmic Reticulum in nrc(a14) mutant cones is normal. Golgi develop normally, but later become disordered. Large vesicular structures accumulate within nrc(a14) cone photoreceptor inner segments, particularly after prolonged incubation in darkness. Cone inner segments of nrc(a14) mutants also have enlarged acidic vesicles, abnormal late endosomes, and a disruption in autophagy. This last pathway also appears exacerbated by darkness. Taken altogether, these findings show that SynJ1 is required in cones for normal endolysosomal trafficking of synaptic proteins.	[George, Ashley A.; Hayden, Sara; Holzhausen, Lars C.; Ma, Eva Y.; Brockerhoff, Susan E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Suzuki, Sachihiro C.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brockerhoff, SE (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	sbrocker@uw.edu	Suzuki, Sachihiro/G-5898-2015		NIH [EY015165, RO1 EY14358]; NEI [EY001730]; UW Vision Core; NATIONAL EYE INSTITUTE [P30EY001730, R01EY015165, R01EY014358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); UW Vision Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by NIH grant EY015165 (SEB), RO1 EY14358 (SS) and NEI grant EY001730, which supports the UW Vision Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwardt BA, 2001, J NEUROSCI, V21, P2330, DOI 10.1523/JNEUROSCI.21-07-02330.2001; Arshavsky Vadim Y, 2003, Sci STKE, V2003, pPE43, DOI 10.1126/stke.2003.204.pe43; Bensen ES, 2000, GENETICS, V154, P83; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BROCKERHOFF SE, 1997, J NEUROSCI, V20, P1; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Easter SS, 1996, DEV BIOL, V180, P646; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gong LW, 2008, P NATL ACAD SCI USA, V105, P17561, DOI 10.1073/pnas.0809221105; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Holzhausen LC, 2009, J COMP NEUROL, V517, P633, DOI 10.1002/cne.22176; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Insinna C, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-12; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Kirkbride KC, 2012, CYTOSKELETON, V69, P625, DOI 10.1002/cm.21051; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kolb H, 2003, AM SCI, V91, P28, DOI 10.1511/2003.11.841; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Rajala A, 2009, BIOCHEMISTRY-US, V48, P5563, DOI 10.1021/bi9000062; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; SCHMIED R, 1989, J NEUROBIOL, V20, P115, DOI 10.1002/neu.480200303; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Singer-Kruger B, 1998, J CELL SCI, V111, P3347; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Van Epps HA, 2001, INVEST OPHTH VIS SCI, V42, P868; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	77	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84394	10.1371/journal.pone.0084394	http://dx.doi.org/10.1371/journal.pone.0084394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392132	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100055
J	Sigvardt, ZMS; Olesen, J				Sigvardt, Zandra M. S.; Olesen, Jorgen			Mating Behaviour in Laevicaudatan Clam Shrimp (Crustacea, Branchiopoda) and Functional Morphology of Male Claspers in a Phylogenetic Context: A Video-Based Analysis	PLOS ONE			English	Article							EULIMNADIA-TEXANA CRUSTACEA; MATE-GUARDING BEHAVIOR; CONCHOSTRACA; CLADOCERA; CLASSIFICATION; EVOLUTION; PACKARD	Clam shrimps are freshwater branchiopod crustaceans which often present complicated breeding systems including asexual reproduction (parthenogenesis) and mixed mating systems (in androdioecious species both selfing and outcrossing occurs due to the co-presence of hermaphrodites and males). Reproductive patterns of Spinicaudata, which contains most clam shrimp species, have received much attention. Another group of clam shrimps, Laevicaudata, which holds a key position in branchiopod phylogeny, has practically not been studied. As a part of the mating process, males clasp to the carapace margin of the females with a pair (or two pairs) of anterior trunk limbs modified as claspers. Previous studies have shown that clasper morphology is important in a phylogenetic context, and that some parts of the claspers in Spinicaudata and Laevicaudata may have undergone a remarkable parallel evolution. Here we have used video microscopy to study aspects of the mating behaviour, egg extrusion, and fertilization in Lynceus brachyurus (Laevicaudata). It is shown that fertilization is likely to be external and that the peculiar tri-lobed lateral lamellae of female's hind body assist in guiding the egg mass to the exopodal egg carriers where they are collected by their distal setation. The functional morphology of the male claspers was studied in detail by close-up video recordings. The movable "finger'' of the clasper bends around the female's carapace edge and serves to hold the female during mating. The larger palp grasps around the female carapace margin in a way very similar to the movable "finger'', possibly indirectly providing sensory input on the "finger'' position. A brief comparative study of the claspers of a spinicaudatan clam shrimp showed both similarities and differences to the laevicaudatan claspers. The presence of two pairs of claspers in Spinicaudata seems to give males a better hold of the female which may play a role during extended mate guarding.	[Sigvardt, Zandra M. S.; Olesen, Jorgen] Nat Hist Museum Denmark, Copenhagen, Denmark		Olesen, J (corresponding author), Nat Hist Museum Denmark, Copenhagen, Denmark.	jolesen@snm.ku.dk	Olesen, Jørgen/A-3353-2013	Olesen, Jørgen/0000-0001-9582-7083; Sigvardt, Zandra/0000-0003-0760-7457; Olesen, Jes/0000-0002-6712-2702				Benvenuto C, 2009, CURR SCI INDIA, V96, P130; Benvenuto C, 2012, BEHAV ECOL, V23, P218, DOI 10.1093/beheco/arr178; Benvenuto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P1899, DOI 10.1007/s00265-011-1199-x; Benvenuto C, 2009, BEHAV ECOL, V20, P1125, DOI 10.1093/beheco/arp106; Botnariuc N, 1947, NOTATIONES BIOL, V5, P68; Brendonck L, 2008, HYDROBIOLOGIA, V595, P167, DOI 10.1007/s10750-007-9119-9; Damgaard J, 1998, HYDROBIOLOGIA, V377, P9, DOI 10.1023/A:1003256906580; Eder E, 2000, J CRUSTACEAN BIOL, V20, P657, DOI 10.1651/0278-0372(2000)020[0657:FROLLM]2.0.CO;2; Elmoor-Loureiro Lourdes M.A., 2006, Nauplius, V14, P19; Ferrari FD, 2012, CRUSTACEANA, V85, P359, DOI 10.1163/156854012X624655; Fox CW, 2003, EVOL ECOL RES, V5, P273; Fritsch M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-35; FRYER G, 1987, ZOOL J LINN SOC-LOND, V91, P357, DOI 10.1111/j.1096-3642.1987.tb01420.x; Fryer G, 2009, ZOOL J LINN SOC-LOND, V155, P513, DOI 10.1111/j.1096-3642.2008.00455.x; Garm A, 2004, ZOOL J LINN SOC-LOND, V142, P233, DOI 10.1111/j.1096-3642.2004.00132.x; KNOLL L, 1995, HYDROBIOLOGIA, V298, P73, DOI 10.1007/BF00033801; KNOLL L, 1995, HYDROBIOLOGIA, V298, P67, DOI 10.1007/BF00033800; Linder Folke, 1945, ARKIV ZOOL, V37A, P1; MARTIN JW, 1986, ZOOL SCR, V15, P221, DOI 10.1111/j.1463-6409.1986.tb00224.x; Medland VL, 2000, ETHOLOGY, V106, P839, DOI 10.1046/j.1439-0310.2000.00603.x; Olesen J, 1996, ZOOL SCR, V25, P291, DOI 10.1111/j.1463-6409.1996.tb00168.x; Olesen J, 1998, ZOOL J LINN SOC-LOND, V122, P491, DOI 10.1111/j.1096-3642.1998.tb02161.x; Olesen J, 2000, CRUSTACEANA, V73, P869, DOI 10.1163/156854000504877; Olesen J, 2014, ATLAS CRUST IN PRESS; Olesen J, 2007, J CRUSTACEAN BIOL, V27, P165, DOI 10.1651/S-2727.1; Olesen J, 2013, J CRUSTACEAN BIOL, V33, P62, DOI 10.1163/1937240X-00002121; Olesen Jorgen, 2009, Arthropod Systematics & Phylogeny, V67, P3; Perez-Bote JL, 2010, CRUSTACEANA, V83, P1327, DOI 10.1163/001121610X535690; Richter S, 2007, CLADISTICS, V23, P301, DOI 10.1111/j.1096-0031.2007.00148.x; ROEN U, 1995, DANMARKS FAUNA, V85; Rogers DC, 2012, J CRUSTACEAN BIOL, V32, P827, DOI 10.1163/193724012X637212; Rogers DC, 2002, HYDROBIOLOGIA, V486, P1, DOI 10.1023/A:1021332610805; Schwentner M, 2011, BIOL J LINN SOC, V104, P575, DOI 10.1111/j.1095-8312.2011.01746.x; Scourfield DJ, 1926, PHILOS T R SOC LON B, V214, P153, DOI 10.1098/rstb.1926.0005; Sichlau MH, 2013, ASLO 2013 AQ SCI M 1; STRENTH N E, 1977, Southwestern Naturalist, V22, P205, DOI 10.2307/3669811; Titelman J, 2007, J PLANKTON RES, V29, P1023, DOI 10.1093/plankt/fbm076; Weeks SC, 2004, INVERTEBR BIOL, V123, P146; Weeks SC, 2002, HYDROBIOLOGIA, V486, P289, DOI 10.1023/A:1021379608504; Weeks SC, 2008, ETHOLOGY, V114, P64, DOI 10.1111/j.1439-0310.2007.01446.x; WINGSTRAND K G, 1978, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V22, P1; Yasui Y, 2001, ECOL RES, V16, P605, DOI 10.1046/j.1440-1703.2001.00423.x; Zucker N, 2002, INVERTEBR BIOL, V121, P66	43	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84021	10.1371/journal.pone.0084021	http://dx.doi.org/10.1371/journal.pone.0084021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392104	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100028
J	Chen, Q; Wang, JW; Tian, J; Tang, X; Yu, CQ; Marshall, RJ; Chen, DF; Cao, WH; Zhan, SY; Lv, J; Lee, LM; Hu, YH				Chen, Qing; Wang, Jinwei; Tian, Jun; Tang, Xun; Yu, Canqing; Marshall, Roger J.; Chen, Dafang; Cao, Weihua; Zhan, Siyan; Lv, Jun; Lee, Liming; Hu, Yonghua			Association between Ambient Temperature and Blood Pressure and Blood Pressure Regulators: 1831 Hypertensive Patients Followed Up for Three Years	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; OUTDOOR TEMPERATURE; ALCOHOL-CONSUMPTION; VARIABILITY; COLD; SENSITIVITY; REACTIVITY; PREDICTOR; INHIBITOR; MORTALITY	Several studies have suggested an association between ambient air temperature and blood pressure. However, this has not been reliably confirmed by longitudinal studies. Also, whether the reaction to temperature stimulation is modified by other factors such as antihypertensive medication is rarely investigated. The present study explores the relationship between ambient temperature and blood pressure, without and with antihypertensive medication, in a study of 1,831 hypertensive patients followed up for three years, in two or four weekly check ups, accumulating 62,452 follow-up records. Both baseline and follow-up blood pressure showed an inverse association with ambient temperature, which explained 32.4% and 65.6% of variation of systolic blood pressure and diastolic blood pressure (P < 0.05) respectively. The amplitude of individual blood pressure fluctuation with temperature throughout a year (a 29 degrees centigrade range) was 9.4/7.3 mmHg. Medication with angiotensin converting enzyme inhibitor benazepril attenuated the blood pressure fluctuation by 2.4/1.3 mmHg each year, though the inverse association of temperature and blood pressure remained. Gender, drinking behavior and body mass index were also found to modify the association between temperature and diastolic blood pressure. The results indicate that ambient temperature may negatively regulate blood pressure. Hypertensive patients should monitor and treat blood pressure more carefully in cold days, and it could be especially important for the males, thinner people and drinkers.	[Chen, Qing] Third Mil Med Univ, Coll Prevent Med, Dept Hygien Toxicol, Chongqing, Peoples R China; [Chen, Qing; Wang, Jinwei; Tian, Jun; Tang, Xun; Yu, Canqing; Chen, Dafang; Cao, Weihua; Zhan, Siyan; Lv, Jun; Lee, Liming; Hu, Yonghua] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Marshall, Roger J.] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand	Army Medical University; Peking University; University of Auckland	Hu, YH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	yhhu@bjmu.edu.cn	陈, 卿/Q-5601-2019; Lv, Jun/O-4746-2019; TANG, Xun/L-8375-2013; Chen, Qing/B-5310-2015	陈, 卿/0000-0003-4108-7977; Lv, Jun/0000-0001-7916-3870; TANG, Xun/0000-0002-6990-0168; Chen, Qing/0000-0003-4108-7977; Marshall, Roger/0000-0001-8278-167X	National Key Technologies R&D Program of China for the 9th Five-Year Plan [96-906-02-05]; National Key Technologies R&D Program of China for the 10th Five-Year Plan [2001BAF03B02]; Mega-projects of Science Research for the 11th Five-Year Plan [2006BAI01A03- ( 16)]	National Key Technologies R&D Program of China for the 9th Five-Year Plan; National Key Technologies R&D Program of China for the 10th Five-Year Plan; Mega-projects of Science Research for the 11th Five-Year Plan(National Key Technology R&D Program)	This study has been supported by grants from the National Key Technologies R&D Program of China for the 9th Five-Year Plan (96-906-02-05), National Key Technologies R&D Program of China for the 10th Five-Year Plan (2001BAF03B02), Mega-projects of Science Research for the 11th Five-Year Plan (2006BAI01A03- ( 16)). Website of the funders:http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Aubiniere-Robb L, 2013, HYPERTENSION, V62, P190, DOI 10.1161/HYPERTENSIONAHA.111.00686; Bailey SR, 2005, AM J PHYSIOL-HEART C, V289, pH243, DOI 10.1152/ajpheart.01305.2004; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bortkiewicz Alicja, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P123, DOI 10.2478/v10001-006-0020-y; Dyson KS, 2006, AM J PHYSIOL-HEART C, V290, pH1446, DOI 10.1152/ajpheart.00771.2005; Fiordaliso F, 2006, LIFE SCI, V79, P121, DOI 10.1016/j.lfs.2005.12.036; Flaa A, 2008, HYPERTENSION, V52, P336, DOI 10.1161/HYPERTENSIONAHA.108.111625; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Goodwin J, 2001, AGE AGEING, V30, P311, DOI 10.1093/ageing/30.4.311; Guo YM, 2013, EPIDEMIOLOGY, V24, P471, DOI 10.1097/EDE.0b013e31828c4a5d; Hozawa A, 2011, CLIN EXP HYPERTENS, V33, P153, DOI 10.3109/10641963.2010.531841; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Isezuo S A, 2003, Int J Circumpolar Health, V62, P397; Kent ST, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-7; Kingma BRM, 2011, ACTA PHYSIOL, V203, P419, DOI 10.1111/j.1748-1716.2011.02336.x; Kovacs I, 2006, EUR J HEART FAIL, V8, P451, DOI 10.1016/j.ejheart.2005.10.011; Madsen C, 2006, EUR J EPIDEMIOL, V21, P485, DOI 10.1007/s10654-006-9025-x; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; MARSHALL RJ, 1988, INT J EPIDEMIOL, V17, P325, DOI 10.1093/ije/17.2.325; MCADOO WG, 1990, J HYPERTENS, V8, P961, DOI 10.1097/00004872-199010000-00012; Metoki H, 2008, J HYPERTENS, V26, P2406, DOI 10.1097/HJH.0b013e32831364a7; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; Munakata M, 2003, CLIN EXP HYPERTENS, V25, P169, DOI 10.1081/CEH-120019149; Murakami S, 2011, HYPERTENS RES, V34, P70, DOI 10.1038/hr.2010.176; Onat A, 2008, ALCOHOL, V42, P593, DOI 10.1016/j.alcohol.2008.06.007; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sander D, 1996, NEUROLOGY, V47, P500, DOI 10.1212/WNL.47.2.500; Srivastava R D, 2010, Indian J Physiol Pharmacol, V54, P174; Su XW, 2007, CIRCULATION, V115, P725, DOI 10.1161/CIRCULATIONAHA.106.642058; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Treiber FA, 2003, PSYCHOSOM MED, V65, P46, DOI 10.1097/00006842-200301000-00007; WAGNER JA, 1985, J APPL PHYSIOL, V58, P187, DOI 10.1152/jappl.1985.58.1.187; Welsh AJL, 2008, INT ARCH OCC ENV HEA, V81, P625, DOI 10.1007/s00420-007-0257-1; Xie X, 2012, EUR J PREV CARDIOL, V19, P314, DOI 10.1177/1741826711404501; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524	37	26	29	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84522	10.1371/journal.pone.0084522	http://dx.doi.org/10.1371/journal.pone.0084522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391962	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900105
J	Sato, D; Bers, DM; Shiferaw, Y				Sato, Daisuke; Bers, Donald M.; Shiferaw, Yohannes			Formation of Spatially Discordant Alternans Due to Fluctuations and Diffusion of Calcium	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC ALTERNANS; ELECTRICAL ALTERNANS; SUBCELLULAR ALTERNANS; TRANSIENT ALTERNANS; ARRHYTHMIAS; MECHANISM; HEART; MYOCYTES; TISSUE	Spatially discordant alternans (SDA) of action potential duration (APD) is a phenomenon where different regions of cardiac tissue exhibit an alternating sequence of APD that are out-of-phase. SDA is arrhythmogenic since it can induce spatial heterogeneity of refractoriness, which can cause wavebreak and reentry. However, the underlying mechanisms for the formation of SDA are not completely understood. In this paper, we present a novel mechanism for the formation of SDA in the case where the cellular instability leading to alternans is caused by intracellular calcium (Ca) cycling, and where Ca transient and APD alternans are electromechanically concordant. In particular, we show that SDA is formed when rapidly paced cardiac tissue develops alternans over many beats due to Ca accumulation in the sarcoplasmic reticulum (SR). The mechanism presented here relies on the observation that Ca cycling fluctuations dictate Ca alternans phase since the amplitude of Ca alternans is small during the early stages of pacing. Thus, different regions of a cardiac myocyte will typically develop Ca alternans which are opposite in phase at the early stages of pacing. These subcellular patterns then gradually coarsen due to interactions with membrane voltage to form steady state SDA of voltage and Ca on the tissue scale. This mechanism for SDA is distinct from well-known mechanisms that rely on conduction velocity restitution, and a Turing-like mechanism known to apply only in the case where APD and Ca alternans are electromechanically discordant. Furthermore, we argue that this mechanism is robust, and is likely to underlie a wide range of experimentally observed patterns of SDA.	[Sato, Daisuke; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Shiferaw, Yohannes] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	University of California System; University of California Davis; California State University System; California State University Northridge	Sato, D (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	dsato@ucdavis.edu		Bers, Donald/0000-0002-2237-9483	National Institutes of Health [K99-HL111334, R37-HL30077, R01-HL105242, R01HL101196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101196, R37HL030077, R01HL105242, K99HL111334, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant K99-HL111334 (DS), National Institutes of Health grant R37-HL30077 and R01-HL105242 (DMB), and National Institutes of Health grant R01HL101196 (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 2006, CIRC RES, V99, pE65, DOI 10.1161/01.RES.0000244087.36230.bf; Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Chen W, 2011, AM J PHYSIOL-HEART C, V300, pH1794, DOI 10.1152/ajpheart.01121.2010; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Clusin WT, 2003, CRIT REV CL LAB SCI, V40, P337, DOI 10.1080/713609356; Coote JH, 2010, EXP PHYSIOL, V95, P431, DOI 10.1113/expphysiol.2009.047548; Cordeiro JM, 2007, AM J PHYSIOL-HEART C, V293, pH3506, DOI 10.1152/ajpheart.00757.2007; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Echebarria B, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.208101; Echebarria B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051911; Euler DE, 1999, CARDIOVASC RES, V42, P583, DOI 10.1016/S0008-6363(99)00011-5; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Gaeta SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00157; Gaeta SA, 2009, CIRC RES, V105, P335, DOI 10.1161/CIRCRESAHA.109.197590; Gizzi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00071; Gyorke S, 2009, HEART RHYTHM, V6, P123, DOI 10.1016/j.hrthm.2008.09.013; Hayashi H, 2007, BIOPHYS J, V92, P448, DOI 10.1529/biophysj.106.091009; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Langer GA, 1997, CIRCULATION, V96, P3761; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Murphy CF, 1996, CARDIOVASC RES, V32, P138, DOI 10.1016/S0008-6363(96)00033-8; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Pogwizd SM, 2002, J CARDIOVASC ELECTR, V13, P88, DOI 10.1046/j.1540-8167.2002.00088.x; Qian YW, 2001, CIRCULATION, V104, P2082, DOI 10.1161/hc4201.097136; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; Qu ZL, 1999, IEEE T BIO-MED ENG, V46, P1166, DOI 10.1109/10.784149; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; RUBENSTEIN DS, 1995, CIRCULATION, V91, P201, DOI 10.1161/01.CIR.91.1.201; Sabir IN, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00126; Sato D, 2006, CIRC RES, V99, P520, DOI 10.1161/01.RES.0000240542.03986.e7; Shiferaw Y, 2006, P NATL ACAD SCI USA, V103, P5670, DOI 10.1073/pnas.0511061103; Shiferaw Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021903; Shiferaw Y, 2003, BIOPHYS J, V85, P3666, DOI 10.1016/S0006-3495(03)74784-5; Skardal PS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.108103; Ter Keurs HEDJ, 2006, ANN NY ACAD SCI, V1080, P248, DOI 10.1196/annals.1380.020; Walker ML, 2003, CARDIOVASC RES, V57, P599, DOI 10.1016/S0008-6363(02)00737-X; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x	44	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85365	10.1371/journal.pone.0085365	http://dx.doi.org/10.1371/journal.pone.0085365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392005	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900149
J	Yuan, WJ; Zhou, JF; Zhou, CS				Yuan, Wu-Jie; Zhou, Jian-Fang; Zhou, Changsong			Network Evolution Induced by Asynchronous Stimuli through Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							NEURONAL AVALANCHES; SYNAPTIC PLASTICITY; HUMAN HIPPOCAMPUS; NEURAL-NETWORKS; MECHANISMS; DEPRESSION; SEQUENCES; RECALL	In sensory neural system, external asynchronous stimuli play an important role in perceptual learning, associative memory and map development. However, the organization of structure and dynamics of neural networks induced by external asynchronous stimuli are not well understood. Spike-timing-dependent plasticity (STDP) is a typical synaptic plasticity that has been extensively found in the sensory systems and that has received much theoretical attention. This synaptic plasticity is highly sensitive to correlations between pre-and postsynaptic firings. Thus, STDP is expected to play an important role in response to external asynchronous stimuli, which can induce segregative pre-and postsynaptic firings. In this paper, we study the impact of external asynchronous stimuli on the organization of structure and dynamics of neural networks through STDP. We construct a two-dimensional spatial neural network model with local connectivity and sparseness, and use external currents to stimulate alternately on different spatial layers. The adopted external currents imposed alternately on spatial layers can be here regarded as external asynchronous stimuli. Through extensive numerical simulations, we focus on the effects of stimulus number and inter-stimulus timing on synaptic connecting weights and the property of propagation dynamics in the resulting network structure. Interestingly, the resulting feedforward structure induced by stimulus-dependent asynchronous firings and its propagation dynamics reflect both the underlying property of STDP. The results imply a possible important role of STDP in generating feedforward structure and collective propagation activity required for experience-dependent map plasticity in developing in vivo sensory pathways and cortices. The relevance of the results to cue-triggered recall of learned temporal sequences, an important cognitive function, is briefly discussed as well. Furthermore, this finding suggests a potential application for examining STDP by measuring neural population activity in a cultured neural network.	[Yuan, Wu-Jie; Zhou, Jian-Fang] Huaibei Normal Univ, Coll Phys & Elect Informat, Huaibei, Peoples R China; [Yuan, Wu-Jie; Zhou, Changsong] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Yuan, Wu-Jie; Zhou, Changsong] Hong Kong Baptist Univ, Inst Computat & Theoret Studies, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon Tong, Hong Kong, Peoples R China; [Zhou, Changsong] Beijing Computat Sci Res Ctr, Beijing, Peoples R China; [Zhou, Changsong] HKBU Inst Res & Continuing Educ, Res Ctr, Shenzhen, Peoples R China	Huaibei Normal University; Hong Kong Baptist University; Hong Kong Baptist University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Yuan, WJ (corresponding author), Huaibei Normal Univ, Coll Phys & Elect Informat, Huaibei, Peoples R China.	yuanwj2005@163.com; cszhou@hkbu.edu.hk	Zhou, Changsong/F-4707-2010	Zhou, Changsong/0000-0002-4130-0216	Hong Kong Research Grant Council [HKBU202710]; National Natural Science Foundation of China [11275027, 11005047]; Young University Teacher's Fund of Anhui Provincein China [2008jql071]; Young Fund of Huaibei Normal University [2013xqz17]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young University Teacher's Fund of Anhui Provincein China; Young Fund of Huaibei Normal University	This work is supported by the Hong Kong Research Grant Council No. HKBU202710 (CZ), the National Natural Science Foundation of China under Grant Nos. 11275027 (CZ) and 11005047 (WJY), the Young University Teacher's Fund of Anhui Provincein China under Grant No. 2008jql071 (WJY), and the Young Fund of Huaibei Normal University under Grant No. 2013xqz17 (JFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chance FS, 1998, J NEUROSCI, V18, P4785; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Dayan P., 2001, THEORETICAL NEUROSCI; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Jia L, 2007, INT J MOD PHYS B, V21, P4111; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; MAEDA E, 1995, J NEUROSCI, V15, P6834; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Perc M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/252; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Santos GS, 2010, J NEUROSCI, V30, P8720, DOI 10.1523/JNEUROSCI.6141-09.2010; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Varela JA, 1997, J NEUROSCI, V17, P7926; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yuan WJ, 2007, COMMUN THEOR PHYS, V47, P369; Yuan WJ, 2006, CHINESE PHYS LETT, V23, P3115, DOI 10.1088/0256-307X/23/11/064; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Yuan WJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016116; Zhan X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011907; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007	52	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84644	10.1371/journal.pone.0084644	http://dx.doi.org/10.1371/journal.pone.0084644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391971	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900114
J	Bagnall, J; Leedale, J; Taylor, SE; Spiller, DG; White, MRH; Sharkey, KJ; Bearon, RN; See, V				Bagnall, James; Leedale, Joseph; Taylor, Sarah E.; Spiller, David G.; White, Michael R. H.; Sharkey, Kieran J.; Bearon, Rachel N.; See, Violaine			Tight Control of Hypoxia-inducible Factor-alpha Transient Dynamics Is Essential for Cell Survival in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Hypoxia; Hypoxia-inducible Factor; Imaging; Mathematical Modeling; Negative Feedback Loop; p53; Prolyl Hydroxylase	P53-MDM2 FEEDBACK LOOP; PROLYL HYDROXYLASES; RESPONSIVE ELEMENT; INDIVIDUAL CELLS; GENE-EXPRESSION; OXYGEN SENSOR; HIF-ALPHA; HIF-1-ALPHA; DEGRADATION; FACTOR-1-ALPHA	Background: Hypoxia inducible factor- (HIF-) is the main transcription factor activated in low oxygen conditions. Results: Single cell imaging reveals pulses in nuclear levels of HIF-. Conclusion: The transient nature of the HIF- nuclear accumulation is required to avoid cell death. Significance: The duration of HIF- response depends on cellular oxygenation, and can encode information and dictate cell fate. Intracellular signaling involving hypoxia-inducible factor (HIF) controls the adaptive responses to hypoxia. There is a growing body of evidence demonstrating that intracellular signals encode temporal information. Thus, the dynamics of protein levels, as well as protein quantity and/or localization, impacts on cell fate. We hypothesized that such temporal encoding has a role in HIF signaling and cell fate decisions triggered by hypoxic conditions. Using live cell imaging in a controlled oxygen environment, we observed transient 3-h pulses of HIF-1 and -2 expression under continuous hypoxia. We postulated that the well described prolyl hydroxylase (PHD) oxygen sensors and HIF negative feedback regulators could be the origin of the pulsatile HIF dynamics. We used iterative mathematical modeling and experimental analysis to scrutinize which parameter of the PHD feedback could control HIF timing and we probed for the functional redundancy between the three main PHD proteins. We identified PHD2 as the main PHD responsible for HIF peak duration. We then demonstrated that this has important consequences, because the transient nature of the HIF pulse prevents cell death by avoiding transcription of p53-dependent pro-apoptotic genes. We have further shown the importance of considering HIF dynamics for coupling mathematical models by using a described HIF-p53 mathematical model. Our results indicate that the tight control of HIF transient dynamics has important functional consequences on the cross-talk with key signaling pathways controlling cell survival, which is likely to impact on HIF targeting strategies for hypoxia-associated diseases such as tumor progression and ischemia.	[Bagnall, James; Taylor, Sarah E.; Spiller, David G.; White, Michael R. H.; See, Violaine] Univ Liverpool, Ctr Cell Imaging, Inst Integrat Biol, Liverpool L69 7ZL, Merseyside, England; [Leedale, Joseph; Sharkey, Kieran J.; Bearon, Rachel N.] Univ Liverpool, Dept Math Sci, Liverpool L69 7ZL, Merseyside, England	University of Liverpool; University of Liverpool	Bearon, RN (corresponding author), Univ Liverpool, Peach St, Liverpool L69 7ZL, Merseyside, England.	rbearon@liverpool.ac.uk		Bearon, Rachel/0000-0001-8461-0823; White, Michael/0000-0002-3617-3232; Spiller, David Geoffrey/0000-0003-2502-6787; Bagnall, James/0000-0003-1735-5855; Leedale, Joseph/0000-0001-9010-4126; Sharkey, Kieran/0000-0002-7210-9246	Biotechnology and Biological Sciences Research Council; University of Liverpool; Medical Research Council; BBSRC [BB/F005938/2, BB/F005938/1] Funding Source: UKRI; MRC [MR/K015931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520471/1, BB/F005938/1, BB/F005938/2] Funding Source: researchfish; Medical Research Council [1261183, MR/K015931/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Liverpool; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Recipient of a Biotechnology and Biological Sciences Research Council doctoral training studentship.; Holds University of Liverpool studentship.; Recipient of a Medical Research Council capacity building studentship.	Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blagosklonny MV, 2001, ONCOGENE, V20, P395, DOI 10.1038/sj.onc.1204055; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Grimm C, 2005, SEMIN CELL DEV BIOL, V16, P531, DOI 10.1016/j.semcdb.2005.03.004; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Nguyen LK, 2013, J CELL SCI, V126, P1454, DOI 10.1242/jcs.119974; Pellegrin P, 2002, MOL BIOL CELL, V13, P570, DOI 10.1091/mbc.01-06-0280; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sowter HM, 2001, CANCER RES, V61, P6669; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005	39	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5549	5564		10.1074/jbc.M113.500405	http://dx.doi.org/10.1074/jbc.M113.500405			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394419	Green Published, hybrid			2022-12-25	WOS:000332015500021
J	Runager, K; Bektas, M; Berkowitz, P; Rubenstein, DS				Runager, Kasper; Bektas, Meryem; Berkowitz, Paula; Rubenstein, David S.			Targeting O-Glycosyltransferase (OGT) to Promote Healing of Diabetic Skin Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; O-GlcNAc; siRNA; Skin; Wound Healing	BETA-D-GLUCOSAMINIDASE; GLCNAC; GLUCOSE; STREPTOZOTOCIN; GLYCOSYLATION; EXPRESSION; P135	Background: Increased intracellular protein O-GlcNAc modification may contribute to delayed wound healing in diabetes. Results: Hyperglycemia increases intracellular protein O-GlcNAc modification and delays wound healing in keratinocytes. Targeted knockdown of OGT altered rates of wound closure. Conclusion: OGT knockdown accelerates wound healing under both normal and hyperglycemic culture conditions. Significance: OGT may represent a novel druggable target for promoting healing of diabetic wounds. Non-healing wounds are a significant source of morbidity. This is particularly true for diabetic patients, who tend to develop chronic skin wounds. O-GlcNAc modification of serine and threonine residues is a common regulatory post-translational modification analogous to protein phosphorylation; increased intracellular protein O-GlcNAc modification has been observed in diabetic and hyperglycemic states. Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide -N-acetylglucosaminyl transferase (OGT) and O-GlcNAc-selective N-acetyl--d-glucosaminidase (OGA), mediate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein substrates. Alterations in O-GlcNAc modification of intracellular proteins is linked to diabetes, and the increased levels of protein O-GlcNAc modification observed in diabetic tissues may in part explain some of the observed underlying pathophysiology that contributes to delayed wound healing. We have previously shown that increasing protein O-GlcNAc modification by overexpression of OGT in murine keratinocytes results in elevated protein O-GlcNAc modification and a hyperadhesive phenotype. This study was undertaken to explore the hypothesis that increased O-GlcNAc modification of cellular proteins in diabetic skin could contribute to the delayed wound healing observed in patients with diabetic skin ulcers. In the present study, we show that human keratinocytes cultured under hyperglycemic conditions display increased levels of O-GlcNAc modification as well as a delay in the rate of wound closure in vitro. We further show that specific knockdown of OGT by RNA interference (RNAi) reverses this effect, thereby opening up the opportunity for OGT-targeted therapies to promote wound healing in diabetic patients.	[Runager, Kasper; Bektas, Meryem; Berkowitz, Paula; Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Ste 405 Mary Ellen Jones Bldg CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu		Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health [RO1 AI49427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.). David S. Rubenstein is an inventor on a patent on compositions and methods for targeting OGT and promoting wound healing. Kasper Runager has contributed to the above referenced invention and has a percentage share. Neither licensing agreements nor financial benefit have accrued to either individual.	Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu PQ, 2006, J BIOL CHEM, V281, P12786, DOI 10.1074/jbc.M511702200; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Konrad RJ, 2001, BIOCHEM J, V356, P31, DOI 10.1042/0264-6021:3560031; Konrad RJ, 2001, BIOCHEM BIOPH RES CO, V288, P1136, DOI 10.1006/bbrc.2001.5902; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613	16	9	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5462	5466		10.1074/jbc.M113.513952	http://dx.doi.org/10.1074/jbc.M113.513952			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398691	Green Published, hybrid			2022-12-25	WOS:000332015500010
J	Zhang, Q; Liu, XG; Gao, WQ; Li, PS; Hou, JL; Li, JW; Wong, JM				Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Hou, Jingli; Li, Jiwen; Wong, Jiemin			Differential Regulation of the Ten-Eleven Translocation (TET) Family of Dioxygenases by O-Linked beta-N-Acetylglucosamine Transferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Glucose Metabolism; Histone Modification; O-GlcNAcylation; Protein Export; TET3	ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; MAMMALIAN DNA; PROTEINS; 5-HYDROXYMETHYLCYTOSINE; NUCLEAR; METHYLATION; METHYLTRANSFERASES	Background: TET proteins have been shown to target OGT to chromatin, but whether OGT regulates the TET proteins is not clear. Results: OGT regulates the subcellular localization and enzymatic activity of TET3 but not TET1 and TET2. Conclusion: The TET family of proteins is differentially regulated by OGT. Significance: We reveal a potential mechanism by which glucose metabolism regulates TET3 activity. The ten-eleven translocation (TET) family of dioxygenases (TET1/2/3) converts 5-methylcytosine to 5-hydroxymethylcytosine and provides a vital mechanism for DNA demethylation. However, how TET proteins are regulated is largely unknown. Here we report that the O-linked -GlcNAc (O-GlcNAc) transferase (OGT) is not only a major TET3-interacting protein but also regulates TET3 subcellular localization and enzymatic activity. OGT catalyzes the O-GlcNAcylation of TET3, promotes TET3 nuclear export, and, consequently, inhibits the formation of 5-hydroxymethylcytosine catalyzed by TET3. Although TET1 and TET2 also interact with and can be O-GlcNAcylated by OGT, neither their subcellular localization nor their enzymatic activity are affected by OGT. Furthermore, we show that the nuclear localization and O-GlcNAcylation of TET3 are regulated by glucose metabolism. Our study reveals the differential regulation of TET family proteins by OGT and a novel link between glucose metabolism and DNA epigenetic modification.	[Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Zhang, Qiao; Liu, Xiaoguang; Gao, Wenqi; Li, Pishun; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Hou, Jingli] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200240, Peoples R China	East China Normal University; East China Normal University; Shanghai Jiao Tong University	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn		LIU, XIAOGUANG/0000-0001-6977-5128; Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2010CB944903, 2009CB918402, 2009CB825601]; National Natural Science Foundation of China [90919025, 30871381]; Science Technology Commission of Shanghai Municipality [11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by Ministry of Science and Technology of China Grants 2010CB944903, 2009CB918402, and 2009CB825601); by National Natural Science Foundation of China Grants 90919025 and 30871381, and by Science Technology Commission of Shanghai Municipality Grant 11DZ2260300.	Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiao P, 2013, BIOCHEM BIOPH RES CO, V439, P373, DOI 10.1016/j.bbrc.2013.08.075	33	100	105	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5986	5996		10.1074/jbc.M113.524140	http://dx.doi.org/10.1074/jbc.M113.524140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394411	hybrid, Green Published			2022-12-25	WOS:000332015500054
J	Ye, W; Shen, CH; Lin, YL; Chen, PJ; Xu, XM; Oelmuller, R; Yeh, KW; Lai, ZX				Ye, Wei; Shen, Chin-Hui; Lin, Yuling; Chen, Peng-Jen; Xu, Xuming; Oelmueller, Ralf; Yeh, Kai-Wun; Lai, Zhongxiong			Growth Promotion-Related miRNAs in Oncidium Orchid Roots Colonized by the Endophytic Fungus Piriformospora indica	PLOS ONE			English	Article							SMALL RNAS; TRANSCRIPTION FACTOR; ARABIDOPSIS ROOTS; GOWER RAMSEY; BOX GENES; ENDOPLASMIC-RETICULUM; MERISTEM FORMATION; INNATE IMMUNITY; PLANT-GROWTH; EXPRESSION	Piriformospora indica, an endophytic fungus of Sebacinales, colonizes the roots of a wide range of host plants and establishes various benefits for the plants. In this work, we describe miRNAs which are upregulated in Oncidium orchid roots after colonization by the fungus. Growth promotion and vigorous root development were observed in Oncidium hybrid orchid, while seedlings were colonized by P. indica. We performed a genome-wide expression profiling of small RNAs in Oncidium orchid roots either colonized or not-colonized by P. indica. After sequencing, 24,570,250 and 24744,141 clean reads were obtained from two libraries. 13,736 from 17,036,953 unique sequences showed homology to either 86 miRNA families described in 41 plant species, or to 46 potential novel miRNAs, or to 51 corresponding miRNA precursors. The predicted target genes of these miRNAs are mainly involved in auxin signal perception and transduction, transcription, development and plant defense. The expression analysis of miRNAs and target genes demonstrated the regulatory functions they may participate in. This study revealed that growth stimulation of the Oncidium orchid after colonization by P. indica includes an intricate network of miRNAs and their targets. The symbiotic function of P. indica on Oncidium orchid resembles previous findings on Chinese cabbage. This is the first study on growth regulation and development of Oncidium orchid by miRNAs induced by the symbiotic fungus P. indica.	[Ye, Wei; Lin, Yuling; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China; [Shen, Chin-Hui; Chen, Peng-Jen; Yeh, Kai-Wun] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Ye, Wei; Xu, Xuming] Sanming Acad Agr Sci, Sanming, Fujian, Peoples R China; [Shen, Chin-Hui] Ind Technol Res Inst, Green Energy & Ecotechnol Syst Ctr, Ecol Mat Technol Dept, Tainan, Taiwan; [Oelmueller, Ralf] Univ Jena, Dept Gen Bot & Plant Physiol, Jena, Germany	Fujian Agriculture & Forestry University; National Taiwan University; Industrial Technology Research Institute - Taiwan; Friedrich Schiller University of Jena	Yeh, KW (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan.	ykwbppp@ntu.edu.tw; laizx01@163.com	Ye, Wei/AAR-3837-2021	Ye, Wei/0000-0002-4647-6552	National Science Council [NSC -101-2324-B-002-023-CC2]; National Natural Science Foundation of China [31078717, 31272149, 31201614]; Doctoral Program of Higher Education of the Chinese Ministry of Education [20093515110005, 20123515120008]; Fujian Provincial Natural Science Foundation of China [2012J05042]; NSC, Taiwan; DAAD, Germany; Fujian Provincial Science and Technology Platform Construction Project [2008N2001]	National Science Council(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of the Chinese Ministry of Education; Fujian Provincial Natural Science Foundation of China; NSC, Taiwan(Ministry of Science and Technology, Taiwan); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); Fujian Provincial Science and Technology Platform Construction Project	The work is supported by the fund of National Science Council under the project NSC -101-2324-B-002-023-CC2 to Dr. Kai-Wun Yeh. This work was also funded by the National Natural Science Foundation of China (31078717, 31272149, and 31201614), the Doctoral Program of Higher Education of the Chinese Ministry of Education (20093515110005 and 20123515120008), and Fujian Provincial Natural Science Foundation of China (2012J05042). The authors are also grateful to the support of PPP project, 2013 from both NSC, Taiwan and DAAD, Germany. This work was also funded by the Fujian Provincial Science and Technology Platform Construction Project (2008N2001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Alcantara S, 2006, ANN BOT-LONDON, V98, P1207, DOI 10.1093/aob/mcl202; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Branscheid A, 2010, MOL PLANT MICROBE IN, V23, P915, DOI 10.1094/MPMI-23-7-0915; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Camehl I, 2010, PLANT SIGNAL BEHAV, V5, P932, DOI 10.4161/psb.5.8.12036; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chiou CY, 2008, BIOTECHNOL LETT, V30, P1861, DOI 10.1007/s10529-008-9767-5; Chiou CY, 2008, PLANT MOL BIOL, V66, P379, DOI 10.1007/s11103-007-9275-3; Chiou CY, 2010, PLANTA, V232, P937, DOI 10.1007/s00425-010-1222-x; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Guilfoyle TJ, 1998, CELL MOL LIFE SCI, V54, P619, DOI 10.1007/s000180050190; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Hajdarpasic A, 2012, BOSNIAN J BASIC MED, V12, P169, DOI 10.17305/bjbms.2012.2471; Hou CJ, 2009, PLANT CELL PHYSIOL, V50, P1544, DOI 10.1093/pcp/pcp099; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Khan G, 2011, PLANT MOL BIOL, V77, P1573; Khatabi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035502; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li X, 2005, COMPUT BIOL CHEM, V29, P360, DOI 10.1016/j.compbiolchem.2005.08.005; Liau CH, 2003, TRANSGENIC RES, V12, P329, DOI 10.1023/A:1023343620729; Ling LZ, 2012, GENETICA, V140, P317, DOI 10.1007/s10709-012-9684-3; Liu XJ, 2012, PLANTA, V236, P401, DOI 10.1007/s00425-012-1616-z; Luo Mao, 2011, Yichuan, V33, P1203, DOI 10.3724/SP.J.1005.2011.01203; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Qiang X, 2012, MOL PLANT PATHOL, V13, P508, DOI 10.1111/j.1364-3703.2011.00764.x; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Ramakrishna W, 2002, PLANT CELL, V14, P3213, DOI 10.1105/tpc.006338; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Schafer P, 2009, PLANT RELATIONSHIPS, V5, P99; Senthilkumar S, 2000, CURR SCI INDIA, V79, P1527; Sherameti I, 2005, J BIOL CHEM, V280, P26241, DOI 10.1074/jbc.M500447200; Simon SA, 2009, PLANT PHYSIOL, V151, P1002, DOI 10.1104/pp.109.144345; Singer RB, 2003, J PLANT RES, V116, P19, DOI 10.1007/s10265-002-0064-4; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Tang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-28; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang CY, 2008, PLANTA, V227, P1063, DOI 10.1007/s00425-007-0681-1; Wang CY, 2011, BIOCHEM BIOPH RES CO, V409, P363, DOI 10.1016/j.bbrc.2011.04.123; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; You SJ, 2003, PLANTA, V217, P60, DOI 10.1007/s00425-002-0970-7; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang ZH, 2012, CURR OPIN PLANT BIOL, V15, P652, DOI 10.1016/j.pbi.2012.05.007; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	88	36	44	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84920	10.1371/journal.pone.0084920	http://dx.doi.org/10.1371/journal.pone.0084920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409313	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500037
J	Boyle, DL; Hammaker, D; Edgar, M; Zaiss, MM; Teufel, S; David, JP; Schett, G; Firestein, GS				Boyle, David L.; Hammaker, Deepa; Edgar, Meghan; Zaiss, Mario M.; Teufel, Stefan; David, Jean Pierre; Schett, Georg; Firestein, Gary S.			Differential Roles of MAPK Kinases MKK3 and MKK6 in Osteoclastogenesis and Bone Loss	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; COLLAGEN-INDUCED ARTHRITIS; GENE-EXPRESSION; ESTROGEN DEFICIENCY; SIGNALING PATHWAY; P38 MAPK; FAS LIGAND; OSTEOPOROSIS; DESTRUCTION	Bone mass is maintained by osteoclasts that resorb bone and osteoblasts that promote matrix deposition and mineralization. Bone homeostasis is altered in chronic inflammation as well as in post-menopausal loss of estrogen, which favors osteoclast activity that leads to osteoporosis. The MAPK p38 alpha is a key regulator of bone loss and p38 inhibitors preserve bone mass by inhibiting osteoclastogenesis. p38 function is regulated by two upstream MAPK kinases, namely MKK3 and MKK6. The goal of this study was to assess the effect of MKK3- or MKK6-deficiency on osteoclastogenesis in vitro and on bone loss in ovariectomy-induced osteoporosis in mice. We demonstrated that MKK3 but not MKK6, regulates osteoclast differentiation from bone marrow cells in vitro. Expression of NFATc1, a master transcription factor in osteoclastogenesis, is decreased in cells lacking MKK3 but not MKK6. Expression of osteoclast-specific genes Cathepsin K, osteoclast-associated receptor and MMP9, was inhibited in MKK3-/- cells. The effect of MKK-deficiency on ovariectomy-induced bone loss was then evaluated in female WT, MKK3-/- and MKK6-/- mice by micro-CT analysis. Bone loss was partially inhibited in MKK3-/- as well as MKK6-/- mice, despite normal osteoclastogenesis in MKK6-/- cells. This correlated with the lower osteoclast numbers in the MKK-deficient ovariectomized mice. These studies suggest that MKK3 and MKK6 differentially regulate bone loss due to estrogen withdrawal. MKK3 directly mediates osteoclastogenesis while MKK6 likely contributes to pro-inflammatory cytokine production that promotes osteoclast formation.	[Boyle, David L.; Hammaker, Deepa; Edgar, Meghan; Firestein, Gary S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zaiss, Mario M.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Teufel, Stefan; David, Jean Pierre] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany	University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg	Hammaker, D (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	dhammaker@ucsd.edu		zaiss, mario/0000-0003-3844-1664	NIH [AI-070555, AI-067752]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070555, R01AI067752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the NIH grants AI-070555 and AI-067752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; Bolon B, 2001, MOL THER, V3, P197, DOI 10.1006/mthe.2001.0245; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; David JP, 2010, CURR DIR AUTOIMMUN, V11, P135, DOI 10.1159/000289202; Faienza MF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/575936; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Inoue T, 2006, P NATL ACAD SCI USA, V103, P5484, DOI 10.1073/pnas.0509188103; Inoue T, 2005, J IMMUNOL, V174, P4301, DOI 10.4049/jimmunol.174.7.4301; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Krum SA, 2008, CELL CYCLE, V7, P1348, DOI 10.4161/cc.7.10.5892; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Medicherla S, 2006, J PHARMACOL EXP THER, V318, P132, DOI 10.1124/jpet.105.098020; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; PASSERI G, 1993, ENDOCRINOLOGY, V133, P822, DOI 10.1210/en.133.2.822; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shibata T, 2002, J BONE MINER RES, V17, P622, DOI 10.1359/jbmr.2002.17.4.622; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Srivastava S, 1998, J CLIN INVEST, V102, P1850, DOI 10.1172/JCI4561; Strait K, 2008, INT J MOL MED, V21, P521; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tokuda H, 2004, J CELL BIOCHEM, V91, P1053, DOI 10.1002/jcb.20004; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yoshizawa T, 2009, J IMMUNOL, V183, P1360, DOI 10.4049/jimmunol.0900483; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626	44	17	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84818	10.1371/journal.pone.0084818	http://dx.doi.org/10.1371/journal.pone.0084818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400116	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700050
J	Hinrichsen, I; Kemp, M; Peveling-Oberhag, J; Passmann, S; Plotz, G; Zeuzem, S; Brieger, A				Hinrichsen, Inga; Kemp, Matthias; Peveling-Oberhag, Jan; Passmann, Sandra; Plotz, Guido; Zeuzem, Stefan; Brieger, Angela			Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon of Advanced-Stage HCCs	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; CORE-PROTEIN; COLORECTAL-CANCER; EXPRESSION; HMSH2; GENES; HMLH1; PATHOGENESIS; MUTATIONS	Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hepatocellular carcinoma (HCC) specific protein silencing was previously demonstrated to be associated with the Hepatitis C virus (HCV). However, the proposed HCV dependent promoter methylation of DNA mismatch repair (MMR) genes and thereby enhanced progression of hepatocarcinogenesis has been the subject of controversial discussion. We investigated promoter methylation pattern of the MMR genes MLH1, MSH2 and PMS2 as well as the cyclin-dependent kinase inhibitor 2A gene (p16) in 61 well characterized patients with HCCs associated with HCV, Hepatitis B virus infection or alcoholic liver disease. DNA was isolated from formalin-fixed, paraffin-embedded tumour and non-tumour adjacent tissue and analysed by methylation-specific PCR. Moreover, microsatellite analysis was performed in tissues showing methylation in MMR gene promoters. Our data demonstrated that promoter methylation of MLH1, MSH2, PMS2 and p16 is present among all considered HCCs. Hereby, promoter silencing was detectable more frequently in advanced-stage HCCs than in low-stage ones. However, there was no significant correlation between aberrant DNA methylation of MMR genes or p16 and HCV infection in related HCC specimens. In summary, we show that promoter methylation of essential MMR genes and p16 is detectable in HCCs most dominantly in pT3 stage tumour cases. Since loss of MMR proteins was previously described to be not only responsible for tumour development but also for chemotherapy resistance, the knowledge of mechanisms jointly responsible for HCC progression might enable significant improvement of individual HCC therapy in the future.	[Hinrichsen, Inga; Kemp, Matthias; Peveling-Oberhag, Jan; Passmann, Sandra; Plotz, Guido; Zeuzem, Stefan; Brieger, Angela] Goethe Univ, Biomed Res Lab, Med Clin 1, Frankfurt, Germany	Goethe University Frankfurt	Brieger, A (corresponding author), Goethe Univ, Biomed Res Lab, Med Clin 1, Frankfurt, Germany.	a.brieger@em.uni-frankfurt.de	Plotz, Guido/K-8446-2012; Zeuzem, Stefan/AAE-7435-2019	Plotz, Guido/0000-0001-5314-9739	Deutsche Krebsstiftung [109651]; Goethe-University Frankfurt	Deutsche Krebsstiftung; Goethe-University Frankfurt	This work was supported by grant 109651 of the Deutsche Krebsstiftung and institutional funds (estate of Maria Christine Held und Erika Hecker) of the Goethe-University Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman N, 2001, J EGYPTIAN NAT CANC, V13, P129; Ahmed R, 2010, MED SCI MONITOR, V16, pCR410; Arora P, 2008, CANCER LETT, V261, P244, DOI 10.1016/j.canlet.2007.11.033; Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Fang JY, 2006, CANCER LETT, V233, P124, DOI 10.1016/j.canlet.2005.03.005; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Helal TEA, 2010, APMIS, V118, P934, DOI 10.1111/j.1600-0463.2010.02658.x; ISHAK KG, 1994, HISTOLOGICAL TYPING; Kaneto H, 2001, GUT, V48, P372, DOI 10.1136/gut.48.3.372; Kondoh N, 2001, INT J ONCOL, V18, P1271; Li ZQ, 2012, CELL BIOL INT, V36, P427, DOI 10.1042/CBI20100851; Lim JS, 2012, CANCER LETT, V321, P154, DOI 10.1016/j.canlet.2012.01.044; LIU B, 1994, CANCER RES, V54, P4590; Matsukura S, 2003, BRIT J CANCER, V88, P521, DOI 10.1038/sj.bjc.6600743; Moradpour D, 2000, ZBL CHIR, V125, P592; Neumann O, 2012, HEPATOLOGY, V56, P1817, DOI 10.1002/hep.25870; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; PARSONS R, 1995, CANCER RES, V55, P5548; Pedroni M, 2007, DIS MARKERS, V23, P179, DOI 10.1155/2007/703129; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wang LN, 2001, INT J ONCOL, V19, P567; Wang XW, 2002, TOXICOLOGY, V181, P43, DOI 10.1016/S0300-483X(02)00253-6; Wani Y, 2001, ACTA MED OKAYAMA, V55, P65; Zekri ARN, 2005, WORLD J GASTROENTERO, V11, P3020, DOI 10.3748/wjg.v11.i20.3020; Zhang Cui-juan, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P433	28	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84453	10.1371/journal.pone.0084453	http://dx.doi.org/10.1371/journal.pone.0084453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400091	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700025
J	Mayr, A; Schmid, M				Mayr, Andreas; Schmid, Matthias			Boosting the Concordance Index for Survival Data - A Unified Framework To Derive and Evaluate Biomarker Combinations	PLOS ONE			English	Article							COX REGRESSION; SELECTION; CANCER; MODEL; DISCRIMINATION; CLASSIFICATION; PREDICTION; MARKERS	The development of molecular signatures for the prediction of time-to-event outcomes is a methodologically challenging task in bioinformatics and biostatistics. Although there are numerous approaches for the derivation of marker combinations and their evaluation, the underlying methodology often suffers from the problem that different optimization criteria are mixed during the feature selection, estimation and evaluation steps. This might result in marker combinations that are suboptimal regarding the evaluation criterion of interest. To address this issue, we propose a unified framework to derive and evaluate biomarker combinations. Our approach is based on the concordance index for time-to-event data, which is a non-parametric measure to quantify the discriminatory power of a prediction rule. Specifically, we propose a gradient boosting algorithm that results in linear biomarker combinations that are optimal with respect to a smoothed version of the concordance index. We investigate the performance of our algorithm in a large-scale simulation study and in two molecular data sets for the prediction of survival in breast cancer patients. Our numerical results show that the new approach is not only methodologically sound but can also lead to a higher discriminatory power than traditional approaches for the derivation of gene signatures.	[Mayr, Andreas] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany; [Schmid, Matthias] Univ Munich, Dept Stat, Munich, Germany	University of Erlangen Nuremberg; University of Munich	Mayr, A (corresponding author), Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany.	andreas.mayr@fau.de		Mayr, Andreas/0000-0001-7106-9732; Schmid, Matthias/0000-0002-0788-0317	Deutsche Forschungsgemeinschaft (DFG) [SCHM 2966/1-1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg	The work of Andreas Mayr and Matthias Schmid was supported by Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de), grant SCHM 2966/1-1. The authors further acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PUBMED; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Buhlmann P, 2006, ANN STAT, V34, P559, DOI 10.1214/009053606000000092; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goeman J., 2012, PENALIZED L1 LASSO F; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hothorn T, 2013, MBOOST MODEL BASED B; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Kaderali L, 2006, BIOINFORMATICS, V22, P1495, DOI 10.1093/bioinformatics/btl103; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Lecocke M, 2006, CANCER INFORM, V2, P313; Li H., 2002, PACIFIC S BIOCOMPUTI, V8, P65; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2011, BRIEF BIOINFORM, V12, P33, DOI 10.1093/bib/bbq069; Mayr A, 2012, METHOD INFORM MED, V51, P178, DOI 10.3414/ME11-02-0030; Mayr A, 2012, J R STAT SOC C-APPL, V61, P403, DOI 10.1111/j.1467-9876.2011.01033.x; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2008, LIFETIME DATA ANAL, V14, P86, DOI 10.1007/s10985-007-9073-x; Potapov S, 2012, SURVAUC ESTIMATORS P; R Core Team, 2013, R LANG ENV STAT COMP; Schmid M, 2013, BRIEFINGS BIOINFORMA; Schmid M, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1792; Schmid M, 2012, STAT MED, V31, P2588, DOI 10.1002/sim.5464; Schmid M, 2008, COMPUT STAT DATA AN, V53, P298, DOI 10.1016/j.csda.2008.09.009; Schmid M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-269; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van der Laan M. J., 2003, SPR S STAT; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZF, 2011, BIOSTATISTICS, V12, P369, DOI 10.1093/biostatistics/kxq052; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Witten DM, 2010, STAT METHODS MED RES, V19, P29, DOI 10.1177/0962280209105024; Zhang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057830; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	46	55	55	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84483	10.1371/journal.pone.0084483	http://dx.doi.org/10.1371/journal.pone.0084483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400093	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700027
J	Ballesteros, CI; Galvao, BD; Maisonette, S; Landeira-Fernandez, J				Ballesteros, Carolina Irurita; Galvao, Bruno de Oliveira; Maisonette, Silvia; Landeira-Fernandez, J.			Effect of Dorsal and Ventral Hippocampal Lesions on Contextual Fear Conditioning and Unconditioned Defensive Behavior Induced by Electrical Stimulation of the Dorsal Periaqueductal Gray	PLOS ONE			English	Article							DIFFERENTIAL CONTRIBUTIONS; ENTORHINAL CORTEX; RATS; AMYGDALA; ANXIETY; PROJECTIONS; EXPRESSION; MIDLINE; NUCLEI; MAZE	The dorsal (DH) and ventral (VH) subregions of the hippocampus are involved in contextual fear conditioning. However, it is still unknown whether these two brain areas also play a role in defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray (dPAG). In the present study, rats were implanted with electrodes into the dPAG to determine freezing and escape response thresholds after sham or bilateral electrolytic lesions of the DH or VH. The duration of freezing behavior that outlasted electrical stimulation of the dPAG was also measured. The next day, these animals were subjected to contextual fear conditioning using footshock as an unconditioned stimulus. Electrolytic lesions of the DH and VH impaired contextual fear conditioning. Only VH lesions disrupted conditioned freezing immediately after footshock and increased the thresholds of aversive freezing and escape responses to dPAG electrical stimulation. Neither DH nor VH lesions disrupted post-dPAG stimulation freezing. These results indicate that the VH but not DH plays an important role in aversively defensive behavior induced by dPAG electrical stimulation. Interpretations of these findings should be made with caution because of the fact that a non-fiber-sparing lesion method was employed.	[Ballesteros, Carolina Irurita; Galvao, Bruno de Oliveira; Maisonette, Silvia; Landeira-Fernandez, J.] Pontificia Univ Catolica Rio de Janeiro, Dept Psicol, Rio De Janeiro, RJ, Brazil		Landeira-Fernandez, J (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Psicol, Rio De Janeiro, RJ, Brazil.	landeira@puc-rio.br	Landeira-Fernandez, J./F-6818-2012	Landeira-Fernandez, J./0000-0002-8395-8008	Brazilian National Research Council (CNPq); CNPq	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	SM and JLF were supported by grants from the Brazilian National Research Council (CNPq). BOG was supported by graduate student fellowships from CNPq, and CIB was an international student from Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bland BH, 1998, NEUROSCI BIOBEHAV R, V22, P259, DOI 10.1016/S0149-7634(97)00013-4; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; BRANDAO ML, 1982, PHARMACOL BIOCHEM BE, V16, P397, DOI 10.1016/0091-3057(82)90441-5; Carvalho MC, 2008, PEPTIDES, V29, P1191, DOI 10.1016/j.peptides.2008.02.014; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Kenny PJ, 2000, NEUROPHARMACOLOGY, V39, P300, DOI 10.1016/S0028-3908(99)00114-8; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; KOHLER C, 1985, NEUROSCIENCE, V16, P85, DOI 10.1016/0306-4522(85)90049-1; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Landeira-Fernandez J, 1999, BEHAV NEUROSCI, V113, P1049; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Martinez RCR, 2006, NEUROBIOL LEARN MEM, V85, P58, DOI 10.1016/j.nlm.2005.08.007; McEown K, 2009, BRAIN RES, V1251, P185, DOI 10.1016/j.brainres.2008.11.041; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Oliveira LC, 2004, NEUROREPORT, V15, P2281, DOI 10.1097/00001756-200410050-00028; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rogers JL, 2006, NEUROBIOL LEARN MEM, V86, P72, DOI 10.1016/j.nlm.2006.01.002; Ruiz-Martinez RC, 2006, NEUROBIOL LEARN MEM, V85, P58; RUTH RE, 1982, J COMP NEUROL, V209, P69, DOI 10.1002/cne.902090107; Spolidorio PCM, 2007, PSYCHOPHARMACOLOGY, V195, P183, DOI 10.1007/s00213-007-0890-0; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vianna DML, 2001, LEARN MEMORY, V8, P164, DOI 10.1101/lm.36101; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006	35	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83342	10.1371/journal.pone.0083342	http://dx.doi.org/10.1371/journal.pone.0083342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404134	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800013
J	Sheng, K; Fang, WD; Su, ML; Li, R; Zou, DZ; Han, Y; Wang, XF; Cheng, OM				Sheng, Ke; Fang, Weidong; Su, Meilan; Li, Rong; Zou, Dezhi; Han, Yu; Wang, Xuefeng; Cheng, Oumei			Altered Spontaneous Brain Activity in Patients with Parkinson's Disease Accompanied by Depressive Symptoms, as Revealed by Regional Homogeneity and Functional Connectivity in the Prefrontal-Limbic System	PLOS ONE			English	Article							RESTING-STATE; TREATMENT-RESISTANT; MOTOR CORTEX; RISK-FACTORS; EMOTION; ATTENTION; BIPOLAR; FLUCTUATIONS; PERCEPTION; INHIBITION	As patients with Parkinson's disease (PD) are at high risk for comorbid depression, it is hypothesized that these two diseases are sharing common pathogenic pathways. Using regional homogeneity (ReHo) and functional connectivity approaches, we characterized human regional brain activity at resting state to examine specific brain networks in patients with PD and those with PD and depression (PDD). This study comprised 41 PD human patients and 25 normal human subjects. The patients completed the Hamilton Depression Rating Scale and were further divided into two groups: patients with depressive symptoms and non-depressed PD patients (nD-PD). Compared with the non-depressed patients, those with depressive symptoms exhibited significantly increased regional activity in the left middle frontal gyrus and right inferior frontal gyrus, and decreased ReHo in the left amygdala and bilateral lingual gyrus. Brain network connectivity analysis revealed decreased functional connectivity within the prefrontal-limbic system and increased functional connectivity in the prefrontal cortex and lingual gyrus in PDD compared with the nD-PD group. In summary, the findings showed regional brain activity alterations and disruption of the mood regulation network in PDD patients. The pathogenesis of PDD may be attributed to abnormal neural activity in multiple brain regions.	[Sheng, Ke; Su, Meilan; Li, Rong; Zou, Dezhi; Han, Yu; Wang, Xuefeng; Cheng, Oumei] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Fang, Weidong] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cheng, OM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	chengoumei@gmail.com			National Natural Science Foundation of China [81100981]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Natural Science Foundation Project of Chongqing (CSTC) [2010BB5110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This research was supported by the National Natural Science Foundation of China (No. 81100981), The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, Natural Science Foundation Project of Chongqing (CSTC, 2010BB5110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Benuzzi F, 2009, MAGN RESON IMAGING, V27, P1088, DOI 10.1016/j.mri.2009.05.037; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Carballedo A, 2011, J AFFECT DISORDERS, V134, P272, DOI 10.1016/j.jad.2011.06.021; Cardoso EF, 2009, NEUROIMAGE, V47, P467, DOI 10.1016/j.neuroimage.2009.04.059; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; D'Andrea JNA, 2013, NEUROPSYCHOLOGIA, V51, P1195, DOI 10.1016/j.neuropsychologia.2013.04.003; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; De Smet HJ, 2013, BRAIN LANG, V17, P00201; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Ehrt U, 2006, INT J GERIATR PSYCH, V21, P252, DOI 10.1002/gps.1456; Feldmann A, 2008, MOVEMENT DISORD, V23, P42, DOI 10.1002/mds.21765; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gmitrowicz A, 1994, Psychiatr Pol, V28, P509; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kostic VS, 2010, NEUROLOGY, V75, P857, DOI 10.1212/WNL.0b013e3181f11c1d; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Lindeman S, 2000, ACTA PSYCHIAT SCAND, V102, P178, DOI 10.1034/j.1600-0447.2000.102003178.x; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Machizawa MG, 2010, J NEUROPHYSIOL, V103, P1569, DOI 10.1152/jn.90937.2008; Matsui H, 2007, J NEUROL, V254, P1170, DOI 10.1007/s00415-006-0236-6; Meppelink AM, 2009, BRAIN, V132, P2980, DOI 10.1093/brain/awp223; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Murray JB, 1996, J PSYCHOL, V130, P659, DOI 10.1080/00223980.1996.9915039; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAJPUT DR, 1993, J NEUROL NEUROSUR PS, V56, P938, DOI 10.1136/jnnp.56.8.938; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; RING HA, 1994, BRIT J PSYCHIAT, V165, P333, DOI 10.1192/bjp.165.3.333; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; SANTAMARIA J, 1986, NEUROLOGY, V36, P1130, DOI 10.1212/WNL.36.8.1130; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schoevers RA, 2000, J AFFECT DISORDERS, V59, P127, DOI 10.1016/S0165-0327(99)00124-X; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; STARKSTEIN SE, 1990, J NERV MENT DIS, V178, P27, DOI 10.1097/00005053-199001000-00005; Suslow T, 2012, PSYCHIAT RES, V3, P00245; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vohn R, 2007, HUM BRAIN MAPP, V28, P1267, DOI 10.1002/hbm.20350; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	84	66	69	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84705	10.1371/journal.pone.0084705	http://dx.doi.org/10.1371/journal.pone.0084705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404185	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800064
J	Navarro-Gonzalez, I; Perez-Sanchez, H; Martin-Pozuelo, G; Garcia-Alonso, J; Periago, MJ				Navarro-Gonzalez, Inmaculada; Perez-Sanchez, Horacio; Martin-Pozuelo, Gala; Garcia-Alonso, Javier; Jesus Periago, Maria			The Inhibitory Effects of Bioactive Compounds of Tomato Juice Binding to Hepatic HMGCR: In Vivo Study and Molecular Modelling	PLOS ONE			English	Article							COENZYME-A REDUCTASE; CHLOROGENIC ACID; COA REDUCTASE; VITAMIN-C; LYCOPENE; METABOLISM; PRODUCTS; BIOAVAILABILITY; CAROTENOIDS; NARINGENIN	The hypocholesterolemic effect of tomato juice has been investigated in an intervention study with rats, along with the possible inhibition effect of bioactive tomato compounds binding to the HMGCR enzyme. Two experimental groups (n = 8 Sprague-Dawley rats) were fed ad libitum for five weeks, with water or tomato juice provided to the control and intervention groups, respectively. Total, LDL and HDL cholesterol, and total triglycerides were analysed in plasma, and the lycopene content and the expression and activity of the enzyme HMGCR were determined in liver samples. A computational molecular modelling was carried out to determine the interactions between HMGCR and lycopene, chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were significantly lower in the intervention group after the intake of tomato juice. In addition, a significant reduction in HMGCR activity was observed, although this was not accompanied by changes in gene expression. The molecular modelling showed that components of tomato can bind to the active site of the enzyme and compete with the ligand HMGCoA. Lycopene, from tomato juice, accumulates in the liver and can inhibit the activity of the rate-limiting enzyme of cholesterol biosynthesis, HMGCR.	[Navarro-Gonzalez, Inmaculada; Martin-Pozuelo, Gala; Garcia-Alonso, Javier; Jesus Periago, Maria] Univ Murcia, Fac Vet Sci, Dept Food Sci & Nutr, Murcia, Spain; [Perez-Sanchez, Horacio] Catholic Univ Murcia UCAM, Dept Comp Sci, Murcia, Spain	University of Murcia; Universidad Catolica de Murcia	Navarro-Gonzalez, I (corresponding author), Univ Murcia, Fac Vet Sci, Dept Food Sci & Nutr, Campus Espinardo Reg Campus Int Excellence Campus, Murcia, Spain.	inmaculada.navarro@um.es; horacio@ucam.edu	Pérez-Sánchez, Horacio/O-5017-2016; Periago, María Jesús/K-5251-2017	Pérez-Sánchez, Horacio/0000-0003-4468-7898; 	projects MINECO (Spanish)/FEDER-EU [BIO2012-38103]; CONSOLIDER Fun-C-Food CSD; Research Regional Agency Fundacion Seneca (Murcia, Spain) [12031/PI/09]; Murcia University	projects MINECO (Spanish)/FEDER-EU; CONSOLIDER Fun-C-Food CSD; Research Regional Agency Fundacion Seneca (Murcia, Spain); Murcia University	This research was supported by the projects MINECO (Spanish)/FEDER-EU BIO2012-38103 and CONSOLIDER Fun-C-Food CSD2007, and by the Research Regional Agency Fundacion Seneca (Murcia, Spain) project 12031/PI/09. GMP acknowledges a PhD fellowship from Murcia University. The authors also thank Zumos Hesperia Filab and Juver Alimentacion (Cabezo de Torres, Murcia, Spain) for providing the tomato juice samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab L, 2000, AM J CLIN NUTR, V71, p1691S, DOI 10.1093/ajcn/71.6.1691S; BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; BILHEIMER DW, 1989, P NATL ACAD SCI USA, V80, P4142; Bohm V, 2001, J SEP SCI, V24, P955, DOI 10.1002/1615-9314(20011201)24:12&lt;955::AID-JSSC955&gt;3.0.CO;2-; BROWN MS, 1980, J LIPID RES, V21, P505; Chen ZY, 2008, J AGR FOOD CHEM, V56, P8761, DOI 10.1021/jf801566r; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Frohlich K, 2007, INT J VITAM NUTR RES, V77, P369, DOI 10.1024/0300-9831.77.6.369; Fuhrman B, 1997, BIOCHEM BIOPH RES CO, V233, P658, DOI 10.1006/bbrc.1997.6520; Garcia-Alonso FJ, 2012, EUR J NUTR, V51, P415, DOI 10.1007/s00394-011-0225-0; Garcia-Valverde V, 2013, FOOD BIOPROCESS TECH, V6, P391, DOI 10.1007/s11947-011-0687-3; Gark VK, 1983, 3 HYDROXY 3 METHYLGL, P29; Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853; Hazai E, 2006, BIOORGAN MED CHEM, V14, P6859, DOI 10.1016/j.bmc.2006.06.045; Hsu YM, 2008, BIOSCI BIOTECH BIOCH, V72, P677, DOI 10.1271/bbb.70402; Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894; Periago MJ, 2009, INT J FOOD SCI NUTR, V60, P694, DOI 10.3109/09637480701833457; Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026; Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192; Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714; Lee SH, 1999, ANN NUTR METAB, V43, P173, DOI 10.1159/000012783; Leopoldini M, 2010, J AGR FOOD CHEM, V58, P10768, DOI 10.1021/jf102576j; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordente A, 2011, CURR MED CHEM, V18, P1146, DOI 10.2174/092986711795029717; Navarro-Fernandez J, 2012, J MED CHEM, V55, P6403, DOI 10.1021/jm300621j; Omar MH, 2012, J AGR FOOD CHEM, V60, P5205, DOI 10.1021/jf3001185; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Rai SK, 2009, LIFE SCI, V85, P211, DOI 10.1016/j.lfs.2009.05.020; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; RAO AV, 1975, CLIN CHEM, V21, P1523; Rao AV, 1998, FOOD RES INT, V31, P737, DOI 10.1016/S0963-9969(99)00053-8; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; Ried K, 2011, MATURITAS, V68, P299, DOI 10.1016/j.maturitas.2010.11.018; Sanchez-Moreno C, 2006, J NUTR BIOCHEM, V17, P183, DOI 10.1016/j.jnutbio.2005.07.001; Sesso HD, 2012, J NUTR, V142, P326, DOI 10.3945/jn.111.150631; Silaste ML, 2007, BRIT J NUTR, V98, P1251, DOI 10.1017/S0007114507787445; Stroganov OV, 2008, J CHEM INF MODEL, V48, P2371, DOI 10.1021/ci800166p; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Willcox JK, 2003, CRIT REV FOOD SCI, V43, P1, DOI 10.1080/10408690390826437	46	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83968	10.1371/journal.pone.0083968	http://dx.doi.org/10.1371/journal.pone.0083968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392102	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100026
J	Okamoto, N; Keeling, PJ				Okamoto, Noriko; Keeling, Patrick J.			The 3D Structure of the Apical Complex and Association with the Flagellar Apparatus Revealed by Serial TEM Tomography in Psammosa pacifica, a Distant Relative of the Apicomplexa	PLOS ONE			English	Article							RDNA-BASED PHYLOGENY; STRIATED FIBER ASSEMBLIN; SP-NOV; INTRACELLULAR PARASITE; FINE-STRUCTURE; CELL INVASION; POLAR RING; N-SP; ULTRASTRUCTURE; DINOFLAGELLATE	The apical complex is one of the defining features of apicomplexan parasites, including the malaria parasite Plasmodium, where it mediates host penetration and invasion. The apical complex is also known in a few related lineages, including several non-parasitic heterotrophs, where it mediates feeding behaviour. The origin of the apical complex is unclear, and one reason for this is that in apicomplexans it exists in only part of the life cycle, and never simultaneously with other major cytoskeletal structures like flagella and basal bodies. Here, we used conventional TEM and serial TEM tomography to reconstruct the three dimensional structure of the apical complex in Psammosa pacifica, a predatory relative of apicomplexans and dinoflagellates that retains the archetype apical complex and the flagellar apparatus simultaneously. The P. pacifica apical complex is associated with the gullet and consists of the pseudoconoid, micronemes, and electron dense vesicles. The pseudoconoid is a convex sheet consisting of eight short microtubules, plus a band made up of microtubules that originate from the flagellar apparatus. The flagellar apparatus consists of three microtubular roots. One of the microtubular roots attached to the posterior basal body is connected to bypassing microtubular strands, which are themselves connected to the extension of the pseudoconoid. These complex connections where the apical complex is an extension of the flagellar apparatus, reflect the ancestral state of both, dating back to the common ancestor of apicaomplexans and dinoflagellates.	[Okamoto, Noriko; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Okamoto, N (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	okamoton@mail.ubc.ca		Keeling, Patrick/0000-0002-7644-0745	Canadian Insititutes for Health Research [MOP-42517]; Tula Foundation	Canadian Insititutes for Health Research; Tula Foundation	This work was supported by a grant from the Canadian Insititutes for Health Research (MOP-42517) and from the Tula Foundation to the Centre for Microbial Diversity and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; BRUGEROLLE G, 1979, PROTISTOLOGICA, V15, P183; Brugerolle G, 2002, EUR J PROTISTOL, V38, P113, DOI 10.1078/0932-4739-00864; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Calado AJ, 2006, J PHYCOL, V42, P434, DOI 10.1111/j.1529-8817.2006.00195.x; Calado AJ, 2002, PHYCOLOGIA, V41, P567, DOI 10.2216/i0031-8884-41-6-567.1; Calado AJ, 2009, J PHYCOL, V45, P1195, DOI 10.1111/j.1529-8817.2009.00735.x; Calado SCFCM, 2010, THESIS U AVEIRO PORT; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Craveiro SC, 2011, PROTIST, V162, P590, DOI 10.1016/j.protis.2011.03.003; Craveiro SC, 2010, J EUKARYOT MICROBIOL, V57, P568, DOI 10.1111/j.1550-7408.2010.00512.x; Cumbo VR, 2013, PROTIST, V164, P237, DOI 10.1016/j.protis.2012.08.003; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; de Leon JC, 2013, EUKARYOT CELL, V12, P1009, DOI 10.1128/EC.00096-13; DODGE J D, 1971, Protistologica, V7, P399; DYSON J, 1994, J NAT HIST, V28, P1, DOI 10.1080/00222939400770011; FOISSNER W, 1984, PROTISTOLOGICA, V20, P635; Francia ME, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001444; Garces E, 2010, HARMFUL ALGAE, V10, P64, DOI 10.1016/j.hal.2010.07.001; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Gubbels MJ, 2012, INT J PARASITOL, V42, P1071, DOI 10.1016/j.ijpara.2012.09.009; GUSTAFSON PV, 1954, AM J TROP MED HYG, V3, P1008, DOI 10.4269/ajtmh.1954.3.1008; Hansen G, 2007, PHYCOLOGIA, V46, P86, DOI 10.2216/0031-8884(2007)46[86:BAGESN]2.0.CO;2; Harper JDI, 2009, PROTOPLASMA, V236, P97, DOI 10.1007/s00709-009-0041-z; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Jacobson DM, 1996, J PHYCOL, V32, P279, DOI 10.1111/j.0022-3646.1996.00279.x; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kato KH, 2000, BIOL CELL, V92, P583, DOI 10.1016/S0248-4900(00)01106-0; Kemp LE, 2013, FEMS MICROBIOL REV, V37, P607, DOI 10.1111/1574-6976.12013; Leander BS, 2008, EUR J PROTISTOL, V44, P55, DOI 10.1016/j.ejop.2007.08.004; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lechtreck KF, 2003, MOL BIOCHEM PARASIT, V128, P95, DOI 10.1016/S0166-6851(03)00038-0; Lechtreck KF, 2002, J CELL SCI, V115, P1511; Miller JJ, 2012, PROTIST, V163, P720, DOI 10.1016/j.protis.2011.11.007; MOESTRUP O, 1982, PHYCOLOGIA, V21, P427, DOI 10.2216/i0031-8884-21-4-427.1; Moestrup O, 2000, SYST ASSOC SPEC VOL, V59, P69; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Myl'nikova ZM, 2009, INLAND WATER BIOL, V2, P199, DOI 10.1134/S199508290903002X; Mylnikov AP, 2009, BIOL BULL+, V36, P582, DOI 10.1134/S1062359009060065; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Obornik M, 2011, PROTIST, V162, P115, DOI 10.1016/j.protis.2010.02.004; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Okamoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034900; PATERSON WB, 1988, J PROTOZOOL, V35, P73, DOI 10.1111/j.1550-7408.1988.tb04080.x; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Portman N, 2014, EUKARYOT CELL, V13, P10, DOI 10.1128/EC.00155-13; ROBERTS KR, 1985, J PHYCOL, V21, P641; ROBERTS KR, 1991, PROTOPLASMA, V164, P105, DOI 10.1007/BF01320818; RUSSELL DG, 1984, J CELL SCI, V65, P193; SCHNEPF E, 1984, NATURWISSENSCHAFTEN, V71, P218, DOI 10.1007/BF00490442; SCHOLTYSECK E, 1970, Z PARASITENK, V34, P68, DOI 10.1007/BF00629180; SCHOLTYSECK E, 1970, Z PARASITENK, V34, P97; Shanmugasundram A, 2013, NUCLEIC ACIDS RES, V41, pD706, DOI 10.1093/nar/gks1139; Shaw MK, 2003, TRENDS PARASITOL, V19, P2, DOI 10.1016/S1471-4922(02)00015-6; Shen B, 2012, CURR OPIN MICROBIOL, V15, P449, DOI 10.1016/j.mib.2012.02.007; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Simpson AGB, 1996, SYST PARASITOL, V33, P187, DOI 10.1007/BF01531200; Tran JQ, 2010, CYTOSKELETON, V67, P586, DOI 10.1002/cm.20469; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yubuki N, 2013, PLANT J, V75, P230, DOI 10.1111/tpj.12145	64	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84653	10.1371/journal.pone.0084653	http://dx.doi.org/10.1371/journal.pone.0084653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392150	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100073
J	Fang, SY; Han, JL; Zhang, MF; Wang, LE; Wei, QY; Amos, CI; Lee, JE				Fang, Shenying; Han, Jiali; Zhang, Mingfeng; Wang, Li-e; Wei, Qingyi; Amos, Christopher I.; Lee, Jeffrey E.			Joint Effect of Multiple Common SNPs Predicts Melanoma Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFYING INDIVIDUALS; GENETIC-DETERMINANTS; CUTANEOUS MELANOMA; HIGH-RISK; PIGMENTATION; VARIANTS; EYE; HAIR	Single genetic variants discovered so far have been only weakly associated with melanoma. This study aims to use multiple single nucleotide polymorphisms (SNPs) jointly to obtain a larger genetic effect and to improve the predictive value of a conventional phenotypic model. We analyzed 11 SNPs that were associated with melanoma risk in previous studies and were genotyped in MD Anderson Cancer Center (MDACC) and Harvard Medical School investigations. Participants with >= 15 risk alleles were 5-fold more likely to have melanoma compared to those carrying <= 6. Compared to a model using the most significant single variant rs12913832, the increase in predictive value for the model using a polygenic risk score (PRS) comprised of 11 SNPs was 0.07(95% Cl, 0.05-0.07). The overall predictive value of the PRS together with conventional phenotypic factors in the MDACC population was 0.69 (95% Cl, 0.64-0.69). PRS significantly improved the risk prediction and reclassification in melanoma as compared with the conventional model. Our study suggests that a polygenic profile can improve the predictive value of an individual gene polymorphism and may be able to significantly improve the predictive value beyond conventional phenotypic melanoma risk factors.	[Fang, Shenying; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Han, Jiali; Zhang, Mingfeng] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Li-e; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Amos, Christopher I.] Dartmouth Coll, Geisel Coll Med Community & Family Med, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Lee, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	jelee@mdanderson.org		Fang, Shenying/0000-0002-0604-793X	National Cancer Institute SPORE grant [P50 CA093459]; Marit Peterson Fund for Melanoma Research; Michael W. McCarthy Foundation; Miriam and Jim Mulva Melanoma Research Fund; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER	National Cancer Institute SPORE grant; Marit Peterson Fund for Melanoma Research; Michael W. McCarthy Foundation; Miriam and Jim Mulva Melanoma Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute SPORE grant P50 CA093459, the Marit Peterson Fund for Melanoma Research, the Michael W. McCarthy Foundation, and the Miriam and Jim Mulva Melanoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; [Anonymous], 2010, SURV HLTH POL RES; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Breitbart EW, 2012, J AM ACAD DERMATOL, V66, P201, DOI 10.1016/j.jaad.2010.11.016; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Snoo FA, 2005, CANCER LETT, V230, P153, DOI 10.1016/j.canlet.2004.12.033; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fears TR, 2006, J CLIN ONCOL, V24, P3590, DOI 10.1200/JCO.2005.04.1277; Fortes C, 2010, EUR J CANCER PREV, V19, P393, DOI 10.1097/CEJ.0b013e32833b492f; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13	28	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85642	10.1371/journal.pone.0085642	http://dx.doi.org/10.1371/journal.pone.0085642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392023	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900167
J	Riddle, A; Maire, J; Cai, V; Nguyen, T; Gong, X; Hansen, K; Grafe, MR; Hohimer, R; Back, SA				Riddle, Art; Maire, Jennifer; Cai, Victor; Thuan Nguyen; Gong, Xi; Hansen, Kelly; Grafe, Marjorie R.; Hohimer, Roger; Back, Stephen A.			Hemodynamic and Metabolic Correlates of Perinatal White Matter Injury Severity	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MIDGESTATIONAL SHEEP FETUSES; IMMATURE FETAL SHEEP; CARBOHYDRATE-METABOLISM; ACUTE HYPOXEMIA; GLUCOSE-METABOLISM; BRAIN ISCHEMIA; LACTATE; HYPOGLYCEMIA; RESPONSES	Background and Purpose: Although the spectrum of perinatal white matter injury (WMI) in preterm infants is shifting from cystic encephalomalacia to milder forms of WMI, the factors that contribute to this changing spectrum are unclear. We hypothesized that the variability in WMI quantified by immunohistochemical markers of inflammation could be correlated with the severity of impaired blood oxygen, glucose and lactate. Methods: We employed a preterm fetal sheep model of in utero moderate hypoxemia and global severe but not complete cerebral ischemia that reproduces the spectrum of human WMI. Since there is small but measurable residual brain blood flow during occlusion, we sought to determine if the metabolic state of the residual arterial blood was associated with severity of WMI. Near the conclusion of hypoxia-ischemia, we recorded cephalic arterial blood pressure, blood oxygen, glucose and lactate levels. To define the spectrum of WMI, an ordinal WMI rating scale was compared against an unbiased quantitative image analysis protocol that provided continuous histo-pathological outcome measures for astrogliosis and microgliosis derived from the entire white matter. Results: A spectrum of WMI was observed that ranged from diffuse non-necrotic lesions to more severe injury that comprised discrete foci of microscopic or macroscopic necrosis. Residual arterial pressure, oxygen content and blood glucose displayed a significant inverse association with WMI and lactate concentrations were directly related. Elevated glucose levels were the most significantly associated with less severe WMI. Conclusions: Our results suggest that under conditions of hypoxemia and severe cephalic hypotension, WMI severity measured using unbiased immunohistochemical measurements correlated with several physiologic parameters, including glucose, which may be a useful marker of fetal response to hypoxia or provide protection against energy failure and more severe WMI.	[Riddle, Art; Maire, Jennifer; Cai, Victor; Gong, Xi; Hansen, Kelly; Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Thuan Nguyen] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Grafe, Marjorie R.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Hohimer, Roger] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Back, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	backs@ohsu.edu			National Institutes of Health: National Institute of Neurological Disorders and Stroke [1RO1NS054044, R37NS045737-06S1/06S2, 1F30NS066704]; NICHD [P01HD03443]; American Heart Association; March of Dimes Birth Defects Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS066704, R37NS045737, R01NS054044] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); March of Dimes Birth Defects Foundation(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health: National Institute of Neurological Disorders and Stroke awards: 1RO1NS054044, R37NS045737-06S1/06S2 to SAB and 1F30NS066704 to AR and NICHD award P01HD03443. Supported by a Grant in Aid from the American Heart Association (SAB) and the March of Dimes Birth Defects Foundation (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ABRAMS RM, 1984, AM J PHYSIOL, V246, pR608, DOI 10.1152/ajpregu.1984.246.4.R608; ASANO H, 1994, AM J OBSTET GYNECOL, V170, P939, DOI 10.1016/S0002-9378(94)70310-8; Back S, 2012, ACQUIRED BRAIN INJUR, P29; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P523; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; BISSONNETTE JM, 1984, J DEV PHYSIOL, V6, P275; BISSONNETTE JM, 1985, J DEV PHYSIOL, V7, P421; BISSONNETTE JM, 1991, EXP PHYSIOL, V76, P515, DOI 10.1113/expphysiol.1991.sp003517; BRISTOW J, 1983, J CLIN INVEST, V71, P1047, DOI 10.1172/JCI110855; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; CALLAHAN DJ, 1990, PEDIATR RES, V27, P186, DOI 10.1203/00006450-199002000-00020; CHAO CR, 1989, J CEREBR BLOOD F MET, V9, P53, DOI 10.1038/jcbfm.1989.7; CHAO CR, 1989, AM J OBSTET GYNECOL, V161, P221, DOI 10.1016/0002-9378(89)90270-6; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fletcher AJW, 2003, J PHYSIOL-LONDON, V549, P271, DOI 10.1113/jphysiol.2002.036418; Fowden AL, 1998, J PHYSIOL-LONDON, V508, P937, DOI 10.1111/j.1469-7793.1998.937bp.x; GLEASON CA, 1989, AM J PHYSIOL, V256, pR1264, DOI 10.1152/ajpregu.1989.256.6.R1264; GLEASON CA, 1990, AM J PHYSIOL, V258, pH1064, DOI 10.1152/ajpheart.1990.258.4.H1064; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; HARPER AM, 1963, J NEUROL NEUROSUR PS, V26, P341, DOI 10.1136/jnnp.26.4.341; HERMANSEN MC, 1984, BRAIN RES, V324, P101, DOI 10.1016/0006-8993(84)90626-7; HOHIMER AR, 1989, AM J OBSTET GYNECOL, V161, P1344; HOOPER SB, 1995, AM J PHYSIOL-REG I, V268, pR303, DOI 10.1152/ajpregu.1995.268.2.R303; IWAMOTO HS, 1989, AM J PHYSIOL, V256, pH613, DOI 10.1152/ajpheart.1989.256.3.H613; JONES MD, 1979, SEMIN PERINATOL, V3, P121; JONES MD, 1975, AM J PHYSIOL, V229, P235; Lawn CJ, 2005, COCHRANE DB SYST REV, V2; LeBlanc MH, 1997, BIOL NEONATE, V72, P243; MANN LI, 1970, PEDIATR RES, V4, P46, DOI 10.1203/00006450-197001000-00005; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; McQuillen PS, 2010, ANN NY ACAD SCI, V1184, P68, DOI 10.1111/j.1749-6632.2009.05116.x; MEDINA JM, 1985, BIOL NEONATE, V48, P237, DOI 10.1159/000242176; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; Nadeem M, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-10; Petersson KH, 2004, PEDIATR RES, V56, P621, DOI 10.1203/01.PDR.0000139415.96985.BF; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Powers MJ, 2007, AM J PHYSIOL-REG I, V292, pR1542, DOI 10.1152/ajpregu.00300.2006; RICHARDSON BS, 1985, AM J PHYSIOL, V248, pR72, DOI 10.1152/ajpregu.1985.248.1.R72; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; RUDOLPH CD, 1989, J DEV PHYSIOL, V11, P219; Nguyen T, 2011, STAT MED, V30, P3403, DOI 10.1002/sim.4366; TING P, 1983, EXP NEUROL, V80, P227, DOI 10.1016/0014-4886(83)90019-5; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; VANNUCCI RC, 1978, ANN NEUROL, V4, P73, DOI 10.1002/ana.410040114; Volpe JJ, 2008, NEUROLOGY NEWBORN, P399; WAGNER KR, 1986, J CEREBR BLOOD F MET, V6, P425, DOI 10.1038/jcbfm.1986.75; Wong DST, 2013, AM J NEURORADIOL, V34, P1456, DOI 10.3174/ajnr.A3423	54	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82940	10.1371/journal.pone.0082940	http://dx.doi.org/10.1371/journal.pone.0082940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24416093	Green Published, gold, Green Submitted			2022-12-25	WOS:000328730300114
J	Hasenour, CM; Ridley, DE; Hughey, CC; James, FD; Donahue, EP; Shearer, J; Viollet, B; Foretz, M; Wasserman, DH				Hasenour, Clinton M.; Ridley, D. Emerson; Hughey, Curtis C.; James, Freyja D.; Donahue, E. Patrick; Shearer, Jane; Viollet, Benoit; Foretz, Marc; Wasserman, David H.			5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; AMP Kinase; AMP-activated Kinase (AMPK); Energy Metabolism; Liver Metabolism; AICAR; Fat Metabolism; In Vivo	ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ISOLATED RAT HEPATOCYTES; NUCLEAR RECEPTOR SHP; INSULIN-RESISTANCE; GLUCOKINASE TRANSLOCATION; GLUCAGON RECEPTOR; GENE-EXPRESSION; SHORT-TERM; COMPLEX I	Metabolic stress, as well as several antidiabetic agents, increases hepatic nucleotide monophosphate (NMP) levels, activates AMP-activated protein kinase (AMPK), and suppresses glucose production. We tested the necessity of hepatic AMPK for the in vivo effects of an acute elevation in NMP on metabolism. 5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR; 8 mg center dot kg(-1)min(-1))-euglycemic clamps were performed to elicit an increase in NMP in wild type (alpha 1 alpha 2(lox/lox)) and liver-specific AMPK knock-out mice (alpha 1 alpha 2(lox/lox) + Albcre) in the presence of fixed glucose. Glucose kinetics were equivalent in 5-h fasted alpha 1 alpha 2(lox/lox) and alpha 1 alpha 2(lox/lox) + Albcre mice. AMPK was not required for AICAR-mediated suppression of glucose production and increased glucose disappearance. These results demonstrate that AMPK is unnecessary for normal 5-h fasting glucose kinetics and AICAR-mediated inhibition of glucose production. Moreover, plasma fatty acids and triglycerides also decreased independently of hepatic AMPK during AICAR administration. Although the glucoregulatory effects of AICAR were shown to be independent of AMPK, these studies provide in vivo support for the AMPK energy sensor paradigm. AICAR reduced hepatic energy charge by approximate to 20% in alpha 1 alpha 2(lox/lox), which was exacerbated by approximate to 2-fold in alpha 1 alpha 2(lox/lox) + Albcre. This corresponded to a approximate to 6-fold rise in AMP/ATP in alpha 1 alpha 2(lox/lox) + Albcre. Consistent with the effects on adenine nucleotides, maximal mitochondrial respiration was approximate to 30% lower in alpha 1 alpha 2(lox/lox) + Albcre than alpha 1 alpha 2(lox/lox) livers. Mitochondrial oxidative phosphorylation efficiency was reduced by 25%. In summary, these results demonstrate that the NMP capacity to inhibit glucose production in vivo is independent of liver AMPK. In contrast, AMPK promotes mitochondrial function and protects against a more precipitous fall in ATP during AICAR administration.	[Hasenour, Clinton M.; Ridley, D. Emerson; James, Freyja D.; Donahue, E. Patrick; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Viollet, Benoit; Foretz, Marc] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Hughey, Curtis C.; Shearer, Jane] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Calgary; University of Calgary	Hasenour, CM (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	clinton.m.hasenour@vanderbilt.edu	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [U24 DK59637, R37 DK50277, DK20593]; Molecular Endocrinology Training Program at Vanderbilt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, R37DK050277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Endocrinology Training Program at Vanderbilt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U24 DK59637 and R37 DK50277 (to D. H. W.) and DK20593 (the Diabetes Research and Training Center). This work was also supported by the Molecular Endocrinology Training Program at Vanderbilt.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Berglund ED, 2011, DIABETES, V60, P2720, DOI 10.2337/db11-0455; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hughey CC, 2011, JOVE-J VIS EXP, V48, P2431, DOI DOI 10.3791/2431; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Pencek RR, 2005, DIABETES, V54, P355, DOI 10.2337/diabetes.54.2.355; Romestaing C, 2008, AM J PHYSIOL-ENDOC M, V294, pE110, DOI 10.1152/ajpendo.00407.2007; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shirai T, 2011, BIOCHEM BIOPH RES CO, V414, P287, DOI 10.1016/j.bbrc.2011.08.120; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; TAKETA K, 1965, J BIOL CHEM, V240, P651; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	63	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5950	5959		10.1074/jbc.M113.528232	http://dx.doi.org/10.1074/jbc.M113.528232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403081	Green Published, hybrid			2022-12-25	WOS:000332015500051
J	Jeong, JH; Kim, K; Lim, D; Jeong, K; Hong, Y; Nguyen, VH; Kim, TH; Ryu, S; Lim, JA; Kim, JI; Kim, GJ; Kim, SC; Min, JJ; Choy, HE				Jeong, Jae-Ho; Kim, Kwangsoo; Lim, Daejin; Jeong, Kwangjoon; Hong, Yeongjin; Nguyen, Vu H.; Kim, Tae-Hyoung; Ryu, Sangryeol; Lim, Jeong-A; Kim, Jae Il; Kim, Geun-Joong; Kim, Sun Chang; Min, Jung-Joon; Choy, Hyon E.			Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSDUCTION; STATIONARY-PHASE; BCL-2 FAMILY; CELL; BACTERIA; CANCER; LYSIS; GENE; INDUCTION	Bacterial cancer therapy relies on the fact that several bacterial species are capable of targeting tumor tissue and that bacteria can be genetically engineered to selectively deliver therapeutic proteins of interest to the targeted tumors. However, the challenge of bacterial cancer therapy is the release of the therapeutic proteins from the bacteria and entry of the proteins into tumor cells. This study employed an attenuated Salmonella typhimurium to selectively deliver the mitochondrial targeting domain of Noxa (MTD) as a potential therapeutic cargo protein, and examined its anti-cancer effect. To release MTD from the bacteria, a novel bacterial lysis system of phage origin was deployed. To facilitate the entry of MTD into the tumor cells, the MTD was fused to DS4.3, a novel cell-penetrating peptide (CPP) derived from a voltage-gated potassium channel (K(v)2.1). The gene encoding DS4.3-MTD and the phage lysis genes were placed under the control of P-BAD, a promoter activated by L-arabinose. We demonstrated that DS4.3-MTD chimeric molecules expressed by the Salmonellae were anti-tumoral in cultured tumor cells and in mice with CT26 colon carcinoma.	[Jeong, Jae-Ho; Kim, Kwangsoo; Lim, Daejin; Jeong, Kwangjoon; Hong, Yeongjin; Choy, Hyon E.] Chonnam Natl Univ, Dept Microbiol, Sch Med, Kwangju, South Korea; [Nguyen, Vu H.; Min, Jung-Joon] Chonnam Natl Univ, Dept Nucl Med, Sch Med, Kwangju, South Korea; [Kim, Tae-Hyoung] Chonnam Natl Univ, Dept Biochem, Sch Med, Kwangju, South Korea; [Ryu, Sangryeol; Lim, Jeong-A] Seoul Natl Univ, Dept Food & Anim Biotechnol, Seoul, South Korea; [Kim, Jae Il] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Kim, Geun-Joong] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Kwangju, South Korea; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Korea Advanced Institute of Science & Technology (KAIST)	Min, JJ (corresponding author), Chonnam Natl Univ, Dept Nucl Med, Sch Med, Kwangju, South Korea.	jjmin@jnu.ac.kr; hyonchoy@jnu.ac.kr	Nguyen, Vu/HGV-1806-2022; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Jeong, Jae-Ho/0000-0002-5544-9572	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST) [2011-0031958]; National Research Foundation of Korea (NRF) [2012-0006072]; Pioneer Research Center Program "Bacteriobot" through NFR; MEST [2012-0001031]; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program; the Rural Development Administration, Republic of Korea [PJ008158]	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Pioneer Research Center Program "Bacteriobot" through NFR; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program; the Rural Development Administration, Republic of Korea	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project funded by the Ministry of Education, Science, and Technology (MEST) (2011-0031958). JJM was supported by the National Research Foundation of Korea (NRF) (No. 2012-0006072). YH was supported by the Pioneer Research Center Program "Bacteriobot" through NFR funded by MEST (2012-0001031). SR was supported by the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. JIK was supported by grant from the Next-Generation BioGreen 21 Program (PJ008158); the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Dom G, 2003, NUCLEIC ACIDS RES, V31, P556, DOI 10.1093/nar/gkg160; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1; GARRETT J, 1990, J BACTERIOL, V172, P7275, DOI 10.1128/jb.172.12.7275-7277.1990; GARRETT J, 1981, MOL GEN GENET, V182, P326, DOI 10.1007/BF00269678; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598; Jain V, 2000, INFECT IMMUN, V68, P986, DOI 10.1128/IAI.68.2.986-989.2000; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jiang SN, 2013, MOL THER; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060511; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Le UN, 2011, MOL THER, V19, P951, DOI 10.1038/mt.2011.25; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; MARATEA D, 1985, GENE, V40, P39, DOI 10.1016/0378-1119(85)90022-8; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Miksch G, 1997, ARCH MICROBIOL, V167, P143, DOI 10.1007/s002030050427; Miller J.H., 1972, EXPT MOL GENETICS; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; NAUTS H C, 1953, Acta Med Scand Suppl, V276, P1; Nguyen VH, 2010, CANCER RES, V70, P18, DOI 10.1158/0008-5472.CAN-09-3453; Park SY, 2011, J MICROBIOL METH, V86, P108, DOI 10.1016/j.mimet.2011.04.003; Pawelek JM, 1997, CANCER RES, V57, P4537; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; SARVAS M, 1971, J BACTERIOL, V105, P467, DOI 10.1128/JB.105.2.467-471.1971; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seo YW, 2009, CANCER RES, V69, P8356, DOI 10.1158/0008-5472.CAN-09-0349; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Shokri A, 2003, APPL MICROBIOL BIOT, V60, P654, DOI 10.1007/s00253-002-1156-8; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; STREILEIN JW, 1995, SCIENCE, V270, P1158, DOI 10.1126/science.270.5239.1158; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Suzuki S, 2009, CANCER SCI, V100, P759, DOI 10.1111/j.1349-7006.2009.01096.x; Thamm DH, 2005, CLIN CANCER RES, V11, P4827, DOI 10.1158/1078-0432.CCR-04-2510; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; WU HC, 1971, J BACTERIOL, V105, P455, DOI 10.1128/JB.105.2.455-466.1971; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	59	44	47	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e80050	10.1371/journal.pone.0080050	http://dx.doi.org/10.1371/journal.pone.0080050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416126	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500006
J	Komatsu, S; Kamata, T; Imai, A; Ohara, T; Miyaji, K; Kobayashi, Y; Kodama, K				Komatsu, Sei; Kamata, Teruaki; Imai, Atsuko; Ohara, Tomoki; Miyaji, Kazuaki; Kobayashi, Yasuhiko; Kodama, Kazuhisa			Quantitative Analysis of Coronary Vessels with Optimized Intracoronary CT Number	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE; ANGIOGRAPHY; PLAQUE; SYSTEM; REPRODUCIBILITY; DETERMINANTS; ATTENUATION; CARDIOLOGY	Background: Variability in intracoronary computed tomography (CT) number may influence vessel quantification. We confirmed the feasibility of a novel method for measuring vessel diameter and area using coronary CT angiography (CCTA) with an optimized intracoronary CT number, 350 HU. Methods: We performed intravascular ultrasound (IVUS) imaging in 52 patients with significant stenosis detected by coronary CT angiography targeting 350 HU using a CT number-controlling system. We measured 0-to-0 HU distances in the cross-sectional coronary images of 32 patients. We analyzed the ratio of 0-to-0 HU distances in CT images to media-to-media distances in IVUS images (C: I ratio). The area of >= 0 HU for 103 representative points in the remaining 20 patients was compared to the area of the traced external elastic membrane (EEM) in IVUS images. Results: There was a strong correlation between 0-to-0 HU distance in CT images and media-to-media diameter in IVUS images (r = 0.97, p < 0.001). The C: I ratio was 1.1. EEM area was estimated by dividing the area of >= 0 HU by the square of C: I. There was also a strong correlation between the estimated EEM area and the EEM area in IVUS images (r = 0.95, p < 0.001). Conclusions: Media-to-media diameter and EEM area can be estimated by CCTA targeting the optimized intracoronary CT number when blood vessel borders are defined at 0 HU.	[Komatsu, Sei; Imai, Atsuko; Ohara, Tomoki; Kobayashi, Yasuhiko; Kodama, Kazuhisa] Amagasaki Cent Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Kamata, Teruaki; Miyaji, Kazuaki] Amagasaki Cent Hosp, Dept Diagnost Imaging, Amagasaki, Hyogo, Japan; [Imai, Atsuko] Osaka Univ, Sch Med, Dept Cardiol, Osaka, Japan	Osaka University	Komatsu, S (corresponding author), Amagasaki Cent Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan.	plaquemap@yahoo.co.jp	Komatsu, Sei/AAQ-6467-2020					Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; ALFONSO F, 1994, J AM COLL CARDIOL, V23, P879, DOI 10.1016/0735-1097(94)90632-7; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Cademartiri F, 2005, EUR RADIOL, V15, P1426, DOI 10.1007/s00330-005-2697-x; Fei XL, 2008, AM J ROENTGENOL, V191, P43, DOI 10.2214/AJR.07.2653; Herzog BA, 2009, INT J CARDIOVAS IMAG, V25, P625, DOI 10.1007/s10554-009-9460-3; Komatsu S, 2005, CIRC J, V69, P72, DOI 10.1253/circj.69.72; Komatsu S, 2013, J CARDIOL, V62, P82, DOI 10.1016/j.jjcc.2013.03.004; Komatsu S, 2013, J CARDIOL, V61, P155, DOI 10.1016/j.jjcc.2012.09.006; Komatsu S, 2011, CIRC J, V75, P1515, DOI 10.1253/circj.CJ-11-0252; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Marwan M, 2011, J COMPUT ASSIST TOMO, V35, P113, DOI 10.1097/RCT.0b013e3181f7cb30; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Pazhenkottil AP, 2010, INT J CARDIOVAS IMAG, V26, P591, DOI 10.1007/s10554-010-9594-3; Peters RJG, 1996, EUR HEART J, V17, P1593; Petranovic Milena, 2009, J Cardiovasc Comput Tomogr, V3, P24, DOI 10.1016/j.jcct.2008.12.005; Voros S, 2011, JACC-CARDIOVASC INTE, V4, P198, DOI 10.1016/j.jcin.2010.10.008	17	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85312	10.1371/journal.pone.0085312	http://dx.doi.org/10.1371/journal.pone.0085312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409326	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500050
J	Martinez, C; Ortiz, AM; Juarranz, Y; Lamana, A; Seoane, IV; Leceta, J; Garcia-Vicuna, R; Gomariz, RP; Gonzalez-Alvaro, I				Martinez, Carmen; Ortiz, Ana M.; Juarranz, Yasmina; Lamana, Amalia; Seoane, Iria V.; Leceta, Javier; Garcia-Vicuna, Rosario; Gomariz, Rosa P.; Gonzalez-Alvaro, Isidoro			Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis	PLOS ONE			English	Article							T-CELL SUBSETS; RHEUMATOID-ARTHRITIS; VIP; MICE; AUTOIMMUNE; MODEL; PACAP; PHARMACOLOGY; ASSOCIATION; RECEPTORS	Objective: Suitable biomarkers are essential for the design of therapeutic strategies in personalized medicine. Vasoactive intestinal peptide (VIP) has demonstrated immunomodulatory properties in autoimmune murine and ex vivo human models. Our aim was to study serum levels of VIP during the follow-up of an early arthritis (EA) cohort and to analyze its value as a biomarker predicting severity and therapeutic requirements. Methods: Data from 91 patients on an EA register were analyzed (76% rheumatoid arthritis (RA), 24% undifferentiated arthritis, 73% women, and median age 54 years; median disease duration at entry, 5.4 months). We collected per protocol sociodemographic, clinical, and therapeutic data. VIP levels were determined by enzyme immunoassay in sera harvested from the 91 patients (353 visits; 3.9 visit/patient) and from 100 healthy controls. VIP values below the 25th percentile of those assessed in healthy population were considered low. To determine the effect of independent variables on VIP levels, we performed a longitudinal multivariate analysis nested by patient and visit. A multivariate ordered logistic regression was modeled to determine the effect of low VIP serum levels on disease activity at the end of follow-up. Results: VIP concentrations varied considerably across EA patients. Those fulfilling the criteria for RA had the lowest values in the whole sample, although no significant differences were observed compared with healthy donors. Disease activity, which was assessed using DAS28, inversely correlated with VIP levels. After a two-year follow-up, those patients with low baseline levels of VIP displayed higher disease activity and received more intensive treatment. Conclusion: Patients who are unable to up-regulate VIP seem to have a worse clinical course despite receiving more intense treatment. Therefore, measurement of VIP levels may be suitable as a prognostic biomarker.	[Martinez, Carmen] Univ Complutense Madrid, Fac Med, Dept Biol Celular, Madrid, Spain; [Ortiz, Ana M.; Lamana, Amalia; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Serv Reumatol, Madrid, Spain; [Juarranz, Yasmina; Seoane, Iria V.; Leceta, Javier; Gomariz, Rosa P.] Univ Complutense Madrid, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Martinez, C (corresponding author), Univ Complutense Madrid, Fac Med, Dept Biol Celular, Madrid, Spain.	cmmora@bio.ucm.es	Seoane, Iria/M-4236-2017; Martínez, Carmen/AAC-2077-2020; Juarranz, Yasmina/H-5545-2019; LAMANA, AMALIA/I-6971-2017; de VicuÃa, Rosario Garcia/ABD-7892-2020; Juarranz, Yasmina/H-7942-2016; Leceta, Javier/H-6940-2017	Seoane, Iria/0000-0002-3644-1444; Juarranz, Yasmina/0000-0001-5886-8273; LAMANA, AMALIA/0000-0001-8779-5034; de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Juarranz, Yasmina/0000-0001-5886-8273; Leceta, Javier/0000-0003-4845-0046	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [PI08/0025, PI11/00195, PI11/00505, PI12/0758]; RETICS [RD08/0075, RD12/0009]; EU; Comunidad de Madrid [S2010/BMD-2350]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS; EU(European Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (PI08/0025, PI11/00195, PI11/00505, PI12/0758, RETICS RD08/0075, RD12/0009) and by FEDER funds from EU, S2010/BMD-2350 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036922; Abad C, 2011, CURR PHARM DESIGN, V17, P1025, DOI 10.2174/138161211795589364; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Couvineau A, 2012, BRIT J PHARMACOL, V166, P42, DOI 10.1111/j.1476-5381.2011.01676.x; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Diez JJ, 2008, NEPHROL DIAL TRANSPL, V23, P1387, DOI 10.1093/ndt/gfm776; El-Sayed ZA, 2009, RHEUMATOLOGY, V48, P843, DOI 10.1093/rheumatology/kep134; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Gomariz RP, 2006, ANN NY ACAD SCI, V1070, P51, DOI 10.1196/annals.1317.031; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; GOZES I, 1993, J MOL NEUROSCI, V4, P185, DOI 10.1007/BF02782501; Gutierrez-Canas I, 2008, BRAIN BEHAV IMMUN, V22, P312, DOI 10.1016/j.bbi.2007.09.007; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Jiang W, 2012, CLIN BIOCHEM, V45, P1607, DOI 10.1016/j.clinbiochem.2012.08.020; Jimeno R, 2010, IMMUNOL CELL BIOL, V88, P734, DOI 10.1038/icb.2010.29; Juarranz MG, 2004, RHEUMATOLOGY, V43, P416, DOI 10.1093/rheumatology/keh061; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; Perez-Garcia S, 2011, J CELL PHYSIOL, V226, P3261, DOI 10.1002/jcp.22687; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raza Karim, 2009, Best Pract Res Clin Rheumatol, V23, P25, DOI 10.1016/j.berh.2008.08.001; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Smolen JS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2418; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006	32	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85248	10.1371/journal.pone.0085248	http://dx.doi.org/10.1371/journal.pone.0085248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409325	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500049
J	Decaro, N; Pinto, P; Mari, V; Elia, G; Larocca, V; Camero, M; Terio, V; Losurdo, M; Martella, V; Buonavoglia, C				Decaro, Nicola; Pinto, Pierfrancesco; Mari, Viviana; Elia, Gabriella; Larocca, Vittorio; Camero, Michele; Terio, Valentina; Losurdo, Michele; Martella, Vito; Buonavoglia, Canio			Full-Genome Analysis of a Canine Pneumovirus Causing Acute Respiratory Disease in Dogs, Italy	PLOS ONE			English	Article							REAL-TIME PCR; PNEUMONIA VIRUS; CORONAVIRUS; RNA; INFECTION; QUANTITATION; EVOLUTION; SEQUENCE; HOMOLOG; MOUSE	An outbreak of canine infectious respiratory disease (CIRD) associated to canine pneumovirus (CnPnV) infection is reported. The outbreak occurred in a shelter of the Apulia region and involved 37 out of 350 dogs that displayed cough and/or nasal discharge with no evidence of fever. The full-genomic characterisation showed that the causative agent (strain Bari/100-12) was closely related to CnPnVs that have been recently isolated in the USA, as well as to murine pneumovirus, which is responsible for respiratory disease in mice. The present study represents a useful contribution to the knowledge of the pathogenic potential of CnPnV and its association with CIRD in dogs. Further studies will elucidate the pathogenicity and epidemiology of this novel pneumovirus, thus addressing the eventual need for specific vaccines.	[Decaro, Nicola; Pinto, Pierfrancesco; Mari, Viviana; Elia, Gabriella; Larocca, Vittorio; Camero, Michele; Terio, Valentina; Losurdo, Michele; Martella, Vito; Buonavoglia, Canio] Univ Bari, Dept Vet Med, Valenzano, Italy	Universita degli Studi di Bari Aldo Moro	Decaro, N (corresponding author), Univ Bari, Dept Vet Med, Valenzano, Italy.	nicola.decaro@uniba.it	Decaro, Nicola/ABB-1426-2021; Terio, Valentina/Z-1206-2018; Martella, Vito/K-3146-2016; Decaro, Nicola/K-2560-2018; Elia, Gabriella/K-5286-2018; Decaro, Nicola/AAB-8820-2019; Larocca, Vittorio/K-4058-2016	Terio, Valentina/0000-0002-8908-6749; Martella, Vito/0000-0002-5740-6947; Elia, Gabriella/0000-0001-7469-2175; Decaro, Nicola/0000-0001-6348-7969; Camero, Michele/0000-0003-0026-8325; Larocca, Vittorio/0000-0003-1679-5699	Italian Ministry of Health, Ricerca corrente [IZS VE 21/09 RC]	Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Bukh J, 2011, P NATL ACAD SCI USA, V108, P12563, DOI 10.1073/pnas.1107612108; Buonavoglia C, 2007, VET RES, V38, P355, DOI 10.1051/vetres:2006058; Chalker VJ, 2004, MICROBIOL-SGM, V150, P3491, DOI 10.1099/mic.0.26848-0; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2004, J VIROL METHODS, V119, P145, DOI 10.1016/j.jviromet.2004.03.012; Decaro N, 2002, MICROBIOLOGICA, V25, P291; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2008, J VIROL METHODS, V151, P167, DOI 10.1016/j.jviromet.2008.05.016; Decaro N, 2008, VET CLIN N AM-SMALL, V38, P799, DOI 10.1016/j.cvsm.2008.02.006; Decaro N, 2010, J VIROL METHODS, V169, P176, DOI 10.1016/j.jviromet.2010.07.021; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Dibben O, 2007, VIRUS RES, V130, P303, DOI 10.1016/j.virusres.2007.06.009; Dubovi EJ, 2010, VET CLIN N AM-SMALL, V40, P1063, DOI 10.1016/j.cvsm.2010.07.005; Elia G, 2006, J VIROL METHODS, V136, P171, DOI 10.1016/j.jviromet.2006.05.004; Ellis JA, 2012, JAVMA-J AM VET MED A, V240, P273, DOI 10.2460/javma.240.3.273; Erles K, 2004, J CLIN MICROBIOL, V42, P4524, DOI 10.1128/JCM.42.10.4524-4529.2004; Erles K, 2003, VIROLOGY, V310, P216, DOI 10.1016/S0042-6822(03)00160-0; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Glineur SF, 2013, VIROLOGY, V443, P257, DOI 10.1016/j.virol.2013.05.011; Greenwood AG, 2002, VET REC, V150, P543, DOI 10.1136/vr.150.17.543; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; KAPLAN C, 1980, J HYG-CAMBRIDGE, V84, P285, DOI 10.1017/S0022172400026784; Kapoor A, 2012, J GEN VIROL, V93, P341, DOI 10.1099/vir.0.036624-0; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Krempl CD, 2005, VIRUS GENES, V30, P237, DOI 10.1007/s11262-004-5631-4; Leary TP, 2002, J CLIN MICROBIOL, V40, P1368, DOI 10.1128/JCM.40.4.1368-1375.2002; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Mitchell JA, 2013, J CLIN MICROBIOL, V51, P4112, DOI 10.1128/JCM.02312-13; Percopo CM, 2011, VIROLOGY, V416, P26, DOI 10.1016/j.virol.2011.04.010; Priestnall SL, 2010, CLIN VACCINE IMMUNOL, V17, P1790, DOI 10.1128/CVI.00188-10; Renshaw R, 2011, VET MICROBIOL, V150, P88, DOI 10.1016/j.vetmic.2011.01.013; Renshaw RW, 2010, EMERG INFECT DIS, V16, P993, DOI 10.3201/eid1606.091778; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zenner L, 2000, LAB ANIM-UK, V34, P76, DOI 10.1258/002367700780577957; Zhao ZQ, 2011, VET J, V188, P337, DOI 10.1016/j.tvjl.2010.05.022	37	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85220	10.1371/journal.pone.0085220	http://dx.doi.org/10.1371/journal.pone.0085220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400129	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700063
J	Gilman, E; Chaloupka, M; Wiedoff, B; Willson, J				Gilman, Eric; Chaloupka, Milani; Wiedoff, Brett; Willson, Jeremy			Mitigating Seabird Bycatch during Hauling by Pelagic Longline Vessels	PLOS ONE			English	Article							CATCH RATES; BY-CATCH; ALBATROSSES; FISHERIES; MORTALITY; BAIT	Bycatch in longline fisheries threatens the viability of some seabird populations. The Hawaii longline swordfish fishery reduced seabird captures by an order of magnitude primarily through mitigating bycatch during setting. Now, 75% of captures occur during hauling. We fit observer data to a generalized additive regression model with mixed effects to determine the significance of the effect of various factors on the standardized seabird haul catch rate. Density of albatrosses attending vessels during hauling, leader length and year had largest model effects. The standardized haul catch rate significantly increased with increased albatross density during hauling. The standardized catch rate was significantly higher the longer the leader: shorter leaders place weighted swivels closer to hooks, reducing the likelihood of baited hooks becoming available to surface-scavenging albatrosses. There was a significant linear increasing temporal trend in the standardized catch rate, possibly partly due to an observed increasing temporal trend in the local abundance of albatrosses attending vessels during hauling. Swivel weight, Beaufort scale and season were also significant but smaller model effects. Most (81%) haul captures were on branchlines actively being retrieved. Future haul mitigation research should therefore focus on reducing bird access to hooks as crew coil branchlines, including methods identified here of shorter leaders and heavier swivels, and other potentially effective methods, including faster branchline coiling and shielding the area where hooks becomes accessible. The proportion of Laysan albatross (Phoebastria immutabilis) captures that occurred during hauling was significantly, 1.6 times, higher than for black-footed albatrosses (P. nigripes), perhaps due to differences in the time of day of foraging and in daytime scavenging competitiveness; mitigating haul bycatch would therefore be a larger benefit to Laysans. Locally, findings identify opportunities to nearly eliminate seabird bycatch. Globally, findings fill a gap in knowledge of methods to mitigate seabird bycatch during pelagic longline hauling.	[Gilman, Eric] Hawaii Pacific Univ, Coll Nat Sci, Honolulu, HI 96813 USA; [Chaloupka, Milani] Ecol Modeling Serv, St Lucia, Qld, Australia; [Wiedoff, Brett; Willson, Jeremy] Natl Marine Fisheries Serv, Pacific Islands Reg Off, Honolulu, HI USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Gilman, E (corresponding author), Hawaii Pacific Univ, Coll Nat Sci, Honolulu, HI 96813 USA.	EricLGilman@gmail.com	Gilman, Eric/AAF-2147-2019; Fennell, Hannah/AAI-1408-2019	Gilman, Eric/0000-0002-4216-2513; 				ACAP, 2013, 14 ACAP AC7 SEAB BYC; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Aragon TJ, 2012, EPITOOLS R PACKAGE E; Baker GB, 2007, BIOL CONSERV, V137, P319, DOI 10.1016/j.biocon.2007.02.012; Beverly S, 1996, SPC FISHERIES NEWSLE, V79, P22; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; Brothers N, 2006, TECHNICAL ASSISTANCE; Brothers N. P., 1999, 937 FAO UN; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; CCAMLR, 2009, CONS MEAS 25 02 MIN; Cocking LJ, 2008, BIOL CONSERV, V141, P1354, DOI 10.1016/j.biocon.2008.03.003; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fernandez P, 2000, CONDOR, V102, P577, DOI 10.1650/0010-5422(2000)102[0577:NADFAO]2.0.CO;2; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Food and Agriculture Organization of the United Nations (FAO), 2011, INT GUID BYC MAN RED; Gilman E, 2006, FISH FISH, V7, P2, DOI 10.1111/j.1467-2979.2006.00196.x; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; Gilman E, 2013, P 6 WORLD FISH C ED, P711; Gilman E., 2012, ANN REPORT SEABIRD I; Gilman E., 2011, ANN REPORT SEABIRD I; Gilman E, 2007, SHARK DEPREDATION UN, P121; Gilman E, 2007, 1025 FAO UN; Gilman Eric, 2008, Endangered Species Research, V5, P309, DOI 10.3354/esr00133; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2014, FISH FISH, V15, P327, DOI 10.1111/faf.12021; Gilman E, 2012, AQUAT CONSERV, V22, P446, DOI 10.1002/aqc.2237; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Gould P, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P199; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hyrenbach K. David, 2002, Marine Ornithology, V30, P85; Hyrenbach KD, 2003, BIOL CONSERV, V112, P391, DOI 10.1016/S0006-3207(02)00337-3; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; IUCN, 2012, UCN RED LIST THREAT; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; McCracken M. L., 2004, NMFSPIFSC3 NOAA; NMFS, 2012, DR12008 NMFS PIFSC; NMFS, 2004, FED REGISTER, V69, P17329; NMFS, 2005, FED REGISTER, V70, P75075; NMFS, 2012, HAW LONGL FISH LOGB; NMFS (National Marine Fisheries Service), 2010, HAW LONGL OBS PROGR; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Reid E, 2010, CCAMLR SCI, V17, P155; Reid TA, 2004, POLAR BIOL, V27, P131, DOI 10.1007/s00300-003-0547-3; RICKER W E, 1975, P382; Ricker W. E., 1958, BULLETIN, V119; Seber G.A.F., 1973, ESTIMATION ANIMAL AB; Sullivan BJ, 2012, FISH RES, V134, P125, DOI 10.1016/j.fishres.2012.07.024; Tasker Mark L., 1992, Netherlands Journal of Aquatic Ecology, V26, P59, DOI 10.1007/BF02298028; Ward P, 2008, FISH RES, V90, P100, DOI 10.1016/j.fishres.2007.09.034; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767; Wood S., 2011, R PACKAGE VERSION, V0, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	58	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84499	10.1371/journal.pone.0084499	http://dx.doi.org/10.1371/journal.pone.0084499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400096	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700030
J	Denkinger, CM; Pai, M; Dowdy, DW				Denkinger, Claudia M.; Pai, Madhukar; Dowdy, David W.			Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; INITIAL-DRUG RESISTANCE; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; ANTIRETROVIRAL THERAPY; PREVENTIVE THERAPY; INFECTION; RISK; TRANSMISSION	Background: Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH). Whereas many TB diagnostics detect RIF-resistance, few detect INH-monoresistance, which is common and may increase risk of acquired MDR-TB. Whether inclusion of INH-resistance in a first-line rapid test for TB would have an important impact on MDR-TB rates remains uncertain. Methods: We developed a transmission model to evaluate three tests in a population similar to that of India: a rapid molecular test for TB, the same test plus RIF-resistance detection ("TB+RIF''), and detection of RIF and INH-resistance ("TB+RIF/INH''). Our primary outcome was the prevalence of INH-resistant and MDR-TB at ten years. Results: Compared to the TB test alone and assuming treatment of all diagnosed MDR cases, the TB+RIF test reduced the prevalence of MDR-TB among all TB cases from 5.5% to 3.8% (30.6% reduction, 95% uncertainty range, UR: 17-54%). Despite using liberal assumptions about the impact of INH-monoresistance on treatment outcomes and MDR-TB acquisition, expansion from TB+RIF to TB+RIF/INH lowered this prevalence only from 3.8% to 3.6% further (4% reduction, 95% UR: 3-7%) and INH-monoresistant TB from 15.8% to 15.1% (4% reduction, 95% UR: (-8)-19%). Conclusion: When added to a rapid test for TB plus RIF-resistance, detection of INH-resistance has minimal impact on transmission of TB, MDR-TB, and INH-monoresistant TB.	[Denkinger, Claudia M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Dowdy, David W.] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Dowdy, David W.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; McGill University; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Dowdy, DW (corresponding author), Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ddowdy@jhsph.edu	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536	New Diagnostics working groups of the Stop TB Partnership; Bill and Melinda Gates Foundation [OPP1061487]; Canadian Institute of Health Research [MOP 123291]; US National Institutes of Health [1R21AI101152]; McGill University; American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101152] Funding Source: NIH RePORTER	New Diagnostics working groups of the Stop TB Partnership; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGill University; American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Development and publication of this manuscript was made possible with financial support from the New Diagnostics working groups of the Stop TB Partnership, grants from the Bill and Melinda Gates Foundation (OPP1061487), and the Canadian Institute of Health Research (MOP 123291) to MP as well as a US National Institutes of Health grant (1R21AI101152) to DWD. CMD is supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P661; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Girosi Federico, 2006, Nature, V444 Suppl 1, P3, DOI 10.1038/nature05441; GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70; *HONG KONG CHEST S, 1981, LANCET, V1, P171; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Law S, 2013, EUR RESPIR J; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Niemz A, 2012, EXPERT REV MOL DIAGN, V12, P687, DOI [10.1586/ERM.12.71, 10.1586/erm.12.71]; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; PARAMASIVAN CN, 1993, TUBERCLE LUNG DIS, V74, P23, DOI 10.1016/0962-8479(93)90064-5; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Revised National Tuberculosis Control Program I, 2011, PERFORMANCE DATA ON; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Smith SE, 2012, INT J TUBERC LUNG D, V16, P203, DOI 10.5588/ijtld.11.0445; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Styblo K, 1991, EPIDEMIOLOGY OF TUBE; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2008, ANTI TUBERCULOSIS DR; World Health Organization, 2008, MOLECULAR LINE PROBE; World Health Organization, 2011, AUTOMATED REAL TIME; World Health Organization, 2011, RAPID IMPLEMENTATION; World Health Organization, 2012, WHO MONITORING OF XP	57	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84197	10.1371/journal.pone.0084197	http://dx.doi.org/10.1371/journal.pone.0084197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404155	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800034
J	He, BJ; Soderlund, DM				He, Bingjun; Soderlund, David M.			Functional Expression of Rat Na(v)1.6 Voltage-Gated Sodium Channels in HEK293 Cells: Modulation by the Auxiliary beta 1 Subunit	PLOS ONE			English	Article							PURKINJE NEURONS; ALPHA-SUBUNIT; INACTIVATION; CURRENTS; BETA-1-SUBUNIT; COEXPRESSION; TEFLUTHRIN; LINE	The Na(v)1.6 voltage-gated sodium channel alpha subunit isoform is abundantly expressed in the adult rat brain. To assess the functional modulation of Na(v)1.6 channels by the auxiliary beta 1 subunit we expressed the rat Na(v)1.6 sodium channel alpha subunit by stable transformation in HEK293 cells either alone or in combination with the rat beta 1 subunit and assessed the properties of the reconstituted channels by recording sodium currents using the whole-cell patch clamp technique. Coexpression with the beta 1 subunit accelerated the inactivation of sodium currents and shifted the voltage dependence of channel activation and steady-state fast inactivation by approximately 5-7 mV in the direction of depolarization. By contrast the beta 1 subunit had no effect on the stability of sodium currents following repeated depolarizations at high frequencies. Our results define modulatory effects of the beta 1 subunit on the properties of rat Na(v)1.6-mediated sodium currents reconstituted in HEK293 cells that differ from effects measured previously in the Xenopus oocyte expression system. We also identify differences in the kinetic and gating properties of the rat Na(v)1.6 channel expressed in the absence of the beta 1 subunit compared to the properties of the orthologous mouse and human channels expressed in this system.	[He, Bingjun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Soderlund, David M.] Cornell Univ, Dept Entomol, Geneva, NY 14456 USA	Nankai University; Cornell University	Soderlund, DM (corresponding author), Cornell Univ, Dept Entomol, Geneva, NY 14456 USA.	dms6@cornell.edu			National Institute of Environmental Health Sciences, National Institutes of Health [R01-ES013686, R01-014591]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013686] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by grants (R01-ES013686 and R01-014591) from the National Institute of Environmental Health Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Dietrich PS, 1998, J NEUROCHEM, V70, P2262; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Ferrera L, 2006, EXP BRAIN RES, V172, P139, DOI 10.1007/s00221-005-0323-4; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Goldin AL., 2006, EXPRESSION ANAL RECO, P1; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; He BJ, 2011, TOXICOL APPL PHARM, V257, P377, DOI 10.1016/j.taap.2011.09.021; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Moran O, 2003, NEUROSCI LETT, V336, P175, DOI 10.1016/S0304-3940(02)01284-3; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Tan JG, 2011, PESTIC BIOCHEM PHYS, V101, P256, DOI 10.1016/j.pestbp.2011.10.003; Tan JG, 2011, BIOCHEM BIOPH RES CO, V407, P788, DOI 10.1016/j.bbrc.2011.03.101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Welch NC, 2008, NEUROPHARMACOLOGY, V55, P1165, DOI 10.1016/j.neuropharm.2008.07.015; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011	37	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85188	10.1371/journal.pone.0085188	http://dx.doi.org/10.1371/journal.pone.0085188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404202	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800081
J	Pyka, M; Cheng, S				Pyka, Martin; Cheng, Sen			Pattern Association and Consolidation Emerges from Connectivity Properties between Cortex and Hippocampus	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; CA3 NMDA RECEPTORS; SPATIAL MAP; MEMORY; RAT; MODEL; SEQUENCES; REPLAY; CELLS; AXONS	The basic structure of the cortico-hippocampal system is highly conserved across mammalian species. Comparatively few hippocampal neurons can represent and address a multitude of cortical patterns, establish associations between cortical patterns and consolidate these associations in the cortex. In this study, we investigate how elementary anatomical properties in the cortex-hippocampus loop along with synaptic plasticity contribute to these functions. Specifically, we focus on the high degree of connectivity between cortex and hippocampus leading to converging and diverging forward and backward projections and heterogenous synaptic transmission delays that result from the detached location of the hippocampus and its multiple loops. We found that in a model incorporating these concepts, each cortical pattern can evoke a unique spatio-temporal spiking pattern in hippocampal neurons. This hippocampal response facilitates a reliable disambiguation of learned associations and a bridging of a time interval larger than the time window of spike-timing dependent plasticity in the cortex. Moreover, we found that repeated retrieval of a stored association leads to a compression of the interval between cue presentation and retrieval of the associated pattern from the cortex. Neither a high degree of connectivity nor heterogenous synaptic delays alone is sufficient for this behavior. We conclude that basic anatomical properties between cortex and hippocampus implement mechanisms for representing and consolidating temporal information. Since our model reveals the observed functions for a range of parameters, we suggest that these functions are robust to evolutionary changes consistent with the preserved function of the hippocampal loop across different species.	[Pyka, Martin; Cheng, Sen] Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Bochum, Germany; [Pyka, Martin; Cheng, Sen] Ruhr Univ Bochum, Fac Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Pyka, M (corresponding author), Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Univ Str 150, Bochum, Germany.	martin.pyka@gmx.de	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB 874]; Stiftung Mercator	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Stiftung Mercator	This work was supported by a grant (SFB 874, project B2) from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) and a grant from the Stiftung Mercator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Carasatorre M, 2016, NEUROLOGIA, V31, P543, DOI 10.1016/j.nrl.2012.12.005; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, P1; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Eichenbaum H, 2013, TRENDS COGN SCI, V17, P81, DOI 10.1016/j.tics.2012.12.007; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hornby G., 2001, P 3 ANN C GENETIC EV, P868; INSAUSTI R, 1993, HIPPOCAMPUS, V3, P19; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Lall S, 2001, ANN REV GENETICS; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LEGENDY CR, 1967, MATH BIOSCI, V1, P555, DOI DOI 10.1016/0025-5564(67)90003-X; Levy W, 1983, NEUROSCIENCE, V8; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1989, NEUROBIOLOGY SPATIAL; Meeks JP, 2005, J PHYSIOL-LONDON, V566, P425, DOI 10.1113/jphysiol.2005.089086; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ohno M, 2005, LEARN MEMORY, V12, P211, DOI 10.1101/lm.90205; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Palm G, 1982, STUDIES BRAIN FUNCTI; PETIT TL, 1989, EXP NEUROL, V105, P72, DOI 10.1016/0014-4886(89)90173-8; Ragozzino ME, 2001, NEUROSCI LETT, V308, P145, DOI 10.1016/S0304-3940(01)02020-1; Risi S, 2013, CONFRONTING CHALLENG; Roland P E, 1984, Hum Neurobiol, V2, P205; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Rolls ET, 2006, REV NEUROSCIENCE, V17, P175; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Sakamoto T, 2005, BRAIN RES, V1039, P130, DOI 10.1016/j.brainres.2005.01.068; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Soleng AF, 2003, HIPPOCAMPUS, V13, P953, DOI 10.1002/hipo.10141; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stanley KO, 2009, ARTIF LIFE, V15, P1; Staresina B, 2006, J NEUROSCIENCE; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stein B.E., 1993, COGNITIVE NEUROSCIEN, P2; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Waddington A, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00088; Walton ME, 2002, J NEUROSCI, V22, P10996; Wharton C, 1998, TRENDS COGNITIVE SCI; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341	75	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85016	10.1371/journal.pone.0085016	http://dx.doi.org/10.1371/journal.pone.0085016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404200	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800079
J	Tomaiuolo, G; Rusciano, G; Caserta, S; Carciati, A; Carnovale, V; Abete, P; Sasso, A; Guido, S				Tomaiuolo, Giovanna; Rusciano, Giulia; Caserta, Sergio; Carciati, Antonio; Carnovale, Vincenzo; Abete, Pasquale; Sasso, Antonio; Guido, Stefano			A New Method to Improve the Clinical Evaluation of Cystic Fibrosis Patients by Mucus Viscoelastic Properties	PLOS ONE			English	Article							SPUTUM; DYNAMICS; RHEOLOGY; DISEASE; TISSUE	In cystic fibrosis (CF) patients airways mucus shows an increased viscoelasticity due to the concentration of high molecular weight components. Such mucus thickening eventually leads to bacterial overgrowth and prevents mucus clearance. The altered rheological behavior of mucus results in chronic lung infection and inflammation, which causes most of the cases of morbidity and mortality, although the cystic fibrosis complications affect other organs as well. Here, we present a quantitative study on the correlation between cystic fibrosis mucus viscoelasticity and patients clinical status. In particular, a new diagnostic parameter based on the correlation between CF sputum viscoelastic properties and the severity of the disease, expressed in terms of FEV1 and bacterial colonization, was developed. By using principal component analysis, we show that the types of colonization and FEV1 classes are significantly correlated to the elastic modulus, and that the latter can be used for CF severity classification with a high predictive efficiency (88%). The data presented here show that the elastic modulus of airways mucus, given the high predictive efficiency, could be used as a new clinical parameter in the prognostic evaluation of cystic fibrosis.	[Tomaiuolo, Giovanna; Caserta, Sergio; Carciati, Antonio; Guido, Stefano] Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy; [Tomaiuolo, Giovanna; Caserta, Sergio; Guido, Stefano] CEINGE Adv Biotechnol, Naples, Italy; [Rusciano, Giulia; Sasso, Antonio] Complesso Univ MS Angelo, Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [Carnovale, Vincenzo; Abete, Pasquale] Univ Naples Federico II, Dipartimento Sci Med Traslaz, Unita Fibrosi Cist Adulto, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	Tomaiuolo, G (corresponding author), Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy.	g.tomaiuolo@unina.it	Tomaiuolo, Giovanna/K-8312-2019; Caserta, Sergio/E-4602-2012; Abete, Pasquale/AAC-2455-2022; Guido, Stefano/B-9928-2011; Rusciano, Giulia/A-2079-2010	Caserta, Sergio/0000-0002-4400-0059; Abete, Pasquale/0000-0002-4585-5390; Guido, Stefano/0000-0002-9247-6852; Rusciano, Giulia/0000-0002-7152-5352; Sasso, Antonio/0000-0003-3591-3531; Tomaiuolo, Giovanna/0000-0003-3012-0356; Carnovale, Vincenzo/0000-0002-4246-6883	Italian Ministry of Research under PRIN program	Italian Ministry of Research under PRIN program	Financial support from the Italian Ministry of Research under PRIN 2008 program is gratefully acknowledged. http://prin.miur.it/index.php?pag=2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060448; Amato F, 2012, J MOL DIAGN, V14, P81, DOI 10.1016/j.jmoldx.2011.09.001; Caserta S, 2005, CHEM ENG SCI, V60, P1019, DOI 10.1016/j.ces.2004.09.076; Caserta S, 2012, LANGMUIR, V28, P16254, DOI 10.1021/la303232w; Caserta S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137801; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; DAVIS S S, 1969, Biorheology, V6, P11; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; de Jong BWD, 2006, ANAL CHEM, V78, P7761, DOI 10.1021/ac061417b; Feng W, 1998, AM J RESP CRIT CARE, V157, P710, DOI 10.1164/ajrccm.157.3.9703059; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Giordano S, 2013, J MOL DIAGN, V15, P331, DOI 10.1016/j.jmoldx.2013.01.001; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Jolliffe, 2002, PRINCIPAL COMPONENT; Jonas A, 2010, LANGMUIR, V26, P14223, DOI 10.1021/la101498h; King M, 1997, AM J RESP CRIT CARE, V156, P173, DOI 10.1164/ajrccm.156.1.9512074; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Livak-Dahl E, 2013, LAB CHIP, V13, P297, DOI 10.1039/c2lc41130j; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Minale M, 2010, LANGMUIR, V26, P126, DOI 10.1021/la902187a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Serisier DJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-63; Sheppard M., 2002, CURR DIAGN PATHOL, V8, P50, DOI 10.1054/cdip.2001.0088; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Tomaiuolo G, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4721811; Tomaiuolo G, 2011, MICROVASC RES, V82, P35, DOI 10.1016/j.mvr.2011.03.004; Tomaiuolo G, 2011, LAB CHIP, V11, P449, DOI [10.1039/c0lc00348d, 10.1039/c01c00348d]; Tomaiuolo R, 2011, CLIN CHEM LAB MED, V49, P1289, DOI 10.1515/CCLM.2011.637; Vandenginste B.G.M., 1998, HDB CHEMOMETRICS QUA; Vij N, 2013, AM J RESP CRIT CARE, V187, P120, DOI 10.1164/rccm.201211-2011ED; Voter KZ, 2008, CLIN REV ALLERG IMMU, V35, P100, DOI 10.1007/s12016-008-8078-x; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC	38	31	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82297	10.1371/journal.pone.0082297	http://dx.doi.org/10.1371/journal.pone.0082297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404129	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800008
J	Cengiz, P; Kintner, DB; Chanana, V; Yuan, H; Akture, E; Kendigelen, P; Begum, G; Fidan, E; Uluc, K; Ferrazzano, P; Sun, DD				Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Yuan, Hui; Akture, Erinc; Kendigelen, Pinar; Begum, Gulnaz; Fidan, Emin; Uluc, Kutluay; Ferrazzano, Peter; Sun, Dandan			Sustained Na+/H+ Exchanger Activation Promotes Gliotransmitter Release from Reactive Hippocampal Astrocytes following Oxygen-Glucose Deprivation	PLOS ONE			English	Article							INTRACELLULAR PH REGULATION; CULTURED ASTROCYTES; IN-VITRO; GLUTAMATE TRANSPORTER; RAT HIPPOCAMPUS; KAPPA-B; EXPRESSION; ISOFORM-1; INHIBITION; PHOSPHORYLATION	Hypoxia ischemia (HI)-related brain injury is the major cause of long-term morbidity in neonates. One characteristic hallmark of neonatal HI is the development of reactive astrogliosis in the hippocampus. However, the impact of reactive astrogliosis in hippocampal damage after neonatal HI is not fully understood. In the current study, we investigated the role of Na+/H+ exchanger isoform 1 (NHE1) protein in mouse reactive hippocampal astrocyte function in an in vitro ischemia model (oxygen/glucose deprivation and reoxygenation, OGD/REOX). 2 h OGD significantly increased NHE1 protein expression and NHE1-mediated H+ efflux in hippocampal astrocytes. NHE1 activity remained stimulated during 1-5 h REOX and returned to the basal level at 24 h REOX. NHE1 activation in hippocampal astrocytes resulted in intracellular Na+ and Ca2+ overload. The latter was mediated by reversal of Na+/Ca2+ exchange. Hippocampal astrocytes also exhibited a robust release of gliotransmitters (glutamate and pro-inflammatory cytokines IL-6 and TNF alpha) during 1-24 h REOX. Interestingly, inhibition of NHE1 activity with its potent inhibitor HOE 642 not only reduced Na+ overload but also gliotransmitter release from hippocampal astrocytes. The noncompetitive excitatory amino acid transporter inhibitor TBOA showed a similar effect on blocking the glutamate release. Taken together, we concluded that NHE1 plays an essential role in maintaining H+ homeostasis in hippocampal astrocytes. Over-stimulation of NHE1 activity following in vitro ischemia disrupts Na+ and Ca2+ homeostasis, which reduces Na+-dependent glutamate uptake and promotes release of glutamate and cytokines from reactive astrocytes. Therefore, blocking sustained NHE1 activation in reactive astrocytes may provide neuroprotection following HI.	[Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Kendigelen, Pinar; Fidan, Emin; Ferrazzano, Peter] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Ferrazzano, Peter] Univ Wisconsin, Dept Waisman Ctr, Sch Med & Publ Hlth, Madison, WI USA; [Akture, Erinc; Uluc, Kutluay] Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, Madison, WI USA; [Yuan, Hui; Begum, Gulnaz; Sun, Dandan] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Kendigelen, Pinar] Istanbul Univ, Cerrahpasa Med Sch, Dept Anesthesiol, Istanbul, Turkey	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Istanbul University; Istanbul University - Cerrahpasa	Cengiz, P (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	cengiz@pediatrics.wisc.edu	KENDIGELEN, PINAR/U-8532-2017; sun, dandan/GZG-6540-2022; chanana, vishal/F-3738-2014	KENDIGELEN, PINAR/0000-0001-6224-0585; 	National Institutes of Health (NIH) [RO1NS38118, RO1NS48216, P30 HD03352]; Univ. of Wis. Dept. of Pediatrics.;  [CTSA/NCATS: UL1 TR0000427]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, KL2TR000428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048216, R01NS038118] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Univ. of Wis. Dept. of Pediatrics.; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) RO1NS38118, RO1NS48216 (Sun D) and P30 HD03352 (Waisman Center); Univ. of Wis. Dept. of Pediatrics., R&D grant (Cengiz P), CTSA/NCATS: UL1 TR0000427 (Cengiz P and Ferrazzano P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baker-Andresen D, 2013, LEARN MEMORY, V20, P237, DOI 10.1101/lm.029520.112; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; BOYARSKY G, 1993, GLIA, V8, P241, DOI 10.1002/glia.440080404; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cengiz P, 2011, ANTIOXID REDOX SIGN, V14, P1803, DOI 10.1089/ars.2010.3468; Chen Shih-Heng, 2013, Methods Mol Biol, V1041, P231, DOI 10.1007/978-1-62703-520-0_21; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Lai PC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-69; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Li S, 1999, J Neurosci, V19, pRC16; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; LONGUEMARE MC, 1995, J NEUROSCI RES, V40, P379, DOI 10.1002/jnr.490400312; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Luo J, 2007, J BIOL CHEM, V282, P28274, DOI 10.1074/jbc.M702373200; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; McKhann GM, 1997, J NEUROSCI, V17, P6850; MILLER RT, 1991, J BIOL CHEM, V266, P10813; OGATA T, 1995, NEUROCHEM RES, V20, P737, DOI 10.1007/BF01705543; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; Rutledge EM, 1996, J NEUROSCI, V16, P7803; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Swanson RA, 1997, J NEUROSCI, V17, P932; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wang YP, 2008, EUR J NEUROSCI, V28, P51, DOI 10.1111/j.1460-9568.2008.06304.x; WUTTKE WA, 1990, NEUROSCI LETT, V117, P105, DOI 10.1016/0304-3940(90)90127-U; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie MJ, 2008, J CEREBR BLOOD F MET, V28, P456, DOI 10.1038/sj.jcbfm.9600545; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011; Xue J, 2003, NEUROSCIENCE, V122, P37, DOI 10.1016/S0306-4522(03)00598-0; Zeevalk GD, 1998, J NEUROCHEM, V71, P2373	53	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84294	10.1371/journal.pone.0084294	http://dx.doi.org/10.1371/journal.pone.0084294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392123	gold, Green Accepted, Green Published			2022-12-25	WOS:000329460100046
J	Kheradpisheh, SR; Nowzari-Dalini, A; Ebrahimpour, R; Ganjtabesh, M				Kheradpisheh, Saeed Reza; Nowzari-Dalini, Abbas; Ebrahimpour, Reza; Ganjtabesh, Mohammad			An Evidence-Based Combining Classifier for Brain Signal Analysis	PLOS ONE			English	Article							SINGLE-TRIAL EEG; COMPUTER INTERFACES; SPATIAL FILTERS; COMBINATION; BCI; MOVEMENT; ENSEMBLE	Nowadays, brain signals are employed in various scientific and practical fields such as Medical Science, Cognitive Science, Neuroscience, and Brain Computer Interfaces. Hence, the need for robust signal analysis methods with adequate accuracy and generalizability is inevitable. The brain signal analysis is faced with complex challenges including small sample size, high dimensionality and noisy signals. Moreover, because of the non-stationarity of brain signals and the impacts of mental states on brain function, the brain signals are associated with an inherent uncertainty. In this paper, an evidence-based combining classifiers method is proposed for brain signal analysis. This method exploits the power of combining classifiers for solving complex problems and the ability of evidence theory to model as well as to reduce the existing uncertainty. The proposed method models the uncertainty in the labels of training samples in each feature space by assigning soft and crisp labels to them. Then, some classifiers are employed to approximate the belief function corresponding to each feature space. By combining the evidence raised from each classifier through the evidence theory, more confident decisions about testing samples can be made. The obtained results by the proposed method compared to some other evidence-based and fixed rule combining methods on artificial and real datasets exhibit the ability of the proposed method in dealing with complex and uncertain classification problems.	[Kheradpisheh, Saeed Reza; Nowzari-Dalini, Abbas; Ganjtabesh, Mohammad] Univ Tehran, Sch Math Stat & Comp Sci, Dept Comp Sci, Tehran, Iran; [Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab, Tehran, Iran; [Kheradpisheh, Saeed Reza; Ebrahimpour, Reza; Ganjtabesh, Mohammad] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran	University of Tehran; Shahid Rajaee Teacher Training University (SRTTU)	Ebrahimpour, R (corresponding author), Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab, Tehran, Iran.	ebrahimpour@ipm.ir	nowzari-dalini, abbas/X-8074-2019; Kheradpisheh, Saeed Reza/Q-1161-2017; Ebrahimpour, Reza/AAH-8531-2019; Ebrahimpour, Reza/A-9721-2009	Kheradpisheh, Saeed Reza/0000-0001-6168-4379; Ebrahimpour, Reza/0000-0002-7013-8078; 				Alexandre LA, 2001, PATTERN RECOGN LETT, V22, P1283, DOI 10.1016/S0167-8655(01)00073-3; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; ARROYO S, 1993, ELECTROEN CLIN NEURO, V87, P76, DOI 10.1016/0013-4694(93)90114-B; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Brunner C, 2008, BCI COMPETITION 2008; Cobb BR, 2006, INT J APPROX REASON, V41, P314, DOI 10.1016/j.ijar.2005.06.008; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Ebrahimpour Reza, 2012, 2012 16th CSI International Symposium on Artificial Intelligence and Signal Processing (AISP), P458, DOI 10.1109/AISP.2012.6313791; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Furdea A, 2012, J NEUROSCI METH, V203, P233, DOI 10.1016/j.jneumeth.2011.09.013; Hayashi I, 2012, 2012 IEEE INT C FUZZ, P1; Herman P, 2005, P ANN INT IEEE EMBS, P5354, DOI 10.1109/IEMBS.2005.1615691; Hsu WY, 2010, J NEUROSCI METH, V189, P295, DOI 10.1016/j.jneumeth.2010.03.030; Hui-Min Feng, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P332, DOI 10.1109/ICMLC.2010.5581040; Kheradpisheh SR, 2013, APPL SOFT COMPUT, V13, P4570, DOI 10.1016/j.asoc.2013.07.028; Khorshidtalab A, 2011, 2011 4 INT C MECH IC, P1, DOI DOI 10.1109/1COM.2011.5937154; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Kuncheva LI, 2002, IEEE T PATTERN ANAL, V24, P281, DOI 10.1109/34.982906; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lin CJ, 2009, NEUROCOMPUTING, V72, P1121, DOI 10.1016/j.neucom.2008.02.017; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Millan JD, 2004, IEEE IJCNN, P2877; Millan JD, 2003, IEEE T NEUR SYS REH, V11, P159, DOI 10.1109/TNSRE.2003.814435; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Naseem I, 2010, COMBINING CLASSIFIER; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Qin JZ, 2005, LECT NOTES COMPUT SC, V3496, P973; Quost B., 2009, P 1 ACM SIGKDD WORKS, P38; Quost B, 2007, PATTERN RECOGN LETT, V28, P644, DOI 10.1016/j.patrec.2006.11.002; Rakotomamonjy A, 2005, LECT NOTES COMPUT SC, V3696, P45, DOI 10.1007/11550822_8; ROGOVA G, 1994, NEURAL NETWORKS, V7, P777, DOI 10.1016/0893-6080(94)90099-X; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Ruta D., 2005, Information Fusion, V6, P63, DOI 10.1016/j.inffus.2004.04.008; Sanei S, 2007, EEG SIGNAL PROCESSIN; Shafer G., 1976, MATH THEORY EVIDENCE; Smets P, 2005, INT J APPROX REASON, V38, P133, DOI 10.1016/j.ijar.2004.05.003; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Soria-Frisch A, 2013, PRACTICAL BRAIN COMP, P41; Sun SL, 2007, PATTERN RECOGN LETT, V28, P2157, DOI 10.1016/j.patrec.2007.06.018; Tabassian M, 2012, EXPERT SYST APPL, V39, P1698, DOI 10.1016/j.eswa.2011.06.061; Tao Geng, 2010, International Journal of Advanced Mechatronic Systems, V2, P28, DOI 10.1504/IJAMECHS.2010.030846; Ubeyli ED, 2009, DIGIT SIGNAL PROCESS, V19, P297, DOI 10.1016/j.dsp.2008.07.004; Ulas A, 2009, INFORM SCIENCES, V179, P1298, DOI 10.1016/j.ins.2008.12.024; Wang D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00151; Wu W, 2005, P ANN INT IEEE EMBS, P2387; Windeatt T., 2003, Information Fusion, V4, P11, DOI 10.1016/S1566-2535(02)00101-X; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu SL, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE, COGNITIVE ALGORITHMS, MIND, AND BRAIN (CCMB), P146, DOI 10.1109/CCMB.2013.6609178; Yager RR, 2008, STUD FUZZ SOFT COMP, V219, P1, DOI 10.1007/978-3-540-44792-4; Yazdani A, 2009, I IEEE EMBS C NEUR E, P320	56	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84341	10.1371/journal.pone.0084341	http://dx.doi.org/10.1371/journal.pone.0084341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392125	Green Published, gold			2022-12-25	WOS:000329460100048
J	Sotgia, S; Zinellu, A; Mangoni, AA; Pintus, G; Attia, J; Carru, C; McEvoy, M				Sotgia, Salvatore; Zinellu, Angelo; Mangoni, Arduino A.; Pintus, Gianfranco; Attia, John; Carru, Ciriaco; McEvoy, Mark			Clinical and Biochemical Correlates of Serum L-Ergothioneine Concentrations in Community-Dwelling Middle-Aged and Older Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PLASMA TOTAL HOMOCYSTEINE; CAPILLARY-ELECTROPHORESIS; CATION TRANSPORTER; GENES; ASSOCIATION; PERFORMANCE; SLC22A4; BLOOD	Background: Despite the increasing interest towards the biological role of L-ergothioneine, little is known about the serum concentrations of this unusual aminothiol in older adults. We addressed this issue in a representative sample of community-dwelling middle-aged and older adults. Methods: Body mass index, estimated glomerular filtration rate, serum concentrations of L-ergothioneine, taurine, homocysteine, cysteine, glutathione, cysteinylglycine, and glutamylcysteine were evaluated in 439 subjects (age 55-85 years) randomly selected from the Hunter Community Study. Results: Median L-ergothioneine concentration in the entire cohort was 1.01 IQR 0.78-1.33 mu mol/L. Concentrations were not affected by gender (P = 0.41) or by presence of chronic medical conditions (P = 0.15). By considering only healthy subjects, we defined a reference interval for L-ergothioneine serum concentrations from 0.36 (90% CI 0.31-0.44) to 3.08 (90% CI 2.45-3.76) mu mol/L. Using stepwise multiple linear regression analysis L-ergothioneine was negatively correlated with age (rpartial = -0.15; P = 0.0018) and with glutamylcysteine concentrations (rpartial = -0.13; P = 0.0063). Conclusions: A thorough analysis of serum L-ergothioneine concentrations was performed in a large group of community-dwelling middle-aged and older adults. Reference intervals were established. Age and glutamylcysteine were independently negatively associated with L-ergothioneine serum concentration.	[Sotgia, Salvatore; Zinellu, Angelo; Pintus, Gianfranco; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Mangoni, Arduino A.] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA 5001, Australia; [Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Level Hunter Med Res Inst 3, Newcastle, NSW 2300, Australia; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of Sassari; Flinders University South Australia; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Sotgia, S (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	salvatore.sotgia@gmail.com	Attia, John R/F-5376-2013; Pintus, Gianfranco/C-2975-2009; Carru, Ciriaco/AAI-9996-2021; Mangoni, Arduino Aleksander/I-5109-2019; Sotgia, Salvatore/T-6598-2019	Attia, John R/0000-0001-9800-1308; Pintus, Gianfranco/0000-0002-3031-7733; Mangoni, Arduino Aleksander/0000-0001-8699-1412; Zinellu, Angelo/0000-0002-8396-0968; Carru, Ciriaco/0000-0002-6985-4907; McEvoy, Mark/0000-0002-5505-5557; Sotgia, Salvatore/0000-0002-3717-3437	University of Newcastle Strategic Initiative Fund; "Fondazione Banco di Sardegna - Sassari'' Italy; "Ministero dell'Universita e della Ricerca'' Italy	University of Newcastle Strategic Initiative Fund; "Fondazione Banco di Sardegna - Sassari'' Italy(Fondazione Banco di Sardegna); "Ministero dell'Universita e della Ricerca'' Italy(Ministry of Education, Universities and Research (MIUR))	Funding were provided by the University of Newcastle Strategic Initiative Fund, by the "Fondazione Banco di Sardegna - Sassari'' Italy, and by the "Ministero dell'Universita e della Ricerca'' Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, C28A3 CLSI; Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Aruoma OI, 1999, FOOD CHEM TOXICOL, V37, P1043, DOI 10.1016/S0278-6915(99)00098-8; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Grundemann D, 2012, PREV MED, V54, pS71, DOI 10.1016/j.ypmed.2011.12.001; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Kimmons Joel E, 2006, MedGenMed, V8, P59; Kumosani TA, 2001, EXP MOL MED, V33, P20, DOI 10.1038/emm.2001.4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Mitsuyama H, 1999, CLIN SCI, V97, P407, DOI 10.1042/CS19990111; Nakamura YK, 2012, LIFE SCI, V90, P116, DOI 10.1016/j.lfs.2011.10.016; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pfeiffer C, 2011, FOOD CHEM, V129, P1766, DOI 10.1016/j.foodchem.2011.06.047; Quintana-Cabrera R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1722; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Santiago JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-54; Schauss AG, 2010, TOXICOLOGY, V278, P39, DOI 10.1016/j.tox.2010.07.015; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Sotgia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070374; Sotgia S, 2013, J SEP SCI, V36, P1002, DOI 10.1002/jssc.201201016; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Waller S, 2006, GUT, V55, P809, DOI 10.1136/gut.2005.084574; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Zinellu A, 2003, ELECTROPHORESIS, V24, P2796, DOI 10.1002/elps.200305570; Zinellu A, 2009, AMINO ACIDS, V36, P35, DOI 10.1007/s00726-007-0022-5	30	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84918	10.1371/journal.pone.0084918	http://dx.doi.org/10.1371/journal.pone.0084918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392160	Green Published, gold			2022-12-25	WOS:000329460100083
J	Zhang, Y; Yang, E; Pu, J; Liu, LD; Che, YC; Wang, JJ; Liao, Y; Wang, LC; Ding, D; Zhao, T; Ma, N; Song, M; Wang, X; Shen, D; Tang, DH; Huang, HT; Zhang, ZX; Chen, D; Feng, MF; Li, QH				Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Chen, Dai; Feng, Mingfei; Li, Qihan			The Gene Expression Profile of Peripheral Blood Mononuclear Cells from EV71-Infected Rhesus Infants and the Significance in Viral Pathogenesis	PLOS ONE			English	Article							SUBSTANCE-P; CHEMOKINE RELEASE; GRO-ALPHA; IL-17; ENTEROVIRUS-71; CYTOKINES; PROTEIN; NEUROPEPTIDES; TACHYKININS; LYMPHOCYTES	Enterovirus 71 (EV71) is the major pathogen responsible for fatal hand, foot and mouth disease (HFMD). Our previous work reported on an EV71-infected rhesus monkey infant model that presented with histo-pathologic changes of the central nervous system (CNS) and lungs. This study is focused on the correlated modulation of gene expression in the peripheral blood mononuclear cells (PBMCs) from EV71-infected rhesus monkey infants. The expression of more than 500 functional genes associated with multiple pathways was modulated. The expression of genes associated with immune inflammatory responses was up-regulated during the period from days 4 to 10 post-infection. The expression of two genes (TAC1 and IL17A), which play major roles in inflammatory reactions, was remarkably up-regulated during the infection period. Furthermore, a higher expression level of the TAC1 gene was identified in the CNS compared to the lungs, but a high expression level of the IL-17A gene was observed in the lungs and not in the CNS. The results of this study suggest at least two facts about EV71 infection, which are that: the TAC1 gene that encodes substance P and neurokinin-A is present in both PBMCs and the hypothalamus; and the up-regulation of IL-17A is sustained in the peripheral blood.	[Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Li, Qihan] Peking Union Med Coll, Kunming, Peoples R China; [Chen, Dai; Feng, Mingfei] Novel Bioinformat Co Ltd, Dept Bioinformat Anal, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	liqihan@imbcams.com.cn		Zhang, Zhixiao/0000-0002-2307-880X	National Basic Research Program [2011CB504903, 2012CB518901]; National High-Tech RD Program [2012AA02A404]; National Natural Sciences Foundation of China [81171573, 31100127]; Yunnan Natural Science Foundation [2011FB116]; Youth Foundation of Peking Union Medical College [3332013083]	National Basic Research Program(National Basic Research Program of China); National High-Tech RD Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Youth Foundation of Peking Union Medical College	This work was supported by the National Basic Research Program (2011CB504903 and 2012CB518901), National High-Tech R&D Program (2012AA02A404), National Natural Sciences Foundation of China (81171573 and 31100127), the Yunnan Natural Science Foundation (2011FB116) and Youth Foundation of Peking Union Medical College (3332013083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA H, 1990, RESPIRATION, V57, P338; Anim L, 2011, GUIDE CARE USE LAB A; Arita M, 2006, J GEN VIROL, V87, P3317, DOI 10.1099/vir.0.82172-0; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1391, DOI 10.1164/ajrccm/144.6.1391; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1187, DOI 10.1164/ajrccm/144.5.1187; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chen HC, 2012, VIROLOGY, V432, P417, DOI 10.1016/j.virol.2012.06.026; Chen LCYT, 2009, J BIOMED LAB SCI, V21, P82; Chen R, 1999, CLIN CHEM, V45, P1693; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; China, 2006, GUIDANCE EXPT ANIMAL; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; Delves PJ, 2017, ROITTS ESSENTIAL IMM; HALL AK, 1989, BRIT J PHARMACOL, V97, P274, DOI 10.1111/j.1476-5381.1989.tb11951.x; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; HARTUNG HP, 1983, EUR J PHARMACOL, V89, P301, DOI 10.1016/0014-2999(83)90511-3; Ho WZ, 1997, J IMMUNOL, V159, P5654; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-147; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Laan M, 1999, J IMMUNOL, V162, P2347; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Liu LD, 2011, VIROLOGY, V412, P91, DOI 10.1016/j.virol.2010.12.058; LUNDBERG JM, 1987, ANNU REV PHYSIOL, V49, P557; Ma Shao-hui, 2009, Virologica Sinica, V24, P162, DOI 10.1007/s12250-009-3033-4; MAGGI CA, 1993, EUR RESPIR J, V6, P735; Maggi CA, 2000, REGUL PEPTIDES, V93, P53, DOI 10.1016/S0167-0115(00)00177-4; Marui T, 2007, BRAIN DEV-JPN, V29, P510, DOI 10.1016/j.braindev.2007.01.010; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Page NM, 2003, P NATL ACAD SCI USA, V100, P6245, DOI 10.1073/pnas.0931458100; PAYAN DG, 1989, ANNU REV MED, V40, P341; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang JJ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.44; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; *WHO, 1988, PROC US LYOPH LBM PO; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Zaborowska J, 2012, TRANSCR-AUSTIN, V3, P92, DOI 10.4161/trns.19783; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82	62	5	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83766	10.1371/journal.pone.0083766	http://dx.doi.org/10.1371/journal.pone.0083766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392094	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100018
J	Haimerl, M; Verloh, N; Zeman, F; Fellner, C; Muller-Wille, R; Schreyer, AG; Stroszczynski, C; Wiggermann, P				Haimerl, Michael; Verloh, Niklas; Zeman, Florian; Fellner, Claudia; Mueller-Wille, Rene; Schreyer, Andreas G.; Stroszczynski, Christian; Wiggermann, Philipp			Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI	PLOS ONE			English	Article							RELAXATION-TIME; HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-EVALUATION; MOLECULAR-MECHANISMS; CHRONIC HEPATITIS; CONTRAST AGENT; PHASE-III; FIBROSIS; RATS; INFECTION	Objectives: To assess the differences between normal and cirrhotic livers by means of T1 mapping of liver parenchyma on gadoxetic acid (Gd-EOB-DTPA)-enhanced 3 Tesla (3T) MR imaging (MRI). Methods: 162 patients with normal (n = 96) and cirrhotic livers (n = 66; Child-Pugh class A, n = 30; B, n = 28; C, n = 8) underwent Gd-EOB-DTPA-enhanced 3T MRI. To obtain T1 maps, two TurboFLASH sequences (TI = 400 ms and 1000 ms) before and 20 min after Gd-EOB-DTPA administration were acquired. T1 relaxation times of the liver and the reduction rate between pre-and post-contrast enhancement images were measured. Results: The T1 relaxation times for Gd-EOB-DTPA-enhanced MRI showed significant differences between patients with normal liver function and patients with Child-Pugh class A, B, and C (p < 0.001). The T1 relaxation times showed a constant significant increase from Child-Pugh class A up to class C (Child-Pugh class A, 335 ms +/- 80 ms; B, 431 ms +/- 75 ms; C, 557 ms +/- 99 ms; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001) and a constant decrease of the reduction rate of T1 relaxation times (Child-Pugh class A, 57.1% +/- 8.8%; B, 44.3% +/- 10.2%, C, 29.9% +/- 6.9%; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001). Conclusion: Gd-EOB-DTPA-enhanced T1 mapping of the liver parenchyma may present a useful method for determining severity of liver cirrhosis.	[Haimerl, Michael; Verloh, Niklas; Fellner, Claudia; Mueller-Wille, Rene; Schreyer, Andreas G.; Stroszczynski, Christian; Wiggermann, Philipp] Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany; [Zeman, Florian] Univ Hosp Regensburg, Ctr Clin Trials, Regensburg, Germany	University of Regensburg; University of Regensburg	Haimerl, M (corresponding author), Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany.	michael.haimerl@ukr.de	Zeman, Florian/GNH-3239-2022; Wiggermann, Philipp/AAY-6759-2021; Schreye, Andreas/ABC-3197-2020; Verloh, Niklas/AAS-5386-2021; WIGGERMANN, Philipp/AAX-6721-2021	Verloh, Niklas/0000-0002-8424-5827; Schreyer, Andreas/0000-0002-2539-059X				AISEN AM, 1994, MAGNET RESON MED, V31, P551, DOI 10.1002/mrm.1910310513; Aube C, 2007, DIGEST DIS SCI, V52, P2601, DOI 10.1007/s10620-006-9143-z; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bota S, 2012, ULTRASOUND MED BIOL, V38, P1103, DOI 10.1016/j.ultrasmedbio.2012.02.032; CHAMULEAU RAFM, 1988, HEPATOLOGY, V8, P217, DOI 10.1002/hep.1840080204; Chow AM, 2012, J MAGN RESON IMAGING, V36, P152, DOI 10.1002/jmri.23606; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; GOLDBERG HI, 1984, RADIOLOGY, V153, P737, DOI 10.1148/radiology.153.3.6494469; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Heye T, 2012, EUR RADIOL, V22, P1224, DOI 10.1007/s00330-012-2378-5; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Ito K, 1999, RADIOLOGY, V212, P235, DOI 10.1148/radiology.212.1.r99jl41235; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Kim AI, 2005, AM J MED, V118, P808, DOI 10.1016/j.amjmed.2005.01.073; Kim KA, 2012, J MAGN RESON IMAGING, V36, P405, DOI 10.1002/jmri.23620; Kreft B, 1999, INVEST RADIOL, V34, P360, DOI 10.1097/00004424-199905000-00006; Kumada H, 2010, HEPATOL RES, V40, P1, DOI 10.1111/j.1872-034X.2009.00633.x; LEE JKT, 1990, RADIOLOGY, V177, P21, DOI 10.1148/radiology.177.1.2399319; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Nojiri S, 2013, J GASTROENTEROL HEPA; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; THOMSEN C, 1990, MAGN RESON IMAGING, V8, P599, DOI 10.1016/0730-725X(90)90137-Q; Tschirch FTC, 2008, EUR RADIOL, V18, P1577, DOI 10.1007/s00330-008-0929-6; Tsuda N, 2007, INVEST RADIOL, V42, P242, DOI 10.1097/01.rli.0000258058.44876.a5; Tsuda N, 2011, J GASTROEN HEPATOL, V26, P568, DOI 10.1111/j.1440-1746.2010.06494.x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43	35	70	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85658	10.1371/journal.pone.0085658	http://dx.doi.org/10.1371/journal.pone.0085658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392025	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900169
J	Karnik, R; Ludlow, MJ; Abuarab, N; Smith, AJ; Hardy, MEL; Elliott, DJS; Sivaprasadarao, A				Karnik, Rucha; Ludlow, Melanie J.; Abuarab, Nada; Smith, Andrew J.; Hardy, Matthew E. L.; Elliott, David J. S.; Sivaprasadarao, Asipu			Endocytosis of hERG Is Clathrin-Independent and Involves Arf6	PLOS ONE			English	Article							LONG QT SYNDROME; K+ CHANNEL FUNCTION; CELL-SURFACE; POTASSIUM CHANNELS; RAB GTPASES; LIPID RAFTS; TRAFFICKING; MECHANISMS; ENDOSOMES; DEGRADATION	The hERG potassium channel is critical for repolarisation of the cardiac action potential. Reduced expression of hERG at the plasma membrane, whether caused by hereditary mutations or drugs, results in long QT syndrome and increases the risk of ventricular arrhythmias. Thus, it is of fundamental importance to understand how the density of this channel at the plasma membrane is regulated. We used antibodies to an extracellular native or engineered epitope, in conjunction with immunofluorescence and ELISA, to investigate the mechanism of hERG endocytosis in recombinant cells and validated the findings in rat neonatal cardiac myocytes. The data reveal that this channel undergoes rapid internalisation, which is inhibited by neither dynasore, an inhibitor of dynamin, nor a dominant negative construct of Rab5a, into endosomes that are largely devoid of the transferrin receptor. These results support a clathrin-independent mechanism of endocytosis and exclude involvement of dynamin-dependent caveolin and RhoA mechanisms. In agreement, internalised hERG displayed marked overlap with glycosylphosphatidylinositol-anchored GFP, a clathrin-independent cargo. Endocytosis was significantly affected by cholesterol extraction with methyl-beta-cyclodextrin and inhibition of Arf6 function with dominant negative Arf6-T27N-eGFP. Taken together, we conclude that hERG undergoes clathrin-independent endocytosis via a mechanism involving Arf6.	[Karnik, Rucha; Ludlow, Melanie J.; Abuarab, Nada; Smith, Andrew J.; Hardy, Matthew E. L.; Elliott, David J. S.; Sivaprasadarao, Asipu] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Ludlow, Melanie J.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Multidisciplinary Cardiovasc Ctr, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk	Hardy, Matt/ABD-1397-2022	Hardy, Matt/0000-0002-3129-9549; Ludlow, Melanie/0000-0002-0720-5581; Sivaprasadarao, Asipu/0000-0002-6755-3502; Karnik, Rucha Anil/0000-0001-6876-4099	British Heart Foundation [PG/10/68/28528]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (grant number PG/10/68/28528; http://www.bhf.org. uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dennis AT, 2011, J BIOL CHEM, V286, P34413, DOI 10.1074/jbc.M111.254367; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; El Azreq MA, 2010, J IMMUNOL, V184, P637, DOI 10.4049/jimmunol.0901654; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ganapathi SB, 2010, AM J PHYSIOL-CELL PH, V299, pC74, DOI 10.1152/ajpcell.00462.2009; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mitcheson JS, 2008, CHEM RES TOXICOL, V21, P1005, DOI 10.1021/tx800035b; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Ramstrom C, 2010, CELL MOL LIFE SCI, V67, P157, DOI 10.1007/s00018-009-0176-2; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rodman JS, 2000, J CELL SCI, V113, P183; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	70	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85630	10.1371/journal.pone.0085630	http://dx.doi.org/10.1371/journal.pone.0085630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392021	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329323900165
J	Park, J; Werley, CA; Venkatachalam, V; Kralj, JM; Dib-Hajj, SD; Waxman, SG; Cohen, AE				Park, Jeehae; Werley, Christopher A.; Venkatachalam, Veena; Kralj, Joel M.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Cohen, Adam E.			Screening Fluorescent Voltage Indicators with Spontaneously Spiking HEK Cells	PLOS ONE			English	Article							ACTION-POTENTIALS; MICROBIAL RHODOPSIN; NEURONS; PROTEIN; NA(V)1.3; CURRENTS; TISSUES	Development of improved fluorescent voltage indicators is a key challenge in neuroscience, but progress has been hampered by the low throughput of patch-clamp characterization. We introduce a line of non-fluorescent HEK cells that stably express Na-V 1.3 and K-IR 2.1 and generate spontaneous electrical action potentials. These cells enable rapid, electrode-free screening of speed and sensitivity of voltage sensitive dyes or fluorescent proteins on a standard fluorescence microscope. We screened a small library of mutants of archaerhodopsin 3 (Arch) in spiking HEK cells and identified two mutants with greater voltage-sensitivity than found in previously published Arch voltage indicators.	[Park, Jeehae; Werley, Christopher A.; Venkatachalam, Veena; Kralj, Joel M.; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, West Haven, CT 06516 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Hosp, Neurorehabil Res Ctr, West Haven, CT USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	PECASE [N00014-11-1-0549]; Harvard Center for Brain Science; NIH [1-R01-EB012498-01, 1-DP2-OD007428]; Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience; Sloan Foundation fellowship; Dreyfus Teacher Scholar award; Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007428] Funding Source: NIH RePORTER	PECASE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center for Brain Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience; Sloan Foundation fellowship(Alfred P. Sloan Foundation); Dreyfus Teacher Scholar award; Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by PECASE award N00014-11-1-0549, the Harvard Center for Brain Science, NIH grants 1-R01-EB012498-01 and New Innovator grant 1-DP2-OD007428, the Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience, a Sloan Foundation fellowship, a Dreyfus Teacher Scholar award, and by grants from the Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Del Re AM, 2005, DRUG ALCOHOL DEPEN, V78, P221, DOI 10.1016/j.drugalcdep.2004.10.005; GRINVALD A, 1982, BIOPHYS J, V39, P301, DOI 10.1016/S0006-3495(82)84520-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Maclaurin D, 2013, P NATL ACAD SCI USA, V110, P5939, DOI 10.1073/pnas.1215595110; Marshall JD, 2013, ACS NANO, V7, P4601, DOI 10.1021/nn401410k; MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Park K, 2012, ACS NANO, V6, P10013, DOI 10.1021/nn303719m; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Pucihar G, 2009, J VIS EXP, V33, pe1659; Samad OA, 2013, MOL THER, V21, P49, DOI 10.1038/mt.2012.169; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3	25	39	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85221	10.1371/journal.pone.0085221	http://dx.doi.org/10.1371/journal.pone.0085221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391999	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900142
J	Vardakis, JC; Tully, BJ; Ventikos, Y				Vardakis, John C.; Tully, Brett J.; Ventikos, Yiannis			Exploring the Efficacy of Endoscopic Ventriculostomy for Hydrocephalus Treatment via a Multicompartmental Poroelastic Model of CSF Transport: A Computational Perspective	PLOS ONE			English	Article							CEREBROSPINAL-FLUID FLOW; 3RD VENTRICULOSTOMY; MICROSURGICAL ANATOMY; CHOROIDAL ARTERIES; BRAIN; DYNAMICS; PRESSURE; PHYSIOLOGY; SHUNT	This study proposes the implementation of a Multiple-Network Poroelastic Theory (MPET) model coupled with finite-volume computational fluid dynamics for the purpose of studying, in detail, the effects of obstructing CSF transport within an anatomically accurate cerebral environment. The MPET representation allows the investigation of fluid transport between CSF, brain parenchyma and cerebral blood, in an integral and comprehensive manner. A key novelty in the model is the amalgamation of anatomically accurate choroid plexuses with their feeding arteries and a simple relationship relaxing the constraint of a unique permeability for the CSF compartment. This was done in order to account for the Aquaporin-4mediated swelling characteristics. The aim of this varying permeability compartment was to bring to light a feedback mechanism that could counteract the effects of ventricular dilation and subsequent elevations of CSF pressure through the efflux of excess CSF into the blood system. This model is used to demonstrate the impact of aqueductal stenosis and fourth ventricle outlet obstruction (FVOO). The implications of treating such a clinical condition with the aid of endoscopic third (ETV) and endoscopic fourth (EFV) ventriculostomy are considered. We observed peak CSF velocities in the aqueduct of the order of 15.6 cm/s in the healthy case, 45.4 cm/s and 72.8 cm/s for the mild and severe cases respectively. The application of ETV reduced the aqueductal velocity to levels around 16-17 cm/s. Ventricular displacement, CSF pressure, wall shear stress (WSS) and pressure difference between lateral and fourth ventricles (DP) increased with applied stenosis, and subsequently dropped to nominal levels with the application of ETV. The greatest reversal of the effects of atresia come by opting for ETV rather than the more complicated procedure of EFV.	[Vardakis, John C.] Univ Oxford, Inst Biomed Engn, Oxford, England; [Vardakis, John C.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Tully, Brett J.] Univ Oxford, Dept Engn Sci, Oxyntix Ltd, Oxford OX1 3PJ, England; [Ventikos, Yiannis] UCL, Dept Mech Engn, London, England	University of Oxford; University of Oxford; University of Oxford; University of London; University College London	Ventikos, Y (corresponding author), UCL, Dept Mech Engn, London, England.	y.ventikos@ucl.ac.uk	Vardakis, John/AAF-3070-2019; Vardakis, John/N-4625-2013	Vardakis, John/0000-0003-2391-5257; Vardakis, John/0000-0003-2391-5257; Tully, Brett/0000-0001-6892-2771; Ventikos, Yiannis/0000-0002-8589-8117	Digital Economy Programme; Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC); Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities; EPSRC [EP/F033710/1]; Engineering and Physical Sciences Research Council [EP/F033710/1] Funding Source: researchfish	Digital Economy Programme; Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is financially supported by the Digital Economy Programme; a Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC) and contributed to by AHRC, ESRC, and MRC. VPH-DARE@ IT, a collaborative Research Project funded under the Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities, is also kindly acknowledged. The EPSRC is further acknowledged for providing the resources necessary for the High Performance Computing simulations conducted in this study, through grant EP/F033710/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Bammer R, 2007, MAGN RESON MED, V57, P127, DOI 10.1002/mrm.21109; Barbara B, 2010, CURR NEUROPHARMACOL, V8, P97, DOI 10.2174/157015910791233204; BECKETT RS, 1950, AM J PATHOL, V26, P755; Belonogov A, 2005, TOR CAN INT S SOC CO; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Bradbury M, 1993, HYDROCEPHALUS SERIES; Buonocore MH, 1998, MAGN RESON MED, V40, P210, DOI 10.1002/mrm.1910400207; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cheng SK, 2010, J BIOMECH, V43, P579, DOI 10.1016/j.jbiomech.2009.10.002; Drake JM, 2009, CHILD NERV SYST, V25, P467, DOI 10.1007/s00381-008-0761-y; Dutta-Roy T, 2008, J BIOMECH, V41, P2263, DOI 10.1016/j.jbiomech.2008.04.014; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; Fay J., 1994, INTRO FLUID MECH; Ferrer A, 2012, WORLD NEUROSURGERY; FUJII K, 1980, J NEUROSURG, V52, P165, DOI 10.3171/jns.1980.52.2.0165; FUJII K, 1980, J NEUROSURG, V52, P504, DOI 10.3171/jns.1980.52.4.0504; Giannetti AV, 2011, J NEUROSURG-PEDIATR, V7, P152, DOI 10.3171/2010.11.PEDS1080; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Gupta S, 2009, BIOMECHANICAL ENG, V131; Hatem SM, 2010, BRAIN, V133, P3409, DOI 10.1093/brain/awq244; Hellwig D, 2005, NEUROSURG REV, V28, P1, DOI 10.1007/s10143-004-036-2; Howden L, 2008, COMPUT METHOD BIOMEC, V11, P123, DOI 10.1080/10255840701492118; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Irani DN., 2009, CEREBROSPINAL FLUID; Jacobson EE, 1999, MED BIOL ENG COMPUT, V37, P59, DOI 10.1007/BF02513267; Jacobson EE, 1996, PEDIATR NEUROSURG, V24, P229, DOI 10.1159/000121044; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Kurtcuoglu V, 2005, J BIOMECH ENG-T ASME, V127, P264, DOI 10.1115/1.1865191; Levine DN, 2008, J NEUROL SCI, V269, P1, DOI 10.1016/j.jns.2007.12.022; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; Levine DN, 2000, J NEUROL SCI, V177, P85, DOI 10.1016/S0022-510X(00)00348-8; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Mallucci C, 2009, CEREBROSPINAL FLUID; Marinkovic S, 2005, NEUROSURGERY, V57, P22, DOI 10.1227/01.NEU.0000163479.41621.39; Martin, 2012, SURGERY, V30, P142, DOI 10.1016/j.mpsur.2011.12.010; Mohanty A, 2008, NEUROSURGERY, V63, P905, DOI 10.1227/01.NEU.0000333262.38548.E1; Mugamba J, 2012, WORLD NEUROSURGERY; Owler B, 2010, CEREBROSPINAL FLUID, V7, P1; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Penn RD, 2009, PEDIATR NEUROSURG, V45, P161, DOI 10.1159/000218198; POLLAY M, 1967, AM J PHYSIOL, V213, P1031, DOI 10.1152/ajplegacy.1967.213.4.1031; Pollay M, 2010, CEREBROSPINAL FLUID, V7, P1; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, P59; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Redzic ZB, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-10; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Shen XQ, 2006, J NEUROSURG, V105, P459, DOI 10.3171/ped.2006.105.6.459; Sivaloganathan S, 2005, INT J NONLIN MECH, V40, P1149, DOI 10.1016/j.ijnonlinmec.2005.04.004; Skjolding AD, 2010, CEREBROSPINAL FLUID, V5, P7; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Sobey I, 2006, MATH MED BIOL, V23, P339, DOI 10.1093/imammb/dql015; Spennato P, 2013, WORLD NEUROSURGERY; Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Stagno V, 2012, WORLD NEUROSURGERY; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Sweetman B, 2011, COMPUT BIOL MED, V41, P67, DOI 10.1016/j.compbiomed.2010.12.001; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thompson DN, 2009, CLASSIFICATION HYDRO, V27, P130, DOI 10.1016/j.mpsur.2009.02.005; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; Tully B, 2009, IEEE T BIO-MED ENG, V56, P1644, DOI 10.1109/TBME.2009.2016427; Vardakis JC, 2013, COMPUTER MODELS BIOM, P305; Vogel TW, 2013, J NEUROSURG PEDIAT, P1; Wang ZJ, 2002, INT J NUMER METH FL, V39, P703, DOI 10.1002/fld.344; Wetzel S, 2007, AM J NEURORADIOL, V28, P433; Wilson R, 2009, CEREBROSPINAL FLUID, P99; Wirth B, 2006, MATH MED BIOL, V23, P1, DOI DOI 10.1093/IMAMMB/DQL014); Woodworth GF, 2012, WORLD NEUROSURG, V78, P312, DOI 10.1016/j.wneu.2011.09.018; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang Y, 2012, NEUROSURGERY	78	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84577	10.1371/journal.pone.0084577	http://dx.doi.org/10.1371/journal.pone.0084577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391968	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900111
J	Luo, J; Baranov, P; Patel, S; Ouyang, H; Quach, J; Wu, F; Qiu, A; Luo, HR; Hicks, C; Zeng, J; Zhu, J; Lu, J; Sfeir, N; Wen, C; Zhang, MX; Reade, V; Patel, S; Sinden, J; Sun, XD; Shaw, P; Young, M; Zhang, K				Luo, Jing; Baranov, Petr; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Hicks, Caroline; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Zhang, Meixia; Reade, Victoria; Patel, Sara; Sinden, John; Sun, Xiaodong; Shaw, Peter; Young, Michael; Zhang, Kang			Human Retinal Progenitor Cell Transplantation Preserves Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eye; Neuroprogenitor Cell; Retinal Degeneration; Stem Cells; Transplantation; Retinal Progenitor Cells	VISUAL FUNCTION; PHOTORECEPTOR DEGENERATION; GEOGRAPHIC ATROPHY; ROYAL-COLLEGE; RCS RATS; RESTORATION; RESCUE; GENERATION; PROTECTION; MODEL	Background: Human retinal progenitor cells (hRPCs) are expandable in vitro and represent a possible therapy for retinal degenerative diseases. Results: In a rat model of retinal degeneration, transplantation of hRPCs preserved photoreceptors and visual function. Conclusion: Subretinal injection of hRPCs rescues photoreceptors without causing adverse effects. Significance: This study provides proof of concept for hRPC transplantation and paves the way for further studies and human trials. Cell transplantation is a potential therapeutic strategy for retinal degenerative diseases involving the loss of photoreceptors. However, it faces challenges to clinical translation due to safety concerns and a limited supply of cells. Human retinal progenitor cells (hRPCs) from fetal neural retina are expandable in vitro and maintain an undifferentiated state. This study aimed to investigate the therapeutic potential of hRPCs transplanted into a Royal College of Surgeons (RCS) rat model of retinal degeneration. At 12 weeks, optokinetic response showed that hRPC-grafted eyes had significantly superior visual acuity compared with vehicle-treated eyes. Histological evaluation of outer nuclear layer (ONL) characteristics such as ONL thickness, spread distance, and cell count demonstrated a significantly greater preservation of the ONL in hRPC-treated eyes compared with both vehicle-treated and control eyes. The transplanted hRPCs arrested visual decline over time in the RCS rat and rescued retinal morphology, demonstrating their potential as a therapy for retinal diseases. We suggest that the preservation of visual acuity was likely achieved through host photoreceptor rescue. We found that hRPC transplantation into the subretinal space of RCS rats was well tolerated, with no adverse effects such as tumor formation noted at 12 weeks after treatment.	[Luo, Jing; Zhang, Kang] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 410011, Hunan, Peoples R China; [Luo, Jing; Zhang, Kang] Cent S Univ, Int Acad Translat Med, Changsha 410011, Hunan, Peoples R China; [Luo, Jing; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Shaw, Peter; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Luo, Jing; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Shaw, Peter; Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Baranov, Petr; Young, Michael] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Qiu, Austin; Luo, Hongrong; Zhu, Jing; Zhang, Meixia; Patel, Sara; Sinden, John; Zhang, Kang] West China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Hicks, Caroline] ReNeuron Ltd, Guildford GU2 7AF, Surrey, England; [Zeng, Jing] Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning 530021, Guangxi, Peoples R China; [Reade, Victoria] Da Vinci Consulting, Los Angeles, CA 90069 USA; [Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China; [Sun, Xiaodong] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai 200080, Peoples R China; [Zhang, Kang] Vet Affairs Healthcare Syst, San Diego, CA 92161 USA	Central South University; Central South University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Guangxi Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China.	xdsun@sjtu.edu.cn; kang.zhang@gmail.com	Quach, John/AAS-9482-2021; Zhang, Kang/Y-2740-2019; luo, hongrong/B-2714-2015	Zhang, Kang/0000-0002-4549-1697; luo, hongrong/0000-0001-7994-1193; Ouyang, Hong/0000-0002-7622-7733; Luo, Jing/0000-0002-8905-9388	973 Program [2013CB967504, 2014CB964900]; Natural Science Foundation of China [81130017, 81276019]; National Institutes of Health Director's Transformative R01 Program [R01 EY021374]; National Institutes of Health, NEI [R01 EY018660, P30 EY022589]; King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Macula Vision Research Foundation; Beckman Initiative for Macular Research; Macular Society; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; ReNeuron Ltd.; NATIONAL EYE INSTITUTE [P30EY022589, R01EY018660, R01EY021374] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health Director's Transformative R01 Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Macula Vision Research Foundation; Beckman Initiative for Macular Research; Macular Society; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); ReNeuron Ltd.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the 973 Program (2013CB967504 and 2014CB964900), Natural Science Foundation of China (81130017 and 81276019), National Institutes of Health Director's Transformative R01 Program (Grant R01 EY021374), and National Institutes of Health Grants R01 EY018660 and P30 EY022589 from the NEI. This work was also supported by a grant from the King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine, Macula Vision Research Foundation, Beckman Initiative for Macular Research, Macular Society, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and a contract from ReNeuron Ltd.	Aftab U, 2009, EXP EYE RES, V89, P301, DOI 10.1016/j.exer.2009.03.025; Baranov P, 2013, TISSUE ENG PART C-ME, V19, P265, DOI [10.1089/ten.tec.2012.0217, 10.1089/ten.TEC.2012.0217]; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Du HJ, 2011, SEMIN OPHTHALMOL, V26, P216, DOI 10.3109/08820538.2011.577498; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Larsen KB, 2009, INT J DEV NEUROSCI, V27, P485, DOI 10.1016/j.ijdevneu.2009.04.004; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lawrence JM, 2004, INVEST OPHTH VIS SCI, V45, P267, DOI 10.1167/iovs.03-0093; Lu B, 2010, INVEST OPHTH VIS SCI, V51, P2269, DOI 10.1167/iovs.09-4526; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Lund RD, 2001, PROG RETIN EYE RES, V20, P415, DOI 10.1016/S1350-9462(01)00003-9; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; McGill TJ, 2004, INVEST OPHTH VIS SCI, V45, P932, DOI 10.1167/iovs.03-0964; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; PERRY J, 1995, CURR EYE RES, V14, P585, DOI 10.3109/02713689508998406; Sauve Y, 2004, VISION RES, V44, P9, DOI 10.1016/j.visres.2003.08.015; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110; Wang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009200; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhang K, 2011, NEW ENGL J MED, V365, P370, DOI 10.1056/NEJMcibr1105280; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	35	77	84	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6362	6371		10.1074/jbc.M113.513713	http://dx.doi.org/10.1074/jbc.M113.513713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407289	hybrid, Green Published			2022-12-25	WOS:000332389400005
J	Lee, Y; Villar, MT; Artigues, A; Beamer, LJ				Lee, Yingying; Villar, Maria T.; Artigues, Antonio; Beamer, Lesa J.			Promotion of Enzyme Flexibility by Dephosphorylation and Coupling to the Catalytic Mechanism of a Phosphohexomutase*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Enzyme Catalysis; Phosphorylation; Protein Dynamics; Pseudomonas aeruginosa; Hydrogen-Deuterium Exchange; Small Angle X-ray Scattering	PSEUDOMONAS-AERUGINOSA; ALLOSTERIC REGULATION; PHOSPHORYLATION; SUBSTRATE; EXCHANGE; PMM/PGM; KINASE; PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE; IDENTIFICATION; SUPERFAMILY	Background: Enzyme function involves both specific conformational change and intrinsic flexibility of proteins. Results: Dephosphorylation of a catalytic phosphoserine causes a global increase in flexibility of a phosphohexomutase. Conclusion: Increased flexibility following phosphoryl transfer is critical to catalytic mechanism. Significance: Other phosphotransfer enzymes may undergo changes in flexibility linked to dephosphorylation. The enzyme phosphomannomutase/phosphoglucomutase (PMM/PGM) from Pseudomonas aeruginosa catalyzes an intramolecular phosphoryl transfer across its phosphosugar substrates, which are precursors in the synthesis of exoproducts involved in bacterial virulence. Previous structural studies of PMM/PGM have established a key role for conformational change in its multistep reaction, which requires a dramatic 180 degrees reorientation of the intermediate within the active site. Here hydrogen-deuterium exchange by mass spectrometry and small angle x-ray scattering were used to probe the conformational flexibility of different forms of PMM/PGM in solution, including its active, phosphorylated state and the unphosphorylated state that occurs transiently during the catalytic cycle. In addition, the effects of ligand binding were assessed through use of a substrate analog. We found that both phosphorylation and binding of ligand produce significant effects on deuterium incorporation. Phosphorylation of the conserved catalytic serine has broad effects on residues in multiple domains and is supported by small angle x-ray scattering data showing that the unphosphorylated enzyme is less compact in solution. The effects of ligand binding are generally manifested near the active site cleft and at a domain interface that is a site of conformational change. These results suggest that dephosphorylation of the enzyme may play two critical functional roles: a direct role in the chemical step of phosphoryl transfer and secondly through propagation of structural flexibility. We propose a model whereby increased enzyme flexibility facilitates the reorientation of the reaction intermediate, coupling changes in structural dynamics with the unique catalytic mechanism of this enzyme.	[Lee, Yingying; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu			DOE Office of Biological and Environmental Research; National Institute of Health Project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health Project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Fraser, Jack Tanner, and Steven Van Doren for helpful discussions and Brian Mooney and Beverly DaGue of the University of Missouri Charles W. Gehrke Proteomics Center and Cristina Furdui for assistance with initial mass spectrometry. We thank Kevin Dyer for collecting the SAXS data through the SIBYLS mail-in program. Part of this work was conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy (DOE), Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health Project MINOS (Grant R01GM105404).	Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee Y, 2013, FEBS J, V280, P2622, DOI 10.1111/febs.12249; Lee YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045836; Liu X, 2013, STRUCTURE, V21, P342, DOI 10.1016/j.str.2013.01.004; Liu YH, 2009, J MOL BIOL, V391, P149, DOI 10.1016/j.jmb.2009.06.017; Luebbering EK, 2012, J MOL BIOL, V423, P831, DOI 10.1016/j.jmb.2012.08.013; Ma LY, 2012, ENVIRON MICROBIOL, V14, P1995, DOI 10.1111/j.1462-2920.2012.02753.x; Moorthy BS, 2012, J MOL BIOL, V417, P468, DOI 10.1016/j.jmb.2012.01.052; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naught LE, 2005, BIOCHEMISTRY-US, V44, P6831, DOI 10.1021/bi0501380; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Nishitani Y, 2006, J BIOL CHEM, V281, P19740, DOI 10.1074/jbc.M600801200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasannan CB, 2013, BIOCHEMISTRY-US, V52, P1998, DOI 10.1021/bi400117q; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RAY WJ, 1964, J BIOL CHEM, V239, P1228; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Regni CA, 2000, ACTA CRYSTALLOGR D, V56, P761, DOI 10.1107/S0907444900004431; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Sarma AVS, 2012, BIOCHEMISTRY-US, V51, P807, DOI 10.1021/bi201609n; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Schramm AM, 2010, PROTEIN SCI, V19, P1235, DOI 10.1002/pro.402; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Villar Maria T, 2010, Proteomica, V6, P63; Wei Y, 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9511-5; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	41	15	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4674	4682		10.1074/jbc.M113.532226	http://dx.doi.org/10.1074/jbc.M113.532226			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403075	Green Published, hybrid			2022-12-25	WOS:000331607900015
J	Lindsey-Boltz, LA; Kemp, MG; Reardon, JT; Derocco, V; Iyer, RR; Modrich, P; Sancar, A				Lindsey-Boltz, Laura A.; Kemp, Michael G.; Reardon, Joyce T.; Derocco, Vanessa; Iyer, Ravi R.; Modrich, Paul; Sancar, Aziz			Coupling of Human DNA Excision Repair and the DNA Damage Checkpoint in a Defined in Vitro System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; DNA Damage Response; DNA Nucleotide Excision Repair; p53; Protein Kinases	REPLICATION PROTEIN-A; ATR ACTIVATION; ATAXIA-TELANGIECTASIA; FUNCTIONAL-CHARACTERIZATION; H2AX PHOSPHORYLATION; UV-IRRADIATION; KINASE; TOPBP1; COMPLEXES; RPA	Background: Nucleotide excision repair and the ATR-mediated DNA damage checkpoint responses are genetically coupled. Results: We have analyzed the basic steps of ATR activation in a biochemically defined system. Conclusion: ATR signaling requires enlargement of the DNA excision gap by EXO1. Significance: The six excision repair factors, ATR-ATRIP, TopBP1, and EXO1 constitute the minimum essential set of proteins for ATR-activation upon UV-induced DNA damage. DNA repair and DNA damage checkpoints work in concert to help maintain genomic integrity. In vivo data suggest that these two global responses to DNA damage are coupled. It has been proposed that the canonical 30 nucleotide single-stranded DNA gap generated by nucleotide excision repair is the signal that activates the ATR-mediated DNA damage checkpoint response and that the signal is enhanced by gap enlargement by EXO1 (exonuclease 1) 5 to 3 exonuclease activity. Here we have used purified core nucleotide excision repair factors (RPA, XPA, XPC, TFIIH, XPG, and XPF-ERCC1), core DNA damage checkpoint proteins (ATR-ATRIP, TopBP1, RPA), and DNA damaged by a UV-mimetic agent to analyze the basic steps of DNA damage checkpoint response in a biochemically defined system. We find that checkpoint signaling as measured by phosphorylation of target proteins by the ATR kinase requires enlargement of the excision gap generated by the excision repair system by the 5 to 3 exonuclease activity of EXO1. We conclude that, in addition to damaged DNA, RPA, XPA, XPC, TFIIH, XPG, XPF-ERCC1, ATR-ATRIP, TopBP1, and EXO1 constitute the minimum essential set of factors for ATR-mediated DNA damage checkpoint response.	[Lindsey-Boltz, Laura A.; Kemp, Michael G.; Reardon, Joyce T.; Derocco, Vanessa; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Iyer, Ravi R.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Howard Hughes Medical Institute	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745; Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [GM32833, GM45190]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM32833 (to A. S.) and GM45190 (to P. M.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2011, J BIOL CHEM, V286, P19237, DOI 10.1074/jbc.M111.235036; Kershnar E, 1998, J BIOL CHEM, V273, P34444, DOI 10.1074/jbc.273.51.34444; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Leroy C, 2001, EMBO J, V20, P2896, DOI 10.1093/emboj/20.11.2896; Lindsey-Boltz LA, 2012, J BIOL CHEM, V287, P36123, DOI 10.1074/jbc.M112.407825; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Munoz DP, 2013, NUCLEIC ACIDS RES, V41, P2894, DOI 10.1093/nar/gks1478; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Novarina D, 2011, DNA REPAIR, V10, P751, DOI 10.1016/j.dnarep.2011.04.030; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vidal-Eychenie S, 2013, J CELL BIOL, V202, P421, DOI 10.1083/jcb.201304139; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	45	46	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5074	5082		10.1074/jbc.M113.542787	http://dx.doi.org/10.1074/jbc.M113.542787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403078	Green Published, hybrid			2022-12-25	WOS:000331607900051
J	Stahlschmidt, W; Robertson, MJ; Robinson, PJ; McCluskey, A; Haucke, V				Stahlschmidt, Wiebke; Robertson, Mark J.; Robinson, Phillip J.; McCluskey, Adam; Haucke, Volker			Clathrin Terminal Domain- Ligand Interactions Regulate Sorting of Mannose 6-Phosphate Receptors Mediated by AP-1 and GGA Adaptors*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endosomes; Lysosomes; Membrane Trafficking; Molecular Cell Biology; Protein Sorting	GOLGI; TRAFFICKING; COMPLEX; DYNAMIN; UBIQUITINATION; INACTIVATION; DIVERSITY; ENDOSOMES; MECHANISM; PROTEINS	Background: Clathrin is a coat protein involved in intracellular membrane traffic. Results: Acute inhibition of clathrin-ligand association by Pitstop (R) compounds perturbs intracellular receptor sorting mediated by AP-1 and GGA adaptors. Conclusion: Clathrin is required for intracellular receptor sorting by AP-1 and GGA adaptor proteins. Significance: Pitstop (R) compounds are tools for the functional dissection of intracellular trafficking pathways. Clathrin plays important roles in intracellular membrane traffic including endocytosis of plasma membrane proteins and receptors and protein sorting between the trans-Golgi network (TGN) and endosomes. Whether clathrin serves additional roles in receptor recycling, degradative sorting, or constitutive secretion has remained somewhat controversial. Here we have used acute pharmacological perturbation of clathrin terminal domain (TD) function to dissect the role of clathrin in intracellular membrane traffic. We report that internalization of major histocompatibility complex I (MHCI) is inhibited in cells depleted of clathrin or its major clathrin adaptor complex 2 (AP-2), a phenotype mimicked by application of Pitstop (R) inhibitors of clathrin TD function. Hence, MHCI endocytosis occurs via a clathrin/AP-2-dependent pathway. Acute perturbation of clathrin also impairs the dynamics of intracellular clathrin/adaptor complex 1 (AP-1)- or GGA (Golgi-localized, -ear-containing, Arf-binding protein)-coated structures at the TGN/endosomal interface, resulting in the peripheral dispersion of mannose 6-phosphate receptors. By contrast, secretory traffic of vesicular stomatitis virus G protein, recycling of internalized transferrin from endosomes, or degradation of EGF receptor proceeds unperturbed in cells with impaired clathrin TD function. These data indicate that clathrin is required for the function of AP-1- and GGA-coated carriers at the TGN but may be dispensable for outward traffic en route to the plasma membrane.	[Stahlschmidt, Wiebke; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Robertson, Mark J.; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2145, Australia	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Haucke, V (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Robinson, Phillip J/G-4008-2011; Robertson, Mark/E-9173-2014	Robinson, Phillip J/0000-0002-7878-0313; Robertson, Mark/0000-0002-2140-2717; McCluskey, Adam/0000-0001-7125-863X; Haucke, Volker/0000-0003-3119-6993	Deutsche Forschungsgemeinschaft Grants [FOR 806-HA2686/3-1,3-2, SFB765/B4]; National Health and Medical Research Council	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 806-HA2686/3-1,3-2 and SFB765/B4 (to V. H.) and grants from the National Health and Medical Research Council. The equipment supported by the Ramaciotti Foundation, the Australian Cancer Research Foundation, and the Cancer Institute NSW (to P. J. R. and A. M.).	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; Goto E, 2010, J BIOL CHEM, V285, P35311, DOI 10.1074/jbc.M110.112763; Govero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030184; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hirst J, 2012, CURR BIOL, V22, P1711, DOI 10.1016/j.cub.2012.07.012; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Kural C, 2012, CELL REP, V2, P1111, DOI 10.1016/j.celrep.2012.09.025; Larsen JE, 2004, MOL BIOL CELL, V15, P323, DOI 10.1091/mbc.E03-08-0578; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Luo Y, 2013, TRAFFIC, V14, P97, DOI 10.1111/tra.12014; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sharma Mahak, 2009, Commun Integr Biol, V2, P431; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub L. M., 2013, COLD SPRING HARBOR P, V5; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wieffer M, 2009, CELL, V137, DOI 10.1016/j.cell.2009.04.012	56	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4906	4918		10.1074/jbc.M113.535211	http://dx.doi.org/10.1074/jbc.M113.535211			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24407285	Green Published, hybrid			2022-12-25	WOS:000331607900037
J	Tondeleir, D; Noelanders, R; Bakkali, K; Ampe, C				Tondeleir, Davina; Noelanders, Rivka; Bakkali, Karima; Ampe, Christophe			Beta-Actin Is Required for Proper Mouse Neural Crest Ontogeny	PLOS ONE			English	Article							CELL-CELL ADHESION; MESSENGER-RNA LOCALIZATION; N-CADHERIN; IN-VIVO; MESENCHYMAL PHENOTYPE; XENOPUS CADHERIN-11; EXPRESSION PATTERN; MIGRATION; APOPTOSIS; MOTILITY	The mouse genome consists of six functional actin genes of which the expression patterns are temporally and spatially regulated during development and in the adult organism. Deletion of beta-actin in mouse is lethal during embryonic development, although there is compensatory expression of other actin isoforms. This suggests different isoform specific functions and, more in particular, an important function for beta-actin during early mammalian development. We here report a role for beta-actin during neural crest ontogeny. Although beta-actin null neural crest cells show expression of neural crest markers, less cells delaminate and their migration arrests shortly after. These phenotypes were associated with elevated apoptosis levels in neural crest cells, whereas proliferation levels were unchanged. Specifically the pre-migratory neural crest cells displayed higher levels of apoptosis, suggesting increased apoptosis in the neural tube accounts for the decreased amount of migrating neural crest cells seen in the beta-actin null embryos. These cells additionally displayed a lack of membrane bound N-cadherin and dramatic decrease in cadherin-11 expression which was more pronounced in the pre-migratory neural crest population, potentially indicating linkage between the cadherin-11 expression and apoptosis. By inhibiting ROCK ex vivo, the knockout neural crest cells regained migratory capacity and cadherin-11 expression was upregulated. We conclude that the presence of beta-actin is vital for survival, specifically of pre-migratory neural crest cells, their proper emigration from the neural tube and their subsequent migration. Furthermore, the absence of beta-actin affects cadherin-11 and N-cadherin function, which could partly be alleviated by ROCK inhibition, situating the Rho-ROCK signaling in a feedback loop with cadherin-11.	[Tondeleir, Davina; Noelanders, Rivka; Bakkali, Karima; Ampe, Christophe] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University	Ampe, C (corresponding author), Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	christophe.ampe@ugent.be		Christophe, Ampe/0000-0002-8554-3594	Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium); Fund for Scientific Research Flanders (FWO, Belgium); CA [G.0441.10N]	Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium); Fund for Scientific Research Flanders (FWO, Belgium)(FWO); CA	This work was supported by the Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium) and by the Fund for Scientific Research Flanders (FWO, Belgium). DT is a pre doctoral fellow of this Fund and CA received a research grant G.0441.10N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL, Vxxxiv, P1548; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Bergeron KF, 2013, CLIN GENET, V83, P15, DOI 10.1111/cge.12032; Berndt JD, 2008, DEV BIOL, V324, P236, DOI 10.1016/j.ydbio.2008.09.013; BOBER E, 1994, DEVELOPMENT, V120, P603; Bononi J, 2008, MECH DEVELOP, V125, P1033, DOI 10.1016/j.mod.2008.07.007; Borchers A, 2001, DEVELOPMENT, V128, P3049; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Chalpe AJ, 2010, CELL ADHES MIGR, V4, P431, DOI 10.4161/cam.4.3.12138; Cheever TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032970; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Clay MR, 2011, CURR OPIN NEUROBIOL, V21, P17, DOI 10.1016/j.conb.2010.09.013; Conway SJ, 1997, DEVELOPMENT, V124, P505; Dupin E, 2006, ADV EXP MED BIOL, P58996; Espada J, 2009, J CELL PHYSIOL, V219, P84, DOI 10.1002/jcp.21652; Gartner A, 2012, EMBO J, V31, P1893, DOI 10.1038/emboj.2012.41; Gammill LS, 2010, DEV BIOL, V344, P555, DOI 10.1016/j.ydbio.2010.04.009; Groysman M, 2008, NEURAL DEV, V327; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Hofer D, 1997, J CELL SCI, V110, P765; HOFFMANN I, 1995, DEV BIOL, V169, P337, DOI 10.1006/dbio.1995.1148; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Jiang M, 2011, CURR TOP DEV BIOL, P9477; Kalcheim C, 1999, NEURAL CREST, Vxxiii; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; Kiener HP, 2009, ARTHRITIS RHEUM-US, V60, P1305, DOI 10.1002/art.24453; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Li Yong, 2011, Genes Cancer, V2, P880, DOI 10.1177/1947601911433129; Liu JP, 1998, DEVELOPMENT, V125, P5055; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Mayanil CS, 2013, DEV NEUROSCI; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; Micholt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066170; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; Nagy A, 2003, MANIPULATING MOUSE E, VIX; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Peckham M, 2001, J CELL SCI, V114, P1367; Phillips HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037685; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Schulte JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070962; Schulz A, 2004, ANN NEUROL, V56, P342, DOI 10.1002/ana.20187; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Tamura D, 2008, INT J ONCOL, V33, P17; Taneyhill LA, 2013, PROG MOL BIOL TRANSL; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tondeleir D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067855; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Wheelock MJ, 2003, ANNU REV CELL DEV BI, P19207; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773	79	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85608	10.1371/journal.pone.0085608	http://dx.doi.org/10.1371/journal.pone.0085608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409333	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500057
J	Ferreira, NC; Marques, IA; Conceicao, WA; Macedo, B; Machado, CS; Mascarello, A; Chiaradia-Delatorre, LD; Yunes, RA; Nunes, RJ; Hughson, AG; Raymond, LD; Pascutti, PG; Caughey, B; Cordeiro, Y				Ferreira, Natalia C.; Marques, Icaro A.; Conceicao, Wesley A.; Macedo, Bruno; Machado, Clarice S.; Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose; Hughson, Andrew G.; Raymond, Lynne D.; Pascutti, Pedro G.; Caughey, Byron; Cordeiro, Yraima			Anti-Prion Activity of a Panel of Aromatic Chemical Compounds: In Vitro and In Silico Approaches	PLOS ONE			English	Article							QUINOLINE DERIVATIVES; ANTIPRION ACTIVITY; PROTEIN; INHIBITORS; CHALCONES; AGGREGATION; QUINACRINE; MECHANISM; DISEASES; ASSAYS	The prion protein (PrP) is implicated in the Transmissible Spongiform Encephalopathies (TSEs), which comprise a group of fatal neurodegenerative diseases affecting humans and other mammals. Conversion of cellular PrP (PrPC) into the scrapie form (PrPSc) is the hallmark of TSEs. Once formed, PrPSc aggregates and catalyzes PrPC misfolding into new PrPSc molecules. Although many compounds have been shown to inhibit the conversion process, so far there is no effective therapy for TSEs. Besides, most of the previously evaluated compounds failed in vivo due to poor pharmacokinetic profiles. In this work we propose a combined in vitro/in silico approach to screen for active anti-prion compounds presenting acceptable drugability and pharmacokinetic parameters. A diverse panel of aromatic compounds was screened in neuroblastoma cells persistently infected with PrPSc (ScN2a) for their ability to inhibit PK-resistant PrP (PrPRes) accumulation. From,200 compounds, 47 were effective in decreasing the accumulation of PrPRes in ScN2a cells. Pharmacokinetic and physicochemical properties were predicted in silico, allowing us to obtain estimates of relative blood brain barrier permeation and mutagenicity. MTT reduction assays showed that most of the active compounds were non cytotoxic. Compounds that cleared PrPRes from ScN2a cells, were non-toxic in the MTT assay, and presented a good pharmacokinetic profile were investigated for their ability to inhibit aggregation of an amyloidogenic PrP peptide fragment (PrP109-149). Molecular docking results provided structural models and binding affinities for the interaction between PrP and the most promising compounds. In summary, using this combined in vitro/in silico approach we have identified new small organic anti-scrapie compounds that decrease the accumulation of PrPRes in ScN2a cells, inhibit the aggregation of a PrP peptide, and possess pharmacokinetic characteristics that support their drugability. These compounds are attractive candidates for prion disease therapy.	[Ferreira, Natalia C.; Marques, Icaro A.; Conceicao, Wesley A.; Macedo, Bruno; Machado, Clarice S.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil; [Conceicao, Wesley A.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose] Univ Fed Santa Catarina, Dept Quim, Florianopolis, SC, Brazil; [Hughson, Andrew G.; Raymond, Lynne D.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Santa Catarina (UFSC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cordeiro, Y (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.	yraima@pharma.ufrj.br	Ferreira, Natália/S-2158-2017; Pascutti, Pedro/AAP-7752-2020; Cordeiro, Yraima/J-7619-2012	Ferreira, Natália/0000-0002-5381-6666; Cordeiro, Yraima/0000-0003-4278-212X; Pascutti, Pedro/0000-0002-5454-560X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil; Intramural Research Program of the NIAID, NIH, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001087] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Intramural Research Program of the NIAID, NIH, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), from the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil, and by the Intramural Research Program of the NIAID, NIH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Borchhardt DM, 2010, J BRAZIL CHEM SOC, V21, P142, DOI 10.1590/S0103-50532010000100021; Cashman NR, 2004, NAT REV DRUG DISCOV, V3, P874, DOI 10.1038/nrd1525; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chiaradia LD, 2008, BIOORG MED CHEM LETT, V18, P6227, DOI 10.1016/j.bmcl.2008.09.105; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2009, J COMPUT CHEM, V30, P2021, DOI 10.1002/jcc.21202; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hosokawa-Muto J, 2009, ANTIMICROB AGENTS CH, V53, P765, DOI 10.1128/AAC.01112-08; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; Kamatari YO, 2013, PROTEIN SCI, V22, P22, DOI 10.1002/pro.2180; Klingenstein R, 2006, J MED CHEM, V49, P5300, DOI 10.1021/jm0602763; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, J VIROL, V80, P1044, DOI 10.1128/JVI.80.2.1044-1046.2006; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Kocisko DA, 2007, ANAL BIOCHEM, V363, P154, DOI 10.1016/j.ab.2006.11.007; Kocisko DA, 2006, METHOD ENZYMOL, V412, P223, DOI 10.1016/S0076-6879(06)12014-5; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Macedo B, 2010, EUR J MED CHEM, V45, P5468, DOI 10.1016/j.ejmech.2010.07.054; Marzo L, 2013, J CELL SCI, V126, P1345, DOI 10.1242/jcs.114801; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; Mielcke TR, 2012, EUR J MED CHEM, V48, P255, DOI 10.1016/j.ejmech.2011.12.023; Murakami-Kubo I, 2004, J VIROL, V78, P1281, DOI 10.1128/JVI.78.3.1281-1288.2004; Nunes RJ, 2012, Brazilian patent, Patent No. [PCT/BR2012/000480, 2012000480]; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Osorio TM, 2012, BIOORG MED CHEM LETT, V22, P225, DOI 10.1016/j.bmcl.2011.11.059; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; STICH I, 1989, PHYS REV B, V39, P4997, DOI 10.1103/PhysRevB.39.4997; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Votano JR, 2004, MOL DIVERS, V8, P379, DOI 10.1023/B:MODI.0000047512.82293.75; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575	54	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84531	10.1371/journal.pone.0084531	http://dx.doi.org/10.1371/journal.pone.0084531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400098	gold, Green Submitted, Green Published			2022-12-25	WOS:000329462700032
J	Letheulle, J; Tattevin, P; Saunders, L; Kerjouan, M; Lena, H; Desrues, B; Le Tulzo, Y; Jouneau, S				Letheulle, Julien; Tattevin, Pierre; Saunders, Lauren; Kerjouan, Mallorie; Lena, Herve; Desrues, Benoit; Le Tulzo, Yves; Jouneau, Stephane			Iterative Thoracentesis as First-Line Treatment of Complicated Parapneumonic Effusion	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PERCUTANEOUS CATHETER DRAINAGE; PLEURAL FLUID COLLECTIONS; THORACIC EMPYEMA; 10-YEAR EXPERIENCE; BACTERIAL EMPYEMA; MANAGEMENT; INFECTION; GUIDELINE; MORTALITY	Rationale: Optimal management of complicated parapneumonic effusions (CPPE) remains controversial. Objectives: to assess safety and efficacy of iterative therapeutic thoracentesis (ITTC), the first-line treatment of CPPE in Rennes University Hospital. Methods: Patients with CPPE were identified through our computerized database. We retrospectively studied all cases of CPPE initially managed with ITTC in our institution between 2001 and 2010. ITTC failure was defined by the need for additional treatment (i.e. surgery or percutaneous drainage), or death. Results: Seventy-nine consecutive patients were included. The success rate was 81% (n = 64). Only 3 patients (4%) were referred to thoracic surgery. The one-year survival rate was 88%. On multivariate analysis, microorganisms observed in pleural fluid after Gram staining and first thoracentesis volume >= 450 mL were associated with ITTC failure with adjusted odds-ratios of 7.65 [95% CI, 1.44-40.67] and 6.97 [95% CI, 1.86-26.07], respectively. The main complications of ITTC were iatrogenic pneumothorax (n = 5, 6%) and vasovagal reactions (n = 3, 4%). None of the pneumothoraces required chest tube drainage, and no hemothorax or re-expansion pulmonary edema was observed. Conclusions: Although not indicated in international recommendations, ITTC is safe and effective as first-line treatment of CPPE, with limited invasiveness.	[Letheulle, Julien; Kerjouan, Mallorie; Lena, Herve; Desrues, Benoit; Jouneau, Stephane] Univ Rennes 1, Pontchaillou Hosp, Dept Resp Med, Rennes, France; [Letheulle, Julien; Tattevin, Pierre; Le Tulzo, Yves] Univ Rennes 1, Pontchaillou Hosp, Infect Dis & Intens Care Unit, Rennes, France; [Tattevin, Pierre] Univ Rennes 1, INSERM, U835, Rennes, France; [Saunders, Lauren] Univ Rennes 1, Pontchaillou Hosp, Dept Med Informat, Rennes, France; [Le Tulzo, Yves] Univ Rennes 1, CIC INSERM 0203, Rennes, France; [Jouneau, Stephane] Univ Rennes 1, IRSET U1085, Rennes, France	CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes	Jouneau, S (corresponding author), Univ Rennes 1, Pontchaillou Hosp, Dept Resp Med, Rennes, France.	Stephane.jouneau@chu-rennes.fr	Jouneau, Stephane/K-9956-2015	Desrues, Benoit/0000-0002-1748-1694				Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; ALFAGEME I, 1993, CHEST, V103, P839, DOI 10.1378/chest.103.3.839; BARTTER T, 1993, CHEST, V103, P1873, DOI 10.1378/chest.103.6.1873; BENFIELD GFA, 1981, BRIT J DIS CHEST, V75, P358, DOI 10.1016/0007-0971(81)90023-1; CHAM CW, 1993, THORAX, V48, P925, DOI 10.1136/thx.48.9.925; Chapman SJ, 2004, CURR OPIN PULM MED, V10, P299, DOI 10.1097/01.mcp.0000129755.79467.67; Chen KY, 2000, CHEST, V117, P1685, DOI 10.1378/chest.117.6.1685; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; COLLINS TR, 1987, CHEST, V91, P817, DOI 10.1378/chest.91.6.817; Colt HG, 1999, CHEST, V116, P134, DOI 10.1378/chest.116.1.134; CROUCH JD, 1987, AM REV RESPIR DIS, V136, P174, DOI 10.1164/ajrccm/136.1.174; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GROGAN DR, 1990, ARCH INTERN MED, V150, P873, DOI 10.1001/archinte.150.4.873; Hasley PB, 1996, ARCH INTERN MED, V156, P2206, DOI 10.1001/archinte.156.19.2206; Huang HC, 1999, CHEST, V115, P751, DOI 10.1378/chest.115.3.751; HUNNAM GR, 1988, CLIN RADIOL, V39, P121; Jones PW, 2003, CHEST, V123, P418, DOI 10.1378/chest.123.2.418; Keeling AN, 2008, CARDIOVASC INTER RAD, V31, P135, DOI 10.1007/s00270-007-9197-0; Koegelenberg CFN, 2008, RESPIRATION, V75, P241, DOI 10.1159/000117172; Lawrence DR, 1997, ANN THORAC SURG, V64, P1448, DOI 10.1016/S0003-4975(97)00917-X; LEMMER JH, 1985, J THORAC CARDIOV SUR, V90, P849; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Luh SP, 2005, CHEST, V127, P1427, DOI 10.1378/chest.127.4.1427; MANDAL AK, 1987, J THORAC CARDIOV SUR, V94, P414; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; MERRIAM MA, 1988, AM J ROENTGENOL, V151, P1113, DOI 10.2214/ajr.151.6.1113; MOULTON JS, 1995, CHEST, V108, P1252, DOI 10.1378/chest.108.5.1252; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Riquet M, 2003, PNEUMOLOGIE; Sahn SA, 2007, CLIN INFECT DIS, V45, P1480, DOI 10.1086/522996; SENEFF MG, 1986, CHEST, V90, P97, DOI 10.1378/chest.90.1.97; Shankar S, 2000, EUR RADIOL, V10, P495, DOI 10.1007/s003300050083; SILVERMAN SG, 1988, RADIOLOGY, V169, P5, DOI 10.1148/radiology.169.1.3047789; Simmers TA, 1999, THORAC CARDIOV SURG, V47, P77, DOI 10.1055/s-2007-1013115; STORM HKR, 1992, THORAX, V47, P821, DOI 10.1136/thx.47.10.821; ULMER JL, 1991, J THORAC IMAG, V6, P65, DOI 10.1097/00005382-199109000-00014; VIANNA NJ, 1971, J AMER MED ASSOC, V215, P69, DOI 10.1001/jama.215.1.69; Wait MA, 1997, CHEST, V111, P1548, DOI 10.1378/chest.111.6.1548; WEHR CJ, 1986, SOUTH MED J, V79, P171, DOI 10.1097/00007611-198602000-00009	43	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84788	10.1371/journal.pone.0084788	http://dx.doi.org/10.1371/journal.pone.0084788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400113	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700047
J	Rotem, S; Cohen, O; Bar-Haim, E; Bar-On, L; Ehrlich, S; Shafferman, A				Rotem, Shahar; Cohen, Ofer; Bar-Haim, Erez; Bar-On, Liat; Ehrlich, Sharon; Shafferman, Avigdor			Protective Immunity against Lethal F. tularensis holarctica LVS Provided by Vaccination with Selected Novel CD8(+) T Cell Epitopes	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; TULAREMIA VACCINES; CONFERS PROTECTION; INFECTION; STRAIN; LIVE; PATHOGEN; CD4(+); GROWTH; MACROPHAGES	Recently we described an unbiased bacterial whole-genome immunoinformatic analysis aimed at selection of potential CTL epitopes located in "hotspots" of predicted MHC-I binders. Applying this approach to the proteome of the facultative intracellular pathogen Francisella tularensis resulted in identification of 170 novel CTL epitopes, several of which were shown to elicit highly robust T cell responses. Here we demonstrate that by DNA immunization using a short DNA fragment expressing six of the most prominent identified CTL epitopes a potent and specific CD8+ T cell responses is being induced, to all encoded epitopes, a response not observed in control mice immunized with the DNA vector alone Moreover, this CTL-specific mediated immune response prevented disease development, allowed for a rapid clearance of the bacterial infection and provided complete protection against lethal challenge (10LD(50)) with F. tularensis holarctica Live Vaccine Strain (LVS) (a total to 30 of 30 immunized mice survived the challenge while all control DNA vector immunized mice succumbed). Furthermore, and in accordance with these results, CD8 deficient mice could not be protected from lethal challenge after immunization with the CTL-polyepitope. Vaccination with the DNA poly-epitope construct could even protect mice (8/10) against the more demanding pulmonary lethal challenge of LVS. Our approach provides a proof-of-principle for selecting and generating a multi-epitpoe CD8 T cell-stimulating vaccine against a model intracellular bacterium.	[Rotem, Shahar; Cohen, Ofer; Bar-Haim, Erez; Bar-On, Liat; Ehrlich, Sharon; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Shafferman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdors@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	Israel Institute for Biological Research [SB/5110-137]	Israel Institute for Biological Research	Israel Institute for Biological Research funds, grant number SB/5110-137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Conlan W, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P213, DOI 10.1007/978-90-481-9054-6_23; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Grosfeld H, 2003, INFECT IMMUN, V71, P374, DOI 10.1128/IAI.71.1.374-383.2003; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; LIPFORD GB, 1994, IMMUNOL LETT, V40, P101, DOI 10.1016/0165-2478(94)90179-1; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; McMurry Julie A, 2007, Med Health R I, V90, P311; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Ozawa Y, 2009, AM J RESP CELL MOL, V41, P440, DOI 10.1165/rcmb.2008-0446OC; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Pinchuk I, 2005, J IMMUNOL, V174, P5729, DOI 10.4049/jimmunol.174.9.5729; Rotem S, 2012, ANTIMICROB AGENTS CH, V56, P5406, DOI 10.1128/AAC.01104-12; Teixeira FM, 2006, CLIN VACCINE IMMUNOL, V13, P930, DOI 10.1128/CVI.00151-06; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Yee D, 1996, J IMMUNOL, V157, P5042; Yoshida A, 2001, VACCINE, V19, P4297, DOI 10.1016/S0264-410X(01)00146-3; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zvi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036440; Zvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020050	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85215	10.1371/journal.pone.0085215	http://dx.doi.org/10.1371/journal.pone.0085215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400128	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700062
J	Hintzpeter, J; Stapelfeld, C; Loerz, C; Martin, HJ; Maser, E				Hintzpeter, Jan; Stapelfeld, Claudia; Loerz, Christine; Martin, Hans-Joerg; Maser, Edmund			Green Tea and One of Its Constituents, Epigallocatechine-3-gallate, Are Potent Inhibitors of Human 11 beta-hydroxysteroid Dehydrogenase Type 1	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; VISCERAL OBESITY; CELL-CULTURE; IN-VIVO; PREVENTION; MICE; REGULATOR; CHEMISTRY	The microsomal enzyme 11 beta-hydroxysteroid deydrogenase type 1 (11 beta-HSD1) catalyzes the interconversion of glucocorticoid receptor-inert cortisone to receptor-active cortisol, thereby acting as an intracellular switch for regulating the access of glucocorticoid hormones to the glucocorticoid receptor. There is strong evidence for an important aetiological role of 11 beta-HSD1 in various metabolic disorders including insulin resistance, diabetes type 2, hypertension, dyslipidemia and obesity. Hence, modulation of 11 beta-HSD1 activity with selective inhibitors is being pursued as a new therapeutic approach for the treatment of the metabolic syndrome. Since tea has been associated with health benefits for thousands of years, we sought to elucidate the active principle in tea with regard to diabetes type 2 prevention. Several teas and tea specific polyphenolic compounds were tested for their possible inhibition of cortisone reduction with human liver microsomes and purified human 11 beta-HSD1. Indeed we found that tea extracts inhibited 11 beta-HSD1 mediated cortisone reduction, where green tea exhibited the highest inhibitory potency with an IC50 value of 3.749 mg dried tea leaves per ml. Consequently, major polyphenolic compounds from green tea, in particular catechins were tested with the same systems. (2)Epigallocatechin gallate (EGCG) revealed the highest inhibition of 11 beta-HSD1 activity (reduction: IC50 = 57.99 mu M; oxidation: IC50 = 131.2 mu M). Detailed kinetic studies indicate a direct competition mode of EGCG, with substrate and/or cofactor binding. Inhibition constants of EGCG on cortisone reduction were Ki = 22.68 mu M for microsomes and Ki = 18.74 mu M for purified 11 beta-HSD1. In silicio docking studies support the view that EGCG binds directly to the active site of 11 beta-HSD1 by forming a hydrogen bond with Lys187 of the catalytic triade. Our study is the first to provide evidence that the health benefits of green tea and its polyphenolic compounds may be attributed to an inhibition of the cortisol producing enzyme 11 beta-HSD1.	[Hintzpeter, Jan; Stapelfeld, Claudia; Loerz, Christine; Martin, Hans-Joerg; Maser, Edmund] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Maser, E (corresponding author), Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Campus Kiel, Kiel, Germany.	maser@toxi.uni-kiel.de	Maser, Edmund/B-1728-2010		German Federal Ministry of Education and Research [0315397A]; Deutsche Forschungsgemeinschaft [MA 1704/5-2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work on 11 beta-HSD1 in our laboratory is funded by the German Federal Ministry of Education and Research (0315397A) and the Deutsche Forschungsgemeinschaft (MA 1704/5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Bhagwat S., 2011, USDA DATABASE FLAVON; Blum A, 2000, TOXICOLOGY, V144, P113, DOI 10.1016/S0300-483X(99)00197-3; Blum A, 2003, PROG NUCLEIC ACID RE, V75, P173, DOI 10.1016/S0079-6603(03)75006-5; Blum A, 2012, J STEROID BIOCHEM, V128, P51, DOI 10.1016/j.jsbmb.2011.09.003; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Ge R, 2010, CURR MED CHEM, V17, P412, DOI 10.2174/092986710790226147; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Hughes KA, 2012, DIABETES, V61, P1357, DOI 10.2337/db11-1345; Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006; Ikeda I, 2008, ASIA PAC J CLIN NUTR, V17, P273; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; Macfarlane, 2004, EMPIRE TEA; Maeda-Yamamoto M, 2013, CURR PHARM DES; Maser E, 2002, BIOCHEMISTRY-US, V41, P2459, DOI 10.1021/bi015803t; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; SATO Y, 1989, TOHOKU J EXP MED, V157, P337, DOI 10.1620/tjem.157.337; Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231; Shen Yao, 2010, Comb Chem High Throughput Screen, V13, P885, DOI 10.2174/138620710793360239; Staab CA, 2010, J STEROID BIOCHEM, V119, P56, DOI 10.1016/j.jsbmb.2009.12.013; Sueoka N, 2001, ANN NY ACAD SCI, V928, P274; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Szelenyi P, 2013, BIOFACTORS OXF ENGL, DOI [10.1002/biof.1095, DOI 10.1002/BI0F.1095]; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Weng ZQ, 2012, TOXICOL LETT, V214, P328, DOI 10.1016/j.toxlet.2012.09.011; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135	44	34	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84468	10.1371/journal.pone.0084468	http://dx.doi.org/10.1371/journal.pone.0084468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404164	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800043
J	Wain, LV; Odenthal-Hesse, L; Abujaber, R; Sayers, I; Beardsmore, C; Gaillard, EA; Chappell, S; Dogaru, CM; McKeever, T; Guetta-Baranes, T; Kalsheker, N; Kuehni, CE; Hall, IP; Tobin, MD; Hollox, EJ				Wain, Louise V.; Odenthal-Hesse, Linda; Abujaber, Razan; Sayers, Ian; Beardsmore, Caroline; Gaillard, Erol A.; Chappell, Sally; Dogaru, Cristian M.; McKeever, Tricia; Guetta-Baranes, Tamar; Kalsheker, Noor; Kuehni, Claudia E.; Hall, Ian P.; Tobin, Martin D.; Hollox, Edward J.			Copy Number Variation of the Beta-Defensin Genes in Europeans: No Supporting Evidence for Association with Lung Function, Chronic Obstructive Pulmonary Disease or Asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AIRWAY EPITHELIAL-CELLS; RESPIRATORY-TRACT; FLOW OBSTRUCTION; CROHNS-DISEASE; POPULATION; EXPRESSION; HEALTH; RISK; SUSCEPTIBILITY	Lung function measures are heritable, predict mortality and are relevant in diagnosis of chronic obstructive pulmonary disease (COPD). COPD and asthma are diseases of the airways with major public health impacts and each have a heritable component. Genome-wide association studies of SNPs have revealed novel genetic associations with both diseases but only account for a small proportion of the heritability. Complex copy number variation may account for some of the missing heritability. A well-characterised genomic region of complex copy number variation contains beta-defensin genes (DEFB103, DEFB104 and DEFB4), which have a role in the innate immune response. Previous studies have implicated these and related genes as being associated with asthma or COPD. We hypothesised that copy number variation of these genes may play a role in lung function in the general population and in COPD and asthma risk. We undertook copy number typing of this locus in 1149 adult and 689 children using a paralogue ratio test and investigated association with COPD, asthma and lung function. Replication of findings was assessed in a larger independent sample of COPD cases and smoking controls. We found evidence for an association of beta-defensin copy number with COPD in the adult cohort (OR = 1.4, 95% CI: 1.02-1.92, P = 0.039) but this finding, and findings from a previous study, were not replicated in a larger follow-up sample(OR = 0.89, 95% CI: 0.72-1.07, P = 0.217). No robust evidence of association with asthma in children was observed. We found no evidence for association between beta-defensin copy number and lung function in the general populations. Our findings suggest that previous reports of association of beta-defensin copy number with COPD should be viewed with caution. Suboptimal measurement of copy number can lead to spurious associations. Further beta-defensin copy number measurement in larger sample sizes of COPD cases and children with asthma are needed.	[Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Odenthal-Hesse, Linda; Abujaber, Razan; Tobin, Martin D.; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Sayers, Ian; Hall, Ian P.] Univ Nottingham, Sch Med, Div Resp Med, Nottingham, England; [Beardsmore, Caroline; Gaillard, Erol A.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Beardsmore, Caroline; Gaillard, Erol A.; Tobin, Martin D.] Glenfield Hosp, Inst Lung Hlth, NIHR, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Chappell, Sally; Guetta-Baranes, Tamar; Kalsheker, Noor] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Dogaru, Cristian M.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [McKeever, Tricia] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England	University of Leicester; University of Leicester; University of Nottingham; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Nottingham; University of Bern; University of Nottingham	Wain, LV (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	louisewain@le.ac.uk	Odenthal-Hesse, Linda/HCI-6463-2022; Dogaru, Cristian/N-6290-2015; Dogaru, Cristian/I-1861-2019	Dogaru, Cristian/0000-0002-0722-6147; Dogaru, Cristian/0000-0002-0722-6147; Hall, Ian/0000-0001-9933-3216; Sayers, Ian/0000-0001-5601-5410; Tobin, Martin/0000-0002-3596-7874; McKeever, Tricia/0000-0003-0914-0416; Kuehni, Claudia E./0000-0001-8957-2002; Gaillard, Erol/0000-0003-0996-8133; Odenthal-Hesse, Linda/0000-0002-5519-2375; Chappell, Sally/0000-0002-0841-6655; Wain, Louise/0000-0003-4951-1867; Hollox, Edward/0000-0002-0115-2298	Higher Education Innovation Fund (HEIF); Asthma UK [07/048]; British Lung Foundation; Swiss National Science Foundation [3200B0-122341]; Medical Research Council Senior Clinical Fellowship [G0902313]; National Institute for Health Research (NIHR); Medical Research Council [G1000861]; Medical Research Council [G0902313, G0801123] Funding Source: researchfish; MRC [G0902313, G1000861] Funding Source: UKRI	Higher Education Innovation Fund (HEIF); Asthma UK; British Lung Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DNA extraction from LRC samples and PRT DEFB genotyping of LRC and Gedling samples was funded by a Higher Education Innovation Fund (HEIF) funded Impact Award to Louise V. Wain. The Nottingham Gedling cohort collection was funded by Asthma UK and the British Lung Foundation. Leicester Respiratory Cohort (LRC) was funded by Swiss National Science Foundation grant 3200B0-122341 and Asthma UK grant 07/048. Martin D. Tobin holds a Medical Research Council Senior Clinical Fellowship (G0902313). The research was part-funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Ian Hall and Ian Sayers hold a Medical Research Council programme grant (G1000861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Andresen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021898; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; ARTIGAS MS, 2011, NAT GENET, V43, P1082, DOI DOI 10.1038/NG.941; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; BRITTON JR, 1995, AM J RESP CRIT CARE, V151, P1383, DOI 10.1164/ajrccm.151.5.7735589; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Chappell S, 2006, HUM MUTAT, V27, P103, DOI 10.1002/humu.20275; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cookson William O C, 2011, Proc Am Thorac Soc, V8, P149, DOI 10.1513/pats.201101-003MS; Dogaru CM, 2012, AM J RESP CRIT CARE, V185, P874, DOI 10.1164/rccm.201108-1490OC; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; *GOLD, 2006, GLOB STRAT DIAGN MAN; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 2003, CHEST, V124, P1805, DOI 10.1378/chest.124.5.1805; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hardwick RJ, 2012, J INFECT DIS, V206, P1012, DOI 10.1093/infdis/jis448; Hardwick RJ, 2011, HUM MUTAT, V32, P743, DOI 10.1002/humu.21491; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2010, AM J GASTROENTEROL, V105, P360, DOI 10.1038/ajg.2009.573; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013; Liao ZL, 2012, PEPTIDES, V38, P350, DOI 10.1016/j.peptides.2012.09.013; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Myers RA, 2012, J ALLERGY CLIN IMMUN, V130, P1294, DOI 10.1016/j.jaci.2012.07.054; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; STRIPPOLI MP, 2013, PEDIATRICS; Stuart PE, 2012, J INVEST DERMATOL, V132, P2407, DOI 10.1038/jid.2012.191; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Yanagi S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-130; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84192	10.1371/journal.pone.0084192	http://dx.doi.org/10.1371/journal.pone.0084192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404154	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800033
J	Wang, P; Wu, TH; Zhang, Y				Wang, Ping; Wu, Tun-Hua; Zhang, Yong			In Situ Investigation the Photolysis of the PAHs Adsorbed on Mangrove Leaf Surfaces by Synchronous Solid Surface Fluorimetry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FIBEROPTIC SENSOR; FLUORESCENCE; ANTHRACENE; PLANT; L.; PHOTOCHEMISTRY; NEEDLES; WATER; PHOTODEGRADATION	An established synchronous solid surface fluorimetry (S-SSF) was utilized for in situ study the photolysis processes of anthracene (An) and pyrene (Py) adsorbed on the leaf surfaces of Kandelia obovata seedlings (Ko) and Aegiceras corniculata (L.) Blanco seedlings (Ac). Experimental results demonstrated that the photolysis of An and Py adsorbed on the leaf surfaces of two mangrove species under the laboratory conditions, followed first-order kinetics with their photolysis rates in the order of Ac. Ko. In addition, with the same amount of substances, the photolysis rate of An adsorbed on the same mangrove leaf surfaces was much faster than the adsorbed Py. In order to investigate further, the photolysis processes of An and Py in water were also studied for comparison. And the photolysis of An and Py in water also followed first-order kinetics. Moreover, for the same initial amount, the photolysis rate of the PAH in water was faster than that adsorbed on the leaf surfaces of two mangrove species. Therefore, photochemical behaviors of PAHs were dependent not only on their molecular structures but also the physical-chemical properties of the substrates on which they are adsorbed.	[Wang, Ping] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China; [Wu, Tun-Hua] Wenzhou Med Univ, Sch Informat & Engn, Wenzhou, Peoples R China; [Zhang, Yong] Xiamen Univ, Environm Sci Res Ctr, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Xiamen University	Zhang, Y (corresponding author), Xiamen Univ, Environm Sci Res Ctr, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	fruitful@xmu.edu.cn	Wu, Tunhua/L-9511-2019; 张, 勇/G-3426-2010; Wang, Ping/I-8405-2019		National Natural Science Foundation of China [21177102, 21075102, 21207103]; Public Benefit Project of Zhejiang Province [2012C31025]; Natural Science Foundation of Zhejiang Province [LY13H180012]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201222932]; Project of Wenzhou Municipal Science and Technology [G20110004]; Science and Technology Innovation Action of College Student of Zhejiang Province [2013R413010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Benefit Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Project of Wenzhou Municipal Science and Technology; Science and Technology Innovation Action of College Student of Zhejiang Province	National Natural Science Foundation of China (21177102, 21075102 and 21207103), Public Benefit Project of Zhejiang Province (2012C31025), Natural Science Foundation of Zhejiang Province (LY13H180012), Scientific Research Fund of Zhejiang Provincial Education Department (Y201222932), Project of Wenzhou Municipal Science and Technology (G20110004) and Science and Technology Innovation Action of College Student of Zhejiang Province (2013R413010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto S, 2010, ENVIRON POLLUT, V158, P483, DOI 10.1016/j.envpol.2009.08.016; CHEN GZ, 1990, FLUORESCENCE ANAL; Chen L, 2011, J FLUORESC, V21, P765, DOI 10.1007/s10895-010-0769-z; Chen L, 2010, TALANTA, V83, P324, DOI 10.1016/j.talanta.2010.09.025; De Laender F, 2011, ENVIRON SCI TECHNOL, V45, P9024, DOI 10.1021/es202423f; Feilberg A, 2001, ENVIRON SCI TECHNOL, V35, P108, DOI 10.1021/es990834l; Fioressi S, 2003, J PHYS CHEM A, V107, P5968, DOI 10.1021/jp027305f; Fioressi S, 1999, POLYCYCL AROMAT COMP, V14, P285, DOI 10.1080/10406639908019134; Gao YZ, 2006, CHEMOSPHERE, V63, P1560, DOI 10.1016/j.chemosphere.2005.09.058; Gorshkov AG, 2008, J ANAL CHEM+, V63, P805, DOI 10.1134/S1061934808080169; HUANG XD, 1993, ENVIRON TOXICOL CHEM, V12, P1067, DOI 10.1002/etc.5620120613; Kahan TF, 2007, J PHYS CHEM A, V111, P1277, DOI 10.1021/jp066660t; Ke L, 2002, MAR POLLUT BULL, V45, P339, DOI 10.1016/S0025-326X(02)00117-0; Komp P, 2000, SCI TOTAL ENVIRON, V250, P63, DOI 10.1016/S0048-9697(00)00364-8; KORFMACHER WA, 1980, ENVIRON SCI TECHNOL, V14, P1094, DOI 10.1021/es60169a019; Lehto KM, 2000, J PHOTOCH PHOTOBIO A, V136, P53, DOI 10.1016/S1010-6030(00)00321-X; LI YQ, 1991, THESIS XIAMEN U XIAM; Mackay Donald, 1997, ILLUSTRATED HDB PHYS; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; NIESSNER R, 1991, ANAL CHIM ACTA, V255, P231, DOI 10.1016/0003-2670(91)80051-T; Niu JF, 2003, ENVIRON POLLUT, V123, P39, DOI 10.1016/S0269-7491(02)00362-7; Oyo-Ita OE, 2013, APPL GEOCHEM, V28, P212, DOI 10.1016/j.apgeochem.2012.09.011; Pagni Richard M., 2005, V2, P193, DOI 10.1007/b138184; PANNE U, 1993, SENSOR ACTUAT B-CHEM, V13, P288, DOI 10.1016/0925-4005(93)85383-L; Ramdine G, 2012, ECOTOX ENVIRON SAFE, V79, P80, DOI 10.1016/j.ecoenv.2011.12.005; Reyes CA, 2000, ENVIRON SCI TECHNOL, V34, P415, DOI 10.1021/es9905391; Reza D, 1995, J PHOTOCH PHOTOBIO A, V86, P231; Robert AY, 1986, ENVIRON SCI TECHNOL, V20, P86; Rogers KR, 1996, CHEMOSPHERE, V33, P1151, DOI 10.1016/0045-6535(96)00255-X; Schuler F, 1998, CHEMOSPHERE, V36, P21, DOI 10.1016/S0045-6535(97)00349-4; Tham YWF, 2007, B ENVIRON CONTAM TOX, V79, P670, DOI 10.1007/s00128-007-9309-1; Wang DG, 2005, ATMOS ENVIRON, V39, P4583, DOI 10.1016/j.atmosenv.2005.04.008; Wang P, 2008, TALANTA, V76, P1177, DOI 10.1016/j.talanta.2008.05.021; Wang P, 2012, MAR POLLUT BULL, V64, P1654, DOI 10.1016/j.marpolbul.2012.05.034; Wang P, 2012, J COASTAL RES, V28, P499, DOI 10.2112/JCOASTRES-D-11-00111.1; Wang Ping, 2010, Toxicological and Environmental Chemistry, V92, P1825, DOI 10.1080/02772248.2010.482833; Wang P, 2010, J COASTAL RES, V26, P549, DOI 10.2112/08-1148.1; Wang XT, 2013, SCI TOTAL ENVIRON, V447, P80, DOI 10.1016/j.scitotenv.2012.12.086; Wild E, 2005, ENVIRON SCI TECHNOL, V39, P3695, DOI 10.1021/es048136a; Wild E, 2004, ENVIRON SCI TECHNOL, V38, P4195, DOI 10.1021/es049915u; Worrall DR, 1997, J PHYS CHEM B, V101, P4709, DOI 10.1021/jp970133f; Wu NY, 2009, ENVIRON POLLUT, V157, P1613, DOI 10.1016/j.envpol.2008.12.022; Xiao X, 2015, ORAL LIT CONTINUUM C; Xu Z, 2004, THESIS DALIAN U TECH	44	15	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84296	10.1371/journal.pone.0084296	http://dx.doi.org/10.1371/journal.pone.0084296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404158	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800037
J	Ciappio, ED; Krausz, KW; Rochman, M; Furusawa, T; Bonzo, JA; Tessarollo, L; Gonzalez, FJ; Bustin, M				Ciappio, Eric D.; Krausz, Kristopher W.; Rochman, Mark; Furusawa, Takashi; Bonzo, Jessica A.; Tessarollo, Lino; Gonzalez, Frank J.; Bustin, Michael			Metabolomics Reveals a Role for the Chromatin-Binding Protein HMGN5 in Glutathione Metabolism	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; HISTONE H1; FAMILY; METLIN	High mobility group nucleosome-binding protein 5 (HMGN5) is a chromatin architectural protein that binds specifically to nucleosomes and reduces the compaction of the chromatin fiber. The protein is present in most vertebrate tissues however the physiological function of this protein is unknown. To examine the function of HMGN5 in vivo, mice lacking the nucleosome-binding domain of HMGN5 were generated and characterized. Serological analysis revealed that compared to wild-type littermates (Hmgn5(+/Y)), mice with a targeted mutation in the HMGN5 gene (Hmgn5(tm1/Y)), had elevated serum albumin, non-HDL cholesterol, triglycerides, and alanine transaminase, suggesting mild hepatic abnormalities. Metabolomics analysis of liver extracts and urine revealed clear differences in metabolites between Hmgn5(tm1/Y) and their Hmgn5(+/Y) littermates. Hmgn5(tm1/Y) mice had a significant increase in hepatic glutathione levels and decreased urinary concentrations of betaine, phenylacetylglycine, and creatine, all of which are metabolically related to the glutathione precursor glycine. Microarray and qPCR analysis revealed that expression of two genes affecting glutathione metabolism, glutathione peroxidase 6 (Gpx6) and hexokinase 1 (Hk1), was significantly decreased in Hmgn5(tm1/Y) mouse liver tissue. Analysis of chromatin structure by DNase I digestion revealed alterations in the chromatin structure of these genes in the livers of Hmgn5(tm1/Y) mice. Thus, functional loss of HMGN5 leads to changes in transcription of Gpx6 and Hk1 that alter glutathione metabolism.	[Ciappio, Eric D.; Krausz, Kristopher W.; Rochman, Mark; Furusawa, Takashi; Bonzo, Jessica A.; Gonzalez, Frank J.; Bustin, Michael] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustin, M (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	Bustin, Michael/G-6155-2015	Rochman, Mark/0000-0002-0818-927X; Bustin, Michael/0000-0002-5147-7242	Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health; United States-Israeli Binational foundation [2009326]; NATIONAL CANCER INSTITUTE [ZIABC011154, ZIABC004496] Funding Source: NIH RePORTER	Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health; United States-Israeli Binational foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This was funded by the Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health, and by grant #2009326 from the United States-Israeli Binational foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Bi HC, 2013, ANAL BIOANAL CHEM, V405, P5279, DOI 10.1007/s00216-013-6927-9; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Bonin A, 2000, METH MOL B, V158, P121; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Deng T, 2013, MOL CELL BIOL; Huang Z.Z., 2000, FASEB J; Huang ZZ, 2000, BBA-GENE STRUCT EXPR, V1493, P48, DOI 10.1016/S0167-4781(00)00156-1; Kugler JE, 2013, J BIOL CHEM, V288, P16690, DOI 10.1074/jbc.M113.463315; Kugler JE, 2012, BBA-GENE REGUL MECH, V1819, P652, DOI 10.1016/j.bbagrm.2012.01.013; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LU SC, 1992, J CLIN INVEST, V90, P524, DOI 10.1172/JCI115890; Pallardo FV, 2009, MOL ASPECTS MED, V30, P77, DOI 10.1016/j.mam.2009.01.001; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rochman M, 2010, BBA-GENE REGUL MECH, V1799, P86, DOI 10.1016/j.bbagrm.2009.09.012; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Shirakawa H, 2000, J BIOL CHEM, V275, P6368, DOI 10.1074/jbc.275.9.6368; Slyshenkov VS, 2004, FEBS LETT, V569, P169, DOI 10.1016/j.febslet.2004.05.044; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tessarollo L, 2000, METH MOL B, V158, P47; Ueda T, 2009, MOL CELL BIOL, V29, P5264, DOI 10.1128/MCB.00526-09; West KL, 2003, METHOD ENZYMOL, V371, P521; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	32	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84583	10.1371/journal.pone.0084583	http://dx.doi.org/10.1371/journal.pone.0084583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392144	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100067
J	Hamamoto, G; Suzuki, T; Suzuki, MG; Aoki, F				Hamamoto, Go; Suzuki, Tsukasa; Suzuki, Masataka G.; Aoki, Fugaku			Regulation of Transketolase Like 1 Gene Expression in the Murine One-Cell Stage Embryos	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYO; RNA-POLYMERASE-II; DNA-REPLICATION; 1ST MITOSIS; ACTIVATION; TRANSCRIPTION; PROMOTER; SP1; IDENTIFICATION; REPRESSION	In mice, transcription from the zygotic genome starts at the mid-one-cell stage after fertilization. Previous studies showed that an enhancer is not required for transcription at this stage, and that the enhancer-dependent mechanism of transcription is established during the two-cell stage. However, these results were obtained using reporter gene assays with promoters derived from viruses, rather than from endogenous genes. We conducted a reporter-gene assay using the promoter of Tktl1, which is transcribed after fertilization, to investigate the mechanism regulating gene expression at the one-cell stage. When a plasmid containing the 2467 bp upstream and 25 bp downstream of the Tktl1 transcription start site (TSS) was microinjected into the nuclei of growing oocytes, and one-cell stage and early and late two-cell-stage embryos, transcriptional activity was detected in the one-cell- and two-cell-stage embryos, but not in the oocytes. It was highest at the early two-cell stage and was reduced at the late two-cell stage. The decrease in activity at the late two-cell stage was prevented by inhibiting the second round of DNA replication, suggesting that the transcriptionally repressive state is established during the two-cell stage by a mechanism coupled to DNA replication. When the Tktl1 promoter was deleted to leave 56 bp upstream of the TSS which includes GC and TATA boxes, transcriptional activity was still detected in one-cell-stage embryos, but not early or late two-cell-stage embryos. The core promoter of Tktl1 alone seems to be able to induce basal transcription at the one-cell stage. These results suggest that repressive chromatin is established after fertilization in two steps, which occur during the transition from the one-to two-cell stage and during DNA replication at the two-cell stage.	[Hamamoto, Go; Suzuki, Tsukasa; Suzuki, Masataka G.; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Aoki, F (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	aokif@k.u-tokyo.ac.jp	AOKI, FUGAKU/AAO-7617-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [20062002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid (to F.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20062002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Bevilacqua A, 1997, NUCLEIC ACIDS RES, V25, P1333, DOI 10.1093/nar/25.7.1333; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cho T., 2002, Animal Science Journal, V73, P113, DOI 10.1046/j.1344-3941.2002.00017.x; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; Davis W, 1996, DEV BIOL, V174, P190, DOI 10.1006/dbio.1996.0065; Forlani S, 1998, DEVELOPMENT, V125, P3153; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HENERY CC, 1995, DEV BIOL, V169, P448, DOI 10.1006/dbio.1995.1160; Kageyama S, 2007, ZYGOTE, V15, P117, DOI 10.1017/S096719940700411X; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Liu HL, 2005, CELL RES, V15, P127, DOI 10.1038/sj.cr.7290277; MAJUMDER S, 1993, EMBO J, V12, P1131, DOI 10.1002/j.1460-2075.1993.tb05754.x; MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203; QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147; RAM PT, 1993, DEV BIOL, V156, P552, DOI 10.1006/dbio.1993.1101; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; TURNER BM, 1991, J CELL SCI, V99, P13; Wang Y, 1996, NUCLEIC ACIDS RES, V24, P3100, DOI 10.1093/nar/24.15.3100; WIEKOWSKI M, 1991, DEV BIOL, V147, P403, DOI 10.1016/0012-1606(91)90298-H; WIEKOWSKI M, 1993, DEV BIOL, V159, P366, DOI 10.1006/dbio.1993.1248; WORRAD DM, 1995, DEVELOPMENT, V121, P2949; WORRAD DM, 1994, DEVELOPMENT, V120, P2347	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e82087	10.1371/journal.pone.0082087	http://dx.doi.org/10.1371/journal.pone.0082087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392079	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100003
J	Mattioli, MC; Boehm, AB; Davis, J; Harris, AR; Mrisho, M; Pickering, AJ				Mattioli, Mia Catharine; Boehm, Alexandria B.; Davis, Jennifer; Harris, Angela R.; Mrisho, Mwifadhi; Pickering, Amy J.			Enteric Pathogens in Stored Drinking Water and on Caregiver's Hands in Tanzanian Households with and without Reported Cases of Child Diarrhea	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEVELOPING-COUNTRIES; MICROBIAL-CONTAMINATION; BACTERIAL INDICATORS; HUMAN ADENOVIRUSES; HYGIENE BEHAVIORS; FECAL INDICATORS; COASTAL WATERS; RISK; QUALITY	Background: Diarrhea is one of the leading causes of mortality in young children. Diarrheal pathogens are transmitted via the fecal-oral route, and for children the majority of this transmission is thought to occur within the home. However, very few studies have documented enteric pathogens within households of low-income countries. Methods and Findings: The presence of molecular markers for three enteric viruses (enterovirus, adenovirus, and rotavirus), seven Escherichia coli virulence genes (ECVG), and human-specific Bacteroidales was assessed in hand rinses and household stored drinking water in Bagamoyo, Tanzania. Using a matched case-control study design, we examined the relationship between contamination of hands and water with these markers and child diarrhea. We found that the presence of ECVG in household stored water was associated with a significant decrease in the odds of a child within the home having diarrhea (OR = 0.51; 95% confidence interval 0.27-0.93). We also evaluated water management and hygiene behaviors. Recent hand contact with water or food was positively associated with detection of enteric pathogen markers on hands, as was relatively lower volumes of water reportedly used for daily hand washing. Enteropathogen markers in stored drinking water were more likely found among households in which the markers were also detected on hands, as well as in households with unimproved water supply and sanitation infrastructure. Conclusions: The prevalence of enteric pathogen genes and the human-specific Bacteroidales fecal marker in stored water and on hands suggests extensive environmental contamination within homes both with and without reported child diarrhea. Better stored water quality among households with diarrhea indicates caregivers with sick children may be more likely to ensure safe drinking water in the home. Interventions to increase the quantity of water available for hand washing, and to improve food hygiene, may reduce exposure to enteric pathogens in the domestic environment.	[Mattioli, Mia Catharine; Boehm, Alexandria B.; Davis, Jennifer; Harris, Angela R.; Pickering, Amy J.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Davis, Jennifer; Pickering, Amy J.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Mrisho, Mwifadhi] Bagamoyo Res & Training Unit, Ifakara Hlth Inst, Bagamoyo, Tanzania	Stanford University; Stanford University; Ifakara Health Institute	Pickering, AJ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	amyjanel@stanford.edu	Richardson, Mary/M-9299-2016	Boehm, Alexandria/0000-0002-8162-5090; Harris, Angela/0000-0001-8639-8539	National Science Foundation [SES-0827384]; Stanford University Shah Research Fellowship; Divn Of Social and Economic Sciences [0827384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Stanford University Shah Research Fellowship(Stanford University); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the National Science Foundation (SES-0827384) and by the Stanford University Shah Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030; Baggi F, 2001, RES MICROBIOL, V152, P743, DOI 10.1016/S0923-2508(01)01255-4; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; BLACK RE, 1981, B WORLD HEALTH ORGAN, V59, P263; Bonadonna L, 2002, ENVIRON MONIT ASSESS, V75, P241, DOI 10.1023/A:1014852201424; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Brown J, 2013, TROP MED INT HEALTH, V18, P65, DOI 10.1111/tmi.12010; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; CAIRNCROSS AM, 1990, J INST WATER ENV MAN, V4, P571; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Davis J, 2011, AM J TROP MED HYG, V84, P184, DOI 10.4269/ajtmh.2011.10-0126; DAY NE, 1980, AM J EPIDEMIOL, V112, P696, DOI 10.1093/oxfordjournals.aje.a113042; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dufour AP, 1986, AMBIENT WATER QUALIT; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Ferguson AS, 2011, J WATER HEALTH, V9, P708, DOI 10.2166/wh.2011.106; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; FUJIOKA RS, 1988, TOXIC ASSESS, V3, P613, DOI 10.1002/tox.2540030514; Gasana J, 2002, ENVIRON RES, V90, P76, DOI 10.1006/enrs.2002.4394; Gascon J, 2000, J CLIN MICROBIOL, V38, P4459; Gundry S, 2004, J WATER HEALTH, V2, P1; HAAS CN, 1993, RISK ANAL, V13, P545, DOI 10.1111/j.1539-6924.1993.tb00013.x; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Horman A, 2004, APPL ENVIRON MICROB, V70, P87, DOI 10.1128/AEM.70.1.87-95.2004; Howard CM, 2010, AM J TROP MED HYG, V83, P1170, DOI 10.4269/ajtmh.2010.10-0384; Howard G., 2003, DOMESTIC WATER QUANT; Jensen PK, 2004, TROP MED INT HEALTH, V9, P1210, DOI 10.1111/j.1365-3156.2004.01329.x; Jensen PK, 2002, TROP MED INT HEALTH, V7, P604, DOI 10.1046/j.1365-3156.2002.00901.x; Jiang S, 2001, APPL ENVIRON MICROB, V67, P179, DOI 10.1128/AEM.67.1.179-184.2001; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Keating DTK, 2008, EXP LUNG RES, V34, P455, DOI 10.1080/01902140802093162; Khush RS, 2013, AM J TROP MED HYG, V89, P251, DOI 10.4269/ajtmh.13-0067; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kotloff KL, 2013, LANCET; Kremer M, 2011, Q J ECON, V126, P145, DOI 10.1093/qje/qjq010; Lemarchand K, 2003, FEMS MICROBIOL LETT, V218, P203, DOI 10.1111/j.1574-6968.2003.tb11519.x; Levine MM, 2012, CLIN INFECT DIS, V55, pS303, DOI 10.1093/cid/cis789; Levy K, 2008, ENVIRON HEALTH PERSP, V116, P1533, DOI 10.1289/ehp.11296; Levy K, 2012, AM J TROP MED HYG, V86, P499, DOI 10.4269/ajtmh.2012.11-0263; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luby SP, 2001, EPIDEMIOL INFECT, V127, P237, DOI 10.1017/S0950268801005829; Luby SP, 2007, TROP MED INT HEALTH, V12, P765, DOI 10.1111/j.1365-3156.2007.01847.x; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; MOE CL, 1991, B WORLD HEALTH ORGAN, V69, P305; Noble RT, 2001, HYDROBIOLOGIA, V460, P175, DOI 10.1023/A:1013121416891; Organization WH UNICeF, 2012, PROGR SAN DRINK WAT; Pickering AJ, 2012, ENV SCI TECHNOL; Pickering AJ, 2011, TROP MED INT HEALTH, V16, P233, DOI 10.1111/j.1365-3156.2010.02677.x; Pickering AJ, 2010, ENVIRON SCI TECHNOL, V44, P3267, DOI 10.1021/es903524m; PINFOLD JV, 1990, EPIDEMIOL INFECT, V105, P377, DOI 10.1017/S0950268800047968; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Pusch D, 2005, ARCH VIROL, V150, P929, DOI 10.1007/s00705-004-0467-8; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Silva PA, 2008, J MED VIROL, V80, P1790, DOI 10.1002/jmv.21231; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Thompson J., 2001, DRAWERS WATER, VII; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; USEPA, 2002, 1604 USEPA OFF WAT; USEPA, 2009, 1600 USEPA OFF WAT; Valentiner-Branth P, 2003, J CLIN MICROBIOL, V41, P4238, DOI 10.1128/JCM.41.9.4238-4245.2003; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; VANDERSLICE J, 1993, WATER RESOUR RES, V29, P1983, DOI 10.1029/92WR02994; Viau EJ, 2011, WATER RES, V45, P3279, DOI 10.1016/j.watres.2011.03.033; Victoria M, 2009, J VIROL METHODS, V156, P73, DOI 10.1016/j.jviromet.2008.11.003; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; WHO UNICEF, 2012, PROGR DRINK WAT SAN; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Wu J, 2011, J WATER HEALTH, V9, P265, DOI 10.2166/wh.2011.117; Yamahara KM, 2009, APPL ENVIRON MICROB, V75, P1517, DOI 10.1128/AEM.02278-08	77	44	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84939	10.1371/journal.pone.0084939	http://dx.doi.org/10.1371/journal.pone.0084939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392161	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100084
J	Liu, S; Dunwell, TL; Pfeifer, GP; Dunwell, JM; Ullah, I; Wang, YS				Liu, Shuo; Dunwell, Thomas L.; Pfeifer, Gerd P.; Dunwell, Jim M.; Ullah, Ihsan; Wang, Yinsheng			Detection of Oxidation Products of 5-Methyl-2'-Deoxycytidine in Arabidopsis DNA	PLOS ONE			English	Article							MASS-SPECTROMETRY; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; METHYLATION; DEMETHYLATION; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; GLYCOSYLASE	Epigenetic regulations play important roles in plant development and adaptation to environmental stress. Recent studies from mammalian systems have demonstrated the involvement of ten-eleven translocation (Tet) family of dioxygenases in the generation of a series of oxidized derivatives of 5-methylcytosine (5-mC) in mammalian DNA. In addition, these oxidized 5-mC nucleobases have important roles in epigenetic remodeling and aberrant levels of 5-hydroxymethyl-2'-deoxycytidine (5-HmdC) were found to be associated with different types of human cancers. However, there is a lack of evidence supporting the presence of these modified bases in plant DNA. Here we reported the use of a reversed-phase HPLC coupled with tandem mass spectrometry method and stable isotope-labeled standards for assessing the levels of the oxidized 5-mC nucleosides along with two other oxidatively induced DNA modifications in genomic DNA of Arabidopsis. These included 5-HmdC, 5-formyl-2'-deoxycytidine (5-FodC), 5-carboxyl-2'-deoxycytidine (5-CadC), 5-hydroxymethyl-2'-deoxyuridine (5HmdU), and the (5'S) diastereomer of 8,5';-cyclo-2'-deoxyguanosine (S-cdG). We found that, in Arabidopsis DNA, the levels of 5-HmdC, 5-FodC, and 5-CadC are approximately 0.8 modifications per 10(6) nucleosides, with the frequency of 5-HmdC (per 5-mdC) being comparable to that of 5-HmdU (per thymidine). The relatively low levels of the 5-mdC oxidation products suggest that they arise likely from reactive oxygen species present in cells, which is in line with the lack of homologous Tetfamily dioxygenase enzymes in Arabidopsis.	[Liu, Shuo; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Dunwell, Thomas L.; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Dunwell, Jim M.; Ullah, Ihsan] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Ullah, Ihsan] Agr Biotechnol Res Inst, Faisalabad, Pakistan; [Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; City of Hope; Beckman Research Institute of City of Hope; University of Reading; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Dunwell, Jim/AAS-6217-2020; Liu, Shuo/F-8229-2017	Dunwell, Jim/0000-0003-2147-665X; Ullah, Ihsan/0000-0002-9367-6741; Dunwell, Thomas/0000-0001-9985-3828	National Institutes of Health [R01 CA101864, CA160965]; NATIONAL CANCER INSTITUTE [R01CA101864, R01CA160965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA101864 to Y.W. and CA160965 to G.P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Frelon S, 2000, CHEM RES TOXICOL, V13, P1002, DOI 10.1021/tx000085h; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Gehring Mary, 2008, Arabidopsis Book, V6, pe0102, DOI 10.1199/tab.0102; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hong HZ, 2006, CHEM RES TOXICOL, V19, P614, DOI 10.1021/tx060025x; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krais AM, 2011, EPIGENETICS-US, V6, P560, DOI 10.4161/epi.6.5.15678; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang J, 2012, AGING CELL; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Yao Q, 2012, PROTEIN EXPRES PURIF, V83, P104, DOI 10.1016/j.pep.2012.03.003; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	35	23	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84620	10.1371/journal.pone.0084620	http://dx.doi.org/10.1371/journal.pone.0084620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391970	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329323900113
J	Mannino, GC; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, MA; Perticone, F; Sesti, G				Mannino, Gaia Chiara; Greco, Annalisa; De Lorenzo, Carlo; Andreozzi, Francesco; Marini, Maria A.; Perticone, Francesco; Sesti, Giorgio			A Fasting Insulin-Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity	PLOS ONE			English	Article							GROWTH-FACTOR-I; HYBRID RECEPTORS; SKELETAL-MUSCLE; GLUCOSE; HOMEOSTASIS; EXPRESSION; RESISTANCE; GENE	Background: A meta-analysis of genome-wide data reported the discovery of the rs35767 polymorphism near IGF1 with genome-wide significant association with fasting insulin levels. However, it is unclear whether the effects of this polymorphism on fasting insulin are mediated by a reduced insulin sensitivity or impaired insulin clearance. We investigated the effects of the rs35767 polymorphism on circulating IGF-1 levels, insulin sensitivity, and insulin clearance. Methodology/Principal Findings: Two samples of adult nondiabetic white Europeans were studied. In sample 1 (n=569), IGF-1 levels were lower in GG genotype carriers compared with A allele carriers (190 +/- 77 vs. 218 +/- 97 ng/ml, respectively; P=0.007 after adjusting for age, gender, and BMI). Insulin sensitivity assessed by euglycaemic-hyperinsulinemic clamp was lower in GG genotype carriers compared with A allele carriers (8.9 +/- 4.1 vs. 10.1 +/- 5.1 mg x Kg(-1) free fat mass x min(-1), respectively; P=0.03 after adjusting for age, gender, and BMI). The rs35767 polymorphism did not show significant association with insulin clearance. In sample 2 (n=859), IGF-1 levels were lower in GG genotype carriers compared with A allele carriers (155 +/- 60 vs. 164 +/- 63 ng/ml, respectively; P=0.02 after adjusting for age, gender, and BMI). Insulin sensitivity, as estimated by the HOMA index, was lower in GG genotype carriers compared with A allele carriers (2.8 +/- 2.2 vs. 2.5 +/- 1.3, respectively; P=0.03 after adjusting for age, gender, and BMI). Conclusion/Significance: The rs35767 polymorphism near IGF1 was associated with circulating IGF-1 levels, and insulin sensitivity with carriers of the GG genotype exhibiting lower IGF-1 concentrations and insulin sensitivity as compared with subjects carrying the A allele.	[Mannino, Gaia Chiara; Greco, Annalisa; De Lorenzo, Carlo; Andreozzi, Francesco; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Marini, Maria A.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	Magna Graecia University of Catanzaro; University of Rome Tor Vergata	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	DE LORENZO, Carlo/R-4050-2016; Sesti, Giorgio/B-1509-2012; Mannino, Gaia C/K-1580-2016; Perticone, Francesco/I-4260-2017; Andreozzi, Francesco/J-4073-2018	Mannino, Gaia C/0000-0002-6341-4572; Andreozzi, Francesco/0000-0001-9375-1513; De Lorenzo, Carlo/0000-0002-2579-683X; Sesti, Giorgio/0000-0002-1618-7688	European Community [Medigene-FP7-279171-1]	European Community(European Commission)	This work was supported, in part, by the European Community (grant number Medigene-FP7-279171-1) to Giorgio Sesti. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V129, P121, DOI 10.1016/S0303-7207(97)04050-1; Federici M, 1998, DIABETES, V47, P87, DOI 10.2337/diabetes.47.1.87; Federici M, 1998, J CLIN ENDOCR METAB, V83, P2911, DOI 10.1210/jc.83.8.2911; Goodarzi MO, 2013, DIABETOLOGIA, V56, P1282, DOI 10.1007/s00125-013-2880-6; Goodarzi MO, 2011, AM J PHYSIOL-ENDOC M, V301, pE402, DOI 10.1152/ajpendo.00013.2011; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Scarpelli D, 2006, DIABETES, V55, P1529, DOI 10.2337/db06-0047; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Succurro E, 2009, NUTR METAB CARDIOVAS, V19, P713, DOI 10.1016/j.numecd.2008.12.011; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110	20	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85483	10.1371/journal.pone.0085483	http://dx.doi.org/10.1371/journal.pone.0085483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392014	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900158
J	Qian, YF; Kachroo, AH; Yellman, CM; Marcotte, EM; Johnson, KA				Qian, Yufeng; Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.; Johnson, Kenneth A.			Yeast Cells Expressing the Human Mitochondrial DNA Polymerase Reveal Correlations between Polymerase Fidelity and Human Disease Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Replication; Mitochondrial DNA; Nucleic Acid Enzymology; Yeast; Human Mitochondria	SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; POLG MUTATIONS; MTDNA; GAMMA; DEFECTS; RECONSTITUTION; REPLICATION; MUTAGENESIS; GENES	Background: Mutations in the human mitochondrial DNA polymerase (Pol-) have been linked to diseases with varying severity and age of onset. Results: Yeast cells expressing human Pol- reveal a correlation of Pol- fidelity with human disease onset. Conclusion: Humanized yeast provides an efficient system to correlate biochemical defects in Pol- with physiological consequences. Significance: The Pol--associated diseases may be caused by the low accuracy of Pol- mutants, not low rates of replication. Mutations in the human mitochondrial polymerase (polymerase- (Pol-)) are associated with various mitochondrial disorders, including mitochondrial DNA (mtDNA) depletion syndrome, Alpers syndrome, and progressive external opthamalplegia. To correlate biochemically quantifiable defects resulting from point mutations in Pol- with their physiological consequences, we created humanized yeast, replacing the yeast mtDNA polymerase (MIP1) with human Pol-. Despite differences in the replication and repair mechanism, we show that the human polymerase efficiently complements the yeast mip1 knockouts, suggesting common fundamental mechanisms of replication and conserved interactions between the human polymerase and other components of the replisome. We also examined the effects of four disease-related point mutations (S305R, H932Y, Y951N, and Y955C) and an exonuclease-deficient mutant (D198A/E200A). In haploid cells, each mutant results in rapid mtDNA depletion, increased mutation frequency, and mitochondrial dysfunction. Mutation frequencies measured in vivo equal those measured with purified enzyme in vitro. In heterozygous diploid cells, wild-type Pol- suppresses mutation-associated growth defects, but continuous growth eventually leads to aerobic respiration defects, reduced mtDNA content, and depolarized mitochondrial membranes. The severity of the Pol- mutant phenotype in heterozygous diploid humanized yeast correlates with the approximate age of disease onset and the severity of symptoms observed in humans.	[Qian, Yufeng; Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Kachroo, Aashiq H.; Yellman, Christopher M.; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Marcotte, Edward M.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Qian, YF (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	yufengqian1005@gmail.com; kajohnson@mail.utexas.edu	Qian, Yufeng/F-3699-2012; Kachroo, Aashiq/Z-2505-2019	Qian, Yufeng/0000-0002-9901-6154; Kachroo, Aashiq/0000-0001-9770-778X; Marcotte, Edward/0000-0001-8808-180X	National Institutes of Health [GM044613]; National Institutes of Health, NIGMS; Welch Foundation [F-1604, F-1515]; National Science Foundation; Cancer Prevention Research Institute of Texas; United States Army [58343-MA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536, R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; United States Army(United States Department of DefenseUnited States Army); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044613 (to K. A. J.) and a grant from the National Institutes of Health, NIGMS (to E. M. M.). This work was also supported by Welch Foundation Grants F-1604 (to K. A. J.) and F-1515 (to E. M. M.), the National Science Foundation (to E. M. M.), the Cancer Prevention Research Institute of Texas (to E. M. M.), and United States Army Grant 58343-MA (to E. M. M.).	Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565; Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002; Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Dunham MJ, 2013, CURR OPIN GENET DEV, V23, P658, DOI 10.1016/j.gde.2013.10.001; Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9; Franssens V, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/760629; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003; Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332; Kuusk S, 2005, J BIOL CHEM, V280, P24322, DOI 10.1074/jbc.M500354200; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Lai CY, 2002, GENETICS, V162, P73; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Qian YF, 2013, BIOPHYS J, V104, p74A, DOI 10.1016/j.bpj.2012.11.448; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007; Vogelsang M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-382; Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020	56	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5970	5985		10.1074/jbc.M113.526418	http://dx.doi.org/10.1074/jbc.M113.526418			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398692	Green Published, hybrid			2022-12-25	WOS:000332015500053
J	Ruiz, R; Jideonwo, V; Ahn, M; Surendran, S; Tagliabracci, VS; Hou, YY; Gamble, A; Kerner, J; Irimia-Dominguez, JM; Puchowicz, MA; DePaoli-Roach, A; Hoppel, C; Roach, P; Morral, N				Ruiz, Rafaela; Jideonwo, Victoria; Ahn, Miwon; Surendran, Sneha; Tagliabracci, Vincent S.; Hou, Yongyong; Gamble, Aisha; Kerner, Janos; Irimia-Dominguez, Jose M.; Puchowicz, Michelle A.; DePaoli-Roach, Anna; Hoppel, Charles; Roach, Peter; Morral, Nuria			Sterol Regulatory Element-binding Protein-1 (SREBP-1) Is Required to Regulate Glycogen Synthesis and Gluconeogenic Gene Expression in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Gluconeogenesis; Glucose Metabolism; Insulin Resistance; Liver Metabolism	DEPENDENT ADENOVIRAL VECTORS; HEPATIC STEATOSIS; INSULIN-RESISTANCE; FATTY LIVERS; MICE LACKING; OB/OB MICE; RAT-LIVER; IN-VIVO; GLUCOSE; OBESITY	Background: The role of SREBP-1 in regulating carbohydrate metabolism is unclear. Results: Silencing SREBP-1 reduced glycogen buildup and expression of genes involved in glycogen synthesis as well as gluconeogenesis. Conclusion: SREBP-1 is needed to regulate carbohydrate metabolism during the fed state. Thus, its depletion does not improve insulin resistance. Significance: This report provides a novel function for SREBP-1. Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor that regulates genes in the de novo lipogenesis and glycolysis pathways. The levels of SREBP-1 are significantly elevated in obese patients and in animal models of obesity and type 2 diabetes, and a vast number of studies have implicated this transcription factor as a contributor to hepatic lipid accumulation and insulin resistance. However, its role in regulating carbohydrate metabolism is poorly understood. Here we have addressed whether SREBP-1 is needed for regulating glucose homeostasis. Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in normal and obese mice. In normal animals, SREBP-1 deficiency increased Pck1 and reduced glycogen deposition during fed conditions, providing evidence that SREBP-1 is necessary to regulate carbohydrate metabolism during the fed state. Knocking SREBP-1 down in db/db mice resulted in a significant reduction in triglyceride accumulation, as anticipated. However, mice remained hyperglycemic, which was associated with up-regulation of gluconeogenesis gene expression as well as decreased glycolysis and glycogen synthesis gene expression. Furthermore, glycogen synthase activity and glycogen accumulation were significantly reduced. In conclusion, silencing both isoforms of SREBP-1 leads to significant changes in carbohydrate metabolism and does not improve insulin resistance despite reducing steatosis in an animal model of obesity and type 2 diabetes.	[Ruiz, Rafaela; Jideonwo, Victoria; Ahn, Miwon; Surendran, Sneha; Hou, Yongyong; Gamble, Aisha; Morral, Nuria] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Tagliabracci, Vincent S.; Irimia-Dominguez, Jose M.; DePaoli-Roach, Anna; Roach, Peter; Morral, Nuria] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ruiz, Rafaela] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kerner, Janos; Hoppel, Charles] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Puchowicz, Michelle A.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Case Western Reserve University; Case Western Reserve University	Morral, N (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, 975 W Walnut St,IB 130, Indianapolis, IN 46202 USA.	nmorralc@iu.edu	Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	National Institutes of Health through the NIDDK [R01DK078595]; American Diabetes Association [1-08-RA-135]; National Institutes of Health [DK59637, U24-DK76174, R01DK078595-05S1]; T32-Diabetes and Obesity Research Training Program [DK064466]; DeVault diabetes and obesity program; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, U24DK059637, R01DK078595, U2CDK059637, T32DK064466, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32-Diabetes and Obesity Research Training Program; DeVault diabetes and obesity program; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK078595 through the NIDDK. This work was also supported by American Diabetes Association Grant 1-08-RA-135. The Mouse Metabolic Phenotyping Centers at Vanderbilt University and Case Western Reserve University are supported by National Institutes of Health Grants DK59637 and U24-DK76174, respectively.; Supported by National Institutes of Health Grant R01DK078595-05S1.; Supported by the T32-Diabetes and Obesity Research Training Program Grant DK064466.; Supported by predoctoral fellowships from the DeVault diabetes and obesity program and the American Heart Association.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Li QL, 2012, FREE RADICAL BIO MED, V52, P1043, DOI 10.1016/j.freeradbiomed.2011.12.022; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Moore DD, 2012, CELL METAB, V15, P615, DOI 10.1016/j.cmet.2012.03.016; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Richard J, 2011, EXPERT REV CARDIOVAS, V9, P321, DOI [10.1586/ERC.11.15, 10.1586/erc.11.15]; Ruiz R, 2009, HUM GENE THER, V20, P87, DOI 10.1089/hum.2008.081; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200	40	83	84	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5510	5517		10.1074/jbc.M113.541110	http://dx.doi.org/10.1074/jbc.M113.541110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398675	Green Published, hybrid			2022-12-25	WOS:000332015500015
J	Kimura, T; Takahashi, M; Yan, K; Sakurai, H				Kimura, Toru; Takahashi, Michi; Yan, Kunimasa; Sakurai, Hiroyuki			Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RENAL HYPOURICEMIA; DILEUCINE MOTIF; URATE EXCRETION; GLUT9; IDENTIFICATION	Background: Many genome-wide association studies pointed out that SLC2A9 gene, which encodes a voltage-driven urate transporter, SLC2A9/GLUT9 (a.k.a. URATv1), as one of the most influential genes for serum urate levels. SLC2A9 is reported to encode two splice variants: SLC2A9-S (512 amino acids) and SLC2A9-L (540 amino acids), only difference being at their N-termini. We investigated isoform-specific localization of SLC2A9 in the human kidney and role of N-terminal amino acids in differential sorting in vitro. Methodology/Principal Findings: Isoform specific antibodies against SLC2A9 were developed and human kidney sections were stained. SLC2A9-S was expressed in the apical side of the collecting duct while SLC2A9-L was expressed in the basolateral side of the proximal tubule. GFP fused SLC2A9s were expressed in MDCK cells and intracellular localization was observed. SLC2A9-S was expressed at both apical and basolateral membranes, whereas SLC2A9-L was expressed only at the basolateral membrane. Although SLC2A9-L has a putative di-leucine motif at 33th and 34th leucine, deletion of the motif or replacement of leucine did not affect its subcellular localization. When up to 16 amino acids were removed from the N-terminal of SLC2A9-S or when up to 25 amino acids were removed from the N-terminal of SLC2A9-L, there was no change in their sorting. Deletion of 20 amino acids from SLC2A9-S was not expressed in the cell. More than 30 amino acids deletion from SLC2A9-L resulted in expression at both apical and basolateral membranes as well as in the lysosome. When amino acids from 25th and 30th were changed to alanine in SLC2A9-L, expression pattern was the same as wild-type. Conclusions/Significance: SLC2A9-L was expressed in the basolateral membrane of kidney proximal tubules in humans and this isoform is likely to responsible for urate reabsorption. N-terminal amino acids unique to each isoform played an important role in protein stability and trafficking.	[Kimura, Toru; Takahashi, Michi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan; [Yan, Kunimasa] Kyorin Univ, Sch Med, Dept Pediat, Mitaka, Tokyo 181, Japan	Kyorin University; Kyorin University	Sakurai, H (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan.	hsakurai@ks.kyorin-u.ac.jp			JSPS KAKENHI [21790819, 23791852]; Kanzawa Medical Research Foundation; Gout Research Foundation of Japan; Kyorin University School of Medicine; Grants-in-Aid for Scientific Research [23791852] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Gout Research Foundation of Japan(Gout Research Foundation of Japan); Kyorin University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by in whole or in part, by JSPS KAKENHI Grant Numbers 21790819 and 23791852, Kanzawa Medical Research Foundation, the Gout Research Foundation of Japan, and Kyorin University School of Medicine (Research Encouragement Award and Collaborative Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bibee KP, 2013, MOL CELL BIOCHEM, V376, P163, DOI 10.1007/s11010-013-1564-3; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Dinour D, 2012, NEPHROL DIAL TRANSPL, V27, P1035, DOI 10.1093/ndt/gfr419; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kimura T, 2011, NUCLEOS NUCLEOT NUCL, V30, P1295, DOI 10.1080/15257770.2011.628354; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Lisinski I, 2001, BIOCHEM J, V358, P517, DOI 10.1042/0264-6021:3580517; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Regeer RR, 2004, AM J PHYSIOL-CELL PH, V287, pC365, DOI 10.1152/ajpcell.00502.2003; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	26	53	57	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84996	10.1371/journal.pone.0084996	http://dx.doi.org/10.1371/journal.pone.0084996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409316	Green Submitted, gold, Green Published			2022-12-25	WOS:000329463500040
J	Sike, A; Nagy, E; Vedelek, B; Pusztai, D; Szeremy, P; Venetianer, A; Boros, IM				Sike, Adam; Nagy, Enikoe; Vedelek, Balazs; Pusztai, David; Szeremy, Peter; Venetianer, Aniko; Boros, Imre M.			mRNA Levels of Related Abcb Genes Change Opposite to Each Other upon Histone Deacetylase Inhibition in Drug-Resistant Rat Hepatoma Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN GENE; MULTIDRUG-RESISTANCE; TRANSCRIPTIONAL REGULATION; MDR1 EXPRESSION; PROMOTER REGION; BREAST-CANCER; HUMAN GENOME; LINES; ACETYLATION; ACTIVATION	The multidrug-resistant phenotype of tumor cells is acquired via an increased capability of drug efflux by ABC transporters and causes serious problems in cancer treatment. With the aim to uncover whether changes induced by epigenetic mechanisms in the expression level of drug transporter genes correlates with changes in the drug resistance phenotypes of resistant cells, we studied the expression of drug transporters in rat hepatoma cell lines. We found that of the three major rat ABC transporter genes Abcb1a, Abcb1b and Abcc1 the activity of only Abcb1b increased significantly in colchicine-selected, drug-resistant cells. Increased transporter expression in drug-resistant cells results primarily from transcriptional activation. A change in histone modification at the regulatory regions of the chromosomally adjacent Abcb1a and Abcb1b genes differentially affects the levels of corresponding mRNAs. Transcriptional up-and down-regulation accompany an increase in acetylation levels of histone H3 lysine 9 at the promoter regions of Abcb1b and Abcb1a, respectively. Drug efflux activity, however, does not follow tightly the transcriptional activity of drug transporter genes in hepatoma cells. Our results point out the need for careful analysis of cause-and-effect relationships between changes in histone modification, drug transporter expression and drug resistance phenotypes.	[Sike, Adam; Nagy, Enikoe; Vedelek, Balazs; Pusztai, David; Boros, Imre M.] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Boros, Imre M.] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Szeremy, Peter] SOLVO Biotechnol, Szeged, Hungary; [Venetianer, Aniko] Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center	Boros, IM (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary.	borosi@bio.u-szeged.hu	Vedelek, Balázs/M-4274-2018	Vedelek, Balázs/0000-0001-6981-0026; Boros, Imre/0000-0001-8504-9687	European Union; Europian Social Fund [HURO/1101/173/2.2.1, TAMOP-4.2.2.A-11/1/KONV-2012-0035]; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0035];  [TAMOP 4.2.4. A/2-11-1-2012-0001]	European Union(European Commission); Europian Social Fund; European Social Fund(European Social Fund (ESF)); 	This work was supported by the European Union and co-funded by the Europian Social Fund. Project numbers: HURO/1101/173/2.2.1; TAMOP-4.2.2.A-11/1/KONV-2012-0035. AS was supported by fellowships of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program'' The project was subsidized by the European Union and co-financed by the European Social Fund and until 31st of May, 2013 from TAMOP-4.2.2/B-10/1-2010-0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN D, 1991, J BIOL CHEM, V266, P2239; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; El-Khoury V, 2007, BRIT J CANCER, V97, P562, DOI 10.1038/sj.bjc.6603914; Eyal S, 2006, BRIT J PHARMACOL, V149, P250, DOI 10.1038/sj.bjp.0706830; FARDEL O, 1993, FEBS LETT, V327, P189, DOI 10.1016/0014-5793(93)80167-S; Fazlina N, 2008, Malays J Pathol, V30, P87; Gatti L, 2005, METH MOLEC MED, V111, P127; Hever-Szabo A, 1998, ANTICANCER RES, V18, P3045; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; HSU SIH, 1990, MOL CELL BIOL, V10, P3596, DOI 10.1128/MCB.10.7.3596; HSU SIH, 1989, J BIOL CHEM, V264, P12053; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Katoh M, 2006, J PHARM SCI-US, V95, P2673, DOI 10.1002/jps.20686; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; KOHNO K, 1994, J BIOL CHEM, V269, P20503; KUO MT, 1992, CELL GROWTH DIFFER, V3, P531; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Loeuillet C, 2007, PHARMACOGENET GENOM, V17, P951, DOI 10.1097/FPC.0b013e3282eff934; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mickley LA, 1997, J CLIN INVEST, V99, P1947, DOI 10.1172/JCI119362; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Pirity M, 1996, CYTOTECHNOLOGY, V19, P207, DOI 10.1007/BF00744214; Raguz S, 2008, INT J CANCER, V122, P1058, DOI 10.1002/ijc.23149; Rajagopal A, 2002, CANCER RES, V62, P391; Robey RW, 2006, CLIN CANCER RES, V12, P1547, DOI 10.1158/1078-0432.CCR-05-1423; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; SONG RD, 1995, J BIOL CHEM, V270, P25468, DOI 10.1074/jbc.270.43.25468; STEIN U, 1994, EUR J CANCER, V30A, P1541, DOI 10.1016/0959-8049(94)00287-F; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TEETER LD, 1993, MOL CARCINOGEN, V8, P67, DOI 10.1002/mc.2940080202; Toth M, 2012, CANC SCI; UEDA K, 1987, J BIOL CHEM, V262, P17432; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; YANG CPH, 1990, J BIOL CHEM, V265, P10282; Yatouji S, 2007, INT J ONCOL, V30, P1003; ZHAO JY, 1993, ENDOCRINOLOGY, V133, P521, DOI 10.1210/en.133.2.521	45	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84915	10.1371/journal.pone.0084915	http://dx.doi.org/10.1371/journal.pone.0084915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409311	gold, Green Submitted, Green Published			2022-12-25	WOS:000329463500035
J	Sripetchwandee, J; Pipatpiboon, N; Chattipakorn, N; Chattipakorn, S				Sripetchwandee, Jirapas; Pipatpiboon, Noppamas; Chattipakorn, Nipon; Chattipakorn, Siriporn			Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity	PLOS ONE			English	Article							RECOGNITION MEMORY IMPAIRMENT; INSULIN-RECEPTOR FUNCTION; INDUCED OXIDATIVE STRESS; SYNAPTIC PLASTICITY; MITOCHONDRIAL DYSFUNCTION; INFLAMMATION ALTERS; EXPERIMENTAL STROKE; LIPID-PEROXIDATION; N-ACETYLCYSTEINE; OVERLOAD	Background: Excessive iron accumulation leads to iron toxicity in the brain; however the underlying mechanism is unclear. We investigated the effects of iron overload induced by high iron-diet consumption on brain mitochondrial function, brain synaptic plasticity and learning and memory. Iron chelator (deferiprone) and antioxidant (n-acetyl cysteine) effects on iron-overload brains were also studied. Methodology: Male Wistar rats were fed either normal diet or high iron-diet consumption for 12 weeks, after which rats in each diet group were treated with vehicle or deferiprone (50 mg/kg) or n-acetyl cysteine (100 mg/kg) or both for another 4 weeks. High iron-diet consumption caused brain iron accumulation, brain mitochondrial dysfunction, impaired brain synaptic plasticity and cognition, blood-brain-barrier breakdown, and brain apoptosis. Although both iron chelator and antioxidant attenuated these deleterious effects, combined therapy provided more robust results. Conclusion: In conclusion, this is the first study demonstrating that combined iron chelator and anti-oxidant therapy completely restored brain function impaired by iron overload.	[Sripetchwandee, Jirapas; Pipatpiboon, Noppamas; Chattipakorn, Nipon; Chattipakorn, Siriporn] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit,Dept Physiol, Chiang Mai 50000, Thailand; [Chattipakorn, Siriporn] Chiang Mai Univ, Fac Dent, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit,Dept Physiol, Chiang Mai 50000, Thailand.	scchattipakorn@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021	Pipatpiboon, Noppamas/0000-0001-8600-7681; Sripetchwandee, Jirapas/0000-0002-4473-7018; Chattipakorn, Nipon/0000-0003-3026-718X	Thailand Research Fund TRF-BRG [TRF-RTA5580006]; Faculty of Medicine Chiang Mai University Endowment Fund; National Research Council of Thailand; Thailand Research Fund through the Royal Golden Jubilee Program [PHD/0248/2552]; Chiang Mai University Excellent Center Award	Thailand Research Fund TRF-BRG(Thailand Research Fund (TRF)); Faculty of Medicine Chiang Mai University Endowment Fund; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Thailand Research Fund through the Royal Golden Jubilee Program; Chiang Mai University Excellent Center Award	This work was supported by grants from the Thailand Research Fund TRF-BRG (SC), TRF-RTA5580006 (NC), Faculty of Medicine Chiang Mai University Endowment Fund (NC), National Research Council of Thailand (SC), Thailand Research Fund through the Royal Golden Jubilee Program (PHD/0248/2552: JS and SC), and Chiang Mai University Excellent Center Award (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Armstrong FD, 2005, ANN NY ACAD SCI, V1054, P283, DOI 10.1196/annals.1345.036; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barichello T, 2012, EUR J CLIN MICROBIOL, V31, P2005, DOI 10.1007/s10096-011-1533-2; Barluzzi R, 2002, J NEUROIMMUNOL, V132, P140, DOI 10.1016/S0165-5728(02)00324-7; Bartfay W J, 2000, Biol Res Nurs, V2, P49, DOI 10.1177/109980040000200106; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Cassinerio E, 2012, ANN HEMATOL, V91, P1443, DOI 10.1007/s00277-012-1480-8; Ceci A, 2003, EXPERT OPIN PHARMACO, V4, P1763, DOI 10.1517/14656566.4.10.1763; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Cheng J, 2011, EUR J PHARMACOL, V650, P184, DOI 10.1016/j.ejphar.2010.09.033; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Darley-Usmar V, 2004, FREE RADICAL BIO MED, V37, P753, DOI 10.1016/j.freeradbiomed.2004.05.026; de Lima MNM, 2007, EUR J PHARMACOL, V570, P111, DOI 10.1016/j.ejphar.2007.06.002; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Fabian E, 2011, J ASTHMA, V48, P351, DOI 10.3109/02770903.2011.560319; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Fredenburg AM, 1996, TOXICOLOGY, V108, P191, DOI 10.1016/0300-483X(95)03301-U; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gao YG, 2013, J ETHNOPHARMACOL, V145, P254, DOI 10.1016/j.jep.2012.10.060; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; Hider RC, 2011, METALLOMICS, V3, P239, DOI 10.1039/c0mt00087f; Hua Y, 2008, ACTA NEUROCHIR SUPPL, V105, P3; Jamuar SS, 2012, THER ADV HEMATOL, V3, P299, DOI 10.1177/2040620712450252; JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Khanna AK, 2012, LAB INVEST, V92, P224, DOI 10.1038/labinvest.2011.146; Kontoghiorghes GJ, 2010, HEMOGLOBIN, V34, P227, DOI 10.3109/03630269.2010.483662; Koppenol WH, 2001, REDOX REP, V6, P229, DOI 10.1179/135100001101536373; Kulawiak B, 2008, EXP NEUROL, V212, P543, DOI 10.1016/j.expneurol.2008.05.004; Kumfu S, 2012, BIOMETALS, V25, P1167, DOI 10.1007/s10534-012-9579-x; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Lekawanvijit S, 2009, CAN J CARDIOL, V25, P213, DOI 10.1016/S0828-282X(09)70064-9; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Long JG, 2009, NEUROCHEM RES, V34, P786, DOI 10.1007/s11064-008-9882-7; Maaroufi K, 2011, NEUROSCIENCE, V186, P39, DOI 10.1016/j.neuroscience.2011.04.003; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mariani R, 2009, MEDITERR J HEMATOL I, V1, DOI [10.4084/MMID.2009.006, 10.4084/MJHID.2009.006]; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; McNeill Alisdair, 2011, Handb Clin Neurol, V100, P161, DOI 10.1016/B978-0-444-52014-2.00009-4; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Miura Y, 2010, CASE REP MED, V2010, DOI 10.1155/2010/675060; Monastero R, 2000, ACTA NEUROL SCAND, V102, P162, DOI 10.1034/j.1600-0404.2000.102003162.x; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Novalija E, 2003, ANESTHESIOLOGY, V98, P1155, DOI 10.1097/00000542-200305000-00018; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Ortiz GG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/708659; Perez VP, 2010, CURR NEUROVASC RES, V7, P15, DOI 10.2174/156720210790820172; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Reddy PS, 2011, J TRACE ELEM MED BIO, V25, P247, DOI 10.1016/j.jtemb.2011.08.145; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; Sen T, 2006, NEUROCHEM INT, V49, P20, DOI 10.1016/j.neuint.2005.12.018; Spellberg B, 2009, ANTIMICROB AGENTS CH, V53, P3122, DOI 10.1128/AAC.00361-09; Sripetchwandee J, 2013, LIFE SCI, V92, P298, DOI 10.1016/j.lfs.2013.01.004; Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199; Tong V, 2005, TOXICOL SCI, V86, P436, DOI 10.1093/toxsci/kfi185; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Vatassery GT, 2004, BBA-MOL BASIS DIS, V1688, P265, DOI 10.1016/j.bbadis.2003.12.013; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker J M, 1994, Methods Mol Biol, V32, P5; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; Yin F, 2012, ANTIOXID REDOX SIGNA; YOUDIM MBH, 1978, P NUTR SOC, V37, P173, DOI 10.1079/PNS19780022; Zagaar M, 2013, SLEEP, V36, P751, DOI 10.5665/sleep.2642; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zhu Y, 2012, MOL BIOL REP, V39, P3727, DOI 10.1007/s11033-011-1148-9	89	65	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85115	10.1371/journal.pone.0085115	http://dx.doi.org/10.1371/journal.pone.0085115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400127	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700061
J	Dolinska, MB; Kovaleva, E; Backlund, P; Wingfield, PT; Brooks, BP; Sergeev, YV				Dolinska, Monika B.; Kovaleva, Elena; Backlund, Peter; Wingfield, Paul T.; Brooks, Brian P.; Sergeev, Yuri V.			Albinism-Causing Mutations in Recombinant Human Tyrosinase Alter Intrinsic Enzymatic Activity	PLOS ONE			English	Article							I OCULOCUTANEOUS ALBINISM; MOLECULAR-BASIS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; MELANOSOMAL PH; TYPE-1 OCA1; MELANOMA; PROTEIN; MUTANT; BRENDA	Background: Tyrosinase (TYR) catalyzes the rate-limiting, first step in melanin production and its gene (TYR) is mutated in many cases of oculocutaneous albinism (OCA1), an autosomal recessive cause of childhood blindness. Patients with reduced TYR activity are classified as OCA1B; some OCA1B mutations are temperature-sensitive. Therapeutic research for OCA1 has been hampered, in part, by the absence of purified, active, recombinant wild-type and mutant human enzymes. Methodology/Principal Findings: The intra-melanosomal domain of human tyrosinase (residues 19-469) and two OCA1B related temperature-sensitive mutants, R422Q and R422W were expressed in insect cells and produced in T. ni larvae. The short trans-membrane fragment was deleted to avoid potential protein insolubility, while preserving all other functional features of the enzymes. Purified tyrosinase was obtained with a yield of > 1 mg per 10 g of larval biomass. The protein was a monomeric glycoenzyme with maximum enzyme activity at 37 degrees C and neutral pH. The two purified mutants when compared to the wild-type protein were less active and temperature sensitive. These differences are associated with conformational perturbations in secondary structure. Conclusions/Significance: The intramelanosomal domains of recombinant wild-type and mutant human tyrosinases are soluble monomeric glycoproteins with activities which mirror their in vivo function. This advance allows for the structure - function analyses of different mutant TYR proteins and correlation with their corresponding human phenotypes; it also provides an important tool to discover drugs that may improve tyrosinase activity and treat OCA1.	[Dolinska, Monika B.; Brooks, Brian P.; Sergeev, Yuri V.] NEI, NIH, Bethesda, MD 20892 USA; [Kovaleva, Elena] Chesapeake PERL, Savage, MD USA; [Backlund, Peter] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Wingfield, Paul T.] NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Brooks, BP (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	brooksb@nei.nih.gov; sergeevy@nei.nih.gov		Wingfield, Paul/0000-0002-9515-4752	Intramural program of National Eye Institute, National Institutes of Health [Z01-EY000476-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	Intramural program of National Eye Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural program of National Eye Institute, National Institutes of Health (Z01-EY000476-01 to YVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancans J, 2001, J INVEST DERMATOL, V117, P158, DOI 10.1046/j.0022-202x.2001.01397.x; Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; Halaban R, 2002, J INVEST DERMATOL, V119, P481, DOI 10.1046/j.1523-1747.2002.01824.x; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HEARING VJ, 1987, METHOD ENZYMOL, V142, P154; HEARING VJ, 1976, BIOCHEM J, V157, P549, DOI 10.1042/bj1570549; IMOKAWA G, 1982, CANCER RES, V42, P1994; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Jeong CH, 2004, BIOSCI BIOTECH BIOCH, V68, P1984, DOI 10.1271/bbb.68.1984; Kong JN, 2010, PROTEIN PEPTIDE LETT, V17, P1026, DOI 10.2174/092986610791498957; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; LERCH K, 1987, METHOD ENZYMOL, V142, P165; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Lopez-Serrano D, 2007, MICROBIOL-SGM, V153, P2241, DOI 10.1099/mic.0.2007/006833-0; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Onojafe IF, 2011, J CLIN INVEST, V121, P3914, DOI 10.1172/JCI59372; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIBAHARA S, 1988, TOHOKU J EXP MED, V156, P403, DOI 10.1620/tjem.156.403; Shire SJ, 1992, DS837; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Spritz RA, 1997, HUM MUTAT, V10, P171, DOI 10.1002/(SICI)1098-1004(1997)10:2<171::AID-HUMU11>3.3.CO;2-9; Summers C G, 1996, Trans Am Ophthalmol Soc, V94, P1095; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Wang T, 2005, BRIT J OPHTHALMOL, V89, P1383, DOI 10.1136/bjo.2005.070243; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WITTBJER A, 1990, PIGM CELL RES, V3, P168, DOI 10.1111/j.1600-0749.1990.tb00283.x; WITTBJER A, 1990, ACTA DERM-VENEREOL, V70, P291; WITTBJER A, 1989, ACTA DERM-VENEREOL, V69, P125	60	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84494	10.1371/journal.pone.0084494	http://dx.doi.org/10.1371/journal.pone.0084494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392141	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100064
J	Earland, K; Lee, M; Shaw, P; Law, J				Earland, Kevin; Lee, Mark; Shaw, Patricia; Law, James			Overlapping Structures in Sensory-Motor Mappings	PLOS ONE			English	Article							RECEPTIVE-FIELDS; MAPS; EYE; INTEGRATION; NEURONS; VISION	This paper examines a biologically-inspired representation technique designed for the support of sensory-motor learning in developmental robotics. An interesting feature of the many topographic neural sheets in the brain is that closely packed receptive fields must overlap in order to fully cover a spatial region. This raises interesting scientific questions with engineering implications: e. g. is overlap detrimental? does it have any benefits? This paper examines the effects and properties of overlap between elements arranged in arrays or maps. In particular we investigate how overlap affects the representation and transmission of spatial location information on and between topographic maps. Through a series of experiments we determine the conditions under which overlap offers advantages and identify useful ranges of overlap for building mappings in cognitive robotic systems. Our motivation is to understand the phenomena of overlap in order to provide guidance for application in sensory-motor learning robots.	[Earland, Kevin; Lee, Mark; Shaw, Patricia; Law, James] Aberystwith Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales	Aberystwyth University	Earland, K (corresponding author), Aberystwith Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales.	kee8@aber.ac.uk		Law, James/0000-0002-4966-3556; Shaw, Patricia/0000-0002-6994-8647	European Commission [ICT-IP-231722]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research has received funds from the European Commission 7th Framework Programme (FP7/2007-2013), Challenge 2 - Cognitive Systems, Interaction, Robotics, grant agreement No. ICT-IP-231722, project IM- CLeVeR - Intrinsically Motivated Cumulative Learning Versatile Robots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Balasuriya S, 2005, IEEE IJCNN, P3069; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Braitenberg V, 1991, ANATOMY OF THE CORTE; Carreira-Perpinan MA, 2005, CEREB CORTEX, V15, P1222, DOI 10.1093/cercor/bhi004; Chaisanguanthum KS, 2011, J NEUROSCI, V31, P4868, DOI 10.1523/JNEUROSCI.6776-10.2011; Dayan P., 2001, THEORETICAL NEUROSCI; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Einarsdottir H, 2007, INT C DEVEL LEARN, P28; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Hulse M, 2010, IEEE T AUTON MENT DE, V2, P355, DOI 10.1109/TAMD.2010.2081667; Hulse M., 2009, P IEEE 8 INT C DEV L, P1; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KANDEL ER, 2000, PRINCIPLES OF NEURAL, V4; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lee MH, 2007, ADAPT BEHAV, V15, P241, DOI 10.1177/1059712307082085; Lehky SR, 2010, FRONTIERS IN COMPUTA, P4; Liu YS, 2009, P NATL ACAD SCI USA, V106, P16499, DOI 10.1073/pnas.0908926106; LO SH, 1989, INT J NUMER METH ENG, V28, P2695, DOI 10.1002/nme.1620281113; MacLennan B, 1997, ADV PSYCHOL, V119, P37; MALLOT HA, 1990, NEURAL NETWORKS, V3, P245, DOI 10.1016/0893-6080(90)90069-W; Manolakis DE, 1996, IEEE T AERO ELEC SYS, V32, P1239, DOI 10.1109/7.543845; Meng QG, 2007, CONNECT SCI, V19, P25, DOI 10.1080/09540090600971302; Natale L., 2013, INTRINSICALLY MOTIVA, P433, DOI DOI 10.1007/978-3-642-32375-1_17; Nummela SU, 2011, J NEUROSCI, V31, P8059, DOI 10.1523/JNEUROSCI.5480-10.2011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Roka A., 2007, ACTA POLYTECH HUNG, V4, P31; Sterling P, 1999, NAT NEUROSCI, V2, P851, DOI 10.1038/13142; Utans J., 1996, P AAAI 96 WORKSH INT, P133; Van der Willigen RF, 2011, J INTEGR NEUROSCI, V10, P277, DOI 10.1142/S0219635211002750; VANGISBERGEN JAM, 1987, NEUROSCIENCE, V21, P541, DOI 10.1016/0306-4522(87)90140-0; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weng J, 2006, 5TH INTERNATIONAL CO	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84240	10.1371/journal.pone.0084240	http://dx.doi.org/10.1371/journal.pone.0084240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392118	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000329460100041
J	Kang, HS; Ahn, SH; Mishra, SK; Hong, KM; Lee, ES; Shin, KH; Ro, J; Lee, KS; Kim, MK				Kang, Han-Sung; Ahn, Sei Hyun; Mishra, Siddhartha Kumar; Hong, Kyeong-Man; Lee, Eun Sook; Shin, Kyung Hwan; Ro, Jungsil; Lee, Keun Seok; Kim, Mi Kyung			Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women	PLOS ONE			English	Article							FACTOR-I RECEPTOR; GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; BINDING PROTEIN-3; COPY NUMBER; CELL-LINES; SUSCEPTIBILITY; TUMORS; EXPRESSION; MUTATIONS	The insulin-like growth factor (IGF) signaling pathway plays an important role in cancer biology. The IGF 1 receptor (IGF1R) overexpression has been associated with a number of hematological neoplasias and solid tumors including breast cancer. However, molecular mechanism involving IGF1R in carcinogenic developments is clearly not known. We investigated the genetic variations across the IGF1R polymorphism and the risk of breast cancer risk in Korean women. A total of 1418 individuals comprising 1026 breast cancer cases and 392 age-matched controls of Korean were included for the analysis. Genomic DNA was extracted from whole blood and single nucleotide polymorphisms (SNPs) were analyzed on the GoldenGate Assay system by Illumina's Custom Genetic Analysis service. SNPs were selected for linkage disequilibrium (LD) analysis by Haploview. We genotyped total 51 SNPs in the IGF1R gene and examined for association with breast cancer. All the SNPs investigated were in Hardy-Weinberg equilibrium. These SNPs tested were significantly associated with breast cancer risk, after correction for multiple comparisons by adjusting for age at diagnosis, BMI, age at menarche, and age at first parturition. Among 51 IGF1R SNPs, five intron located SNPs (rs8032477, rs7175052, rs12439557, rs11635251 and rs12916884) with homozygous genotype (variant genotype) were associated with decreased risk of breast cancer. Fisher's combined p-value for the five SNPs was 0.00032. Three intron located SNPs with heterozygous genotypes also had decreased risk of breast cancer. Seven of the 51 IGF1R SNPs were in LD and in one haplotype block, and were likely to be associated with breast cancer risk. Overall, this case-control study demonstrates statistically significant associations between breast cancer risk and polymorphisms in IGF1R gene.	[Kang, Han-Sung; Lee, Eun Sook; Shin, Kyung Hwan; Ro, Jungsil; Lee, Keun Seok] Natl Canc Ctr, Ctr Breast Canc, Goyang Si, Gyeonggi Do, South Korea; [Ahn, Sei Hyun] Asan Med Ctr, Div Breast & Endocrine Surg, Dept Surg, Seoul, South Korea; [Mishra, Siddhartha Kumar; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol, Goyang Si, Gyeonggi Do, South Korea; [Hong, Kyeong-Man] Natl Canc Ctr, Div Canc Biol, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol, Goyang Si, Gyeonggi Do, South Korea.	alrud@ncc.re.kr	Mishra, Siddhartha Kumar/A-4344-2016	Mishra, Siddhartha Kumar/0000-0003-1627-1377	Korea National Cancer Center [NCC-0910310, NCC-1310361]; Asan Institute for Life Sciences, Seoul, Republic of Korea [2009-022]	Korea National Cancer Center; Asan Institute for Life Sciences, Seoul, Republic of Korea	This study was supported by grant-in-aids from the Korea National Cancer Center (grant nos. NCC-0910310, NCC-1310361) and a grant (2009-022) from the Asan Institute for Life Sciences, Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Armengol G, 2000, CANCER GENET CYTOGEN, V116, P133, DOI 10.1016/S0165-4608(99)00118-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BONNETERRE J, 1990, CANCER RES, V50, P6931; Browne BC, 2012, BREAST CANCER RES TR, V136, P717, DOI 10.1007/s10549-012-2260-9; Chakraborty AK, 2010, BREAST CANCER RES TR, V120, P327, DOI 10.1007/s10549-009-0382-5; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Nakagawa M, 2012, CLIN LUNG CANCER, V13, P136, DOI 10.1016/j.cllc.2011.10.006; Natrajan R, 2006, CANCER RES, V66, P11148, DOI 10.1158/0008-5472.CAN-06-1931; NCC, 2011, CANC FACTS FIG 2011; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Renehan AG, 2005, INT J CANCER, V115, P1006, DOI 10.1002/ijc.20975; Resnik JL, 1998, CANCER RES, V58, P1159; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Surmacz E, 2003, ONCOGENE, V22, P6589, DOI 10.1038/sj.onc.1206772; Tamimi RM, 2011, BREAST CANCER RES TR, V128, P243, DOI 10.1007/s10549-010-1313-1; Tamimi RM, 2010, CANCER-AM CANCER SOC, V116, P4944, DOI 10.1002/cncr.25386; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Tushir JS, 2010, MOL BIOL CELL, V21, P2355, DOI 10.1091/mbc.E09-09-0824; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84532	10.1371/journal.pone.0084532	http://dx.doi.org/10.1371/journal.pone.0084532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392142	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100065
J	Forbes, N; Selman, M; Pelchat, M; Jia, JJ; Stintzi, A; Brown, EG				Forbes, Nicole; Selman, Mohammed; Pelchat, Martin; Jia, Jian Jun; Stintzi, Alain; Brown, Earl G.			Identification of Adaptive Mutations in the Influenza A Virus Non-Structural 1 Gene That Increase Cytoplasmic Localization and Differentially Regulate Host Gene Expression	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; NS1 PROTEIN TARGETS; STRIKING DIFFERENCES; BETA-INTERFERON; RNA-BINDING; MOUSE LUNG; RIG-I; INHIBITION; VIRULENCE; HEMAGGLUTININ	The NS1 protein of influenza A virus (IAV) is a multifunctional virulence factor. We have previously characterized gain-offunction mutations in the NS1 protein arising from the experimental adaptation of the human isolate A/ Hong Kong/ 1/ 1968(H3N2) (HK) to the mouse. The majority of these mouse adapted NS1 mutations were demonstrated to increase virulence, viral fitness, and interferon antagonism, but differ in binding to the post-transcriptional processing factor cleavage and polyadenylation specificity factor 30 (CPSF30). Because nuclear trafficking is a major genetic determinant of influenza virus host adaptation, we assessed subcellular localization and host gene expression of NS1 adaptive mutations. Recombinant HK viruses with adaptive mutations in the NS1 gene were assessed for NS1 protein subcellular localization in mouse and human cells using confocal microscopy and cellular fractionation. In human cells the HK wild-type (HK-wt) virus NS1 protein partitioned equivalently between the cytoplasm and nucleus but was defective in cytoplasmic localization in mouse cells. Several adaptive mutations increased the proportion of NS1 in the cytoplasm of mouse cells with the greatest effects for mutations M106I and D125G. The host gene expression profile of the adaptive mutants was determined by microarray analysis of infected mouse cells to show either high or low extents of host-gene regulation (HGR or LGR) phenotypes. While host genes were predominantly down regulated for the HGR group of mutants (D2N, V23A, F103L, M106I+ L98S, L98S, M106V, and M106V+ M124I), the LGR phenotype mutants (D125G, M106I, V180A, V226I, and R227K) were characterized by a predominant up regulation of host genes. CPSF30 binding affinity of NS1 mutants did not predict effects on host gene expression. To our knowledge this is the first report of roles of adaptive NS1 mutations that impact intracellular localization and regulation of host gene expression.	[Forbes, Nicole; Selman, Mohammed; Pelchat, Martin; Jia, Jian Jun; Stintzi, Alain; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forbes, Nicole; Selman, Mohammed; Brown, Earl G.] Univ Ottawa, Fac Med, Emerging Pathogens Res Ctr, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Brown, EG (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	ebrown@uottawa.ca		Forbes, Nicole/0000-0002-2645-695X; Selman, Mohammed/0000-0002-3265-2009	Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team [TPA-90188]; CIHR [MOP-74526]; Ontario Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology	This project has been funded by the Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB) TPA-90188, and CIHR operating grant MOP-74526 (EGB); http:// www.cihr-irsc.gc.ca/. NE Forbes was funded from an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Han H, 2010, J GEN VIROL, V91, P2907, DOI 10.1099/vir.0.024943-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li W, 2011, J GEN VIROL, V92, P1832, DOI 10.1099/vir.0.031336-0; Li Y, 2010, J VIROL, V84, P7204, DOI 10.1128/JVI.00203-10; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Melen K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-167; Meng J, 2012, SCI CHINA LIFE SCI, V55, P933, DOI 10.1007/s11427-012-4393-9; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Rahim MN, 2013, J GEN VIROL, V94, P593, DOI 10.1099/vir.0.046649-0; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Resa-Infante P, 2013, BIOESSAYS, V35, P23, DOI 10.1002/bies.201200138; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; SHAW MW, 1978, J VIROL, V25, P608, DOI 10.1128/JVI.25.2.608-615.1978; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84673	10.1371/journal.pone.0084673	http://dx.doi.org/10.1371/journal.pone.0084673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391972	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900115
J	Zhu, GM; Ou, Q; Zhang, T; Jiang, XD; Sun, GZ; Zhang, N; Wang, KF; Fang, H; Wang, MF; Sun, J; Ge, TD				Zhu, Guiming; Ou, Qin; Zhang, Tao; Jiang, Xudong; Sun, Guozhi; Zhang, Ning; Wang, Kunfu; Fang, Heng; Wang, Mingfu; Sun, Jie; Ge, Tangdong			A More Desirable Balanced Polyunsaturated Fatty Acid Composition Achieved by Heterologous Expression of Delta 15/Delta 4 Desaturases in Mammalian Cells	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; EUGLENA-GRACILIS; MARINE CYANOBACTERIUM; SYNECHOCOCCUS SP; GENE-CLUSTER; IDENTIFICATION; N-3; BIOSYNTHESIS	Arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are the most biologically active polyunsaturated fatty acids, but their biosyntheses in mammals are very limited. The biosynthesis of DHA is the most difficult, because this undergoes the Sprecher pathway-a further elongation step from docosapentaenoic acid (DPA), a Delta 6-desaturase acting on a C24 fatty acid substrate followed by a peroxisomal chain shortening step. This paper reports the successful heterologous expression of two non-mammalian genes (with modification of codon usage), coding for Euglena gracilis Delta 4-desaturase and Siganus canaliculatus Delta 4-desaturase respectively, in mammalian cells (HEK293 cell line). Both of the Delta 4-desaturases can efficiently function, directly converting DPA into DHA. Moreover, the cooperation of the E. gracilis Delta 4-desaturase with C. elegans Delta 15-desaturase (able to convert a number of n-6 PUFAs to their corresponding n-3 PUFAs) in transgenic HEK293 cells made a more desirable fatty acid composition -a drastically reduced n-6/ n-3 PUFAs ratio and a high level of DHA as well as EPA and ARA. Our findings provide a basis for potential applications of the gene constructs for expression of Delta 15/Delta 4-desaturases in transgenic livestock to produce such a fatty acid profile in the related products, which certainly will bring benefit to human health.	[Zhu, Guiming; Ou, Qin; Zhang, Tao; Jiang, Xudong; Sun, Guozhi; Wang, Kunfu; Wang, Mingfu; Sun, Jie; Ge, Tangdong] Jiamusi Univ, Coll Basic Med, Lab Biochem & Mol Biol, Jiamusi, Heilongjiang, Peoples R China; [Zhang, Ning] Heilongjiang Univ Chinese Med, Jiamusi Coll, Jiamusi, Heilongjiang, Peoples R China; [Fang, Heng] Jiamusi Univ, Coll Pharm, Jiamusi, Heilongjiang, Peoples R China	Jiamusi University; Heilongjiang University of Chinese Medicine; Jiamusi University	Zhu, GM (corresponding author), Jiamusi Univ, Coll Basic Med, Lab Biochem & Mol Biol, Jiamusi, Heilongjiang, Peoples R China.	xi78926@sina.com	wang, kunfu/AAS-2456-2021		National Natural Science Foundation of China [31000984]; Science and Technology Research Project of Heilongjiang Provincal Education Department [12511563]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Heilongjiang Provincal Education Department	This work was supported by grants from the National Natural Science Foundation of China (No. 31000984) and Science and Technology Research Project of Heilongjiang Provincal Education Department (No. 12511563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; BAJPAI PK, 1991, J AM OIL CHEM SOC, V68, P509, DOI 10.1007/BF02663823; Chajes V, 2012, CANCER EPIDEM BIOMAR, V21, P319, DOI 10.1158/1055-9965.EPI-11-0896; CLANDININ MT, 1985, CAN J PHYSIOL PHARM, V63, P546, DOI 10.1139/y85-094; Cook H.W., 2004, BIOCH LIPIDS LIPOPRO, P181; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Gao F, 2010, J LIPID RES, V51, P2940, DOI 10.1194/jlr.M005595; Grenon SM, 2012, VASC MED, V17, P51, DOI 10.1177/1358863X11429175; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; Institute of Medicine, 2005, DIET REF INT EN CARB; Jiang Y, 2000, PROCESS BIOCHEM, V35, P1205, DOI 10.1016/S0032-9592(00)00163-1; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; KORN ED, 1964, J LIPID RES, V5, P352; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Meyer A, 2003, BIOCHEMISTRY-US, V42, P9779, DOI 10.1021/bi034731y; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Perica MM, 2011, NUTR CLIN PRACT, V26, P409, DOI 10.1177/0884533611411306; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Simopoulos AP, 2003, WORLD REV NUTR DIET, V92, P1; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Tonon T, 2003, FEBS LETT, V553, P440, DOI 10.1016/S0014-5793(03)01078-0; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Yokochi T, 1998, APPL MICROBIOL BIOT, V49, P72, DOI 10.1007/s002530051139; Yu R, 2000, LIPIDS, V35, P1061, DOI 10.1007/s11745-000-0619-6	37	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84871	10.1371/journal.pone.0084871	http://dx.doi.org/10.1371/journal.pone.0084871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391980	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900123
J	Kauder, SE; Santell, L; Mai, E; Wright, LY; Luis, E; N'Diaye, EN; Lutman, J; Ratti, N; Sa, SM; Maun, HR; Stefanich, E; Gonzalez, LC; Graham, RR; Diehl, L; Faubion, WA; Keir, ME; Young, J; Chaudhuri, A; Lazarus, RA; Egen, JG				Kauder, Steven E.; Santell, Lydia; Mai, Elaine; Wright, Lilyan Y.; Luis, Elizabeth; N'Diaye, Elsa N.; Lutman, Jeff; Ratti, Navneet; Sa, Susan M.; Maun, Henry R.; Stefanich, Eric; Gonzalez, Lino C.; Graham, Robert R.; Diehl, Lauri; Faubion, William A., Jr.; Keir, Mary E.; Young, Judy; Chaudhuri, Amitabha; Lazarus, Robert A.; Egen, Jackson G.			Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GENOME-WIDE ASSOCIATION; ULCERATIVE-COLITIS; BETA-CHAIN; PERITONEAL-MACROPHAGES; PROTEOLYTIC CLEAVAGE; CRYSTAL-STRUCTURE; IFN-GAMMA; RON; EXPRESSION	Background: Macrophage stimulating protein (MSP) is a serum growth factor that binds to and activates the receptor tyrosine kinase, Recepteur d'Origine Nantais (RON). A non-synonymous coding variant in MSP (689C) has been associated with genetic susceptibility to both Crohn's disease and ulcerative colitis, two major types of inflammatory bowel disease (IBD) characterized by chronic inflammation of the digestive tract. We investigated the consequences of this polymorphism for MSP-RON pathway activity and IBD pathogenesis. Methods: RON expression patterns were examined on mouse and human cells and tissues under normal and disease conditions to identify cell types regulated by MSP-RON. Recombinant MSP variants were tested for their ability to bind and stimulate RON and undergo proteolytic activation. MSP concentrations were quantified in the serum of individuals carrying the MSP 689R and 689C alleles. Results: In intestinal tissue, RON was primarily expressed by epithelial cells under normal and disease conditions. The 689C polymorphism had no impact on the ability of MSP to bind to or signal through RON. In a cohort of normal individuals and IBD patients, carriers of the 689C polymorphism had lower concentrations of MSP in their serum. Conclusions: By reducing the quantities of circulating MSP, the 689C polymorphism, or a variant in linkage disequilibrium with this polymorphism, may impact RON ligand availability and thus receptor activity. Given the known functions of RON in regulating wound healing and our analysis of RON expression patterns in human intestinal tissue, these data suggest that decreased RON activity may impact the efficiency of epithelial repair and thus underlie the increased IBD susceptibility associated with the MSP 689C allele.	[Kauder, Steven E.; N'Diaye, Elsa N.; Egen, Jackson G.] Genentech Inc, Discovery Immunol, San Francisco, CA 94080 USA; [Santell, Lydia; Maun, Henry R.; Lazarus, Robert A.] Genentech Inc, Early Discovery Biochem, San Francisco, CA 94080 USA; [Mai, Elaine; Young, Judy] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Wright, Lilyan Y.; Keir, Mary E.] Genentech Inc, Immunol Tissue Growth & Repair Diagnost Discovery, San Francisco, CA 94080 USA; [Luis, Elizabeth; Gonzalez, Lino C.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Lutman, Jeff; Stefanich, Eric] Genentech Inc, Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Ratti, Navneet; Sa, Susan M.; Diehl, Lauri] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Graham, Robert R.] Genentech Inc, Immunol Tissue Growth & Repair Human Genet, San Francisco, CA 94080 USA; [Chaudhuri, Amitabha] Genentech Inc, Mol Oncol, San Francisco, CA 94080 USA; [Faubion, William A., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Mayo Clinic	Egen, JG (corresponding author), Genentech Inc, Discovery Immunol, San Francisco, CA 94080 USA.	egen.jackson@gene.com	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450; Egen, Jackson/0000-0003-2053-0837	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was supported by Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benight NM, 2012, EXPERT OPIN THER TAR, V16, P921, DOI 10.1517/14728222.2012.710200; Brunelleschi S, 2001, BRIT J PHARMACOL, V134, P1285, DOI 10.1038/sj.bjp.0704356; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carafoli F, 2005, FEBS J, V272, P5799, DOI 10.1111/j.1742-4658.2005.04968.x; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Chaudhuri A, 2013, IMMUNOL CELL BIOL, V91, P451, DOI 10.1038/icb.2013.27; Chaudhuri A, 2011, J BIOL CHEM, V286, P32762, DOI 10.1074/jbc.M111.239384; Chen YQ, 1998, J IMMUNOL, V161, P4950; Correll Pamela H., 1997, Genes and Function, V1, P69; Danilkovitch A, 1999, EXP CELL RES, V248, P575, DOI 10.1006/excr.1999.4429; Danilkovitch A, 2000, MOL CELL BIOL, V20, P2218, DOI 10.1128/MCB.20.6.2218-2227.2000; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Faubion Jr WA, 2013, AM J GASTROENTEROL; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Ganesan R, 2012, PROTEIN ENG DES SEL, V25, P127, DOI 10.1093/protein/gzr067; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gaudino G, 1995, ONCOGENE, V11, P2627; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Hauser F, 2012, GENES IMMUN, V13, P321, DOI 10.1038/gene.2011.88; IWAMA A, 1995, BLOOD, V86, P3394, DOI 10.1182/blood.V86.9.3394.bloodjournal8693394; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Leonard EJ, 1996, J LEUKOCYTE BIOL, V60, P453, DOI 10.1002/jlb.60.4.453; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Montero-Julian FA, 1998, HYBRIDOMA, V17, P541, DOI 10.1089/hyb.1998.17.541; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nanney LB, 1998, J INVEST DERMATOL, V111, P573, DOI 10.1046/j.1523-1747.1998.00332.x; Okino T, 2001, DIGEST DIS SCI, V46, P424, DOI 10.1023/A:1005673420464; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Srivastava B, 2012, SCAND J GASTROENTERO, V47, P820, DOI 10.3109/00365521.2012.682090; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239; Wahl RC, 1997, J BIOL CHEM, V272, P15053, DOI 10.1074/jbc.272.24.15053; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; WANG MH, 1994, J BIOL CHEM, V269, P3436; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; YOSHIMURA T, 1993, J BIOL CHEM, V268, P15461	56	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83958	10.1371/journal.pone.0083958	http://dx.doi.org/10.1371/journal.pone.0083958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24409221	gold, Green Submitted, Green Published			2022-12-25	WOS:000328882000134
J	Nin, V; Chini, CCS; Escande, C; Capellini, V; Chini, EN				Nin, Veronica; Chini, Claudia C. S.; Escande, Carlos; Capellini, Verena; Chini, Eduardo N.			Deleted in Breast Cancer 1 (DBC1) Protein Regulates Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Metabolism; Nuclear Receptors; Signal Transduction; SIRT1; Deleted In Breast Cancer 1; Rev-erb	REV-ERB-ALPHA; GLUCOSE-HOMEOSTASIS; CIRCADIAN BEHAVIOR; SIRT1; METABOLISM; HEME; DEACETYLATION; BETA; MICE; INHIBITION	Background: Gluconeogenesis is an important physiological pathway in response to fasting and stress. Results: DBC1 regulates gluconeogenesis and PEPCK expression by a mechanism that is at least in part explained by the Rev-erb and the deacetylase SIRT1. Conclusion: A new role for DBC1as a regulator of PEPCK expression is described. Significance: We aim to understand the molecular mechanisms of glucose metabolism and response to fasting. Liver gluconeogenesis is essential to provide energy to glycolytic tissues during fasting periods. However, aberrant up-regulation of this metabolic pathway contributes to the progression of glucose intolerance in individuals with diabetes. Phosphoenolpyruvate carboxykinase (PEPCK) expression plays a critical role in the modulation of gluconeogenesis. Several pathways contribute to the regulation of PEPCK, including the nuclear receptor Rev-erb and the histone deacetylase SIRT1. Deleted in breast cancer 1 (DBC1) is a nuclear protein that binds to and regulates both Rev-erb and SIRT1 and, therefore, is a candidate to participate in the regulation of PEPCK. In this work, we provide evidence that DBC1 regulates glucose metabolism and the expression of PEPCK. We show that DBC1 levels decrease early in the fasting state. Also, DBC1 KO mice display higher gluconeogenesis in a normal and a high-fat diet. DBC1 absence leads to an increase in PEPCK mRNA and protein expression. Conversely, overexpression of DBC1 results in a decrease in PEPCK mRNA and protein levels. DBC1 regulates the levels of Rev-erb, and manipulation of Rev-erb activity or levels prevents the effect of DBC1 on PEPCK. In addition, Rev-erb levels decrease in the first hours of fasting. Finally, knockdown of the deacetylase SIRT1 eliminates the effect of DBC1 knockdown on Rev-erb levels and PEPCK expression, suggesting that the mechanism of PEPCK regulation is, at least in part, dependent on the activity of this enzyme. Our results point to DBC1 as a novel regulator of gluconeogenesis.	[Chini, Eduardo N.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; Mayo Clin, Kogod Ctr Aging, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Ctr GI Signaling, Ctr Canc, Lab Signal Transduct,Dept Anesthesiol, Rochester, MN 55905 USA.	chini.eduardo@mayo.edu			NIDDK, National Institutes of Health [DK-084055]; American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; Mayo-UOFM Decade of Discovery Grant [63-01]; Minnesota Obesity Council [DK-50456-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK084055] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; Mayo-UOFM Decade of Discovery Grant; Minnesota Obesity Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant DK-084055. This work was also supported by grants from the American Federation of Aging Research and from the Mayo Foundation, by the Strickland Career Development Award, by Mayo-UOFM Decade of Discovery Grant 63-01, and by Minnesota Obesity Council grant DK-50456-15.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chini CCS, 2013, BIOCHEM J, V451, P453, DOI 10.1042/BJ20121085; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Chini E. N., 2013, BIOSCI REP, V33; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Linares A., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P151, DOI 10.2174/187152906778249545; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	41	13	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5518	5527		10.1074/jbc.M113.512913	http://dx.doi.org/10.1074/jbc.M113.512913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415752	Green Published, hybrid			2022-12-25	WOS:000332015500016
J	Rogacheva, MV; Manhart, CM; Chen, C; Guarne, A; Surtees, J; Alani, E				Rogacheva, Maria V.; Manhart, Carol M.; Chen, Cheng; Guarne, Alba; Surtees, Jennifer; Alani, Eric			Mlh1-Mlh3, a Meiotic Crossover and DNA Mismatch Repair Factor, Is a Msh2-Msh3-stimulated Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Enzymes; DNA Mismatch Repair; DNA Recombination; DNA Repair; Meiosis; Mlh1-Mlh3; Crossing Over; Endonuclease	DOUBLE-STRAND BREAKS; MUTL-ALPHA; HOLLIDAY JUNCTIONS; YEAST MSH2-MSH6; CROSSING-OVER; MEIOSIS; RECOMBINATION; BINDING; PROTEIN; MLH1-PMS1	Background: Meiotic crossing over requires resolution of Holliday junctions through actions of the DNA mismatch repair factor Mlh1-Mlh3. Results: Mlh1-Mlh3 is a metal-dependent, Msh2-Msh3-stimulated endonuclease. Conclusion: Our observations support a direct role for Mlh1-Mlh3 endonuclease activity in recombination and repair. Significance: An enzymatic activity is identified for a key recombination and repair factor. Crossing over between homologous chromosomes is initiated in meiotic prophase in most sexually reproducing organisms by the appearance of programmed double strand breaks throughout the genome. In Saccharomyces cerevisiae the double-strand breaks are resected to form three prime single-strand tails that primarily invade complementary sequences in unbroken homologs. These invasion intermediates are converted into double Holliday junctions and then resolved into crossovers that facilitate homolog segregation during Meiosis I. Work in yeast suggests that Msh4-Msh5 stabilizes invasion intermediates and double Holliday junctions, which are resolved into crossovers in steps requiring Sgs1 helicase, Exo1, and a putative endonuclease activity encoded by the DNA mismatch repair factor Mlh1-Mlh3. We purified Mlh1-Mlh3 and showed that it is a metal-dependent and Msh2-Msh3-stimulated endonuclease that makes single-strand breaks in supercoiled DNA. These observations support a direct role for an Mlh1-Mlh3 endonuclease activity in resolving recombination intermediates and in DNA mismatch repair.	[Rogacheva, Maria V.; Manhart, Carol M.; Chen, Cheng; Alani, Eric] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Guarne, Alba] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Surtees, Jennifer] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	Cornell University; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Alani, E (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 459 Biotechnol Bldg, Ithaca, NY 14853 USA.	eea3@cornell.edu	Manhart, Carol/AAQ-4938-2020		National Institutes of Health [GM53085, DG288295, GM087549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53085 (to M. V. R., C. M., C. C., and E. A.), DG288295 (Natural Science and Engineering Research Council; to A. G.), and GM087549 (to J. S.).	ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MS, 2013, G3-GENES GENOM GENET, V3, P9, DOI 10.1534/g3.112.004622; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Dixon F. J., 1969, INTRO STAT ANAL; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drotschmann K, 2002, BIOL CHEM, V383, P969, DOI 10.1515/BC.2002.103; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; HUNTER N, 2007, TOPICS CURRENT GENET, V17, P381; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kijas AW, 2003, J MOL BIOL, V331, P123, DOI 10.1016/S0022-2836(03)00694-6; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lenhart JS, 2013, MOL MICROBIOL, V90, P680, DOI 10.1111/mmi.12389; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Moens PB, 2002, J CELL SCI, V115, P1611; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Nishant KT, 2010, PLOS GENET, V6; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Rose MD., 1990, METHODS YEAST GENETI; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	70	80	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5664	5673		10.1074/jbc.M113.534644	http://dx.doi.org/10.1074/jbc.M113.534644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403070	hybrid, Green Published			2022-12-25	WOS:000332015500029
J	Zhu, WY; Schmehl, DR; Mullin, CA; Frazier, JL				Zhu, Wanyi; Schmehl, Daniel R.; Mullin, Christopher A.; Frazier, James L.			Four Common Pesticides, Their Mixtures and a Formulation Solvent in the Hive Environment Have High Oral Toxicity to Honey Bee Larvae	PLOS ONE			English	Article							APIS-MELLIFERA; RISK-ASSESSMENT; N-METHYL; INSECTICIDES; N-ETHYL-2-PYRROLIDONE; CHLOROTHALONIL; HYMENOPTERA; METABOLITES; MITICIDES; POLLEN	Recently, the widespread distribution of pesticides detected in the hive has raised serious concerns about pesticide exposure on honey bee (Apis mellifera L.) health. A larval rearing method was adapted to assess the chronic oral toxicity to honey bee larvae of the four most common pesticides detected in pollen and wax - fluvalinate, coumaphos, chlorothalonil, and chloropyrifos - tested alone and in all combinations. All pesticides at hive-residue levels triggered a significant increase in larval mortality compared to untreated larvae by over two fold, with a strong increase after 3 days of exposure. Among these four pesticides, honey bee larvae were most sensitive to chlorothalonil compared to adults. Synergistic toxicity was observed in the binary mixture of chlorothalonil with fluvalinate at the concentrations of 34 mg/L and 3 mg/L, respectively; whereas, when diluted by 10 fold, the interaction switched to antagonism. Chlorothalonil at 34 mg/L was also found to synergize the miticide coumaphos at 8 mg/L. The addition of coumaphos significantly reduced the toxicity of the fluvalinate and chlorothalonil mixture, the only significant non-additive effect in all tested ternary mixtures. We also tested the common 'inert' ingredient N-methyl-2-pyrrolidone at seven concentrations, and documented its high toxicity to larval bees. We have shown that chronic dietary exposure to a fungicide, pesticide mixtures, and a formulation solvent have the potential to impact honey bee populations, and warrants further investigation. We suggest that pesticide mixtures in pollen be evaluated by adding their toxicities together, until complete data on interactions can be accumulated.	[Zhu, Wanyi; Mullin, Christopher A.; Frazier, James L.] Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA; [Schmehl, Daniel R.] Univ Florida, Dept Entomol & Nematol, Honey Bee Res & Extens Lab, Gainesville, FL 32611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Florida	Zhu, WY (corresponding author), Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA.	wanyizhupsu@gmail.com		Schmehl, Daniel/0000-0003-1591-8722	North American Pollinator Protection Campaign (NAPPC); United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA)	North American Pollinator Protection Campaign (NAPPC); United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA)	Funding for this work was provided by the North American Pollinator Protection Campaign (NAPPC) and the United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA) Managed Pollinator Coordinated Agricultural Project (CAP) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins E, 1981, 2883 U CAL DIV AGR; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bonzini S, 2011, APIDOLOGIE, V42, P378, DOI 10.1007/s13592-011-0011-2; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; Cox C, 2006, ENVIRON HEALTH PERSP, V114, P1803, DOI 10.1289/ehp.9374; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; DAVIS AR, 1989, BEE WORLD, V70, P163, DOI 10.1080/0005772X.1989.11099013; DeGrandi-Hoffman G, 2009, AM BEE J, V149, P667; DeLorenzo ME, 2003, J ENVIRON SCI HEAL B, V38, P529, DOI 10.1081/PFC-120023511; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Donovan Y, 2006, REREGISTRATION ELIGI; EC, 2009, OFF J EU L 200, P1; Everich R, 2009, J ECON ENTOMOL, V102, P20, DOI 10.1603/029.102.0104; FIEDLER L, 1987, J APICULT RES, V26, P115, DOI 10.1080/00218839.1987.11100747; Health and Safety Executive, 1997, 7210 EH HLTH SAF EX; Hendriksma HP, 2012, APIDOLOGIE, V43, P549, DOI 10.1007/s13592-012-0123-3; Hendriksma HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028174; Hendriksma HP, 2011, METHODS ECOL EVOL, V2, P509, DOI 10.1111/j.2041-210X.2011.00099.x; Hertzberg RC, 2002, SCI TOTAL ENVIRON, V288, P31, DOI 10.1016/S0048-9697(01)01113-5; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Hung YM, 2005, TOXICOL IND HEALTH, V21, P137, DOI 10.1191/0748233705th217oa; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2011, AM BEE J, V151, P975; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jouyban A, 2010, J PHARM PHARM SCI, V13, P524, DOI 10.18433/J3P306; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kudsk P, 2004, WEED RES, V44, P313, DOI 10.1111/j.1365-3180.2004.00405.x; Ladurner E, 2005, APIDOLOGIE, V36, P449, DOI 10.1051/apido:2005032; Lan CH, 2004, B ENVIRON CONTAM TOX, V73, P392, DOI 10.1007/s00128-004-0441-x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Saillenfait AM, 2007, J APPL TOXICOL, V27, P491, DOI 10.1002/jat.1237; Schindler BK, 2012, ANAL CHEM, V84, P3787, DOI 10.1021/ac300439w; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; VANBUREN NWM, 1992, PHYSIOL ENTOMOL, V17, P288, DOI 10.1111/j.1365-3032.1992.tb01024.x; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; WARNE MSJ, 1995, ECOTOX ENVIRON SAFE, V31, P23, DOI 10.1006/eesa.1995.1039; Winston M.L., 1991, BIOL HONEY BEE; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	53	230	238	5	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e77547	10.1371/journal.pone.0077547	http://dx.doi.org/10.1371/journal.pone.0077547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416121	Green Published, gold			2022-12-25	WOS:000329862500002
J	Maia, GH; Quesado, JL; Soares, JI; do Carmo, JM; Andrade, PA; Andrade, JP; Lukoyanov, NV				Maia, Gisela H.; Quesado, Jose L.; Soares, Joana I.; do Carmo, Joana M.; Andrade, Pedro A.; Andrade, Jose P.; Lukoyanov, Nikolai V.			Loss of Hippocampal Neurons after Kainate Treatment Correlates with Behavioral Deficits	PLOS ONE			English	Article							RETROSPLENIAL CORTEX LESIONS; SPONTANEOUS MOTOR SEIZURES; STATUS EPILEPTICUS; KAINIC ACID; FUNCTIONAL-CHANGES; RATS; MEMORY; EPILEPSY; MODEL; PILOCARPINE	Treating rats with kainic acid induces status epilepticus (SE) and leads to the development of behavioral deficits and spontaneous recurrent seizures later in life. However, in a subset of rats, kainic acid treatment does not induce overt behaviorally obvious acute SE. The goal of this study was to compare the neuroanatomical and behavioral changes induced by kainate in rats that developed convulsive SE to those who did not. Adult male Wistar rats were treated with kainic acid and tested behaviorally 5 months later. Rats that had experienced convulsive SE showed impaired performance on the spatial water maze and passive avoidance tasks, and on the context and tone retention tests following fear conditioning. In addition, they exhibited less anxiety-like behaviors than controls on the open-field and elevated plus-maze tests. Histologically, convulsive SE was associated with marked neuron loss in the hippocampal CA3 and CA1 fields, and in the dentate hilus. Rats that had not experienced convulsive SE after kainate treatment showed less severe, but significant impairments on the spatial water maze and passive avoidance tasks. These rats had fewer neurons than control rats in the dentate hilus, but not in the hippocampal CA3 and CA1 fields. Correlational analyses revealed significant relationships between spatial memory indices of rats and neuronal numbers in the dentate hilus and CA3 pyramidal field. These results show that a part of the animals that do not display intense behavioral seizures (convulsive SE) immediately after an epileptogenic treatment, later in life, they may still have noticeable structural and functional changes in the brain.	[Maia, Gisela H.; Quesado, Jose L.; Andrade, Jose P.; Lukoyanov, Nikolai V.] Univ Porto, Fac Med, Dept Anat, P-4100 Oporto, Portugal; [Maia, Gisela H.; Soares, Joana I.; Lukoyanov, Nikolai V.] Univ Porto, Inst Biol Mol & Celular, Neural Networks Grp, P-4100 Oporto, Portugal; [Maia, Gisela H.; Soares, Joana I.; do Carmo, Joana M.; Andrade, Pedro A.; Lukoyanov, Nikolai V.] Univ Porto, Programa Doutoral Neurociencias, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Lukoyanov, NV (corresponding author), Univ Porto, Fac Med, Dept Anat, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	luk@med.up.pt	Andrade, Pedro/N-8410-2018; Andrade, José Paulo/L-8036-2013; Lukoyanov, Nikolay/X-9360-2019; Lukoyanov, Nikolai/N-1235-2013; Soares, Joana Isabel/ABC-5544-2021	Andrade, Pedro/0000-0001-9118-8341; Andrade, José Paulo/0000-0003-2585-200X; Lukoyanov, Nikolay/0000-0002-5206-7819; Lukoyanov, Nikolai/0000-0002-5206-7819; Soares, Joana I./0000-0002-3549-6873; Maia, Gisela/0000-0002-3199-340X	FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-015919, PTDC/SAU-NSC/115506/2009]; Strategic Project Centro de Morfologia Experimental (CME/FM/UP) [PEst-OE/SAU/UI0121/2011]	FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; Strategic Project Centro de Morfologia Experimental (CME/FM/UP)	This work was supported by FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE and National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within the scope of the Project FCOMP-01-0124-FEDER-015919 PTDC/SAU-NSC/115506/2009, Strategic Project Centro de Morfologia Experimental (CME/FM/UP) - 2011-2012, Project PEst-OE/SAU/UI0121/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Akaike K, 2001, BRAIN RES, V900, P65, DOI 10.1016/S0006-8993(01)02252-1; Aldenkamp AP, 1996, ACTA NEUROL SCAND, V93, P253; Alessio A, 2004, EPILEPSY BEHAV, V5, P22, DOI 10.1016/j.yebeh.2003.10.010; Amaral David G., 1995, P443; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barkas L, 2012, BRAIN, V135, P2358, DOI 10.1093/brain/aws176; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; Bonilha L, 2007, HUM BRAIN MAPP, V28, P1376, DOI 10.1002/hbm.20373; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Cardoso A, 2008, BRAIN RES, V1218, P206, DOI 10.1016/j.brainres.2008.04.074; Cardoso A, 2011, BEHAV BRAIN RES, V225, P538, DOI 10.1016/j.bbr.2011.07.057; Cavarsan CF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00106; Chen SY, 2005, BRAIN RES, V1057, P141, DOI 10.1016/j.brainres.2005.07.058; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; GAARSKJAER FB, 1978, J COMP NEUROL, V178, P49, DOI 10.1002/cne.901780104; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Gilby KL, 2005, EPILEPSIA, V46, P3, DOI 10.1111/j.1528-1167.2005.01001.x; Gilby KL, 2009, BEHAV NEUROSCI, V123, P337, DOI 10.1037/a0014730; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hattiangady B, 2011, AGING DIS, V2, P1; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hellier JL, 1999, EPILEPSY RES, V35, P47, DOI 10.1016/S0920-1211(98)00127-2; Herguido MJ, 1999, NEUROSCIENCE, V93, P71, DOI 10.1016/S0306-4522(99)00163-3; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Inostroza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038959; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Kemppainen EJS, 2006, EPILEPSIA, V47, P820, DOI 10.1111/j.1528-1167.2006.00542.x; Kubova H, 2013, NEUROSCIENCE, V235, P232, DOI 10.1016/j.neuroscience.2012.12.055; Langer M, 2011, EPILEPSY RES, V96, P207, DOI 10.1016/j.eplepsyres.2011.06.005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Lukoyanov NV, 2005, BEHAV BRAIN RES, V158, P175, DOI 10.1016/j.bbr.2004.08.023; Lynch M, 2000, EUR J NEUROSCI, V12, P2252, DOI 10.1046/j.1460-9568.2000.00117.x; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MATHERN GW, 1995, J NEUROSCI, V15, P3990; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; O'Reilly RC, 2014, COGNITIVE SCI, V38, P1229, DOI 10.1111/j.1551-6709.2011.01214.x; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STAFSTROM CE, 1993, EPILEPSIA, V34, P420, DOI 10.1111/j.1528-1157.1993.tb02582.x; Suarez LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048128; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Szyndler J, 2005, PHARMACOL BIOCHEM BE, V81, P15, DOI 10.1016/j.pbb.2005.01.020; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tuunanen J, 1999, NEUROSCIENCE, V94, P473, DOI 10.1016/S0306-4522(99)00251-1; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009	63	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84722	10.1371/journal.pone.0084722	http://dx.doi.org/10.1371/journal.pone.0084722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409306	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500030
J	Stepanenko, OV; Stepanenko, OV; Staiano, M; Kuznetsova, IM; Turoverov, KK; D'Auria, S				Stepanenko, Olga V.; Stepanenko, Olesya V.; Staiano, Maria; Kuznetsova, Irina M.; Turoverov, Konstantin K.; D'Auria, Sabato			The Quaternary Structure of the Recombinant Bovine Odorant-Binding Protein Is Modulated by Chemical Denaturants	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DOMAIN; MECHANISM; FLUORESCENCE; STABILITY; COMPLEX; ANTICALINS; REVEALS; POCKET; FORMS	A large group of odorant-binding proteins (OBPs) has attracted great scientific interest as promising building blocks in constructing optical biosensors for dangerous substances, such as toxic and explosive molecules. Native tissue-extracted bovine OBP (bOBP) has a unique dimer folding pattern that involves crossing the a-helical domain in each monomer over the other monomer's b-barrel. In contrast, recombinant bOBP maintaining the high level of stability inherent to native tissue bOBP is produced in a stable native-like state with a decreased tendency for dimerization and is a mixture of monomers and dimers in a buffered solution. This work is focused on the study of the quaternary structure and the folding-unfolding processes of the recombinant bOBP in the absence and in the presence of guanidine hydrochloride (GdnHCl). Our results show that the recombinant bOBP native dimer is only formed at elevated GdnHCl concentrations (1.5 M). This process requires re-organizing the protein structure by progressing through the formation of an intermediate state. The bOBP dimerization process appears to be irreversible and it occurs before the protein unfolds. Though the observed structural changes for recombinant bOBP at pre-denaturing GdnHCl concentrations show a local character and the overall protein structure is maintained, such changes should be considered where the protein is used as a sensitive element in a biosensor system.	[Stepanenko, Olga V.; Stepanenko, Olesya V.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Staiano, Maria; D'Auria, Sabato] CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy; [Kuznetsova, Irina M.] St Petersburg State Polytech Univ, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru; s.dauria@ibp.cnr.it	Kuznetsova, Irina M./R-9844-2017; Stepanenko, Olga/S-3427-2017; STAIANO, MARIA/B-9584-2015; Stepanenko, Olesya V/S-3433-2017; d'auria, sabato/C-3565-2015; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; STAIANO, MARIA/0000-0003-0223-1825; d'auria, sabato/0000-0001-9320-494X; Stepanenko, Olesya/0000-0003-3779-6711; Stepanenko, Olga/0000-0002-9145-3480; Turoverov, Konstantin/0000-0002-6977-1896	Program MCB RAS; RAS; CNR; RF	Program MCB RAS; RAS(Russian Academy of SciencesRegione Sardegna); CNR(Consiglio Nazionale delle Ricerche (CNR)); RF	This work was supported in part by the Program MCB RAS (Konstantin K. Turoverov), the Scholarships from the President of RF (Olga V. Stepanenko and Olesya V. Stepanenko), and the Program of Cooperation between RAS and CNR (Sabato D'Auria and Konstantin K. Turoverov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Giordano A, 2004, J PROTEOME RES, V3, P613, DOI 10.1021/pr034132d; Golebiowski J, 2007, PROTEINS, V67, P448, DOI 10.1002/prot.21307; Hakansson M, 2002, CURR PROTEIN PEPT SC, V3, P629, DOI 10.2174/1389203023380459; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Ikematsu M, 2005, BIOCHEM BIOPH RES CO, V333, P1227, DOI 10.1016/j.bbrc.2005.06.031; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Kuznetsova IM, 2005, J PROTEOME RES, V4, P417, DOI 10.1021/pr0498077; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Malevanets A, 2008, J MOL BIOL, V382, P223, DOI 10.1016/j.jmb.2008.06.025; Mazzini A, 2002, BBA-PROTEINS PROTEOM, V1599, P90, DOI 10.1016/S1570-9639(02)00404-1; Mazzini A, 2007, J STRUCT BIOL, V159, P82, DOI 10.1016/j.jsb.2007.02.007; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pace C N, 1986, Methods Enzymol, V131, P266; PARKER CA, 1962, ANALYST, V87, P83, DOI 10.1039/an9628700083; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Ramoni R, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395012; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; Stepanenko OV, 2013, INT REV CEL MOL BIO, V302, P221, DOI 10.1016/B978-0-12-407699-0.00004-2; Stepanenko OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048809; Stepanenko OV, 2011, J PHYS CHEM B, V115, P9022, DOI 10.1021/jp204555h; Stepanenko OV, 2011, J PHYS CHEM B, V115, P2765, DOI 10.1021/jp1095486; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P5296, DOI 10.1021/bi0359325; Sulatskaya Anna I, 2012, Methods Mol Biol, V895, P441, DOI 10.1007/978-1-61779-927-3_26; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Turoverov K K, 1998, Tsitologiia, V40, P806; TUROVEROV KK, 1985, BIOPHYS CHEM, V23, P79, DOI 10.1016/0301-4622(85)80066-1; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; UVERSKY VN, 2013, BIOPOLYMERS; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Verkhusha VV, 2003, FEMS YEAST RES, V3, P105, DOI 10.1111/j.1567-1364.2003.tb00145.x; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Wei Y, 2008, BBA-PROTEINS PROTEOM, V1784, P666, DOI 10.1016/j.bbapap.2008.01.012; Zerovnik E, 2010, BIOCHIMIE, V92, P1597, DOI 10.1016/j.biochi.2010.05.012	53	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85169	10.1371/journal.pone.0085169	http://dx.doi.org/10.1371/journal.pone.0085169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409322	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500046
J	Lei, NY; Jabaji, Z; Wang, JF; Joshi, VS; Brinkley, GJ; Khalil, H; Wang, FC; Jaroszewicz, A; Pellegrini, M; Li, LH; Lewis, M; Stelzner, M; Dunn, JCY; Martin, MG				Lei, Nan Ye; Jabaji, Ziyad; Wang, Jiafang; Joshi, Vaidehi S.; Brinkley, Garrett J.; Khalil, Hassan; Wang, Fengchao; Jaroszewicz, Artur; Pellegrini, Matteo; Li, Linheng; Lewis, Michael; Stelzner, Matthias; Dunn, James C. Y.; Martin, G. Martin			Intestinal Subepithelial Myofibroblasts Support the Growth of Intestinal Epithelial Stem Cells	PLOS ONE			English	Article							IN-VITRO; WNT/BETA-CATENIN; SELF-RENEWAL; LGR5; DIFFERENTIATION; TRANSPLANTATION; RECEPTORS	Intestinal epithelial stem cells (ISCs) are the focus of recent intense study. Current in vitro models rely on supplementation with the Wnt agonist R-spondin1 to support robust growth, ISC self-renewal, and differentiation. Intestinal subepithelial myofibroblasts (ISEMFs) are important supportive cells within the ISC niche. We hypothesized that co-culture with ISEMF enhances the growth of ISCs in vitro and allows for their successful in vivo implantation and engraftment. ISC-containing small intestinal crypts, FACS-sorted single ISCs, and ISEMFs were procured from C57BL/6 mice. Crypts and single ISCs were grown in vitro into enteroids, in the presence or absence of ISEMFs. ISEMFs enhanced the growth of intestinal epithelium in vitro in a proximity-dependent fashion, with co-cultures giving rise to larger enteroids than monocultures. Co-culture of ISCs with supportive ISEMFs relinquished the requirement of exogenous R-spondin1 to sustain long-term growth and differentiation of ISCs. Mono-and co-cultures were implanted subcutaneously in syngeneic mice. Co-culture with ISEMFs proved necessary for successful in vivo engraftment and proliferation of enteroids; implants without ISEMFs did not survive. ISEMF whole transcriptome sequencing and qPCR demonstrated high expression of specific R-spondins, well-described Wnt agonists that supports ISC growth. Specific non-supportive ISEMF populations had reduced expression of R-spondins. The addition of ISEMFs in intestinal epithelial culture therefore recapitulates a critical element of the intestinal stem cell niche and allows for its experimental interrogation and biodesign-driven manipulation.	[Lei, Nan Ye; Joshi, Vaidehi S.; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Lei, Nan Ye; Jabaji, Ziyad; Khalil, Hassan; Stelzner, Matthias; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Wang, Jiafang; Brinkley, Garrett J.; Martin, G. Martin] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA; [Wang, Jiafang; Brinkley, Garrett J.; Martin, G. Martin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wang, Fengchao; Li, Linheng] Stowers Inst Med Res, Kansas City, MO USA; [Jaroszewicz, Artur; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Li, Linheng] Univ Kansas, Med Ctr, Lab Med, Kansas City, KS 66103 USA; [Lewis, Michael] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol, Los Angeles, CA USA; [Stelzner, Matthias] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stowers Institute for Medical Research; University of California System; University of California Los Angeles; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Martin, MG (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA.	mmartin@mednet.ucla.edu	Martín, María/HDL-9512-2022; Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290; Pellegrini, Matteo/0000-0001-9355-9564; Li, Linheng/0000-0001-9963-430X; Brinkley, Garrett/0000-0003-2622-3416	National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium [DK085535-01, DK085535-02S2, DK083762, DK083319]; California Institute for Regenerative Medicine [RT2-01985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, U01DK085507, R01DK083762, R01DK083319, U01DK085535] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium (DK085535-01 and DK085535-02S2), DK083762, DK083319 and the California Institute for Regenerative Medicine (RT2-01985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2009, J GASTROINTEST SURG, V13, P971, DOI 10.1007/s11605-009-0806-x; Avansino JR, 2006, SURGERY, V140, P423, DOI 10.1016/j.surg.2006.03.012; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen DC, 2006, CELLS TISSUES ORGANS, V184, P154, DOI 10.1159/000099622; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fritsch C, 2002, J CLIN INVEST, V110, P1629, DOI 10.1172/200213588; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Plateroti M, 1998, AM J PHYSIOL-GASTR L, V274, pG945, DOI 10.1152/ajpgi.1998.274.5.G945; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang F, 2013, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2013.04.050, DOI 10.1053/J.GAS-TR0.2013.04.050]; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	30	71	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84651	10.1371/journal.pone.0084651	http://dx.doi.org/10.1371/journal.pone.0084651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400106	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700040
J	Lin, RS; Jimenez-Movilla, M; Dean, J				Lin, Ruei-Shiuan; Jimenez-Movilla, Maria; Dean, Jurrien			Figla-Cre Transgenic Mice Expressing Myristoylated EGFP in Germ Cells Provide a Model for Investigating Perinatal Oocyte Dynamics	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PRIMORDIAL FOLLICLES; GENE-EXPRESSION; UNDIFFERENTIATED SPERMATOGONIA; MEIOTIC PROPHASE; OVARIAN-FOLLICLE; SPERM CHROMATIN; MOUSE OOCYTES; APOPTOSIS; DNA	FIGLA (Factor in the germline, alpha) is a bHLH transcription factor expressed abundantly in female and less so in male germ cells. Mice lacking FIGLA do not form primordial follicles in the ovary and females are sterile, but there is no obvious phenotype in males. Using the Figla promoter to express Cre recombinase, we have established mEGFP/mTomato reporter mice with green germ cells and red somatic tissue. These mice were crossed into the Figla null background to accelerate perinatal oocyte loss. Live imaging of cultured newborn ovaries provides evidence that few oocytes egress and the vast majority disappear within the confines of the ovary. Although a cohort of mobile, phagocytic cells was observed, macrophage depletion in Csf1(op/op) mice did not affect oocyte loss. Investigations with TUNEL assays and caspase inhibitors suggest that apoptosis plays a role in the perinatal loss of oocyte in female mice. These results establish the utility of Figla-EGFP/Cre; mTomato/mEGFP in investigating germ cell dynamics in prepubertal mice.	[Lin, Ruei-Shiuan; Jimenez-Movilla, Maria; Dean, Jurrien] Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD USA.	jurriend@helix.nih.gov	Movilla, Maria Jiménez/I-1004-2015	Movilla, Maria Jiménez/0000-0002-1572-8219	Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton M, 2007, J CELL SCI, V120, P417, DOI 10.1242/jcs.03332; Amleh A, 2002, HUM REPROD UPDATE, V8, P395, DOI 10.1093/humupd/8.5.395; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Cohen PE, 1997, BIOL REPROD, V56, P110, DOI 10.1095/biolreprod56.1.110; Ene AC, 2013, DEV BIOL, V377, P213, DOI 10.1016/j.ydbio.2013.01.027; Erkek S, 2013, NAT STRUCT MOL BIOL; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GATEWOOD JM, 1987, SCIENCE, V236, P962, DOI 10.1126/science.3576213; Gawriluk TR, 2011, REPRODUCTION, V141, P759, DOI 10.1530/REP-10-0489; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liang LF, 1997, DEVELOPMENT, V124, P4939; Matikainen T, 2001, ENDOCRINOLOGY, V142, P2468, DOI 10.1210/en.142.6.2468; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; MILLAR SE, 1991, MOL CELL BIOL, V11, P6197, DOI 10.1128/MCB.11.12.6197; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; MOTTA PM, 1994, ARCH HISTOL CYTOL, V57, P369, DOI 10.1679/aohc.57.369; MOTTA PM, 1986, EUR J OBSTET GYN R B, V22, P271, DOI 10.1016/0028-2243(86)90115-2; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Pellegrini M, 2011, J CELL SCI, V124, P91, DOI 10.1242/jcs.072959; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Pittoggi C, 1999, J CELL SCI, V112, P3537; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; WORDINGER R, 1990, ANAT REC, V227, P187, DOI 10.1002/ar.1092270207; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84477	10.1371/journal.pone.0084477	http://dx.doi.org/10.1371/journal.pone.0084477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400092	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700026
J	Michael, N; Bischof, HJ; Lowel, S				Michael, Neethu; Bischof, Hans-Joachim; Loewel, Siegrid			Flavoprotein Autofluorescence Imaging of Visual System Activity in Zebra Finches and Mice	PLOS ONE			English	Article							INTRINSIC SIGNAL; PLASTICITY; CORTEX; BRAIN; MOUSE; BIRDS; MECHANISMS; MAPS	Large-scale brain activity patterns can be visualized by optical imaging of intrinsic signals (OIS) based on activity-dependent changes in the blood oxygenation level. Another method, flavoprotein autofluorescence imaging (AFI), exploits the mitochondrial flavoprotein autofluorescence, which is enhanced during neuronal activity. In birds, topographic mapping of visual space has been shown in the visual wulst, the avian homologue of the mammalian visual cortex by using OIS. We here applied the AFI method to visualize topographic maps in the visual wulst because with OIS, which depends on blood flow changes, blood vessel artifacts often obscure brain activity maps. We then compared both techniques quantitatively in zebra finches and in C57Bl/6J mice using the same setup and stimulation conditions. In addition to experiments with craniotomized animals, we also examined mice with intact skull (in zebra finches, intact skull imaging is not feasible probably due to the skull construction). In craniotomized animals, retinotopic maps were obtained by both methods in both species. Using AFI, artifacts caused by blood vessels were generally reduced, the magnitude of neuronal activity significantly higher and the retinotopic map quality better than that obtained by OIS in both zebra finches and mice. In contrast, our measurements in non-craniotomized mice did not reveal any quantitative differences between the two methods. Our results thus suggest that AFI is the method of choice for investigations of visual processing in zebra finches. In mice, however, if researchers decide to use the advantages of imaging through the intact skull, they will not be able to exploit the higher signals obtainable by the AFI-method.	[Michael, Neethu; Loewel, Siegrid] Univ Gottingen, Bernstein Focus Neurotechnol & Johann Friedrich B, Syst Neurosci Grp, D-37073 Gottingen, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, D-33615 Bielefeld, Germany	University of Gottingen; University of Bielefeld	Michael, N (corresponding author), Univ Gottingen, Bernstein Focus Neurotechnol & Johann Friedrich B, Syst Neurosci Grp, D-37073 Gottingen, Germany.	neethu.michael@biologie.uni-goettingen.de			Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01GQ0810]; Deutsche Forschungsgemeinschaft (DFG) [BI 245/21-1, LO 442/8-1]	Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by grants from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, http://www.bmbf.de/), grant number 01GQ0810 (S. L) and the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp), grant numbers BI 245/21-1 and LO 442/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof H, 2012, ANIMALS SEE WORLD CO, P483; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Goetze B, 2010, NEUROIMAGE, V49, P1622, DOI 10.1016/j.neuroimage.2009.10.019; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; GRINVALD A, 1983, BIOPHYS J, V42, P195, DOI 10.1016/S0006-3495(83)84386-0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Husson TR, 2007, J NEUROSCI, V27, P8665, DOI 10.1523/JNEUROSCI.2156-07.2007; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shibuki K., 2009, IN VIVO OPTICAL IMAG; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Vazquez Alberto L, 2010, Front Neuroenergetics, V2, P11, DOI 10.3389/fnene.2010.00011; Zapeda A, 2004, J NEUROSCI METH, V136, P1, DOI 10.1016/j.jneumeth.2004.02.025; Zeigler H. P., 1993, VISION BRAIN BEHAV B, P415	29	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85225	10.1371/journal.pone.0085225	http://dx.doi.org/10.1371/journal.pone.0085225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400130	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700064
J	Garcia, S; Krausz, S; Ambarus, CA; Fernandez, BM; Hartkamp, LM; van Es, IE; Hamann, J; Baeten, DL; Tak, PP; Reedquist, KA				Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Hamann, Jorg; Baeten, Dominique L.; Tak, Paul P.; Reedquist, Kris A.			Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype	PLOS ONE			English	Article							TIE2-EXPRESSING MONOCYTES; OVEREXPRESSING ANGIOPOIETIN-1; TISSUE MACROPHAGES; ENDOTHELIAL-CELLS; DISEASE-ACTIVITY; GENE-EXPRESSION; SYNOVIAL TISSUE; IN-VIVO; POLARIZATION; PHOSPHORYLATION	Angiopoietin (Ang) -1 and -2 and their receptor Tie2 play critical roles in regulating angiogenic processes during development, homeostasis, tumorigenesis, inflammation and tissue repair. Tie2 signaling is best characterized in endothelial cells, but a subset of human and murine circulating monocytes/macrophages essential to solid tumor formation express Tie2 and display immunosuppressive properties consistent with M2 macrophage polarization. However, we have recently shown that Tie2 is strongly activated in pro-inflammatory macrophages present in rheumatoid arthritis patient synovial tissue. Here we examined the relationship between Tie2 expression and function during human macrophage polarization. Tie2 expression was observed under all polarization conditions, but was highest in IFN-gamma and IL-10 -differentiated macrophages. While TNF enhanced expression of a common restricted set of genes involved in angiogenesis and inflammation in GM-CSF, IFN-gamma and IL-10 -differentiated macrophages, expression of multiple chemokines and cytokines, including CXCL3, CXCL5, CXCL8, IL6, and IL12B was further augmented in the presence of Ang-1 and Ang-2, via Tie2 activation of JAK/STAT signaling. Conditioned medium from macrophages stimulated with Ang-1 or Ang-2 in combination with TNF, sustained monocyte recruitment. Our findings suggest a general role for Tie2 in cooperatively promoting the inflammatory activation of macrophages, independently of polarization conditions.	[Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Hamann, Jorg; Baeten, Dominique L.; Reedquist, Kris A.] Univ Amsterdam, Dept Expt Immunol, Amsterdam, Netherlands; [Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Baeten, Dominique L.; Tak, Paul P.; Reedquist, Kris A.] Univ Amsterdam, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Reedquist, KA (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam, Netherlands.	k.a.reedquist@amc.uva.nl	Garcia Perez, Samuel/I-4729-2015	Garcia Perez, Samuel/0000-0002-5902-2699; Hamann, Jorg/0000-0002-9448-1727	Dutch Arthritis Association [NR 04-1-301, NR 09-1-405]; Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia); Anxeles Alvarino postdoctoral program (European Social Fund (ESF))	Dutch Arthritis Association; Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia); Anxeles Alvarino postdoctoral program (European Social Fund (ESF))	This research was supported by Dutch Arthritis Association project grants (NR 04-1-301 and NR 09-1-405) to Dr. K. A. Reedquist. Dr. S. Garcia is supported by the Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia and the European Social Fund (ESF)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Ambarus CA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3796; Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Baeten D, 2005, ARTHRITIS RES THER, V7, pR359, DOI 10.1186/ar1501; Chen JX, 2004, AM J PHYSIOL-HEART C, V287, pH187, DOI 10.1152/ajpheart.01058.2003; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Haq R, 2002, J BIOL CHEM, V277, P17359, DOI 10.1074/jbc.M201842200; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hatfield K, 2009, BRIT J HAEMATOL, V144, P53, DOI 10.1111/j.1365-2141.2008.07411.x; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krausz S, 2012, ANN RHEUM DIS, V71, P1402, DOI 10.1136/annrheumdis-2011-200718; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P966, DOI 10.1002/art.24406; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhang YG, 2004, CARCINOGENESIS, V25, P1165, DOI 10.1093/carcin/bgh115	44	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82088	10.1371/journal.pone.0082088	http://dx.doi.org/10.1371/journal.pone.0082088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404127	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800006
J	Marshall, SM; Kelley, KL; Davis, MA; Wilson, MD; McDaniel, AL; Lee, RG; Crooke, RM; Graham, MJ; Rudel, LL; Brown, JM; Temel, RE				Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; McDaniel, Allison L.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.			Reduction of VLDL Secretion Decreases Cholesterol Excretion in Niemann-Pick C1-Like 1 Hepatic Transgenic Mice	PLOS ONE			English	Article							LIVER-X-RECEPTOR; TRIGLYCERIDE TRANSFER PROTEIN; BILIARY STEROL SECRETION; ABSORPTION; ACTIVATION; TRANSPORT; INHIBITION; EFFLUX; LIPOPROTEIN; ABCA1	An effective way to reduce LDL cholesterol, the primary risk factor of atherosclerotic cardiovascular disease, is to increase cholesterol excretion from the body. Our group and others have recently found that cholesterol excretion can be facilitated by both hepatobiliary and transintestinal pathways. However, the lipoprotein that moves cholesterol through the plasma to the small intestine for transintestinal cholesterol efflux (TICE) is unknown. To test the hypothesis that hepatic very low-density lipoproteins (VLDL) support TICE, antisense oligonucleotides (ASO) were used to knockdown hepatic expression of microsomal triglyceride transfer protein (MTP), which is necessary for VLDL assembly. While maintained on a high cholesterol diet, Niemann-Pick C1-like 1 hepatic transgenic (L1Tg) mice, which predominantly excrete cholesterol via TICE, and wild type (WT) littermates were treated with control ASO or MTP ASO. In both WT and L1Tg mice, MTP ASO decreased VLDL triglyceride (TG) and cholesterol secretion. Regardless of treatment, L1Tg mice had reduced biliary cholesterol compared to WT mice. However, only L1Tg mice treated with MTP ASO had reduced fecal cholesterol excretion. Based upon these findings, we conclude that VLDL or a byproduct such as LDL can move cholesterol from the liver to the small intestine for TICE.	[Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; McDaniel, Allison L.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA; [Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.] ISIS Pharmaceut, Antisense Drug Discovery, Cardiovasc Grp, Carlsbad, CA 92008 USA; [Marshall, Stephanie M.; Brown, J. Mark] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Temel, Ryan E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	Wake Forest University; Wake Forest Baptist Medical Center; Isis Pharmaceuticals Inc; Cleveland Clinic Foundation; University of Kentucky	Brown, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA.	brownm5@ccf.org; ryan.temel@uky.edu			National Heart, Lung, and Blood Institute of the NIH [P01-HL049373, K99/R00-HL096166, K99/R00-HL088528]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, K99HL096166] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute of the NIH (http://www.nhlbi.nih.gov/) funded this work through the following awards: P01-HL049373 to L. L. R., K99/R00-HL096166 to J.M.B., and K99/R00-HL088528 to R. E. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Bura KS, 2013, J LIPID RES, V54, P1567, DOI 10.1194/jlr.M034454; Cai SF, 2001, J LIPID RES, V42, P902; CHENG SH, 1959, P SOC EXP BIOL MED, V101, P223; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Davis HR, 2011, CURR OPIN LIPIDOL, V22, P467, DOI 10.1097/MOL.0b013e32834c7c28; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Le May C, 2012, ARTERIOSCLER THROMB, V32, pA22; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nijstad N, 2011, GASTROENTEROLOGY, V140, P1043, DOI 10.1053/j.gastro.2010.11.055; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; SIMMONDS WJ, 1967, J CLIN INVEST, V46, P874, DOI 10.1172/JCI105587; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2012, CURR OPIN LIPIDOL, V23, P85, DOI 10.1097/MOL.0b013e3283508c21; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vrins CLJ, 2012, J LIPID RES, V53, P2017, DOI 10.1194/jlr.M022194; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200	29	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84418	10.1371/journal.pone.0084418	http://dx.doi.org/10.1371/journal.pone.0084418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404162	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800041
J	Tang, L; van de Ven, AL; Guo, DM; Andasari, V; Cristini, V; Li, KC; Zhou, XB				Tang, Lei; van de Ven, Anne L.; Guo, Dongmin; Andasari, Vivi; Cristini, Vittorio; Li, King C.; Zhou, Xiaobo			Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; CELL-PROLIFERATION; NONLINEAR SIMULATION; MATHEMATICAL-MODEL; OXYGEN-CONSUMPTION; IN-VIVO; CANCER; TRANSPORT; DELIVERY; PHARMACOKINETICS	Solid tumors develop abnormally at spatial and temporal scales, giving rise to biophysical barriers that impact anti-tumor chemotherapy. This may increase the expenditure and time for conventional drug pharmacokinetic and pharmacodynamic studies. In order to facilitate drug discovery, we propose a mathematical model that couples three-dimensional tumor growth and angiogenesis to simulate tumor progression for chemotherapy evaluation. This application-oriented model incorporates complex dynamical processes including cell-and vascular-mediated interstitial pressure, mass transport, angiogenesis, cell proliferation, and vessel maturation to model tumor progression through multiple stages including tumor initiation, avascular growth, and transition from avascular to vascular growth. Compared to pure mechanistic models, the proposed empirical methods are not only easy to conduct but can provide realistic predictions and calculations. A series of computational simulations were conducted to demonstrate the advantages of the proposed comprehensive model. The computational simulation results suggest that solid tumor geometry is related to the interstitial pressure, such that tumors with high interstitial pressure are more likely to develop dendritic structures than those with low interstitial pressure.	[Tang, Lei] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Guo, Dongmin; Andasari, Vivi; Li, King C.; Zhou, Xiaobo] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27106 USA; [van de Ven, Anne L.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Cristini, Vittorio] Univ New Mexico, Dept Pathol, Canc Res & Treatment Ctr, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; [Cristini, Vittorio] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Wake Forest University; Northeastern University; University of New Mexico; University of New Mexico	Zhou, XB (corresponding author), Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27106 USA.	xizhou@wakehealth.edu	Cristini, Vittorio/N-3540-2013	Cristini, Vittorio/0000-0002-7909-4278; Li, King/0000-0002-6473-2687; van de Ven, Anne/0000-0002-0347-4004	National Institutes of Health [5R01EB009009-06, U01CA166886-01]; Radiology Pilot Grant from Wake Forest University Health Sciences; National Science Foundation [DMS - 1263742, CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, ICBP - 1U54CA149196, NSF SBIR 1315372]; Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; NATIONAL CANCER INSTITUTE [U54CA143907, U01CA166886, U54CA151668, U54CA149196, U54CA143837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiology Pilot Grant from Wake Forest University Health Sciences; National Science Foundation(National Science Foundation (NSF)); Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by the National Institutes of Health grants 5R01EB009009-06 (KL), U01CA166886-01 and Radiology Pilot Grant from Wake Forest University Health Sciences (XZ), National Science Foundation Grant DMS - 1263742, CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, ICBP - 1U54CA149196, NSF SBIR 1315372, the Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer (VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Baish JW, 2011, P NATL ACAD SCI USA, V108, P1799, DOI 10.1073/pnas.1018154108; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; BOUCHER Y, 1992, CANCER RES, V52, P5110; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Dingemanse J, 2007, CLIN PHARMACOKINET, V46, P713, DOI 10.2165/00003088-200746090-00001; DiResta GR, 2005, ANN BIOMED ENG, V33, P1270, DOI 10.1007/s10439-005-5732-9; Dormann Sabine, 2002, In Silico Biology, V2, P393; ENDRICH B, 1979, J NATL CANCER I, V62, P387; Folkman J, 1992, Semin Cancer Biol, V3, P65; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; LANGER R, 1980, P NATL ACAD SCI-BIOL, V77, P4331, DOI 10.1073/pnas.77.7.4331; Luo JC, 1998, CANCER RES, V58, P2652; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nathan SS, 2005, CLIN CANCER RES, V11, P2389, DOI 10.1158/1078-0432.CCR-04-2048; Olsen MM, 2013, PROCEDIA COMPUT SCI, V18, P1016, DOI 10.1016/j.procs.2013.05.267; Orsolic N, 2003, TOXICON, V41, P861, DOI 10.1016/S0041-0101(03)00045-X; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Ribba B, 2006, J THEOR BIOL, V243, P532, DOI 10.1016/j.jtbi.2006.07.013; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Sanga S, 2006, EXPERT REV ANTICANC, V6, P1361, DOI 10.1586/14737140.6.10.1361; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Sinek J, 2004, BIOMED MICRODEVICES, V6, P297, DOI 10.1023/B:BMMD.0000048562.29657.64; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Tanaka T, 1997, HEPATOLOGY, V26, P283, DOI 10.1002/hep.510260205; Tang L, 2012, ISRN BIOMATHEMATICS, V2012; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; VAUPEL P, 1987, CANCER RES, V47, P3496; Wang CH, 1998, CHEM ENG SCI, V53, P3579, DOI 10.1016/S0009-2509(98)00173-0; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wiig H, 2010, FIBROGENESIS TISSUE, V3; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	54	50	52	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83962	10.1371/journal.pone.0083962	http://dx.doi.org/10.1371/journal.pone.0083962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404145	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800024
J	Hoeksema, L; Los, LI				Hoeksema, Lisette; Los, Leonoor I.			Vision-Related Quality of Life in Herpetic Anterior Uveitis Patients	PLOS ONE			English	Article							VISUAL FUNCTION QUESTIONNAIRE; INFLAMMATORY DISEASE; DEPRESSION	We investigated the vision-related quality of life (VR-QOL) and the prevalence and severity of depression in patients with herpetic anterior uveitis (AU). This study was conducted in 2012 at the ophthalmology department of the University Medical Center of Groningen (tertiary referral center). We selected patients from an existing uveitis database, all eligible patients were approached. Thirty-six of 66 (55%) patients with herpetic AU (herpes simplex virus or varicella zoster virus) participated, patients were 18 years or older. The diagnosis was made by clinical presentation or a positive anterior chamber tap. All patients received an information letter, informed consent form, National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Beck Depression Inventory (BDI-II), Social Support List - Interactions (SSL-I), Social Support List - Discrepancies (SSL-D) and an additional questionnaire for gathering general information. Medical records were reviewed for clinical characteristics. Analyses were conducted on various patient and ocular characteristics. We compared our NEI VFQ-25 scores with those previously found in the literature. Our main outcome measures were VR-QOL, prevalence and severity of depression, social support and various patient and ocular characteristics that could influence the VR-QOL. We found that the NEI VFQ-25 mean overall composite score (OCS) was 88.1 +/- 10.6. Compared with other ocular diseases our OCS is relatively high, but lower than that found in a normal working population. The mean general health score was 59.0 +/- 19.0; this score is lower than in patients with other ocular diseases, except for untreated Behcet's patients. Depression was scarce, with only one patient (2.8%) having a moderate depression (BDI-II score of 21). We concluded that herpetic AU affects the VR-QOL in a moderate way. The prevalence of depression in our group of herpetic AU patients was low and therefore does not seem to indicate a need for specific screening and intervention measures in these patients.	[Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	l.hoeksema@umcg.nl			Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp	Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp	Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Cahill MT, 2005, OPHTHALMOLOGY, V112, P152, DOI 10.1016/j.ophtha.2004.06.036; de Graaf R, 2012, Tijdschr Psychiatr, V54, P27; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Huang JJ, 2010, OCULAR INFLAMMATORY, P41; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102; Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021; Kuiper JJW, 2013, ACTA OPHTHALMOL, V91, pE329, DOI 10.1111/aos.12054; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Lukas K, 2012, J PUBLIC HEALTH-HEID, V20, P441, DOI 10.1007/s10389-011-0481-8; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2000, NEI VFO SCORING ALGO; PavanLangston D, 1995, NEUROLOGY, V45, pS50, DOI 10.1212/WNL.45.12_Suppl_8.S50; Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Sakai T, 2013, BRIT J OPHTHALMOL, V97, P338, DOI 10.1136/bjophthalmol-2012-302515; Schiffman RM, 2001, ARCH OPHTHALMOL-CHIC, V119, P841; Schweitzer KD, 2011, CAN J OPHTHALMOL, V46, P232, DOI 10.1016/j.jcjo.2011.05.010; Wensing B, 2011, OPHTHALMOLOGY, V118, P1905, DOI 10.1016/j.ophtha.2011.03.033	22	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85224	10.1371/journal.pone.0085224	http://dx.doi.org/10.1371/journal.pone.0085224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392164	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100087
J	Tian, HF; Zhang, Y; Sun, Q; Zhu, SL; Li, XJ; Pan, Z; Xu, WB; Xu, BH				Tian, Huifang; Zhang, Yong; Sun, Qiang; Zhu, Shuangli; Li, Xiujuan; Pan, Zhuo; Xu, Wenbo; Xu, Baohong			Prevalence of Multiple Enteroviruses Associated with Hand, Foot, and Mouth Disease in Shijiazhuang City, Hebei Province, China: Outbreaks of Coxsackieviruses A10 and B3	PLOS ONE			English	Article							ACUTE-FLACCID-PARALYSIS; MALAYSIA; A6; EPIDEMIC	Hand, foot, and mouth disease (HFMD) has been one of the most common infectious diseases in Shijiazhuang City, as is the situation in China overall. In the National HFMD surveillance system, the pathogen detection was focused on EV-A71 and CVA16, and therefore, information on the other EVs is very limited. In order to identify the circulating EV serotypes in the HFMD outbreaks in Shijiazhuang City during 2010-2012, 4045 patients presented with HFMD were recruited in the study, and clinical samples were investigated. Typing of EV serotypes was performed using the molecular typing methods, and phylogenetic analyses based on entire VP1 sequences of human enterovirus 71 (EV-A71), coxsackievirus A16 (CVA16), CVA10 and CVB3 was performed. The results revealed that EV-A71 and CVA16 were the 2 most important pathogens but the circulating trends of the 2 viruses showed a shift, the spread of EV-A71 became increasingly weak, whereas the spread of CVA16 became increasingly stronger. CVA10 and CVB3 were the third and fourth most prevalent pathogens, respectively. Co-infection of two viruses at the same time was not found in these samples. Based on entire VP1 region sequences, the phylogenetic analysis revealed that C4a subgenotype EV-A71, B1a and B1b subgenotype CVA16 continued to evolve. The CVA10 strains were assigned to 4 genotypes (A-D), whereas the CVB3 strains were assigned to 5 genotypes (A-E), with clear geographical and temporal-specific distributions. The Shijiazhuang CVA10 sequences belonged to 4 epidemic lineages within genotype C, whereas the Shijiazhuang CVB3 sequences belonged to 2 epidemic lineages within genotype E, which may have the same origins as the strains reported in other part of China. CVA10 and CVB3, 2 pathogens that were previously infrequently detected, were identified as pathogens causing the HFMD outbreaks. This study underscores the need for detailed laboratory-based surveillances of HFMD in mainland China.	[Tian, Huifang; Li, Xiujuan; Pan, Zhuo; Xu, Baohong] Shijiazhuang Ctr Dis Control & Prevent, Microbiol Lab, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhu, Shuangli; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Minist Hlth Key Lab Med Virol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, BH (corresponding author), Shijiazhuang Ctr Dis Control & Prevent, Microbiol Lab, Shijiazhuang, Hebei, Peoples R China.	wsws661120@126.com	li, xiu/GXV-1745-2022	Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [30900063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (project no. 30900063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chan YF, 2012, TROP BIOMED, V29, P451; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YF, 2012, J INFECTION, V65, P189, DOI 10.1016/j.jinf.2012.03.021; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Shahmahmoodi S, 2008, J CLIN VIROL, V42, P409, DOI 10.1016/j.jcv.2008.02.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu J, 2013, PLOS ONE, V8; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	23	47	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84233	10.1371/journal.pone.0084233	http://dx.doi.org/10.1371/journal.pone.0084233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392117	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100040
J	de Souza, JDA; Coelho, RR; Lourenco, IT; Fragoso, RD; Viana, AAB; de Macedo, LLP; da Silva, MCM; Carneiro, RMG; Engler, G; de Almeida-Engler, J; Grossi-de-Sa, MF				Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan; Fragoso, Rodrigo da Rocha; Barbosa Viana, Antonio Americo; Pepino de Macedo, Leonardo Lima; Mattar da Silva, Maria Cristina; Gomes Carneiro, Regina Maria; Engler, Gilbert; de Almeida-Engler, Janice; Grossi-de-Sa, Maria Fatima			Knocking-Down Meloidogyne incognita Proteases by Plant-Delivered dsRNA Has Negative Pleiotropic Effect on Nematode Vigor	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CATHEPSIN-L PROTEASE; PARASITIC NEMATODE; HETERODERA-GLYCINES; PROTEINASE-INHIBITORS; MOLECULAR-CLONING; GENE-EXPRESSION; INTERFERENCE; GROWTH; HOST	The root-knot nematode Meloidogyne incognita causes serious damage and yield losses in numerous important crops worldwide. Analysis of the M. incognita genome revealed a vast number of proteases belonging to five different catalytic classes. Several reports indicate that M. incognita proteases could play important roles in nematode parasitism, besides their function in ordinary digestion of giant cell contents for feeding. The precise roles of these proteins during parasitism however are still unknown, making them interesting targets for gene silencing to address protein function. In this study we have knocked-down an aspartic (Mi-asp-1), a serine (Mi-ser-1) and a cysteine protease (Mi-cpl-1) by RNAi interference to get an insight into the function of these enzymes during a host/nematode interaction. Tobacco lines expressing dsRNA for Mi-ser-1 (dsSER), Mi-cpl-1 (dsCPL) and for the three genes together (dsFusion) were generated. Histological analysis of galls did not show clear differences in giant cell morphology. Interestingly, nematodes that infected plants expressing dsRNA for proteases produced a reduced number of eggs. In addition, nematode progeny matured in dsSER plants had reduced success in egg hatching, while progeny resulting from dsCPL and dsFusion plants were less successful to infect wild-type host plants. Quantitative PCR analysis confirmed a reduction in transcripts for Mi-cpl-1 and Mi-ser-1 proteases. Our results indicate that these proteases are possibly involved in different processes throughout nematode development, like nutrition, reproduction and embryogenesis. A better understanding of nematode proteases and their possible role during a plant-nematode interaction might help to develop new tools for phytonematode control.	[Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan] Univ Brasilia, Grad Program Biol Mol, Brasilia, DF, Brazil; [Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan; Pepino de Macedo, Leonardo Lima; Mattar da Silva, Maria Cristina; Gomes Carneiro, Regina Maria; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Fragoso, Rodrigo da Rocha] Embrapa Cerrados, Planaltina, DF, Brazil; [Barbosa Viana, Antonio Americo; Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Engler, Gilbert; de Almeida-Engler, Janice] Univ Nice Sophia Antipolis, CNRS, INRA, UMR ISA,UMR ISA 1355,UMR ISA 7254, Sophia Antipolis, France	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Grossi-de-Sa, MF (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	fatima.grossi@embrapa.br	Grossi-de-Sa, Maria Fatima/N-7856-2017; de Souza, Jose Dijair Antonino/I-1028-2014	de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Fragoso, Rodrigo/0000-0003-4337-1947; GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599	'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil [142341/2007-0]	'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil	JDASJ has been supported by a doctoral scholarship from 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), from Brazil (142341/2007-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 1996, J NEMATOL, V28, P209; Bakhetia M, 2008, INT J PARASITOL, V38, P1589, DOI 10.1016/j.ijpara.2008.05.003; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Beynon RJ, 1994, PROTEOLYTIC ENZIMES; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; BOLTER CJ, 1995, J INSECT PHYSIOL, V41, P1071, DOI 10.1016/0022-1910(95)00073-4; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Castagnone-Sereno P, 2011, GENOMICS, V97, P29, DOI 10.1016/j.ygeno.2010.10.002; Charlton WL, 2010, INT J PARASITOL, V40, P855, DOI 10.1016/j.ijpara.2010.01.003; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Souza DDDE, 2011, PLANT SCI, V180, P276, DOI 10.1016/j.plantsci.2010.09.003; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Fanelli E, 2005, GENE, V349, P87, DOI 10.1016/j.gene.2004.11.045; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fragoso RD, 2005, EXP PARASITOL, V110, P123, DOI 10.1016/j.exppara.2005.02.010; Fragoso RD, 2009, EXP PARASITOL, V121, P115, DOI 10.1016/j.exppara.2008.09.017; Gallois P, 1995, PLANT GENE TRASNFER, P38; Gatehouse LN, 1997, INSECT BIOCHEM MOLEC, V27, P929, DOI 10.1016/S0965-1748(97)00074-X; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Li JR, 2010, PLANTA, V232, P775, DOI 10.1007/s00425-010-1209-7; Li JR, 2010, PLANT CELL REP, V29, P113, DOI 10.1007/s00299-009-0803-2; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P378, DOI 10.1271/bbb.110661; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neveu C, 2003, PHYSIOL MOL PLANT P, V63, P159, DOI 10.1016/j.pmpp.2003.10.005; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; VRAIN TC, 1977, J NEMATOL, V9, P249; Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013; Youssef RM, 2013, EXP PARASITOL, V134, P266, DOI 10.1016/j.exppara.2013.03.009; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	57	35	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85364	10.1371/journal.pone.0085364	http://dx.doi.org/10.1371/journal.pone.0085364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392004	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900148
J	Shaw, DJ; Czekoova, K; Chromec, J; Marecek, R; Brazdil, M				Shaw, Daniel Joel; Czekoova, Kristina; Chromec, Jakub; Marecek, Radek; Brazdil, Milan			Copying You Copying Me: Interpersonal Motor Co-Ordination Influences Automatic Imitation	PLOS ONE			English	Article							A-PRIORI LIKING; SOCIAL COGNITION; SYNCHRONY; SELF; MIRROR; EXPERIENCE; INHIBITION; MODULATION; MIMICRY; REPRESENTATIONS	Moving in a co-ordinated fashion with another individual changes our behaviour towards them; we tend to like them more, find them more attractive, and are more willing to co-operate with them. It is generally assumed that this effect on behaviour results from alterations in representations of self and others. Specifically, through neurophysiological perception-action matching mechanisms, interpersonal motor co-ordination (IMC) is believed to forge a neural coupling between actor and observer, which serves to blur boundaries in conceptual self-other representations and causes positive views of the self to be projected onto others. An investigation into this potential neural mechanism is lacking, however. Moreover, the specific components of IMC that might influence this mechanism have not yet been specified. In the present study we exploited a robust behavioural phenomenon -automatic imitation -to assess the degree to which IMC influences neural action observation-execution matching mechanisms. This revealed that automatic imitation is reduced when the actions of another individual are perceived to be synchronised in time, but are spatially incongruent, with our own. We interpret our findings as evidence that IMC does indeed exert an effect on neural perception-action matching mechanisms, but this serves to promote better self-other distinction. Our findings demonstrate that further investigation is required to understand the complex relationship between neural perception-action coupling, conceptual self-other representations, and social behaviour.	[Shaw, Daniel Joel; Czekoova, Kristina; Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, CEITEC Cent European Inst Technol, Behav & Social Neurosci Res Grp, Brno, Czech Republic; [Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, Fac Med, Dept Neurol 1, Brno, Czech Republic; [Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, St Annes Univ Hosp, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Shaw, DJ (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Behav & Social Neurosci Res Grp, Brno, Czech Republic.	daniel.shaw@ceitec.muni.cz	Brazdil, Milan/D-6836-2012; Czekóová, Kristína/E-3233-2012; Marecek, Radek/AAM-4984-2020; Shaw, Daniel/E-3362-2012	Czekóová, Kristína/0000-0001-9198-1083; Shaw, Daniel/0000-0003-1139-8301; Marecek, Radek/0000-0001-8399-3455; Brazdil, Milan/0000-0001-7979-2343	CEITEC - Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Laboratory for the Experimental Research of Religion (LEVYNA) [CZ.1.07/2.3.00/20.0048]; European Social Fund; state budget of the Czech Republic	CEITEC - Central European Institute of Technology from European Regional Development Fund; Laboratory for the Experimental Research of Religion (LEVYNA); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund, and partly by the project "Laboratory for the Experimental Research of Religion (LEVYNA)" (CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aron A., 2013, OXFORD HDB CLOSE REL; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2003, NEUROPSYCHOLOGY, V17, P265, DOI 10.1037/0894-4105.17.2.265; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Farmer H, 2012, REV PHILOS PSYCHOL, V3, P125, DOI 10.1007/s13164-012-0092-5; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Galinsky AD, 2005, GROUP PROCESS INTERG, V8, P109, DOI 10.1177/1368430205051060; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Hayes A.F, 2013, MEDIATION MODERATION; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; James W., 1890, PRINCIPLES PSYCHOL, V2; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Knoblich G, 2008, PHILOS T R SOC B, V363, P2021, DOI 10.1098/rstb.2008.0006; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Launay J, 2013, EXP PSYCHOL, V60, P53, DOI 10.1027/1618-3169/a000173; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; Maddux WW, 2008, J EXP SOC PSYCHOL, V44, P461, DOI 10.1016/j.jesp.2007.02.003; Mazzurega M, 2011, EXP BRAIN RES, V213, P213, DOI 10.1007/s00221-011-2744-6; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31, DOI DOI 10.3389/FPSYG.2016.00458; Miles LK, 2010, J EXP SOC PSYCHOL, V46, P457, DOI 10.1016/j.jesp.2009.12.006; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Press C, 2008, BRAIN COGNITION, V67, P44, DOI 10.1016/j.bandc.2007.11.001; Press C, 2007, P ROY SOC B-BIOL SCI, V274, P2509, DOI 10.1098/rspb.2007.0774; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Santiesteban I, 2012, COGNITION, V122, P228, DOI 10.1016/j.cognition.2011.11.004; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Smith ER, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P148; Spengler S, 2009, HUM BRAIN MAPP, V30, P3704, DOI 10.1002/hbm.20800; Stel M, 2010, EXP PSYCHOL, V57, P412, DOI 10.1027/1618-3169/a000050; Stel M, 2010, EUR J SOC PSYCHOL, V40, P867, DOI 10.1002/ejsp.655; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Swaab RI, 2011, J EXP SOC PSYCHOL, V47, P616, DOI 10.1016/j.jesp.2011.01.005; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	66	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84820	10.1371/journal.pone.0084820	http://dx.doi.org/10.1371/journal.pone.0084820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391976	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900119
J	Yang, XJ; Guo, YZ; Luo, JS; Pu, XM; Li, ML				Yang, Xiaojiao; Guo, Yanzhi; Luo, Jiesi; Pu, Xuemei; Li, Menglong			Effective Identification of Gram-Negative Bacterial Type III Secreted Effectors Using Position-Specific Residue Conservation Profiles	PLOS ONE			English	Article							RNA-BINDING SITES; MESSENGER-RNA; SOLVENT ACCESSIBILITY; YERSINIA-ENTEROCOLITICA; CAMPYLOBACTER-JEJUNI; ACCURATE PREDICTION; VIRULENCE EFFECTORS; MUTATIONAL ANALYSIS; SIGNAL PEPTIDES; RANDOM FOREST	Backgroud: Type III secretion systems (T3SSs) are central to the pathogenesis and specifically deliver their secreted substrates (type III secreted proteins, T3SPs) into host cells. Since T3SPs play a crucial role in pathogen-host interactions, identifying them is crucial to our understanding of the pathogenic mechanisms of T3SSs. This study reports a novel and effective method for identifying the distinctive residues which are conserved different from other SPs for T3SPs prediction. Moreover, the importance of several sequence features was evaluated and further, a promising prediction model was constructed. Results: Based on the conservation profiles constructed by a position-specific scoring matrix (PSSM), 52 distinctive residues were identified. To our knowledge, this is the first attempt to identify the distinct residues of T3SPs. Of the 52 distinct residues, the first 30 amino acid residues are all included, which is consistent with previous studies reporting that the secretion signal generally occurs within the first 30 residue positions. However, the remaining 22 positions span residues 30-100 were also proven by our method to contain important signal information for T3SP secretion because the translocation of many effectors also depends on the chaperone-binding residues that follow the secretion signal. For further feature optimisation and compression, permutation importance analysis was conducted to select 62 optimal sequence features. A prediction model across 16 species was developed using random forest to classify T3SPs and non-T3 SPs, with high receiver operating curve of 0.93 in the 10-fold cross validation and an accuracy of 94.29% for the test set. Moreover, when performing on a common independent dataset, the results demonstrate that our method outperforms all the others published to date. Finally, the novel, experimentally confirmed T3 effectors were used to further demonstrate the model's correct application. The model and all data used in this paper are freely available at http://cic.scu.edu.cn/bioinformatics/ T3SPs.zip.	[Yang, Xiaojiao; Guo, Yanzhi; Luo, Jiesi; Pu, Xuemei; Li, Menglong] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Sichuan University	Guo, YZ (corresponding author), Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.	yzguo@scu.edu.cn; liml@scu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [20905054, 20972103, 20973115]; Specialized Research Fund for the Doctoral Program of Higher Education [20090181120058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn; No. 20905054, 20972103, 20973115) and the Specialized Research Fund for the Doctoral Program of Higher Education (http://www.cutech.edu.cn; No. 20090181120058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2009, FEMS MICROBIOL LETT, V296, P18, DOI 10.1111/j.1574-6968.2009.01607.x; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Cornelis GR, 2007, INT J MED MICROBIOL, V297, P28; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Crawford JA, 2002, MOL MICROBIOL, V46, P855, DOI 10.1046/j.1365-2958.2002.03214.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Dong XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056632; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee SH, 2003, J BACTERIOL, V185, P7279, DOI 10.1128/JB.185.24.7279-7284.2003; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Luo JS, 2012, CHEMOMETR INTELL LAB, V110, P163, DOI 10.1016/j.chemolab.2011.11.008; Ma WB, 2008, CURR OPIN PLANT BIOL, V11, P412, DOI 10.1016/j.pbi.2008.05.001; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Qin WL, 2012, COMPUT BIOL CHEM, V36, P31, DOI 10.1016/j.compbiolchem.2011.12.001; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Ramamurthi KS, 2002, J BACTERIOL, V184, P3321, DOI 10.1128/JB.184.12.3321-3328.2002; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Sato Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-442; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomalka AG, 2012, MOL MICROBIOL, V86, P1464, DOI 10.1111/mmi.12069; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Wang Y, 2008, AMINO ACIDS, V35, P295, DOI 10.1007/s00726-007-0634-9; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Wilkins MR, 1999, METH MOL B, V112, P531; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Xiao JM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-165; Xiao JM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-427; Xue B, 2010, GENES CELLS, V15, P635, DOI 10.1111/j.1365-2443.2010.01407.x; Yahara Koji, 2011, Information and Media Technologies, V6, P39; Yan CH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-47; Yang Y, 2011, P 8 INT C FUZZ SYST, P1560; Yang Y, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/696190; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Yu LZ, 2010, PEPTIDES, V31, P574, DOI 10.1016/j.peptides.2009.12.026; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266	83	6	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84439	10.1371/journal.pone.0084439	http://dx.doi.org/10.1371/journal.pone.0084439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391954	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900097
J	Benbahouche, NE; Iliopoulos, I; Torok, I; Marhold, J; Henri, J; Kajava, AV; Farkas, R; Kempf, T; Schnolzer, M; Meyer, P; Kiss, I; Bertrand, E; Mechler, BM; Pradet-Balade, B				Benbahouche, Nour El Houda; Iliopoulos, Ioannis; Toeroek, Istvan; Marhold, Joachim; Henri, Julien; Kajava, Andrey V.; Farkas, Robert; Kempf, Tore; Schnoelzer, Martina; Meyer, Philippe; Kiss, Istvan; Bertrand, Edouard; Mechler, Bernard M.; Pradet-Balade, Berengere			Drosophila Spag Is the Homolog of RNA Polymerase II-associated Protein 3 (RPAP3) and Recruits the Heat Shock Proteins 70 and 90 (Hsp70 and Hsp90) during the Assembly of Cellular Machineries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; Protein Assembly; RNA Polymerase II; Small Nucleolar RNA (snoRNA); TOR Complex (TORC); Hsp70; R2TP Complex; RPAP3; Spaghetti Gene	HUMAN TRANSCRIPTION MACHINERY; INTERACTION NETWORK; BINDING-PROTEIN; 2ND CHROMOSOME; R2TP COMPLEX; CHAPERONE; GENE; MELANOGASTER; COCHAPERONE; REVEALS	Background: Mammalian RNA polymerase II-associated protein 3 (RPAP3) recruits heat shock protein 90 (Hsp90) to assemble cellular machineries such as RNA polymerases. Results:Spaghetti encodes the Drosophila homolog of RPAP3. Spaghetti is essential for development. Spag protein binds and stimulates Hsp90 and Hsp70. Conclusion: RPAP3 function is conserved among metazoans. Significance: Our data suggest that Hsp70 assists RPAP3 in complex assembly. The R2TP is a recently identified Hsp90 co-chaperone, composed of four proteins as follows: Pih1D1, RPAP3, and the AAA(+)-ATPases RUVBL1 and RUVBL2. In mammals, the R2TP is involved in the biogenesis of cellular machineries such as RNA polymerases, small nucleolar ribonucleoparticles and phosphatidylinositol 3-kinase-related kinases. Here, we characterize the spaghetti (spag) gene of Drosophila, the homolog of human RPAP3. This gene plays an essential function during Drosophila development. We show that Spag protein binds Drosophila orthologs of R2TP components and Hsp90, like its yeast counterpart. Unexpectedly, Spag also interacts and stimulates the chaperone activity of Hsp70. Using null mutants and flies with inducible RNAi, we show that spaghetti is necessary for the stabilization of snoRNP core proteins and target of rapamycin activity and likely the assembly of RNA polymerase II. This work highlights the strong conservation of both the HSP90/R2TP system and its clients and further shows that Spag, unlike Saccharomyces cerevisiae Tah1, performs essential functions in metazoans. Interaction of Spag with both Hsp70 and Hsp90 suggests a model whereby R2TP would accompany clients from Hsp70 to Hsp90 to facilitate their assembly into macromolecular complexes.	[Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, F-34293 Montpellier 5, France; [Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] Univ Montpellier 2, F-34095 Montpellier 5, France; [Benbahouche, Nour El Houda; Bertrand, Edouard; Pradet-Balade, Berengere] Univ Montpellier I, F-34967 Montpellier 2, France; [Iliopoulos, Ioannis; Toeroek, Istvan; Marhold, Joachim; Kiss, Istvan; Mechler, Bernard M.] German Canc Res Ctr, DKFZ ZMBH Alliance, Dept Dev Genet, D-69120 Heidelberg, Germany; [Henri, Julien; Meyer, Philippe] CNRS, FRE 3354, Lab Biol Mol & Cellulaire Eucaryotes, Inst Biol Phys Chim, F-75005 Paris, France; [Henri, Julien; Meyer, Philippe] Sorbonne Univ, Univ Paris 06, Inst Biol Phys Chim, Lab Biol Mol & Cellulaire Eucaryotes,FRE 3354, F-75005 Paris, France; [Kajava, Andrey V.] CNRS, UMR5237, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Kajava, Andrey V.] Inst Biol Computat, F-34095 Montpellier, France; [Farkas, Robert] Slovak Acad Sci, Inst Expt Endocrinol, Lab Dev Genet, Bratislava 83306, Slovakia; [Kempf, Tore; Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Mechler, Bernard M.] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, CZ-12801 Prague, Czech Republic; [Mechler, Bernard M.] VIT Univ, Vellore 632014, Tamil Nadu, India	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Slovak Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague; Vellore Institute of Technology	Bertrand, E (corresponding author), CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, 1919 Route Mende, F-34293 Montpellier 5, France.	edouard.bertrand@igmm.cnrs.fr; mechler@bluewin.ch; pradet@igmm.cnrs.fr	Henri, Julien/AAB-3427-2020; Meyer, Philippe/AAC-6038-2019; Kajava, Andrey V/E-1107-2014; Farkas, Robert/ABB-1990-2021; Henri, Julien B/E-3340-2017	Henri, Julien/0000-0003-0772-8881; Meyer, Philippe/0000-0002-6220-0679; Kajava, Andrey V/0000-0002-2342-6886; Henri, Julien B/0000-0003-0772-8881; Farkas, Robert/0000-0002-9138-7567; bertrand, edouard/0000-0002-9642-7994	La Ligue Nationale Contre le Cancer; ANR; Czech Grant Foundation Grant [P302/11/1640]; Charles University Center [UNCE 204022]; First Faculty of Medicine [Prvouk/ILF/1]; Agence National de la Recherche Grant [ANR-11-BSV8-015-03]; LABEX DYNAMO Grant [ANR-11-LABX-0011]; Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant [SFI20101201793]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ANR(French National Research Agency (ANR)); Czech Grant Foundation Grant; Charles University Center; First Faculty of Medicine; Agence National de la Recherche Grant(French National Research Agency (ANR)); LABEX DYNAMO Grant; Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant	This work was supported in part by La Ligue Nationale Contre le Cancer and ANR Grant Hsp90 Assembly.com (to E. B.); work in the laboratory of B. M. M. was supported by the Czech Grant Foundation Grant P302/11/1640, the Charles University Center UNCE 204022, and the First Faculty of Medicine Prvouk/ILF/1 (to B. M. M.); and work in the laboratory of P. M. was supported by Agence National de la Recherche Grant ANR-11-BSV8-015-03, the LABEX DYNAMO Grant ANR-11-LABX-0011, and the Fondation Agence National de la Recherche pour la Recherche sur le Cancer Grant SFI20101201793.	Back R, 2013, STRUCTURE, V21, P1834, DOI 10.1016/j.str.2013.07.024; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2012, RNA BIOL, V9, DOI 10.4161/rna.9.2.18494; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Forget D, 2010, MOL CELL PROTEOMICS, V9, P2827, DOI 10.1074/mcp.M110.003616; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; HOHFELD J, 1995, CELL, V83, P589; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Iliopoulos I, 1997, BIOL CHEM, V378, P1177; Itsuki Y, 2008, FEBS LETT, V582, P2365, DOI 10.1016/j.febslet.2008.05.041; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Lee JS, 2012, PLOS ONE, V7; Makhnevych T, 2012, J CELL BIOL, V198, P623, DOI 10.1083/jcb.201111105; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pradet-Balade B, 2011, EMBO J, V30, P2205, DOI 10.1038/emboj.2011.128; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/PL00008620; Rodor J, 2011, PLANT J, V65, P807, DOI 10.1111/j.1365-313X.2010.04468.x; Rodor J, 2010, BIOCHEM SOC T, V38, P672, DOI 10.1042/BST0380672; Santos MG, 2007, CYTOTECHNOLOGY, V54, P15, DOI 10.1007/s10616-007-9060-9; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Torok I, 1999, MOL CELL BIOL, V19, P2308; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; TOROK T, 1993, GENETICS, V135, P71; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Vorbruggen G, 2000, MECH DEVELOP, V90, P305, DOI 10.1016/S0925-4773(99)00249-X; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	42	34	34	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6236	6247		10.1074/jbc.M113.499608	http://dx.doi.org/10.1074/jbc.M113.499608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24394412	Green Published, hybrid			2022-12-25	WOS:000332015500076
J	Higman, VA; Briggs, DC; Mahoney, DJ; Blundell, CD; Sattelle, BM; Dyer, DP; Green, DE; DeAngelis, PL; Almond, A; Milner, CM; Day, AJ				Higman, Victoria A.; Briggs, David C.; Mahoney, David J.; Blundell, Charles D.; Sattelle, Benedict M.; Dyer, Douglas P.; Green, Dixy E.; DeAngelis, Paul L.; Almond, Andrew; Milner, Caroline M.; Day, Anthony J.			A Refined Model for the TSG-6 Link Module in Complex with Hyaluronan USE OF DEFINED OLIGOSACCHARIDES TO PROBE STRUCTURE AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin; Hyaluronate; Isothermal Titration Calorimetry; Molecular Modeling; NMR; Defined Sugars; TSG-6	INTER-ALPHA-INHIBITOR; MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN TSG-6; BINDING DOMAIN; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; TRYPSIN INHIBITOR; HEAVY-CHAINS; NMR; SURFACE	Background: The polysaccharide hyaluronan is organized through interactions with the protein TSG-6 during inflammation and ovulation. Results: NMR spectroscopy on TSG-6 in the presence of defined sugars provided restraints that allowed modeling of a refined hyaluronan/TSG-6 complex. Conclusion: TSG-6 binding causes bending of hyaluronan that explains its condensation of this polysaccharide. Significance: This provides novel structural insights into protein-hyaluronan interactions. Tumor necrosis factor-stimulated gene-6 (TSG-6) is an inflammation-associated hyaluronan (HA)-binding protein that contributes to remodeling of HA-rich extracellular matrices during inflammatory processes and ovulation. The HA-binding domain of TSG-6 consists solely of a Link module, making it a prototypical member of the superfamily of proteins that interacts with this high molecular weight polysaccharide composed of repeating disaccharides of d-glucuronic acid and N-acetyl-d-glucosamine (GlcNAc). Previously we modeled a complex of the TSG-6 Link module in association with an HA octasaccharide based on the structure of the domain in its HA-bound conformation. Here we have generated a refined model for a HA/Link module complex using novel restraints identified from NMR spectroscopy of the protein in the presence of 10 distinct HA oligosaccharides (from 4- to 8-mers); the model was then tested using unique sugar reagents, i.e. chondroitin/HA hybrid oligomers and an octasaccharide in which a single sugar ring was C-13-labeled. The HA chain was found to make more extensive contacts with the TSG-6 surface than thought previously, such that a d-glucuronic acid ring makes stacking and ionic interactions with a histidine and lysine, respectively. Importantly, this causes the HA to bend around two faces of the Link module (resembling the way that HA binds to CD44), potentially providing a mechanism for how TSG-6 can reorganize HA during inflammation. However, the HA-binding site defined here may not play a role in TSG-6-mediated transfer of heavy chains from inter--inhibitor onto HA, a process known to be essential for ovulation.	[Higman, Victoria A.; Mahoney, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Briggs, David C.; Dyer, Douglas P.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Briggs, David C.; Blundell, Charles D.; Sattelle, Benedict M.; Dyer, Douglas P.; Almond, Andrew; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oxford; University of Manchester; University of Manchester; University of Oklahoma System; University of Oklahoma Health Sciences Center	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Dyer, Douglas/L-9679-2019; Milner, Caroline M/P-5526-2015; Dyer, Douglas/J-2675-2015; Day, Anthony/O-1658-2015; Higman, Victoria/H-3795-2011	Dyer, Douglas/0000-0001-5567-6241; Milner, Caroline M/0000-0001-7355-9655; Dyer, Douglas/0000-0001-5567-6241; Day, Anthony/0000-0002-1415-3134; Higman, Victoria/0000-0002-3204-2665; Briggs, David/0000-0002-9793-7339; Blundell, Charles/0000-0002-1439-9126; Almond, Andrew/0000-0001-7471-6333	Arthritis Research UK [16539, 18472, 19489]; Medical Research Council [G0701180]; Biotechnology and Biological Sciences Research Council CASE studentship [BB/D526561/1]; Oklahoma Center for Advancement of Science and Technology; Medical Research Council [MC_U138274352] Funding Source: researchfish; Versus Arthritis [18472, 19489] Funding Source: researchfish; MRC [MC_U138274352, G0701180] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oklahoma Center for Advancement of Science and Technology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK Grants 16539, 18472, and 19489 and Medical Research Council Grant G0701180.; Supported by Biotechnology and Biological Sciences Research Council CASE studentship (BB/D526561/1).; Recipient of an Oklahoma Center for Advancement of Science and Technology Health Research grant.	Almond A, 1998, GLYCOBIOLOGY, V8, P973, DOI 10.1093/glycob/8.10.973; Almond A, 1997, GLYCOBIOLOGY, V7, P597, DOI 10.1093/glycob/7.5.597; Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P189; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Blundell CD, 2006, CARBOHYD RES, V341, P1985, DOI 10.1016/j.carres.2006.05.017; Blundell CD, 2006, ANAL BIOCHEM, V353, P236, DOI 10.1016/j.ab.2006.03.013; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Day A. J., 2004, HYALURONAN STRUCTURE, VII, P675; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Itano N, 2008, J BIOCHEM, V144, P131, DOI 10.1093/jb/mvn046; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tracy BS, 2007, J BIOL CHEM, V282, P337, DOI 10.1074/jbc.M607569200; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	78	35	36	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5619	5634		10.1074/jbc.M113.542357	http://dx.doi.org/10.1074/jbc.M113.542357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403066	Green Published, hybrid			2022-12-25	WOS:000332015500026
J	Ishii, K; Adachi, T; Hamamoto, H; Sekimizu, K				Ishii, Kenichi; Adachi, Tatsuo; Hamamoto, Hiroshi; Sekimizu, Kazuhisa			Serratia marcescens Suppresses Host Cellular Immunity via the Production of an Adhesion-inhibitory Factor against Immunosurveillance Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Bacterial Toxins; Cellular Immune Response; Innate Immunity; Insect Immunity; Macrophages; Metalloprotease; Protein Purification; Silkworm	SILKWORM PARALYTIC PEPTIDE; INTENSIVE-CARE-UNIT; INNATE IMMUNITY; BOMBYX-MORI; PROTEUS-MIRABILIS; PHAGOCYTOSIS; CALRETICULIN; ACTIVATION; DROSOPHILA; METALLOPROTEASE	Background:Serratia marcescens induced an acute increase in immune cell numbers in silkworms. Results: Serralysin metalloprotease was identified as a factor that inhibited immune cell adhesion and bacterial clearance. Conclusion:S. marcescens suppresses cellular immunity by degrading adhesion molecules. Significance: A novel mode of immune evasion by S. marcescens is proposed. Injection of a culture supernatant of Serratia marcescens into the bloodstream of the silkworm Bombyx mori increased the number of freely circulating immunosurveillance cells (hemocytes). Using a bioassay with live silkworms, serralysin metalloprotease was purified from the culture supernatant and identified as the factor responsible for this activity. Serralysin inhibited the in vitro attachment of both silkworm hemocytes and murine peritoneal macrophages. Incubation of silkworm hemocytes or murine macrophages with serralysin resulted in degradation of the cellular immune factor BmSPH-1 or calreticulin, respectively. Furthermore, serralysin suppressed in vitro phagocytosis of bacteria by hemocytes and in vivo bacterial clearance in silkworms. Disruption of the ser gene in S. marcescens attenuated its host killing ability in silkworms and mice. These findings suggest that serralysin metalloprotease secreted by S. marcescens suppresses cellular immunity by decreasing the adhesive properties of immunosurveillance cells, thereby contributing to bacterial pathogenesis.	[Ishii, Kenichi; Adachi, Tatsuo; Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan	University of Tokyo	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Ishii, Kenichi/H-5469-2019; Hamamoto, Hiroshi/G-6397-2019	Hamamoto, Hiroshi/0000-0001-9315-7442	Japan Society for the Promotion of Science [21-10519, 24689008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Japan Society of the Promotion of Science Fellows 21-10519 from the Japan Society for the Promotion of Science and in part by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (A) 24689008.	Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Bowen DJ, 2003, MICROBIOL-SGM, V149, P1581, DOI 10.1099/mic.0.26171-0; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; CHADWICK JS, 1990, J INVERTEBR PATHOL, V55, P133, DOI 10.1016/0022-2011(90)90044-7; Cho JH, 1999, EUR J BIOCHEM, V266, P878, DOI 10.1046/j.1432-1327.1999.00920.x; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; Fadel MP, 1999, J BIOL CHEM, V274, P15085, DOI 10.1074/jbc.274.21.15085; Gandhe AS, 2007, J IMMUNOL, V179, P6943, DOI 10.4049/jimmunol.179.10.6943; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; HOU RF, 1985, APPL ENTOMOL ZOOL, V20, P118, DOI 10.1303/aez.20.118; Imamura K, 2011, DRUG DISCOV THER, V5, P125, DOI 10.5582/ddt.2011.v5.3.125; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2013, DEV COMP IMMUNOL, V39, P147, DOI 10.1016/j.dci.2012.10.014; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; KOBAYASHI H, 1991, INSECT BIOCHEM, V21, P517, DOI 10.1016/0020-1790(91)90105-N; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Maragakis LL, 2008, INFECT CONT HOSP EP, V29, P418, DOI 10.1086/587969; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; Means TK, 2010, VIRULENCE, V1, P37, DOI 10.4161/viru.1.1.10228; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Qi W, 2005, GUT, V54, P1091, DOI 10.1136/gut.2004.061887; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Toratani T, 2008, MICROBIOL-SGM, V154, P1326, DOI 10.1099/mic.0.2007/016246-0; Usui K, 2009, MICROB PATHOGENESIS, V46, P59, DOI 10.1016/j.micpath.2008.10.010; Villari P, 2001, INFECT CONT HOSP EP, V22, P630, DOI 10.1086/501834; Walker KE, 1999, MOL MICROBIOL, V32, P825, DOI 10.1046/j.1365-2958.1999.01401.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	43	47	50	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5876	5888		10.1074/jbc.M113.544536	http://dx.doi.org/10.1074/jbc.M113.544536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398686	hybrid, Green Published			2022-12-25	WOS:000332015500045
J	Ohara-Nemoto, Y; Rouf, SMA; Naito, M; Yanase, A; Tetsuo, F; Ono, T; Kobayakawa, T; Shimoyama, Y; Kimura, S; Nakayama, K; Saiki, K; Konishi, K; Nemoto, TK				Ohara-Nemoto, Yuko; Rouf, Shakh M. A.; Naito, Mariko; Yanase, Amie; Tetsuo, Fumi; Ono, Toshio; Kobayakawa, Takeshi; Shimoyama, Yu; Kimura, Shigenobu; Nakayama, Koji; Saiki, Keitarou; Konishi, Kiyoshi; Nemoto, Takayuki K.			Identification and Characterization of Prokaryotic Dipeptidyl-peptidase 5 from Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Metabolism; Peptidases; Periodontal Disease; Subcellular Fractionation	SECRETED DIPEPTIDYL; GENOME SEQUENCE; OUTER-MEMBRANE; DPP 7; PURIFICATION; CHAIN; PROTEIN; SUBSTRATE; RESIDUES; COMPLEX	Background: Dipeptidyl-peptidases (DPPs) are key factors for amino acid metabolism and bacterial growth of asaccharolytic Porphyromonas gingivalis. Results: DPP5, which is specific for Ala and hydrophobic residues, is expressed in the periplasmic space of P. gingivalis.Conclusion: DPP5 was discovered in prokaryotes for the first time. Significance: The discovery of DPP5 expands understanding of amino acid and energy metabolism in prokaryotes. Porphyromonas gingivalis, a Gram-negative asaccharolytic anaerobe, is a major causative organism of chronic periodontitis. Because the bacterium utilizes amino acids as energy and carbon sources and incorporates them mainly as dipeptides, a wide variety of dipeptide production processes mediated by dipeptidyl-peptidases (DPPs) should be beneficial for the organism. In the present study, we identified the fourth P. gingivalis enzyme, DPP5. In a dpp4-7-11-disrupted P. gingivalis ATCC 33277, a DPP7-like activity still remained. PGN_0756 possessed an activity indistinguishable from that of the mutant, and was identified as a bacterial orthologue of fungal DPP5, because of its substrate specificity and 28.5% amino acid sequence identity with an Aspergillus fumigatus entity. P. gingivalis DPP5 was composed of 684 amino acids with a molecular mass of 77,453, and existed as a dimer while migrating at 66 kDa on SDS-PAGE. It preferred Ala and hydrophobic residues, had no activity toward Pro at the P1 position, and no preference for hydrophobic P2 residues, showed an optimal pH of 6.7 in the presence of NaCl, demonstrated K-m and k(cat)/K-m values for Lys-Ala-MCA of 688 m and 11.02 m(-1) s(-1), respectively, and was localized in the periplasm. DPP5 elaborately complemented DPP7 in liberation of dipeptides with hydrophobic P1 residues. Examinations of DPP- and gingipain gene-disrupted mutants indicated that DPP4, DPP5, DPP7, and DPP11 together with Arg- and Lys-gingipains cooperatively liberate most dipeptides from nutrient oligopeptides. This is the first study to report that DPP5 is expressed not only in eukaryotes, but also widely distributed in bacteria and archaea.	[Ohara-Nemoto, Yuko; Rouf, Shakh M. A.; Yanase, Amie; Tetsuo, Fumi; Ono, Toshio; Kobayakawa, Takeshi; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan; [Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan; [Shimoyama, Yu; Kimura, Shigenobu] Iwate Med Univ, Div Mol Microbiol, Morioka, Iwate 0283694, Japan; [Saiki, Keitarou; Konishi, Kiyoshi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Tokyo 1028159, Japan	Nagasaki University; Nagasaki University; Iwate Medical University; Nippon Dental University	Nemoto, TK (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	tnemoto@nagasaki-u.ac.jp	Keitarou, Saiki/AAV-6909-2020	NAITO, Mariko/0000-0003-0769-7747; Nemoto, Takayuki K./0000-0002-5007-6260; Tetsuo, Fumi/0000-0002-6443-9827	Japan Society for the Promotion of Science; Institute for Fermentation, Osaka; Japanese Government (MEXT); Grants-in-Aid for Scientific Research [24592775] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to Y. O.-N., T. K. N., T. K., and S. K.) and a grant from the Institute for Fermentation, Osaka (to T. K. N.).; Graduate student supported by a Japanese Government (MEXT) Scholarship. Present address: Laboratory of Biochemistry and Molecular Biology, Dept. of Applied Nutrition and Food Technology, Faculty of Applied Science and Technology, Islamic University, Kushtia-7003, Bangladesh.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; ELLIS S, 1967, J BIOL CHEM, V242, P4623; FUJIMURA S, 1992, ORAL MICROBIOL IMMUN, V7, P212, DOI 10.1111/j.1399-302X.1992.tb00027.x; Herman GA, 2006, J CLIN PHARMACOL, V46, P876, DOI 10.1177/0091270006289850; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Hovik H, 2012, J BACTERIOL, V194, P100, DOI 10.1128/JB.06385-11; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Monod M, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3392, DOI 10.1016/B978-0-12-382219-2.00749-3; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Oda H, 2009, J PERIODONTAL RES, V44, P362, DOI 10.1111/j.1600-0765.2008.01117.x; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Pederson RA, 1998, DIABETES, V47, P1253, DOI 10.2337/diabetes.47.8.1253; PIKE R, 1994, J BIOL CHEM, V269, P406; Pollanen MT, 2000, EUR J ORAL SCI, V108, P523, DOI 10.1034/j.1600-0722.2000.00881.x; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Vermout S, 2008, FEMS IMMUNOL MED MIC, V54, P299, DOI 10.1111/j.1574-695X.2008.00479.x; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193	48	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5436	5448		10.1074/jbc.M113.527333	http://dx.doi.org/10.1074/jbc.M113.527333			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398682	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000332015500008
J	Zanusso, G; Fiorini, M; Ferrari, S; Meade-White, K; Barbieri, I; Brocchi, E; Ghetti, B; Monaco, S				Zanusso, Gianluigi; Fiorini, Michele; Ferrari, Sergio; Meade-White, Kimberly; Barbieri, Ilaria; Brocchi, Emiliana; Ghetti, Bernardino; Monaco, Salvatore			Gerstmann-Str ussler-Scheinker Disease and "Anchorless Prion Protein" Mice Share Prion Conformational Properties Diverging from Sporadic Creutzfeldt-Jakob Disease*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Glycosyl Phosphatidylinositol Anchors; Neurodegenerative Diseases; Prions; Transgenic Mice	TRUNCATED FORMS; IDENTIFICATION; PHENOTYPE; AMYLOIDOSIS; ISOFORMS; VARIANT	Background: Prion strains exhibit distinct physical and biochemical repertoires, aggregation propensity, and biological properties. Results: A biochemical approach is developed for defining the conformational features of prions with or without glycosylphosphatidylinositol (GPI)-anchor. Conclusion: GPI anchorless prions are detected in human genetic prion diseases, but not in sporadic forms. Significance: Unveiling the structure of GPI anchorless prions to predict pathological properties. The role of the GPI-anchor in prion disease pathogenesis is still a challenging issue. In vitro studies have shown that anchorless cellular prion protein (PrPC) undergoes aberrant post-translational processing and metabolism. Moreover, transgenic (Tg) mice overexpressing anchorless PrPC develop a spontaneous neurological disease accompanied with widespread brain PrP amyloid deposition, in the absence of spongiform changes. Generation of PrP forms lacking the GPI and PrP amyloidosis are striking features of human stop codon mutations in the PrP gene (PRNP), associated with PrP cerebral amyloid angiopathy (PrP-CAA) and Gerstmann-Straussler-Scheinker (GSS) syndrome. More recently, the presence of anchorless PrP species has been also claimed in sporadic Creutzfeldt-Jakob disease (sCJD). Using a highly sensitive protein separation technique and taking advantage of reference maps of synthetic PrP peptides, we investigated brain tissues from scrapie-infected anchorless PrP Tg mice and wild type mice to determine the contribution of the GPI-anchor to the molecular mass and isoelectric point of PrP quasispecies under two-dimensional electrophoresis. We also assessed the conformational properties of anchorless and anchored prions under standard and inactivating conditions. These studies were extended to sCJD and GSS. At variance with GSS, characterization of PrP quasispecies in different sCJD subtypes ruled out the presence of anchorless prions. Moreover, under inactivating conditions, mice anchorless prions, but not sCJD prions, generated internal PrP fragments, cleaved at both N and C termini, similar to those found in PrP-CAA and GSS brain tissues. These findings show that anchorless PrPSc generates GSS-like PrP fragments, and suggest a major role for unanchored PrP in amyloidogenesis.	[Zanusso, Gianluigi; Fiorini, Michele; Ferrari, Sergio; Monaco, Salvatore] Univ Verona, Dept Neurol & Movement Sci, I-37134 Verona, Italy; [Meade-White, Kimberly] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA; [Barbieri, Ilaria; Brocchi, Emiliana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, I-25124 Brescia, Italy; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Verona; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); IZS Lombardia e Emilia; Indiana University System; Indiana University Bloomington	Zanusso, G (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37134 Verona, Italy.	gianluigi.zanusso@univr.it; salvatore.monaco@univr.it	Monaco, Salvatore/K-4659-2018; Brocchi, Emiliana/G-1810-2019; Zanusso, Gianluigi/K-2823-2018; Ferrari, Sergio/AAE-5649-2019	Monaco, Salvatore/0000-0003-3191-8597; Brocchi, Emiliana/0000-0003-1864-080X; Zanusso, Gianluigi/0000-0001-5199-6264; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	"Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona;  [RF2009-1474758]	"Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona; 	This work was supported in part by RF2009-1474758 (to G. Z.) and by "Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi" from Fondazione Cariverona (to S. M.).	Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; Castagna A, 2002, ELECTROPHORESIS, V23, P339, DOI 10.1002/1522-2683(200202)23:2<339::AID-ELPS339>3.0.CO;2-Y; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; GHETTI B, 1995, BRAIN PATHOL, V5, P61, DOI 10.1111/j.1750-3639.1995.tb00578.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Nishina KA, 2007, ANAL BIOCHEM, V363, P318, DOI 10.1016/j.ab.2007.01.032; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2012, EMERG INFECT DIS, V18, P21, DOI 10.3201/eid1801.110589; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zanusso G, 2002, ELECTROPHORESIS, V23, P347, DOI 10.1002/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	30	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4870	4881		10.1074/jbc.M113.531335	http://dx.doi.org/10.1074/jbc.M113.531335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24398683	Green Published, hybrid			2022-12-25	WOS:000331607900034
J	Mason, H; Shoaibi, A; Ghandour, R; O'Flaherty, M; Capewell, S; Khatib, R; Jabr, S; Unal, B; Sozmen, K; Arfa, C; Aissi, W; Ben Romdhane, H; Fouad, F; Al-Ali, R; Husseini, A				Mason, Helen; Shoaibi, Azza; Ghandour, Rula; O'Flaherty, Martin; Capewell, Simon; Khatib, Rana; Jabr, Samer; Unal, Belgin; Soezmen, Kaan; Arfa, Chokri; Aissi, Wafa; Ben Romdhane, Habiba; Fouad, Fouad; Al-Ali, Radwan; Husseini, Abdullatif		MedCHAMPS Project Team	A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; MORTALITY; HEALTH; INTERVENTIONS; LIFE; PREVENTION; STRATEGIES; ENGLAND	Background: Coronary Heart Disease (CHD) is rising in middle income countries. Population based strategies to reduce specific CHD risk factors have an important role to play in reducing overall CHD mortality. Reducing dietary salt consumption is a potentially cost-effective way to reduce CHD events. This paper presents an economic evaluation of population based salt reduction policies in Tunisia, Syria, Palestine and Turkey. Methods and Findings: Three policies to reduce dietary salt intake were evaluated: a health promotion campaign, labelling of food packaging and mandatory reformulation of salt content in processed food. These were evaluated separately and in combination. Estimates of the effectiveness of salt reduction on blood pressure were based on a literature review. The reduction in mortality was estimated using the IMPACT CHD model specific to that country. Cumulative population health effects were quantified as life years gained (LYG) over a 10 year time frame. The costs of each policy were estimated using evidence from comparable policies and expert opinion including public sector costs and costs to the food industry. Health care costs associated with CHDs were estimated using standardized unit costs. The total cost of implementing each policy was compared against the current baseline (no policy). All costs were calculated using 2010 PPP exchange rates. In all four countries most policies were cost saving compared with the baseline. The combination of all three policies (reducing salt consumption by 30%) resulted in estimated cost savings of $235,000,000 and 6455 LYG in Tunisia; $39,000,000 and 31674 LYG in Syria; $6,000,000 and 2682 LYG in Palestine and $1,3000,000,000 and 378439 LYG in Turkey. Conclusion: Decreasing dietary salt intake will reduce coronary heart disease deaths in the four countries. A comprehensive strategy of health education and food industry actions to label and reduce salt content would save both money and lives.	[Mason, Helen] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland; [Shoaibi, Azza; Ghandour, Rula; Khatib, Rana; Husseini, Abdullatif] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine, Israel; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Jabr, Samer] Minist Hlth, Dept Hlth Econ, Nablus, Palestine, Israel; [Unal, Belgin] Dokuz Eylul Univ, Fac Med, Dept Publ Hlth, Inciralti Izmir, Turkey; [Soezmen, Kaan] Prov Hlth Directorate Izmir, Narlidere Community Hlth Ctr, Izmir, Turkey; [Arfa, Chokri] Univ Carthage, INTES, Tunis, Tunisia; [Aissi, Wafa; Ben Romdhane, Habiba] Univ Tunis El Manar, Fac Med, Cardiovasc Dis Epidemiol & Prevent Res Lab, Tunis, Tunisia; [Fouad, Fouad; Al-Ali, Radwan] Syrian Ctr Tobacco Studies, Aleppo, Syria; [Husseini, Abdullatif] Qatar Univ, Dept Hlth Sci, Publ Hlth Program, Doha, Qatar	Glasgow Caledonian University; Birzeit University; University of Liverpool; Dokuz Eylul University; Universite de Carthage; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Qatar University	Mason, H (corresponding author), Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland.	Helen.mason@gcu.ac.uk	Unal, Belgin/E-7064-2017; Rastam, M. Samer/N-6365-2017; Husseini, Abdullatif/E-8377-2015; Ghandour, Rula/AHE-4572-2022	Unal, Belgin/0000-0002-4354-8266; Rastam, M. Samer/0000-0002-4004-7773; Husseini, Abdullatif/0000-0001-8767-5956; Satman, Ilhan/0000-0001-8613-1797; Critchley, Julia/0000-0002-5248-4188; Bennett, Kathleen/0000-0002-2861-7665; Collins, Marissa/0000-0002-0896-6673; Ahmad, Balsam/0000-0002-9146-3806; Unwin, Nigel/0000-0002-1368-1648; Arik Tasyikan, Hale/0000-0003-4298-4952; O'Flaherty, Martin/0000-0001-8944-4131; Demiral, Yucel/0000-0002-4281-0218; Roglic, Gojka/0000-0003-0872-0689; Mason, Helen/0000-0002-9303-2794	European Community [223075]	European Community(European Commission)	The research leading to these results has received funding from the European Community' Seventh Framework Programme (FP7/2007-2013) under grant agreement no223075 - the MedCHAMPS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001061; Appel LJ, 2012, ANN EPIDEMIOL, V22, P417, DOI 10.1016/j.annepidem.2012.04.003; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Daviglus ML, 2005, ARCH INTERN MED, V165, P1028, DOI 10.1001/archinte.165.9.1028; Edejer T, 2003, MAKING CHOICES HLTH; Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; Hooper L, 2004, COCHRANE DATABASE SY, DOI [DOI 10.1002/14651858.CD003656.PUB2, 10.1002/14651858.CD003656.pub2]; Lenoir-Wijnkoop I, 2012, BRIT J NUTR, V108, P1714, DOI 10.1017/S0007114512003704; Lenoir-Wijnkoop I, 2011, Br J Nutr, V105, P157, DOI 10.1017/S0007114510003041; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; PUSKA P, 1985, ANNU REV PUBL HEALTH, V6, P147, DOI 10.1146/annurev.pu.06.050185.001051; Rappange DR, 2008, PHARMACOECONOMICS, V26, P815, DOI 10.2165/00019053-200826100-00003; Rastam S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-754; Selmer RM, 2000, J EPIDEMIOL COMMUN H, V54, P697, DOI 10.1136/jech.54.9.697; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; World Health Organisation, 2012, HIGH LEV M GEN ASS P; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization (WHO), 2010, JOINT TECHN M HELD W; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	62	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84445	10.1371/journal.pone.0084445	http://dx.doi.org/10.1371/journal.pone.0084445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286JC	24409297	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000329463500021
J	Nozari, N; Woodard, K; Thompson-Schill, SL				Nozari, Nazbanou; Woodard, Kristina; Thompson-Schill, Sharon L.			Consequences of Cathodal Stimulation for Behavior: When Does It Help and When Does It Hurt Performance?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; ELECTRICAL-STIMULATION; ANTERIOR CINGULATE; STATE-DEPENDENCY; WORKING-MEMORY; POLARIZATION; EXCITABILITY	Cathodal Transcranial Direct Current Stimulation (C-tDCS) has been reported, across different studies, to facilitate or hinder performance, or simply to have no tangible effect on behavior. This discrepancy is most prominent when C-tDCS is used to alter a cognitive function, questioning the assumption that cathodal stimulation always compromises performance. In this study, we aimed to study the effect of two variables on performance in a simple cognitive task (letter Flanker), when C-tDCS was applied to the left prefrontal cortex (PFC): (1) the time of testing relative to stimulation (during or after), and (2) the nature of the cognitive activity during stimulation in case of post-tDCS testing. In three experiments, we had participants either perform the Flanker task during C-tDCS (Experiment 1), or after C-tDCS. When the Flanker task was administered after C-tDCS, we varied whether during stimulation subjects were engaged in activities that posed low (Experiment 2) or high (Experiment 3) demands on the PFC. Our findings show that the nature of the task during C-tDCS has a systematic influence on the outcome, while timing per se does not.	[Nozari, Nazbanou; Woodard, Kristina; Thompson-Schill, Sharon L.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Nozari, N (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	nozari@sas.upenn.edu		Woodard, Kristina/0000-0002-7848-3829	 [R01-DC009209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grant number R01-DC009209 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chrysikou EG, 2013, COGN NEUROSCI-UK, V4, P81, DOI 10.1080/17588928.2013.768221; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Friederici AD, 2013, J COGNITIVE NEUROSCI, V25, P814, DOI 10.1162/jocn_a_00350; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Lang N, 2003, SUPPL CLIN NEUROPHYS, V56, P277; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Lupyan G, 2012, COGNITION, V124, P36, DOI 10.1016/j.cognition.2012.04.002; Madhavan S, 2010, BRAIN STIMUL, V3, P42, DOI 10.1016/j.brs.2009.06.005; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Rogalewski A, 2004, EUR J NEUROSCI, V20, P313, DOI 10.1111/j.0953-816X.2004.03450.x; ROTH BJ, 1994, CRIT REV BIOMED ENG, V22, P253; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sloutsky VM, 2004, J EXP PSYCHOL GEN, V133, P166, DOI 10.1037/0096-3445.133.2.166; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stone DB, 2009, NEUROREPORT, V20, P1115, DOI 10.1097/WNR.0b013e32832e9aa2; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Touge T, 2001, CLIN NEUROPHYSIOL, V112, P2138, DOI 10.1016/S1388-2457(01)00651-4; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vandermeeren Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-38; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Walsh V, 2003, BRADFORD BOOKS, P1; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; You DS, 2011, BRAIN LANG, V119, P1, DOI 10.1016/j.bandl.2011.05.002; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	63	55	59	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84338	10.1371/journal.pone.0084338	http://dx.doi.org/10.1371/journal.pone.0084338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409291	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500015
J	Takeuchi, H; Taki, Y; Sassa, Y; Hashizume, H; Sekiguchi, A; Fukushima, A; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta			Regional Gray Matter Volume Is Associated with Empathizing and Systemizing in Young Adults	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HIGH-FUNCTIONING AUTISM; MIRROR-NEURON SYSTEM; SPECTRUM QUOTIENT AQ; ASPERGER-SYNDROME; WHITE-MATTER; HUMAN BRAIN; INTERINDIVIDUAL DIFFERENCES; EMOTIONAL INTELLIGENCE; INDIVIDUAL-DIFFERENCES	Empathizing is defined as the drive to identify the mental states of others for predicting their behavior and responding with an appropriate emotion. Systemizing is defined as the drive to analyze a system in terms of the rules that govern the system in order to predict its behavior. Using voxel-based morphometry and questionnaires in a large sample of normal, right-handed young adults, we investigated the regional gray matter volume (rGMV) correlates of empathizing and systemizing and additionally those of the D score, which is the difference between systemizing and empathizing, to reveal the comprehensive picture of those correlates. Negative rGMV correlates of empathizing and positive rGMV correlates of the D score (formed by the negative correlation between rGMV and empathizing), were found primarily in nodes in the default mode network, mirror neuron system, dorsal anterior cingulate cortex, and the lateral part of the prefrontal cortex together with other areas. Positive rGMV correlates of systemizing and of the D score (formed by the positive correlation between rGMV and systemizing) were found primarily in nodes in the external attention system, middle cingulate cortex, and other regions. Negative rGMV correlates of systemizing were found in an area close to the left posterior insula and putamen. These findings reconcile some previously inconsistent findings, provide other new findings and suggest that these areas contribute to empathizing-systemizing. Furthermore, the negative/positive rGMV correlates of empathizing and positive/negative rGMV correlates of systemizing overlapped substantially. This may be in line with the notion that empathizing and systemizing compete neurally in the brain.	[Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	JST/RISTEX, JST/CREST	JST/RISTEX, JST/CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST/RISTEX, JST/CREST (no particular numbers exist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambery FZ, 2006, AUTISM, V10, P551, DOI 10.1177/1362361306068507; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrew J, 2008, PERS INDIV DIFFER, V44, P1203, DOI 10.1016/j.paid.2007.11.014; [Anonymous], 2001, Z DIFFERENTIELLE DIA, DOI [10.1024//0170-1789.22.1.70, DOI 10.1024//0170-1789.22.1.70]; Antonova E, 2005, BIOL PSYCHIAT, V58, P457, DOI 10.1016/j.biopsych.2005.04.036; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Banissy MJ, 2012, NEUROIMAGE; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2007, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Billington J, 2008, NEUROPSYCHOLOGIA, V46, P511, DOI 10.1016/j.neuropsychologia.2007.09.003; Billington J, 2007, LEARN INDIVID DIFFER, V17, P260, DOI 10.1016/j.lindif.2007.02.004; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlson JM, 2012, NEUROIMAGE, V59, P1713, DOI 10.1016/j.neuroimage.2011.09.040; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa P.T., 1992, PSYCHOL ASSESSMENT R, V396; Davis M. H., 1980, JCAS CAT SEL DOC PSY, V75, P989; DeGutis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058253; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Duerden EG, 2012, AUTISM RES, V5, P49, DOI 10.1002/aur.235; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Egner T, 2011, NAT NEUROSCI, V14, P1219, DOI 10.1038/nn.2932; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Focquaert F, 2007, PERS INDIV DIFFER, V43, P619, DOI 10.1016/j.paid.2007.01.004; Fornito A, 2008, BIOL PSYCHIAT, V64, P758, DOI 10.1016/j.biopsych.2008.05.032; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gaser C., 2007, VBM TOOLBOX SPM2 VBM; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kanai R, 2012, CURR BIOL, V22, P1975, DOI 10.1016/j.cub.2012.08.045; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Krill AL, 2008, PERS INDIV DIFFER, V45, P684, DOI 10.1016/j.paid.2008.07.016; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lai MC, 2012, NEUROIMAGE, V61, P1347, DOI 10.1016/j.neuroimage.2012.03.018; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Liu MJ, 2011, RES AUTISM SPECT DIS, V5, P294, DOI 10.1016/j.rasd.2010.04.011; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Montgomery JM, 2010, EDUC TRAIN AUTISM DE, V45, P566; Mutschler I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00177; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Nettle D, 2006, PERS INDIV DIFFER, V40, P375, DOI 10.1016/j.paid.2005.07.008; Nettle D, 2007, BRIT J PSYCHOL, V98, P237, DOI 10.1348/000712606X117612; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Olson IR, 2006, BRAIN COGNITION, V60, P262, DOI 10.1016/j.bandc.2005.11.010; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paulus MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010096; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Penton-Voak IS, 2007, PERS INDIV DIFFER, V43, P2229, DOI 10.1016/j.paid.2007.07.004; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rameson L.T., 2011, J COGNITIVE NEUROSCI, V8, P1; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Raven J.C., 1998, ADV PROGR MATRICES; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rizzolatti G, 2005, RES PER NEUROSCI, P107, DOI 10.1007/3-540-29803-7_9; Sassa Y, 2012, NEUROIMAGE, V60, P2035, DOI 10.1016/j.neuroimage.2012.02.021; Schultheiss OC, 2008, SOC COGN AFFECT NEUR, V3, P333, DOI 10.1093/scan/nsn030; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Singer T, 2005, NAT NEUROSCI, V8, P845, DOI 10.1038/nn0705-845; Sinzig Judith, 2008, Child Adolesc Psychiatry Ment Health, V2, P4, DOI 10.1186/1753-2000-2-4; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stileman E, 2007, THESIS U EDINBURGH E; Strayer J, 2004, SOC DEV, V13, P1, DOI 10.1111/j.1467-9507.2004.00254.x; Takeuchi H, 2012, HUMAN BRAIN MAPPING; Takeuchi H, 2013, HUMAN BRAIN MAPPING; Takeuchi H, 2012, BRAIN STRUCTURE FUNC; Takeuchi H, 2013, BRAIN STRUCT FUNCT, V218, P1017, DOI 10.1007/s00429-012-0444-z; Takeuchi H, 2013, NEUROIMAGE, V77, P222, DOI 10.1016/j.neuroimage.2013.04.004; Takeuchi H, 2013, CORTEX, V49, P1148, DOI 10.1016/j.cortex.2013.01.014; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Tazaki M, 2007, REVISED MANUAL WHO Q, V26; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P1823, DOI 10.1007/s10803-006-0316-6; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wakabayashi Akio, 2006, Shinrigaku Kenkyu, V77, P271; Wallace GL, 2012, J NEUROSCI, V32, P4856, DOI 10.1523/JNEUROSCI.6214-11.2012; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wray S, 2007, P PPIG 19 ANN WORKSH; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556; Zhou YA, 2010, COGN NEURODYNAMICS, V4, P275, DOI 10.1007/s11571-010-9126-9; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	129	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84782	10.1371/journal.pone.0084782	http://dx.doi.org/10.1371/journal.pone.0084782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409308	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500032
J	Brugnano, JL; Panitch, A				Brugnano, Jamie L.; Panitch, Alyssa			Matrix Stiffness Affects Endocytic Uptake of MK2-Inhibitor Peptides	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; CELL-ADHESION; SUBSTRATE; INHIBITION; MECHANISM; MORPHOLOGY; MIGRATION; HYDROGELS	In this study, the role of substrate stiffness on the endocytic uptake of a cell-penetrating peptide was investigated. The cell-penetrating peptide, an inhibitor of mitogen-activated protein kinase activated protein kinase II (MK2), enters a primary mesothelial cell line predominantly through caveolae. Using tissue culture polystyrene and polyacrylamide gels of varying stiffness for cell culture, and flow cytometry quantification and enzyme-linked immunoassays (ELISA) for uptake assays, we showed that the amount of uptake of the peptide is increased on soft substrates. Further, peptide uptake per cell increased at lower cell density. The improved uptake seen on soft substrates in vitro better correlates with in vivo functional studies where 10-100 mM concentrations of the MK2 inhibitor cell penetrating peptide demonstrated functional activity in several disease models. Additional characterization showed actin polymerization did not affect uptake, while microtubule polymerization had a profound effect on uptake. This work demonstrates that cell culture substrate stiffness can play a role in endocytic uptake, and may be an important consideration to improve correlations between in vitro and in vivo drug efficacy.	[Brugnano, Jamie L.; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Panitch, A (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	apanitch@purdue.edu			National Institutes of Health [R01HL106792]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health grant R01HL106792. JLB was support by an National Science Foundation graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugnano J, 2013, J PEPT SCI, V19, P629, DOI 10.1002/psc.2541; Brugnano JL, 2011, J CONTROL RELEASE, V155, P128, DOI 10.1016/j.jconrel.2011.05.007; Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r; Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kavalukas SL, 2009, J AM COLL SURGEONS, V209, pS17, DOI 10.1016/j.jamcollsurg.2009.06.028; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g; Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o; Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605; Liu AP, 2009, BIOPHYS J, V97, P1038, DOI 10.1016/j.bpj.2009.06.003; Maheshwari G, 2000, J CELL SCI, V113, P1677; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Muto A, 2012, VASC PHARMACOL, V56, P47, DOI 10.1016/j.vph.2011.07.008; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vittal R, 2013, AM J RESP CELL MOL, V49, P47, DOI 10.1165/rcmb.2012-0389OC; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Ward BC, 2011, J SURG RES, V169, pE27, DOI 10.1016/j.jss.2011.01.043; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	44	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84821	10.1371/journal.pone.0084821	http://dx.doi.org/10.1371/journal.pone.0084821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400117	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700051
J	Li, B; Chen, SB; Li, PC; Luo, QM; Gong, H				Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui			Refractory Period Modulates the Spatiotemporal Evolution of Cortical Spreading Depression: A Computational Study	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNAL; EXTRACELLULAR GLUTAMATE; PROPAGATION VELOCITY; IN-VIVO; WAVES; MODEL; MIGRAINE; BRAIN	Cortical spreading depression (CSD) is a pathophysiological phenomenon, which underlies some neurological disorders, such as migraine and stroke, but its mechanisms are still not completely understood. One of the striking facts is that the spatiotemporal evolution of CSD wave is varying. Observations in experiments reveal that a CSD wave may propagate through the entire cortex, or just bypass some areas of the cortex. In this paper, we have applied a 2D reaction-diffusion equation with recovery term to study the spatiotemporal evolution of CSD. By modulating the recovery rate from CSD in the modeled cortex, CSD waves with different spatiotemporal evolutions, either bypassing some areas or propagating slowly in these areas, were present. Moreover, spiral CSD waves could also be induced in case of the transiently altered recovery rate, i.e. block release from the absolute refractory period. These results suggest that the refractory period contributes to the different propagation patterns of CSD, which may help to interpret the mechanisms of CSD propagation.	[Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, SB (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	sbchen@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311; Li, Bing/0000-0001-8949-733X	National Natural Science Foundation of China [61371014]; National High-Tech Research and Development Program of China (863 Program) [2012AA020401]; Fundamental Research Funds for the Central Universities [HUST: 2013TS038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 61371014), the National High-Tech Research and Development Program of China (863 Program: 2012AA020401), and the Fundamental Research Funds for the Central Universities, HUST: 2013TS038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Bennett MR, 2008, BIOPHYS J, V95, P5648, DOI 10.1529/biophysj.108.137190; Brand S, 1998, N-S ARCH PHARMACOL, V357, P419, DOI 10.1007/PL00005188; Buchheim K, 2002, EXP NEUROL, V175, P76, DOI 10.1006/exnr.2002.7893; Chang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070469; Chapuisat G, 2008, PROG BIOPHYS MOL BIO, V97, P4, DOI 10.1016/j.pbiomolbio.2007.10.004; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Chen SB, 2007, P SPIE, V6445; Chen SB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203654; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Dahlem YA, 2005, BRAIN RES, V1049, P15, DOI 10.1016/j.brainres.2005.04.059; Dronne MA, 2009, MATH COMPUT MODEL, V49, P2138, DOI 10.1016/j.mcm.2008.07.024; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; GARDNERMEDWIN AR, 1984, AN ACAD BRAS CIENC, V56, P423; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Grenier E, 2008, PROG BIOPHYS MOL BIO, V97, P54, DOI 10.1016/j.pbiomolbio.2007.10.002; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KOROLEVA V I, 1983, Neirofiziologiya, V15, P226; Koroleva V I, 2009, Neurosci Behav Physiol, V39, P87, DOI 10.1007/s11055-008-9096-0; Korolleva VI, 2007, ZH VYSSH NERV DEYAT+, V57, P729; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Kumagai T, 2011, J CEREBR BLOOD F MET, V31, P580, DOI 10.1038/jcbfm.2010.128; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Mayevsky A, 2011, J INNOV OPT HEAL SCI, V4, P337, DOI 10.1142/S1793545811001654; Miura RM, 2007, EUR PHYS J-SPEC TOP, V147, P287, DOI 10.1140/epjst/e2007-00214-8; Miura RM, 2013, SCIENCE, V23; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Obrenovitch TP, 1996, J CEREBR BLOOD F MET, V16, P923, DOI 10.1097/00004647-199609000-00016; REGGIA JA, 1994, J AM MED INFORM ASSN, P873; Revett K, 1998, J CEREBR BLOOD F MET, V18, P998, DOI 10.1097/00004647-199809000-00009; Shapiro BE, 2001, J COMPUT NEUROSCI, V10, P99, DOI 10.1023/A:1008924227961; SHIBATA M, 1975, J NEUROPHYSIOL, V38, P158, DOI 10.1152/jn.1975.38.1.158; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun XL, 2010, J INNOV OPT HEAL SCI, V3, P103, DOI 10.1142/S1793545810000915; Teixeira HZ, 2008, COMPUT BIOL CHEM, V32, P273, DOI 10.1016/j.compbiolchem.2008.03.011; Tuckwell HC, 2008, AIP CONF PROC, V1028, P46, DOI 10.1063/1.2965101; Weimer M, 2005, EXP BRAIN RES, V161, P201, DOI 10.1007/s00221-004-2060-5; Weimer MS, 2005, EXP BRAIN RES, V164, P185, DOI 10.1007/s00221-005-2241-x	48	0	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84609	10.1371/journal.pone.0084609	http://dx.doi.org/10.1371/journal.pone.0084609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400104	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700038
J	Sjoerds, Z; van den Brink, W; Beekman, ATF; Penninx, BWJH; Veltman, DJ				Sjoerds, Zsuzsika; van den Brink, Wim; Beekman, Aartjan T. F.; Penninx, Brenda W. J. H.; Veltman, Dick J.			Cue Reactivity Is Associated with Duration and Severity of Alcohol Dependence: An fMRI Study	PLOS ONE			English	Article							DORSAL STRIATUM; PSYCHOMETRIC PROPERTIES; INDIVIDUAL-DIFFERENCES; ABSTINENT ALCOHOLICS; VENTRAL STRIATUM; COCAINE-SEEKING; DRUG-ADDICTION; DOPAMINE; ANXIETY; ACTIVATION	Introduction: With the progression of substance dependence, drug cue-related brain activation is thought to shift from motivational towards habit pathways. However, a direct association between cue-induced brain activation and dependence duration has not yet been shown. We therefore examined the relationship between alcohol cue-reactivity in the brain, cue-induced subjective craving and alcohol dependence duration and severity. Since alcohol dependence is highly comorbid with depression/anxiety, which may modulate brain responses to alcohol cues, we also examined the relation between comorbid depression/anxiety and cue-reactivity. Methods: We compared 30 alcohol dependent patients with 15 healthy controls and 15 depression/anxiety patients during a visual alcohol cue-reactivity task using functional magnetic resonance imaging blood oxygenated level-dependent responses and subjective craving as outcomes. Within the alcohol dependent group we correlated cue-reactivity with alcohol dependence severity and duration, with cue-induced craving and with depression/anxiety levels. Results: Alcohol dependent patients showed greater cue-reactivity in motivational brain pathways and stronger subjective craving than depression/anxiety patients and healthy controls. Depression/anxiety was not associated with cue-reactivity, but depression severity in alcohol dependent patients was positively associated with craving. Within alcohol dependence, longer duration of alcohol dependence was associated with stronger cue-related activation of the posterior putamen, a structure involved in habits, whereas higher alcohol dependence severity was associated with lower cue-reactivity in the anterior putamen, an area implicated in goal-directed behavior preceding habit formation. Conclusion: Cue-reactivity in alcohol dependence is not modulated by comorbid depression or anxiety. More importantly, the current data confirm the hypothesis of a ventral to dorsal striatal shift of learning processes with longer dependence duration, which could underlie increasingly habitual substance use with progressing substance dependence.	[Sjoerds, Zsuzsika; Beekman, Aartjan T. F.; Penninx, Brenda W. J. H.; Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Sjoerds, Zsuzsika; van den Brink, Wim] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Sjoerds, Z (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sjoerds.zs@gmail.com	Sjoerds, Zsuzsika/E-9311-2012; Penninx, Brenda WJH/S-7627-2017	Sjoerds, Zsuzsika/0000-0001-9467-3772; Penninx, Brenda WJH/0000-0001-7779-9672	Netherlands Organization for Health Research and Development (Zon-Mw) [31160004]	Netherlands Organization for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development)	Funding for this study was provided by grant 31160004 from the Netherlands Organization for Health Research and Development (Zon-Mw), commissioned by the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; BABOR TF, 1989, ADDICT BEHAV, V14, P139, DOI 10.1016/0306-4603(89)90043-9; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Boschloo L, 2011, J AFFECT DISORDERS, V131, P233, DOI 10.1016/j.jad.2010.12.014; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Breese GR, 2011, PHARMACOL THERAPEUT, V129, P149, DOI 10.1016/j.pharmthera.2010.09.007; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ewing SWF, 2010, ALCOHOL CLIN EXP RES, V34, P396, DOI 10.1111/j.1530-0277.2009.01104.x; Fontenelle LF, 2011, DRUGS, V71, P827, DOI 10.2165/11591790-000000000-00000; FOX PT, 1994, SCIENCE, V266, P994, DOI 10.1126/science.7973682; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heilig M, 2010, NEUROSCI BIOBEHAV R, V35, P334, DOI 10.1016/j.neubiorev.2009.11.018; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Ito R, 2002, J NEUROSCI, V22, P6247; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Love A, 1998, ADDICTION, V93, P1091, DOI 10.1046/j.1360-0443.1998.937109113.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MONTI PM, 1987, J ABNORM PSYCHOL, V96, P122, DOI 10.1037/0021-843X.96.2.122; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Nielsen F.A., 2002, NEUROIMAGE, V16, P2; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sayette MA, 2000, ADDICTION, V95, pS189; Schacht JP, 2012, ADDICT BIOL; Sjoerds Z, 2013, TRANSLATION IN PRESS; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Tiffany ST, 1998, J PSYCHOPHARMACOL, V12, P23, DOI 10.1177/026988119801200104; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Strien J. W., 1992, NEDERLANDS TIJDSCHRI, V47, P88; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	51	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84560	10.1371/journal.pone.0084560	http://dx.doi.org/10.1371/journal.pone.0084560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400099	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700033
J	Ryan, C; Ross, S; Davey, P; Duncan, EM; Francis, JJ; Fielding, S; Johnston, M; Ker, J; Lee, AJ; MacLeod, MJ; Maxwell, S; McKay, GA; McLay, JS; Webb, DJ; Bond, C				Ryan, Cristin; Ross, Sarah; Davey, Peter; Duncan, Eilidh M.; Francis, Jill J.; Fielding, Shona; Johnston, Marie; Ker, Jean; Lee, Amanda Jane; MacLeod, Mary Joan; Maxwell, Simon; McKay, Gerard A.; McLay, James S.; Webb, David J.; Bond, Christine			Prevalence and Causes of Prescribing Errors: The PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) Study	PLOS ONE			English	Article							IN-HOSPITAL INPATIENTS; MEDICAL-STUDENTS; JUNIOR DOCTORS; INTERVENTIONS	Objectives: Study objectives were to investigate the prevalence and causes of prescribing errors amongst foundation doctors (i.e. junior doctors in their first (F1) or second (F2) year of post-graduate training), describe their knowledge and experience of prescribing errors, and explore their self-efficacy (i.e. confidence) in prescribing. Method: A three-part mixed-methods design was used, comprising: prospective observational study; semi-structured interviews and cross-sectional survey. All doctors prescribing in eight purposively selected hospitals in Scotland participated. All foundation doctors throughout Scotland participated in the survey. The number of prescribing errors per patient, doctor, ward and hospital, perceived causes of errors and a measure of doctors' self-efficacy were established. Results: 4710 patient charts and 44,726 prescribed medicines were reviewed. There were 3364 errors, affecting 1700 (36.1%) charts (overall error rate: 7.5%; F1: 7.4%; F2: 8.6%; consultants: 6.3%). Higher error rates were associated with : teaching hospitals (p<0.001), surgical (p =<0.001) or mixed wards (0.008) rather than medical ward, higher patient turnover wards (p<0.001), a greater number of prescribed medicines (p<0.001) and the months December and June (p<0.001). One hundred errors were discussed in 40 interviews. Error causation was multi-factorial; work environment and team factors were particularly noted. Of 548 completed questionnaires (national response rate of 35.4%), 508 (92.7% of respondents) reported errors, most of which (328 (64.6%) did not reach the patient. Pressure from other staff, workload and interruptions were cited as the main causes of errors. Foundation year 2 doctors reported greater confidence than year 1 doctors in deciding the most appropriate medication regimen. Conclusions: Prescribing errors are frequent and of complex causation. Foundation doctors made more errors than other doctors, but undertook the majority of prescribing, making them a key target for intervention. Contributing causes included work environment, team, task, individual and patient factors. Further work is needed to develop and assess interventions that address these.	[Ryan, Cristin] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Ross, Sarah; MacLeod, Mary Joan; McLay, James S.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Davey, Peter; Ker, Jean] Univ Dundee, Sch Med, Dundee, Scotland; [Duncan, Eilidh M.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Francis, Jill J.] City Univ London, Hlth Serv Res & Management Div, London EC1V 0HB, England; [Fielding, Shona; Lee, Amanda Jane] Univ Aberdeen, Med Stat Team, Aberdeen, Scotland; [Johnston, Marie] Univ Aberdeen, Aberdeen, Scotland; [Maxwell, Simon] Univ Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland; [McKay, Gerard A.] Glasgow Royal Infirm, Dept Clin Pharmacol, Glasgow G4 0SF, Lanark, Scotland; [Webb, David J.] Univ Edinburgh, Royal Infirm Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland; [Bond, Christine] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	Queens University Belfast; University of Aberdeen; University of Dundee; University of Aberdeen; City University London; University of Aberdeen; University of Aberdeen; University of Edinburgh; University of Glasgow; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen	Bond, C (corresponding author), Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland.	c.m.bond@abdn.ac.uk	Francis, Jill/AHE-6998-2022	Macleod, Mary Joan/0000-0003-2115-8184; Francis, Jill/0000-0001-5784-8895; Maxwell, Simon/0000-0002-3032-7237; Duncan, Eilidh/0000-0002-1009-9732; Ryan, Cristin/0000-0002-6037-4413	Scottish Chief Scientists Office; Chief Scientist Office [CZH/4/505, HSRU2] Funding Source: researchfish	Scottish Chief Scientists Office; Chief Scientist Office	This project was funded by the Scottish Chief Scientists Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DEV EVALUATING COMPL; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Bandura A., 1986, SOCIAL FDN THOUGHT A, DOI DOI 10.4135/9781446221129.N6; Coombes ID, 2008, MED J AUSTRALIA, V188, P89, DOI 10.5694/j.1326-5377.2008.tb01529.x; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; Dean B, 2000, QUAL HEALTH CARE, V9, P232, DOI 10.1136/qhc.9.4.232; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002; Marteau TM, 1989, PSYCHOL HEALTH, V3, P173; Mayo E, 1993, HUMAN PROBLEMS IND C, V3, P53; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Reason J., 1990, HUMAN ERROR; Ross S, 2012, POSTGRAD MED J, DOI [10.1136/postgradmedj-2011-130602, DOI 10.1136/P0STGRADMEDJ-2011-130602]; Ross S, 2013, BMJ QUAL SAF, V22, P97, DOI 10.1136/bmjqs-2012-001175; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P662, DOI 10.1111/j.1365-2125.2009.03395.x; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P629, DOI 10.1111/j.1365-2125.2008.03330.x; Ryan C, 2013, BR J CLIN P IN PRESS; T Dornan, 2009, DEPTH INVESTIGATION; Tobaiqy M, 2007, BRIT J CLIN PHARMACO, V64, P363, DOI 10.1111/j.1365-2125.2007.02925.x; WYNNE G, 1987, BRIT MED J, V294, P1198, DOI 10.1136/bmj.294.6581.1198	23	104	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e79802	10.1371/journal.pone.0079802	http://dx.doi.org/10.1371/journal.pone.0079802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404122	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329460800001
J	Shakibaei, M; Buhrmann, C; Kraehe, P; Shayan, P; Lueders, C; Goel, A				Shakibaei, Mehdi; Buhrmann, Constanze; Kraehe, Patricia; Shayan, Parviz; Lueders, Cora; Goel, Ajay			Curcumin Chemosensitizes 5-Fluorouracil Resistant MMR-Deficient Human Colon Cancer Cells in High Density Cultures	PLOS ONE			English	Article							FACTOR-KAPPA-B; MISMATCH REPAIR DEFICIENCY; STEM-CELLS; DNA METHYLATION; TUMOR-CELLS; INHIBITION; GROWTH; EXPRESSION; PROLIFERATION; INFLAMMATION	Objective: Treatment of colorectal cancer (CRC) remains a clinical challenge, as more than 15% of patients are resistant to 5-Fluorouracil (5-FU)-based chemotherapeutic regimens, and tumor recurrence rates can be as high as 50-60%. Cancer stem cells (CSC) are capable of surviving conventional chemotherapies that permits regeneration of original tumors. Therefore, we investigated the effectiveness of 5-FU and plant polyphenol (curcumin) in context of DNA mismatch repair (MMR) status and CSC activity in 3D cultures of CRC cells. Methods: High density 3D cultures of CRC cell lines HCT116, HCT116+ch3 (complemented with chromosome 3) and their corresponding isogenic 5-FU-chemo-resistant derivative clones (HCT116R, HCT116+ch3R) were treated with 5-FU either without or with curcumin in time-and dose-dependent assays. Results: Pre-treatment with curcumin significantly enhanced the effect of 5-FU on HCT116R and HCR116+ch3R cells, in contrast to 5-FU alone as evidenced by increased disintegration of colonospheres, enhanced apoptosis and by inhibiting their growth. Curcumin and/or 5-FU strongly affected MMR-deficient CRC cells in high density cultures, however MMR-proficient CRC cells were more sensitive. These effects of curcumin in enhancing chemosensitivity to 5-FU were further supported by its ability to effectively suppress CSC pools as evidenced by decreased number of CSC marker positive cells, highlighting the suitability of this 3D culture model for evaluating CSC marker expression in a close to vivo setting. Conclusion: Our results illustrate novel and previously unrecognized effects of curcumin in enhancing chemosensitization to 5-FU-based chemotherapy on DNA MMR-deficient and their chemo-resistant counterparts by targeting the CSC sub-population. (246 words in abstract).	[Shakibaei, Mehdi; Buhrmann, Constanze; Kraehe, Patricia] Univ Munich, Inst Anat, Munich, Germany; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran, Iran; [Lueders, Cora] German Heart Inst Berlin, Dept Thorac & Cardiovasc Surg, Lab Tissue Engn, Berlin, Germany; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	University of Munich; German Heart Center Berlin; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de; ajay.goel@baylorhealth.edu	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Goel, Ajay/0000-0003-1396-6341; Buhrmann, Constanze/0000-0002-0786-0463				Abdul Khalek Feras J, 2010, Gastrointest Cancer Res, pS16; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Chauhan DP, 2002, CURR PHARM DESIGN, V8, P1695, DOI 10.2174/1381612023394016; Chibaudel B, 2012, THER ADV MED ONCOL, V4, P75, DOI 10.1177/1758834011431592; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Du BY, 2006, CHEMOTHERAPY, V52, P23, DOI 10.1159/000090238; Duarte VM, 2010, MOL CANCER THER, V9, P2665, DOI 10.1158/1535-7163.MCT-10-0064; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fujita H, 2007, ONCOL REP, V18, P1129; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gonzalez-Vallinas M, 2013, PHARM RES; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollenbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021808; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Jiang ZH, 2010, MOL CANCER THER, V9, P558, DOI 10.1158/1535-7163.MCT-09-0627; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kanwar SS, 2011, PHARM RES-DORDR, V28, P827, DOI 10.1007/s11095-010-0336-y; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Majumdar APN, 2009, NUTR CANCER, V61, P544, DOI 10.1080/01635580902752262; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Sung MK, 2013, WORLD J GASTROENTERO, V19, P994, DOI 10.3748/wjg.v19.i7.994; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Vaish M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-26; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551	57	82	85	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85397	10.1371/journal.pone.0085397	http://dx.doi.org/10.1371/journal.pone.0085397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404205	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329460800084
J	Cerulo, L; Tagliaferri, D; Marotta, P; Zoppoli, P; Russo, F; Mazio, C; DeFelice, M; Ceccarelli, M; Falco, G				Cerulo, Luigi; Tagliaferri, Daniela; Marotta, Pina; Zoppoli, Pietro; Russo, Filomena; Mazio, Claudia; DeFelice, Mario; Ceccarelli, Michele; Falco, Geppino			Identification of a Novel Gene Signature of ES Cells Self-Renewal Fluctuation through System-Wide Analysis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENOMIC STABILITY; MOUSE; PLURIPOTENCY; ZSCAN4; PREIMPLANTATION; DIFFERENTIATION; EXPRESSION; POTENCY; ABSENCE	Embryonic Stem cells (ESCs) can be differentiated into ectoderm, endoderm, and mesoderm derivatives, producing the majority of cell types. In regular culture conditions, ESCs' self-renewal is maintained through molecules that inhibit spontaneous differentiation enabling long-term cellular expansion. This undifferentiating condition is characterized by multiple metastable states that fluctuate between self-renewal and differentiation balance. Here, we aim to characterize the high-pluripotent ESC metastate marked by the expression of Zscan4 through a supervised machine learning framework based on an ensemble of support vector machine (SVM) classifiers. Our study revealed a leukaemia inhibitor factor (Lif) dependent not-canonical pluripotency signature (AF067063, BC061212, Dub1, Eif1a, Gm12794, Gm13871, Gm4340, Gm4850, Tcstv1/3, and Zfp352), that specifically marks Zscan4 ESCs' fluctuation. This novel ESC metastate is enhanced by high-pluripotency culture conditions obtained through Extracellular signal Regulated-Kinase (ERK) and Glycogen synthase kinase-3 (Gsk-3) signaling inhibition (2i). Significantly, we reported that the conditional ablation of the novel ESC metastate marked by the expression of Gm12794 is required for ESCs self-renewal maintenance. In conclusion, we extend the comprehension of ESCs biology through the identification of a novel molecular signature associated to pluripotency programming.	[Cerulo, Luigi; Tagliaferri, Daniela; Marotta, Pina; Zoppoli, Pietro; Russo, Filomena; Mazio, Claudia; DeFelice, Mario; Ceccarelli, Michele; Falco, Geppino] Ist Ric Genet Gaetano Salvatore Biogem Scarl, Dept Stem Cell & Dev, Ariano Irpino, Italy; [Cerulo, Luigi; Tagliaferri, Daniela; Ceccarelli, Michele; Falco, Geppino] Univ Sannio, Dept Sci, Benevento, Italy; [DeFelice, Mario] Univ Naples Federico II, Dept Med Mol & Biotecnol Med, Naples, Italy	Italfarmaco; University of Sannio; University of Naples Federico II	Ceccarelli, M (corresponding author), Ist Ric Genet Gaetano Salvatore Biogem Scarl, Dept Stem Cell & Dev, Ariano Irpino, Italy.	michele.ceccarelli@unisannio.it; gfalco@unisannio.it	Ceccarelli, Michele/AGP-1739-2022; Marotta, Pina e/K-5785-2018; Marotta, Pina/W-5262-2019; Zoppoli, Pietro/J-9954-2018	Marotta, Pina e/0000-0001-6857-8325; Marotta, Pina/0000-0001-6857-8325; Zoppoli, Pietro/0000-0002-7860-9655; falco, geppino/0000-0001-6193-7233; Ceccarelli, Michele/0000-0002-4702-6617; Mazio, Claudia/0000-0002-6432-4907	European International Reintegration Grant [239519]; Basic research investment fund [RBFR10XCD3_002]; IRGS Biogem Institute	European International Reintegration Grant; Basic research investment fund; IRGS Biogem Institute	The study was funded by European International Reintegration Grant (number 239519), by Basic research investment fund (number RBFR10XCD3_002), and by IRGS Biogem Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Forrai A, 2006, STEM CELLS, V24, P604, DOI 10.1634/stemcells.2005-0323; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Liu TYC, 2003, MOL REPROD DEV, V64, P52, DOI 10.1002/mrd.10218; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Scheubert L, 2011, DNA RES, V18, P233, DOI 10.1093/dnares/dsr016; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Treff NR, 2006, STEM CELLS, V24, P2529, DOI 10.1634/stemcells.2006-0082; Vapnik V., 1998, STAT LEARNING THEORY; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83235	10.1371/journal.pone.0083235	http://dx.doi.org/10.1371/journal.pone.0083235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392082	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100006
J	Hu, XL; Zhang, JW; Li, JM; Zhang, B				Hu, Xiaolin; Zhang, Jianwei; Li, Jianmin; Zhang, Bo			Sparsity-Regularized HMAX for Visual Recognition	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; OBJECT RECOGNITION; NEURONS; REPRESENTATION; ARCHITECTURE; EMERGENCE; FEATURES; STRIATE; SHIFT; MODEL	About ten years ago, HMAX was proposed as a simple and biologically feasible model for object recognition, based on how the visual cortex processes information. However, the model does not encompass sparse firing, which is a hallmark of neurons at all stages of the visual pathway. The current paper presents an improved model, called sparse HMAX, which integrates sparse firing. This model is able to learn higher-level features of objects on unlabeled training images. Unlike most other deep learning models that explicitly address global structure of images in every layer, sparse HMAX addresses local to global structure gradually along the hierarchy by applying patch-based learning to the output of the previous layer. As a consequence, the learning method can be standard sparse coding (SSC) or independent component analysis (ICA), two techniques deeply rooted in neuroscience. What makes SSC and ICA applicable at higher levels is the introduction of linear higher-order statistical regularities by max pooling. After training, high-level units display sparse, invariant selectivity for particular individuals or for image categories like those observed in human inferior temporal cortex (ITC) and medial temporal lobe (MTL). Finally, on an image classification benchmark, sparse HMAX outperforms the original HMAX by a large margin, suggesting its great potential for computer vision.	[Hu, Xiaolin; Li, Jianmin; Zhang, Bo] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China; [Hu, Xiaolin; Li, Jianmin; Zhang, Bo] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China; [Zhang, Jianwei] Univ Hamburg, Dept Informat, Hamburg, Germany	Tsinghua University; Tsinghua University; University of Hamburg	Hu, XL (corresponding author), Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China.	xlhu@tsinghua.edu.cn	Hu, Xiaolin/K-2443-2013; Tong, Raymond Kai-yu/C-3546-2009	Tong, Raymond Kai-yu/0000-0003-4375-653X	National Basic Research Program (973 Program) of China [2013CB329403, 2012CB316301]; National Natural Science Foundation of China [61273023]; Beijing Natural Science Foundation [4132046]; Tsinghua University Initiative Scientific Research Program [20121088071]; Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Tsinghua University Initiative Scientific Research Program; Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS	This work was supported by the National Basic Research Program (973 Program) of China (Grant Nos. 2013CB329403 and 2012CB316301), the National Natural Science Foundation of China (Grant No. 61273023), the Beijing Natural Science Foundation (Grant No. 4132046), the Tsinghua University Initiative Scientific Research Program (Grant No. 20121088071), and the Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carlson ET, 2011, CURR BIOL, V21, P288, DOI 10.1016/j.cub.2011.01.013; Coates A., 2012, NIPS, V25, P2690; Dayan P., 2001, THEORETICAL NEUROSCI; DESIMONE R, 1984, J NEUROSCI, V4, P2051; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gutmann MU, 2013, 3 LAYER MODEL NATURA; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hyvarinen A, 2000, NEURAL COMPUT, V12, P1705, DOI 10.1162/089976600300015312; Hyvarinen A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-12; Hyvarinen A, 1998, SIGNAL PROCESS, V64, P301, DOI 10.1016/S0165-1684(97)00197-7; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; Kavukcuoglu K., 2010, ADV NEURAL INFORM PR, P1090; Knoblich U, 2007, BIOPHYSICAL MODELS N; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Le Q, 2012, P 29 INT C MACH LEAR, P81, DOI DOI 10.1109/MSP.2011.940881; Lee H., 2006, ADV NEURAL INFORM PR, P801, DOI DOI 10.1371/J0URNAL.P0NE.0006098; Lee H., 2009, P ANN INT C MACH LEA, P609; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mairal J., 2009, P 26 INT C MACH LEAR; MUTCH J., 2006, P IEEE C COMP VIS PA; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ranzato M., 2007, ADV NEURAL INFORM PR, V19, P1137, DOI DOI 10.7551/mitpress/7503.003.0147; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Serre T, 2005, PROC CVPR IEEE, P994; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shan H., 2006, ADV NEURAL INFORM PR, V19, P1273; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493; Willmore BDB, 2011, J NEUROPHYSIOL, V105, P2907, DOI 10.1152/jn.00594.2010; Yan KL, 2005, NEURAL COMPUT, V17, P397, DOI 10.1162/0899766053011474; Yang J., 2009, P IEEE C COMP VIS PA; Yu K., 2011, P IEEE C COMP VIS PA; Zeiler M. D., 2010, P IEEE C COMP VIS PA; Zeiler M. D., 2011, P INT C COMP VIS; Zou W., 2012, ADV NEURAL INFORM PR, P3203	46	41	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e81813	10.1371/journal.pone.0081813	http://dx.doi.org/10.1371/journal.pone.0081813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392078	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100002
J	He, LL; Parikh, NA				He, Lili; Parikh, Nehal A.			Atlas-Guided Quantification of White Matter Signal Abnormalities on Term-Equivalent Age MRI in Very Preterm Infants: Findings Predict Language and Cognitive Development at Two Years of Age	PLOS ONE			English	Article							HUMAN BRAIN; PROBABILISTIC ATLAS; NEURODEVELOPMENTAL OUTCOMES; SPATIOTEMPORAL ATLAS; CHILDREN; SEGMENTATION; INTENSITY; IMAGES; BIRTH; CONSTRUCTION	The developmental significance of the frequently encountered white matter signal abnormality (WMSA) findings on MRI around term-equivalent age (TEA) in very preterm infants, remains in question. The use of conventional qualitative analysis methods is subjective, lacks sufficient reliability for producing accurate and reproducible WMSA diagnosis, and possibly contributes to suboptimal neurodevelopmental outcome prediction. The advantages of quantitative over qualitative diagnostic approaches have been widely acknowledged and demonstrated. The purpose of this study is to objectively and accurately quantify WMSA on TEA T2-weighted MRI in very preterm infants and to assess whether such quantifications predict 2-year language and cognitive developmental outcomes. To this end, we constructed a probabilistic brain atlas, exclusively for very preterm infants to embed tissue distributions (i.e. to encode shapes, locations and geometrical proportion of anatomical structures). Guided with this atlas, we then developed a fully automated method for WMSA detection and quantification using T2-weighted images. Computer simulations and experiments using in vivo very preterm data showed very high detection accuracy. WMSA volume, particularly in the centrum semiovale, on TEA MRI was a significant predictor of standardized language and cognitive scores at 2 years of age. Independent validation of our automated WMSA detection algorithm and school age follow-up are important next steps.	[He, Lili; Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	He, LL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA.	Lili.He@NationwideChildrens.org; Nehal.Parikh@NationwideChildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development [UL1 RR024148-04S3]; Research Institute at Nationwide Children's Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development; Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development grant UL1 RR024148-04S3 (Best Pharmaceuticals for Children Act) and The Research Institute at Nationwide Children's Hospital (to NAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrman RE, 2007, PRETERM BIRTH CAUSES, P346; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Brickman AM, 2011, PSYCHIAT RES-NEUROIM, V193, P101, DOI 10.1016/j.pscychresns.2011.03.007; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Counsell SJ, 2002, PEDIATR RES, V51, p438A; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hagmann CF, 2009, RADIOLOGY, V252, P209, DOI 10.1148/radiol.2522080589; Hart A, 2011, PEDIATR RADIOL, V41, P1284, DOI 10.1007/s00247-011-2155-7; Hart AR, 2010, PEDIATR RADIOL, V40, P1390, DOI 10.1007/s00247-010-1633-7; He LL, 2013, NEUROIMAGE, V64, P328, DOI 10.1016/j.neuroimage.2012.08.081; Hernandez M, 2008, WORKSH MATH FDN COMP, P24; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jeon TY, 2012, RADIOLOGY, V263, P518, DOI 10.1148/radiol.12111615; Judas M, 2005, AM J NEURORADIOL, V26, P2671; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kostovic I, 2002, CEREB CORTEX, V12, P536, DOI 10.1093/cercor/12.5.536; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Pogribna U, AJNR AM J NEURORADIO; Potharst ES, 2011, J PEDIATR-US, V159, P79, DOI 10.1016/j.jpeds.2010.12.055; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Shi F, 2009, P SOC PHOTO-OPT INST, V1, P7259; Shi F, 2010, LECT NOTES COMPUT SC, V6326, P42; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874	49	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85475	10.1371/journal.pone.0085475	http://dx.doi.org/10.1371/journal.pone.0085475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392012	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900156
J	Park, JT; Leach, SD				Park, Joon Tae; Leach, Steven D.			TAILOR: Transgene Activation and Inactivation Using Lox and Rox in Zebrafish	PLOS ONE			English	Article							SITE-DIRECTED RECOMBINATION; GENE-EXPRESSION; CRE; SYSTEM; CELLS; TRAP; STRATEGIES; EMBRYOS; MODEL; LINES	The ability to achieve precisely tailored activation and inactivation of gene expression represents a critical utility for vertebrate model organisms. In this regard, Cre and other site-specific DNA recombinases have come to play a central role in achieving temporally regulated and cell type-specific genetic manipulation. In zebrafish, both Cre and Flp recombinases have been applied for inducible activation, inactivation and inversion of inserted genomic elements. Here we describe the addition of Dre, a heterospecific Cre-related site-specific recombinase, to the zebrafish genomic toolbox. Combining Dre-based recombination in zebrafish with established Cre/lox technology, we have established an effective strategy for transgene activation and inactivation using lox and rox (TAILOR). Using stable transgenic lines expressing tamoxifen-inducible CreER(T2) and RU486-inducible DrePR fusions, we demonstrate that Cre and Dre retain non-overlapping specificities for their respective lox and rox target sites in larval zebrafish, and that their combinatorial and sequential activation can achieve precisely timed transgene activation and inactivation. In addition to TAILOR, the successful application of Dre/rox technology in zebrafish will facilitate a variety of additional downstream genetic applications, including sequential lineage labeling, complex genomic rearrangements and the precise temporal and spatial control of gene expression through the intersection of partially overlapping promoter activities.	[Park, Joon Tae; Leach, Steven D.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [Leach, Steven D.] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Leach, SD (corresponding author), Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA.	stleach@jhmi.edu			NIH [DK56211, HD058530]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK56211 and HD058530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2000, EXP CELL RES, V256, P282, DOI 10.1006/excr.2000.4805; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Collins RT, 2010, NAT METHODS, V7, P219, DOI [10.1038/NMETH.1423, 10.1038/nmeth.1423]; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Hirsch MR, 2013, GENESIS; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jie D, 2004, METHOD CELL BIOL, V77, P363; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Liu WY, 2007, MAR BIOTECHNOL, V9, P420, DOI 10.1007/s10126-007-9000-x; Maddison LA, 2011, METHOD CELL BIOL, V104, P3, DOI 10.1016/B978-0-12-374814-0.00001-X; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Pan XF, 2005, TRANSGENIC RES, V14, P217, DOI 10.1007/s11248-004-5790-z; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Seok SH, 2010, CANCER SCI, V101, P149, DOI 10.1111/j.1349-7006.2009.01393.x; Sinha DK, 2010, ZEBRAFISH, V7, P199, DOI 10.1089/zeb.2009.0632; Speck NA, 2009, BLOOD CELL MOL DIS, V43, P6, DOI 10.1016/j.bcmd.2009.01.010; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Wong AC, 2011, TRANSGENIC RES, V20, P409, DOI 10.1007/s11248-010-9410-9; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	35	17	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85218	10.1371/journal.pone.0085218	http://dx.doi.org/10.1371/journal.pone.0085218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391998	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900141
J	Feher, K; Lisec, J; Romisch-Margl, L; Selbig, J; Gierl, A; Piepho, HP; Nikoloski, Z; Willmitzer, L				Feher, Kristen; Lisec, Jan; Roemisch-Margl, Lilla; Selbig, Joachim; Gierl, Alfons; Piepho, Hans-Peter; Nikoloski, Zoran; Willmitzer, Lothar			Deducing Hybrid Performance from Parental Metabolic Profiles of Young Primary Roots of Maize by Using a Multivariate Diallel Approach	PLOS ONE			English	Article							VECTOR MACHINE REGRESSION; GENE-EXPRESSION; PREDICTION; HETEROSIS; CROSSES	Heterosis, the greater vigor of hybrids compared to their parents, has been exploited in maize breeding for more than 100 years to produce ever better performing elite hybrids of increased yield. Despite extensive research, the underlying mechanisms shaping the extent of heterosis are not well understood, rendering the process of selecting an optimal set of parental lines tedious. This study is based on a dataset consisting of 112 metabolite levels in young roots of four parental maize inbred lines and their corresponding twelve hybrids, along with the roots' biomass as a heterotic trait. Because the parental biomass is a poor predictor for hybrid biomass, we established a model framework to deduce the biomass of the hybrid from metabolite profiles of its parental lines. In the proposed framework, the hybrid metabolite levels are expressed relative to the parental levels by incorporating the standard concept of additivity/dominance, which we name the Combined Relative Level (CRL). Our modeling strategy includes a feature selection step on the parental levels which are demonstrated to be predictive of CRL across many hybrid metabolites. We demonstrate that these selected parental metabolites are further predictive of hybrid biomass. Our approach directly employs the diallel structure in a multivariate fashion, whereby we attempt to not only predict macroscopic phenotype (biomass), but also molecular phenotype (metabolite profiles). Therefore, our study provides the first steps for further investigations of the genetic determinants to metabolism and, ultimately, growth. Finally, our success on the small-scale experiments implies a valid strategy for large-scale experiments, where parental metabolite profiles may be used together with profiles of selected hybrids as a training set to predict biomass of all possible hybrids.	[Feher, Kristen; Lisec, Jan; Selbig, Joachim; Nikoloski, Zoran; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Feher, Kristen; Selbig, Joachim] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Roemisch-Margl, Lilla; Gierl, Alfons] Tech Univ Munich, Dept Plants Genet, Freising Weihenstephan, Germany; [Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Stuttgart, Germany	Max Planck Society; University of Potsdam; Technical University of Munich; University Hohenheim	Lisec, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	Lisec@mpimp-golm.mpg.de		Lisec, Jan/0000-0003-1220-2286; Piepho, Hans-Peter/0000-0001-7813-2992; Nikoloski, Zoran/0000-0003-2671-6763	Deutsche Forschungsgemeinschaft (DFG) [SPP 1149]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (DFG) grant "Heterosis in plants" (SPP 1149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmuller E, 2005, BIOINFORMATICS, V21, P1635, DOI DOI 10.1093/BI0INF0RMATICS/BTI236; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Boulesteix A.-L., 2004, STAT APPL GENET MOL, V3, P1075, DOI DOI 10.2202/1544-6115.1075; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cilas C, 1998, EUPHYTICA, V104, P49, DOI 10.1023/A:1018635216182; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Duvick DN, 2005, MAYDICA, V50, P193; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Fu JJ, 2012, THEOR APPL GENET, V124, P825, DOI 10.1007/s00122-011-1747-9; Gartner T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005220; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Hoecker N, 2008, GENETICS, V179, P1275, DOI 10.1534/genetics.108.088278; Lenarcic AB, 2012, GENETICS, V190, P413, DOI 10.1534/genetics.111.132563; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; Maenhout S, 2007, THEOR APPL GENET, V115, P1003, DOI 10.1007/s00122-007-0627-9; MCWILLIAM JR, 1965, AUST J BIOL SCI, V18, P569, DOI 10.1071/BI9650569; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mohring J, 2011, CROP SCI, V51, P470, DOI 10.2135/cropsci2010.05.0272; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schrag TA, 2009, MAYDICA, V54, P353; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Shull, 1914, Z INDUKT ABSTAMMUNGS, V12, P97, DOI DOI 10.1007/BF01837282; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steinfath M, 2010, THEOR APPL GENET, V120, P239, DOI 10.1007/s00122-009-1191-2; Sulpice R, 2010, PLANT CELL, V22, P2872, DOI 10.1105/tpc.110.076653; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Vuylsteke M, 2000, HEREDITY, V85, P208, DOI 10.1046/j.1365-2540.2000.00747.x; Yang WZ, 2012, GENETICS, V190, P1491, DOI 10.1534/genetics.111.131540; ZANONI U, 1989, CROP SCI, V29, P577, DOI 10.2135/cropsci1989.0011183X002900030005x	41	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85435	10.1371/journal.pone.0085435	http://dx.doi.org/10.1371/journal.pone.0085435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409329	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500053
J	Koci, J; Ramaseshadri, P; Bolognesi, R; Segers, G; Flannagan, R; Park, Y				Koci, Juraj; Ramaseshadri, Parthasarathy; Bolognesi, Renata; Segers, Gerrit; Flannagan, Ronald; Park, Yoonseong			Ultrastructural Changes Caused by Snf7 RNAi in Larval Enterocytes of Western Corn Rootworm (Diabrotica virgifera virgifera Le Conte)	PLOS ONE			English	Article							BETA-GALACTOSIDASE; ESCRT-II; MACHINERY; AUTOPHAGY; TRANSPORT	The high sensitivity to oral RNA interference (RNAi) of western corn rootworm (WCR, Diabrotica virgifera virgifera Le Conte) provides a novel tool for pest control. Previous studies have shown that RNAi of DvSnf7, an essential cellular component of endosomal sorting complex required for transport (ESCRT), caused deficiencies in protein de-ubiquitination and autophagy, leading to WCR death. Here we investigated the detailed mechanism leading to larval death by analyzing the ultrastructural changes in midgut enterocytes of WCR treated with double-stranded RNA (ds-DvSnf7). The progressive phases of pathological symptoms caused by DvSnf7-RNAi in enterocytes include: 1) the appearance of irregularly shaped macroautophagic complexes consisting of relatively large lysosomes and multi-lamellar bodies, indicative of failure in autolysosome formation; 2) cell sloughing and loss of apical microvilli, and eventually, 3) massive loss of cellular contents indicating loss of membrane integrity. These data suggest that the critical functions of Snf7 in insect midgut cells demonstrated by the ultrastructural changes in DvSnf7 larval enterocytes underlies the conserved essential function of the ESCRT pathway in autophagy and membrane stability in other organisms.	[Koci, Juraj; Park, Yoonseong] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Ramaseshadri, Parthasarathy; Bolognesi, Renata; Segers, Gerrit; Flannagan, Ronald] Monsanto Co, Dept Biotechnol, Chesterfield, MO USA	Kansas State University; Monsanto	Park, Y (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ypark@ksu.edu	Koči, Juraj/C-3754-2014; Park, Yoonseong/J-5861-2013	Koči, Juraj/0000-0002-5560-806X; Park, Yoonseong/0000-0003-1191-7335	Monsanto Company	Monsanto Company	The scientists in Monsanto Company, the funder, were involved in study design, decision to publish, and preparation of the manuscript.	ALLEGRANZA A, 1989, CLIN NEUROPATHOL, V8, P266; ALROY J, 1985, SCIENCE, V229, P470, DOI 10.1126/science.3925555; Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; AMANO N, 1983, ACTA NEUROPATHOL, V61, P283, DOI 10.1007/BF00691999; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bachman PM, 2013, TRANSGENIC RES; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Capalbo L, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120070; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Segers G, 2010, IN VITRO CELL DEV-AN, V46, pS69; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wong ASL, 2011, BBA-MOL BASIS DIS, V1812, P1490, DOI 10.1016/j.bbadis.2011.07.005; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yu L, 2004, CELL CYCLE, V3, P1124	29	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83985	10.1371/journal.pone.0083985	http://dx.doi.org/10.1371/journal.pone.0083985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409288	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500012
J	Pinato, DJ; Stavraka, C; Flynn, MJ; Forster, MD; O'Cathail, SM; Seckl, MJ; Kristeleit, RS; Olmos, D; Turnbull, SJ; Blagden, SP				Pinato, David J.; Stavraka, Chara; Flynn, Michael J.; Forster, Martin D.; O'Cathail, Sean M.; Seckl, Michael J.; Kristeleit, Rebecca S.; Olmos, David; Turnbull, Samantha J.; Blagden, Sarah P.			An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; I TRIALS; SYSTEMIC INFLAMMATION; LYMPHOCYTE RATIO; SURVIVAL; PARTICIPANTS; EXPERIENCE; MORTALITY; CONTEXT; INDEX	Background: Adequate organ function and good performance status (PS) are common eligibility criteria for phase I trials. As inflammation is pathogenic and prognostic in cancer we investigated the prognostic performance of inflammation-based indices including the neutrophil (NLR) and platelet to lymphocyte ratio (PLR). Methods: We studied inflammatory scores in 118 unselected referrals. NLR normalization was recalculated at disease reassessment. Each variable was assessed for progression-free (PFS) and overall survival (OS) on uni- and multivariate analyses and tested for 90 days survival (90DS) prediction using receiving operator curves (ROC). Results: We included 118 patients with median OS 4.4 months, 23% PS>1. LDH >= 450 and NLR >= 5 were multivariate predictors of OS (p<0.001). NLR normalization predicted for longer OS (p<0.001) and PFS (p<0.05). PS and NLR ranked as most accurate predictors of both 90DS with area under ROC values of 0.66 and 0.64, and OS with c-score of 0.69 and 0.60. The combination of NLR+PS increased prognostic accuracy to 0.72. The NLR was externally validated in a cohort of 126 subjects. Conclusions: We identified the NLR as a validated and objective index to improve patient selection for experimental therapies, with its normalization following treatment predicting for a survival benefit of 7 months. Prospective validation of the NLR is warranted.	[Pinato, David J.; Stavraka, Chara] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Wellcome Trust McMichael Clin Res Facil, London, England; [Flynn, Michael J.; Forster, Martin D.; Kristeleit, Rebecca S.; Turnbull, Samantha J.; Blagden, Sarah P.] Univ Coll London Hosp, Univ Coll London Clin Res Facil, London, England; [O'Cathail, Sean M.; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England; [Olmos, David] Royal Marsden Hosp, Sutton, Surrey, England; [Olmos, David] Inst Canc Res, Sutton, Surrey, England	Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Blagden, SP (corresponding author), Univ Coll London Hosp, Univ Coll London Clin Res Facil, London, England.	s.blagden@imperial.ac.uk	Olmos, David/L-5664-2015; Blagden, Sarah Patricia/I-2096-2019; Pinato, David James/ABB-3719-2020; OCathail, Sean/GON-8094-2022; Stavraka, Chara/F-8385-2013	Pinato, David James/0000-0002-3529-0103; Olmos Hidalgo, David/0000-0002-7003-4826; O'Cathail, Sean Micheal/0000-0001-5574-9199; Stavraka, Chara/0000-0001-7623-299X	Wellcome Trust; Imperial Experimental Cancer Medicine Centre (ECMC); Cancer Research UK (CRUK); Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); Ovarian Cancer Action [OCA10] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial Experimental Cancer Medicine Centre (ECMC); Cancer Research UK (CRUK)(Cancer Research UK); Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); Ovarian Cancer Action(Ovarian Cancer Action)	This work has been in part supported by grants from the Wellcome Trust (http://www.wellcome.ac.uk/), Imperial Experimental Cancer Medicine Centre (ECMC, http://www.ecmcnetwork.org.uk/network-centres/london-imperial/), Cancer Research UK (CRUK, http://www.cancerresearchuk.org/home/) and the Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC, http://imperialbrc.org/our-research/research-themes/cancer). UCL members of staff have received support from ECMC and BRC (http://www.ecmcnetwork.org.uk/network-centres/london-ucl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8; Aliustaoglu M, 2010, HEPATO-GASTROENTEROL, V57, P640; Arkenau HT, 2008, BRIT J CANCER, V98, P1029, DOI 10.1038/sj.bjc.6604218; Arkenau HT, 2008, EUR J CANCER, V44, P1536, DOI 10.1016/j.ejca.2008.04.017; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Blagden SP, 2003, BRIT J CANCER, V89, P1022, DOI 10.1038/sj.bjc.6601231; Chau NG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-426; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Chua W, 2012, SUPPORT CARE CANCER, V20, P1869, DOI 10.1007/s00520-011-1289-3; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erdman SE, 2010, INT J CANCER, V127, P768, DOI 10.1002/ijc.25430; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; Harrell FE, 2010, RMS REGRESSION MODEL; Ho J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-263; Italiano A, 2008, ANN ONCOL, V19, P787, DOI 10.1093/annonc/mdm548; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Karavasilis V, 2008, EUR J CANCER, V44, P978, DOI 10.1016/j.ejca.2008.02.040; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Moore MM, 2010, CLIN PHARMACOL THER, V87, P504, DOI 10.1038/clpt.2009.254; Murry DJ, 1998, INT J CANCER, V78, P48; Olmos D, 2012, J CLIN ONCOL, V30, P996, DOI 10.1200/JCO.2010.34.5074; Olmos D, 2012, EUR J CANCER, V48, P594, DOI 10.1016/j.ejca.2011.11.004; Parulekar WR, 2004, JNCI-J NATL CANCER I, V96, P990, DOI 10.1093/jnci/djh182; Penel N, 2008, INVEST NEW DRUG, V26, P53, DOI 10.1007/s10637-007-9088-x; Penel N, 2010, INVEST NEW DRUG, V28, P76, DOI 10.1007/s10637-009-9224-x; Penel N, 2009, J CLIN ONCOL, V27, pE105, DOI 10.1200/JCO.2009.24.1810; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Ploquin A, 2012, CRIT REV ONCOL HEMAT; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Rivory LP, 2002, BRIT J CANCER, V87, P277, DOI 10.1038/sj.bjc.6600448; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Stavraka C, 2014, CANCER-AM CANCER SOC, V120, P262, DOI 10.1002/cncr.28381; Team RDC, 2010, R LANG ENV STAT COMP; Wheler J, 2009, CANCER, V115, P1091, DOI 10.1002/cncr.24018; Yamamoto N, 1999, INT J ONCOL, V15, P737	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83279	10.1371/journal.pone.0083279	http://dx.doi.org/10.1371/journal.pone.0083279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409281	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000329463500005
J	Ezkurdia, N; Raurell, I; Rodriguez, S; Gonzalez, A; Esteban, R; Genesca, J; Martell, M				Ezkurdia, Nahia; Raurell, Imma; Rodriguez, Sarai; Gonzalez, Antonio; Esteban, Rafael; Genesca, Joan; Martell, Maria			Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats	PLOS ONE			English	Article							HYPERDYNAMIC SPLANCHNIC CIRCULATION; SIGNALING PATHWAYS; GROWTH-FACTOR; NITRIC-OXIDE; CELL-DEATH; VASODILATION; ACTIVATION; CONTRIBUTE; CIRRHOSIS; SURVIVAL	Background and Aim: A neuronal pathway participates in the development of portal hypertension: blockade of afferent sensory nerves in portal vein ligated (PVL) rats simultaneously prevents brain cardiovascular regularory nuclei activation, neuromodulator overexpression in superior mesenteric ganglia, sympathetic atrophy of mesenteric innervation and hemodynamic alterations. Here we investigated in PVL rats alterations in neuromodulators and signaling pathways leading to axonal regression or apoptosis in the superior mesenteric ganglia and tested the effects of the stimulation of neuronal proliferation/survival by using a tyrosine kinase receptor A agonist, gambogic amide. Results: The neuronal pathway was confirmed by an increased neuronal afferent activity at the vagal nodose ganglia and the presence of semaphorin3A in sympathetic pre-ganglionic neurons at the intermediolateral nucleus of the spinal cord of PVL rats. Expression of the active form of tyrosine kinase receptor A (phosphorylated), leading to proliferation and survival signaling, showed a significant reduction in PVL comparing to sham rats. In contrast, the apoptotic and axonal retraction pathways were stimulated in PVL, demonstrated by a significant overexpression of semaphorin 3A and its receptor neuropilin1, together with increases of cleaved caspase7, inactive poly(ADP-ribose) polymerase and Rho kinase expression. Finally, the administration of gambogic amide in PVL rats showed an amelioration of hemodynamic alterations and sympathetic atrophy, through the activation of survival pathways together with the inhibition of apoptotic cascades and Rho kinase mediated axonal regression. Conclusion: The adrenergic alteration and sympathetic atrophy in mesenteric vessels during portal hypertension is caused by alterations on neuromodulation leading to post-ganglionic sympathetic regression and apoptosis and contributing to splanchnic vasodilation.	[Ezkurdia, Nahia; Raurell, Imma; Rodriguez, Sarai; Gonzalez, Antonio; Esteban, Rafael; Genesca, Joan; Martell, Maria] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, VHIR, Dept Internal Med,Hepat Dis Lab,Liver Unit, E-08193 Barcelona, Spain; [Esteban, Rafael; Genesca, Joan] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Genesca, J (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, VHIR, Dept Internal Med,Hepat Dis Lab,Liver Unit, E-08193 Barcelona, Spain.	jgenesca@vhebron.net	Martell, Maria/J-8191-2013; Genesca, Joan/H-7467-2019; Rodriguez Navarro, Sarai/C-4500-2014	Martell, Maria/0000-0002-0935-0029; Genesca, Joan/0000-0002-0831-8422; esteban, rafael/0000-0001-5280-392X; Rodriguez Navarro, Sarai/0000-0002-7489-4532	VHIR; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-08354]; Instituto de Salud Carlos III (ISCIII-FIS) [PI12/01759]	VHIR; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (ISCIII-FIS)(Instituto de Salud Carlos III)	Nahia Ezkurdia is a recipient of a pre-doctoral fellowship grant from the VHIR and is enrolled in the postgraduate program of the Universitat Autonoma de Barcelona. Imma Raurell is a recipient of a fellowship grant from the Instituto de Salud Carlos III. CIBERehd is supported by Instituto de Salud Carlos III. The study was funded by grants from Ministerio de Ciencia e Innovacion (MICINN) SAF2009-08354 and Instituto de Salud Carlos III (ISCIII-FIS) PI12/01759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2003, J NEUROSCI, V23, P7602; Ben-Zvi A, 2008, CELL SIGNAL, V20, P467, DOI 10.1016/j.cellsig.2007.10.023; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coll M, 2008, J HEPATOL, V49, P43, DOI 10.1016/j.jhep.2008.03.015; Coll M, 2010, LIVER INT, V30, P593, DOI 10.1111/j.1478-3231.2009.02176.x; Ezkurdia N, 2012, LIVER INT, V32, P1295, DOI 10.1111/j.1478-3231.2012.02762.x; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Iwakiri Y, 2007, J HEPATOL, V46, P927, DOI 10.1016/j.jhep.2007.02.006; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEE SS, 1993, AM J PHYSIOL, V264, pG868, DOI 10.1152/ajpgi.1993.264.5.G868; Lievremont JP, 1999, J BIOL CHEM, V274, P15466, DOI 10.1074/jbc.274.22.15466; Liu H, 2008, GUT, V57, P966, DOI 10.1136/gut.2007.135020; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Sobottka B, 2008, J NEUROCHEM, V107, P1294, DOI 10.1111/j.1471-4159.2008.05690.x; Song DS, 2002, HEPATOLOGY, V35, P159, DOI 10.1053/jhep.2002.30417; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Tonges L, 2011, J MOL NEUROSCI, V45, P284, DOI 10.1007/s12031-011-9519-1; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84374	10.1371/journal.pone.0084374	http://dx.doi.org/10.1371/journal.pone.0084374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400086	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700020
J	Menzies, AM; Haydu, LE; Carlino, MS; Azer, MWF; Carr, PJA; Kefford, RF; Long, GV				Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Azer, Mary W. F.; Carr, Peter J. A.; Kefford, Richard F.; Long, Georgina V.			Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma	PLOS ONE			English	Article							BRAF-MUTANT; TUMOR MICROENVIRONMENT; MEK INHIBITION; VEMURAFENIB; DABRAFENIB	Background: MAPK inhibitors (MAPKi) are active in BRAF-mutant metastatic melanoma patients, but the extent of response and progression-free survival (PFS) is variable, and complete responses are rare. We sought to examine the patterns of response and progression in patients treated with targeted therapy. Methods: MAPKi-naive patients treated with combined dabrafenib and trametinib had all metastases >= 5 mm (lymph nodes >= 15 mm in short axis) visible on computed tomography measured at baseline and throughout treatment. Results: 24 patients had 135 measured metastases (median 4.5/patient, median diameter 16 mm). Time to best response (median 5.5 mo, range 1.7-20.1 mo), and the degree of best response (median -70%, range +9 to -100%) varied amongst patients. 17% of patients achieved complete response (CR), whereas 53% of metastases underwent CR, including 42% >= 10 mm. Metastases that underwent CR were smaller than non-CR metastases (median 11 vs 20 mm, P<0.001). PFS was variable among patients (median 8.2 mo, range 2.6-18.3 mo), and 50% of patients had disease progression in new metastases only. Only 1% (1/71) of CR-metastases subsequently progressed. Twelve-month overall survival was poorer in those with a more heterogeneous initial response to therapy than less heterogeneous (67% vs 93%, P=0.009). Conclusion: Melanoma response and progression with MAPKi displays marked inter-and intra-patient heterogeneity. Most metastases undergo complete response, yet only a small proportion of patients achieve an overall complete response. Similarly, disease progression often occurs only in a subset of the tumor burden, and often in new metastases alone. Clinical heterogeneity, likely reflecting molecular heterogeneity, remains a barrier to the effective treatment of melanoma patients.	[Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Kefford, Richard F.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Carr, Peter J. A.; Kefford, Richard F.; Long, Georgina V.] Univ Sydney, Sydney, NSW 2006, Australia; [Carlino, Matteo S.; Azer, Mary W. F.; Kefford, Richard F.] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia; [Carr, Peter J. A.] Westmead Hosp, Dept Radiol, Sydney, NSW, Australia; [Carlino, Matteo S.; Kefford, Richard F.] Westmead Inst Canc Res, Westmead, NSW, Australia	Melanoma Institute Australia; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Menzies, AM (corresponding author), Melanoma Inst Australia, Sydney, NSW, Australia.	alexander.menzies@sydney.edu.au	Long, Georgina V/C-1771-2013; Carlino, Matteo/GRS-7198-2022	Long, Georgina V/0000-0001-8894-3545; Menzies, Alexander Maxwell/0000-0001-5183-7562; Kefford, Richard/0000-0001-9251-9229; Carlino, Matteo/0000-0002-7861-4104	National Health and Medical Research Council of Australia (NHMRC); Cancer Institute NSW; Australian Cancer Research Foundation; Melanoma Foundation of the University of Sydney; Melanoma Institute Australia; GlaxoSmithKline	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Cancer Research Foundation; Melanoma Foundation of the University of Sydney(University of Sydney); Melanoma Institute Australia; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by Program Grants from the National Health and Medical Research Council of Australia (NHMRC), Cancer Institute NSW, Australian Cancer Research Foundation, the Melanoma Foundation of the University of Sydney and Melanoma Institute Australia. GlaxoSmithKline funded the clinical trial from which these data were obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman A, 2013, CANCER IN PRESS; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-107; Azer MF, 2013, CANCER IN PRESS; Carlino MS, 2013, MOL CANCER THER, V12, P1332, DOI 10.1158/1535-7163.MCT-13-0011; Carlino MS, 2013, EUR J CANCER, V49, P395, DOI 10.1016/j.ejca.2012.08.018; Chan M, 2013, J CLIN ONCOLOGY, V31; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Kim KB, 2011, J CLIN ONCOLOGY, V29; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Takata M, 2000, INT J CANCER, V85, P492, DOI 10.1002/(SICI)1097-0215(20000215)85:4<492::AID-IJC8>3.3.CO;2-R; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wilmott JS, 2012, MOL CANCER THER, V11, P2704, DOI 10.1158/1535-7163.MCT-12-0530; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336	22	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85004	10.1371/journal.pone.0085004	http://dx.doi.org/10.1371/journal.pone.0085004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400126	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700060
J	Sun, K; Zhao, Y; Wang, HT; Sun, H				Sun, Kun; Zhao, Yu; Wang, Huating; Sun, Hao			Sebnif: An Integrated Bioinformatics Pipeline for the Identification of Novel Large Intergenic Noncoding RNAs (lincRNAs) - Application in Human Skeletal Muscle Cells	PLOS ONE			English	Article							GENOME ANNOTATION; REVEALS; SEQ; TRANSCRIPTOMES; VERTEBRATE; EVOLUTION; GENCODE	Ab initio assembly of transcriptome sequencing data has been widely used to identify large intergenic non-coding RNAs (lincRNAs), a novel class of gene regulators involved in many biological processes. To differentiate real lincRNA transcripts from thousands of assembly artifacts, a series of filtering steps such as filters of transcript length, expression level and coding potential, need to be applied. However, an easy-to-use and publicly available bioinformatics pipeline that integrates these filters is not yet available. Hence, we implemented sebnif, an integrative bioinformatics pipeline to facilitate the discovery of bona fide novel lincRNAs that are suitable for further functional characterization. Specifically, sebnif is the only pipeline that implements an algorithm for identifying high-quality single-exonic lincRNAs that were often omitted in many studies. To demonstrate the usage of sebnif, we applied it on a real biological RNA-seq dataset from Human Skeletal Muscle Cells (HSkMC) and built a novel lincRNA catalog containing 917 highly reliable lincRNAs. Sebnif is available at http://sunlab.lihs.cuhk.edu.hk/sebnif/.	[Sun, Kun; Sun, Hao] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Yu; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Sun, H (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk	Zhao, Yu/AAF-9618-2019; Sun, Hao/T-5576-2019; Sun, Kun/Q-6479-2018; sun, hao/GRS-7732-2022; Sun, Hao/J-9964-2013; Wang, Huating/C-6719-2014	Sun, Hao/0000-0002-5547-9501; Sun, Kun/0000-0002-9883-1616; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Zhao, Yu/0000-0002-0349-7206	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [CUHK 476310, CUHK 473211]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was substantially supported by the General Research Funds (GRF) o HW and HS from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project Code: CUHK 476310 to HW and CUHK 473211 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Giles PJ, 2003, BIOINFORMATICS, V19, P2254, DOI 10.1093/bioinformatics/btg311; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Managadze D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002917; Mourier Tobias, 2009, Briefings in Functional Genomics & Proteomics, V8, P493, DOI 10.1093/bfgp/elp036; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RIPLEY WNV, 2002, PLOS BIOL, V9; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Team RDC, 2012, R LANG ENV STAT COMP; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	33	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84500	10.1371/journal.pone.0084500	http://dx.doi.org/10.1371/journal.pone.0084500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400097	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700031
J	Molet, M; Maicher, V; Peeters, C				Molet, Mathieu; Maicher, Vincent; Peeters, Christian			Bigger Helpers in the Ant Cataglyphis bombycina: Increased Worker Polymorphism or Novel Soldier Caste?	PLOS ONE			English	Article							MAJOR WORKERS; HYMENOPTERA; EVOLUTION; QUEENS; REPRODUCTIVES; SMALLER	Introduction: The mechanisms by which development favors or constrains the evolution of new phenotypes are incompletely understood. Polyphenic species may benefit from developmental plasticity not only regarding ecological advantages, but also potential for evolutionary diversification. For instance, the repeated evolution of novel castes in ants may have been facilitated by the existence of alternative queen and worker castes and their respective developmental programs. Material and Methods: Cataglyphis bombycina is exceptional in its genus because winged queens and size-polymorphic workers occur together with bigger individuals having saber-shaped mandibles. We measured seven body parts in more than 150 individuals to perform a morphometric analysis and assess the developmental origin of this novel phenotype. Results: Adults with saber-shaped mandibles differ from both workers and queens regarding the size of most body parts. Their relative growth rates are identical to workers for some pairs of body parts, and identical to queens for other pairs of body parts; critical sizes differ in all cases. Conclusions: Big individuals are a third caste, i.e. soldiers, not major workers. Novel traits such as elongated mandibles are combined with a mix of queen and worker growth rates. We also reveal the existence of a dimorphism in the queen caste (microgynes and macrogynes). We discuss how novel phenotypes can evolve more readily in the context of an existing polyphenism. Both morphological traits and growth rules from existing queen and worker castes can be recombined, hence mosaic phenotypes are more likely to be viable. In C. bombycina, such a mosaic phenotype appears to function both for defense (saber-shaped mandibles) and fat storage (big abdomen). Recycling of developmental programs may have contributed to the morphological diversity and ecological success of ants.	[Molet, Mathieu; Maicher, Vincent; Peeters, Christian] Univ Paris 06, UMR 7625, Lab Ecol & Evolut, Paris, France; [Molet, Mathieu; Maicher, Vincent; Peeters, Christian] CNRS, UMR 7625, Lab Ecol & Evolut, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Molet, M (corresponding author), Univ Paris 06, UMR 7625, Lab Ecol & Evolut, Paris, France.	mathieu.molet@upmc.fr	Peeters, Christian/G-2696-2013; Molet, Mathieu/ABB-3127-2020	Peeters, Christian/0000-0002-0964-0819; Molet, Mathieu/0000-0002-1247-8904	Agence Nationale de la Recherche [ANTEVO ANR-12-JSV7-0003-01]; Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique)	This work was funded by Agence Nationale de la Recherche (project ANTEVO ANR-12-JSV7-0003-01) and by Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bernard F., 1951, Bull Soc Hist nat Toulouse, V86, P88; Billick I, 2007, INSECT SOC, V54, P113, DOI 10.1007/s00040-007-0918-9; Cagniant Henri, 2009, ORSIS Organismes i Sistemes, V24, P41; Delye G., 1957, Insectes Sociaux Paris, V4, P77, DOI 10.1007/BF02224144; Gobin B, 2000, NATURWISSENSCHAFTEN, V87, P323, DOI 10.1007/s001140050731; GOTWALD WH, 1978, BIOTROPICA, V10, P161, DOI 10.2307/2387902; HASEGAWA E, 1993, BEHAV ECOL SOCIOBIOL, V33, P73; Heinze J, 1999, NATURWISSENSCHAFTEN, V86, P93, DOI 10.1007/s001140050579; Holldobler B., 1990, pi; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Lachaud JP, 1999, OECOLOGIA, V120, P515, DOI 10.1007/s004420050885; Leniaud L, 2013, INSECT SOC, V60, P337, DOI 10.1007/s00040-013-0298-2; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; Molet M, 2007, NATURWISSENSCHAFTEN, V94, P280, DOI 10.1007/s00114-006-0190-2; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2013, EVOLUTION SOLDIER CA; Peeters C, 2012, MYRMECOL NEWS, V16, P75; PISARSKI B, 1965, B ACAD POL SCI BIOL, V13, P417; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; TSUJI K, 1990, APPL ENTOMOL ZOOL, V25, P283, DOI 10.1303/aez.25.283; Urbani CB, 1998, INSECT SOC, V45, P315, DOI 10.1007/s000400050091; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Wheeler Diana E., 1994, P245; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	30	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84929	10.1371/journal.pone.0084929	http://dx.doi.org/10.1371/journal.pone.0084929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404196	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800075
J	van Brunschot, SL; Bergervoet, JHW; Pagendam, DE; de Weerdt, M; Geering, ADW; Drenth, A; van der Vlugt, RAA				van Brunschot, Sharon L.; Bergervoet, Jan H. W.; Pagendam, Daniel E.; de Weerdt, Marjanne; Geering, Andrew D. W.; Drenth, Andre; van der Vlugt, Rene A. A.			Development of a Multiplexed Bead-Based Suspension Array for the Detection and Discrimination of Pospiviroid Plant Pathogens	PLOS ONE			English	Article							RT-PCR ASSAY; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; VIROID DISEASE; POTATO; IDENTIFICATION; TRANSMISSION; TECHNOLOGY; STRAIN	Efficient and reliable diagnostic tools for the routine indexing and certification of clean propagating material are essential for the management of pospiviroid diseases in horticultural crops. This study describes the development of a true multiplexed diagnostic method for the detection and identification of all nine currently recognized pospiviroid species in one assay using Luminex bead-based suspension array technology. In addition, a new data-driven, statistical method is presented for establishing thresholds for positivity for individual assays within multiplexed arrays. When applied to the multiplexed array data generated in this study, the new method was shown to have better control of false positives and false negative results than two other commonly used approaches for setting thresholds. The 11-plex Luminex MagPlex-TAG pospiviroid array described here has a unique hierarchical assay design, incorporating a near-universal assay in addition to nine species-specific assays, and a co-amplified plant internal control assay for quality assurance purposes. All assays of the multiplexed array were shown to be 100% specific, sensitive and reproducible. The multiplexed array described herein is robust, easy to use, displays unambiguous results and has strong potential for use in routine pospiviroid indexing to improve disease management strategies.	[van Brunschot, Sharon L.; Geering, Andrew D. W.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [van Brunschot, Sharon L.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Bergervoet, Jan H. W.; de Weerdt, Marjanne; van der Vlugt, Rene A. A.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Pagendam, Daniel E.] Commonwealth Sci & Ind Res Org Math Informat & St, Dutton Pk, Qld, Australia; [Geering, Andrew D. W.; Drenth, Andre] Univ Queensland, Ctr Plant Sci, St Lucia, Qld, Australia	University of Queensland; Wageningen University & Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	van der Vlugt, RAA (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	rene.vandervlugt@wur.nl	van der Vlugt, Rene/D-3001-2017; Geering, Andrew/A-7912-2011; Pagendam, Daniel E/B-1683-2010; Drenth, Andre/A-4915-2008	van der Vlugt, Rene/0000-0001-9094-685X; Pagendam, Daniel E/0000-0002-8347-4767; Drenth, Andre/0000-0002-8510-1534; van Brunschot, Sharon/0000-0002-9634-9463	Interreg "Healthy Greenhouse"; Plant Biosecurity Cooperative Research Centre under the Australian Government's Cooperative Research Centres Program [CRC60070]	Interreg "Healthy Greenhouse"; Plant Biosecurity Cooperative Research Centre under the Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was supported by a grant from Interreg "Healthy Greenhouse" (www.gezondekas.eu). The authors would like to acknowledge the support of the Plant Biosecurity Cooperative Research Centre (Project No. CRC60070), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignus Y, 2002, PHYTOPARASITICA, V30, P502, DOI 10.1007/BF02979755; Babady NE, 2011, J CLIN MICROBIOL, V49, P3777, DOI 10.1128/JCM.01135-11; Balada-Llasat JM, 2012, J CLIN MICROBIOL, V50, P492, DOI 10.1128/JCM.06375-11; Battaglia A, 2011, J FORENSIC SCI, V56, P760, DOI 10.1111/j.1556-4029.2011.01708.x; Bergervoet JHW, 2008, J VIROL METHODS, V149, P63, DOI 10.1016/j.jviromet.2008.01.020; Boonham N, 2004, J VIROL METHODS, V116, P139, DOI 10.1016/j.jviromet.2003.11.005; Bostan H, 2004, J VIROL METHODS, V116, P189, DOI 10.1016/j.jviromet.2003.11.014; Botermans M, 2013, J VIROL METHODS, V187, P43, DOI 10.1016/j.jviromet.2012.09.004; Diener TO, 1999, ARCH VIROL, P203; Dorak M.T., 2006, ADV METHODS SERIES, P93; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Foord AJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/289295; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; GALINDO J, 1982, PHYTOPATHOLOGY, V72, P49, DOI 10.1094/Phyto-72-49; Hailstones DL, 2003, AUSTRALAS PLANT PATH, V32, P317, DOI 10.1071/AP03005; KRAMER SM, 1983, J IMMUNOL METHODS, V60, P243, DOI 10.1016/0022-1759(83)90352-6; Landlinger C, 2009, J CLIN MICROBIOL, V47, P1063, DOI 10.1128/JCM.01558-08; Lebas BSM, 2005, AUSTRALAS PLANT PATH, V34, P129, DOI 10.1071/AP05002; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Matsushita Y, 2008, J GEN PLANT PATHOL, V74, P182, DOI 10.1007/s10327-008-0076-6; Monger W, 2010, J VIROL METHODS, V169, P207, DOI 10.1016/j.jviromet.2010.07.002; Owens R. A., 2012, VIRUS TAXONOMY, P1221; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Roenhorst J. W., 2005, Bulletin OEPP, V35, P133, DOI 10.1111/j.1365-2338.2005.00798.x; Shamloul AM, 1997, CAN J PLANT PATHOL, V19, P89, DOI 10.1080/07060669709500580; SINGH RP, 1993, CAN J PLANT PATHOL, V15, P134, DOI 10.1080/07060669309500813; Singh RP, 2009, EUR J PLANT PATHOL, V124, P691, DOI 10.1007/s10658-009-9440-4; Singh RP, 2009, EUR J PLANT PATHOL, V123, P111, DOI 10.1007/s10658-008-9344-8; Skelton A., 2009, NEW DIS REP, V19, P30; Steyer S, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02261.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhoeven J. T. J., 2011, New Disease Reports, V23, P15, DOI 10.5197/j.2044-0588.2011.023.015; Verhoeven JTJ, 2007, PLANT DIS, V91, P1055, DOI 10.1094/PDIS-91-8-1055A; Verhoeven JTJ, 2011, ARCH VIROL, V156, P1433, DOI 10.1007/s00705-011-0975-2; Verhoeven JTJ, 2010, PLANT DIS, V94, P920, DOI 10.1094/PDIS-94-7-0920C; Verhoeven JTJ, 2010, ARCH VIROL, V155, P269, DOI 10.1007/s00705-009-0572-9; Verhoeven JTJ, 2010, PLANT PATHOL, V59, P3, DOI 10.1111/j.1365-3059.2009.02173.x; Verhoeven JTJ, 2009, VIRUS RES, V144, P209, DOI 10.1016/j.virusres.2009.05.002; Verhoeven JTJ, 1998, EUR J PLANT PATHOL, V104, P383, DOI 10.1023/A:1008688023649; Verhoeven JTJ, 2004, EUR J PLANT PATHOL, V110, P823, DOI 10.1007/s10658-004-2493-5; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005; Wu Y, 2011, J CLIN MICROBIOL, V49, P419, DOI 10.1128/JCM.01871-10	45	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84743	10.1371/journal.pone.0084743	http://dx.doi.org/10.1371/journal.pone.0084743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404188	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000329460800067
J	Caspi, Y				Caspi, Yaron			Deformation of Filamentous Escherichia coli Cells in a Microfluidic Device: A New Technique to Study Cell Mechanics	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ACTIN-LIKE CYTOSKELETON; HIGH-SPEED AFM; BACTERIAL-CELLS; NANOMECHANICAL PROPERTIES; FTSZ POLYMERIZATION; STRESS-BEARING; SINGLE-CELL; SHAPE; SURFACE	The mechanical properties of bacterial cells are determined by their stress-bearing elements. The size of typical bacterial cells, and the fact that different time and length scales govern their behavior, necessitate special experimental techniques in order to probe their mechanical properties under various spatiotemporal conditions. Here, we present such an experimental technique to study cell mechanics using hydrodynamic forces in a microfluidic device. We demonstrate the application of this technique by calculating the flexural rigidity of non-growing Escherichia coli cells. In addition, we compare the deformation of filamentous cells under growing and non-growing conditions during the deformation process. We show that, at low forces, the force needed to deform growing cells to the same extent as non-growing cells is approximately two times smaller. Following previous works, we interpret these results as the outcome of the difference between the elastic response of non-growing cells and the plastic-elastic response of growing cells. Finally, we observe some heterogeneity in the response of individual cells to the applied force. We suggest that this results from the individuality of different bacterial cells.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Caspi, Y (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	Y.Caspi@tudelft.nl	Caspi, Yaron/O-2518-2016	Caspi, Yaron/0000-0003-0328-0186	US National Institutes of Health [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work has been partly supported by the US National Institutes of Health www.nih.gov/(grant P50 GM068763). The submission of this article is, however, done without the support of any grant or funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, ARXIV13055843CONDMAT; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; Chen YY, 2009, LANGMUIR, V25, P4607, DOI 10.1021/la8036346; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; Dombrowski C, 2009, BIOPHYS J, V96, P4409, DOI 10.1016/j.bpj.2009.02.066; Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Felgner H, 1996, J CELL SCI, V109, P509; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Gondret P, 1997, PHYS FLUIDS, V9, P1841, DOI 10.1063/1.869301; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Jiang HY, 2011, BIOPHYS J, V101, P327, DOI 10.1016/j.bpj.2011.06.005; Jiang HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.028101; Katan AJ, 2011, CELL, V147, P979, DOI 10.1016/j.cell.2011.11.017; KOCH AL, 1988, MICROBIOL REV, V52, P337, DOI 10.1128/MMBR.52.3.337-353.1988; Lan GH, 2007, P NATL ACAD SCI USA, V104, P16110, DOI 10.1073/pnas.0702925104; Landau L., 1986, THEORY ELASTICITY CO; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885; Mukhopadhyay R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.062901; Nezhad AS, 2013, LAB CHIP, V13, P2599, DOI [10.1039/c3lc00012e, 10.1039/c31c00012e]; Pilizota T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035205; Pozrikidis C, 2011, INT J SOLIDS STRUCT, V48, P137, DOI 10.1016/j.ijsolstr.2010.09.012; Sliusarenko O, 2010, P NATL ACAD SCI USA, V107, P10086, DOI 10.1073/pnas.1000737107; Sullivan CJ, 2007, ULTRAMICROSCOPY, V107, P934, DOI 10.1016/j.ultramic.2007.04.017; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tuson HH, 2012, MOL MICROBIOL, V84, P874, DOI 10.1111/j.1365-2958.2012.08063.x; Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08; Vadillo-Rodriguez V, 2009, J BACTERIOL, V191, P5518, DOI 10.1128/JB.00528-09; VENIER P, 1994, J BIOL CHEM, V269, P13353; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	54	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83775	10.1371/journal.pone.0083775	http://dx.doi.org/10.1371/journal.pone.0083775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392095	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100019
J	Tivers, MS; Handel, I; Gow, AG; Lipscomb, VJ; Jalan, R; Mellanby, RJ				Tivers, Mickey S.; Handel, Ian; Gow, Adam G.; Lipscomb, Vicky J.; Jalan, Rajiv; Mellanby, Richard J.			Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs with Congenital Portosystemic Shunts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AMMONIA; DIAGNOSIS; CIRRHOSIS; HYPONATREMIA; PATHOGENESIS; IMPAIRMENT; GLUTAMINE; SEVERITY; MODELS	Hepatic encephalopathy (HE) is an important cause of morbidity and mortality in patients with liver disease. The pathogenesis of he is incompletely understood although ammonia and inflammatory cytokines have been implicated as key mediators. To facilitate further mechanistic understanding of the pathogenesis of HE, a large number of animal models have been developed which often involve the surgical creation of an anastomosis between the hepatic portal vein and the caudal vena cava. One of the most common congenital abnormalities in dogs is a congenital portosystemic shunt (cpss), which closely mimics these surgical experimental models of HE. Dogs with a cPSS often have clinical signs which mimic clinical signs observed in humans with HE. Our hypothesis is that the pathogenesis of HE in dogs with a cPSS is similar to humans with HE. The aim of the study was to measure a range of clinical, haematological and biochemical parameters, which have been linked to the development of HE in humans, in dogs with a cPSS and a known HE grade. One hundred and twenty dogs with a cPSS were included in the study and multiple regression analysis of clinical, haematological and biochemical variables revealed that plasma ammonia concentrations and systemic inflammatory response syndrome scores predicted the presence of HE. Our findings further support the notion that the pathogenesis of canine and human HE share many similarities and indicate that dogs with cPSS may be an informative spontaneous model of human HE. Further investigations on dogs with cPSS may allow studies on HE to be undertaken without creating surgical models of HE thereby allowing the number of large animals used in animal experimentation to be reduced.	[Tivers, Mickey S.; Lipscomb, Vicky J.] Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, London, England; [Mellanby, Richard J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of London; University of London Royal Veterinary College; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University College London; University of Edinburgh	Mellanby, RJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Tivers, Michael/0000-0001-7047-9334; Mellanby, Richard John/0000-0002-3467-7007	BSAVA Petsavers; MRC [G0701742] Funding Source: UKRI; Medical Research Council [G0701742] Funding Source: researchfish	BSAVA Petsavers; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BSAVA Petsavers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek Ehab E, 2011, Arab J Gastroenterol, V12, P173, DOI 10.1016/j.ajg.2011.11.006; Amodio P, 2001, J HEPATOL, V35, P37, DOI 10.1016/S0168-8278(01)00129-5; Angeli P, 2006, HEPATOLOGY, V44, P1535, DOI 10.1002/hep.21412; Aronson LR, 1997, VET SURG, V26, P189, DOI 10.1111/j.1532-950X.1997.tb01483.x; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; COHN R, 1966, J LAB CLIN MED, V68, P195; Cordoba J, 2010, METAB BRAIN DIS, V25, P73, DOI 10.1007/s11011-010-9172-3; D'Anjou MA, 2004, VET RADIOL ULTRASOUN, V45, P424, DOI 10.1111/j.1740-8261.2004.04076.x; EICHLER M, 1962, J NERV MENT DIS, V134, P539, DOI 10.1097/00005053-196206000-00007; Felipo V, 2012, METAB BRAIN DIS, V27, P51, DOI 10.1007/s11011-011-9269-3; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gerritzen-Bruning MJ, 2006, J VET INTERN MED, V20, P13, DOI 10.1892/0891-6640(2006)20[13:DVOFPA]2.0.CO;2; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Gow AG, 2012, METAB BRAIN DIS, V27, P227, DOI 10.1007/s11011-012-9278-x; Gow AG, 2010, J VET INTERN MED, V24, P90, DOI 10.1111/j.1939-1676.2009.0408.x; Guevara M, 2010, LIVER INT, V30, P1137, DOI 10.1111/j.1478-3231.2010.02293.x; Guevara M, 2009, AM J GASTROENTEROL, V104, P1382, DOI 10.1038/ajg.2009.293; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Holt DE, 2002, AM J VET RES, V63, P1167, DOI 10.2460/ajvr.2002.63.1167; Jover R, 2005, METAB BRAIN DIS, V20, P399, DOI 10.1007/s11011-005-7925-1; MADDISON JE, 1992, J VET INTERN MED, V6, P341, DOI 10.1111/j.1939-1676.1992.tb00367.x; Mas A, 2006, DIGESTION, V73, P86, DOI 10.1159/000089783; Meyer HP, 1999, METAB BRAIN DIS, V14, P103, DOI 10.1023/A:1020757730386; Nelson NC, 2011, VET RADIOL ULTRASOUN, V52, P498, DOI 10.1111/j.1740-8261.2011.01827.x; Normandin L, 2002, METAB BRAIN DIS, V17, P375, DOI 10.1023/A:1021970120965; Odeh M, 2007, EUR J CLIN INVEST, V37, P291, DOI 10.1111/j.1365-2362.2007.01778.x; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Odeh M, 2004, LIVER INT, V24, P110, DOI 10.1111/j.1478-3231.2004.0894.x; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Pelander L, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-35; Poordad FF, 2007, ALIMENT PHARM THERAP, V25, P3, DOI 10.1111/j.1746-6342.2006.03215.x; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; ROTHUIZEN J, 1982, RES VET SCI, V33, P17, DOI 10.1016/S0034-5288(18)32352-X; Seguin B, 1999, VET RADIOL ULTRASOUN, V40, P251, DOI 10.1111/j.1740-8261.1999.tb00357.x; Sharma P, 2009, LIVER INT, V29, P1365, DOI 10.1111/j.1478-3231.2009.02067.x; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Shawcross DL, 2005, METAB BRAIN DIS, V20, P169, DOI 10.1007/s11011-005-7205-0; Sterczer A, 1999, RES VET SCI, V66, P63, DOI 10.1053/rvsc.1998.0243; TABOADA J, 1995, VET CLIN N AM-SMALL, V25, P337, DOI 10.1016/S0195-5616(95)50030-0; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; Watanabe M, 1997, PHARMACOL BIOCHEM BE, V57, P367, DOI 10.1016/S0091-3057(96)00305-X; White RN, 2003, VET RADIOL ULTRASOUN, V44, P514, DOI 10.1111/j.1740-8261.2003.tb00499.x; Wilkinson DJ, 2011, METAB BRAIN DIS, V26, P203, DOI 10.1007/s11011-011-9251-0; Winkler JT, 2003, J AM ANIM HOSP ASSOC, V39, P169, DOI 10.5326/0390169; Wright G, 2007, HEPATOLOGY, V45, P1517, DOI 10.1002/hep.21599; Ytrebo LM, 2006, AM J PHYSIOL-GASTR L, V291, pG373, DOI 10.1152/ajpgi.00440.2005; Zandvliet MMJM, 2007, J VET INTERN MED, V21, P215	52	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e82303	10.1371/journal.pone.0082303	http://dx.doi.org/10.1371/journal.pone.0082303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392080	Green Accepted, Green Published, gold			2022-12-25	WOS:000329460100004
J	Troxell, B; Zhang, JJ; Bourret, TJ; Zeng, MY; Blum, J; Gherardini, F; Hassan, HM; Yang, XF				Troxell, Bryan; Zhang, Jun-Jie; Bourret, Travis J.; Zeng, Melody Yue; Blum, Janice; Gherardini, Frank; Hassan, Hosni M.; Yang, X. Frank			Pyruvate Protects Pathogenic Spirochetes from H2O2 Killing	PLOS ONE			English	Article							EXPERIMENTAL LYME ARTHRITIS; A DISULFIDE REDUCTASE; NF-KAPPA-B; BORRELIA-BURGDORFERI; HYDROGEN-PEROXIDE; NITRIC-OXIDE; LEPTOSPIRA-INTERROGANS; ANAEROBIC METABOLISM; SUPEROXIDE-DISMUTASE; BLOOD PYRUVATE	Pathogenic spirochetes cause clinically relevant diseases in humans and animals, such as Lyme disease and leptospirosis. The causative agent of Lyme disease, Borrelia burgdorferi, and the causative agent of leptospirosis, Leptospria interrogans, encounter reactive oxygen species (ROS) during their enzootic cycles. This report demonstrated that physiologically relevant concentrations of pyruvate, a potent H2O2 scavenger, and provided passive protection to B. burgdorferi and L. interrogans against H2O2. When extracellular pyruvate was absent, both spirochetes were sensitive to a low dose of H2O2 (approximate to 0.6 mu M per h) generated by glucose oxidase (GOX). Despite encoding a functional catalase, L. interrogans was more sensitive than B. burgdorferi to H2O2 generated by GOX, which may be due to the inherent resistance of B. burgdorferi because of the virtual absence of intracellular iron. In B. burgdorferi, the nucleotide excision repair (NER) and the DNA mismatch repair (MMR) pathways were important for survival during H2O2 challenge since deletion of the uvrB or the mutS genes enhanced its sensitivity to H2O2 killing; however, the presence of pyruvate fully protected Delta uvrB and Delta mutS from H2O2 killing further demonstrating the importance of pyruvate in protection. These findings demonstrated that pyruvate, in addition to its classical role in central carbon metabolism, serves as an important H2O2 scavenger for pathogenic spirochetes. Furthermore, pyruvate reduced ROS generated by human neutrophils in response to the Toll-like receptor 2 (TLR2) agonist zymosan. In addition, pyruvate reduced neutrophil-derived ROS in response to B. burgdorferi, which also activates host expression through TLR2 signaling. Thus, pathogenic spirochetes may exploit the metabolite pyruvate, present in blood and tissues, to survive H2O2 generated by the host antibacterial response generated during infection.	[Troxell, Bryan; Zhang, Jun-Jie; Zeng, Melody Yue; Blum, Janice; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Bourret, Travis J.] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA; [Hassan, Hosni M.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA; [Gherardini, Frank] NIAID, Lab Zoonot Pathogens, NIH, Hamilton, MT USA	Indiana University System; Indiana University Bloomington; University of Nebraska System; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hassan, HM (corresponding author), N Carolina State Univ, Prestage Dept Poultry Sci, Raleigh, NC 27695 USA.	hmhassan@ncsu.edu; xfyang@iupui.edu	zhang, junjie/P-2376-2015; Bourret, Travis/J-4673-2019	zhang, junjie/0000-0002-5108-2072; Troxell, Bryan/0000-0002-0533-6721; Hassan, Hosni/0000-0002-3076-9772; Bourret, Travis/0000-0002-4154-929X	NIH [R01 AI083640]; Lilly Endowment, Inc.; National Center for Research Resources [5P20RR016469]; National Institute for General Medical Science (NIGMS) [5P20GM103427]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469, C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905, R01AI083640, T32AI060519, R01AI079065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment, Inc.; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was partially provided by NIH grant R01 AI083640, Indiana INGEN and METACyt grants of Indiana University, funded by the Lilly Endowment, Inc. (to XFY), National Center for Research Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (5P20GM103427) (to TJB). A component of the National Institutes of Health (NIH) and its contents are the sole responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. BT and MYZ were supported by NIH T32 training grant 5T32AI060519. This investigation was partially conducted in a facility constructed with support from research facilities improvement program grant number C06 RR015481-01 from National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; AUSTIN FE, 1981, INFECT IMMUN, V33, P372, DOI 10.1128/IAI.33.2.372-379.1981; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; BEERS RF, 1952, J BIOL CHEM, V195, P133; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2006, MOL MICROBIOL, V59, P475, DOI 10.1111/j.1365-2958.2005.04963.x; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown CR, 2004, INFECT IMMUN, V72, P4956, DOI 10.1128/IAI.72.9.4956-4965.2004; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Campbell JA, 1931, PHYSIOL REV, V11, P1; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; DECHATELET LR, 1982, J IMMUNOL, V129, P1589; Desagher S, 1997, J NEUROSCI, V17, P9060; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eggers CH, 2011, MOL MICROBIOL, V82, P679, DOI 10.1111/j.1365-2958.2011.07845.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; FAINE S, 1959, J GEN MICROBIOL, V20, P246, DOI 10.1099/00221287-20-2-246; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; FETTIPLACE R, 1978, BIOCHIM BIOPHYS ACTA, V513, P1, DOI 10.1016/0005-2736(78)90106-2; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; FULTON JD, 1960, BIOCHEM J, V76, P491, DOI 10.1042/bj0760491; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; GILBERT VE, 1968, METABOLISM, V17, P943, DOI 10.1016/0026-0495(68)90162-5; Gore DC, 1996, ANN SURG, V224, P97, DOI 10.1097/00000658-199607000-00015; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hardy PO, 2013, J BACTERIOL, V195, P2220, DOI 10.1128/JB.00043-13; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Holleman AF, 1904, RECL TRAV CH PAYS-BA, V23, P169; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; HUCKABEE WE, 1958, J CLIN INVEST, V37, P264, DOI 10.1172/JCI103605; HUCKABEE WE, 1958, J CLIN INVEST, V37, P244, DOI 10.1172/JCI103603; HUCKABEE WE, 1958, J CLIN INVEST, V37, P255, DOI 10.1172/JCI103604; HUGHES CAN, 1992, J CLIN MICROBIOL, V30, P698, DOI 10.1128/JCM.30.3.698-703.1992; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; JOHNSON RC, 1973, APPL MICROBIOL, V26, P118, DOI 10.1128/AEM.26.1.118-119.1973; Jozsef L, 2003, FREE RADICAL BIO MED, V35, P1018, DOI 10.1016/S0891-5849(03)00439-8; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; KELLY R, 1971, SCIENCE, V173, P443, DOI 10.1126/science.173.3995.443; KRIEG NR, 1986, ANNU REV MICROBIOL, V40, P107, DOI 10.1146/annurev.micro.40.1.107; LANDON J, 1962, J CLIN PATHOL, V15, P579, DOI 10.1136/jcp.15.6.579; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; Lusitani D, 2002, J INFECT DIS, V185, P797, DOI 10.1086/339341; MARGOLIS SA, 1986, ANAL CHEM, V58, P2504, DOI 10.1021/ac00125a033; Mathioudakis D, 2011, AMINO ACIDS, V40, P1077, DOI 10.1007/s00726-010-0731-z; Menten-Dedoyart C, 2012, J IMMUNOL, V189, P5393, DOI 10.4049/jimmunol.1103771; Mik EG, 2004, J APPL PHYSIOL, V97, P1962, DOI 10.1152/japplphysiol.01399.2003; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; NATH KA, 1994, KIDNEY INT, V45, P166, DOI 10.1038/ki.1994.20; NORROD EP, 1982, J CLIN MICROBIOL, V15, P103, DOI 10.1128/JCM.15.1.103-108.1982; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; OHNO Y, 1985, J BIOL CHEM, V260, P8438; PINE L, 1986, J CLIN MICROBIOL, V23, P33, DOI 10.1128/JCM.23.1.33-42.1986; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ramakrishnan N, 1998, FREE RADICAL RES, V29, P283, DOI 10.1080/10715769800300321; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; RAO PJ, 1964, J BACTERIOL, V88, P1045, DOI 10.1128/JB.88.4.1045-1048.1964; Ritzman AM, 2010, INFECT IMMUN, V78, P4593, DOI 10.1128/IAI.00798-10; ROOT RK, 1975, J CLIN INVEST, V55, P945, DOI 10.1172/JCI108024; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Sambir M, 2011, FEMS MICROBIOL LETT, V317, P172, DOI 10.1111/j.1574-6968.2011.02226.x; Samuels D S, 1995, Methods Mol Biol, V47, P253; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508; THOMPSON TL, 1951, J BACTERIOL, V62, P39, DOI 10.1128/JB.62.1.39-44.1951; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; VasquezVivar J, 1997, CHEM RES TOXICOL, V10, P786, DOI 10.1021/tx970031g; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; VLESSIS AA, 1990, BIOCHEM BIOPH RES CO, V170, P1281, DOI 10.1016/0006-291X(90)90532-R; XIANG TX, 1994, J MEMBRANE BIOL, V140, P111; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zouki C, 2001, J LEUKOCYTE BIOL, V69, P815	97	32	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84625	10.1371/journal.pone.0084625	http://dx.doi.org/10.1371/journal.pone.0084625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392147	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100070
J	Banke-Thomas, AO; Kouraogo, SF; Siribie, A; Taddese, HB; Mueller, JE				Banke-Thomas, Aduragbemi O.; Kouraogo, Salam F.; Siribie, Aboubacar; Taddese, Henock B.; Mueller, Judith E.			Knowledge of Obstetric Fistula Prevention amongst Young Women in Urban and Rural Burkina Faso: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH	Obstetric fistula is a sequela of complicated labour, which, if untreated, leaves women handicapped and socially excluded. In Burkina Faso, incidence of obstetric fistula is 6/10,000 cases amongst gynaecological patients, with more patients affected in rural areas. This study aims to evaluate knowledge on obstetric fistula among young women in a health district of Burkina Faso, comparing rural and urban communities. This cross-sectional study employed multi-stage sampling to include 121 women aged 18-20 years residing in urban and rural communities of Boromo health district. Descriptive statistics and multiple logistic regression analysis were used to compare differences between the groups and to identify predictors of observed knowledge levels. Rural women were more likely to be married (p<0.000) and had higher propensity to teenage pregnancy (p=0.006). The survey showed overall poor obstetric fistula awareness (36%). Rural residents were less likely to have adequate preventive knowledge than urban residents [OR=0.35 (95%-CI, 0.16-0.79)]. This effect was only slightly explained by lack of education [OR=0.41 (95%-CI, 0.18-0.93)] and only slightly underestimated due to previous pregnancy [OR=0.27 (95%-CI, 0.09-0.79)]. Media were the most popular source of awareness amongst urban young women in contrast to their rural counterparts (68% vs. 23%). Most rural young women became 'aware' through word-of-mouth (68% vs. 14%). All participants agreed that the hospital was safer for emergency obstetric care, but only 11.0% believed they could face pregnancy complications that would require emergency treatment. There is urgent need to increase emphasis on neglected health messages such as the risks of obstetric fistula. In this respect, obstetric fistula prevention programs need to be adapted to local contexts, whether urban or rural, and multi-sectoral efforts need to be exerted to maximise use of other sectoral resources and platforms, including existing routine health services and schools, to ensure sustainability of health literacy efforts.	[Banke-Thomas, Aduragbemi O.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England; [Banke-Thomas, Aduragbemi O.; Mueller, Judith E.] Ecole Hautes Etud Sante Publ, Epidemiol & Biostat Dept, Rennes, Bretagne, France; [Kouraogo, Salam F.; Siribie, Aboubacar] Dist Hosp, Ctr Med Avec Antenne Chirurg, Dept Surg, Boromo, Boucle Du Mouho, Burkina Faso; [Banke-Thomas, Aduragbemi O.; Taddese, Henock B.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Sheffield	Banke-Thomas, AO (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England.	a.banke-thomas@liverpool.ac.uk	Banke-Thomas, Aduragbemi/AAM-5463-2020	Banke-Thomas, Aduragbemi/0000-0002-4449-0131				Agha S, 2002, INT FAM PLAN PERSPEC, V28, P151, DOI 10.2307/3088258; Ahmed S, 2011, HLTH FERTILITY STUDY; Ahmed S, 2013, GLOB HEALTH-SCI PRAC, V1, P262, DOI 10.9745/GHSP-D-13-00002; Bangser M, 2006, LANCET, V367, P535, DOI 10.1016/S0140-6736(06)68188-9; Barnett V., 2002, SAMPLE SURVEY PRINCI, Vthird; Boucle du Mouhoun DRS, 2012, PRES GEN REG SAN; Brady M, 2007, ADOLESCENCE FILLES B; Capes T, 2011, MT SINAI J MED, V78, P352, DOI 10.1002/msj.20265; Cook RJ, 2004, INT J GYNECOL OBSTET, V87, P72, DOI 10.1016/j.ijgo.2004.07.005; Cutler David., 2006, NATL BUREAU EC RES W; de Bernis L, 2007, INT J GYNECOL OBSTET, V99, pS117, DOI 10.1016/j.ijgo.2007.06.032; de Dedougou CHR, 2011, BUDGET CAMPAGNE CURE; de la justice Ministere, 1989, COD PERS FAM, P24; EFE-Burkina, 2012, MISS NOV 2012 RAPAP; GORGEN R, 1993, STUD FAMILY PLANN, V24, P283, DOI 10.2307/2939222; Hassan MA, 2009, ANN AFR MED, V8, P122, DOI 10.4103/1596-3519.56241; Hilton P, 2003, INT J GYNECOL OBSTET, V82, P285, DOI 10.1016/S0020-7292(03)00222-4; INSD, 2007, RES PREL REC GEN POP; INSD ICF International, 2010, ENQ DEM SANT IND MUL; Kalembo F, 2012, ARTS SOC SCI J, V2012; Kishk Nahla A, 2002, J Egypt Public Health Assoc, V77, P479; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Lule E, 2003, ACHIEVING MILLENIUM; Montez D.., 2011, FAMILY PLANNING MATE; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Paris 21, 2004, RAPP ET PAYS BURK FA; Plummer ML, 2007, HEALTH EDUC RES, V22, P500, DOI 10.1093/her/cyl103; Ridde V, 2011, HEALTH POLICY PLANN, V26, pII30, DOI 10.1093/heapol/czr060; Shefren JM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.03.008; Slinger G, 2011, PREVENTING OBSTET FI; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; Tebeu PM, 2012, INT UROGYNECOL J, V23, P387, DOI 10.1007/s00192-011-1622-x; Tebeu PM, 2009, INT J GYNECOL OBSTET, V107, P12, DOI 10.1016/j.ijgo.2009.05.019; UNFPA, 2009, PROGR LUTT FIST OBST; UNFPA, 2012, MARR TOO YOUNG END C; UNFPA, 2012, PROGR NAT LUTT FIST, P2011; UNFPA and EngenderHealth, 2003, OBST FIST NEEDS ASS; UNFPA DSF, 2004, AN PRIS CHARG FIST U; Vangeenderhuysen C, 2001, AFRICA INT J GYNECOL, V73, P65, DOI [10.1016/S0020-7292(00)00374-X, DOI 10.1016/S0020-7292(00)00374-X]; Wall LL, 2012, OBSTET GYNECOL SURV, V67, P111, DOI 10.1097/OGX.0b013e3182438788; Wanyonyi KL, 2011, PATIENT EDUC COUNS, V85, P348, DOI 10.1016/j.pec.2011.02.006; WHEC, 2013, GLOB EFF END OBST 1; Zhang Y, 2006, COMP EDUC REV, V50, P581, DOI 10.1086/507056; Zhao Qi, 2009, BMC Womens Health, V9, P5, DOI 10.1186/1472-6874-9-5	44	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85921	10.1371/journal.pone.0085921	http://dx.doi.org/10.1371/journal.pone.0085921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24392032	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000329323900176
J	Donati, S; Satolli, R; Colombo, C; Senatore, S; Cotichini, R; Da Cas, R; Alegiani, SS; Mosconi, P				Donati, Serena; Satolli, Roberto; Colombo, Cinzia; Senatore, Sabrina; Cotichini, Rodolfo; Da Cas, Roberto; Alegiani, Stefania Spila; Mosconi, Paola			Informing Women on Menopause and Hormone Therapy: Know the Menopause a Multidisciplinary Project Involving Local Healthcare System	PLOS ONE			English	Article								Background: Hormone therapy (HT) in the menopause is still a tricky question among healthcare providers, women and mass media. Informing women about hormone replacement therapy was a Consensus Conference (CC) organized in 2008: the project Know the Menopause has been launched to shift out the results to women and healthcare providers and to assess the impact of the cc's statement. Methods: And Findings: The project, aimed at women aged 45-60 years, was developed in four Italian Regions: Lombardy, Tuscany, Lazio, Sicily, each with one Local Health Unit (LHU) as "intervention" and one as "control". Activities performed were: survey on the press; training courses for health professionals; educational materials for target populations; survey aimed at women, general practitioners (GPs), and gynaecologists; data analysis on HT drugs' prescription. Local activities were: training courses; public meetings; dissemination on mass media. About 3,700 health professionals were contacted and 1,800 participated in the project. About 146,500 printed leaflets on menopause were distributed to facilitate the dialogue among women and health care professionals. Training courses and educational cascade-process activities: participation ranged 25-72% of GPs, 17-71% of gynaecologists, 14-78% of pharmacists, 34-85% of midwives. Survey: 1,281 women interviewed. More than 90% believed menopause was a normal phase in life. More than half did not receive information about menopause and therapies. HT prescription analysis: prevalence fell from 6% to 4% in five years. No differences in time trends before-after the intervention. Major limitations are: organizational difficulties met by LHU, too short time for some local activities. Conclusions: A huge amount of information was spread through health professionals and women. The issue of menopause was also used to discuss women's wellbeing. This project offered an opportunity to launch a multidisciplinary, multimodal approach to menopause looking not only at pharmacological aspects, but also at quality of life and information.	[Donati, Serena; Senatore, Sabrina; Cotichini, Rodolfo; Da Cas, Roberto; Alegiani, Stefania Spila] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, I-00161 Rome, Italy; [Satolli, Roberto] Agenzia Editoria Sci Zadig, Milan, Italy; [Colombo, Cinzia; Mosconi, Paola] IRCCS, Ist Ric Farmacol Mario Negri, Lab Med Res & Consumers Involvement, Milan, Italy	Istituto Superiore di Sanita (ISS); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Mosconi, P (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Lab Med Res & Consumers Involvement, Milan, Italy.	paola.mosconi@marionegri.it	Colombo, Cinzia/K-8981-2016; Paola, Mosconi/K-5596-2016; COLOMBO, CINZIA/ABG-6433-2020	Colombo, Cinzia/0000-0001-6639-694X; Paola, Mosconi/0000-0003-0415-3744; COLOMBO, CINZIA/0000-0001-6639-694X; Donati, Serena/0000-0002-4607-2072	Italian Agency for Drugs (AIFA)	Italian Agency for Drugs (AIFA)	This work was supported by the Italian Agency for Drugs (AIFA) in the context of a multi-regional project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Colombo C, 2010, EUR J OBSTET GYN R B, V153, P56, DOI 10.1016/j.ejogrb.2010.07.026; de Villiers TJ, 2013, CLIMACTERIC, V16, P203, DOI 10.3109/13697137.2013.771520; Donati S, 2009, MATURITAS, V63, P246, DOI 10.1016/j.maturitas.2009.04.001; Guallar E, 2013, ANN INTERN MED, V158, P69, DOI 10.7326/0003-4819-158-1-201301010-00015; Mosconi P, 2010, OBSTET GYNECOL, V116, P442, DOI 10.1097/AOG.0b013e3181eb539c; Mosconi Paola, 2009, BMC Womens Health, V9, P14, DOI 10.1186/1472-6874-9-14; Mosconi P, 2009, CANCER J, V15, P344, DOI 10.1097/PPO.0b013e3181b282c2; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; NELSON HD, 2012, ANN INTERN MED, V157, pW1; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Pal L, 2012, MENOPAUSE, V19, P597, DOI 10.1097/gme.0b013e31825397f0; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409	13	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85121	10.1371/journal.pone.0085121	http://dx.doi.org/10.1371/journal.pone.0085121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391988	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900131
J	Rauhamaki, V; Wolfram, J; Jokitalo, E; Hanski, I; Dahlhoff, EP				Rauhamaki, Virve; Wolfram, Joy; Jokitalo, Eija; Hanski, Ilkka; Dahlhoff, Elizabeth P.			Differences in the Aerobic Capacity of Flight Muscles between Butterfly Populations and Species with Dissimilar Flight Abilities	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PHOSPHOGLUCOSE ISOMERASE PGI; RESPIRATORY-CHAIN ENZYMES; HONEYBEES APIS-MELLIFERA; DISPERSAL RATE; INSECT FLIGHT; EVOLUTIONARY DYNAMICS; FITNESS DIFFERENCES; ENERGY-METABOLISM; GENETIC-VARIATION	Habitat loss and climate change are rapidly converting natural habitats and thereby increasing the significance of dispersal capacity for vulnerable species. Flight is necessary for dispersal in many insects, and differences in dispersal capacity may reflect dissimilarities in flight muscle aerobic capacity. In a large metapopulation of the Glanville fritillary butterfly in the A land Islands in Finland, adults disperse frequently between small local populations. Individuals found in newly established populations have higher flight metabolic rates and field-measured dispersal distances than butterflies in old populations. To assess possible differences in flight muscle aerobic capacity among Glanville fritillary populations, enzyme activities and tissue concentrations of the mitochondrial protein Cytochrome-c Oxidase (CytOx) were measured and compared with four other species of Nymphalid butterflies. Flight muscle structure and mitochondrial density were also examined in the Glanville fritillary and a long-distance migrant, the red admiral. Glanville fritillaries from new populations had significantly higher aerobic capacities than individuals from old populations. Comparing the different species, strong-flying butterfly species had higher flight muscle CytOx content and enzymatic activity than short-distance fliers, and mitochondria were larger and more numerous in the flight muscle of the red admiral than the Glanville fritillary. These results suggest that superior dispersal capacity of butterflies in new populations of the Glanville fritillary is due in part to greater aerobic capacity, though this species has a low aerobic capacity in general when compared with known strong fliers. Low aerobic capacity may limit dispersal ability of the Glanville fritillary.	[Rauhamaki, Virve] Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, Helsinki Bioenerget Grp, Helsinki, Finland; [Wolfram, Joy; Hanski, Ilkka; Dahlhoff, Elizabeth P.] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland; [Dahlhoff, Elizabeth P.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	University of Helsinki; University of Helsinki; University of Helsinki; Santa Clara University	Dahlhoff, EP (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	edahlhoff@scu.edu	Wolfram, Joy/I-1574-2019; Dahlhoff, Elizabeth/AAI-1636-2020; Jokitalo, Eija/C-8375-2009	Wolfram, Joy/0000-0003-0579-9897; Dahlhoff, Elizabeth/0000-0002-7019-5005; Jokitalo, Eija/0000-0002-4159-6934	European Research Council [232826]; Academy of Finland [131155, 38604, 44887]; Sigrid Juselius Foundation; Biocentrum Helsinki; Fulbright U.S. Scholar Program (Dahlhoff); Division Of Environmental Biology [0844406] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Fulbright U.S. Scholar Program (Dahlhoff); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the European Research Council (AdG grant number 232826 to Hanski), Academy of Finland (Finnish CoE Programme, grant numbers 131155, 38604 and 44887 to Hanski), Sigrid Juselius Foundation and Biocentrum Helsinki, and the Fulbright U.S. Scholar Program (Dahlhoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio H, 2011, BUTTERFLIES EUROPE P; Asher J, 2001, MILLENNIUM ATLAS BUT; Asher J, 2011, J INSECT CONSERV, V15, P291, DOI 10.1007/s10841-010-9346-7; Austin A, 2011, OIKOS, V120, P1357, DOI 10.1111/j.1600-0706.2010.18992.x; BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Billeter Regula, 2003, Bulletin of the Geobotanical Institute ETH, V69, P45; Brattstrom O, 2010, ECOL ENTOMOL, V35, P248, DOI 10.1111/j.1365-2311.2009.01163.x; Brower LP, 2006, INTEGR COMP BIOL, V46, P1123, DOI 10.1093/icb/icl029; BROWN W D, 1990, Journal of Research on the Lepidoptera, V29, P1; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Guerra PA, 2009, BIOL LETTERS, V5, P229, DOI 10.1098/rsbl.2008.0570; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; Hanski I, 2002, OIKOS, V98, P87, DOI 10.1034/j.1600-0706.2002.980109.x; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hanski I, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P290; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Hanski IA, 2011, P NATL ACAD SCI USA, V108, P14397, DOI 10.1073/pnas.1110020108; Heidl SJ, 2013, EFFECTS LOCAL ENV GE; JOOS B, 1987, J EXP BIOL, V133, P317; Kallioniemi E, 2011, FUNCT ECOL, V25, P1032, DOI 10.1111/j.1365-2435.2011.01854.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Keppel J., 1997, DATA ANAL RES DESIGN; Klemme I, 2009, J EVOLUTION BIOL, V22, P1944, DOI 10.1111/j.1420-9101.2009.01807.x; Marden JH, 2013, EVOLUTION, V67, P1105, DOI 10.1111/evo.12004; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; Mikkola K, 2003, EUR J ENTOMOL, V100, P625, DOI 10.14411/eje.2003.091; Niitepold K, 2011, OECOLOGIA, V165, P847, DOI 10.1007/s00442-010-1886-8; Niitepold K, 2010, J EXP BIOL, V213, P1042, DOI 10.1242/jeb.034132; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Niven JE, 2005, BIOL LETTERS, V1, P346, DOI 10.1098/rsbl.2005.0311; O'Brien DM, 1999, J EXP BIOL, V202, P441; OBRIEN J, 1991, PHYSIOL ZOOL, V64, P1509, DOI 10.1086/physzool.64.6.30158227; Orsini L, 2009, J EVOLUTION BIOL, V22, P367, DOI 10.1111/j.1420-9101.2008.01653.x; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261; Saastamoinen M, 2008, HEREDITY, V100, P39, DOI 10.1038/sj.hdy.6801056; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Sacktor B, 1976, Biochem Soc Symp, P111; Shreeve TG, 2001, J INSECT CONSERV, V5, P145, DOI 10.1023/A:1017556113534; Sogl B, 2000, EUR J BIOCHEM, V267, P11, DOI 10.1046/j.1432-1327.2000.00936.x; Stefanescu C, 2001, ECOL ENTOMOL, V26, P525, DOI 10.1046/j.1365-2311.2001.00347.x; Suarez RK, 2011, J EXP BIOL, V214, P172, DOI 10.1242/jeb.047936; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; Suarez RK, 1999, J EXP ZOOL, V284, P1, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;1::AID-JEZ1&gt;3.0.CO;2-P; Suarez RK, 2000, J EXP BIOL, V203, P905; Sutcliffe OL, 1996, CONSERV BIOL, V10, P1359, DOI 10.1046/j.1523-1739.1996.10051359.x; Sutcliffe OL, 1997, OECOLOGIA, V109, P235, DOI 10.1007/s004420050078; TAYLOR CR, 1987, ANNU REV PHYSIOL, V49, P135, DOI 10.1146/annurev.ph.49.030187.001031; Van Dyck S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013923; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Vogt JT, 2000, J INSECT PHYSIOL, V46, P697, DOI 10.1016/S0022-1910(99)00158-4; Wang RJ, 2011, ECOL ENTOMOL, V36, P251, DOI 10.1111/j.1365-2311.2011.01267.x; Watt Ward B., 2003, P319; WATT WB, 1992, P NATL ACAD SCI USA, V89, P10608, DOI 10.1073/pnas.89.22.10608; WATT WB, 1977, GENETICS, V87, P177; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2007, ANNU REV ECOL EVOL S, V38, P793, DOI 10.1146/annurev.ecolsys.38.091206.095615; Zheng CZ, 2009, PHILOS T R SOC B, V364, P1519, DOI 10.1098/rstb.2009.0005	74	12	12	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e78069	10.1371/journal.pone.0078069	http://dx.doi.org/10.1371/journal.pone.0078069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416122	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500003
J	Gkouvatsos, K; Fillebeen, C; Daba, A; Wagner, J; Sebastiani, G; Pantopoulos, K				Gkouvatsos, Konstantinos; Fillebeen, Carine; Daba, Alina; Wagner, John; Sebastiani, Giada; Pantopoulos, Kostas			Iron-Dependent Regulation of Hepcidin in Hjv-/- Mice: Evidence That Hemojuvelin Is Dispensable for Sensing Body Iron Levels	PLOS ONE			English	Article							DIETARY IRON; OVERLOAD; MODEL; EXPRESSION; LIVER; SERUM	Hemojuvelin (Hjv) is a bone morphogenetic protein (BMP) co-receptor involved in the control of systemic iron homeostasis. Functional inactivation of Hjv leads to severe iron overload in humans and mice due to marked suppression of the ironregulatory hormone hepcidin. To investigate the role of Hjv in body iron sensing, Hjv-/- mice and isogenic wild type controls were placed on a moderately low, a standard or a high iron diet for four weeks. Hjv-/- mice developed systemic iron overload under all regimens. Transferrin (Tf) was highly saturated regardless of the dietary iron content, while liver iron deposition was proportional to it. Hepcidin mRNA expression responded to fluctuations in dietary iron intake, despite the absence of Hjv. Nevertheless, iron-dependent upregulation of hepcidin was more than an order of magnitude lower compared to that seen in wild type controls. Likewise, iron signaling via the BMP/ Smad pathway was preserved but substantially attenuated. These findings suggest that Hjv is not required for sensing of body iron levels and merely functions as an enhancer for iron signaling to hepcidin.	[Gkouvatsos, Konstantinos; Fillebeen, Carine; Daba, Alina; Wagner, John; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sebastiani, Giada] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3A 1A1, Canada; [Sebastiani, Giada; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Royal Victoria Hospital; McGill University	Pantopoulos, K (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	kostas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057; Sebastiani, Giada/0000-0003-2655-8283	Canadian Institutes for Health Research (CIHR) [MOP-86515]; Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (CIHR; MOP-86515). KG and AD are recipients of doctoral fellowships from the Fonds de la Recherche en Sante du Quebec (FRSQ). GS and KP hold Chercheur-Boursier and Chercheur National career awards, respectively, from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Camus LM, 2007, J MOL EVOL, V65, P68, DOI 10.1007/s00239-006-0241-5; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; Chua ACG, 2011, HEPATOLOGY, V54, P16, DOI 10.1002/hep.24449; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2007, BLOOD CELL MOL DIS, V39, P92, DOI 10.1016/j.bcmd.2007.02.004; Krijt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037391; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138; Sebastiani G, 2011, METALLOMICS, V3, P971, DOI 10.1039/c1mt00082a; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	26	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85530	10.1371/journal.pone.0085530	http://dx.doi.org/10.1371/journal.pone.0085530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409331	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500055
J	Liu, F; Gore, AJ; Wilson, JL; Korc, M				Liu, Fang; Gore, A. Jesse; Wilson, Julie L.; Korc, Murray			DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; MKP-1; INHIBITION; EXPRESSION; GROWTH; OVEREXPRESSION; RESISTANCE; BIOLOGY	Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a poor prognosis that is characterized by excessive mitogenic pathway activation and marked chemoresistance to a broad spectrum of chemotherapeutic drugs. Dual specificity protein phosphatase 1 (DUSP1) is a key negative regulator of mitogen activated protein kinases (MAPKs). Yet, DUSP1 is overexpressed in pancreatic cancer cells (PCCs) in PDAC where it paradoxically enhances colony formation in soft agar and promotes in vivo tumorigenicity. However, it is not known whether DUSP1 overexpression contributes to PDAC chemoresistance. Using BxPC3 and COLO-357 human PCCs, we show that gemcitabine activates c-JUN N-terminal kinase (JNK) and p38 mitogen activated protein kinase (p38 MAPK), key kinases in two major stress-activated signaling pathways. Gemcitabine-induced JNK and p38 MAPK activation mediates increased apoptosis, but also transcriptionally upregulates DUSP1, as evidenced by increased DUSP1 mRNA levels and RNA polymerase II loading at DUSP1 gene body. Conversely, shRNA-mediated inhibition of DUSP1 enhances JNK and p38 MAPK activation and gemcitabine chemosensitivity. Using doxycycline-inducible knockdown of DUSP1 in established orthotopic pancreatic tumors, we found that combining gemcitabine with DUSP1 inhibition improves animal survival, attenuates angiogenesis, and enhances apoptotic cell death, as compared with gemcitabine alone. Taken together, these results suggest that gemcitabine-mediated upregulation of DUSP1 contributes to a negative feedback loop that attenuates its beneficial actions on stress pathways and apoptosis, raising the possibility that targeting DUSP1 in PDAC may have the advantage of enhancing gemcitabine chemosensitivity while suppressing angiogenesis.	[Korc, Murray] Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Mol Biol, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Ctr Pancreat Canc Res, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Korc, M (corresponding author), Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA.	mkorc@iu.edu			National Cancer Institute (NCI) [CA-R37-075059]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA075059, R37CA075059] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant CA-R37-075059 to MK, awarded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bang YJ, 1998, BIOCHEM BIOPH RES CO, V250, P43, DOI 10.1006/bbrc.1998.9256; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Casals-Casas C, 2009, EUR J IMMUNOL, V39, P1902, DOI 10.1002/eji.200839037; CHANG SC, 1990, J NUTR, V120, P1228, DOI 10.1093/jn/120.10.1228; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; Denkert C, 2002, INT J CANCER, V102, P507, DOI 10.1002/ijc.10746; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Kleeff J, 1998, J BIOL CHEM, V273, P7495, DOI 10.1074/jbc.273.13.7495; Korc M, 2003, MOL CANCER, V2, P1; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Landry J, 2010, J SURG ONCOL, V101, P587, DOI 10.1002/jso.21527; Liao Q, 2003, GASTROENTEROLOGY, V124, P1830, DOI 10.1016/S0016-5085(03)00398-6; Liu F, 2012, MOL CANCER THER, V11, P2138, DOI 10.1158/1535-7163.MCT-12-0562; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Loda M, 1996, AM J PATHOL, V149, P1553; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Moncho-Amor V, 2011, ONCOGENE, V30, P668, DOI 10.1038/onc.2010.449; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schutte M, 1997, CANCER RES, V57, P3126; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Srikanth S, 1999, MOL CELL BIOCHEM, V199, P169, DOI 10.1023/A:1006980326855; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang JL, 2007, CANCER RES, V67, P6737, DOI 10.1158/0008-5472.CAN-06-4402; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188	41	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84982	10.1371/journal.pone.0084982	http://dx.doi.org/10.1371/journal.pone.0084982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409315	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500039
J	Park, B; Kim, DS; Park, HJ				Park, Bumhee; Kim, Dae-Shik; Park, Hae-Jeong			Graph Independent Component Analysis Reveals Repertoires of Intrinsic Network Components in the Human Brain	PLOS ONE			English	Article							RESTING-STATE NETWORKS; HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; ARCHITECTURE; MODEL; FMRI; MRI; PET	Does each cognitive task elicit a new cognitive network each time in the brain? Recent data suggest that pre-existing repertoires of a much smaller number of canonical network components are selectively and dynamically used to compute new cognitive tasks. To this end, we propose a novel method (graph-ICA) that seeks to extract these canonical network components from a limited number of resting state spontaneous networks. Graph-ICA decomposes a weighted mixture of source edge-sharing subnetworks with different weighted edges by applying an independent component analysis on cross-sectional brain networks represented as graphs. We evaluated the plausibility in our simulation study and identified 49 intrinsic subnetworks by applying it in the resting state fMRI data. Using the derived subnetwork repertories, we decomposed brain networks during specific tasks including motor activity, working memory exercises, and verb generation, and identified subnetworks associated with performance on these tasks. We also analyzed sex differences in utilization of subnetworks, which was useful in characterizing group networks. These results suggest that this method can effectively be utilized to identify task-specific as well as sex-specific functional subnetworks. Moreover, graph-ICA can provide more direct information on the edge weights among brain regions working together as a network, which cannot be directly obtained through voxel-level spatial ICA.	[Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul 120749, South Korea; [Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120749, South Korea; [Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Park, HJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea.	parkhj@yuhs.ac	Kim, Dae-Shik/C-2071-2011	Park, Hae-Jeong/0000-0002-4633-0756	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20100018839]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20100018839 for HJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Karunanayaka P, 2010, NEUROIMAGE, V51, P472, DOI 10.1016/j.neuroimage.2009.12.108; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Llinas R.R., 2001, I VORTEX NEURONS SEL; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; McIntosh AR, 2004, NEUROINFORMATICS, V2, P175, DOI 10.1385/NI:2:2:175; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074935; Park HJ, 2003, HUM BRAIN MAPP, V18, P284, DOI 10.1002/hbm.10085; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2007, NEUROIMAGE, V37, P1050, DOI 10.1016/j.neuroimage.2007.02.021; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	48	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e82873	10.1371/journal.pone.0082873	http://dx.doi.org/10.1371/journal.pone.0082873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409279	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500003
J	Alemu, JB I; Clement, Y				Alemu, Jahson Berhane, I; Clement, Ysharda			Mass Coral Bleaching in 2010 in the Southern Caribbean	PLOS ONE			English	Article							CLIMATE-CHANGE; REEFS; MORTALITY; ISLAND	Ocean temperatures are increasing globally and the Caribbean is no exception. An extreme ocean warming event in 2010 placed Tobago's coral reefs under severe stress resulting in widespread coral bleaching and threatening the livelihoods that rely on them. The bleaching response of four reef building taxa was monitored over a six month period across three major reefs systems in Tobago. By identifying taxa resilient to bleaching we propose to assist local coral reef managers in the decision making process to cope with mass bleaching events. The bleaching signal (length of exposure to high ocean temperatures) varied widely between the Atlantic and Caribbean reefs, but regardless of this variation most taxa bleached. Colpophyllia natans, Montastraea faveolata and Siderastrea siderea were considered the most bleaching vulnerable taxa. Interestingly, reefs with the highest coral cover showed the greatest decline reef building taxa, and conversely, reefs with the lowest coral cover showed the most bleaching but lowest change in coral cover with little algal overgrowth post-bleaching.	[Alemu, Jahson Berhane, I; Clement, Ysharda] Inst Marine Affairs, Biodivers & Ecol Res Programme, Chaguaramas, Trinidad Tobago; [Alemu, Jahson Berhane, I] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Alemu, JB I (corresponding author), Inst Marine Affairs, Biodivers & Ecol Res Programme, Hilltop Lane, Chaguaramas, Trinidad Tobago.	jalemu@ima.gov.tt		Alemu I, Jahson/0000-0002-6936-2857	IMA; DMRF	IMA; DMRF	This report is dedicated to the memory of the late Learmond Chapman, a friend and colleague who assisted in this assessment. Special thanks to the staff and support at the IMA and DMRF, TNC and reviewers RvW, RL, PK, RJ, SW, MCM, DATP, AG, ASC and PM.	Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Burke L., 2008, COASTAL CAPITAL EC V; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; EGANA AC, 1982, PAC SCI, V36, P61; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Hill JJ, 2004, METHODS ECOLOGICAL M; JAAP WC, 1985, P 5 INT COR REEF C T, V6, P143; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LANG JC, 1992, AM ZOOL, V32, P696; LAYDOO RS, 1991, GUIDE CORAL REEFS TO; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mallela J, 2010, CARIBB J SCI, V46, P83; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; McGrath TA, 1998, REV BIOL TROP, V46, P91; MULLERKARGER FE, 1988, NATURE, V333, P56, DOI 10.1038/333056a0; NOAA Coral Reef Watch, 2000, NOAA COR REEF WATCH; O'Farrell S, 2006, REPORT 2005 MASS C 1; Oxenford HA, 2008, CLIMATIC CHANGE, V87, P435, DOI 10.1007/s10584-007-9311-y; Phongsuwan N, 1998, CORAL REEFS, V17, P70, DOI 10.1007/s003380050097; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Tan J, 2012, IEEE POW ENER SOC GE; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CARIBBEAN COR; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1	27	42	42	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83829	10.1371/journal.pone.0083829	http://dx.doi.org/10.1371/journal.pone.0083829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400078	gold, Green Published, Green Submitted			2022-12-25	WOS:000329462700012
J	Chakravorty, R; Rawlinson, D; Zhang, A; Markham, J; Dowling, MR; Wellard, C; Zhou, JHS; Hodgkin, PD				Chakravorty, Rajib; Rawlinson, David; Zhang, Alan; Markham, John; Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.			Labour-Efficient In Vitro Lymphocyte Population Tracking and Fate Prediction Using Automation and Manual Review	PLOS ONE			English	Review							CELL TRACKING; LINEAGE CONSTRUCTION; CHEMOTAXIS; SOFTWARE; MINIMUM	Interest in cell heterogeneity and differentiation has recently led to increased use of time-lapse microscopy. Previous studies have shown that cell fate may be determined well in advance of the event. We used a mixture of automation and manual review of time-lapse live cell imaging to track the positions, contours, divisions, deaths and lineage of 44 B-lymphocyte founders and their 631 progeny in vitro over a period of 108 hours. Using this data to train a Support Vector Machine classifier, we were retrospectively able to predict the fates of individual lymphocytes with more than 90% accuracy, using only time-lapse imaging captured prior to mitosis or death of 90% of all cells. The motivation for this paper is to explore the impact of labour-efficient assistive software tools that allow larger and more ambitious live-cell time-lapse microscopy studies. After training on this data, we show that machine learning methods can be used for realtime prediction of individual cell fates. These techniques could lead to realtime cell culture segregation for purposes such as phenotype screening. We were able to produce a large volume of data with less effort than previously reported, due to the image processing, computer vision, tracking and human-computer interaction tools used. We describe the workflow of the software-assisted experiments and the graphical interfaces that were needed. To validate our results we used our methods to reproduce a variety of published data about lymphocyte populations and behaviour. We also make all our data publicly available, including a large quantity of lymphocyte spatio-temporal dynamics and related lineage information.	[Chakravorty, Rajib; Rawlinson, David; Zhang, Alan; Markham, John] Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic, Australia; [Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	NICTA; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Chakravorty, R (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic, Australia.	rajib.chakravorty@nicta.com.au		Hodgkin, Philip/0000-0002-8604-1940; Zhou, Jie/0000-0002-9113-800X; Dowling, Mark/0000-0002-8056-5348; Rawlinson, David/0000-0001-9443-3840; Markham, John/0000-0002-5738-3861	Australian Government; Australian Research Council through the ICT Centre of Excellence program	Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. WEHI contribution to this work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-74; Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; BARSHALOM Y, 1975, AUTOMATICA, V11, P451, DOI 10.1016/0005-1098(75)90021-7; BISE R, 2011, IEEE INT S BIOM IM; *BITPL, IM; Brown MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000741; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; BRUCE V, 1999, J EXPT PSYCHOL APPL, V5; CHALLA S, 2002, TARGET TRACKING BAYE, V1, P437; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; COLLINS M, 2009, COMBINATORIAL CHEM H, V12; Debeir O, 2004, CYTOM PART A, V60A, P29, DOI 10.1002/cyto.a.20040; DOWNEY M, 2011, IEEE INT S BIOM IM N; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; FENDLEY ME, 2009, THESIS WRIGHT STATE; Fortmann T. E., 1980, Proceedings of the 19th IEEE Conference on Decision & Control Including the Symposium on Adaptive Processes, P807; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Higgins JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000288; *INSTR K, 2011, MAN CELL TRACK FIJ; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kachouie NN, 2007, IEEE T BIO-MED ENG, V54, P2011, DOI 10.1109/TBME.2007.895747; Kan A, 2011, J MICROSC-OXFORD, V244, P194, DOI 10.1111/j.1365-2818.2011.03529.x; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Li K, 2007, LECT NOTES COMPUT SC, V4792, P295; Markham JF, 2010, J R SOC INTERFACE, V7, P1049, DOI 10.1098/rsif.2009.0488; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; *MOL DEV, MET; MOLLER C, 2010, DRUG DISCOVERY TODAY, V15; MOOGK DR, 2009, THESIS WATERLOO; Musicki D, 2002, IEEE DECIS CONTR P, P2415, DOI 10.1109/CDC.2002.1184197; MUSICKI D, 1994, IEEE T AUTOMAT CONTR, V39, P1237, DOI 10.1109/9.293185; PAVLIDIS T, 1978, IEEE T SYST MAN CYB, V8, P66; *PERKINELMER, VOL; Rapoport DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027315; Rasband W., 2006, IMAGEJ; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Scherf N, 2012, EXP HEMATOL, V40, P119, DOI 10.1016/j.exphem.2011.10.009; SCHROEDER T, 2011, NATURE METHODS, V8; Schroeder T, 2010, NAT METHODS, V7, P190, DOI 10.1038/nmeth0310-190; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; *WARW SYST BIOL CT, CELLTR; *WARW SYST BIOL CT, LIN; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; ZANELLA F, 2010, TRENDS BIOTECHNOLOGY, V28; Zhou J, 2007, LECT NOTES COMPUT SC, V4552, P1028; Zhou J, 2006, ISPRS J PHOTOGRAMM, V61, P108, DOI 10.1016/j.isprsjprs.2006.09.002; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83251	10.1371/journal.pone.0083251	http://dx.doi.org/10.1371/journal.pone.0083251			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404133	Green Published, gold			2022-12-25	WOS:000329460800012
J	Boyer-Di Ponio, J; El-Ayoubi, F; Glacial, F; Ganeshamoorthy, K; Driancourt, C; Godet, M; Perriere, N; Guillevic, O; Couraud, PO; Uzan, G				Boyer-Di Ponio, Julie; El-Ayoubi, Fida; Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Driancourt, Catherine; Godet, Maeva; Perriere, Nicolas; Guillevic, Oriane; Couraud, Pierre Olivier; Uzan, Georges			Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes	PLOS ONE			English	Article							RISK-FACTORS; CELLS; DIFFERENTIATION; EXPRESSION; MODEL; NOTCH; IDENTIFICATION; ARTERIOGENESIS; ACTIVATION; INTEGRITY	Objective: The vascular system is adapted to specific functions in different tissues and organs. Vascular endothelial cells are important elements of this adaptation, leading to the concept of 'specialized endothelial cells'. The phenotype of these cells is highly dependent on their specific microenvironment and when isolated and cultured, they lose their specific features after few passages, making models using such cells poorly predictive and irreproducible. We propose a new source of specialized endothelial cells based on cord blood circulating endothelial progenitors (EPCs). As prototype examples, we evaluated the capacity of EPCs to acquire properties characteristic of cerebral microvascular endothelial cells (blood-brain barrier (BBB)) or of arterial endothelial cells, in specific inducing culture conditions. Approach and Results: First, we demonstrated that EPC-derived endothelial cells (EPDCs) co-cultured with astrocytes acquired several BBB phenotypic characteristics, such as restricted paracellular diffusion of hydrophilic solutes and the expression of tight junction proteins. Second, we observed that culture of the same EPDCs in a high concentration of VEGF resulted, through activation of Notch signaling, in an increase of expression of most arterial endothelial markers. Conclusions: We have thus demonstrated that in vitro culture of early passage human cord blood EPDCs under specific conditions can induce phenotypic changes towards BBB or arterial phenotypes, indicating that these EPDCs maintain enough plasticity to acquire characteristics of a variety of specialized phenotypes. We propose that this property of EPDCs might be exploited for producing specialized endothelial cells in culture to be used for drug testing and predictive in vitro assays.	[Boyer-Di Ponio, Julie; Driancourt, Catherine; Guillevic, Oriane; Uzan, Georges] Hop Paul Brousse, INSERM, U972, Villejuif, France; [El-Ayoubi, Fida] ABCell Bio, Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] CNRS, UMR8104, Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Perriere, Nicolas] VigiCell Villejuif Biopk, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Uzan, G (corresponding author), Hop Paul Brousse, INSERM, U972, Villejuif, France.	georges.uzan@inserm.fr	Uzan, Georges/M-8199-2018	Uzan, Georges/0000-0002-0178-5386	National Research Agency (ANR, Barrier project, Fond unique d'investissement) [AAP7:109-2024/R]	National Research Agency (ANR, Barrier project, Fond unique d'investissement)(French National Research Agency (ANR))	This work was supported by a grant by the National Research Agency (ANR, Barrier project, Fond unique d'investissement AAP7:109-2024/R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2011, ARTERIOSCL THROM VAS, V31, P1476, DOI 10.1161/ATVBAHA.111.228999; Avouac J, 2008, JOINT BONE SPINE, V75, P131, DOI 10.1016/j.jbspin.2007.09.006; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Disassa NM, 2009, PHYSIOL RES, V58, P193, DOI 10.33549/physiolres.931410; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; FINA L, 1990, BLOOD, V75, P2417; Fujii T, 2008, ATHEROSCLEROSIS, V200, P51, DOI 10.1016/j.atherosclerosis.2007.12.012; Han JW, 2012, ANTIOXID REDOX SIGN, V17, P205, DOI 10.1089/ars.2011.4375; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kikuchi R, 2011, LAB INVEST, V91, P691, DOI 10.1038/labinvest.2011.5; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Luissint AC, 2012, J CEREBR BLOOD F MET, V32, P860, DOI 10.1038/jcbfm.2011.202; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Ribatti D, 2009, ANGIOGENESIS, V12, P101, DOI 10.1007/s10456-008-9125-1; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Umemura T, 2008, AM J HYPERTENS, V21, P1203, DOI 10.1038/ajh.2008.278; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	47	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84179	10.1371/journal.pone.0084179	http://dx.doi.org/10.1371/journal.pone.0084179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392113	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100037
J	Forterre, A; Jalabert, A; Berger, E; Baudet, M; Chikh, K; Errazuriz, E; De Larichaudy, J; Chanon, S; Weiss-Gayet, M; Hesse, AM; Record, M; Geloen, A; Lefai, E; Vidal, H; Coute, Y; Rome, S				Forterre, Alexis; Jalabert, Audrey; Berger, Emmanuelle; Baudet, Mathieu; Chikh, Karim; Errazuriz, Elisabeth; De Larichaudy, Joffrey; Chanon, Stephanie; Weiss-Gayet, Michele; Hesse, Anne-Marie; Record, Michel; Geloen, Alain; Lefai, Etienne; Vidal, Hubert; Coute, Yohann; Rome, Sophie			Proteomic Analysis of C2C12 Myoblast and Myotube Exosome-Like Vesicles: A New Paradigm for Myoblast-Myotube Cross Talk?	PLOS ONE			English	Article							CELL-DERIVED EXOSOMES; DENDRITIC CELLS; PROTEINS; DIFFERENTIATION; IDENTIFICATION; FUSION; MECHANISM; COMMITMENT; TRANSPORT; MICRORNAS	Exosomes are nanometer-sized microvesicles formed in multivesicular bodies (MVBs) during endosome maturation. Exosomes are released from cells into the microenvironment following fusion of MVBs with the plasma membrane. During the last decade, skeletal muscle-secreted proteins have been identified with important roles in intercellular communications. To investigate whether muscle-derived exosomes participate in this molecular dialog, we determined and compared the protein contents of the exosome-like vesicles (ELVs) released from C2C12 murine myoblasts during proliferation (ELV-MB), and after differentiation into myotubes (ELV-MT). Using a proteomic approach combined with electron microscopy, western-blot and bioinformatic analyses, we compared the protein repertoires within ELV-MB and ELV-MT. We found that these vesicles displayed the classical properties of exosomes isolated from other cell types containing components of the ESCRT machinery of the MVBs, as well as numerous tetraspanins. Specific muscle proteins were also identified confirming that ELV composition also reflects their muscle origin. Furthermore quantitative analysis revealed stage-preferred expression of 31 and 78 proteins in ELV-MB and ELV-MT respectively. We found that myotube-secreted ELVs, but not ELV-MB, reduced myoblast proliferation and induced differentiation, through, respectively, the down-regulation of Cyclin D1 and the up-regulation of myogenin. We also present evidence that proteins from ELV-MT can be incorporated into myoblasts by using the GFP protein as cargo within ELV-MT. Taken together, our data provide a useful database of proteins from C2C12-released ELVs throughout myogenesis and reveals the importance of exosome-like vesicles in skeletal muscle biology.	[Forterre, Alexis; Jalabert, Audrey; Berger, Emmanuelle; Chikh, Karim; De Larichaudy, Joffrey; Chanon, Stephanie; Geloen, Alain; Lefai, Etienne; Vidal, Hubert; Rome, Sophie] Univ Lyon, Fac Med Lyon Sud, CarMeN Lab, INSERM 1060,INRA 1362,INSA, Oullins, France; [Errazuriz, Elisabeth] Univ Lyon, SFR Sante Lyon Est, Ctr Commun Imagerie Laennec CeCIL, Lyon, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Record, Michel] CRCT, INSERM UMR 1037, Toulouse, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] INSERM, U1038, Grenoble, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] Grenoble Alpes Univ, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Weiss-Gayet, Michele] Univ Lyon, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire CGPhiMC, Lyon, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rome, S (corresponding author), Univ Lyon, Fac Med Lyon Sud, CarMeN Lab, INSERM 1060,INRA 1362,INSA, Oullins, France.	srome@univ-lyon1.fr	RECORD, Michel/G-3493-2017; Carmen, Team1/Y-7382-2019; Couté, Yohann/G-2695-2015; Vidal, Hubert/M-6674-2017; Lefai, Etienne/E-9615-2019; Lefai, Etienne/L-7961-2019	RECORD, Michel/0000-0003-1893-0022; Carmen, Team1/0000-0003-4234-1746; Couté, Yohann/0000-0003-3896-6196; Vidal, Hubert/0000-0002-9467-0317; Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Lab, Carmen/0000-0002-5935-3236; Chanon, Stephanie/0000-0001-6930-6671; GELOEN, Alain/0000-0001-7921-1254; Hesse, Anne-Marie/0000-0001-6110-0636; ROME, SOPHIE/0000-0003-3986-5936; Forterre, Alexis/0000-0002-5000-9009; CHIKH, Karim/0000-0002-1217-4193	Fondation pour la Recherche Medicale (FRM); Association Francaise de recherche sur les Myopathies (AFM); Association Francaise de Diabetologie (SDF/Rochediagnostics France); INRA specific grant (ANSSD)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise de recherche sur les Myopathies (AFM); Association Francaise de Diabetologie (SDF/Rochediagnostics France); INRA specific grant (ANSSD)	This work was supported by grants from Fondation pour la Recherche Medicale (FRM), Association Francaise de recherche sur les Myopathies (AFM), Association Francaise de Diabetologie (SDF/Rochediagnostics France) and INRA specific grant (ANSSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN JH, 1993, BLOOD, V81, P2442; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; BISCHOFF R, 1990, J CELL BIOL, V111, P201, DOI 10.1083/jcb.111.1.201; Bolton K, 2009, INT J OBESITY, V33, P1153, DOI 10.1038/ijo.2009.148; Bortoluzzi S, 2006, PROTEINS, V62, P776, DOI 10.1002/prot.20803; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Charlton CA, 2000, DEV BIOL, V221, P112, DOI 10.1006/dbio.2000.9654; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; DOERING JL, 1977, EXP CELL RES, V105, P437, DOI 10.1016/0014-4827(77)90140-9; Estelles A, 2007, INT J NANOMED, V2, P751; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Grabowska I, 2011, CELL BIOL INT, V35, P125, DOI 10.1042/CBI20090335; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hindle AK, 2010, INT J OBESITY, V34, P1020, DOI 10.1038/ijo.2010.23; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; KONIGSBERG IR, 1971, DEV BIOL, V26, P133, DOI 10.1016/0012-1606(71)90113-8; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Azevedo LCP, 2007, CRIT CARE, V11, DOI 10.1186/cc6176; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Rana S, 2012, INT J BIOCH CELL BIO; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yoon JH, 2009, PROTEOMICS, V9, P51, DOI 10.1002/pmic.200800187; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163	64	117	120	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84153	10.1371/journal.pone.0084153	http://dx.doi.org/10.1371/journal.pone.0084153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392111	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100035
J	Haupert, S; Guerard, S; Peyrin, F; Mitton, D; Laugier, P				Haupert, Sylvain; Guerard, Sandra; Peyrin, Francoise; Mitton, David; Laugier, Pascal			Non Destructive Characterization of Cortical Bone Micro-Damage by Nonlinear Resonant Ultrasound Spectroscopy	PLOS ONE			English	Article							IN-VIVO; MICRODAMAGE ACCUMULATION; MECHANICAL-PROPERTIES; FATIGUE RESISTANCE; FRACTURE; ELASTICITY; MORPHOLOGY; TIME; MICROCRACKS; DEGRADATION	The objective of the study was to evaluate the ability of a nonlinear ultrasound technique, the so-called nonlinear resonant ultrasound spectroscopy (NRUS) technique, for detecting early microdamage accumulation in cortical bone induced by four-point bending fatigue. Small parallelepiped beam-shaped human cortical bone specimens were subjected to cyclic four-point bending fatigue in several steps. The specimens were prepared to control damage localization during four-point bending fatigue cycling and to unambiguously identify resonant modes for NRUS measurements. NRUS measurements were achieved to follow the evolution of the nonlinear hysteretic elastic behavior during fatigue-induced damage. After each fatigue step, a small number of specimens was removed from the protocol and set apart to quantitatively assess the microcrack number density and length using synchrotron radiation micro-computed tomography (SR-mu CT). The results showed a significant effect of damage steps on the nonlinear hysteretic elastic behavior. No significant change in the overall length of microcracks was observed in damaged regions compared to the load-free control regions. Only an increased number of shortest microcracks, those in the lowest quartile, was noticed. This was suggestive of newly formed microcracks during the early phases of damage accumulation. The variation of nonlinear hysteretic elastic behavior was significantly correlated to the variation of the density of short microcracks. Our results suggest that the nonlinear hysteretic elastic behavior is sensitive to early bone microdamage. Therefore NRUS technique can be used to monitor fatigue microdamage progression in in vitro experiments.	[Haupert, Sylvain; Laugier, Pascal] Univ Paris 06, CNRS UMR7623, Lab Imagerie Parametr, Paris, France; [Guerard, Sandra] Arts & Metiers ParisTech, LBM, Paris, France; [Peyrin, Francoise] Univ Lyon 1, INSA Lyon, CNRS 5220, CREATIS,INSERM U1044, F-69365 Lyon, France; [Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Mitton, David] Univ Lyon 1, IFSTTAR, LBMC, UMR T 9406, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Arts et Metiers Institute of Technology; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel	Haupert, S (corresponding author), Univ Paris 06, CNRS UMR7623, Lab Imagerie Parametr, Paris, France.	sylvain.haupert@upmc.fr	Mitton, David/H-5695-2018; Peyrin, Francoise/G-2823-2013; Laugier, Pascal/P-1658-2017	Mitton, David/0000-0001-9260-0916; Peyrin, Francoise/0000-0002-1988-3435; Laugier, Pascal/0000-0002-7498-0262; haupert, sylvain/0000-0003-4705-4527; Guerard, Sandra/0000-0002-5601-1054	Agence Nationale pour la Recherche (ANR), France [BONUS_07BLAN0197]	Agence Nationale pour la Recherche (ANR), France(French National Research Agency (ANR))	This research was supported by the Agence Nationale pour la Recherche (ANR), France (Grant BONUS_07BLAN0197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2011, BONE, V49, P56, DOI 10.1016/j.bone.2010.10.159; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; ASTM, 2008, D6272 ASTM; BEHIRI JC, 1980, J MATER SCI, V15, P1841, DOI 10.1007/BF00550605; Bennell KL, 1998, CALCIFIED TISSUE INT, V63, P505, DOI 10.1007/s002239900565; Boyce TM, 1998, J ORTHOP RES, V16, P322, DOI 10.1002/jor.1100160308; Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Chapurlat RD, 2009, OSTEOPOROSIS INT, V20, P1299, DOI 10.1007/s00198-009-0899-9; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Diab T, 2006, BONE, V38, P427, DOI 10.1016/j.bone.2005.09.002; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; Diab T, 2007, BONE, V40, P612, DOI 10.1016/j.bone.2006.09.027; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Engan HE, 2006, ULTRASON, P2096, DOI 10.1109/ULTSYM.2006.502; Frost H, 1960, H FORD HOSP MED B, V8, P35; GRANATO A, 1956, J APPL PHYS, V27, P583, DOI 10.1063/1.1722436; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; Griffin LV, 1997, J BIOMECH, V30, P185, DOI 10.1016/S0021-9290(96)00124-8; Gupta HS, 2008, MED ENG PHYS, V30, P1209, DOI 10.1016/j.medengphy.2008.09.007; Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b; Guyer RA, 1999, PHYS TODAY, V52, P30, DOI 10.1063/1.882648; Haupert S, 2011, J ACOUST SOC AM, V130, P2654, DOI 10.1121/1.3641405; Hoff L, 2003, ULTRASON, P1010; Huja SS, 1999, J BIOMECH, V32, P1243, DOI 10.1016/S0021-9290(99)00047-0; Johnson P, 2005, J ACOUST SOC AM, V117, P124, DOI 10.1121/1.1823351; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Landrigan MD, 2009, J BIOMECH, V42, P1212, DOI 10.1016/j.jbiomech.2009.03.016; Larrue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021297; Laugier P, 2008, IEEE T ULTRASON FERR, V55, P1179, DOI 10.1109/TUFFC.2008.782; Lee TC, 2000, J ORTHOPAED RES, V18, P322, DOI 10.1002/jor.1100180222; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Lee TC, 1998, J ANAT, V193, P179, DOI 10.1046/j.1469-7580.1998.19320179.x; Li JL, 2005, BONE, V37, P819, DOI 10.1016/j.bone.2005.06.022; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; Martin RB, 2007, BONE, V40, P1159, DOI 10.1016/j.bone.2006.11.014; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Moreschi H, 2011, P I MECH ENG H, V225, P1; Muller M, 2008, J BIOMECH, V41, P1062, DOI 10.1016/j.jbiomech.2007.12.004; Muller M, 2006, ULTRASONICS, V44, pE245, DOI 10.1016/j.ultras.2006.06.043; Muller M, 2005, J ACOUST SOC AM, V118, P3946, DOI 10.1121/1.2126917; Nalla RK, 2005, BIOMATERIALS, V26, P2183, DOI 10.1016/j.biomaterials.2004.05.024; Nicholson PHF, 2000, J BONE MINER RES, V15, P2467, DOI 10.1359/jbmr.2000.15.12.2467; Nicolella DP, 2011, J MECH BEHAV BIOMED, V4, P383, DOI 10.1016/j.jmbbm.2010.11.007; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; O'Brien FJ, 2007, INT J FATIGUE, V29, P1051, DOI 10.1016/j.ijfatigue.2006.09.017; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Payan C, 2010, CEMENT CONCRETE RES, V40, P473, DOI 10.1016/j.cemconres.2009.10.021; Presbitero G, 2012, J THEOR BIOL, V304, P164, DOI 10.1016/j.jtbi.2012.03.027; REIFSNIDER KL, 1982, INT J FATIGUE, V4, P187, DOI 10.1016/0142-1123(82)90001-9; Renaud G, 2008, IEEE T ULTRASON FERR, V55, P1497, DOI 10.1109/TUFFC.2008.825; Renaud G, 2008, INT J NONLIN MECH, V43, P194, DOI 10.1016/j.ijnonlinmec.2007.12.007; Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034; Tai K, 2006, NANO LETT, V6, P2520, DOI 10.1021/nl061877k; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Ulrich TJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2809565; Van Den Abeele K, 2009, J ACOUST SOC AM, V126, P963, DOI 10.1121/1.3184583; Van den Abeele K, 2001, POLYM COMPOSITE, V22, P555, DOI 10.1002/pc.10559; Van Den Abeele KEA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000368; Van den Abeele KEA, 2000, RES NONDESTRUCT EVAL, V12, P31, DOI 10.1080/09349840009409647; Voide R, 2011, BONE, V49, P1186, DOI 10.1016/j.bone.2011.08.011; Wasserman N, 2008, BONE, V43, P856, DOI 10.1016/j.bone.2008.07.238; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wynnyckyj C, 2011, J ORTHOP RES, V29, P197, DOI 10.1002/jor.21228; Yeni YN, 2007, J BIOMED MATER RES A, V82A, P530, DOI 10.1002/jbm.a.31169; Yeni YN, 2002, BONE, V30, P509, DOI 10.1016/S8756-3282(01)00696-2; Zacharias K, 2009, J BIOMECH, V42, P581, DOI 10.1016/j.jbiomech.2008.12.018; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x	75	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83599	10.1371/journal.pone.0083599	http://dx.doi.org/10.1371/journal.pone.0083599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392089	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100013
J	Terzuoli, E; Meini, S; Cucchi, P; Catalani, C; Cialdai, C; Maggi, CA; Giachetti, A; Ziche, M; Donnini, S				Terzuoli, Erika; Meini, Stefania; Cucchi, Paola; Catalani, Claudio; Cialdai, Cecilia; Maggi, Carlo Alberto; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra			Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation	PLOS ONE			English	Article							FACTOR-KAPPA-B; B-2 RECEPTOR; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; RADIOLIGAND BINDING; UP-REGULATION; VE-CADHERIN; KNEE-JOINT; RAT; ANGIOGENESIS	Background: Bradykinin (BK) induces angiogenesis by promoting vessel permeability, growth and remodeling. This study aimed to demonstrate that the B2R antagonist, fasitibant, inhibits the BK pro-angiogenic effects. Methodology: We assesed the ability of fasibitant to antagonize the BK stimulation of cultured human cells (HUVEC) and circulating pro-angiogenic cells (PACs), in producing cell permeability (paracellular flux), migration and pseocapillary formation. The latter parameter was studied in vitro (matrigel assay) and in vivo in mice (matrigel plug) and in rat model of experimental osteoarthritis (OA). We also evaluated NF-kappa B activation in cultured cells by measuring its nuclear translocation and its downstream effectors such as the proangiogenic ciclooxygenase-2 (COX-2), prostaglandin E-2 and vascular endothelial growth factor (VEGF). Principal findings: HUVEC, exposed to BK (1-10 mu M), showed increased permeability, disassembly of adherens and tight-junction, increased cell migration, and pseudocapillaries formation. We observed a significant increase of vessel density in the matrigel assay in mice and in rats OA model. Importantly, B2R stimulation elicited, both in HUVEC and PACs, NF-kappa B activation, leading to COX-2 overexpression, enhanced prostaglandin E-2 production. and VEGF output. The BK/NF-kappa B axis, and the ensuing amplification of inflammatory/angiogenic responses were fully prevented by fasitibant as well as by IKK VII, an NF-kappa B. Inhibitor. Conclusion: This work illustrates the role of the endothelium in the inflammation provoked by the BK/NF-kappa B axis. It also demonstates that B2R blockade by the antaogonist fasibitant, abolishes both the initial stimulus and its amplification, strongly attenuating the propagation of inflammation.	[Terzuoli, Erika; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Meini, Stefania; Cucchi, Paola; Catalani, Claudio; Cialdai, Cecilia; Maggi, Carlo Alberto] Menarini Ric SpA, Dept Pharmacol, Florence, Italy	University of Siena; Menarini Group; University of Florence	Ziche, M (corresponding author), Univ Siena, Dept Life Sci, Via Laterina 8, I-53100 Siena, Italy.	marina.ziche@unisi.it; sandra.donnini@unisi.it	Donnini, Sandra/K-9252-2019; Terzuoli, Erika/M-7346-2016	Donnini, Sandra/0000-0001-6617-1644; Terzuoli, Erika/0000-0001-9248-4505; Ziche, Marina/0000-0002-9564-214X; Meini, Stefania/0000-0002-7155-599X	Fondazione Italiana per la Ricerca sul Cancro (FIRC); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Menarini Ricerche S.p.A. provided, in part, the resources for the study. Erika Terzuoli was supported by a fellowship from the Fondazione Italiana per la Ricerca sul Cancro (FIRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bas M, 2012, EXPERT REV CLIN IMMU, V8, P707, DOI [10.1586/ECI.12.67, 10.1586/eci.12.67]; Bellucci F, 2009, BRIT J PHARMACOL, V158, P1996, DOI 10.1111/j.1476-5381.2009.00511.x; Bond AP, 1997, IMMUNOPHARMACOLOGY, V36, P209, DOI 10.1016/S0162-3109(97)00023-4; Cao T, 2002, INFLAMM RES, V51, P295, DOI 10.1007/PL00000307; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Charignon D, 2012, EXPERT OPIN PHARMACO, V13, P2233, DOI 10.1517/14656566.2012.723692; Cialdai C, 2009, J PHARMACOL EXP THER, V331, P1025, DOI 10.1124/jpet.109.159657; Cucchi P, 2005, EUR J PHARMACOL, V528, P7, DOI 10.1016/j.ejphar.2005.10.014; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; Fincham CI, 2009, EXPERT OPIN THER PAT, V19, P919, DOI 10.1517/13543770902994389; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Frimm CD, 1996, J MOL CELL CARDIOL, V28, P1279; Gomis A, 2013, OSTEOARTHR CARTILAGE, V21, P1346, DOI 10.1016/j.joca.2013.03.013; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Meini S, 2008, INFLAMM RES, V57, P351, DOI 10.1007/s00011-007-7204-1; Meini S, 2007, BRIT J PHARMACOL, V150, P313, DOI 10.1038/sj.bjp.0706995; Meini S, 2011, BRIT J PHARMACOL, V162, P1202, DOI 10.1111/j.1476-5381.2010.01133.x; Meini S, 2011, BRIT J PHARMACOL, V162, P611, DOI 10.1111/j.1476-5381.2010.01062.x; Meini S, 2010, EUR J PHARMACOL, V635, P34, DOI 10.1016/j.ejphar.2010.03.012; Meini S, 2009, EUR J PHARMACOL, V615, P10, DOI 10.1016/j.ejphar.2009.04.057; Morbidelli L, 1998, BRIT J PHARMACOL, V124, P1286, DOI 10.1038/sj.bjp.0701943; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Shaw OM, 2011, BIOCHEM BIOPH RES CO, V416, P266, DOI 10.1016/j.bbrc.2011.10.137; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tirziu D, 2012, CIRCULATION, V126, P2589, DOI 10.1161/CIRCULATIONAHA.112.119321; Valenti C, 2010, BRIT J PHARMACOL, V161, P1616, DOI 10.1111/j.1476-5381.2010.00995.x; Valenti C, 2008, EUR J PHARMACOL, V579, P350, DOI 10.1016/j.ejphar.2007.10.025; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; Walsh D A, 2001, Curr Opin Investig Drugs, V2, P1054; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wieczorek M, 1997, BIOCHEM PHARMACOL, V54, P283, DOI 10.1016/S0006-2952(97)00186-X; Wohlfart P, 1997, J PHARMACOL EXP THER, V280, P1109	38	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84358	10.1371/journal.pone.0084358	http://dx.doi.org/10.1371/journal.pone.0084358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392129	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100052
J	Li, L; Nadanaciva, S; Berger, Z; Shen, W; Paumier, K; Schwartz, J; Mou, K; Loos, P; Milici, AJ; Dunlop, J; Hirst, WD				Li, Li; Nadanaciva, Sashi; Berger, Zdenek; Shen, Wei; Paumier, Katrina; Schwartz, Joel; Mou, Kewa; Loos, Paula; Milici, Anthony J.; Dunlop, John; Hirst, Warren D.			Human A53T alpha-Synuclein Causes Reversible Deficits in Mitochondrial Function and Dynamics in Primary Mouse Cortical Neurons	PLOS ONE			English	Article							AXONAL-TRANSPORT; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; MUTANT HUNTINGTIN; AUTOPHAGY; LOCALIZATION; MUTATIONS; PROTEIN; DEGENERATION; MITOPHAGY	Parkinson's disease (PD) is the second most common neurodegenerative disease. A key pathological feature of PD is Lewy bodies, of which the major protein component is a-synuclein (alpha-syn). Human genetic studies have shown that mutations (A53T, A30P, E46K) and multiplication of the a-syn gene are linked to familial PD. Mice overexpressing the human A53T mutant a-syn gene develop severe movement disorders. However, the molecular mechanisms of alpha-syn toxicity are not well understood. Recently, mitochondrial dysfunction has been linked with multiple neurodegenerative diseases including Parkinson's disease. Here we investigated whether mitochondrial motility, dynamics and respiratory function are affected in primary neurons from a mouse model expressing the human A53T mutation. We found that mitochondrial motility was selectively inhibited in A53T neurons while transport of other organelles was not affected. In addition, A53T expressing neurons showed impairment in mitochondrial membrane potential and mitochondrial respiratory function. Furthermore, we found that rapamycin, an autophagy inducer, rescued the decreased mitochondrial mobility. Taken together, these data demonstrate that A53T a-syn impairs mitochondrial function and dynamics and the deficit of mitochondrial transport is reversible, providing further understanding of the disease pathogenesis and a potential therapeutic strategy for PD.	[Li, Li; Berger, Zdenek; Shen, Wei; Paumier, Katrina; Schwartz, Joel; Mou, Kewa; Loos, Paula; Milici, Anthony J.; Dunlop, John; Hirst, Warren D.] Pfizer Inc, Neurosci Res Unit, Cambridge, MA USA; [Nadanaciva, Sashi] Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA	Pfizer; Pfizer	Hirst, WD (corresponding author), Pfizer Inc, Neurosci Res Unit, Cambridge, MA USA.	warren.hirst@pfizer.com		Hirst, Warren/0000-0003-0389-8891	Michael J Fox Foundation	Michael J Fox Foundation	This work was funded, in part, by a grant from the Michael J Fox Foundation. www.michaeljfox.org. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin TA, 2011, MOL PSYCHIATR, V16, P122, DOI 10.1038/mp.2010.110; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; BANKER G, 1998, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gui YX, 2012, NEUROBIOL AGING, V33, P2841, DOI 10.1016/j.neurobiolaging.2012.02.001; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Hettiarachchi NT, 2009, J NEUROCHEM, V111, P1192, DOI 10.1111/j.1471-4159.2009.06411.x; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rose C, 2010, HUM MOL GENET, V19, P2144, DOI 10.1093/hmg/ddq093; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tang Y, 2012, TRAFFIC, V13, P681, DOI 10.1111/j.1600-0854.2012.01340.x; VALTORTA F, 1989, CELL BIOL INT REP, V13, P1023, DOI 10.1016/0309-1651(89)90017-9; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602	78	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85815	10.1371/journal.pone.0085815	http://dx.doi.org/10.1371/journal.pone.0085815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392030	Green Submitted, gold, Green Published			2022-12-25	WOS:000329323900174
J	Stock, M; Gretscher, RR; Groth, M; Eiserloh, S; Boland, W; Burse, A				Stock, Magdalena; Gretscher, Rene R.; Groth, Marco; Eiserloh, Simone; Boland, Wilhelm; Burse, Antje			Putative Sugar Transporters of the Mustard Leaf Beetle Phaedon cochleariae: Their Phylogeny and Role for Nutrient Supply in Larval Defensive Glands	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TIGR GENE INDEXES; GLUCOSE-TRANSPORTER; TREHALOSE TRANSPORTER; CHEMICAL DEFENSE; APHIDIUS-ERVI; GLUT-FAMILY; FAT-BODY; INSECT; METABOLISM	Background: Phytophagous insects have emerged successfully on the planet also because of the development of diverse and often astonishing defensive strategies against their enemies. The larvae of the mustard leaf beetle Phaedon cochleariae, for example, secrete deterrents from specialized defensive glands on their back. The secretion process involves ATP-binding cassette transporters. Therefore, sugar as one of the major energy sources to fuel the ATP synthesis for the cellular metabolism and transport processes, has to be present in the defensive glands. However, the role of sugar transporters for the production of defensive secretions was not addressed until now. Results: To identify sugar transporters in P. cochleariae, a transcript catalogue was created by Illumina sequencing of cDNA libraries. A total of 68,667 transcripts were identified and 68 proteins were annotated as either members of the solute carrier 2 (SLC2) family or trehalose transporters. Phylogenetic analyses revealed an extension of the mammalian GLUT6/8 class in insects as well as one group of transporters exhibiting distinctive conserved motifs only present in the insect order Coleoptera. RNA-seq data of samples derived from the defensive glands revealed six transcripts encoding sugar transporters with more than 3,000 counts. Two of them are exclusively expressed in the glandular tissue. Reduction in secretions production was accomplished by silencing two of four selected transporters. RNA-seq experiments of transporter-silenced larvae showed the down-regulation of the silenced transporter but concurrently the up-regulation of other SLC2 transporters suggesting an adaptive system to maintain sugar homeostasis in the defensive glands. Conclusion: We provide the first comprehensive phylogenetic study of the SLC2 family in a phytophagous beetle species. RNAi and RNA-seq experiments underline the importance of SLC2 transporters in defensive glands to achieve a chemical defense for successful competitive interaction in natural ecosystems.	[Stock, Magdalena; Gretscher, Rene R.; Eiserloh, Simone; Boland, Wilhelm; Burse, Antje] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Thuringia, Germany; [Groth, Marco] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal Grp, Jena, Thuringia, Germany	Max Planck Society; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Burse, A (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Thuringia, Germany.	aburse@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Gretscher, Rene/0000-0002-0249-4978; Groth, Marco/0000-0002-9199-8990	Max Planck Society; Deutsche Forschungsgemeinschaft [BU1862/2-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors' work was funded by the Max Planck Society (http://www.mpg.de/en) and the Deutsche Forschungsgemeinschaft (grand number BU1862/2-1; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bifano TD, 2010, COMP BIOCHEM PHYS B, V157, P1, DOI 10.1016/j.cbpb.2010.05.014; Bodemann RR, 2012, P ROY SOC B-BIOL SCI, V279, P4126, DOI 10.1098/rspb.2012.1342; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOUNIAS M, 1993, BIOCHEM MOL BIOL INT, V31, P249; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caccia S, 2007, AM J PHYSIOL-REG I, V292, pR2284, DOI 10.1152/ajpregu.00847.2006; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Chen ME, 2006, ARCH INSECT BIOCHEM, V62, P55, DOI 10.1002/arch.20119; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; DEROE C, 1982, J CHEM ECOL, V8, P67, DOI 10.1007/BF00984006; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; Frick S, 2013, P NATL ACAD SCI USA, V110, P4194, DOI 10.1073/pnas.1221489110; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibanez S, 2012, TOXINS, V4, P228, DOI 10.3390/toxins4040228; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikuta S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00290; Kikuta S, 2010, INSECT BIOCHEM MOLEC, V40, P805, DOI 10.1016/j.ibmb.2010.07.008; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhnle A, 2009, ENTOMOL EXP APPL, V131, P189, DOI 10.1111/j.1570-7458.2009.00848.x; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laurent P, 2005, TOP CURR CHEM, V240, P167; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Meyer H, 2011, J CELL SCI, V124, P1984, DOI 10.1242/jcs.082024; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; NOIROT C, 1991, ANN SOC ENTOMOL FR, V27, P123; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pascual I, 2006, COMP BIOCHEM PHYS B, V143, P20, DOI 10.1016/j.cbpb.2005.09.008; Pasteels J.M., 1989, Entomography, V6, P423; Pasteels Jacques M., 1994, Series Entomologica (Dordrecht), V50, P289; PASTEELS JM, 1982, TETRAHEDRON, V38, P1891, DOI 10.1016/0040-4020(82)80038-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Price DRG, 2010, INSECT MOL BIOL, V19, P97, DOI 10.1111/j.1365-2583.2009.00918.x; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; Quackenbush J, 2000, NUCLEIC ACIDS RES, V28, P141, DOI 10.1093/nar/28.1.141; Quennedey A, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P177; RENNER K, 1970, Beitraege zur Entomologie, V20, P527; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; SCHURMANN A, 1993, BIOCHEM J, V290, P497, DOI 10.1042/bj2900497; SHIMADA S, 1979, J COMP PHYSIOL, V131, P333, DOI 10.1007/BF00688808; Silva MCP, 2010, INSECT BIOCHEM MOLEC, V40, P733, DOI 10.1016/j.ibmb.2010.07.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tremmel M, 2013, J INSECT PHYSIOL, V59, P840, DOI 10.1016/j.jinsphys.2013.05.009; Uddin MM, 2009, J APPL BOT FOOD QUAL, V82, P108; Wegener G, 2010, J EXP BIOL, V213, P3852, DOI 10.1242/jeb.042028; Whitman DW, 1990, ALLOMONES CHEM DEFEN, P289; Wilson-O'Brien AL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-152; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	85	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84461	10.1371/journal.pone.0084461	http://dx.doi.org/10.1371/journal.pone.0084461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391959	Green Published, gold			2022-12-25	WOS:000329323900102
J	Zhou, H; Wan, JL; Wu, L; Yi, T; Liu, W; Xu, HB; Yang, XL				Zhou, Hui; Wan, Jiangling; Wu, Lei; Yi, Tao; Liu, Wei; Xu, Huibi; Yang, Xiangliang			A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS	PLOS ONE			English	Article							DELIVERY SYSTEMS SNEDDS; IN-VIVO PERFORMANCE; LIQUID-CHROMATOGRAPHY; SELF; VITRO; SCUTELLARIN; OPTIMIZATION; IMPACT; BREVISCAPINE; PERMEABILITY	A novel supersaturated self-emulsifying drug delivery system (Super-SEDDS) loaded with scutellarin-phospholipid complex (SPC) was developed. The system aimed to address the limitations presented by conventional SEDDS as delivery carriers for drugs with poor water-solubility, low liposolubility and high dose. As an intermediate, SPC was first prepared based on the response surface design. The presence of amorphous scutellarin was demonstrated through differential scanning calorimetry (DSC) and X-ray diffraction (XRD), while enhanced liposolubility was confirmed through comparison with scutellarin powder via an octanol/water distribution test. On the basis of the solubility study and ternary phase diagram, Super-SEDDS containing SPC of up to 200% equilibrium solubility (S-eq) was designed, which composed of ethyl oleate, Cremophor RH40 and Transcutol HP with a ratio of 60:25:15 (w/w%). The subsequent in vitro lipolysis study and ex vivo intestinal absorption test indicated that Super-SEDDS enhanced the cumulative dissolution from 70% to 100% and improved the intestinal absorption from 0.04 to 0.12 mu g/cm(2) compared with scutellarin powder. Furthermore, an in vivo study demonstrated that Super-SEDDS achieved the AUC(o-t) of scutellarin up to approximate 1.7-fold as scutellarin powder. It was also proved superior to SPC and the conventional SEDDS. Super-SEDDS showed great potential for expanding the usage of SEDDS and could act as an alternative to conventional SEDDS.	[Zhou, Hui; Wan, Jiangling; Wu, Lei; Liu, Wei; Xu, Huibi; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China; [Yi, Tao] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China	Huazhong University of Science & Technology; Macau University of Science & Technology	Yi, T (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China.	yiaaron@outlook.com; nanomedicine@hust.edu.cn			Special Project on the Integration of Industry Education Research of Guangdong Province [2009B090300321]; Science and Technology Development Fund of Macao Special Administrative Region [094/2012/A3]; National High Technology Research and Development Program of China [2012AA022704]	Special Project on the Integration of Industry Education Research of Guangdong Province; Science and Technology Development Fund of Macao Special Administrative Region; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by the Special Project on the Integration of Industry Education Research of Guangdong Province (No. 2009B090300321), the Science and Technology Development Fund of Macao Special Administrative Region (No. 094/2012/A3) and the National High Technology Research and Development Program of China (No. 2012AA022704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2012, J PHARM PHARMACOL, V64, P326, DOI 10.1111/j.2042-7158.2011.01391.x; Anby MU, 2012, MOL PHARMACEUT, V9, P2063, DOI 10.1021/mp300164u; Buyukozturk F, 2010, J CONTROL RELEASE, V142, P22, DOI 10.1016/j.jconrel.2009.10.005; Cao F, 2006, EUR J PHARM SCI, V29, P385, DOI 10.1016/j.ejps.2006.07.007; Cao Feng, 2006, Yaoxue Xuebao, V41, P595; [陈鹰 CHEN Ying], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P374; Fei X, 2009, J DRUG TARGET, V17, P408, DOI 10.1080/10611860902913380; Fernandez S, 2009, PHARM RES-DORDR, V26, P1901, DOI 10.1007/s11095-009-9906-2; Gao P, 2009, J PHARM SCI-US, V98, P516, DOI 10.1002/jps.21451; Ju W Z, 2006, CHIN J CLIN PHARM TH, V11, P292; Kiss L, 2013, J PHARM SCI-US, V102, P1173, DOI 10.1002/jps.23458; Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042; Miller JM, 2011, MOL PHARMACEUT, V8, P1848, DOI 10.1021/mp200181v; Mukherjee T, 2010, J PHARM PHARMACOL, V62, P1112, DOI 10.1111/j.2042-7158.2010.01149.x; Peng Q, 2010, MOL PHARMACEUT, V7, P565, DOI 10.1021/mp900274u; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Prachi S., 2012, INT RES J PHARM, V3, P1; Ruan JH, 2010, INT J PHARMACEUT, V386, P282, DOI 10.1016/j.ijpharm.2009.11.026; Sakai K, 2012, DRUG DEV IND PHARM, V38, P1254, DOI 10.3109/03639045.2011.645832; Sarparanta MP, 2012, BIOMATERIALS, V33, P3353, DOI 10.1016/j.biomaterials.2012.01.029; Sassene PJ, 2010, J PHARM SCI-US, V99, P4982, DOI 10.1002/jps.22226; Villar AMS, 2012, INT J PHARMACEUT, V431, P161, DOI 10.1016/j.ijpharm.2012.04.001; Singh B, 2011, DRUG DELIV, V18, P599, DOI 10.3109/10717544.2011.604686; Tang SY, 2012, ULTRASON SONOCHEM, V19, P330, DOI 10.1016/j.ultsonch.2011.07.001; Tang Xiao-Qiao, 2005, Zhongguo Zhongyao Zazhi, V30, P222; Thomas N, 2012, J CONTROL RELEASE, V160, P25, DOI 10.1016/j.jconrel.2012.02.027; Ujhelyi Z, 2012, EUR J PHARM SCI, V47, P564, DOI 10.1016/j.ejps.2012.07.005; Ward, 2000, Pharm Sci Technol Today, V3, P346, DOI 10.1016/S1461-5347(00)00302-3; Williams H, 2013, PHARM RES, P1; Wu ZB, 2011, DRUG DEV IND PHARM, V37, P103, DOI 10.3109/03639045.2010.495752; Yang SC, 2004, PHARM RES-DORDR, V21, P261, DOI 10.1023/B:PHAM.0000016238.44452.f1; YOSHIMURA Y, 1989, J FOOD HYG SOC JPN, V30, P218; Yulan S, 2006, J CHROMATOGR B, V830, P1, DOI 10.1016/j.jchromb.2005.10.016; Zhang Hai-yan, 2005, Yaoxue Xuebao, V40, P563; Zhang JJ, 2011, INT J NANOMED, V6, P3405, DOI 10.2147/IJN.S25824; Zhang L, 2012, INT J NANOMED, V7, P151, DOI 10.2147/IJN.S27639; Zhang QY, 2012, J BIOMED NANOTECHNOL, V8, P90, DOI 10.1166/jbn.2012.1371; Zhang XY, 2009, HERALD MED, V5, P571; Zhang ZW, 2011, NANOSCALE, V3, P1780, DOI 10.1039/c0nr00879f; Zhong DF, 2003, J CHROMATOGR B, V796, P439, DOI 10.1016/j.jchromb.2003.08.002; Zhong HJ, 2005, PHARMAZIE, V60, P475	41	23	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84530	10.1371/journal.pone.0084530	http://dx.doi.org/10.1371/journal.pone.0084530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391965	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900108
J	Lin, C; Song, L; Liu, A; Gong, H; Lin, X; Wu, J; Li, M; Li, J				Lin, C.; Song, L.; Liu, A.; Gong, H.; Lin, X.; Wu, J.; Li, M.; Li, J.			Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma	ONCOGENE			English	Article						AKIP1; angiogenesis; lymphangiogenesis; VEGF-C	ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; NF-KAPPA-B; VEGF-C; TUMOR LYMPHANGIOGENESIS; CANCER-CELLS; GENE-EXPRESSION; UP-REGULATION; IN-VIVO; SURVIVAL	A-kinase-interacting protein 1 (AKIP1) is found to be overexpressed in breast and prostate cancers, suggesting that AKIP1 might act as a potent oncogenic protein. However, the clinical significance and biological role of AKIP1 in cancer progression remain largely unknown. Herein, we report that AKIP1 is markedly overexpressed in esophageal squamous cell carcinoma (ESCC) cell lines and clinical ESCC samples. AKIP1 expression significantly correlates with ESCC progression and patients' shorter survival time. Furthermore, we find that overexpressing AKIP1 induces, whereas silencing AKIP1 reduces, ESCC angiogenesis and lymphangiogenesis both in vitro and in vivo. Moreover, we demonstrate that AKIP1 transcriptionally upregulates vascular endothelial growth factor-C (VEGF-C) via interaction with its promoter through cooperation with multiple transcriptional factors, including SP1, AP2 and nuclear factor-kappa B (NF-kappa B). Importantly, significant correlation between levels of AKIP1 and VEGF-C is observed in a cohort of human ESCC, as well as in non-small cell lung cancer, hepatocellular carcinoma and ovarian cancer. Hence, these findings indicate an important role for AKIP1 in ESCC angiogenesis and lymphangiogenesis, and uncover a novel mechanism for the upregulation of VEGF-C in cancers.	[Lin, C.; Song, L.; Lin, X.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Expt Res, Guangzhou 510080, Guangdong, Peoples R China; [Lin, C.; Liu, A.; Gong, H.; Li, J.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Wu, J.; Li, M.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China; [Wu, J.; Li, M.; Li, J.] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, J (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	lijun37@mail.sysu.edu.cn	Lin, Chuyong/AAA-9931-2020; Song, LB/AAL-1968-2020; Liu, Aibin/S-7252-2019	Lin, Chuyong/0000-0003-4887-5386; Liu, Aibin/0000-0003-1600-8288	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Natural Science Foundation of China [81325013, 81071780, 81030048, 91229101, U1201121, 81272196, 81272198]; Science and Technology Department of Guangdong Province [S2011020002757, S2012020010946]; Ministry of Education of China [20130171110085, 20120171110055]	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guangdong Province; Ministry of Education of China(Ministry of Education, China)	This work was supported by the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2012), Natural Science Foundation of China (81325013, 81071780, 81030048, 91229101, U1201121, 81272196 and 81272198), the Science and Technology Department of Guangdong Province (S2011020002757 and S2012020010946) and Ministry of Education of China (20130171110085, 20120171110055).	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Chen XT, 2013, J CLIN INVEST, V123, P2576, DOI 10.1172/JCI68143; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng YK, 2011, EUR J CANCER, V47, P2353, DOI 10.1016/j.ejca.2011.05.006; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gao N, 2010, J BIOL CHEM, V285, P28097, DOI 10.1074/jbc.M110.116566; Gomes FG, 2013, LIFE SCI, V92, P101, DOI 10.1016/j.lfs.2012.10.008; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hosch SB, 2001, J CLIN ONCOL, V19, P1970, DOI 10.1200/JCO.2001.19.7.1970; Joukov V, 1996, EMBO J, V15, P290; Karpanen T, 2001, CANCER RES, V61, P1786; Kimura H, 1999, DIS ESOPHAGUS, V12, P205; Kitadai Y, 2004, ONCOL REP, V11, P315; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Krzystek-Korpacka M, 2007, CANCER LETT, V249, P171, DOI 10.1016/j.canlet.2006.08.011; Kubota Y, 2009, FRONT BIOSCI-LANDMRK, V14, P3872, DOI [10.2735/3495, 10.2741/3495]; Kumar B, 2011, ANGIOGENESIS, V14, P371, DOI 10.1007/s10456-011-9221-5; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Lin CY, 2013, CANCER RES, V73, P3638, DOI 10.1158/0008-5472.CAN-12-4028; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mariette C, 2003, CANCER-AM CANCER SOC, V97, P1616, DOI 10.1002/cncr.11228; Miebach S, 2006, J NEURO-ONCOL, V76, P39, DOI 10.1007/s11060-005-3674-6; Ooki A, 2007, WORLD J SURG, V31, P2184, DOI 10.1007/s00268-007-9198-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Sato T, 2006, INT J ONCOL, V28, P1043; Scavelli C, 2004, LEUKEMIA, V18, P1054, DOI 10.1038/sj.leu.2403355; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sobin LH, 1997, TNM CLASSIFICATION M, P54; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Tanigawa N, 1997, CANCER, V79, P220; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Zhang HL, 2010, DIS ESOPHAGUS, V23, P53, DOI 10.1111/j.1442-2050.2009.00971.x; Zhang Y, 2012, GASTROENTEROLOGY, V142, P521, DOI 10.1053/j.gastro.2011.11.023	46	50	53	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					332	341		10.1038/onc.2013.559	http://dx.doi.org/10.1038/onc.2013.559			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24413079				2022-12-25	WOS:000348145500007
J	Frirdich, E; Vermeulen, J; Biboy, J; Soares, F; Taveirne, ME; Johnson, JG; DiRita, VJ; Girardin, SE; Vollmer, W; Gaynor, EC				Frirdich, Emilisa; Vermeulen, Jenny; Biboy, Jacob; Soares, Fraser; Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.; Girardin, Stephen E.; Vollmer, Waldemar; Gaynor, Erin C.			Peptidoglycan LD-Carboxypeptidase Pgp2 Influences Campylobacter jejuni Helical Cell Shape and Pathogenic Properties and Provides the Substrate for the DL-Carboxypeptidase Pgp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Campylobacter; Carboxypeptidase; Host-Pathogen Interactions; Microbial Pathogenesis; Peptidoglycan; Bacterial Cell Shape	BACTERIAL MURAMYL DIPEPTIDE; BIOFILM FORMATION; HOST RECOGNITION; NOD1; MOTILITY; IDENTIFICATION; COLONIZATION; GENES; BIOSYNTHESIS; RESTORATION	Background:C. jejuni helical shape is important to pathogenesis. Results: Deletion of pgp2 results in loss of C. jejuni helical shape and change in peptidoglycan structure and pathogenic properties. Conclusion: Pgp2 is a ld-carboxypeptidase cleaving peptidoglycan tetrapeptides to tripeptides. Significance: Characterization of enzymes involved in C. jejuni peptidoglycan and cell shape maintenance is crucial to the understanding of fundamental properties of this organism. Despite the importance of Campylobacter jejuni as a pathogen, little is known about the fundamental aspects of its peptidoglycan (PG) structure and factors modulating its helical morphology. A PG dl-carboxypeptidase Pgp1 essential for maintenance of C. jejuni helical shape was recently identified. Bioinformatic analysis revealed the CJJ81176_0915 gene product as co-occurring with Pgp1 in several organisms. Deletion of cjj81176_0915 (renamed pgp2) resulted in straight morphology, representing the second C. jejuni gene affecting cell shape. The PG structure of a pgp2 mutant showed an increase in tetrapeptide-containing muropeptides and a complete absence of tripeptides, consistent with ld-carboxypeptidase activity, which was confirmed biochemically. PG analysis of a pgp1pgp2 double mutant demonstrated that Pgp2 activity is required to generate the tripeptide substrate for Pgp1. Loss of pgp2 affected several pathogenic properties; the deletion strain was defective for motility in semisolid agar, biofilm formation, and fluorescence on calcofluor white. pgp2 PG also caused decreased stimulation of the human nucleotide-binding oligomerization domain 1 (Nod1) proinflammatory mediator in comparison with wild type, as expected from the reduction in muropeptide tripeptides (the primary Nod1 agonist) in the mutant; however, these changes did not alter the ability of the pgp2 mutant strain to survive within human epithelial cells or to elicit secretion of IL-8 from epithelial cells after infection. The pgp2 mutant also showed significantly reduced fitness in a chick colonization model. Collectively, these analyses enhance our understanding of C. jejuni PG maturation and help to clarify how PG structure and cell shape impact pathogenic attributes.	[Frirdich, Emilisa; Vermeulen, Jenny; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Soares, Fraser; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of British Columbia; Newcastle University - UK; University of Toronto; University of Michigan System; University of Michigan	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	egaynor@mail.ubc.ca	Johnson, Jeremiah/AFL-6049-2022	Johnson, Jeremiah/0000-0001-5302-3247; Biboy, jacob/0000-0002-1286-6851; Soares, Fraser/0000-0002-3977-7939	Canadian Institutes for Health Research (CIHR) [MOP-68981]; Burroughs Wellcome Fund; Biotechnology and Biological Sciences Research Council [BB/I020012/1]; National Institutes of Health [R01 AI069383]; United States Department of Agriculture (USDA) [2012-67012-19704]; USDA [2013-67012-21136]; Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research; Canada Research Chair award; Burroughs Wellcome Fund Career Development Award; BBSRC [BB/I020012/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007528, R01AI069383] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); USDA(United States Department of Agriculture (USDA)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Burroughs Wellcome Fund Career Development Award(Burroughs Wellcome Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-68981 and the Burroughs Wellcome Fund (to E. C. G.), Biotechnology and Biological Sciences Research Council Grant BB/I020012/1 (to W. V.), National Institutes of Health Grant R01 AI069383 (to V. J. D.), United States Department of Agriculture (USDA) Grant 2012-67012-19704 (to M. E. T.), and USDA Grant 2013-67012-21136 (to J. G. J.).; Supported by postdoctoral fellowships from the Canadian Institutes for Health Research (CIHR) and the Michael Smith Foundation for Health Research.; Supported by a Canada Research Chair award and a Burroughs Wellcome Fund Career Development Award. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of British Columbia, 13652350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. Tel.: 604-822-2710; Fax: 604-822-6041; E-mail: egaynor@mail.ubc.ca.	Al-Sayeqh AF, 2010, MICROB PATHOGENESIS, V49, P294, DOI 10.1016/j.micpath.2010.06.011; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Boudreau MA, 2012, BIOCHEMISTRY-US, V51, P2974, DOI 10.1021/bi300174x; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Gallant CV, 2005, MOL MICROBIOL, V58, P1012, DOI 10.1111/j.1365-2958.2005.04892.x; Garrity GM, 2005, BERGEYS MANUAL SYST, P1145; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Hendrixson DR, 2008, MOL MICROBIOL, V70, P519, DOI 10.1111/j.1365-2958.2008.06428.x; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hu L, 2008, CAMPYLOBACTER, 3RD EDITION, P297; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Iovine NM, 2008, CAMPYLOBACTER, 3RD EDITION, P333; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; Korza HJ, 2005, J BIOL CHEM, V280, P40802, DOI 10.1074/jbc.M506328200; Kumar A, 2012, RES MICROBIOL, V163, P254, DOI 10.1016/j.resmic.2012.01.006; Kumar S, 2013, CRIT REV MICROBIOL, V39, P229, DOI 10.3109/1040841X.2012.706249; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Moe KK, 2010, J VET MED SCI, V72, P411, DOI 10.1292/jvms.09-0339; Molbak K, 2008, CAMPYLOBACTER, 3RD EDITION, P151; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Rashid Y, 2011, PROTEIN J, V30, P558, DOI 10.1007/s10930-011-9364-7; RATTEE ID, 1974, PHYS CHEM DYE ABSORP, P180; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Young KD, 2007, CURR OPIN MICROBIOL, V10, P596, DOI 10.1016/j.mib.2007.09.009; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Zilbauer M, 2007, CELL MICROBIOL, V9, P2404, DOI 10.1111/j.1462-5822.2007.00969.x	73	54	56	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8007	8018		10.1074/jbc.M113.491829	http://dx.doi.org/10.1074/jbc.M113.491829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24394413	Green Published, hybrid			2022-12-25	WOS:000333157500001
J	Gupta, S; Hirota, M; Waugh, SM; Murakami, I; Suzuki, T; Muraguchi, M; Shibamori, M; Ishikawa, Y; Jarvis, TC; Carter, JD; Zhang, C; Gawande, B; Vrkljan, M; Janjic, N; Schneider, DJ				Gupta, Shashi; Hirota, Masao; Waugh, Sheela M.; Murakami, Ikuo; Suzuki, Tomoki; Muraguchi, Masahiro; Shibamori, Masafumi; Ishikawa, Yuichi; Jarvis, Thale C.; Carter, Jeffrey D.; Zhang, Chi; Gawande, Bharat; Vrkljan, Michael; Janjic, Nebojsa; Schneider, Daniel J.			Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aptamers; Cell Signaling; Drug Discovery; Interleukin; Molecular Evolution; Nucleic Acid Chemistry; Protein-DNA Interaction; SELEX; SOMAmer; Nuclease Stability	SOLUBLE IL-6 RECEPTOR; RHEUMATOID-ARTHRITIS; IN-VITRO; VASCULAR-PERMEABILITY; CRYSTAL-STRUCTURE; RNA LIGANDS; ANTIBODY; TOCILIZUMAB; COMPLEX; CLAZAKIZUMAB	Background: IL-6 signaling is a key component of inflammatory diseases. Results: Modified DNA aptamers that inhibit IL-6 signaling were discovered and optimized. Conclusion: Modified aptamers are stable in serum and block the interaction of IL-6 with its receptor IL-6R. Significance: Modified aptamers are a new class of antagonist with properties potentially suitable for clinical treatment of inflammation. Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates immune and inflammatory responses, and its overproduction is a hallmark of inflammatory diseases. Inhibition of IL-6 signaling with the anti-IL-6 receptor antibody tocilizumab has provided some clinical benefit to patients; however, direct cytokine inhibition may be a more effective option. We used the systematic evolution of ligands by exponential enrichment (SELEX) process to discover slow off-rate modified aptamers (SOMAmers) with hydrophobic base modifications that inhibit IL-6 signaling in vitro. Two classes of IL-6 SOMAmers were isolated from modified DNA libraries containing 40 random positions and either 5-(N-benzylcarboxamide)-2-deoxyuridine (Bn-dU) or 5-[N-(1-naphthylmethyl)carboxamide]-2-deoxyuridine (Nap-dU) replacing dT. These modifications facilitate the high affinity binding interaction with IL-6 and provide resistance against degradation by serum endonucleases. Post-SELEX optimization of one Bn-dU and one Nap-dU SOMAmer led to improvements in IL-6 binding (10-fold) and inhibition activity (greater than 20-fold), resulting in lead SOMAmers with sub-nanomolar affinity (K-d = 0.2 nm) and potency (IC50 = 0.2 nm). Although similar in inhibition properties, the two SOMAmers have unique sequences and different ortholog specificities. Furthermore, these SOMAmers were stable in human serum in vitro for more than 48 h. Both SOMAmers prevented IL-6 signaling by blocking the interaction of IL-6 with its receptor and inhibited the proliferation of tumor cells in vitro as effectively as tocilizumab. This new class of IL-6 inhibitor may be an effective therapeutic alternative for patients suffering from inflammatory diseases.	[Gupta, Shashi; Waugh, Sheela M.; Jarvis, Thale C.; Carter, Jeffrey D.; Zhang, Chi; Gawande, Bharat; Vrkljan, Michael; Janjic, Nebojsa; Schneider, Daniel J.] SomaLog Inc, Boulder, CO 80301 USA; [Hirota, Masao; Murakami, Ikuo; Suzuki, Tomoki; Muraguchi, Masahiro; Shibamori, Masafumi; Ishikawa, Yuichi] Otsuka Pharmaceut Co Ltd, Kawaguchi, Tokushima 7710192, Japan	Otsuka Pharmaceutical	Schneider, DJ (corresponding author), SomaLog Inc, 2945 Wilderness Pl, Boulder, CO 80301 USA.	dschneider@somalogic.com						Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BEIGELMAN L, 1995, J BIOL CHEM, V270, P25702, DOI 10.1074/jbc.270.43.25702; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; BOYER D, 2013, INVESTI OPHTHALMOL V, V54; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Chan MY, 2008, J THROMB HAEMOST, V6, P789, DOI 10.1111/j.1538-7836.2008.02932.x; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Eaton BE, 1997, BIOORGAN MED CHEM, V5, P1087, DOI 10.1016/S0968-0896(97)00044-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gelinas AD, 2014, J BIOL CHEM, V289, P8720, DOI 10.1074/jbc.M113.532697; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; GRIFFIN LC, 1993, BLOOD, V81, P3271, DOI 10.1182/blood.V81.12.3271.3271; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; GUSCHLBAUER W, 1980, NUCLEIC ACIDS RES, V8, P1421, DOI 10.1093/nar/8.6.1421; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HONDA M, 1992, J IMMUNOL, V148, P2175; JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; KAWAGUCHI T, 1995, BIOL PHARM BULL, V18, P474; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Mascini M, 2008, BIOMARKERS, V13, P637, DOI [10.1080/13547500802645905, 10.1080/13547500802645905 ]; Meyer C, 2014, RNA BIOL, V11, P57, DOI 10.4161/rna.27447; Nishimoto N, 2000, ANN RHEUM DIS, V59, P21, DOI 10.1136/ard.59.suppl_1.i21; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Pons M, 2010, INVEST OPHTH VIS SCI, V51; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Singh JA, 2011, J RHEUMATOL, V38, P10, DOI 10.3899/jrheum.100717; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Watson SR, 2000, ANTISENSE NUCLEIC A, V10, P63, DOI 10.1089/oli.1.2000.10.63; Weinblatt M, 2013, ARTHRITIS RHEUM-US, V65, pS735; Zhao Q, 2013, ARTHRITIS RHEUM-US, V65, pS1020	51	103	107	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8706	8719		10.1074/jbc.M113.532580	http://dx.doi.org/10.1074/jbc.M113.532580			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24415766	hybrid, Green Published			2022-12-25	WOS:000333157500059
J	Al-Salahi, OSA; Ji, D; Majid, AMSA; Kit-Lam, C; Abdullah, WZ; Zaki, A; Din, SKKJ; Yusoff, NM; Majid, ASA				Al-Salahi, Omar Saeed Ali; Ji, Dan; Majid, Amin Malik Shah Abdul; Kit-Lam, Chan; Abdullah, Wan Zaidah; Zaki, Abdelhamid; Din, Shah Kamal Khan Jamal; Yusoff, Narazah Mohd; Majid, Aman Shah Abdul			Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYCLE ARREST; DNA-DAMAGE; GROWTH ARREST; CYTOCHROME-C; CANCER-CELLS; ANTIPROLIFERATIVE ACTIVITY; PLASMODIUM-FALCIPARUM; SIGNALING PATHWAYS; INDUCED APOPTOSIS	Eurycoma longifolia Jack has been widely used in traditional medicine for its antimalarial, aphrodisiac, anti-diabetic, antimicrobial and anti-pyretic activities. Its anticancer activity has also been recently reported on different solid tumors, however no anti-leukemic activity of this plant has been reported. Thus the present study assesses the in vitro and in vivo anti-proliferative and apoptotic potentials of E. longifolia on K-562 leukemic cell line. The K-562 cells (purchased from ATCC) were isolated from patients with chronic myelocytic leukemia (CML) were treated with the various fractions (TAF273, F3 and F4) of E. longifolia root methanolic extract at various concentrations and time intervals and the anti-proliferative activity assessed by MTS assay. Flow cytometry was used to assess the apoptosis and cell cycle arrest. Nude mice injected subcutaneously with 10(7) K-562 cells were used to study the anti-leukemic activity of TAF273 in vivo. TAF273, F3 and F4 showed various degrees of growth inhibition with IC50 values of 19, 55 and 62 mu g/ml, respectively. TAF273 induced apoptosis in a dose and time dependent manner. TAF273 arrested cell cycle at G1and S phases. Intraperitoneal administration of TAF273 (50 mg/kg) resulted in a significant growth inhibition of subcutaneous tumor in TAF273-treated mice compared with the control mice (P = 0.024). TAF273 shows potent anti-proliferative activity in vitro and in vivo models of CML and therefore, justifies further efforts to define more clearly the potential benefits of using TAF273 as a novel therapeutic strategy for CML management.	[Al-Salahi, Omar Saeed Ali; Zaki, Abdelhamid; Yusoff, Narazah Mohd; Majid, Aman Shah Abdul] Univ Sains Malaysia, AMDI, Kepala Batas, Pulau Pinang, Malaysia; [Ji, Dan] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Key Lab Visual Damage & Regenerat & Restorat Chon, Chongqing, Peoples R China; [Majid, Amin Malik Shah Abdul; Kit-Lam, Chan] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Abdullah, Wan Zaidah] USM, Sch Med Sci, Dept Haematol, Kubang Kerian, Kelantan, Malaysia; [Zaki, Abdelhamid] Cairo Univ, Natl Res Ctr, Therapeut Chem Dept, Cairo, Egypt; [Din, Shah Kamal Khan Jamal] Hosp Sultanah Bhiyah, OMF Surg, Alor Setar, Kedah, Malaysia	Universiti Sains Malaysia; Army Medical University; Universiti Sains Malaysia; Universiti Sains Malaysia; Egyptian Knowledge Bank (EKB); Cairo University; National Research Centre (NRC)	Yusoff, NM (corresponding author), Univ Sains Malaysia, AMDI, Kepala Batas, Pulau Pinang, Malaysia.	narazah@amdi.usm.edu.my; amanshah75@gmail.com	Abdullah, Wan Zaidah/K-9935-2017; Majid, Aman Shah Abdul/I-3809-2012; Abdullah, Wan Zaidah/E-3526-2012; Mohd Yusoff, Narazah/I-3203-2017	Abdullah, Wan Zaidah/0000-0002-4008-6772; Majid, Aman Shah Abdul/0000-0001-9679-122X; Abdullah, Wan Zaidah/0000-0002-4008-6772; Abdul Majid, Amin Malik Shah/0000-0001-7499-2258; Mohd Yusoff, Narazah/0000-0001-6801-2508				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Bunch RT, 1997, CELL GROWTH DIFFER, V8, P779; Chan KL, 2004, J ETHNOPHARMACOL, V92, P223, DOI 10.1016/j.jep.2004.02.025; De Feudis P, 2000, NEOPLASIA, V2, P202, DOI 10.1038/sj.neo.7900086; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; Eshkoor SA, 2008, ARCH MED RES, V39, P668, DOI 10.1016/j.arcmed.2008.06.003; Gao L, 2006, CHINESE MED J-PEKING, V119, P911, DOI 10.1097/00029330-200606010-00006; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144; Han ZY, 1999, MOL CELL BIOL, V19, P1381; Jabbour E, 2009, BLOOD, V114, P2037, DOI 10.1182/blood-2009-01-197715; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Jiwajinda S, 2002, J ETHNOPHARMACOL, V82, P55, DOI 10.1016/S0378-8741(02)00160-5; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kaur M, 2009, J NUTR, V139, p1806S, DOI 10.3945/jn.109.106864; KELLOFF GJ, 1993, J CELL BIOCHEM, P2; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kim DW, 2009, INT J HEMATOL, V89, P664, DOI 10.1007/s12185-009-0326-1; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Liang YY, 2005, CELL SIGNAL, V17, P243, DOI 10.1016/j.cellsig.2004.07.006; Lim TH, 2005, ANN ACAD MED SINGAP, V34, P533; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Low BS, 2013, J ETHNOPHARMACOL, V149, P201, DOI 10.1016/j.jep.2013.06.023; Low B, 2011, NAT PROD COMMUN, V6, P337; Low BS, 2005, PLANTA MED, V71, P803, DOI 10.1055/s-2005-871259; Mahfudh N., 2008, CANC MOL, V4, P109; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; O'Brien S, 2009, J NATL COMPR CANC NE, V7, P984, DOI 10.6004/jnccn.2009.0065; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Purwantinings Hussin AH, 2009, INT J PHARM PHARM SC, V3, P343; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Shi L, 2010, BIOCHEM BIOPH RES CO, V396, P224, DOI 10.1016/j.bbrc.2010.04.068; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Tee TT, 2007, ANTICANCER RES, V27, P3425; Teh CH, 2009, ACTA CRYSTALLOGR E, V65, pO898, DOI 10.1107/S1600536809010502; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Ueda JY, 2002, BIOL PHARM BULL, V25, P753, DOI 10.1248/bpb.25.753; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Wernsdorfer WH, 2009, WIEN KLIN WOCHENSCHR, V121, P23, DOI 10.1007/s00508-009-1230-7; Wong PF, 2012, PHYTOMEDICINE, V19, P138, DOI 10.1016/j.phymed.2011.07.001; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zakaria Y, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-16; Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12	53	16	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83818	10.1371/journal.pone.0083818	http://dx.doi.org/10.1371/journal.pone.0083818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409284	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500008
J	Bansal, V; Dorn, C; Grunert, M; Klaassen, S; Hetzer, R; Berger, F; Sperling, SR				Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Klaassen, Sabine; Hetzer, Roland; Berger, Felix; Sperling, Silke R.			Outlier-Based Identification of Copy Number Variations Using Targeted Resequencing in a Small Cohort of Patients with Tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; 22Q11.2 DELETION SYNDROME; AORTIC-VALVE; GENOME; DEFECTS; DUPLICATION; PREVALENCE; MUTATIONS; PHENOTYPE; FREQUENCY	Copy number variations (CNVs) are one of the main sources of variability in the human genome. Many CNVs are associated with various diseases including cardiovascular disease. In addition to hybridization-based methods, next-generation sequencing (NGS) technologies are increasingly used for CNV discovery. However, respective computational methods applicable to NGS data are still limited. We developed a novel CNV calling method based on outlier detection applicable to small cohorts, which is of particular interest for the discovery of individual CNVs within families, de novo CNVs in trios and/or small cohorts of specific phenotypes like rare diseases. Approximately 7,000 rare diseases are currently known, which collectively affect similar to 6% of the population. For our method, we applied the Dixon's Q test to detect outliers and used a Hidden Markov Model for their assessment. The method can be used for data obtained by exome and targeted resequencing. We evaluated our outlier-based method in comparison to the CNV calling tool CoNIFER using eight HapMap exome samples and subsequently applied both methods to targeted resequencing data of patients with Tetralogy of Fallot (TOF), the most common cyanotic congenital heart disease. In both the HapMap samples and the TOF cases, our method is superior to CoNIFER, such that it identifies more true positive CNVs. Called CNVs in TOF cases were validated by qPCR and HapMap CNVs were confirmed with available array-CGH data. In the TOF patients, we found four copy number gains affecting three genes, of which two are important regulators of heart development (NOTCH1, ISL1) and one is located in a region associated with cardiac malformations (PRODH at 22q11). In summary, we present a novel CNV calling method based on outlier detection, which will be of particular interest for the analysis of de novo or individual CNVs in trios or cohorts up to 30 individuals, respectively.	[Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Sperling, Silke R.] Charite, Expt & Clin Res Ctr, Dept Cardiovasc Genet, D-13353 Berlin, Germany; [Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Klaassen, Sabine; Sperling, Silke R.] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [Bansal, Vikas] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Dorn, Cornelia; Sperling, Silke R.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Klaassen, Sabine] Natl Register Congenital Heart Defects, Berlin, Germany; [Klaassen, Sabine] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Klaassen, Sabine; Berger, Felix] Charite, Dept Pediat Cardiol, D-13353 Berlin, Germany; [Hetzer, Roland] German Heart Inst, Dept Cardiac Surg, Berlin, Germany; [Berger, Felix] German Heart Inst, Dept Pediat Cardiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Heart Center Berlin	Sperling, SR (corresponding author), Charite, Expt & Clin Res Ctr, Dept Cardiovasc Genet, D-13353 Berlin, Germany.	silke.sperling@charite.de		Klaassen, Sabine/0000-0001-5925-9912; Berger, Felix/0000-0001-7881-1557; Bansal, Vikas/0000-0002-0944-7226; Grunert, Marcel/0000-0002-2375-6404; Rickert-Sperling, Silke/0000-0002-7135-3298	European Community [2009-223463, People-2011-ITN-289600]; Studienstiftung des Deutschen Volkes; German Research Foundation [574157]; Competence Network for Congenital Heart Defects; Federal Ministry of Education and Research (BMBF) [FKZ 01GI0601]; MRC [G0700929] Funding Source: UKRI; Medical Research Council [G0700929] Funding Source: researchfish	European Community(European Commission); Studienstiftung des Deutschen Volkes; German Research Foundation(German Research Foundation (DFG)); Competence Network for Congenital Heart Defects; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Community's Seventh Framework Programme contracts ("CardioGeNet") 2009-223463 and ("CardioNet") People-2011-ITN-289600 (all to SRS), a Marie Curie PhD fellowship to VB, a PhD scholarship to CD by the Studienstiftung des Deutschen Volkes, and the German Research Foundation (Heisenberg professorship and grant 574157 to SRS). This work was also supported by the Competence Network for Congenital Heart Defects funded by the Federal Ministry of Education and Research (BMBF), support code FKZ 01GI0601. The funders had no role in study design, data collection and analysis.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Amarasinghe KC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S2; Apitz C, 2009, SCIENCEDIRECT COM LA; Baum LE, 1970, MAXIMIZATION TECHNIQ, DOI DOI 10.2307/2239727; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cuturilo G, 2011, EUR J PEDIATR, V170, P1465, DOI 10.1007/s00431-011-1533-3; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Dixon WJ, 1950, ANAL EXTREME VALUES, DOI DOI 10.2307/2236602; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Humphreys G, 2012, B WORLD HEALTH ORGAN, V90, P406, DOI 10.2471/BLT.12.020612; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Luo C, 2012, AM J MED GENET A, V158A, P1918, DOI 10.1002/ajmg.a.35471; Luo H, 2012, EUR J MED GENET, V55, P646, DOI 10.1016/j.ejmg.2012.07.006; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rorabacher DB, 1991, STAT TREATMENT REJEC, DOI DOI 10.1021/AC00002A010; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Toenjes M, 2008, MOL BIOSYST, V4, P589, DOI 10.1039/b800207j; Viterbi A, 1967, ERROR BOUNDS CONVOLU	40	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85375	10.1371/journal.pone.0085375	http://dx.doi.org/10.1371/journal.pone.0085375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400131	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329462700065
J	Zimman, A; Titz, B; Komisopoulou, E; Biswas, S; Graeber, TG; Podrez, EA				Zimman, Alejandro; Titz, Bjoern; Komisopoulou, Evangelia; Biswas, Sudipta; Graeber, Thomas G.; Podrez, Eugene A.			Phosphoproteomic Analysis of Platelets Activated by Pro-Thrombotic Oxidized Phospholipids and Thrombin	PLOS ONE			English	Article							AORTIC ENDOTHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; RECEPTOR GAMMA-CHAIN; LYN TYROSINE KINASE; OXIDATION-PRODUCTS; P-SELECTIN; PHOSPHORYLATION; IDENTIFICATION; CD36; FAMILY	Specific oxidized phospholipids (oxPC(CD36)) promote platelet hyper-reactivity and thrombosis in hyperlipidemia via the scavenger receptor CD36, however the signaling pathway(s) induced in platelets by oxPC(CD36) are not well defined. We have employed mass spectrometry-based tyrosine, serine, and threonine phosphoproteomics for the unbiased analysis of platelet signaling pathways induced by oxPC(CD36) as well as by the strong physiological agonist thrombin. oxPC(CD36) and thrombin induced differential phosphorylation of 115 proteins (162 phosphorylation sites) and 181 proteins (334 phosphorylation sites) respectively. Most of the phosphoproteome changes induced by either agonist have never been reported in platelets; thus they provide candidates in the study of platelet signaling. Bioinformatic analyses of protein phosphorylation dependent responses were used to categorize preferential motifs for (de) phosphorylation, predict pathways and kinase activity, and construct a phosphoproteome network regulating integrin activation. A putative signaling pathway involving Src-family kinases, SYK, and PLCc2 was identified in platelets activated by oxPC(CD36). Subsequent ex vivo studies in human platelets demonstrated that this pathway is downstream of the scavenger receptor CD36 and is critical for platelet activation by oxPC(CD36). Our results provide multiple insights into the mechanism of platelet activation and specifically in platelet regulation by oxPC(CD36).	[Zimman, Alejandro; Biswas, Sudipta; Podrez, Eugene A.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Titz, Bjoern; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Inst Mol Med, Crump Inst Mol Imaging,Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Titz, Bjoern; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Cleveland Clinic Foundation; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Podrez, EA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	podreze@ccf.org	Titz, Bjoern/G-6317-2017	Titz, Bjoern/0000-0003-4414-4105; Graeber, Thomas/0000-0001-8574-9181	National Institutes of Health [HL077213, HL077213-05S1, 5P01HL073311-06]; NCI/NIH [P01 CA168585, R21 CA169993]; American Cancer Society [RSG-12-257-01-TBE]; CalTech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; UCLA Institute for Molecular Medicine; National Center for Advancing Translational Sciences UCLA CTSI [UL1TR000124]; Concern Fondation CONquer CanCER Now Award; NATIONAL CANCER INSTITUTE [R21CA169993, P01CA168585] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL077213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); CalTech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; UCLA Institute for Molecular Medicine; National Center for Advancing Translational Sciences UCLA CTSI; Concern Fondation CONquer CanCER Now Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL077213, HL077213-05S1 and 5P01HL073311-06 (to EAP). TGG is supported by the NCI/NIH (P01 CA168585, R21 CA169993), an American Cancer Society Research Scholar Award (RSG-12-257-01-TBE), the CalTech-UCLA Joint Center for Translational Medicine, the UCLA Jonsson Cancer Center Foundation, the UCLA Institute for Molecular Medicine, the National Center for Advancing Translational Sciences UCLA CTSI Grant UL1TR000124, and a Concern Fondation CONquer CanCER Now Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Bartsch I, 2011, THROMB HAEMOSTASIS, V106, P475, DOI 10.1160/TH11-05-0305; Berrou E, 2013, ARTERIOSCL THROM VAS, V33, pE11, DOI 10.1161/ATVBAHA.112.300603; Bleijerveld OB, 2013, ARTERIOSCLER THROMB; Buga GM, 2010, ARTERIOSCL THROM VAS, V30, P283, DOI 10.1161/ATVBAHA.109.200162; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Davi G, 1998, CIRCULATION, V97, P953; Edelstein LC, 2012, CIRCULATION, V125, P2762, DOI 10.1161/CIRCULATIONAHA.112.091462; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Herczenik E, 2007, ARTERIOSCL THROM VAS, V27, P1657, DOI 10.1161/ATVBAHA.107.143479; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Mahfouz MM, 1998, PROSTAG OTH LIPID M, V56, P197, DOI 10.1016/S0090-6980(98)00056-2; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Murohara T, 1996, CIRC RES, V78, P780, DOI 10.1161/01.RES.78.5.780; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nergiz-Unal R, 2011, J THROMB HAEMOST, V9, P1835, DOI 10.1111/j.1538-7836.2011.04416.x; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Rubbi L, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001314; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Severin S, 2012, J THROMB HAEMOST; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Springstead JR, 2012, J LIPID RES, V53, P1304, DOI 10.1194/jlr.M025320; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df; Zimman Alejandro, 2013, Methods Mol Biol, V1000, P53, DOI 10.1007/978-1-62703-405-0_5; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	61	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84488	10.1371/journal.pone.0084488	http://dx.doi.org/10.1371/journal.pone.0084488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400094	Green Submitted, gold, Green Published			2022-12-25	WOS:000329462700028
J	Nsubuga, RN; White, RG; Mayanja, BN; Shafer, LA				Nsubuga, Rebecca N.; White, Richard G.; Mayanja, Billy N.; Shafer, Leigh Anne			Estimation of the HIV Basic Reproduction Number in Rural South West Uganda: 1991-2008	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ANTIRETROVIRAL THERAPY; TRANSMISSION; RATIO; SURVIVAL; SPREAD; MODELS; COHORT	Background: The basic reproduction number, R-0, is one of the many measures of the epidemic potential of an infection in a population. We estimate HIV R-0 over 18 years in a rural population in Uganda, examine method-specific differences in estimated R-0, and estimate behavioural changes that would reduce R-0 below one. Methods: Data on HIV natural history and infectiousness were collated from literature. Data on new sexual partner count were available from a rural clinical cohort in Uganda over 1991-2008. R-0 was estimated using six methods. Behavioural changes required to reduce R-0 below one were calculated. Results: Reported number of new partners per year was 0 to 16 (women) and 0 to 80 (men). When proportionate sexual mixing was assumed, the different methods yielded comparable R-0 estimates. Assuming totally assortative mixing led to increased R-0 estimates in the high sexual activity class while all estimates in the low-activity class were below one. Using the "effective" partner change rate introduced by Anderson and colleagues resulted in R-0 estimates all above one except in the lowest sexual activity class. R-0 could be reduced below one if: (a) medium risk individuals reduce their partner acquisition rate by 70% and higher risk individuals reduce their partner acquisition rate by 93%, or (b) higher risk individuals reduce the partner acquisition rate by 95%. Conclusions: The estimated R-0 depended strongly on the method used. Ignoring variation in sexual activity leads to an underestimation of R-0. Relying on behaviour change alone to eradicate HIV may require unrealistically large reductions in risk behaviour, even though for a small proportion of the population. To control HIV, complementary prevention strategies such as male circumcision and HIV treatment services need rapid scale up.	[Nsubuga, Rebecca N.; Mayanja, Billy N.] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Shafer, Leigh Anne] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Manitoba; Children's Hospital Research Institute of Manitoba	Nsubuga, RN (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	rebecca.nsubuga@mrcuganda.org	Mayanja, Billy/AAL-5087-2021; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635	Medical Research Council, UK [G0501499, G0802414, MR/J005088/1]; Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic) [19790.01]; Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium) [21675]; Medical Research Council [G0501499, MC_U950080928, MR/J005088/1, G0802414] Funding Source: researchfish; MRC [G0501499, G0802414, MR/J005088/1, MC_U950080928] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic); Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was part of a programme of research funded by the Medical Research Council, UK, (G0501499). RGW is funded the Medical Research Council (UK) (Methodology Research Fellowship: G0802414 and grant MR/J005088/1) and the Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic: 19790.01, and the TB Modelling and Analysis Consortium: 21675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; ANDERSON R M, 1991; ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; DIEKMANN O, 1991, MATH BIOSCI, V107, P325, DOI 10.1016/0025-5564(91)90012-8; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIETZ K, 1993, MATH BIOSCI, V117, P35, DOI 10.1016/0025-5564(93)90016-4; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Garnett GP, 1996, SEX TRANSM DIS, V23, P248, DOI 10.1097/00007435-199605000-00015; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Hyman JM, 2000, MATH BIOSCI, V167, P65, DOI 10.1016/S0025-5564(00)00025-0; JACQUEZ JA, 1991, MATH BIOSCI, V107, P161, DOI 10.1016/0025-5564(91)90003-2; Kazooba P, 2012, TROP MED INT HEALTH, V17, pe49, DOI 10.1111/j.1365-3156.2012.02942.x; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; Morgan D, 2000, SEX TRANSM INFECT, V76, P193, DOI 10.1136/sti.76.3.193; Ngom P, 2004, INDEPTH MOD LIF TABL; SEELEY J, 1991, AIDS Care, V3, P207, DOI 10.1080/09540129108253064; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Van der Paal L, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000299407.52399.05; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	21	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83778	10.1371/journal.pone.0083778	http://dx.doi.org/10.1371/journal.pone.0083778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404138	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800017
J	Chamie, G; Kwarisiima, D; Clark, TD; Kabami, J; Jain, V; Geng, E; Balzer, LB; Petersen, ML; Thirumurthy, H; Charlebois, ED; Kamya, MR; Havlir, DV				Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Balzer, Laura B.; Petersen, Maya L.; Thirumurthy, Harsha; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.			Uptake of Community-Based HIV Testing during a Multi-Disease Health Campaign in Rural Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GENDER; HOME; INFECTION; HOUSEHOLD; CARE	Background: The high burden of undiagnosed HIV in sub-Saharan Africa is a major obstacle for HIV prevention and treatment. Multi-disease, community health campaigns (CHCs) offering HIV testing are a successful approach to rapidly increase HIV testing rates and identify undiagnosed HIV. However, a greater understanding of population-level uptake is needed to maximize effectiveness of this approach. Methods: After community sensitization and a census, a five-day campaign was performed in May 2012 in a rural Ugandan community. The census enumerated all residents, capturing demographics, household location, and fingerprint biometrics. The CHC included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Residents who attended vs. did not attend the CHC were compared to determine predictors of participation. Results: Over 12 days, 18 census workers enumerated 6,343 residents. 501 additional residents were identified at the campaign, for a total community population of 6,844. 4,323 (63%) residents and 556 non-residents attended the campaign. HIV tests were performed in 4,795/4,879 (98.3%) participants; 1,836 (38%) reported no prior HIV testing. Of 2674 adults tested, 257 (10%) were HIV-infected; 125/257 (49%) reported newly diagnosed HIV. In unadjusted analyses, adult resident campaign non-participation was associated with male sex (62% male vs. 67% female participation, p = 0.003), younger median age (27 years in non-participants vs. 32 in participants; p<0.001), and marital status (48% single vs. 71% married/widowed/divorced participation; p<0.001). In multivariate analysis, single adults were significantly less likely to attend the campaign than non-single adults (relative risk [RR]: 0.63 [95% CI: 0.53-0.74]; p<0.001), and adults at home vs. not home during census activities were significantly more likely to attend the campaign (RR: 1.20 [95% CI: 1.13-1.28]; p<0.001). Conclusions: CHCs provide a rapid approach to testing a majority of residents for HIV in rural African settings. However, complementary strategies are still needed to engage young, single adults and achieve universal testing.	[Chamie, Gabriel; Clark, Tamara D.; Jain, Vivek; Geng, Elvin; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.] Makerere Univ Univ Calif San Francisco MU UCSF Re, Kampala, Uganda; [Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Balzer, Laura B.; Petersen, Maya L.; Thirumurthy, Harsha; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.] Sustainable East Africa Res Community Hlth SEARCH, San Francisco, CA USA; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Kampala, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Mbarara, Uganda; [Balzer, Laura B.; Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Charlebois, Edwin D.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Makerere University	Chamie, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	Gabriel.chamie@ucsf.edu		Thirumurthy, Harsha/0000-0002-3308-7603	National Institutes of Health/National Institute of Allergy and Infectious Diseases [3P30AI027763-19S1]; Doris Duke Clinical Scientist Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI099959] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of Funding - The National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant 3P30AI027763-19S1 to DVH). Maya Petersen is a recipient of a Doris Duke Clinical Scientist Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WHO GUID INT TUB CAS; Bembom O, 2009, STAT MED, V28, P152, DOI 10.1002/sim.3414; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Kranzer K, 2008, TROP MED INT HEALTH, V13, P1341, DOI 10.1111/j.1365-3156.2008.02148.x; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Marrazzo J, 2013, C RETR OPP INF CROI; Matovu JKB, 2002, TROP MED INT HEALTH, V7, P1064, DOI 10.1046/j.1365-3156.2002.00964.x; Ministry of Health, 2005, UG NAT POL GUID HIV; Mulogo EM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-54; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Ramirez-Avila L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045507; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Uganda Bureau of Statistics, 2008, POP PROJ 2008 2012; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; UNICEF, 2011, OPP CRIS PREV HIV EA; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	26	54	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84317	10.1371/journal.pone.0084317	http://dx.doi.org/10.1371/journal.pone.0084317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392124	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100047
J	Forbes, PA; Dakin, CJ; Geers, AM; Vlaar, MP; Happee, R; Siegmund, GP; Schouten, AC; Blouin, JS				Forbes, Patrick A.; Dakin, Christopher J.; Geers, Anoek M.; Vlaar, Martijn P.; Happee, Riender; Siegmund, Gunter P.; Schouten, Alfred C.; Blouin, Jean-Sebastien			Electrical Vestibular Stimuli to Enhance Vestibulo-Motor Output and Improve Subject Comfort	PLOS ONE			English	Article							GALVANIC STIMULATION; RESPONSES; REFLEXES; MODULATION; OTOLITH; TIME	Electrical vestibular stimulation is often used to assess vestibulo-motor and postural responses in both clinical and research settings. Stochastic vestibular stimulation (SVS) is a recently established technique with many advantages over its square-wave counterpart; however, the evoked muscle responses remain relatively small. Although the vestibular-evoked responses can be enhanced by increasing the stimulus amplitude, subjects often perceive these higher intensity electrical stimuli as noxious or painful. Here, we developed multisine vestibular stimulation (MVS) signals that include precise frequency contributions to increase signal-to-noise ratios (SNR) of stimulus-evoked muscle and motor responses. Subjects were exposed to three different MVS stimuli to establish that: 1) MVS signals evoke equivalent vestibulo-motor responses compared to SVS while improving subject comfort and reducing experimentation time, 2) stimulus-evoked vestibulo-motor responses are reliably estimated as a linear system and 3) specific components of the cumulant density time domain vestibulo-motor responses can be targeted by controlling the frequency content of the input stimulus. Our results revealed that in comparison to SVS, MVS signals increased the SNR 3-6 times, reduced the minimum experimentation time by 85% and improved subjective measures of comfort by 20-80%. Vestibulo-motor responses measured using both EMG and force were not substantially affected by nonlinear distortions. In addition, by limiting the contribution of high frequencies within the MVS input stimulus, the magnitude of the medium latency time domain motor output response was increased by 58%. These results demonstrate that MVS stimuli can be designed to target and enhance vestibulo-motor output responses while simultaneously improving subject comfort, which should prove beneficial for both research and clinical applications.	[Forbes, Patrick A.; Geers, Anoek M.; Vlaar, Martijn P.; Happee, Riender; Schouten, Alfred C.] Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands; [Schouten, Alfred C.] Univ Twente, Lab Biomech Engn, Inst Biomed Technol & Tech Med MIRA, NL-7500 AE Enschede, Netherlands; [Dakin, Christopher J.; Siegmund, Gunter P.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC V5Z 1M9, Canada; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, Richmond, BC, Canada	Delft University of Technology; University of Twente; University of British Columbia; University of British Columbia; University of British Columbia	Forbes, PA (corresponding author), Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands.	p.a.forbes@tudelft.nl	Siegmund, Gunter P/B-7003-2013; Schouten, Alfred C./AAH-3560-2019; Happee, Riender/A-2621-2011; Forbes, Patrick/GZH-1852-2022	Schouten, Alfred C./0000-0003-3149-6726; Happee, Riender/0000-0001-5878-3472; Forbes, Patrick/0000-0002-0230-9971; Siegmund, Gunter/0000-0003-2387-941X; Dakin, Chris/0000-0002-6781-0281	Dutch Technology Foundation STW; Ministry of Economic Affairs, Agriculture and Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research; Canadian Chiropractic Research Foundation; Canadian Institutes of Health Research	Dutch Technology Foundation STW(Technologiestichting STW); Ministry of Economic Affairs, Agriculture and Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Chiropractic Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by (1) the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation (PAF, MPV, AMG, RH and ACS), and (2) the Natural Sciences and Engineering Research Council of Canada (NSERC), the Michael Smith Foundation for Health Research, the Canadian Chiropractic Research Foundation and the Canadian Institutes of Health Research (CJD, GPS and JSB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin JS, 2011, J APPL PHYSIOL, V111, P1484, DOI 10.1152/japplphysiol.00621.2011; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Cathers I, 2005, J PHYSIOL-LONDON, V563, P229, DOI 10.1113/jphysiol.2004.079525; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2013, J NEUROPHYSIOL, V110, P86, DOI 10.1152/jn.00843.2012; Dakin CJ, 2011, EXP BRAIN RES, V209, P345, DOI 10.1007/s00221-011-2549-7; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Ehtemam F, 2012, IEEE T BIO-MED ENG, V59, P1978, DOI 10.1109/TBME.2012.2195178; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Forbes PA, 2013, J NEUROPHYS IN PRESS; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; ILES JF, 1992, J PHYSIOL-LONDON, V455, P407, DOI 10.1113/jphysiol.1992.sp019308; Iles JF, 2004, BRAIN, V127, P1584, DOI 10.1093/brain/awh173; Iles JF, 2007, EXP BRAIN RES, V178, P151, DOI 10.1007/s00221-006-0721-2; Jankelowitz SK, 2004, CLIN NEUROPHYSIOL, V115, P1796, DOI 10.1016/j.clinph.2004.03.021; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MAKI BE, 1986, IEEE T BIO-MED ENG, V33, P775, DOI 10.1109/TBME.1986.325901; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Mian OS, 2009, J PHYSIOL-LONDON, V587, P2869, DOI 10.1113/jphysiol.2009.171256; Monobe H, 2004, CLIN NEUROPHYSIOL, V115, P807, DOI 10.1016/j.clinph.2003.11.035; Mugge W, 2007, INT C REHAB ROBOT, P575, DOI 10.1109/ICORR.2007.4428483; NASHNER LM, 1974, BRAIN RES, V67, P255, DOI 10.1016/0006-8993(74)90276-5; PASTOR MA, 1993, BRAIN, V116, P1177, DOI 10.1093/brain/116.5.1177; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Pintelon R., 2001, SYSTEM IDENTIFICATIO; Pintelon R., 2012, SYSTEM IDENTIFICATIO, V2nd, DOI DOI 10.1002/9781118287422; Reynolds RF, 2011, J PHYSIOL-LONDON, V589, P3943, DOI 10.1113/jphysiol.2011.209163; Reynolds RF, 2010, EXP BRAIN RES, V201, P133, DOI 10.1007/s00221-009-2017-9; Schoukens J, 1993, DESIGN BROADBAND EXC; Schouten AC, 2008, IEEE T BIO-MED ENG, V55, P1612, DOI 10.1109/TBME.2007.912432; Stuart A, 1998, KENDALLS ADV THEORY, V1; Tax CM, 2013, CLIN NEUROPHYSIOLOGY	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84385	10.1371/journal.pone.0084385	http://dx.doi.org/10.1371/journal.pone.0084385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392130	gold, Green Published			2022-12-25	WOS:000329460100053
J	Mikami, Y; Mizuno, S; Nakamoto, N; Hayashi, A; Sujino, T; Sato, T; Kamada, N; Matsuoka, K; Hisamatsu, T; Ebinuma, H; Hibi, T; Yoshimura, A; Kanai, T				Mikami, Yohei; Mizuno, Shinta; Nakamoto, Nobuhiro; Hayashi, Atsushi; Sujino, Tomohisa; Sato, Toshiro; Kamada, Nobuhiko; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Ebinuma, Hirotoshi; Hibi, Toshifumi; Yoshimura, Akihiko; Kanai, Takanori			Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; DSS-INDUCED COLITIS; T-CELLS; BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOTA; MICE; PATHOGENESIS; TOLERANCE	The liver is a physiological site of immune tolerance, the breakdown of which induces immunity. Liver antigen-presenting cells may be involved in both immune tolerance and activation. Although inflammatory diseases of the liver are frequently associated with inflammatory bowel diseases, the underlying immunological mechanisms remain to be elucidated. Here we report two murine models of inflammatory bowel disease: RAG-2(-/-) mice adoptively transferred with CD4(+)CD45RB(high) T cells; and IL-10(-/-) mice, accompanied by the infiltration of mononuclear cells in the liver. Notably, CD11b(-) CD11c(low)PDCA-1(+) plasmacytoid dendritic cells (DCs) abundantly residing in the liver of normal wild-type mice disappeared in colitic CD4(+)CD45RB(high) T cell-transferred RAG-2(-/-) mice and IL-10(-/-) mice in parallel with the emergence of macrophages (MQs) and conventional DCs (cDCs). Furthermore, liver MQ/cDCs emerging during intestinal inflammation not only promote the proliferation of naive CD4(+) T cells, but also instruct them to differentiate into IFN-gamma-producing Th1 cells in vitro. The emergence of pathological M phi/cDCs in the liver also occurred in a model of acute dextran sulfate sodium (DSS)-induced colitis under specific pathogen-free conditions, but was canceled in germ-free conditions. Last, the MQ/cDCs that emerged in acute DSS colitis significantly exacerbated Fas-mediated hepatitis. Collectively, intestinal inflammation skews the composition of antigen-presenting cells in the liver through signaling from commensal bacteria and predisposes the liver to inflammation.	[Mikami, Yohei; Mizuno, Shinta; Nakamoto, Nobuhiro; Hayashi, Atsushi; Sujino, Tomohisa; Sato, Toshiro; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Ebinuma, Hirotoshi; Hibi, Toshifumi; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Mikami, Yohei; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hayashi, Atsushi] Miyarisan Pharmaceut, Res Lab, Tokyo, Japan; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA	Keio University; Keio University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp; takagast@z2.keio.jp	Kamada, Nobuhiko/AAW-3299-2020; MIKAMI, YOHEI/GRJ-8133-2022; Matsuoka, Katsuyoshi/AAB-1580-2022; Yoshimura, Akihiko/K-5515-2013; Sato, Toshiro/J-3522-2014	Kamada, Nobuhiko/0000-0002-1980-4178; MIKAMI, YOHEI/0000-0001-5104-4415; Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sato, Toshiro/0000-0001-8353-8137; Sujino, Tomohisa/0000-0003-0699-6577; Kanai, Takanori/0000-0002-1466-4532	Japanese Ministry of Education, Culture, Sports, Science and Technology [21390233, 22021038]; Japanese Ministry of Health, Labour and Welfare [22790667]; Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare	This study was supported in part by Grants-in-Aid for Scientific Research [21390233], Scientific Research on Priority Areas [22021038] from the Japanese Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Young Scientists [22790667] from the Japanese Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants for research on intractable diseases from the Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare; a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bjornsson E, 2008, GASTROENTEROLOGY, V134, P975, DOI 10.1053/j.gastro.2008.01.042; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ishii K, 2004, J GASTROEN HEPATOL, V19, P174, DOI 10.1111/j.1440-1746.2004.03202.x; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kimura K, 2012, BIOCHEM BIOPH RES CO, V427, P694, DOI 10.1016/j.bbrc.2012.09.091; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mikami Y, 2010, EUR J IMMUNOL, V40, P2409, DOI 10.1002/eji.201040379; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nakamoto N, 2012, GASTROENTEROLOGY, V142, P366, DOI 10.1053/j.gastro.2011.10.039; Nemoto Y, 2009, J IMMUNOL, V183, P5059, DOI 10.4049/jimmunol.0803684; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ojiro K, 2010, BIOCHEM BIOPH RES CO, V399, P744, DOI 10.1016/j.bbrc.2010.08.012; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasmussen HH, 1997, SCAND J GASTROENTERO, V32, P604, DOI 10.3109/00365529709025107; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tokita D, 2008, J HEPATOL, V49, P1008, DOI 10.1016/j.jhep.2008.07.028; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84619	10.1371/journal.pone.0084619	http://dx.doi.org/10.1371/journal.pone.0084619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392145	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100068
J	Yuan, J; Kang, CY; Wang, M; Wang, Q; Li, PK; Liu, H; Hou, Y; Su, P; Yang, F; Wei, YJ; Yang, JZ				Yuan, Jing; Kang, ChuanYuan; Wang, Min; Wang, Qiang; Li, PeiKai; Liu, Hua; Hou, Yu; Su, Ping; Yang, Fan; Wei, YuJun; Yang, JianZhong			Association Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; 5-HYDROXYTRYPTAMINE; PREDOMINANT; CONSTIPATION; SYMPTOMS; PROTEIN	Objective: Irritable bowel syndrome (IBS) is a common clinical gastrointestinal dysfunction disorders. 5-sertonon (5-hydroxytryptamine, 5-HT) is a very important neurotransmitter, which is involved in gastrointestinal motion and sensation. Solute carrier family 6 member 4 (SLC6A4) gene encode serotonin transporter (SERT) which function is to rapidly reuptake the most of 5-HT. Therefore, it is needed to explore the association between SLC6A4 gene polymorphisms and IBS. Methods: 119 patients and 238 healthy controls were administrated to detect the SLC6A4 gene polymorphisms including 5-HT-transporter-gene-linked polymorphic region (5-HTTLPR), variable number of tandem repeats (VNTRs) and three selected tag Single Nucleotide Polymorphisms (SNPs) rs1042173, rs3794808, rs2020936 by using polymerase chain reaction (PCR) and TaqMan (R) SNP Genotyping. Results: There were significant difference for 5-HTTLPR between IBS and control groups (X2 = 106.168, P < 0.0001). In control group, genotypes were mainly L/L (58.4%), however, the genotypes in IBS were S/S (37.8%). The significant difference was shown in D-IBS subjects when compared to the controls (X-2 = 50.850, P < 0.0001) for 5-HTTLPR. For STin2 VNTR, rs1042173, rs3794808, and rs2020936 polymorphisms, there were no any significant differences between IBS and control groups. There were no statistical significantly haplotypes for 5-HTTLPR, VNTRs and the three SNPs between IBS and controls. Conclusion: The S allele in 5-HTTLPR was a susceptible allele with Chinese Han IBS, but other associations of VNTRs, three selected Tag SNPs and positive haplotype with IBS were not found. It is indicated that much research are needed to study the relationship between other polymorphisms in SLC6A4 gene and IBS.	[Yuan, Jing; Li, PeiKai; Hou, Yu; Su, Ping; Yang, Fan; Wei, YuJun; Yang, JianZhong] 2 Peoples Hosp Yunnan Prov, Dept Clin Psychol, Kunming, Peoples R China; [Kang, ChuanYuan] Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Peoples R China; [Wang, Min; Wang, Qiang] 2 Peoples Hosp Yunnan Prov, Dept Gastroenterol, Kunming, Peoples R China; [Liu, Hua] Kunming Med Univ, Affiliated Hosp 1, Dept Lab, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University	Yang, JZ (corresponding author), 2 Peoples Hosp Yunnan Prov, Dept Clin Psychol, Kunming, Peoples R China.	jzhyang2004@163.com			National Natural Scientific Foundation of China [81160170]; National Key Technologies RD Program [2009BAI77B05]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work was supported by Grant 81160170 from the National Natural Scientific Foundation of China, Grant 2009BAI77B05 from National Key Technologies R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areeshi MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075567; Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Chang Full-Young, 2010, J Neurogastroenterol Motil, V16, P389, DOI 10.5056/jnm.2010.16.4.389; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; De Ponti F, 2004, GUT, V53, P1520, DOI 10.1136/gut.2003.035568; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Hotoleanu C, 2008, WORLD J GASTROENTERO, V14, P6636, DOI 10.3748/wjg.14.6636; Houghton LA, 2003, GUT, V52, P663, DOI 10.1136/gut.52.5.663; Jarrett ME, 2007, BIOL RES NURS, V9, P161, DOI 10.1177/1099800407307822; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kohen R, 2009, DIGEST DIS SCI, V54, P2663, DOI 10.1007/s10620-008-0666-3; Lee Dok Yong, 2004, Korean J Gastroenterol, V43, P18; Lee Oh Young, 2010, J Neurogastroenterol Motil, V16, P5, DOI 10.5056/jnm.2010.16.1.5; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Makharia GK, 2011, J NEUROGASTROENTEROL, V17, P82, DOI 10.5056/jnm.2011.17.1.82; Markoutsaki T, 2011, DIGEST DIS SCI, V56, P3276, DOI 10.1007/s10620-011-1726-7; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Saito YA, 2005, CLIN GASTROENTEROL H, V3, P1057, DOI 10.1016/S1542-3565(05)00184-9; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Wang Bang-mao, 2004, Zhonghua Nei Ke Za Zhi, V43, P439; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	25	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84414	10.1371/journal.pone.0084414	http://dx.doi.org/10.1371/journal.pone.0084414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392134	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100057
J	de Oliveira, SV; Escobar, LE; Peterson, AT; Gurgel-Goncalves, R				de Oliveira, Stefan Vilges; Escobar, Luis E.; Peterson, A. Townsend; Gurgel-Goncalves, Rodrigo			Potential Geographic Distribution of Hantavirus Reservoirs in Brazil	PLOS ONE			English	Article							POPULATION-DYNAMICS; PULMONARY SYNDROME; NECROMYS-LASIURUS; WILD RODENTS; INFECTION; CERRADO; MAMMALS; RISK; SIGMODONTINAE; CONSERVATISM	Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Brazil. Human infections occur via inhalation of aerosolized viral particles from excreta of infected wild rodents. Necromys lasiurus and Oligoryzomys nigripes appear to be the main reservoirs of hantavirus in the Atlantic Forest and Cerrado biomes. We estimated and compared ecological niches of the two rodent species, and analyzed environmental factors influencing their occurrence, to understand the geography of hantavirus transmission. N. lasiurus showed a wide potential distribution in Brazil, in the Cerrado, Caatinga, and Atlantic Forest biomes. Highest climate suitability for O. nigripes was observed along the Brazilian Atlantic coast. Maximum temperature in the warmest months and annual precipitation were the variables that most influence the distributions of N. lasiurus and O. nigripes, respectively. Models based on occurrences of infected rodents estimated a broader area of risk for hantavirus transmission in southeastern and southern Brazil, coinciding with the distribution of human cases of hantavirus cardiopulmonary syndrome. We found no demonstrable environmental differences among occurrence sites for the rodents and for human cases of hantavirus. However, areas of northern and northeastern Brazil are also apparently suitable for the two species, without broad coincidence with human cases. Modeling of niches and distributions of rodent reservoirs indicates potential for transmission of hantavirus across virtually all of Brazil outside the Amazon Basin.	[de Oliveira, Stefan Vilges] Univ Brasilia, Postgrad Program Trop Med, Brasilia, DF, Brazil; [de Oliveira, Stefan Vilges] Minist Saude, Unidade Tecn Vigilancia Zoonoses, Brasilia, DF, Brazil; [Escobar, Luis E.] Univ Andres Bello, Conservat Med Program, Fac Ecol & Recursos Nat, Santiago, Chile; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Gurgel-Goncalves, Rodrigo] Univ Brasilia, Lab Parasitol Med & Biol Vetores, Brasilia, DF, Brazil	Universidade de Brasilia; Universidad Andres Bello; University of Kansas; Universidade de Brasilia	Gurgel-Goncalves, R (corresponding author), Univ Brasilia, Lab Parasitol Med & Biol Vetores, Brasilia, DF, Brazil.	gurgelrg@hotmail.com	Escobar, Luis E./I-2204-2019; Gurgel-Goncalves, Rodrigo/AAD-7955-2020; Peterson, A. Townsend/I-5697-2013	Escobar, Luis E./0000-0001-5735-2750; Gurgel-Goncalves, Rodrigo/0000-0001-8252-8690; Peterson, A. Townsend/0000-0003-0243-2379	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Stefan Vilges de Oliveira received financial support (scholarship) from CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrellos R, 2012, ZOOTAXA, P1; Alger, 2003, CORREDOR BIODIVERSID, P1; Alho CJR, 2011, BRAZ J BIOL, V71, P297, DOI 10.1590/S1519-69842011000200009; ALHO C J R, 1982, Annals of Carnegie Museum, V51, P127; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Astua Diego, 2006, Boletim do Museu de Biologia Mello Leitao Nova Serie, V19, P31; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Becker Rafael G., 2007, Mastozool. neotrop., V14, P157; Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; Bezerra AMR, 2009, ZOOL STUD, V48, P861; Bonvicino C. R., 2005, Braz. J. Biol., V65, P395, DOI 10.1590/S1519-69842005000300004; Bonvicino CR, 2008, GUIA ROED BRAS COM C; Brasil, 2009, GUIA VIG EP; Cademartori Cristina Vargas, 2008, Biodiversidade Pampeana, V6, P34; Caldas EP, 2003, THESIS U FEDERAL DO, P63; Carbajo AE, 2007, J MAMMAL, V88, P1555, DOI 10.1644/06-MAMM-A-183R1.1; Cherem Jorge J., 2004, Mastozool. neotrop., V11, P151; Chioratto Gerlane Tavares de Souza, 2010, Revista de Patologia Tropical, V39, P1; D'Elia G, 2008, J MAMMAL, V89, P778, DOI 10.1644/07-MAMM-A-246R1.1; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Eisenberg JF, 1999, MAMMALS NEOTROPICS; Gazeta GS, 2004, ARQ BRAS MED VET ZOO, V56, P741, DOI 10.1590/S0102-09352004000600007; Ghizoni IR, 2005, J MAMMAL, V86, P677, DOI 10.1644/1545-1542(2005)086[0677:SEPDIA]2.0.CO;2; Glass GE, 2002, P NATL ACAD SCI USA, V99, P16817, DOI 10.1073/pnas.252617999; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Katz G, 2001, ZOO DROSOPHILA INF S, V1, P181; Lemos Elba Regina S. de, 2004, Pesq. Vet. Bras., V24, P71, DOI 10.1590/S0100-736X2004000200004; Loehman RA, 2012, J WILDLIFE DIS, V48, P348, DOI 10.7589/0090-3558-48.2.348; Lustosa GS, 2007, AN 8 C EC BRAS 23 28; Machado Leonardo F., 2011, Pap. Avulsos Zool. (São Paulo), V51, P29, DOI 10.1590/S0031-10492011000300001; MELLO DA, 1982, REV SAUDE PUBL, V16, P282, DOI 10.1590/S0034-89101982000500003; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; OLIVEIRA F.F., 2004, REV NORDESTINA BIOL, V18, P19; Oliveira J., 2006, MAMIFEROS BRASIL, P347; OLIVEIRA J. A., 2003, ECOLOGIA CONSERVACAO, P275; Oliveira RC, 2009, ACTA TROP, V112, P212, DOI 10.1016/j.actatropica.2009.07.029; Oliveira RC, 2011, VECTOR BORNE ZOO DIS, V11, P302; Paglia AP., 2012, OCCAS PAP CONSERV BI, V4, P76; Paresque Roberta, 2004, Boletim do Museu de Biologia Mello Leitao Nova Serie, P5; Paresque R, 2007, GENET MOL BIOL, V30, P43, DOI 10.1590/S1415-47572007000100010; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pereira LE, 2006, THESIS SECRETARIA ES, P165; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qiao H, 2013, NICHEA VERSION 1 2 B; Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0; Raboni SM, 2009, J CLIN VIROL, V45, P153, DOI 10.1016/j.jcv.2009.03.015; Romano-Lieber Nicolina Silvana, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P325, DOI 10.1590/S0036-46652001000600005; Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11; Saavedra RD, 2011, REV SOC BRAS MED TRO, V44, P223, DOI 10.1590/S0037-86822011005000008; Santos JP, 2001, REV SOC BRAS MED TRO, V44, P53; Silva Marcos Vinicius Da, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P231; Sobreira M, 2008, ACTA TROP, V107, P150, DOI 10.1016/j.actatropica.2008.05.018; Sousa MAN, 2004, BREJOS ALTITUDE PERN, P229, DOI DOI 10.15560/9.6.1527; Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295; da Rosa EST, 2012, EMERG INFECT DIS, V18, P982, DOI 10.3201/eid1806.110948; da Rosa EST, 2011, EMERG INFECT DIS, V17, P1527, DOI 10.3201/eid1708.101547; Travassos da Rosa ES, 2008, THESIS I O CRUZ RIO; Vasconcelos M I, 1997, Rev Inst Med Trop Sao Paulo, V39, P237; Vieira EM, 2005, MAMM BIOL, V70, P359, DOI 10.1016/j.mambio.2005.08.002; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678	67	10	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85137	10.1371/journal.pone.0085137	http://dx.doi.org/10.1371/journal.pone.0085137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391989	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900132
J	Paolella, G; Caputo, I; Marabotti, A; Lepretti, M; Salzano, AM; Scaloni, A; Vitale, M; Zambrano, N; Sblattero, D; Esposito, C				Paolella, Gaetana; Caputo, Ivana; Marabotti, Anna; Lepretti, Marilena; Salzano, Anna Maria; Scaloni, Andrea; Vitale, Monica; Zambrano, Nicola; Sblattero, Daniele; Esposito, Carla			Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; TISSUE TRANSGLUTAMINASE; KINASE-ACTIVITY; POSTTRANSLATIONAL MODIFICATION; SURFACE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM; CREATINE-KINASE; HUMAN-DISEASES; PHOSPHORYLATION; IDENTIFICATION	Background: Celiac disease is an inflammatory condition of the small intestine that affects genetically predisposed individuals after dietary wheat gliadin ingestion. Type 2-transglutaminase (TG2) activity seems to be responsible for a strong autoimmune response in celiac disease, TG2 being the main autoantigen. Several studies support the concept that celiac anti-TG2 antibodies may contribute to disease pathogenesis. Our recent findings on the ability of anti-TG2 antibodies to induce a rapid intracellular mobilization of calcium ions, as well as extracellular signal-regulated kinase phosphorylation, suggest that they potentially act as signaling molecules. In line with this concept, we have investigated whether anti-TG2 antibodies can induce phosphoproteome modification in an intestinal epithelial cell line. Methods and Principal Findings: We studied phosphoproteome modification in Caco-2 cells treated with recombinant celiac anti-TG2 antibodies. We performed a two-dimensional electrophoresis followed by specific staining of phosphoproteins and mass spectrometry analysis of differentially phosphorylated proteins. Of 14 identified proteins (excluding two uncharacterized proteins), three were hypophosphorylated and nine were hyperphosphorylated. Bioinformatics analyses confirmed the presence of phosphorylation sites in all the identified proteins and highlighted their involvement in several fundamental biological processes, such as cell cycle progression, cell stress response, cytoskeletal organization and apoptosis. Conclusions: Identification of differentially phosphorylated proteins downstream of TG2-antibody stimulation suggests that in Caco-2 cells these antibodies perturb cell homeostasis by behaving as signaling molecules. We hypothesize that anti-TG2 autoantibodies may destabilize the integrity of the intestinal mucosa in celiac individuals, thus contributing to celiac disease establishment and progression. Since several proteins here identified in this study were already known as TG2 substrates, we can also suppose that transamidating activity and differential phosphorylation of the same targets may represent a novel regulatory mechanism whose relevance in celiac disease pathogenesis is still unexplored.	[Paolella, Gaetana; Caputo, Ivana; Marabotti, Anna; Lepretti, Marilena; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Caputo, Ivana; Esposito, Carla] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy; [Vitale, Monica; Zambrano, Nicola] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Vitale, Monica; Zambrano, Nicola] CEINGE Biotecnol Avanzate, Naples, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy	University of Salerno; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Caputo, I (corresponding author), Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy.	icaputo@unisa.it	Salzano, Anna Maria/C-7139-2012; Zambrano, Nicola/B-9352-2014	Salzano, Anna Maria/0000-0001-7192-8760; Zambrano, Nicola/0000-0001-9395-3481; Marilena, Lepretti/0000-0003-4441-7214; Caputo, Ivana/0000-0003-2825-9711; PAOLELLA, Gaetana/0000-0003-2188-3829; Scaloni, Andrea/0000-0001-9362-8515; VITALE, MONICA/0000-0003-1517-7426; Marabotti, Anna/0000-0002-9510-5205; Sblattero, Daniele/0000-0003-4309-242X	PRIN; P.O.R. Campania FSE; Project CREME; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); P.O.R. Campania FSE(Regione Campania); Project CREME; EC Marie Curie Research Training Network(European Commission)	This work was supported by grants from PRIN 2008. It was supported also by P.O.R. Campania FSE 2007-2013, Project CREME and by the EC Marie Curie Research Training Network [contract no. MRTN-CT-20010-289964]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; Biagi F, 2006, DIGEST LIVER DIS, V38, P652, DOI 10.1016/j.dld.2006.05.021; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Caja S, 2011, CELL MOL IMMUNOL, V8, P103, DOI 10.1038/cmi.2010.65; Caputo I, 2004, AMINO ACIDS, V26, P381, DOI 10.1007/s00726-004-0083-7; Caputo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045209; Caputo I, 2013, AMINO ACIDS, V44, P251, DOI 10.1007/s00726-011-1120-y; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; D'Ambrosio C, 2008, PROTEOMICS, V8, P3657, DOI 10.1002/pmic.200701148; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Joseph J, 1997, BRIT J CANCER, V76, P600, DOI 10.1038/bjc.1997.432; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaukinen K, 2005, SCAND J GASTROENTERO, V40, P564, DOI 10.1080/00365520510023422; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Lin G, 2009, CELL MOL LIFE SCI, V66, P135, DOI 10.1007/s00018-008-8575-3; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Monnier A, 2001, NUCLEIC ACIDS RES, V29, P1453, DOI 10.1093/nar/29.7.1453; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, SCAND J GASTROENTERO, V44, P162, DOI 10.1080/00365520802400875; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Orru S, 2003, J BIOL CHEM, V278, P31766, DOI 10.1074/jbc.M305080200; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; QUEMENEUR E, 1994, J BIOL CHEM, V269, P5485; Sakly W, 2005, VIRCHOWS ARCH, V446, P613, DOI 10.1007/s00428-005-1237-z; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Schuppan D, 1998, NAT MED, V4, P666, DOI 10.1038/nm0698-666; Sefton B M, 2001, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1401s00; Sivaramakrishnan M, 2013, AMINO ACIDS, V44, P19, DOI 10.1007/s00726-011-1113-x; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Villanacci V, 2009, J CELL MOL MED, V13, P334, DOI 10.1111/j.1582-4934.2008.00325.x; Wang S, 2008, ACTA PHARMACOL SIN, V29, P135, DOI 10.1111/j.1745-7254.2008.00753.x; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	71	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84403	10.1371/journal.pone.0084403	http://dx.doi.org/10.1371/journal.pone.0084403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391952	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900095
J	Szabo, A; Radisky, ES; Sahin-Toth, M				Szabo, Andras; Radisky, Evette S.; Sahin-Toth, Miklos			Zymogen Activation Confers Thermodynamic Stability on a Key Peptide Bond and Protects Human Cationic Trypsin from Degradation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Pancreas; Protein Degradation; Proteolytic Enzymes; Serine Protease; Chymotrypsin C; Proteolytic Stability; Trypsin; Trypsinogen; Zymogen Activation	STRUCTURAL BASIS; REACTIVE-SITE; DETERMINANTS; ABSORPTION; MECHANISM; RESYNTHESIZE; HYDROLYSIS; EQUILIBRIA; INHIBITORS; DIGESTION	Background: Initial cleavage by chymotrypsin C regulates degradation of human cationic trypsin. Results: Cleavage is reversible and favors calcium-dependent bond formation in trypsin, but not in trypsinogen. Conclusion: Trypsin resistance to degradation derives from the regulated thermodynamic stability of a specific peptide bond that is responsive to physiological environment. Significance: This new paradigm explains the robustness of trypsin functioning in the protease-rich intestinal milieu. Human cationic trypsinogen, precursor of the digestive enzyme trypsin, can be rapidly degraded to protect the pancreas when pathological conditions threaten, while trypsin itself is impressively resistant to degradation. For either form, degradation is controlled by two necessary initial proteolytic events: cleavage of the Leu81-Glu82 peptide bond by chymotrypsin C (CTRC) and cleavage of the Arg122-Val123 peptide bond by trypsin. Here we demonstrate that the Leu81-Glu82 peptide bond of human cationic trypsin, but not trypsinogen, is thermodynamically stable, such that cleavage by CTRC leads to an equilibrium mixture containing 10% cleaved and 90% uncleaved trypsin. When cleaved trypsin was incubated with CTRC, the Leu81-Glu82 peptide bond was re-synthesized to establish the same equilibrium. The thermodynamic stability of the scissile peptide bond was not dependent on CTRC or Leu-81, as re-synthesis was also accomplished by other proteases acting on mutated cationic trypsin. The Leu81-Glu82 peptide bond is located within a calcium binding loop, and thermodynamic stability of the bond was strictly dependent on calcium and on the calcium-coordinated residue Glu-85. Trypsinolytic cleavage of the Arg122-Val123 site was also delayed in trypsin relative to trypsinogen in a calcium-dependent manner, but for this bond cleavage was modulated by kinetic rather than thermodynamic control. Our results reveal that the trypsinogen to trypsin conformational switch modulates cleavage susceptibility of nick sites by altering both the thermodynamics and kinetics of cleavage to protect human cationic trypsin from premature degradation.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Boston University; Mayo Clinic	Radisky, ES (corresponding author), 4500 San Pablo Rd,310 Griffin Bldg, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu; miklos@bu.edu	Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK058088, R01DK082412, R01DK095753, R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK058088, R01DK082412, and R01DK095753 (to M. S.-T.) and R01CA154387 (to E. S. R.).	Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; BOHE M, 1986, DIGESTION, V34, P127, DOI 10.1159/000199321; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; Bronner F, 2003, J CELL BIOCHEM, V88, P387, DOI 10.1002/jcb.10330; DELAAGE M, 1967, BIOCHEM BIOPH RES CO, V28, P390, DOI 10.1016/0006-291X(67)90323-3; DUFLOS C, 1995, J NUTR, V125, P2348, DOI 10.1093/jn/125.9.2348; Finkenstadt W. R., 1974, KINETICS THERMODYNAM, P389; FREEMAN HJ, 1978, ANNU REV MED, V29, P99, DOI 10.1146/annurev.me.29.020178.000531; HOMANDBERG GA, 1978, BIOCHEMISTRY-US, V17, P5220, DOI 10.1021/bi00617a023; HOMANDBERG GA, 1979, BIOCHEMISTRY-US, V18, P586, DOI 10.1021/bi00571a006; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAYER P, 1986, AM J PHYSIOL, V251, pG475, DOI 10.1152/ajpgi.1986.251.4.G475; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; NIEKAMP CW, 1969, BIOCHEMISTRY-US, V8, P16, DOI 10.1021/bi00829a004; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SEALOCK RW, 1973, BIOCHEMISTRY-US, V12, P3139, DOI 10.1021/bi00741a001; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; TARLOW MJ, 1970, ARCH DIS CHILD, V45, P651, DOI 10.1136/adc.45.243.651; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	34	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4753	4761		10.1074/jbc.M113.538884	http://dx.doi.org/10.1074/jbc.M113.538884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403079	Green Published, hybrid			2022-12-25	WOS:000331607900022
J	Matsuda, I; Matsuo, K; Matsushita, Y; Haruna, Y; Niwa, M; Kataoka, T				Matsuda, Iyo; Matsuo, Kentaro; Matsushita, Yuka; Haruna, Yasushi; Niwa, Masamitsu; Kataoka, Takao			The C-terminal Domain of the Long Form of Cellular FLICE-inhibitory Protein (c-FLIPL) Inhibits the Interaction of the Caspase 8 Prodomain with the Receptor-interacting Protein 1 (RIP1) Death Domain and Regulates Caspase 8-dependent Nuclear Factor kappa B (NF-kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Death Domain; Fas; NF-B; RIP	SIGNALING COMPLEX; LYMPHOCYTE-PROLIFERATION; INTERLEUKIN-8 PRODUCTION; CFLIP ISOFORMS; IMMUNE-SYSTEM; APOPTOSIS; NECROSIS; LIFE; FAS; SURVIVAL	Caspase 8 plays an essential role in the regulation of apoptotic and non-apoptotic signaling pathways. The long form of cellular FLICE-inhibitory protein (c-FLIPL) has been shown previously to regulate caspase 8-dependent nuclear factor B (NF-B) activation by receptor-interacting protein 1 (RIP1) and TNF receptor-associated factor 2 (TRAF2). In this study, the molecular mechanism by which c-FLIPL regulates caspase 8-dependent NF-B activation was further explored in the human embryonic kidney cell line HEK 293 and variant cells barely expressing caspase 8. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone greatly diminished caspase 8-dependent NF-B activation induced by Fas ligand (FasL) when c-FLIPL, but not its N-terminal fragment c-FLIP(p43), was expressed. The prodomain of caspase 8 was found to interact with the RIP1 death domain and to be sufficient to mediate NF-B activation induced by FasL or c-FLIP(p43). The interaction of the RIP1 death domain with caspase 8 was inhibited by c-FLIPL but not c-FLIP(p43). Thus, these results reveal that the C-terminal domain of c-FLIPL specifically inhibits the interaction of the caspase 8 prodomain with the RIP1 death domain and, thereby, regulates caspase 8-dependent NF-B activation.	[Matsuda, Iyo; Matsuo, Kentaro; Matsushita, Yuka; Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Haruna, Yasushi; Niwa, Masamitsu; Kataoka, Takao] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kyoto Institute of Technology; Tokyo Institute of Technology	Kataoka, T (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	takao.kataoka@kit.ac.jp			Japan Society for the Promotion of Science (JSPS) [19380057, 22380060, 25292061]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research (KAKENHI) Grant numbers 19380057, 22380060, and 25292061 (to T. K.) from the Japan Society for the Promotion of Science (JSPS).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kavuri SM, 2011, J BIOL CHEM, V286, P16631, DOI 10.1074/jbc.M110.148585; Kawadler H, 2008, MOL CELL, V31, P415, DOI 10.1016/j.molcel.2008.06.008; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	54	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3876	3887		10.1074/jbc.M113.506485	http://dx.doi.org/10.1074/jbc.M113.506485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24398693	hybrid, Green Published			2022-12-25	WOS:000331403800005
J	Weinreb, V; Li, L; Chandrasekaran, SN; Koehl, P; Delarue, M; Carter, CW				Weinreb, Violetta; Li, Li; Chandrasekaran, Srinivas Niranj; Koehl, Patrice; Delarue, Marc; Carter, Charles W., Jr.			Enhanced Amino Acid Selection in Fully Evolved Tryptophanyl-tRNA Synthetase, Relative to Its Urzyme, Requires Domain Motion Sensed by the D1 Switch, a Remote Dynamic Packing Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Cooperativity; Enzyme Mechanisms; Mutagenesis Site Specific; Thermodynamics; Conformational Change; Minimum Action Path; Transition State; Allostery; Pocket Volume	GENETIC-CODE; CLASS-I; MG2+-ASSISTED CATALYSIS; ESCHERICHIA-COLI; BINDING; SPECIFICITY; TRPRS; RECOGNITION; ACTIVATION; GLUTAMINE	Background: Amino acid selection by tryptophanyl-tRNA synthetase (TrpRS) requires intermodular coupling. Results: Dynamic repacking of four side chains increases amino acid specificity 500-fold in contemporary TrpRS by reducing pocket size near the transition state. Conclusion: An ancient tertiary packing motif not only activates the catalytic Mg2+ ion during catalysis, but also determines cognate amino acid specificity. Significance: Allosteric enforcement of specificity increases robustness to mutation. We previously showed (Li, L., and Carter, C. W., Jr. (2013) J. Biol. Chem. 288, 34736-34745) that increased specificity for tryptophan versus tyrosine by contemporary Bacillus stearothermophilus tryptophanyl-tRNA synthetase (TrpRS) over that of TrpRS Urzyme results entirely from coupling between the anticodon-binding domain and an insertion into the Rossmann-fold known as Connecting Peptide 1. We show that this effect is closely related to a long range catalytic effect, in which side chain repacking in a region called the D1 Switch, accounts fully for the entire catalytic contribution of the catalytic Mg2+ ion. We report intrinsic and higher order interaction effects on the specificity ratio, (k(cat)/K-m)(Trp)/(k(cat)/K-m)(Tyr), of 15 combinatorial mutants from a previous study (Weinreb, V., Li, L., and Carter, C. W., Jr. (2012) Structure 20, 128-138) of the catalytic role of the D1 Switch. Unexpectedly, the same four-way interaction both activates catalytic assist by Mg2+ ion and contributes -4.4 kcal/mol to the free energy of the specificity ratio. A minimum action path computed for the induced-fit and catalytic conformation changes shows that repacking of the four residues precedes a decrease in the volume of the tryptophan-binding pocket. We suggest that previous efforts to alter amino acid specificities of TrpRS and glutaminyl-tRNA synthetase (GlnRS) by mutagenesis without extensive, modular substitution failed because mutations were incompatible with interdomain motions required for catalysis.	[Weinreb, Violetta; Li, Li; Chandrasekaran, Srinivas Niranj; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Delarue, Marc] Inst Pasteur, CNRS, Unite Mixte Rech 3528, F-75015 Paris, France	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu	Chandrasekaran, Srinivas Niranj/J-8262-2019	Chandrasekaran, Srinivas Niranj/0000-0001-8874-9988	National Institutes of Health from the NIGMS [40906]	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 40906 from the NIGMS.	Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER C W JR, 1990, Methods (Orlando), V1, P12, DOI 10.1016/S1046-2023(05)80142-2; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Corigliano EM, 2009, BIOCHEMISTRY-US, V48, P676, DOI 10.1021/bi801552y; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Franklin J, 2007, NUCLEIC ACIDS RES, V35, pW477, DOI 10.1093/nar/gkm342; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; LAM SSM, 1975, BIOCHEMISTRY-US, V14, P2775, DOI 10.1021/bi00683a034; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Li L, 2013, J BIOL CHEM, V288, P34736, DOI 10.1074/jbc.M113.510958; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; ROGERS MJ, 1992, P NATL ACAD SCI USA, V89, P3463, DOI 10.1073/pnas.89.8.3463; ROGERS MJ, 1993, BIOCHIMIE, V75, P1083, DOI 10.1016/0300-9084(93)90007-F; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Weinreb V, 2008, J AM CHEM SOC, V130, P1488, DOI 10.1021/ja076557x; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007	33	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4367	4376		10.1074/jbc.M113.538660	http://dx.doi.org/10.1074/jbc.M113.538660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24394410	Green Published, hybrid			2022-12-25	WOS:000331403800047
J	Gartner, S; Gunesch, A; Knyazeva, T; Wolf, P; Hogel, B; Eiermann, W; Ullrich, A; Knyazev, P; Ataseven, B				Gaertner, Silvia; Gunesch, Angela; Knyazeva, Tatiana; Wolf, Petra; Hoegel, Bernhard; Eiermann, Wolfgang; Ullrich, Axel; Knyazev, Pjotr; Ataseven, Beyhan			PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement	PLOS ONE			English	Article							TYROSINE KINASE FAMILY; EXPRESSION SIGNATURE; EPITHELIAL-CELLS; MIGRATION; MOLECULE; DEFINES; RNA	Protein Tyrosin Kinase 7 (PTK7) is upregulated in several human cancers; however, its clinical implication in breast cancer (BC) and lymph node (LN) is still unclear. In order to investigate the function of PTK7 in mediating BC cell motility and invasivity, PTK7 expression in BC cell lines was determined. PTK7 signaling in highly invasive breast cancer cells was inhibited by a dominant-negative PTK7 mutant, an antibody against the extracellular domain of PTK7, and siRNA knockdown of PTK7. This resulted in decreased motility and invasivity of BC cells. We further examined PTK7 expression in BC and LN tissue of 128 BC patients by RT-PCR and its correlation with BC related genes like HER2, HER3, PAI1, MMP1, K19, and CD44. Expression profiling in BC cell lines and primary tumors showed association of PTK7 with ER/PR/HER2-negative (TNBC-triple negative BC) cancer. Oncomine data analysis confirmed this observation and classified PTK7 in a cluster with genes associated with agressive behavior of primary BC. Furthermore PTK7 expression was significantly different with respect to tumor size (ANOVA, p = 0.033) in BC and nodal involvement (ANOVA, p = 0.007) in LN. PTK7 expression in metastatic LN was related to shorter DFS (Cox Regression, p = 0.041). Our observations confirmed the transforming potential of PTK7, as well as its involvement in motility and invasivity of BC cells. PTK7 is highly expressed in TNBC cell lines. It represents a novel prognostic marker for BC patients and has potential therapeutic significance.	[Gaertner, Silvia; Gunesch, Angela; Knyazeva, Tatiana; Ullrich, Axel; Knyazev, Pjotr] Max Planck Inst Biochem, Dept Mol Biol, Martinsried, Germany; [Ataseven, Beyhan] Red Cross Hosp, Dept Gynecol & Obstet, Munich, Germany; [Ataseven, Beyhan] Kliniken Essen Mitte Evangel Huyssens Stiftung, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Hoegel, Bernhard] Red Cross Hosp, Dept Pathol, Munich, Germany; [Wolf, Petra] Tech Univ, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany; [Eiermann, Wolfgang] Interdisziplinares Onkolog Zentrum, Dept Gynecol & Gynecol Oncol, Munich, Germany	Max Planck Society; Kliniken Essen-Mitte; Technical University of Munich	Knyazev, P (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Martinsried, Germany.	knzayev@biochem.mpg.de; ataseven@gmx.net			Max-Planck-Society	Max-Planck-Society(Max Planck Society)	The work was funded by the Max-Planck-Society www.mpg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2000.0207; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Ferlay SH, 2010, IARC CANCERBASE; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Golubkov VS, 2012, J BIOL CHEM; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Lin Y, 2012, J SURG ONCOL; MOSSIE K, 1995, ONCOGENE, V11, P2179; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park SK, 1996, J BIOCHEM, V119, P235; Peradziryi H, 2012, ARCH BIOCH BIOPHYS; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; SOULE HD, 1990, CANCER RES, V50, P6075; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zelinski DP, 2001, CANCER RES, V61, P2301	32	38	39	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84472	10.1371/journal.pone.0084472	http://dx.doi.org/10.1371/journal.pone.0084472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409301	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500025
J	Shivapurkar, N; Weiner, LM; Marshall, JL; Madhavan, S; Mays, AD; Juhl, H; Wellstein, A				Shivapurkar, Narayan; Weiner, Louis M.; Marshall, John L.; Madhavan, Subha; Mays, Anne Deslattes; Juhl, Hartmut; Wellstein, Anton			Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs	PLOS ONE			English	Article							COLORECTAL-CANCER; PLASMA MICRORNAS; BIOMARKERS; CELLS; SERUM; TUMORS; ADENOCARCINOMA; SIGNATURE; DIAGNOSIS; SURVIVAL	Systemic treatment of patients with early-stage cancers attempts to eradicate occult metastatic disease to prevent recurrence and increased morbidity. However, prediction of recurrence from an analysis of the primary tumor is limited because disseminated cancer cells only represent a small subset of the primary lesion. Here we analyze the expression of circulating microRNAs (miRs) in serum obtained pre-surgically from patients with early stage colorectal cancers. Groups of five patients with and without disease recurrence were used to identify an informative panel of circulating miRs using quantitative PCR of genome-wide miR expression as well as a set of published candidate miRs. A panel of six informative miRs (miR-15a, mir-103, miR-148a, miR-320a, miR-451, miR-596) was derived from this analysis and evaluated in a separate validation set of thirty patients. Hierarchical clustering of the expression levels of these six circulating miRs and Kaplan-Meier analysis showed that the risk of disease recurrence of early stage colon cancer can be predicted by this panel of miRs that are measurable in the circulation at the time of diagnosis (P = 0.0026; Hazard Ratio 5.4; 95% CI of 1.9 to 15).	[Shivapurkar, Narayan; Weiner, Louis M.; Marshall, John L.; Madhavan, Subha; Mays, Anne Deslattes; Juhl, Hartmut; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA; [Juhl, Hartmut] Indivumed GmbH, Hamburg, Germany	Georgetown University	Shivapurkar, N (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA.	nms35@georgetown.edu; wellstea@georgetown.edu		Deslattes Mays, Anne/0000-0001-7951-3439; Wellstein, Anton/0000-0002-0570-4950	NIH [CA108440, P30 CA051008, HHSN2612200800001E]; Lombardi Cancer Center; Ruesch Center; NATIONAL CANCER INSTITUTE [R01CA108440, T32CA009686, R01CA050633, R01CA071508, P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lombardi Cancer Center; Ruesch Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported in part by NIH grants CA108440 (AW), P30 CA051008 (LW), HHSN2612200800001E (SM), the Lombardi Cancer Center (NS) and the Ruesch Center (NS, JLM, SM, and AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Buchholz M, 2005, CLIN CANCER RES, V11, P8048, DOI 10.1158/1078-0432.CCR-05-1274; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Gibby KA, 2009, P NATL ACAD SCI USA, V106, P8585, DOI 10.1073/pnas.0810952106; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kerr DJ, 2013, NAT REV CLIN ON 0611, P1; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LaConti JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020687; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012976; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Okada H, 2010, INT J BIOCHEM CELL B, V42, P1256, DOI 10.1016/j.biocel.2010.02.002; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Poste G, 2012, CLIN CANCER RES, V18, P1515, DOI 10.1158/1078-0432.CCR-11-2206; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Redis RS, 2012, PHARMACOL THERAPEUT, V136, P169, DOI 10.1016/j.pharmthera.2012.08.003; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	55	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84686	10.1371/journal.pone.0084686	http://dx.doi.org/10.1371/journal.pone.0084686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400111	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700045
J	O'Hara, L; York, JP; Zhang, PM; Smith, LB				O'Hara, Laura; York, Jean Philippe; Zhang, Pumin; Smith, Lee B.			Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both Drives Cre Recombinase Expression in Steroidogenic Cells and Permits Generation of Cyp11a1 Knock Out Mice	PLOS ONE			English	Article							DEFICIENCY SYNDROMES; DISRUPTION; ENZYMES; BRAIN; OVARY	To permit conditional gene targeting of floxed alleles in steroidogenic cell-types we have generated a transgenic mouse line that expresses Cre Recombinase under the regulation of the endogenous Cytochrome P450 side chain cleavage enzyme (Cyp11a1) promoter. Mice Carrying the Cyp11a1-GC (GFP-Cre) allele express Cre Recombinase in fetal adrenal and testis, and adrenal cortex, testicular Leydig cells (and a small proportion of Sertoli cells), theca cells of the ovary, and the hindbrain in postnatal life. Circulating testosterone concentration is unchanged in Cyp11(+/GC) males, suggesting steroidogenesis is unaffected by loss of one allele of Cyp11a1, mice are grossly normal, and Cre Recombinase functions to recombine floxed alleles of both a YFP reporter gene and the Androgen Receptor (AR) in steroidogenic cells of the testis, ovary, adrenal and hindbrain. Additionally, when bred to homozygosity (Cyp11a1(GC/GC)), knock-in of GFP-Cre to the endogenous Cyp11a1 locus results in a novel mouse model lacking endogenous Cyp11a1 (P450-SCC) function. This unique dual-purpose model has utility both for those wishing to conditionally target genes within steroidogenic cell types and for studies requiring mice lacking endogenous steroid hormone production.	[O'Hara, Laura; Smith, Lee B.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [York, Jean Philippe; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	University of Edinburgh; Baylor College of Medicine	Smith, LB (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	lee.smith@ed.ac.uk		O'Hara, Laura/0000-0001-7790-9261; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council [G1100354/1]; National Institute of Diabetes and Digestive and Kidney Diseases [DK070214]; NATIONAL CANCER INSTITUTE [R01CA122623, R01CA116097] Funding Source: NIH RePORTER; Medical Research Council [G1002033, G1100354] Funding Source: researchfish; MRC [G1100354, G1002033] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a UK Medical Research Council Programme Grant award (G1100354/1) to LBS, and by a U01 grant from National Institute of Diabetes and Digestive and Kidney Diseases (DK070214) to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Buaas FW, 2012, DEVELOPMENT, V139, P4561, DOI 10.1242/dev.087247; Chiang YF, 2011, J CELL PHYSIOL, V226, P1998, DOI 10.1002/jcp.22534; Chung BC, 2002, ENDOCR RES, V28, P575, DOI 10.1081/ERC-120016842; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Hu MC, 2002, MOL ENDOCRINOL, V16, P1943, DOI 10.1210/me.2002-0055; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; O'Hara Laura, 2012, BMC Res Notes, V5, P16, DOI 10.1186/1756-0500-5-16; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pelletier G, 2010, PROG BRAIN RES, V181, P193, DOI 10.1016/S0079-6123(08)81011-4; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsutsui K, 1999, COMP BIOCHEM PHYS C, V124, P121, DOI 10.1016/S0742-8413(99)00065-1; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wu HS, 2007, GENESIS, V45, P59, DOI 10.1002/dvg.20266; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	19	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84541	10.1371/journal.pone.0084541	http://dx.doi.org/10.1371/journal.pone.0084541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404170	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800049
J	Jiang, LY; Eriksson, J; Lage, S; Jonasson, S; Shams, S; Mehine, M; Ilag, LL; Rasmussen, U				Jiang, Liying; Eriksson, Johan; Lage, Sandra; Jonasson, Sara; Shams, Shiva; Mehine, Martin; Ilag, Leopold L.; Rasmussen, Ulla			Diatoms: A Novel Source for the Neurotoxin BMAA in Aquatic Environments	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; CYANOBACTERIAL NEUROTOXIN; CYCAD NEUROTOXINS; FLYING FOXES; DOMOIC ACID; AMINO-ACID; ALS-PDC; BIOMAGNIFICATION; CONSUMPTION; PATHWAYS	Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease is a neurological disorder linked to environmental exposure to a non-protein amino acid, beta-N-methylamino-L-alanine (BMAA). The only organisms reported to be BMAA-producing, are cyanobacteria - prokaryotic organisms. In this study, we demonstrate that diatoms - eukaryotic organisms - also produce BMAA. Ultra-high-performance liquid chromatography coupled with tandem mass spectrometry revealed the occurrence of BMAA in six investigated axenic diatom cultures. BMAA was also detected in planktonic field samples collected on the Swedish west coast that display an overrepresentation of diatoms relative to cyanobacteria. Given the ubiquity of diatoms in aquatic environments and their central role as primary producers and the main food items of zooplankton, the use of filter and suspension feeders as livestock fodder dramatically increases the risk of human exposure to BMAA-contaminated food.	[Eriksson, Johan; Lage, Sandra; Jonasson, Sara; Rasmussen, Ulla] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Jiang, Liying; Mehine, Martin; Ilag, Leopold L.] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Shams, Shiva] Fdn Edmund Mach, IASMA Res & Innovat Ctr, Sustainable Agroecosyst & Bioresources Dept, Trento, Italy	Stockholm University; Stockholm University; Fondazione Edmund Mach	Rasmussen, U (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	ulla.rasmussen@su.se	Lage, Sandra/AAH-9309-2019	Lage, Sandra/0000-0003-0167-7163; Ilag, Leopold/0000-0003-3678-7100	Foundation for Strategic Environmental Research; Baltic Ecosystem Adaptive Management (BEAM); Swedish Research Council Formas	Foundation for Strategic Environmental Research; Baltic Ecosystem Adaptive Management (BEAM); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The authors thank the Foundation for Strategic Environmental Research, the Baltic Ecosystem Adaptive Management (BEAM), the Swedish Research Council Formas for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH; Andjelkovic M, 2012, ENVIRON INT, V49, P115, DOI 10.1016/j.envint.2012.08.007; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2003, BOT J LINN SOC, V143, P165, DOI 10.1046/j.1095-8339.2003.00217.x; Banack SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049043; Banack SA, 2010, TOXINS, V2, P2837, DOI 10.3390/toxins2122837; Banack SA, 2009, AMYOTROPH LATERAL SC, V10, P34, DOI 10.3109/17482960903278451; Bates S. S., 1998, PHYSL ECOLOGY HARMFU, P405; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2002, NEUROLOGY, V58, P956, DOI 10.1212/WNL.58.6.956; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DOUGLAS B, 1958, J ECOL, V46, P295, DOI 10.2307/2257397; Duncan M. W., 1989, J ANAL TOXICOL SA, V13; DUNCAN MW, 1990, NEUROLOGY, V40, P767, DOI 10.1212/WNL.40.5.767; Esterhuizen M, 2008, ECOTOX ENVIRON SAFE, V71, P309, DOI 10.1016/j.ecoenv.2008.04.010; Faassen EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036667; Graneli E, 1989, NOVEL PHYTOPLANKTON, V35, P407; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallegraeff GM, 2012, HARMFUL ALGAE, V14, P130, DOI 10.1016/j.hal.2011.10.018; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Jiang LY, 2013, ANAL BIOANAL CHEM, V405, P1283, DOI 10.1007/s00216-012-6550-1; Jiang LY, 2012, ANAL BIOANAL CHEM, V403, P1719, DOI 10.1007/s00216-012-5966-y; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Kruger T, 2010, TOXICON, V55, P547, DOI 10.1016/j.toxicon.2009.10.009; Kubo T, 2008, TOXICON, V51, P1264, DOI 10.1016/j.toxicon.2008.02.015; Lage S, 2012, MAR BIOL RES, V8, P784, DOI 10.1080/17451000.2012.659668; Lefebvre KA, 2002, MAR BIOL, V140, P625, DOI 10.1007/s00227-001-0713-5; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Richardson RW, 2004, THESIS; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Rosen J, 2008, ANALYST, V133, P1785, DOI 10.1039/b809231a; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Spacil Z, 2010, ANALYST, V135, P127, DOI 10.1039/b921048b; STEWART PM, 1991, J FRESHWATER ECOL, V6, P249, DOI 10.1080/02705060.1991.9665301; Trainer VL, 2000, LIMNOL OCEANOGR, V45, P1818, DOI 10.4319/lo.2000.45.8.1818; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71	42	160	163	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84578	10.1371/journal.pone.0084578	http://dx.doi.org/10.1371/journal.pone.0084578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392143	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100066
J	Braun, A; Schneider, S; Auerswald, K; Bellof, G; Schnyder, H				Braun, Alexander; Schneider, Stephan; Auerswald, Karl; Bellof, Gerhard; Schnyder, Hans			Forward Modeling of Fluctuating Dietary C-13 Signals to Validate C-13 Turnover Models of Milk and Milk Components from a Diet-Switch Experiment	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; STABLE-ISOTOPES; BREATH CO2; NITROGEN; CATTLE; HAIR; DIGESTION; ECOLOGY; RATES; COWS	Isotopic variation of food stuffs propagates through trophic systems. But, this variation is dampened in each trophic step, due to buffering effects of metabolic and storage pools. Thus, understanding of isotopic variation in trophic systems requires knowledge of isotopic turnover. In animals, turnover is usually quantified in diet-switch experiments in controlled conditions. Such experiments usually involve changes in diet chemical composition, which may affect turnover. Furthermore, it is uncertain if diet-switch based turnover models are applicable under conditions with randomly fluctuating dietary input signals. Here, we investigate if turnover information derived from diet-switch experiments with dairy cows can predict the isotopic composition of metabolic products (milk, milk components and feces) under natural fluctuations of dietary isotope and chemical composition. First, a diet-switch from a C-3-grass/maize diet to a pure C-3-grass diet was used to quantify carbon turnover in whole milk, lactose, casein, milk fat and feces. Data were analyzed with a compartmental mixed effects model, which allowed for multiple pools and intra-population variability, and included a delay between feed ingestion and first tracer appearance in outputs. The delay for milk components and whole milk was similar to 12 h, and that of feces similar to 20 h. The half-life (t(1/2)) for carbon in the feces was 9 h, while lactose, casein and milk fat had a t(1/2) of 10, 18 and 19 h. The C-13 kinetics of whole milk revealed two pools, a fast pool with a t(1/2) of 10 h (likely representing lactose), and a slower pool with a t(1/2) of 21 h (likely including casein and milk fat). The diet-switch based turnover information provided a precise prediction (RMSE similar to 0.2 parts per thousand) of the natural C-13 fluctuations in outputs during a 30 days-long period when cows ingested a pure C3 grass with naturally fluctuating isotope composition.	[Braun, Alexander; Auerswald, Karl; Schnyder, Hans] Tech Univ Munich, Dept Plant Sci, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany; [Schneider, Stephan; Bellof, Gerhard] Hsch Weihenstephan Triesdorf, Fachgebiet Tierernahrung, Fak Land & Ernahrungswirtschaft, Freising Weihenstephan, Germany	Technical University of Munich	Auerswald, K (corresponding author), Tech Univ Munich, Dept Plant Sci, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany.	Auerswald@wzw.tum.de	Schnyder, Hans/B-7089-2011; Auerswald, Karl/C-5186-2008; Braun, Alexander AB/G-2589-2010	Schnyder, Hans/0000-0002-0139-7535; Auerswald, Karl/0000-0001-5275-4320; Braun, Alexander AB/0000-0003-0610-9827	DFG [Au 183/3-1]	DFG(German Research Foundation (DFG))	The work was funded by the DFG, project number Au 183/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Stanley CD, 2009, J EXP BIOL, V212, P2349, DOI 10.1242/jeb.027565; Auerswald K, 2010, J APPL ECOL, V47, P936, DOI 10.1111/j.1365-2664.2009.01764.x; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bahar B, 2009, J ANIM SCI, V87, P905, DOI 10.2527/jas.2008-1360; BOUTTON TW, 1988, J ANIM SCI, V66, P2636; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; CHATTERTON NJ, 1989, J PLANT PHYSIOL, V134, P169, DOI 10.1016/S0176-1617(89)80051-3; CHEESEMAN JM, 1986, PLANT PHYSIOL, V80, P1006, DOI 10.1104/pp.80.4.1006; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Edwards JE, 2008, ANIMAL, V2, P653, DOI 10.1017/S1751731108002164; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Gessler A, 2008, PLANT CELL ENVIRON, V31, P941, DOI 10.1111/j.1365-3040.2008.01806.x; Haramis GM, 2001, AUK, V118, P1008, DOI 10.1642/0004-8038(2001)118[1008:SIAOCW]2.0.CO;2; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; KLEIBER M, 1952, J BIOL CHEM, V195, P707; Klein PD, 1986, J ANIM SCI, V63, P102; Knobbe N, 2006, ANAL BIOANAL CHEM, V386, P104, DOI 10.1007/s00216-006-0644-6; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Lattanzi FA, 2012, J EXP BOT, V63, P2363, DOI 10.1093/jxb/ers020; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Martin O, 2007, ANIMAL, V1, P1143, DOI 10.1017/S1751731107000377; MARTINEAU A, 1985, ANAL BIOCHEM, V151, P495, DOI 10.1016/0003-2697(85)90210-6; Miller JF, 2008, CAN J ZOOL, V86, P685, DOI 10.1139/Z08-042; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; NOCEK JE, 1991, J DAIRY SCI, V74, P3598, DOI 10.3168/jds.S0022-0302(91)78552-4; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; R Core Team, 2012, R LANG ENV STAT COMP; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sarkar D., 2019, NLME LINEAR NONLINEA; Schneider S, 2011, ANIM FEED SCI TECH, V170, P1, DOI 10.1016/j.anifeedsci.2011.07.014; Schnyder H, 2012, ECOL STUD-ANAL SYNTH, V220, P157, DOI 10.1007/978-3-642-30645-7_7; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sponheimer M, 2006, RAPID COMMUN MASS SP, V20, P1395, DOI 10.1002/rcm.2454; SUSMEL P, 1991, ANIM PROD, V53, P305, DOI 10.1017/S0003356100020304; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Ungar ED, 1999, GRASS FORAGE SCI, V54, P357, DOI 10.1046/j.1365-2494.1999.00188.x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WILSON JR, 1994, J AGR SCI, V122, P173, DOI 10.1017/S0021859600087347; Wingfield WE, 2002, VET ICU BOOK; Witting DA, 2004, CAN J FISH AQUAT SCI, V61, P2069, DOI 10.1139/F04-156; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Woodward SJR, 1998, APPL ANIM BEHAV SCI, V56, P203, DOI 10.1016/S0168-1591(97)00089-0; Wright LE, 2012, J ANTHROPOL ARCHAEOL, V31, P334, DOI 10.1016/j.jaa.2012.02.001; Yang H, 2011, J EXP BOT, V62, P4143, DOI 10.1093/jxb/err102; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zazzo A, 2008, RAPID COMMUN MASS SP, V22, P2937, DOI 10.1002/rcm.3693	56	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85235	10.1371/journal.pone.0085235	http://dx.doi.org/10.1371/journal.pone.0085235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392000	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900143
J	Parente, DJ; Swint-Kruse, L				Parente, Daniel J.; Swint-Kruse, Liskin			Multiple Co-Evolutionary Networks Are Supported by the Common Tertiary Scaffold of the LacI/GalR Proteins	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; CORRELATED MUTATIONS; TRANSCRIPTIONAL REGULATION; ALLOSTERIC COMMUNICATION; SPECIFICITY DETERMINANTS; SEQUENCE ALIGNMENTS; BACILLUS-SUBTILIS; PURINE REPRESSOR; FUNCTIONAL SITES	Protein families might evolve paralogous functions on their common tertiary scaffold in two ways. First, the locations of functionally-important sites might be "hard-wired'' into the structure, with novel functions evolved by altering the amino acid (e.g. Ala vs Ser) at these positions. Alternatively, the tertiary scaffold might be adaptable, accommodating a unique set of functionally important sites for each paralogous function. To discriminate between these possibilities, we compared the set of functionally important sites in the six largest paralogous subfamilies of the LacI/GalR transcription repressor family. LacI/GalR paralogs share a common tertiary structure, but have low sequence identity (<= 30%), and regulate a variety of metabolic processes. Functionally important positions were identified by conservation and co-evolutionary sequence analyses. Results showed that conserved positions use a mixture of the "hard-wired'' and "accommodating'' scaffold frameworks, but that the co-evolution networks were highly dissimilar between any pair of subfamilies. Therefore, the tertiary structure can accommodate multiple networks of functionally important positions. This possibility should be included when designing and interpreting sequence analyses of other protein families. Software implementing conservation and co-evolution analyses is available at https://sourceforge. net/projects/coevolutils/.	[Parente, Daniel J.; Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Swint-Kruse, L (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	lswint-kruse@kumc.edu	Parente, Daniel/AAM-3887-2021	Parente, Daniel/0000-0002-7990-4576; Swint-Kruse, Liskin/0000-0002-5925-9741	NIH [GM 079423]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH GM 079423 to LSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, PDB 3HS3 CRYSTAL STR; Agarwal R, 2009, PDB 3CS3 CRYSTAL STR; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bagaria A, 2009, PDB 3GV0 CRYSTAL STR; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bharatham K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024382; Bonanno JB, 2007, PDB 3BIL CRYSTAL STR; Bonanno JB, 2008, PDB 3E3M CRYSTAL STR; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Cai ZH, 2004, HUM MUTAT, V24, P178, DOI 10.1002/humu.20063; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; CHOI KY, 1994, J BIOL CHEM, V269, P24066; de Vos MGJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003580; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eick GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003072; Flynn TC, 2003, PROTEIN SCI, V12, P2523, DOI 10.1110/ps.03188303; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Geanacopoulos M, 1999, GENE DEV, V13, P1251, DOI 10.1101/gad.13.10.1251; Geanacopoulos M, 2002, J BIOL CHEM, V277, P33148, DOI 10.1074/jbc.M202445200; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Hars U, 1998, PROTEIN SCI, V7, P2511, DOI 10.1002/pro.5560071204; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Horlacher R, 1997, J BIOL CHEM, V272, P13026, DOI 10.1074/jbc.272.20.13026; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Izu H, 1997, J MOL BIOL, V267, P778, DOI 10.1006/jmbi.1996.0913; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-417; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kim JH, 1998, P NATL ACAD SCI USA, V95, P9590, DOI 10.1073/pnas.95.16.9590; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008311; Lee Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038114; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopez P, 2002, MOL BIOL EVOL, V19, P1; LOPILATO JE, 1984, J BACTERIOL, V158, P665, DOI 10.1128/JB.158.2.665-673.1984; MAJUMDAR A, 1987, J BIOL CHEM, V262, P2326; MAKAROFF CA, 1985, J BIOL CHEM, V260, P378; Malashkevich VN, 2009, PDB 3K4H CRYSTAL STR; Matthews KS, 1998, PROG NUCLEIC ACID RE, V58, P127; MAUZY CA, 1992, PROTEIN SCI, V1, P843, DOI 10.1002/pro.5560010702; MAUZY CA, 1992, PROTEIN SCI, V1, P831, DOI 10.1002/pro.5560010701; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Meinhardt S, 2008, PROTEINS, V73, P941, DOI 10.1002/prot.22121; MENG LM, 1990, MOL MICROBIOL, V4, P2187, DOI 10.1111/j.1365-2958.1990.tb00580.x; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Needham CJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-405; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Palani K, 2009, PDB 3H5T CRYSTAL STR; Palani K, 2009, PDB 3KJX CRYSTAL STR; Patskovsky Y, 2009, PDB 3JVD CRYSTAL STR; Peekhaus N, 1998, J BACTERIOL, V180, P1777, DOI 10.1128/JB.180.7.1777-1785.1998; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qian Z, 2012, P NATL ACAD SCI USA, V109, P11336, DOI 10.1073/pnas.1208595109; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; ROLFES RJ, 1990, J BACTERIOL, V172, P5637, DOI 10.1128/jb.172.10.5637-5642.1990; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; Schumacher MA, 2007, J MOL BIOL, V368, P1042, DOI 10.1016/j.jmb.2007.02.054; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Syed Ibrahim B, 2009, PDB 3JY6 CRYSTAL STR; Tan K, 2008, PDB 3D8U CRYSTAL STR; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; Vicatos S, 2005, PROTEINS, V58, P935, DOI 10.1002/prot.20370; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	102	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84398	10.1371/journal.pone.0084398	http://dx.doi.org/10.1371/journal.pone.0084398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391951	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900094
J	Siddon, EC; Kristiansen, T; Mueter, FJ; Holsman, KK; Heintz, RA; Farley, EV				Siddon, Elizabeth Calvert; Kristiansen, Trond; Mueter, Franz J.; Holsman, Kirstin K.; Heintz, Ron A.; Farley, Edward V.			Spatial Match-Mismatch between Juvenile Fish and Prey Provides a Mechanism for Recruitment Variability across Contrasting Climate Conditions in the Eastern Bering Sea	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; COD GADUS-MORHUA; WALLEYE POLLOCK; BIOENERGETICS MODEL; MALLOTUS-VILLOSUS; HABITAT SELECTION; BODY-SIZE; LARVAL; AGE-0; TEMPERATURE	Understanding mechanisms behind variability in early life survival of marine fishes through modeling efforts can improve predictive capabilities for recruitment success under changing climate conditions. Walleye pollock (Theragra chalcogramma) support the largest single-species commercial fishery in the United States and represent an ecologically important component of the Bering Sea ecosystem. Variability in walleye pollock growth and survival is structured in part by climate-driven bottom-up control of zooplankton composition. We used two modeling approaches, informed by observations, to understand the roles of prey quality, prey composition, and water temperature on juvenile walleye pollock growth: (1) a bioenergetics model that included local predator and prey energy densities, and (2) an individual-based model that included a mechanistic feeding component dependent on larval development and behavior, local prey densities and size, and physical oceanographic conditions. Prey composition in late-summer shifted from predominantly smaller copepod species in the warmer 2005 season to larger species in the cooler 2010 season, reflecting differences in zooplankton composition between years. In 2010, the main prey of juvenile walleye pollock were more abundant, had greater biomass, and higher mean energy density, resulting in better growth conditions. Moreover, spatial patterns in prey composition and water temperature lead to areas of enhanced growth, or growth 'hot spots', for juvenile walleye pollock and survival may be enhanced when fish overlap with these areas. This study provides evidence that a spatial mismatch between juvenile walleye pollock and growth 'hot spots' in 2005 contributed to poor recruitment while a higher degree of overlap in 2010 resulted in improved recruitment. Our results indicate that climate-driven changes in prey quality and composition can impact growth of juvenile walleye pollock, potentially severely affecting recruitment variability.	[Siddon, Elizabeth Calvert; Mueter, Franz J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA; [Kristiansen, Trond] Inst Marine Res, N-5024 Bergen, Norway; [Holsman, Kirstin K.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv,Natl Ocean & Atmospher, Seattle, WA 98195 USA; [Heintz, Ron A.; Farley, Edward V.] Natl Ocean & Atmospher Adm, Ted Stevens Marine Res Inst, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Siddon, EC (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA.	ecsiddon@alaska.edu	Farley, E/HHM-4227-2022	Kristiansen, Trond/0000-0001-6121-297X	North Pacific Anadromous Fish Commission; North Pacific Research Board; Norwegian Research Council	North Pacific Anadromous Fish Commission; North Pacific Research Board; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the North Pacific Anadromous Fish Commission; North Pacific Research Board; and Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Buchheister A, 2005, J FISH BIOL, V67, P541, DOI 10.1111/j.0022-1112.2005.00741.x; Buchheister A, 2006, T AM FISH SOC, V135, P897, DOI 10.1577/T05-105.1; Ciannelli L, 1998, J FISH BIOL, V52, P879, DOI 10.1111/j.1095-8649.1998.tb00589.x; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2008, DEEP-SEA RES PT II, V55, P1775, DOI 10.1016/j.dsr2.2008.04.029; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Duffy-Anderson JT, 2006, FISH OCEANOGR, V15, P80, DOI 10.1111/j.1365-2419.2005.00348.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Farley Edward V. Jr, 2005, Alaska Fishery Research Bulletin, V11, P15; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Hanson P. C., 1997, WISCUT97001 U WISC S; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; Holsman KK, MAR ECOL PR IN PRESS; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Ianelli JN, 2012, STOCK ASSESSMENT FIS; Kachel NB, 2002, DEEP-SEA RES PT II, V49, P5889, DOI 10.1016/S0967-0645(02)00324-7; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kristiansen T, 2007, CAN J FISH AQUAT SCI, V64, P136, DOI 10.1139/F06-176; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Kristiansen T, 2009, MAR ECOL PROG SER, V376, P227, DOI 10.3354/meps07796; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Logerwell EA, 2010, FISH OCEANOGR, V19, P262, DOI 10.1111/j.1365-2419.2010.00542.x; Moss JH, 2009, T AM FISH SOC, V138, P497, DOI 10.1577/T08-126.1; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; NEY JJ, 1990, REV AQUAT SCI, V2, P55; Paul AJ, 1998, J EXP MAR BIOL ECOL, V226, P75, DOI 10.1016/S0022-0981(97)00241-4; Peck MA, 2006, ENVIRON BIOL FISH, V75, P419, DOI 10.1007/s10641-006-0031-3; Ressler PH, 2012, DEEP-SEA RES PT II, V65-70, P184, DOI 10.1016/j.dsr2.2012.02.015; Siddon EC, 2013, DEEP-SEA RES PT II, V94, P140, DOI 10.1016/j.dsr2.2012.12.007; Sogard SM, 2000, J FISH BIOL, V56, P1; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Volkov A.F., 2007, IZV TINRO, V151, P338	37	53	54	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84526	10.1371/journal.pone.0084526	http://dx.doi.org/10.1371/journal.pone.0084526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391963	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900106
J	Coffman, K; Yang, B; Lu, J; Tetlow, AL; Pelliccio, E; Lu, S; Guo, DC; Tang, C; Dong, MQ; Tamanoi, F				Coffman, Kimberly; Yang, Bing; Lu, Jie; Tetlow, Ashley L.; Pelliccio, Emelia; Lu, Shan; Guo, Da-Chuan; Tang, Chun; Dong, Meng-Qiu; Tamanoi, Fuyuhiko			Characterization of the Raptor/ 4E-BP1 Interaction by Chemical Cross- linking Coupled with Mass Spectrometry Analysis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR; mTOR Complex (mTORC); Protein Cross-linking; Protein Kinases; Signaling; 4E-BP1; TOS Motif; Cross-linking Mass Spectrometry; Raptor	TRANSLATION FACTOR EIF4E; PROTEIN-STRUCTURE; STRUCTURAL BASIS; LINKED PEPTIDES; BINDING PARTNER; MTOR; PHOSPHORYLATION; ACTIVATION; COMPLEX; PATHWAY	Background: mTORC1 recruits its substrate 4E-BP1 via Raptor/4E-BP1 interaction. Chemical cross-linking/mass spectrometry permits characterization of protein-protein interactions. Results: Cross-linked peptides between Raptor and 4E-BP1 were identified. Raptor intramolecular cross-links were also identified. Conclusion: Raptor N-terminal region containing RNC1 is implicated in the interaction with the central region of 4E-BP1. Significance: Our study provides novel insight into how mTORC1 recognizes 4E-BP1. mTORC1 plays critical roles in the regulation of protein synthesis, growth, and proliferation in response to nutrients, growth factors, and energy conditions. One of the substrates of mTORC1 is 4E-BP1, whose phosphorylation by mTORC1 reverses its inhibitory action on eIF4E, resulting in the promotion of protein synthesis. Raptor in mTOR complex 1 is believed to recruit 4E-BP1, facilitating phosphorylation of 4E-BP1 by the kinase mTOR. We applied chemical cross-linking coupled with mass spectrometry analysis to gain insight into interactions between mTORC1 and 4E-BP1. Using the cross-linking reagent bis[sulfosuccinimidyl] suberate, we showed that Raptor can be cross-linked with 4E-BP1. Mass spectrometric analysis of cross-linked Raptor-4E-BP1 led to the identification of several cross-linked peptide pairs. Compilation of these peptides revealed that the most N-terminal Raptor N-terminal conserved domain (in particular residues from 89 to 180) of Raptor is the major site of interaction with 4E-BP1. On 4E-BP1, we found that cross-links with Raptor were clustered in the central region (amino acid residues 56-72) we call RCR (Raptor cross-linking region). Intramolecular cross-links of Raptor suggest the presence of two structured regions of Raptor: one in the N-terminal region and the other in the C-terminal region. In support of the idea that the Raptor N-terminal conserved domain and the 4E-BP1 central region are closely located, we found that peptides that encompass the RCR of 4E-BP1 inhibit cross-linking and interaction of 4E-BP1 with Raptor. Furthermore, mutations of residues in the RCR decrease the ability of 4E-BP1 to serve as a substrate for mTORC1 in vitro and in vivo.	[Coffman, Kimberly; Lu, Jie; Tetlow, Ashley L.; Pelliccio, Emelia; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Inst Mol Biol, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yang, Bing; Lu, Shan; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Guo, Da-Chuan; Tang, Chun] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Hubei, Peoples R China	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Dong, MQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	dongmengqiu@nibs.ac.cn; fuyut@microbio.ucla.edu	Yang, Bing/L-2768-2015; Lu, Shan/ABI-5830-2020; Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500; Lu, Shan/0000-0003-4740-0610	National Institutes of Health [CA41996]; Ministry of Science and Technology of China [2010CB835203, 2013CB910200]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996 (to F. T.). This work was also supported by Ministry of Science and Technology of China Grants 2010CB835203 (to M.-Q. D.) and 2013CB910200 (to C. T.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bermejo GA, 2012, PROTEIN SCI, V21, P1824, DOI 10.1002/pro.2163; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Eguchi S, 2006, GENES CELLS, V11, P757, DOI 10.1111/j.1365-2443.2006.00977.x; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu WZ, 2011, NUCLEIC ACIDS RES, V39, P8820, DOI 10.1093/nar/gkr650; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Pandey A, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.37.pl1; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Rousseau D, 1996, ONCOGENE, V13, P2415; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Siddiqui N, 2012, J MOL BIOL, V415, P781, DOI 10.1016/j.jmb.2011.12.002; Singh P, 2010, ANAL CHEM, V82, P2636, DOI 10.1021/ac1000724; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; Tabb DL, 2012, NAT METHODS, V9, P879, DOI 10.1038/nmeth.2139; Tamanoi F., 2010, STRUCTURE FUNCTION B, V28; Tang C, 2006, J BIOMOL NMR, V36, P37, DOI 10.1007/s10858-006-9065-2; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	50	13	13	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4723	4734		10.1074/jbc.M113.482067	http://dx.doi.org/10.1074/jbc.M113.482067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403073	Green Published, hybrid			2022-12-25	WOS:000331607900019
J	Li, YH; Sun, XX; Elferich, J; Shinde, U; David, LL; Dai, MS				Li, Yuhuang; Sun, Xiao-Xin; Elferich, Johannes; Shinde, Ujwal; David, Larry L.; Dai, Mu-Shui			Monoubiquitination Is Critical for Ovarian Tumor Domain- containing Ubiquitin Aldehyde Binding Protein 1 ( Otub1) to Suppress UbcH5 Enzyme and Stabilize p53 Protein*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; p53; Ubiquitin; Ubiquitin-conjugating Enzyme (Ubc); Ubiquitination; Deubiquitinating Enzymes; Otub1; UbcH5; Monoubiquitination	DEGRADATION SIGNAL; MDM2; DEUBIQUITINATION; HAUSP; INHIBITION; MECHANISM; SUBSTRATE; PATHWAY; COMPLEX; LIGASE	Background: Otub1 suppresses E2 UbcH5 to stabilize and activate p53. Results: UbcH5 monoubiquitinates Otub1, and monoubiquitination-defective Otub1 mutants fail to inhibit UbcH5 and induce p53. Conclusion: Monoubiquitination is critical for Otub1 to suppress UbcH5 and induce p53. Significance: We report the discovery of a novel molecular mechanism underlying Otub1 suppression of E2 and activation of p53. Ovarian tumor domain-containing ubiquitin (Ub) aldehyde binding protein 1 (Otub1) regulates p53 stability and activity via non-canonical inhibition of the MDM2 cognate Ub-conjugating enzyme (E2) UbcH5. However, it is not clear how this activity of Otub1 is regulated in cells. Here we report that Otub1 is monoubiquitinated by UbcH5 in cells and in vitro, primarily at the lysine 59 and 109 residues. This monoubiquitination, in turn, contributes to the activity of Otub1 to suppress UbcH5. The lysine-free Otub1 mutant (Otub1(K0)) fails to be monoubiquitinated and is unable to suppress the Ub-conjugating activity of UbcH5 in vitro and the MDM2-mediated p53 ubiquitination in cells. Consistently, this mutant is unable to stabilize p53, induce apoptosis, and suppress cell proliferation. Overexpression of Otub1(K0) inhibits DNA-damage induced apoptosis. Adding either Lys-59 or Lys-109 back to the Otub1(K0) mutant restores the monoubiquitination of Otub1 and its function to stabilize and activate p53. We further show that UbcH5 preferentially binds to the monoubiquitinated Otub1 via Ub interaction with its backside donor Ub-interacting surface, suggesting that this binding interferes with the self-assembly of Ub-charged UbcH5 (UbcH5 approximate to Ub) conjugates, which is critical for Ub transfer. Thus, our data reveal novel insights into the Otub1 inhibition of E2 wherein monoubiquitination promotes the interaction of Otub1 with UbcH5 and the function to suppress it.	[Li, Yuhuang; Sun, Xiao-Xin; Dai, Mu-Shui] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA; [Elferich, Johannes; Shinde, Ujwal; David, Larry L.] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Li, Yuhuang; Sun, Xiao-Xin; David, Larry L.; Dai, Mu-Shui] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	daim@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	NCI, National Institutes of Health [R00 CA127134, R01 CA160474]; Department of Defense [W81XWH-10-1029]; NATIONAL CANCER INSTITUTE [R01CA160474, R00CA127134, P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020863] Funding Source: NIH RePORTER; Direct For Biological Sciences [0746589] Funding Source: National Science Foundation	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by NCI, National Institutes of Health grants R00 CA127134 and R01 CA160474 (to M. S. D.). This work was also supported by Department of Defense Grant W81XWH-10-1029 (to M. S. D.).	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; DeVine T, 2013, CURR PHARM DESIGN, V19, P3248, DOI 10.2174/1381612811319180009; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ju DH, 2006, J BIOL CHEM, V281, P10657, DOI 10.1074/jbc.M513790200; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zulkifle N, 2013, INT J BIOL CHEM, V7, P1, DOI DOI 10.3923/ijbc.2013.1.14	42	37	38	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5097	5108		10.1074/jbc.M113.533109	http://dx.doi.org/10.1074/jbc.M113.533109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403071	Green Published, hybrid			2022-12-25	WOS:000331607900053
J	Kawakami, T; He, J; Morita, H; Yokoyama, K; Kaji, H; Tanaka, C; Suemori, S; Tohyama, K; Tohyama, Y				Kawakami, Tatsumi; He, Jinsong; Morita, Hiroyuki; Yokoyama, Kunio; Kaji, Hiroaki; Tanaka, Chisato; Suemori, Shin-ichiro; Tohyama, Kaoru; Tohyama, Yumi			Rab27a Is Essential for the Formation of Neutrophil Extracellular Traps (NETs) in Neutrophil-Like Differentiated HL60 Cells	PLOS ONE			English	Article							NETTING NEUTROPHILS; MYELOPEROXIDASE; EXOCYTOSIS; MATURATION; IMMUNITY	Neutrophils play a crucial role in host defence. In response to a variety of inflammatory stimulation, they form neutrophil extracellular traps (NETs). NETs are extracellular structures composed of chromatin fibers decorated with antimicrobial proteins and developing studies indicate that NETs contribute to extracellular microbial killing. While the intracellular signaling pathways that regulate NET formation remain largely unknown, there is growing evidence that generation of reactive oxygen species (ROS) is a key event for NET formation. The Rab family small GTPase Rab27a is an important component of the secretory machinery of azurophilic granules in neutrophils. However, the precise mechanism of NET formation and whether or not Rab27a contributes to this process are unknown. Using neutrophil-like differentiated HL60 cells, we show here that Rab27a plays an essential role in both phorbol myristate acetate (PMA)- and Candida albicans-induced NET formation by regulating ROS production. Rab27a-knockdown inhibited ROS-positive phagosome formation during complement-mediated phagocytosis. To investigate the role of Rab27a in neutrophil function in detail, both primary human neutrophils and neutrophil-like differentiated HL60 cells were treated with PMA, and NET formation process was assessed by measurement of release of histone H3 into the medium, citrullination of the arginine in position 3 of histone H4 and chase of the nuclear change of the living cells in the co-existence of both cell-permeable and -impermeable nuclear indicators. PMA-induced NET formation occured sequentially in both neutrophil-like differentiated HL60 cells and primary neutrophils, and Rab27a-knockdown clearly inhibited NET formation in association with reduced ROS production. We also found that serum-treated Candida albicans triggers NET formation in a ROS-dependent manner, and that Rab27a-knockdown inhibits this process as well. Our findings demonstrate that Rab27a plays an important role in NET formation induced by both Candida albicans infection and PMA treatment by regulating ROS production.	[Kawakami, Tatsumi; He, Jinsong; Morita, Hiroyuki; Yokoyama, Kunio; Kaji, Hiroaki; Tanaka, Chisato; Tohyama, Yumi] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo, Japan; [Yokoyama, Kunio] Kobe Univ, Grad Sch Med, Div Gastroenterol Surg, Kobe, Hyogo 657, Japan; [Suemori, Shin-ichiro; Tohyama, Kaoru] Kawasaki Med Sch, Dept Lab Med, Kurashiki, Okayama, Japan	Himeji Dokkyo University; Kobe University; Kawasaki Medical School	Tohyama, Y (corresponding author), Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo, Japan.	ytohyama@himeji-du.ac.jp			KAKENHI; Japan Society for the Promotion of Sciences; Grants-in-Aid for Scientific Research [23590374] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI; a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Sciences (to Y.T. and K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pang L, 2013, J IMMUNOL, V190, P6488, DOI 10.4049/jimmunol.1203215; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702	40	28	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84704	10.1371/journal.pone.0084704	http://dx.doi.org/10.1371/journal.pone.0084704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404184	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800063
J	Yan, X; Lin, JT; Talabattula, VAN; Mussmann, C; Yang, F; Wree, A; Rolfs, A; Luo, JK				Yan, Xin; Lin, Juntang; Talabattula, Venkata Ajay Narendra; Mussmann, Carolin; Yang, Fan; Wree, Andreas; Rolfs, Arndt; Luo, Jiankai			ADAM10 Negatively Regulates Neuronal Differentiation during Spinal Cord Development	PLOS ONE			English	Article							NERVOUS-SYSTEM DEVELOPMENT; NEURAL PROGENITOR CELLS; SONIC HEDGEHOG; MOTOR-NEURONS; N-CADHERIN; NOTCH; EXPRESSION; NEUROGENESIS; CLEAVAGE; FAMILY	Members of the ADAM (a disintegrin and metalloprotease) family are involved in embryogenesis and tissue formation via their proteolytic function, cell-cell and cell-matrix interactions. ADAM10 is expressed temporally and spatially in the developing chicken spinal cord, but its function remains elusive. In the present study, we address this question by electroporating ADAM10 specific morpholino antisense oligonucleotides (ADAM10-mo) or dominant-negative ADAM10 (dn-ADAM10) plasmid into the developing chicken spinal cord as well as by in vitro cell culture investigation. Our results show that downregulation of ADAM10 drives precocious differentiation of neural progenitor cells and radial glial cells, resulting in an increase of neurons in the developing spinal cord, even in the prospective ventricular zone. Remarkably, overexpression of the dn-ADAM10 plasmid mutated in the metalloprotease domain (dn-ADAM10-me) mimics the phenotype as found by the ADAM10-mo transfection. Furthermore, in vitro experiments on cultured cells demonstrate that downregulation of ADAM10 decreases the amount of the cleaved intracellular part of Notch1 receptor and its target, and increases the number of beta III-tubulin-positive cells during neural progenitor cell differentiation. Taken together, our data suggest that ADAM10 negatively regulates neuronal differentiation, possibly via its proteolytic effect on the Notch signaling during development of the spinal cord.	[Yan, Xin; Talabattula, Venkata Ajay Narendra; Mussmann, Carolin; Yang, Fan; Rolfs, Arndt; Luo, Jiankai] Univ Rostock, Sch Med, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany; [Lin, Juntang] Xinxiang Med Univ, Key Lab Med Tissue Regenerat Henan Prov, Xinxiang, Peoples R China; [Lin, Juntang] Univ Jena, Sch Med, Inst Anat 1, Jena, Germany; [Wree, Andreas] Univ Rostock, Sch Med, Inst Anat, D-18055 Rostock, Germany	University of Rostock; Xinxiang Medical University; Friedrich Schiller University of Jena; University of Rostock	Luo, JK (corresponding author), Univ Rostock, Sch Med, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.	jiankai.luo@uni-rostock.de	Yan, Xin/AAF-9039-2019	Yan, Xin/0000-0002-9135-7915	German Research Foundation [DFG LU 1455/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG LU 1455/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfandari D, 2009, SEMIN CELL DEV BIOL, V20, P153, DOI 10.1016/j.semcdb.2008.09.006; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chen YYY, 2007, J NEUROSCI, V27, P8448, DOI 10.1523/JNEUROSCI.1841-07.2007; Christian LM, 2012, FLY, V6, P30, DOI 10.4161/fly.18823; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Giese AK, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-94; Hall RJ, 2003, DEV BIOL, V256, P146, DOI 10.1016/S0012-1606(02)00133-1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hatakeyama J, 2006, DEV NEUROSCI-BASEL, V28, P92, DOI 10.1159/000090756; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kimura J, 2004, DEV GROWTH DIFFER, V46, P219; Kos R, 2003, DEV DYNAM, V226, P470, DOI 10.1002/dvdy.10254; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Lin J, 2008, NEUROSCIENCE, V157, P360, DOI 10.1016/j.neuroscience.2008.08.053; Lin JT, 2010, DEV DYNAM, V239, P1246, DOI 10.1002/dvdy.22272; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Luo J, 2006, NEUROSCIENCE, V142, P1133, DOI 10.1016/j.neuroscience.2006.07.038; Luo J, 2007, DEV DYNAM, V236, P2331, DOI 10.1002/dvdy.21248; Luo JK, 2009, NEUROREPORT, V20, P365, DOI 10.1097/WNR.0b013e3283243fe4; Luo JK, 2005, DEV DYNAM, V233, P1470, DOI 10.1002/dvdy.20454; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Schweitzer R, 2000, MECH DEVELOP, V98, P171, DOI 10.1016/S0925-4773(00)00458-5; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Varnum-Finney B, 2008, BLOOD, V111, P2615, DOI 10.1182/blood-2007-03-079855; Yan X, 2011, DEV GROWTH DIFFER, V53, P726, DOI 10.1111/j.1440-169X.2011.01282.x; Yan X, 2011, DEV GROWTH DIFFER, V53, P333, DOI 10.1111/j.1440-169X.2010.01238.x; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	55	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84617	10.1371/journal.pone.0084617	http://dx.doi.org/10.1371/journal.pone.0084617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404179	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800058
J	Zhang, NN; Liu, YT; Ma, L; Wang, L; Hao, XZ; Yuan, Z; Lin, DM; Li, D; Zhou, YJ; Lin, H; Han, XH; Sun, Y; Shi, YK				Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Yuan, Zheng; Lin, Dong-Mei; Li, Dan; Zhou, Yu-Jie; Lin, Hua; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai			The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy	PLOS ONE			English	Article							EML4-ALK FUSION GENE; INTERNATIONAL-ASSOCIATION; TYROSINE KINASE; EGFR MUTATION; ADENOCARCINOMA; CRIZOTINIB; SURVIVAL; INHIBITOR; CLASSIFICATION; FEATURES	Background: This study aimed to elucidate clinical significance of anaplastic lymphoma kinase (ALK) rearrangement in selected advanced non-small cell lung cancer (NSCLC), to compare the application of different ALK detection methods, and especially evaluate a possible association between ALK expression and clinical outcomes in crizotinib-treated patients. Methods: ALK status was assessed by fluorescent in situ hybridization (FISH), immunohistochemistry (IHC) and quantitative RT-PCR (qRT-PCR) in 173 selected advanced NSCLC patients. Clinicopathologic data, genotype status and survival outcomes were analyzed. Moreover, the association of ALK expression with clinical outcomes was evaluated in ALK FISH-positive crizotinib-treated patients including two patients with concurrent epidermal growth factor receptor (EGFR) mutation. Results: The positivity detection rate of ALK rearrangement by FISH, IHC and qRT-PCR was 35.5% (59/166), 35.7% (61/171), and 27.9% (34/122), respectively. ALK rearrangement was observed predominantly in young patients, never or light smokers, and adenocarcinomas, especially with signet ring cell features and poor differentiation. Median progression-free survival (PFS) of crizotinib-treated patients was 7.6 months. The overall survival (OS) of these patients was longer compared with that of crizotinib-naive or wild-type cohorts, but there was no significant difference in OS compared with patients with EGFR mutation. ALK expression did not associate with PFS; but, when ALK expression was analyzed as a dichotomous variable, moderate and strong ALK expression had a decreased risk of death (P = 0.026). The two patients with concomitant EGFR and ALK alterations showed difference in ALK expression, response to EGFR and ALK inhibitors, and overall survival. Conclusions: Selective enrichment according to clinicopathologic features in NSCLC patients could highly improve the positivity detection rate of ALK rearrangement for ALK-targeted therapy. IHC could provide more clues for clinical trial design and therapeutic strategies for ALK-positive NSCLC patients including patients with double genetic aberration of ALK and EGFR.	[Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Li, Dan; Zhou, Yu-Jie; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Yuan, Zheng; Lin, Dong-Mei; Li, Dan; Zhou, Yu-Jie; Lin, Hua; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Li, Dan; Zhou, Yu-Jie; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Yuan, Zheng; Lin, Dong-Mei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Lin, Hua] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Record, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	syuankaipumc@126.com	Zhou, Yu/HHN-3071-2022; han, xiao/HDN-9782-2022		Research Special Fund for Public Welfare Industry of Health [200902002-1]; National Science and Technology Major Project [2008ZX09312, 2012ZX09303012]; National High Technology Research and Development Program of China [2011AA02A110]; Beijing Municipal Science and Technology Commission [Z121107005112005, Z121102009212055]; Special Funds for Central Health Authority [B2009B124]; Cancer Institute and Hospital of Chinese Academy of Medical Sciences [LC2012A18]	Research Special Fund for Public Welfare Industry of Health; National Science and Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Special Funds for Central Health Authority; Cancer Institute and Hospital of Chinese Academy of Medical Sciences	Funding: This study was supported in part by grants from the Research Special Fund for Public Welfare Industry of Health (200902002-1), National Science and Technology Major Project (2008ZX09312, 2012ZX09303012), National High Technology Research and Development Program of China (2011AA02A110), Beijing Municipal Science and Technology Commission (Z121107005112005, Z121102009212055), Special Funds for Central Health Authority (B2009B124) and Major Research Program of Cancer Institute and Hospital of Chinese Academy of Medical Sciences (LC2012A18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuo YW, 2010, J THORAC ONCOL, V5, P2039, DOI 10.1097/JTO.0b013e3181f43274; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lee JK, 2012, CANCER-AM CANCER SOC, V118, P3579, DOI 10.1002/cncr.26668; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Marchetti A, 2013, J THORAC ONCOL, V8, P352, DOI 10.1097/JTO.0b013e31827d5280; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Miyanaga A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-262; Orenstein JM, 2011, NEW ENGL J MED, V364, P777, DOI 10.1056/NEJMc1013325; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Popat S, 2011, J THORAC ONCOL, V6, P1962, DOI 10.1097/JTO.0b013e31822eec5e; Ren SX, 2012, CANCER-AM CANCER SOC, V118, P5588, DOI 10.1002/cncr.27603; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Yang P, 2012, J THORAC ONCOL, V7, P90, DOI 10.1097/JTO.0b013e31823c5c32; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188	37	13	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84501	10.1371/journal.pone.0084501	http://dx.doi.org/10.1371/journal.pone.0084501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404167	gold, Green Submitted, Green Published			2022-12-25	WOS:000329460800046
J	Chantratita, N; Tandhavanant, S; Myers, ND; Chierakul, W; Wuthiekanun, V; Mahavanakul, W; Limmathurotsakul, D; Peacock, SJ; West, TE				Chantratita, Narisara; Tandhavanant, Sarunporn; Myers, Nicolle D.; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Mahavanakul, Weera; Limmathurotsakul, Direk; Peacock, Sharon J.; West, T. Eoin			Common TLR1 Genetic Variation Is Not Associated with Death from Melioidosis, a Common Cause of Sepsis in Rural Thailand	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; NORTHEAST THAILAND; SUSCEPTIBILITY; POLYMORPHISM; RESPONSES; TUBERCULOSIS; LEPROSY; INTERLEUKIN-6; PSEUDOMALLEI	Melioidosis, infection caused by the Gram-negative bacterium Burkholderia pseudomallei, is a common cause of sepsis in northeast Thailand. In white North Americans, common functional genetic variation in TLR1 is associated with organ failure and death from sepsis. We hypothesized that TLR1 variants would be associated with outcomes in Thais with melioidosis. We collated the global frequencies of three TLR1 variants that are common in white North American populations: rs5743551 (-7202A/G), rs4833095 (742A/G), and rs5743618 (1804G/T). We noted a reversal of the minor allele from white North American subjects to Asian populations that was particularly pronounced for rs5743618. In the Utah residents of European ancestry, the frequency of the rs5743618 T allele was 17% whereas in Vietnamese subjects the frequency was >99%. We conducted a genetic association study in 427 patients with melioidosis to determine the association of TLR1 variation with organ failure or death. We genotyped rs5743551 and rs4833095. The variants were in high linkage disequilibrium but neither variant was associated with organ failure or in-hospital death. In 300 healthy Thai individuals we further tested the association of TLR1 variation with ex vivo blood responses to Pam3CSK4, a TLR1 agonist. Neither variant was robustly associated with blood cytokine responses induced by Pam3CSK4. We identified additional common variation in TLR1 by searching public databases and the published literature and screened three additional TLR1 variants for associations with Pam3CSK4-induced responses but found none. We conclude that the genetic architecture of TLR1 variation differs substantially in southeast Asians compared to other populations and common variation in TLR1 in Thais is not associated with outcome from melioidosis or with altered blood responses to Pam3CSK4. Our findings highlight the need for additional studies of TLR1 and other innate immune genetic modulators of the inflammatory host response and determinants of sepsis in southeast Asian populations.	[Chantratita, Narisara; Tandhavanant, Sarunporn; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Chantratita, Narisara; Tandhavanant, Sarunporn; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Myers, Nicolle D.; West, T. Eoin] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Chierakul, Wirongrong] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [West, T. Eoin] Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Washington; University of Washington Seattle	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	narisara@tropmedres.ac	Chantratita, Narisara/P-2169-2019; Tandhavanant, Sarunporn/R-7620-2019; Peacock, Sharon J/ABE-6331-2020; Chierakul, Wirongrong/AAC-3226-2020; Tandhavanant, Sarunporn/Q-7376-2019	Tandhavanant, Sarunporn/0000-0003-0261-3233; Chierakul, Wirongrong/0000-0003-2103-9425; Tandhavanant, Sarunporn/0000-0003-0261-3233; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782; West, T Eoin/0000-0001-5503-7204	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; US National Institutes of Health [K08HL094759]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094759] Funding Source: NIH RePORTER	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z to NC), by the US National Institutes of Health award K08HL094759 (TEW), and by the Parker B. Francis Foundation (TEW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Cheng AC, 2006, T ROY SOC TROP MED H, V100, P64, DOI 10.1016/j.trstmh.2005.04.019; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; FRIEDLAND JS, 1992, INFECT IMMUN, V60, P2402, DOI 10.1128/IAI.60.6.2402-2408.1992; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133; Mikacenic C, 2013, GENES IMMUN, V14, P52, DOI 10.1038/gene.2012.53; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Ocejo-Vinyals JG, 2013, INT J TUBERC LUNG D, V17, P652, DOI 10.5588/ijtld.12.0767; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; SUPUTTAMONGKOL Y, 1992, J INFECT DIS, V165, P561, DOI 10.1093/infdis/165.3.561; Thompson CM, 2013, ANN SURG, DOI 10.1097/SLA.0b013e31828538e8 23478521; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Wurfel MM, 2008, CURR PHARM DESIGN, V14, P1900, DOI 10.2174/138161208784980554; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83285	10.1371/journal.pone.0083285	http://dx.doi.org/10.1371/journal.pone.0083285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392083	Green Published, gold			2022-12-25	WOS:000329460100007
J	Kurczy, ME; Mellander, LJ; Najafinobar, N; Cans, AS				Kurczy, Michael E.; Mellander, Lisa J.; Najafinobar, Neda; Cans, Ann-Sofie			Composition Based Strategies for Controlling Radii in Lipid Nanotubes	PLOS ONE			English	Article							ENZYMATIC-REACTIONS; MEMBRANE CURVATURE; EXOCYTOSIS; PROTEINS; BILAYERS; VESICLES; LEAFLET; CELLS; SHAPE	Nature routinely carries out small-scale chemistry within lipid bound cells and organelles. Liposome-lipid nanotube networks are being developed by many researchers in attempt to imitate these membrane enclosed environments, with the goal to perform small-scale chemical studies. These systems are well characterized in terms of the diameter of the giant unilamellar vesicles they are constructed from and the length of the nanotubes connecting them. Here we evaluate two methods based on intrinsic curvature for adjusting the diameter of the nanotube, an aspect of the network that has not previously been controllable. This was done by altering the lipid composition of the network membrane with two different approaches. In the first, the composition of the membrane was altered via lipid incubation of exogenous lipids; either with the addition of the low intrinsic curvature lipid soy phosphatidylcholine (soy-PC) or the high intrinsic curvature lipid soy phosphatidylethanolamine (soy-PE). In the second approach, exogenous lipids were added to the total lipid composition during liposome formation. Here we show that for both lipid augmentation methods, we observed a decrease in nanotube diameter following soy-PE additions but no significant change in size following the addition of soy-PC. Our results demonstrate that the effect of soy-PE on nanotube diameter is independent of the method of addition and suggests that high curvature soy-PE molecules facilitate tube membrane curvature.	[Kurczy, Michael E.; Najafinobar, Neda; Cans, Ann-Sofie] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Mellander, Lisa J.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Cans, AS (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	cans@chalmers.se	Cans, Ann-Sofie/A-5987-2011	Cans, Ann-Sofie/0000-0002-3059-2399; Kurczy, Michael/0000-0001-6579-9691	Swedish Research Council [80348401, 80348402, 349-2007-8680]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been funded by The Swedish Research Council with grant ID 80348401, 80348402, and 349-2007-8680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2010, ANAL CHEM, V82, P1020, DOI 10.1021/ac902282d; Amatore C, 2006, CHEMBIOCHEM, V7, P1998, DOI 10.1002/cbic.200600194; Bashkirov PV, 2011, BIOL MEMBRANY, V28, P145; Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; Cans AS, 2003, P NATL ACAD SCI USA, V100, P400, DOI 10.1073/pnas.232702599; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cooke IR, 2006, BIOPHYS J, V91, P487, DOI 10.1529/biophysj.105.078683; Garcia-Manyes S, 2010, J AM CHEM SOC, V132, P12874, DOI 10.1021/ja1002185; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Heinrich M, 2010, P NATL ACAD SCI USA, V107, P7208, DOI 10.1073/pnas.0913997107; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; HUI SW, 1995, BIOPHYS J, V68, P171, DOI 10.1016/S0006-3495(95)80172-4; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; Karlsson A, 2005, J PHYS CHEM B, V109, P1609, DOI 10.1021/jp0459716; Karlsson M, 2001, LANGMUIR, V17, P6754, DOI 10.1021/la0108611; Kurczy ME, 2010, P NATL ACAD SCI USA, V107, P2751, DOI 10.1073/pnas.0908101107; Lanekoff I, 2011, ANAL CHEM, V83, P5337, DOI 10.1021/ac200771g; LEIBLER S, 1986, J PHYS-PARIS, V47, P507, DOI 10.1051/jphys:01986004703050700; Lobovkina T., 2006, PHYS REV LETT, V97; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Mellander LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00907; NANAVATI C, 1992, BIOPHYS J, V63, P1118, DOI 10.1016/S0006-3495(92)81679-X; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sott K, 2006, NANO LETT, V6, P209, DOI 10.1021/nl052078p; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stepanyants N, 2012, NANO LETT, V12, P1372, DOI 10.1021/nl203983e; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Uchiyama Y, 2007, BRAIN RES, V1151, P46, DOI 10.1016/j.brainres.2007.03.012; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	33	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e81293	10.1371/journal.pone.0081293	http://dx.doi.org/10.1371/journal.pone.0081293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392077	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100001
J	Caudill, CC; Keefer, ML; Clabough, TS; Naughton, GP; Burke, BJ; Peery, CA				Caudill, Christopher C.; Keefer, Matthew L.; Clabough, Tami S.; Naughton, George P.; Burke, Brian J.; Peery, Christopher A.			Indirect Effects of Impoundment on Migrating Fish: Temperature Gradients in Fish Ladders Slow Dam Passage by Adult Chinook Salmon and Steelhead	PLOS ONE			English	Article							SOCKEYE-SALMON; COLUMBIA RIVER; BEHAVIORAL THERMOREGULATION; ONCORHYNCHUS-NERKA; SNAKE RIVER; WATER TEMPERATURE; MORTALITY; TROUT; FLOW; RESERVOIR	Thermal layering in reservoirs upstream from hydroelectric dams can create temperature gradients in fishways used by upstream migrating adults. In the Snake River, Washington, federally-protected adult salmonids (Oncorhynchus spp.) often encounter relatively cool water in dam tailraces and lower ladder sections and warmer water in the upstream portions of ladders. Using radiotelemetry, we examined relationships between fish passage behavior and the temperature difference between the top and bottom of ladders (Delta T) at four dams over four years. Some spring Chinook salmon (O. tshawytscha) experienced Delta T >= 0.5 degrees C. Many summer and fall Chinook salmon and summer steelhead (O. mykiss) experienced Delta T >= 1.0 degrees C, and some individuals encountered Delta T > 4.0 degrees C. As Delta T increased, migrants were consistently more likely to move down fish ladders and exit into dam tailraces, resulting in upstream passage delays that ranged from hours to days. Fish body temperatures equilibrated to ladder temperatures and often exceeded 20 degrees C, indicating potential negative physiological and fitness effects. Collectively, the results suggest that gradients in fishway water temperatures present a migration obstacle to many anadromous migrants. Unfavorable temperature gradients may be common at reservoir-fed fish passage facilities, especially those with seasonal thermal layering or stratification. Understanding and managing thermal heterogeneity at such sites may be important for ensuring efficient upstream passage and minimizing stress for migratory, temperature-sensitive species.	[Caudill, Christopher C.; Keefer, Matthew L.; Clabough, Tami S.; Naughton, George P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Burke, Brian J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Seattle, WA 98115 USA; [Peery, Christopher A.] US Fish & Wildlife Serv, Idaho Fisheries Resource Off, Ahsahka, ID USA	Idaho; University of Idaho; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Caudill, CC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	caudill@uidaho.edu	Caudill, Christopher C/M-7906-2014	Caudill, Christopher C/0000-0002-7129-8620	United States Army Corps of Engineers, Walla Walla District	United States Army Corps of Engineers, Walla Walla District	This study was funded by the United States Army Corps of Engineers, Walla Walla District, with assistance provided by M. Shutters and K. Zelch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2012, CATEGORICAL DATA ANA, P744; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Bradford MJ, 2010, CAN J FISH AQUAT SCI, V67, P673, DOI 10.1139/F10-017; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Brett J.R., 1995, P3; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Caudill CC, 2007, CAN J FISH AQUAT SCI, V64, P979, DOI 10.1139/F07-065; Clay C.H., 1995, DESIGN FISHWAYS OTHE, V2nd, DOI 10.1201/9781315141046; Connor WP, 2005, T AM FISH SOC, V134, P291, DOI 10.1577/T03-131.1; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Fowler SL, 2009, CAN J FISH AQUAT SCI, V66, P91, DOI 10.1139/F08-192; Geist DR, 2000, T AM FISH SOC, V129, P126, DOI 10.1577/1548-8659(2000)129&lt;0126:TUOETT&gt;2.0.CO;2; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Hamblin PF, 2003, HYDROBIOLOGIA, V504, P3, DOI 10.1023/B:HYDR.0000008503.75784.ee; Harmon JR, 2003, N AM J FISH MANAGE, V23, P989, DOI 10.1577/M02-035; Haro A, 2004, CAN J FISH AQUAT SCI, V61, P1590, DOI 10.1139/F04-093; Hasler CT, 2012, J THERM BIOL, V37, P265, DOI 10.1016/j.jtherbio.2011.02.003; Johnson EL, 2010, J FISH BIOL, V76, P1520, DOI 10.1111/j.1095-8649.2010.02578.x; Johnson EL, 2005, T AM FISH SOC, V134, P1213, DOI 10.1577/T04-116.1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Keefer ML, 2008, ECOL FRESHW FISH, V17, P136, DOI 10.1111/j.1600-0633.2007.00267.x; Keefer ML, 2008, N AM J FISH MANAGE, V28, P81, DOI 10.1577/M07-011.1; Keefer ML, 2013, ENVIRON BIOL FISH, V96, P691, DOI 10.1007/s10641-012-0059-5; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Keefer ML, 2005, CAN J FISH AQUAT SCI, V62, P930, DOI 10.1139/F04-246; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; Lund SG, 2002, CAN J FISH AQUAT SCI, V59, P1553, DOI [10.1139/f02-117, 10.1139/F02-117]; Macdonald JS, 2012, N AM J FISH MANAGE, V32, P415, DOI 10.1080/02755947.2012.675946; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; McArdle BH, 2004, CAN J FISH AQUAT SCI, V61, P1294, DOI 10.1139/F04-051; Mccullough DA, 2009, REV FISH SCI, V17, P90, DOI 10.1080/10641260802590152; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; National Marine Fisheries Service, 2011, FED REGISTER, V76, P50448; Naughton GP, 2005, CAN J FISH AQUAT SCI, V62, P30, DOI 10.1139/F04-147; Odeh M., 1999, INNOVATIONS FISH PAS; Olden JD, 2010, FRESHWATER BIOL, V55, P86, DOI 10.1111/j.1365-2427.2009.02179.x; Pankhurst NW, 1996, AQUACULTURE, V146, P277, DOI 10.1016/S0044-8486(96)01374-9; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Roscoe DW, 2010, FISH FISH, V11, P12, DOI 10.1111/j.1467-2979.2009.00333.x; Salinger DH, 2006, T AM FISH SOC, V135, P188, DOI 10.1577/T04-181.1; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Strange JS, 2012, T AM FISH SOC, V141, P1622, DOI 10.1080/00028487.2012.716010; Tiffan KF, 2009, J FISH BIOL, V74, P1562, DOI 10.1111/j.1095-8649.2009.02228.x; U.S. Army Corps of Engineers, 2004, WAT TEMP AD FISHW MA; U.S. Army Corps of Engineers, 2011, ANN FISH PASS REP; Young JL, 2006, CAN J FISH AQUAT SCI, V63, P1067, DOI 10.1139/F06-014	49	25	27	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85586	10.1371/journal.pone.0085586	http://dx.doi.org/10.1371/journal.pone.0085586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392020	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900164
J	Cheng, X; Li, H; Chen, YC; Luo, BH; Liu, XH; Liu, W; Xu, HB; Yang, XL				Cheng, Xin; Li, Huan; Chen, Yunchao; Luo, Binhua; Liu, Xuhan; Liu, Wei; Xu, Haibo; Yang, Xiangliang			Ultrasound-Triggered Phase Transition Sensitive Magnetic Fluorescent Nanodroplets as a Multimodal Imaging Contrast Agent in Rat and Mouse Model	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MULTIFUNCTIONAL NANOPARTICLES; POLYMERIC MICELLES; NANOBUBBLES; CANCER; EMULSIFICATION; MICROCAPSULES; MR	Ultrasound-triggered phase transition sensitive nanodroplets with multimodal imaging functionality were prepared via premix Shirasu porous glass (SPG) membrane emulsification method. The nanodroplets with fluorescence dye DiR and SPIO nanoparticles (DiR-SPIO-NDs) had a polymer shell and a liquid perfluoropentane (PFP) core. The as-formed DiR-SPIO-NDs have a uniform size of 385 +/- 5.0 nm with PDI of 0.169 +/- 0.011. The TEM and microscopy imaging showed that the DiR-SPIO-NDs existed as core-shell spheres, and DiR and SPIO nanoparticles dispersed in the shell or core. The MTT and hemolysis studies demonstrated that the nanodroplets were biocompatible and safe. Moreover, the proposed nanodroplets exhibited significant ultrasound-triggered phase transition property under clinical diagnostic ultrasound irradiation due to the vaporization of PFP inside. Meanwhile, the high stability and R-2 relaxivity of the DiR-SPIO-NDs suggested its applicability in MRI. The in vivo T-2-weighted images of MRI and fluorescence images both showed that the image contrast in liver and spleen of rats and mice model were enhanced after the intravenous injection of DiR-SPIO-NDs. Furthermore, the ultrasound imaging (US) in mice tumor as well as MRI and fluorescence imaging in liver of rats and mice showed that the DiR-SPIO-NDs had long-lasting contrast ability in vivo. These in vitro and in vivo findings suggested that DiR-SPIO-NDs could potentially be a great MRI/US/fluorescence multimodal imaging contrast agent in the diagnosis of liver tissue diseases.	[Cheng, Xin; Luo, Binhua; Liu, Xuhan; Liu, Wei; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Cheng, Xin; Luo, Binhua; Liu, Xuhan; Liu, Wei; Yang, Xiangliang] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Hubei, Peoples R China; [Cheng, Xin] Yunnan Univ Tradit Chinese Med, Coll Pharm, Kunming, Yunnan, Peoples R China; [Li, Huan; Xu, Haibo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Hubei, Peoples R China; [Chen, Yunchao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Yunnan University of Chinese Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, W (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	wliu@hust.edu.cn; xuhaibo1120@hotmail.com			National Basic Research Program of China (973 Program) [2012CB932500]; National High Technology Research and Development Program of China (863 Program) [2012AA022704]; National Science Foundation of China (NSFC) [31170960]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China (973 Program, 2012CB932500), National High Technology Research and Development Program of China (863 Program, 2012AA022704), National Science Foundation of China (NSFC, 31170960). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; Borden MA, 2010, MOL IMAGING, P425; Cho H, 2012, NANOMED-NANOTECHNOL, V8, P228, DOI 10.1016/j.nano.2011.06.009; Huang YR, 2012, NANOSCALE, V4, P6135, DOI 10.1039/c2nr31715j; Jin YS, 2013, BIOMATERIALS, V34, P4794, DOI 10.1016/j.biomaterials.2013.03.027; Ke H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425105; Kiessling F, 2009, CURR MED CHEM, V16, P627, DOI 10.2174/092986709787458470; Kukizaki M, 2006, J MEMBRANE SCI, V281, P386, DOI 10.1016/j.memsci.2006.04.007; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; Li XL, 2012, BIOMATERIALS, V33, P3013, DOI 10.1016/j.biomaterials.2011.12.042; Liu R, 2006, COLLOID SURFACE B, V51, P30, DOI 10.1016/j.colsurfb.2006.05.014; Liu W, 2011, J PHARM SCI-US, V100, P75, DOI 10.1002/jps.22272; Liu Z, 2011, BIOMATERIALS, V32, P6155, DOI 10.1016/j.biomaterials.2011.05.019; Ma Y, 2013, BIOMATERIALS, V34, P7706, DOI 10.1016/j.biomaterials.2013.07.007; Mai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061224; Nazir A, 2010, J MEMBRANE SCI, V362, P1, DOI 10.1016/j.memsci.2010.06.044; O'Neill BE, 2011, THER DELIV, V2, P1165, DOI [10.4155/tde.11.81, 10.4155/TDE.11.81]; Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005; Park YI, 2011, J MATER CHEM, V21, P11472, DOI 10.1039/c1jm10432b; Platts DG, 2011, CRIT CARE RESUSC, V13, P44; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Torigan DA, 2007, CA-CANCER J CLIN, V57, P206, DOI 10.3322/canjclin.57.4.206; Wang Y, 2010, INT J PHARMACEUT, V384, P148, DOI 10.1016/j.ijpharm.2009.09.027; Wei Q, 2008, J COLLOID INTERF SCI, V323, P267, DOI 10.1016/j.jcis.2008.04.058; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wong ZZ, 2011, SOFT MATTER, V7, P4009, DOI 10.1039/c1sm00007a; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Xing HY, 2012, BIOMATERIALS, V33, P1079, DOI 10.1016/j.biomaterials.2011.10.039; Xu JS, 2010, BIOMATERIALS, V31, P1716, DOI 10.1016/j.biomaterials.2009.11.052; Xu RX, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147424; Xu ZC, 2009, CHEM MATER, V21, P1778, DOI 10.1021/cm802978z; Yang F, 2009, BIOMATERIALS, V30, P3882, DOI 10.1016/j.biomaterials.2009.03.051; Yang H, 2010, BIOMATERIALS, V31, P3667, DOI 10.1016/j.biomaterials.2010.01.055; Yin TH, 2013, BIOMATERIALS, V34, P4532, DOI 10.1016/j.biomaterials.2013.02.067; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830	35	21	23	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85003	10.1371/journal.pone.0085003	http://dx.doi.org/10.1371/journal.pone.0085003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391983	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900126
J	Zhao, B; Zhang, M; Han, X; Zhang, XY; Xing, Q; Dong, X; Shi, QJ; Huang, P; Lu, YB; Wei, EQ; Xia, Q; Zhang, WP; Tang, C				Zhao, Bing; Zhang, Meng; Han, Xue; Zhang, Xia-Yan; Xing, Qiong; Dong, Xu; Shi, Qiao-Juan; Huang, Peng; Lu, Yun-Bi; Wei, Er-Qing; Xia, Qiang; Zhang, Wei-Ping; Tang, Chun			Cerebral Ischemia Is Exacerbated by Extracellular Nicotinamide Phosphoribosyltransferase via a Non-Enzymatic Mechanism	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; VISFATIN CONCENTRATIONS; NEUROPROTECTION; METABOLISM; EXPRESSION; PROTECTS; STROKE; NAD(+); MODEL	Intracellular nicotinamide phosphoribosyltransferase (iNAMPT) in neuron has been known as a protective factor against cerebral ischemia through its enzymatic activity, but the role of central extracellular NAMPT (eNAMPT) is not clear. Here we show that eNAMPT protein level was elevated in the ischemic rat brain after middle-cerebral-artery occlusion (MCAO) and reperfusion, which can be traced to at least in part from blood circulation. Administration of recombinant NAMPT protein exacerbated MCAO-induced neuronal injury in rat brain, while exacerbated oxygen-glucose-deprivation (OGD) induced neuronal injury only in neuron-glial mixed culture, but not in neuron culture. In the mixed culture, NAMPT protein promoted TNF-alpha release in a time-and concentration-dependent fashion, while TNF-alpha neutralizing antibody protected OGD-induced, NAMPT-enhanced neuronal injury. Importantly, H247A mutant of NAMPT with essentially no enzymatic activity exerted similar effects on ischemic neuronal injury and TNF-alpha release as the wild type protein. Thus, eNAMPT is an injurious and inflammatory factor in cerebral ischemia and aggravates ischemic neuronal injury by triggering TNF-alpha release from glia cells, via a mechanism not related to NAMPT enzymatic activity.	[Zhao, Bing; Han, Xue; Zhang, Xia-Yan; Shi, Qiao-Juan; Huang, Peng; Lu, Yun-Bi; Wei, Er-Qing; Zhang, Wei-Ping] Zhejiang Univ, Sch Med, Dept Pharmacol,Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Qiong; Dong, Xu; Tang, Chun] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Zhang, Meng; Xia, Qiang] Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Bing] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Zhejiang University; Zhejiang University	Zhang, WP (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol,Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China, Hangzhou 310003, Zhejiang, Peoples R China.	weiping601@zju.edu.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Ministry of Science and Technology [2013CB910200]; National Natural Sciences Foundation [81072619, 81373392, 81173041, 81272594, 81273491, 30873053]; Zhejiang Provincial Natural Science Foundation of China [Z2110059]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by funds from the Ministry of Science and Technology (2013CB910200), the National Natural Sciences Foundation (81072619, 81373392, 81173041, 81272594, 81273491 and 30873053) and Zhejiang Provincial Natural Science Foundation of China (Z2110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Chan TF, 2007, FERTIL STERIL, V88, P401, DOI 10.1016/j.fertnstert.2006.11.120; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; ERECINSKA M, 1978, AM J PHYSIOL, V234, pC82, DOI 10.1152/ajpcell.1978.234.3.C82; Filippatos TD, 2013, NUTR METAB CARDIOVAS, V23, P330, DOI 10.1016/j.numecd.2011.07.002; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jin H, 2008, DIABETES RES CLIN PR, V79, P412, DOI 10.1016/j.diabres.2007.09.019; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Love S, 1999, BRAIN PATHOL, V9, P119; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Pillai VB, 2013, AM J PHYSIOL-HEART C, V304, pH415, DOI 10.1152/ajpheart.00468.2012; Presumey J, 2013, ANN RHEUM DIS, V72, P1717, DOI 10.1136/annrheumdis-2012-202403; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Siegel C, 2011, ACTA PHYSIOL, V203, P225, DOI 10.1111/j.1748-1716.2010.02229.x; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Taskesen D, 2012, J CLIN RES PEDIATR E, V4, P76, DOI [10.4274/Jcrpe.547, 10.4274/jcrpe.547]; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2012, J CARDIOVASC PHARM, V59, P1, DOI 10.1097/FJC.0b013e31820eb8f6; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhao CZ, 2011, NEUROSCIENCE, V189, P1, DOI 10.1016/j.neuroscience.2011.05.066	40	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85403	10.1371/journal.pone.0085403	http://dx.doi.org/10.1371/journal.pone.0085403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392007	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900151
J	Blanco-Suarez, E; Hanley, JG				Blanco-Suarez, Elena; Hanley, Jonathan G.			Distinct Subunit-specific alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking Mechanisms in Cultured Cortical and Hippocampal Neurons in Response to Oxygen and Glucose Deprivation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Excitotoxicity; Glutamate Receptors Ionotropic (AMPA; NMDA); Ischemia; Neurons; Receptor Endocytosis	LONG-TERM POTENTIATION; GLOBAL-ISCHEMIA; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; BRAIN ISCHEMIA; EXPRESSION; DEATH; ENDOCYTOSIS; SYNAPSES; PROTEINS	Background: Hippocampal CA1 neurons are more vulnerable to global ischemia than cortical neurons. Rapid internalization of GluA2 subunit contributes to OGD-induced hippocampal neuronal death. Results: GluA2 subunit is not internalized in response to OGD in cortical neurons. Conclusion: A crucial aspect of the mechanism leading to cell death is absent in cortical neurons. Significance: Differences in GluA2 trafficking may contribute to neuronal vulnerability to ischemia. Brain ischemia occurs when the blood supply to the brain is interrupted, leading to oxygen and glucose deprivation (OGD). This triggers a cascade of events causing a synaptic accumulation of glutamate. Excessive activation of glutamate receptors results in excitotoxicity and delayed cell death in vulnerable neurons. Following global cerebral ischemia, hippocampal CA1 pyramidal neurons are more vulnerable to injury than their cortical counterparts. The mechanisms that underlie this difference are unclear. Cultured hippocampal neurons respond to OGD with a rapid internalization of AMPA receptor (AMPAR) subunit GluA2, resulting in a switch from GluA2-containing Ca2+-impermeable receptors to GluA2-lacking Ca2+-permeable subtypes (CP-AMPARs). GluA2 internalization is a critical component of OGD-induced cell death in hippocampal neurons. It is unknown how AMPAR trafficking is affected in cortical neurons following OGD. Here, we show that cultured cortical neurons are resistant to an OGD insult that causes cell death in hippocampal neurons. GluA1 is inserted at the plasma membrane in both cortical and hippocampal neurons in response to OGD. In contrast, OGD causes a rapid endocytosis of GluA2 in hippocampal neurons, which is absent in cortical neurons. These data demonstrate that populations of neurons with different vulnerabilities to OGD recruit distinct cell biological mechanisms in response to insult, and that a crucial aspect of the mechanism leading to OGD-induced cell death is absent in cortical neurons. This strongly suggests that the absence of OGD-induced GluA2 trafficking contributes to the relatively low vulnerability of cortical neurons to ischemia.	[Blanco-Suarez, Elena; Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk		Hanley, Jonathan/0000-0003-1704-4707; Blanco-Suarez, Elena/0000-0002-2131-6376	SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant [238608]; MRC [MR/L011131/1] Funding Source: UKRI; Medical Research Council [MR/L011131/1] Funding Source: researchfish	SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by SyMBaD-ITN ("Synapses: From Molecules to higher Brain Function and Diseases," Initial Training Network) Marie Curie Actions Grant 238608.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cronberg T, 2005, EUR J NEUROSCI, V22, P310, DOI 10.1111/j.1460-9568.2005.04235.x; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Gorter JA, 1997, J NEUROSCI, V17, P6179; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jaafari N, 2012, J NEUROSCI, V32, P11618, DOI 10.1523/JNEUROSCI.5068-11.2012; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shepherd JD, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00049; Soundarapandian MM, 2005, MOL NEUROBIOL, V32, P145, DOI 10.1385/MN:32:2:145; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yang YL, 2010, P NATL ACAD SCI USA, V107, P11999, DOI 10.1073/pnas.0913004107	34	20	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4644	4651		10.1074/jbc.M113.533182	http://dx.doi.org/10.1074/jbc.M113.533182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403083	Green Published, hybrid			2022-12-25	WOS:000331607900012
J	Nakamichi, Y; Mikami, B; Murata, K; Hashimoto, W				Nakamichi, Yusuke; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			Crystal Structure of a Bacterial Unsaturated Glucuronyl Hydrolase with Specificity for Heparin*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin; Enzyme Structure; Glycosaminoglycan; Glycoside Hydrolases; Heparan Sulfate; Heparin; Streptococcus; X-ray Crystallography	BACILLUS-SP GL1; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; EXPRESSION; DEGRADATION; CLONING; GLYCOSAMINOGLYCAN; BINDING; GLYCURONIDASE; PURIFICATION	Background: Bacterial unsaturated glucuronyl hydrolase (UGL) is essential for complete degradation of host glycosaminoglycans. Results: Crystal structure of Pedobacter heparinus UGL, Phep_2830 specific for heparin degradation, was determined. Conclusion: The pocket-like structure and lid loop of Phep_2830 are involved in heparin disaccharide recognition. Significance: This work contributes to understanding the bacterial degradation of host extracellular matrix components. Extracellular matrix molecules such as glycosaminoglycans (GAGs) are typical targets for some pathogenic bacteria, which allow adherence to host cells. Bacterial polysaccharide lyases depolymerize GAGs in -elimination reactions, and the resulting unsaturated disaccharides are subsequently degraded to constituent monosaccharides by unsaturated glucuronyl hydrolases (UGLs). UGL substrates are classified as 1,3- and 1,4-types based on the glycoside bonds. Unsaturated chondroitin and heparin disaccharides are typical members of 1,3- and 1,4-types, respectively. Here we show the reaction modes of bacterial UGLs with unsaturated heparin disaccharides by x-ray crystallography, docking simulation, and site-directed mutagenesis. Although streptococcal and Bacillus UGLs were active on unsaturated heparin disaccharides, those preferred 1,3- rather than 1,4-type substrates. The genome of GAG-degrading Pedobacter heparinus encodes 13 UGLs. Of these, Phep_2830 is known to be specific for unsaturated heparin disaccharides. The crystal structure of Phep_2830 was determined at 1.35- resolution. In comparison with structures of streptococcal and Bacillus UGLs, a pocket-like structure and lid loop at subsite +1 are characteristic of Phep_2830. Docking simulations of Phep_2830 with unsaturated heparin disaccharides demonstrated that the direction of substrate pyranose rings differs from that in unsaturated chondroitin disaccharides. Acetyl groups of unsaturated heparin disaccharides are well accommodated in the pocket at subsite +1, and aromatic residues of the lid loop are required for stacking interactions with substrates. Thus, site-directed mutations of the pocket and lid loop led to significantly reduced enzyme activity, suggesting that the pocket-like structure and lid loop are involved in the recognition of 1,4-type substrates by UGLs.	[Nakamichi, Yusuke; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/H-1221-2018; Nakamichi, Yusuke/Y-2830-2019	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [23580112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. N.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, CCP4 NEWSL, V42; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dong W, 2012, PROTEIN CELL, V3, P950, DOI 10.1007/s13238-012-2056-z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; Han C, 2009, STAND GENOMIC SCI, V1, P54, DOI 10.4056/sigs.22138; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hyun YJ, 2010, J APPL MICROBIOL, V108, P226, DOI 10.1111/j.1365-2672.2009.04418.x; Hyun YJ, 2010, APPL MICROBIOL BIOT, V86, P879, DOI 10.1007/s00253-009-2327-7; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kim WS, 2004, J BIOCHEM MOL BIOL, V37, P684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Luo YD, 2007, ARCH BIOCHEM BIOPHYS, V460, P17, DOI 10.1016/j.abb.2007.01.029; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Nakamichi Y, 2011, J BIOL CHEM, V286, P6262, DOI 10.1074/jbc.M110.182618; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Shim KW, 2008, PROTEIN EXPRES PURIF, V58, P222, DOI 10.1016/j.pep.2007.11.014; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	43	7	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4787	4797		10.1074/jbc.M113.522573	http://dx.doi.org/10.1074/jbc.M113.522573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403065	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000331607900025
J	Kim, YS; Jung, SH; Jung, DH; Choi, SJ; Lee, YR; Kim, JS				Kim, Young Sook; Jung, Seung-Hyun; Jung, Dong Ho; Choi, So-Jin; Lee, Yu-Ri; Kim, Jin Sook			Gas6 Stimulates Angiogenesis of Human Retinal Endothelial Cells and of Zebrafish Embryos via ERK1/2 Signaling	PLOS ONE			English	Article							GROWTH ARREST; DIABETIC-RETINOPATHY; ANTI-VEGF; GENE 6; AXL; RECEPTOR; PROLIFERATION; CARCINOMA; MIGRATION; PATHWAY	Aim: To determine if growth arrest-specific 6 (Gas6) plays an important role in the regulation of angiogenesis in human retinal microvascular endothelial cells (HRMECs) and in vessel development of zebrafish. Methods: Proliferation, wound-healing cell migration, and tube formation were measured in HRMECs treated with recombinant human Gas6 (rhGas6). Sprague-Dawley rat aortas in Matrigels were treated with rhGas6, and microvessel sprouting emanating from arterial rings was analyzed. Transgenic zebrafish embryos (flk:GFP) were microinjected with rhGas6 at 50 hours post-fertilization (hpf), and ectopic sprouting of subintestinal vessels (SIVs) was observed under a confocal microscope. Morpholino oligonucleotides (MOs) were microinjected to knockdown gas6 in zebrafish embryos, and intersegmental vessel impairment was observed. The effect of the extracellular signal-regulated kinase (ERK1/2) inhibitor on the migration of HRMECs and on vessel development in zebrafish embryos was tested. Results: rhGas6 stimulated proliferation, migration, and tube formation in HRMECs in a dose-dependent manner. In rat aortas, rhGas6 induced vessel outgrowth, and the sprouting length was longer than that of controls. The rhGas6-microinjected zebrafish embryos had significantly increased vessel outgrowth in the SIVs. Recombinant human vascular endothelial growth factor (rhVEGF) served as a positive control. Knockdown of gas6 inhibited angiogenesis in the developing vessels of zebrafish. The ERK1/2 inhibitor inhibited HRMEC migration and intersegmental vessel formation in zebrafish embryos. Conclusions/Interpretations: These data suggest that Gas6 plays a pivotal role in proliferation, migration, and sprouting of angiogenic endothelial cells in the retina and in zebrafish embryos. Furthermore, Gas6 induced angiogenic processes are induced via phosphorylation of ERK1/2.	[Kim, Young Sook; Jung, Seung-Hyun; Jung, Dong Ho; Choi, So-Jin; Lee, Yu-Ri; Kim, Jin Sook] KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, JS (corresponding author), KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Dev Grp, Taejon, South Korea.	jskim@kiom.re.kr		jeong, dongho/0000-0002-6250-5720	Korea Institute of Oriental Medicine (KIOM) [K12040, K13040]	Korea Institute of Oriental Medicine (KIOM)	This research was supported by grants [K12040 and K13040] from the Korea Institute of Oriental Medicine (KIOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2010, ANGIOGENESIS; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Binu S, 2012, J PHYSL BIOCH; Boosani CS, 2010, CURR EYE RES, V35, P45, DOI 10.3109/02713680903374208; Castellon R, 2002, EXP EYE RES, V74, P523, DOI 10.1006/exer.2001.1161; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gustafsson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007575; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kim YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050297; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sepe L, 2013, CELL PHYSIOL BIOCHEM, V31, P123, DOI 10.1159/000343355; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Yanagita Motoko, 2004, Clin Exp Nephrol, V8, P304; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	30	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83901	10.1371/journal.pone.0083901	http://dx.doi.org/10.1371/journal.pone.0083901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409287	gold, Green Submitted, Green Published			2022-12-25	WOS:000329463500011
J	Ngufor, C; Tchicaya, E; Koudou, B; N'Fale, S; Dabire, R; Johnson, P; Ranson, H; Rowland, M				Ngufor, Corine; Tchicaya, Emile; Koudou, Benjamin; N'Fale, Sagnon; Dabire, Roch; Johnson, Paul; Ranson, Hilary; Rowland, Mark			Combining Organophosphate Treated Wall Linings and Long-lasting Insecticidal Nets for Improved Control of Pyrethroid Resistant Anopheles gambiae	PLOS ONE			English	Article							MALARIA CONTROL; INDOOR USE; EFFICACY; AREA; MOSQUITOS	Background: New approaches to delivering insecticides need to be developed to improve malaria vector control. Insecticidal durable wall lining (DL) and net wall hangings (NWH) are novel alternatives to indoor residual spraying which can be produced in a long-lasting format. Non-pyrethroid versions could be used in combination with long-lasting insecticidal nets for improved control and management of insecticide resistant vector populations. Methods: Experimental hut trials were carried out in Valley du Kou, Burkina Faso to evaluate the efficacy of pirimiphos methyl treated DL and NWH either alone or in combination with LLINs against pyrethroid resistant Anopheles gambiae ss. Comparison was made with pyrethroid DL. Mosquitoes were genotyped for kdr and ace-1R resistant genes to investigate the insecticide resistance management potential of the combination. Results: The overall kdr and ace-1(R) allele frequencies were 0.95 and 0.01 respectively. Mortality with p-methyl DL and NWH alone was higher than with pyrethroid DL alone (>95% vs 40%; P<0.001). Combining pyrethroid DL with LLINs did not show improvement in mortality (48%) compared to the LLIN alone (44%) (P>0.1). Combining p-methyl DL or NWH with LLINs reduced biting rates significantly (8-9%) compared to p-methyl DL and NWH alone (>40%) and killed all An gambiae that entered the huts. Mosquitoes bearing the ace-1(R) gene were more likely to survive in huts with p-methyl DL alone (p<0.03) whereas all resistant and susceptible genotypes were killed by the combination. Conclusion: P-methyl DL and NWH outperformed pyrethroid DL. Combining p-methyl DL and NWH with LLINs could provide significant epidemiological benefits against a vector population which is resistant to pyrethroids but susceptible to organophosphates. There was evidence that the single intervention would select kdr and ace-1(R) resistance genes and the combination intervention might select less strongly. Technology to bind organophosphates to plastic wall lining would be worth developing.	[Ngufor, Corine; Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Tchicaya, Emile; Koudou, Benjamin] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire; [N'Fale, Sagnon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Dabire, Roch] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Johnson, Paul] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	corine.ngufor@lshtm.ac.uk	Johnson, Paul C D/O-9695-2014; Dabire, Roch Kounbobr/ABF-3525-2020	Johnson, Paul C D/0000-0001-6663-7520; Ngufor, Corine/0000-0002-7755-9609; Ranson, Hilary/0000-0003-2332-8247	European Union [265660 AvecNet]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7 (2007-2013) under grant agreement no 265660 AvecNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 2011, R LANG ENV STAT COMP; [Anonymous], 2006, PESTICIDES THEIR APP; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Djenontin A, 2010, AM J TROP MED HYG, V83, P266, DOI 10.4269/ajtmh.2010.10-0012; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; *IRAC, 2010, VECT PUBL HLTH IMP I; LIVAK KJ, 1984, GENETICS, V107, P611; Messenger LA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-358; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; ROUSH RT, 1993, PARASITOL TODAY, V9, P174, DOI 10.1016/0169-4758(93)90141-2; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Sharma SK, 2009, INDIAN J MED RES, V130, P458; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2010, GLOB MAL PROGR M REP; World Health Organization, 2012, WHO GLOB MAL PROGR G; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	33	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83897	10.1371/journal.pone.0083897	http://dx.doi.org/10.1371/journal.pone.0083897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409286	Green Accepted, gold, Green Published			2022-12-25	WOS:000329463500010
J	Payne, BAI; Hollingsworth, KG; Baxter, J; Wilkins, E; Lee, V; Price, DA; Trenell, M; Chinnery, PF				Payne, Brendan A. I.; Hollingsworth, Kieren G.; Baxter, Joanne; Wilkins, Edmund; Lee, Vincent; Price, D. Ashley; Trenell, Michael; Chinnery, Patrick F.			In Vivo Mitochondrial Function in HIV-Infected Persons Treated with Contemporary Anti-Retroviral Therapy: A Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; DNA; TOXICITY; STAVUDINE; FATIGUE	Modern anti-retroviral therapy is highly effective at suppressing viral replication and restoring immune function in HIV-infected persons. However, such individuals show reduced physiological performance and increased frailty compared with age-matched uninfected persons. Contemporary anti-retroviral therapy is thought to be largely free from neuromuscular complications, whereas several anti-retroviral drugs previously in common usage have been associated with mitochondrial toxicity. It has recently been established that patients with prior exposure to such drugs exhibit irreversible cellular and molecular mitochondrial defects. However the functional significance of such damage remains unknown. Here we use phosphorus magnetic resonance spectroscopy (P-31-MRS) to measure in vivo muscle mitochondrial oxidative function, in patients treated with contemporary anti-retroviral therapy, and compare with biopsy findings (cytochrome c oxidase (COX) histochemistry). We show that dynamic oxidative function (post-exertional ATP (adenosine triphosphate) resynthesis) was largely maintained in the face of mild to moderate COX defects (affecting up to similar to 10% of fibers): iota(1/2) ADP (half-life of adenosine diphosphate clearance), HIV-infected 22.1 +/- 9.9 s, HIV-uninfected 18.8 +/- 4.4 s, p = 0.09. In contrast, HIV-infected patients had a significant derangement of resting state ATP metabolism compared with controls: ADP/ATP ratio, HIV-infected 1.24 +/- 0.08x10(-3), HIV-uninfected 1.16 +/- 0.05x10(-3), p = 0.001. These observations are broadly reassuring in that they suggest that in vivo mitochondrial function in patients on contemporary anti-retroviral therapy is largely maintained at the whole organ level, despite histochemical (COX) defects within individual cells. Basal energy requirements may nevertheless be increased.	[Payne, Brendan A. I.; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Payne, Brendan A. I.; Price, D. Ashley] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hollingsworth, Kieren G.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baxter, Joanne; Wilkins, Edmund] North Manchester Gen Hosp, Dept Infect Dis, Manchester, Lancs, England; [Lee, Vincent] Manchester Royal Infirm, Manchester Ctr Sexual Hlth, Manchester M13 9WL, Lancs, England; [Trenell, Michael] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Manchester; Newcastle University - UK	Payne, BAI (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	brendan.payne@ncl.ac.uk	Payne, Brendan/I-1233-2016	Payne, Brendan/0000-0002-3101-3512; Price, David/0000-0002-0562-7326; Trenell, Michael/0000-0001-8253-5620; Chinnery, Patrick/0000-0002-7065-6617	Medical Research Council (MRC, UK) [G1100160]; Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases; Medical Research Council (MRC, UK) Centre for Translational Muscle Disease; Wellcome Trust [084980/Z/08/Z, 096919Z/11/Z]; MRC [G0800470, G1100160, MC_G0802536, MR/K000608/1] Funding Source: UKRI; Medical Research Council [G0700718B, G0800470, MC_G0802536, MR/K000608/1, G1100160] Funding Source: researchfish; National Institute for Health Research [CL-2013-01-004, SRF-2011-04-017] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases(National Institute for Health Research (NIHR)); Medical Research Council (MRC, UK) Centre for Translational Muscle Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	This work received financial support from: Medical Research Council (MRC, UK) (BP)(www.mrc.ac.uk); Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases (BP, PFC) (http://www.ncl.ac.uk/biomedicine/research/brc); Medical Research Council (MRC, UK) Centre for Translational Muscle Disease (PFC); Wellcome Trust (084980/Z/08/Z & 096919Z/11/Z, PFC) (www.wellcome.ac.uk); Medical Research Council (MRC, UK) (G1100160, KGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/01.QAI.0000017962.22053.0E, 10.1097/00126334-200207010-00002]; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Hoschele D, 2006, TOXICOL IN VITRO, V20, P535, DOI 10.1016/j.tiv.2005.11.007; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Jeneson JAL, 1996, J BIOL CHEM, V271, P27995, DOI 10.1074/jbc.271.45.27995; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Payne BAI, 2013, HIV MED, V14, P247, DOI 10.1111/j.1468-1293.2012.01050.x; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484; Yu-Wai-Man P, 2011, BRAIN, V134, DOI 10.1093/brain/awq288	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84678	10.1371/journal.pone.0084678	http://dx.doi.org/10.1371/journal.pone.0084678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409305	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500029
J	Zhang, XJ; Li, YH; Romeis, J; Yin, XM; Wu, KM; Peng, YF				Zhang, Xiaojie; Li, Yunhe; Romeis, Joerg; Yin, Xinming; Wu, Kongming; Peng, Yufa			Use of a Pollen-Based Diet to Expose the Ladybird Beetle Propylea japonica to Insecticidal Proteins	PLOS ONE			English	Article							COLEOMEGILLA-MACULATA COLEOPTERA; TRANSGENIC CORN POLLEN; RISK-ASSESSMENT; NONTARGET ARTHROPODS; BORER LEPIDOPTERA; ADALIA-BIPUNCTATA; RICE POLLEN; BT MAIZE; COCCINELLIDAE; CRY1AB	A rape seed pollen-based diet was developed and found to be suitable for use in a dietary exposure assay for Propylea japonica. Using the diet, we established and validated a dietary exposure assay by using the protease inhibitor E-64 as positive control. Dose-dependent responses were documented for all observed life-table parameters of P. japonica including survival, pupation and eclosion rates, development time and adult weight. Results suggested that the dietary assay can detect the effects of insecticidal compounds on the survival and development of P. japonica. Using the established dietary assay, we subsequently tested the toxicity of Cry1Ab, Cry1Ac and Cry1F proteins that are expressed by transgenic maize, cotton or rice plants to P. japonica larvae. The diet containing E-64 was included as a positive control. Survival and development of P. japonica larvae were not adversely affected when the diet contained purified Cry1Ab, Cry1Ac, or Cry1F at 500 mg/g diet representing a worst-case exposure scenario. In contrast, P. japonica larvae were adversely affected when the diet contained E-64. The bioactivity and stability of the Cry proteins in the diet and Cry protein uptake by the ladybird larvae were confirmed by bioassay with a Cry-sensitive insect species and by ELISA. The current study describes a suitable experimental system for assessing the potential effects of gut-active insecticidal compounds on ladybird beetle larvae. The experiments with the Cry proteins demonstrate that P. japonica larvae are not sensitive to Cry1Ab, Cry1Ac and Cry1F.	[Zhang, Xiaojie; Yin, Xinming] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Zhang, Xiaojie; Li, Yunhe; Romeis, Joerg; Wu, Kongming; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] ISS, Agroscope, Zurich, Switzerland	Henan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope	Li, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yunhe.li@hotmail.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of PRC [2013ZX08011-001]	National GMO New Variety Breeding Program of PRC	The study was supported by the National GMO New Variety Breeding Program of PRC (2013ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Alvarez-Alfageme F, 2012, ENVIRON ENTOMOL, V41, P1687, DOI 10.1603/EN12032; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; CERA, 2013, REV ENV SAF CRY1F PR; Dhillon MK, 2009, BIOCONTROL SCI TECHN, V19, P407, DOI 10.1080/09583150902783801; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutra CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044867; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Garcia-Alonso M, 2014, TRANSGENIC RES, V23, P945, DOI 10.1007/s11248-013-9760-1; Han LZ, 2012, ANN ENTOMOL SOC AM, V105, P253, DOI 10.1603/AN10170; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; Huang FN, 2006, J ECON ENTOMOL, V99, P194, DOI 10.1603/0022-0493(2006)099[0194:CSOECB]2.0.CO;2; Li KS, 1992, SHANXI FOREST SCI TE, V2, P84; Li Y., 2011, P IEEE INT S ASS MAN, V1, P1, DOI DOI 10.1080/21573727.2011.601453; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Marcon PCRG, 1999, J ECON ENTOMOL, V92, P279, DOI 10.1093/jee/92.2.279; Mc Lean Morven, 2011, Environmental Biosafety Research, V10, P51, DOI [10.1051/ebr/2012003, 10.1051/ebr:2012003]; Moser SE, 2008, ENVIRON ENTOMOL, V37, P525, DOI 10.1603/0046-225X(2008)37[525:LFOBHA]2.0.CO;2; Nakasu EYT, 2013, ENTOMOL EXP APPL, V148, P105, DOI 10.1111/eea.12082; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Perry JN, 2013, ECOL MODEL, V268, P103, DOI 10.1016/j.ecolmodel.2013.08.004; Porcar M, 2010, B ENTOMOL RES, V100, P297, DOI 10.1017/S0007485309990290; Rauschen S, 2010, TRANSGENIC RES, V19, P13, DOI 10.1007/s11248-009-9301-0; Raybould A, 2013, TRANSGENIC RES, V22, P445, DOI 10.1007/s11248-012-9658-3; Ricroch A, 2010, TRANSGENIC RES, V19, P1, DOI 10.1007/s11248-009-9297-5; Romeis J, 2011, J APPL ENTOMOL, V135, P1, DOI 10.1111/j.1439-0418.2010.01546.x; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, NAT BIOTECHNOL, V31, P386, DOI 10.1038/nbt.2578; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis Joerg, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-18; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rose R., 2007, WHITE PAPER TIER BAS; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; Schmidt JEU, 2009, ARCH ENVIRON CON TOX, V56, P221, DOI 10.1007/s00244-008-9191-9; Song H., 1988, Natural Enemies of Insects, V10, P22; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Yang J. H., 1983, Insect Knowledge (Kunchong Zhishi), V20, P215; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x; Zhang Gui-Fen, 2004, Acta Entomologica Sinica, V47, P334; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zhang SY, 2006, J APPL ENTOMOL, V130, P206, DOI 10.1111/j.1439-0418.2006.01049.x; Zhou K., 1987, Natural Enemies of Insects, V9, P17; Zou Y. D., 1986, Insect Knowledge, V23, P219	54	27	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85395	10.1371/journal.pone.0085395	http://dx.doi.org/10.1371/journal.pone.0085395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409328	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500052
J	Li, M; Hotaling, NA; Ku, DN; Forest, CR				Li, Melissa; Hotaling, Nathan A.; Ku, David N.; Forest, Craig R.			Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses	PLOS ONE			English	Article							VARIABLE PLATELET RESPONSE; VON-WILLEBRAND-FACTOR; FLOW-CHAMBER SYSTEM; ASPIRIN RESISTANCE; BLOOD-FLOW; MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA; FUNCTION TESTS; EPTIFIBATIDE; CLOPIDOGREL	The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and resistance are poorly understood, leading to potential incorrect and ineffective dosing. Shear rate is also suspected to play a major role in thrombosis, but instrumentation to measure its influence has been limited by flow conditions, agonist use, and non-systematic and/or non-quantitative studies. In this work we measured occlusion times and thrombus detachment for a range of initial shear rates (500, 1500, 4000, and 10000 s(-1)) and therapy concentrations (0-2.4 mu M for eptifibatide, 0-2 mM for acetyl-salicylic acid (ASA), 3.5-40 Units/L for heparin) using a microfluidic device. We also measured complete blood counts (CBC) and platelet activity using whole blood impedance aggregometry. Effects of shear rate and dose were analyzed using general linear models, logistic regressions, and Cox proportional hazards models. Shear rates have significant effects on thrombosis/dose-response curves for all tested therapies. ASA has little effect on high shear occlusion times, even at very high doses (up to 20 times the recommended dose). Under ASA therapy, thrombi formed at high shear rates were 4 times more prone to detachment compared to those formed under control conditions. Eptifibatide reduced occlusion when controlling for shear rate and its efficacy increased with dose concentration. In contrast, the hazard of occlusion from ASA was several orders of magnitude higher than that of eptifibatide. Our results show similar dose efficacy to our low shear measurements using whole blood aggregometry. This quantitative and statistically validated study of the effects of a wide range of shear rate and antiplatelet therapy doses on occlusive thrombosis contributes to more accurate understanding of thrombosis and to models for optimizing patient treatment.	[Li, Melissa; Hotaling, Nathan A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ku, David N.; Forest, Craig R.] Georgia Inst Technol, George W Woodruff Dept Mech Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Li, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	melli@uw.edu	Ku, David N./X-5216-2019; Hotaling, Nathan/F-2763-2014	Ku, David N./0000-0002-6034-8004; Hotaling, Nathan/0000-0001-8423-6464	Wallace H. Coulter Foundation; Georgia Institute of Technology	Wallace H. Coulter Foundation; Georgia Institute of Technology	This study was made possible by the American Heart Association (10GRNT4430029), the Wallace H. Coulter Foundation Translational Grant, and by a fellowship from the Technological Innovation Generating Economic Results (TI:GER) program at the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Barstad RM, 1996, THROMB HAEMOSTASIS, V75, P827; BARSTAD RM, 1994, ARTERIOSCLER THROMB, V14, P1984, DOI 10.1161/01.ATV.14.12.1984; Bernardo A, 2004, J THROMB HAEMOST, V2, P660, DOI 10.1111/j.1538-7836.2004.00661.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Colace TV, 2012, ARTERIOSCL THROM VAS, V32, P1466, DOI 10.1161/ATVBAHA.112.249789; Conant Carolyn G, 2009, J Vis Exp, DOI 10.3791/1644; Dalby M, 2004, J AM COLL CARDIOL, V43, P162, DOI 10.1016/j.jacc.2003.08.033; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; Eikelboom JW, 2003, J AM COLL CARDIOL, V41, P966, DOI 10.1016/S0735-1097(02)03013-9; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Goto S, 2003, J THROMB HAEMOST, V1, P2022, DOI 10.1046/j.1538-7836.2003.00349.x; Grosser T., 2012, CIRCULATION; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Gutierrez E, 2008, LAB CHIP, V8, P1486, DOI 10.1039/b804795b; Hanson SR, 1998, AM HEART J, V135, pS132, DOI 10.1016/S0002-8703(98)70241-8; Hofer CK, 2010, EXPERT REV MED DEVIC, V7, P625, DOI [10.1586/erd.10.29, 10.1586/ERD.10.29]; Hosokawa K, 2011, J THROMB HAEMOST, V9, P2029, DOI 10.1111/j.1538-7836.2011.04464.x; Hosokawa K, 2012, MICROVASC RES, V83, P154, DOI 10.1016/j.mvr.2011.11.007; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026437; Kottke-Marchant K, 1999, CLIN APPL THROMB-HEM, V5, P122, DOI 10.1177/107602969900500209; Li M, 2011, P 15 INT C MIN CHEM, P541; Li M, 2012, LAB CHIP, V12, P1355, DOI 10.1039/c2lc21145a; Li RZ, 2013, CLIN CHEM, V59, P1195, DOI 10.1373/clinchem.2012.198101; Looney MR, 2009, J CLIN INVEST; Lordkipanidze M, 2007, EUR HEART J, V28, P1702, DOI 10.1093/eurheartj/ehm226; Lucitt MB, 2013, ANAL BIOANAL CHEM, V405, P4823, DOI 10.1007/s00216-013-6897-y; Magallon J, 2011, CIRCULATION, V123, P319, DOI 10.1161/CIRCULATIONAHA.110.951970; Maree AO, 2007, CIRCULATION, V115, P2196, DOI 10.1161/CIRCULATIONAHA.106.675991; Mendolicchio GL, 2011, J THROMB HAEMOST, V9, P373, DOI 10.1111/j.1538-7836.2010.04144.x; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; Millenium Pharmaceuticals Inc. Merck and Co. Inc., 2011, INT EPT INJ INTR ADM; Mueller MR, 1997, THROMB HAEMOSTASIS, V78, P1003; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Neeves KB, 2008, LAB CHIP, V8, P701, DOI 10.1039/b717824g; Neeves KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054680; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Neumann FJ, 2001, J AM COLL CARDIOL, V37, P1323, DOI 10.1016/S0735-1097(01)01165-2; Para A, 2011, ANN BIOMED ENG, V39, P1961, DOI 10.1007/s10439-011-0296-3; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; ROALD HE, 1994, ARTERIOSCLER THROMB, V14, P617, DOI 10.1161/01.ATV.14.4.617; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Sodemann A, 2009, P ANN M AM SOC PREC, P4; Storey RF, 1998, CIRCULATION, V98, P1616, DOI 10.1161/01.CIR.98.16.1616; Topol E, 1998, NEW ENGL J MED, V339, P436; Tovar-Lopez FJ, 2010, LAB CHIP, V10, P291, DOI 10.1039/b916757a; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; TURNER NA, 1995, CIRCULATION, V91, P1354, DOI 10.1161/01.CIR.91.5.1354; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Zhao R, 2007, BIORHEOLOGY, V44, P161; Zwaginga JJ, 2006, J THROMB HAEMOST, V4, P2716, DOI 10.1111/j.1538-7836.2006.02178.x	60	57	60	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82493	10.1371/journal.pone.0082493	http://dx.doi.org/10.1371/journal.pone.0082493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404131	Green Published, Green Submitted			2022-12-25	WOS:000329460800010
J	Ludecke, C; Jandt, KD; Siegismund, D; Kujau, MJ; Zang, E; Rettenmayr, M; Bossert, J; Roth, M				Luedecke, Claudia; Jandt, Klaus D.; Siegismund, Daniel; Kujau, Marian J.; Zang, Emerson; Rettenmayr, Markus; Bossert, Joerg; Roth, Martin			Reproducible Biofilm Cultivation of Chemostat-Grown Escherichia coli and Investigation of Bacterial Adhesion on Biomaterials Using a Non-Constant-Depth Film Fermenter	PLOS ONE			English	Article							TITANIUM THIN-FILMS; SURFACE-ROUGHNESS; MICROBIAL ADHESION; QUANTIFICATION; TOPOGRAPHY; ATTACHMENT; SOFTWARE; CULTURE; PROTEIN; IMPACT	Biomaterials-associated infections are primarily initiated by the adhesion of microorganisms on the biomaterial surfaces and subsequent biofilm formation. Understanding the fundamental microbial adhesion mechanisms and biofilm development is crucial for developing strategies to prevent such infections. Suitable in vitro systems for biofilm cultivation and bacterial adhesion at controllable, constant and reproducible conditions are indispensable. This study aimed (i) to modify the previously described constant-depth film fermenter for the reproducible cultivation of biofilms at non-depth-restricted, constant and low shear conditions and (ii) to use this system to elucidate bacterial adhesion kinetics on different biomaterials, focusing on biomaterials surface nanoroughness and hydrophobicity. Chemostat-grown Escherichia coli were used for biofilm cultivation on titanium oxide and investigating bacterial adhesion over time on titanium oxide, poly(styrene), poly(tetrafluoroethylene) and glass. Using chemostat-grown microbial cells (single-species continuous culture) minimized variations between the biofilms cultivated during different experimental runs. Bacterial adhesion on biomaterials comprised an initial lag-phase I followed by a fast adhesion phase II and a phase of saturation III. With increasing biomaterials surface nanoroughness and increasing hydrophobicity, adhesion rates increased during phases I and II. The influence of materials surface hydrophobicity seemed to exceed that of nanoroughness during the lag-phase I, whereas it was vice versa during adhesion phase II. This study introduces the non-constant-depth film fermenter in combination with a chemostat culture to allow for a controlled approach to reproducibly cultivate biofilms and to investigate bacterial adhesion kinetics at constant and low shear conditions. The findings will support developing and adequate testing of biomaterials surface modifications eventually preventing biomaterial-associated infections.	[Luedecke, Claudia; Kujau, Marian J.; Zang, Emerson; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Luedecke, Claudia; Jandt, Klaus D.; Bossert, Joerg] Univ Jena, Fac Phys & Astron, Chair Mat Sci, D-07743 Jena, Germany; [Siegismund, Daniel; Rettenmayr, Markus] Univ Jena, Dept Metall Mat, Otto Schott Inst Mat Res OSIM, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Jandt, KD (corresponding author), Univ Jena, Fac Phys & Astron, Chair Mat Sci, Max Wien Pl 1, D-07743 Jena, Germany.	k.jandt@uni-jena.de; martin.roth@hki-jena.de	Jandt, Klaus D./C-8077-2016	Jandt, Klaus D./0000-0002-7537-5603	Excellence Graduate School "Jena School for Microbial Communication"; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK); German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) [INST 275/241-1 FUGG]; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK) [62-4264 925/1/10/1/01]	Excellence Graduate School "Jena School for Microbial Communication"; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK); German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK)	This work was supported by the Excellence Graduate School "Jena School for Microbial Communication" (JSMC MikroInter supported by the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK) which is funded by the German Excellence Initiative. KDJ gratefully acknowledges, furthermore, the partial financial support of the Deutsche Forschungsgemeinschaft (DFG), grant reference INST 275/241-1 FUGG, and of the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK), grant reference 62-4264 925/1/10/1/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0; Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Boland T., 2000, HDB BACTERIAL ADHESI, P29; Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4; BUCKINGHAMMEYER K, 2003, BIOFILM LAB STEP BY, P31; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013; Chen MY, 2010, BIOCHEM ENG J, V53, P121, DOI 10.1016/j.bej.2010.10.003; Christensen G.D., HDB BACTERIAL ADHESI, V1st ed., P213; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; GILBERT P, 1991, J ANTIMICROB CHEMOTH, V27, P550, DOI 10.1093/jac/27.4.550; Goeres, 2003, BIOFILM LAB STEP BY, P13; Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; Hoffmann AS, 2004, INTRO MAT MED, P197; Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014; Hope CK, 2012, J APPL MICROBIOL, V113, P601, DOI 10.1111/j.1365-2672.2012.05368.x; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c; JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kinniment SL, 1996, J APPL BACTERIOL, V81, P120, DOI 10.1111/j.1365-2672.1996.tb04488.x; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; LIN FYH, 1993, J COLLOID INTERF SCI, V159, P86, DOI 10.1006/jcis.1993.1300; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2; McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x; MCCOY WF, 1981, CAN J MICROBIOL, V27, P910, DOI 10.1139/m81-143; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Noimark S, 2009, CHEM SOC REV, V38, P3435, DOI 10.1039/b908260c; Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e; PETERS AC, 1988, BIOTECHNOL BIOENG, V32, P263, DOI 10.1002/bit.260320302; Peterson BW, 2012, APPL ENVIRON MICROB, V78, P120, DOI 10.1128/AEM.06780-11; Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020; Pratten Jonathan, 2007, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b05s6; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016; Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727; Stewart PS, 2001, J APPL MICROBIOL, V91, P525, DOI 10.1046/j.1365-2672.2001.01413.x; Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Webb HK, 2013, BIOFOULING, V29, P163, DOI 10.1080/08927014.2012.757697; Webb HK, 2012, SCANNING, V34, P257, DOI 10.1002/sca.21002; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001; Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232	59	32	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84837	10.1371/journal.pone.0084837	http://dx.doi.org/10.1371/journal.pone.0084837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404192	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800071
J	Kedracka-Krok, S; Jankowska, U; Elas, M; Sowa, U; Swakon, J; Cierniak, A; Olko, P; Romanowska-Dixon, B; Urbanska, K				Kedracka-Krok, Sylwia; Jankowska, Urszula; Elas, Martyna; Sowa, Urszula; Swakon, Jan; Cierniak, Agnieszka; Olko, Pawel; Romanowska-Dixon, Bozena; Urbanska, Krystyna			Proteomic Analysis of Proton Beam Irradiated Human Melanoma Cells	PLOS ONE			English	Article							MAJOR VAULT PROTEIN; RECEPTOR-ASSOCIATED PROTEIN; CHINESE-HAMSTER CELLS; STRESS GRANULES; PROSTATE-CANCER; TGF-BETA; UVEAL MELANOMA; LAMIN A/C; RADIATION; APOPTOSIS	Proton beam irradiation is a form of advanced radiotherapy providing superior distributions of a low LET radiation dose relative to that of photon therapy for the treatment of cancer. Even though this clinical treatment has been developing for several decades, the proton radiobiology critical to the optimization of proton radiotherapy is far from being understood. Proteomic changes were analyzed in human melanoma cells treated with a sublethal dose (3 Gy) of proton beam irradiation. The results were compared with untreated cells. Two-dimensional electrophoresis was performed with mass spectrometry to identify the proteins. At the dose of 3 Gy a minimal slowdown in proliferation rate was seen, as well as some DNA damage. After allowing time for damage repair, the proteomic analysis was performed. In total 17 protein levels were found to significantly (more than 1.5 times) change: 4 downregulated and 13 upregulated. Functionally, they represent four categories: (i) DNA repair and RNA regulation (VCP, MVP, STRAP, FAB-2, Lamine A/C, GAPDH), (ii) cell survival and stress response (STRAP, MCM7, Annexin 7, MVP, Caprin-1, PDCD6, VCP, HSP70), (iii) cell metabolism (TIM, GAPDH, VCP), and (iv) cytoskeleton and motility (Moesin, Actinin 4, FAB-2, Vimentin, Annexin 7, Lamine A/C, Lamine B). A substantial decrease (2.3 x) was seen in the level of vimentin, a marker of epithelial to mesenchymal transition and the metastatic properties of melanoma.	[Kedracka-Krok, Sylwia; Jankowska, Urszula; Elas, Martyna; Cierniak, Agnieszka; Urbanska, Krystyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sowa, Urszula; Swakon, Jan; Olko, Pawel] PAS, Inst Nucl Phys, Krakow, Poland; [Romanowska-Dixon, Bozena] Jagiellonian Univ, Coll Med, Dept Ophthalmol & Ophthalm Oncol, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula] Malopolska Ctr Biotechnol, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University	Elas, M (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	martyna.elas@uj.edu.pl	Jankowska, Urszula/C-4898-2015; Olko, Pawel/AAM-4279-2021; Swakoń, Jan/M-5808-2018; Olko, Pawel/V-9030-2018; Elas, Martyna/E-3584-2017; Cierniak, Agnieszka/O-3139-2019; Sowa, Urszula/N-7162-2018	Jankowska, Urszula/0000-0002-7165-8964; Olko, Pawel/0000-0001-5554-8178; Swakoń, Jan/0000-0001-9262-7326; Olko, Pawel/0000-0001-5554-8178; Elas, Martyna/0000-0001-6296-2844; Cierniak, Agnieszka/0000-0001-6537-2954; Sowa, Urszula/0000-0002-0619-4358; Urbanska, Krystyna/0000-0001-9643-4740	European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program [POIG.02.01.00-12-167/08]	European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program	The MS measurements were performed using the spectrometer MicroTOF purchased by the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-167/08, project Malopolska Center of Biotechnology, http://www.poig.gov.pl/english/Strony/Introduction. aspx), supported by grant Nr 2023/B/P01/2010/39 (K/PBW/000676) from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/en/), and by grants UMO-2012/05/B/NZ4/02428 (K/PBO/000134) and 012/07/B/NZ4/01657 from the National Science Center, Krakow, Poland (http://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, EXP CELL RES, V319, P1, DOI 10.1016/j.yexcr.2012.09.003; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Atkinson MJ, 2013, ADV EXP MED BIOL, V990, P49, DOI 10.1007/978-94-007-5896-4_3; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; BENZEEV A, 1985, CANCER RES, V45, P2632; Berardi MJ, 2011, CURR OPIN GENET DEV, V21, P59, DOI 10.1016/j.gde.2010.10.001; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Calugaru V, 2011, INT J RADIAT ONCOL, V81, P1136, DOI 10.1016/j.ijrobp.2010.09.003; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Cukier CD, 2010, NAT STRUCT MOL BIOL, V17, P1058, DOI 10.1038/nsmb.1883; Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Fernandez-Flores A, 2012, ROM J MORPHOL EMBRYO, V53, P449; Finnberg N, 2008, CANCER BIOL THER, V7, P2023, DOI 10.4161/cbt.7.12.7417; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Formentini L, 2010, IUBMB LIFE, V62, P554, DOI 10.1002/iub.352; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Ghosh S, 2010, CANCER INVEST, V28, P615, DOI 10.3109/07357901003630991; Girdhani S., 2013, RADIAT RES, V179, P1; Gridley DS, 2011, INT J RADIAT BIOL, V87, P1173, DOI 10.3109/09553002.2011.624393; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Helfand BT, 2012, J PATHOL, V226, P735, DOI 10.1002/path.3033; Hofmann UB, 2000, J INVEST DERMATOL, V2; Huang SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004430; Ianzini F, 1999, INT J RADIAT BIOL, V75, P717, DOI 10.1080/095530099140050; Ibanez IL, 2009, INT J RADIAT ONCOL, V74, P1226, DOI 10.1016/j.ijrobp.2009.02.070; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Ivaska Johanna, 2011, Small GTPases, V2, P51; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Koricanac L, 2007, RUSS J PHYS CHEM A+, V81, P1467, DOI 10.1134/S0036024407090233; Koricanac LB, 2010, CHEMOTHERAPY, V56, P214, DOI 10.1159/000316333; Lara PC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-148; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lee KB, 2008, EXP MOL MED, V40, P118, DOI 10.3858/emm.2008.40.1.118; Lee KB, 2008, INT J ONCOL, V33, P1247, DOI 10.3892/ijo_00000115; Leloup C, 2005, INT J RADIAT BIOL, V81, P41, DOI 10.1080/09553000400017895; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Linge A, 2012, INVEST OPHTH VIS SCI, V53, P4634, DOI 10.1167/iovs.11-9019; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Lloret M, 2009, INT J RADIAT ONCOL, V73, P976, DOI 10.1016/j.ijrobp.2008.11.013; LOCKSHIN A, 1985, CANCER RES, V45, P345; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Malz M, 2009, HEPATOLOGY, V50, P1130, DOI 10.1002/hep.23051; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meir T, 2007, INVEST OPHTH VIS SCI, V48, P4890, DOI 10.1167/iovs.07-0215; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Mukherjee P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005462; Ogata T, 2005, CANCER RES, V65, P113; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Pardo M, 2005, PROTEOMICS, V5, P4980, DOI 10.1002/pmic.200500030; Park SH, 2012, CELL SIGNAL, V24, P726, DOI 10.1016/j.cellsig.2011.11.006; Petrovic I, 2006, INT J RADIAT BIOL, V82, P251, DOI 10.1080/09553000600669859; Petrovic I, 2010, INT J RADIAT BIOL, V86, P742, DOI 10.3109/09553002.2010.481322; Petrovic IM, 2007, ANN NY ACAD SCI, V1095, P154, DOI 10.1196/annals.1397.019; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Reiner JE, 2011, FRONT BIOSCI-LANDMRK, V16, P105, DOI 10.2741/3678; Rho SB, 2012, CELL SIGNAL, V24, P131, DOI 10.1016/j.cellsig.2011.08.013; Ristic-Fira A, 2004, ONCOL REP, V12, P1323; Ristic-Fira A, 2001, J EXP CLIN CANC RES, V20, P135; Ristic-Fira AM, 2007, ANN NY ACAD SCI, V1095, P165, DOI 10.1196/annals.1397.020; Ristic-Fira AM, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-50; Ristic-Fira AM, 2008, PHYS MEDICA, V24, P187, DOI 10.1016/j.ejmp.2008.04.002; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Rodriguez-Cerdeira Carmen, 2011, Open Biochem J, V5, P60, DOI 10.2174/1874091X01105010060; Saffari M, 2009, CANCER LETT, V273, P316, DOI 10.1016/j.canlet.2008.08.020; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2011, J BIOL CHEM, V286, P7439, DOI 10.1074/jbc.M110.184382; Sgura A, 2000, INT J RADIAT BIOL, V76, P367, DOI 10.1080/095530000138709; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Shimamoto Y, 2006, ONCOL REP, V15, P645; Silva P, 2007, INT J RADIAT ONCOL, V69, P133, DOI 10.1016/j.ijrobp.2007.02.025; SINGH NP, 1994, INT J RADIAT BIOL, V66, P23, DOI 10.1080/09553009414550911; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Sun MZ, 2009, PROTEOMICS, V9, P3285, DOI 10.1002/pmic.200701002; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Todorovic D, 2008, J MICROSC-OXFORD, V232, P517, DOI 10.1111/j.1365-2818.2008.02151.x; Torosyan Y, 2009, INT J CANCER, V125, P2528, DOI 10.1002/ijc.24592; Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Wloga D, 2011, J CELL SCI, V124, P154, DOI 10.1242/jcs.083576; Wu Y, 2002, ONCOGENE, V21, P6801, DOI 10.1038/sj.onc.1205849; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Zhou YM, 2012, LIVER INT, V32, P1505, DOI 10.1111/j.1478-3231.2012.02846.x	106	19	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84621	10.1371/journal.pone.0084621	http://dx.doi.org/10.1371/journal.pone.0084621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392146	gold, Green Published			2022-12-25	WOS:000329460100069
J	Roach, KM; Duffy, SM; Coward, W; Feghali-Bostwick, C; Wulff, H; Bradding, P				Roach, Katy Morgan; Duffy, Stephen Mark; Coward, William; Feghali-Bostwick, Carol; Wulff, Heike; Bradding, Peter			The K+ Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; EXTRACELLULAR-MATRIX; CELL PROLIFERATION; UP-REGULATION; LUNG; FIBROBLASTS; GROWTH; 1-ETHYL-2-BENZIMIDAZOLINONE; DIFFERENTIATION; MYOFIBROBLASTS	Background: Idiopathic pulmonary fibrosis (IPF) is a common, progressive and invariably lethal interstitial lung disease with no effective therapy. We hypothesised that K(Ca)3.1 K+ channel-dependent cell processes contribute to IPF pathophysiology. Methods: K(Ca)3.1 expression in primary human lung myofibroblasts was examined using RT-PCR, western blot, immunofluorescence and patch-clamp electrophysiology. The role of K(Ca)3.1 channels in myofibroblast proliferation, wound healing, collagen secretion and contraction was examined using two specific and distinct K(Ca)3.1 blockers (TRAM-34 and ICA-17043 [Senicapoc]). Results: Both healthy non fibrotic control and IPF-derived human lung myofibroblasts expressed K(Ca)3.1 channel mRNA and protein. K(Ca)3.1 ion currents were elicited more frequently and were larger in IPF-derived myofibroblasts compared to controls. K(Ca)3.1 currents were increased in myofibroblasts by TGF beta 1 and basic FGF. K(Ca)3.1 was expressed strongly in IPF tissue. K(Ca)3.1 pharmacological blockade attenuated human myofibroblast proliferation, wound healing, collagen secretion and contractility in vitro, and this was associated with inhibition of TGF beta 1-dependent increases in intracellular free Ca2+. Conclusions: K(Ca)3.1 activity promotes pro-fibrotic human lung myofibroblast function. Blocking K(Ca)3.1 may offer a novel approach to treating IPF with the potential for rapid translation to the clinic.	[Roach, Katy Morgan; Duffy, Stephen Mark; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Coward, William] Univ Nottingham, Div Resp Med, Ctr Resp Res, Nottingham NG7 2RD, England; [Coward, William] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Leicester; University of Nottingham; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Bradding, P (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	pbradding@hotmail.com	wulff, Heike/Z-2056-2019	Bradding, Peter/0000-0001-8403-0319; Roach, Katy M/0000-0002-4825-8719	College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom; Dunhill Medical Trust [R270/1112]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; National Institute of Health [RO1 GM076063]; The Dunhill Medical Trust [R270/1112] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER	College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom; Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Dunhill Medical Trust(Dunhill Medical Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Katy Roach was supported by a PhD Studentship from the College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom, and project grant R270/1112 from Dunhill Medical Trust. The work was also supported in part by supported by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. HW was supported by RO1 GM076063 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Bi D, 2013, J BIOL CHEM, V288, P15843, DOI 10.1074/jbc.M112.427187; Chen MX, 2004, N-S ARCH PHARMACOL, V369, P602, DOI 10.1007/s00210-004-0934-5; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Keira Sidney Mamoru, 2004, Acta Cir. Bras., V19, P11, DOI 10.1590/S0102-86502004000700004; Koegel H, 2003, J BIOL CHEM, V278, P3323, DOI 10.1074/jbc.M208914200; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; RAGHU G, 1989, AM REV RESPIR DIS, V140, P95, DOI 10.1164/ajrccm/140.1.95; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Strieter RM, 2005, CHEST, V128, p526S, DOI 10.1378/chest.128.5_suppl_1.526S; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Zhou X, 2011, AM J RESP CELL MOL B	40	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85244	10.1371/journal.pone.0085244	http://dx.doi.org/10.1371/journal.pone.0085244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392001	Green Accepted, Green Published, gold			2022-12-25	WOS:000329323900144
J	Smith, TJS; Rubenstein, LS; Nachman, KE				Smith, Tyler J. S.; Rubenstein, Leonard S.; Nachman, Keeve E.			Availability of Information about Airborne Hazardous Releases from Animal Feeding Operations	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; QUALITY-OF-LIFE; NEIGHBORING RESIDENTS; HEALTH; AMMONIA; EXPOSURE; ODORS; HOMES	Introduction: Air from animal feeding operations (AFOs) has been shown to transport numerous contaminants of public health concern. While federal statutes like the Emergency Planning and Community Right-to-Know Act (EPCRA) generally require that facilities report hazardous releases, AFOs have been exempted from most of these requirements by the U. S. Environmental Protection Agency (EPA). We assessed the availability of information about AFO airborne hazardous releases following these exemptions. Methods: We submitted public records requests to 7 states overlapping with or adjacent to the Chesapeake Bay watershed for reports of hazardous releases made by AFOs under EPCRA. From the records received, we calculated the proportion of AFOs in each state for which >= 1 reports were available. We also determined the availability of specific types of information required under EPCRA. The numbers of AFOs permitted under the Clean Water Act (CWA) or analogous state laws, as determined from permitting databases obtained from states, were used as denominators. Results: We received both EPCRA reports and permitting databases from 4 of 7 states. Across these 4 states, the mean proportion of AFOs for which >= 1 EPCRA reports were available was 15% (range: 2-33%). The mean proportions of AFOs for which the name or identity of the substance released, >= 1 estimates of quantity released, and information about nearby population density and sensitive populations were available were 15% (range: 2-33%), 8% (range: 0-22%), and 14% (range: 2-8%), respectively. Discussion: These results suggest that information about the airborne hazardous releases of a large majority of AFOs is not available under federal law in the states that we investigated. While the results cannot be attributed to specific factors by this method, attention to multiple factors, including revision of the EPA's exemptions, may increase the availability of information relevant to the health of populations living or working near AFOs.	[Smith, Tyler J. S.; Rubenstein, Leonard S.; Nachman, Keeve E.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA; [Smith, Tyler J. S.; Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Rubenstein, Leonard S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA.	knachman@jhsph.edu		Smith, Tyler/0000-0003-4692-2206; Nachman, Keeve/0000-0003-4925-4151	Johns Hopkins Center for a Livable Future	Johns Hopkins Center for a Livable Future	The study was funded by a Directed Research grant from the Johns Hopkins Center for a Livable Future. The Center (aside from TJSS and KEN, who are both authors and CLF staff members) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja VP, 2009, ENVIRON SCI TECHNOL, V43, P4234, DOI 10.1021/es8024403; Assardourian E, 2004, STAT WORLD 2004 WORL; Blunden J, 2008, ATMOS ENVIRON, V42, P3315, DOI 10.1016/j.atmosenv.2007.06.040; Bullers S, 2005, HUM ECOL, V33, P1, DOI 10.1007/s10745-005-1653-3; Centner TJ, 2010, ENVIRON INT, V36, P237, DOI 10.1016/j.envint.2009.11.007; Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Copeland C, 2011, ANIMAL WASTE HAZARDO; DEMARCHI S, 2006, ASSESSING ACCURACY, V32, P57; Donham Kelley J, 2006, J Agromedicine, V11, P15, DOI 10.1300/J096v11n03_03; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Graham JP, 2010, J WATER HEALTH, V8, P646, DOI 10.2166/wh.2010.075; Heinzen T, 2008, NY U ENV LAW J, V17, P1482; Ko G, 2010, ENVIRON SCI TECHNOL, V44, P3442, DOI 10.1021/es9026024; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; National Chicken Council U.S. Poultry & Egg Association National Turkey Federation, PET EX EPCRA CERCLA; Radon K, 2004, ANN AGR ENV MED, V11, P59; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Thu K., 1997, Journal of Agricultural Safety and Health, V3, P13; US Department of Agriculture, 2007, CENS AGR STAT PROF N; US Environmental Protection Agency, CERCLA EPCRA ADM REP; US Environmental Protection Agency, SAB REV EMISSIONS LA; US Environmental Protection Agency, 1985, FED REGISTER, V50, P13456; US Environmental Protection Agency, 2007, FED REG, V72, P73700; US Environmental Protection Agency, 2012, FED REGISTER, V77, P42679; US Environmental Protection Agency, 2011, FED REGISTER, V76, P65431; US Environmental Protection Agency Agriculture, AIR MON; US Government Accountability Office, CONC AN FEED OP EPA; US National Research Council, 2002, AIR EM AN FEED OP CU; USEPA, 2008, FED REGISTER, V73, P76948; Williams DL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-72; Wilson SM, 2007, ATMOS ENVIRON, V41, P4977, DOI 10.1016/j.atmosenv.2006.12.055; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439; 2005, FED REG, V70, P4958	37	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85342	10.1371/journal.pone.0085342	http://dx.doi.org/10.1371/journal.pone.0085342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24400039	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900147
J	Xu, C; Fan, CD; Wang, X				Xu, C.; Fan, C. D.; Wang, X.			Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase	ONCOGENE			English	Article						Mdm2; p53; NEDD4-1; E3 ligases; degradation; ubiquitination	ACUTE LYMPHOBLASTIC-LEUKEMIA; UBIQUITIN LIGASE; NEGATIVE REGULATOR; PROMOTES; ACTIVATION; CANCER; INACTIVATION; DEGRADATION; ONCOPROTEIN; PATHWAY	Mdm2 is a critical negative regulator of the tumor suppressor protein p53. Mdm2 is an E3 ligase whose overexpression leads to functional inactivation of p53. Mdm2 protein stability is regulated by several mechanisms including RING (Really Interesting New Gene) domain-mediated autoubiquitination. Here we report biochemical identification of NEDD4-1 as an E3 ligase for Mdm2 that contributes to the regulation of Mdm2 protein stability in cells. NEDD4-1 was identified from Jurkat cytosolic fractions using an enzyme-dead Mdm2 mutant protein as a substrate for in vitro E3 ligase assays. We show that lysates from Nedd4-1 knockout (KO) mouse embryonic fibroblasts (MEFs) have significantly diminished E3 ligase activity toward Mdm2 compared with lysates from wildtype (WT) MEFs. Recombinant NEDD4-1 promotes Mdm2 ubiquitination in vitro in a concentration-and time-dependent manner. In cells, NEDD4-1 physically interacts with Mdm2 via the RING domain of Mdm2. Overexpression of NEDD4-1, but not an enzyme-dead NEDD4-1CS mutant, increases ubiquitination of Mdm2. NEDD4-1 catalyzes the formation of K63-type polyubiquitin chains on Mdm2 that are distinct from K48-type polyubiquitination chains mediated by the Mdm2/MdmX complex. Importantly, K63-type polyubiquitination by NEDD4-1 competes with K48-type polyubiquitination on Mdm2 in cells. As a result, NEDD4-1-mediated ubiquitination stabilizes Mdm2. NEDD4-1 knockdown reduces the t(1/2) (half-life) of endogenous Mdm2 from 20 to 12 min in U2OS cells. Nedd4-1 KO MEFs manifest increased p53 levels and activity, a more robust DNA damage response and increased G1 arrest compared with WT MEFs. Similarly, NEDD4-1 knockdown in WT-p53-bearing cells increases basal p53 levels and activity in an Mdm2-dependent manner, causes stronger p53 responses to DNA damage and results in p53-dependent growth inhibition compared with corresponding NEDD4-1-proficient control cells. This study identifies NEDD4-1 as a novel component of the p53/Mdm2 regulatory feedback loop that controls p53 activity during stress responses.	[Xu, C.; Fan, C. D.; Wang, X.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Wang, X (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton St, Buffalo, NY 14263 USA.	xinjiang.wang@roswellpark.org			Roswell Park Cancer Institute; Roswell Park Core Grant [CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute; Roswell Park Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by start-p funds from Roswell Park Cancer Institute (XW). The Roswell Park Core Grant CA16056 is also gratefully acknowledged. We sincerely thank Dr Baoli Yang for providing Nedd4-1 -/- and parental MEFs; Dr Yosef Shiloh and Dr Jiandong Chen and Dr Dirk P Bohmann for providing DNA constructs; Dr Moshe Oren for antibodies, Bert Vogelstein for providing HCT116-p53 -/- cells and Dr Gigi Lozano for p53/Mdm2 DKO MEFs, respectively. We also thank Dr David Goodrich and other faculty colleagues at the Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute for their critical reading of the manuscript.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Khor LY, 2009, J CLIN ONCOL, V27, P3177, DOI 10.1200/JCO.2008.19.8267; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUNA RMD, 1995, NATURE, V378, P203; Marks DI, 1996, BLOOD, V87, P1155, DOI 10.1182/blood.V87.3.1155.bloodjournal8731155; Mosesson Y, 2009, DEV CELL, V16, P687, DOI 10.1016/j.devcel.2009.03.015; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang X, J BIOL CHEM, V286, P23725; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wang ZW, 2012, ONCOTARGET, V3, P1026; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	30	47	48	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					342	350		10.1038/onc.2013.557	http://dx.doi.org/10.1038/onc.2013.557			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24413081				2022-12-25	WOS:000348145500008
J	Tourette, C; Li, B; Bell, R; O'Hare, S; Kaltenbach, LS; Mooney, SD; Hughes, RE				Tourette, Cendrine; Li, Biao; Bell, Russell; O'Hare, Shannon; Kaltenbach, Linda S.; Mooney, Sean D.; Hughes, Robert E.			A Large Scale Huntingtin Protein Interaction Network Implicates Rho GTPase Signaling Pathways in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Motility; Computational Biology; Huntington Disease; Neurodegeneration; Neurodegenerative Diseases; Protein-Protein Interactions; Proteomics; Rho GTPases	INSULIN-RECEPTOR SUBSTRATE; MUTANT HUNTINGTIN; GENE-EXPRESSION; HOMOLOGY DOMAIN; SPINY NEURONS; FF DOMAIN; WILD-TYPE; FILOPODIA; IRSP53; TOXICITY	Background: Huntington disease is a fatal neuropsychiatric disorder caused by aberrant protein folding and interactions. Results: An interaction network composed of primary and secondary huntingtin-interacting proteins is significantly enriched for pathways implicated in HD, including RhoGTPases. Conclusion: Huntingtin interacts with members of the Rho GTPase signaling pathways and regulates filipodial dynamics. Significance: This protein interaction network provides a resource for HD target discovery. Huntington disease (HD) is an inherited neurodegenerative disease caused by a CAG expansion in the HTT gene. Using yeast two-hybrid methods, we identified a large set of proteins that interact with huntingtin (HTT)-interacting proteins. This network, composed of HTT-interacting proteins (HIPs) and proteins interacting with these primary nodes, contains 3235 interactions among 2141 highly interconnected proteins. Analysis of functional annotations of these proteins indicates that primary and secondary HIPs are enriched in pathways implicated in HD, including mammalian target of rapamycin, Rho GTPase signaling, and oxidative stress response. To validate roles for HIPs in mutant HTT toxicity, we show that the Rho GTPase signaling components, BAIAP2, EZR, PIK3R1, PAK2, and RAC1, are modifiers of mutant HTT toxicity. We also demonstrate that Htt co-localizes with BAIAP2 in filopodia and that mutant HTT interferes with filopodial dynamics. These data indicate that HTT is involved directly in membrane dynamics, cell attachment, and motility. Furthermore, they implicate dysregulation in these pathways as pathological mechanisms in HD.	[Tourette, Cendrine; Li, Biao; O'Hare, Shannon; Mooney, Sean D.; Hughes, Robert E.] Buck Inst Res Aging, Novato, CA 94945 USA; [Bell, Russell; Kaltenbach, Linda S.] Prolexys Pharmaceut, Salt Lake City, UT 84116 USA; [Bell, Russell] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Kaltenbach, Linda S.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC 27704 USA; [Kaltenbach, Linda S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27704 USA	Buck Institute for Research on Aging; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Duke University; Duke University	Mooney, SD (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	smooney@buckinstitute.org; rhughes@buckinstitute.org	Tourette, Cendrine/U-2540-2017	MOONEY, SEAN D/0000-0003-2654-0833	National Institutes of Health [NS055247, GM084432, LM009722]; CHDI Foundation Inc.; National Center for Biomedical Ontology Grant [U54-HG004028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055247] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation Inc.; National Center for Biomedical Ontology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055247 and GM084432 (to R. E. H.). This work was also supported by a grant from CHDI Foundation Inc. (to R. E. H.).; Supported by National Institutes of Health Grant LM009722, National Center for Biomedical Ontology Grant U54-HG004028, and the CHDI Foundation Inc.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Borgonovo JE, 2013, EXP NEUROL, V241, P75, DOI 10.1016/j.expneurol.2012.11.025; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Chow WNV, 2012, BIOCHEM J, V443, P681, DOI 10.1042/BJ20112175; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Lee JY, 2012, ANN NY ACAD SCI, V1271, P68, DOI 10.1111/j.1749-6632.2012.06725.x; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marsick BM, 2012, CYTOSKELETON, V69, P496, DOI 10.1002/cm.21016; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Menna E, 2011, EUR J NEUROSCI, V34, P1655, DOI 10.1111/j.1460-9568.2011.07897.x; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; MORTON CJ, 1994, CURR BIOL, V4, P615, DOI 10.1016/S0960-9822(00)00134-2; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Neveklovska M, 2012, J HUNTINGTONS DIS, V1, P71, DOI 10.3233/JHD-2012-120016; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; RIVAS JD, 2010, PLOS COMPUT BIOL, V6; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Spillane M, 2012, J NEUROSCI, V32, P17671, DOI 10.1523/JNEUROSCI.1079-12.2012; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Thomas EA, 2001, NEUROSCI LETT, V309, P145, DOI 10.1016/S0304-3940(01)02064-X; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2006, HUM MOL GENET, V15, P3578, DOI 10.1093/hmg/ddl434; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1; Yu ZF, 2000, J MOL NEUROSCI, V15, P31, DOI 10.1385/JMN:15:1:31; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zheng SQ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-28; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	92	60	61	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6709	6726		10.1074/jbc.M113.523696	http://dx.doi.org/10.1074/jbc.M113.523696			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407293	hybrid, Green Published			2022-12-25	WOS:000332389400033
J	Cao, ZB; Subramaniam, S; Bulleid, NJ				Cao, Zhenbo; Subramaniam, Suraj; Bulleid, Neil J.			Lack of an Efficient Endoplasmic Reticulum-localized Recycling System Protects Peroxiredoxin IV from Hyperoxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Peroxiredoxin; Protein Isomerase; Thioredoxin; Thioredoxin Reductase	CYSTEINE-SULFINIC ACID; DISULFIDE BOND FORMATION; ACTIVE-SITE CYSTEINE; OXIDATIVE STRESS; 2-CYS PEROXIREDOXINS; SECRETORY PATHWAY; HYDROGEN-PEROXIDE; CELLS; INACTIVATION; REDUCTION	Background: Peroxiredoxin IV metabolizes endoplasmic reticulum-derived hydrogen peroxide. Results: In contrast to other peroxiredoxins, peroxiredoxin IV is insensitive to hyperoxidation within its cellular environment. Conclusion: There is a lack of a robust peroxiredoxin IV recycling system within the endoplasmic reticulum. Significance: Studying the reduction of peroxiredoxin IV highlights the different mechanisms for maintaining redox status within different cellular compartments. Typical 2-Cys peroxiredoxins are required to remove hydrogen peroxide from several different cellular compartments. Their activity can be regulated by hyperoxidation and consequent inactivation of the active-site peroxidatic cysteine. Here we developed a simple assay to quantify the hyperoxidation of peroxiredoxins. Hyperoxidation of peroxiredoxins can only occur efficiently in the presence of a recycling system, usually involving thioredoxin and thioredoxin reductase. We demonstrate that there is a marked difference in the sensitivity of the endoplasmic reticulum-localized peroxiredoxin to hyperoxidation compared with either the cytosolic or mitochondrial enzymes. Each enzyme is equally sensitive to hyperoxidation in the presence of a robust recycling system. Our results demonstrate that peroxiredoxin IV recycling in the endoplasmic reticulum is much less efficient than in the cytosol or mitochondria, leading to the protection of peroxiredoxin IV from hyperoxidation.	[Cao, Zhenbo; Subramaniam, Suraj; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [088053]; Scottish University Life Science Alliance (SULSA); BBSRC [BB/L00593X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L00593X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Science Alliance (SULSA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 088053 and by the Scottish University Life Science Alliance (SULSA).	Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Stacey MM, 2012, ANTIOXID REDOX SIGN, V17, P411, DOI 10.1089/ars.2011.4348; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	28	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5490	5498		10.1074/jbc.M113.529305	http://dx.doi.org/10.1074/jbc.M113.529305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403061	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000332015500013
J	Chung, HH; Sze, SK; Woo, ARE; Sun, Y; Sim, KH; Dong, XM; Lin, VCL				Chung, Hwa Hwa; Sze, Siu Kwan; Woo, Amanda Rui En; Sun, Yang; Sim, Kae Hwan; Dong, Xue Ming; Lin, Valerie C-L.			Lysine Methylation of Progesterone Receptor at Activation Function 1 Regulates both Ligand-independent Activity and Ligand Sensitivity of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Post-translational Modification; Protein Methylation; Steroid Hormone; Steroid Hormone Receptor; Transcription	BREAST-CANCER CELLS; ESTROGEN PLUS PROGESTIN; TRANSCRIPTIONAL ACTIVITY; ISOFORM-B; CO-REPRESSOR; CROSS-TALK; ALPHA; PHOSPHORYLATION; RESISTANCE; DOMAINS	Background: Activation function 1 (AF-1) is important for the activity of progesterone receptor (PR), but its functional motif is not known. Results: AF-1 of progesterone receptor (PR) is monomethylated at Lys-464. Lys-464 mutation markedly alters PR properties and ligand sensitivity. Conclusion: Lys-464 is critical for AF-1 function. Significance: Lys-464 is a potential target for modulating AF-1 activity of PR. Progesterone receptor (PR) exists in two isoforms, PRA and PRB, and both contain activation functions AF-1 and AF-2. It is believed that AF-1 is primarily responsible for the ligand-independent activity, whereas AF-2 mediates ligand-dependent PR activation. Although more than a dozen post-translational modifications of PR have been reported, no post-translational modification on AF-1 or AF-2 has been reported. Using LC-MS/MS-based proteomic analysis, this study revealed AF-1 monomethylation at Lys-464. Mutational analysis revealed the remarkable importance of Lys-464 in regulating PR activity. Single point mutation K464Q or K464A led to ligand-independent PR gel upshift similar to the ligand-induced gel upshift. This upshift was associated with increases in both ligand-dependent and ligand-independent PR phosphorylation and PR activity due to the hyperactivation of AF-1. In contrast, mutation of Lys-464 to the bulkier phenylalanine to mimic the effect of methylation caused a drastic decrease in PR activity. Importantly, PR-K464Q also showed heightened ligand sensitivity, and this was associated with increases in its functional interaction with transcription co-regulators NCoR1 and SRC-1. These results suggest that monomethylation of PR at Lys-464 probably has a repressive effect on AF-1 activity and ligand sensitivity.	[Chung, Hwa Hwa; Sze, Siu Kwan; Woo, Amanda Rui En; Sun, Yang; Sim, Kae Hwan; Dong, Xue Ming; Lin, Valerie C-L.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lin, VCL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	cllin@ntu.edu.sg	Sze, Siu_kwan Newman/A-2199-2011; Sze, Siu Kwan/AAO-3342-2020; Dong, Xueming/M-2137-2017; Chun Ling, Valerie Lin/A-2188-2011	Sze, Siu_kwan Newman/0000-0002-5652-1687; Sze, Siu Kwan/0000-0002-5652-1687; Dong, Xueming/0000-0001-8726-7565	Ministry of Education of Singapore	Ministry of Education of Singapore(Ministry of Education, Singapore)	This work was supported by a grant from the Ministry of Education of Singapore (to V. C.-L. L.).	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Arnal JF, 2013, STEROIDS, V78, P576, DOI 10.1016/j.steroids.2012.11.011; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baptist Alan P, 2004, Clin Mol Allergy, V2, P10, DOI 10.1186/1476-7961-2-10; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Buzdar A, 2001, J CLIN ONCOL, V19, P3357, DOI 10.1200/JCO.2001.19.14.3357; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Dong X, 2004, J MOL ENDOCRINOL, V32, P843, DOI 10.1677/jme.0.0320843; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Gan CS, 2008, J PROTEOME RES, V7, P4869, DOI 10.1021/pr800473j; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Konno T, 2010, ENDOCRINOLOGY, V151, P4537, DOI 10.1210/en.2010-0440; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange CA, 2008, J STEROID BIOCHEM, V108, P203, DOI 10.1016/j.jsbmb.2007.09.019; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Leo JCL, 2005, INT J CANCER, V117, P561, DOI 10.1002/ijc.21186; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Liu YY, 2012, J BIOL CHEM, V287, P36499, DOI 10.1074/jbc.M112.344317; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nasabzadeh TJ, 2010, J CUTAN PATHOL, V37, P1164, DOI 10.1111/j.1600-0560.2010.01607.x; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Staka CM, 2005, ENDOCR-RELAT CANCER, V12, pS85, DOI 10.1677/erc.1.01006; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513; Zheng ZY, 2008, BREAST CANCER RES TR, V110, P111, DOI 10.1007/s10549-007-9711-8; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	80	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5704	5722		10.1074/jbc.M113.522839	http://dx.doi.org/10.1074/jbc.M113.522839			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415758	Green Published, hybrid			2022-12-25	WOS:000332015500032
J	Das, PK; Merits, A; Lulla, A				Das, Pratyush Kumar; Merits, Andres; Lulla, Aleksei			Functional Cross-talk between Distant Domains of Chikungunya Virus Non-structural Protein 2 Is Decisive for Its RNA-modulating Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Positive-strand RNA Viruses; Protein Purification; RNA Helicase; Viral Replication; Chikungunya Virus; NTPase; RNA Annealing; SF1 Helicase; Alphavirus	SINDBIS-VIRUS; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; NS3 HELICASE; MOLECULAR DETERMINANTS; REPLICATION COMPLEXES; SERINE-PROTEASE; MINUS-STRAND; BINDING; DNA	Background: RNA helicase activity of chikungunya virus (CHIKV) non-structural protein 2 (nsP2) has not been previously demonstrated. Results: CHIKV nsP2 possesses 5-3 RNA helicase and RNA annealing activities. Conclusion: RNA-modulating activities of nsP2 apparently depend on communication between N-terminal and C-terminal domains of nsP2. Significance: Optimization of RNA helicase assay for nsP2 of highly medically important CHIKV opens opportunities for inhibitor screening studies. Chikungunya virus (CHIKV) non-structural protein 2 (nsP2) is a multifunctional protein that is considered a master regulator of the viral life cycle and a main viral factor responsible for cytopathic effects and subversion of antiviral defense. The C-terminal part of nsP2 possesses protease activity, whereas the N-terminal part exhibits NTPase and RNA triphosphatase activity and is proposed to have helicase activity. Bioinformatics analysis classified CHIKV nsP2 into helicase superfamily 1. However, the biochemical significance of a coexistence of two functionally unrelated modules in this single protein remains unknown. In this study, recombinant nsP2 demonstrated unwinding of double-stranded RNA in a 5-3 directionally biased manner and RNA strand annealing activity. Comparative analysis of NTPase and helicase activities of wild type nsP2 with enzymatic capabilities of different truncated or N-terminally extended variants of nsP2 revealed that the C-terminal part of the protein is indispensable for helicase functionality and presumably provides a platform for RNA binding, whereas the N-terminal-most region is apparently involved in obtaining a conformation of nsP2 that allows for its maximal enzymatic activities. The establishment of the protocols for the production of biochemically active CHIKV nsP2 and optimization of the parameters for helicase and NTPase assays are expected to provide the starting point for a further search of possibilities for therapeutic interventions to suppress alphaviral infections.	[Das, Pratyush Kumar; Merits, Andres; Lulla, Aleksei] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	University of Tartu	Merits, A (corresponding author), Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.	andres.merits@ut.ee	Merits, Andres/H-3125-2015	Merits, Andres/0000-0001-8193-0071; Das, Pratyush Kumar/0000-0003-2822-9619	Estonian Science Foundation [9421]; Targeted Financing Project [SF0180087s08]; European Union; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	Estonian Science Foundation; Targeted Financing Project; European Union(European Commission); European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	This work was supported in part by Estonian Science Foundation Grant 9421, Targeted Financing Project SF0180087s08, the European Union 7th Framework Integrated Chikungunya Research project, and the European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology.; Recipient of a scholarship from the European Union Social Fund via Activity 4 of the Doctoral Studies and Internationalisation Programme.	Adedeji AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036521; Adhikari S, 2010, ANAL BIOCHEM, V400, P203, DOI 10.1016/j.ab.2010.01.011; AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; Gros C, 1996, VIROLOGY, V217, P367, DOI 10.1006/viro.1996.0125; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hardy RW, 2006, VIROLOGY, V345, P520, DOI 10.1016/j.virol.2005.10.018; HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989; Jankowsky E, 2010, RSC BIOMOL SCI, P1; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jankowsky Eckhard, 2008, V488, P343, DOI 10.1007/978-1-60327-475-3_22; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; Karpe YA, 2010, J VIROL, V84, P3595, DOI 10.1128/JVI.02130-09; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Kulasegaran-Shylini R, 2009, J VIROL, V83, P8327, DOI 10.1128/JVI.00586-09; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; Lee NR, 2010, NUCLEIC ACIDS RES, V38, P7626, DOI 10.1093/nar/gkq647; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEMM JA, 1994, EMBO J, V13, P2925, DOI 10.1002/j.1460-2075.1994.tb06587.x; Leshchiner AD, 2006, J GEN VIROL, V87, P3087, DOI 10.1099/vir.0.81971-0; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lulla A, 2006, J VIROL, V80, P5413, DOI 10.1128/JVI.00229-06; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Lulla V, 2013, J VIROL, V87, P10207, DOI 10.1128/JVI.01485-13; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Mayuri, 2008, J VIROL, V82, P7284, DOI 10.1128/JVI.00224-08; MI S, 1991, VIROLOGY, V184, P423, DOI 10.1016/0042-6822(91)90862-6; Nishikiori M, 2012, J VIROL, V86, P7565, DOI 10.1128/JVI.00118-12; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; PERANEN J, 1990, J VIROL, V64, P1888; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Pyle AM, 2011, CURR OPIN CHEM BIOL, V15, P636, DOI 10.1016/j.cbpa.2011.07.019; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; RIKKONEN M, 1992, VIROLOGY, V189, P462, DOI 10.1016/0042-6822(92)90570-F; Rikkonen M, 1996, VIROLOGY, V218, P352, DOI 10.1006/viro.1996.0204; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; Russo AT, 2010, J MOL GRAPH MODEL, V29, P46, DOI 10.1016/j.jmgm.2010.04.005; Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931; Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109; Shirako Y, 1998, J VIROL, V72, P2310, DOI 10.1128/JVI.72.3.2310-2315.1998; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Springer CL, 2013, J VIROL, V87, P5994, DOI 10.1128/JVI.03491-12; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Taylor SD, 2010, J BIOL CHEM, V285, P11692, DOI 10.1074/jbc.M109.088559; Thal MA, 2007, VIROLOGY, V358, P221, DOI 10.1016/j.virol.2006.08.022; Vasiljeva L, 2003, J BIOL CHEM, V278, P41636, DOI 10.1074/jbc.M307481200; Vasiljeva L, 2001, J BIOL CHEM, V276, P30786, DOI 10.1074/jbc.M104786200; Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; WENGLER G, 1979, NATURE, V282, P754, DOI 10.1038/282754a0; Wu YL, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/140601; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	82	56	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5635	5653		10.1074/jbc.M113.503433	http://dx.doi.org/10.1074/jbc.M113.503433			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407286	Green Published, hybrid			2022-12-25	WOS:000332015500027
J	Kocsis, ZS; Sarlos, K; Harami, GM; Martina, M; Kovacs, M				Kocsis, Zsuzsa S.; Sarlos, Kata; Harami, Gabor M.; Martina, Mate; Kovacs, Mihaly			A Nucleotide-dependent and HRDC Domain-dependent Structural Transition in DNA-bound RecQ Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; DNA Repair; DNA-Protein Interaction; Molecular Motors; Protein Conformation; Recombination; Structure	ESCHERICHIA-COLI RECQ; SINGLE-STRANDED-DNA; WERNER-SYNDROME PROTEIN; WINGED-HELIX DOMAIN; REP HELICASE; CONFORMATIONAL-CHANGES; KINETIC MECHANISM; ATP HYDROLYSIS; GENOME MAINTENANCE; CRYSTAL-STRUCTURES	Background: The mechanistic role of DNA-induced structural changes in RecQ helicases is largely unexplored. Results: DNA interaction of RecQ helicase depends on the nucleotide state of the enzyme and the presence of an intact HRDC domain. Conclusion: We identified a structural transition of the RecQ-DNA complex that is linked to the mechanoenzymatic cycle. Significance: This transition contributes to translocation along DNA and genome-maintaining activities. The allosteric communication between the ATP- and DNA-binding sites of RecQ helicases enables efficient coupling of ATP hydrolysis to translocation along single-stranded DNA (ssDNA) and, in turn, the restructuring of multistranded DNA substrates during genome maintenance processes. In this study, we used the tryptophan fluorescence signal of Escherichia coli RecQ helicase to decipher the kinetic mechanism of the interaction of the enzyme with ssDNA. Rapid kinetic experiments revealed that ssDNA binding occurs in a two-step mechanism in which the initial binding step is followed by a structural transition of the DNA-bound helicase. We found that the nucleotide state of RecQ greatly influences the kinetics of the detected structural transition, which leads to a high affinity DNA-clamped state in the presence of the nucleotide analog ADP-AlF4. The DNA binding mechanism is largely independent of ssDNA length, indicating the independent binding of RecQ molecules to ssDNA and the lack of significant DNA end effects. The structural transition of DNA-bound RecQ was not detected when the ssDNA binding capability of the helicase-RNase D C-terminal domain was abolished or the domain was deleted. The results shed light on the nature of conformational changes leading to processive ssDNA translocation and multistranded DNA processing by RecQ helicases.	[Kocsis, Zsuzsa S.; Sarlos, Kata; Harami, Gabor M.; Martina, Mate; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, H-1117 Budapest, Hungary	Eotvos Lorand University	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, Pazmany Ps 1-C, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Kovacs, Mihaly/A-6841-2011; Harami, Gábor/I-2756-2017	Harami, Gábor/0000-0001-7234-2710; Horvath-Sarlos, Kata/0000-0003-3813-0209; Kocsis, Zsuzsa/0000-0002-4336-3325; Kovacs, Mihaly/0000-0002-1200-4741	Human Frontier Science Program Grant [RGY0072/2010]; "Momentum" Program of the Hungarian Academy of Sciences Grant [LP2011-006/2011]; European Union; European Social Fund [TAMOP 4.2.4.A/1-11-1-2012-0001]; State of Hungary	Human Frontier Science Program Grant(Human Frontier Science Program); "Momentum" Program of the Hungarian Academy of Sciences Grant; European Union(European Commission); European Social Fund(European Social Fund (ESF)); State of Hungary	This work was supported by Human Frontier Science Program Grant RGY0072/2010 (to M. K.) and "Momentum" Program of the Hungarian Academy of Sciences Grant LP2011-006/2011 (to M. K.). This work was also supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of the TAMOP 4.2.4.A/1-11-1-2012-0001 "National Excellence Program."	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bjornson KP, 1998, BIOCHEMISTRY-US, V37, P891, DOI 10.1021/bi9719307; Bjornson KP, 1996, BIOCHEMISTRY-US, V35, P2268, DOI 10.1021/bi9522763; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Bujalowski W, 2000, J MOL BIOL, V295, P831, DOI 10.1006/jmbi.1999.3378; CHAO KL, 1990, J BIOL CHEM, V265, P1067; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Flowers S, 2003, BIOCHEMISTRY-US, V42, P1910, DOI 10.1021/bi025992v; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gyimesi M, 2010, NUCLEIC ACIDS RES, V38, P4404, DOI 10.1093/nar/gkq145; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Harrigan JA, 2003, BIOCHIMIE, V85, P1185, DOI 10.1016/j.biochi.2003.10.006; Heilek GM, 1997, J VIROL, V71, P6264, DOI 10.1128/JVI.71.8.6264-6266.1997; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Hu JS, 2005, P NATL ACAD SCI USA, V102, P18379, DOI 10.1073/pnas.0509380102; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Liu SS, 2013, FEBS LETT, V587, P2635, DOI 10.1016/j.febslet.2013.06.048; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7237, DOI 10.1021/bi0518287; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pan BY, 2010, J BIOL CHEM, V285, P15884, DOI 10.1074/jbc.M110.104299; Pandey N, 2011, BIOINFORMATION, V7, P371; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Rad B, 2012, BIOCHEMISTRY-US, V51, P2921, DOI 10.1021/bi3000676; Rad B, 2012, P NATL ACAD SCI USA, V109, P1443, DOI 10.1073/pnas.1119952109; Ren H, 2007, NUCLEIC ACIDS RES, V35, P6029, DOI 10.1093/nar/gkm544; Sarlos K, 2012, P NATL ACAD SCI USA, V109, P9804, DOI 10.1073/pnas.1114468109; Sato A, 2010, J BIOCHEM, V148, P517, DOI 10.1093/jb/mvq097; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Stole E, 1997, BIOCHEMISTRY-US, V36, P3483, DOI 10.1021/bi962881l; Tadokoro T, 2012, AGING-US, V4, P418, DOI 10.18632/aging.100463; Toseland CP, 2013, J BIOL CHEM, V288, P25183, DOI 10.1074/jbc.M113.484667; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zittel MC, 2005, NUCLEIC ACIDS RES, V33, P6982, DOI 10.1093/nar/gki999	59	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5938	5949		10.1074/jbc.M113.530741	http://dx.doi.org/10.1074/jbc.M113.530741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403069	Green Published, hybrid			2022-12-25	WOS:000332015500050
J	Ichimura, T; Chiu, LD; Fujita, K; Kawata, S; Watanabe, TM; Yanagida, T; Fujita, H				Ichimura, Taro; Chiu, Liang-da; Fujita, Katsumasa; Kawata, Satoshi; Watanabe, Tomonobu M.; Yanagida, Toshio; Fujita, Hideaki			Visualizing Cell State Transition Using Raman Spectroscopy	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIATION; PLURIPOTENT; DYNAMICS; NUCLEUS; PROTEIN; BODIES; CYCLE	System level understanding of the cell requires detailed description of the cell state, which is often characterized by the expression levels of proteins. However, understanding the cell state requires comprehensive information of the cell, which is usually obtained from a large number of cells and their disruption. In this study, we used Raman spectroscopy, which can report changes in the cell state without introducing any label, as a non-invasive method with single cell capability. Significant differences in Raman spectra were observed at the levels of both the cytosol and nucleus in different cell-lines from mouse, indicating that Raman spectra reflect differences in the cell state. Difference in cell state was observed before and after the induction of differentiation in neuroblastoma and adipocytes, showing that Raman spectra can detect subtle changes in the cell state. Cell state transitions during embryonic stem cell (ESC) differentiation were visualized when Raman spectroscopy was coupled with principal component analysis (PCA), which showed gradual transition in the cell states during differentiation. Detailed analysis showed that the diversity between cells are large in undifferentiated ESC and in mesenchymal stem cells compared with terminally differentiated cells, implying that the cell state in stem cells stochastically fluctuates during the self-renewal process. The present study strongly indicates that Raman spectral morphology, in combination with PCA, can be used to establish cells' fingerprints, which can be useful for distinguishing and identifying different cellular states.	[Ichimura, Taro; Watanabe, Tomonobu M.; Yanagida, Toshio; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Chiu, Liang-da; Fujita, Katsumasa; Kawata, Satoshi] Osaka Univ, Dept Appl Phys, Suita, Osaka 565, Japan; [Kawata, Satoshi] RIKEN, Nanophoton Lab, Wako, Saitama, Japan; [Yanagida, Toshio; Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka, Japan	RIKEN; Osaka University; RIKEN; Osaka University	Fujita, H (corresponding author), RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan.	hideaki.fujita@riken.jp	Fujita, Hideaki/B-7633-2008; Fujita, Katsumasa/F-6699-2015; Watanabe, Tomonobu/J-4812-2013; Chiu, Liang-da/H-4151-2015; Ichimura, Taro/E-2792-2010	Fujita, Hideaki/0000-0003-3430-5681; Chiu, Liang-da/0000-0002-8178-1800; Ichimura, Taro/0000-0002-3740-3634; Watanabe, Tomonobu/0000-0002-2420-4230	PRESTO, the Japan Science and Technology Agency	PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	PRESTO, the Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckmaster R, 2009, ANALYST, V134, P1440, DOI 10.1039/b900420c; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; FRENSTER JH, 1973, NEW ENGL J MED, V288, P1224, DOI 10.1056/NEJM197306072882310; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hamada K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952192; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Nakamura MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071739; NAKATSU SL, 1974, NATURE, V248, P334, DOI 10.1038/248334a0; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pascut FC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3570302; Pascut FC, 2011, BIOPHYS J, V100, P251, DOI 10.1016/j.bpj.2010.11.043; Pliss A, 2010, BIOPHYS J, V99, P3483, DOI 10.1016/j.bpj.2010.06.069; Poplineau M, 2011, EPIGENOMICS-UK, V3, P785, DOI [10.2217/EPI.11.102, 10.2217/epi.11.102]; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; Shav-Tal Y, 2001, J CELL BIOCHEM, V81, P379, DOI 10.1002/1097-4644(20010601)81:3<379::AID-JCB1052>3.0.CO;2-8; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720; Waddington C., 1957, STRATEGY GENES; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	32	68	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84478	10.1371/journal.pone.0084478	http://dx.doi.org/10.1371/journal.pone.0084478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409302	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500026
J	Sathe, A; Reddy, KVR				Sathe, Ameya; Reddy, Kudumula Venkata Rami			TLR9 and RIG-I Signaling in Human Endocervical Epithelial Cells Modulates Inflammatory Responses of Macrophages and Dendritic Cells In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INNATE IMMUNITY; GENITAL-TRACT; RECOGNITION; EXPRESSION; TISSUE; ALPHA; QUANTIFICATION; PROTECTION; RECEPTORS	The innate immune system has evolved to recognize invading pathogens through pattern recognition receptors (PRRs). Among PRRs, Toll like receptors (TLRs 3, 7/8,9) and RIG-I like receptors (RLRs) have been shown to recognize viral components. Mucosal immune responses to viral infections require coordinated actions from epithelial as well as immune cells. In this respect, endocervical epithelial cells (EEC's) play an important role in initiating innate immune responses via PRRs. It is unknown whether EEC's can alter immune responses of macrophages and dendritic cells (DC's) like its counterparts in intestinal and respiratory systems. In this study, we show that endocervical epithelial cells (End1/E6E7) express two key receptors, TLR9 and RIG-I involved in anti-viral immunity. Stimulation of End1/E6E7 cells lead to the activation of NF-kappa B and increased secretion of pro-inflammatory cytokines, IL-6 and IL-8. Polarized End1/E6E7 cells responded to apical stimulation with ligands of TLR9 and RIG-I, CpG-ODN and Poly(I:C)LL respectively, without compromising End1/E6E7 cell integrity. At steady state, spent medium from End1/E6E7 cells significantly reduced secretion of pro-inflammatory cytokines from LPS treated human primary monocyte derived macrophages (MDMs) and DC: T cell co-cultures. Spent medium from End1/E6E7 cells stimulated with ligands of TLR9/RIG-I restored secretion of pro-inflammatory cytokines as well as enhanced phagocytosis and chemotaxis of monocytic U937 cells. Spent medium from CpG-ODN and Poly(I: C) LL stimulated End1/E6E7 cells showed significant increased secretion of IL-12p70 from DC: T cell co-cultures. The anti-inflammatory effect of spent media of End1/E6E7 cell was observed to be TGF-beta dependent. In summary, the results of our study indicate that EEC's play an indispensable role in modulating anti-viral immune responses at the female lower genital tract.	[Sathe, Ameya; Reddy, Kudumula Venkata Rami] Indian Council Med Res, NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Reddy, KVR (corresponding author), Indian Council Med Res, NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India.	reddyk@nirrh.res.in		Sathe, Ameya/0000-0001-8343-1196	Indian Council of Medical Research (ICMR) [NIRRH/MS/92/2013]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This study was partially supported by grants from Indian Council of Medical Research (ICMR)(NIRRH/MS/92/2013). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Fichorova RN, 2005, ANTIMICROB AGENTS CH, V49, P323, DOI 10.1128/AAC.49.1.323-335.2005; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Galen B, 2006, J VIROL, V80, P12209, DOI 10.1128/JVI.01503-06; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; HEINONEN PK, 1985, OBSTET GYNECOL, V66, P384; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; Hershberg RM, 2002, AM J PHYSIOL-GASTR L, V283, pG833, DOI 10.1152/ajpgi.00208.2002; Hibma Merilyn H, 2012, Open Virol J, V6, P241, DOI 10.2174/1874357901206010241; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2010, ARCH DERMATOL RES, V302, P301, DOI 10.1007/s00403-009-1012-0; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mayer AK, 2008, EUR J IMMUNOL, V38, P1689, DOI 10.1002/eji.200737936; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Puthenveedu MA, 2003, MOL BIOL CELL, V14, P1801, DOI 10.1091/mbc.E02-10-0692; Sajic D, 2003, J MED VIROL, V71, P561, DOI 10.1002/jmv.10518; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Sharma S, 2011, MICROB PATHOGENESIS, V50, P179, DOI 10.1016/j.micpath.2010.12.007; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Wang H, 2009, THORAX, V64, P283, DOI 10.1136/thx.2007.094870; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Zhang T, 2011, EUR J PHARM BIOPHARM, V79, P526, DOI 10.1016/j.ejpb.2011.06.007	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83882	10.1371/journal.pone.0083882	http://dx.doi.org/10.1371/journal.pone.0083882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409285	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500009
J	Schecklmann, M; Landgrebe, M; Kleinjung, T; Frank, E; Rupprecht, R; Sand, PG; Eichhammer, P; Hajak, G; Langguth, B				Schecklmann, Martin; Landgrebe, Michael; Kleinjung, Tobias; Frank, Elmar; Rupprecht, Rainer; Sand, Philipp G.; Eichhammer, Peter; Hajak, Goeran; Langguth, Berthold			State- and Trait-Related Alterations of Motor Cortex Excitability in Tinnitus Patients	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; NETWORK CONNECTIVITY; SLEEP-DEPRIVATION; PLASTICITY; INHIBITION; MECHANISMS; TMS; CONSISTENCY; DISORDERS	Chronic tinnitus is a brain network disorder with involvement of auditory and non-auditory areas. Repetitive transcranial magnetic stimulation (rTMS) over the temporal cortex has been investigated for the treatment of tinnitus. Several small studies suggest that motor cortex excitability is altered in people with tinnitus. We retrospectively analysed data from 231 patients with chronic tinnitus and 120 healthy controls by pooling data from different studies. Variables of interest were resting motor threshold (RMT), short-interval intra-cortical inhibition (SICI), intra-cortical facilitation (ICF), and cortical silent period (CSP). 118 patients were tested twice - before and after ten rTMS treatment sessions over the left temporal cortex. In tinnitus patients SICI and ICF were increased and CSP was shortened as compared to healthy controls. There was no group difference in RMT. Treatment related amelioration of tinnitus symptoms were correlated with normalisations in SICI. These findings confirm earlier studies of abnormal motor cortex excitability in tinnitus patients. Moreover our longitudinal data suggest that altered SICI may reflect a state parameter, whereas CSP and ICF may rather mirror a trait-like predisposing factor of tinnitus. These findings are new and innovative as they enlarge the knowledge about basic physiologic and neuroplastic processes in tinnitus.	[Schecklmann, Martin; Frank, Elmar; Rupprecht, Rainer; Sand, Philipp G.; Eichhammer, Peter; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Landgrebe, Michael] Social Fdn Bamberg, Dept Psychiat Psychosomat Med & Psychotherapy, Bamberg, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland	University of Regensburg; University of Zurich	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	martin.schecklmann@medbo.de	Kleinjung, Tobias/AAJ-3141-2020; Sand, Philipp G/C-1924-2009; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; Sand, Philipp G/0000-0001-5806-5841; 				Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Chen R, 1998, J NEUROSCI, V18, P3443; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Gennaro L, 2004, NEUROSCI RES, V48, P129, DOI 10.1016/j.neures.2003.10.004; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dovern A, 2012, J NEUROSCI, V32, P7614, DOI 10.1523/JNEUROSCI.5401-11.2012; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eichhammer P, 2007, PROG BRAIN RES, V166, P369, DOI 10.1016/S0079-6123(07)66035-X; GOEBEL G, 1994, HNO, V42, P166; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Khedr EM, 2008, NEUROPHYSIOL CLIN, V38, P243, DOI 10.1016/j.neucli.2008.03.004; Kreuzer P, 2011, NEUROSCI LETT, V493, P63, DOI 10.1016/j.neulet.2011.02.044; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Langguth B, 2005, NEUROSCI LETT, V380, P326, DOI 10.1016/j.neulet.2005.01.069; Langguth B, 2012, WORLD J BIOL PSYCHIA; Langguth B, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-45; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Lehner A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00011; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Petitjean M, 2013, CLIN NEUROPHYSIOL, V124, P346, DOI 10.1016/j.clinph.2012.07.006; Placidi F, 2013, SLEEP MED, V14, P288, DOI 10.1016/j.sleep.2012.11.020; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothen N, 2012, J NEUROSCI, V32, P13641, DOI 10.1523/JNEUROSCI.3577-12.2012; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Sanchez TG, 2011, CLINICS, V66, P1089, DOI 10.1590/S1807-59322011000600028; Sand PG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00041; Schecklmann M, 2013, HUM BRAIN MAPP, V34, P233, DOI 10.1002/hbm.21426; Schecklmann M, 2012, INT J PSYCHOPHYSIOL, V83, P323, DOI 10.1016/j.ijpsycho.2011.11.013; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schwenkreis P, 2000, NEUROSCI LETT, V293, P143, DOI 10.1016/S0304-3940(00)01517-2; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Wolters A., 2012, OXFORD HDB TRANSCRAN; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Ziemann U, 1998, J NEUROSCI, V18, P7000; Ziemann U, 2006, NEUROREHAB NEURAL RE, V20, P243, DOI 10.1177/1545968306287154; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85015	10.1371/journal.pone.0085015	http://dx.doi.org/10.1371/journal.pone.0085015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409317	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000329463500041
J	Belloni, V; Sorci, G; Paccagnini, E; Guerreiro, R; Bellenger, J; Faivre, B				Belloni, Virginia; Sorci, Gabriele; Paccagnini, Eugenio; Guerreiro, Romain; Bellenger, Jerome; Faivre, Bruno			Disrupting Immune Regulation Incurs Transient Costs in Male Reproductive Function	PLOS ONE			English	Article							SPERM PRODUCTION; TESTES SIZE; EVOLUTION; LIPOPOLYSACCHARIDE; IMMUNOPATHOLOGY; INFLAMMATION; COMPETITION; CYTOKINES; STRESS; CONSEQUENCES	Background: Immune protection against pathogenic organisms has been shown to incur costs. Previous studies investigating the cost of immunity have mostly focused on the metabolic requirements of immune maintenance and activation. In addition to these metabolic costs, the immune system can induce damage to the host if the immune response is mis-targeted or over-expressed. Given its non-specific nature, an over-expressed inflammatory response is often associated with substantial damage for the host. Here, we investigated the cost of an over-expressed inflammatory response in the reproductive function of male mice. Methodology/Principal Findings: We experimentally blocked the receptors of an anti-inflammatory cytokine (IL-10) in male mice exposed to a mild inflammatory challenge, with each treatment having an appropriate control group. The experiment was conducted on two age classes, young (3 month old) and old (15 month old) mice, to assess any age-related difference in the cost of a disrupted immune regulation. We found that the concomitant exposure to an inflammatory insult and the blockade of IL-10 induced a reduction in testis mass, compared to the three other groups. The frequency of abnormal sperm morphology was also higher in the group of mice exposed to the inflammatory challenge but did not depend on the blockade of the IL-10. Conclusions: Our results provide evidence that immune regulation confers protection against the risk of inflammation-induced infertility during infection. They also suggest that disruption of the effectors involved in the regulation of the inflammatory response can have serious fitness consequences even under mild inflammatory insult and benign environmental conditions.	[Belloni, Virginia; Sorci, Gabriele; Guerreiro, Romain; Faivre, Bruno] Univ Bourgogne, CNRS UMR 6282, Dijon, France; [Belloni, Virginia] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA; [Paccagnini, Eugenio] Univ Siena, Dipartimento Biol Evolutiva, I-53100 Siena, Italy; [Bellenger, Jerome] Univ Bourgogne, INSERM, UMR 866, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Bourgogne; Tulane University; University of Siena; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Belloni, V (corresponding author), Univ Bourgogne, CNRS UMR 6282, Dijon, France.	vbelloni@tulane.edu	Guerreiro, Rita J L/A-1327-2011; BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Paccagnini, Eugenio/0000-0002-9784-2057; Belloni, Virginia/0000-0001-9807-1912; Sorci, Gabriele/0000-0002-0799-3995	Region Bourgogne; ANR - Project EVOREGIM	Region Bourgogne(Region Bourgogne-Franche-Comte); ANR - Project EVOREGIM(French National Research Agency (ANR))	Financial support was received from the Region Bourgogne and ANR - Project EVOREGIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RP, 1970, FERTIL STERIL, V21, P662; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Day T, 2007, P ROY SOC B-BIOL SCI, V274, P2685, DOI 10.1098/rspb.2007.0809; Dejaco C, 2006, EXP GERONTOL, V41, P339, DOI 10.1016/j.exger.2006.01.008; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Guerreiro R, 2012, EVOLUTION, V66, P3615, DOI 10.1111/j.1558-5646.2012.01708.x; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; JOUANNET P, 1988, INT J ANDROL, V11, P379, DOI 10.1111/j.1365-2605.1988.tb01011.x; Kawai Y, 2006, J REPROD DEVELOP, V52, P561, DOI 10.1262/jrd.18023; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Licastro Federico, 2005, Immun Ageing, V2, P8; Liew SH, 2007, J ANDROL, V28, P176, DOI 10.2164/jandrol.106.000752; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Long GH, 2011, TRENDS PARASITOL, V27, P300, DOI 10.1016/j.pt.2011.03.012; Long GH, 2011, EVOL APPL, V4, P278, DOI 10.1111/j.1752-4571.2010.00178.x; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Max EE, 2001, IMMUNOLOGY IMMUNOPAT; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Menkveld R, 2001, HUM REPROD, V16, P1165, DOI 10.1093/humrep/16.6.1165; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nussey D, 2011, IMMUNOLOGY, V135, P30; O'Bryan MK, 2000, BIOL REPROD, V63, P1285, DOI 10.1095/biolreprod63.5.1285; O'Bryan MK, 2005, AM J PHYSIOL-REG I, V288, pR1744, DOI 10.1152/ajpregu.00651.2004; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Plas E, 2000, EXP GERONTOL, V35, P543, DOI 10.1016/S0531-5565(00)00120-0; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953; RATHJE TA, 1995, J ANIM SCI, V73, P2177; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Scharer L, 2007, EVOL ECOL, V21, P295, DOI 10.1007/s10682-006-9101-4; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schradin C, 2009, BIOL REPROD, V81, P111, DOI 10.1095/biolreprod.108.075838; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Winnall WR, 2011, J LEUKOCYTE BIOL, V90, P133, DOI 10.1189/jlb.1010557; Zhang M, 2012, POULTRY SCI, V91, P1997, DOI 10.3382/ps.2012-02236	56	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84606	10.1371/journal.pone.0084606	http://dx.doi.org/10.1371/journal.pone.0084606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400103	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700037
J	Forlim, CG; Pinto, RD				Forlim, Caroline G.; Pinto, Reynaldo D.			Automatic Realistic Real Time Stimulation/Recording in Weakly Electric Fish: Long Time Behavior Characterization in Freely Swimming Fish and Stimuli Discrimination	PLOS ONE			English	Article							WAVE-FORM GENERATION; ACTIVE ELECTROLOCATION; JAMMING AVOIDANCE; ORGAN; COMMUNICATION; RECOGNITION; INFORMATION; ELECTROCOMMUNICATION; MECHANISMS; MORMYRIDAE	Weakly electric fish are unique model systems in neuroethology, that allow experimentalists to non-invasively, access, central nervous system generated spatio-temporal electric patterns of pulses with roles in at least 2 complex and incompletely understood abilities: electrocommunication and electrolocation. Pulse-type electric fish alter their inter pulse intervals (IPIs) according to different behavioral contexts as aggression, hiding and mating. Nevertheless, only a few behavioral studies comparing the influence of different stimuli IPIs in the fish electric response have been conducted. We developed an apparatus that allows real time automatic realistic stimulation and simultaneous recording of electric pulses in freely moving Gymnotus carapo for several days. We detected and recorded pulse timestamps independently of the fish's position for days. A stimulus fish was mimicked by a dipole electrode that reproduced the voltage time series of real conspecific according to previously recorded timestamp sequences. We characterized fish behavior and the eletrocommunication in 2 conditions: stimulated by IPIs pre-recorded from other fish and random IPI ones. All stimuli pulses had the exact Gymontus carapo waveform. All fish presented a surprisingly long transient exploratory behavior (more than 8 h) when exposed to a new environment in the absence of electrical stimuli. Further, we also show that fish are able to discriminate between real and random stimuli distributions by changing several characteristics of their IPI distribution.	[Forlim, Caroline G.] Univ Sao Paulo, Dept Fis Geral, Sao Paulo, Brazil; [Forlim, Caroline G.; Pinto, Reynaldo D.] Univ Sao Paulo, Lab Neurodinam Neurobiofis, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pinto, RD (corresponding author), Univ Sao Paulo, Lab Neurodinam Neurobiofis, Sao Carlos, SP, Brazil.	reynaldo@ifsc.usp.br	Forlim, Caroline G/GLU-9139-2022; Pinto, Reynaldo D/K-7181-2014	Forlim, Caroline G/0000-0003-4709-7797	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (www.capes.gov.br), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brochini L, 2011, J NEUROSCI, V31, P12297, DOI 10.1523/JNEUROSCI.1568-11.2011; BULLOCK TH, 1969, BRAIN BEHAV EVOLUT, V2, P85, DOI 10.1159/000125815; Bullock TH, 1999, J EXP BIOL, V202, P1455; Capurro A, 2004, B MATH BIOL, V66, P885, DOI 10.1016/j.bulm.2004.02.002; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; Caputi AA, 2004, J PHYSIOL-PARIS, V98, P81, DOI 10.1016/j.jphysparis.2004.03.002; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; CAPUTI AA, 2012, SENSING NATURE; Carlson BA, 2002, J PHYSIOLOGY-PARIS, V96, P405, DOI 10.1016/S0928-4257(03)00019-6; Carlson BA, 2011, SCIENCE, V332, P583, DOI 10.1126/science.1201524; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Castello ME, 2009, J EXP BIOL, V212, P1351, DOI 10.1242/jeb.022566; CLEWORTH PA, 1970, ANIM BEHAV MONOGR, V3, P1; Cuddy M, 2012, HORM BEHAV, V61, P4, DOI 10.1016/j.yhbeh.2011.09.003; Dayan P., 2001, THEORETICAL NEUROSCI; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Engelmann J, 2010, J NEUROPHYSIOL, V104, P1955, DOI 10.1152/jn.00503.2009; Engelmann J, 2008, BIOL CYBERN, V98, P519, DOI 10.1007/s00422-008-0213-5; FORLIM CG, 2008, THESIS U SAO PAULO; FORLIM CG, 2011, BMC NEUROSCIENCE S1, V12, pP253; FORLIM CG, 2013, BMC NEUROSCIENCE S1, V2013, pP405; FORLIM CG, 2012, 2012 NEUR M PLANN; Fortune ES, 2006, J COMP PHYSIOL A, V192, P625, DOI 10.1007/s00359-006-0102-0; HEILIGENBERG W, 1978, J COMP PHYSIOL, V124, P211, DOI 10.1007/BF00657053; Heiligenberg W, 1991, Curr Opin Neurobiol, V1, P187, DOI 10.1016/0959-4388(91)90076-J; Ho WW, 2010, ETHOLOGY, V116, P1050, DOI 10.1111/j.1439-0310.2010.01823.x; Jun JJ, 2012, J NEUROPHYSIOL, V107, P1996, DOI 10.1152/jn.00757.2011; Jun JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066596; KRAMER B, 1979, BEHAV ECOL SOCIOBIOL, V6, P67, DOI 10.1007/BF00293246; KRAMER B, 1994, ANIM BEHAV, V48, P435, DOI 10.1006/anbe.1994.1257; LISSMANN HW, 1958, J EXP BIOL, V35, P156; Nogueira J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022159; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Perrone R, 2009, J COMP PHYSIOL A, V195, P501, DOI 10.1007/s00359-009-0427-6; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; PINTO RD, 2007, 2007 NEUR M PLANN; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Rieke F., 1999, SPIKES EXPLORING NEU; Schuster S, 2002, J EXP BIOL, V205, P3307; Schuster S, 2002, J EXP BIOL, V205, P2525; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SZABO T, 1975, BRAIN RES, V95, P459, DOI 10.1016/0006-8993(75)90121-3; TEYSSEDRE C, 1986, BEHAV PROCESS, V12, P77, DOI 10.1016/0376-6357(86)90073-2; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Varona P., 2011, BMC NEUROSCI S1, V12, pP358, DOI [DOI 10.1186/1471-2202-12-S1-P358, 10.1186/1471-2202-12-S1-P358]; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; Von der Emde G, 1999, J EXP BIOL, V202, P1205; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; von der Emde G, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00026; von der Emde G, 2008, J PHYSIOL-PARIS, V102, P279, DOI 10.1016/j.jphysparis.2008.10.017; WESTBY GWM, 1979, BEHAV ECOL SOCIOBIOL, V4, P381; WESTBY GWM, 1975, ANIM BEHAV, V23, P192, DOI 10.1016/0003-3472(75)90065-2; Wong RY, 2007, J EXP BIOL, V210, P2244, DOI 10.1242/jeb.003509	56	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84885	10.1371/journal.pone.0084885	http://dx.doi.org/10.1371/journal.pone.0084885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400122	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700056
J	Knodler, LA; Nair, V; Steele-Mortimer, O				Knodler, Leigh A.; Nair, Vinod; Steele-Mortimer, Olivia			Quantitative Assessment of Cytosolic Salmonella in Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTRACELLULAR LIFE-STYLE; SHIGELLA-FLEXNERI; MYCOBACTERIUM-TUBERCULOSIS; CONTAINING VACUOLE; COXIELLA-BURNETII; III SECRETION; PHAGOLYSOSOMAL ALKALINIZATION; FRANCISELLA-TULARENSIS; ESCHERICHIA-COLI	Within mammalian cells, Salmonella enterica serovar Typhimurium (S. Typhimurium) inhabits a membrane-bound vacuole known as the Salmonella-containing vacuole (SCV). We have recently shown that wild type S. Typhimurium also colonizes the cytosol of epithelial cells. Here we sought to quantify the contribution of cytosolic Salmonella to the total population over a time course of infection in different epithelial cell lines and under conditions of altered vacuolar escape. We found that the lysosomotropic agent, chloroquine, acts on vacuolar, but not cytosolic, Salmonella. After chloroquine treatment, vacuolar bacteria are not transcriptionally active or replicative and appear degraded. Using a chloroquine resistance assay, in addition to digitonin permeabilization, we found that S. Typhimurium lyses its nascent vacuole in numerous epithelial cell lines, albeit with different frequencies, and hyper-replication in the cytosol is also widespread. At later times post-infection, cytosolic bacteria account for half of the total population in some epithelial cell lines, namely HeLa and Caco-2 C2Bbe1. Both techniques accurately measured increased vacuole lysis in epithelial cells upon treatment with wortmannin. By chloroquine resistance assay, we also determined that Salmonella pathogenicity island-1 (SPI-1), but not SPI-2, the virulence plasmid nor the flagellar apparatus, was required for vacuolar escape and cytosolic replication in epithelial cells. Together, digitonin permeabilization and the chloroquine resistance assay will be useful, complementary tools for deciphering the mechanisms of SCV lysis and Salmonella replication in the epithelial cell cytosol.	[Knodler, Leigh A.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Knodler, Leigh A.; Steele-Mortimer, Olivia] NIAID, Rocky Mt Labs, Intracellular Parasites Lab, NIH, Hamilton, MT 59840 USA; [Nair, Vinod] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Knodler, LA (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	lknodler@vetmed.wsu.edu		Knodler, Leigh/0000-0002-3028-2198	Paul G. Allen School for Global Animal Health; Stanley L. Adler Research Endowment; Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000909, ZICAI001052] Funding Source: NIH RePORTER	Paul G. Allen School for Global Animal Health; Stanley L. Adler Research Endowment; Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Paul G. Allen School for Global Animal Health, the Stanley L. Adler Research Endowment and the Intramural Research Program of NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiastui A, 2010, INFECT IMMUN, V78, P2700, DOI 10.1128/IAI.01389-09; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Barzu S, 1997, INFECT IMMUN, V65, P1599; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; BYRD TF, 1991, J CLIN INVEST, V88, P351, DOI 10.1172/JCI115301; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; CIAK J, 1966, SCIENCE, V151, P347, DOI 10.1126/science.151.3708.347; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; CROWLE AJ, 1990, ANTIMICROB AGENTS CH, V34, P2217, DOI 10.1128/AAC.34.11.2217; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Fernandez IM, 2001, J INFECT DIS, V184, P743, DOI 10.1086/323035; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; GALAN JE, 1991, INFECT IMMUN, V59, P2901; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Giannasca KT, 1996, INFECT IMMUN, V64, P135, DOI 10.1128/IAI.64.1.135-145.1996; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; MAURIN M, 1992, J INFECT DIS, V166, P1097, DOI 10.1093/infdis/166.5.1097; MAURIN M, 1994, J INFECT DIS, V169, P330, DOI 10.1093/infdis/169.2.330; MIDDLETON KR, 1974, J PHARM PHARMACOL, V26, pP99, DOI 10.1111/j.2042-7158.1974.tb10128.x; Mostowy S, 2012, CELL MICROBIOL; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; POPIEL I, 1985, INFECT IMMUN, V47, P786, DOI 10.1128/IAI.47.3.786-792.1985; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; RAOULT D, 1990, ANTIMICROB AGENTS CH, V34, P1512, DOI 10.1128/AAC.34.8.1512; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Rosselin M, 2011, MICROBIOL-SGM, V157, P839, DOI 10.1099/mic.0.044941-0; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Santos RL, 2004, INT J MED MICROBIOL, V294, P225, DOI 10.1016/j.ijmm.2004.06.029; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; STEINBERG TH, 1994, CLIN INFECT DIS, V19, P916, DOI 10.1093/clinids/19.5.916; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; TULKENS P, 1978, BIOCHEM PHARMACOL, V27, P415, DOI 10.1016/0006-2952(78)90370-2; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	72	88	89	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84681	10.1371/journal.pone.0084681	http://dx.doi.org/10.1371/journal.pone.0084681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400108	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700042
J	Lopez, AV; Garcia, MNV; Melen, GJ; Martinez, AE; Moreno, IC; Garcia-Castro, J; Orellana, MR; Gonzalez, AGZ				Vicente Lopez, Angeles; Vazquez Garcia, Miriam Nohemi; Melen, Gustavo J.; Entrena Martinez, Ana; Cubillo Moreno, Isabel; Garcia-Castro, Javier; Ramirez Orellana, Manuel; Zapata Gonzalez, Agustin Gregorio			Mesenchymal Stromal Cells Derived from the Bone Marrow of Acute Lymphoblastic Leukemia Patients Show Altered BMP4 Production: Correlations with the Course of Disease	PLOS ONE			English	Article							CANCER STEM-CELLS; HEMATOPOIETIC STEM; SONIC HEDGEHOG; PROLIFERATION; DIFFERENTIATION; MAINTENANCE; INDUCTION; SURVIVAL; ADIPOCYTES; EXPRESSION	The relevance of tumor microenvironment for the development and progression of tumor cells in hematological malignancies has been extensively reported. Identification of factors involved in the information exchange between the malignant cells and the bone marrow mesenchymal stem cells (BM-MSCs) and the knowledge on their functioning may provide important information to eliminate leukemic cells from protective BM niches. We evaluated changes in BM-MSCs obtained from children with acute lymphoblastic leukemia (ALL) at different times in the course of disease. Whereas ALL-MSCs did not exhibit phenotypic changes compared to BM-derived MSCs isolated from healthy donors, they exhibited increased adipogenic capacity. In addition, the viability of healthy CD34+ hematopoietic progenitors was significantly reduced when co-cultured with ALL-MSCs. ALL-MSCs grow less efficiently, although gradually recover normal growth with treatment. Accordingly, proliferation is particularly low in MSCs obtained at diagnosis and in the first days of treatment (+15 days), recovering to control levels after 35 days of treatment. Correlating these results with bone morphogenetic protein 4 (BMP4) production, a molecule demonstrated to affect MSC biology, we found higher production of BMP4 in ALL-MSCs derived from patients over the course of disease but not in those free of leukemia. However, no significant differences in the expression of different members of the BMP4 signaling pathway were observed. Furthermore, an inverse correlation between high levels of BMP4 production in the cultures and MSC proliferation was found, as observed in MSCs derived from patients at diagnosis that produce high BMP4 levels. In addition, co-culturing ALL-MSC with the REH leukemia cell line, but not CD34+ hematopoietic progenitors, powerfully enhanced BMP4 production, suggesting an intimate crosstalk among ALL-MSCs isolated from BM colonized by ALL cells that presumably also occurs in situ conditions. Our data may support the participation of BMP4 in BM niche, but the mechanism remains to be elucidated.	[Vicente Lopez, Angeles; Vazquez Garcia, Miriam Nohemi; Entrena Martinez, Ana] Univ Complutense Madrid, Sch Med, Dept Cell Biol, Madrid, Spain; [Melen, Gustavo J.; Ramirez Orellana, Manuel] Hosp Nino Jesus, Dept Oncohematol, Madrid, Spain; [Cubillo Moreno, Isabel; Garcia-Castro, Javier] Inst Hlth Carlos III, Cellular Biotechnol Unit, Madrid, Spain; [Zapata Gonzalez, Agustin Gregorio] Univ Complutense Madrid, Fac Biol, Dept Cell Biol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Lopez, AV (corresponding author), Univ Complutense Madrid, Sch Med, Dept Cell Biol, Madrid, Spain.	avicente@bio.ucm.es; zapata@ucm.es	Garcia-Castro, Javier/ABC-9741-2021; Garcia-Castro, Javier/H-5274-2011; Melen, Gustavo/L-5918-2014; GARCIA, MIRIAM NOHEMI N VAZQUEZ/G-8866-2017; Vicente, Angeles/B-7951-2015; García, Miriam/HGD-0780-2022; VICENTE, LIERN/B-6112-2008; Ramirez, Manuel/H-7710-2015	Garcia-Castro, Javier/0000-0001-7604-1640; Garcia-Castro, Javier/0000-0001-7604-1640; Melen, Gustavo/0000-0001-9743-8903; GARCIA, MIRIAM NOHEMI N VAZQUEZ/0000-0002-9810-884X; Vicente, Angeles/0000-0002-9456-5541; VICENTE, LIERN/0000-0001-5883-9640; Ramirez, Manuel/0000-0003-0332-6973; Zapata, Agustin G/0000-0003-0576-2672	Spanish Ministry of Science and Innovation [BFU2009-10315, SAF2012-33180, BFU2010-18250]; Spanish Association Against Cancer AECC; Regional Government of Madrid [P2010/BMD-2420-CellCAM]; Network from the Health Institute Carlos III [RD12/0019/0007-TerCell]; Comunidad de Madrid [50053735]; Ministry of Education, Culture and Sports [AP2010-0795]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association Against Cancer AECC; Regional Government of Madrid; Network from the Health Institute Carlos III; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture and Sports	This work was supported by grands BFU2009-10315, SAF2012-33180, and BFU2010-18250 from the Spanish Ministry of Science and Innovation, Spanish Association Against Cancer 2010 AECC; P2010/BMD-2420-CellCAM from Regional Government of Madrid and RD12/0019/0007-TerCell Network from the Health Institute Carlos III. MNVG contract UCM number 50053735 by Comunidad de Madrid. AE grant number AP2010-0795 of Ministry of Education, Culture and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Campioni D, 2006, HAEMATOLOGICA, V91, P364; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Detmer K, 1999, BLOOD CELL MOL DIS, V25, P310, DOI 10.1006/bcmd.1999.0259; Detmer K, 2002, CYTOKINE, V17, P36, DOI 10.1006/cyto.2001.0984; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dosen-Dahl G, 2008, INT J CANCER, V123, P2759, DOI 10.1002/ijc.23833; Farre J, 2007, GROWTH FACTORS, V25, P71, DOI 10.1080/08977190701345200; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Grassinger J, 2007, CYTOKINE, V40, P165, DOI 10.1016/j.cyto.2007.09.004; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khurana S, 2013, BLOOD, V121, P781, DOI 10.1182/blood-2012-07-446443; Klaus M, 2010, STEM CELLS DEV, V19, P1043, DOI 10.1089/scd.2009.0286; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Laperrousaz B, 2013, BLOOD, V122, P3767, DOI 10.1182/blood-2013-05-501460; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Lee JS, 2013, BIOCHEM BIOPH RES CO, V435, P696, DOI 10.1016/j.bbrc.2013.05.045; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; MANABE A, 1992, BLOOD, V79, P2370; Martinez-Laperche C, 2013, AM J HEMATOL, V88, P359, DOI 10.1002/ajh.23407; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Mesa RA, 2005, BLOOD, V105, P973, DOI 10.1182/blood-2004-07-2864; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Ortega JJ, 2001, HAEMATOLOGICA, V86, P586; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schindeler A, 2005, BIOCHEM BIOPH RES CO, V338, P710, DOI 10.1016/j.bbrc.2005.09.198; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Solmesky LJ, 2009, STEM CELLS DEV, V18, P1283, DOI 10.1089/scd.2009.0020; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Varas A, 2009, CELL CYCLE, V8, P4119, DOI 10.4161/cc.8.24.10149; Varga G, 2007, PATHOL ONCOL RES, V13, P311, DOI 10.1007/BF02940310; Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao ZG, 2007, STEM CELLS DEV, V16, P637, DOI 10.1089/scd.2007.0008	55	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84496	10.1371/journal.pone.0084496	http://dx.doi.org/10.1371/journal.pone.0084496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400095	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700029
J	Sousa, A; Ribeiro, J; Sousa, M; Vilas-Boas, JP; Fernandes, RJ				Sousa, Ana; Ribeiro, Joao; Sousa, Marisa; Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.			Influence of Prior Exercise on VO2 Kinetics Subsequent Exhaustive Rowing Performance	PLOS ONE			English	Article							PULMONARY O-2 UPTAKE; OXYGEN-UPTAKE KINETICS; PRIOR HEAVY EXERCISE; HIGH-INTENSITY EXERCISE; LINE METABOLIC-RATE; UPTAKE ON-KINETICS; PRIMING EXERCISE; DEOXYGENATION KINETICS; RECOVERY DURATION; SPRINT EXERCISE	Prior exercise has the potential to enhance subsequent performance by accelerating the oxygen uptake (VO2) kinetics. The present study investigated the effects of two different intensities of prior exercise on pulmonary VO2 kinetics and exercise time during subsequent exhaustive rowing exercise. It was hypothesized that in prior heavy, but not prior moderate exercise condition, overall VO2 kinetics would be faster and the VO2 primary amplitude would be higher, leading to longer exercise time at VO2max. Six subjects (mean +/- SD; age: 22.9 +/- 4.5 yr; height: 181.2 +/- 7.1 cm and body mass: 75.5 +/- 3.4 kg) completed square-wave transitions to 100% of VO2max from three different conditions: without prior exercise, with prior moderate and heavy exercise. VO2 was measured using a telemetric portable gas analyser (K4b(2), Cosmed, Rome, Italy) and the data were modelled using either mono or double exponential fittings. The use of prior moderate exercise resulted in a faster VO2 pulmonary kinetics response (tau(1) = 13.41 +/- 3.96 s), an improved performance in the time to exhaustion (238.8 +/- 50.2 s) and similar blood lactate concentrations ([La-]) values (11.8 +/- 1.7 mmol.L-1) compared to the condition without prior exercise (16.0 +/- 5.56 s, 215.3 +/- 60.1 s and 10.7 +/- 1.2 mmol.L-1, for tau(1), time sustained at VO2max and [La-], respectively). Performance of prior heavy exercise, although useful in accelerating the VO2 pulmonary kinetics response during a subsequent time to exhaustion exercise (tau(1) = 9.18 +/- 1.60 s), resulted in a shorter time sustained at VO2max (155.5 +/- 46.0 s), while [La-] was similar (13.5 +/- 1.7 mmol.L-1) compared to the other two conditions. Although both prior moderate and heavy exercise resulted in a faster pulmonary VO2 kinetics response, only prior moderate exercise lead to improved rowing performance.	[Sousa, Ana; Ribeiro, Joao; Sousa, Marisa; Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.] Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, P-4100 Oporto, Portugal; [Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.] Univ Porto, LABIOMEP, Porto Biomech Lab, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Sousa, A (corresponding author), Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sousa.acm@gmail.com	Fernandes, Ricardo J./A-1040-2012	Fernandes, Ricardo J./0000-0002-5811-0443; Vilas-Boas, J. Paulo/0000-0002-4109-2939; Ribeiro, Joao/0000-0002-7658-4837	Portuguese Foundation for Science and Technology [SFRH/BD/72610/2010]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology - Ref. SFRH/BD/72610/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SJ, 2009, J APPL PHYSIOL, V107, P1743, DOI 10.1152/japplphysiol.00810.2009; Barker AR, 2010, J APPL PHYSIOL, V109, P491, DOI 10.1152/japplphysiol.00139.2010; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; Breese BC, 2012, RESP PHYSIOL NEUROBI, V180, P223, DOI 10.1016/j.resp.2011.11.013; Burnley M, 2005, MED SCI SPORT EXER, V37, P838, DOI 10.1249/01.MSS.0000162617.18250.77; Burnley M, 2002, J APPL PHYSIOL, V93, P167, DOI 10.1152/japplphysiol.01217.2001; Burnley M, 2002, EUR J APPL PHYSIOL, V87, P424, DOI 10.1007/s00421-002-0647-8; Burnley M, 2001, EXP PHYSIOL, V86, P417, DOI 10.1113/eph8602122; Burnley M, 2000, J APPL PHYSIOL, V89, P1387, DOI 10.1152/jappl.2000.89.4.1387; Burnley M, 2011, MED SCI SPORT EXER, V43, P2171, DOI 10.1249/MSS.0b013e31821ff26d; DiMenna FJ, 2008, J APPL PHYSIOL, V105, P538, DOI 10.1152/japplphysiol.90357.2008; DiMenna FJ, 2010, J APPL PHYSIOL, V109, P1148, DOI 10.1152/japplphysiol.00550.2010; DiMenna FJ, 2010, RESP PHYSIOL NEUROBI, V173, P138, DOI 10.1016/j.resp.2010.07.005; DiMenna FJ, 2010, RESP PHYSIOL NEUROBI, V172, P15, DOI 10.1016/j.resp.2010.04.017; DiMenna FJ, 2010, J APPL PHYSIOL, V108, P283, DOI 10.1152/japplphysiol.01047.2009; DiMenna FJ, 2009, RESP PHYSIOL NEUROBI, V169, P16, DOI 10.1016/j.resp.2009.08.001; Ferguson C, 2007, J APPL PHYSIOL, V103, P812, DOI 10.1152/japplphysiol.01410.2006; Fernandes RJ, 2008, INT J SPORTS MED, V29, P145, DOI 10.1055/s-2007-965113; Fernandes RJ, 2012, INT J SPORTS MED, V33, P1010, DOI 10.1055/s-0032-1316362; Gaesser G A, 1996, Exerc Sport Sci Rev, V24, P35; Gerbino A, 1996, J APPL PHYSIOL, V80, P99, DOI 10.1152/jappl.1996.80.1.99; Grassi B, 1996, J APPL PHYSIOL, V80, P988, DOI 10.1152/jappl.1996.80.3.988; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jones A.M., 2005, OXYGEN UPTAKE KINETI; Jones AM, 2003, MED SCI SPORT EXER, V35, P2085, DOI 10.1249/01.MSS.0000099108.55944.C4; Jones AM, 2003, SPORTS MED, V33, P949, DOI 10.2165/00007256-200333130-00002; Jones AM, 2008, RESP PHYSIOL NEUROBI, V161, P182, DOI 10.1016/j.resp.2008.02.001; Jones AM, 2008, EXP PHYSIOL, V93, P468, DOI 10.1113/expphysiol.2007.041897; Jones AM, 2008, J PHYSIOL-LONDON, V586, P889, DOI 10.1113/jphysiol.2007.142026; Jones AM, 2006, J APPL PHYSIOL, V101, P1432, DOI 10.1152/japplphysiol.00436.2006; Koppo K, 2003, EUR J APPL PHYSIOL, V88, P593, DOI 10.1007/s00421-002-0735-9; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Krustrup P, 2001, J PHYSIOL-LONDON, V536, P947, DOI 10.1111/j.1469-7793.2001.00947.x; Palmer CD, 2009, MED SCI SPORT EXER, V41, P221, DOI 10.1249/MSS.0b013e31818313b6; Pringle JSM, 2003, EUR J APPL PHYSIOL, V89, P289, DOI 10.1007/s00421-003-0799-1; Roberts CL, 2005, RESP PHYSIOL NEUROBI, V146, P247, DOI 10.1016/j.resp.2004.12.012; SECHER NH, 1977, ACTA PHYSIOL SCAND, V100, P288, DOI 10.1111/j.1748-1716.1977.tb05952.x; SECHER NH, 1993, SPORTS MED, V15, P24, DOI 10.2165/00007256-199315010-00004; Secher NH, 2006, MED SCI SPORT EXER, V38, P1797, DOI 10.1249/01.mss.0000230343.64000.ac; Simpson LP, 2012, EUR J APPL PHYSIOL, V112, P2467, DOI 10.1007/s00421-011-2214-7; Wilkerson DP, 2007, RESP PHYSIOL NEUROBI, V156, P203, DOI 10.1016/j.resp.2006.09.008; Wilkerson DP, 2004, J APPL PHYSIOL, V97, P1227, DOI 10.1152/japplphysiol.01325.2003	42	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84208	10.1371/journal.pone.0084208	http://dx.doi.org/10.1371/journal.pone.0084208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404156	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800035
J	Chen, SH; Plank, JL; Willcox, S; Griffith, JD; Hsieh, TS				Chen, Stefanie Hartman; Plank, Jody L.; Willcox, Smaranda; Griffith, Jack D.; Hsieh, Tao-shih			Top3 alpha Is Required during the Convergent Migration Step of Double Holliday Junction Dissolution	PLOS ONE			English	Article							TOPOISOMERASE-III-ALPHA; BLOOMS-SYNDROME HELICASE; BRANCH MIGRATION; SYNDROME PROTEIN; BREAK REPAIR; DNA; BLM; MOLECULE; RECOMBINATION; FLUORESCENCE	Although Blm and Top3 alpha are known to form a minimal dissolvasome that can uniquely undo a double Holliday junction structure, the details of the mechanism remain unknown. It was originally suggested that Blm acts first to create a hemicatenane structure from branch migration of the junctions, followed by Top3 alpha performing strand passage to decatenate the interlocking single strands. Recent evidence suggests that Top3 alpha may also be important for assisting in the migration of the junctions. Using a mismatch-dHJ substrate (MM-DHJS) and eukaryotic Top1 (in place of Top3 alpha), we show that the presence of a topoisomerase is required for Blm to substantially migrate a topologically constrained Holliday junction. When investigated by electron microscopy, these migrated structures did not resemble a hemicatenane. However, when Blm is together with Top3 alpha, the dissolution reaction is processive with no pausing at a partially migrated structure. Potential mechanisms are discussed.	[Chen, Stefanie Hartman; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Plank, Jody L.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA; [Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Duke University; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Academia Sinica - Taiwan	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	thsieh@duke.edu		Chen, Stefanie/0000-0002-9550-971X; Plank, Jody/0000-0002-8025-7935	NIH [GM 29006, GM031819]; NSC, Taiwan; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM029006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH GM 29006 and NSC, Taiwan (TSH), and NIH GM031819 (JDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chen SH, 2012, J BIOL CHEM; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karymov MA, 2008, BIOPHYS J, V95, P4372, DOI 10.1529/biophysj.108.135103; Killen MW, 2009, HUM MOL GENET, V18, P3417, DOI 10.1093/hmg/ddp282; Larocque JR, 2011, P NATL ACAD SCI US; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Mayanagi K, 2008, BIOCHEM BIOPH RES CO, V365, P273, DOI 10.1016/j.bbrc.2007.10.165; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Shaiu WL, 1998, MOL CELL BIOL, V18, P4358, DOI 10.1128/MCB.18.7.4358; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Wang X, 2010, P NATL ACAD SCI USA, V107, P12547, DOI 10.1073/pnas.1000105107; Weinstein J, 2008, DNA REPAIR, V7, P558, DOI 10.1016/j.dnarep.2007.12.010; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	32	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83582	10.1371/journal.pone.0083582	http://dx.doi.org/10.1371/journal.pone.0083582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392087	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100011
J	Kim, WK; Kim, D; Cui, J; Jang, HH; Kim, KS; Lee, HJ; Kim, SU; Ahn, SM				Kim, Woo Kyung; Kim, Deokhoon; Cui, Jun; Jang, Ho Hee; Kim, Kwang Sei; Lee, Hong Jun; Kim, Seung U.; Ahn, Sung-Min			Secretome Analysis of Human Oligodendrocytes Derived from Neural Stem Cells	PLOS ONE			English	Article							RECEPTOR/IL-6 FUSION PROTEIN; IN-VITRO DIFFERENTIATION; GROWTH-FACTOR; SPINAL-CORD; MATRIX-METALLOPROTEINASE; INTERLEUKIN-6 IL-6; BRAIN EXPRESSION; PROGENITOR CELLS; MYELIN FORMATION; HUMAN FETAL	In this study, we investigated the secretome of human oligodendrocytes (F3.Olig2 cells) generated from human neural stem cells by transduction with the gene encoding the Olig2 transcription factor. Using mRNA sequencing and protein cytokine arrays, we identified a number of biologically important secretory proteins whose expression has not been previously reported in oligodendrocytes. We found that F3.Olig2 cells secrete IL-6, PDGF-AA, GRO, GM-CSF, and M-CSF, and showed prominent expression of their corresponding receptors. Co-expression of ligands and receptors suggests that autocrine signaling loops may play important roles in both differentiation and maintenance of oligodendrocytes. We also found that F3.Olig2 cells secrete matrix metalloproteinases and matrix metalloproteinase-associated proteins associated with functional competence of oligodendrocytes. The results of our secretome analysis provide insights into the functional and molecular details of human oligodendrocytes. To the best of our knowledge, this is the first systematic analysis of the secretome of oligodendrocytes.	[Kim, Woo Kyung; Cui, Jun; Jang, Ho Hee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Woo Kyung; Kim, Deokhoon; Ahn, Sung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Ctr Canc Genome Discovery,Asan Inst Life Sci, Seoul, South Korea; [Kim, Woo Kyung] BRC Genome Res Ctr, Inchon, South Korea; [Ahn, Sung-Min] Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea; [Kim, Kwang Sei; Lee, Hong Jun; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada	Gachon University; University of Ulsan; Asan Medical Center; University of Ulsan; Chung Ang University; Chung Ang University Hospital; University of British Columbia	Kim, SU (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	sukim@mail.ubc.ca; smahn@amc.seoul.kr		Ahn, Sung-Min/0000-0002-5031-1929	National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [NRF-2011-0014717]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by basic science research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0014717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Ahmed S, 2009, CELL ADHES MIGR, V3, P412, DOI 10.4161/cam.3.4.8803; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Bansal R, 2002, DEV NEUROSCI-BASEL, V24, P35, DOI 10.1159/000064944; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; BUNGE MB, 1962, J CELL BIOL, V12, P448, DOI 10.1083/jcb.12.2.448; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choi JK, 2007, NEUROSCI LETT, V420, P217, DOI 10.1016/j.neulet.2007.03.065; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Copray S, 2006, STEM CELLS, V24, P1001, DOI 10.1634/stemcells.2005-0239; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; delosMonteros AE, 1997, J NEUROSCI RES, V50, P872; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; Filipovic R, 2003, DEV NEUROSCI-BASEL, V25, P279, DOI 10.1159/000072275; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Hosking MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011340; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; KAHN MA, 1994, GLIA, V12, P87, DOI 10.1002/glia.440120202; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; KIM SU, 1990, J NEUROSCI RES, V27, P712, DOI 10.1002/jnr.490270432; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1985, J NEUROIMMUNOL, V10, P141, DOI 10.1016/0165-5728(85)90004-9; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Larsen PH, 2004, J NEUROSCI, V24, P7597, DOI 10.1523/JNEUROSCI.2092-04.2004; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Masaki T, 2012, ISRN NEUROL, V2012, P1; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1246, DOI 10.1056/NEJM198211113072005; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Messersmith DJ, 2000, J NEUROSCI RES, V62, P241, DOI 10.1002/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D; Mewar R, 1997, J NEUROSCI RES, V50, P721, DOI 10.1002/(SICI)1097-4547(19971201)50:5<721::AID-JNR9>3.0.CO;2-J; Mey J, 2002, CELL TISSUE RES, V310, P155, DOI 10.1007/s00441-002-0624-x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Murtie JC, 2005, GLIA, V49, P542, DOI 10.1002/glia.20142; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Paty D, 1988, MULTIPLE SCLEROSIS; PETERS A, 1964, J ANAT, V98, P125; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Relucio J, 2012, GLIA, V60, P1451, DOI 10.1002/glia.22365; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Robinson S, 1998, J NEUROSCI, V18, P10457; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Tsiper MV, 2002, J CELL SCI, V115, P1005; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Valerio A, 2002, MOL CELL NEUROSCI, V21, P602, DOI 10.1006/mcne.2002.1208; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wen S, 2009, CELL ADHES MIGR, V3, P107, DOI 10.4161/cam.3.1.7602; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zhang PL, 2004, STEM CELLS, V22, P344, DOI 10.1634/stemcells.22-3-344	97	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84292	10.1371/journal.pone.0084292	http://dx.doi.org/10.1371/journal.pone.0084292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392122	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100045
J	Zhang, WD; Zu, ZH; Xu, Q; Xu, ZJ; Liu, JJ; Zheng, T				Zhang, Wen-Dou; Zu, Zheng-Hu; Xu, Qing; Xu, Zhi-Jing; Liu, Jin-Jie; Zheng, Tao			Optimized Strategy for the Control and Prevention of Newly Emerging Influenza Revealed by the Spread Dynamics Model	PLOS ONE			English	Article							2009 H1N1 INFLUENZA; TRANSMISSION DYNAMICS; VIRUS-INFECTION; QUARANTINE; HUMANS; SARS	No matching vaccine is immediately available when a novel influenza strain breaks out. Several nonvaccine-related strategies must be employed to control an influenza epidemic, including antiviral treatment, patient isolation, and immigration detection. This paper presents the development and application of two regional dynamic models of influenza with Pontryagin's Maximum Principle to determine the optimal control strategies for an epidemic and the corresponding minimum antiviral stockpiles. Antiviral treatment was found to be the most effective measure to control new influenza outbreaks. In the case of inadequate antiviral resources, the preferred approach was the centralized use of antiviral resources in the early stage of the epidemic. Immigration detection was the least cost-effective; however, when used in combination with the other measures, it may play a larger role. The reasonable mix of the three control measures could reduce the number of clinical cases substantially, to achieve the optimal control of new influenza.	[Zhang, Wen-Dou; Zu, Zheng-Hu; Xu, Qing; Xu, Zhi-Jing; Liu, Jin-Jie; Zheng, Tao] Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China		Zheng, T (corresponding author), Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China.	zt19721@hotmail.com	Xu, Zhijing/E-3220-2013	Xu, Zhijing/0000-0003-1792-4229	Mega-Project on Infectious Disease Prevention of China [2013ZX10004-605, 2012ZX10004-402]; National High Technology Research and Development Program of China (863 Program) [2012AA022007]; Medical Science and Technology Research Projects of Chinese Army [AWS11L009, 13QNP156]; National Natural Science Foundation of China (NSFC) [90924019]	Mega-Project on Infectious Disease Prevention of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Medical Science and Technology Research Projects of Chinese Army; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding was provided by Mega-Project on Infectious Disease Prevention of China (No. 2013ZX10004-605, No. 2012ZX10004-402 (http://www.moh.gov.cn/qjjys/crbfz/list.shtml), National High Technology Research and Development Program of China (863 Program) (No. 2012AA022007), Medical Science and Technology Research Projects of Chinese Army (No. AWS11L009, No. 13QNP156), and National Natural Science Foundation of China (NSFC) (No. 90924019) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barucci E, 2012, APPL MATH COMPUT, V218, P5588, DOI 10.1016/j.amc.2011.11.052; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gupta AG, 2005, J INFECTION, V50, P386, DOI 10.1016/j.jinf.2004.08.006; Howlett P, 1996, AUTOMATICA, V32, P519, DOI 10.1016/0005-1098(95)00184-0; Hsu SB, 2008, B MATH BIOL, V70, P134, DOI 10.1007/s11538-007-9245-6; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jung E, 2009, J THEOR BIOL, V260, P220, DOI 10.1016/j.jtbi.2009.05.031; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kieny MP, 2006, VACCINE, V24, P6367, DOI 10.1016/j.vaccine.2006.07.021; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; Lau JTF, 2006, PREV MED, V43, P406, DOI 10.1016/j.ypmed.2006.06.007; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Liang W, 2012, PUBLIC HEALTH, V126, P427, DOI 10.1016/j.puhe.2012.02.008; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; LOURIZ M, 2009, INT ARCH MED, V3, P26; McLeod MA, 2008, EMERG INFECT DIS, V14, P468, DOI 10.3201/eid1403.070927; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Poletti P, 2011, PLOS ONE, V7, P1; Pontryagin LS., 1987, MATH THEORY OPTIMAL, DOI [10.1201/9780203749319, DOI 10.1201/9780203749319]; Shim E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S4; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003; Yang J, 2009, CLIN INFECT DIS, V49, P1622, DOI 10.1086/644775	34	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84694	10.1371/journal.pone.0084694	http://dx.doi.org/10.1371/journal.pone.0084694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392151	Green Published, gold			2022-12-25	WOS:000329460100074
J	Abraham, AB; Bronstein, R; Reddy, AS; Maletic-Savatic, M; Aguirre, A; Tsirka, SE				Abraham, Ariel B.; Bronstein, Robert; Reddy, Avanish S.; Maletic-Savatic, Mirjana; Aguirre, Adan; Tsirka, Stella E.			Aberrant Neural Stem Cell Proliferation and Increased Adult Neurogenesis in Mice Lacking Chromatin Protein HMGB2	PLOS ONE			English	Article							OLFACTORY-BULB; PROGENITOR CELLS; GERMINAL ZONE; NEURONS; ASTROCYTES; ORGANIZATION; DEMONSTRATE; POPULATION; PRECURSORS; MIGRATE	Neural stem and progenitor cells (NSCs/NPCs) are distinct groups of cells found in the mammalian central nervous system (CNS). Previously we determined that members of the High Mobility Group (HMG) B family of chromatin structural proteins modulate NSC proliferation and self-renewal. Among them HMGB2 was found to be dynamically expressed in proliferating and differentiating NSCs, suggesting that it may regulate NSC maintenance. We report now that Hmgb2(-/-) mice exhibit SVZ hyperproliferation, increased numbers of SVZ NSCs, and a trend towards aberrant increases in newly born neurons in the olfactory bulb (OB) granule cell layer. Increases in the levels of the transcription factor p21 and the Neural cell adhesion molecule (NCAM), along with down-regulation of the transcription/pluripotency factor Oct4 in the Hmgb2(-/-) SVZ point to a possible pathway for this increased proliferation/differentiation. Our findings suggest that HMGB2 functions as a modulator of neurogenesis in young adult mice through regulation of NSC proliferation, and identify a potential target via which CNS repair could be amplified following trauma or disease-based neuronal degeneration.	[Abraham, Ariel B.; Tsirka, Stella E.] SUNY Stony Brook, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Bronstein, Robert] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Maletic-Savatic, Mirjana] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Abraham, Ariel B.] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Abraham, Ariel B.; Bronstein, Robert; Reddy, Avanish S.; Aguirre, Adan; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsirka, SE (corresponding author), SUNY Stony Brook, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA.	styliani-anna.tsirka@stonybrook.edu	Tsirka, Stella/AAD-4018-2019	Maletic-Savatic, Mirjana/0000-0002-6548-4662	National Institute of General Medical Sciences Medical Scientist Training Program [T32GM080444]; American Heart Association [12PRE12060489]; NIH [R01NS42168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by National Institute of General Medical Sciences Medical Scientist Training Program (T32GM080444 to ABA), American Heart Association predoctoral fellowship (12PRE12060489 to RB), and NIH (R01NS42168 to SET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AB, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-18; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Campbell PA, 2013, STEM CELLS; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirzadeh Z., 2010, J VIS EXP; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Petreanu L, 2002, J NEUROSCI, V22, P6106; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ronfani L, 2001, DEVELOPMENT, V128, P1265; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zhen HY, 2012, BIOCHEM BIOPH RES CO, V421, P44, DOI 10.1016/j.bbrc.2012.03.105	39	20	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84838	10.1371/journal.pone.0084838	http://dx.doi.org/10.1371/journal.pone.0084838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391977	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900120
J	Cohen, MR; Huynh, KW; Cawley, D; Moiseenkova-Bell, VY				Cohen, Matthew R.; Huynh, Kevin W.; Cawley, Daniel; Moiseenkova-Bell, Vera Y.			Understanding the Cellular Function of TRPV2 Channel through Generation of Specific Monoclonal Antibodies	PLOS ONE			English	Article							CAPSAICIN-RECEPTOR; ION-CHANNEL; CATION CHANNELS; LINE F-11; TRANSLOCATION; NOCICEPTION; ACTIVATION; EXPRESSION; RESISTANCE; MIGRATION	Transient receptor potential vanilloid 2 (TRPV2) is a Ca2+-permeable nonselective cation channel proposed to play a critical role in a wide array of cellular processes. Although TRPV2 surface expression was originally determined to be sensitive to growth factor signaling, regulated trafficking of TRPV2 has remained controversial. TRPV2 has proven difficult to study due to the lack of specific pharmacological tools to modulate channel activity; therefore, most studies of the cellular function of TRPV2 rely on immuno-detection techniques. Polyclonal antibodies against TRPV2 have not been properly validated and characterized, which may contribute to conflicting results regarding its function in the cell. Here, we developed monoclonal antibodies using full-length TRPV2 as an antigen. Extensive characterization of these antibodies and comparison to commonly used commercially available TRPV2 antibodies revealed that while monoclonal antibodies generated in our laboratory were suitable for detection of endogenous TRPV2 by western blot, immunoprecipitation and immunocytochemistry, the commercially available polyclonal antibodies we tested were not able to recognize endogenous TRPV2. We used our newly generated and validated TRPV2 antibodies to determine the effects of insulin-like growth factor 1 (IGF-1) on TRPV2 surface expression in heterologous and endogenous expression systems. We found that IGF-1 had little to no effect on trafficking and plasma membrane expression of TRPV2. Overall, these new TRPV2 monoclonal antibodies served to dispel the controversy of the effects of IGF-1 on TRPV2 plasma membrane expression and will clarify the role TRPV2 plays in cellular function. Furthermore, our strategy of using full-length tetrameric TRP channels may allow for the generation of antibodies against other TRP channels of unclear function.	[Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cohen, Matthew R.; Huynh, Kevin W.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Cawley, Daniel] Oregon Hlth & Sci Univ, Monoclonal Antibody Core Facil, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Case Western Reserve University; Case Western Reserve University; Oregon Health & Science University	Moiseenkova-Bell, VY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	vxm102@case.edu			American Heart Association (NCRP Scientist Development Grant) [11SDG5280029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103899] Funding Source: NIH RePORTER	American Heart Association (NCRP Scientist Development Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (NCRP Scientist Development Grant 11SDG5280029)[www.heart.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colton C. K., 2007, V179, P173; Harlow D., 1988, ANTIBODIES LAB MANUA; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Jahnel R, 2003, EUR J BIOCHEM, V270, P4264, DOI 10.1046/j.1432-1033.2003.03811.x; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Meissner M, 2012, LESSONS STUDYING TRP; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Monet M, 2010, CANCER RES, V70, P1225, DOI 10.1158/0008-5472.CAN-09-2205; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nabissi M, 2013, CARCINOGENESIS, V34, P48, DOI 10.1093/carcin/bgs328; Nabissi M, 2010, CARCINOGENESIS, V31, P794, DOI 10.1093/carcin/bgq019; Nedungadi TP, 2012, EXP NEUROL, V237, P223, DOI 10.1016/j.expneurol.2012.06.017; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Peralvarez-Marin A, 2013, FEBS J; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85392	10.1371/journal.pone.0085392	http://dx.doi.org/10.1371/journal.pone.0085392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392006	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900150
J	Fekete, T; Zach, N; Mujica-Parodi, LR; Turner, MR				Fekete, Tomer; Zach, Neta; Mujica-Parodi, Lilianne R.; Turner, Martin R.			Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DIFFUSION TENSOR; BRAIN NETWORK; ALS; NEURODEGENERATION; DEGENERATION; PEOPLE; CORTEX; SCALE	There is significant clinical and prognostic heterogeneity in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), despite a common immunohistological signature. Consistent extra-motor as well as motor cerebral, spinal anterior horn and distal neuromuscular junction pathology supports the notion of ALS a system failure. Establishing a disease biomarker is a priority but a simplistic, coordinate-based approach to brain dysfunction using MRI is not tenable. Resting-state functional MRI reflects the organization of brain networks at the systems-level, and so changes in of motor functional connectivity were explored to determine their potential as the substrate for a biomarker signature. Intra-as well as inter-motor functional networks in the 0.03-0.06 Hz frequency band were derived from 40 patients and 30 healthy controls of similar age, and used as features for pattern detection, employing multiple kernel learning. This approach enabled an accurate classification of a group of patients that included a range of clinical sub-types. An average of 13 regions-of-interest were needed to reach peak discrimination. Subsequent analysis revealed that the alterations in motor functional connectivity were widespread, including regions not obviously clinically affected such as the cerebellum and basal ganglia. Complex network analysis showed that functional networks in ALS differ markedly in their topology, reflecting the underlying altered functional connectivity pattern seen in patients: 1) reduced connectivity of both the cortical and subcortical motor areas with non motor areas 2) reduced subcortical-cortical motor connectivity and 3) increased connectivity observed within sub-cortical motor networks. This type of analysis has potential to non-invasively define a biomarker signature at the systems-level. As the understanding of neurodegenerative disorders moves towards studying pre-symptomatic changes, there is potential for this type of approach to generate biomarkers for the testing of neuroprotective strategies.	[Fekete, Tomer; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, New York, NY USA; [Zach, Neta] Univ Penn, Biol Basis Behav Program, Philadelphia, PA 19104 USA; [Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; University of Oxford	Turner, MR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	martin.turner@ndcn.ox.ac.uk		Turner, Martin/0000-0003-0267-3180; Fekete, Tomer/0000-0003-3164-125X; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519	National Science Foundation; Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship; MRC [MR/K01014X/1, G0701923] Funding Source: UKRI; Medical Research Council [G0701923, MR/K01014X/1] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish; Div Of Chem, Bioeng, Env, & Transp Sys [0954643] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	TF and LRMP are funded by the National Science Foundation. MRT is funded by the Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Agosta F, 2011, CEREB CORTEX, V21, P2291, DOI 10.1093/cercor/bhr002; Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Benatar M, 2012, NEUROLOGY, V79, P1732, DOI 10.1212/WNL.0b013e31826e9b1d; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cao J, 1999, ADV APPL PROBAB, V31, P579, DOI 10.1239/aap/1029955192; Carew JD, 2011, NEUROLOGY, V77, P1370, DOI 10.1212/WNL.0b013e318231526a; Castro E, 2011, NEUROIMAGE, V58, P526, DOI 10.1016/j.neuroimage.2011.06.044; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Eisen A, 2013, AMYOTROPH LATERAL SC; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062867; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gordon PH, 2006, NEUROLOGY, V66, P647, DOI 10.1212/01.wnl.0000200962.94777.71; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kollewe K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/608501; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Leung CC, 2007, PHYSICA A, V378, P591, DOI 10.1016/j.physa.2006.12.022; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Luo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045470; Mahoney CJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt144; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ng MC, 2008, J MAGN RESON IMAGING, V27, P8, DOI 10.1002/jmri.21217; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Reading SAJ, 2004, ANN NEUROL, V55, P879, DOI 10.1002/ana.20121; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sherman AV, 2013, AMYOTROPH LAT SCL FR, V14, P53, DOI 10.3109/21678421.2013.779058; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Tedeschi G, 2012, NEUROBIOL AGING, V33, P886, DOI 10.1016/j.neurobiolaging.2010.07.011; Trojsi F, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/473538; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Turner MR, 2012, AMYOTROPH LATERAL SC, V13, P245, DOI 10.3109/17482968.2011.636050; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Turner MR, 2005, BRAIN, V128, P1323, DOI 10.1093/brain/awh509; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Verstraete E., 2013, HUM BRAIN MAPP; Verstraete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024239; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Welsh Robert C, 2013, Front Hum Neurosci, V7, P251, DOI 10.3389/fnhum.2013.00251; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008	59	44	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85190	10.1371/journal.pone.0085190	http://dx.doi.org/10.1371/journal.pone.0085190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391997	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900140
J	Smith, AO; Bowers, SLK; Stratman, AN; Davis, GE				Smith, Annie O.; Bowers, Stephanie L. K.; Stratman, Amber N.; Davis, George E.			Hematopoietic Stem Cell Cytokines and Fibroblast Growth factor-2 Stimulate Human Endothelial Cell-Pericyte Tube Co-Assembly in 3D Fibrin Matrices under Serum-Free Defined Conditions	PLOS ONE			English	Article							AORTIC RING MODEL; LUMEN FORMATION; EXTRACELLULAR-MATRIX; VASCULAR MORPHOGENESIS; MOLECULAR-MECHANISMS; CAPILLARY LUMEN; ANGIOGENESIS; REQUIRES; REGRESSION; VASCULOGENESIS	We describe a novel 3D fibrin matrix model using recombinant hematopoietic stem cell cytokines under serum-free defined conditions which promotes the assembly of human endothelial cell (EC) tubes with co-associated pericytes. Individual ECs and pericytes are randomly mixed together and EC tubes form that is accompanied by pericyte recruitment to the EC tube abluminal surface over a 3-5 day period. These morphogenic processes are stimulated by a combination of the hematopoietic stem cell cytokines, stem cell factor, interleukin-3, stromal derived factor-1 alpha, and Flt-3 ligand which are added in conjunction with fibroblast growth factor (FGF)-2 into the fibrin matrix. In contrast, this tube morphogenic response does not occur under serum-free defined conditions when VEGF and FGF-2 are added together in the fibrin matrices. We recently demonstrated that VEGF and FGF-2 are able to prime EC tube morphogenic responses (i.e. added overnight prior to the morphogenic assay) to hematopoietic stem cell cytokines in collagen matrices and, interestingly, they also prime EC tube morphogenesis in 3D fibrin matrices. EC-pericyte interactions in 3D fibrin matrices leads to marked vascular basement membrane assembly as demonstrated using immunofluorescence and transmission electron microscopy. Furthermore, we show that hematopoietic stem cell cytokines and pericytes stimulate EC sprouting in fibrin matrices in a manner dependent on the alpha 5 beta 1 integrin. This novel co-culture system, under serum-free defined conditions, allows for a molecular analysis of EC tube assembly, pericyte recruitment and maturation events in a critical ECM environment (i.e. fibrin matrices) that regulates angiogenic events in postnatal life.	[Davis, George E.] Dalton Cardiovasc Sci Ctr, Dept Med Pharmacol & Physiol, Columbia, MO USA; Univ Missouri, Sch Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia	Davis, GE (corresponding author), Dalton Cardiovasc Sci Ctr, Dept Med Pharmacol & Physiol, Columbia, MO USA.	davisgeo@health.missouri.edu			NIH [HL108670, HL105606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105606, R01HL108670] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by two NIH grants that are listed, which are HL105606 and HL108670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AC, 2009, AM J PHYSIOL-CELL PH, V297, pC471, DOI 10.1152/ajpcell.00019.2009; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis GE, 2001, J CELL SCI, V114, P917; Davis GE, 2012, MOL TRANSLATIONAL VA, P169; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; Davis GE, 2013, METHODS MOL BIOL, V1066, P17, DOI 10.1007/978-1-62703-604-7_2; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Iacobas I, 2010, ARTERIOSCL THROM VAS, V30, P1110, DOI 10.1161/ATVBAHA.109.191601; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Sacharidou A, 2010, BLOOD; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stratman AN, 2012, TXB ANGIOGENESIS LYM, P101; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Zhu WH, 2003, J VASC RES, V40, P140, DOI 10.1159/000070711	47	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85147	10.1371/journal.pone.0085147	http://dx.doi.org/10.1371/journal.pone.0085147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391990	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900133
J	Zajac, P; Islam, S; Hochgerner, H; Lonnerberg, P; Linnarsson, S				Zajac, Pawel; Islam, Saiful; Hochgerner, Hannah; Lonnerberg, Peter; Linnarsson, Sten			Base Preferences in Non-Templated Nucleotide Incorporation by MMLV-Derived Reverse Transcriptases	PLOS ONE			English	Article							FULL-LENGTH CDNA; RNA-SEQ; SAMPLES; BIAS	Reverse transcriptases derived from Moloney Murine Leukemia Virus (MMLV) have an intrinsic terminal transferase activity, which causes the addition of a few non-templated nucleotides at the 3' end of cDNA, with a preference for cytosine. This mechanism can be exploited to make the reverse transcriptase switch template from the RNA molecule to a secondary oligonucleotide during first-strand cDNA synthesis, and thereby to introduce arbitrary barcode or adaptor sequences in the cDNA. Because the mechanism is relatively efficient and occurs in a single reaction, it has recently found use in several protocols for single-cell RNA sequencing. However, the base preference of the terminal transferase activity is not known in detail, which may lead to inefficiencies in template switching when starting from tiny amounts of mRNA. Here, we used fully degenerate oligos to determine the exact base preference at the template switching site up to a distance of ten nucleotides. We found a strong preference for guanosine at the first non-templated nucleotide, with a greatly reduced bias at progressively more distant positions. Based on this result, and a number of careful optimizations, we report conditions for efficient template switching for cDNA amplification from single cells.	[Zajac, Pawel; Islam, Saiful; Hochgerner, Hannah; Lonnerberg, Peter; Linnarsson, Sten] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022	Hochgerner, Hannah/0000-0002-7739-666X	Swedish Foundation for Strategic Research [MDB09-0052]; European Research Council [261063/BRAINCELL]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Swedish Foundation for Strategic Research (MDB09-0052) and the European Research Council (261063/BRAINCELL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pinto FL, 2010, ANAL BIOCHEM, V397, P227, DOI 10.1016/j.ab.2009.10.022; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/nmeth.1470, 10.1038/NMETH.1470]; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Salimullah M., 2011, COLD SPRING HARBOR P, V2011; Schmidt W M, 1999, Nucleic Acids Res, V27, pe31, DOI 10.1093/nar/27.21.e31; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Tang DTP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1128; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zajac P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00821; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	24	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85270	10.1371/journal.pone.0085270	http://dx.doi.org/10.1371/journal.pone.0085270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392002	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900145
J	Lopez-Fernandez, L; Ruiz-Roldan, C; Pareja-Jaime, Y; Prieto, A; Khraiwesh, H; Roncero, MIG				Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Prieto, Alicia; Khraiwesh, Husam; Roncero, M. Isabel G.			The Fusarium oxysporum gnt2, Encoding a Putative N-Acetylglucosamine Transferase, Is Involved in Cell Wall Architecture and Virulence	PLOS ONE			English	Article							PROTEIN O-MANNOSYLATION; OLIGOSACCHARIDE STRUCTURES; FUSARIUM-OXYSPORUM; CANDIDA-ALBICANS; GOLGI-APPARATUS; MANNOSYLTRANSFERASE PMT4; ENDOPLASMIC-RETICULUM; PATTERN-RECOGNITION; MOLECULAR-CLONING; USTILAGO-MAYDIS	With the aim to decipher the molecular dialogue and cross talk between Fusarium oxysporum f. sp. lycopersci and its host during infection and to understand the molecular bases that govern fungal pathogenicity, we analysed genes presumably encoding N-acetylglucosaminyl transferases, involved in glycosylation of glycoproteins, glycolipids, proteoglycans or small molecule acceptors in other microorganisms. In silico analysis revealed the existence of seven putative N-glycosyl transferase encoding genes (named gnt) in F. oxysporum f. sp. lycopersici genome. gnt2 deletion mutants showed a dramatic reduction in virulence on both plant and animal hosts. Delta gnt2 mutants had alpha alterations in cell wall properties related to terminal alpha or beta-linked N-acetyl glucosamine. Mutant conidia and germlings also showed differences in structure and physicochemical surface properties. Conidial and hyphal aggregation differed between the mutant and wild type strains, in a pH independent manner. Transmission electron micrographs of germlings showed strong cell-to-cell adherence and the presence of an extracellular chemical matrix. Delta gnt2 cell walls presented a significant reduction in N-linked oligosaccharides, suggesting the involvement of Gnt2 in N-glycosylation of cell wall proteins. Gnt2 was localized in Golgi-like sub-cellular compartments as determined by fluorescence microscopy of GFP:: Gnt2 fusion protein after treatment with the antibiotic brefeldin A or by staining with fluorescent sphingolipid BODIPY-TR ceramide. Furthermore, density gradient ultracentrifugation allowed co-localization of GFP:: Gnt2 fusion protein and Vps10p in subcellular fractions enriched in Golgi specific enzymatic activities. Our results suggest that N-acetylglucosaminyl transferases are key components for cell wall structure and influence interactions of F. oxysporum with both plant and animal hosts during pathogenicity.	[Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Roncero, M. Isabel G.] Univ Cordoba, Dept Genet, Cordoba, Spain; [Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Roncero, M. Isabel G.] Campus Excelencia Agroalimentario CeiA3, Cordoba, Spain; [Prieto, Alicia] CSIC, Ctr Invest Biol, Madrid, Spain; [Khraiwesh, Husam] Univ Cordoba, Dept Biol Celular Fisiol & Inmunol, Cordoba, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Cordoba	Roncero, MIG (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	roncero@uco.es	Prieto, Alicia/M-7899-2017; Roldán, Carmen Ruiz/AAB-2100-2019; Roncero, M. Isabel G./M-2496-2014	Prieto, Alicia/0000-0002-5075-4025; Ruiz Roldan, M. Carmen/0000-0003-3427-2998; Lopez-Fernandez, Loida/0000-0002-6270-9301; Roncero, M. Isabel G./0000-0002-5283-7836	Ministerio de Ciencia y Tecnologia of Spain [BIO2010-015505]; Junta de Andalucia [P08-CVI-3847]; Ministerio de Ciencia y Tecnologia	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Ministerio de Ciencia y Tecnologia (BIO2010-015505) of Spain, and Junta de Andalucia (P08-CVI-3847). L.L.F. was supported by a PhD fellowship from the former Ministerio de Ciencia y Tecnologia. L.L.F. was supported by a PhD fellowship from the former Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrazem O, 2000, ARCH MICROBIOL, V173, P296, DOI 10.1007/s002030000149; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bai C, 2006, EUKARYOT CELL, V5, P238, DOI 10.1128/EC.5.2.238-247.2006; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Buse E, 1998, HISTOCHEM J, V30, P819, DOI 10.1023/A:1003550612096; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4; DANHASH N, 1993, PLANT MOL BIOL, V22, P1017, DOI 10.1007/BF00028974; de Wit P J G M, 2007, Cell Mol Life Sci, V64, P2726; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fernandez-Alvarez A, 2010, PLANT SIGNAL BEHAV, V5, P412, DOI 10.4161/psb.5.4.10805; Fernandez-Alvarez A, 2010, FUNGAL GENET BIOL, V47, P727, DOI 10.1016/j.fgb.2010.06.004; Fernandez-Alvarez A, 2009, PLANT CELL, V21, P3397, DOI 10.1105/tpc.109.065839; Garcia-Pedrajas MD, 2010, METHODS MOL BIOL, V638, P55, DOI 10.1007/978-1-60761-611-5_5; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hall T., 2004, BIOEDIT; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERNANDEZ LM, 1992, BIOCHEMISTRY-US, V31, P9823, DOI 10.1021/bi00155a039; Herrero AB, 2002, EUKARYOT CELL, V1, P420, DOI 10.1128/EC.1.3.420-431.2002; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; LEHLE L, 1979, J BIOL CHEM, V254, P2209; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lengeler KB, 2008, CELL MOL LIFE SCI, V65, P528, DOI 10.1007/s00018-007-7409-z; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; LIS H, 1986, ANNU REV BIOCHEM, V55, P35, DOI 10.1146/annurev.bi.55.070186.000343; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lopez-Avalos MD, 2001, GLYCOBIOLOGY, V11, P413, DOI 10.1093/glycob/11.5.413; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Motteram J, 2011, MOL MICROBIOL, V81, P415, DOI 10.1111/j.1365-2958.2011.07701.x; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Odani T, 1997, FEBS LETT, V420, P186, DOI 10.1016/S0014-5793(97)01513-5; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pareja-Jaime Y, 2010, MOL PLANT PATHOL, V11, P479, DOI [10.1111/j.1364-3703.2010.00624.x, 10.1111/J.1364-3703.2010.00624.X]; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Peumans WJ, 1998, CRIT REV BIOCHEM MOL, V33, P209; Priegnitz BE, 2012, FUNGAL GENET BIOL, V49, P30, DOI 10.1016/j.fgb.2011.12.002; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rocha ALM, 2008, MOL PLANT PATHOL, V9, P293, DOI 10.1111/J.1364-3703.2007.00463.X; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Schirawski J, 2005, PLANT CELL, V17, P3532, DOI 10.1105/tpc.105.036285; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Strasser R, 1999, GLYCOBIOLOGY, V9, P779, DOI 10.1093/glycob/9.8.779; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351; Yang DH, 2000, HISTOCHEM J, V32, P187, DOI 10.1023/A:1004051408239; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063	87	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84690	10.1371/journal.pone.0084690	http://dx.doi.org/10.1371/journal.pone.0084690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24416097	Green Published, gold			2022-12-25	WOS:000329117900106
J	Moy, I; Todorovic, V; Dubash, AD; Coon, JS; Parker, JB; Buranapramest, M; Huang, CC; Zhao, H; Green, KJ; Bulun, SE				Moy, I.; Todorovic, V.; Dubash, A. D.; Coon, J. S.; Parker, J. B.; Buranapramest, M.; Huang, C. C.; Zhao, H.; Green, K. J.; Bulun, S. E.			Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells	ONCOGENE			English	Article						sushi domain containing 3; estrogen receptor; aromatase inhibitors; breast cancer; migration	FOCAL ADHESION KINASE; AROMATASE INHIBITORS; MESENCHYMAL TRANSITION; RHO-GTPASES; RECEPTOR; EXPRESSION; CADHERIN; THERAPY; PREDICTORS; DYNAMICS	Aromatase inhibitors (AIs) are the standard endocrine therapy for postmenopausal breast cancer; however, currently used biomarkers, such as, estrogen receptor-alpha/progesterone receptor (ER alpha/PR), predict only slightly more than half of the potential responders to AI treatment. To identify novel markers of AI responsiveness, a genome-wide microarray analysis was performed using primary breast tumor samples from 50 postmenopausal women who later developed metastatic breast cancer. Sushi domain containing 3 (SUSD3) is a significantly differentially expressed gene, with 3.38-fold higher mRNA levels in AI-responsive breast tumors vs non-responders (P<0.001). SUSD3 was highly expressed in ER alpha-positive breast tumors and treatment with estradiol increased SUSD3 expression in ERa-positive breast cancer cells. Treatment with an antiestrogen or ER alpha knockdown abolished basal and estradiol-dependent SUSD3 expression. Recruitment of ERa upstream of the transcription start site of SUSD3 was demonstrated by chromatin immunoprecipitation-PCR. Flow cytometric analysis of SUSD3-knockdown cells revealed blunted estradiol effects on progression into S and M phases. SUSD3 was localized to the plasma membrane of breast cancer cells. SUSD3 knockdown decreased the appearance of actin-rich protrusions, stress fibers and large basal focal adhesions, while increasing the presence of cortical actin concomitant with a decrease in Rho and focal adhesion kinase activity. SUSD3-deficient cells demonstrated diminished cell spreading, cell-cell adhesion and motility. In conclusion, SUSD3 is a novel promoter of estrogen-dependent cell proliferation and regulator of cell-cell and cell-substrate interactions and migration in breast cancer. It may serve as a novel predictor of response to endocrine therapy and potential therapeutic target.	[Moy, I.; Coon, J. S.; Parker, J. B.; Buranapramest, M.; Zhao, H.; Bulun, S. E.] Northwestern Univ, Dept Obstet & Gynecol, Div Reprod Biol, Feinberg Sch Med, Chicago, IL 60610 USA; [Todorovic, V.; Dubash, A. D.; Green, K. J.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60610 USA; [Huang, C. C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60610 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bulun, SE (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Div Reprod Biol, 303 East Super,Suite 4-123, Chicago, IL 60610 USA.	s-bulun@northwestern.edu		Zhao, Hong/0000-0003-4616-3123	AVON Foundation; Northwestern Memorial Foundation Dixon Priority Initiative Grant; National Cancer Institute [CA122151]; NCI CCSG [P30 CA060553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD038691] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA070085, P30CA060553, R01CA122151, R01CA067167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER	AVON Foundation; Northwestern Memorial Foundation Dixon Priority Initiative Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI CCSG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the AVON Foundation (to SEB), a Northwestern Memorial Foundation Dixon Priority Initiative Grant (SEB) and National Cancer Institute (CA122151, to KJG). The imaging work performed at Northwestern University Cell Imaging Facility was supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. We thank Satya Khuon for her assistance in our confocal work. We thank Mitch Dowsett, Helen Cotterill, Roger A'Hern, Ben Haynes and Ian Smith from the Royal Marsden Hospital in London, England, for making the patient samples available.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Ahn RW, 2010, CLIN CANCER RES, V16, P3607, DOI 10.1158/1078-0432.CCR-10-0068; Anderson H, 2011, ANN ONCOL, V22, P1770, DOI 10.1093/annonc/mdq700; Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bernhard J, 1999, J CLIN ONCOL, V17, P1672, DOI 10.1200/JCO.1999.17.6.1672; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Chakravarty D, 2010, CANCER RES, V70, P4092, DOI 10.1158/0008-5472.CAN-09-3834; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Jacobberger JW, 2000, IMMUNOPHENOTYPING, P361; Juan G, 2004, CURR PROTOC CYTOMETR; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; KNIGHT WA, 1980, CLIN ENDOCRINOL META, V9, P361, DOI 10.1016/S0300-595X(80)80038-7; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li Y, 2010, ENDOCRINOLOGY, V151, P5146, DOI 10.1210/en.2009-1506; Lin Z, 2010, ONCOGENE, V29, P1114, DOI 10.1038/onc.2009.409; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Miller WR, 2006, MATURITAS, V54, P335, DOI 10.1016/j.maturitas.2006.04.020; Miller WR, 2010, EXPERT OPIN PHARMACO, V11, P1873, DOI 10.1517/14656566.2010.487863; Moy I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077543; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Provenzano PP, 2009, CELL ADHES MIGR, V3, P347, DOI 10.4161/cam.3.4.9458; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Schug J, 2008, CURR PROTOC BIOINFOR; Sieg DJ, 1999, J CELL SCI, V112, P2677; Smith IE, 2006, J CLIN ONCOL, V24, P2444, DOI 10.1200/JCO.2005.05.3694; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stuart-Harris R, 2009, BREAST, V18, P351, DOI 10.1016/j.breast.2009.09.002; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	56	10	11	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					362	372		10.1038/onc.2013.553	http://dx.doi.org/10.1038/onc.2013.553			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24413080	Green Accepted			2022-12-25	WOS:000348145500010
J	Ichikawa, M; Scott, DA; Losfeld, ME; Freeze, HH				Ichikawa, Mie; Scott, David A.; Losfeld, Marie-Estelle; Freeze, Hudson H.			The Metabolic Origins of Mannose in Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GC-MS; Genetic Diseases; Glucose Metabolism; Glycoconjugate; Metabolic Tracers	PHOSPHOMANNOSE ISOMERASE DEFICIENCY; N-GLYCOSYLATION; GLYCOGEN-PHOSPHORYLASE; MASS-SPECTROMETRY; CARBOHYDRATE; FIBROBLASTS; THERAPY; GLUCOSE; ACTIVATION; CORRECTS	Background: Metabolic origins of mannose in glycoproteins have not been studied. Results: Glucose is the major source of N-glycan mannose, but exogenous mannose provides up to 50%. Man salvaged from glycoprotein turnover, glycogen, and gluconeogenesis is insignificant. Conclusion: Exogenous mannose is incorporated into N-glycans much more efficiently than that derived from glucose. Significance: This study provides quantitation of metabolic origins of Man in N-glycans. Mannose in N-glycans is derived from glucose through phosphomannose isomerase (MPI, Fru-6-P Man-6-P) whose deficiency causes a congenital disorder of glycosylation (CDG)-Ib (MPI-CDG). Mannose supplements improve patients' symptoms because exogenous mannose can also directly contribute to N-glycan synthesis through Man-6-P. However, the quantitative contributions of these and other potential pathways to glycosylation are still unknown. We developed a sensitive GC-MS-based method using [1,2-C-13]glucose and [4-C-13]mannose to measure their contribution to N-glycans synthesized under physiological conditions (5 mm glucose and 50 m mannose). Mannose directly provides approximate to 10-45% of the mannose found in N-glycans, showing up to a 100-fold preference for mannose over exogenous glucose based on their exogenous concentrations. Normal human fibroblasts normally derive 25-30% of their mannose directly from exogenous mannose, whereas MPI-deficient CDG fibroblasts with reduced glucose flux secure 80% of their mannose directly. Thus, both MPI activity and exogenous mannose concentration determine the metabolic flux into the N-glycosylation pathway. Using various stable isotopes, we found that gluconeogenesis, glycogen, and mannose salvaged from glycoprotein degradation do not contribute mannose to N-glycans in fibroblasts under physiological conditions. This quantitative assessment of mannose contribution and its metabolic fate provides information that can help bolster therapeutic strategies for treating glycosylation disorders with exogenous mannose.	[Ichikawa, Mie; Losfeld, Marie-Estelle; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Human Genet Program, La Jolla, CA 92037 USA; [Scott, David A.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Scott, David/0000-0002-8668-2449; Freeze, Hudson/0000-0001-6316-0501	Rocket Fund; National Institutes of Health [R01DK55615]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Rocket Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by The Rocket Fund and by National Institutes of Health Grant R01DK55615 (to H. H. F).	Gill A, 2002, J BIOL CHEM, V277, P44747, DOI 10.1074/jbc.M205001200; Grempler R, 2012, FEBS LETT, V586, P248, DOI 10.1016/j.febslet.2011.12.027; Halket JM, 2003, EUR J MASS SPECTROM, V9, P1, DOI 10.1255/ejms.527; Harms HK, 2002, ACTA PAEDIATR, V91, P1065, DOI 10.1080/080352502760311566; Kjaergaard S, 1998, ACTA PAEDIATR, V87, P884, DOI 10.1080/080352598750013680; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; Malaisse WJ, 2004, ENDOCRINE, V24, P105, DOI 10.1385/ENDO:24:2:105; Mayatepek E, 1998, EUR J PEDIATR, V157, P605, DOI 10.1007/s004310050889; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Panneerselvam K, 1997, J BIOL CHEM, V272, P23123, DOI 10.1074/jbc.272.37.23123; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; ROSE IA, 1973, J BIOL CHEM, V248, P2232; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Sickmann HM, 2005, NEUROCHEM RES, V30, P1295, DOI 10.1007/s11064-005-8801-4; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393	26	42	42	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6751	6761		10.1074/jbc.M113.544064	http://dx.doi.org/10.1074/jbc.M113.544064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407290	Green Published, hybrid			2022-12-25	WOS:000332389400036
J	Banerjee, P; Bandyopadhyay, A				Banerjee, Priyam; Bandyopadhyay, Arun			Cytosolic Dynamics of Annexin A6 Trigger Feedback Regulation of Hypertrophy via Atrial Natriuretic Peptide in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Annexin; Cardiac Hypertrophy; Cell Biology; Microscopy; Natriuretic Peptides; Protein Dynamics; Signaling; Trafficking	CARDIAC-HYPERTROPHY; PHOSPHOLIPID-BINDING; SECRETORY VESICLES; MEMBRANE-BINDING; VI; HEART; PROTEIN; MECHANISMS; CELL; AGGREGATION	Background: Altered annexin A6 expression is associated with several cardiovascular disorders, including myocyte hypertrophy, but precise functions of the protein remain elusive. Results: Dynamic association of annexin A6 with intracellular atrial natriuretic peptide precursor protects against adrenergic stimulation-induced hypertrophy of H9c2 cardiomyocytes. Conclusion: Annexin A6 negatively regulates hypertrophic progression of cardiomyocytes. Significance: Annexin A6 exhibits potential for antihypertrophic therapeutics. Malfunctions in regulatory pathways that control cell size are prominent in pathological cardiac hypertrophy. Here, we show annexin A6 (Anxa6) to be a crucial regulator of atrial natriuretic peptide (ANP)-mediated counterhypertrophic responses in cardiomyocytes. Adrenergic stimulation of H9c2 cardiomyocytes by phenylephrine (PE) increased the cell size with enhanced expression of biochemical markers of hypertrophy, concomitant with elevated expression and subcellular redistribution of Anxa6. Stable cell lines with controlled increase in Anxa6 levels were protected against PE-induced adverse changes, whereas Anxa6 knockdown augmented the hypertrophic responses. Strikingly, Anxa6 knockdown also abrogated PE-induced juxtanuclear accumulation of secretory granules (SG) containing ANP propeptides (pro-ANP), a signature of maladaptive hypertrophy having counteractive functions. Mechanistically, PE treatment prompted a dynamic association of Anxa6 with pro-ANP-SG, parallel to their participation in anterograde traffic, in an isoform-specific fashion. Moreover, Anxa6 mutants that failed to associate with pro-ANP hindered ANP-mediated protection against hypertrophy, which was rescued, at least partially, by WT Anxa6. Additionally, elevated intracellular calcium (Ca2+) stimulated Anxa6-pro-ANP colocalization and membrane association. It also rescued pro-ANP translocation in cells expressing an Anxa6 mutant (Anxa6(C)). Furthermore, stable overexpression of Anxa6(T356D), a mutant with superior flexibility, provided enhanced protection against PE, compared with WT, presumably due to enhanced membrane-binding capacity. Together, the present study delivers a cooperative mechanism where Anxa6 potentiates ANP-dependent counterhypertrophic responses in cardiomyocytes by facilitating regulated traffic of pro-ANP.	[Banerjee, Priyam; Bandyopadhyay, Arun] CSIR, Indian Inst Chem Biol, Cell Biol & Physiol Div, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, A (corresponding author), CSIR, Indian Inst Chem Biol, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	arunb@iicb.res.in	Banerjee, Priyam/D-2363-2011	Banerjee, Priyam/0000-0001-9398-9345	CSIR; Wellcome Trust	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Professor Anna Huttenlocher (University of Wisconsin, Madison, WI) for the tol2-mpx-Dendra2 construct, Swapan Mondal for laboratory assistance, and Thangamuniyadi Muruganandan and Diptadeep Sarkar for technical support with AFM and spinning disc microscopy, respectively. A. B. gratefully acknowledges the Central Confocal and Atomic Force Microscopy Facility at IICB (funded by CSIR) and the CSIR-IICB Live Cell Imaging Facility (co-funded by the Wellcome Trust and CSIR) for the imaging experiments.	Ayala-Sanmartin J, 2001, BIOCHEM BIOPH RES CO, V283, P72, DOI 10.1006/bbrc.2001.4748; Baertschi AJ, 2001, CIRC RES, V89, pE23, DOI 10.1161/hh1501.095715; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; Calvieri C, 2012, J MOL MED, V90, P5, DOI 10.1007/s00109-011-0801-z; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Canaff L, 1996, P NATL ACAD SCI USA, V93, P9483, DOI 10.1073/pnas.93.18.9483; Chen MZ, 2012, MOL CELL BIOCHEM, V371, P77, DOI 10.1007/s11010-012-1424-6; Chlystun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053774; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; CREUTZ CE, 1992, BIOCHEM BIOPH RES CO, V184, P347, DOI 10.1016/0006-291X(92)91199-Z; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; De K, 2004, J ENDOCRINOL, V182, P303, DOI 10.1677/joe.0.1820303; Donnelly SR, 1997, CELL MOL LIFE SCI, V53, P533, DOI 10.1007/s000180050068; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; DOUBELL AF, 1991, HYPERTENSION, V18, P648, DOI 10.1161/01.HYP.18.5.648; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; Frentzou GA, 2010, MOL CELL BIOCHEM, V345, P119, DOI 10.1007/s11010-010-0565-8; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Freye-Minks C, 2003, BIOCHEMISTRY-US, V42, P620, DOI 10.1021/bi026742h; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; GOLDBERG M, 1991, CELL TISSUE RES, V263, P81, DOI 10.1007/BF00318402; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; HAZARIKA P, 1991, J CELL BIOCHEM, V46, P78, DOI 10.1002/jcb.240460112; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; JACKLE S, 1994, J BIOL CHEM, V269, P1026; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; KAETZEL MA, 1994, BBA-MOL CELL RES, V1223, P368, DOI 10.1016/0167-4889(94)90097-3; Klaiber M, 2010, BASIC RES CARDIOL, V105, P583, DOI 10.1007/s00395-010-0098-z; Koese M, 2013, ONCOGENE, V32, P2858, DOI 10.1038/onc.2012.303; Locate S, 2008, CELL BIOL INT, V32, P1388, DOI 10.1016/j.cellbi.2008.08.009; Ma HL, 2012, J VIROL, V86, P1789, DOI 10.1128/JVI.06003-11; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Masedunskas A, 2012, TRAFFIC, V13, P627, DOI 10.1111/j.1600-0854.2012.01328.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mishra S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-7; Molkentin JD, 2003, J CLIN INVEST, V111, P1275, DOI 10.1172/JCI200318389; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; O'Donnell PJ, 2003, J MOL CELL CARDIOL, V35, P915, DOI 10.1016/S0022-2828(03)00171-8; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Podszywalow-Bartnicka P, 2010, J CELL BIOCHEM, V111, P168, DOI 10.1002/jcb.22685; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Rosenkranz AC, 2003, CARDIOVASC RES, V57, P515, DOI 10.1016/S0008-6363(02)00667-3; Rybkin II, 2007, J CELL BIOL, V179, P527, DOI 10.1083/jcb.200707101; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song GJ, 1998, J MOL CELL CARDIOL, V30, P443, DOI 10.1006/jmcc.1997.0608; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sztolsztener ME, 2010, ARCH BIOCHEM BIOPHYS, V493, P221, DOI 10.1016/j.abb.2009.11.001; THIBAULT G, 1992, AM J PHYSIOL, V262, pC907, DOI 10.1152/ajpcell.1992.262.4.C907; Trouve P, 1999, AM J PHYSIOL-HEART C, V276, pH1159, DOI 10.1152/ajpheart.1999.276.4.H1159; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567	60	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5371	5385		10.1074/jbc.M113.514810	http://dx.doi.org/10.1074/jbc.M113.514810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403064	Green Published, hybrid			2022-12-25	WOS:000332015500003
J	Noam, Y; Ehrengruber, MU; Koh, A; Feyen, P; Manders, EMM; Abbott, GW; Wadman, WJ; Baram, TZ				Noam, Yoav; Ehrengruber, Markus U.; Koh, Annie; Feyen, Paul; Manders, Erik M. M.; Abbott, Geoffrey W.; Wadman, Wytse J.; Baram, Tallie Z.			Filamin A Promotes Dynamin-dependent Internalization of Hyperpolarization-activated Cyclic Nucleotide-gated Type 1 (HCN1) Channels and Restricts I-h in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Endocytosis; Ion Channels; Neurons; Trafficking; HCN; Ih; Filamin A	BINDING PROTEIN FILAMIN; SURFACE EXPRESSION; ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; POTASSIUM CHANNEL; PYRAMIDAL NEURONS; EXCITABILITY; LOCALIZATION; TRIP8B; COLOCALIZATION	Background: HCN channels influence neuronal excitability. Results: Filamin-A (FLNa) facilitated selective, reversible dynamin-dependent internalization of HCN1 and reduced I-h. In hippocampal neurons, dominant-negative FLNa enhanced native HCN1, and decoy peptides disrupting HCN1-FLNa binding reduced channel clustering and augmented endogenous I-h. Conclusion: FLNa modulates neuronal excitability via dynamin-mediated HCN1 endocytosis. Significance: Novel roles for FLNa in mature neuronal function are presented. The actin-binding protein filamin A (FLNa) regulates neuronal migration during development, yet its roles in the mature brain remain largely obscure. Here, we probed the effects of FLNa on the regulation of ion channels that influence neuronal properties. We focused on the HCN1 channels that conduct I-h, a hyperpolarization-activated current crucial for shaping intrinsic neuronal properties. Whereas regulation of HCN1 channels by FLNa has been observed in melanoma cell lines, its physiological relevance to neuronal function and the underlying cellular pathways that govern this regulation remain unknown. Using a combination of mutational, pharmacological, and imaging approaches, we find here that FLNa facilitates a selective and reversible dynamin-dependent internalization of HCN1 channels in HEK293 cells. This internalization is accompanied by a redistribution of HCN1 channels on the cell surface, by accumulation of the channels in endosomal compartments, and by reduced I-h density. In hippocampal neurons, expression of a truncated dominant-negative FLNa enhances the expression of native HCN1. Furthermore, acute abrogation of HCN1-FLNa interaction in neurons, with the use of decoy peptides that mimic the FLNa-binding domain of HCN1, abolishes the punctate distribution of HCN1 channels in neuronal cell bodies, augments endogenous I-h, and enhances the rebound-response (voltage-sag) of the neuronal membrane to transient hyperpolarizing events. Together, these results support a major function of FLNa in modulating ion channel abundance and membrane trafficking in neurons, thereby shaping their biophysical properties and function.	[Noam, Yoav; Ehrengruber, Markus U.; Koh, Annie; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat Neurobiol & Pediat, Irvine, CA 92697 USA; [Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Feyen, Paul; Wadman, Wytse J.] Univ Amsterdam, SILS Ctr Neurosci, NL-1098 XH Amsterdam, Netherlands; [Manders, Erik M. M.] Univ Amsterdam, van Leeuwenhoek Ctr Adv Microscopy, NL-1098 XH Amsterdam, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Amsterdam; University of Amsterdam	Baram, TZ (corresponding author), Univ Calif Irvine, Med Sci 1,ZOT 4475, Irvine, CA 92697 USA.	tallie@uci.edu	Baram, Tallie Z/J-6447-2014		National Institutes of Health [R37 NS35439, T32 NS45540]; Netherlands Organization for Scientific Research; Dutch National Epilepsy Fund Grant [NEF 08-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035439, T32NS045540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch National Epilepsy Fund Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS35439 and T32 NS45540 (to T. Z. B. and Y. N.). This work was also supported by a Rubicon grant from the Netherlands Organization for Scientific Research (to Y. N.) and Dutch National Epilepsy Fund Grant NEF 08-01 (to W. J. W.).	Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; D'Amelio M, 2012, PROG NEUROBIOL, V99, P42, DOI 10.1016/j.pneurobio.2012.07.001; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jung S, 2011, J NEUROSCI, V31, P14291, DOI 10.1523/JNEUROSCI.1148-11.2011; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Liao ZD, 2011, CHANNELS, V5, P115, DOI 10.4161/chan.5.2.14195; Lin RW, 2002, PHARMACOLOGY, V66, P173, DOI 10.1159/000065531; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lu Q, 2010, J ALZHEIMERS DIS, V22, P235, DOI 10.3233/JAD-2010-100585; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Minsaas L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012212; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Narayanan R, 2010, NEURON, V68, P921, DOI 10.1016/j.neuron.2010.11.033; Noam Y, 2012, J COMP NEUROL, V520, P3013, DOI 10.1002/cne.23106; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Petrecca K, 2000, J NEUROSCI, V20, P8736; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Saito Y, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-50; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suphamungmee W, 2012, J MOL BIOL, V424, P248, DOI 10.1016/j.jmb.2012.09.025; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Tsang SY, 2004, J BIOL CHEM, V279, P43752, DOI 10.1074/jbc.M408747200; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang HY, 2012, J NEUROSCI, V32, P9773, DOI 10.1523/JNEUROSCI.0354-12.2012; Zhang WJ, 1998, J NEUROSCI, V18, P914	68	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5889	5903		10.1074/jbc.M113.522060	http://dx.doi.org/10.1074/jbc.M113.522060			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24403084	hybrid, Green Published			2022-12-25	WOS:000332015500046
J	Singh, V; Lin, R; Yang, JB; Cha, B; Sarker, R; Tse, CM; Donowitz, M				Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark			AKT and GSK-3 Are Necessary for Direct Ezrin Binding to NHE3 as Part of a C-terminal Stimulatory Complex ROLE OF A NOVEL SER-RICH NHE3 C-TERMINAL MOTIF IN NHE3 ACTIVITY AND TRAFFICKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Ezrin; Membrane; Phosphorylation; Trafficking; Na+; H+ Exchanger; Absorption; Alpha Helix	BORDER NA+/H+ EXCHANGER; GLYCOGEN-SYNTHASE KINASE-3; ISOFORM 3; MOLECULAR PHYSIOLOGY; BASAL ACTIVITY; ERM PROTEINS; INHIBITION; DOMAIN; PHOSPHORYLATION; ACTIVATION	Background: Phosphoinositides and ezrin form a complex with NHE3, which stimulates basal transport activity. How this complex is regulated is unknown. Results: GSK-3 and Akt stimulate NHE3 activity by changing ezrin binding. Conclusion: Sequential effects of two kinase regulate the association of NHE3 with ezrin to affect basal activity. Significance: A novel Ser cluster in the NHE3 C-terminal domain regulates its ezrin binding. Basal activity of the BB Na+/H+ exchanger NHE3 requires multiprotein complexes that form on its C terminus. One complex stimulates basal NHE3 activity and contains ezrin and phosphoinositides as major components; how it stimulates NHE3 activity is not known. This study tested the hypothesis that ezrin dynamically associates with this complex, which sets ezrin binding. NHE3 activity was reduced by an Akt(i). This effect was eliminated if ezrin binding to NHE3 was inhibited by a point mutant. Recombinant AKT phosphorylated NHE3 C terminus in the domain ezrin directly binds. This domain (amino acids 475-589) is predicted to be -helical and contains a conserved cluster of three serines (Ser(515), Ser(522), and Ser(526)). Point mutations of two of these (S515A, S515D, or S526A) reduced basal NHE3 activity and surface expression and had no Akt(i) inhibition. S526D had NHE3 activity equal to wild type with normal Akt(i) inhibition. Ezrin binding to NHE3 was regulated by Akt, being eliminated by Akt(i). NHE3-S515A and -S526D did not bind ezrin; NHE3-S515D had reduced ezrin binding; NHE3-S526D bound ezrin normally. NHE3-Ser(526) is predicted to be a GSK-3 kinase phosphorylation site. A GSK-3 inhibitor reduced basal NHE3 activity as well as ezrin-NHE3 binding, and this effect was eliminated in NHE3-S526A and -S526D mutants. The conclusions were: 1) NHE3 basal activity is regulated by a signaling complex that is controlled by sequential effects of two kinases, Akt and GSK-3, which act on a Ser cluster in the same NHE3 C-terminal domain that binds ezrin; and 2) these kinases regulate the dynamic association of ezrin with NHE3 to affect basal NHE3 activity.	[Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Singh, Varsha; Lin, Rong; Yang, Jianbo; Cha, Boyoung; Sarker, Rafiquel; Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Lin, Rong] Huazhong Univ Sci & Technol, Tongji Med Sch, Union Hosp, Tongji Med Coll,Div Gastroenterol, Wuhan 430074, Peoples R China	Johns Hopkins University; Johns Hopkins University; Huazhong University of Science & Technology	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Ross 925,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Yang, Jianbo/G-1254-2013		National Institutes of Health [R01DK26523, R01DK61765, P01DK072084, K08DK088950]; Conte Hopkins Digestive Diseases Basic and Translational Research Core Center from NIDDK, National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, R01DK026523, P01DK072084, K08DK088950, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Hopkins Digestive Diseases Basic and Translational Research Core Center from NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK26523, R01DK61765, P01DK072084, and K08DK088950. This work was also supported by Conte Hopkins Digestive Diseases Basic and Translational Research Core Center Grant P30DK089502 from NIDDK, National Institutes of Health.	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2008, CLIN EXP PHARMACOL P, V35, P863, DOI 10.1111/j.1440-1681.2008.04931.x; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Donowitz M, 2000, ANN NY ACAD SCI, V915, P30; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Lee-Kwon W, 2001, J BIOL CHEM, V276, P31296, DOI 10.1074/jbc.M103900200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Noel J, 1996, J CELL SCI, V109, P929; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Sandu C, 2006, AM J PHYSIOL-GASTR L, V291, pG868, DOI 10.1152/ajpgi.00023.2006; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Singh V, 2014, CLIN GASTROENTEROL H, V12, P27, DOI 10.1016/j.cgh.2013.10.020; Wagner U, 1996, J CELL SCI, V109, P1537; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; YUN CHC, 1995, P NATL ACAD SCI USA, V92, P10723, DOI 10.1073/pnas.92.23.10723; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	50	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5449	5461		10.1074/jbc.M113.521336	http://dx.doi.org/10.1074/jbc.M113.521336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398676	hybrid, Green Published			2022-12-25	WOS:000332015500009
J	Kline, CF; Scott, J; Curran, J; Hund, TJ; Mohler, PJ				Kline, Crystal F.; Scott, John; Curran, Jerry; Hund, Thomas J.; Mohler, Peter J.			Ankyrin-B Regulates Ca(v)2.1 and Ca(v)2.2 Channel Expression and Targeting*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Cytoskeleton; Ion Channels; Membrane Trafficking; Protein Sorting; Protein Targeting	GATED CALCIUM-CHANNELS; AXON INITIAL SEGMENT; G-PROTEIN MODULATION; BETA-GAMMA-SUBUNITS; CA2+ CHANNELS; N-TYPE; SYNAPTIC-TRANSMISSION; PURKINJE-CELLS; CARDIAC DEATH; MICE LACKING	Background: Calcium channels control membrane excitability. The mechanisms underlying Ca(v)2.1/Ca(v)2.2 targeting are not well understood. Results: Ankyrin-B associates with Ca(v)2.1/Ca(v)2.2. Loss of ankyrin-B results in reduced expression of Ca(v)2.1/Ca(v)2.2 in select brain regions. Conclusion: Ankyrin-B plays a role in the expression of Ca(v)2.1/Ca(v)2.2. Significance: Results identify pathway for membrane targeting of calcium channels and regulation of membrane excitability. N-type and P/Q-type calcium channels are documented players in the regulation of synaptic function; however, the mechanisms underlying their expression and cellular targeting are poorly understood. Ankyrin polypeptides are essential for normal integral membrane protein expression in a number of cell types, including neurons, cardiomyocytes, epithelia, secretory cells, and erythrocytes. Ankyrin dysfunction has been linked to defects in integral protein expression, abnormal cellular function, and disease. Here, we demonstrate that ankyrin-B associates with Ca(v)2.1 and Ca(v)2.2 in cortex, cerebellum, and brain stem. Additionally, using in vitro and in vivo techniques, we demonstrate that ankyrin-B, via its membrane-binding domain, associates with a highly conserved motif in the DII/III loop domain of Ca(v)2.1 and Ca(v)2.2. Further, we demonstrate that this domain is necessary for proper targeting of Ca(v)2.1 and Ca(v)2.2 in a heterologous system. Finally, we demonstrate that mutation of a single conserved tyrosine residue in the ankyrin-binding motif of both Ca(v)2.1 (Y797E) and Ca(v)2.2 (Y788E) results in loss of association with ankyrin-B in vitro and in vivo. Collectively, our findings identify an interaction between ankyrin-B and both Ca(v)2.1 and Ca(v)2.2 at the amino acid level that is necessary for proper Ca(v)2.1 and Ca(v)2.2 targeting in vivo.	[Kline, Crystal F.; Scott, John; Curran, Jerry; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kline, CF (corresponding author), Dorothy M Davis Heart & Lung Res Inst, 473 W 12th Ave,DHLRI 110G, Columbus, OH 43210 USA.	faith.kline@osumc.edu	Curran, Jerry W/B-9762-2012		National Institutes of Health [HL084583, HL083422, HL114383, HL096805, HL114893]; American Heart Association; Saving Tiny Hearts Society; Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114383, R01HL084583, R00HL096805, R01HL114893, K99HL096805, R01HL083422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Saving Tiny Hearts Society; Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583, HL083422, and HL114383 (to P. J. M.) and HL096805 and HL114893 (to T. J. H.). This work was also supported by the American Heart Association (to P. J. M.), the Saving Tiny Hearts Society (to P. J. M.), and The Ohio State University William D. and Jacquelyn L. Wells Fund for Cardiovascular Research (to P. J. M.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheever TR, 2013, INT REV CEL MOL BIO, V301, P157, DOI 10.1016/B978-0-12-407704-1.00004-X; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Indriati DW, 2013, J NEUROSCI, V33, P3668, DOI 10.1523/JNEUROSCI.2921-12.2013; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Kim C, 2009, J BIOL CHEM, V284, P2738, DOI 10.1074/jbc.M807179200; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Luvisetto S, 2006, NEUROSCIENCE, V142, P823, DOI 10.1016/j.neuroscience.2006.06.049; Miller RJ, 1997, TRENDS NEUROSCI, V20, P189, DOI 10.1016/S0166-2236(96)01037-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mohler PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001051; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2011, J MOL CELL CARDIOL, V50, P939, DOI 10.1016/j.yjmcc.2011.04.003; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Nooney JM, 1996, EUR J PHARMACOL, V306, P41, DOI 10.1016/0014-2999(96)00195-1; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	52	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5285	5295		10.1074/jbc.M113.523639	http://dx.doi.org/10.1074/jbc.M113.523639			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394417	Green Published, hybrid			2022-12-25	WOS:000331607900069
J	Castilla-Ortega, E; Escuredo, L; Bilbao, A; Pedraza, C; Orio, L; Estivill-Torrus, G; Santin, LJ; de Fonseca, FR; Pavon, FJ				Castilla-Ortega, Estela; Escuredo, Leticia; Bilbao, Ainhoa; Pedraza, Carmen; Orio, Laura; Estivill-Torrus, Guillermo; Santin, Luis J.; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco			1-Oleoyl Lysophosphatidic Acid: A New Mediator of Emotional Behavior in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; RECEPTOR-DEFICIENT MICE; ELEVATED PLUS-MAZE; PROTEIN-KINASE-C; PERIAQUEDUCTAL GRAY; ANXIOLYTIC-LIKE; LPA RECEPTORS; ANIMAL-MODELS; ANXIETY; ACTIVATION	The role of lysophosphatidic acid (LPA) in the control of emotional behavior remains to be determined. We analyzed the effects of the central administration of 1-oleoyl-LPA (LPA 18:1) in rats tested for food consumption and anxiety-like and depression-like behaviors. For this purpose, the elevated plus-maze, open field, Y maze, forced swimming and food intake tests were performed. In addition, c-Fos expression in the dorsal periaqueductal gray matter (DPAG) was also determined. The results revealed that the administration of LPA 18:1 reduced the time in the open arms of the elevated plus-maze and induced hypolocomotion in the open field, suggesting an anxiogenic-like phenotype. Interestingly, these effects were present following LPA 18:1 infusion under conditions of novelty but not under habituation conditions. In the forced swimming test, the administration of LPA 18:1 dose-dependently increased depression-like behavior, as evaluated according to immobility time. LPA treatment induced no effects on feeding. However, the immunohistochemical analysis revealed that LPA 18:1 increased c-Fos expression in the DPAG. The abundant expression of the LPA(1) receptor, one of the main targets for LPA 18:1, was detected in this brain area, which participates in the control of emotional behavior, using immunocytochemistry. These findings indicate that LPA is a relevant transmitter potentially involved in normal and pathological emotional responses, including anxiety and depression.	[Castilla-Ortega, Estela; Bilbao, Ainhoa; Orio, Laura; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga IBIMA, Unidad Gest,Clin Salud Mental, E-29071 Malaga, Spain; [Castilla-Ortega, Estela; Pedraza, Carmen; Santin, Luis J.] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain; [Escuredo, Leticia; Orio, Laura; Rodriguez de Fonseca, Fernando] Univ Complutense Madrid, Dept Psicobiol, Madrid, Spain; [Estivill-Torrus, Guillermo] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga IBIMA, Unidad Gest,Clin Neurociencias, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Complutense University of Madrid; Universidad de Malaga	Santin, LJ (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain.	luis@uma.es; fernando.rodriguez@fundacionimabis.org	Castilla-Ortega, Estela/K-2811-2015; Santin, Luis Javier LJ/G-4364-2011; Benitez, Carmen Pedraza/K-2328-2017; Torrús, Guillermo Estivill/L-5157-2015; Orio, Laura/F-4827-2016; Bilbao, Ainhoa/AAW-6230-2020; Pavón Morón, Francisco Javier/AAG-9721-2020; Santin, Luis Javier/G-4364-2011	Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier LJ/0000-0003-0894-8536; Benitez, Carmen Pedraza/0000-0002-0011-2817; Torrús, Guillermo Estivill/0000-0002-7124-2678; Orio, Laura/0000-0002-9614-4062; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Santin, Luis Javier/0000-0003-1755-6497; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER [RD06/0001/0000, RD12/0028/0001]; Ministerio de Ciencia e Innovacion [SEJ2007-61187, PSI2010-16160, SAF2010-20521]; I3SNS Programme; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [CTS-433, CTS-065]; Instituto de Salud Carlos III	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); I3SNS Programme; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The present study was supported through funding from the Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER RD06/0001/0000 and RD12/0028/0001 (F.R.d.F. and F.J.P.), Ministerio de Ciencia e Innovacion SEJ2007-61187 and PSI2010-16160 (L.J.S.), and SAF2010-20521 (F.R.d.F.), I3SNS Programme (G.E.O.), and Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (grants CTS-433 and CTS-065). E.C.O. received a 'Sara Borrell' fellowship from the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060918; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Blanco E, 2012, PSYCHOPHARMACOLOGY, V220, P27, DOI 10.1007/s00213-011-2446-6; Brandao ML, 2003, EUR J PHARMACOL, V463, P225, DOI 10.1016/S0014-2999(03)01284-6; BRITTON DR, 1982, LIFE SCI, V31, P363, DOI 10.1016/0024-3205(82)90416-7; CALLAERTSVEGH Z, 2012, GENES BRAIN BEHAV; Casarotto PC, 2010, INT J NEUROPSYCHOPH, V13, P573, DOI 10.1017/S146114570999112X; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Castilla-Ortega E, 2012, BEHAV BRAIN RES, V232, P400, DOI 10.1016/j.bbr.2012.04.018; Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Castilla-Ortega E, 2010, NEUROBIOL LEARN MEM, V94, P73, DOI 10.1016/j.nlm.2010.04.003; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; DRAGO F, 1986, BRAIN RES, V368, P287, DOI 10.1016/0006-8993(86)90573-1; Dubin AE, 1999, J NEUROSCI, V19, P1371; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Garcia-Fernandez M, 2012, INT J NEUROSCI, V122, P583, DOI 10.3109/00207454.2012.693998; Gomez R, 2002, J NEUROSCI, V22, P9612; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Handford EJ, 2001, NEUROREPORT, V12, P757, DOI 10.1097/00001756-200103260-00029; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; HEILIG M, 1993, NEUROPSYCHOPHARMACOL, V8, P357, DOI 10.1038/npp.1993.35; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hogg S, 2006, NEUROPHARMACOLOGY, V51, P141, DOI 10.1016/j.neuropharm.2006.03.009; Jimenez-Velazquez G, 2010, BRAIN RES, V1349, P11, DOI 10.1016/j.brainres.2010.06.014; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Litvin Y, 2007, HORM BEHAV, V52, P244, DOI 10.1016/j.yhbeh.2007.04.012; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Muscella A, 2003, J CELL PHYSIOL, V195, P234, DOI 10.1002/jcp.10242; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Navarro M, 1996, J NEUROCHEM, V67, P1982; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Navarro M, 1996, BEHAV BRAIN RES, V75, P91, DOI 10.1016/0166-4328(96)00176-3; Nishikawa H, 2004, BIOL PHARM BULL, V27, P352, DOI 10.1248/bpb.27.352; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEDRAZA C, 2013, BRAIN STRUCT FUNCT; Pilpel Y, 2006, J NEUROCHEM, V97, P1379, DOI 10.1111/j.1471-4159.2006.03825.x; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Reyes-Cabello C, 2012, PHARMACOL BIOCHEM BE, V101, P1, DOI 10.1016/j.pbb.2011.11.011; Roberts C, 2005, NEUROCHEM RES, V30, P371, DOI 10.1007/s11064-005-2611-6; Ryan PJ, 2011, NEUROSCI BIOBEHAV R, V35, P1326, DOI 10.1016/j.neubiorev.2011.02.004; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Sela VR, 2011, NEUROSCI LETT, V495, P63, DOI 10.1016/j.neulet.2011.03.040; Shin TJ, 2012, MOL CELLS, V34, P563, DOI 10.1007/s10059-012-0254-4; TAKAHASHI LK, 1989, BEHAV NEUROSCI, V103, P648, DOI 10.1037/0735-7044.103.3.648; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; TSUDA T, 1986, FEBS LETT, V208, P39, DOI 10.1016/0014-5793(86)81527-7; Vahidy WH, 2006, EXP BRAIN RES, V174, P781, DOI 10.1007/s00221-006-0672-7; Veloso A, 2011, ANAL BIOANAL CHEM, V401, P89, DOI 10.1007/s00216-011-4882-x; Weiner JA, 1998, J COMP NEUROL, V398, P587; Xiao ZY, 2012, HIPPOCAMPUS, V22, P1438, DOI 10.1002/hipo.20984; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Zarrindast MR, 2001, PHARMACOL BIOCHEM BE, V69, P9, DOI 10.1016/S0091-3057(01)00518-4	69	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85348	10.1371/journal.pone.0085348	http://dx.doi.org/10.1371/journal.pone.0085348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409327	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500051
J	Vormoor, B; Knizia, HK; Batey, MA; Almeida, GS; Wilson, I; Dildey, P; Sharma, A; Blair, H; Hide, IG; Heidenreich, O; Vormoor, J; Maxwell, RJ; Bacon, CM				Vormoor, Britta; Knizia, Henrike K.; Batey, Michael A.; Almeida, Gilberto S.; Wilson, Ian; Dildey, Petra; Sharma, Abhishek; Blair, Helen; Hide, I. Geoff; Heidenreich, Olaf; Vormoor, Josef; Maxwell, Ross J.; Bacon, Chris M.			Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ZOLEDRONIC ACID; SURVIVAL ANALYSIS; STEM-CELLS; NUDE-MOUSE; GROWTH; TUMORS; MICE; ESTABLISHMENT; OSTEOSARCOMA	Ewing sarcoma and osteosarcoma represent the two most common primary bone tumours in childhood and adolescence, with bone metastases being the most adverse prognostic factor. In prostate cancer, osseous metastasis poses a major clinical challenge. We developed a preclinical orthotopic model of Ewing sarcoma, reflecting the biology of the tumour-bone interactions in human disease and allowing in vivo monitoring of disease progression, and compared this with models of osteosarcoma and prostate carcinoma. Human tumour cell lines were transplanted into non-obese diabetic/severe combined immunodeficient (NSG) and Rag2(-/-) gamma c(-/-) mice by intrafemoral injection. For Ewing sarcoma, minimal cell numbers (1000-5000) injected in small volumes were able to induce orthotopic tumour growth. Tumour progression was studied using positron emission tomography, computed tomography, magnetic resonance imaging and bioluminescent imaging. Tumours and their interactions with bones were examined by histology. Each tumour induced bone destruction and outgrowth of extramedullary tumour masses, together with characteristic changes in bone that were well visualised by computed tomography, which correlated with post-mortem histology. Ewing sarcoma and, to a lesser extent, osteosarcoma cells induced prominent reactive new bone formation. Osteosarcoma cells produced osteoid and mineralised "malignant'' bone within the tumour mass itself. Injection of prostate carcinoma cells led to osteoclast-driven osteolytic lesions. Bioluminescent imaging of Ewing sarcoma xenografts allowed easy and rapid monitoring of tumour growth and detection of tumour dissemination to lungs, liver and bone. Magnetic resonance imaging proved useful for monitoring soft tissue tumour growth and volume. Positron emission tomography proved to be of limited use in this model. Overall, we have developed an orthotopic in vivo model for Ewing sarcoma and other primary and secondary human bone malignancies, which resemble the human disease. We have shown the utility of small animal bioimaging for tracking disease progression, making this model a useful assay for preclinical drug testing.	[Vormoor, Britta; Knizia, Henrike K.; Batey, Michael A.; Almeida, Gilberto S.; Wilson, Ian; Sharma, Abhishek; Blair, Helen; Heidenreich, Olaf; Vormoor, Josef; Maxwell, Ross J.; Bacon, Chris M.] Newcastle Univ, Newcastle Canc Ctr, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dildey, Petra; Hide, I. Geoff; Bacon, Chris M.] Newcastle Upon Tyne Hosp, NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Vormoor, Britta; Vormoor, Josef] Great North Childrens Hosp, Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Bacon, CM (corresponding author), Newcastle Univ, Newcastle Canc Ctr, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	chris.bacon@ncl.ac.uk	Heidenreich, Olaf/AAP-5045-2021; Sharma, Abhishek/V-9874-2018; Vormoor, Josef/GPS-7248-2022	Heidenreich, Olaf/0000-0001-5404-6483; Sharma, Abhishek/0000-0003-2554-1025; Vormoor, Josef/0000-0002-1825-1890; Bacon, Chris/0000-0002-8268-2812	Bone Cancer Research Trust; Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund; Newcastle Healthcare Charity; Academy of medical Sciences/Wellcome Trust/; Wellcome trust [087961]; Cancer Research UK [10348] Funding Source: researchfish	Bone Cancer Research Trust; Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund; Newcastle Healthcare Charity; Academy of medical Sciences/Wellcome Trust/(Wellcome Trust); Wellcome trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was generously supported by grants from the Bone Cancer Research Trust/www. bonecancerresearch.org.uk, Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund/www.neccr.org.uk and Newcastle Healthcare Charity (all to JV) and by a Clinical Lecturer's Starter Grant from the Academy of medical Sciences/Wellcome Trust/www.acmedsci.ac.uk (to BV). The IVIS Spectrum was funded by a grant from the Wellcome trust, grant 087961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bomken S, 2013, LEUKEMIA, V27, P718, DOI 10.1038/leu.2012.206; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Dalal S, 2009, EUR J CANCER, V45, P713, DOI 10.1016/j.ejca.2008.11.045; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Franzius C, 2006, EUR J NUCL MED MOL I, V33, P1432, DOI 10.1007/s00259-006-0106-6; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Hauer K, 2013, CANCER RES, V73, P967, DOI 10.1158/0008-5472.CAN-12-1492; Henry MD, 2005, PROSTATE, V65, P347, DOI 10.1002/pros.20300; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Labrinidis A, 2009, CLIN CANCER RES, V15, P3451, DOI 10.1158/1078-0432.CCR-08-1616; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; LOKESHWAR BL, 1993, CANCER RES, V53, P4493; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Montague R, 2004, EUR UROL, V46, P389, DOI 10.1016/j.eururo.2004.04.022; NAGLE RB, 1994, J CELL BIOCHEM, P232; Nargund VH, 2007, UROLOGICAL ONCOLOGY; Odri GA, 2010, CANCER RES, V70, P7610, DOI 10.1158/0008-5472.CAN-09-4272; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Paulussen M, 1998, J CLIN ONCOL, V16, P3044, DOI 10.1200/JCO.1998.16.9.3044; Paulussen M, 2001, J CLIN ONCOL, V19, P1818, DOI 10.1200/JCO.2001.19.6.1818; Paulussen M, 1998, ANN ONCOL, V9, P275, DOI 10.1023/A:1008208511815; Reinus WR, 1984, RADIOGRAPHICS, V4, P929; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sampson ER, 2011, J BONE MINER RES, V26, P1283, DOI 10.1002/jbmr.336; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Soos G, 1997, ANTICANCER RES, V17, P4253; VANVALEN F, 1992, J CANCER RES CLIN, V118, P269, DOI 10.1007/BF01208615; Vormoor J, 2001, PEDIATR RES, V49, P332, DOI 10.1203/00006450-200103000-00006; Wang YX, 2009, IN VIVO, V23, P903; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; Winter GE, 2011, MOL CANCER THER, V10, P1846, DOI 10.1158/1535-7163.MCT-11-0100; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhou ZC, 2005, CANCER-AM CANCER SOC, V104, P1713, DOI 10.1002/cncr.21383	41	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85128	10.1371/journal.pone.0085128	http://dx.doi.org/10.1371/journal.pone.0085128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409320	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500044
J	Chen, W; Xu, YF; Li, H; Tao, WY; Xiang, Y; Huang, B; Niu, JQ; Zhong, J; Meng, GX				Chen, Wei; Xu, Yongfen; Li, Hua; Tao, Wanyin; Xiang, Yu; Huang, Bing; Niu, Junqi; Zhong, Jin; Meng, Guangxun			HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PLASMA INTERLEUKIN-18 LEVELS; INDUCIBLE GENE-I; RIG-I; INFECTION; REPLICATION; RECOGNITION; PROTEIN; ENHANCEMENT; ASSOCIATION	Background: Elevated plasma levels of IL-1 beta and IL-18 from patients with hepatitis C virus (HCV) infection indicate a possible activation of inflammasome by HCV. Methodology/Principal Findings: To demonstrate whether HCV infection activates the inflammasome, we investigated inflammasome activation from HCV infected hepatic Huh7 cells, or monocytic cells and THP-1 derived macrophages challenged with HCV virions, but no any inflammasome activation was detected in these cells. However, when we transfected HCV genomic RNA into monocytes or macrophages, IL-1 beta was secreted in a dose-dependent manner. We also detected ASC oligomerization and caspase-1 cleavage in HCV RNA transfected macrophages. Using shRNA-mediated gene silencing or specific inhibitors, we found that HCV RNA-induced IL-1 beta secretion was dependent on the presence of inflammasome components such as NLRP3, ASC and caspase-1. Furthermore, we also found that RIG-I was dispensable for HCV RNA-induced NLRP3 inflammasome activation, while reactive oxygen species (ROS) production was required. Conclusions: Our results indicate that HCV RNA activates the NLRP3 inflammasome in a ROS-dependent manner, and RIG-I is not required for this process.	[Chen, Wei; Xu, Yongfen; Li, Hua; Tao, Wanyin; Xiang, Yu; Huang, Bing; Zhong, Jin; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Jilin University	Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	jzhong@sibs.ac.cn; gxmeng@sibs.ac.cn	Xu, Yongfen/CAF-5582-2022; Zhong, Jin/J-4613-2019; li, hua/I-1881-2016; Tao, Wanyin/AAR-9230-2020; Zhong, Jin/M-6859-2018	Xu, Yongfen/0000-0002-2845-7753; li, hua/0000-0001-6367-4764; Xiang, Yu/0000-0001-8333-0782; Zhong, Jin/0000-0002-3554-1275	Chinese Academy of Sciences; Natural Science Foundation of China [91029707, 31170868]; Novo Nordisk-CAS Research Foundation; SA-SIBS Scholarship Program; National Key Programs on Infectious Disease [2012ZX10002007-003]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); SA-SIBS Scholarship Program; National Key Programs on Infectious Disease	This work was supported by grants from 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (91029707, 31170868), Novo Nordisk-CAS Research Foundation, SA-SIBS Scholarship Program, as well as grants from the National Key Programs on Infectious Disease (2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroucha DCBL, 2013, CYTOKINE, V62, P421, DOI 10.1016/j.cyto.2013.03.024; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boaru SG, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-49; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dental C, 2012, J VIROL, V86, P1090, DOI 10.1128/JVI.05444-11; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lapinski TW, 2001, ARCH IMMUNOL THER EX, V49, P311; Lawrence TM, 2013, J VIROL, V87, P5848, DOI 10.1128/JVI.00203-13; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lei G, 2013, CELL RES; Li H, 2013, PROTEIN CELL, V4, P529, DOI 10.1007/s13238-013-2127-9; MADY BJ, 1993, J GEN VIROL, V74, P839, DOI 10.1099/0022-1317-74-5-839; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Meng GX, 2010, EUR J IMMUNOL, V40, P649, DOI 10.1002/eji.200940191; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nishitsuji H, 2013, J VIROL; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poeck H, 2012, EUR J CELL BIOL, V91, P59, DOI 10.1016/j.ejcb.2011.01.013; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma A, 2009, IMMUNOLOGY, V128, pe514, DOI 10.1111/j.1365-2567.2008.03021.x; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shrivastava S, 2013, J VIROL; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Vecchiet J, 2005, ANN CLIN LAB SCI, V35, P415; Wang HB, 2013, PROTEIN CELL, V4, P565, DOI 10.1007/s13238-013-3905-0; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Yoneda S, 2011, J INFECT DIS, V203, P1087, DOI 10.1093/infdis/jiq165; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	65	55	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84953	10.1371/journal.pone.0084953	http://dx.doi.org/10.1371/journal.pone.0084953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400125	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700059
J	Pinatel, EM; Orso, F; Penna, E; Cimino, D; Elia, AR; Circosta, P; Dentelli, P; Brizzi, MF; Provero, P; Taverna, D				Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Elia, Angela Rita; Circosta, Paola; Dentelli, Patrizia; Brizzi, Maria Felice; Provero, Paolo; Taverna, Daniela			miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions	PLOS ONE			English	Article							EXPRESSION SIGNATURE; DOWN-REGULATION; TUMOR PROGRESSION; INDUCED APOPTOSIS; STEM-CELLS; MICRORNA; INVASION; METASTASIS; PROLIFERATION; TRANSDUCER	MicroRNAs are single-stranded non-coding RNAs that simultaneously down-modulate the expression of multiple genes post-transcriptionally by binding to the 3'UTRs of target mRNAs. Here we used computational methods to predict microRNAs relevant in breast cancer progression. Specifically, we applied different microRNA target prediction algorithms to various groups of differentially expressed protein-coding genes obtained from four breast cancer datasets. Six potential candidates were identified, among them miR-223, previously described to be highly expressed in the tumor microenvironment and known to be actively transferred into breast cancer cells. To investigate the function of miR-223 in tumorigenesis and to define its molecular mechanism, we overexpressed miR-223 in breast cancer cells in a transient or stable manner. Alternatively we overexpressed miR-223 in mouse embryonic fibroblasts or HEK293 cells and used their conditioned medium to treat tumor cells. With both approaches, we obtained elevated levels of miR-223 in tumor cells and observed decreased migration, increased cell death in anoikis conditions and augmented sensitivity to chemotherapy but no effect on adhesion and proliferation. The analysis of miR-223 predicted targets revealed enrichment in cell death and survival-related genes and in pathways frequently altered in breast cancer. Among these genes, we showed that protein levels for STAT5A, ITGA3 and NRAS were modulated by miR-223. In addition, we proved that STAT5A is a direct miR-223 target and highlighted a possible correlation between miR-223 and STAT5A in migration and chemotherapy response. Our investigation revealed that a computational analysis of cancer gene expression datasets can be a relevant tool to identify microRNAs involved in cancer progression and that miR-223 has a prominent role in breast malignancy that could potentially be exploited therapeutically.	[Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Elia, Angela Rita; Circosta, Paola; Provero, Paolo; Taverna, Daniela] Univ Turin, MBC, Turin, Italy; [Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Provero, Paolo; Taverna, Daniela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Orso, Francesca; Cimino, Daniela; Taverna, Daniela] Univ Turin, Ctr Mol Syst Biol, Turin, Italy; [Dentelli, Patrizia; Brizzi, Maria Felice] Univ Turin, Dept Med Sci, Turin, Italy; [Provero, Paolo] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	University of Turin; University of Turin; University of Turin; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Taverna, D (corresponding author), Univ Turin, MBC, Turin, Italy.	daniela.taverna@unito.it	Provero, Paolo/AAC-1930-2019; Brizzi, Maria Felice/J-7882-2016; taverna, daniela/J-8358-2016; Pinatel, Eva Maria/AAC-1365-2019; Orso, Francesca/B-1985-2014	taverna, daniela/0000-0002-6365-527X; Pinatel, Eva Maria/0000-0002-2544-4594; circosta, paola/0000-0001-8251-6905; Orso, Francesca/0000-0003-4706-6464	Compagnia San Paolo [2008.1054/DT]; PRIN; AIRC [IG10104/DT, IG5649/MFB]; FIRB giovani [RBFR08F2FS-002/FO]	Compagnia San Paolo(Compagnia di San Paolo); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); FIRB giovani	This work was supported by grants from the Compagnia San Paolo (2008.1054/DT), PRIN 2008/DT, AIRC (IG10104/DT; IG5649/MFB) and FIRB giovani 2008 (RBFR08F2FS-002/FO). EP is an FIRC fellow (2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatheeswaran S, 2013, LEUKEMIA, V27, P1578, DOI 10.1038/leu.2012.339; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Breakefield XO, 2011, MOL THER, V19, P1574, DOI 10.1038/mt.2011.169; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Ferbeyre G, 2010, BIOCHIM BIOPHYS ACTA, V1815, P104; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Furth PA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2921; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong B, 2013, BIOMED PHARMACOTHER; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heys SD, 2012, BREAST CANCER RES TR, V135, P539, DOI 10.1007/s10549-012-2190-6; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Kosova B, 2010, LEUKEMIA LYMPHOMA, V51, P1895, DOI 10.3109/10428194.2010.507830; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Martins VR DM, 2013, CURRENT OPINION ONCO; Masciarelli S., 2013, ONCOGENE; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Purclutepe O, 2012, ANTICANCER RES, V32, P2885; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Shi Z, 2012, MOL CANCER RES, V8, P615; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Team RDC, 2008, R LANG ENV STAT COMP; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wang Y, 2009, EUR J NUCL MED MOL I, V36, P1977, DOI 10.1007/s00259-009-1201-2; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; WU ZS, 2011, CANCER; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yang T, 2013, EXP BIOL MED MAYWOOD; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079	85	49	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84859	10.1371/journal.pone.0084859	http://dx.doi.org/10.1371/journal.pone.0084859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400121	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700055
J	Roer, JP; Bell, R; Buchner, A				Roeer, Jan P.; Bell, Raoul; Buchner, Axel			What Determines Auditory Distraction? On the Roles of Local Auditory Changes and Expectation Violations	PLOS ONE			English	Article							SHORT-TERM-MEMORY; TOKEN SET SIZE; IRRELEVANT-SOUND; MISMATCH NEGATIVITY; INVOLUNTARY ATTENTION; SPEECH; DISRUPTION; HABITUATION; INFORMATION; MECHANISMS	Both the acoustic variability of a distractor sequence and the degree to which it violates expectations are important determinants of auditory distraction. In four experiments we examined the relative contribution of local auditory changes on the one hand and expectation violations on the other hand in the disruption of serial recall by irrelevant sound. We present evidence for a greater disruption by auditory sequences ending in unexpected steady state distractor repetitions compared to auditory sequences with expected changing state endings even though the former contained fewer local changes. This effect was demonstrated with piano melodies (Experiment 1) and speech distractors (Experiment 2). Furthermore, it was replicated when the expectation violation occurred after the encoding of the target items (Experiment 3), indicating that the items' maintenance in short-term memory was disrupted by attentional capture and not their encoding. This seems to be primarily due to the violation of a model of the specific auditory distractor sequences because the effect vanishes and even reverses when the experiment provides no opportunity to build up a specific neural model about the distractor sequence (Experiment 4). Nevertheless, the violation of abstract long-term knowledge about auditory regularities seems to cause a small and transient capture effect: Disruption decreased markedly over the course of the experiments indicating that participants habituated to the unexpected distractor repetitions across trials. The overall pattern of results adds to the growing literature that the degree to which auditory distractors violate situation-specific expectations is a more important determinant of auditory distraction than the degree to which a distractor sequence contains local auditory changes.	[Roeer, Jan P.; Bell, Raoul; Buchner, Axel] Univ Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Roer, JP (corresponding author), Univ Dusseldorf, Dusseldorf, Germany.	jan.roeer@hhu.de		Bell, Raoul/0000-0002-0592-0362	German Research Foundation [BU 945/9-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant from the German Research Foundation (BU 945/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Beaman CP, 2005, EUR J COGN PSYCHOL, V17, P241, DOI 10.1080/09541440440000023; Bell R, 2007, MEM COGNITION, V35, P352, DOI 10.3758/BF03193456; Bell R, 2013, EXP PSYCHOL, V60, P376, DOI 10.1027/1618-3169/a000212; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P1542, DOI 10.1037/a0028459; Bell R, 2011, Q J EXP PSYCHOL, V64, P146, DOI 10.1080/17470218.2010.483769; Bell R, 2010, PSYCHOPHYSIOLOGY, V47, P1182, DOI 10.1111/j.1469-8986.2010.01029.x; Bendixen A, 2007, J COGNITIVE NEUROSCI, V19, P1664, DOI 10.1162/jocn.2007.19.10.1664; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Buchner A, 1996, Q J EXP PSYCHOL-A, V49, P765, DOI 10.1080/713755633; Buchner A, 2004, MEM COGNITION, V32, P722, DOI 10.3758/BF03195862; Campbell T, 2003, COGNITIVE BRAIN RES, V18, P39, DOI 10.1016/j.cogbrainres.2003.09.001; Campbell T, 2002, MEMORY, V10, P199, DOI 10.1080/09658210143000335; Cock JJ, 2002, EUR J COGN PSYCHOL, V14, P27, DOI 10.1080/09541440042000151; COLLE HA, 1976, J VERB LEARN VERB BE, V15, P17, DOI 10.1016/S0022-5371(76)90003-7; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cowan N., 1995, ATTENTION MEMORY INT; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2002, COGNITIVE BRAIN RES, V14, P325, DOI 10.1016/S0926-6410(02)00135-0; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; JONES D, 1992, Q J EXP PSYCHOL-A, V44, P645, DOI 10.1080/14640749208401304; Jones DM., 1993, ATTENTION SELECTION, P87, DOI DOI 10.1037/A0017008; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lange EB, 2005, J MEM LANG, V53, P513, DOI 10.1016/j.jml.2005.07.002; LECOMPTE DC, 1995, PSYCHON B REV, V2, P391, DOI 10.3758/BF03210978; LeCompte DC, 1997, J EXP PSYCHOL LEARN, V23, P472, DOI 10.1037/0278-7393.23.2.472; Marsh JE, 2008, J MEM LANG, V58, P682, DOI 10.1016/j.jml.2007.05.002; MILES C, 1991, J EXP PSYCHOL LEARN, V17, P578, DOI 10.1037/0278-7393.17.3.578; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Neath I, 2001, SCI CON SER, P247, DOI 10.1037/10394-013; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; Ohman A., 1979, ORIENTING REFLEX HUM, P443; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Roer JP, 2014, MEM COGNITION, V42, P609, DOI 10.3758/s13421-013-0381-y; Roer JP, 2013, J COGN PSYCHOL, V25, P925, DOI 10.1080/20445911.2013.828063; Roer JP, 2011, MEM COGNITION, V39, P839, DOI 10.3758/s13421-010-0070-z; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Sokolov E.N., 1963, PERCEPTION CONDITION; Tremblay S, 1998, J EXP PSYCHOL LEARN, V24, P659, DOI 10.1037/0278-7393.24.3.659; Vachon F, 2012, J EXP PSYCHOL LEARN, V38, P164, DOI 10.1037/a0025054; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	52	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84166	10.1371/journal.pone.0084166	http://dx.doi.org/10.1371/journal.pone.0084166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IW	24400081	gold, Green Published			2022-12-25	WOS:000329462700015
J	Young, C; Wong, KY; Cheung, LK				Young, Cecilia; Wong, Kin Yau; Cheung, Lim K.			A Survey on Hong Kong Secondary School Students' Knowledge of Emergency Management of Dental Trauma	PLOS ONE			English	Article							PERMANENT TEETH; INJURIES; SCHOOLCHILDREN; AVULSION; GUIDELINES; CHILDREN; PREVALENCE; TEACHERS; ETIOLOGY	Objectives: To investigate Hong Kong secondary school students' knowledge of emergency management of dental trauma. Method: A questionnaire survey on randomly selected secondary school students using cluster sampling. Results: Only 36.6% (209/571) of the respondents were able to correctly identify the appropriate place for treatment of dental injury. 55.2% of the respondents knew the suitable time for treatment. Only 24.7% of the respondents possessed the knowledge of how to correctly manage fractured teeth. Only 23.6% of them knew how to manage displaced teeth. 62.5% of them correctly answered that knocked-out deciduous teeth should not be replanted to the original position, but few of them (23.6%) knew that permanent teeth should be replanted. Moreover, 37.1% of the respondents correctly identified at least one of the appropriate media for storing a knocked-out tooth. First-aid training and acquisition of dental injury information from other sources were significant factors that positive responses from these questions would lead to higher scores. Conclusion: Hong Kong secondary school students' knowledge of emergency management of dental trauma is considered insufficient. An educational campaign in secondary schools dedicated to students is recommended. Prior first-aid training and acquisition of dental injury information from other sources positively relate to the level of knowledge. Dental trauma emergency management is recommended to be added to first-aid publications and be taught to students and health professionals.	[Wong, Kin Yau] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cheung, Lim K.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong		ceciliatyp@yahoo.com.hk	Young, Cecilia/K-1699-2018	Young, Cecilia/0000-0003-1698-7738; , Kin Yau/0000-0001-9066-1619				Andersson L, 2006, DENT TRAUMATOL, V22, P57, DOI 10.1111/j.1600-9657.2006.00338.x; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; Andreasen FM, 2007, TXB COLOUR ATLAS TRA; Andreasen FM, 2007, TXB COLOR ATLAS TRAU, P290; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; Andreasen JO, 2007, TXB COLOUR ATLAS TRA, P444; Bendo CB, 2010, J PUBLIC HEALTH DENT, V70, P313, DOI 10.1111/j.1752-7325.2010.00190.x; Biagi R, 2010, EUR J PAEDIATR DENT, V11, P66; Castilho LR, 2009, DENT TRAUMATOL, V25, P429, DOI 10.1111/j.1600-9657.2008.00756.x; Fakhruddin KS, 2008, DENT TRAUMATOL, V24, P305, DOI 10.1111/j.1600-9657.2007.00548.x; Fariniuk LF, 2010, J APPL ORAL SCI, V18, P343, DOI 10.1590/S1678-77572010000400004; Faus-Damia M, 2011, MED ORAL PATOL ORAL, V16, pE292, DOI 10.4317/medoral.16.e292; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; Flores MT, 2007, DENT TRAUMATOL, V23, P130, DOI 10.1111/j.1600-9657.2007.00605.x; Flores MT, 2007, TXB COLOUR ATLAS TRA, P869; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Huang BY, 2009, DENT TRAUMATOL, V25, P64, DOI 10.1111/j.1600-9657.2008.00685.x; Lam R, 2008, DENT TRAUMATOL, V24, P663, DOI 10.1111/j.1600-9657.2008.00689.x; Levin L, 2007, DENT TRAUMATOL, V23, P356, DOI 10.1111/j.1600-9657.2006.00473.x; Lieger O, 2009, DENT TRAUMATOL, V25, P406, DOI 10.1111/j.1600-9657.2009.00798.x; Naidoo S, 2009, DENT TRAUMATOL, V25, P224, DOI 10.1111/j.1600-9657.2008.00749.x; Navabazam A, 2010, DENT TRAUMATOL, V26, P154, DOI 10.1111/j.1600-9657.2009.00861.x; Noori AJ, 2009, DENT TRAUMATOL, V25, P442, DOI 10.1111/j.1600-9657.2009.00791.x; Thelen DS, 2010, DENT TRAUMATOL, V26, P284, DOI 10.1111/j.1600-9657.2010.00918.x; Underwood M, 1998, BRIT J GEN PRACT, V48, P1089; Wilson S, 1997, PEDIATR EMERG CARE, V13, P12, DOI 10.1097/00006565-199702000-00004; Young C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074833; Young C, 2012, HONG KONG MED J, V18, P362	28	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84406	10.1371/journal.pone.0084406	http://dx.doi.org/10.1371/journal.pone.0084406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400088	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700022
J	Chu, B; Yao, F; Cheng, C; Wu, Y; Mei, YL; Li, XJ; Liu, Y; Wang, PS; Hou, L; Zou, XY				Chu, Bing; Yao, Feng; Cheng, Cheng; Wu, Yang; Mei, Yanli; Li, Xuejie; Liu, Yan; Wang, Peisheng; Hou, Lin; Zou, Xiangyang			The Potential Role of As-sumo-1 in the Embryonic Diapause Process and Early Embryo Development of Artemia sinica	PLOS ONE			English	Article							SUMO-1; EXPRESSION; SUMOYLATION; ACTIVATION; COMPLEX; KINASE; PHASE; CRAB	During embryonic development of Artemia sinica, environmental stresses induce the embryo diapause phenomenon, required to resist apoptosis and regulate cell cycle activity. The small ubiquitin-related modifier-1 (SUMO), a reversible post-translational protein modifier, plays an important role in embryo development. SUMO regulates multiple cellular processes, including development and other biological processes. The molecular mechanism of diapause, diapause termination and the role of As-sumo-1 in this processes and in early embryo development of Artemia sinica still remains unknown. In this study, the complete cDNA sequences of the sumo-1 homolog, sumo ligase homolog, caspase-1 homolog and cyclin B homolog from Artemia sinica were cloned. The mRNA expression patterns of As-sumo-1, sumo ligase, caspase-1, cyclin B and the location of As-sumo-1 were investigated. SUMO-1, p53, Mdm2, Caspase-1, Cyclin B and Cyclin E proteins were analyzed during different developmental stages of the embryo of A. sinica. Small interfering RNA (siRNA) was used to verify the function of sumo-1 in A. sinica. The full-length cDNA of As-sumo-1 was 476 bp, encoding a 92 amino acid protein. The As-caspases-1 cDNA was 966 bp, encoding a 245 amino-acid protein. The As-sumo ligase cDNA was 1556 bp encoding, a 343 amino acid protein, and the cyclin B cDNA was 739 bp, encoding a 133 amino acid protein. The expressions of As-sumo-1, As-caspase-1 and As-cyclin B were highest at the 10 h stage of embryonic development, and As-sumo ligase showed its highest expression at 0 h. The expression of As-SUMO-1 showed no tissue or organ specificity. Western blotting showed high expression of As-SUMO-1, p53, Mdm2, Caspase-1, Cyclin B and Cyclin E at the 10 h stage. The siRNA caused abnormal development of the embryo, with increased malformation and mortality. As-SUMO-1 is a crucial regulation and modification protein resumption of embryonic diapause and early embryo development of A. sinica.	[Chu, Bing; Yao, Feng; Cheng, Cheng; Wu, Yang; Mei, Yanli; Li, Xuejie; Liu, Yan; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China; [Wang, Peisheng; Zou, Xiangyang] Dalian Med Univ, Dept Biol, Dalian, Peoples R China	Liaoning Normal University; Dalian Medical University	Hou, L (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China.	houlin@lnnu.edu.cn; zouxiangyang@126.com			National Natural Science Foundation of China [31272644]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (31272644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Artus J, 2006, CELL CYCLE, V5, P499, DOI 10.4161/cc.5.5.2500; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Conte FP, 2007, INT REV CYTOL, V91, P46; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dai YB, 2012, GENE, V503, P260, DOI 10.1016/j.gene.2012.04.056; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gupta S, 2001, J BIOL CHEM, V276, P10585, DOI 10.1074/jbc.C100025200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jaclyn RG, 2012, J BIOL CHEM, V287, P4740; Jiang LJ, 2007, ACTA BIOCH BIOPH SIN, V39, P351, DOI 10.1111/j.1745-7270.2007.00287.x; Jingjing L, 2008, PLANT CELL, V20, P1536; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lorca Thierry, 2012, Genes Cancer, V3, P712, DOI 10.1177/1947601912473478; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Robert VT, 1997, J BIOL CHEM, V272, P9677; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rohit M, 2007, CELL, V88, P98; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang Q, 2012, GENE, V501, P135, DOI 10.1016/j.gene.2012.04.016; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	43	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85343	10.1371/journal.pone.0085343	http://dx.doi.org/10.1371/journal.pone.0085343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404204	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800083
J	Li, Y; Wang, L; Zhao, SH; He, ZX; Wang, DY; Guo, F; Fang, W; Yang, MF				Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei; Yang, Min-Fu			Gated F-18 FDG PET for Assessment of Left Ventricular Volumes and Ejection Fraction Using QGS and 4D-MSPECT in Patients with Heart Failure: A Comparison with Cardiac MRI	PLOS ONE			English	Article							EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY; MYOCARDIAL-PERFUSION SPECT; CORONARY-ARTERY-DISEASE; DILATED CARDIOMYOPATHY; EUROPEAN-SOCIETY; ASSOCIATION HFA; TASK-FORCE; VALIDATION; QUANTIFICATION; GUIDELINES	Purpose: Ventricular function is a powerful predictor of survival in patients with heart failure (HF). However, studies characterizing gated F-18 FDG PET for the assessment of the cardiac function are rare. The aim of this study was to prospectively compare gated F-18 FDG PET and cardiac MRI for the assessment of ventricular volume and ejection fraction (EF) in patients with HF. Methods: Eighty-nine patients with diagnosed HF who underwent both gated F-18 FDG PET/CT and cardiac MRI within 3 days were included in the analysis. Left ventricular (LV) end-diastolic volume (EDV), end-systolic volume (ESV), and EF were obtained from gated F-18 FDG PET/CT using the Quantitative Gated SPECT (QGS) and 4D-MSPECT software. Results: LV EDV and LV ESV measured by QGS were significantly lower than those measured by cardiac MRI (both P<0.0001). In contrast, the corresponding values for LV EDV for 4D-MSPECT were comparable, and LV ESV was underestimated with borderline significance compared with cardiac MRI (P = 0.047). LV EF measured by QGS and cardiac MRI showed no significant differences, whereas the corresponding values for 4D-MSPECT were lower than for cardiac MRI (P<0.0001). The correlations of LV EDV, LV ESV, and LV EF between gated F-18 FDG PET/CT and cardiac MRI were excellent for both QGS (r = 0.92, 0.92, and 0.76, respectively) and 4D-MSPECT (r = 0.93, 0.94, and 0.75, respectively). However, Bland-Altman analysis revealed a significant systemic error, where LV EDV (-27.9 +/- 37.0 mL) and ESV (-18.6 +/- 33.8 mL) were underestimated by QGS. Conclusion: Despite the observation that gated F-18 FDG PET/CT were well correlated with cardiac MRI for assessing LV function, variation was observed between the two imaging modalities, and so these imaging techniques should not be used interchangeably.	[Li, Yan; Wang, Li; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Peking Union Med Coll, Cardiovasc Inst, Dept Nucl Med, Beijing 100021, Peoples R China; [Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Peking Union Med Coll, Fu Wai Hosp, Beijing 100021, Peoples R China; [Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhao, Shi-Hua] Peking Union Med Coll, Cardiovasc Inst, Dept Radiol, Beijing 100021, Peoples R China; [Yang, Min-Fu] Capital Med Univ, Chaoyang Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Fang, W (corresponding author), Peking Union Med Coll, Cardiovasc Inst, Dept Nucl Med, Beijing 100021, Peoples R China.	tsenyuan@yahoo.com.cn; yang_minfu@yahoo.com.cn	Lu, Minjie/AAF-5091-2020; Zhao, Shihua/A-7553-2019; Yang, min-fu/K-7438-2014	Lu, Minjie/0000-0001-8696-318X; Zhao, Shihua/0000-0003-1339-7476; 				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chander A, 2008, J NUCL MED, V49, P1643, DOI 10.2967/jnumed.108.053819; Dilsizian V, 2009, J NUCL CARDIOL, V16, P651, DOI DOI 10.1007/S12350-009-9094-9; DULCE MC, 1993, RADIOLOGY, V188, P371, DOI 10.1148/radiology.188.2.8327680; Faber TL, 2001, J NUCL CARDIOL, V8, P645, DOI 10.1067/mnc.2001.117173; Gaemperli O, 2011, ANN NY ACAD SCI, V1228, P109, DOI 10.1111/j.1749-6632.2011.06030.x; GERMANO G, 1995, J NUCL MED, V36, P2138; Hesse B, 2008, EUR J NUCL MED MOL I, V35, P851, DOI 10.1007/s00259-007-0694-9; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Ioannidis JPA, 2002, J AM COLL CARDIOL, V39, P2059, DOI 10.1016/S0735-1097(02)01882-X; Iskandrian AE, 1998, J NUCL CARDIOL, V5, P574, DOI 10.1016/S1071-3581(98)90111-8; Khorsand A, 2005, J NUCL MED, V46, P2009; Kostkiewicz Magdalena, 2012, Przegl Lek, V69, P80; Kumita S, 2001, J NUCL CARDIOL, V8, P568, DOI 10.1067/mnc.2001.116853; Mahmarian JJ, 2006, J AM COLL CARDIOL, V48, P2448, DOI 10.1016/j.jacc.2006.07.069; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moon JCC, 2002, RADIOLOGY, V223, P789, DOI 10.1148/radiol.2233011181; Okazawa H, 2002, J NUCL MED, V43, P999; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Schaefer WM, 2005, J NUCL MED, V46, P1256; Schaefer WM, 2004, J NUCL MED, V45, P74; Schaefer WM, 2003, EUR J NUCL MED MOL I, V30, P545, DOI 10.1007/s00259-003-1123-3; Slart RHJA, 2004, J NUCL MED, V45, P176; STARLING MR, 1981, CIRCULATION, V63, P1075, DOI 10.1161/01.CIR.63.5.1075; VANDERWALL EE, 1995, CIRCULATION, V92, P2723, DOI 10.1161/01.CIR.92.9.2723; WACKERS FJT, 1979, AM J CARDIOL, V43, P1159, DOI 10.1016/0002-9149(79)90148-6; Wang F, 2009, EUR J NUCL MED MOL I, V36, P1611, DOI 10.1007/s00259-009-1136-7; Wang L, 2012, CLIN NUCL MED, V37, P1163, DOI 10.1097/RLU.0b013e3182708794; Wang L, 2013, ANN NUCL MED, V27, P325, DOI 10.1007/s12149-013-0691-y; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Xie BQ, 2012, J NUCL MED, V53, P584, DOI 10.2967/jnumed.111.096057; Yamaguchi A, 1998, ANN THORAC SURG, V65, P434, DOI 10.1016/S0003-4975(97)01155-7; Yang MF, 2007, CLIN NUCL MED, V32, P685, DOI 10.1097/RLU.0b013e318123f7d2	34	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e80227	10.1371/journal.pone.0080227	http://dx.doi.org/10.1371/journal.pone.0080227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404123	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800002
J	Srinivasan, S; Threet, D; Worton, LE; Ausk, BJ; Bain, SD; Gardiner, EM; Kwon, RY; Gross, TS				Srinivasan, Sundar; Threet, Dewayne; Worton, Leah E.; Ausk, Brandon J.; Bain, Steven D.; Gardiner, Edith M.; Kwon, Ronald Y.; Gross, Ted S.			Distinct Cyclosporin A Doses Are Required to Enhance Bone Formation Induced by Cyclic and Rest-Inserted Loading in the Senescent Skeleton	PLOS ONE			English	Article							AGE-RELATED DECLINE; OSTEOGENIC RESPONSE; RECOVERY PERIODS; MAP KINASE; FLUID-FLOW; OSTEOPOROSIS; OSTEOBLASTS; CELLS; MECHANOTRANSDUCTION; MECHANOSENSITIVITY	Age-related decline in periosteal adaptation negatively impacts the ability to utilize exercise to enhance bone mass and strength in the elderly. We recently observed that in senescent animals subject to cyclically applied loading, supplementation with Cyclosporin A (CsA) substantially enhanced the periosteal bone formation rates to levels observed in young animals. We therefore speculated that if the CsA supplement could enhance bone response to a variety of types of mechanical stimuli, this approach could readily provide the means to expand the range of mild stimuli that are robustly osteogenic at senescence. Here, we specifically hypothesized that a given CsA supplement would enhance bone formation induced in the senescent skeleton by both cyclic (1-Hz) and rest-inserted loading (wherein a 10-s unloaded rest interval is inserted between each load cycle). To examine this hypothesis, the right tibiae of senescent female C57BL/6 mice (22 Mo) were subjected to cyclic or rest-inserted loading supplemented with CsA at 3.0 mg/kg. As previously, we initially found that while the periosteal bone formation rate (p. BFR) induced by cyclic loading was enhanced when supplemented with 3.0 mg/kg CsA (by 140%), the response to rest-inserted loading was not augmented at this CsA dosage. In follow-up experiments, we observed that while a 30-fold lower CsA dosage (0.1 mg/kg) significantly enhanced p. BFR induced by rest-inserted loading (by 102%), it was ineffective as a supplement with cyclic loading. Additional experiments and statistical analysis confirmed that the dose-response relations were significantly different for cyclic versus rest-inserted loading, only because the two stimuli required distinct CsA dosages for efficacy. While not anticipated a priori, clarifying the complexity underlying the observed interaction between CsA dosage and loading type holds potential for insight into how bone response to a broad range of mechanical stimuli may be substantially enhanced in the senescent skeleton.	[Srinivasan, Sundar; Threet, Dewayne; Worton, Leah E.; Ausk, Brandon J.; Bain, Steven D.; Gardiner, Edith M.; Kwon, Ronald Y.; Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	sundars@uw.edu			National Institutes of Health [AR056235, AR056652]; Sigvard T. Hansen, Jr. Endowed Chair; Zimmer Fracture Biology Professorship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056235, R01AR056652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigvard T. Hansen, Jr. Endowed Chair; Zimmer Fracture Biology Professorship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in part, by funding from the National Institutes of Health (SS: AR056235; TSG: AR056652), the Sigvard T. Hansen, Jr. Endowed Chair (TSG) and the Zimmer Fracture Biology Professorship (SDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bass SL, 2002, J BONE MINER RES, V17, P2274, DOI 10.1359/jbmr.2002.17.12.2274; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Karinkanta S, 2007, OSTEOPOROSIS INT, V18, P453, DOI 10.1007/s00198-006-0256-1; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kukuljan S, 2011, J CLIN ENDOCRINOL ME; LaMothe JM, 2004, J APPL PHYSIOL, V96, P1788, DOI 10.1152/japplphysiol.01145.2003; Leppanen OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002540; Manolagas SC, 2007, MOL ENDOCRINOL; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pahlavani MA, 1999, MECH AGEING DEV, V112, P59, DOI 10.1016/S0047-6374(99)00077-9; PAHLAVANI MA, 1995, CELL IMMUNOL, V165, P84, DOI 10.1006/cimm.1995.1190; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Robling AG, 2001, J EXP BIOL, V204, P3389; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; Seeman E, 2001, Rev Endocr Metab Disord, V2, P45; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007; Srinivasan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000924; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Umemura Y, 2002, J APPL PHYSIOL, V93, P1345, DOI 10.1152/japplphysiol.00358.2002; Worton LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074205; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zar J. H., 1996, BIOSTATISTICAL ANAL	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84868	10.1371/journal.pone.0084868	http://dx.doi.org/10.1371/journal.pone.0084868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404194	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800073
J	Wu, JY; Cheng, CC; Wang, JY; Wu, DC; Hsieh, JS; Lee, SC; Wang, WM				Wu, Jeng-Yih; Cheng, Chun-Chia; Wang, Jaw-Yuan; Wu, Deng-Chyang; Hsieh, Jan-Sing; Lee, Shui-Cheng; Wang, Wen-Ming			Discovery of Tumor Markers for Gastric Cancer by Proteomics	PLOS ONE			English	Article							REGULATED PROTEINS GRP78; S-TRANSFERASE-PI; HEPATOCELLULAR-CARCINOMA; EXPRESSION; GRP94; ALPHA-1-ANTITRYPSIN; OVEREXPRESSION; EPITHELIUM; DIAGNOSIS; SURVIVAL	Gastric cancer (GC) has a high rate of morbidity and mortality among various cancers worldwide. The development of noninvasive diagnostic methods or technologies for tracking the occurrence of GC is urgent, and searching reliable biomarkers is considered. This study intended to directly discover differential biomarkers from GC tissues by two-dimension-differential gel electrophoresis (2D-DIGE), and further validate protein expression by western blotting (WB) and immunohistochemistry (IHC). Pairs of GC tissues (gastric cancer tissues and the adjacent normal tissues) obtained from surgery was investigated for 2D-DIEG. Five proteins were confirmed by WB and IHC, including glucose-regulated protein 78 (GRP78), glutathione s-transferase pi (GSTpi), apolipoprotein AI (ApoAI), alpha-1 antitrypsin (A1AT) and gastrokine-1 (GKN-1). Among the results, GRP78, GSTpi and A1AT were significantly up-regulated and down-regulated respectively in gastric cancer patients. Moreover, GRP78 and ApoAI were correlated with A1AT for protein expressions. This study presumes these proteins could be candidates of reliable biomarkers for gastric cancer.	[Wu, Jeng-Yih; Wang, Wen-Ming] Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Jeng-Yih; Wu, Deng-Chyang; Lee, Shui-Cheng; Wang, Wen-Ming] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Jeng-Yih; Wu, Deng-Chyang; Wang, Wen-Ming] Kaohsiung Med Univ, Dept Med, Coll Med, Fac Med, Kaohsiung, Taiwan; [Cheng, Chun-Chia] Atom Energy Council, Inst Nucl Energy Res, Executive Yuan, Taiwan; [Wang, Jaw-Yuan; Hsieh, Jan-Sing] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Institute of Nuclear Energy Research - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wang, WM (corresponding author), Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan.	d680027@kmu.edu.tw	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621	National Science Council of Republic of China; Kaohsiung Medical University Hospital [KMUH97-7R32, KMUH98-8R33];  [NSC96-3111-P-042A-004-Y];  [NSC100-2314-B-037-040]	National Science Council of Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; ; 	This work was supported by grants NSC96-3111-P-042A-004-Y, NSC100-2314-B-037-040, and by National Science Council of Republic of China. This work was also supported by Kaohsiung Medical University Hospital (KMUH97-7R32, KMUH98-8R33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; BERNACKA K, 1988, CANCER, V62, P1188, DOI 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Ferlay J, GLOBOCAN 2008 V2 0 C; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; LACY ER, 1993, J CLIN GASTROENTEROL, V17, pS125, DOI 10.1097/00004836-199312001-00023; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Monden N, 1997, ONCOLOGY-BASEL, V54, P391; Nasrollahzadeh D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026957; NIITSU Y, 1989, CANCER-AM CANCER SOC, V63, P317, DOI 10.1002/1097-0142(19890115)63:2<317::AID-CNCR2820630219>3.0.CO;2-P; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Rippa E, 2011, J CELL PHYSIOL, V226, P2571, DOI 10.1002/jcp.22601; Sant M, 1998, INT J CANCER, V77, P679, DOI 10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-S; Takahashi H, 2011, HISTOL HISTOPATHOL, V26, P663, DOI 10.14670/HH-26.663; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Torpy Janet M, 2010, JAMA, V303, P1771, DOI 10.1001/jama.303.17.1771; TSUTSUMI M, 1987, JPN J CANCER RES, V78, P631; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9	30	28	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84158	10.1371/journal.pone.0084158	http://dx.doi.org/10.1371/journal.pone.0084158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404153	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800032
J	Cho, YR; Lim, JH; Kim, MY; Kim, TW; Hong, BY; Kim, YS; Chang, YS; Kim, HW; Park, CW				Cho, Ye Rim; Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Hong, Bo Young; Kim, Yong-Soo; Chang, Yoon Sik; Kim, Hye Won; Park, Cheol Whee			Therapeutic Effects of Fenofibrate on Diabetic Peripheral Neuropathy by Improving Endothelial and Neural Survival in db/db Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; GROWTH-FACTOR; CELL-SURVIVAL; PEPTIDE; VEGF; ANGIOGENESIS; PATHOGENESIS; INFLAMMATION; EXPRESSION; APOPTOSIS	Neural vascular insufficiency plays an important role in diabetic peripheral neuropathy (DPN). Peroxisome proliferative-activated receptor (PPAR)alpha has an endothelial protective effect related to activation of PPAR gamma coactivator (PGC)-1 alpha and vascular endothelial growth factor (VEGF), but its role in DPN is unknown. We investigated whether fenofibrate would improve DPN associated with endothelial survival through AMPK-PGC-1 alpha-eNOS pathway. Fenofibrate was given to db/db mice in combination with anti-flt-1 hexamer and anti-flk-1 heptamer (VEGFR inhibition) for 12 weeks. The db/db mice displayed sensory-motor impairment, nerve fibrosis and inflammation, increased apoptotic cells, disorganized myelin with axonal shrinkage and degeneration, fewer unmyelinated fibers, and endoneural vascular rarefaction in the sciatic nerve compared to db/m mice. These findings were exacerbated with VEGFR inhibition in db/db mice. Increased apoptotic cell death and endothelial dysfunction via inactivation of the PPAR alpha-AMPK-PGC-1 alpha pathway and their downstream PI3K-Akt-eNOS-NO pathway were noted in db/db mice, human umbilical vein endothelial cells (HUVECs) and human Schwann cells (HSCs) in high-glucose media. The effects were more prominent in response to VEGFR inhibition. In contrast, fenofibrate treatment ameliorated neural and endothelial damage by activating the PPAR alpha-AMPK-PGC-1 alpha-eNOS pathway in db/db mice, HUVECs and HSCs. Fenofibrate could be a promising therapy to prevent DPN by protecting endothelial cells through VEGF-independent activation of the PPAR alpha-AMPK-PGC-1 alpha-eNOS-NO pathway.	[Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Kim, Yong-Soo; Chang, Yoon Sik; Park, Cheol Whee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Ye Rim; Hong, Bo Young; Kim, Hye Won] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, HW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	kimhw@catholic.ac.kr; cheolwhee@hanmail.net			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111055]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A3020151]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (C.W.P; A111055) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (H.W.K; 2012R1A1A3020151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Anand P, 1996, NAT MED, V2, P703, DOI 10.1038/nm0696-703; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bae DG, 2005, CLIN CANCER RES, V11, P2651, DOI 10.1158/1078-0432.CCR-04-1564; BEHSE F, 1977, J NEUROL NEUROSUR PS, V40, P1072, DOI 10.1136/jnnp.40.11.1072; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Britland ST, 1985, LIFE SUPPORT SYST S, V1, P525; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fioretto P, 2010, NAT REV ENDOCRINOL, V6, P19, DOI 10.1038/nrendo.2009.213; Fissithaler B, 2009, CIRC RES, V105, P1114; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; Greene Douglas A., 1999, American Journal of Medicine, V107, p2S; Iversen N, 2011, EXP GERONTOL, V46, P670, DOI 10.1016/j.exger.2011.03.004; JAKOBSEN J, 1976, DIABETOLOGIA, V12, P539, DOI 10.1007/BF01220629; Kilo S, 2000, NEUROLOGY, V54, P1246, DOI 10.1212/WNL.54.6.1246; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Nissen NN, 1998, AM J PATHOL, V152, P1445; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sima AAF, 1997, DIABETOLOGIA, V40, pB74, DOI 10.1007/BF03168192; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Stevens EJ, 1994, DIABETOLOGIA, V36, P1266; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tomizawa A, 2011, METABOLISM, V60, P513, DOI 10.1016/j.metabol.2010.04.020; van Dam PS, 2002, DIABETES-METAB RES, V18, P176, DOI 10.1002/dmrr.287; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; YOUNG MJ, 1992, DIABETOLOGIA, V35, P1146, DOI 10.1007/BF00401368	44	33	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83204	10.1371/journal.pone.0083204	http://dx.doi.org/10.1371/journal.pone.0083204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392081	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100005
J	Gu, SH; Zhang, W; Chen, J; Ma, RL; Xiao, X; Ma, XT; Yao, Z; Chen, YF				Gu, Shenhong; Zhang, Wei; Chen, Ji; Ma, Ruilian; Xiao, Xiang; Ma, Xiaotang; Yao, Zhen; Chen, Yanfang			EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; INDUCED CARDIAC-HYPERTROPHY; CHRONIC PRESSURE-OVERLOAD; MEMBRANE MICROPARTICLES; VASCULAR CELLS; NADPH OXIDASE; IN-VITRO; PATHWAY; INJURY; INFORMATION	Cell-released microvesicles (MVs) represent a novel way of cell-to-cell communication. Previous evidence indicates that endothelial progenitor cells (EPCs)-derived MVs can modulate endothelial cell survival and proliferation. In this study, we evaluated whether EPC-MVs protect cardiomyocytes (CMs) against angiotensin II (Ang II)-induced hypertrophy and apoptosis. The H9c2 CMs were exposed to Ang II in the presence or absence of EPC-MVs. Cell viability, apoptosis, surface area and beta-myosin heavy chain (beta-MHC) expression were analyzed. Meanwhile, reactive oxygen species (ROS), serine/threonine kinase (Akt), endothelial nitric oxide synthase (eNOS), and their phosphorylated proteins (p-Akt, p-eNOS) were measured. Phosphatidylinositol-3-kinase (PI3K) and NOS inhibitors were used for pathway verification. The role of MV-carried RNAs in mediating these effects was also explored. Results showed 1) EPC-MVs were able to protect CMs against Ang II-induced changes in cell viability, apoptosis, surface area, beta-MHC expression and ROS over-production; 2) The effects were accompanied with the up-regulation of Akt/p-Akt and its downstream eNOS/p-eNOS, and were abolished by PI3K inhibition or partially blocked by NOS inhibition; 3) Depletion of RNAs from EPC-MVs partially or totally eliminated the effects of EPC-MVs. Our data indicate that EPC-MVs protect CMs from hypertrophy and apoptosis through activating the PI3K/Akt/eNOS pathway via the RNAs carried by EPC-MVs.	[Gu, Shenhong; Chen, Ji; Ma, Ruilian; Xiao, Xiang; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Gu, Shenhong] Hainan Med Coll, Affiliated Hosp, Dept Gerontol, Haikou, Peoples R China; [Zhang, Wei; Ma, Ruilian; Yao, Zhen] Peoples Hosp Sanya, Dept Cardiol, Sanya, Peoples R China; [Chen, Ji; Ma, Xiaotang; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Dept Neurol, Zhanjiang, Guangdong, Peoples R China	University System of Ohio; Wright State University Dayton; Hainan Medical University; Guangdong Medical University	Yao, Z (corresponding author), Peoples Hosp Sanya, Dept Cardiol, Sanya, Peoples R China.	yao.zhen@126.com; yanfang.chen@wright.edu		Bihl, Ji/0000-0003-2404-1782	National Heart, Lung, and Blood Institute [HL-098637]; American Heart Association (AHA) [13POST14780018]; National Natural Science Foundation of China (NSFC) [81260060, 81300079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (HL-098637, YC), the American Heart Association (AHA, 13POST14780018 to JC) and the National Natural Science Foundation of China (NSFC, #81260060, #81300079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Buys ES, 2007, AM J PHYSIOL-HEART C, V293, pH620, DOI 10.1152/ajpheart.01236.2006; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Chavakis E, 2001, CIRCULATION, V103, P2102; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050105; Chen J, 2011, AM J PHYSIOL-ENDOC M, V301, pE62, DOI 10.1152/ajpendo.00026.2011; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Izumiya Y, 2012, INT J VASC MED, V2012, P1155, DOI DOI 10.1155/2012/246058; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liou SF, 2012, J NAT MED-TOKYO, V66, P311, DOI 10.1007/s11418-011-0592-0; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu JJ, 2011, APOPTOSIS, V16, P94, DOI 10.1007/s10495-010-0549-x; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McVey M, 2012, AM J PHYSIOL-LUNG C, V303, pL364, DOI 10.1152/ajplung.00354.2011; Meziani F, 2008, PHARMACOL REP, V60, P75; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Shanmugam P, 2011, J MOL CELL CARDIOL, V50, P928, DOI 10.1016/j.yjmcc.2011.02.012; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Ullal AJ, 2010, CYTOM PART A, V77A, P294, DOI 10.1002/cyto.a.20833; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Wang S, 2012, N-S ARCH PHARMACOL, V385, P823, DOI 10.1007/s00210-012-0740-4; Wen Y, 2009, SCAND J CLIN LAB INV, V69, P518, DOI 10.1080/00365510902802286; Wu Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/384627; Yang CY, 2012, J CARDIOVASC PHARM, V59, P465, DOI 10.1097/FJC.0b013e31824a7b60	40	55	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85396	10.1371/journal.pone.0085396	http://dx.doi.org/10.1371/journal.pone.0085396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392165	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100088
J	Poutahidis, T; Springer, A; Levkovich, T; Qi, PM; Varian, BJ; Lakritz, JR; Ibrahim, YM; Chatzigiagkos, A; Alm, EJ; Erdman, SE				Poutahidis, Theofilos; Springer, Alex; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Chatzigiagkos, Antonis; Alm, Eric J.; Erdman, Susan E.			Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LEYDIG-CELLS; RAT TESTIS; VITAMIN-D; REPLACEMENT THERAPY; GUT MICROBIOTA; T-LYMPHOCYTES; MEN; MOUSE; DIET	The decline of circulating testosterone levels in aging men is associated with adverse health effects. During studies of probiotic bacteria and obesity, we discovered that male mice routinely consuming purified lactic acid bacteria originally isolated from human milk had larger testicles and increased serum testosterone levels compared to their age-matched controls. Further investigation using microscopy-assisted histomorphometry of testicular tissue showed that mice consuming Lactobacillus reuteri in their drinking water had significantly increased seminiferous tubule cross-sectional profiles and increased spermatogenesis and Leydig cell numbers per testis when compared with matched diet counterparts This showed that criteria of gonadal aging were reduced after routinely consuming a purified microbe such as L. reuteri. We tested whether these features typical of sustained reproductive fitness may be due to anti-inflammatory properties of L. reuteri, and found that testicular mass and other indicators typical of old age were similarly restored to youthful levels using systemic administration of antibodies blocking pro-inflammatory cytokine interleukin-17A. This indicated that uncontrolled host inflammatory responses contributed to the testicular atrophy phenotype in aged mice. Reduced circulating testosterone levels have been implicated in many adverse effects; dietary L. reuteri or other probiotic supplementation may provide a viable natural approach to prevention of male hypogonadism, absent the controversy and side-effects of traditional therapies, and yield practical options for management of disorders typically associated with normal aging. These novel findings suggest a potential high impact for microbe therapy in public health by imparting hormonal and gonad features of reproductive fitness typical of much younger healthy individuals.	[Poutahidis, Theofilos; Springer, Alex; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Chatzigiagkos, Antonis] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, GR-54006 Thessaloniki, Greece; [Springer, Alex; Alm, Eric J.] MIT, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869	National Institutes of Health [P30-ES002109, U01 CA164337, RO1CA108854]; NATIONAL CANCER INSTITUTE [R01CA108854, U01CA164337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to SEE and EJA), U01 CA164337 (to SEE and EJA), and RO1CA108854 (to SEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova N, 1999, ENDOCRINOLOGY, V140, P5364, DOI 10.1210/en.140.11.5364; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Baer Janine T, 2012, Nurse Pract, V37, P39, DOI 10.1097/01.NPR.0000415874.61843.a6; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bassil N, 2010, CLIN GERIATR MED, V26, P197, DOI 10.1016/j.cger.2010.02.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; CHRISTENSEN AK, 1980, BIOL REPROD, V22, P383; Dombrowicz D, 1996, J ANDROL, V17, P639; Duckett RJ, 1997, J ANDROL, V18, P417; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; HAFFNER SM, 1993, INT J OBESITY, V17, P643; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Harris DM, 2004, J NUTR, V134, p3463S, DOI 10.1093/jn/134.12.3463S; Hijazi RA, 2005, ANNU REV MED, V56, P117, DOI 10.1146/annurev.med.56.082103.104518; Ibrahim HAM, 2012, BIOL TRACE ELEM RES, V147, P251, DOI 10.1007/s12011-011-9308-2; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; KERR JB, 1985, CELL TISSUE RES, V239, P405, DOI 10.1007/BF00218021; Kim SW, 2013, BIOCHEM BIOPH RES CO, V431, P258, DOI 10.1016/j.bbrc.2012.12.121; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; MORI H, 1980, J CELL BIOL, V84, P340, DOI 10.1083/jcb.84.2.340; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; NAKAGATA N, 1992, THERIOGENOLOGY, V37, P1283, DOI 10.1016/0093-691X(92)90183-R; NAKAGATA N, 1994, EXP ANIM TOKYO, V43, P11, DOI 10.1538/expanim1978.43.1_11; Oksaharju A., 2012, BR J NUTR, P1; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Payne A.H., 2007, LEYDIG CELL HLTH DIS; Pines A, 2011, CLIMACTERIC, V14, P15, DOI 10.3109/13697137.2010.507442; Poutahidis T, 2007, CARCINOGENESIS, V28, P2614, DOI 10.1093/carcin/bgm180; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Stanworth RD, 2008, CLIN INTERV AGING, V3, P25; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; TAKANO H, 1987, ARCH HISTOL CYTOL, V50, P533, DOI 10.1679/aohc.50.533; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107	58	86	93	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84877	10.1371/journal.pone.0084877	http://dx.doi.org/10.1371/journal.pone.0084877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392159	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100082
J	Becker, SFS; Mayor, R; Kashef, J				Becker, Sarah F. S.; Mayor, Roberto; Kashef, Jubin			Cadherin-11 Mediates Contact Inhibition of Locomotion during Xenopus Neural Crest Cell Migration	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; REQUIRES; GTPASES; TRIO; POPULATIONS; MECHANISMS; EXPRESSION; PROMOTES; RHO	Collective cell migration is an essential feature both in embryonic development and cancer progression. The molecular mechanisms of these coordinated directional cell movements still need to be elucidated. The migration of cranial neural crest (CNC) cells during embryogenesis is an excellent model for collective cell migration in vivo. These highly motile and multipotent cells migrate directionally on defined routes throughout the embryo. Interestingly, local cell-cell interactions seem to be the key force for directionality. CNC cells can change their migration direction by a repulsive cell response called contact inhibition of locomotion (CIL). Cell protrusions collapse upon homotypic cell-cell contact and internal repolarization leads to formation of new protrusions toward cell-free regions. Wnt/PCP signaling was shown to mediate activation of small RhoGTPase RhoA and inhibition of cell protrusions at the contact side. However, the mechanism how a cell recognizes the contact is poorly understood. Here, we demonstrate that Xenopus cadherin-11 (Xcad-11) mediated cell-cell adhesion is necessary in CIL for directional and collective migration of CNC cells. Reduction of Xcad-11 adhesive function resulted in higher invasiveness of CNC due to loss of CIL. Additionally, transplantation analyses revealed that CNC migratory behaviour in vivo is non-directional and incomplete when Xcad-11 adhesive function is impaired. Blocking Wnt/PCP signaling led to similar results underlining the importance of Xcad-11 in the mechanism of CIL and directional migration of CNC.	[Becker, Sarah F. S.; Kashef, Jubin] Karlsruhe Inst Technol, Zool Inst Cell & Dev Biol, D-76021 Karlsruhe, Germany; [Mayor, Roberto] UCL, Dept Cell & Dev Biol, London, England	Helmholtz Association; Karlsruhe Institute of Technology; University of London; University College London	Kashef, J (corresponding author), Karlsruhe Inst Technol, Zool Inst Cell & Dev Biol, D-76021 Karlsruhe, Germany.	jubin.kashef@kit.edu		Mayor, Roberto/0000-0001-9053-9613	DFG [WE-1208-13-1, FOR 1756]; "Concept for the Future'' of the Karlsruhe Institute of Technology; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology; MRC [MR/J000655/1, G117/506, G0801145] Funding Source: UKRI; Medical Research Council [G117/506, MR/J000655/1, G0801145] Funding Source: researchfish	DFG(German Research Foundation (DFG)); "Concept for the Future'' of the Karlsruhe Institute of Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is partially supported by the DFG WE-1208-13-1 and DFG FOR 1756 (www.dfg.de). J. Kashef's Young Investigator Group received financial support from the "Concept for the Future'' of the Karlsruhe Institute of Technology within the framework of the German Excellence Initiative. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; ABERCROMBIE M, 1962, CANCER RES, V22, P525; Alfandari D, 2010, CELL ADHES MIGR, V4, P553, DOI 10.4161/cam.4.4.12202; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Becker SF, 2012, ARCH BIOCHEM BIOPHYS, V524, P30, DOI 10.1016/j.abb.2012.02.013; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Borchers A, 2001, DEVELOPMENT, V128, P3049; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 1999, NEURAL CREST, V2; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Moore R, 2013, DEVELOPMENT; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pishvaian MJ, 1999, CANCER RES, V59, P947; SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shoval I, 2012, DEV DYNAM, V241, P1155, DOI 10.1002/dvdy.23799; Steventon B, 2012, DEV BIOL, V365, P196, DOI 10.1016/j.ydbio.2012.02.029; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tomita K, 2000, CANCER RES, V60, P3650; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; van Rijssel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029912; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020	39	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85717	10.1371/journal.pone.0085717	http://dx.doi.org/10.1371/journal.pone.0085717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392028	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900172
J	Mahajan, L; Pandit, H; Madan, T; Gautam, P; Yadav, AK; Warke, H; Sundaram, CS; Sirdeshmukh, R; Sarma, PU; Kishore, U; Surolia, A				Mahajan, Lakshna; Pandit, Hrishikesh; Madan, Taruna; Gautam, Poonam; Yadav, Ajit K.; Warke, Himangi; Sundaram, Curam S.; Sirdeshmukh, Ravi; Sarma, P. Usha; Kishore, Uday; Surolia, Avadhesha			Human Surfactant Protein D Alters Oxidative Stress and HMGA1 Expression to Induce p53 Apoptotic Pathway in Eosinophil Leukemic Cell Line	PLOS ONE			English	Article							SP-A; PROLIFERATION; SURVIVAL; MODEL; SURVEILLANCE; ANTIGENS; THERAPY; ARREST; ROLES; GENE	Surfactant protein D (SP-D), an innate immune molecule, has an indispensable role in host defense and regulation of inflammation. Immune related functions regulated by SP-D include agglutination of pathogens, phagocytosis, oxidative burst, antigen presentation, T lymphocyte proliferation, cytokine secretion, induction of apoptosis and clearance of apoptotic cells. The present study unravels a novel ability of SP-D to reduce the viability of leukemic cells (eosinophilic leukemic cell line, AML14.3D10; acute myeloid leukemia cell line, THP-1; acute lymphoid leukemia cell lines, Jurkat, Raji; and human breast epithelial cell line, MCF-7), and explains the underlying mechanisms. SP-D and a recombinant fragment of human SP-D (rhSP-D) induced G2/M phase cell cycle arrest, and dose and time-dependent apoptosis in the AML14.3D10 eosinophilic leukemia cell line. Levels of various apoptotic markers viz. activated p53, cleaved caspase-9 and PARP, along with G2/M checkpoints (p21 and Tyr15 phosphorylation of cdc2) showed significant increase in these cells. We further attempted to elucidate the underlying mechanisms of rhSP-D induced apoptosis using proteomic analysis. This approach identified large scale molecular changes initiated by SP-D in a human cell for the first time. Among others, the proteomics analysis highlighted a decreased expression of survival related proteins such as HMGA1, overexpression of proteins to protect the cells from oxidative burst, while a drastic decrease in mitochondrial antioxidant defense system. rhSP-D mediated enhanced oxidative burst in AML14.3D10 cells was confirmed, while antioxidant, N-acetyl-L-cysteine, abrogated the rhSP-D induced apoptosis. The rhSP-D mediated reduced viability was specific to the cancer cell lines and viability of human PBMCs from healthy controls was not affected. The study suggests involvement of SP-D in host's immunosurveillance and therapeutic potential of rhSP-D in the eosinophilic leukemia and cancers of other origins.	[Mahajan, Lakshna; Madan, Taruna; Gautam, Poonam; Sarma, P. Usha] IGIB, Delhi, India; [Mahajan, Lakshna; Surolia, Avadhesha] NII, Ctr Mol Med, New Delhi, India; [Pandit, Hrishikesh; Madan, Taruna; Yadav, Ajit K.] NIRRH, Bombay, Maharashtra, India; [Gautam, Poonam; Sundaram, Curam S.; Sirdeshmukh, Ravi] CCMB, Prote Res Facil, Hyderabad, Andhra Pradesh, India; [Warke, Himangi] King Edward Mem Hosp, Dept Obstet & Gynecol, Bombay, Maharashtra, India; [Warke, Himangi] Seth GS Med Coll, Bombay, Maharashtra, India; [Kishore, Uday] Brunel Univ, CIIDM, London, England	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Brunel University	Madan, T (corresponding author), IGIB, Delhi, India.	taruna_m@hotmail.com; Uday.Kishore@brunel.ac.uk	Kishore, Uday/Y-7976-2018; Pandit, Hrishikesh/GON-8428-2022; Pandit, Hrishikesh/AGZ-4050-2022	Kishore, Uday/0000-0002-6033-6759; Pandit, Hrishikesh/0000-0003-0994-6778	DBT Research Associateship under DBT-RA program	DBT Research Associateship under DBT-RA program	This work was supported by DBT Research Associateship under DBT-RA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brinker KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1453, DOI 10.1152/ajplung.2001.281.6.L1453; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cleynen I, 2008, INT J ONCOL, V32, P289; Dong JM, 2004, FREE RADICAL RES, V38, P629, DOI 10.1080/10715760410001694053; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esposito F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.126; Feng RT, 2007, J BIOL CHEM, V282, P13468, DOI 10.1074/jbc.M610616200; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Li LY, 2011, J VIROL, V85, P6774, DOI 10.1128/JVI.02577-10; Madan T, 2005, J IMMUNOL, V174, P6943, DOI 10.4049/jimmunol.174.11.6943; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Mahajan L, 2008, INT IMMUNOL, V20, P993, DOI 10.1093/intimm/dxn058; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Paul CC, 1997, AM J HEMATOL, V56, P79, DOI 10.1002/(SICI)1096-8652(199710)56:2<79::AID-AJH2>3.0.CO;2-Y; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Schagat TL, 2003, AM J PHYSIOL-LUNG C, V284, pL140, DOI 10.1152/ajplung.00125.2002; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P2262, DOI 10.1158/1055-9965.EPI-11-0326; Silva J, 2004, PROTEIN PEPTIDE LETT, V11, P189, DOI 10.2174/0929866043478293; Singh M, 2003, IMMUNOL LETT, V86, P299, DOI 10.1016/S0165-2478(03)00033-6; STEWART N, 1995, ONCOGENE, V10, P109; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Waters P, 2009, ADV EXP MED BIOL, V653, P74; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Yamaguchi H, 2011, CANCER CHEMOTH PHARM, V67, P331, DOI 10.1007/s00280-010-1325-x; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	42	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85046	10.1371/journal.pone.0085046	http://dx.doi.org/10.1371/journal.pone.0085046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391984	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900127
J	Oksuz, M; Sadikoglu, H; Cakir, T				Oksuz, Melik; Sadikoglu, Hasan; Cakir, Tunahan			Sparsity as Cellular Objective to Infer Directed Metabolic Networks from Steady-State Metabolome Data: A Theoretical Analysis	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; RECONSTRUCTION; YEAST	Since metabolome data are derived from the underlying metabolic network, reverse engineering of such data to recover the network topology is of wide interest. Lyapunov equation puts a constraint to the link between data and network by coupling the covariance of data with the strength of interactions (Jacobian matrix). This equation, when expressed as a linear set of equations at steady state, constitutes a basis to infer the network structure given the covariance matrix of data. The sparse structure of metabolic networks points to reactions which are active based on minimal enzyme production, hinting at sparsity as a cellular objective. Therefore, for a given covariance matrix, we solved Lyapunov equation to calculate Jacobian matrix by a simultaneous use of minimization of Euclidean norm of residuals and maximization of sparsity (the number of zeros in Jacobian matrix) as objective functions to infer directed small-scale networks from three kingdoms of life (bacteria, fungi, mammalian). The inference performance of the approach was found to be promising, with zero False Positive Rate, and almost one True positive Rate. The effect of missing data on results was additionally analyzed, revealing superiority over similarity-based approaches which infer undirected networks. Our findings suggest that the covariance of metabolome data implies an underlying network with sparsest pattern. The theoretical analysis forms a framework for further investigation of sparsity-based inference of metabolic networks from real metabolome data.	[Oksuz, Melik; Cakir, Tunahan] Gebze Inst Technol, Dept Bioengn, TR-41400 Gebze, Kocaeli, Turkey; [Oksuz, Melik; Sadikoglu, Hasan] Gebze Inst Technol, Dept Chem Engn, TR-41400 Gebze, Kocaeli, Turkey	Gebze Technical University; Gebze Technical University	Cakir, T (corresponding author), Gebze Inst Technol, Dept Bioengn, TR-41400 Gebze, Kocaeli, Turkey.	tcakir@gyte.edu.tr	ÖKSÜZ, Melik/AAA-4737-2020; Cakir, Tunahan/F-4523-2011; SADIKOGLU, Hasan/AAZ-4975-2020	Cakir, Tunahan/0000-0001-8262-4420; SADIKOGLU, HASAN/0000-0002-0234-8428	TUBITAK, The Scientific and Technological Research Council of Turkey [110M464]	TUBITAK, The Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The financial support by TUBITAK, The Scientific and Technological Research Council of Turkey, through a career grant (Project Code: 110M464) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Cakir T, 2004, BIOTECHNOL BIOENG, V86, P251, DOI 10.1002/bit.20020; Cakir T, 2009, METABOLOMICS, V5, P318, DOI 10.1007/s11306-009-0156-4; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Hendrickx DM, 2011, MOL BIOSYST, V7, P511, DOI 10.1039/c0mb00083c; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Nemenman I, 2007, ANN NY ACAD SCI, V1115, P102, DOI 10.1196/annals.1407.013; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Sun N, 2009, STAT METHODS MED RES, V18, P595, DOI 10.1177/0962280209351890; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Tegner J, 2007, TRENDS GENET, V23, P34, DOI 10.1016/j.tig.2006.11.003; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yang L, 2010, P AMER CONTR CONF, P5143; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183	33	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84505	10.1371/journal.pone.0084505	http://dx.doi.org/10.1371/journal.pone.0084505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391961	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900104
J	Spear, M; Guo, J; Turner, A; Yu, DY; Wang, WF; Meltzer, B; He, SJ; Hu, XH; Shang, H; Kuhn, J; Wu, YT				Spear, Mark; Guo, Jia; Turner, Amy; Yu, Dongyang; Wang, Weifeng; Meltzer, Beatrix; He, Sijia; Hu, Xiaohua; Shang, Hong; Kuhn, Jeffrey; Wu, Yuntao			HIV-1 Triggers WAVE2 Phosphorylation in Primary CD4 T Cells and Macrophages, Mediating Arp2/3-dependent Nuclear Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Immunology; Microbiology; Signal Transduction; Virology; Arp2; 3; CCR5; CD4; Wav2	ARP2/3 COMPLEX; CORTICAL ACTIN; GAG PROTEIN; VIRUS; TRANSCRIPTION; ENTRY; REPLICATION; BINDING; SPREAD; ASSAY	Background: Arp2/3 and the upstream modulator, WAVE2, regulate actin branching and polymerization. Results: HIV triggers WAVE2 phosphorylation for Arp2/3 activity, which is essential for nuclear migration. Conclusion: Arp2/3 and WAVE2 are cellular cofactors hijacked by HIV for intracellular migration. Significance: HIV-mediated WAVE2-Arp2/3 activity may serve as novel therapeutic targets. The human immunodeficiency virus type 1 (HIV-1) initiates receptor signaling and early actin dynamics during viral entry. This process is required for viral infection of primary targets such as resting CD4 T cells. WAVE2 is a component of a multiprotein complex linking receptor signaling to dynamic remodeling of the actin cytoskeleton. WAVE2 directly activates Arp2/3, leading to actin nucleation and filament branching. Although several bacterial and viral pathogens target Arp2/3 for intracellular mobility, it remains unknown whether HIV-1 actively modulates the Arp2/3 complex through virus-mediated receptor signal transduction. Here we report that HIV-1 triggers WAVE2 phosphorylation at serine 351 through gp120 binding to the chemokine coreceptor CXCR4 or CCR5 during entry. This phosphorylation event involves both G(i)-dependent and -independent pathways, and is conserved both in X4 and R5 viral infection of resting CD4 T cells and primary macrophages. We further demonstrate that inhibition of WAVE2-mediated Arp2/3 activity through stable shRNA knockdown of Arp3 dramatically diminished HIV-1 infection of CD4 T cells, preventing viral nuclear migration. Inhibition of Arp2/3 through a specific inhibitor, CK548, also drastically inhibited HIV-1 nuclear migration and infection of CD4 T cells. Our results suggest that Arp2/3 and the upstream regulator, WAVE2, are essential co-factors hijacked by HIV for intracellular migration, and may serve as novel targets to prevent HIV transmission.	[Spear, Mark; Guo, Jia; Turner, Amy; Yu, Dongyang; Wang, Weifeng; Meltzer, Beatrix; Wu, Yuntao] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [He, Sijia; Shang, Hong] China Med Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Immunol AIDS, Shenyang 110001, Liaoning Provin, Peoples R China; [Hu, Xiaohua; Kuhn, Jeffrey] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA	George Mason University; China Medical University; Virginia Polytechnic Institute & State University	Wu, YT (corresponding author), George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, 10900 Univ Blvd, Manassas, VA 20110 USA.	ywu8@gmu.edu	He, Sijia/M-1157-2019	He, Sijia/0000-0002-1932-1141	Public Health Service Grants from NIAID, National Institutes of Health [1R01AI081568, 1R03AI093157]; NYCDC AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081568, R03AI093157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102144] Funding Source: NIH RePORTER	Public Health Service Grants from NIAID, National Institutes of Health; NYCDC AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by Public Health Service Grants 1R01AI081568 and 1R03AI093157 from NIAID, National Institutes of Health (to Y.W.) and in part by the 2010 NYCDC AIDS Ride (to M.S.).	Alfano M, 2001, J IMMUNOL, V166, P1863, DOI 10.4049/jimmunol.166.3.1863; Alfano M, 1999, J EXP MED, V190, P597, DOI 10.1084/jem.190.5.597; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; DE BP, 1993, J BIOL CHEM, V268, P5703; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Graziano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023674; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Hu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049500; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lehmann M, 2011, VIRUSES-BASEL, V3, P1757, DOI 10.3390/v3091757; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; NIEDERMAN TMJ, 1993, VIROLOGY, V197, P420, DOI 10.1006/viro.1993.1605; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wen X., 2013, 20 C RETR OPP INF MA; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zaitseva M, 2005, J LEUKOCYTE BIOL, V78, P1306, DOI 10.1189/jlb.0105043	57	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6949	6959		10.1074/jbc.M113.492132	http://dx.doi.org/10.1074/jbc.M113.492132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415754	Green Published, hybrid			2022-12-25	WOS:000332389400055
J	Cho, KI; Patil, H; Senda, E; Wang, J; Yi, HQ; Qiu, S; Yoon, D; Yu, MZ; Orry, A; Peachey, NS; Ferreira, PA				Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Yu, Minzhong; Orry, Andrew; Peachey, Neal S.; Ferreira, Paulo A.			Differential Loss of Prolyl Isomerase or Chaperone Activity of Ran- binding Protein 2 ( Ranbp2) Unveils Distinct Physiological Roles of Its Cyclophilin Domain in Proteostasis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Chaperone Chaperonin; Enzymes; Proteasome; Protein Misfolding; Ubiquitination	CIS-TRANS ISOMERASE; CYCLOSPORINE-A-BINDING; HEPATITIS-C VIRUS; UBIQUITIN-PROTEASOME SYSTEM; NUCLEAR-PORE COMPLEX; PROLINE ISOMERIZATION; HOMOLOG NINAA; IN-VIVO; GENE ENCODES; DROSOPHILA	Background: Cyclophilins harbor ill-defined chaperone and prolyl isomerase activities toward physiological substrates. Results: Nonoverlapping chaperone or prolyl isomerase activity loss of Ran-binding protein 2 (Ranbp2) cyclophilin domain triggers unique impairments of proteostasis in distinct cell types and ubiquitin-proteasome system. Conclusion: Ranbp2 cyclophilin subdomains present discriminating physiological activities toward substrates or regulation of ubiquitin-proteasome system. Significance: Ranbp2-mediated mechanistic links in proteostasis with physiological and therapeutic relevance are uncovered. The immunophilins, cyclophilins, catalyze peptidyl cis-trans prolyl-isomerization (PPIase), a rate-limiting step in protein folding and a conformational switch in protein function. Cyclophilins are also chaperones. Noncatalytic mutations affecting the only cyclophilins with known but distinct physiological substrates, the Drosophila NinaA and its mammalian homolog, cyclophilin-B, impair opsin biogenesis and cause osteogenesis imperfecta, respectively. However, the physiological roles and substrates of most cyclophilins remain unknown. It is also unclear if PPIase and chaperone activities reflect distinct cyclophilin properties. To elucidate the physiological idiosyncrasy stemming from potential cyclophilin functions, we generated mice lacking endogenous Ran-binding protein-2 (Ranbp2) and expressing bacterial artificial chromosomes of Ranbp2 with impaired C-terminal chaperone and with (Tg-Ranbp2(WT-HA)) or without PPIase activities (Tg-Ranbp2(R2944A-HA)). The transgenic lines exhibit unique effects in proteostasis. Either line presents selective deficits in M-opsin biogenesis with its accumulation and aggregation in cone photoreceptors but without proteostatic impairment of two novel Ranbp2 cyclophilin partners, the cytokine-responsive effectors, STAT3/STAT5. Stress-induced STAT3 activation is also unaffected in Tg-Ranbp2(R2944A-HA)::Ranbp2(-/-). Conversely, proteomic analyses found that the multisystem proteinopathy/amyotrophic lateral sclerosis proteins, heterogeneous nuclear ribonucleoproteins A2/B1, are down-regulated post-transcriptionally only in Tg-Ranbp2(R2944A-HA)::Ranbp2(-/-). This is accompanied by the age- and tissue-dependent reductions of diubiquitin and ubiquitylated proteins, increased deubiquitylation activity, and accumulation of the 26 S proteasome subunits S1 and S5b. These manifestations are absent in another line, Tg-Ranbp2(CLDm-HA)::Ranbp2(-/-), harboring SUMO-1 and S1-binding mutations in the Ranbp2 cyclophilin-like domain. These results unveil distinct mechanistic and biological links between PPIase and chaperone activities of Ranbp2 cyclophilin toward proteostasis of selective substrates and with novel therapeutic potential.	[Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Ferreira, Paulo A.] Duke Univ, Dept Ophthalmol, Med Ctr, Durham, NC 27710 USA; [Cho, Kyoung-in; Patil, Hemangi; Senda, Eugene; Wang, Jessica; Yi, Haiqing; Qiu, Sunny; Yoon, Dosuk; Ferreira, Paulo A.] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27710 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA; [Orry, Andrew] MolSoft LLC, San Diego, CA 92121 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Ophthalmol, Cleveland, OH 44195 USA	Duke University; Duke University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Ferreira, PA (corresponding author), Duke Univ, Med Ctr, DUEC 3802,2351 Erwin Rd, Durham, NC 27710 USA.	paulo.ferreira@duke.edu	Peachey, Neal/G-5533-2010; Ferreira, Paulo A/S-4209-2016	Peachey, Neal/0000-0002-4419-7226; Ferreira, Paulo A/0000-0003-4585-1717	National Institutes of Health [EY019492, GM083165, GM083165-03S1, 2P30-EY005722, 5P30NS061789]; Foundation Fighting Blindness; Department of Veterans Affairs; Research to Prevent Blindness to Cleveland Clinic; Duke University; NATIONAL EYE INSTITUTE [R01EY019492, P30EY005722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); Research to Prevent Blindness to Cleveland Clinic(Research to Prevent Blindness (RPB)); Duke University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019492, GM083165, and GM083165-03S1 (to P. A. F.), 2P30-EY005722 (to Duke University Eye Center), and 5P30NS061789 (to Duke Neurotransgenic Laboratory). This work was also supported by the Foundation Fighting Blindness, the Department of Veterans Affairs, and an unrestricted award from Research to Prevent Blindness to Cleveland Clinic.; Supported by Deans' Summer Undergraduate Research Fellowships at Duke University.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bauer K, 2009, ONCOGENE, V28, P2784, DOI 10.1038/onc.2009.142; Baugh J, 2012, BIOL CHEM, V393, P579, DOI 10.1515/hsz-2012-0151; Ben-Gedalya T, 2011, J CELL SCI, V124, P1891, DOI 10.1242/jcs.077693; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cho KI, 2009, CELL DEATH DIFFER, V16, P287, DOI 10.1038/cdd.2008.153; Cho KI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003555; Cho KI, 2010, DIS MODEL MECH, V3, P595, DOI 10.1242/dmm.004648; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Dennissen FJA, 2012, PROG NEUROBIOL, V96, P190, DOI 10.1016/j.pneurobio.2012.01.003; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Fauser S, 2001, MAMM GENOME, V12, P406, DOI 10.1007/s003350010291; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; Ferreira PA, 2012, J NEUROGENET, V26, P132, DOI 10.3109/01677063.2011.647143; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRESKGARD PO, 1992, SCIENCE, V258, P466, DOI 10.1126/science.1357751; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Galat A, 2010, CELL MOL LIFE SCI, V67, P3467, DOI 10.1007/s00018-010-0437-0; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hopkins S, 2012, J HEPATOL, V57, P47, DOI 10.1016/j.jhep.2012.02.024; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ingelfinger D, 2003, NUCLEIC ACIDS RES, V31, P4791, DOI 10.1093/nar/gkg660; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jackson SE, 2013, TOP CURR CHEM, V328, P35, DOI 10.1007/128_2011_151; Kassube SA, 2012, J MOL BIOL, V423, P752, DOI 10.1016/j.jmb.2012.08.026; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Langer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017011; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mahadevan K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001545; Mandel Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2980; Mavlyutov TA, 2002, TRAFFIC, V3, P630, DOI 10.1034/j.1600-0854.2002.30905.x; Moparthi SB, 2010, BIOCHEMISTRY-US, V49, P1137, DOI 10.1021/bi901997q; Munte TF, 1998, J NEUROL, V245, P206, DOI 10.1007/s004150050206; NAIR APK, 1994, NATURE, V369, P239, DOI 10.1038/369239a0; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; ONDEK B, 1992, J BIOL CHEM, V267, P16460; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Park JM, 2013, CELL, V154, P637, DOI 10.1016/j.cell.2013.07.001; Patil H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.96; Patil H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120183; Patil H, 2012, BIOL OPEN, V1, P140, DOI 10.1242/bio.2011489; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Ramanathan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015827; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; REGAN D, 1976, BRAIN, V99, P43, DOI 10.1093/brain/99.1.43; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Setsuie R, 2009, NEUROCHEM INT, V54, P314, DOI 10.1016/j.neuint.2008.12.013; Shen Z., 2013, PLOS ONE, V8; Sherry B, 1998, P NATL ACAD SCI USA, V95, P1758, DOI 10.1073/pnas.95.4.1758; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Smajlovic A, 2009, FEBS LETT, V583, P1114, DOI 10.1016/j.febslet.2009.02.037; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yi HQ, 2007, J BIOL CHEM, V282, P34770, DOI 10.1074/jbc.M706903200; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Yu MZ, 2012, EXP EYE RES, V96, P124, DOI 10.1016/j.exer.2011.12.011; Zhang R., 2010, PLOS ONE, V5; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	136	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4600	4625		10.1074/jbc.M113.538215	http://dx.doi.org/10.1074/jbc.M113.538215			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24403063	Green Published, hybrid			2022-12-25	WOS:000331607900009
J	Anderluh, A; Klotzsch, E; Reismann, AWAF; Brameshuber, M; Kudlacek, O; Newman, AH; Sitte, HH; Schutz, GJ				Anderluh, Andreas; Klotzsch, Enrico; Reismann, Alexander W. A. F.; Brameshuber, Mario; Kudlacek, Oliver; Newman, Amy Hauck; Sitte, Harald H.; Schuetz, Gerhard J.			Single Molecule Analysis Reveals Coexistence of Stable Serotonin Transporter Monomers and Oligomers in the Live Cell Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Proteins; Protein Dynamics; Protein-Protein Interactions; Serotonin Transporters; Single Molecule Biophysics; Oligomerization	HUMAN DOPAMINE TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; NEUROTRANSMITTER TRANSPORTERS; LIVING CELLS; TRANSMEMBRANE SEGMENT; COCAINE ANALOGS; CROSS-LINKING; PROTEIN; TRAFFICKING	Background: The serotonin transporter (SERT) terminates synaptic signaling by reuptake of the neurotransmitter serotonin. Results: Interaction kinetics and number of subunits are elucidated by single molecule brightness analysis of SERT complexes. Conclusion: The oligomeric state of SERT complexes is stably determined before being integrated into the plasma membrane. Significance: The results reveal the first evidence for kinetic trapping of preformed neurotransmitter transporter oligomers. The human serotonin transporter (hSERT) is responsible for the termination of synaptic serotonergic signaling. Although there is solid evidence that SERT forms oligomeric complexes, the exact stoichiometry of the complexes and the fractions of different coexisting oligomeric states still remain enigmatic. Here we used single molecule fluorescence microscopy to obtain the oligomerization state of the SERT via brightness analysis of single diffraction-limited fluorescent spots. Heterologously expressed SERT was labeled either with the fluorescent inhibitor JHC 1-64 or via fusion to monomeric GFP. We found a variety of oligomerization states of membrane-associated transporters, revealing molecular associations larger than dimers and demonstrating the coexistence of different degrees of oligomerization in a single cell; the data are in agreement with a linear aggregation model. Furthermore, oligomerization was found to be independent of SERT surface density, and oligomers remained stable over several minutes in the live cell plasma membrane. Together, the results indicate kinetic trapping of preformed SERT oligomers at the plasma membrane.	[Anderluh, Andreas; Klotzsch, Enrico; Reismann, Alexander W. A. F.; Brameshuber, Mario; Schuetz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1060 Vienna, Austria; [Kudlacek, Oliver; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Newman, Amy Hauck] NIDA, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program, Baltimore, MD 21224 USA	Technische Universitat Wien; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Klotzsch, E (corresponding author), Vienna Univ Technol, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria.	enricoklotzsch@gmail.com; schuetz@iap.tuwien.ac.at	Klotzsch, Enrico/J-8831-2012; Sitte, Harald/N-2681-2013; Schuetz, Gerhard/B-1243-2008	Klotzsch, Enrico/0000-0002-7577-9042; Brameshuber, Mario/0000-0001-8672-2255; Kudlacek, Oliver/0000-0002-3086-8551; Sitte, Harald/0000-0002-1339-7444; Schuetz, Gerhard/0000-0003-1542-1089	Austrian Science Fund/FWF Projects [F3506-B20, F3519-B20]; National Institute on Drug Abuse-Intramural Research Program; Federation of European Biochemical Societies; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	Austrian Science Fund/FWF Projects(Austrian Science Fund (FWF)); National Institute on Drug Abuse-Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Federation of European Biochemical Societies; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Austrian Science Fund/FWF Projects F3506-B20 (to H. H. S.) and F3519-B20 (to G. J. S.) and by the National Institute on Drug Abuse-Intramural Research Program (to A. H. N.).; Supported by a long term fellowship from the Federation of European Biochemical Societies. To whom correspondence may be addressed. Tel.: 43-01-58801134884; E-mail: enricoklotzsch@gmail.com.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schoen I, 2011, NANO LETT, V11, P4008, DOI 10.1021/nl2025954; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Ulbrich M, 2011, COUNTING MOL QUANTIT, P1; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	44	44	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4387	4394		10.1074/jbc.M113.531632	http://dx.doi.org/10.1074/jbc.M113.531632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24394416	Green Published, hybrid			2022-12-25	WOS:000331403800049
J	Yamashita, T; Ono, K; Ohuchi, H; Yumoto, A; Gotoh, H; Tomonari, S; Sakai, K; Fujita, H; Imamoto, Y; Noji, S; Nakamura, K; Shichida, Y				Yamashita, Takahiro; Ono, Katsuhiko; Ohuchi, Hideyo; Yumoto, Akane; Gotoh, Hitoshi; Tomonari, Sayuri; Sakai, Kazumi; Fujita, Hirofumi; Imamoto, Yasushi; Noji, Sumihare; Nakamura, Katsuki; Shichida, Yoshinori			Evolution of Mammalian Opn5 as a Specialized UV-absorbing Pigment by a Single Amino Acid Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Molecular Evolution; Photoreceptors; Rhodopsin; Signal Transduction; Nonvisual Photoreception	VISUAL PIGMENT; DEEP BRAIN; OPSIN; MELANOPSIN; GENE; PHOTORECEPTORS; ISOMERIZATION	Opn5 is one of the recently identified opsin groups that is responsible for nonvisual photoreception in animals. We previously showed that a chicken homolog of mammalian Opn5 (Opn5m) is a G(i)-coupled UV sensor having molecular properties typical of bistable pigments. Here we demonstrated that mammalian Opn5m evolved to be a more specialized photosensor by losing one of the characteristics of bistable pigments, direct binding of all-trans-retinal. We first confirmed that Opn5m proteins in zebrafish, Xenopus tropicalis, mouse, and human are also UV-sensitive pigments. Then we found that only mammalian Opn5m proteins lack the ability to directly bind all-trans-retinal. Mutational analysis showed that these characteristics were acquired by a single amino acid replacement at position 168. By comparing the expression patterns of Opn5m between mammals and chicken, we found that, like chicken Opn5m, mammalian Opn5m was localized in the ganglion cell layer and inner nuclear layer of the retina. However, the mouse and primate (common marmoset) opsins were distributed not in the posterior hypothalamus (including the region along the third ventricle) where chicken Opn5m is localized, but in the preoptic hypothalamus. Interestingly, RPE65, an essential enzyme for forming 11-cis-retinal in the visual cycle is expressed near the preoptic hypothalamus of the mouse and common marmoset brain but not near the region of the chicken brain where chicken Opn5m is expressed. Therefore, mammalian Opn5m may work exclusively as a short wavelength sensor in the brain as well as in the retina with the assistance of an 11-cis-retinal-supplying system.	[Yamashita, Takahiro; Yumoto, Akane; Sakai, Kazumi; Imamoto, Yasushi; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Ono, Katsuhiko; Gotoh, Hitoshi] Kyoto Prefectural Univ Med, Dept Biol, Kyoto 6038334, Japan; [Ohuchi, Hideyo; Fujita, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama 7008558, Japan; [Tomonari, Sayuri; Noji, Sumihare] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan; [Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Okayama University; Tokushima University; Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Imamoto, Yasushi/0000-0002-0803-4163	Cooperation Research Program of Primate Research Institute, Kyoto University; Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Grants-in-Aid for Scientific Research [25440167] Funding Source: KAKEN	Cooperation Research Program of Primate Research Institute, Kyoto University; Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Cooperation Research Program of Primate Research Institute, Kyoto University. This work was also supported in part by Grants-in-Aid for Scientific Research (to T. Y., K. O., H. O., S. N., K. N., and Y. S.) and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" of the Ministry of Education, Culture, Sports, Science and Technology (Japan).	Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Forger NG, 2009, J NEUROENDOCRINOL, V21, P393, DOI 10.1111/j.1365-2826.2009.01825.x; Franklin K., 2007, MOUSE BRAIN STEREOTA; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HOFFMAN RA, 1965, SCIENCE, V148, P1609, DOI 10.1126/science.148.3677.1609; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Kuraku S, 2011, GENOME BIOL EVOL, V3, P1449, DOI 10.1093/gbe/evr120; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nieto PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026417; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031534; OISHI T, 1993, ZOOL SCI, V10, P757; Oishi T, 2001, MICROSC RES TECHNIQ, V53, P43, DOI 10.1002/jemt.1067; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Tang PH, 2011, J NEUROSCI, V31, P10403, DOI 10.1523/JNEUROSCI.0182-11.2011; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555, DOI 10.14670/HH-17.555; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WADE PD, 1988, P NATL ACAD SCI USA, V85, P9322, DOI 10.1073/pnas.85.23.9322; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Yuasa S., 2010, STEREOTAXIC ATLAS MA	41	40	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					3991	4000		10.1074/jbc.M113.514075	http://dx.doi.org/10.1074/jbc.M113.514075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24403072	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000331403800014
J	Nalawade-Chavan, S; McCullagh, J; Hedges, R				Nalawade-Chavan, Shweta; McCullagh, James; Hedges, Robert			New Hydroxyproline Radiocarbon Dates from Sungir, Russia, Confirm Early Mid Upper Palaeolithic Burials in Eurasia	PLOS ONE			English	Article							AMINO-ACIDS; BONE; PRETREATMENT; AGE; HAIR; SITE	Sungir (Russia) is a key Mid-Upper Palaeolithic site in Eurasia, containing several spectacular burials that disclose early evidence for complex burial rites in the form of a range of grave goods deposited along with the dead. Dating has been particularly challenging, with multiple radiocarbon dates ranging from 19,160 +/- 270 to 28,800 +/- 240 BP for burials that are believed to be closely similar in age. There are disparities in the radiocarbon dates of human bones, faunal remains and charcoal found on the floor of burials [1], [2], [3]. Our approach has been to develop compound-specific methods using High Performance Liquid Chromatography (HPLC) to separate single amino acids, such as hydroxyproline, and thereby avoid the known human contamination on the bones themselves. Previously, we applied this technique to obtain radiocarbon dates of similar to 30,000 BP for Sungir 2, Sungir 3 and a mammoth bone from the occupation levels of the site [4]. The single amino acid radiocarbon dates were in good agreement with each other compared to all the dates previously reported, supporting their reliability. Here we report new hydroxyproline dates for two more human burials from the same site, Sungir 1 and Sungir 4. All five hydroxyproline dates reported are statistically indistinguishable and support an identical age for the group. The results suggest that compound-specific radiocarbon analysis should be considered seriously as the method of choice when precious archaeological remains are to be dated because they give a demonstrably contaminant-free radiocarbon age. The new ages are, together with the previously dated 'Red Lady of Paviland' human in the British Isles, the earliest for Mid Upper Palaeolithic burial behaviour in Eurasia, and point to the precocious appearance of this form of rite in Europe Russia.	[Nalawade-Chavan, Shweta; McCullagh, James; Hedges, Robert] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Lab Archaeol & Hist Art, Oxford, England	University of Oxford	Nalawade-Chavan, S (corresponding author), Univ Oxford, Oxford Radiocarbon Accelerator Unit, Lab Archaeol & Hist Art, Oxford, England.	shweta.chavan@rlaha.ox.ac.uk	McCullagh, James/AAD-2669-2022	McCullagh, James/0000-0003-4733-1205	NERC [NE/H004491/1]; Natural Environment Research Council [NE/H004491/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NERC grant NE/H004491/1; http://www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Bradley BA, 1995, ANTIQUITY, V69, P989, DOI 10.1017/S0003598X00082521; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Dobrovolskaya M., 2012, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V24, P96, DOI 10.1007/s13219-011-0044-4; Einwogerer T, 2009, RADIOCARBON, V51, P847, DOI 10.1017/S0033822200056150; Formicola V, 2004, CURR ANTHROPOL, V45, P114, DOI 10.1086/381008; Grun R, 2006, YEARB PHYS ANTHROPOL, V49, P2, DOI 10.1002/ajpa.20516; HEDGES REM, 1992, RADIOCARBON, V34, P279, DOI 10.1017/S0033822200063438; Henry-Gambier D, 2002, PALEO, V14, P201; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Jacobi RM, 2008, J HUM EVOL, V55, P898, DOI 10.1016/j.jhevol.2008.08.007; Kuzmin YV, 2004, NUCL INSTRUM METH B, V223, P731, DOI 10.1016/j.nimb.2004.04.135; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; McCullagh JSO, 2010, RADIOCARBON, V52, P620, DOI 10.1017/S0033822200045653; Nalawade-Chavan S, 2013, RADIOCARBON, V55, P709, DOI 10.1017/S0033822200057866; O'Connell TC, 1999, J ARCHAEOL SCI, V26, P661, DOI 10.1006/jasc.1998.0383; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Pettitt PB, 2000, ANTIQUITY, V74, P269, DOI 10.1017/S0003598X00059196; Pettitt PB, 2003, ANTIQUITY, V77, P15, DOI 10.1017/S0003598X00061305; PETTITT PB, 2000, ANTHROPOLOGIE, V38, P149; PETTITT PB, 2002, TRABALHOS ARQUEOLOGI, V22, P132; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Sinitsyn A., 2004, ERAUL, V106, P237; SINITSYN AA, 1996, PREHISTOIRE EUROPEEN, V9, P273; STAFFORD TW, 1991, J ARCHAEOL SCI, V18, P35, DOI 10.1016/0305-4403(91)90078-4; Svoboda JA, 2002, ANTIQUITY, V76, P957, DOI 10.1017/S0003598X00091754; Van Klinken GJ, 1998, RADIOCARBON, V40, P51; van Klinken GJ, 1994, GEOCHIMICA COSMOCHIM, V58, P2453	32	29	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e76896	10.1371/journal.pone.0076896	http://dx.doi.org/10.1371/journal.pone.0076896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416120	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500001
J	Kapoor, N; Maxwell, JT; Mignery, GA; Will, D; Blatter, LA; Banach, K				Kapoor, Nidhi; Maxwell, Joshua T.; Mignery, Gregory A.; Will, David; Blatter, Lothar A.; Banach, Kathrin			Spatially Defined InsP(3)-Mediated Signaling in Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRACELLULAR CA2+ OSCILLATIONS; VENTRICULAR CARDIAC MYOCYTES; SARCOPLASMIC-RETICULUM; ANKYRIN-B; RYANODINE RECEPTOR; HEART; ARRHYTHMIAS; 5-PHOSPHATASE; EXPRESSION	The functional role of inositol 1,4,5-trisphosphate (InsP(3)) signaling in cardiomyocytes is not entirely understood but it was linked to an increased propensity for triggered activity. The aim of this study was to determine how InsP(3) receptors can translate Ca2+ release into a depolarization of the plasma membrane and consequently arrhythmic activity. We used embryonic stem cell-derived cardiomyocytes (ESdCs) as a model system since their spontaneous electrical activity depends on InsP(3)-mediated Ca2+ release. [InsP(3)](i) was monitored with the FRET-based InsP(3)-biosensor FIRE-1 (Fluorescent InsP(3) Responsive Element) and heterogeneity in sub-cellular [InsP(3)](i) was achieved by targeted expression of FIRE-1 in the nucleus (FIRE-1nuc) or expression of InsP(3) 5-phosphatase (m43) localized to the plasma membrane. Spontaneous activity of ESdCs was monitored simultaneously as cytosolic Ca2+ transients (Fluo-4/AM) and action potentials (current clamp). During diastole, the diastolic depolarization was paralleled by an increase of [Ca2+] i and spontaneous activity was modulated by [InsP(3)](i). A 3.7% and 1.7% increase of FIRE-1 FRET ratio and 3.0 and 1.5 fold increase in beating frequency was recorded upon stimulation with endothelin-1 (ET-1, 100 nmol/L) or phenylephrine (PE, 10 mmol/L), respectively. Buffering of InsP(3) by FIRE-1nuc had no effect on the basal frequency while attenuation of InsP(3) signaling throughout the cell (FIRE-1), or at the plasma membrane (m43) resulted in a 53.7% and 54.0% decrease in beating frequency. In m43 expressing cells the response to ET-1 was completely suppressed. Ca2+ released from InsP(3)Rs is more effective than Ca2+ released from RyRs to enhance INCX. The results support the hypothesis that in ESdCs InsP(3)Rs form a functional signaling domain with NCX that translates Ca2+ release efficiently into a depolarization of the membrane potential.	[Kapoor, Nidhi] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA; [Maxwell, Joshua T.; Blatter, Lothar A.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Will, David; Banach, Kathrin] Univ Illinois, Dept Med, Cardiovasc Res Ctr, Cardiol Sect, Chicago, IL 60607 USA	Cedars Sinai Medical Center; Loyola University Chicago; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Banach, K (corresponding author), Univ Illinois, Dept Med, Cardiovasc Res Ctr, Cardiol Sect, Chicago, IL 60607 USA.	kbanach@uic.edu	Blatter, Lothar/AAC-8431-2020		NIH [HL89617, PO1HL080101, HL062231, HL080101]; AHA [0330393Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089617, P01HL080101, R01HL062231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (HL89617 to KB; PO1HL080101 to GAM; HL062231 and HL080101 to LAB) and AHA (0330393Z to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Escobar M, 2011, J MOL CELL CARDIOL, V50, P451, DOI 10.1016/j.yjmcc.2010.11.021; Franzini-Armstrong C, 2005, ANN NY ACAD SCI, V1047, P76, DOI 10.1196/annals.1341.007; Garcia KD, 2004, AM J PHYSIOL-CELL PH, V287, pC1048, DOI 10.1152/ajpcell.00004.2004; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Horn T, 2013, J PHYSIOL-LONDON, V591, P2103, DOI 10.1113/jphysiol.2012.247288; Hund TJ, 2008, CHANNELS, V2, P404, DOI 10.4161/chan.2.6.7220; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lipp P, 2000, CURR BIOL, V10, P939, DOI 10.1016/S0960-9822(00)00624-2; LUO D, 2007, CELL CALCIUM; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Proven A, 2006, J CELL SCI, V119, P3363, DOI 10.1242/jcs.03073; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Rapila R, 2008, J GEN PHYSIOL, V132, P397, DOI 10.1085/jgp.200809960; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Slavikova J, 2006, LIFE SCI, V78, P1598, DOI 10.1016/j.lfs.2005.07.012; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Swietach P, 2008, BIOPHYS J, V95, P1412, DOI 10.1529/biophysj.108.130385; Vasilevski O, 2008, J MOL CELL CARDIOL, V45, P679, DOI 10.1016/j.yjmcc.2008.07.006; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529; Zima AV, 2007, J PHYSL	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83715	10.1371/journal.pone.0083715	http://dx.doi.org/10.1371/journal.pone.0083715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409283	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500007
J	He, MH; Pan, H; Chang, RCC; So, KF; Brecha, NC; Pu, ML				He, Meihua; Pan, Hong; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Brecha, Nicholas C.; Pu, Mingliang			Activation of the Nrf2/HO-1 Antioxidant Pathway Contributes to the Protective Effects of Lycium Barbarum Polysaccharides in the Rodent Retina after Ischemia-Reperfusion-Induced Damage	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HEME OXYGENASE-1; CAPILLARY DEGENERATION; GLUCOSE DEPRIVATION; GENE-EXPRESSION; CARBON-MONOXIDE; FREE-RADICALS; IN-VIVO; INJURY; CELLS	Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are protective to retina after ischemia-reperfusion (I/R). The antioxidant response element (ARE)-mediated antioxidant pathway plays an important role in maintaining the redox status of the retina. Heme oxygenase-1 (HO-1), combined with potent AREs in its promoter, is a highly effective therapeutic target for the protection against neurodegenerative diseases, including I/R-induced retinal damage. The aim of our present study was to investigate whether the protective effect of LBP after I/R damage was mediated via activation of the Nrf2/HO-1-antioxidant pathway in the retina. Retinal I/R was induced by an increase in intraocular pressure to 130 mm Hg for 60 minutes. Prior to the induction of ischemia, rats were orally treated with either vehicle (PBS) or LBP (1 mg/kg) once a day for 1 week. For specific experiments, zinc protoporphyrin (ZnPP, 20 mg/kg), an HO-1 inhibitor, was intraperitoneally administered at 24 h prior to ischemia. The protective effects of LBP were evaluated by quantifying ganglion cell and amacrine cell survival, and by measuring cell apoptosis in the retinal layers. In addition, HO-1 expression was examined using Western blotting and immunofluorescence analyses. Cytosolic and nuclear Nrf2 was measured using immunofluorescent staining. LBP treatment significantly increased Nrf2 nuclear accumulation and HO-1 expression in the retina after I/R injury. Increased apoptosis and a decrease in the number of viable cells were observed in the ganglion cell layer (GCL) and inner nuclear layer (INL) in the I/R retina, which were reversed by LBP treatment. The HO-1 inhibitor, ZnPP, diminished the LBP treatment-induced protective effects in the retina after I/R. Taken together, these results suggested that LBP partially exerted its beneficial neuroprotective effects via the activation of Nrf2 and an increase in HO-1 protein expression.	[He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Sch Basic Med Sci, Dept Anat Embryol, Beijing 100871, Peoples R China; [He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Minist Educ, Key Lab Visual Impairment & Restorat, Beijing 100871, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] LKS Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Brecha, Nicholas C.] Univ Hong Kong, Dept Ophthalmol, Pokfulam, Hong Kong, Peoples R China; [Brecha, Nicholas C.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med Los Angeles, CURE Digest Dis Res Ctr,Dept Neurobiol,Dept Med, Los Angeles, CA 90024 USA; [Brecha, Nicholas C.] Greater Los Angeles Hlth Syst, Vet Adm, Los Angeles, CA USA	Peking University; Peking University; Peking University; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University; University of Hong Kong; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pu, ML (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat Embryol, Beijing 100871, Peoples R China.	mpu@hsc.pku.edu.cn	Chang, Raymond Chuen-Chung/C-1107-2009; He, Meihua/D-4312-2017	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; So, Kwok-Fai/0000-0003-4039-4246	National Basic Research Program of China (973 Program) [2009CB320900, 2011CB510206]; National Science Foundation of China [30831160516, 81200691]; Ministry of Education of China [20090001120075]; Azalea Endowment Fund; Fundamental Research Fund for the Central Universities [21609101]; NIH [EY04067]; VA Merit Review; NATIONAL EYE INSTITUTE [R01EY004067, R56EY004067] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Azalea Endowment Fund; Fundamental Research Fund for the Central Universities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants obtained from the National Basic Research Program of China (973 Program, 2009CB320900 [MP] and 2011CB510206 [MP]), the National Science Foundation of China (30831160516 [MP] and 81200691 [MH]), the Ministry of Education of China (20090001120075 [MH]), Azalea (1972) Endowment Fund (KS & RC), and the Fundamental Research Fund for the Central Universities (21609101, KS), NIH EY04067 (NCB) and VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Bonne C, 1998, GEN PHARMACOL, V30, P275, DOI 10.1016/S0306-3623(97)00357-1; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chao HM, 2013, J OCUL PHARMACOL TH, V29, P539, DOI 10.1089/jop.2012.0179; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Danilov CA, 2009, GLIA, V57, P645, DOI 10.1002/glia.20793; Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619, DOI 10.1016/S1357-2725(02)00097-3; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Lau BWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033374; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024; Liu XQ, 2013, J OCUL PHARMACOL TH, V29, P33, DOI 10.1089/jop.2012.0141; Lu SP, 2010, INT J BIOL MACROMOL, V47, P681, DOI 10.1016/j.ijbiomac.2010.08.016; Luo Q, 2009, J MED FOOD, V12, P695, DOI 10.1089/jmf.2008.1232; Mao F, 2011, MED ONCOL, V28, P121, DOI 10.1007/s12032-009-9415-5; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Muller A, 1998, GEN PHARMACOL, V30, P315, DOI 10.1016/S0306-3623(97)00362-5; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Osborne NN, 1999, SURV OPHTHALMOL, V43, pS102, DOI 10.1016/S0039-6257(99)00044-2; Panahian N, 1999, J NEUROCHEM, V72, P1187; Peng PH, 2011, CURR EYE RES, V36, P238, DOI 10.3109/02713683.2010.539760; rai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Shan XZ, 2011, INT J MOL SCI, V12, P1081, DOI 10.3390/ijms12021081; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Szabo ME, 2004, INVEST OPHTH VIS SCI, V45, P3727, DOI 10.1167/iovs.03-1324; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Varga B, 2013, J MOL NEUROSCI, V50, P558, DOI 10.1007/s12031-013-9998-3; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Wu HT, 2010, INT J BIOL MACROMOL, V46, P540, DOI 10.1016/j.ijbiomac.2010.02.010; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xin YF, 2011, BIOL PHARM BULL, V34, P1523, DOI 10.1248/bpb.34.1523; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	51	120	141	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84800	10.1371/journal.pone.0084800	http://dx.doi.org/10.1371/journal.pone.0084800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400114	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700048
J	Cheng, KD; Sloan, A; Avery, KM; Coulthart, M; Carpenter, M; Knox, JD				Cheng, Keding; Sloan, Angela; Avery, Kristen M.; Coulthart, Michael; Carpenter, Michael; Knox, J. David			Exploring Physical and Chemical Factors Influencing the Properties of Recombinant Prion Protein and the Real-Time Quaking-Induced Conversion (RT-QuIC) Assay	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SEEDED CONVERSION	Real-time quaking-induced conversion (RT-QuIC), a highly specific and sensitive assay able to detect low levels of the disease-inducing isoform of the prion protein (PrPd) in brain tissue biopsies and cerebral spinal fluid, has great potential to become a method for diagnosing prion disease ante mortem. In order to standardize the assay method for routine analysis, an understanding of how physical and chemical factors affect the stability of the recombinant prion protein (rPrP) substrate and the RT-QuIC assay's sensitivity, specificity, and reproducibility is required. In this study, using sporadic Creutzfeldt-Jakob Disease brain homogenate to seed the reactions and an in vitro-expressed recombinant prion protein, hamster rPrP, as the substrate, the following factors affecting the RT-QuIC assay were examined: salt and substrate concentrations, substrate storage, and pH. Results demonstrated that both the generation of the quality and quantities of rPrP substrate critical to the reaction, as well as the RT-QuIC reaction itself required strict adherence to specific physical and chemical conditions. Once optimized, the RT-QuIC assay was confirmed to be a very specific and sensitive assay method for sCJD detection. Findings in this study indicate that further optimization and standardization of RT-QuIC assay is required before it can be adopted as a routine diagnostic test.	[Cheng, Keding; Sloan, Angela; Avery, Kristen M.; Carpenter, Michael; Knox, J. David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cheng, Keding] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Coulthart, Michael] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Ottawa, ON, Canada; [Carpenter, Michael; Knox, J. David] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; Public Health Agency of Canada; University of Manitoba	Cheng, KD (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Keding.Cheng@phac-aspc.gc.ca; David.Knox@phac-aspc.gc.ca						Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Coulthart MB, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-133; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; O'Callaghan T, 2011, NAT; Orru CD, 2011, TOP CURR CHEM, V305, P121, DOI 10.1007/128_2011_184; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	12	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84812	10.1371/journal.pone.0084812	http://dx.doi.org/10.1371/journal.pone.0084812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404191	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800070
J	Etebari, K; Asgari, S				Etebari, Kayvan; Asgari, Sassan			Accuracy of MicroRNA Discovery Pipelines in Non-Model Organisms Using Closely Related Species Genomes	PLOS ONE			English	Article							DEEP-SEQUENCING DATA; AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; EXPRESSION ANALYSIS; WOLBACHIA USES; IDENTIFICATION; MIRNAS; MIRANALYZER; BIOMARKERS; DISEASES	Mapping small reads to genome reference is an essential and more common approach to identify microRNAs (miRNAs) in an organism. Using closely related species genomes as proxy references can facilitate miRNA expression studies in non-model species that their genomes are not available. However, the level of error this introduces is mostly unknown, as this is the result of evolutionary distance between the proxy reference and the species of interest. To evaluate the accuracy of miRNA discovery pipelines in non-model organisms, small RNA library data from a mosquito, Aedes aegypti, were mapped to three well annotated insect genomes as proxy references using miRanalyzer with two strict and loose mapping criteria. In addition, another web-based miRNA discovery pipeline (DSAP) was used as a control for program performance. Using miRanalyzer, more than 80% reduction was observed in the number of mapped reads using strict criterion when proxy genome references were used; however, only 20% reduction was recorded for mapped reads to other species known mature miRNA datasets. Except a few changes in ranking, mapping criteria did not make any significant differences in the profile of the most abundant miRNAs in A. aegypti when its original or a proxy genome was used as reference. However, more variation was observed in miRNA ranking profile when DSAP was used as analysing tool. Overall, the results also suggested that using a proxy reference did not change the most abundant miRNAs' differential expression profiles when infected or non-infected libraries were compared. However, usage of a proxy reference could provide about 67% of the original outcome from more extremely up-or down-regulated miRNA profiles. Although using closely related species genome incurred some losses in the number of miRNAs, the most abundant miRNAs along with their differential expression profile would be acceptable based on the sensitivity level of each project.	[Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	s.asgari@uq.edu.au	Etebari, Kayvan/C-6436-2008; Asgari, Sassan/G-2678-2011	Etebari, Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544	Australian Research Council [DP110102112]; University of Queensland	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	This work was supported by an Australian Research Council (www.arc.gov.au) Discovery grant to S. A. (DP110102112) and a University of Queensland (www.uq.edu.au) PhD scholarship to K. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504; Belles X, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P30, DOI 10.1016/B978-0-12-384747-8.10002-9; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Gu JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067638; Gu LQ, 2012, EXPERT REV MOL DIAGN, V12, P573, DOI [10.1586/erm.12.58, 10.1586/ERM.12.58]; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Huang PJ, 2010, NUCLEIC ACIDS RES, V38, pW385, DOI 10.1093/nar/gkq392; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Tanzer Andrea, 2006, V342, P335; Van Roosbroeck K, 2013, EXPERT REV MOL DIAGN, V13, P183, DOI [10.1586/ERM.12.134, 10.1586/erm.12.134]; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Wilbert ML, 2011, WIRES SYST BIOL MED, V3, P491, DOI 10.1002/wsbm.128; Williamson V, 2013, BRIEF BIOINFORM, V14, P36, DOI 10.1093/bib/bbs010; WU W, 2013, PLOS ONE, V8; Yu DB, 2013, J INTEGR AGR, V12, P136, DOI 10.1016/S2095-3119(13)60214-2; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks196; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110	42	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84747	10.1371/journal.pone.0084747	http://dx.doi.org/10.1371/journal.pone.0084747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404190	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800069
J	Romio, S; Weibel, D; Dieleman, JP; Olberg, HK; de Vries, CS; Sammon, C; Andrews, N; Svanstrom, H; Molgaard-Nielsen, D; Hviid, A; Lapeyre-Mestre, M; Sommet, A; Saussier, C; Castot, A; Heijbel, H; Arnheim-Dahlstrom, L; Sparen, P; Mosseveld, M; Schuemie, M; van der Mass, N; Jacobs, BC; Leino, T; Kilpi, T; Storsaeter, J; Johansen, K; Kramarz, P; Bonhoeffer, J; Sturkenboom, MCJM				Romio, Silvana; Weibel, Daniel; Dieleman, Jeanne P.; Olberg, Henning K.; de Vries, Corinne S.; Sammon, Cormac; Andrews, Nick; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Hviid, Anders; Lapeyre-Mestre, Maryse; Sommet, Agnes; Saussier, Christel; Castot, Anne; Heijbel, Harald; Arnheim-Dahlstrom, Lisen; Sparen, Par; Mosseveld, Mees; Schuemie, Martijn; van der Mass, Nicoline; Jacobs, Bart C.; Leino, Tuija; Kilpi, Terhi; Storsaeter, Jann; Johansen, Kari; Kramarz, Piotr; Bonhoeffer, Jan; Sturkenboom, Miriam C. J. M.			Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe	PLOS ONE			English	Article							MONOVALENT VACCINE; UNITED-STATES; SAFETY; RISK; IMMUNOGENICITY; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; ADOLESCENTS; CHILDREN	Background: The risk of Guillain-Barre syndrome (GBS) following the United States' 1976 swine flu vaccination campaign in the USA led to enhanced active surveillance during the pandemic influenza (A(H1N1)pdm09) immunization campaign. This study aimed to estimate the risk of GBS following influenza A(H1N1) pdm09 vaccination. Methods: A self-controlled case series (SCCS) analysis was performed in Denmark, Finland, France, Netherlands, Norway, Sweden, and the United Kingdom. Information was collected according to a common protocol and standardised procedures. Cases classified at levels 1-4a of the Brighton Collaboration case definition were included. The risk window was 42 days starting the day after vaccination. Conditional Poisson regression and pooled random effects models estimated adjusted relative incidences (RI). Pseudo likelihood and vaccinated-only methods addressed the potential contraindication for vaccination following GBS. Results: Three hundred and three (303) GBS and Miller Fisher syndrome cases were included. Ninety-nine (99) were exposed to A(H1N1) pdm09 vaccination, which was most frequently adjuvanted (Pandemrix and Focetria). The unadjusted pooled RI for A(H1N1) pdm09 vaccination and GBS was 3.5 (95% Confidence Interval (CI): 2.2-5.5), based on all countries. This lowered to 2.0 (95% CI: 1.2-3.1) after adjustment for calendartime and to 1.9 (95% CI: 1.1-3.2) when we accounted for contra-indications. In a subset (Netherlands, Norway, and United Kingdom) we further adjusted for other confounders and there the RI decreased from 1.7 (adjusted for calendar month) to 1.4 (95% CI: 0.7-2.8), which is the main finding. Conclusion: This study illustrates the potential of conducting European collaborative vaccine safety studies. The main, fully adjusted analysis, showed that the RI of GBS was not significantly elevated after influenza A(H1N1) pdm09 vaccination (RI = 1.4 (95% CI: 0.7-2.8). Based on the upper limits of the pooled estimate we can rule out with 95% certainty that the number of excess GBS cases after influenza A(H1N1) pdm09 vaccination would be more than 3 per million vaccinated.	[Romio, Silvana; Weibel, Daniel; Dieleman, Jeanne P.; Mosseveld, Mees; Schuemie, Martijn; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Olberg, Henning K.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [de Vries, Corinne S.; Sammon, Cormac] Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Andrews, Nick] Hlth Protect Agcy, London, England; [Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lapeyre-Mestre, Maryse; Sommet, Agnes] Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France; [Lapeyre-Mestre, Maryse; Sommet, Agnes] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Saussier, Christel] French Natl Agcy Med & Hlth Prod Safety, St Denis, France; [Heijbel, Harald] Swedish Inst Infect Dis Control, Dept Vaccinol, Solna, Sweden; [Arnheim-Dahlstrom, Lisen; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [van der Mass, Nicoline] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Leino, Tuija; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Storsaeter, Jann] Norwegian Inst Publ Hlth, Dept Vaccines, Oslo, Norway; [Johansen, Kari; Kramarz, Piotr] ECDC, European Ctr Dis Prevent & Control, Surveillance & Response Support Unit, Stockholm, Sweden; [Weibel, Daniel; Bonhoeffer, Jan] Brighton Collaborat Fdn, Basel, Switzerland; [Bonhoeffer, Jan] Univ Childrens Hosp, Dept Infect Dis & Vaccinol, Basel, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Bergen; Haukeland University Hospital; University of Bath; Health Protection Agency; Statens Serum Institut; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Swedish Institute for Infectious Disease Control; Karolinska Institutet; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); European Centre for Disease Prevention & Control	Weibel, D (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	d.weibel@erasmusmc.nl	Sammon, Cormac/B-7340-2015; Lapeyre-Mestre, Maryse/C-8710-2012; Kramarz, Piotr/U-9442-2019; Bonhoeffer, Jan/E-5903-2014; Jacobs, Bart/ABE-2210-2021; Hviid, Anders/AAH-4319-2020	Sammon, Cormac/0000-0002-7921-4858; Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Hviid, Anders/0000-0002-7509-9127; Olberg, Henning/0000-0002-0675-3690; Bonhoeffer, Jan/0000-0001-9704-8315; Sparen, Par/0000-0002-5184-8971; Schuemie, Martijn/0000-0002-0817-5361	European Centre for Disease Prevention and Control (ECDC)	European Centre for Disease Prevention and Control (ECDC)	The study was funded by European Centre for Disease Prevention and Control (ECDC) and co-funded by all participating centers from Denmark, Finland, France, Netherlands, Norway, Sweden, and the United Kingdom as specified in the Authors' affiliations. Funders have been involved in designing the study, collecting the data. analysis, decisions to publish, and in reviewing the manuscript.	Andrews N, 2011, VACCINE, V29, P7878, DOI 10.1016/j.vaccine.2011.08.069; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Govoni V, 2001, CURR OPIN NEUROL, V14, P605, DOI 10.1097/00019052-200110000-00009; Greene SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067185; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; Lu W, 2010, EXPERT REV VACCINES, V9, P365, DOI 10.1586/ERV.10.23; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Paul-Ehrlich-Institut, 2012, ZUS ZWISCH PAND INFL; Poland GA, 2013, LANCET, V381, P1437, DOI 10.1016/S0140-6736(13)60182-8; Salmon DA, 2013, LANCET; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197	28	45	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82222	10.1371/journal.pone.0082222	http://dx.doi.org/10.1371/journal.pone.0082222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404128	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800007
J	Hughes, GM; Teeling, EC; Higgins, DG				Hughes, Graham M.; Teeling, Emma C.; Higgins, Desmond G.			Loss of Olfactory Receptor Function in Hominin Evolution	PLOS ONE			English	Article							DNA-SEQUENCING DATA; GENOME; GENERATION; REPERTOIRES; NEANDERTHAL; FRAMEWORK; SIBERIA	The mammalian sense of smell is governed by the largest gene family, which encodes the olfactory receptors (ORs). The gain and loss of OR genes is typically correlated with adaptations to various ecological niches. Modern humans have 853 OR genes but 55% of these have lost their function. Here we show evidence of additional OR loss of function in the Neanderthal and Denisovan hominin genomes using comparative genomic methodologies. Ten Neanderthal and 8 Denisovan ORs show evidence of loss of function that differ from the reference modern human OR genome. Some of these losses are also present in a subset of modern humans, while some are unique to each lineage. Morphological changes in the cranium of Neanderthals suggest different sensory arrangements to that of modern humans. We identify differences in functional olfactory receptor genes among modern humans, Neanderthals and Denisovans, suggesting varied loss of function across all three taxa and we highlight the utility of using genomic information to elucidate the sensory niches of extinct species.	[Hughes, Graham M.; Teeling, Emma C.] Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 2, Ireland; [Hughes, Graham M.; Higgins, Desmond G.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Teeling, EC (corresponding author), Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 2, Ireland.	emma.teeling@ucd.ie		Teeling, Emma/0000-0002-3309-1346; Hughes, Graham/0000-0003-3088-345X; Higgins, Des/0000-0002-3952-3285	Irish Research Council (IRC) Graduate Research Education Programme (GREP); Science Foundation Ireland PIYRA [06/YI3/B932]	Irish Research Council (IRC) Graduate Research Education Programme (GREP)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland PIYRA(Science Foundation Ireland)	This project was funded: by the Irish Research Council (IRC) Graduate Research Education Programme (GREP) awarded to GH, ECT and DH; a Science Foundation Ireland PIYRA 06/YI3/B932 awarded to ECT. (http://www.research.ie/) (http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Martin F, 2011, J INSECT PHYSIOL, V57, P1631, DOI 10.1016/j.jinsphys.2011.08.016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75	20	18	18	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84714	10.1371/journal.pone.0084714	http://dx.doi.org/10.1371/journal.pone.0084714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392153	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100076
J	Liaw, WJ; Tsao, CM; Huang, GS; Wu, CC; Ho, ST; Wang, JJ; Tao, YX; Shui, HA				Liaw, Wen-Jinn; Tsao, Cheng-Ming; Huang, Go-Shine; Wu, Chin-Chen; Ho, Shung-Tai; Wang, Jhi-Joung; Tao, Yuan-Xiang; Shui, Hao-Ai			Phosphoproteomics and Bioinformatics Analyses of Spinal Cord Proteins in Rats with Morphine Tolerance	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SIGNAL-TRANSDUCTION; PROTEOMIC ANALYSIS; CHAPERONE PROTEIN-14-3-3; PHOSPHOTYROSYL PROTEINS; ALPHA-INTERNEXIN; GAMMA-ENOLASE; UP-REGULATION; KINASE; EXPRESSION	Introduction: Morphine is the most effective pain-relieving drug, but it can cause unwanted side effects. Direct neuraxial administration of morphine to spinal cord not only can provide effective, reliable pain relief but also can prevent the development of supraspinal side effects. However, repeated neuraxial administration of morphine may still lead to morphine tolerance. Methods: To better understand the mechanism that causes morphine tolerance, we induced tolerance in rats at the spinal cord level by giving them twice-daily injections of morphine (20 mu g/10 mu L) for 4 days. We confirmed tolerance by measuring paw withdrawal latencies and maximal possible analgesic effect of morphine on day 5. We then carried out phosphoproteomic analysis to investigate the global phosphorylation of spinal proteins associated with morphine tolerance. Finally, pull-down assays were used to identify phosphorylated types and sites of 14-3-3 proteins, and bioinformatics was applied to predict biological networks impacted by the morphine-regulated proteins. Results: Our proteomics data showed that repeated morphine treatment altered phosphorylation of 10 proteins in the spinal cord. Pull-down assays identified 2 serine/threonine phosphorylated sites in 14-3-3 proteins. Bioinformatics further revealed that morphine impacted on cytoskeletal reorganization, neuroplasticity, protein folding and modulation, signal transduction and biomolecular metabolism. Conclusions: Repeated morphine administration may affect multiple biological networks by altering protein phosphorylation. These data may provide insight into the mechanism that underlies the development of morphine tolerance.	[Liaw, Wen-Jinn] Tungs Taichung MetroHarbor Hosp, Dept Anesthesiol, Taichung, Taiwan; [Liaw, Wen-Jinn; Tsao, Cheng-Ming; Huang, Go-Shine] Natl Def Med Ctr, Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liaw, Wen-Jinn; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Tsao, Cheng-Ming; Ho, Shung-Tai] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming; Ho, Shung-Tai] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu, Chin-Chen] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Tao, Yuan-Xiang] Rutgers State Univ, Dept Anesthesiol, New Jersey Med Sch, Newark, NJ 07102 USA; [Shui, Hao-Ai] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tungs' Taichung MetroHarbor Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Chi Mei Hospital; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Defense Medical Center	Shui, HA (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	haoai@ndmctsgh.edu.tw			National Science Council [NSC 99-2628-B-016 -013 -MY3]; Tri-Service General Hospital, Taiwan, R.O.C. [TSGH-C97-13-S03, TSGH-C98-05-S03]; NIH [RO1 NS058886, NS072206]; Rita Allen Foundation; Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund; Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072206, R01NS058886] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan, R.O.C.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund; Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NSC 99-2628-B-016 -013 -MY3 from the National Science Council and TSGH-C97-13-S03, TSGH-C98-05-S03, and TSGH-C98-05-S03 from the Tri-Service General Hospital, Taiwan, R.O.C. to W.-J.L. and by the NIH grants RO1 NS058886 and NS072206, the Rita Allen Foundation, Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund, and the Blaustein Pain Research Fund to Y.X.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso E, 2007, NEUROSCI LETT, V412, P163, DOI 10.1016/j.neulet.2006.11.002; Berhow MT, 1996, J NEUROSCI, V16, P4707; Chan CC, 2009, J PROTEOME RES, V8, P5382, DOI 10.1021/pr9003932; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen PH, 2011, J PROTEOMICS, V74, P2760, DOI 10.1016/j.jprot.2011.09.019; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Dobashi T, 2010, J CELL MOL MED, V14, P2816, DOI 10.1111/j.1582-4934.2009.00932.x; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; Ferrer-Alcon M, 2000, J NEUROSCI RES, V61, P338, DOI 10.1002/1097-4547(20000801)61:3<338::AID-JNR12>3.0.CO;2-5; Foucault I, 2003, J BIOL CHEM, V278, P7146, DOI 10.1074/jbc.M209509200; Gerber Helmut R, 2003, Best Pract Res Clin Anaesthesiol, V17, P429, DOI 10.1016/S1521-6896(03)00014-4; GUTSTEIN HB, 1993, BRAIN RES, V626, P332, DOI 10.1016/0006-8993(93)90597-G; Guzel E, 2011, BIOL REPROD, V85, P121, DOI 10.1095/biolreprod.110.089532; Hafner A, 2013, AGING CELL, V12, P604, DOI 10.1111/acel.12093; Hafner A, 2012, BIOCHEM J, V443, P439, DOI 10.1042/BJ20111351; Hafner A, 2010, NEUROSIGNALS, V18, P246, DOI 10.1159/000324292; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim S, 2011, BEHAV NEUROSCI, V125, P404, DOI 10.1037/a0023185; Kim SY, 2004, J NEUROSCI RES, V77, P867, DOI 10.1002/jnr.20214; Kim SY, 2005, MOL BRAIN RES, V133, P58, DOI 10.1016/j.molbrainres.2004.09.018; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lelevich S. V., 2007, Biomeditsinskaya Khimiya, V53, P284; Lelevich S. V., 2004, Biomeditsinskaya Khimiya, V50, P273; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Li JG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.359679; Liaw WJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-45; Liaw WJ, 2004, NEUROSCIENCE, V123, P11, DOI 10.1016/j.neuroscience.2003.09.007; MAO J, 1994, J NEUROSCI, V14, P2301; MENARD DP, 1995, J PHARMACOL EXP THER, V273, P887; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Mumby M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-230; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; OLASMAA M, 1988, BRAIN RES, V475, P291, DOI 10.1016/0006-8993(88)90617-8; Osenbach R K, 2001, Curr Pain Headache Rep, V5, P241, DOI 10.1007/s11916-001-0038-6; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2011.09.001; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Ram PT, 2012, MOL ONCOL, V6, P147, DOI 10.1016/j.molonc.2012.01.008; Ramagli LS, 1999, METH MOL B, V112, P99; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rodnight R, 1997, BRAZ J MED BIOL RES, V30, P325, DOI 10.1590/S0100-879X1997000300005; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma SK, 2003, NEUROCHEM RES, V28, P1369, DOI 10.1023/A:1024996415795; Shea TB, 1999, CELL MOTIL CYTOSKEL, V43, P322, DOI 10.1002/(SICI)1097-0169(1999)43:4<322::AID-CM5>3.0.CO;2-B; Shui HA, 2007, PROTEOMICS, V7, P796, DOI 10.1002/pmic.200600699; Shui HA, 2012, J PROTEOMICS, V75, P1170, DOI 10.1016/j.jprot.2011.10.029; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Tao F, 2001, NEUROREPORT, V12, P3251, DOI 10.1097/00001756-200110290-00022; Tao YX, 2000, NEUROSCIENCE, V95, P525; Tao YX, 2002, NEUROSCIENCE, V112, P439, DOI 10.1016/S0306-4522(02)00075-1; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Ueda H, 2009, FRONT BIOSCI, V14, P5260, DOI 10.2741/3596; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012	62	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83817	10.1371/journal.pone.0083817	http://dx.doi.org/10.1371/journal.pone.0083817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392096	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100020
J	Tserevelakis, GJ; Megalou, EV; Filippidis, G; Petanidou, B; Fotakis, C; Tavernarakis, N				Tserevelakis, George J.; Megalou, Evgenia V.; Filippidis, George; Petanidou, Barbara; Fotakis, Costas; Tavernarakis, Nektarios			Label-Free Imaging of Lipid Depositions in C. elegans Using Third-Harmonic Generation Microscopy	PLOS ONE			English	Article							FAT REGULATORY GENES; CAENORHABDITIS-ELEGANS; SRS MICROSCOPY; STORAGE	Elucidation of the molecular mechanisms regulating lipid storage and metabolism is essential for mitigating excess adiposity and obesity, which has been associated with increased prevalence of severe pathological conditions such as cardiovascular disorders and type II diabetes, worldwide. However, imaging fatty acid distribution and dynamics in vivo, at the cellular or organismal level is challenging. We developed a label-free method for visualizing lipid depositions in vivo, based on third harmonic generation (THG) microscopy. THG imaging requires a single pulsed-laser light source, alleviating the technical challenges of implementing coherent anti-Stokes Raman scattering spectroscopy (CARS) to detect fat stores in living cells. We demonstrate that THG can be used to efficiently and reliably visualize lipid droplets in Caenorhabditis elegans. Thus, THG microscopy offers a versatile alternative to fluorescence and dye-based approaches for lipid biology research.	[Tserevelakis, George J.; Filippidis, George; Petanidou, Barbara; Fotakis, Costas] Fdn Res & Technol, Inst Elect Struct & Laser, Iraklion, Greece; [Tserevelakis, George J.; Petanidou, Barbara; Fotakis, Costas] Univ Crete, Dept Phys, Iraklion, Greece; [Megalou, Evgenia V.; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Tavernarakis, Nektarios] Univ Crete, Sch Med, Iraklion, Greece	University of Crete; University of Crete	Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Filippidis, George/A-2473-2014; Tserevelakis, George/ABB-5778-2020; Fotakis, Costas/G-8751-2011	Tavernarakis, Nektarios/0000-0002-5253-1466; Filippidis, George/0000-0003-4748-5968; Tserevelakis, George/0000-0002-9938-3472; FOTAKIS, COSTAS/0000-0001-9526-6714	Bodossaki Foundation; European Research Council [ADG - 233358]	Bodossaki Foundation; European Research Council(European Research Council (ERC)European Commission)	Funding replacement: E.V.M. was supported by a postdoctoral fellowship from the Bodossaki Foundation. This work was in part funded by grants from the European Research Council (Grant ERC 2008 ADG - 233358 NEURONAGE), the European Commission Marie Curie Programme Grant ITN CodeAge 264049), and the General Secretariat for Research and Technology of Greece Grant Aristeia 1823 - Necrosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Barros AGD, 2012, METHOD CELL BIOL, V107, P383, DOI 10.1016/B978-0-12-394620-1.00013-8; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; Debarre D, 2005, OPT LETT, V30, P2134, DOI 10.1364/OL.30.002134; Debarre D, 2007, OPT EXPRESS, V15, P8913, DOI 10.1364/OE.15.008913; Debarre D, 2007, BIOPHYS J, V92, P603, DOI 10.1529/biophysj.106.094946; Folick A, 2011, CURR OPIN GENET DEV, V21, P585, DOI 10.1016/j.gde.2011.09.003; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ranall MV, 2011, BIOTECHNIQUES, V51, P35, DOI 10.2144/000113702; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Squier J, 2001, REV SCI INSTRUM, V72, P2855, DOI 10.1063/1.1379598; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810	20	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84431	10.1371/journal.pone.0084431	http://dx.doi.org/10.1371/journal.pone.0084431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392137	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100060
J	Cizmeci, D; Arkun, Y				Cizmeci, Deniz; Arkun, Yaman			Regulatory Networks and Complex Interactions between the Insulin and Angiotensin II Signalling Systems: Models and Implications for Hypertension and Diabetes	PLOS ONE			English	Article							NITRIC-OXIDE; RECEPTOR SUBSTRATE-1; OXIDATIVE STRESS; FEEDBACK LOOPS; KINASE-B; AKT; SENSITIVITY; MTOR; RESISTANCE; PHOSPHORYLATION	The cross-talk between insulin and angiotensin II signalling pathways plays a significant role in the co-occurrence of diabetes and hypertension. We developed a mathematical model of the system of interactions among the biomolecules that are involved in the cross-talk between the insulin and angiotensin II signalling pathways. We have identified several feedback structures that regulate the dynamic behavior of the individual signalling pathways and their interactions. Different scenarios are simulated and dominant steady-state, dynamic and stability characteristics are revealed. The proposed mechanistic model describes how angiotensin II inhibits the actions of insulin and impairs the insulin-mediated vasodilation. The model also predicts that poor glycaemic control induced by diabetes contributes to hypertension by activating the renin angiotensin aystem.	[Cizmeci, Deniz; Arkun, Yaman] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr		Cizmeci, Deniz/0000-0003-3231-7726	Koc University	Koc University(Koc University)	Koc University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2006, DIABETES OBES METAB, V8, P396, DOI 10.1111/j.1463-1326.2005.00526.x; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceriello A, 2004, DIABETOLOGIA, V47, P1535, DOI 10.1007/s00125-004-1487-3; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; CIZMECI D, 2012, REGULATORY NETWORKS; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010070; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fan QL, 2004, NEPHROL DIAL TRANSPL, V19, P3012, DOI 10.1093/ndt/gfh499; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo W, 2003, AM J PHYSIOL-HEART C, V285, pH1396, DOI 10.1152/ajpheart.00096.2003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kurtz A, 1998, AM J PHYSIOL-RENAL, V275, pF849, DOI 10.1152/ajprenal.1998.275.6.F849; Kwon YK, 2008, BIOINFORMATICS, V24, P1926, DOI 10.1093/bioinformatics/btn337; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Nawano M, 1999, METABOLISM, V48, P1248, DOI 10.1016/S0026-0495(99)90263-9; Nayak S, 2011, IET SYST BIOL, V5, P2, DOI 10.1049/iet-syb.2009.0065; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Perkins JM, 2008, CURR OPIN ENDOCRINOL, V15, P147, DOI 10.1097/MED.0b013e3282f7026f; Peti-Peterdi J, 2008, NEPHROL DIAL TRANSPL, V23, P3047, DOI 10.1093/ndt/gfn377; Pueyo ME, 1998, AM J PHYSIOL-CELL PH, V274, pC214, DOI 10.1152/ajpcell.1998.274.1.C214; Pulakat L, 2011, CARDIORENAL MED, V1, P102, DOI 10.1159/000327140; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scheen AJ, 2004, DIABETES METAB, V30, P498, DOI 10.1016/S1262-3636(07)70147-7; SOWERS JR, 1990, MOL CELL ENDOCRINOL, V74, pC87, DOI 10.1016/0303-7207(90)90110-T; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Wang GY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046015; Wattanapitayakul SK, 2000, FASEB J, V14, P271, DOI 10.1096/fasebj.14.2.271; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	55	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83640	10.1371/journal.pone.0083640	http://dx.doi.org/10.1371/journal.pone.0083640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24400038	Green Published, gold			2022-12-25	WOS:000329325200098
J	Hayakawa, EH; Mochizuki, E; Tsuda, T; Akiyoshi, K; Matsuoka, H; Kuwabata, S				Hayakawa, Eri H.; Mochizuki, Eiko; Tsuda, Tetsuya; Akiyoshi, Kazunari; Matsuoka, Hiroyuki; Kuwabata, Susumu			The Effect of Hydrophilic Ionic Liquids 1-Ethyl-3-Methylimidazolium Lactate and Choline Lactate on Lipid Vesicle Fusion	PLOS ONE			English	Article							MEMBRANE-FUSION; MASS-SPECTROMETRY; POLYETHYLENE-GLYCOL; GENE DELIVERY; CELL-FUSION; CHROMATOGRAPHY; PARAMETERS; MECHANISM; MATRICES; POLAR	Ionic liquids (ILs) are room-temperature molten salts that have applications in both physical sciences and more recently in the purification of proteins and lipids, gene transfection and sample preparation for electron microscopy (EM) studies. Transfection of genes into cells requires membrane fusion between the cell membrane and the transfection reagent, thus, ILs may be induce a membrane fusion event. To clarify the behavior of ILs with cell membranes the effect of ILs on model membranes, i.e., liposomes, were investigated. We used two standard ILs, 1-ethyl-3-methylimidazolium lactate ([EMI][Lac]) and choline lactate ([Ch][Lac]), and focused on whether these ILs can induce lipid vesicle fusion. Fluorescence resonance energy transfer and dynamic light scattering were employed to determine whether the ILs induced vesicle fusion. Vesicle solutions at low IL concentrations showed negligible fusion when compared with the controls in the absence of ILs. At concentrations of 30% (v/v), both types of ILs induced vesicle fusion up to 1.3 and 1.6 times the fluorescence intensity of the control in the presence of [Ch][Lac] and [EMI] [Lac], respectively. This is the first demonstration that [EMI][Lac] and [Ch][Lac] induce vesicle fusion at high IL concentrations and this observation should have a significant influence on basic biophysical studies. Conversely, the ability to avoid vesicle fusion at low IL concentrations is clearly advantageous for EM studies of lipid samples and cells. This new information describing IL-lipid membrane interactions should impact EM observations examining cell morphology.	[Hayakawa, Eri H.; Matsuoka, Hiroyuki] Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi, Japan; [Mochizuki, Eiko; Tsuda, Tetsuya; Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka, Japan; [Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto, Japan; [Akiyoshi, Kazunari] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama, Japan; [Kuwabata, Susumu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Jichi Medical University; Osaka University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Hayakawa, EH (corresponding author), Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi, Japan.	erihayakawa@jichi.ac.jp; kuwabata@chem.eng.osaka-u.ac.jp	Kuwabata, Susumu/N-3492-2018; Tsuda, Tetsuya/F-7234-2014	Kuwabata, Susumu/0000-0002-4606-964X; Tsuda, Tetsuya/0000-0001-9462-8066; Matsuoka, Hiroyuki/0000-0001-8839-0012; Hayakawa, Eri/0000-0001-5067-2161	CREST of the Japan Science and Technology Agency; Ohyama Health Foundation Inc	CREST of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ohyama Health Foundation Inc	This work was supported by grants from CREST of the Japan Science and Technology Agency to SK and EHH was supported by Ohyama Health Foundation Inc. and Grant-in-Aid for Scientific Research (C), partially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2011, ANALYST, V136, P4020, DOI 10.1039/c1an15350a; Cherta L, 2013, J CHROMATOGR A, V1314, P224, DOI 10.1016/j.chroma.2013.09.029; Cromie SRT, 2009, J PHYS CHEM B, V113, P11642, DOI 10.1021/jp904060y; Delmonte P, 2012, J CHROMATOGR A, V1233, P137, DOI 10.1016/j.chroma.2012.02.012; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dyson PJ, 2003, CHEM COMMUN, P2418, DOI 10.1039/b308309h; Fitzgerald JJD, 2010, ANAL CHEM, V82, P4413, DOI 10.1021/ac100133c; Fujita K, 2012, RSC ADV, V2, P4018, DOI 10.1039/c2ra01045c; Fukaya Y, 2006, BIOMACROMOLECULES, V7, P3295, DOI 10.1021/bm060327d; Giese G, 2013, J CHROMATOGR B, V938, P14, DOI 10.1016/j.jchromb.2013.08.029; Hayakawa E, 2007, BIOPHYS J, V93, P4018, DOI 10.1529/biophysj.107.104075; He ZY, 2013, APPL MICROBIOL BIOT, V97, P9175, DOI 10.1007/s00253-013-5195-0; Jessop PG, 2012, GREEN CHEM, V14, P1245, DOI 10.1039/c2gc16670d; Lee JM, 2008, J PHYS CHEM B, V112, P1473, DOI 10.1021/jp076895k; Lentz BR, 1999, MOL MEMBR BIOL, V16, P279, DOI 10.1080/096876899294508; LENTZ BR, 1994, CHEM PHYS LIPIDS, V73, P91, DOI 10.1016/0009-3084(94)90176-7; Li JG, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919565; LI LH, 1994, BIOPHYS J, V67, P2361, DOI 10.1016/S0006-3495(94)80722-2; Li YL, 2005, J AM SOC MASS SPECTR, V16, P679, DOI 10.1016/j.jasms.2005.01.017; Malinin VS, 2001, BIOCHEMISTRY-US, V40, P8292, DOI 10.1021/bi010570r; Murphy PJ, 2011, J VIS EXP; Pedrazzoli F, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-32; Schmieder AH, 2007, BIOTECHNOL BIOENG, V96, P967, DOI 10.1002/bit.21199; Suh JH, 2013, J PHARMACEUT BIOMED, V75, P214, DOI 10.1016/j.jpba.2012.11.041; Tamura K, 2012, BIOTECHNOL BIOENG, V109, P729, DOI 10.1002/bit.24357; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Weingartner H, 2012, PHYS CHEM CHEM PHYS, V14, P415, DOI 10.1039/c1cp21947b; Weinreb G, 2007, BIOPHYS J, V92, P4012, DOI 10.1529/biophysj.106.090043; Xu W, 2003, J PHYS CHEM B, V107, P6170, DOI 10.1021/jp0275894; Zhang QG, 2010, J PHYS CHEM B, V114, P4747, DOI 10.1021/jp1009498; Zhang YY, 2009, CHEM BIOL DRUG DES, V74, P282, DOI 10.1111/j.1747-0285.2009.00858.x	31	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85467	10.1371/journal.pone.0085467	http://dx.doi.org/10.1371/journal.pone.0085467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392011	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900155
J	Mulero, M; Perroy, J; Federici, C; Cabello, G; Ollendorff, V				Mulero, Miquel; Perroy, Julie; Federici, Carole; Cabello, Gerard; Ollendorff, Vincent			Analysis of RXR/THR and RXR/PPARG2 Heterodimerization by Bioluminescence Resonance Energy Transfer (BRET)	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PPAR-GAMMA-RXR; PEROXISOME PROLIFERATOR; DNA-BINDING; PRIMARY TARGET; IDENTIFICATION; MOBILITY; AGONISTS; COMPLEX; GENES	Background: Nuclear receptors (NR) regulate transcription of genes involved in many biological processes such as development, cell proliferation, differentiation and cell death. Amongst them, PPARG2 and THR control tissue glucose and lipid homeostasis which are deregulated in severe pathophysiological conditions such as metabolic syndromes. Methodology/Principal Findings: Here, we describe a real time BRET approach to monitor heterodimerization between RXR and PPARG2 or THR in vitro or in living cells. The presence of a specific DNA target was required to induce in vitro a BRET shift reflecting heterodimerization of RXR/PPARG2 or RXR/THR. As in electrophoretic mobility shift assay (EMSA), the stringency and specificity of the BRET shift assay depended upon assay condition optimization including MgCl2 concentration. For the nuclear receptors, we found by mutagenesis analysis that each heterodimer partner must harbor an intact DNA binding domain to induce BRET and heterodimerization on a DNA target. Moreover the interaction between the PPARG2 ligand binding domain and the RXR DNA binding domain stabilized the heterodimer on its DNA target. BRET microscopy in living cells highlighted the heterodimerization of RXR/PPARG2 within the nucleus clustered in discrete foci that may represent active target gene transcription regulation regions. BRET imaging also suggested that heterodimerization between RXR and PPARG2 required the DNA binding of PPARG2. Conclusions/Significance: The BRET approach described here allowed us to study the dynamic interactions which exist between NR in vitro or in living cells and can provide important information on heterodimerization modes, affinity with a given RE and subcellular localization of the heterodimers. This method could be used to study real time changes of NR heterodimers occurring on DNA depending upon cell activation, chromatin state and help to define the mechanisms of ligands or drug action designed to target NRs.	[Mulero, Miquel; Federici, Carole; Cabello, Gerard; Ollendorff, Vincent] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Cabello, Gerard; Ollendorff, Vincent] Univ Montpellier I, Montpellier, France; [Mulero, Miquel] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Biochem & Biotechnol, E-43007 Tarragona, Spain; [Perroy, Julie] CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France; [Perroy, Julie] INSERM, U661, Montpellier, France; [Perroy, Julie] Univ Montpellier I, UMR 5203, Montpellier, France; [Perroy, Julie] Univ Montpellier 2, UMR 5203, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Universitat Rovira i Virgili; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Ollendorff, V (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	ollendor@supagro.inra.fr	Mulero, Miquel/L-4672-2014	Mulero, Miquel/0000-0003-2545-2065; perroy, julie/0000-0001-6199-0448; Ollendorff, Vincent/0000-0001-9751-2202	INRA (Institut National de la Recherche Agronomique); Ministerio de Educacion y Ciencia of the Spanish Government [AGL2011-25831]	INRA (Institut National de la Recherche Agronomique); Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government)	This work was supported by grants from INRA (Institut National de la Recherche Agronomique) and Miquel Mulero was supported by a grant AGL2011-25831 from the Ministerio de Educacion y Ciencia of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Akiyama TE, 2002, MOL ENDOCRINOL, V16, P707, DOI 10.1210/me.16.4.707; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Chan LS, 2007, BIOCHEM BIOPH RES CO, V358, P1080, DOI 10.1016/j.bbrc.2007.05.051; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; Coulon V, 2008, BIOPHYS J, V94, P1001, DOI 10.1529/biophysj.107.117275; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Gaikwad AB, 2007, PHARMACOL RES, V55, P400, DOI 10.1016/j.phrs.2007.01.015; Glass CK, 2000, GENE DEV, V14, P121; Gross B, 2007, BEST PRACT RES CL EN, V21, P687, DOI 10.1016/j.beem.2007.09.004; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Moll JR, 2002, NUCLEIC ACIDS RES, V30, P1240, DOI 10.1093/nar/30.5.1240; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Perroy J, 2010, METHODS MOL BIOL, V591, P325, DOI 10.1007/978-1-60761-404-3_19; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pott S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048102; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200	36	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84569	10.1371/journal.pone.0084569	http://dx.doi.org/10.1371/journal.pone.0084569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391967	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900110
J	Matsuda-Lennikov, M; Suizu, F; Hirata, N; Hashimoto, M; Kimura, K; Nagamine, T; Fujioka, Y; Ohba, Y; Iwanaga, T; Noguchi, M				Matsuda-Lennikov, Mami; Suizu, Futoshi; Hirata, Noriyuki; Hashimoto, Manabu; Kimura, Kohki; Nagamine, Tadashi; Fujioka, Yoichiro; Ohba, Yusuke; Iwanaga, Toshihiko; Noguchi, Masayuki			Lysosomal Interaction of Akt with Phafin2: A Critical Step in the Induction of Autophagy	PLOS ONE			English	Article							ISOLATED RAT HEPATOCYTES; FYVE DOMAINS; PROTEIN; PATHWAY; MACROAUTOPHAGY; VISUALIZATION; DEGRADATION; DOWNSTREAM; 3-KINASES; MECHANISM	Autophagy is an evolutionarily conserved mechanism for the gross disposal of intracellular proteins in mammalian cells and dysfunction in this pathway has been associated with human disease. Although the serine threonine kinase Akt is suggested to play a role in this process, little is known about the molecular mechanisms by which Akt induces autophagy. Using a yeast two-hybrid screen, Phafin2 (EAPF or PLEKHF2), a lysosomal protein with a unique structure of N-terminal PH (pleckstrin homology) domain and C-terminal FYVE (Fab 1, YOTB, Vac 1, and EEA1) domain was found to interact with Akt. A sucrose gradient fractionation experiment revealed that both Akt and Phafin2 co-existed in the same lysosome enriched fraction after autophagy induction. Confocal microscopic analysis and BiFC analysis demonstrated that both Akt and Phafin2 accumulate in the lysosome after induction of autophagy. BiFC analysis using PtdIns (3) P interaction defective mutant of Phafin2 demonstrated that lysosomal accumulation of the Akt-Phafin2 complex and subsequent induction of autophagy were lysosomal PtdIns (3) P dependent events. Furthermore, in murine macrophages, both Akt and Phafin2 were required for digestion of fluorescent bacteria and/or LPS-induced autophagy. Taken together, these findings establish that lysosomal accumulation of Akt and Phafin2 is a critical step in the induction of autophagy via an interaction with PtdIns (3)P.	[Matsuda-Lennikov, Mami; Suizu, Futoshi; Hirata, Noriyuki; Hashimoto, Manabu; Kimura, Kohki; Nagamine, Tadashi; Noguchi, Masayuki] Hokkaido Univ, Div Canc Biol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Fujioka, Yoichiro; Ohba, Yusuke] Hokkaido Univ, Lab Pathophysiol & Signal Transduct, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Iwanaga, Toshihiko] Hokkaido Univ, Lab Histol & Cytol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Noguchi, M (corresponding author), Hokkaido Univ, Div Canc Biol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	m_noguch@igm.hokudai.ac.jp	Fujioka, Yoichiro/AAF-3313-2019; Suizu, Futoshi/G-3530-2019	Fujioka, Yoichiro/0000-0002-5760-9357; Suizu, Futoshi/0000-0003-0206-4289; Nagamine, Tadashi/0000-0002-8339-4177	Japanese Ministry Education; Takeda Science foundation	Japanese Ministry Education; Takeda Science foundation(Takeda Science Foundation (TSF))	M.N. and F. S. are supported by Grant Aid from the Japanese Ministry Education. M.N. is supported by Takeda Science foundation. M. M.-L. and Y.F. are JSPS research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chen W, 2005, J BIOL CHEM, V280, P40985, DOI 10.1074/jbc.M502190200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lin WJ, 2010, BIOCHEM BIOPH RES CO, V391, P1043, DOI 10.1016/j.bbrc.2009.12.016; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	30	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e79795	10.1371/journal.pone.0079795	http://dx.doi.org/10.1371/journal.pone.0079795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416124	Green Published, gold			2022-12-25	WOS:000329862500005
J	Doughty, DM; Dieterle, M; Sessions, AL; Fischer, WW; Newman, DK				Doughty, David M.; Dieterle, Michael; Sessions, Alex L.; Fischer, Woodward W.; Newman, Dianne K.			Probing the Subcellular Localization of Hopanoid Lipids in Bacteria Using NanoSIMS	PLOS ONE			English	Article							ION MASS-SPECTROMETRY; PLASMA-MEMBRANES; RHODOPSEUDOMONAS-PALUSTRIS; SPHINGOLIPID DOMAINS; NOSTOC-PUNCTIFORME; PHASE; RAFTS; IDENTIFICATION; MICRODOMAINS; FIBROBLASTS	The organization of lipids within biological membranes is poorly understood. Some studies have suggested lipids group into microdomains within cells, but the evidence remains controversial due to non-native imaging techniques. A recently developed NanoSIMS technique indicated that sphingolipids group into microdomains within membranes of human fibroblast cells. We extended this NanoSIMS approach to study the localization of hopanoid lipids in bacterial cells by developing a stable isotope labeling method to directly detect subcellular localization of specific lipids in bacteria with ca. 60 nm resolution. Because of the relatively small size of bacterial cells and the relative abundance of hopanoid lipids in membranes, we employed a primary H-2-label to maximize our limit of detection. This approach permitted the analysis of multiple stable isotope labels within the same sample, enabling visualization of subcellular lipid microdomains within different cell types using a secondary label to mark the growing end of the cell. Using this technique, we demonstrate subcellular localization of hopanoid lipids within alpha-proteobacterial and cyanobacterial cells. Further, we provide evidence of hopanoid lipid domains in between cells of the filamentous cyanobacterium Nostoc punctiforme. More broadly, our method provides a means to image lipid microdomains in a wide range of cell types and test hypotheses for their functions in membranes.	[Doughty, David M.; Dieterle, Michael; Newman, Dianne K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sessions, Alex L.; Fischer, Woodward W.; Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Doughty, David M.; Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Fischer, WW (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	wfischer@caltech.edu; dkn@caltech.edu	Sessions, Alex/ABC-9207-2020	Sessions, Alex/0000-0001-6120-2763; Dieterle, Michael/0000-0002-3109-6151	Howard Hughes Medical Institute (HHMI); NASA Exobiology program [NNX12AD93G]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NASA Exobiology program(National Aeronautics & Space Administration (NASA))	Grants to D.K.N. from the Howard Hughes Medical Institute (HHMI) and the NASA Exobiology program (NNX12AD93G) supported this work. D.K.N. is an HHMI Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Doughty DM, 2009, GEOBIOLOGY, V7, P524, DOI 10.1111/j.1472-4669.2009.00217.x; Doughty DM, 2011, P NATL ACAD SCI USA, V108, pE1045, DOI 10.1073/pnas.1104209108; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Ginsbach G, 1987, HISTOCHEMISTRY, V86, P241; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; Owen DM, 2012, BIOESSAYS, V34, P739, DOI 10.1002/bies.201200044; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Saenz JP, 2012, P NATL ACAD SCI USA, V109, P14236, DOI 10.1073/pnas.1212141109; Sato S, 2012, J BIOL CHEM, V287, P24113, DOI 10.1074/jbc.M111.318311; Sessions AL, 2004, GEOCHIM COSMOCHIM AC, V68, P1545, DOI 10.1016/j.gca.2003.06.004; Suzuki KGN, 2012, BIOTECHNOL J, V7, P753, DOI 10.1002/biot.201100360; Welander PV, 2012, GEOBIOLOGY, V10, P163, DOI 10.1111/j.1472-4669.2011.00314.x; Welander PV, 2010, P NATL ACAD SCI USA, V107, P8537, DOI 10.1073/pnas.0912949107; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; WESTMACOTT D, 1976, J GEN MICROBIOL, V94, P117, DOI 10.1099/00221287-94-1-117; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	30	32	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84455	10.1371/journal.pone.0084455	http://dx.doi.org/10.1371/journal.pone.0084455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409299	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000329463500023
J	Banda, M; Speyer, CL; Semma, SN; Osuala, KO; Kounalakis, N; Torres, KET; Barnard, NJ; Kim, HJ; Sloane, BF; Miller, FR; Goydos, JS; Gorski, DH				Banda, Malathi; Speyer, Cecilia L.; Semma, Sara N.; Osuala, Kingsley O.; Kounalakis, Nicole; Torres, Keila E. Torres; Barnard, Nicola J.; Kim, Hyunjin J.; Sloane, Bonnie F.; Miller, Fred R.; Goydos, James S.; Gorski, David H.			Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-COUPLED RECEPTORS; CELL-LINES; MOLECULAR PORTRAITS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; XENOGRAFT MODEL; KINASE-C; MELANOMA; RAS	TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR) or amplified human epidermal growth factor receptor type 2 (HER2), and there currently exist no targeted therapies effective against it. Consequently, finding new molecular targets in triple negative breast cancer (TNBC) is critical to improving patient outcomes. Previously, we have detected the expression of metabotropic glutamate receptor-1 (gene: GRM1; protein: mGluR1) in TNBC and observed that targeting glutamatergic signaling inhibits TNBC growth both in vitro and in vivo. In this study, we explored how mGluR1 contributes to TNBC progression, using the isogenic MCF10 progression series, which models breast carcinogenesis from nontransformed epithelium to malignant basal-like breast cancer. We observed that mGluR1 is expressed in human breast cancer and that in MCF10A cells, which model nontransformed mammary epithelium, but not in MCF10AT1 cells, which model atypical ductal hyperplasia, mGluR1 overexpression results in increased proliferation, anchorage-independent growth, and invasiveness. In contrast, mGluR1 knockdown results in a decrease in these activities in malignant MCF10CA1d cells. Similarly, pharmacologic inhibition of glutamatergic signaling in MCF10CA1d cells results in a decrease in proliferation and anchorage-independent growth. Finally, transduction of MCF10AT1 cells, which express c-Ha-ras, using a lentiviral construct expressing GRM1 results in transformation to carcinoma in 90% of resultant xenografts. We conclude that mGluR1 cooperates with other factors in hyperplastic mammary epithelium to contribute to TNBC progression and therefore propose that glutamatergic signaling represents a promising new molecular target for TNBC therapy.	[Banda, Malathi; Speyer, Cecilia L.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; [Banda, Malathi; Speyer, Cecilia L.; Semma, Sara N.; Gorski, David H.] Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Osuala, Kingsley O.; Sloane, Bonnie F.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Kounalakis, Nicole; Torres, Keila E. Torres; Kim, Hyunjin J.; Goydos, James S.] UMDNJ Robert Wood Johnson Univ, Div Surg Oncol, Sch Med, New Brunswick, NJ USA; [Barnard, Nicola J.] UMDNJ Robert Wood Johnson Univ, Dept Pathol, Sch Med, New Brunswick, NJ USA; [Barnard, Nicola J.; Goydos, James S.] Canc Inst New Jersey, New Brunswick, NJ USA; [Miller, Fred R.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Wayne State University	Gorski, DH (corresponding author), Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA.	gorskid@med.wayne.edu	Sloane, Bonnie F/A-1050-2009; Goydos, James/AAR-8990-2020; Gorski, David/AAE-6399-2022	Goydos, James/0000-0001-9811-939X; Gorski, David/0000-0002-9805-6699; Torres, Keila E/0000-0002-1855-0989	Conquer Cancer Foundation of ASCO; "Grants4Targets" (G4T) program of Bayer Healthcare; Bayer Healthcare; NATIONAL CANCER INSTITUTE [R01CA140314, P30CA022453] Funding Source: NIH RePORTER	Conquer Cancer Foundation of ASCO; "Grants4Targets" (G4T) program of Bayer Healthcare; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work described in this manuscript was supported by an Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation of ASCO, as well as a grant from the "Grants4Targets" (G4T) program of Bayer Healthcare. David H. Gorski received a small amount of funding from Bayer Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOS JL, 1989, CANCER RES, V49, P4682; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; CIARDIELLO F, 1992, MOL CARCINOGEN, V6, P43, DOI 10.1002/mc.2940060108; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Esseltine JL, 2013, MOL PHARMACOL, V83, P770, DOI 10.1124/mol.112.081695; Esseltine JL, 2012, J NEUROSCI, V32, P16933, DOI 10.1523/JNEUROSCI.0625-12.2012; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gorski DH, 2003, J AM COLL SURGEONS, V197, P408, DOI 10.1016/S1072-7515(03)00388-0; Goydos JS, 2003, CLIN CANCER RES, V9, P5962; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kim S, 2013, TUMOUR BIOL; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marin YE, 2005, NEUROPHARMACOLOGY, V49, P70, DOI 10.1016/j.neuropharm.2005.05.018; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Mullins SR, 2012, BIOL CHEM IN PRESS; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Sameni M, 2012, JOVE-J VIS EXP, DOI 10.3791/3661; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shah SP, 2012, NATURE; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Shin SS, 2010, PIGM CELL MELANOMA R, V23, P103, DOI 10.1111/j.1755-148X.2009.00648.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1990, CANCER RES, V50, P6075; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; THOR A, 1986, LAB INVEST, V55, P603; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang SJ, 2004, NEUROSCIENCE, V125, P191, DOI 10.1016/j.neuroscience.2004.01.019; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303	53	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e81126	10.1371/journal.pone.0081126	http://dx.doi.org/10.1371/journal.pone.0081126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404125	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800004
J	Cheng, KC; Asakawa, A; Li, YX; Chung, HH; Amitani, H; Ueki, T; Cheng, JT; Inui, A				Cheng, Kai-Chun; Asakawa, Akihiro; Li, Ying-Xiao; Chung, Hsien-Hui; Amitani, Haruka; Ueki, Takatoshi; Cheng, Juei-Tang; Inui, Akio			Silymarin Induces Insulin Resistance through an Increase of Phosphatase and Tensin Homolog in Wistar Rats	PLOS ONE			English	Article							GLUCOSE-UPTAKE; MILK THISTLE; CELL-PROLIFERATION; LIVER-DISEASE; SILIBININ; PTEN; ADIPOCYTES; INHIBITION; GROWTH; STIMULATION	Background and aims: Phosphatase and tensin homolog (PTEN) is a phosphoinositide phosphatase that regulates crucial cellular functions, including insulin signaling, lipid and glucose metabolism, as well as survival and apoptosis. Silymarin is the active ingredient in milk thistle and exerts numerous effects through the activation of PTEN. However, the effect of silymarin on the development of insulin resistance remains unknown. Methods: Wistar rats fed fructose-rich chow or normal chow were administered oral silymarin to identify the development of insulin resistance using the homeostasis model assessment of insulin resistance and hyperinsulinemic-euglycemic clamping. Changes in PTEN expression in skeletal muscle and liver were compared using western blotting analysis. Further investigation was performed in L6 cells to check the expression of PTEN and insulin-related signals. PTEN deletion in L6 cells was achieved by small interfering ribonucleic acid transfection. Results: Oral administration of silymarin at a dose of 200 mg/kg once daily induced insulin resistance in normal rats and enhanced insulin resistance in fructose-rich chow-fed rats. An increase of PTEN expression was observed in the skeletal muscle and liver of rats with insulin resistance. A decrease in the phosphorylation of Akt in L6 myotube cells, which was maintained in a high-glucose condition, was also observed. Treatment with silymarin aggravated high-glucose-induced insulin resistance. Deletion of PTEN in L6 cells reversed silymarin-induced impaired insulin signaling and glucose uptake. Conclusions: Silymarin has the ability to disrupt insulin signaling through increased PTEN expression. Therefore, silymarin should be used carefully in type-2 diabetic patients.	[Cheng, Kai-Chun; Asakawa, Akihiro; Li, Ying-Xiao; Amitani, Haruka; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Chung, Hsien-Hui] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Ueki, Takatoshi] Hamamatsu Univ Sch Med, Dept Neuroanat, Hamamatsu, Shizuoka 4313192, Japan; [Cheng, Juei-Tang] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan	Kagoshima University; National Cheng Kung University; Hamamatsu University School of Medicine; Chi Mei Hospital	Inui, A (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan.	inui@m.kufm.kagoshima-u.ac.jp	Chung, Hsien-Hui/W-4061-2019	Kai Chun, Cheng/0000-0003-4983-4666	Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science	Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science	This work was supported by the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V118, P252, DOI 10.1016/j.jep.2008.04.007; Ashkavand Z, 2012, PHYTOMEDICINE, V19, P1200, DOI 10.1016/j.phymed.2012.07.008; Baluchnejadmojarad T, 2010, PHYTOTHER RES, V24, P1120, DOI 10.1002/ptr.3078; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; Bu ZQ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-10; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Louzao MC, 2008, GLYCOCONJUGATE J, V25, P503, DOI 10.1007/s10719-007-9075-7; Cecen E, 2011, ASIAN PAC J CANCER P, V12, P2697; Chiu YJ, 2011, PHYTOTHER RES, V25, P1306, DOI 10.1002/ptr.3379; Contos Melissa J, 2004, Clin Liver Dis, V8, P481, DOI 10.1016/j.cld.2004.04.013; DEFRONZO RA, 1983, DIABETES, V32, P35, DOI 10.2337/diab.32.1.35; Flora K, 1998, AM J GASTROENTEROL, V93, P139, DOI 10.1111/j.1572-0241.1998.00139.x; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Jacobs BP, 2002, AM J MED, V113, P506, DOI 10.1016/S0002-9343(02)01244-5; Alonso-Castro AJ, 2011, PHYTOMEDICINE, V18, P926, DOI 10.1016/j.phymed.2011.02.015; Kamezaki F, 2012, INTERNAL MED, V51, P2119, DOI 10.2169/internalmedicine.51.7235; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-114; Lah JJ, 2007, WORLD J GASTROENTERO, V13, P5299, DOI 10.3748/wjg.v13.i40.5299; Landau BR, 2007, AM J PHYSIOL-ENDOC M, V293, pE237, DOI 10.1152/ajpendo.00022.2007; LEBER HW, 1976, ARZNEIMITTEL-FORSCH, V26, P1603; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Lieber CS, 2003, J CLIN GASTROENTEROL, V37, P336, DOI 10.1097/00004836-200310000-00013; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Malekinejad H, 2012, PHYTOMEDICINE, V19, P583, DOI 10.1016/j.phymed.2012.02.009; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Schrieber SJ, 2011, DRUG METAB DISPOS, V39, P2182, DOI 10.1124/dmd.111.040212; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Singh RP, 2003, CANCER EPIDEM BIOMAR, V12, P933; Singh RP, 2002, CANCER RES, V62, P3063; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Su CH, 2009, NEUROSCI LETT, V457, P125, DOI 10.1016/j.neulet.2009.03.093; Tyagi A, 2002, PROSTATE, V53, P211, DOI 10.1002/pros.10146; Tyagi A, 2002, MOL CANCER THER, V1, P525; Tzeng JI, 2013, PHYTOTHER RES, V27, P1023, DOI 10.1002/ptr.4829; Varghese L, 2005, CLIN CANCER RES, V11, P8441, DOI 10.1158/1078-0432.CCR-05-1646; Vengerovskii AI, 2007, B EXP BIOL MED+, V144, P53, DOI 10.1007/s10517-007-0252-2; Vessal G, 2010, RENAL FAILURE, V32, P733, DOI 10.3109/0886022X.2010.486488; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Wang L, 2007, HEPATOL RES, V37, P389, DOI 10.1111/j.1872-034X.2007.00042.x; Wang SH, 2011, J AGR FOOD CHEM, V59, P3686, DOI 10.1021/jf1048386; Wang XK, 2012, EXP DIABETES RES, DOI 10.1155/2012/847246; Wedin WK, 2012, DIABETES METAB SYNDR, V5, P219, DOI 10.2147/DMSO.S33478; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yu HC, 2012, PHYTOTHER RES, V26, P709, DOI 10.1002/ptr.3618; Zhang ZW, 2012, MOL CELL ENDOCRINOL, V361, P213, DOI 10.1016/j.mce.2012.04.012; Zhao D, 2012, J PHARMACOL EXP THER, V343, P206, DOI 10.1124/jpet.112.194738; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	53	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84550	10.1371/journal.pone.0084550	http://dx.doi.org/10.1371/journal.pone.0084550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404172	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800051
J	Liu, Y; Yin, Y; Sheng, Q; Lu, XT; Wang, F; Lin, ZY; Tian, HP; Xu, AJ; Zhang, J				Liu, Yan; Yin, You; Sheng, Qi; Lu, Xiaotong; Wang, Fang; Lin, Zhiyan; Tian, Huaiping; Xu, Ajing; Zhang, Jian			Association of ABCC2-24C > T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							THERAPY; GENE; TRANSPORTERS; CHILDREN; TRIAL	Methotrexate (MTX) is a key agent for the treatment of childhood acute lymphoblastic leukemia (ALL). Increased MTX plasma concentrations are associated with a higher risk of adverse drug effects. ATP-binding cassette subfamily C member 2 (ABCC2) is important for excretion of MTX and its toxic metabolite. The ABCC2 -24C>T polymorphism (rs717620) reportedly contributes to variability of MTX kinetics. In the present study, we assessed the association between the ABCC2 -24C>T polymorphism and methotrexate (MTX) toxicities in childhood ALL patients treated with high-dose MTX. A total of 112 Han Chinese ALL patients were treated with high-dose MTX according to the ALL-Berlin-Frankfurt-Muenster 2000 protocol. Our results showed that presence of the -24T allele in ABCC2 gene led to significantly higher MTX plasma concentrations at 48 hours after the start of infusion, which would strengthen over repeated MTX infusion. The -24T allele in ABCC2 gene was significantly associated with higher risks of high-grade hematologic (leucopenia, anemia, and thrombocytopenia) and non-hematologic (gastrointestinal and mucosal damage/oral mucositis) MTX toxicities. This study provides the first evidence that the -24T allele in ABCC2 gene is associated with the severity of MTX toxicities, which add fresh insights into clinical application of high-dose MTX and individualization of MTX treatment.	[Liu, Yan; Lu, Xiaotong; Wang, Fang; Lin, Zhiyan; Tian, Huaiping; Xu, Ajing; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200030, Peoples R China; [Yin, You] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai, Peoples R China; [Sheng, Qi] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Hematol Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200030, Peoples R China.	zj_xhpharm@126.com			Research Award Fund for Outstanding Young Teachers of Shanghai [2007087]; Shanghai Municipal Health Bureau Research Foundation [2009068]	Research Award Fund for Outstanding Young Teachers of Shanghai; Shanghai Municipal Health Bureau Research Foundation	This study was supported by Research Award Fund for Outstanding Young Teachers of Shanghai (#2007087) and Shanghai Municipal Health Bureau Research Foundation (#2009068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; de Beaumais TA, 2012, CURR DRUG METAB, V13, P822; Dragun AE, 2013, INT J RADIAT ONCOL, V85, pE123, DOI 10.1016/j.ijrobp.2012.10.021; HAGLEITNER MM, 2010, J CLIN ONCOL, V28, pS15; Hampras SS, 2010, INT J MOL EPIDEMIOL, V1, P201; Huang Y, 2007, CANCER METAST REV, V26, P183, DOI 10.1007/s10555-007-9050-6; Kantar M, 2009, LEUKEMIA LYMPHOMA, V50, P912, DOI 10.1080/10428190902893819; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Longo-Sorbello GSA, 2001, HAEMATOLOGICA, V86, P121; Lopez-Lopez Elixabet, 2013, Pharmacogenet Genomics, V23, P53, DOI 10.1097/FPC.0b013e32835c3b24; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Ramsey LB, 2013, BLOOD, V121, P898, DOI 10.1182/blood-2012-08-452839; Rau T, 2006, CLIN PHARMACOL THER, V80, P468, DOI 10.1016/j.clpt.2006.08.012; Simon N, 2013, PHARMACOGENOMICS J, V13, P507, DOI 10.1038/tpj.2012.37; Tanaka T, 1999, HEPATOLOGY, V30, P1507, DOI 10.1002/hep.510300617; Uga H, 2006, MOL PHARMACOL, V70, P1832, DOI 10.1124/mol.106.025866; van den Bongard HJGD, 2000, CLIN PHARMACOKINET, V39, P345, DOI 10.2165/00003088-200039050-00004; Zhang WX, 2008, XENOBIOTICA, V38, P1422, DOI 10.1080/00498250802488585	20	37	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82681	10.1371/journal.pone.0082681	http://dx.doi.org/10.1371/journal.pone.0082681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404132	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800011
J	Talaber, G; Miklossy, G; Oaks, Z; Liu, YX; Tooze, SA; Chudakov, DM; Banki, K; Perl, A				Talaber, Gergely; Miklossy, Gabriella; Oaks, Zachary; Liu, Yuxin; Tooze, Sharon A.; Chudakov, Dmitriy M.; Banki, Katalin; Perl, Andras			HRES-1/Rab4 Promotes the Formation of LC3(+) Autophagosomes and the Accumulation of Mitochondria during Autophagy	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REDUCES DISEASE-ACTIVITY; BAFILOMYCIN A1; MAMMALIAN TARGET; RAB4 CONTROLS; T-CELLS; PATHWAY; RAPAMYCIN; COMPARTMENTS; TRAFFICKING	HRES-1/Rab4 is a small GTPase that regulates endocytic recycling. It has been colocalized to mitochondria and the mechanistic target of rapamycin (mTOR), a suppressor of autophagy. Since the autophagosomal membrane component microtubule-associated protein light chain 3 (LC3) is derived from mitochondria, we investigated the impact of HRES-1/Rab4 on the formation of LC3(+) autophagosomes, their colocalization with HRES-1/Rab4 and mitochondria, and the retention of mitochondria during autophagy induced by starvation and rapamycin. HRES-1/Rab4 exhibited minimal baseline colocalization with LC3, which was enhanced 22-fold upon starvation or 6-fold upon rapamycin treatment. Colocalization of HRES-1/Rab4 with mitochondria was increased >2-fold by starvation or rapamycin. HRES-1/Rab4 overexpression promoted the colocalization of mitochondria with LC3 upon starvation or rapamycin treatment. A dominant-negative mutant, HRES-1/Rab4(S27N) had reduced colocalization with LC3 and mitochondria upon starvation but not rapamycin treatment. A constitutively active mutant, HRES-1/Rab4(Q72L) showed diminished colocalization with LC3 but promoted the partitioning of mitochondria with LC3 upon starvation or rapamycin treatment. Phosphorylation-resistant mutant HRES-1/Rab4(S204Q) showed diminished colocalization with LC3 but increased partitioning to mitochondria. A newly discovered C-terminally truncated native isoform, HRES-1/Rab4(1-121), showed enhanced localization to LC3 and mitochondria without starvation or rapamycin treatment. HRES-1/Rab4(1-121) increased the formation of LC3(+) autophagosomes in resting cells, while other isoforms promoted autophagosome formation upon starvation. HRES-1/Rab4, HRES-1/Rab4(1-121), HRES-1/Rab4(Q72L) and HRES-1/Rab4(S204Q) promoted the accumulation of mitochondria during starvation. The specificity of HRES-1/Rab4-mediated mitochondrial accumulation is indicated by its abrogation by dominant-negative HRES-1/Rab4(S27N) mutation. The formation of interconnected mitochondrial tubular networks was markedly enhanced by HRES-1/Rab4(Q72L) upon starvation, which may contribute to the retention of mitochondria during autophagy. The present study thus indicates that HRES-1/Rab4 regulates autophagy through promoting the formation of LC3(+) autophagosomes and the preservation of mitochondria.	[Talaber, Gergely; Miklossy, Gabriella; Oaks, Zachary; Liu, Yuxin; Perl, Andras] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Oaks, Zachary; Perl, Andras] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Tooze, Sharon A.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Chudakov, Dmitriy M.] RAS, Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow 117901, Russia; [Banki, Katalin] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cancer Research UK; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Perl, A (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.	perla@upstate.edu	Talaber, Gergely/C-2638-2013; Chudakov, Dmitriy M/G-7741-2014	Chudakov, Dmitriy M/0000-0003-0430-790X; Talaber, Gergely/0000-0003-2457-3236; Tooze, Sharon/0000-0002-2182-3116; Perl, Andras/0000-0002-5017-1348; Liu, Yuxin/0000-0002-0623-2561	National Institutes of Health [AI048079, AI072648]; Central New York Community Foundation; Cancer Research UK [15153] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048079, R01AI048079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central New York Community Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants AI048079 and AI072648 from the National Institutes of Health and the Central New York Community Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Caza TN, 2013, ANN RHEUM D IN PRESS; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kim B, 2013, AM J PHYSIOL-REG I, V305, pR927, DOI 10.1152/ajpregu.00502.2012; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Lai ZW, 2013, J IMMUNOL, V191, P2236, DOI 10.4049/jimmunol.1301005; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lazzarino DA, 1998, J EXP MED, V188, P1769, DOI 10.1084/jem.188.10.1769; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Longatti A, 2012, AUTOPHAGY, V8, P1682, DOI 10.4161/auto.21486; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Mari M, 2006, J CELL SCI, V119, P1297, DOI 10.1242/jcs.02850; Metcalf DJ, 2012, EXP NEUROL, V238, P22, DOI 10.1016/j.expneurol.2010.11.003; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagy G, 2006, J BIOL CHEM, V281, P34574, DOI 10.1074/jbc.M606301200; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Zhdanov AV, 2012, BIOSCIENCE REP, V32, P587, DOI 10.1042/BSR20120085; Zhdanov AV, 2011, CELL MOL LIFE SCI, V68, P903, DOI 10.1007/s00018-010-0502-8	40	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84392	10.1371/journal.pone.0084392	http://dx.doi.org/10.1371/journal.pone.0084392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404161	Green Published, gold			2022-12-25	WOS:000329460800040
J	Powe, DG; Dhondalay, GKR; Lemetre, C; Allen, T; Habashy, HO; Ellis, IO; Rees, R; Ball, GR				Powe, Desmond G.; Dhondalay, Gopal Krishna R.; Lemetre, Christophe; Allen, Tony; Habashy, Hany O.; Ellis, Ian O.; Rees, Robert; Ball, Graham R.			DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; ESTROGEN-RECEPTOR; CYCLIN D1; EXPRESSION; DACHSHUND; PREDICTION; HOMOLOG; GATA-3; EYE	Background: Oestrogen receptor (ER) positive (luminal) tumours account for the largest proportion of females with breast cancer. Theirs is a heterogeneous disease presenting clinical challenges in managing their treatment. Three main biological luminal groups have been identified but clinically these can be distilled into two prognostic groups in which Luminal A are accorded good prognosis and Luminal B correlate with poor prognosis. Further biomarkers are needed to attain classification consensus. Machine learning approaches like Artificial Neural Networks (ANNs) have been used for classification and identification of biomarkers in breast cancer using high throughput data. In this study, we have used an artificial neural network (ANN) approach to identify DACH1 as a candidate luminal marker and its role in predicting clinical outcome in breast cancer is assessed. Materials and methods: A reiterative ANN approach incorporating a network inferencing algorithm was used to identify ER-associated biomarkers in a publically available cDNA microarray dataset. DACH1 was identified in having a strong influence on ER associated markers and a positive association with ER. Its clinical relevance in predicting breast cancer specific survival was investigated by statistically assessing protein expression levels after immunohistochemistry in a series of unselected breast cancers, formatted as a tissue microarray. Results: Strong nuclear DACH1 staining is more prevalent in tubular and lobular breast cancer. Its expression correlated with ER-alpha positive tumours expressing PgR, epithelial cytokeratins (CK) 18/19 and 'luminal-like' markers of good prognosis including FOXA1 and RERG (p < 0.05). DACH1 is increased in patients showing longer cancer specific survival and disease free interval and reduced metastasis formation (p < 0.001). Nuclear DACH1 showed a negative association with markers of aggressive growth and poor prognosis. Conclusion: Nuclear DACH1 expression appears to be a Luminal A biomarker predictive of good prognosis, but is not independent of clinical stage, tumour size, NPI status or systemic therapy.	[Powe, Desmond G.; Dhondalay, Gopal Krishna R.; Rees, Robert; Ball, Graham R.] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England; [Powe, Desmond G.; Ellis, Ian O.] Nottingham Univ Hosp NHS Trust, Dept Cellular Pathol, Nottingham, England; [Lemetre, Christophe] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Allen, Tony] Nottingham Trent Univ, Dept Comp & Informat, Nottingham, England; [Habashy, Hany O.] Mansoura Univ, Fac Med, Dept Pathol, Mansoura, Daqahlia, Egypt	Nottingham Trent University; Nottingham University Hospital NHS Trust; Yeshiva University; Albert Einstein College of Medicine; Nottingham Trent University; Egyptian Knowledge Bank (EKB); Mansoura University	Powe, DG (corresponding author), Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England.	des.powe@nottingham.ac.uk	Habashy, Hany Onsy/N-1488-2018; Dhondalay, Gopal Krishna Ramadas/A-3369-2014	Habashy, Hany Onsy/0000-0003-3685-5273; Dhondalay, Gopal Krishna Ramadas/0000-0002-1020-0175; Ellis, Ian/0000-0001-5292-8474; Ball, Graham/0000-0001-5828-7129	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This study received financial support from the John and Lucille van Geest Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Cruz JA, 2006, CANCER INFORM, V2, P59; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeAngelis T, 2011, CELL CYCLE, V10, P1956, DOI 10.4161/cc.10.12.15800; Dhondalay GK, 2011, ESTROGE RECEPTOR STA, P727; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Habashy HO, 2013, BREAST CANCER RES TR, V140, P307, DOI 10.1007/s10549-013-2614-y; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Habashy HO, 2010, BREAST CANC RES TREA; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heanue TA, 2002, MECH DEVELOP, V111, P75, DOI 10.1016/S0925-4773(01)00611-6; Hoch RV, 1999, INT J CANCER, V84, P122; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim HJ, 2006, CLIN CANCER RES, V12, p1013S, DOI 10.1158/1078-0432.CCR-05-2128; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lancashire LJ, 2008, ARTIF INTELL MED, V43, P99, DOI 10.1016/j.artmed.2008.03.001; Lancashire LJ, 2011, INT J CANCER, V128, P1843, DOI 10.1002/ijc.25513; Lemetre C, 2009, LECT NOTES COMPUT SC, V5517, P877, DOI 10.1007/978-3-642-02478-8_110; Liang F, 2012, INT J GYNECOL CANCER, V22, P386, DOI 10.1097/IGC.0b013e31824311e6; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; MARDON G, 1994, DEVELOPMENT, V120, P3473; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Ward S, 2012, GENE EXPRESSION PROF; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5	42	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84428	10.1371/journal.pone.0084428	http://dx.doi.org/10.1371/journal.pone.0084428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392136	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000329460100059
J	van Berlo, JH; Aronow, BJ; Molkentin, JD				van Berlo, Jop H.; Aronow, Bruce J.; Molkentin, Jeffery D.			Parsing the Roles of the Transcription Factors GATA-4 and GATA-6 in the Adult Cardiac Hypertrophic Response	PLOS ONE			English	Article								The transcriptional code that programs cardiac hypertrophy involves the zinc finger-containing DNA binding factors GATA-4 and GATA-6, both of which are required to mount a hypertrophic response of the adult heart. Here we performed conditional gene deletion of Gata4 or Gata6 in the mouse heart in conjunction with reciprocal gene replacement using a transgene encoding either GATA-4 or GATA-6 in the heart as a means of parsing dosage effects of GATA-4 and GATA-6 versus unique functional roles. We determined that GATA-4 and GATA-6 play a redundant and dosage-sensitive role in programming the hypertrophic growth response of the heart following pressure overload stimulation. However, nonredundant functions were identified in allowing the heart to compensate and resist heart failure after pressure overload stimulation, as neither Gata4 nor Gata6 deletion was fully rescued by expression of the reciprocal transgene. For example, only Gata4 heart-specific deletion blocked the neoangiogenic response to pressure overload stimulation. Gene expression profiling from hearts of these gene-deleted mice showed both overlapping and unique transcriptional codes, which is presented. These results indicate that GATA-4 and GATA-6 play a dosage-dependent and redundant role in programming cardiac hypertrophy, but that each has a more complex role in maintaining cardiac homeostasis and resistance to heart failure following injury that cannot be compensated by the other.	[van Berlo, Jop H.; Aronow, Bruce J.; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45221 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45221 USA.	Jeff.Molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; van Berlo, Jop/0000-0001-9229-4429	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060562, R00HL112852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (J.D.M., J.H.v.B.) and the Howard Hughes Medical Institute (J.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charron F, 1999, MOL CELL BIOL, V19, P4355; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	11	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84591	10.1371/journal.pone.0084591	http://dx.doi.org/10.1371/journal.pone.0084591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391969	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900112
J	Wang, CM; Li, TC; Jhan, YL; Weng, JH; Chou, CH				Wang, Chao-Min; Li, Tsai-Chi; Jhan, Yun-Lian; Weng, Jen-Hsien; Chou, Chang-Hung			The Impact of Microbial Biotransformation of Catechin in Enhancing the Allelopathic Effects of Rhododendron formosanum	PLOS ONE			English	Article							GREEN TEA EXTRACT; ALLELOCHEMICAL (+/-)-CATECHIN; CHLOROPHYLL FLUORESCENCE; BACTERIAL-DEGRADATION; LITTER DECOMPOSITION; ROOT EXUDATE; SOIL BIOTA; A-RING; PLANT; FLAVONOIDS	Rhododendron formosanum is distributed widely in the central mountains in Taiwan and the major allelopathic compound in the leaves has been identified as (-)-catechin, which is also a major allelochemical of an invasive spotted knapweed in North America. Soil microorganisms play key roles in ecosystems and influence various important processes, including allelopathy. However, no microorganism has been identified as an allelochemical mediator. This study focused on the role of microorganisms in the allelopathic effects of R. formosanum. The microorganism population in the rhizosphere of R. formosanum was investigated and genetic analysis revealed that the predominant genera of microorganisms in the rhizosphere of R. formosanum were Pseudomonas, Herbaspirillum, and Burkholderia. The dominant genera Pseudomonas utilized (-)-catechin as the carbon source and catalyzed the conversion of (-)-catechin into protocatechuic acid in vitro. The concentrations of allelochemicals in the soil were quantified by liquid chromatography-electrospray ionization/tandem mass spectrometry. The concentration of (-)-catechin in the soil increased significantly during the extreme rainfall in the summer season and suppressed total bacterial populations. Protocatechuic acid accumulation was observed while total bacterial populations increased abundantly in both laboratory and field studies. Allelopathic interactions were tested by evaluating the effects of different allelochemicals on the seed germination, radicle growth, and photosynthesis system II of lettuce. Protocatechuic acid exhibited higher phytotoxicity than (-)-catechin did and the effect of (-)-catechin on the inhibition of seed germination was enhanced by combining it with protocatechuic acid at a low concentration. This study revealed the significance of the allelopathic interactions between R. formosanum and microorganisms in the rhizosphere. These findings demonstrate that knowledge regarding the precise biotransformation process of (-)-catechin by microorganisms in the environment is necessary to increase our understanding of allelopathy.	[Wang, Chao-Min; Li, Tsai-Chi; Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung, Taiwan; [Jhan, Yun-Lian; Weng, Jen-Hsien; Chou, Chang-Hung] China Med Univ, Grad Inst Ecol & Evolutionary Biol, Taichung, Taiwan; [Chou, Chang-Hung] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Cheng Kung University	Chou, CH (corresponding author), China Med Univ, Res Ctr Biodivers, Taichung, Taiwan.	choumasa@mail.cmu.edu.tw	Wang, Chao-Min/V-8680-2018	Wang, Chao-Min/0000-0002-8954-6151	National Science Council of Taiwan [NSC101-2811-B-039-013, NSC102-2811-B-039-005, NSC101-2621-B-039-001, NSC102-2313-B-039-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from the National Science Council of Taiwan (NSC101-2811-B-039-013, NSC102-2811-B-039-005, NSC101-2621-B-039-001 and NSC102-2313-B-039-001) to C. H. Chou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PI, 2012, OECOLOGIA, V168, P221, DOI 10.1007/s00442-011-2063-4; Arunachalam M, 2003, BBA-GEN SUBJECTS, V1621, P261, DOI 10.1016/S0304-4165(03)00077-1; Arunachalam M, 2003, MICROBIOL RES, V158, P37, DOI 10.1078/0944-5013-00174; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bais HP, 2003, J AGR FOOD CHEM, V51, P897, DOI 10.1021/jf020978a; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carando S, 2000, BASIC LIFE SCI, V66, P725; Chobot V, 2009, J CHEM ECOL, V35, P980, DOI 10.1007/s10886-009-9681-x; Chou C.H., 1999, RECENT ADV ALLELOPAT, V1, P3; Chou CH, 1999, CRIT REV PLANT SCI, V18, P609, DOI 10.1016/S0735-2689(99)00393-7; Chou SC, 2010, ALLELOPATHY J, V25, P73; Chou SC, 2009, NAT PROD COMMUN, V4, P1189; Dai CM, 2010, ENVIRON TOXICOL PHAR, V30, P284, DOI 10.1016/j.etap.2010.08.002; Das S, 2006, J NAT PROD, V69, P499, DOI 10.1021/np0504659; Donovan JL, 2006, FREE RADICAL RES, V40, P1029, DOI 10.1080/10715760600868545; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Ferrazzano GF, 2011, J MED FOOD, V14, P907, DOI 10.1089/jmf.2010.0196; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Hussain MI, 2011, PLANT PHYSIOL BIOCH, V49, P1290, DOI 10.1016/j.plaphy.2011.08.007; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; JEFFREY AM, 1972, BIOCHEM J, V130, P383, DOI 10.1042/bj1300383; JEFFREY AM, 1972, BIOCHEM J, V130, P373, DOI 10.1042/bj1300373; Keswani J, 2001, INT J SYST EVOL MICR, V51, P667, DOI 10.1099/00207713-51-2-667; Kim YO, 2005, J CHEM ECOL, V31, P1175, DOI 10.1007/s10886-005-4255-z; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Lin LC, 2011, MYCORRHIZA, V21, P331, DOI 10.1007/s00572-010-0342-2; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MULLER CH, 1966, B TORREY BOT CLUB, V93, P332, DOI 10.2307/2483447; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Pollock JL, 2011, J CHEM ECOL, V37, P1044, DOI 10.1007/s10886-011-0005-6; Sakanaka S, 2000, J BIOSCI BIOENG, V90, P81, DOI 10.1016/S1389-1723(00)80038-9; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Schweizer HP, 1996, J BACTERIOL, V178, P5215, DOI 10.1128/jb.178.17.5215-5221.1996; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Tharayil N, 2008, J AGR FOOD CHEM, V56, P3706, DOI 10.1021/jf073310a; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Valverde A, 2003, INT J SYST EVOL MICR, V53, P1979, DOI 10.1099/ijs.0.02677-0; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Veluri R, 2004, J AGR FOOD CHEM, V52, P1077, DOI 10.1021/jf030653+; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wang CM, 2007, MICROB ECOL, V54, P1, DOI 10.1007/s00248-006-9139-4; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	57	37	43	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85162	10.1371/journal.pone.0085162	http://dx.doi.org/10.1371/journal.pone.0085162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391991	Green Submitted, Green Published, gold			2022-12-25	WOS:000329323900134
J	Zhang, C; Huang, Y; Jiang, YS; Mulpuri, N; Wei, L; Hamelberg, D; Brown, EM; Yang, JJ				Zhang, Chen; Huang, Yun; Jiang, Yusheng; Mulpuri, Nagaraju; Wei, Ling; Hamelberg, Donald; Brown, Edward M.; Yang, Jenny J.			Identification of an L-Phenylalanine Binding Site Enhancing the Cooperative Responses of the Calcium-sensing Receptor to Calcium*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Calcium Imaging; Calcium Signaling; Cooperativity; G Protein-coupled Receptors (GPCR); Calcium-sensing Receptor; Calcium Oscillation	EXTRACELLULAR CA2+-SENSING RECEPTOR; MOLECULAR-DYNAMICS; CA2+-BINDING SITES; AMINO-ACIDS; PROTEIN; DOMAIN; OSCILLATIONS; MECHANISM; SPECIFICITY; ACTIVATION	Background: The calcium-sensing receptor (CaSR) is a key mediator of Ca2+ homeostasis in vivo. Results: An l-Phe binding site at the CaSR hinge region globally enhances its cooperative activation by Ca2+. Conclusion: Communication between the binding sites for Ca2+ and l-Phe is crucial for functional cooperativity of CaSR-mediated signaling. Significance: The results provide important insights into the molecular basis of Ca2+ sensing by the CaSR. Functional positive cooperative activation of the extracellular calcium ([Ca2+](o))-sensing receptor (CaSR), a member of the family C G protein-coupled receptors, by [Ca2+](o) or amino acids elicits intracellular Ca2+ ([Ca2+](i)) oscillations. Here, we report the central role of predicted Ca2+-binding site 1 within the hinge region of the extracellular domain (ECD) of CaSR and its interaction with other Ca2+-binding sites within the ECD in tuning functional positive homotropic cooperativity caused by changes in [Ca2+](o). Next, we identify an adjacent l-Phe-binding pocket that is responsible for positive heterotropic cooperativity between [Ca2+](o) and l-Phe in eliciting CaSR-mediated [Ca2+](i) oscillations. The heterocommunication between Ca2+ and an amino acid globally enhances functional positive homotropic cooperative activation of CaSR in response to [Ca2+](o) signaling by positively impacting multiple [Ca2+](o)-binding sites within the ECD. Elucidation of the underlying mechanism provides important insights into the longstanding question of how the receptor transduces signals initiated by [Ca2+](o) and amino acids into intracellular signaling events.	[Zhang, Chen; Huang, Yun; Jiang, Yusheng; Mulpuri, Nagaraju; Wei, Ling; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Dept Chem, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Univ Plaza, Atlanta, GA 30303 USA.	jenny@gsu.edu	Jiang, Yusheng/A-1087-2016	Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM081749, EB007268]; National Science Foundation [MCB-0953061]; Center for Diagnostics and Therapeutics (CDT) fellowship; Georgia Research Alliance; Direct For Biological Sciences [0953061] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for Diagnostics and Therapeutics (CDT) fellowship; Georgia Research Alliance; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749 and EB007268 (to J. J. Y.). This work was also supported by National Science Foundation Grant MCB-0953061 (to D. H.), a Center for Diagnostics and Therapeutics (CDT) fellowship (to C. Z.), and funds from the Georgia Research Alliance.	Ackers GK, 1998, ADV PROTEIN CHEM, V51, P185; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; [Anonymous], 2008, AMBER 10; Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1482, DOI 10.1210/me.2011-1370; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Buchan AMJ, 2001, GASTROENTEROLOGY, V120, P1128, DOI 10.1053/gast.2001.23246; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Cheng SX, 2004, GASTROENTEROLOGY, V126, P148, DOI 10.1053/j.gastro.2003.10.064; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Doshi U, 2012, J CHEM THEORY COMPUT, V8, P4004, DOI 10.1021/ct3004194; Doshi U, 2009, J PHYS CHEM B, V113, P16590, DOI 10.1021/jp907388m; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hendy GN, 2009, PROG MOL BIOL TRANSL, V89, P31, DOI 10.1016/S1877-1173(09)89003-0; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2003, TRENDS ENDOCRIN MET, V14, P282, DOI 10.1016/S1043-2760(03)00104-8; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; Jolliffe, 2002, PRINCIPAL COMPONENT; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Mathias RS, 2001, J BONE MINER RES, V16, P2238, DOI 10.1359/jbmr.2001.16.12.2238; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Mongan J, 2004, J COMPUT AID MOL DES, V18, P433, DOI 10.1007/s10822-004-4121-z; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Tordoff MG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00496; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	70	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5296	5309		10.1074/jbc.M113.537357	http://dx.doi.org/10.1074/jbc.M113.537357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394414	Green Published, hybrid			2022-12-25	WOS:000331607900070
J	McGarry, LJ; Krishnarajah, G; Hill, G; Masseria, C; Skornicki, M; Pruttivarasin, N; Arondekar, B; Roiz, J; Pelton, SI; Weinstein, MC				McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Masseria, Cristina; Skornicki, Michelle; Pruttivarasin, Narin; Arondekar, Bhakti; Roiz, Julie; Pelton, Stephen I.; Weinstein, Milton C.			Cost-Effectiveness of Tdap Vaccination of Adults Aged >= 65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; SEASONAL INFLUENZA; MORBIDITY; SPREAD	Objectives: In February 2012, the Advisory Committee on Immunization Practices (ACIP) advised that all adults aged >= 65 years receive a single dose of reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap), expanding on a 2010 recommendation for adults >= 65 that was limited to those with close contact with infants. We evaluated clinical and economic outcomes of adding Tdap booster of adults aged >= 65 to "baseline" practice [full-strength DTaP administered from 2 months to 4-6 years, and one dose of Tdap at 11-64 years replacing decennial Td booster], using a dynamic model. Methods: We constructed a population-level disease transmission model to evaluate the cost-effectiveness of supplementing baseline practice by vaccinating 10% of eligible adults aged >= 65 with Tdap replacing the decennial Td booster. US population effects, including indirect benefits accrued by unvaccinated persons, were estimated during a 1-year period after disease incidence reached a new steady state, with consequences of deaths and long-term pertussis sequelae projected over remaining lifetimes. Model outputs include: cases by severity, encephalopathy, deaths, costs (of vaccination and pertussis care) and quality-adjusted life-years (QALYs) associated with each strategy. Results in terms of incremental cost/QALY gained are presented from payer and societal perspectives. Sensitivity analyses vary key parameters within plausible ranges. Results: For the US population, the intervention is expected to prevent >97,000 cases (>4,000 severe and >5,000 among infants) of pertussis annually at steady state. Additional vaccination costs are $4.7 million. Net cost savings, including vaccination costs, are $47.7 million (societal perspective) and $44.8 million (payer perspective). From both perspectives, the intervention strategy is dominant (less costly, and more effective by >3,000 QALYs) versus baseline. Results are robust to sensitivity analyses and alternative scenarios. Conclusions: Immunization of eligible adults aged >65, consistent with the current ACIP recommendation, is cost saving from both payer and societal perspectives.	[McGarry, Lisa J.; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Weinstein, Milton C.] OptumInsight, Cambridge, MA USA; [Krishnarajah, Girishanthy; Masseria, Cristina; Arondekar, Bhakti; Roiz, Julie] GlaxoSmithKline, Philadelphia, PA USA; [Pelton, Stephen I.] Boston Univ, Boston, MA 02215 USA; [Weinstein, Milton C.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Optum; GlaxoSmithKline; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	McGarry, LJ (corresponding author), OptumInsight, Cambridge, MA USA.	mcgarry.nagar@gmail.com		Pelton, Stephen/0000-0003-4862-5344	GlaxoSmithKline Group of Companies	GlaxoSmithKline Group of Companies(GlaxoSmithKline)	GH, LJM, NP, MS, MCW (OptumInsight) received funding from GlaxoSmithKline Group of Companies to complete the disclosed research. The GSK employees listed as coauthors (BA, GK, JR and CM) participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2010, INF PRESCR INF; [Anonymous], 2010, PHYS FEE COD GUID; [Anonymous], 2012, ADV COMM IMM PRACT A; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Beeler Asay GR, 2011, TDAP VACCINATION PRE; Bureau of Labor Statistics, 2011, CONS PRIC IND; Bureau of Labor Statistics, 2010, CURR POP SURV 2010; Bureau of Labor Statistics, 2011, EMPL HOURS EARN CURR; California Department of Public Health, 2011, PERT REP SEPT 15 201; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Centers for Disease Control and Prevention, 2012, SURV REP TRENDS US R; Centers for Disease Control and Prevention, 2011, PERT SUMM VACC REC; Centers for Disease Control and Prevention, 2010, VACC PRIC LIST; Centers for Disease Control and Prevention, 2011, SUMM NOT DIS US, V58, P36; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Clements KM, 2011, VALUE HEALTH, V14, P800, DOI 10.1016/j.jval.2011.03.005; Cortese MM, 2007, AM J PREV MED, V32, P177, DOI 10.1016/j.amepre.2006.10.015; Coudeville L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006284; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Epidemiology and Prevention of Vaccine-Preventable Diseases, 2012, PINK BOOK COURS TXB; Gold MR, 1996, COST EFFECTIVENESS H; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; GSK - data on file, PERT UN ROUT PROT LI; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; McDowell Margaret A, 2009, Vital Health Stat 11, P1; McGarry LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067260, 10.1371/journal.pone.0074170]; Miller B. L., 2010, Morbidity and Mortality Weekly Report, V59, P1302; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Network for Immunization Information, 2011, PERT WHOOP COUGH; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; Red Book, 2010, PHARM FUND REF; Rothberg MB, 2007, CLIN INFECT DIS, V44, P1280, DOI 10.1086/514342; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Westra TA, 2010, CLIN THER, V32, P1479, DOI 10.1016/j.clinthera.2010.07.017; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	51	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e72723	10.1371/journal.pone.0072723	http://dx.doi.org/10.1371/journal.pone.0072723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416118	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300001
J	Jayavelu, ND; Bar, N				Jayavelu, Naresh Doni; Bar, Nadav			Dynamics of Regulatory Networks in Gastrin-Treated Adenocarcinoma Cells	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; RESPONSE ELEMENT; GENOMIC ANALYSIS; MAP KINASES; IN-VITRO; RECEPTOR; MOTIFS; GROWTH	Understanding gene transcription regulatory networks is critical to deciphering the molecular mechanisms of different cellular states. Most studies focus on static transcriptional networks. In the current study, we used the gastrin-regulated system as a model to understand the dynamics of transcriptional networks composed of transcription factors (TFs) and target genes (TGs). The hormone gastrin activates and stimulates signaling pathways leading to various cellular states through transcriptional programs. Dysregulation of gastrin can result in cancerous tumors, for example. However, the regulatory networks involving gastrin are highly complex, and the roles of most of the components of these networks are unknown. We used time series microarray data of AR42J adenocarcinoma cells treated with gastrin combined with static TF-TG relationships integrated from different sources, and we reconstructed the dynamic activities of TFs using network component analysis (NCA). Based on the peak expression of TGs and activity of TFs, we created active sub-networks at four time ranges after gastrin treatment, namely immediate-early (IE), mid-early (ME), mid-late (ML) and very late (VL). Network analysis revealed that the active sub-networks were topologically different at the early and late time ranges. Gene ontology analysis unveiled that each active sub-network was highly enriched in a particular biological process. Interestingly, network motif patterns were also distinct between the sub-networks. This analysis can be applied to other time series microarray datasets, focusing on smaller sub-networks that are activated in a cascade, allowing better overview of the mechanisms involved at each time range.	[Jayavelu, Naresh Doni; Bar, Nadav] Norwegian Univ Sci & Technol, Dept Chem Engn, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Jayavelu, ND (corresponding author), Norwegian Univ Sci & Technol, Dept Chem Engn, N-7034 Trondheim, Norway.	nareshd@chemeng.ntnu.no	Jayavelu, Naresh Doni/H-5376-2019		Research Council of Norway [70174300]	Research Council of Norway(Research Council of Norway)	This work was funded by Research Council of Norway (project number : 70174300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boscolo R, 2005, IEEE ACM T COMPUT BI, V2, P289, DOI 10.1109/TCBB.2005.47; Cao J, 2006, WORLD J GASTROENTERO, V12, P7482, DOI 10.3748/wjg.v12.i46.7482; Clarke PA, 2006, CANCER RES, V66, P3504, DOI 10.1158/0008-5472.CAN-05-0280; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Ferrand A, 2005, J BIOL CHEM, V280, P10710, DOI 10.1074/jbc.M413309200; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Goetze JP, 2013, SCAND J GASTROENTERO, V48, P688, DOI 10.3109/00365521.2013.783101; Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465; Guo YS, 2002, J BIOL CHEM, V277, P48755, DOI 10.1074/jbc.M209016200; Hwang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046521; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jain RN, 2007, PHYSIOL GENOMICS, V29, P1, DOI 10.1152/physiolgenomics.00176.2006; Jain RN, 2006, PHYSIOL GENOMICS, V24, P124, DOI 10.1152/physiolgenomics.00133.2005; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Lefranc F, 2004, CLIN CANCER RES, V10, P8250, DOI 10.1158/1078-0432.CCR-04-0343; Lepoivre C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-19; Leung-Theung-Long S, 2005, J BIOL CHEM, V280, P7976, DOI 10.1074/jbc.M407485200; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Matysiak-Budnik T, 2006, EUR J CANCER, V42, P708, DOI 10.1016/j.ejca.2006.01.020; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Muerkoster S, 2005, GASTROENTEROLOGY, V129, P952, DOI 10.1053/j.gastro.2005.06.059; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Noble F, 1999, PHARMACOL REV, V51, P745; Pagliocca A, 2002, AM J PHYSIOL-GASTR L, V283, pG292, DOI 10.1152/ajpgi.00056.2002; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031984; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stepan V, 2004, AM J PHYSIOL-GASTR L, V287, pG715, DOI 10.1152/ajpgi.00169.2003; Stepan VM, 1999, AM J PHYSIOL-GASTR L, V276, pG1363, DOI 10.1152/ajpgi.1999.276.6.G1363; Subramaniam D, 2008, GASTROENTEROLOGY, V134, P1070, DOI 10.1053/j.gastro.2008.01.040; Tateishi K, 1998, PANCREAS, V16, P499, DOI 10.1097/00006676-199805000-00007; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Wang JG, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S8; Wang Z, 2003, WORLD J GASTROENTERO, V9, P1786, DOI 10.3748/wjg.v9.i8.1786; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HG, 2005, CELL SIGNAL, V17, P1505, DOI 10.1016/j.cellsig.2005.03.009; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Yu Jie-Ping, 2007, Zhonghua Zhongliu Zazhi, V29, P4; Zvelebil M.J., 2008, UNDERSTANDING BIOINF	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e78349	10.1371/journal.pone.0078349	http://dx.doi.org/10.1371/journal.pone.0078349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416123	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500004
J	Chang, JC; Ramasamy, S				Chang, Jian-Cheng; Ramasamy, Srinivasan			Identification and Expression Analysis of Diapause Hormone and Pheromone Biosynthesis Activating Neuropeptide (DH-PBAN) in the Legume Pod Borer, Maruca vitrata Fabricius	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REFERENCE GENE SELECTION; MOLECULAR CHARACTERIZATION; SEX-PHEROMONE; SUBESOPHAGEAL GANGLION; ENCODING DH; HELICOVERPA-ARMIGERA; FXPRL NEUROPEPTIDES; FUNCTIONAL-ANALYSIS; CLEAVAGE SITES	Neuropeptides play essential roles in a variety of physiological responses that contribute to the development and reproduction of insects. Both the diapause hormone (DH) and pheromone biosynthesis activating neuropeptide (PBAN) belong to the PBAN/ pyrokinin neuropeptide family, which has a conserved pentapeptide motif FXPRL at the C-terminus. We identified the full-length cDNA encoding DH-PBAN in Maruca vitrata, a major lepidopteran pest of leguminous crops. The open reading frame of Marvi-DH-PBAN is 591 bp in length, encoding 197 amino acids, from which five putative neuropeptides [DH, PBAN, alpha-subesophageal ganglion neuropeptide (SGNP), beta-SGNP and gamma-SGNP] are derived. Marvi-DH-PBAN was highly similar (83%) to DH-PBAN of Omphisa fuscidentalis (Lepidoptera: Crambidae), but possesses a unique C-terminal FNPRL motif, where asparagine has replaced a serine residue present in other lepidopteran PBAN peptides. The genomic DNA sequence of Marvi-DH-PBAN is 6,231 bp in size and is composed of six exons. Phylogenetic analysis has revealed that the Marvi-DH-PBAN protein sequence is closest to its homolog in Crambidae, but distant from Diptera, Coleoptera and Hymenoptera DH-PBAN, which agrees with the current taxonomy. DH-PBAN transcripts were present in the head and thoracic complex, but absent in the abdomen of M. vitrata. Real-time quantitative PCR assays have demonstrated a relatively higher expression of Marvi-DH-PBAN mRNA in the latter half of the pupal stages and in adults. These findings represent a significant step forward in our understanding of the DH-PBAN gene architecture and phylogeny, and raise the possibility of using Marvi-DH-PBAN to manage M. vitrata populations through molecular techniques.	[Chang, Jian-Cheng; Ramasamy, Srinivasan] AVRDC World Vegetable Ctr, Tainan, Taiwan		Ramasamy, S (corresponding author), AVRDC World Vegetable Ctr, Tainan, Taiwan.	srini.ramasamy@worldveg.org	Ramasamy, Srinivasan/N-1686-2019; Chang, Jian-Cheng/L-4818-2013	Ramasamy, Srinivasan/0000-0002-8454-7331; Chang, Jian-Cheng/0000-0001-5241-8175	Federal Ministry for Economic Cooperation and Development, Germany	Federal Ministry for Economic Cooperation and Development, Germany	This study was supported by the financial support of the Federal Ministry for Economic Cooperation and Development, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Altstein M, 1996, ARCH INSECT BIOCHEM, V31, P355, DOI 10.1002/(SICI)1520-6327(1996)31:4&lt;355::AID-ARCH1&gt;3.0.CO;2-V; Arabanian A, 2010, J IRAN CHEM SOC, V7, P840, DOI 10.1007/BF03246077; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belth J.E., 2012, BUTTERFLIES INDIANA; Bober R, 2010, P NATL ACAD SCI USA, V107, P16858, DOI 10.1073/pnas.1008812107; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Choi MY, 2009, INSECT MOL BIOL, V18, P161, DOI 10.1111/j.1365-2583.2009.00867.x; Choi Man-Yeon, 2012, Front Endocrinol (Lausanne), V3, P32, DOI 10.3389/fendo.2012.00032; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Choi MY, 2010, ARCH INSECT BIOCHEM, V74, P67, DOI 10.1002/arch.20356; Choi MY, 2004, INSECT BIOCHEM MOLEC, V34, P927, DOI 10.1016/j.ibmb.2004.06.003; Choi MY, 2001, CELL TISSUE RES, V306, P459, DOI 10.1007/s00441-001-0467-x; Conant GC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r50; Cranston P.S., 2009, ENCY INSECTS, P780; DARBY NJ, 1990, BIOSCIENCE REP, V10, P1, DOI 10.1007/BF01116845; Downham MCA, 2004, ENTOMOL EXP APPL, V110, P151, DOI 10.1111/j.0013-8703.2004.00128.x; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; DREYER H, 1994, INT J PEST MANAGE, V40, P252, DOI 10.1080/09670879409371893; FONAGY A, 1992, J INSECT PHYSIOL, V38, P651, DOI 10.1016/0022-1910(92)90046-G; FOSTER SP, 1993, J INSECT PHYSIOL, V39, P267, DOI 10.1016/0022-1910(93)90098-C; FOSTER SP, 1994, ARCH INSECT BIOCHEM, V25, P271, DOI 10.1002/arch.940250404; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groot AT, 2005, J CHEM ECOL, V31, P14, DOI 10.1007/s10886-005-0970-8; Hassan MN, 2007, REINVESTIGATION FEMA; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jing TZ, 2007, INSECT BIOCHEM MOLEC, V37, P1262, DOI 10.1016/j.ibmb.2007.07.012; Jurenka Russell, 2011, Front Endocrinol (Lausanne), V2, P46, DOI 10.3389/fendo.2011.00046; Kabir K H, 1996, BANGLADESH J AGR RES, V21, P241; Kawai T, 2007, INSECT BIOCHEM MOLEC, V37, P330, DOI 10.1016/j.ibmb.2006.12.002; Kitching IJ, 2011, VERTEBR PALEOBIOL PA, P549, DOI 10.1007/978-90-481-9962-4_20; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lee DW, 2005, PEPTIDES, V26, P2404, DOI 10.1016/j.peptides.2005.04.016; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Long MY, 1998, P NATL ACAD SCI USA, V95, P219, DOI 10.1073/pnas.95.1.219; Lu PF, 2007, PAN-PAC ENTOMOL, V83, P226, DOI 10.3956/0031-0603-83.3.226; Ma PWK, 1996, J INSECT PHYSIOL, V42, P257, DOI 10.1016/0022-1910(95)00114-X; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V137, P936, DOI 10.1016/0006-291X(86)90315-3; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; OKEYOOWUOR JB, 1981, INSECT SCI APPL, V1, P263, DOI 10.1017/S1742758400000503; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Predel R, 2001, J INSECT PHYSIOL, V47, P287, DOI 10.1016/S0022-1910(00)00113-X; RAINA AK, 1990, INSECT BIOCHEM, V20, P849, DOI 10.1016/0020-1790(90)90103-2; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; RAINA AK, 1992, INSECT BIOCHEM MOLEC, V22, P221, DOI 10.1016/0965-1748(92)90058-M; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; RASHID A, 2003, ASIAN J PLANT SCI, V2, P403; Riechmann L, 2000, P NATL ACAD SCI USA, V97, P10068, DOI 10.1073/pnas.170145497; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Singh SR, 1990, INSECT PESTS TROPICA, P43; Southey BR, 2008, BIOINFORMATICS, V24, P815, DOI 10.1093/bioinformatics/btn044; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Sun JS, 2003, REGUL PEPTIDES, V116, P163, DOI 10.1016/j.regpep.2003.09.002; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; SUWAN S, 1994, INSECT BIOCHEM MOLEC, V24, P1001, DOI 10.1016/0965-1748(94)90137-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ulrichs C, 2004, J APPL ENTOMOL, V128, P426, DOI 10.1111/j.1439-0418.2004.00867.x; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Wei ZJ, 2008, J APPL ENTOMOL, V132, P59, DOI 10.1111/j.1439-0418.2007.01249.x; Wei ZJ, 2004, J INSECT PHYSIOL, V50, P1151, DOI 10.1016/j.jinsphys.2004.10.007; Xu WH, 2004, PEPTIDES, V25, P1099, DOI 10.1016/j.peptides.2004.03.021; Xu WH, 2003, INSECT MOL BIOL, V12, P509, DOI 10.1046/j.1365-2583.2003.00437.x; XU WH, 1995, BBA-GENE STRUCT EXPR, V1261, P83, DOI 10.1016/0167-4781(94)00238-X; Zdarek J, 1997, ANN NY ACAD SCI, V814, P67, DOI 10.1111/j.1749-6632.1997.tb46145.x; Zhang TY, 2004, J INSECT PHYSIOL, V50, P547, DOI 10.1016/j.jinsphys.2004.03.011; Zhang TY, 2005, BBA-GENE STRUCT EXPR, V1728, P44, DOI 10.1016/j.bbaexp.2005.01.009; Zhang TY, 2004, J INSECT PHYSIOL, V50, P25, DOI 10.1016/j.jinsphys.2003.09.006; Zhao JY, 2004, REGUL PEPTIDES, V118, P25, DOI 10.1016/j.regpep.2003.10.024; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	85	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84916	10.1371/journal.pone.0084916	http://dx.doi.org/10.1371/journal.pone.0084916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409312	Green Submitted, Green Published, gold			2022-12-25	WOS:000329463500036
J	Abbas, A; Aukrust, P; Russell, D; Krohg-Sorensen, K; Almas, T; Bundgaard, D; Bjerkeli, V; Sagen, EL; Michelsen, AE; Dahl, TB; Holm, S; Ueland, T; Skjelland, M; Halvorsen, B				Abbas, Azhar; Aukrust, Pal; Russell, David; Krohg-Sorensen, Kirsten; Almas, Trine; Bundgaard, Dorte; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Holm, Sverre; Ueland, Thor; Skjelland, Mona; Halvorsen, Bente			Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis	PLOS ONE			English	Article							ARTERY STENOSIS; PLAQUE; MACROPHAGES; INFLAMMATION; EXPRESSION; STABILITY	Background: Atherosclerosis is a major cause of cerebrovascular disease. Matrix metalloproteinases (MMPs) play an important role in matrix degradation within the atherosclerotic lesion leading to plaque destabilization and ischemic stroke. We hypothesized that MMP-7 could be involved in this process. Methods: Plasma levels of MMP-7 were measured in 182 consecutive patients with moderate (50-69%) or severe (>= 70%) internal carotid artery stenosis, and in 23 healthy controls. The mRNA levels of MMP-7 were measured in atherosclerotic carotid plaques with different symptomatology, and based on its localization to macrophages, the in vitro regulation of MMP-7 in primary monocytes was examined. Results: Our major findings were (i) Patients with carotid atherosclerosis had markedly increased plasma levels of MMP-7 compared to healthy controls, with particularly high levels in patients with recent symptoms (i. e., within the last 2 months). (ii) A similar pattern was found within carotid plaques with markedly higher mRNA levels of MMP-7 than in non-atherosclerotic vessels. Particularly high protein levels of MMP-7 levels were found in those with the most recent symptoms. (iii) Immunhistochemistry showed that MMP-7 was localized to macrophages, and in vitro studies in primary monocytes showed that the inflammatory cytokine tumor necrosis factor-a in combination with hypoxia and oxidized LDL markedly increased MMP-7 expression. (iv) During the follow-up of patients with carotid atherosclerosis, high plasma levels of MMP-7 were independently associated with total mortality. Conclusion: Our findings suggest that MMP-7 could contribute to plaque instability in carotid atherosclerosis, potentially involving macrophage-related mechanisms.	[Abbas, Azhar; Russell, David; Skjelland, Mona] Univ Oslo, Dept Neurol, Oslo, Norway; [Abbas, Azhar; Aukrust, Pal; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Holm, Sverre; Ueland, Thor; Skjelland, Mona; Halvorsen, Bente] Univ Oslo, Internal Med Res Inst, Oslo, Norway; [Krohg-Sorensen, Kirsten] Univ Oslo, Dept Thorac & Cardiovasc Surg, Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Aukrust, Pal; Russell, David; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Ueland, Thor; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Almas, Trine] Ostfold Hosp Trust, Dept Neurol, Fredrikstad, Norway; [Bundgaard, Dorte] Ostfold Hosp Trust, Dept Thorac & Cardiovasc Surg, Fredrikstad, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Abbas, A (corresponding author), Univ Oslo, Dept Neurol, Oslo, Norway.	azhar.abbas@ous-hf.no	Skjelland, Mona/B-7362-2016; Skjelland, Mona/Q-4674-2017	Dahl, Tuva/0000-0001-7818-9411; Holm, Sverre/0000-0003-1064-3926; Skjelland, Mona/0000-0001-7950-4882; Krohg-Sorensen, Kirsten/0000-0002-5713-809X	Norwegian Council of Cardiovascular Research; Research Council of Norway; University of Oslo; South-Eastern Norway Regional Health Authority	Norwegian Council of Cardiovascular Research; Research Council of Norway(Research Council of Norway); University of Oslo; South-Eastern Norway Regional Health Authority	This study was supported by grants from The Norwegian Council of Cardiovascular Research, Research Council of Norway, University of Oslo, and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen F, 2005, INT J MOL MED, V15, P57; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Furman C, 2004, ATHEROSCLEROSIS, V174, P93, DOI 10.1016/j.atherosclerosis.2004.01.009; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Halvorsen B, 1998, BIOCHEM J, V331, P743, DOI 10.1042/bj3310743; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Pelisek J, 2009, CEREBROVASC DIS, V28, P601, DOI 10.1159/000247605; Razuvaev A, 2011, EUR J VASC ENDOVASC, V42, P722, DOI 10.1016/j.ejvs.2011.05.023; Sapienza P, 2009, EUR J VASC ENDOVASC, V37, P525, DOI 10.1016/j.ejvs.2009.01.012; SILLESEN H, 1995, EUR J VASC ENDOVASC, V10, P23; Stylianou E, 2001, CYTOKINE, V14, P56, DOI 10.1006/cyto.2000.0850; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042	19	49	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84935	10.1371/journal.pone.0084935	http://dx.doi.org/10.1371/journal.pone.0084935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400123	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700057
J	Fu, YQ; Jiang, JJ; Zhou, H; Jiang, Y; Fu, Y; Yu, YS; Zhou, JY				Fu, Yiqi; Jiang, Jingjin; Zhou, Hua; Jiang, Yan; Fu, Ying; Yu, Yunsong; Zhou, Jianying			Characterization of a Novel Plasmid Type and Various Genetic Contexts of bla(OXA-58) in Acinetobacter spp. from Multiple Cities in China	PLOS ONE			English	Article							HYDROLYZING OXACILLINASE OXA-58; D BETA-LACTAMASE; BAUMANNII; RESISTANCE; EMERGENCE; DISSEMINATION; SEQUENCE; CARBAPENEMASES; ACQUISITION; COMPLEX	Background/Objective: Several studies have described the epidemiological distribution of bla(OXA-58)-harboring Acinetobacter baumannii in China. However, there is limited data concerning the replicon types of bla(OXA-58)-carrying plasmids and the genetic context surrounding bla(OXA-58) in Acinetobacter spp. in China. Methodology/Principal Findings: Twelve non-duplicated bla(OXA-58)-harboring Acinetobacter spp. isolates were collected from six hospitals in five different cities between 2005 and 2010. The molecular epidemiology of the isolates was carried out using PFGE and multilocus sequence typing. Carbapenemase-encoding genes and plasmid replicase genes were identified by PCR. The genetic location of bla(OXA-58) was analyzed using S1-nuclease method. Plasmid conjugation and electrotransformation were performed to evaluate the transferability of bla(OXA-58)-harboring plasmids. The genetic structure surrounding bla(OXA-58) was determined by cloning experiments. The twelve isolates included two Acinetobacter pittii isolates (belong to one pulsotype), three Acinetobacter nosocomialis isolates (belong to two pulsotypes) and seven Acinetobacter baumannii isolates (belong to two pulsotypes/sequence types). A. baumannii ST91 was found to be a potential multidrug resistant risk clone carrying both bla(OXA-58) and bla(OXA-23). bla(OXA-58) located on plasmids varied from ca. 52 kb to ca. 143 kb. All plasmids can be electrotransformed to A. baumannii recipient, but were untypeable by the current replicon typing scheme. A novel plasmid replicase named repAci10 was identified in bla(OXA-58)-harboring plasmids of two A. pittii isolates, three A. nosocomialis isolates and two A. baumannii isolates. Four kinds of genetic contexts of bla(OXA-58) were identified. The transformants of plasmids with structure of IS6 family insertion sequence (ISOur1, IS1008 or IS15)-Delta ISAba3-like element-bla(OXA-58) displayed carbapenem nonsusceptible, while others with structure of intact ISAba3-like element-bla(OXA-58) were carbapenem susceptible. Conclusion: The study revealed the unique features of bla(OXA-58)-carrying plasmids in Acinetobacter spp. in China, which were different from that of Acinetobacter spp. found in European countries. The diversity of the genetic contexts of bla(OXA-58) contributed to various antibiotics resistance profiles.	[Fu, Yiqi; Zhou, Hua; Zhou, Jianying] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Jingjin] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept VIP, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Yan; Fu, Ying; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com; zjyhz@zju.edu.cn		Zhou, Hua/0000-0001-6397-3203	National Natural Science Foundation of China [81230039, 81000757]; Science Technology Department of Zhejiang Province [2008C13029-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province	This work was funded by research grants from National Natural Science Foundation of China (nos. 81230039 and 81000757) and Science Technology Department of Zhejiang Province (no. 2008C13029-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Boo TW, 2009, J MED MICROBIOL, V58, P839, DOI 10.1099/jmm.0.008904-0; Castanheira M, 2008, J CLIN MICROBIOL, V46, P3179, DOI 10.1128/JCM.00988-08; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P3107, DOI 10.1128/AAC.00128-10; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Coelho J, 2006, ANTIMICROB AGENTS CH, V50, P756, DOI 10.1128/AAC.50.2.756-758.2006; D'Arezzo S, 2009, CLIN MICROBIOL INFEC, V15, P347, DOI 10.1111/j.1469-0691.2009.02668.x; Evans BA, 2010, J ANTIMICROB CHEMOTH, V65, P1586, DOI 10.1093/jac/dkq180; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; He C, 2011, INT J ANTIMICROB AG, V38, P257, DOI 10.1016/j.ijantimicag.2011.04.015; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P5035, DOI 10.1128/AAC.00856-09; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Marti S, 2008, DIAGN MICR INFEC DIS, V61, P468, DOI 10.1016/j.diagmicrobio.2008.03.014; Marti S, 2008, ANTIMICROB AGENTS CH, V52, P2955, DOI 10.1128/AAC.00072-08; MARTIN P, 1988, MOL MICROBIOL, V2, P615, DOI 10.1111/j.1365-2958.1988.tb00070.x; Mendes RE, 2009, ANTIMICROB AGENTS CH, V53, P843, DOI 10.1128/AAC.00999-08; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P1504, DOI 10.1093/jac/dkr163; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2006, ANTIMICROB AGENTS CH, V50, P399, DOI 10.1128/AAC.50.1.399-400.2006; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Towner KJ, 2011, ANTIMICROB AGENTS CH, V55, P2154, DOI 10.1128/AAC.01661-10; Wang H, 2007, ANTIMICROB AGENTS CH, V51, P4022, DOI 10.1128/AAC.01259-06; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Zhang JP, 2010, J MICROBIOL, V48, P689, DOI 10.1007/s12275-010-0137-3; Zhou H, 2007, J CLIN MICROBIOL, V45, P4054, DOI 10.1128/JCM.00343-07	35	38	38	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84680	10.1371/journal.pone.0084680	http://dx.doi.org/10.1371/journal.pone.0084680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400107	Green Published, Green Submitted, gold			2022-12-25	WOS:000329462700041
J	Sakakura, H; Murakumo, Y; Mii, SJ; Hagiwara, S; Kato, T; Asai, M; Hoshino, A; Yamamoto, N; Sobue, S; Ichihara, M; Ueda, M; Takahashi, M				Sakakura, Hiroki; Murakumo, Yoshiki; Mii, Shinji; Hagiwara, Sumitaka; Kato, Takuya; Asai, Masato; Hoshino, Akiyoshi; Yamamoto, Noriyuki; Sobue, Sayaka; Ichihara, Masatoshi; Ueda, Minoru; Takahashi, Masahide			Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice	PLOS ONE			English	Article							CELL-SURFACE; HUMAN KERATINOCYTES; HUMAN PLATELETS; EXPRESSION; RECEPTOR; IDENTIFICATION; CARCINOMAS; CD34(+); PROTEIN; SYSTEM	CD109, a glycosylphosphatidylinositol-anchored glycoprotein, is expressed at high levels in some human tumors including squamous cell carcinomas. As CD109 is reportedly cleaved by furin and its soluble form is secreted into culture medium in vitro, we hypothesized that CD109 could serve as a tumor marker in vivo. In this study, we investigated CD109 as a novel serum tumor marker using transgenic mice that overexpress mouse CD109 (mCD109-TG mice) and tumor xenografted mice inoculated with human CD109 (hCD109)-overexpressing HEK293 cells. In sera and urine of mCD109-TG mice, mCD109 was detected using western blotting. In xenografted mice, hCD109 secreted from inoculated tumors was detected in sera, using western blotting and CD109 ELISA. Concentrations of tumor-secreted CD109 increased proportionally as tumors enlarged. Concentrations of secreted CD109 decreased notably by 17 h after tumor resection, and became undetectable 48 h after resection. The half-life of tumor-secreted CD109 was about 5.86+/-0.17 h. These results indicate that CD109 is present in serum as a soluble form, and suggest its potential as a novel tumor marker in patients with cancers that express CD109.	[Sakakura, Hiroki; Murakumo, Yoshiki; Mii, Shinji; Kato, Takuya; Asai, Masato; Hoshino, Akiyoshi; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan; [Sakakura, Hiroki; Hagiwara, Sumitaka; Yamamoto, Noriyuki; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; [Murakumo, Yoshiki] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 228, Japan; [Sobue, Sayaka; Ichihara, Masatoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan	Nagoya University; Nagoya University; Kitasato University; Chubu University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan.	mtakaha@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Mii, Shinji/I-7480-2014; TAKAHASHI, Masahide/I-7244-2014; asai, masato/I-7294-2014	Takahashi, Masahide/0000-0002-2803-2683; Mii, Shinji/0000-0001-8266-3235; 				Caccia D, 2011, J PROTEOME RES, V10, P4196, DOI 10.1021/pr200344n; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Giesert C, 2003, ANN NY ACAD SCI, V996, P227, DOI 10.1111/j.1749-6632.2003.tb03250.x; Hagikura M, 2010, PATHOL INT, V60, P735, DOI 10.1111/j.1440-1827.2010.02592.x; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Hagiwara S, 2008, CANCER SCI, V99, P1916, DOI 10.1111/j.1349-7006.2008.00949.x; HAREGEWOIN A, 1994, CELL IMMUNOL, V156, P357, DOI 10.1006/cimm.1994.1181; Hasegawa M, 2008, PATHOL INT, V58, P288, DOI 10.1111/j.1440-1827.2008.02225.x; Hasegawa M, 2007, PATHOL INT, V57, P245, DOI 10.1111/j.1440-1827.2007.02097.x; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Ichihara M, 1997, BLOOD, V90, P165; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Janik JE, 2004, BLOOD, V104, P3355, DOI 10.1182/blood-2003-11-3922; KELTON JG, 1990, BLOOD, V75, P2172; Kim Seung Cheol, 2004, J Low Genit Tract Dis, V8, P292, DOI 10.1097/00128360-200410000-00006; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Litvinov IV, 2011, EXP DERMATOL, V20, P627, DOI 10.1111/j.1600-0625.2011.01288.x; Mii S, 2012, AM J PATHOL, V181, P1180, DOI 10.1016/j.ajpath.2012.06.021; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohshima Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/j.jdermsci.2009.11.004; Sato T, 2007, PATHOL INT, V57, P719, DOI 10.1111/j.1440-1827.2007.02168.x; SMITH JW, 1995, BLOOD, V86, P2807; SUTHERLAND DR, 1991, BLOOD, V77, P84; Vaidyanathan K, 2012, INDIAN J CLIN BIOCHE, V27, P110, DOI 10.1007/s12291-011-0173-8; Yoshimasu T, 1999, INT J BIOL MARKER, V14, P99, DOI 10.1177/172460089901400207; Zhang JM, 2005, PATHOL INT, V55, P165, DOI 10.1111/j.1440-1827.2005.01807.x	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83385	10.1371/journal.pone.0083385	http://dx.doi.org/10.1371/journal.pone.0083385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400073	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700007
J	Wu, BB; Yu, ZP; You, S; Zheng, YH; Liu, J; Gao, YJ; Lin, H; Lian, QQ				Wu, Binbin; Yu, Zipu; You, Shan; Zheng, Yihu; Liu, Jin; Gao, Yajing; Lin, Han; Lian, Qingquan			Physiological Disturbance May Contribute to Neurodegeneration Induced by Isoflurane or Sevoflurane in 14 Day Old Rats	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; NEURAL STEM-CELLS; INSULIN-SECRETION; NEURONAL DEGENERATION; AFFECTS NEUROGENESIS; ANESTHESIA; EXPOSURE; ADULT; BRAIN; METABOLISM	Background: Volatile anesthetics are widely used in pediatric anesthesia but their potential neurotoxicity raise significant concerns regarding sequelae after anesthesia. However, whether physiological disturbance during anesthetic exposure contributes to such side effects remains unknown. The aim of the current study is to compare the neurotoxic effects of isoflurane and sevoflurane in 14 day old rat pups under spontaneous breathing or ventilated conditions. Methods: Postnatal 14 day rats were assigned to one of five groups: 1) spontaneous breathing (SB) + room air (control, n = 17); 2) SB + isoflurane (n = 35); 3) SB + sevoflurane (n = 37); 4) mechanical ventilation (MV) + isoflurane (n = 29); 5) MV + sevoflurane (n = 32). Anesthetized animal received either 1.7% isoflurane or 2.4% seveoflurane for 4 hours. Arterial blood gases and blood pressure were monitored in the anesthetized groups. Neurodegeneration in the CA3 region of hippocampus was assessed with terminal deoxynucleotidyl transferase-mediated DNA nick-end labeling immediately after exposure. Spatial learning and memory were evaluated with the Morris water maze in other cohorts 14 days after experiments. Results: Most rats in the SB groups developed physiological disturbance whereas ventilated rats did not but become hyperglycemic. Mortality from anesthesia in the SB groups was significantly higher than that in the MV groups. Cell death in the SB but not MV groups was significantly higher than controls. SB + anesthesia groups performed worse on the Morris water maze behavioral test, but no deficits were found in the MV group compared with the controls. Conclusions: These findings could suggest that physiological disturbance induced by isoflurane or sevoflurane anesthesia may also contribute to their neurotoxicity.	[Wu, Binbin; Yu, Zipu; You, Shan; Liu, Jin; Gao, Yajing; Lin, Han; Lian, Qingquan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Peoples R China; [Zheng, Yihu] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wu, BB (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Peoples R China.	wbb19880117@163.com; lianqingquanmz@163.com	Wu, Binbin/AAT-7000-2021	Wu, Binbin/0000-0001-7953-0992	National Science Foundation of China [81271469]; Research Foundation of Doctor Program [20113321110003]; National Science Foundation of Zhejiang Province [Z2101211]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Doctor Program; National Science Foundation of Zhejiang Province	The work was supported in part by National Science Foundation of China (81271469) and Research Foundation of Doctor Program (20113321110003) to QL, National Science Foundation of Zhejiang Province (Z2101211) to QL. The funder is the corresponding author of this study, and he gave final approval of the version to be published.	Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Camu F, 1976, Acta Anaesthesiol Belg, V27 suppl, P267; Ceccom J, 2013, LEARN MEMORY, V20, P348, DOI 10.1101/lm.029017.112; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DILTOER M, 1988, ANESTHESIOLOGY, V68, P880, DOI 10.1097/00000542-198806000-00008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; EISENHAUER CL, 1994, LAB ANIM SCI, V44, P245; Fang F, 2012, NEUROSCI BULL, V28, P499, DOI 10.1007/s12264-012-1260-4; Hayashi H, 2002, PAEDIATR ANAESTH, V12, P770, DOI 10.1046/j.1460-9592.2002.00883.x; Holmstrom A, 2005, ACTA ANAESTH SCAND, V49, P754, DOI 10.1111/j.1399-6576.2005.00697.x; Jochems A, 2013, EUR J NEUROSCI, V38, P2250, DOI 10.1111/ejn.12236; Lattermann R, 2001, ANESTH ANALG, V93, P121; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nixon K, 2010, ALCOHOL, V44, P39, DOI 10.1016/j.alcohol.2009.11.001; Ogata ES., 1999, NEONATOLOGY PATHOPHY, V5th ed, P699; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Popic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034396; Saho S, 1997, ANESTH ANALG, V84, P1359, DOI 10.1097/00000539-199706000-00034; Stanley CA, 1999, NEW ENGL J MED, V340, P1200, DOI 10.1056/NEJM199904153401510; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Wang YH, 2012, NEUROL SCI, V33, P535, DOI 10.1007/s10072-011-0762-6; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Wong CH, 2006, FOOD CHEM TOXICOL, V44, P1399, DOI 10.1016/j.fct.2006.03.004; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Ying SW, 2009, NEUROPHARMACOLOGY, V56, P438, DOI 10.1016/j.neuropharm.2008.09.015; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	38	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84622	10.1371/journal.pone.0084622	http://dx.doi.org/10.1371/journal.pone.0084622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400105	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700039
J	Yan, A; Wu, MJ; Yan, LM; Hu, R; Ali, I; Gan, YB				Yan, An; Wu, Minjie; Yan, Limei; Hu, Rui; Ali, Imran; Gan, Yinbo			AtEXP2 Is Involved in Seed Germination and Abiotic Stress Response in Arabidopsis	PLOS ONE			English	Article							CELL-WALL EXTENSIBILITY; EXPANSIN GENE; GIBBERELLIN BIOSYNTHESIS; MOLECULAR-CLONING; MULTIGENE FAMILY; LEAF DEVELOPMENT; EXPRESSION; THALIANA; PROTEINS; GROWTH	Expansins are cell wall proteins that promote cell wall loosening by inducing pH-dependent cell wall extension and stress relaxation. Expansins are required in a series of physiological developmental processes in higher plants such as seed germination. Here we identified an Arabidopsis expansin gene AtEXPA2 that is exclusively expressed in germinating seeds and the mutant shows delayed germination, suggesting that AtEXP2 is involved in controlling seed germination. Exogenous GA application increased the expression level of AtEXP2 during seed germination, while ABA application had no effect on AtEXP2 expression. Furthermore, the analysis of DELLA mutants show that RGL1, RGL2, RGA, GAI are all involved in repressing AtEXP2 expression, and RGL1 plays the most dominant role in controlling AtEXP2 expression. In stress response, exp2 mutant shows higher sensitivity than wild type in seed germination, while overexpression lines of AtEXP2 are less sensitive to salt stress and osmotic stress, exhibiting enhanced tolerance to stress treatment. Collectively, our results suggest that AtEXP2 is involved in the GA-mediated seed germination and confers salt stress and osmotic stress tolerance in Arabidopsis.	[Yan, An; Wu, Minjie; Yan, Limei; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Rui] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Gan, YB (corresponding author), Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Gan, Yinbo/N-1480-2015		International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province [2013C34G2010017]; International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China [2010DFA34430]; National Natural Science Foundation of China [31370215, 31228002]; Zhejiang Provincial Natural Science Foundation of China [Z31100041]	International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province; International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The research was supported by International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province (grant number 2013C34G2010017), the International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China (grant number 2010DFA34430), National Natural Science Foundation of China (Grant No. 31370215; 31228002), and Zhejiang Provincial Natural Science Foundation of China (Grant No. Z31100041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bentsink L, 2008, BIOONE, P1; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Budzinski IGF, 2011, PLANT BIOLOGY, V13, P462, DOI 10.1111/j.1438-8677.2010.00400.x; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P5504, DOI 10.1073/pnas.94.11.5504; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Gal TZ, 2006, PLANTA, V224, P155, DOI 10.1007/s00425-005-0204-x; Gan YB, 2011, AGR SCI CHINA, V10, P335, DOI 10.1016/S1671-2927(11)60012-6; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Hutchison KW, 1999, PLANT PHYSIOL, V120, P827, DOI 10.1104/pp.120.3.827; Josse EM, 2011, PLANT CELL, V23, P1337, DOI 10.1105/tpc.110.082594; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kwasniewski M, 2006, PLANT PHYSIOL, V141, P1149, DOI 10.1104/pp.106.078626; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Lu P, 2013, PLANTA, P1; Ma NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075997; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Sabirzhanova IB, 2005, PLANT PHYSIOL BIOCH, V43, P419, DOI 10.1016/j.plaphy.2005.01.021; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Schwechheimer C, 2009, CURR OPIN PLANT BIOL, V12, P57, DOI 10.1016/j.pbi.2008.09.004; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Shin JH, 2005, MOL CELLS, V20, P210; Soltys D, 2012, PLANTA, V236, P1629, DOI 10.1007/s00425-012-1722-y; Stamm P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-179; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; Tabuchi A, 2011, PLANT J, V68, P546, DOI 10.1111/j.1365-313X.2011.04705.x; Vreeburg RAM, 2005, PLANT J, V43, P597, DOI 10.1111/j.1365-313X.2005.02477.x; Wei PC, 2011, PLANT SIGNAL BEHAV, V6, P740, DOI 10.4161/psb.6.5.15144; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Won SK, 2010, MOL CELLS, V30, P369, DOI 10.1007/s10059-010-0127-7; Wu YJ, 2000, J EXP BOT, V51, P1543, DOI 10.1093/jexbot/51.350.1543; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Yamaguchi S, 2001, J PLANT GROWTH REGUL, V20, P369, DOI 10.1007/s003440010035; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang XQ, 2011, PLANT CELL REP, V30, P27, DOI 10.1007/s00299-010-0937-2; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281	71	67	80	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85208	10.1371/journal.pone.0085208	http://dx.doi.org/10.1371/journal.pone.0085208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404203	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800082
J	Davies, GE; Thornton, CR				Davies, Genna E.; Thornton, Christopher R.			Differentiation of the Emerging Human Pathogens Trichosporon asahii and Trichosporon asteroides from Other Pathogenic Yeasts and Moulds by Using Species-Specific Monoclonal Antibodies	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; INFECTIONS; IDENTIFICATION; SURVEILLANCE; DIAGNOSIS; HOUSES; SPP.; DNA	The fungal genus Trichosporon contains emerging opportunistic pathogens of humans, and is the third most commonly isolated non-candidal yeast from humans. Trichosporon asahii and T. asteroides are the most important species causing disseminated disease in immunocompromised patients, while inhalation of T. asahii spores is the most important cause of summer-type hypersensitivity pneumonitis in healthy individuals. Trichosporonosis is misdiagnosed as candidiasis or cryptococcosis due to a lack of awareness and the ambiguity of diagnostic tests for these pathogens. In this study, hybridoma technology was used to produce two murine monoclonal antibodies (MAbs), CA7 and TH1, for detection and differentiation of Trichosporon from other human pathogenic yeasts and moulds. The MAbs react with extracellular antigens from T. asahii and T. asteroides, but do not recognise other related Trichosporon spp., or unrelated pathogenic yeasts and moulds including Candida, Cryptococcus, Aspergillus, Fusarium, and Scedosporium spp., or the etiologic agents of mucormycosis. Immunofluorescence and Western blotting studies show that MAb CA7, an immunoglobulin G1 (IgG1), binds to a major 60 kDa glycoprotein antigen produced on the surface of hyphae, while TH1, an immunoglobulin M (IgM), binds to an antigen produced on the surface of conidia. The MAbs were used in combination with a standard mycological growth medium (Sabouraud Dextrose Agar) to develop an enzyme-linked immunosorbent assay (ELISA) for differentiation of T. asahii from Candida albicans and Cryptococcus neoformans in single and mixed species cultures. The MAbs represent a major advance in the identification of T. asahii and T. asteroides using standard mycological identification methods.	[Davies, Genna E.; Thornton, Christopher R.] Univ Exeter, Exeter, Devon, England	University of Exeter	Thornton, CR (corresponding author), Univ Exeter, Exeter, Devon, England.	C.R.Thornton@ex.ac.uk						Badiye Amit, 2012, J Assoc Physicians India, V60, P21; Bajwa SJ, 2013, ANN MED HEALTH SCI R, V3, P238, DOI 10.4103/2141-9248.113669; Biswas SK, 2005, J CLIN MICROBIOL, V43, P5171, DOI 10.1128/JCM.43.10.5171-5178.2005; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Cordoba S, 2011, REV ARGENT MICROBIOL, V43, P176, DOI 10.1590/S0325-75412011000300003; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Heslop OD, 2011, J CLIN MICROBIOL, V49, P4405, DOI 10.1128/JCM.05028-11; Hirschi S, 2012, J CLIN MICROBIOL, V50, P4168, DOI 10.1128/JCM.01928-12; Kustimur S, 2002, DIAGN MICR INFEC DIS, V43, P167, DOI 10.1016/S0732-8893(02)00385-1; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Miyagawa T, 2000, AM J RESP CRIT CARE, V161, P961, DOI 10.1164/ajrccm.161.3.9802013; Ohtani Y, 2008, INTERNAL MED, V47, P857, DOI 10.2169/internalmedicine.47.0656; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Sano M, 2007, VIRCHOWS ARCH, V451, P929, DOI 10.1007/s00428-007-0484-6; Shinozaki M, 2013, J CLIN MICROBIOL, V51, P295, DOI 10.1128/JCM.02221-12; Silva JO, 2004, MYCOPATHOLOGIA, V157, P29, DOI 10.1023/B:MYCO.0000012223.38967.7d; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Sugita T, 2001, J CLIN MICROBIOL, V39, P2405, DOI 10.1128/JCM.39.7.2405-2411.2001; Thornton CR, 2008, CLIN VACCINE IMMUNOL, V15, P1095, DOI 10.1128/CVI.00068-08; Thornton CR, 2015, CRIT REV MICROBIOL, V41, P27, DOI 10.3109/1040841X.2013.788995; Thornton CR, 2009, CLIN VACCINE IMMUNOL, V16, P756, DOI 10.1128/CVI.00061-09; Tlamcani Z, 2013, J IMMUN TECH INFECT, V2, P1; Unoura K, 2011, RESP MED, V105, P1696, DOI 10.1016/j.rmed.2011.07.009; Vashishtha VM, 2012, INDIAN PEDIATR, V49, P745, DOI 10.1007/s13312-012-0137-y; Vazquez-Gonzalez D, 2013, J DTSCH DERMATOL GES, V11, P381, DOI 10.1111/ddg.12097; Yang YL, 2014, J MICROBIOL IMMUNOL, V47, P339, DOI 10.1016/j.jmii.2013.01.001	30	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84789	10.1371/journal.pone.0084789	http://dx.doi.org/10.1371/journal.pone.0084789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392156	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460100079
J	Nardon, C; Schmitt, SM; Yang, HJ; Zuo, J; Fregona, D; Dou, QP				Nardon, Chiara; Schmitt, Sara M.; Yang, Huanjie; Zuo, Jian; Fregona, Dolores; Dou, Q. Ping			Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia	PLOS ONE			English	Article							GOLD(III) DITHIOCARBAMATE DERIVATIVES; COUPLED PEPTIDE TRANSPORTERS; PROTEASOME INHIBITORS; 20S PROTEASOME; CANCER CELLS; APOPTOSIS INDUCERS; BORTEZOMIB; COMPLEXES; DESIGN; OLIGOPEPTIDES	Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established antitumor agents, despite the fact that their clinical use is limited by many severe side-effects. In order to both improve the chemotherapeutic index and broaden the therapeutic spectrum of current drugs, our most recent anti-neoplastic agents, Au(III) complexes, were designed as carrier-mediated delivery systems exploiting peptide transporters, which are up-regulated in some cancers. Among all, we focused on two compounds and tested them on human MDA-MB-231 (resistant to cisplatin) breast cancer cell cultures and xenografts, discovering the proteasome as a major target both in vitro and in vivo. 53% inhibition of breast tumor growth in mice was observed after 27 days of treatment at 1.0 mg kg(-1) d(-1), compared to control. Remarkably, if only the most responsive mice are taken into account, 85% growth inhibition, with some animals showing tumor shrinkage, was observed after 13 days. These results led us to file an international patent, recognizing this class of gold(III) peptidomimetics as suitable candidates for entering phase I clinical trials.	[Nardon, Chiara; Yang, Huanjie; Fregona, Dolores] Univ Padua, Dept Chem Sci, Padua, Italy; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Mol Therapeut Program, Barbara Ann Karmanos Canc Inst,Dept Oncol, Detroit, MI USA; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Mol Therapeut Program,Barbara Ann Karmanos Canc I, Detroit, MI 48201 USA; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Mol Therapeut Program,Barbara Ann Karmanos Canc I, Detroit, MI 48201 USA; [Zuo, Jian] Ocean Univ China, Coll Chem & Chem Engn, Qingdao, Shandong, Peoples R China	University of Padua; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Ocean University of China	Fregona, D (corresponding author), Univ Padua, Dept Chem Sci, Padua, Italy.	dolores.fregona@unipd.it; doup@karmanos.org	NARDON, CHIARA/AAQ-9251-2021	NARDON, CHIARA/0000-0002-9657-1486; Zuo, Jian/0000-0002-8279-9666; Dou, Qingping/0000-0002-6465-1473	A.R.TE.M.O association; National Cancer Institute [1R01CA120009, 3R01CA120009-04S1, 5R01CA127258-05]; NATIONAL CANCER INSTITUTE [R01CA127258, R21CA184788, R01CA120009] Funding Source: NIH RePORTER	A.R.TE.M.O association; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CN wishes to thank the Ph.D. School in Molecular Sciences (University of Padova) and the Ing. Aldo Gini Foundation (Italy) for supporting her overseas mobility. The A.R.TE.M.O association are gratefully acknowledged for financial support. This work was partially supported by grants from the National Cancer Institute (1R01CA120009, 3R01CA120009-04S1 and 5R01CA127258-05, to QPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, DRUG DISCOV TODAY, V8, P307, DOI 10.1016/S1359-6446(03)02647-3; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Arellano JB, 2011, BIOCHEMISTRY-US, V50, P8291, DOI 10.1021/bi201195u; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013; Casini A, 2009, J BIOL INORG CHEM, V14, P1139, DOI 10.1007/s00775-009-0558-9; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Chen D, 2005, BIOCHEM PHARMACOL, V69, P1421, DOI 10.1016/j.bcp.2005.02.022; Dalla Via L, 2012, FUTURE MED CHEM, V4, P525, DOI [10.4155/FMC.11.187, 10.4155/fmc.11.187]; Daniel KG, 2005, BREAST CANCER RES, V7, pR897, DOI 10.1186/bcr1322; Fregona D, 2010, 2009- EP53296( WO2010105691): 34, Patent No. 53296; Gao G, 2000, J CELL BIOCHEM, V80, P53; Geissler S, 2010, FEBS J, V277, P790, DOI 10.1111/j.1742-4658.2009.07528.x; Gonzalez DE, 1998, CANCER RES, V58, P519; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Hong Y, 2008, BBA-MOL BASIS DIS, V1782, P649, DOI 10.1016/j.bbadis.2008.09.008; Inoue M, 2005, CANCER LETT, V230, P72, DOI 10.1016/j.canlet.2004.12.023; Johnstone SA, 2000, ANTI-CANCER DRUG DES, V15, P151; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Knutter I, 2002, AM J PHYSIOL-GASTR L, V283, pG222, DOI 10.1152/ajpgi.00534.2001; Kostova I, 2006, RECENT PAT ANTI-CANC, V1, P1, DOI 10.2174/157489206775246458; Kouodom MN, 2012, J INORG BIOCHEM, V117, P248, DOI 10.1016/j.jinorgbio.2012.07.001; Kouodom MN, 2012, J MED CHEM, V55, P2212, DOI 10.1021/jm201480u; Marta E, 2012, MINI-REV MED CHEM, V12, P1216; Marzano C, 2011, INT J CANCER, V129, P487, DOI 10.1002/ijc.25684; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Mitsuoka K, 2008, J NUCL MED, V49, P615, DOI 10.2967/jnumed.107.048231; Nakanishi T, 2000, INT J CANCER, V88, P274, DOI 10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.3.CO;2-X; Nakanishi T, 1997, CANCER RES, V57, P4118; PATERSON Y, 1981, J AM CHEM SOC, V103, P2947, DOI 10.1021/ja00401a007; Ronconi L, 2006, J MED CHEM, V49, P1648, DOI 10.1021/jm0509288; Ronconi L, 2005, POLYHEDRON, V24, P521, DOI 10.1016/j.poly.2004.12.015; Ronconi L, 2005, INORG CHEM, V44, P1867, DOI 10.1021/ic048260v; Ronconi L, 2009, DALTON T, P10670, DOI 10.1039/b913597a; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Terada T, 2005, BIOCHEM PHARMACOL, V70, P1756, DOI 10.1016/j.bcp.2005.09.027; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zhang X, 2010, J CELL BIOCHEM, V109, P162, DOI 10.1002/jcb.22394; Zheng J, 2012, CELL PHYSIOL BIOCHEM, V29, P353, DOI 10.1159/000338490	51	39	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84248	10.1371/journal.pone.0084248	http://dx.doi.org/10.1371/journal.pone.0084248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392119	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100042
J	Papaiordanidou, M; Billot, M; Varray, A; Martin, A				Papaiordanidou, Maria; Billot, Maxime; Varray, Alain; Martin, Alain			Neuromuscular Fatigue Is Not Different between Constant and Variable Frequency Stimulation	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; PRESYNAPTIC INHIBITION; ACTIVATION; VOLUNTARY; EXCITABILITY; CONTRACTIONS; RESPONSES; PROPERTY; PATTERNS	This study compared fatigue development of the triceps surae induced by two electrical stimulation protocols composed of constant and variable frequency trains (CFTs, VFTs, 450 trains, 30 Hz, 167 ms ON, 500 ms OFF and 146 ms ON, 500 ms OFF respectively). For the VFTs protocol a doublet (100 Hz) was used at the beginning of each train. The intensity used evoked 30% of a maximal voluntary contraction (MVC) and was defined using CFTs. Neuromuscular tests were performed before and after each protocol. Changes in excitation-contraction coupling were assessed by analysing the M-wave [at rest (M-max) and during MVC (M-sup)] and associated peak twitch (Pt). H-reflex [at rest (H-max) and during MVC (H-sup)] and the motor evoked potential (MEP) during MVC were studied to assess spinal and corticospinal excitability of the soleus muscle. MVC decrease was similar between the protocols (28%, P<0.05). M-max, M-sup and Pt decreased after both protocols (P<0.01). H-max/M-max was decreased (P<0.05), whereas H-sup/M-sup and MEP/M-sup remained unchanged after both protocols. The results indicate that CFTs and VFTs gave rise to equivalent neuromuscular fatigue. This fatigue resulted from alterations taking place at the muscular level. The finding that cortical and spinal excitability remained unchanged during MVC indicates that spinal and/or supraspinal mechanisms were activated to compensate for the loss of spinal excitability at rest.	[Papaiordanidou, Maria] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France; [Papaiordanidou, Maria; Billot, Maxime; Varray, Alain] Univ Montpellier I, Euromov, Movement Hlth Lab, Montpellier, France; [Billot, Maxime] Univ Laval, Fac Med, Dept Kinesiol, GRAME, Quebec City, PQ G1K 7P4, Canada; [Martin, Alain] Univ Bourgogne, UFR STAPS, INSERM Cognit Act & Plast Sensorimotrice U1093, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Papaiordanidou, M (corresponding author), Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France.	maria.papaiordanidou@univ-amu.fr	Varray, Alain/P-6730-2019	Varray, Alain/0000-0003-3876-1211; Billot, Maxime/0000-0003-0979-2182	French Department of Superior Education and Research	French Department of Superior Education and Research	This study was supported by the French Department of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; Allen DG, 2002, CAN J APPL PHYSIOL, V27, P83, DOI 10.1139/h02-006; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Bigland-Ritchie B, 2000, MUSCLE NERVE, V23, P1348, DOI 10.1002/1097-4598(200009)23:9<1348::AID-MUS5>3.0.CO;2-0; Binder-Macleod S, 2005, MUSCLE NERVE, V31, P681, DOI 10.1002/mus.20290; Binder-Macleod SA, 1998, MUSCLE NERVE, V21, P1145, DOI 10.1002/(SICI)1097-4598(199809)21:9<1145::AID-MUS5>3.0.CO;2-7; Binder-MacLeod SA, 2001, ACTA PHYSIOL SCAND, V172, P195, DOI 10.1046/j.1365-201x.2001.00864.x; Binder-MacLeod SA, 1999, J APPL PHYSIOL, V86, P1337, DOI 10.1152/jappl.1999.86.4.1337; Boerio D, 2005, MED SCI SPORT EXER, V37, P973, DOI 10.1249/01.mss.0000166579.81052.9c; BOSTOCK H, 1994, BRAIN, V117, P913, DOI 10.1093/brain/117.5.913; BURKE RE, 1970, SCIENCE, V168, P122, DOI 10.1126/science.168.3927.122; Butler JE, 2003, J APPL PHYSIOL, V94, P567, DOI 10.1152/japplphysiol.01176.2001; Collins DF, 2007, EXERC SPORT SCI REV, V35, P102; Darques JL, 2003, J APPL PHYSIOL, V95, P1476, DOI 10.1152/japplphysiol.00230.2003; DUCHATEAU J, 1993, J PHYSIOL-LONDON, V471, P787, DOI 10.1113/jphysiol.1993.sp019928; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; HICKS A, 1989, J PHYSIOL-LONDON, V414, P337, DOI 10.1113/jphysiol.1989.sp017691; Hortobagyi T, 2011, EUR J APPL PHYSIOL, V111, P2439, DOI 10.1007/s00421-011-2012-2; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; HULTMAN E, 1983, PFLUG ARCH EUR J PHY, V398, P139, DOI 10.1007/BF00581062; Kiernan MC, 1996, BRAIN, V119, P1099, DOI 10.1093/brain/119.4.1099; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; Papaiordanidou M, 2010, MUSCLE NERVE, V41, P54, DOI 10.1002/mus.21427; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Sacco P, 1997, MUSCLE NERVE, V20, P1158, DOI 10.1002/(SICI)1097-4598(199709)20:9<1158::AID-MUS11>3.0.CO;2-P; Scott WB, 2005, MUSCLE NERVE, V31, P581, DOI 10.1002/mus.20300; Steele DS, 2003, ACTA PHYSIOL SCAND, V179, P39, DOI 10.1046/j.1365-201X.2003.01169.x; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Theurel J, 2007, RESP PHYSIOL NEUROBI, V157, P341, DOI 10.1016/j.resp.2006.12.002; Thomas CK, 2003, J NEUROPHYSIOL, V89, P2055, DOI 10.1152/jn.01002.2002; Vanderthommen M, 2003, J APPL PHYSIOL, V94, P1012, DOI 10.1152/japplphysiol.00887.2001; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84740	10.1371/journal.pone.0084740	http://dx.doi.org/10.1371/journal.pone.0084740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392155	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100078
J	Wei, L; Li, SH; Liu, SG; He, AN; Wang, D; Wang, J; Tang, YL; Wu, XJ				Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Wang, Dan; Wang, Jie; Tang, Yulian; Wu, Xianjin			Transcriptome Analysis of Houttuynia cordata Thunb. by Illumina Paired-End RNA Sequencing and SSR Marker Discovery	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; ANTIBACTERIAL ACTIVITIES; MICROSATELLITE MARKERS; INFLUENZA-VIRUS; WATER EXTRACT; SEQ DATA; TRANSFERABILITY; GENOMICS; LEAVES; GROWTH	Background: Houttuynia cordata Thunb. is an important traditional medical herb in China and other Asian countries, with high medicinal and economic value. However, a lack of available genomic information has become a limitation for research on this species. Thus, we carried out high-throughput transcriptomic sequencing of H. cordata to generate an enormous transcriptome sequence dataset for gene discovery and molecular marker development. Principal Findings: Illumina paired-end sequencing technology produced over 56 million sequencing reads from H. cordata mRNA. Subsequent de novo assembly yielded 63,954 unigenes, 39,982 (62.52%) and 26,122 (40.84%) of which had significant similarity to proteins in the NCBI nonredundant protein and Swiss-Prot databases (E-value <10(-5)), respectively. Of these annotated unigenes, 30,131 and 15,363 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. In addition, 24,434 (38.21%) unigenes were mapped onto 128 pathways using the KEGG pathway database and 17,964 (44.93%) unigenes showed homology to Vitis vinifera (Vitaceae) genes in BLASTx analysis. Furthermore, 4,800 cDNA SSRs were identified as potential molecular markers. Fifty primer pairs were randomly selected to detect polymorphism among 30 samples of H. cordata; 43 (86%) produced fragments of expected size, suggesting that the unigenes were suitable for specific primer design and of high quality, and the SSR marker could be widely used in marker-assisted selection and molecular breeding of H. cordata in the future. Conclusions: This is the first application of Illumina paired-end sequencing technology to investigate the whole transcriptome of H. cordata and to assemble RNA-seq reads without a reference genome. These data should help researchers investigating the evolution and biological processes of this species. The SSR markers developed can be used for construction of high-resolution genetic linkage maps and for gene-based association analyses in H. cordata. This work will enable future functional genomic research and research into the distinctive active constituents of this genus.	[Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Wang, Dan; Wang, Jie; Tang, Yulian; Wu, Xianjin] Huaihua Univ, Coll Life Sci, Huaihua, Peoples R China; [Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Tang, Yulian; Wu, Xianjin] Key Lab Hunan Prov Study & Utilizat Ethn Med Plan, Huaihua, Peoples R China; [Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Tang, Yulian; Wu, Xianjin] Key Lab Hunan Higher Educ Hunan Western Med Plant, Huaihua, Peoples R China; [Wang, Jie] Hunan Univ, Coll Life Sci, Changsha 410082, Hunan, Peoples R China	Huaihua University; Hunan University	Wu, XJ (corresponding author), Huaihua Univ, Coll Life Sci, Huaihua, Peoples R China.	hhwuxianjin@163.com			National Natural Science Foundation of China [30870230]; Hunan Provincial Scientific Research Project Funding [12K132, 2013FJ6090]; Foundation of Hunan Key Discipline Construction Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Scientific Research Project Funding; Foundation of Hunan Key Discipline Construction Projects	This work was supported by the National Natural Science Foundation of China (No. 30870230), Hunan Provincial Scientific Research Project Funding (No. 12K132 and No. 2013FJ6090) and the Foundation of Hunan Key Discipline Construction Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Arun KY, 2011, J PARASIT DIS, V35, P190; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doyle J., 1991, MOL TECHNIQUES TAXON; Fang WP, 1981, FLORA SICHUANICA, P126; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim Dajeong, 2012, Lab Anim Res, V28, P137, DOI 10.5625/lar.2012.28.2.137; Kim GS, 2008, BIOL PHARM BULL, V31, P2012, DOI 10.1248/bpb.31.2012; Lai KC, 2010, ANTICANCER RES, V30, P3549; Lau KM, 2008, J ETHNOPHARMACOL, V118, P79, DOI 10.1016/j.jep.2008.03.018; Lee JS, 2008, J ETHNOPHARMACOL, V117, P34, DOI 10.1016/j.jep.2008.01.013; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li GZ, 2005, BIOL PHARM BULL, V28, P1864, DOI 10.1248/bpb.28.1864; Li WF, 2011, J ETHNOPHARMACOL, V133, P922, DOI 10.1016/j.jep.2010.10.048; Li XiaoYing, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P285; Liang Han-Xing, 1995, Acta Botanica Yunnanica, V17, P255; [林美珍 Lin Meizhen], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P1711; Liu Fang-zhou, 2010, Yaoxue Xuebao, V45, P399; Liu Fue, 2012, Liaoning Journal of Traditional Chinese Medicine, V39, P398; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Miyata M, 2010, J NUTR SCI VITAMINOL, V56, P150, DOI 10.3177/jnsv.56.150; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shin S, 2010, J VET SCI, V11, P273, DOI 10.4142/jvs.2010.11.3.273; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Toda S, 2005, J MED FOOD, V8, P266, DOI 10.1089/jmf.2005.8.266; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tseng YC, 1982, FLORAE REIPUBLICAE P; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang D, 2012, HORTICULTURE SEED, V21, P75; Wang D, 2012, HORTICULTURE SEED, V21, P67; Wang Li, 2010, J Evid Based Med, V3, P168, DOI 10.1111/j.1756-5391.2010.01091.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XiaoLi, 2012, China Journal of Traditional Chinese Medicine and Pharmacy, V27, P555; Wang XiaoPeng, 2012, Guangxi Zhiwu / Guihaia, V32, P107; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei L, 2012, INT J MOL SCI, V13, P8159, DOI 10.3390/ijms13078159; Wei W, 2005, GENET RESOUR CROP EV, V52, P473, DOI 10.1007/s10722-005-2261-1; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu W, 2005, HEREDITAS, V142, P24, DOI 10.1111/j.1601-5223.2005.01704.x; Wu Wei, 2002, Acta Pharmaceutica Sinica, V37, P986; Wu XJ, 2011, STUDY GERMPLASM PLAN; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh FC, 1991, BELG J BOT, V129, P157; Yin JC, 2011, AVIAN PATHOL, V40, P491, DOI 10.1080/03079457.2011.605107; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang Jinyu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P97; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhou NN, 2012, LIFE SCI, V90, P770, DOI 10.1016/j.lfs.2012.03.035	68	34	39	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84105	10.1371/journal.pone.0084105	http://dx.doi.org/10.1371/journal.pone.0084105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392108	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460100032
J	Granek, JA; Pisella, L; Stemberger, J; Vighetto, A; Rossetti, Y; Sergio, LE				Granek, Joshua A.; Pisella, Laure; Stemberger, John; Vighetto, Alain; Rossetti, Yves; Sergio, Lauren E.			Decoupled Visually-Guided Reaching in Optic Ataxia: Differences in Motor Control between Canonical and Non-Canonical Orientations in Space	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SENSORIMOTOR ADAPTATION; EXPLICIT STRATEGY; PRISM ADAPTATION; CORTICAL SYSTEMS; HAND MOVEMENTS; VISUOMOTOR; EYE; TARGET; MECHANISMS	Guiding a limb often involves situations in which the spatial location of the target for gaze and limb movement are not congruent (i.e. have been decoupled). Such decoupled situations involve both the implementation of a cognitive rule (i.e. strategic control) and the online monitoring of the limb position relative to gaze and target (i.e. sensorimotor recalibration). To further understand the neural mechanisms underlying these different types of visuomotor control, we tested patient IG who has bilateral caudal superior parietal lobule (SPL) damage resulting in optic ataxia (OA), and compared her performance with six age-matched controls on a series of center-out reaching tasks. The tasks comprised 1) directing a cursor that had been rotated (180 degrees or 90 degrees) within the same spatial plane as the visual display, or 2) moving the hand along a different spatial plane than the visual display (horizontal or para-sagittal). Importantly, all conditions were performed towards visual targets located along either the horizontal axis (left and right; which can be guided from strategic control) or the diagonal axes (top-left and top-right; which require on-line trajectory elaboration and updating by sensorimotor recalibration). The bilateral OA patient performed much better in decoupled visuomotor control towards the horizontal targets, a canonical situation in which well-categorized allocentric cues could be utilized (i.e. guiding cursor direction perpendicular to computer monitor border). Relative to neurologically intact adults, IG's performance suffered towards diagonal targets, a non-canonical situation in which only less-categorized allocentric cues were available (i.e. guiding cursor direction at an off-axis angle to computer monitor border), and she was therefore required to rely on sensorimotor recalibration of her decoupled limb. We propose that an intact caudal SPL is crucial for any decoupled visuomotor control, particularly when relying on the realignment between vision and proprioception without reliable allocentric cues towards non-canonical orientations in space.	[Granek, Joshua A.; Stemberger, John; Sergio, Lauren E.] York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Pisella, Laure; Vighetto, Alain; Rossetti, Yves] CNRS, INSERM, U1028, Impact Ctr Rech Neurosci Lyon,UMR 5092, Bron, France; [Vighetto, Alain; Rossetti, Yves] Univ Lyon, Lyon, France; [Rossetti, Yves] Hop Neurol & Neurochirurg P Wertheimer, Hosp Civils Lyon, Bron, France	York University - Canada; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Sergio, LE (corresponding author), York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	lsergio@yorku.ca	Rossetti, Yves/H-3693-2017; Sergio, Lauren/AAK-3274-2020; Pisella, Laure/H-6072-2017	Rossetti, Yves/0000-0001-8867-4496; Pisella, Laure/0000-0001-6550-3774; Granek, Joshua/0000-0002-7361-5095	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Canadian Institutes of Health Research Canada Graduate Scholarship (JG) and an Natural Sciences and Engineering Research Council discovery operating grant (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; BATTAGLIAMAYER A, 2012, CEREB CORTEX; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; BEDFORD FL, 1993, J EXP PSYCHOL HUMAN, V19, P517, DOI 10.1037/0096-1523.19.3.517; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; BIGUER B, 1984, EXP BRAIN RES, V55, P462; Blangero A, 2007, NEUROIMAGE, V36, pT61, DOI 10.1016/j.neuroimage.2007.03.039; Blangero A, 2009, NEUROPSYCHOLOGIA, V47, P1500, DOI 10.1016/j.neuropsychologia.2008.11.030; Blangero A, 2008, CORTEX, V44, P560, DOI 10.1016/j.cortex.2007.09.004; Blangero A, 2010, CORTEX, V46, P77, DOI 10.1016/j.cortex.2009.02.015; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bock O, 2003, EXP BRAIN RES, V152, P528, DOI 10.1007/s00221-003-1643-x; Bock O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00081; Brogaard B, 2011, COGNITIVE SCI, V35, P1076, DOI 10.1111/j.1551-6709.2011.01171.x; Buiatti T, 2013, BRAIN COGNITION, V82, P6, DOI 10.1016/j.bandc.2013.02.004; Buxbaum LI, 2007, J INT NEUROPSYCH SOC, V13, P993, DOI 10.1017/S1355617707071573; Clavagnier S, 2007, NEUROSCIENTIST, V13, P22, DOI 10.1177/1073858406295688; Clower DM, 2000, J NEUROPHYSIOL, V84, P2703, DOI 10.1152/jn.2000.84.5.2703; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; GIELEN CCAM, 1984, EXP BRAIN RES, V56, P154, DOI 10.1007/BF00237452; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Granek JA, 2010, CORTEX, V46, P1165, DOI 10.1016/j.cortex.2009.10.009; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Hawkins KM, 2013, J COGNITIVE NEUROSCI, V25, P436, DOI 10.1162/jocn_a_00318; Himmelbach M, 2009, NEUROPSYCHOLOGIA, V47, P1508, DOI 10.1016/j.neuropsychologia.2009.01.033; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; Jackson SR, 2009, NEUROPSYCHOLOGIA, V47, P1397, DOI 10.1016/j.neuropsychologia.2009.01.035; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; JEANNEROD M, 1994, NEUROPSYCHOLOGIA, V32, P369, DOI 10.1016/0028-3932(94)90084-1; Jimenez L, 2006, J EXP PSYCHOL LEARN, V32, P475, DOI 10.1037/0278-7393.32.3.475; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Khan AZ, 2007, J VISION, V7, DOI 10.1167/7.5.8; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 2003, PROG BRAIN RES, V142, P223; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Newport R, 2006, CORTEX, V42, P720, DOI 10.1016/S0010-9452(08)70410-6; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 2006, NEUROPSYCHOLOGIA, V44, P2734, DOI 10.1016/j.neuropsychologia.2006.03.027; Pisella L, 2013, NEUROPSYCHOLOGIA, V51, P106, DOI 10.1016/j.neuropsychologia.2012.11.015; Pisella L, 2009, NEUROPSYCHOLOGIA, V47, P3033, DOI 10.1016/j.neuropsychologia.2009.06.020; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Revol P, 2003, SPATIAL VISION, V16, P347, DOI 10.1163/156856803322467572; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; SAYEGH PF, 2013, J NEUROPHYSIOL; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; Schenk T, 2010, COGN NEUROSCI-UK, V1, P52, DOI 10.1080/17588920903388950; Sergio LE, 2009, CORTICAL MECHANISMS OF VISION, P81; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Thaler L, 2011, EXP BRAIN RES, V211, P313, DOI 10.1007/s00221-011-2691-2; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Trillenberg P, 2007, NEUROIMAGE, V36, pT69, DOI 10.1016/j.neuroimage.2007.03.038; Vesia M, 2008, J NEUROPHYSIOL, V100, P2005, DOI 10.1152/jn.90519.2008; Vesia M, 2010, J NEUROSCI, V30, P13053, DOI 10.1523/JNEUROSCI.1644-10.2010; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Werner S, 2010, HUM MOVEMENT SCI, V29, P172, DOI 10.1016/j.humov.2010.02.004; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	90	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e86138	10.1371/journal.pone.0086138	http://dx.doi.org/10.1371/journal.pone.0086138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392035	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900179
J	Mongi, AS; Baisley, K; Ao, TTH; Chilongani, J; Aguirre-Andreasen, A; Francis, SC; Shao, J; Hayes, R; Kapiga, S				Mongi, Aika S.; Baisley, Kathy; Trong Thanh-Hoang Ao; Chilongani, Joseph; Aguirre-Andreasen, Aura; Francis, Suzanna C.; Shao, John; Hayes, Richard; Kapiga, Saidi			Factors Associated with Problem Drinking among Women Employed in Food and Recreational Facilities in Northern Tanzania	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; SUB-SAHARAN AFRICA; ALCOHOL-USE; SEXUAL-BEHAVIOR; HOTEL WORKERS; RISK-FACTORS; HIV-INFECTION; CAGE QUESTIONNAIRE; GLOBAL BURDEN; FEMALE BAR	Background: There is growing evidence that alcohol consumption is associated with increased risk of HIV infection. To determine factors associated with problem drinking, we analyzed data collected in two prospective cohorts of at-risk female food and recreational facility workers in northern Tanzania. Methods: We enrolled HIV seronegative women aged 18-44 years and employed in the towns of Geita, Kahama, Moshi, and Shinyanga. At enrolment, women were interviewed to obtain information about alcohol use, using CAGE and AUDIT screening scales, and risk factors for HIV infection. Blood and genital samples were collected for detection of HIV and sexually transmitted infections (STIs). We characterized alcohol use, concordance, and agreement of the scales, and examined the associations between characteristics of participants and problem drinking as defined by both scales using logistic regression. Lastly, we assessed problem drinking as a risk factor for recent sexual behavior and prevalent STIs. Results: Among enrollees, 68% women reported ever drinking alcohol; of these 76% reported drinking alcohol in the past 12 months. The prevalence of problem drinking was 20% using CAGE and 13% using AUDIT. Overall concordance between the scales was 75.0% with a Kappa statistic of 0.58. After adjusting for age, independent factors associated with problem drinking, on both scales, were marital status, occupation, facility type, increasing number of lifetime sexual partners, and transactional sex in the past 12 months. In addition, women who were problem drinkers on either scale were more likely to report having >= 1 sexual partner (CAGE: aOR = 1.56, 95% confidence interval, CI: 1.10-2.23; AUDIT: aOR = 2.00, 95% CI: 1.34-3.00) and transactional sex (CAGE: aOR = 1.79, 95% CI: 1.26-2.56; AUDIT: aOR = 1.51, 95% CI: 1.04-2.18), in the past 3 months. Conclusion: These findings suggest that interventions to reduce problem drinking in this population may reduce high-risk sexual behaviors and contribute in lowering the risk of HIV infection.	[Mongi, Aika S.; Trong Thanh-Hoang Ao; Francis, Suzanna C.; Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Baisley, Kathy; Trong Thanh-Hoang Ao; Aguirre-Andreasen, Aura; Francis, Suzanna C.; Hayes, Richard; Kapiga, Saidi] London Sch Hyg & Trop Med, London WC1, England; [Chilongani, Joseph] Natl Inst Med Res, Mwanza, Tanzania; [Shao, John] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Kilimanjaro Christian Medical Centre	Kapiga, S (corresponding author), Mwanza Intervent Trials Unit, Mwanza, Tanzania.	Saidi.Kapiga@lshtm.ac.uk	shao, jianfu/N-2447-2018	shao, jianfu/0000-0002-6632-8207; Hayes, Richard/0000-0002-1729-9892; Kapiga, Saidi/0000-0003-1753-4060; Francis, Suzanna Carter/0000-0002-3724-4813; Andreasen, Aura/0000-0003-0664-7342	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_ 32070_002]; EDCTP; Bill and Melinda Gates Foundation [CG_ct_06_33111]; UK aid from the Department of International Development [PHGHHD7610]; MRC [G1002369, G0901756, G0701039] Funding Source: UKRI; Medical Research Council [MR/K012126/1, G0701039, G1002369] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK aid from the Department of International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The microbicide preparedness study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP; project code: CT_ct_05_ 32070_002) and the HIV vaccines feasibility cohort was funded by EDCTP and the Bill and Melinda Gates Foundation (project code: CG_ct_06_33111). Partial support for drafting the manuscript was provided by STRIVE RPC with funding from the UK aid from the Department of International Development (DFID; project code: PHGHHD7610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao T, 2003, INT J STD AIDS, V14, P688, DOI 10.1258/095646203322387956; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Babor TF., 2001, ALCOHOL USE DISORDER; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bradley KA, 1998, JAMA-J AM MED ASSOC, V280, P166, DOI 10.1001/jama.280.2.166; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Ewing JA, 1998, BRIT MED J, V316, P1827, DOI 10.1136/bmj.316.7147.1827; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Ewing JA, 1998, JAMA-J AM MED ASSOC, V280, P1904, DOI 10.1001/jama.280.22.1904; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fritz K, 2010, LANCET, V376, P398, DOI 10.1016/S0140-6736(10)60884-7; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Tassiopoulos KK, 2006, AIDS BEHAV, V10, P405, DOI 10.1007/s10461-006-9112-8; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walker Robert, 2004, Trauma Violence Abuse, V5, P143, DOI 10.1177/1524838003262333; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Health Organization, 2011, GLOB STAT REP ALC HL	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84447	10.1371/journal.pone.0084447	http://dx.doi.org/10.1371/journal.pone.0084447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391956	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000329323900099
J	Nurzaman, SG; Culha, U; Brodbeck, L; Wang, LY; Iida, F				Nurzaman, Surya G.; Culha, Utku; Brodbeck, Luzius; Wang, Liyu; Iida, Fumiya			Active Sensing System with In Situ Adjustable Sensor Morphology	PLOS ONE			English	Article								Background: Despite the widespread use of sensors in engineering systems like robots and automation systems, the common paradigm is to have fixed sensor morphology tailored to fulfill a specific application. On the other hand, robotic systems are expected to operate in ever more uncertain environments. In order to cope with the challenge, it is worthy of note that biological systems show the importance of suitable sensor morphology and active sensing capability to handle different kinds of sensing tasks with particular requirements. Methodology: This paper presents a robotics active sensing system which is able to adjust its sensor morphology in situ in order to sense different physical quantities with desirable sensing characteristics. The approach taken is to use thermoplastic adhesive material, i.e. Hot Melt Adhesive (HMA). It will be shown that the thermoplastic and thermoadhesive nature of HMA enables the system to repeatedly fabricate, attach and detach mechanical structures with a variety of shape and size to the robot end effector for sensing purposes. Via active sensing capability, the robotic system utilizes the structure to physically probe an unknown target object with suitable motion and transduce the arising physical stimuli into information usable by a camera as its only built-in sensor. Conclusions/Significance: The efficacy of the proposed system is verified based on two results. Firstly, it is confirmed that suitable sensor morphology and active sensing capability enables the system to sense different physical quantities, i.e. softness and temperature, with desirable sensing characteristics. Secondly, given tasks of discriminating two visually indistinguishable objects with respect to softness and temperature, it is confirmed that the proposed robotic system is able to autonomously accomplish them. The way the results motivate new research directions which focus on in situ adjustment of sensor morphology will also be discussed.	[Nurzaman, Surya G.; Culha, Utku; Brodbeck, Luzius; Wang, Liyu; Iida, Fumiya] ETH, Dept Mech & Proc Engn, Inst Robot & Intelligent Syst, Bioinspired Robot Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Nurzaman, SG (corresponding author), ETH, Dept Mech & Proc Engn, Inst Robot & Intelligent Syst, Bioinspired Robot Lab, Zurich, Switzerland.	surya.nurzaman@mavt.ethz.ch	Culha, Utku/S-8156-2019; Nurzaman, Surya G/G-9486-2017	Culha, Utku/0000-0002-7788-6124; Nurzaman, Surya G/0000-0002-8157-6495; Iida, Fumiya/0000-0001-9246-7190	Swiss National Science Foundation [PP00P2123387/1]; ETH Zurich Research Grant [ETH-23-10-3]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research Grant(ETH Zurich)	This study was supported by the Swiss National Science Foundation Grant No. PP00P2123387/1 and the ETH Zurich Research Grant ETH-23-10-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; BOCK WJ, 1980, AM ZOOL, V20, P217; Brodbeck L, 2012, IEEE INT CONF ROBOT, P4322, DOI 10.1109/ICRA.2012.6225258; Brown SS, 2013, INT POLIT ECON SER, P1, DOI 10.1007/978-3-642-38812-5_1; Dangles O, 2005, J EXP BIOL, V208, P461, DOI 10.1242/jeb.01369; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Guerin F, 2013, IEEE T AUTON MENT DE, V5, P18, DOI 10.1109/TAMD.2012.2209879; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Kaminka GA, 2008, IEEE T ROBOT, V24, P271, DOI 10.1109/TRO.2008.918054; Klatzky RL, 2011, PHILOS T R SOC B, V366, P3097, DOI 10.1098/rstb.2011.0153; Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365; Lyle AC, 2010, SENSORS-BASEL, V10, P7514, DOI 10.3390/s100807514; Malone E, 2007, RAPID PROTOTYPING J, V13, P245, DOI 10.1108/13552540710776197; Murata S, 2007, IEEE ROBOT AUTOM MAG, V14, P71, DOI 10.1109/MRA.2007.339607; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; Nakata K, 2010, P ROY SOC B-BIOL SCI, V277, P29, DOI 10.1098/rspb.2009.1583; Parker G., 2010, CONCURRENTLY EVOLVIN, P1; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Prescott TJ, 2011, PHILOS T R SOC B, V366, P2989, DOI 10.1098/rstb.2011.0167; Revzen S., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4797, DOI 10.1109/IROS.2011.6048240; Sproewitz A, 2008, IEEE INT CONF ROBOT, P3508, DOI 10.1109/ROBOT.2008.4543747; Stamper SA, 2012, J EXP BIOL, V215, P1567, DOI 10.1242/jeb.068007; Turner JS, 2002, EXTENDED ORGANISM PH; Yim M, 2007, IEEE ROBOT AUTOM MAG, V14, P43, DOI 10.1109/MRA.2007.339623; Zuo YF, 2011, PHILOS T R SOC B, V366, P3058, DOI 10.1098/rstb.2011.0161	26	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84090	10.1371/journal.pone.0084090	http://dx.doi.org/10.1371/journal.pone.0084090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24416094	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700097
J	Parsons, HT; Weinberg, CS; Macdonald, LJ; Adams, PD; Petzold, CJ; Strabala, TJ; Wagner, A; Heazlewood, JL				Parsons, Harriet T.; Weinberg, Cristina S.; Macdonald, Lucy J.; Adams, Paul D.; Petzold, Christopher J.; Strabala, Timothy J.; Wagner, Armin; Heazlewood, Joshua L.			Golgi Enrichment and Proteomic Analysis of Developing Pinus radiata Xylem by Free-Flow Electrophoresis	PLOS ONE			English	Article							TRACHEID CELL-WALLS; COMPRESSION WOOD; CELLULOSE SYNTHASE; BIOSYNTHESIS; EXPRESSION; PROTEINS; LOCALIZATION; APPARATUS; DATABASE	Our understanding of the contribution of Golgi proteins to cell wall and wood formation in any woody plant species is limited. Currently, little Golgi proteomics data exists for wood-forming tissues. In this study, we attempted to address this issue by generating and analyzing Golgi-enriched membrane preparations from developing xylem of compression wood from the conifer Pinus radiata. Developing xylem samples from 3-year-old pine trees were harvested for this purpose at a time of active growth and subjected to a combination of density centrifugation followed by free flow electrophoresis, a surface charge separation technique used in the enrichment of Golgi membranes. This combination of techniques was successful in achieving an approximately 200-fold increase in the activity of the Golgi marker galactan synthase and represents a significant improvement for proteomic analyses of the Golgi from conifers. A total of thirty known Golgi proteins were identified by mass spectrometry including glycosyltransferases from gene families involved in glucomannan and glucuronoxylan biosynthesis. The free flow electrophoresis fractions of enriched Golgi were highly abundant in structural proteins (actin and tubulin) indicating a role for the cytoskeleton during compression wood formation. The mass spectrometry proteomics data associated with this study have been deposited to the ProteomeXchange with identifier PXD000557.	[Weinberg, Cristina S.; Macdonald, Lucy J.; Strabala, Timothy J.; Wagner, Armin] Scion, Rotorua, New Zealand; [Parsons, Harriet T.; Adams, Paul D.; Petzold, Christopher J.; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Parsons, Harriet T.; Adams, Paul D.; Petzold, Christopher J.; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Scion; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Heazlewood, JL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA.	jlheazlewood@lbl.gov	Strabala, Timothy/B-4472-2008; Adams, Paul David/A-1977-2013; Heazlewood, Joshua L/A-2554-2008; Parsons, Harriet/J-9094-2016	Strabala, Timothy/0000-0002-0368-9400; Adams, Paul David/0000-0001-9333-8219; Heazlewood, Joshua L/0000-0002-2080-3826; Parsons, Harriet/0000-0003-1666-9123; Petzold, Christopher/0000-0002-8270-5228	AGMARDT Foundation; Royal Society of New Zealand; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	AGMARDT Foundation; Royal Society of New Zealand(Royal Society of New Zealand); Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by an AGMARDT Foundation postdoctoral fellowship to Cristina Weinberg and an International Mobility Fund Fellowship from the Royal Society of New Zealand. This work was conducted by the Joint BioEnergy Institute and is supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaner CM, 2010, TREE PHYSIOL, V30, P782, DOI 10.1093/treephys/tpq021; ANDERSEN RA, 1968, PHYTOCHEMISTRY, V7, P293, DOI 10.1016/S0031-9422(00)86327-X; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Caffall KH, 2009, MOL PLANT, V2, P1000, DOI 10.1093/mp/ssp062; Cown D. J., 1999, New Zealand Journal of Forestry Science, V29, P203; Cubbage F, 2010, BIOMASS BIOENERG, V34, P1667, DOI 10.1016/j.biombioe.2010.05.008; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Donaldson LA, 2004, IAWA J, V25, P253, DOI 10.1163/22941932-90000364; Donaldson LA, 2012, PLANT PHYSIOL, V158, P642, DOI 10.1104/pp.111.184036; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Floyd S, 2005, HEM WORKSH 2005, P115; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Gion JM, 2005, PROTEOMICS, V5, P3731, DOI 10.1002/pmic.200401197; Gorshkova T, 2006, PLANTA, V223, P149, DOI 10.1007/s00425-005-0118-7; GOUBET F, 1993, PLANT CELL PHYSIOL, V34, P1297; Hatfield RD, 1999, J SCI FOOD AGR, V79, P403, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;403::AID-JSFA263&gt;3.0.CO;2-0; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Kim JS, 2010, PLANTA, V232, P545, DOI 10.1007/s00425-010-1189-7; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Mast S, 2010, TREE PHYSIOL, V30, P1456, DOI 10.1093/treephys/tpq084; Mast SW, 2009, PLANT PHYSIOL, V150, P573, DOI 10.1104/pp.108.134379; Moller R, 2007, P 2 NZ GERM WORKSH P, P105; MORRE DJ, 1964, J CELL BIOL, V23, P295, DOI 10.1083/jcb.23.2.295; Nieminen K, 2012, NEW PHYTOL, V194, P46, DOI 10.1111/j.1469-8137.2011.04011.x; Parsons HT, 2014, METHODS MOL BIOL, V1072, P527, DOI 10.1007/978-1-62703-631-3_35; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; PETTERSEN RC, 1991, J WOOD CHEM TECHNOL, V11, P495, DOI 10.1080/02773819108051089; Plomion C, 2000, PLANT PHYSIOL, V123, P959, DOI 10.1104/pp.123.3.959; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Scheller HV, 2007, PHYSIOL PLANTARUM, V129, P283, DOI 10.1111/j.1399-3054.2006.00834.x; Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/BFS.11.136, 10.4155/bfs.11.136]; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Villalobos DP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-100; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Zhou GK, 2006, PLANT CELL PHYSIOL, V47, P1229, DOI 10.1093/pcp/pcj093	42	10	10	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84669	10.1371/journal.pone.0084669	http://dx.doi.org/10.1371/journal.pone.0084669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24416096	Green Published, gold, Green Submitted			2022-12-25	WOS:000329116700114
J	Roebrock, K; Sunderkotter, C; Munck, NA; Wolf, M; Nippe, N; Barczyk, K; Varga, G; Vogl, T; Roth, J; Ehrchen, J				Roebrock, Kirsten; Sunderkoetter, Cord; Muenck, Niels-Arne; Wolf, Marc; Nippe, Nadine; Barczyk, Katarzyna; Varga, Georg; Vogl, Thomas; Roth, Johannes; Ehrchen, Jan			Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity	FASEB JOURNAL			English	Article						leishmaniasis; keratinocytes	LEISHMANIA-MAJOR INFECTION; SUSCEPTIBLE BALB/C MICE; ANTIGEN-PRESENTING CELLS; HUMAN EPITHELIAL-CELLS; DENDRITIC CELLS; T-CELLS; GENE-EXPRESSION; TH2 RESPONSE; CHEMOKINE; INFLAMMATION	To decipher early promoters of the local microenvironment for Th2-type immunity, we wanted to identify gene patterns that were induced by Leishmania major in the infected skin of susceptible, Th2-prone BALB/c, but not of resistant, Th1-prone C57BL/6 mice. We found a marked up-regulation of the chemokine I-TAC (Cxcl11) during the first 2 d of infection in the epidermis of susceptible but not of resistant mice. Accordingly, local injection of I-TAC (2x1 mu g) in resistant mice on the first day of infection resulted in a Th2-driven, sustained deterioration of disease and dramatically enhanced parasite levels. On the cellular level, I-TAC decreased IL-12 production by dendritic cells (DCs) in skin-draining lymph nodes and by DCs in vitro. Thus, we demonstrate for the first time that epidermis-derived I-TAC triggers a sustained Th2-response that determines the outcome of a complex immunological process.-Roebrock, K., Sunderkotter, C., Munck, N-A., Wolf, M., Nippe, N., Barczyk, K., Varga, G., Vogl, T., Roth, J., Ehrchen, J. Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity.	[Roebrock, Kirsten; Muenck, Niels-Arne; Wolf, Marc; Nippe, Nadine; Barczyk, Katarzyna; Vogl, Thomas; Roth, Johannes; Ehrchen, Jan] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Sunderkoetter, Cord; Ehrchen, Jan] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Varga, Georg] Univ Munster, Dept Pediat Rheumatol & Immunol, D-48149 Munster, Germany; [Roebrock, Kirsten; Sunderkoetter, Cord; Muenck, Niels-Arne; Vogl, Thomas; Roth, Johannes; Ehrchen, Jan] Interdisciplinary Ctr Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster	Ehrchen, J (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 58, D-48149 Munster, Germany.	jan.ehrchen@ukmuenster.de		Sunderkotter, Cord/0000-0002-2929-145X; Munck, Niels-Arne/0000-0002-1875-8894	Deutsche Forschungsgemeinschaft (DFG) [EH 397/1-1, SU 193/3-2]; German Ministry of Research (BMBF) [01KI07100]; IZKF, University of Munster [Eh2/019/11, Sun2/019/07]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Research (BMBF)(Federal Ministry of Education & Research (BMBF)); IZKF, University of Munster	The authors thank Eva Nattkemper, Claudia Sole, and Ulla Nordhues for excellent technical assistance. The authors thank Toni Weinhage for help with the cytometric bead assay. The PRISM T 7000 device was made available by the service and technology platform Integrated Functional Genomics (IFG) of the Interdisciplinary Center for Clinical Research (IZKF) of the University of Munster. This work was funded by Deutsche Forschungsgemeinschaft (DFG; EH 397/1-1 and SU 193/3-2), the German Ministry of Research (BMBF; 01KI07100), and the IZKF, University of Munster (Eh2/019/11, Sun2/019/07).	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Antoniazi S, 2004, INFECT IMMUN, V72, P5168, DOI 10.1128/IAI.72.9.5168-5174.2004; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Barbi J, 2008, J IMMUNOL, V181, P4613, DOI 10.4049/jimmunol.181.7.4613; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ehrchen J, 2001, J ENDOCRINOL, V169, P87, DOI 10.1677/joe.0.1690087; Ehrchen J, 2007, FASEB J, V21, P3208, DOI 10.1096/fj.06-7261com; Ehrchen JM, 2008, INFECT IMMUN, V76, P4241, DOI 10.1128/IAI.01714-07; Ehrchen JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000871; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Katzman SD, 2008, J CLIN INVEST, V118, P801, DOI 10.1172/JCI33174; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Muller K, 2001, MED MICROBIOL IMMUN, V190, P73; Nabors GS, 1995, PARASITE IMMUNOL, V17, P569, DOI 10.1111/j.1365-3024.1995.tb01000.x; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; Nigg AP, 2007, J IMMUNOL, V178, P7251, DOI 10.4049/jimmunol.178.11.7251; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Petkovic V, 2004, J LEUKOCYTE BIOL, V76, P701, DOI 10.1189/jlb.1103570; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; SUNDERKOTTER C, 1993, J IMMUNOL, V151, P4891; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Vester B, 1999, INFECT IMMUN, V67, P3155, DOI 10.1128/IAI.67.6.3155-3159.1999; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; von Stebut E, 2007, EXP DERMATOL, V16, P340, DOI 10.1111/j.1600-0625.2007.00554.x; Westphal G, 2002, METHOD ENZYMOL, V356, P80; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x	55	10	12	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1724	1734		10.1096/fj.13-233593	http://dx.doi.org/10.1096/fj.13-233593			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24398292				2022-12-25	WOS:000335344300019
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			The Influence of Natural Lipid Asymmetry upon the Conformation of a Membrane-inserted Protein (Perfringolysin O)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Cholesterol; Cholesterol-binding Protein; Membrane Bilayer; Membrane Biophysics; Membrane Proteins	CHOLESTEROL-DEPENDENT CYTOLYSIN; TOXIN T-DOMAIN; CLOSTRIDIUM-PERFRINGENS; PORE FORMATION; TRANSMEMBRANE DOMAINS; PREPORE COMPLEX; LOW PH; PHOSPHATIDYLSERINE; OLIGOMERIZATION; TOPOGRAPHY	Background: Lipid asymmetry is an important property of eukaryotic plasma membranes not present in commonly used model membrane vesicles. Results: PFO insertion in asymmetric model membrane vesicles was distinct from that in symmetric vesicles. A novel transmembrane insertion intermediate was identified. Conclusion: Lipid asymmetry can strongly influence protein behavior. Significance: This report illustrates a new approach to study proteins in membranes with natural lipid asymmetry. Eukaryotic membrane proteins generally reside in membrane bilayers that have lipid asymmetry. However, in vitro studies of the impact of lipids upon membrane proteins are generally carried out in model membrane vesicles that lack lipid asymmetry. Our recently developed method to prepare lipid vesicles with asymmetry similar to that in plasma membranes and with controlled amounts of cholesterol was used to investigate the influence of lipid composition and lipid asymmetry upon the conformational behavior of the pore-forming, cholesterol-dependent cytolysin perfringolysin O (PFO). PFO conformational behavior in asymmetric vesicles was found to be distinct both from that in symmetric vesicles with the same lipid composition as the asymmetric vesicles and from that in vesicles containing either only the inner leaflet lipids from the asymmetric vesicles or only the outer leaflet lipids from the asymmetric vesicles. The presence of phosphatidylcholine in the outer leaflet increased the cholesterol concentration required to induce PFO binding, whereas phosphatidylethanolamine and phosphatidylserine in the inner leaflet of asymmetric vesicles stabilized the formation of a novel deeply inserted conformation that does not form pores, even though it contains transmembrane segments. This conformation may represent an important intermediate stage in PFO pore formation. These studies show that lipid asymmetry can strongly influence the behavior of membrane-inserted proteins.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation [DMR 1104367, MCB 1019986]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants DMR 1104367 and MCB 1019986.	Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Cheng HT, 2011, BIOPHYS J, V100, P2671, DOI 10.1016/j.bpj.2011.04.048; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Cockeran Riana, 2003, Expert Rev Anti Infect Ther, V1, P231, DOI 10.1586/14787210.1.2.231; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Lin Q., 2014, PLOS ONE INE PRESS; Lin QQ, 2013, J BIOL CHEM, V288, P1340, DOI 10.1074/jbc.M112.415596; MARINETTI GV, 1976, CHEM PHYS LIPIDS, V16, P239, DOI 10.1016/0009-3084(76)90019-0; Martin G, 2005, HUM REPROD, V20, P3459, DOI 10.1093/humrep/dei245; Moe PC, 2010, BIOCHEMISTRY-US, V49, P9498, DOI 10.1021/bi1013886; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosconi MP, 2004, BIOCHEMISTRY-US, V43, P9127, DOI 10.1021/bi049354j; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Shahidullah K, 2010, J MOL BIOL, V396, P209, DOI 10.1016/j.jmb.2009.11.037; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f	45	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5467	5478		10.1074/jbc.M113.533943	http://dx.doi.org/10.1074/jbc.M113.533943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24398685	hybrid, Green Published			2022-12-25	WOS:000332015500011
J	Siguier, B; Haon, M; Nahoum, V; Marcellin, M; Burlet-Schiltz, O; Coutinho, PM; Henrissat, B; Mourey, L; O'Donohue, MJ; Berrin, JG; Tranier, S; Dumon, C				Siguier, Beatrice; Haon, Mireille; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Coutinho, Pedro M.; Henrissat, Bernard; Mourey, Lionel; O'Donohue, Michael J.; Berrin, Jean-Guy; Tranier, Samuel; Dumon, Claire			First Structural Insights into alpha-L-Arabinofuranosidases from the Two GH62 Glycoside Hydrolase Subfamilies*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Biotechnology; Enzyme Structure; Fungi; Glycoside Hydrolases; Oligosaccharide; Arabinofuranosidase; CAZyme; GH62; Hemicellulase	SEQUENCE; SACCHARIFICATION; SECRETOME; COMPLEX; ENZYMES	Background: -l-Arabinofuranosidases hydrolyze arabinofuranosyl side chains from xylans. Results: The first crystal structures of two fungal -l-arabinofuranosidases representing two distinct subfamilies from the glycoside hydrolase GH62 family are presented. The examination of these unveils specificity determinants. Conclusion: The structures of complexes with arabinose and cellotriose provide preliminary insight into substrate recognition and catalysis. Significance: This work provides the first structural description members of the GH62 family. -l-Arabinofuranosidases are glycoside hydrolases that specifically hydrolyze non-reducing residues from arabinose-containing polysaccharides. In the case of arabinoxylans, which are the main components of hemicellulose, they are part of microbial xylanolytic systems and are necessary for complete breakdown of arabinoxylans. Glycoside hydrolase family 62 (GH62) is currently a small family of -l-arabinofuranosidases that contains only bacterial and fungal members. Little is known about the GH62 mechanism of action, because only a few members have been biochemically characterized and no three-dimensional structure is available. Here, we present the first crystal structures of two fungal GH62 -l-arabinofuranosidases from the basidiomycete Ustilago maydis (UmAbf62A) and ascomycete Podospora anserina (PaAbf62A). Both enzymes are able to efficiently remove the -l-arabinosyl substituents from arabinoxylan. The overall three-dimensional structure of UmAbf62A and PaAbf62A reveals a five-bladed -propeller fold that confirms their predicted classification into clan GH-F together with GH43 -l-arabinofuranosidases. Crystallographic structures of the complexes with arabinose and cellotriose reveal the important role of subsites +1 and +2 for sugar binding. Intriguingly, we observed that PaAbf62A was inhibited by cello-oligosaccharides and displayed binding affinity to cellulose although no activity was observed on a range of cellulosic substrates. Bioinformatic analyses showed that UmAbf62A and PaAbf62A belong to two distinct subfamilies within the GH62 family. The results presented here provide a framework to better investigate the structure-function relationships within the GH62 family.	[Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] INRA, Natl Inst Agr Res, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Siguier, Beatrice; O'Donohue, Michael J.; Dumon, Claire] CNRS, UMR5504, F-31400 Toulouse, France; [Siguier, Beatrice; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, F-31077 Toulouse, France; [Siguier, Beatrice; Nahoum, Virginie; Marcellin, Marlene; Burlet-Schiltz, Odile; Mourey, Lionel; Tranier, Samuel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Haon, Mireille; Berrin, Jean-Guy] Natl Inst Agr Res, Biotechnol Champignons Filamenteux UMR1163, F-13288 Marseille, France; [Haon, Mireille; Berrin, Jean-Guy] Aix Marseille Univ, Polytech Marseille, F-13288 Marseille, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR7257, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Berrin, JG (corresponding author), INRA, Lab Biotechnol Champignons Filamente, Marseille, France.	jean-guy.berrin@univ-amu.fr; samuel.tranier@ipbs.fr; claire.dumon@insa-toulouse.fr	BERRIN, Jean-Guy/AAF-3107-2021; Tranier, Samuel/C-6059-2011; BERRIN, Jean-Guy/E-1460-2014; O'Donohue, Michael/ABD-9239-2021; Henrissat, Bernard/J-2475-2012; Mourey, Lionel/B-5662-2009; O'Donohue, Michael J/E-9183-2013; Claire, Dumon/AAI-2553-2021	BERRIN, Jean-Guy/0000-0001-7570-3745; O'Donohue, Michael/0000-0003-4246-3938; Henrissat, Bernard/0000-0002-3434-8588; Mourey, Lionel/0000-0002-8259-1259; O'Donohue, Michael J/0000-0003-4246-3938; Claire, Dumon/0000-0003-4925-7336; Schiltz, Odile/0000-0002-3606-2356; Tranier, Samuel/0000-0001-9751-163X; Nahoum, Virginie/0000-0003-3125-6618	region Midi-Pyrenees; National Institute of Agricultural Research (INRA) CEPIA research department; European funds (FEDER)	region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); National Institute of Agricultural Research (INRA) CEPIA research department; European funds (FEDER)(European Commission)	This work was supported in part by grants from the region Midi-Pyrenees (to B. S.) and the National Institute of Agricultural Research (INRA) CEPIA research department.; Supported by Region Midi-Pyrenees and European funds (FEDER).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen B., 2013, PLOS ONE, V8; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; De La Mare M, 2013, ENZYME MICROB TECH, V53, P351, DOI 10.1016/j.enzmictec.2013.07.008; Dumon C, 2012, PROCESS BIOCHEM, V47, P346, DOI 10.1016/j.procbio.2011.06.017; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Faraco V, 2013, LIGNOCELLULOSE CONVE, P93; Faure R, 2009, AUST J CHEM, V62, P533, DOI 10.1071/CH08458; Gautier V, 2012, MOL CELL PROTEOMICS, V11, P527, DOI 10.1074/mcp.M111.015230; Gilbert H. J., 2013, GLYCOSIDE HYDROLASE, V62; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashimoto K, 2011, BIOSCI BIOTECH BIOCH, V75, P342, DOI 10.1271/bbb.100434; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leijdekkers AGM, 2013, BIORESOURCE TECHNOL, V128, P518, DOI 10.1016/j.biortech.2012.10.126; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Paoli M, 2001, NAT STRUCT BIOL, V8, P744, DOI 10.1038/nsb0901-744; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Ravalason H, 2012, BIORESOURCE TECHNOL, V114, P589, DOI 10.1016/j.biortech.2012.03.009; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; Saulnier L, 2007, J CEREAL SCI, V46, P261, DOI 10.1016/j.jcs.2007.06.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Vincent P, 1997, BIOCHEM J, V322, P845, DOI 10.1042/bj3220845; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	33	33	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					5261	5273		10.1074/jbc.M113.528133	http://dx.doi.org/10.1074/jbc.M113.528133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24394409	Green Published, hybrid			2022-12-25	WOS:000331607900067
J	Roden, DL; Sewell, GW; Lobley, A; Levine, AP; Smith, AM; Segal, AW				Roden, Daniel L.; Sewell, Gavin W.; Lobley, Anna; Levine, Adam P.; Smith, Andrew M.; Segal, Anthony W.			ZODET: Software for the Identification, Analysis and Visualisation of Outlier Genes in Microarray Expression Data	PLOS ONE			English	Article							CANCER; VARIABILITY; DISEASES	Complex human diseases can show significant heterogeneity between patients with the same phenotypic disorder. An outlier detection strategy was developed to identify variants at the level of gene transcription that are of potential biological and phenotypic importance. Here we describe a graphical software package (z-score outlier detection (ZODET)) that enables identification and visualisation of gross abnormalities in gene expression (outliers) in individuals, using whole genome microarray data. Mean and standard deviation of expression in a healthy control cohort is used to detect both over and under-expressed probes in individual test subjects. We compared the potential of ZODET to detect outlier genes in gene expression datasets with a previously described statistical method, gene tissue index (GTI), using a simulated expression dataset and a publicly available monocyte-derived macrophage microarray dataset. Taken together, these results support ZODET as a novel approach to identify outlier genes of potential pathogenic relevance in complex human diseases. The algorithm is implemented using R packages and Java.	[Roden, Daniel L.; Sewell, Gavin W.; Lobley, Anna; Levine, Adam P.; Smith, Andrew M.; Segal, Anthony W.] UCL, Div Med, London, England	University of London; University College London	Roden, DL (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	dlroden@gmail.com		Levine, Adam/0000-0003-1333-9938; Segal, Anthony/0000-0001-7602-9043; Sewell, Gavin/0000-0002-3002-9248; Smith, Andrew/0000-0002-4691-5973	Wellcome Trust [088683/Z/09/Z]; MRC [MR/L000261/1] Funding Source: UKRI; Medical Research Council [MR/L000261/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust grant number 088683/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnevie-Nielsen V, 2005, AM J HUM GENET, V76, P623, DOI 10.1086/429391; Chase A, 2010, HAEMATOL-HEMATOL J, V95, P20, DOI 10.3324/haematol.2009.011536; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Li J, 2010, PLOS COMPUTATIONAL B, V6, P10, DOI DOI 10.1371/J0URNAL.PCBI.1000910.ACCESSED; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Storey John D, 2003, Methods Mol Biol, V224, P149; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029	17	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81123	10.1371/journal.pone.0081123	http://dx.doi.org/10.1371/journal.pone.0081123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416128	gold, Green Published			2022-12-25	WOS:000329862500008
J	Jimenez-Guri, E; Wotton, KR; Gavilan, B; Jaeger, J				Jimenez-Guri, Eva; Wotton, Karl R.; Gavilan, Brenda; Jaeger, Johannes			A Staging Scheme for the Development of the Moth Midge Clogmia albipunctata	PLOS ONE			English	Article							SEGMENTATION GENE-EXPRESSION; DROSOPHILA; EVOLUTION; LOCALIZATION; CYTOSKELETON; VARIABILITY; AMNIOSEROSA; SUFFICIENT; DOMAINS; SYSTEM	Model organisms, such as Drosophila melanogaster, allow us to address a wide range of biological questions with experimental rigour. However, studies in model species need to be complemented by comparative studies if we are to fully understand the functional properties and evolutionary history of developmental processes. The establishment of new model organisms is crucial for this purpose. One of the first essential steps to establish a species as an experimental model is to carefully describe its life cycle and development. The resulting staging scheme serves as a framework for molecular studies, and allows us to homologise developmental processes between species. In this paper, we have characterised the life cycle and development of an emerging non-drosophilid dipteran model system: the moth midge Clogmia albipunctata. In particular, we focus on early embryogenesis (cleavage and blastoderm cycles before gastrulation), on formation and retraction of extraembryonic tissues, and on formation of the germ line. Considering the large evolutionary distance between the two species (approximately 250 million years), we find that the development of C. albipunctata is remarkably conserved compared to D. melanogaster. On the other hand, we detect significant differences in morphology and timing affecting the development of extraembryonic tissues and the germ line. Moreover, C. albipunctata shows several heterochronic shifts, and lacks head involution and associated processes during late stages of development.	[Jimenez-Guri, Eva; Wotton, Karl R.; Gavilan, Brenda; Jaeger, Johannes] UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Jaeger, J (corresponding author), UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain.	yogi.jaeger@crg.eu		Jaeger, Johannes/0000-0002-2568-2103; jimenez-guri, eva/0000-0002-9592-1077; Wotton, Karl/0000-0002-8672-9948; Gavilan, Brenda/0000-0001-8708-7839	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR [406]; Spanish Ministry of Science (MINECO) [BFU2009-10184, BFU2012-33775]; ERANet: ERASysBio+ grant [EUI2009-04045]	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR; Spanish Ministry of Science (MINECO); ERANet: ERASysBio+ grant	The laboratory of Johannes Jaeger and this study in particular was funded by the MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology, by SGR grant 406 from the Catalan funding agency AGAUR, by grants BFU2009-10184 & BFU2012-33775 from the Spanish Ministry of Science (MICINN, now called MINECO), and by ERANet: ERASysBio+ grant EUI2009-04045 (MODHEART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Becker K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003281; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Garcia-Solache M, 2010, DEV BIOL, V344, P306, DOI 10.1016/j.ydbio.2010.04.019; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Janssens H, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-1; Janssens H, 2013, DEV BIOL, V377, P305, DOI 10.1016/j.ydbio.2013.01.010; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Marshall SA, 2012, FLIES NATURAL HIST D; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rafiqi Ab Matteen, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5602; Rohr KB, 1999, DEV GENES EVOL, V209, P145, DOI 10.1007/s004270050238; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schmidt-Ott U, 2000, DEV GENES EVOL, V210, P373, DOI 10.1007/s004270000068; Schmidt-Ott U, 2010, ADV EXP MED BIOL, V689, P133; SCHMIDTOTT U, 1994, ROUX ARCH DEV BIOL, V203, P298, DOI 10.1007/BF00457800; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wotton KR, 2013, DEV GENES EVOL, V223, P335, DOI 10.1007/s00427-013-0445-9; Wotton KR, 2013, PLOS ONE IN PRESS; Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397	35	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84422	10.1371/journal.pone.0084422	http://dx.doi.org/10.1371/journal.pone.0084422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409296	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500020
J	Caraballo, JC; Borcherding, J; Rector, M; Hornick, E; Stoltz, D; Zabner, J; Comellas, AP				Caraballo, Juan Carlos; Borcherding, Jennifer; Rector, Michael; Hornick, Emma; Stoltz, David; Zabner, Joseph; Comellas, Alejandro P.			Role of PON in Anoxia-Reoxygenation Injury: A Drosophila Melanogaster Transgenic Model	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OXIDATIVE STRESS; GENE POLYMORPHISMS; PARAOXONASE 1; EXPRESSION; TISSUE; LIVER	Background: Paraoxonase 1 (PON1) is a protein found associated with high density lipoprotein (HDL), thought to prevent oxidative modification of low-density lipoprotein (LDL). This enzyme has been implicated in lowering the risk of cardiovascular disease. Anoxia-reoxygenation and oxidative stress are important elements in cardiovascular and cerebrovascular disease. However, the role of PON1 in anoxia-reoxygenation or anoxic injury is unclear. We hypothesize that PON1 prevents anoxia-reoxygenation injury. We set out to determine whether PON1 expression in Drosophila melanogaster protects against anoxia-reoxygenation (A-R) induced injury. Methods: Wild type (WT) and transgenic PON1 flies were exposed to anoxia (100% Nitrogen) for different time intervals (from 1 to 24 hours). After the anoxic period, flies were placed in room air for reoxygenation. Activity and survival of flies was then recorded. Results: Within 5 minutes of anoxia, all flies fell into a stupor state. After reoxygenation, survivor flies resumed activity with some delay. Interestingly, transgenic flies recovered from stupor later than WT. PON1 transgenic flies had a significant survival advantage after A-R stress compared with WT. The protection conferred by PON1 expression was present regardless of the age or dietary restriction. Furthermore, PON1 expression exclusively in CNS conferred protection. Conclusion: Our results support the hypothesis that PON1 has a protective role in anoxia-reoxygenation injury, and its expression in the CNS is sufficient and necessary to provide a 100% survival protection.	[Caraballo, Juan Carlos; Borcherding, Jennifer; Rector, Michael; Hornick, Emma; Stoltz, David; Zabner, Joseph; Comellas, Alejandro P.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Caraballo, JC (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	juan-caraballo@uiowa.edu	Comellas, Alejandro/AAE-5661-2019	Comellas, Alejandro/0000-0003-1521-7520; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015	National Institutes of Health/National Heart, Lung, and Blood Institute [K01HL080966-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute grant K01HL080966-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2010, EUR J EPIDEMIOL, V25, P449, DOI 10.1007/s10654-010-9470-4; Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Deakin SP, 2011, FREE RADICAL BIO MED, V50, P102, DOI 10.1016/j.freeradbiomed.2010.09.002; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Ferretti G, 2008, CLIN CHEM LAB MED, V46, P113, DOI 10.1515/CCLM.2008.011; Giordano G, 2013, FREE RADICAL BIO MED, V58, P98, DOI 10.1016/j.freeradbiomed.2013.01.019; Giordano G, 2011, TOXICOL APPL PHARM, V256, P369, DOI 10.1016/j.taap.2011.02.014; Gungor O, 2011, J ATHEROSCLEROSIS TH; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Huang Y, 2013, J CLIN INVESTIGATION; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Mackness B, 2004, BIOCHEM BIOPH RES CO, V318, P680, DOI 10.1016/j.bbrc.2004.04.056; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Mackness B, 2013, ARCH MED SCI, V9, P8, DOI 10.5114/aoms.2013.33189; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; Mohamed RH, 2010, CLIN BIOCHEM, V43, P553, DOI 10.1016/j.clinbiochem.2009.12.015; Motulsky H., 1995, INTUITIVE BIOSTATIST; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pfohl M, 1999, DIABETES, V48, P623, DOI 10.2337/diabetes.48.3.623; Rice GI, 1997, CORONARY ARTERY DIS, V8, P677, DOI 10.1097/00019501-199711000-00001; Rodrigo L, 2001, CHEM-BIOL INTERACT, V137, P123, DOI 10.1016/S0009-2797(01)00225-3; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Tufek A, 2013, INT J SURG, V11, P96, DOI 10.1016/j.ijsu.2012.12.003; Unal E, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/979506; Vigne P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005422; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84434	10.1371/journal.pone.0084434	http://dx.doi.org/10.1371/journal.pone.0084434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400090	Green Published, gold			2022-12-25	WOS:000329462700024
J	Avila-Cabadilla, LD; Stoner, KE; Nassar, JM; Espirito-Santo, MM; Alvarez-Anorve, MY; Aranguren, CI; Henry, M; Gonzalez-Carcacia, JA; Falcao, LAD; Sanchez-Azofeifa, GA				Daniel Avila-Cabadilla, Luis; Elizabeth Stoner, Kathryn; Nassar, Jafet M.; Espirito-Santo, Mario M.; Yolotl Alvarez-Anorve, Mariana; Aranguren, Carla I.; Henry, Mickael; Gonzalez-Carcacia, Jose A.; Dolabela Falcao, Luiz A.; Arturo Sanchez-Azofeifa, Gerardo			Phyllostomid Bat Occurrence in Successional Stages of Neotropical Dry Forests	PLOS ONE			English	Article							TROPICAL DECIDUOUS FOREST; LEPTONYCTERIS-CURASOAE; SPECIES RICHNESS; FRUGIVOROUS BATS; ABUNDANCE; LANDSCAPE; DIVERSITY; RESPONSES; PATTERNS; FRAGMENTATION	Tropical dry forests (TDFs) are highly endangered tropical ecosystems being replaced by a complex mosaic of patches of different successional stages, agricultural fields and pasturelands. In this context, it is urgent to understand how taxa playing critical ecosystem roles respond to habitat modification. Because Phyllostomid bats provide important ecosystem services (e. g. facilitate gene flow among plant populations and promote forest regeneration), in this study we aimed to identify potential patterns on their response to TDF transformation in sites representing four different successional stages (initial, early, intermediate and late) in three Neotropical regions: Mexico, Venezuela and Brazil. We evaluated bat occurrence at the species, ensemble (abundance) and assemblage level (species richness and composition, guild composition). We also evaluated how bat occurrence was modulated by the marked seasonality of TDFs. In general, we found high seasonal and regional specificities in phyllostomid occurrence, driven by specificities at species and guild levels. For example, highest frugivore abundance occurred in the early stage of the moistest TDF, while highest nectarivore abundance occurred in the same stage of the driest TDF. The high regional specificity of phyllostomid responses could arise from: (1) the distinctive environmental conditions of each region, (2) the specific behavior and ecological requirements of the regional bat species, (3) the composition, structure and phenological patterns of plant assemblages in the different stages, and (4) the regional landscape composition and configuration. We conclude that, in tropical seasonal environments, it is imperative to perform long-term studies considering seasonal variations in environmental conditions and plant phenology, as well as the role of landscape attributes. This approach will allow us to identify potential patterns in bat responses to habitat modification, which constitute an invaluable tool for not only bat biodiversity conservation but also for the conservation of the key ecological processes they provide.	[Daniel Avila-Cabadilla, Luis; Yolotl Alvarez-Anorve, Mariana] Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Daniel Avila-Cabadilla, Luis; Elizabeth Stoner, Kathryn] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Elizabeth Stoner, Kathryn] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Nassar, Jafet M.; Aranguren, Carla I.; Gonzalez-Carcacia, Jose A.] Inst Venezolano Invest Cient Altos de Pipe, Ctr Ecol, Caracas, Venezuela; [Espirito-Santo, Mario M.; Dolabela Falcao, Luiz A.] Univ Estadual Montes Claros, Dept Biol Geral, Montes Claros, MG, Brazil; [Henry, Mickael] INRA, UR Abeilles & Environm 406, Avignon, France; [Arturo Sanchez-Azofeifa, Gerardo] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; New Mexico State University; Universidade Estadual de Montes Claros; INRAE; University of Alberta	Avila-Cabadilla, LD (corresponding author), Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico.	luis_avila@enesmorelia.unam.mx	Cabadilla, Luis Daniel Avila/AAK-9561-2020; caputo, carlo/N-3747-2014; Stoner, Kathryn E/E-1510-2015; Espirito-Santo, Mario/O-4813-2014; Falcão, Luiz/E-3234-2016; Sanchez-Azofeifa, Arturo/F-4700-2014	Cabadilla, Luis Daniel Avila/0000-0003-2501-5690; Stoner, Kathryn E/0000-0002-9964-1697; Espirito-Santo, Mario/0000-0001-8274-3075; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600	University of Alberta; Inter American Institute for Global Change Research (IAI) [Tropi-Dry-CRN2-21]; SEMARNAT-CONACyT, Mexico [2002-C01-0597, CB-2005-51043]; "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG), Brazil [CRA-2288/07, CRA-3042-5.03/07]; "Universidad Nacional Autonoma de Mexico" (UNAM) [PAPITT-IA203413]; "Programa de Apoyo a los Estudios de Posgrado" (PAEP); "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP)	University of Alberta(University of Alberta); Inter American Institute for Global Change Research (IAI); SEMARNAT-CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); "Universidad Nacional Autonoma de Mexico" (UNAM)(Universidad Nacional Autonoma de Mexico); "Programa de Apoyo a los Estudios de Posgrado" (PAEP); "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP)	Financial support was provided by the University of Alberta (www.ualberta.ca), the Inter American Institute for Global Change Research (IAI, http://www.iai.int), (Tropi-Dry-CRN2-21), SEMARNAT-CONACyT (http://www.semarnat.gob.mx, www.conacyt.mx), Mexico (2002-C01-0597 and CB-2005-51043), the "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG, www.fapemig.br), Brazil (CRA-2288/07 and CRA-3042-5.03/07), and "Universidad Nacional Autonoma de Mexico" (UNAM, http://www.unam.mx) through the "Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica" (PAPITT-IA203413), the "Programa de Apoyo a los Estudios de Posgrado" (PAEP) and the "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, J TROP ECOL, V19, P367, DOI [10.1017/S0266467403003419, 10.1017/s0266467403003419]; Alvarez T., 1997, REV MEXICANA MASTOZO, V2, P113; ALVAREZ-ANORVE M, 2008, MANUAL METHODS HUMAN, P15; Antunes FZ., 1994, INF AGROPEC, V17, P15; Aranguren C, 2012, THESIS I VENEZOLANO; Ayala-Berdon J, 2009, J COMP PHYSIOL B, V179, P553, DOI 10.1007/s00360-008-0335-z; Balvanera P, 2002, J VEG SCI, V13, P145, DOI 10.1111/j.1654-1103.2002.tb02034.x; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Brosset A, 1996, CAN J ZOOL, V74, P1974, DOI 10.1139/z96-224; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Carter DC, 1977, BIOL BATS NEW WORL 2, P351; Castro-Arellano I, 2007, BIOL CONSERV, V138, P269, DOI 10.1016/j.biocon.2007.04.025; Charles-Dominique P, 1986, FRUGIVORES SEED DISP, P119, DOI DOI 10.1007/978-94-009-4812-9_12; Chazdon Robin L., 2011, P195; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2009, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Cosson JF, 1999, BIOL CONSERV, V91, P213, DOI 10.1016/S0006-3207(99)00091-9; Avila-Cabadilla LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035228; Avila-Cabadilla LD, 2009, FOREST ECOL MANAG, V258, P986, DOI 10.1016/j.foreco.2008.12.011; de la Pena-Cuellar E, 2012, BIODIVERS CONSERV, V21, P1381, DOI 10.1007/s10531-012-0249-7; Dos Reis NR, 2007, MORCEGOS BRASIL; ESTRADA A, 1993, ECOGRAPHY, V16, P309, DOI 10.1111/j.1600-0587.1993.tb00220.x; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Feinsinger P., 2001, DESIGNING FIELD STUD; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; Fernandez-Hernandez P, 2008, PATRONES FENOLOGICOS; Fleming T.H., 1988, SHORT TAILED FRUIT B; Fleming Theodore H., 2002, P283; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; Garcia AN, 2002, DIVERSIDAD ESTACIONA, P184; Geiselman C.K., 2002, DATABASE NEOTROPICAL; Geiser Fritz, 2004, Australian Mammalogy, V26, P125; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Gotelli N. J., 2010, ECOSIM NULL MODELS S; HEITHAUS ER, 1975, ECOLOGY, V56, P841, DOI 10.2307/1936295; Henry M, 2010, ECOL MODEL, V221, P2018, DOI 10.1016/j.ecolmodel.2010.05.011; Herrera LG, 2001, J MAMMAL, V82, P352, DOI 10.1644/1545-1542(2001)082&lt;0352:SOPITS&gt;2.0.CO;2; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hutson A, 2001, MICROCHIROPTERAN BAT; Instituto Estadual de Florestas [IEF], 2000, PAR TECN CRIAC PARQ; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Kalacska MER, 2005, BIOTROPICA, V37, P486, DOI 10.1111/j.1744-7429.2005.00067.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kelm DH, 2007, J COMP PHYSIOL B, V177, P667, DOI 10.1007/s00360-007-0164-5; Kindt R., 2005, WORLD; Klingbeil BT, 2010, OIKOS, V119, P1654, DOI 10.1111/j.1600-0706.2010.18328.x; Linares O., 1998, MAMIFEROS VENEZUELA; Linares O. J., 1986, MURCIELAGOS VENEZUEL; Lobova TA, 2009, SEED DISPERSAL BATS; Lopezaraiza-Mikel M, 2014, TROPICAL DRY FORESTS IN THE AMERICAS: ECOLOGY, CONSERVATION, AND MANAGEMENT, P101; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Maass J. Manuel, 1995, P399, DOI 10.1017/CBO9780511753398.017; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MacArthur R.H., 1972, pvii; Madeira B, 2009, PLANT ECOL, V201, P291, DOI [10.1007/978-90-481-2795-5_22, 10.1007/s11258-009-9580-9]; Magurran A. E., 2004, MEASURING BIOL DIVER; Marques JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074505; McCune B, 2002, ANAL ECOLOGICAL COMM; Medellin R, 1997, IDENTIFICACION MURCI; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Murphy Peter G., 1995, P9, DOI 10.1017/CBO9780511753398.002; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nogueira M, 1998, THESIS U FEDERAL RUR; Noguera FA, 2002, HIST NATURAL CHAMELA, P379; Oksanen, 2010, MULTIVARIATE ANAL EC; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Pezzini F, 2008, FENOLOGIA CARACTERIS; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Primack R, 2001, FUNDAMENTOS CONSERVA, P183; QUESADA M, 2004, BIOD CONS COST RIC, P00266; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sokal R. R., 2012, BIOMETRY; Stoner KE, 2005, BIOTROPICA, V37, P591, DOI 10.1111/j.1744-7429.2005.00076.x; Stoner KE, 2003, BIODIVERS CONSERV, V12, P357, DOI 10.1023/A:1021963819751; Stoner KE, 2001, CAN J ZOOL, V79, P1626, DOI 10.1139/cjz-79-9-1626; Timm Robert M., 1998, University of Kansas Center of Latin American Studies Occasional Publication Series, V22, P1; Walsh C., 2008, HIER PART HIERARCHIC; Wilkinson GS, 1996, MOL ECOL, V5, P329; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; [No title captured]	94	14	15	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84572	10.1371/journal.pone.0084572	http://dx.doi.org/10.1371/journal.pone.0084572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404175	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460800054
J	Hahn, MB; Gangnon, RE; Barcellos, C; Asner, GP; Patz, JA				Hahn, Micah B.; Gangnon, Ronald E.; Barcellos, Christovam; Asner, Gregory P.; Patz, Jonathan A.			Influence of Deforestation, Logging, and Fire on Malaria in the Brazilian Amazon	PLOS ONE			English	Article							ANOPHELES-DARLINGI; FUTURE; VECTOR; BIODIVERSITY; FEEDBACKS; ECOLOGY; FORESTS; FATE	Malaria is a significant public health threat in the Brazilian Amazon. Previous research has shown that deforestation creates breeding sites for the main malaria vector in Brazil, Anopheles darlingi, but the influence of selective logging, forest fires, and road construction on malaria risk has not been assessed. To understand these impacts, we constructed a negative binomial model of malaria counts at the municipality level controlling for human population and social and environmental risk factors. Both paved and unpaved roadways and fire zones in a municipality increased malaria risk. Within the timber production states where 90% of deforestation has occurred, compared with areas without selective logging, municipalities where 0-7% of the remaining forests were selectively logged had the highest malaria risk (1.72, 95% CI 1.18-2.51), and areas with higher rates of selective logging had the lowest risk (0.39, 95% CI 0.23-0.67). We show that roads, forest fires, and selective logging are previously unrecognized risk factors for malaria in the Brazilian Amazon and highlight the need for regulation and monitoring of sub-canopy forest disturbance.	[Hahn, Micah B.; Patz, Jonathan A.] Univ Wisconsin, Nelson Inst, SAGE Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; [Hahn, Micah B.; Gangnon, Ronald E.; Patz, Jonathan A.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Barcellos, Christovam] Fundacao Oswaldo Cruz, Hlth Informat Res Dept, Rio De Janeiro, Brazil; [Asner, Gregory P.] Stanford Univ, Dept Global Ecol, Carnegie Inst Sci, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Fundacao Oswaldo Cruz; Carnegie Institution for Science; Stanford University	Hahn, MB (corresponding author), Univ Wisconsin, Nelson Inst, SAGE Ctr Sustainabil & Global Environm, Madison, WI 53706 USA.	micah.hahn@gmail.com	Barcellos, Christovam/GQA-5106-2022; Asner, Gregory/G-9268-2013; Barcellos, Christovam/G-6856-2012	Barcellos, Christovam/0000-0002-1161-2753; Asner, Gregory/0000-0001-7893-6421; Barcellos, Christovam/0000-0002-1161-2753; Gangnon, Ronald/0000-0003-2587-6714	NSF IGERT [0549407: CHANGE-IGERT]	NSF IGERT(National Science Foundation (NSF))	This study was supported by the NSF IGERT grant number 0549407: CHANGE-IGERT in the Nelson Institute for Environmental Studies at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, GEOPHYS MONOGR SER, V186, P25, DOI 10.1029/2008GM000723; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Barbieri AF, 2005, HUM ECOL, V33, P847, DOI 10.1007/s10745-005-8213-8; Barreto P., 2006, HUMAN PRESSURE BRAZI; Beyer H. L, 2012, GEOSPATIAL MODELLING; Charlwood JD, 1996, MEM I OSWALDO CRUZ, V91, P391, DOI 10.1590/S0074-02761996000400001; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ferreira MU, 2010, J INFECT DEV COUNTR, V4, P533, DOI 10.3855/jidc.760; Ferreira NC, 2007, EARTH INTERACT, V11, DOI 10.1175/EI201.1; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Instituto Nacional de Pesquisas Espaciais, 2012, PRODES PROGR CALC DE; International Tropical Timber Organization, 2013, RED IMP LOGG; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Oliveira Brandao Junior A de, 2011, AN 15 S BRAS SENS RE; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Sawyer D, 1992, INT M MAL PAN AM HLT; Singer BH, 2001, ANN NY ACAD SCI, V954, P184; Stone TA, 1998, INT J REMOTE SENS, V19, P2517, DOI 10.1080/014311698214604; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	39	82	86	5	247	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85725	10.1371/journal.pone.0085725	http://dx.doi.org/10.1371/journal.pone.0085725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404206	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800085
J	Inaba, H; Takeshita, K; Uchida, Y; Hayashi, M; Okumura, T; Hirashiki, A; Yoshikawa, D; Ishii, H; Yamamoto, K; Nakayama, T; Hirayama, M; Matsumoto, H; Matsushita, T; Murohara, T				Inaba, Hatsumi; Takeshita, Kyosuke; Uchida, Yasuhiro; Hayashi, Motoharu; Okumura, Takahiro; Hirashiki, Akihiro; Yoshikawa, Daiji; Ishii, Hideki; Yamamoto, Koji; Nakayama, Takayuki; Hirayama, Masaaki; Matsumoto, Hiroyuki; Matsushita, Tadashi; Murohara, Toyoaki			Recovery of Flow-Mediated Vasodilatation after Repetitive Measurements Is Involved in Early Vascular Impairment: Comparison with Indices of Vascular Tone	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; BRACHIAL-ARTERY; ULTRASOUND ASSESSMENT; CARDIOVASCULAR RISK; CIGARETTE-SMOKING; TIME-COURSE; DILATION; CONSTRICTION; DILATATION; STIFFNESS	In repetitive measurements of flow-mediated dilatation (FMD), the duration of the interval between measurements remains controversial. In this pilot study, we conducted three sequential measurements of low-flow-mediated constriction (L-FMC), FMD and flow-mediated total dilation (FMTD; L-FMC+FMD) at baseline and intervals of 15 and 60 min in 30 healthy males. FMD15, L-FMC15, and FMTD15 were significantly lower than the respective first measurements, but all indices showed full recovery at 60 min in all subjects. The baseline diameter was slightly increased at 15 min and restored at 60 min, but the maximum diameter, and the baseline and reactive flow velocity unchanged. We examined the relationship between recovery rate of FMTD at 15 min (FMTD-R) and cardio-ankle vascular index (CAVI). Univariate analysis showed moderate correlation between FMTD-R, and CAVI and L-FMC0. Patients were divided according to FMTD-R value; the low-FMTD-R group [below the median value (-26.2%)] included a significantly higher proportion of smokers and higher CAVI values than the high-FMTD-R group. The reproducibility of FMTD and FMTD-R was evaluated in another group of 25 healthy subjects. The range of variation across measurements was 1.1% for FMTD and 4.6% for FMTD-R; with intraclass correlation coefficients of 0.93 and 0.95, respectively. The present study demonstrated blunted recovery of FMD within 15 min, suggesting the need for selection of a more adequate interval between measurements to avoid underestimation of FMD in subsequent measurements. The findings demonstrated the reproducibility of FMTD-R and FMTD measurements, and that FMTD-R might be involved in arterial stiffness and early vascular impairment in the healthy subjects.	[Inaba, Hatsumi; Takeshita, Kyosuke; Hirayama, Masaaki; Matsumoto, Hiroyuki; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Takeshita, Kyosuke; Uchida, Yasuhiro; Hayashi, Motoharu; Okumura, Takahiro; Hirashiki, Akihiro; Yoshikawa, Daiji; Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Yamamoto, Koji; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus, Nagoya, Aichi, Japan; [Nakayama, Takayuki] Aichi Univ Hosp, Dept Transfus, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Takeshita, K (corresponding author), Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan.	kyousuke@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Ishii, Hideki/M-4871-2014; Hirashiki, Akihiro/M-4855-2014; Hirayama, Masaaki/I-9341-2018; Takeshita, Kyosuke/B-7008-2012; Takeshita, Kyosuke/AAD-9515-2020; Hirayama, Masaaki/ABH-2669-2020; Matsushita, Tadadshi/I-7349-2014	Ishii, Hideki/0000-0003-4348-0123; Hirashiki, Akihiro/0000-0002-3234-3177; Hirayama, Masaaki/0000-0003-0092-7837; Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Nakayama, Takayuki/0000-0003-2389-2542	Aichi Health Promotion Foundation; SENSHIN Medical Research Foundation;  [Kakenhi 25461336]	Aichi Health Promotion Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); 	This work was supported by research grants from the Aichi Health Promotion Foundation (to KT), the SENSHIN Medical Research Foundation (to KT), and Grant-in-Aid for Scientific Research (Kakenhi 25461336 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2011, ULTRASOUND MED BIOL, V37, P879, DOI 10.1016/j.ultrasmedbio.2011.03.007; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; Bots ML, 2005, EUR HEART J, V26, P363, DOI 10.1093/eurheartj/ehi017; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Charakida M, 2010, EUR HEART J, V31, P2854, DOI 10.1093/eurheartj/ehq340; Clarkson P, 1997, CIRCULATION, V96, P3378; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DeVan AE, 2011, AM J PHYSIOL-HEART C, V300, pH813, DOI 10.1152/ajpheart.00845.2010; Gori T, 2010, HEART, V96, P141, DOI 10.1136/hrt.2009.167213; Gori T, 2008, J AM COLL CARDIOL, V51, P1953, DOI 10.1016/j.jacc.2008.01.049; Gori T, 2012, EUR HEART J, V33, P363, DOI 10.1093/eurheartj/ehr361; Gori T, 2011, EUR HEART J, V32, P784, DOI 10.1093/eurheartj/ehq412; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Harrison M, 2011, CLIN PHYSIOL FUNCT I, V31, P394, DOI 10.1111/j.1475-097X.2011.01032.x; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; Kabutoya T, 2012, J AM SOC HYPERTENS, V6, P109, DOI 10.1016/j.jash.2011.11.005; Koivistoinen T, 2012, ATHEROSCLEROSIS, V220, P387, DOI 10.1016/j.atherosclerosis.2011.08.007; Ludvig J, 2005, AM HEART J, V149, P565, DOI 10.1016/j.ahj.2004.09.040; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Rakobowchuk M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055385; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Wilkinson IB, 2004, CLIN EXP PHARMACOL P, V31, P795, DOI 10.1111/j.1440-1681.2004.04074.x; Yeboah J, 2008, ATHEROSCLEROSIS, V197, P840, DOI 10.1016/j.atherosclerosis.2007.07.032	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83977	10.1371/journal.pone.0083977	http://dx.doi.org/10.1371/journal.pone.0083977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392103	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100027
J	Voth, WP; Takahata, S; Nishikawa, JL; Metcalfe, BM; Naar, AM; Stillman, DJ				Voth, Warren P.; Takahata, Shinya; Nishikawa, Joy L.; Metcalfe, Benjamin M.; Naeaer, Anders M.; Stillman, David J.			A Role for FACT in Repopulation of Nucleosomes at Inducible Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTORS; YEAST SACCHAROMYCES-CEREVISIAE; PLEIOTROPIC DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; HISTONE CHAPERONE; ABC PROTEINS; IN-VIVO; CANDIDA-ALBICANS; H+-ATPASE	Xenobiotic drugs induce Pleiotropic Drug Resistance (PDR) genes via the orthologous Pdr1/Pdr3 transcription activators. We previously identified the Mediator transcription co-activator complex as a key target of Pdr1 orthologs and demonstrated that Pdr1 interacts directly with the Gal11/Med15 subunit of the Mediator complex. Based on an interaction between Pdr1 and the FACT complex, we show that strains with spt16 or pob3 mutations are sensitive to xenobiotic drugs and display diminished PDR gene induction. Although FACT acts during the activation of some genes by assisting in the nucleosomes eviction at promoters, PDR promoters already contain nucleosome-depleted regions (NDRs) before induction. To determine the function of FACT at PDR genes, we examined the kinetics of RNA accumulation and changes in nucleosome occupancy following exposure to a xenobiotic drug in wild type and FACT mutant yeast strains. In the presence of normal FACT, PDR genes are transcribed within 5 minutes of xenobiotic stimulation and transcription returns to basal levels by 30-40 min. Nucleosomes are constitutively depleted in the promoter regions, are lost from the open reading frames during transcription, and the ORFs are wholly repopulated with nucleosomes as transcription ceases. While FACT mutations cause minor delays in activation of PDR genes, much more pronounced and significant defects in nucleosome repopulation in the ORFs are observed in FACT mutants upon transcription termination. FACT therefore has a major role in nucleosome redeposition following cessation of transcription at the PDR genes, the opposite of its better-known function in nucleosome disassembly.	[Voth, Warren P.; Takahata, Shinya; Metcalfe, Benjamin M.; Stillman, David J.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; [Nishikawa, Joy L.; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Nishikawa, Joy L.; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Stillman, DJ (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.	david.stillman@path.utah.edu		Stillman, David/0000-0002-5268-2416	National Institutes of Health [GM39067, GM64649, GM071449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064649, R01GM071449, R01GM039067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, grant GM39067 awarded to D.J.S, grant GM64649 awarded to Tim Formosa, and grant GM071449 awarded to A.M.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2004, J BIOENERG BIOMEMBR, V36, P5, DOI 10.1023/B:JOBB.0000019593.84933.e6; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2007, MOL CELL BIOL, V27, P6279, DOI 10.1128/MCB.00978-07; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Borecka-Melkusova S, 2008, FEMS YEAST RES, V8, P414, DOI 10.1111/j.1567-1364.2007.00352.x; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Colabufo NA, 2009, CURR TOP MED CHEM, V9, P119, DOI 10.2174/156802609787521553; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; GARCIAARRANZ M, 1994, J BIOL CHEM, V269, P18076; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Kolaczkowska A, 1999, DRUG RESIST UPDATE, V2, P403, DOI 10.1054/drup.1999.0113; Koman IE, 2012, CANCER PREV RES, V5, P1025, DOI 10.1158/1940-6207.CAPR-11-0529; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Ma MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-660; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; Schlesinger MB, 2000, GENETICS, V155, P1593; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; van Kempen GMP, 2000, CYTOMETRY, V39, P300, DOI 10.1002/(SICI)1097-0320(20000401)39:4<300::AID-CYTO8>3.3.CO;2-F; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; Wendler F, 1997, J BIOL CHEM, V272, P27091, DOI 10.1074/jbc.272.43.27091; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	70	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84092	10.1371/journal.pone.0084092	http://dx.doi.org/10.1371/journal.pone.0084092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392107	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100031
J	Guilbert, C; Annis, MG; Dong, ZF; Siegel, PM; Miller, WH; Mann, KK				Guilbert, Cynthia; Annis, Matthew G.; Dong, Zhifeng; Siegel, Peter M.; Miller, Wilson H., Jr.; Mann, Koren K.			Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE-B; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; INHIBITOR EVEROLIMUS; PHASE-I; MTOR; LEUKEMIA; PATHWAY; PHOSPHORYLATION; APOPTOSIS	Inhibitors of the mammalian target of rapamycin (mTORi) have clinical activity; however, the benefits of mTOR inhibition by rapamycin and rapamycin-derivatives (rapalogs) may be limited by a feedback mechanism that results in AKT activation. Increased AKT activity resulting from mTOR inhibition can be a result of increased signaling via the mTOR complex, TORC2. Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Therefore, we propose that combining ATO and rapamycin may circumvent the AKT feedback loop and increase the anti-tumor effects. Using a panel of breast cancer cell lines, we find that ATO, at clinically-achievable doses, can enhance the inhibitory activity of the mTORi temsirolimus. In all cell lines, temsirolimus treatment resulted in AKT activation, which was decreased by concomitant ATO treatment only in those cell lines where ATO enhanced growth inhibition. Treatment with rapalog also results in activated ERK signaling, which is decreased with ATO co-treatment in all cell lines tested. We next tested the toxicity and efficacy of rapamycin plus ATO combination therapy in a MDA-MB-468 breast cancer xenograft model. The drug combination was well-tolerated, and rapamycin did not increase ATO-induced liver enzyme levels. In addition, combination of these drugs was significantly more effective at inhibiting tumor growth compared to individual drug treatments, which corresponded with diminished phospho-Akt and phospho-ERK levels when compared with rapamycin-treated tumors. Therefore, we propose that combining ATO and mTORi may overcome the feedback loop by decreasing activation of the MAPK and AKT signaling pathways.	[Guilbert, Cynthia; Miller, Wilson H., Jr.; Mann, Koren K.] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Annis, Matthew G.; Dong, Zhifeng; Siegel, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Miller, Wilson H., Jr.; Mann, Koren K.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Mann, KK (corresponding author), McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada.	koren.mann@mcgill.ca		Annis, Matthew/0000-0002-8776-004X	Weekend to End Breast Cancer; Canadian Institutes of Health Research [MOP-43979, MOP-119401]	Weekend to End Breast Cancer; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Weekend to End Breast Cancer (KKM) and the Canadian Institutes of Health Research (MOP-43979 to WHM and KKM and MOP-119401 to PMS; http://www.cihr- irsc.gc.ca/e/193.html). KKM is a Junior 2 Chercheur Boursier of the FRSQ (http://www.frsq.gouv.qc.ca/fr/financement/programmes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Awada A, 2008, EUR J CANCER, V44, P84, DOI 10.1016/j.ejca.2007.10.003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bolt AM, 2012, TOXICOL APPL PHARM, V264, P255, DOI 10.1016/j.taap.2012.08.006; Bolt AM, 2010, TOXICOL LETT, V199, P153, DOI 10.1016/j.toxlet.2010.08.017; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Campone M, 2009, BRIT J CANCER, V100, P315, DOI 10.1038/sj.bjc.6604851; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Diaz Z, 2007, LEUKEMIA, V21, P2117, DOI 10.1038/sj.leu.2404891; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HARDIN JA, 1992, J IMMUNOL METHODS, V154, P99, DOI 10.1016/0022-1759(92)90217-H; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang HS, 2011, TOXICOL SCI, V121, P101, DOI 10.1093/toxsci/kfr023; HUOBER J, 2013, EUR J CANC; Kasukabe T, 2013, INT J ONCOL, V42, P767, DOI 10.3892/ijo.2012.1745; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu N, 2012, ENDOCR-RELAT CANCER, V19, P711, DOI 10.1530/ERC-12-0150; Lunghi P, 2005, LEUKEMIA, V19, P234, DOI 10.1038/sj.leu.2403585; Lunghi P, 2006, BLOOD, V107, P4549, DOI 10.1182/blood-2005-07-2829; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mi RF, 2009, J GENET GENOMICS, V36, P355, DOI 10.1016/S1673-8527(08)60124-1; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Mosley JD, 2007, MOL CANCER THER, V6, P2188, DOI 10.1158/1535-7163.MCT-07-0235; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Yardley DA, 2013, BREAST CANCER-BASIC, V7, P7, DOI 10.4137/BCBCR.S10071; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764	45	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85995	10.1371/journal.pone.0085995	http://dx.doi.org/10.1371/journal.pone.0085995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392034	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900178
J	Ibrahim, SA; Hassan, H; Vilardo, L; Kumar, SK; Kumar, AV; Kelsch, R; Schneider, C; Kiesel, L; Eich, HT; Zucchi, I; Reinbold, R; Greve, B; Gotte, M				Ibrahim, Sherif A.; Hassan, Hebatallah; Vilardo, Laura; Kumar, Sampath Katakam; Kumar, Archana Vijaya; Kelsch, Reinhard; Schneider, Cornelia; Kiesel, Ludwig; Eich, Hans Theodor; Zucchi, Ileana; Reinbold, Rolland; Greve, Burkhard; Goette, Martin			Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling	PLOS ONE			English	Article							E-CADHERIN; ALDEHYDE DEHYDROGENASE; GENE-EXPRESSION; SIDE-POPULATION; FLOW-CYTOMETRY; PHENOTYPE; CARCINOMA; MARKERS; DIFFERENTIATION; ACCUMULATION	Syndecan-1 (CD138), a heparan sulfate proteoglycan, acts as a coreceptor for growth factors and chemokines and is a molecular marker associated with epithelial-mesenchymal transition during development and carcinogenesis. Resistance of Syndecan-1-deficient mice to experimentally-induced tumorigenesis has been linked to altered Wnt-responsive precursor cell pools, suggesting a potential role of Syndecan-1 in breast cancer cell stem function. However, the precise molecular mechanism is still elusive. Here, we decipher the functional impact of Syndecan-1 knockdown using RNA interference on the breast cancer stem cell phenotype of human triple-negative MDA-MB-231 and hormone receptor-positive MCF-7 cells in vitro employing an analytical flow cytometric approach. Successful Syndecan-1 siRNA knockdown was confirmed by flow cytometry. Side population measurement by Hoechst dye exclusion and Aldehyde dehydrogenase-1 activity revealed that Syndecan-1 knockdown in MDA-MB-231 cells significantly reduced putative cancer stem cell pools by 60% and 27%, respectively, compared to controls. In MCF-7 cells, Syndecan-1 depletion reduced the side population by 40% and Aldehyde dehydrogenase-1 by 50%, repectively. In MDA-MB-231 cells, the CD44(+)CD24(-/low) phenotype decreased significantly by 6% upon siRNA-mediated Syndecan-1 depletion. Intriguingly, IL-6, its receptor sIL-6R, and the chemokine CCL20, implicated in regulating stemness-associated pathways, were downregulated by > 40% in Syndecan-1-silenced MDA-MB-231 cells, which showed a dysregulated response to IL-6-induced shifts in E-cadherin and vimentin expression. Furthermore, activation of STAT-3 and NFkB transcription factors and expression of a coreceptor for Wnt signaling, LRP-6, were reduced by > 45% in Syndecan-1-depleted cells compared to controls. At the functional level, Syndecan-1 siRNA reduced the formation of spheres and cysts in MCF-7 cells grown in suspension culture. Our study demonstrates the viability of flow cytometric approaches in analyzing cancer stem cell function. As Syndecan-1 modulates the cancer stem cell phenotype via regulation of the Wnt and IL-6/STAT3 signaling pathways, it emerges as a promising novel target for therapeutic approaches.	[Ibrahim, Sherif A.; Hassan, Hebatallah; Kumar, Sampath Katakam; Kumar, Archana Vijaya; Schneider, Cornelia; Kiesel, Ludwig; Goette, Martin] Univ Hosp Munster, Dept Gynecol & Obstet, Munster, Germany; [Kelsch, Reinhard] Univ Hosp Munster, Inst Transfus Med & Transplantat Immunol, Munster, Germany; [Eich, Hans Theodor; Greve, Burkhard] Univ Hosp Munster, Dept Radiotherapy Radiooncol, Munster, Germany; [Vilardo, Laura; Zucchi, Ileana; Reinbold, Rolland] ITB CNR, Segrate, Italy; [Ibrahim, Sherif A.; Hassan, Hebatallah] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt	University of Munster; University of Munster; University of Munster; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Egyptian Knowledge Bank (EKB); Cairo University	Greve, B (corresponding author), Univ Hosp Munster, Dept Radiotherapy Radiooncol, Munster, Germany.	greveb@uni-muenster.de; mgotte@uni-muenster.de	Kiesel, Ludwig/ABC-5333-2020; reinbold, rolland/AAW-8940-2020; Götte, Martin/G-2254-2018; Gotte, M/Z-5878-2019	Kiesel, Ludwig/0000-0002-7247-9247; Götte, Martin/0000-0003-2360-2496; Gotte, M/0000-0003-2360-2496; Ibrahim, Sherif Abdelaziz/0000-0001-6403-7345; hassan, hebatallah/0000-0002-2815-7996	German Academic Exchange Service [DAAD A/06/90277, DAAD 56808461]; International Research Training Group "Molecular and Cellular GlycoSciences" [1549]; Maria Moller Stiftung	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); International Research Training Group "Molecular and Cellular GlycoSciences"; Maria Moller Stiftung	This work was supported by German Academic Exchange Service DAAD A/06/90277 (to SAI), DAAD 56808461 Al Tawasul (to MG and SAI), International Research Training Group "Molecular and Cellular GlycoSciences" Grant GRK 1549 (to MG and SKK), and Maria Moller Stiftung (to MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alaaeddine N, 2011, J RHEUMATOL, V38, P1858, DOI 10.3899/jrheum.110049; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Baston-Bust DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-133; Battaglia F, 2008, J LEUKOCYTE BIOL, V83, P648, DOI 10.1189/jlb.0607349; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Fabian A, 2009, CYTOM PART A, V75A, P67, DOI 10.1002/cyto.a.20690; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; Gotte M, 2010, AM J PATHOL, V176, P25, DOI 10.2353/ajpath.2010.090775; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Greve B, 2012, CYTOM PART A, V81A, P284, DOI 10.1002/cyto.a.22022; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hernandez-Vargas H, 2011, EPIGENETICS-US, V6, P429, DOI 10.4161/epi.6.4.14515; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hosonuma S, 2011, HUM CELL, V24, P9, DOI 10.1007/s13577-010-0002-z; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Iejima D, 2007, ARCH ORAL BIOL, V52, P924, DOI 10.1016/j.archoralbio.2007.04.004; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Leiros GJ, 2011, CURR PHARM BIOTECHNO, V12, P1909; Leivonen M, 2004, ONCOLOGY-BASEL, V67, P11, DOI 10.1159/000080280; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Malhotra Gautam K, 2011, J Carcinog, V10, P38, DOI 10.4103/1477-3163.91413; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; McDermott SP, 2007, ONCOGENE, V26, P1407, DOI 10.1038/sj.onc.1209930; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun DZ, 1998, INT J DEV BIOL, V42, P733; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tsunoda Y, 2011, ONCOLOGY-BASEL, V81, P336, DOI 10.1159/000334690; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zimmerlin L, 2011, METHODS MOL BIOL, V699, P251, DOI 10.1007/978-1-61737-950-5_12; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	73	87	90	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85737	10.1371/journal.pone.0085737	http://dx.doi.org/10.1371/journal.pone.0085737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392029	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900173
J	Price, CA; Knox, SJC; Brodribb, TJ				Price, Charles A.; Knox, Sarah-Jane C.; Brodribb, Tim J.			The Influence of Branch Order on Optimal Leaf Vein Geometries: Murray's Law and Area Preserving Branching	PLOS ONE			English	Article							WOOD SPECIFIC-GRAVITY; GENERAL-MODEL; SCALING LAWS; FORM; SIZE; ARCHITECTURE; PREVENTION; ALLOMETRY; GRADIENTS; TRANSPORT	Models that predict the form of hierarchical branching networks typically invoke optimization based on biomechanical similitude, the minimization of impedance to fluid flow, or construction costs. Unfortunately, due to the small size and high number of vein segments found in real biological networks, complete descriptions of networks needed to evaluate such models are rare. To help address this we report results from the analysis of the branching geometry of 349 leaf vein networks comprising over 1.5 million individual vein segments. In addition to measuring the diameters of individual veins before and after vein bifurcations, we also assign vein orders using the Horton-Strahler ordering algorithm adopted from the study of river networks. Our results demonstrate that across all leaves, both radius tapering and the ratio of daughter to parent branch areas for leaf veins are in strong agreement with the expectation from Murray's law. However, as veins become larger, area ratios shift systematically toward values expected under area-preserving branching. Our work supports the idea that leaf vein networks differentiate roles of leaf support and hydraulic supply between hierarchical orders.	[Price, Charles A.; Knox, Sarah-Jane C.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Brodribb, Tim J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Western Australia; University of Tasmania	Price, CA (corresponding author), Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia.	charles.price@uwa.edu.au	Price, Chuck A/HIK-1431-2022; Price, Charles A/B-1171-2011; Brodribb, Timothy John/C-6797-2013	Brodribb, Timothy John/0000-0002-4964-6107	Australian Research Council [DE120101562]	Australian Research Council(Australian Research Council)	CAP acknowledges the support of a Discovery Early Career Research Award (DE120101562) from the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bohn S., 2002, PHYS REV E, V65, P1; BORCHERT R, 1981, BOT GAZ, V142, P394, DOI 10.1086/337238; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; CANNY MJ, 1993, PHILOS T R SOC B, V341, P87, DOI 10.1098/rstb.1993.0094; Coomes DA, 2008, BIOL LETTERS, V4, P302, DOI 10.1098/rsbl.2008.0094; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Dodds PS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048702; Ellis B, 2009, MANUAL LEAF; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; HOLBROOK NM, 1989, AM J BOT, V76, P1740, DOI 10.2307/2444473; Horn HS, 2000, SCALING BIOL; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Katifori E, 2010, NETWORKS PHYS REV LE, V104, P4; Katifori E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037994; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; McCulloh KA, 2004, FUNCT ECOL, V18, P931, DOI 10.1111/j.0269-8463.2004.00913.x; McCulloh KA, 2005, AM J BOT, V92, P985, DOI 10.3732/ajb.92.6.985; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Mileyko Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036715; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Niklas KJ, 1997, ANN BOT-LONDON, V79, P265, DOI 10.1006/anbo.1996.0340; Perna A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066106; Price C.A., 2012, METHODS MOL BIOL MET, V918; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2012, ECOL LETT, V15, P87, DOI 10.1111/j.1461-0248.2011.01712.x; Price CA, 2011, PLANT PHYSIOL, V155, P236, DOI 10.1104/pp.110.162834; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Restrepo JG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.128101; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; SHERMAN TF, 1989, J THEOR BIOL, V136, P245, DOI 10.1016/S0022-5193(89)80162-6; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Strahler AN., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI DOI 10.1029/TR038I006P00913; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; UYLINGS HBM, 1975, ADV NEUROL, V12, P247; Velleman P. F., 1981, APPL BASICS COMPUTIN; WANG XD, 1985, PLANT CELL ENVIRON, V8, P669, DOI 10.1111/j.1365-3040.1985.tb01707.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WIEMANN MC, 1989, AM J BOT, V76, P924, DOI 10.2307/2444548; WILLIAMSON GB, 1984, B TORREY BOT CLUB, V111, P51, DOI 10.2307/2996210; Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178	52	29	30	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85420	10.1371/journal.pone.0085420	http://dx.doi.org/10.1371/journal.pone.0085420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392008	gold, Green Submitted, Green Published			2022-12-25	WOS:000329323900152
J	Si, CC; Liu, XY; Wang, CY; Wang, L; Dai, ZC; Qi, SS; Du, DL				Si, Chuncan; Liu, Xueyan; Wang, Congyan; Wang, Lei; Dai, Zhicong; Qi, Shanshan; Du, Daolin			Different Degrees of Plant Invasion Significantly Affect the Richness of the Soil Fungal Community	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNCTIONAL DIVERSITY; ENZYME-ACTIVITIES; NITROGEN; FOREST; INVASIBILITY; MOISTURE; BIOTA; ALLOCATION; FACILITATE	Several studies have shown that soil microorganisms play a key role in the success of plant invasion. Thus, ecologists have become increasingly interested in understanding the ecological effects of biological invasion on soil microbial communities given continuing increase in the effects of invasive plants on native ecosystems. This paper aims to provide a relatively complete depiction of the characteristics of soil microbial communities under different degrees of plant invasion. Rhizospheric soils of the notorious invasive plant Wedelia trilobata with different degrees of invasion (uninvaded, low-degree, and high-degree using its coverage in the invaded ecosystems) were collected from five discrete areas in Hainan Province, P. R. China. Soil physicochemical properties and community structure of soil microorganisms were assessed. Low degrees of W. trilobata invasion significantly increased soil pH values whereas high degrees of invasion did not significantly affected soil pH values. Moreover, the degree of W. trilobata invasion exerted significant effects on soil Ca concentration but did not significantly change other indices of soil physicochemical properties. Low and high degrees of W. trilobata invasion increased the richness of the soil fungal community but did not pose obvious effects on the soil bacterial community. W. trilobata invasion also exerted obvious effects on the community structure of soil microorganisms that take part in soil nitrogen cycling. These changes in soil physicochemical properties and community structure of soil microbial communities mediated by different degrees of W. trilobata invasion may present significant functions in further facilitating the invasion process.	[Si, Chuncan; Liu, Xueyan; Wang, Congyan; Wang, Lei; Dai, Zhicong; Qi, Shanshan; Du, Daolin] Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang, Jiangsu, Peoples R China; [Du, Daolin] Jiangsu Univ, Minist Educ & Jiangsu Prov, Key Lab Modern Agr Equipment & Technolu, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Wang, CY (corresponding author), Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang, Jiangsu, Peoples R China.	liuyuexue623@163.com; ddl@ujs.edu.cn	Du, Daolin/HHC-9359-2022; Wang, Congyan/B-1299-2010	Du, Daolin/0000-0003-1764-2205; Wang, Congyan/0000-0002-6132-3319; Dai, Zhi-Cong/0000-0002-0748-8059	National Natural Science Foundation of China [30970556, 31170386]; Doctoral Program of Higher Education of China [20093227110004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Universities Natural Science Research Project of Jiangsu Province [13KJB610002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Universities Natural Science Research Project of Jiangsu Province	This study was partially supported by the National Natural Science Foundation of China (30970556, 31170386), the Doctoral Program of Higher Education of China (20093227110004), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Universities Natural Science Research Project of Jiangsu Province (13KJB610002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2005, P NATL ACAD SCI USA, V102, P4383, DOI 10.1073/pnas.0500823102; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Catford JA, 2012, PERSPECT PLANT ECOL, V14, P231, DOI 10.1016/j.ppees.2011.12.002; Chen Tong, 2012, Chinese Journal of Plant Ecology, V36, P253, DOI 10.3724/SP.J.1258.2012.00253; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; Dassonville N, 2011, BIOL INVASIONS, V13, P1115, DOI 10.1007/s10530-011-9954-5; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Elgersma KJ, 2011, OECOLOGIA, V167, P733, DOI 10.1007/s00442-011-2022-0; Fan L, 2010, GEODERMA, V154, P370, DOI 10.1016/j.geoderma.2009.11.010; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fu QL, 2012, J SOIL SEDIMENT, V12, P1134, DOI 10.1007/s11368-012-0544-7; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Herr-Turoff A, 2005, PLANT SOIL, V277, P19, DOI 10.1007/s11104-004-5980-8; Hickman JE, 2010, P NATL ACAD SCI USA, V107, P10115, DOI 10.1073/pnas.0912279107; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Howard TG, 2004, BIOL INVASIONS, V6, P393, DOI 10.1023/B:BINV.0000041559.67560.7e; Huebner CD, 2006, PLANT ECOL, V186, P57, DOI 10.1007/s11258-006-9112-9; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Ikenaga M, 2010, MICROB ECOL, V59, P284, DOI 10.1007/s00248-009-9572-2; Jiang JP, 2009, PEDOSPHERE, V19, P735, DOI 10.1016/S1002-0160(09)60169-7; Jones RO, 2011, PLANT SOIL, V345, P257, DOI 10.1007/s11104-011-0778-y; [柯展鸿 Ke Zhanhong], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P432; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kuebbing SE, 2014, J APPL ECOL, V51, P124, DOI 10.1111/1365-2664.12161; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Laungani R, 2009, P NATL ACAD SCI USA, V106, P12400, DOI 10.1073/pnas.0900921106; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Li WH, 2008, OPT EXPRESS, V16, P21616, DOI 10.1364/OE.16.021616; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Lowe S, 2000, WORLDS WORST INVASIV, P100; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McLean MA, 2000, BIOL FERT SOILS, V32, P114, DOI 10.1007/s003740000225; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Niu HB, 2007, PLANT SOIL, V294, P73, DOI 10.1007/s11104-007-9230-8; Papatheodorou EM, 2004, APPL SOIL ECOL, V25, P37, DOI 10.1016/S0929-1393(03)00100-8; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Roesti D, 2006, SOIL BIOL BIOCHEM, V38, P1111, DOI 10.1016/j.soilbio.2005.09.010; Sanon A, 2012, J ENVIRON MANAGE, V95, pS275, DOI 10.1016/j.jenvman.2011.01.025; Scharfy D, 2010, J ECOL, V98, P1379, DOI 10.1111/j.1365-2745.2010.01722.x; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018654; SHANNON C. E., 1949, MATH THEORY COMMUNIC, P1, DOI DOI 10.1063/1.3067010; Sharma Gyan P., 2007, Applied Ecology and Environmental Research, V5, P109; Song LY, 2010, BIOL INVASIONS, V12, P1221, DOI 10.1007/s10530-009-9541-1; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Svensson JR, 2013, J ECOL, V101, P140, DOI 10.1111/1365-2745.12028; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thorpe AS, 2006, APPL SOIL ECOL, V32, P118, DOI 10.1016/j.apsoil.2005.02.018; van der Wal R, 2008, GLOBAL CHANGE BIOL, V14, P1428, DOI 10.1111/j.1365-2486.2008.01576.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Vivas A, 2008, J ENVIRON MONITOR, V10, P1287, DOI 10.1039/b808567f; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; Wilson SD, 2013, OIKOS, V122, P129, DOI 10.1111/j.1600-0706.2012.20673.x; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005; Wood YA, 2006, J ENVIRON QUAL, V35, P76, DOI 10.2134/jeq2004.0465; Wu W, 2010, AM J BOT, V97, pE114, DOI 10.3732/ajb.1000327; Xie LJ, 2010, ALLELOPATHY J, V25, P31; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zou JW, 2006, OECOLOGIA, V150, P272, DOI 10.1007/s00442-006-0512-2	74	39	44	13	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85490	10.1371/journal.pone.0085490	http://dx.doi.org/10.1371/journal.pone.0085490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392015	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900159
J	Tremblay, I; Pare, E; Arsenault, D; Douziech, M; Boucher, MJ				Tremblay, Isabelle; Pare, Emanuel; Arsenault, Dominique; Douziech, Melanie; Boucher, Marie-Josee			The MEK/ERK Pathway Promotes NOTCH Signalling in Pancreatic Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; GROWTH-FACTOR; ACTIVATION; PROTEIN; KINASE; INHIBITION; TARGET; PHOSPHORYLATION; TRANSFORMATION; HYPERPHOSPHORYLATION	Activation of the NOTCH receptors relies on their intracellular proteolysis by the gamma-secretase complex. This cleavage liberates the NOTCH intracellular domain (NIC) thereby allowing the translocation of NIC towards the nucleus to assemble into a transcriptional platform. Little information is available regarding the regulatory steps operating on NIC following its release from the transmembrane receptor up to its association with transcriptional partners. Interfering with these regulatory steps might potentially influences the nuclear outcome of NOTCH signalling. Herein, we exploited a reliable model to study the molecular events occurring subsequent to NOTCH1 cleavage. In pancreatic cancer cells, pulse of NOTCH1 activation led to increased expression of NOTCH target genes namely HES1 and c-MYC. We uncovered that, upon its release, the NOTCH1 intracellular domain, NIC1, undergoes a series of post-translational modifications that include phosphorylation. Most interestingly, we found that activation of the MEK/ERK pathway promotes HES1 expression. Inhibition of the gamma-secretase complex prevented the MEK/ERK-induced HES1 expression suggesting a NOTCH-dependent mechanism. Finally, higher levels of NIC1 were found associated with its transcriptional partners [CBF1, Su(H) and LAG-1] (CSL) and MASTERMIND-LIKE 1 (MAML1) upon MEK/ERK activation providing a potential mechanism whereby the MEK/ERK pathway promotes expression of NOTCH target genes. For the first time, our data exposed a signalling pathway, namely the MEK/ERK pathway that positively impacts on NOTCH nuclear outcome.	[Tremblay, Isabelle; Pare, Emanuel; Arsenault, Dominique; Douziech, Melanie; Boucher, Marie-Josee] Univ Sherbrooke, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Boucher, MJ (corresponding author), Univ Sherbrooke, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	marie-josee.boucher@usherbrooke.ca		Boucher, Marie-Josee/0000-0002-7615-3121	Canadian Institutes for Health Research [IC1-102949, MOP-106456]; FRQ-S	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); FRQ-S	This work was supported by grants from the Canadian Institutes for Health Research (IC1-102949 and MOP-106456 to MJB). MJB is a scholar from the Fonds de Recherche Sante Quebec (FRQ-S) and member of the FRQ-S-funded Centre de Recherche Clinique Etienne-Le Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Boucher MJ, 2009, ENDOCRINOLOGY, V150, P87, DOI 10.1210/en.2007-0865; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Boucher MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG736, DOI 10.1152/ajpgi.00453.2003; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Cook N, 2012, J EXP MED, V209, P437, DOI 10.1084/jem.20111923; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Foltz DR, 2001, BIOCHEM BIOPH RES CO, V286, P484, DOI 10.1006/bbrc.2001.5421; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawahashi K, 2010, GENES CELLS, V15, P749, DOI 10.1111/j.1365-2443.2010.01412.x; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Mysliwiec P, 2009, ADV MED SCI-POLAND, V54, P136, DOI 10.2478/v10039-009-0026-3; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Pui CH, 2009, CANCER CELL, V15, P85, DOI 10.1016/j.ccr.2009.01.007; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ranganathan P, 2011, J BIOL CHEM, V286, P28844, DOI 10.1074/jbc.M111.243600; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang ZW, 2006, CANCER RES, V66, P7653, DOI 10.1158/0008-5472.CAN-06-1019; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	56	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85502	10.1371/journal.pone.0085502	http://dx.doi.org/10.1371/journal.pone.0085502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392017	gold, Green Published, Green Submitted			2022-12-25	WOS:000329323900161
J	Wang, L; Xu, K; Lin, J; Shao, SM; Zhang, TT; Xu, HR; Wei, ZH; Zhang, ZY				Wang, Ling; Xu, Kun; Lin, Juan; Shao, Simin; Zhang, Tingting; Xu, Huarong; Wei, Zehui; Zhang, Zhiying			A Novel Genetic System Based on Zinc Finger Nucleases for the Identification of Interactions between Proteins In Vivo	PLOS ONE			English	Article							YEAST 2-HYBRID; DOMAIN; DROSOPHILA; NETWORK; CELLS; MAP	Yeast two-hybrid (Y2H) methods are powerful tools for detecting protein-protein interactions. The traditional Y2H method has been widely applied to screen novel protein interactions since it was established two decades ago. The high false-positive rate of the traditional method drove the development of modified Y2H systems. Here, we describe a novel Y2H system using zinc-finger nucleases (ZFNs). ZFNs contain two functional domains, a zinc-finger DNA-binding domain (ZFP) and a non-specific nuclease domain (FokI). In this system, the bait is expressed as a fusion protein with a specific ZFP, and the prey is fused to the FokI. A reporter vector is designed such that the ZFN target site disrupts the Gal4 open reading frame. By transforming the three plasmids into a yeast strain (AH109), the interaction between the bait and prey proteins reconstitutes ZFN function and generates the double-strand break (DSB) on its target site. The DNA DSB repair restores Gal4 function, which activates the expression of the four reporter genes. We used p53-SV40LT interacting proteins to prove the concept. In addition, 80% positive rate was observed in a cDNA screening test against WDSV orfA protein. Our results strongly suggested that this Y2H system could increase screening reliability and reproducibility, and provide a novel approach for interactomics research.	[Wang, Ling; Xu, Kun; Lin, Juan; Shao, Simin; Zhang, Tingting; Xu, Huarong; Wei, Zehui; Zhang, Zhiying] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, ZY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn		Zhang, Zhiying/0000-0001-6012-0889	National Natural Science Foundation of China (NSFC) [31172186]; 973 program [2011CBA01002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (NSFC) (31172186) (http://www.nsfc.gov.cn) and 973 program (2011CBA01002) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher Sharon L., 2008, Briefings in Functional Genomics & Proteomics, V7, P460, DOI 10.1093/bfgp/eln043; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bobis-Wozowicz S, 2011, METHODS, V53, P339, DOI 10.1016/j.ymeth.2010.12.019; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hastie AR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm894; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Hubsman M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e18; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Ichikawa K, 2006, J BIOCHEM, V139, P105, DOI 10.1093/jb/mvj011; IWABUCHI K, 1993, ONCOGENE, V8, P1693; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xu K, 2013, MOL BIOL REP, V40, P1451, DOI 10.1007/s11033-012-2188-5	26	3	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85650	10.1371/journal.pone.0085650	http://dx.doi.org/10.1371/journal.pone.0085650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392024	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900168
J	Van Audenhove, I; Boucherie, C; Pieters, L; Zwaenepoel, O; Vanloo, B; Martens, E; Verbrugge, C; Hassanzadeh-Ghassabeh, G; Vandekerckhove, J; Cornelissen, M; De Ganck, A; Gettemans, J				Van Audenhove, Isabel; Boucherie, Ciska; Pieters, Leen; Zwaenepoel, Olivier; Vanloo, Berlinda; Martens, Evelien; Verbrugge, Charlotte; Hassanzadeh-Ghassabeh, Gholamreza; Vandekerckhove, Joel; Cornelissen, Maria; De Ganck, Ariane; Gettemans, Jan			Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization	FASEB JOURNAL			English	Article						heavy-chain only antibodies; cytoskeletal protein modulation; invasive protrusions; oncotargets	SQUAMOUS-CELL CARCINOMAS; EXTRACELLULAR-MATRIX DEGRADATION; N-WASP; ACTIN POLYMERIZATION; ARP2/3 COMPLEX; IN-VITRO; F-ACTIN; PROMOTES; INVASIVENESS; MEMBRANE	Invadopodia are actin-rich protrusions arising through the orchestrated regulation of precursor assembly, stabilization, and maturation, endowing cancer cells with invasive properties. Using nanobodies (antigen-binding domains of Camelid heavy-chain antibodies) as perturbators of intracellular functions and/or protein domains at the level of the endogenous protein, we examined the specific contribution of fascin and cortactin during invadopodium formation in MDA-MB-231 breast and PC-3 prostate cancer cells. A nanobody (K-d similar to 35 nM, 1:1 stoichiometry) that disrupts fascin F-actin bundling emphasizes the importance of stable actin bundles in invadopodium array organization and turnover, matrix degradation, and cancer cell invasion. Cortactin-SH3 dependent WIP recruitment toward the plasma membrane was specifically inhibited by a cortactin nanobody (K-d similar to 75 nM, 1:1 stoichiometry). This functional domain is shown to be important for formation of properly organized invadopodia, MMP-9 secretion, matrix degradation, and cancer cell invasion. Notably, using a subcellular delocalization strategy to trigger protein loss of function, we uncovered a fascin-bundling-independent role in MMP-9 secretion. Hence, we demonstrate that nanobodies enable high resolution protein function mapping in cells.-Van Audenhove, I., Boucherie, C., Pieters, L., Zwaenepoel, O., Vanloo, B., Martens, E., Verbrugge, C., Hassanzadeh-Ghassabeh, G., Vandekerckhove, J., Cornelissen, M., De Ganck, A., Gettemans, J. Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.	[Van Audenhove, Isabel; Boucherie, Ciska; Zwaenepoel, Olivier; Vanloo, Berlinda; Martens, Evelien; Verbrugge, Charlotte; Vandekerckhove, Joel; De Ganck, Ariane; Gettemans, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Pieters, Leen; Cornelissen, Maria] Univ Ghent, Dept Basic Med Sci, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Hassanzadeh-Ghassabeh, Gholamreza] VIB, Nanobody Serv Facil, Brussels, Belgium	Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB)	Gettemans, J (corresponding author), Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be			Research Foundation Flanders [Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen]; League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs [IUAP P7/13]; FWO-Flanders	Research Foundation Flanders [Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen]; League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; FWO-Flanders(FWO)	The authors thank Prof. Dr. Marleen Van Troys for advice on confocal microscopy experimental methodology and live-cell imaging techniques, as well as Dr. Isabelle Maridonneau Parini (Institut de Pharmacologie et de Biologie Structural, University of Toulouse, Toulouse, France) for the gift of LifeAct-mCherry and Prof. Roberto Dominguez (Department of Physiology, University of Pennsylvania, Philadelphia, PA, USA) for the gift of pTYB12 vector. The authors thank Prof. Janis Burkhardt (Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA) for the gift of full-length HS1 cDNA and the cDNA of the HS1 SH3 domain in GST-expression vectors, Prof. Laura Machesky (Beatson Institute for Cancer Research, Glasgow, UK) for the gift of pEGFP-C1 WASP, and Prof. Werner Muller-Esterl (Institut fur Biochemie II, Johann Wolfgang Goethe Universitat, Frankfurt, Germany) for the gift of pEGFP-N1 Dynamin II. This work was supported by grants from the Research Foundation Flanders [Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen], the League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA), and the Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs (IUAP P7/13). I.V.A. is supported by the FWO-Flanders.	Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Banon-Rodriguez I, 2011, EUR J CELL BIOL, V90, P213, DOI 10.1016/j.ejcb.2010.09.001; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; De Clercq S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078108; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Gibcus JH, 2008, BRIT J CANCER, V98, P950, DOI 10.1038/sj.bjc.6604246; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayer BJ, 2001, J CELL SCI, V114, P1253; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Onodera M, 2009, LAB INVEST, V89, P1261, DOI 10.1038/labinvest.2009.89; Ortiz CM, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-41; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rodrigo JP, 2009, J PATHOL, V217, P516, DOI 10.1002/path.2462; Rodrigo JP, 2000, CLIN CANCER RES, V6, P3177; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Schoumacher M, 2011, EUR J CELL BIOL, V90, P93, DOI 10.1016/j.ejcb.2010.05.010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Van Audenhove I, 2013, CYTOSKELETON, V70, P604, DOI 10.1002/cm.21122; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; van Rossum AGSH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-15; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Xie JJ, 2010, AM J PATHOL, V176, P939, DOI 10.2353/ajpath.2010.090118; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Zanet J, 2012, J CELL BIOL, V197, P477, DOI 10.1083/jcb.201110135	59	49	49	0	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1805	1818		10.1096/fj.13-242537	http://dx.doi.org/10.1096/fj.13-242537			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24414419				2022-12-25	WOS:000335344300026
J	Bowers, E; Scamurra, RW; Asrani, A; Beniguel, L; MaWhinney, S; Keays, KM; Thurn, JR; Janoff, EN				Bowers, Elisabeth; Scamurra, Ronald W.; Asrani, Anil; Beniguel, Lydie; MaWhinney, Samantha; Keays, Kathryne M.; Thurn, Joseph R.; Janoff, Edward N.			Decreased Mutation Frequencies among Immunoglobulin G Variable Region Genes during Viremic HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED CYTIDINE DEAMINASE; B-CELLS; SOMATIC HYPERMUTATION; CAPSULAR POLYSACCHARIDE; PNEUMOCOCCAL VACCINE; ANTIBODY-RESPONSE; LYMPHOID-TISSUE; DNA-REPAIR; IN-VIVO	Background/Objective: HIV-1 infection is complicated by high rates of opportunistic infections against which specific antibodies contribute to immune defense. Antibody function depends on somatic hypermutation (SHM) of variable regions of immunoglobulin heavy chain genes (V-H-D-J). We characterized the frequency of SHM in expressed IgG mRNA immunoglobulin transcripts from control and HIV-1-infected patients. Design: We compared utilization of genes in the most prominent V-H family (V(H)3) and mutation frequencies and patterns of cDNA from V(H)3-IgG genes from 10 seronegative control subjects and 21 patients with HIV-1 infection (6 without and 15 patients with detectable plasma viremia). Methods: Unique IgG V(H)3 family cDNA sequences (n = 1,565) were PCR amplified, cloned, and sequenced from blood. Sequences were analyzed using online (Vbase) and in-house immunoglobulin alignment resources. Results: Mutation frequencies in the antigen-binding hypervariable complementarity determining regions (CDR1/2) of IgG class-switched B cells were lower among viremic HIV-1-infected patients vs. controls for nucleotides (CDR1/2: 10+/-5% vs. 13.5+/-6%, p = 0.03) and amino acids (CDR: 20%+/-10 vs. 25%+/-12, p = 0.02) and in structural framework regions. Mutation patterns were similar among groups. The most common V(H)3 gene, V(H)3-23, was utilized less frequently among viremic HIV-1-infected patients (p = 0.03), and overall, mutation frequencies were decreased in nearly all V(H)3 genes compared with controls. Conclusions: B cells from HIV-1-infected patients show decreased mutation frequencies, especially in antigen-binding V(H)3 CDR genes, and selective defects in gene utilization. Similar mutation patterns suggest defects in the quantity, but not quality, of mutator activity. Lower levels of SHM in IgG class-switched B cells from HIV-1-infected patients may contribute to the increased risk of opportunistic infections and impaired humoral responses to preventative vaccines.	[Bowers, Elisabeth; MaWhinney, Samantha; Keays, Kathryne M.; Janoff, Edward N.] Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA; [Bowers, Elisabeth; Keays, Kathryne M.; Janoff, Edward N.] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA; [Bowers, Elisabeth; Janoff, Edward N.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [MaWhinney, Samantha] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA; [Bowers, Elisabeth; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Scamurra, Ronald W.; Asrani, Anil; Thurn, Joseph R.] Univ Minnesota, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Beniguel, Lydie] Univ St Etienne, Fac Med, GIMAP EA 3064, Saint Etienne, France	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Universite Jean Monnet	Janoff, EN (corresponding author), Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA.	Edward.Janoff@ucdenver.edu			Veterans Affairs Research Service; University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC); Colorado Center for AIDS Research Grant [P30 AI054907]; University of Colorado Cancer Center [P30CA046934]; Conseil Regional Rhone-Alpes; National Institutes of Health (NIH) [F32DE005703-01, RO1A10495752-01]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907, R01AI108479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE005703] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC); Colorado Center for AIDS Research Grant; University of Colorado Cancer Center; Conseil Regional Rhone-Alpes(Region Auvergne-Rhone-Alpes); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported by the Veterans Affairs Research Service and the University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC) (ENJ) and facilitated by the infrastructure and resources provided by the Colorado Center for AIDS Research Grant (P30 AI054907), the University of Colorado Cancer Center Core Sequencing Facility (P30CA046934), a grant from "Conseil Regional Rhone-Alpes'' (Recontres Regionales de la Recherche) (LB) and National Institutes of Health (NIH) grants F32DE005703-01 and RO1A10495752-01 (RWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi J, 1998, J INFECT DIS, V178, P707, DOI 10.1086/515369; ADDERSON EE, 1993, J CLIN INVEST, V91, P2734, DOI 10.1172/JCI116514; BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; BRUNELL PA, 1995, J ACQ IMMUN DEF SYND, V10, P540, DOI 10.1097/00042560-199510050-00007; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Casali P, 2006, TRENDS IMMUNOL, V27, P313, DOI 10.1016/j.it.2006.05.001; Chong Y, 2003, CLIN EXP IMMUNOL, V133, P59, DOI 10.1046/j.1365-2249.2003.02185.x; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; Fogelman I, 2000, J INFECT DIS, V182, P435, DOI 10.1086/315739; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Janoff EN, 1997, J INFECT DIS, V175, P975, DOI 10.1086/514004; JANOFF EN, 1994, J INFECT DIS, V170, P299, DOI 10.1093/infdis/170.2.299; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Kabat EA, 1991, SEQUENCES PROTEINS I; Karray S, 1998, J IMMUNOL, V161, P6681; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; KRISTIANSEN SV, 1994, J IMMUNOL, V153, P2974; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Luo ZH, 2004, J ALLERGY CLIN IMMUN, V114, P726, DOI 10.1016/j.jaci.2004.07.049; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; MORTARI F, 1993, J IMMUNOL, V150, P1348; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Obaro SK, 2004, LANCET INFECT DIS, V4, P510, DOI 10.1016/S1473-3099(04)01106-5; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Pancharoen C, 2004, CURR HIV RES, V2, P293, DOI 10.2174/1570162043351084; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; PIROFSKI L, 1995, INFECT IMMUN, V63, P3005, DOI 10.1128/IAI.63.8.3005-3014.1995; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rivas P, 2007, AIDS REV, V9, P173; Rogosch T, 2012, J IMMUNOL, V189, P5449, DOI 10.4049/jimmunol.1103347; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Subramaniam K, 2005, CLIN DIAGN LAB IMMUN, V12, P1168, DOI 10.1128/CDLI.12.10.1168-1176.2005; TERPSTRA FG, 1989, EUR J IMMUNOL, V19, P667, DOI 10.1002/eji.1830190415; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Wu YCB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00193	54	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e81913	10.1371/journal.pone.0081913	http://dx.doi.org/10.1371/journal.pone.0081913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409278	gold, Green Published, Green Submitted			2022-12-25	WOS:000329463500002
J	Little, FF; Delgado, DM; Wexler, PJ; Oppenheim, FG; Mitchell, P; Feldman, JA; Walt, DR; Peng, RD; Matsui, EC				Little, Frederic F.; Delgado, Diana M.; Wexler, Philip J.; Oppenheim, Frank G.; Mitchell, Patricia; Feldman, James A.; Walt, David R.; Peng, Roger D.; Matsui, Elizabeth C.			Salivary Inflammatory Mediator Profiling and Correlation to Clinical Disease Markers in Asthma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EOSINOPHIL CATIONIC PROTEIN; EXHALED NITRIC-OXIDE; NASAL LAVAGE; BIOMARKERS; URINE; CYTOKINES; HEALTHY; SPUTUM; IP-10	Rationale: There is a need for a readily available, non-invasive source of biomarkers that predict poor asthma control. Objectives: We sought to determine if there is an association between the salivary inflammatory profile and disease control in children and adults with asthma. Methods: In this cross-sectional study, we collected demographic and clinical information from two independent populations at different sites, resulting in convenience samples of 58 pediatric and 122 adult urban asthmatics. Control was assessed by symptom questionnaire (children) and by Asthma Control Questionnaire and current exacerbation (adults). Saliva was collected in all subjects. We applied principal component analysis to a 10-plex panel of relevant inflammatory markers to characterize marker profiles and determined if profiles were associated with asthma control. Results: There were similar, strong correlations amongst biologically related markers in both populations: eosinophil-related: eotaxin-1/CCL11, RANTES/CCL5, and IL-5 (p<.001); myeloid/innate: IL-1 beta, IL-6, MCP-1/CCL2, and IL-8/CXCL8 (p,. 001). The first three principal components captured >= 74% of variability across all ten analytes in both populations. In adults, the Principal Component 1 score, broadly reflective of all markers, but with greater weight given to myeloid/innate markers, was associated with Asthma Control Questionnaire score and exacerbation. The Principal Component 3 score, reflective of IP-10/CXCL10, was associated with current exacerbation. In children, the Principal Component 1, 2, and 3 scores were associated with recent asthma symptoms. The Principal Component 2 score, reflective of higher eosinophil markers, was inversely correlated with symptoms. The Principal Component 3 score was positively associated with all symptom outcomes. Conclusion: The salivary inflammatory profile is associated with disease control in children and adults with asthma.	[Little, Frederic F.; Delgado, Diana M.; Wexler, Philip J.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Oppenheim, Frank G.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA; [Mitchell, Patricia; Feldman, James A.] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Walt, David R.] Tufts Univ, Dept Chem, Medford, MA USA; [Peng, Roger D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA	Boston University; Boston University; Boston University; Tufts University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Little, FF (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	flittle@bu.edu		Matsui, Elizabeth/0000-0001-8134-5593; Feldman, James/0000-0003-3962-0189	NIH [U01-DE017788, U01-AI083238, P50-ES015903, P01-ES018176, R01-AI070630, M01-RR00052, R01-DE005672, EPA R832139]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083238, R01AI070630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, U01DE017788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018176, P50ES015903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by NIH U01-DE017788, NIH U01-AI083238, NIH P50-ES015903, NIH P01-ES018176, NIH R01-AI070630, NIH M01-RR00052, NIH R01-DE005672, and EPA R832139 (Environmental Protection Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirne P, 2009, EUR RESPIR J, V34, P1376, DOI 10.1183/09031936.00028209; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Blicharz TM, 2009, ANAL CHEM, V81, P2106, DOI 10.1021/ac802181j; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P547; Chapoval SP, 2009, CLIN IMMUNOL, V132, P371, DOI 10.1016/j.clim.2009.05.016; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Cox AJ, 2008, EUR J APPL PHYSIOL, V103, P477, DOI 10.1007/s00421-008-0722-x; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fonseca FJ, 2012, CLIN ORAL IMPLANTS R, V10; Jackson DJ, 2009, J ALLERGY CLIN IMMUN, V124, P949, DOI 10.1016/j.jaci.2009.07.024; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Kaushik R, 2011, J PERIODONTOL, V82, P1353, DOI 10.1902/jop.2011.100472; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Lee A, 2012, J PERIODONTOL, V83, P79, DOI 10.1902/jop.2011.110060; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lonnkvist K, 2004, PEDIAT ALLERG IMM-UK, V15, P351, DOI 10.1111/j.1399-3038.2004.00165.x; Mvula M, 2005, J ASTHMA, V42, P9, DOI 10.1081/JAS-200044746; Nagata K, 2012, INVEST OPHTH VIS SCI, V53, P3827, DOI 10.1167/iovs.11-9244; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ono Emiko, 2011, Allergology International, V60, P37, DOI 10.2332/allergolint.09-OA-0166; Pammer J, 1998, J PATHOL, V186, P186; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schmekel B, 2001, RESP MED, V95, P670, DOI 10.1053/rmed.2001.1123; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; Wojnarowski C, 1999, CLIN EXP ALLERGY, V29, P926; Yao CJ, 2005, IMMUNOLOGY, V116, P213, DOI 10.1111/j.1365-2567.2005.02212.x; Yeh Chih-Ko, 2010, Tex Dent J, V127, P651	36	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84449	10.1371/journal.pone.0084449	http://dx.doi.org/10.1371/journal.pone.0084449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409298	Green Published, Green Submitted, gold			2022-12-25	WOS:000329463500022
J	Riera, M; Marquez, E; Clotet, S; Gimeno, J; Roca-Ho, H; Lloreta, J; Juanpere, N; Batlle, D; Pascual, J; Soler, MJ				Riera, Marta; Marquez, Eva; Clotet, Sergi; Gimeno, Javier; Roca-Ho, Heleia; Lloreta, Josep; Juanpere, Nuria; Batlle, Daniel; Pascual, Julio; Soler, Maria Jose			Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; GLOMERULAR-FILTRATION-RATE; NOD MICE; RENAL-DISEASE; BLOOD-PRESSURE; NEPHROPATHY; EXPRESSION; PODOCYTE; RAT; HYPERTROPHY	We studied the non-obese diabetic (NOD) mice model because it develops autoimmune diabetes that resembles human type 1 diabetes. In diabetic mice, urinary albumin excretion (UAE) was ten-fold increased at an "early stage" of diabetes, and twenty-fold increased at a "later stage" (21 and 40 days, respectively after diabetes diagnosis) as compared to non-obese resistant controls. In NOD Diabetic mice, glomerular enlargement, increased glomerular filtration rate (GFR) and increased blood pressure were observed in the early stage. In the late stage, NOD Diabetic mice developed mesangial expansion and reduced podocyte number. Circulating and urine ACE2 activity were markedly increased both, early and late in Diabetic mice. Insulin administration prevented albuminuria, markedly reduced GFR, blood pressure, and glomerular enlargement in the early stage; and prevented mesangial expansion and the reduced podocyte number in the late stage of diabetes. The increase in serum and urine ACE2 activity was normalized by insulin administration at the early and late stages of diabetes in Diabetic mice. We conclude that the Diabetic mice develops features of early kidney disease, including albuminuria and a marked increase in GFR. ACE2 activity is increased starting at an early stage in both serum and urine. Moreover, these alterations can be completely prevented by the chronic administration of insulin.	[Riera, Marta; Marquez, Eva; Clotet, Sergi; Pascual, Julio; Soler, Maria Jose] Hosp Mar, IMIM, Dept Nephrol, Barcelona, Spain; [Gimeno, Javier; Roca-Ho, Heleia; Lloreta, Josep; Juanpere, Nuria] Hosp Mar, IMIM, Dept Pathol, Barcelona, Spain; [Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Nephrol & Hypertens, Chicago, IL 60611 USA	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Northwestern University; Feinberg School of Medicine	Soler, MJ (corresponding author), Hosp Mar, IMIM, Dept Nephrol, Barcelona, Spain.	92844@parcdesalutmar.cat	Lloreta-Trull, Josep/AAZ-1229-2020; Soler, Maria Jose/ABC-4410-2021; Lloreta-Trull, Josep/GRR-9682-2022; Riera, Marta/V-5016-2017; Lloreta, J/I-2112-2014; Soler, Maria José/AAP-4454-2020; Roca Ho, Heleia/M-9280-2017	Riera, Marta/0000-0003-4362-7965; Lloreta, J/0000-0003-1644-9470; Soler, Maria José/0000-0003-3621-0766; , Eva/0000-0001-8604-7878; Roca Ho, Heleia/0000-0001-7324-5234	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [ISCIII-FEDER. PI081688]; Fundacion Senefro;  [ISCIII-FEDER PI10/01370]	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Senefro; 	This work was supported by grants from the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (ISCIII-FEDER. PI081688), and Fundacion Senefro. J.P. is funded in part through the project ISCIII-FEDER PI10/01370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON AD, 1993, HYPERTENSION, V21, P129, DOI 10.1161/01.HYP.21.2.129; Batlle D, 2008, CURR OPIN NEPHROL HY, V17, P250, DOI 10.1097/MNH.0b013e3282f945c2; Batlle D, 2012, KIDNEY INT, V81, P520, DOI 10.1038/ki.2011.381; Batlle D, 2010, DIABETES, V59, P2994, DOI 10.2337/db10-1205; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Colucci JA, 2011, J RENIN-ANGIO-ALDO S, V12, P15, DOI 10.1177/1470320310375456; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Hale LJ, 2013, AM J PHYSIOL-RENAL, V305, pF182, DOI 10.1152/ajprenal.00548.2012; He CJ, 2000, KIDNEY INT, V58, P1931, DOI 10.1046/j.1523-1755.2000.00365.x; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; Soler MJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/616313; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; MacLeod JM, 1997, KIDNEY INT, V51, P1624, DOI 10.1038/ki.1997.224; MOGENSEN CE, 1973, DIABETES, V22, P706, DOI 10.2337/diab.22.9.706; PETERSEN J, 1988, DIABETES, V37, P1346, DOI 10.2337/diabetes.37.10.1346; PORCELLATI F, 1993, DIABETES, V42, P1055, DOI 10.2337/diabetes.42.7.1055; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Raij L, 2003, AM J HYPERTENS, V16, p46S, DOI 10.1016/S0895-7061(03)01068-9; Rosmalen JGM, 2001, LAB INVEST, V81, P231, DOI 10.1038/labinvest.3780231; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Schmetterer L, 1997, DIABETES, V46, P1868, DOI 10.2337/diabetes.46.11.1868; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Soler MJ, 2008, MED CLIN-BARCELONA, V131, P230; Soler MJ, 2008, EXP PHYSIOL, V93, P549, DOI 10.1113/expphysiol.2007.041350; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; STACKHOUSE S, 1990, DIABETES, V39, P989, DOI 10.2337/diabetes.39.8.989; Sturgeon C, 1998, J APPL PHYSIOL, V84, P2154, DOI 10.1152/jappl.1998.84.6.2154; Tikellis C, 2008, DIABETES, V57, P1018, DOI 10.2337/db07-1212; TUTTLE KR, 1991, NEW ENGL J MED, V324, P1626, DOI 10.1056/NEJM199106063242304; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Xiao XY, 2009, J AUTOIMMUN, V32, P85, DOI 10.1016/j.jaut.2008.12.003; Yamaleyeva LM, 2012, AM J PHYSL RENAL PHY; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; ZATZ R, 1985, P NATL ACAD SCI USA, V82, P5963, DOI 10.1073/pnas.82.17.5963; Zimpelmann J, 2000, KIDNEY INT, V58, P2320, DOI 10.1046/j.1523-1755.2000.00416.x; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	51	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84683	10.1371/journal.pone.0084683	http://dx.doi.org/10.1371/journal.pone.0084683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400109	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700043
J	Norrie, IC; Ohlsson, E; Nielsen, O; Hasemann, MS; Porse, BT				Norrie, Ida Christine; Ohlsson, Ewa; Nielsen, Olaf; Hasemann, Marie Sigurd; Porse, Bo T.			C/EBP alpha Is Dispensable for the Ontogeny of PD-1+CD4+Memory T Cells but Restricts Their Expansion in an Age-Dependent Manner	PLOS ONE			English	Article							BINDING-PROTEIN ALPHA; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; GENE-EXPRESSION; IN-VIVO; B-CELLS; PROLIFERATION; CANCER; GROWTH; MICE	Ageing and cancer is often associated with altered T cell distributions and this phenomenon has been suggested to be the main driver in the development of immunosenescence. Memory phenotype PD-1+ CD4+ T cells accumulate with age and during leukemic development, and they might account for the attenuated T cell response in elderly or diseased individuals. The transcription factor C/EBP alpha has been suggested to be responsible for the accumulation as well as for the senescent features of these cells including impaired TCR signaling and decreased proliferation. Thus modulating the activity of C/EBP alpha could potentially target PD-1+ CD4+ T cells and consequently, impede the development of immunosenescence. To exploit this possibility we tested the importance of C/EBP alpha for the development of age-dependent PD-1+ CD4+ T cells as well as its role in the accumulation of PD-1+ CD4+ T cells during leukemic progression. In contrast to earlier suggestions, we find that loss of C/EBP alpha expression in the lymphoid compartment led to an increase of PD-1+ CD4+ T cells specifically in old mice, suggesting that C/EBP alpha repress the accumulation of these cells in elderly by inhibiting their proliferation. Furthermore, C/EBP alpha-deficiency in the lymphoid compartment had no effect on leukemic development and did not affect the accumulation of PD-1+ CD4+ T cells. Thus, in addition to contradict earlier suggestions of a role for C/EBP alpha in immunosenescence, these findings efficiently discard the potential of using C/EBP alpha as a target for the alleviation of ageing/cancer-associated immunosenescence.	[Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark; [Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark; [Norrie, Ida Christine; Nielsen, Olaf] Univ Copenhagen, Inst Biol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Porse, BT (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark.	bo.porse@finsenlab.dk	Nielsen, Olaf/G-4980-2012	Nielsen, Olaf/0000-0001-7440-5201; Porse, Bo/0000-0001-6043-0844	NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish	NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease; Lundbeck Foundation(Lundbeckfonden)	This study was supported through a center grant from the NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease. Foundation website: http://www.novonordiskfonden.dk; no grant number is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger FO, 2012, NUCL ACIDS RES; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Channappanavar R, 2009, MECH AGEING DEV, V130, P709, DOI 10.1016/j.mad.2009.08.006; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chiu BC, 2007, MECH AGEING DEV, V128, P618, DOI 10.1016/j.mad.2007.09.002; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Gorgun G, 2005, J CLIN INVEST, V115, P1797, DOI 10.1172/JCI24176; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasemann MS, 2013, PLOS GENETI IN PRESS; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kovaiou RD, 2005, INT IMMUNOL, V17, P1359, DOI 10.1093/intimm/dxh314; Lages CS, 2010, AGING CELL, V9, P785, DOI 10.1111/j.1474-9726.2010.00611.x; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lustgarten J, 2004, J IMMUNOL, V173, P4510, DOI 10.4049/jimmunol.173.7.4510; Myers CE, 2011, AGING DIS, V2, P512; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Onizuka S, 1999, CANCER RES, V59, P3128; Porse BT, 2006, MOL CELL BIOL, V26, P1028, DOI 10.1128/MCB.26.3.1028-1037.2006; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shankar EM, 2011, MOL MED, V17, P229, DOI 10.2119/molmed.2010.00175; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Shimada Y, 2009, EXP GERONTOL, V44, P517, DOI 10.1016/j.exger.2009.05.003; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84728	10.1371/journal.pone.0084728	http://dx.doi.org/10.1371/journal.pone.0084728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404186	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800065
J	Suhandono, S; Apriyanto, A; Ihsani, N				Suhandono, Sony; Apriyanto, Ardha; Ihsani, Nisa			Isolation and Characterization of Three Cassava Elongation Factor 1 Alpha (MeEF1A) Promoters	PLOS ONE			English	Article							INTERSTITIAL TELOMERE MOTIFS; INTRON-MEDIATED ENHANCEMENT; CIS-ACTING ELEMENTS; PRE-MESSENGER-RNA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MOLECULAR-CLONING; FACTOR EF-1-ALPHA; PROTEIN; FACTOR-1-ALPHA	In plant genetic engineering, the identification of gene promoters leading to particular expression patterns is crucial for the development of new genetically modified plant generations. This research was conducted in order to isolate and characterize several new promoters from cassava (Manihot esculenta Crantz) elongation factor 1 alpha (EF1A) gene family. Three promoters MeEF1A3, MeEF1A4 and MeEF1A5 were successfully isolated. Sequence analyses showed that all of the promoters contain three conserved putative cis-acting elements which are located upstream of the transcription start site. These elements are included a TEF1, a TELO and TATA boxes. In addition, all of the promoters also have the 5'UTR intron but with a different lengths. These promoters were constructed translationally with gusA reporter gene (promoter:: gusA fusion) in pBI-121 binary vector to build a new binary vector using Overlap Extension PCR Cloning (OEPC) technique. Transient expression assay that was done by using agroinfiltration method was used to show functionality of these promoters. Qualitative and quantitative analysis from GUS assay showed that these promoters were functional and conferred a specific activity in tobacco seedlings (Nicotiana tabacum), tomato fruits (Solanum lycopersicum) and banana fruits (Musa acuminata). We hypothesized that MeEF1A6 could be categorized as a constitutive promoter because it was able to drive the gene expression in all transformed tissue described in here and also comparable to CaMV35S. On the other hand, MeEF1A3 drove specific expression in the aerial parts of seedlings such as hypocotyl and cotyledon thus MeEF1A5 drove specific expression in fruit tissue. The results obtained from transient analysis showed that these promoters had a distinct activity although they came from same gene family. The DNA sequences identified here are new promoters potentially use for genetic engineering in cassava or other plants.	[Suhandono, Sony; Apriyanto, Ardha; Ihsani, Nisa] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Jawa Barat, Indonesia	Institute Technology of Bandung	Apriyanto, A (corresponding author), Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Jawa Barat, Indonesia.	ardha-s2@sith.itb.ac.id	Apriyanto, Ardha/ABC-6407-2021	Apriyanto, Ardha/0000-0001-9032-2983; Suhandono, Sony/0000-0002-2248-3520; Ihsani, Nisa/0000-0002-4595-0806	Hibah Kompetensi, Directorate General of Higher Education, Department of Education, Indonesia	Hibah Kompetensi, Directorate General of Higher Education, Department of Education, Indonesia	This research was partly funded by Hibah Kompetensi 2009-2010, Directorate General of Higher Education, Department of Education, Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR F, 1991, PLANT MOL BIOL, V17, P351, DOI 10.1007/BF00040630; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; AXELOS M, 1989, MOL GEN GENET, V219, P106, DOI 10.1007/BF00261164; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berberich T, 1995, PLANT MOL BIOL, V29, P611, DOI 10.1007/BF00020988; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bukovnik U, 2009, FUNCT PLANT BIOL, V36, P234, DOI 10.1071/FP08266; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Carneiro NP, 1999, PLANT MOL BIOL, V41, P801, DOI 10.1023/A:1006391207980; Ceballos H, 2010, HANDB PLANT BREED; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; CURIE C, 1993, MOL GEN GENET, V238, P428, DOI 10.1007/BF00292002; CURIE C, 1991, NUCLEIC ACIDS RES, V19, P1305, DOI 10.1093/nar/19.6.1305; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2009, GENEIOUS; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gallie DR, 1998, BIOCHEM BIOPH RES CO, V245, P295, DOI 10.1006/bbrc.1998.8427; Gaspin C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-283; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; GOODALL GJ, 1991, EMBO J, V10, P2635, DOI 10.1002/j.1460-2075.1991.tb07806.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Higo K, 1999, PLANT CIS ACTING REG; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Jefferson R A, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KAUR KJ, 1994, J BIOL CHEM, V269, P23045; KAWAHARA R, 1992, EUR J BIOCHEM, V209, P157, DOI 10.1111/j.1432-1033.1992.tb17272.x; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kidou S, 1998, PLANT MOL BIOL, V36, P137, DOI 10.1023/A:1005960721762; Koehorst-van Putten HJJ, 2012, PLANTA, V236, P1955, DOI 10.1007/s00425-012-1796-6; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ZY, 1999, ACTA BOT SIN, V41, P800; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; MAHE A, 1992, MOL PLANT MICROBE IN, V5, P242, DOI 10.1094/MPMI-5-242; Manevski A, 2000, FEBS LETT, V483, P43, DOI 10.1016/S0014-5793(00)02056-1; Manevski A, 1999, MOL GEN GENET, V261, P892, DOI 10.1007/s004380051036; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MORELLI JK, 1994, PLANT PHYSIOL, V106, P897, DOI 10.1104/pp.106.3.897; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; POKALSKY AR, 1989, NUCLEIC ACIDS RES, V17, P4661, DOI 10.1093/nar/17.12.4661; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Ransom-Hodgkins WD, 2009, MOL GENET GENOMICS, V281, P391, DOI 10.1007/s00438-008-0418-2; REGAD F, 1995, MOL GEN GENET, V248, P703, DOI 10.1007/BF02191710; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; SHEWMAKER CK, 1990, NUCLEIC ACIDS RES, V18, P4276, DOI 10.1093/nar/18.14.4276; Shin D, 2009, PLANT SCI, V177, P156, DOI 10.1016/j.plantsci.2009.05.003; Suhandono S, 2001, EUPHYTICA, V120, P49, DOI 10.1023/A:1017543318423; Suhandono S, 2000, THESIS U NEW CASTLE; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Toueille M, 2007, PLANT PHYSIOL BIOCH, V45, P113, DOI 10.1016/j.plaphy.2007.01.006; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; VAYDA ME, 1995, PLANT MOL BIOL, V28, P751, DOI 10.1007/BF00021198; Vedel V, 2011, PLANT SCI, V180, P182, DOI 10.1016/j.plantsci.2010.09.009; Vijaykumar D, 2002, PLANT SCI, V162, P315, DOI 10.1016/S0168-9452(01)00579-9; Wang AiQin, 2008, Sugar Tech, V10, P119, DOI 10.1007/s12355-008-0020-2; Watillon B, 1998, PHYSIOL PLANTARUM, V104, P1, DOI 10.1034/j.1399-3054.1998.1040101.x; Xu WL, 2007, GENE, V389, P27, DOI 10.1016/j.gene.2006.09.014; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Yang MZ, 2003, CROP SCI, V43, P1805, DOI 10.2135/cropsci2003.1805; YANG WN, 1993, J BIOL CHEM, V268, P392	75	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84692	10.1371/journal.pone.0084692	http://dx.doi.org/10.1371/journal.pone.0084692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404183	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460800062
J	Lu, HD; Dai, YH; Lv, LL; Zhao, HQ				Lu, Huading; Dai, Yuhu; Lv, Lulu; Zhao, Huiqing			Chitosan-Graft-Polyethylenimine/DNA Nanoparticles as Novel Non-Viral Gene Delivery Vectors Targeting Osteoarthritis	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENIMINE; ADMINISTRATION IN-VIVO; TRANSFECTION EFFICIENCY; PHYSICOCHEMICAL PROPERTIES; DNA DELIVERY; VITRO; POLY(ETHYLENIMINE); COMPLEXES; SYSTEM; LUNG	The development of safe and efficient gene carriers is the key to the clinical success of gene therapy. The present study was designed to develop and evaluate the chitosan-graft-polyethylenimine (CP)/DNA nanoparticles as novel non-viral gene vectors for gene therapy of osteoarthritis. The CP/DNA nanoparticles were produced through a complex coacervation of the cationic polymers with pEGFP after grafting chitosan (CS) with a low molecular weight (Mw) PEI (Mw = 1.8 kDa). Particle size and zeta potential were related to the weight ratio of CP: DNA, where decreases in nanoparticle size and increases in surface charge were observed as CP content increased. The buffering capacity of CP was significantly greater than that of CS. The transfection efficiency of CP/DNA nanoparticles was similar with that of the Lipofectamine (TM) 2000, and significantly higher than that of CS/DNA and PEI (25 kDa)/DNA nanoparticles. The transfection efficiency of the CP/DNA nanoparticles was dependent on the weight ratio of CP: DNA (w/w). The average cell viability after the treatment with CP/DNA nanoparticles was over 90% in both chondrocytes and synoviocytes, which was much higher than that of PEI (25 kDa)/DNA nanoparticles. The CP copolymers efficiently carried the pDNA inside chondrocytes and synoviocytes, and the pDNA was detected entering into nucleus. These results suggest that CP/DNA nanoparticles with improved transfection efficiency and low cytotoxicity might be a safe and efficient non-viral vector for gene delivery to both chondrocytes and synoviocytes.	[Lu, Huading; Dai, Yuhu; Lv, Lulu; Zhao, Huiqing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lu, HD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China.	johnniehuading@163.com			National Natural Science Foundation of China [81272040, 30600632]; Natural Science Foundation of Guangdong Province, P.R. China [S2011010004808]; Science and Technology Projects of Guangdong Province, P.R. China [2012B031800451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, P.R. China(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province, P.R. China	This study was supported by the National Natural Science Foundation of China (No. 81272040; 30600632), the Natural Science Foundation of Guangdong Province, P.R. China (No. S2011010004808), and the Science and Technology Projects of Guangdong Province, P.R. China (No. 2012B031800451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Chang KL, 2010, BIOCONJUGATE CHEM, V21, P1087, DOI 10.1021/bc1000609; Chang Y, 2009, J ETHNOPHARMACOL, V121, P43, DOI 10.1016/j.jep.2008.09.028; Choi S, 2008, J CONTROL RELEASE, V131, P70, DOI 10.1016/j.jconrel.2008.07.007; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Feng M, 2006, INT J PHARMACEUT, V311, P209, DOI 10.1016/j.ijpharm.2005.12.035; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Gao Y, 2008, INT J PHARMACEUT, V359, P241, DOI 10.1016/j.ijpharm.2008.03.037; Gao Y, 2009, INT J PHARMACEUT, V371, P156, DOI 10.1016/j.ijpharm.2008.12.012; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Hashimoto M, 2006, BIOCONJUGATE CHEM, V17, P309, DOI 10.1021/bc050228h; Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3; Honjo K, 2010, J GENE MED, V12, P219, DOI 10.1002/jgm.1378; Huang MJ, 2012, MED HYPOTHESES, V79, P614, DOI 10.1016/j.mehy.2012.07.035; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Jere D, 2009, INT J PHARMACEUT, V378, P194, DOI 10.1016/j.ijpharm.2009.05.046; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Jiang HL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025013; Kichler A, 2005, J GENE MED, V7, P1459, DOI 10.1002/jgm.805; Kim TH, 2005, J CONTROL RELEASE, V105, P354, DOI 10.1016/j.jconrel.2005.03.024; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327; Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492; Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449; Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Petersen H, 2002, BIOMACROMOLECULES, V3, P926, DOI 10.1021/bm025539z; Pi YB, 2011, BIOMATERIALS, V32, P6324, DOI 10.1016/j.biomaterials.2011.05.017; Rekha M R, 2012, Recent Pat DNA Gene Seq, V6, P98; Sezer AD, 2009, AAPS PHARMSCITECH, V10, P1193, DOI 10.1208/s12249-009-9324-0; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; Sun XL, 2010, MINI-REV MED CHEM, V10, P108, DOI 10.2174/138955710791185109; Tiera MJ, 2011, CURR GENE THER, V11, P288; Tripathi SK, 2012, NANOMED-NANOTECHNOL, V8, P337, DOI 10.1016/j.nano.2011.06.022; Tseng WC, 2004, J GENE MED, V6, P895, DOI 10.1002/jgm.572; Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597; Zhang XL, 2006, BIOCHEM BIOPH RES CO, V341, P202, DOI 10.1016/j.bbrc.2005.12.171; Zhao QQ, 2008, J BIOSCI BIOENG, V105, P65, DOI 10.1263/jbb.105.65; Zhao QQ, 2009, BIOL PHARM BULL, V32, P706, DOI 10.1248/bpb.32.706	43	95	103	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84703	10.1371/journal.pone.0084703	http://dx.doi.org/10.1371/journal.pone.0084703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392152	Green Published, gold			2022-12-25	WOS:000329460100075
J	Liu, Q; Li, H; Wang, NF; Chen, HH; Jin, QH; Zhang, RY; Wang, J; Chen, Y				Liu, Qiang; Li, Hong; Wang, Ningfu; Chen, Huaihong; Jin, Qihui; Zhang, Ruoyu; Wang, Jing; Chen, Ying			Polymorphism of rs1836882 in NOX4 Gene Modifies Associations between Dietary Caloric Intake and ROS Levels in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; SUPEROXIDE-PRODUCTION; WEIGHT-LOSS; OLD MICE; RESTRICTION; DISEASE; OBESITY	Excessive caloric intake is a contributing risk factor for human metabolic disorders. Caloric restriction may prolong a person's life by lowering the incidence of deadly diseases. Reactive oxygen species (ROS) in peripheral blood mononuclear cells (PBMC) have been associated with the biochemical basis of the relationship between caloric intake and pathophysiologic processes. Polymorphisms associated with ROS generation genes are being increasingly implicated in inter-individual responses to daily caloric intake alterations. In the current study, a single nucleotide polymorphism, rs1836882, in the nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) gene's promoter region was found to modulate associations between dietary caloric intake and ROS levels in PBMC. Based on rs1836882, 656 Chinese Han participants were classified into CC, CT and TT genotypes. ROS levels in PBMC were significantly higher in the CC or CT genotypes compared with the TT genotype with the same increases in daily caloric intake. Using an electrophoretic mobility shift assay, NOX4 promoter region with rs1836882 (T) was observed to have a higher affinity for hepatocyte nuclear factor gamma (HNF3y) protein than rs1836882 (C). HNF3. protein over-expression decreased NOX4 gene transcriptional activity in the TT genotype more than in the CC genotype (5.68% vs. 2.12%, P < 0.05) in a dual luciferase reporter assay. By silencing the NOX4 gene using small interfering RNA or over-expressing HNF3. using an expression plasmid, serum from high dietary caloric intake participants decreased ROS levels in PBMC of the TT genotype more than in the CC or CT genotype via HNF3. down-regulating the NOX4 gene expression signaling pathway. This is the first study to report on the functions of phenotypes of rs1836882 in the NOX4 gene, and it suggests rs1836882 as a candidate gene for interpreting inter-individual ROS levels differences in PBMC induced by alterations in daily caloric intake.	[Liu, Qiang; Chen, Huaihong; Jin, Qihui; Zhang, Ruoyu; Wang, Jing; Chen, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gerontol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Hong; Wang, Ningfu] Nanjing Med Univ, Dept Cardiol, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Nanjing Medical University	Li, H (corresponding author), Nanjing Med Univ, Dept Cardiol, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China.	rainbowheart2003@126.com	chen, ying/HHS-8254-2022		Public Welfare Projects of Science and Technology Department of Zhejiang Province [2011C23016]; Zhejiang Provincial Natural Science Foundation [Y2110033]; Zhejiang Provincial Qianjiang Talent Plan [2012R10041]	Public Welfare Projects of Science and Technology Department of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Qianjiang Talent Plan	This research was supported by The Public Welfare Projects of Science and Technology Department of Zhejiang Province (2011C23016), The Zhejiang Provincial Natural Science Foundation(Y2110033) and The Zhejiang Provincial Qianjiang Talent Plan(2012R10041). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Banasik K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-10; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148; Calo LA, 2011, BLOOD PRESSURE, V20, P376, DOI 10.3109/08037051.2011.575570; Cariello M, 2012, ANTIOXID REDOX SIGN, V16, P428, DOI 10.1089/ars.2011.4062; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103; El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003; Fenyo IM, 2011, VASC PHARMACOL, V54, P100, DOI 10.1016/j.vph.2011.03.006; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; Guo JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051082; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Ivanova Diana G, 2013, Folia Med (Plovdiv), V55, P33; Jenkins NT, 2011, J APPL PHYSIOL, V111, P929, DOI 10.1152/japplphysiol.00541.2011; Ketonen J, 2010, HEART VESSELS, V25, P254, DOI 10.1007/s00380-009-1182-x; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kofler PA, 2013, PLANTA MED, V79, P244, DOI 10.1055/s-0032-1328129; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Lee MS, 2006, ASIA PAC J CLIN NUTR, V15, P161; Li JZ, 2012, CAN J PHYSIOL PHARM, V90, P1569, DOI 10.1139/y2012-140; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu Qiang, 2012, Yichuan, V34, P573, DOI 10.3724/SP.J.1005.2012.00573; Matsuo T, 2012, OBESITY, V20, P1122, DOI 10.1038/oby.2011.322; Moreno Maria de Ujue, 2011, Front Biosci (Elite Ed), V3, P1467; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pisciotta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050542; Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x; Rothman SM, 2012, ANN NY ACAD SCI, V1264, P49, DOI 10.1111/j.1749-6632.2012.06525.x; Sevastianova K, 2011, AM J CLIN NUTR, V94, P104, DOI 10.3945/ajcn.111.012369; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stasi MA, 2010, ARTERIOSCL THROM VAS, V30, P426, DOI 10.1161/ATVBAHA.109.201533; Vaccaro O, 2007, DIABETES CARE, V30, P1156, DOI 10.2337/dc06-1153; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang M, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt139	46	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85660	10.1371/journal.pone.0085660	http://dx.doi.org/10.1371/journal.pone.0085660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392026	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900170
J	Ozer, A; Yuan, GH; Yang, GB; Wang, F; Li, WT; Yang, Y; Guo, F; Gao, QP; Shoff, L; Chen, Z; Gay, IC; Donly, KJ; MacDougall, M; Chen, S				Ozer, Alkan; Yuan, Guohua; Yang, Guobin; Wang, Feng; Li, Wentong; Yang, Yuan; Guo, Feng; Gao, Qingping; Shoff, Lisa; Chen, Zhi; Gay, Isabel C.; Donly, Kevin J.; MacDougall, Mary; Chen, Shuo			Domain of Dentine Sialoprotein Mediates Proliferation and Differentiation of Human Periodontal Ligament Stem Cells	PLOS ONE			English	Article							SIALOPHOSPHOPROTEIN DSPP; IN-VITRO; EXPRESSION PATTERNS; BONE-FORMATION; PHOSPHOPROTEIN; GROWTH; OSTERIX; GENE; BMP2; OSTEOPROTEGERIN	Classic embryological studies have documented the inductive role of root dentin on adjacent periodontal ligament differentiation. The biochemical composition of root dentin includes collagens and cleavage products of dentin sialophosphoprotein (DSPP), such as dentin sialoprotein (DSP). The high abundance of DSP in root dentin prompted us to ask the question whether DSP or peptides derived thereof would serve as potent biological matrix components to induce periodontal progenitors to further differentiate into periodontal ligament cells. Here, we test the hypothesis that domain of DSP influences cell fate. In situ hybridization and immunohistochemical analyses showed that the COOH-terminal DSP domain is expressed in mouse periodontium at various stages of root development. The recombinant COOH-terminal DSP fragment (rC-DSP) enhanced attachment and migration of human periodontal ligament stem cells (PDLSC), human primary PDL cells without cell toxicity. rC-DSP induced PDLSC cell proliferation as well as differentiation and mineralization of PDLSC and PDL cells by formation of mineralized tissue and ALPase activity. Effect of rC-DSP on cell proliferation and differentiation was to promote gene expression of tooth/bone-relate markers, transcription factors and growth factors. The results for the first time showed that rC-DSP may be one of the components of cell niche for stimulating stem/progenitor cell proliferation and differentiation and a natural scaffold for periodontal regeneration application.	[Ozer, Alkan; Wang, Feng; Li, Wentong; Yang, Yuan; Guo, Feng; Gao, Qingping; Shoff, Lisa; Donly, Kevin J.; Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Dev Dent, San Antonio, TX 78229 USA; [Ozer, Alkan] Yuzuncu Yil Univ, Dept Orthodont, Fac Dent, Kampus Van, Turkey; [Yuan, Guohua; Yang, Guobin; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Yuan, Guohua; Yang, Guobin; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China; [Gay, Isabel C.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA; [MacDougall, Mary] Univ Alabama Birmingham, Dept Oral Maxillofacial Surg, Birmingham, AL USA	University of Texas System; University of Texas Health San Antonio; Yuzuncu Yil University; Wuhan University; Wuhan University; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham	Chen, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Dev Dent, San Antonio, TX 78229 USA.	Chens0@uthscsa.edu	Chen, Zhi/V-2214-2017; MacDougall, Mary/ABG-8212-2021	Chen, Zhi/0000-0003-2095-1324; 	National Institute of Dental and Craniofacial Research (NIDCR) [DE019892]; National Natural Science Foundation of China (NNSFC) [81000436]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019892] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by grants from the National Institute of Dental and Craniofacial Research (NIDCR) DE019892 and National Natural Science Foundation of China (NNSFC) No. 81000436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Akintoye SO, 2008, CLIN ORAL IMPLAN RES, V19, P1197, DOI 10.1111/j.1600-0501.2008.01592.x; Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Cao ZG, 2012, J BONE MINER RES, V27, P1080, DOI 10.1002/jbmr.1552; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dunn MD, 2007, BONE, V41, P446, DOI 10.1016/j.bone.2007.04.194; Egusa H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012743; Evans ND, 2010, BIOMATERIALS, V31, P3244, DOI 10.1016/j.biomaterials.2010.01.039; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Feng JS, 2012, J MOL HISTOL, V43, P473, DOI 10.1007/s10735-012-9423-1; Feng JS, 2011, CELLS TISSUES ORGANS, V194, P216, DOI 10.1159/000324644; GAY I, 2013, J RES PERIODONT 0513, P14242, DOI DOI 10.1111/JRE.12086.[; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x; GOULD TRL, 1980, J PERIODONTAL RES, V15, P20, DOI 10.1111/j.1600-0765.1980.tb00258.x; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee SY, 2012, J DENT RES, V91, P407, DOI 10.1177/0022034511436113; Luan XG, 2006, STEM CELLS DEV, V15, P595, DOI 10.1089/scd.2006.15.595; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200; Park JC, 2011, J CLIN PERIODONTOL, V38, P721, DOI 10.1111/j.1600-051X.2011.01716.x; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pitaru S, 2002, CONNECT TISSUE RES, V43, P257, DOI 10.1080/03008200290001276; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Silva TA, 2004, CALCIFIED TISSUE INT, V74, P532, DOI 10.1007/s00223-003-0159-5; Silverio KG, 2010, J PERIODONTOL, V81, P1207, DOI 10.1902/jop.2010.090729; Singhatanadgit W, 2009, TISSUE ENG PT A, V15, P2625, DOI [10.1089/ten.tea.2008.0442, 10.1089/ten.TEA.2008.0442]; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tang LA, 2011, J CELL PHYSIOL, V226, P832, DOI 10.1002/jcp.22405; Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wu L, 2008, CELLS TISSUES ORGANS, V187, P103, DOI 10.1159/000110079; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yuan GH, 2012, CELL TISSUE RES, V349, P605, DOI 10.1007/s00441-012-1418-4; Yuan GH, 2009, CELL BIOL INT, V33, P816, DOI 10.1016/j.cellbi.2009.05.001; Yun YR, 2012, PROTEIN EXPRES PURIF, V83, P47, DOI 10.1016/j.pep.2012.03.005; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhou JP, 2011, J OROFAC ORTHOP, V72, P457, DOI 10.1007/s00056-011-0050-3	72	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81655	10.1371/journal.pone.0081655	http://dx.doi.org/10.1371/journal.pone.0081655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24400037	Green Published, gold, Green Submitted			2022-12-25	WOS:000327947800052
J	Schuld, NJ; Vervacke, JS; Lorimer, EL; Simon, NC; Hauser, AD; Barbieri, JT; Distefano, MD; Williams, CL				Schuld, Nathan J.; Vervacke, Jeffrey S.; Lorimer, Ellen L.; Simon, Nathan C.; Hauser, Andrew D.; Barbieri, Joseph T.; Distefano, Mark D.; Williams, Carol L.			The Chaperone Protein SmgGDS Interacts with Small GTPases Entering the Prenylation Pathway by Recognizing the Last Amino Acid in the CAAX Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Isoprenoid; Protein Complexes; Protein Farnesylation; Protein Isoprenylation; Small GTPases; FTI; GGTI; K-Ras; Rap1; SmgGDS	GTP EXCHANGE PROTEIN; TRANSFERASE INHIBITOR R115777; PROSTATE-CANCER; PLASMA-MEMBRANE; FARNESYL DIPHOSPHATE; PHOTOACTIVE ANALOGS; POLYBASIC DOMAIN; BINDING PROTEINS; ONCOGENIC RAS; I-TASSER	Background: SmgGDS-607 and SmgGDS-558 regulate GTPase movement through the prenylation pathway. Results: The specificity of SmgGDS for GTPases depends on the GTPase CAAX sequence and the cellular context. Conclusion: SmgGDS-607 binds to nonprenylated GTPases that end in a leucine and enter the geranylgeranylation pathway. Significance: The identification of SmgGDS-607 as a novel CAAX-binding protein will accelerate the development of more effective cancer therapeutics. Ras family small GTPases localize at the plasma membrane, where they can activate oncogenic signaling pathways. Understanding the mechanisms that promote membrane localization of GTPases will aid development of new therapies to inhibit oncogenic signaling. We previously reported that SmgGDS splice variants promote prenylation and trafficking of GTPases containing a C-terminal polybasic region and demonstrated that SmgGDS-607 interacts with nonprenylated GTPases, whereas SmgGDS-558 interacts with prenylated GTPases in cells. The mechanism that SmgGDS-607 and SmgGDS-558 use to differentiate between prenylated and nonprenylated GTPases has not been characterized. Here, we provide evidence that SmgGDS-607 associates with GTPases through recognition of the last amino acid in the CAAX motif. We show that SmgGDS-607 forms more stable complexes in cells with nonprenylated GTPases that will become geranylgeranylated than with nonprenylated GTPases that will become farnesylated. These binding relationships similarly occur with nonprenylated SAAX mutants. Intriguingly, farnesyltransferase inhibitors increase the binding of WT K-Ras to SmgGDS-607, indicating that the pharmacological shunting of K-Ras into the geranylgeranylation pathway promotes K-Ras association with SmgGDS-607. Using recombinant proteins and prenylated peptides corresponding to the C-terminal sequences of K-Ras and Rap1B, we found that both SmgGDS-607 and SmgGDS-558 directly bind the GTPase C-terminal region, but the specificity of the SmgGDS splice variants for prenylated versus nonprenylated GTPases is diminished in vitro. Finally, we present structural homology models and data from functional prediction software to define both similar and unique features of SmgGDS-607 when compared with SmgGDS-558.	[Schuld, Nathan J.; Lorimer, Ellen L.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Simon, Nathan C.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol Immunol & Mol Genet, Milwaukee, WI 53226 USA; [Hauser, Andrew D.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Vervacke, Jeffrey S.; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55414 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities	Williams, CL (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	williams@mcw.edu		Vervacke, Jeffrey/0000-0002-9903-6219	National Institutes of Health [R01 CA136799, R01 GM084152, GM106082, R01 AI30162, U54 AI057153]; Medical College of Wisconsin Cancer Center; Wisconsin Breast Cancer Showhouse; Rock River Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA136799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI030162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084152, R01GM106082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin Cancer Center; Wisconsin Breast Cancer Showhouse; Rock River Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136799 (to C.L.W.), R01 GM084152 and GM106082 (to M.D.D.), and R01 AI30162 and U54 AI057153 (to J.T.B.). This work was also supported by funds from the Medical College of Wisconsin Cancer Center (to C.L.W.), the Wisconsin Breast Cancer Showhouse (to C.L.W.), and the Rock River Cancer Research Foundation (to C.L.W.).	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; ISOMURA M, 1991, ONCOGENE, V6, P119; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kale TA, 2001, J AM CHEM SOC, V123, P4373, DOI 10.1021/ja0012016; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; KOTANI K, 1992, ONCOGENE, V7, P1699; Kyro K, 2011, BIOORGAN MED CHEM, V19, P7559, DOI 10.1016/j.bmc.2011.10.027; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Lloyd AC, 1998, CURR OPIN GENET DEV, V8, P43, DOI 10.1016/S0959-437X(98)80060-9; Lobell RB, 2001, CANCER RES, V61, P8758; Macdonald JS, 2005, INVEST NEW DRUG, V23, P485, DOI 10.1007/s10637-005-2908-y; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maresso AW, 2002, PROTEIN EXPRES PURIF, V26, P432, DOI 10.1016/S1046-5928(02)00544-2; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Rao S, 2004, J CLIN ONCOL, V22, P3950, DOI 10.1200/JCO.2004.10.037; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126; SHIRATAKI H, 1991, J BIOL CHEM, V266, P20672; Stenmark H, 2001, GENOME BIOL, V2; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Turek TC, 1997, BIOORG MED CHEM LETT, V7, P2125, DOI 10.1016/S0960-894X(97)00373-9; Turek TC, 1997, J LABELLED COMPD RAD, V39, P139, DOI 10.1002/(SICI)1099-1344(199702)39:2<139::AID-JLCR951>3.0.CO;2-A; Turek TC, 2001, J ORG CHEM, V66, P3253, DOI 10.1021/jo991130x; Vervacke JS, 2013, CURR MED CHEM, V20, P1585; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; VIOLA MV, 1986, NEW ENGL J MED, V314, P133, DOI 10.1056/NEJM198601163140301; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	57	30	30	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6862	6876		10.1074/jbc.M113.527192	http://dx.doi.org/10.1074/jbc.M113.527192			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415755	Green Published, hybrid			2022-12-25	WOS:000332389400047
J	Fok, WC; Chen, YD; Bokov, A; Zhang, YQ; Salmon, AB; Diaz, V; Javors, M; Wood, WH; Zhang, YQ; Becker, KG; Perez, VI; Richardson, A				Fok, Wilson C.; Chen, Yidong; Bokov, Alex; Zhang, Yiqiang; Salmon, Adam B.; Diaz, Vivian; Javors, Martin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.; Perez, Viviana I.; Richardson, Arlan			Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome	PLOS ONE			English	Article							GENETICALLY HETEROGENEOUS MICE; INDUCED INSULIN-RESISTANCE; LARGE GENE LISTS; GROWTH-FACTOR; C-ELEGANS; DIETARY RESTRICTION; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; OXIDATIVE STRESS; DOWN-REGULATION	Rapamycin was found to increase (11% to 16%) the lifespan of male and female C57BL/6J mice most likely by reducing the increase in the hazard for mortality (i.e., the rate of aging) term in the Gompertz mortality analysis. To identify the pathways that could be responsible for rapamycin's longevity effect, we analyzed the transcriptome of liver from 25-month-old male and female mice fed rapamycin starting at 4 months of age. Few changes (<300 transcripts) were observed in transcriptome of rapamycin-fed males; however, a large number of transcripts (>4,500) changed significantly in females. Using multidimensional scaling and heatmap analyses, the male mice fed rapamycin were found to segregate into two groups: one group that is almost identical to control males (Rapa-1) and a second group (Rapa-2) that shows a change in gene expression (>4,000 transcripts) with more than 60% of the genes shared with female mice fed Rapa. Using ingenuity pathway analysis, 13 pathways were significantly altered in both Rapa-2 males and rapamycin-fed females with mitochondrial function as the most significantly changed pathway. Our findings show that rapamycin has a major effect on the transcriptome and point to several pathways that would likely impact the longevity.	[Fok, Wilson C.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Bokov, Alex; Zhang, Yiqiang; Salmon, Adam B.; Diaz, Vivian; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Chen, Yidong; Bokov, Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Zhang, Yiqiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Javors, Martin] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.] NIA, Baltimore, MD 21224 USA; [Perez, Viviana I.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Salmon, Adam B.; Richardson, Arlan] Audie Murphy VA Hosp STVHCS, Res Serv, San Antonio, TX USA; [Salmon, Adam B.; Richardson, Arlan] Audie Murphy VA Hosp STVHCS, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon State University; Geriatric Research Education & Clinical Center	Richardson, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	richardsona@uthscsa.edu	Zhang, Yiqiang/AAA-3143-2019; Bokov, Alex/O-9952-2014	Fok, Wilson Chun Yim/0000-0003-3289-2093; Bokov, Alex/0000-0002-0511-9815; Salmon, Adam/0000-0002-1475-7843; Becker, Kevin/0000-0002-6794-6656	San Antonio Nathan Shock Aging Center [1p30-AG-13319]; National Institutes of Health (NIH) [AG036613, AG021890]; Ellison Medical Foundation; Intramural Research Program of the NIH, National Institute on Aging; VA Merit grant from the Department of Veteran Affairs; National Institute on Minority Health and Health Disparities from the NIH [G12MD007591]; NATIONAL INSTITUTE ON AGING [RC2AG036613, ZICAG000616, T32AG021890] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	San Antonio Nathan Shock Aging Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA Merit grant from the Department of Veteran Affairs; National Institute on Minority Health and Health Disparities from the NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Financial support was provided by The San Antonio Nathan Shock Aging Center (1p30-AG-13319, AR), National Institutes of Health (NIH) RC2 Grand Opportunity grant (AG036613, AR), NIH T32 Training Grant (AG021890, WF), the Ellison Medical Foundation (VP), the Intramural Research Program of the NIH, National Institute on Aging, and VA Merit grant (Richardson) from the Department of Veteran Affairs. Computation Support was provided by the Computational System Biology Core funded by the National Institute on Minority Health and Health Disparities (G12MD007591) from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Bronikowski Anne, 2010, NAT ED KNOWL, V1; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chang SB, 2007, J SURG RES, V138, P37, DOI 10.1016/j.jss.2006.07.003; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Drake JC, 2013, J GERONTOL A; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Habib A, 2013, ARTERIOSCL THROM VAS, V33, P2425, DOI 10.1161/ATVBAHA.113.301659; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hine Christopher M, 2012, J Clin Exp Pathol, VS4; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huyghe E, 2007, TRANSPL INT, V20, P305, DOI 10.1111/j.1432-2277.2006.00423.x; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; Zhang Y, 2013, J GERONTOL A	53	87	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83988	10.1371/journal.pone.0083988	http://dx.doi.org/10.1371/journal.pone.0083988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409289	Green Published, gold, Green Submitted			2022-12-25	WOS:000329463500013
J	Yamakawa, RH; Saito, PK; da Silva, WV; de Mattos, LC; Borelli, SD				Yamakawa, Roger Haruki; Saito, Patricia Keiko; da Silva Junior, Waldir Verissimo; de Mattos, Luiz Carlos; Borelli, Sueli Donizete			Polymorphism of Leukocyte and Erythrocyte Antigens in Chronic Kidney Disease Patients in Southern Brazil	PLOS ONE			English	Article							DUFFY BLOOD-GROUP; STAGE RENAL-DISEASE; NEGATIVE INDIVIDUALS; CHEMOKINE RECEPTOR; HLA POLYMORPHISM; VOLUNTEER DONORS; CODING SEQUENCE; 5 CONTINENTS; GENE; POPULATIONS	We investigated the polymorphism of human leukocyte antigens (HLA) and Duffy erythrocyte antigens in chronic kidney disease (CKD) patients in southern Brazil. One hundred and eighty-three CKD patients, over 18 years old, on hemodialysis, were included. HLA-A, -B and -DRB1 typing was performed using the LABType(R)SSO (One Lambda, Inc.). Duffy phenotypes were determined by gel column agglutination using anti-Fy(a) and anti-Fy(b) monoclonal anti-sera. The patients' predominant ages ranged between 51 and 70 years (43%) and the predominant gender, ethnic group and dialysis period were, respectively, male (62%), white (62%) and 1-3 years (40%). The highest and lowest frequencies of Duffy phenotypes were Fy(a+b+) and Fy(a-b-), respectively. Nineteen HLA-A, 30 HLA-B and 13 HLA-DRB1 allele groups were identified. The most frequent HLA allele groups were HLA-A*01, -A*02, -A*03, -A*11, -A*24; HLA-B*07, -B*15, -B*35, -B*44, -B*51; HLA-DRB1*03, -DRB1*04, -DRB1*07, -DRB1*11 and -DRB1*13. Statistically significant differences were observed in the Duffy and HLA polymorphisms compared between CKD patients and healthy subjects. The Fy(a+b-) phenotype (p<0.0001, OR = 2.56, 95% CI = 1.60-4.07) was the most frequent in the patients (p<0.05), and the Fy(a+b+) phenotype (p = 0.0039, OR = 1.71, 95% CI = 1.18-2.51) was the most frequent in the healthy subjects in the same region of Parana state (p<0.05). Regarding HLA, the HLA-B*42, -B*45, -B*51 and -DRB1*03 allele groups were the most frequent in the patients (p<0.05), and the HLA-B*44 allele group was the most frequent in the healthy subjects in the same region of Brazil (p<0.05). The polymorphism of these two markers among CKD patients in southern Brazil and healthy subjects of other studies, suggests that these markers might be involved with CKD development. Further studies should be undertaken to analyze the markers' influence on CKD and the long-term results from kidney transplantation.	[Yamakawa, Roger Haruki; Saito, Patricia Keiko; Borelli, Sueli Donizete] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil; [da Silva Junior, Waldir Verissimo] Univ Estadual Maringa, Dept Estat, Maringa, Parana, Brazil; [de Mattos, Luiz Carlos] Fac Med Sao Jose Do Rio Preto, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Borelli, SD (corresponding author), Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil.	sdborelli@uem.br	DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-3574-2019; de Mattos, Luiz Carlos/P-4005-2019	DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177	Araucaria Foundation [18952 - 08/2009]	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This study was supported by the Araucaria Foundation (grant number 18952 - 08/2009). The funder's website is http://www.fappr.pr.gov.br/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almogren A, 2012, BRIT J BIOMED SCI, V69, P159, DOI 10.1080/09674845.2012.12069145; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Crispim JC, 2008, TRANSPL P, V40, P1333, DOI 10.1016/j.transproceed.2008.02.086; Daniels G, 2002, TRANSFUSION MED, V12, P287, DOI 10.1046/j.1365-3148.2002.00399.x; Giarola Luciana Borges, 2012, BMC Res Notes, V5, P90, DOI 10.1186/1756-0500-5-90; Girard JP, 1999, AM J PATHOL, V155, P2043, DOI 10.1016/S0002-9440(10)65523-X; Gloor J, 2008, AM J TRANSPLANT, V8, P1367, DOI 10.1111/j.1600-6143.2008.02262.x; Guelsin Gláucia Andréia Soares, 2011, Rev. Bras. Hematol. Hemoter., V33, P21, DOI 10.5581/1516-8484.20110009; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; Janeway CA, 2002, IMUNOBIOLOGIA; Kaimen-Maciel DR, 2009, MOL MED REP, V2, P993, DOI 10.3892/mmr_00000204; Lerut E, 2007, TRANSFUSION, V47, P28, DOI 10.1111/j.1537-2995.2007.01060.x; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; MALLINSON G, 1995, BRIT J HAEMATOL, V90, P823, DOI 10.1111/j.1365-2141.1995.tb05202.x; Meny G M, 2010, Immunohematology, V26, P51; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Nigam P, 2004, TISSUE ANTIGENS, V64, P204, DOI 10.1111/j.1399-0039.2004.00264.x; Novaretti MC, 2000, REV BRAS HEMATOL HEM, V22, P23; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Probst CM, 2000, HUM BIOL, V72, P597; Rios M, 2000, BRIT J HAEMATOL, V108, P448; Ruiz TM, 2005, TRANSPL P, V37, P2293, DOI 10.1016/j.transproceed.2005.03.036; Segerer S, 2003, TRANSPLANTATION, V75, P1030, DOI 10.1097/01.TP.0000054679.91112.6F; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TRACHTENBERG A, 1988, ANN HUM BIOL, V15, P213, DOI 10.1080/03014468800009651; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Zarbock A, 2007, CRIT CARE MED, V35, P2156, DOI 10.1097/01.CCM.0000280570.82885.32	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84456	10.1371/journal.pone.0084456	http://dx.doi.org/10.1371/journal.pone.0084456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409300	gold, Green Submitted, Green Published			2022-12-25	WOS:000329463500024
J	Kim, DS; Lee, MW; Yoo, KH; Lee, TH; Kim, HJ; Jang, IK; Chun, YH; Kim, HJ; Park, SJ; Lee, SH; Son, MH; Jung, HL; Sung, KW; Koo, HH				Kim, Dae Seong; Lee, Myoung Woo; Yoo, Keon Hee; Lee, Tae-Hee; Kim, Hye Jin; Jang, In Keun; Chun, Yong Hoon; Kim, Hyung Joon; Park, Seung Jo; Lee, Soo Hyun; Son, Meong Hi; Jung, Hye Lim; Sung, Ki Woong; Koo, Hong Hoe			Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; BONE-MARROW; STROMAL CELLS; CXC CHEMOKINE; CORD BLOOD; MIGRATION; DIFFERENTIATION; PROLIFERATION; STIMULATION; EXPANSION	Previous studies conducted cell expansion ex vivo using low initial plating densities for optimal expansion and subsequent differentiation of mesenchymal stem cells (MSCs). However, MSC populations are heterogeneous and culture conditions can affect the characteristics of MSCs. In this study, differences in gene expression profiles of adipose tissue (AT)-derived MSCs were examined after harvesting cells cultured at different densities. AT-MSCs from three different donors were plated at a density of 200 or 5,000 cells/cm(2). After 7 days in culture, detailed gene expression profiles were investigated using a DNA chip microarray, and subsequently validated using a reverse transcription polymerase chain reaction (RT-PCR) analysis. Gene expression profiles were influenced primarily by the level of cell confluence at harvest. In MSCs harvested at similar to 90% confluence, 177 genes were up-regulated and 102 genes down-regulated relative to cells harvested at similar to 50% confluence (P<0.05, FC>2). Proliferation-related genes were highly expressed in MSCs harvested at low density, while genes that were highly expressed in MSCs harvested at high density (similar to 90% confluent) were linked to immunity and defense, cell communication, signal transduction and cell motility. Several cytokine, chemokine and growth factor genes involved in immunosuppression, migration, and reconstitution of damaged tissues were up-regulated in MSCs harvested at high density compared with MSCs harvested at low density. These results imply that cell density at harvest is a critical factor for modulating the specific gene-expression patterns of heterogeneous MSCs.	[Kim, Dae Seong; Lee, Myoung Woo; Yoo, Keon Hee; Kim, Hye Jin; Jang, In Keun; Park, Seung Jo; Lee, Soo Hyun; Son, Meong Hi; Jung, Hye Lim; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Tae-Hee] Sejong Univ, Plant Engn Inst, Dept Lab Canc & Stem Cell Biol, Seoul, South Korea; [Chun, Yong Hoon; Kim, Hyung Joon] Top Class Plast Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sejong University	Yoo, KH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	hema2170@skku.edu; hhkoo@skku.edu	Kim, Dae Seong/GLU-0329-2022	Park, Seungjo/0000-0002-2087-9628	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0089787]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0089787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2009, ANN THORAC SURG, V88, P1036, DOI 10.1016/j.athoracsur.2009.02.093; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Battiwalla M, 2009, CYTOTHERAPY, V11, P503, DOI 10.1080/14653240903193806; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Braun J, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0263; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Corre J, 2012, CANCER RES, V72, P1395, DOI 10.1158/0008-5472.CAN-11-0188; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Li JT, 2007, SCAND J IMMUNOL, V66, P555, DOI 10.1111/j.1365-3083.2007.02001.x; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Melief SM, 2013, STEM CELL TRANSL MED, V2, P455, DOI 10.5966/sctm.2012-0184; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Robinson SN, 2011, BEST PRACT RES CL HA, V24, P83, DOI 10.1016/j.beha.2010.11.001; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmal H, 2007, CYTOTHERAPY, V9, P69, DOI 10.1080/14653240601011557; Sezer O, 2001, EUR J HAEMATOL, V66, P83, DOI 10.1034/j.1600-0609.2001.00348.x; Shen W, 2012, ENDOCRINOLOGY, V153, P3482, DOI 10.1210/en.2011-1456; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Strieter Robert M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P23, DOI 10.2174/1568010053622902; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Webb TL, 2012, J FELINE MED SURG, V14, P165, DOI 10.1177/1098612X11429224; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	50	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83363	10.1371/journal.pone.0083363	http://dx.doi.org/10.1371/journal.pone.0083363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400072	Green Published, gold, Green Submitted			2022-12-25	WOS:000329462700006
J	Lee, RTH; Asharani, PV; Carney, TJ				Lee, Raymond T. H.; Asharani, P. V.; Carney, Thomas J.			Basal Keratinocytes Contribute to All Strata of the Adult Zebrafish Epidermis	PLOS ONE			English	Article							EXPRESSION; SKIN; DIFFERENTIATION; SPECIFICATION; MORPHOGENESIS; MECHANISMS; PROTEINS; ENVELOPE; PROMOTER; MARKER	The epidermis of terrestrial vertebrates is a stratified epithelium and forms an essential protective barrier. It is continually renewed, with dead corneocytes shed from the surface and replaced from a basal keratinocyte stem cell population. Whilst mouse is the prime model system used for epidermal studies, there is increasing employment of the zebrafish to analyse epidermis development and homeostasis, however the architecture and ontogeny of the epidermis in this system are incompletely described. In particular, it is unclear if adult zebrafish epidermis is derived entirely from the basal epidermal stem cell layer, as in the mouse, or if the most superficial keratinocyte layer is a remnant of the embryonic periderm. Furthermore, a relative paucity of cellular markers and genetic reagents to label and manipulate the basal epidermal stem cell compartment has hampered research. Here we show that the type I keratin, krtt1c19e, is a suitable marker of the basal epidermal layer and identify a krtt1c19e promoter fragment able to drive strong and specific expression in this cell type. Use of this promoter to express an inducible Cre recombinase allowed permanent labelling of basal cells during embryogenesis, and demonstrated that these cells do indeed generate keratinocytes of all strata in the adult epidermis. Further deployment of the Cre-Lox system highlighted the transient nature of the embryonic periderm. We thus show that the epidermis of adult zebrafish, as in the mouse, derives from basal stem cells, further expanding the similarities of epidermal ontogeny across vertebrates. Future use of this promoter will assist genetic analysis of basal keratinocyte biology in zebrafish.	[Lee, Raymond T. H.; Asharani, P. V.; Carney, Thomas J.] ASTAR, IMCB, Div Discovery Res, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Carney, TJ (corresponding author), ASTAR, IMCB, Div Discovery Res, Singapore, Singapore.	tcarney@imcb.a-star.edu.sg	Carney, Tom J/H-4389-2011; RANI, ASHA/AAF-8641-2019	Carney, Tom J/0000-0003-2371-1924; RANI, ASHA/0000-0001-8215-5214; Lee, Raymond Teck Ho/0000-0001-6522-3043	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, J INVEST DERMATOL, V112, P903, DOI 10.1046/j.1523-1747.1999.00592.x; Alibardi L, 2003, J EXP ZOOL PART B, V298B, P12, DOI 10.1002/jez.b.00024; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; BICKENBACH JR, 1995, J INVEST DERMATOL, V104, P405, DOI 10.1111/1523-1747.ep12665896; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Carney TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000907; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Fukazawa C, 2010, DEV BIOL, V346, P272, DOI 10.1016/j.ydbio.2010.07.037; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GLOVER CN, 2013, J COMP PHYSL B; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Imboden M, 1997, CR ACAD SCI III-VIE, V320, P689, DOI 10.1016/S0764-4469(97)84816-0; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; Janicke M, 2010, INT J DEV BIOL, V54, P837, DOI 10.1387/ijdb.092877mj; Kemp Hilary A, 2009, J Vis Exp, DOI 10.3791/1394; Kiener TK, 2008, DEV BIOL, V316, P36, DOI 10.1016/j.ydbio.2007.12.047; Kim SH, 2010, MATRIX BIOL, V29, P629, DOI 10.1016/j.matbio.2010.07.002; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; LEE RTH, 2013, CURRENT BIO IN PRESS, V23; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Padhi BK, 2006, GENE, V368, P37, DOI 10.1016/j.gene.2005.09.016; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Richardson R, 2013, J INVEST DERMATOL, V133, P1655, DOI 10.1038/jid.2013.16; Sabel JL, 2009, DEV BIOL, V325, P249, DOI 10.1016/j.ydbio.2008.10.031; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; vanEeden FJM, 1996, DEVELOPMENT, V123, P255	46	49	50	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84858	10.1371/journal.pone.0084858	http://dx.doi.org/10.1371/journal.pone.0084858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400120	Green Submitted, Green Published, gold			2022-12-25	WOS:000329462700054
J	Chiandetti, C; Pecchia, T; Patt, F; Vallortigara, G				Chiandetti, Cinzia; Pecchia, Tommaso; Patt, Francesco; Vallortigara, Giorgio			Visual Hierarchical Processing and Lateralization of Cognitive Functions through Domestic Chicks' Eyes	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; LIGHT EXPERIENCE; AVIAN BRAIN; PRECEDENCE; FEATURES; STIMULI; HUMANS; INFORMATION; ASYMMETRY; PIGEONS	Hierarchical stimuli have proven effective for investigating principles of visual organization in humans. A large body of evidence suggests that the analysis of the global forms precedes the analysis of the local forms in our species. Studies on lateralization also indicate that analytic and holistic encoding strategies are separated between the two hemispheres of the brain. This raises the question of whether precedence effects may reflect the activation of lateralized functions within the brain. Non-human animals have perceptual organization and functional lateralization that are comparable to that of humans. Here we trained the domestic chick in a concurrent discrimination task involving hierarchical stimuli. Then, we evaluated the animals for analytic and holistic encoding strategies in a series of transformational tests by relying on a monocular occlusion technique. A local precedence emerged in both the left and the right hemisphere, adding further evidence in favour of analytic processing in non-human animals.	[Chiandetti, Cinzia; Pecchia, Tommaso; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy; [Chiandetti, Cinzia; Patt, Francesco] Univ Trieste, Psychol Unit, Dept Life Sci, Trieste, Italy	University of Trento; University of Trieste	Chiandetti, C (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy.	cinzia.chiandetti@unitn.it		CHIANDETTI, CINZIA/0000-0002-7774-6068	Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro); Provincia Autonoma di Trento(Autonomous Province of Trento)	This research was supported by Fondazione Cassa di Risparmio di Trento e Rovereto and Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RJ, 2004, BEHAV BRAIN RES, V155, P67, DOI 10.1016/j.bbr.2004.04.016; Andrew RJ, 1991, USE CHICK MODEL; Cavoto KK, 2001, J EXP PSYCHOL-ANIM B, V27, P3, DOI 10.1037//0097-7403.27.1.3; Chiandetti C, 2011, BEHAV NEUROSCI, V125, P775, DOI 10.1037/a0024721; DELIS DC, 1988, J CLIN EXP NEUROPSYC, V10, P421, DOI 10.1080/01688638808408250; Deruelle C, 1998, PSYCHON B REV, V5, P476, DOI 10.3758/BF03208825; Diekamp B, 2005, CURR BIOL, V15, pR372, DOI 10.1016/j.cub.2005.05.017; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Legge ELG, 2009, BEHAV PROCESS, V80, P128, DOI 10.1016/j.beproc.2008.10.011; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; NAVON D, 1981, PSYCHOL RES-PSYCH FO, V43, P1, DOI 10.1007/BF00309635; Neiworth JJ, 2006, J COMP PSYCHOL, V120, P323, DOI 10.1037/0735-7036.120.4.323; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers Lesley J., 2002, P126, DOI 10.1017/CBO9780511546372.006; ROGERS LJ, 1982, NATURE, V297, P223, DOI 10.1038/297223a0; ROGERS LJ, 1979, PHARMACOL BIOCHEM BE, V10, P679, DOI 10.1016/0091-3057(79)90320-4; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Spinozzi G, 2003, J COMP PSYCHOL, V117, P15, DOI 10.1037/0735-7036.117.1.15; Tommasi L, 2001, BEHAV NEUROSCI, V115, P602, DOI 10.1037//0735-7044.115.3.602; Truppa V, 2010, BEHAV BRAIN RES, V207, P51, DOI 10.1016/j.bbr.2009.09.039; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Yamazaki Y, 2007, COGNITION, V104, P315, DOI 10.1016/j.cognition.2006.07.004	25	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84435	10.1371/journal.pone.0084435	http://dx.doi.org/10.1371/journal.pone.0084435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404163	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460800042
J	Van der Auwera, S; Bulla, I; Ziller, M; Pohlmann, A; Harder, T; Stanke, M				Van der Auwera, Sandra; Bulla, Ingo; Ziller, Mario; Pohlmann, Anne; Harder, Timm; Stanke, Mario			ClassyFlu: Classification of Influenza A Viruses with Discriminatively Trained Profile-HMMs	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PANDEMIC INFLUENZA	Accurate and rapid characterization of influenza A virus (IAV) hemagglutinin (HA) and neuraminidase (NA) sequences with respect to subtype and clade is at the basis of extended diagnostic services and implicit to molecular epidemiologic studies. ClassyFlu is a new tool and web service for the classification of IAV sequences of the HA and NA gene into subtypes and phylogenetic clades using discriminatively trained profile hidden Markov models (HMMs), one for each subtype or clade. ClassyFlu merely requires as input unaligned, full-length or partial HA or NA DNA sequences. It enables rapid and highly accurate assignment of HA sequences to subtypes H1-H17 but particularly focusses on the finer grained assignment of sequences of highly pathogenic avian influenza viruses of subtype H5N1 according to the cladistics proposed by the H5N1 Evolution Working Group. NA sequences are classified into subtypes N1-N10. ClassyFlu was compared to semiautomatic classification approaches using BLAST and phylogenetics and additionally for H5 sequences to the new "Highly Pathogenic H5N1 Clade Classification Tool" (IRD-CT) proposed by the Influenza Research Database. Our results show that both web tools (ClassyFlu and IRD-CT), although based on different methods, are nearly equivalent in performance and both are more accurate and faster than semiautomatic classification. A retraining of ClassyFlu to altered cladistics as well as an extension of ClassyFlu to other IAV genome segments or fragments thereof is undemanding. This is exemplified by unambiguous assignment to a distinct cluster within subtype H7 of sequences of H7N9 viruses which emerged in China early in 2013 and caused more than 130 human infections. http://bioinf.uni-greifswald.de/ClassyFlu is a free web service. For local execution, the ClassyFlu source code in PERL is freely available.	[Van der Auwera, Sandra; Bulla, Ingo; Stanke, Mario] Ernst Moritz Arndt Univ Greifswald, Inst Math & Comp Sci, Greifswald, Germany; [Ziller, Mario; Pohlmann, Anne; Harder, Timm] Fed Res Inst Anim Hlth, Greifswald, Germany; [Bulla, Ingo] Los Alamos Natl Lab, Grp T6, Los Alamos, NM USA	Ernst Moritz Arndt Universitat Greifswald; United States Department of Energy (DOE); Los Alamos National Laboratory	Stanke, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Math & Comp Sci, Greifswald, Germany.	mario.stanke@uni-greifswald.de	Stanke, Mario/P-7876-2019; Harder, Timm/AAE-2932-2019	Stanke, Mario/0000-0001-8696-0384; Harder, Timm/0000-0003-2387-378X	Deutsche Forschungsgemeinschaft [STA 1009/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft grant STA 1009/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2009, J VIROL METHODS, V160, P200, DOI 10.1016/j.jviromet.2009.05.004; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lam TTY, 2013, NATURE; Mak PWY, 2012, CLIN CHEM, V58, P1527, DOI 10.1373/clinchem.2012.182626; Meyer A, 2013, PHIL T R SOC B; Pleschka S, 2013, CURR TOP MICROBIOL, V370, P1, DOI 10.1007/82_2012_272; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2013, UPD UN NOM SYST HIGH; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	20	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84558	10.1371/journal.pone.0084558	http://dx.doi.org/10.1371/journal.pone.0084558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404173	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460800052
J	Chen, DW; Li, B; Aubeeluck, A; Yang, YF; Huang, YG; Zhou, JQ; Yu, GR				Chen, Da-wei; Li, Bing; Aubeeluck, Ashwin; Yang, Yun-feng; Huang, Yi-gang; Zhou, Jia-qian; Yu, Guang-rong			Anatomy and Biomechanical Properties of the Plantar Aponeurosis: A Cadaveric Study	PLOS ONE			English	Article							METATARSOPHALANGEAL JOINT; WINDLASS MECHANISM; HALLUX-RIGIDUS; HEEL PAIN; FOOT; FASCIA; CONSEQUENCES; FASCIOTOMY; KINEMATICS; RELEASE	Objectives: To explore the anatomy of the plantar aponeurosis (PA) and its biomechanical effects on the first metatarsophalangeal (MTP) joint and foot arch. Methods: Anatomic parameters (length, width and thickness of each central PA bundle and the main body of the central part) were measured in 8 cadaveric specimens. The ratios of the length and width of each bundle to the length and width of the central part were used to describe these bundles. Six cadaveric specimens were used to measure the range of motion of the first MTP joint before and after releasing the first bundle of the PA. Another 6 specimens were used to evaluate simulated static weight-bearing. Changes in foot arch height and plantar pressure were measured before and after dividing the first bundle. Results: The average width and thickness of the origin of the central part at the calcaneal tubercle were 15.45 mm and 2.79 mm respectively. The ratio of the length of each bundle to the length of the central part was (from medial to lateral) 0.29, 0.30, 0.28, 0.25, and 0.27, respectively. Similarly, the ratio of the widths was 0.26, 0.25, 0.23, 0.19 and 0.17. The thickness of each bundle at the bifurcation of the PA into bundles was (from medial to lateral) 1.26 mm, 1.04 mm, 0.91 mm, 0.84 mm and 0.72 mm. The average dorsiflexion of the first MTP joint increased 10.16 degrees after the first bundle was divided. Marked acute changes in the foot arch height and the plantar pressure were not observed after division. Conclusions: The first PA bundle was not the longest, widest, or the thickest bundle. Releasing the first bundle increased the range of motion of the first MTP joint, but did not acutely change foot arch height or plantar pressure during static load testing.	[Chen, Da-wei; Li, Bing; Aubeeluck, Ashwin; Yang, Yun-feng; Huang, Yi-gang; Zhou, Jia-qian; Yu, Guang-rong] Tongji Univ, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China	Tongji University	Yu, GR (corresponding author), Tongji Univ, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China.	yuguangrong2012@gmail.com			National Natural Science Foundation of China [10-81071471]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China No. 10-81071471 (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino A, 1990, FOOT, V9, P73, DOI [10.1054/foot.1999.0520, DOI 10.1054/FOOT.1999.0520]; Arangio GA, 1997, CLIN ORTHOP RELAT R, P227; Berlet GC, 2008, FOOT ANKLE INT, V29, P10, DOI 10.3113/FAI.2008.0010; Cardinal E, 1996, RADIOLOGY, V201, P257, DOI 10.1148/radiology.201.1.8816554; Cattrysse E, 2005, ERGONOMICS, V48, P1657, DOI 10.1080/00140130500101189; Davies-Colley, 1887, BMJ-BRIT MED J, V1, P728; Erdemir A, 2004, J BIOMECH ENG-T ASME, V126, P237, DOI 10.1115/1.1691447; Flavin R, 2008, J BONE JOINT SURG BR, V90B, P1334, DOI 10.1302/0301-620X.90B10.20506; Fuller EA, 2000, J AM PODIAT MED ASSN, V90, P35, DOI 10.7547/87507315-90-1-35; Giannini S, 2011, P 78 ANN M AM AC ORT, P886; Harton FM, 2002, J AM PODIAT MED ASSN, V92, P532, DOI 10.7547/87507315-92-10-532; HICKS JH, 1954, J ANAT, V88, P25; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P557, DOI 10.1177/107110079401501007; Maletsky LP, 2007, J BIOMECH, V40, P682, DOI 10.1016/j.jbiomech.2006.01.017; May Todd J, 2002, Curr Sports Med Rep, V1, P278; McMillan AM, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-32; Murphy GA, 1998, FOOT ANKLE INT, V19, P149, DOI 10.1177/107110079801900306; Nester C, 2007, J BIOMECH, V40, P3412, DOI 10.1016/j.jbiomech.2007.05.019; Panchbhavi VK, 2009, J BONE JOINT SURG AM, V91A, P1143, DOI 10.2106/JBJS.H.00162; Sharkey NA, 1999, FOOT ANKLE INT, V20, P86, DOI 10.1177/107110079902000204; Sinnaeve F, 2008, ACTA ORTHOP BELG, V74, P483; Theodorou DJ, 2003, RADIOLOGY, V226, P857, DOI 10.1148/radiol.2263020284; Thordarson DB, 1997, FOOT ANKLE INT, V18, P16, DOI 10.1177/107110079701800104; Tsai WC, 2000, SCAND J RHEUMATOL, V29, P255; Tweed Jo L, 2009, Foot (Edinb), V19, P75, DOI 10.1016/j.foot.2008.11.014; Waldecker U, 2005, FOOT ANKLE SURG, V11, P207; Xia J, 2013, FOOT ANKLE INT, V34, P261, DOI 10.1177/1071100712464211; Yu X, 2011, J INT MED RES, V39, P2352, DOI 10.1177/147323001103900635	28	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84347	10.1371/journal.pone.0084347	http://dx.doi.org/10.1371/journal.pone.0084347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392127	Green Submitted, Green Published, gold			2022-12-25	WOS:000329460100050
J	Minamide, R; Fujiwara, K; Hasegawa, K; Yoshikawa, K				Minamide, Ryohei; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki			Antagonistic Interplay between Necdin and Bmi1 Controls Proliferation of Neural Precursor Cells in the Embryonic Mouse Neocortex	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; MYC TRANSGENIC MICE; SELF-RENEWAL; STEM-CELLS; POSTEMBRYONIC NEUROGENESIS; TRANSCRIPTION FACTOR; POSTMITOTIC NEURONS; GROWTH SUPPRESSOR; GENE-EXPRESSION; PROTEIN	Neural precursor cells (NPCs) in the neocortex exhibit a high proliferation capacity during early embryonic development and give rise to cortical projection neurons after maturation. Necdin, a mammal-specific MAGE (melanoma antigen) family protein that possesses anti-mitotic and pro-survival activities, is expressed abundantly in postmitotic neurons and moderately in tissue-specific stem cells or progenitors. Necdin interacts with E2F transcription factors and suppresses E2F1-dependent transcriptional activation of the cyclin-dependent kinase Cdk1 gene. Here we show that necdin serves as a suppressor of NPC proliferation in the embryonic neocortex. Necdin is moderately expressed in the ventricular zone of mouse embryonic neocortex, in which proliferative cell populations are significantly increased in necdin-null mice. In the neocortex of necdin-null embryos, expression of Cdk1 and Sox2, a stem cell marker, is significantly increased, whereas expression of p16, a cyclin-dependent kinase inhibitor, is markedly diminished. Cdk1 and p16 expression levels are also significantly increased and decreased, respectively, in primary NPCs prepared from necdin-null embryos. Intriguingly, necdin interacts directly with Bmi1, a Polycomb group protein that suppresses p16 expression and promotes NPC proliferation. In HEK293A cells transfected with luciferase reporter constructs, necdin relieves Bmi1-dependent repression of p16 promoter activity, whereas Bmi1 counteracts necdin-mediated repression of E2F1-dependent Cdk1 promoter activity. In lentivirus-infected primary NPCs, necdin overexpression increases p16 expression, suppresses Cdk1 expression, and inhibits NPC proliferation, whereas Bmi1 overexpression suppresses p16 expression, increases Cdk1 expression, and promotes NPC proliferation. Our data suggest that embryonic NPC proliferation in the neocortex is regulated by the antagonistic interplay between necdin and Bmi1.	[Minamide, Ryohei; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan	Osaka University	Yoshikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [24300134]; Grants-in-Aid for Scientific Research [24890104, 25830053] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research B2 (24300134) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; Aizawa T, 2011, CANCER SCI, V102, P122, DOI 10.1111/j.1349-7006.2010.01775.x; Andrieu D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-56; Asai T, 2012, BLOOD, V120, P1601, DOI 10.1182/blood-2011-11-393983; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Forsberg K, 2013, J NEUROSCI, V33, P14318, DOI 10.1523/JNEUROSCI.1056-13.2013; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030948; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Huang ZY, 2013, J NEUROSCI, V33, P10362, DOI 10.1523/JNEUROSCI.5682-12.2013; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	56	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84460	10.1371/journal.pone.0084460	http://dx.doi.org/10.1371/journal.pone.0084460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392139	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100062
J	Stein, GY; Herscovici, G; Korenfeld, R; Matetzky, S; Gottlieb, S; Alon, D; Gevrielov-Yusim, N; Iakobishvili, Z; Fuchs, S				Stein, Gideon Y.; Herscovici, Gabriel; Korenfeld, Roman; Matetzky, Shlomi; Gottlieb, Shmuel; Alon, Danny; Gevrielov-Yusim, Natalie; Iakobishvili, Zaza; Fuchs, Shmuel			Type-II Myocardial Infarction - Patient Characteristics, Management and Outcomes	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; OPTIMIZING PLATELET INHIBITION; UNIVERSAL DEFINITION; PRASUGREL-THROMBOLYSIS; CLASSIFICATION-SYSTEM; THERAPEUTIC OUTCOMES; ASSESS IMPROVEMENT; GLOBAL REGISTRY; RISK; INTERVENTION	Background: Type-II MI is defined as myocardial infarction (MI) secondary to ischemia due to either increased oxygen demand or decreased supply. This categorization has been used for the last five years, yet, little is known about patient characteristics and clinical outcomes. In the current work we assessed the epidemiology, causes, management and outcomes of type II MI patients. Methods: A comparative analysis was performed between patients with type-I and type-II MI who participated in two prospective national Acute Coronary Syndrome Israeli Surveys (ACSIS) performed in 2008 and 2010. Results: The surveys included 2818 patients with acute MI of whom 127 (4.5%) had type-II MI. The main causes of type-II MI were anemia (31%), sepsis (24%), and arrhythmia (17%). Patients with type-II MI tended to be older (75.6 +/- 12 vs. 63.8 +/- 13, p<0.0001), female majority (43.3% vs. 22.3%, p<0.0001), had more frequently impaired functional level (45.7% vs. 17%, p<0.0001) and a higher GRACE risk score (150 +/- 32 vs. 110 +/- 35, p<0.0001). Patients with type-II MI were significantly less often referred for coronary interventions (36% vs. 89%, p<0.0001) and less frequently prescribed guideline-directed medical therapy. Mortality rates were substantially higher among patients with type-II MI both at thirty-day (13.6% vs. 4.9%, p<0.0001) and at one-year (23.9% vs. 8.6%, p<0.0001) follow-ups. Conclusions: Patients with type-II compared to type-I MI have distinct demographics, increased prevalence of multiple comorbidities, a high-risk cardiovascular profile and an overall worse outcome. The complex medical condition of this cohort imposes a great therapeutic challenge and specific guidelines with recommended medical treatment and invasive strategies are warranted.	[Stein, Gideon Y.; Herscovici, Gabriel; Korenfeld, Roman; Alon, Danny; Fuchs, Shmuel] Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Beilinson Hosp, IL-69978 Tel Aviv, Israel; [Matetzky, Shlomi; Gevrielov-Yusim, Natalie] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Cardiol Inst, IL-69978 Tel Aviv, Israel; [Gottlieb, Shmuel] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Neufeld Heart Res Inst, IL-69978 Tel Aviv, Israel; [Gottlieb, Shmuel] Bikur Cholim Hosp, Cardio Dept, Jerusalem, Israel; [Iakobishvili, Zaza] Tel Aviv Univ, Sackler Sch Med, Dept Cardiol, Beilinson Hosp,Rabin Med Ctr, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Beilinson Hosp, IL-69978 Tel Aviv, Israel.	shmuelf@clalit.org.il						Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Bahrmann P, 2012, AGING CLIN EXP RES, V24, P290, DOI 10.3275/7927; Banihashemi B, 2009, AM HEART J, V158, P917, DOI 10.1016/j.ahj.2009.09.016; Behar S, 2003, ISR MED ASSOC J, V5, P249; Bonaca MP, 2012, CIRCULATION, V125, P577, DOI 10.1161/CIRCULATIONAHA.111.041160; De Gennaro L, 2008, J INTERV CARDIOL, V21, P129, DOI 10.1111/j.1540-8183.2007.00336.x; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Jedrzkiewicz S, 2009, CAN J CARDIOL, V25, pE370, DOI 10.1016/S0828-282X(09)70163-1; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Morrow DA, 2009, CIRCULATION, V119, P2758, DOI 10.1161/CIRCULATIONAHA.108.833665; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; White HD, 2012, AM HEART J, V163, P563, DOI 10.1016/j.ahj.2012.01.016	20	99	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84285	10.1371/journal.pone.0084285	http://dx.doi.org/10.1371/journal.pone.0084285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392121	Green Published, Green Submitted, gold			2022-12-25	WOS:000329460100044
J	Urbschat, A; Zacharowski, K; Obermuller, N; Rupprecht, K; Penzkofer, D; Jennewein, C; Tran, N; Scheller, B; Dimmeler, S; Paulus, P				Urbschat, Anja; Zacharowski, Kai; Obermueller, Nicholas; Rupprecht, Katrin; Penzkofer, Daniela; Jennewein, Carla; Nguyen Tran; Scheller, Bertram; Dimmeler, Stefanie; Paulus, Patrick			The Small Fibrinopeptide B beta(15-42) as Renoprotective Agent Preserving the Endothelial and Vascular Integrity in Early Ischemia Reperfusion Injury in the Mouse Kidney	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; VE-CADHERIN; PEPTIDE B-BETA(15-42); MYOCARDIAL-INFARCTION; PIG MODEL; PERMEABILITY; JUNCTIONS; FIBRIN; SEPSIS	Disruption of the renal endothelial integrity is pivotal for the development of a vascular leak, tissue edema and consequently acute kidney injury. Kidney ischemia amplifies endothelial activation and up-regulation of pro-inflammatory mechanisms. After restoring a sufficient blood flow, the kidney is damaged through complex pathomechanisms that are classically referred to as ischemia and reperfusion injury, where the disruption of the inter-endothelial connections seems to be a crucial step in this pathomechanism. Focusing on the molecular cell-cell interaction, the fibrinopeptide B beta(15-42) prevents vascular leakage by stabilizing these inter-endothelial junctions. The peptide associates with vascular endothelial-cadherin, thus preventing early kidney dysfunction by preserving blood perfusion efficacy, edema formation and thus organ dysfunction. We intended to demonstrate the early therapeutic benefit of intravenously administered B beta(15-42) in a mouse model of renal ischemia and reperfusion. After 30 minutes of ischemia, the fibrinopeptide B beta(15-42) was administered intravenously before reperfusion was commenced for 1 and 3 hours. We show that B beta(15-42) alleviates early functional and morphological kidney damage as soon as 1 h and 3 h after ischemia and reperfusion. Mice treated with B beta(15-42) displayed a significantly reduced loss of VE-cadherin, indicating a conserved endothelial barrier leading to less neutrophil infiltration which in turn resulted in significantly reduced structural renal damage. The significant reduction in tissue and serum neutrophil gelatinase-associated lipocalin levels reinforced our findings. Moreover, renal perfusion analysis by color duplex sonography revealed that B beta(15-42) treatment preserved resistive indices and even improved blood velocity. Our data demonstrate the efficacy of early therapeutic intervention using the fibrinopeptide B beta(15-42) in the treatment of acute kidney injury resulting from ischemia and reperfusion. In this context B beta(15-42) may act as a potent renoprotective agent by preserving the endothelial and vascular integrity.	[Urbschat, Anja] Goethe Univ Hosp, Fac Med, Frankfurt, Germany; [Zacharowski, Kai; Rupprecht, Katrin; Jennewein, Carla; Nguyen Tran; Scheller, Bertram; Paulus, Patrick] Goethe Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Obermueller, Nicholas] Goethe Univ Hosp, Div Nephrol, Clin Internal Med 3, Frankfurt, Germany; [Penzkofer, Daniela; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Urbschat, A (corresponding author), Goethe Univ Hosp, Fac Med, Frankfurt, Germany.	urbschat@med.uni-frankfurt.de	Jennewein, Carla/C-2199-2013	Dimmeler, Stefanie/0000-0002-1045-2436	Deutsche Forschungsgesellschaft [SFB 834-B4]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	This research project received funding from Deutsche Forschungsgesellschaft SFB 834-B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Haller H, 1996, KIDNEY INT, V50, P473, DOI 10.1038/ki.1996.338; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; KLAUSNER JM, 1989, AM J PHYSIOL, V256, pF794, DOI 10.1152/ajprenal.1989.256.5.F794; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lote CJ, 1996, BRIT J ANAESTH, V77, P82, DOI 10.1093/bja/77.1.82; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Molitoris BA, 2002, CRIT CARE MED, V30, pS235, DOI 10.1097/00003246-200205001-00011; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Obermuller N, 2013, INT UROL NEPHROL; Paulus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073298; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Roesner JP, 2009, CRIT CARE MED, V37, P598, DOI 10.1097/CCM.0b013e3181959a12; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Schnell D, 2012, INTENS CARE MED, V38, P1751, DOI 10.1007/s00134-012-2692-z; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Singbartl K, 2001, FASEB J, V15, P2337, DOI 10.1096/fj.01-0199com; Sorensen I, 2011, J AM SOC NEPHROL, V22, P1887, DOI 10.1681/ASN.2011010031; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Zacharowski K, 2006, J MOL MED, V84, P469, DOI 10.1007/s00109-006-0051-7	38	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84432	10.1371/journal.pone.0084432	http://dx.doi.org/10.1371/journal.pone.0084432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392138	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100061
J	von Terzi, B; Turnbull, PCB; Bellan, SE; Beyer, W				von Terzi, Britta; Turnbull, Peter C. B.; Bellan, Steve E.; Beyer, Wolfgang			Failure of Sterne- and Pasteur-Like Strains of Bacillus anthracis to Replicate and Survive in the Urban Bluebottle Blow Fly Calliphora vicina under Laboratory Conditions	PLOS ONE			English	Article							TRANSMISSION	This study aimed to elucidate the bacteriological events occurring within the gut of Calliphora vicina, selected as the European representative of blow flies held responsible for the spread of anthrax during epidemics in certain parts of the world. Green-fluorescent-protein-carrying derivatives of Bacillus anthracis were used. These lacked either one of the virulence plasmids pXO1 and pXO2 and were infected, or not infected, with a worm intestine phage (Wip4) known to influence the phenotype and survival of the pathogen. Blood meals were prepared for the flies by inoculation of sheep blood with germinated and, in case of pXO2+ strains, encapsulated cells of the four B. anthracis strains. After being fed for 4 h an initial 10 flies were externally disinfected with peracetic acid to ensure subsequent quantitation representing ingested B. anthracis only. Following neutralization, they were crushed in sterile saline. Over each of the ensuing 7 to 10 days, 10 flies were removed and processed the same way. In the absence of Wip4, strains showed steady declines to undetectable in the total B. anthracis counts, within 7-9 days. With the phage infected strains, the falls in viable counts were significantly more rapid than in their uninfected counterparts. Spores were detectable in flies for longer periods than vegetative bacteria. In line with the findings in both biting and non-biting flies of early workers our results indicate that B. anthracis does not multiply in the guts of blow flies and survival is limited to a matter of days.	[von Terzi, Britta; Turnbull, Peter C. B.; Beyer, Wolfgang] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany; [Bellan, Steve E.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA	University Hohenheim; University of Texas System; University of Texas Austin	Beyer, W (corresponding author), Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany.	wolfgang.beyer@uni-hohenheim.de	Bellan, Steven/D-6368-2013	Bellan, Steven/0000-0002-4110-272X	German Research Foundation (DFG) [BE 2157/3-1]; United States National Institute of General Medical Sciences MIDAS grant [U01GM087719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); United States National Institute of General Medical Sciences MIDAS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant BE 2157/3-1 of the German Research Foundation (DFG). SEB was funded by a United States National Institute of General Medical Sciences MIDAS grant U01GM087719 to Lauren A. Meyers and Alison P. Galvani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn JK, 2010, J WILDLIFE DIS, V46, P918, DOI 10.7589/0090-3558-46.3.918; BRAACK LEO, 1990, ONDERSTEPOORT J VET, V57, P141; Buchanan RM, 1907, LANCET, V2, P216; Carr KA, 2010, MOL MICROBIOL, V75, P365, DOI 10.1111/j.1365-2958.2009.06972.x; DAVIES JCA, 1982, CENT AFR J MED, V28, P291; DEVOS V, 2004, INFECT DIS LIVESTOCK, pCH153; Fasanella A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012219; Graham-Smith GS, 1913, CAMBRIDGE PUBLIC HLT; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Kraneveld F.C., 1940, OVERGEDRUKT UIT NED, V52, P339; Kraneveld FC, 1939, WIED NED IND BL DIER, V51, P62; MINETT FC, 1950, J COMP PATHOL THERAP, V60, P161, DOI 10.1016/S0368-1742(50)80016-4; Morris H, 1918, B LOUISIANA STATE U, V163, P3; Nalisa M, 2012, THESIS U NAMIBIA; Schuch R, 2010, APPL ENVIRON MICROB, V76, P2286, DOI 10.1128/AEM.02518-09; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; Welkos S, 2011, ANTIMICROB AGENTS CH, V55, P4238, DOI 10.1128/AAC.00267-11; WHO, 2008, ANTHRAX HUMANS ANIMA; Zuur Alain F., 2009, P1	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83860	10.1371/journal.pone.0083860	http://dx.doi.org/10.1371/journal.pone.0083860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392098	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100022
J	Wibawa, H; Bingham, J; Nuradji, H; Lowther, S; Payne, J; Harper, J; Junaidi, A; Middleton, D; Meers, J				Wibawa, Hendra; Bingham, John; Nuradji, Harimurti; Lowther, Sue; Payne, Jean; Harper, Jenni; Junaidi, Akhmad; Middleton, Deborah; Meers, Joanne			Experimentally Infected Domestic Ducks Show Efficient Transmission of Indonesian H5N1 Highly Pathogenic Avian Influenza Virus, but Lack Persistent Viral Shedding	PLOS ONE			English	Article							ANAS-PLATYRHYNCHOS; ASIA; EVOLUTION; DISEASE; EPIDEMIOLOGY; PATHOBIOLOGY; SUBLINEAGES; ANTIBODIES; WATERFOWL; CHICKENS	Ducks are important maintenance hosts for avian influenza, including H5N1 highly pathogenic avian influenza viruses. A previous study indicated that persistence of H5N1 viruses in ducks after the development of humoral immunity may drive viral evolution following immune selection. As H5N1 HPAI is endemic in Indonesia, this mechanism may be important in understanding H5N1 evolution in that region. To determine the capability of domestic ducks to maintain prolonged shedding of Indonesian clade 2.1 H5N1 virus, two groups of Pekin ducks were inoculated through the eyes, nostrils and oropharynx and viral shedding and transmission investigated. Inoculated ducks (n = 15), which were mostly asymptomatic, shed infectious virus from the oral route from 1 to 8 days post inoculation, and from the cloacal route from 2-8 dpi. Viral ribonucleic acid was detected from 1-15 days post inoculation from the oral route and 1-24 days post inoculation from the cloacal route (cycle threshold <40). Most ducks seroconverted in a range of serological tests by 15 days post inoculation. Virus was efficiently transmitted during acute infection (5 inoculation-infected to all 5 contact ducks). However, no evidence for transmission, as determined by seroconversion and viral shedding, was found between an inoculation-infected group (n = 10) and contact ducks (n = 9) when the two groups only had contact after 10 days post inoculation. Clinical disease was more frequent and more severe in contact-infected (2 of 5) than inoculation-infected ducks (1 of 15). We conclude that Indonesian clade 2.1 H5N1 highly pathogenic avian influenza virus does not persist in individual ducks after acute infection.	[Wibawa, Hendra; Bingham, John; Nuradji, Harimurti; Lowther, Sue; Payne, Jean; Harper, Jenni; Middleton, Deborah] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Wibawa, Hendra; Nuradji, Harimurti; Meers, Joanne] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Wibawa, Hendra; Junaidi, Akhmad] Dis Invest Ctr Reg IV Wates, Yogyakarta, Indonesia; [Nuradji, Harimurti] Indonesian Res Ctr Vet Sci, Bogor, West Java, Indonesia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Bingham, J (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	John.Bingham@csiro.au	Bingham, John/H-8591-2013; Wibawa, Hendra/AAP-5558-2020; Meers, Joanne/B-4141-2011	Bingham, John/0000-0003-2360-3827; Meers, Joanne/0000-0001-9305-0469; Nuradji, Harimurti/0000-0002-7302-5933	CSIRO [AH/2004/040]; Australian Centre for International Agriculture Research (ACIAR) [AH/2004/040]; ACIAR John Allwright Fellowship	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Centre for International Agriculture Research (ACIAR)(Australian Ctr Intl Agr Res); ACIAR John Allwright Fellowship(Australian Ctr Intl Agr Res)	The study was jointly funded by CSIRO and the Australian Centre for International Agriculture Research (ACIAR) grant number AH/2004/040. Hendra Wibawa was supported by an ACIAR John Allwright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2011, APPR CONTR PREV EL H; Bingham J, 2009, AVIAN PATHOL, V38, P267, DOI 10.1080/03079450903055371; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; CIVAS, 2006, REV FREE RANG DUCK F; FAO, 2011, H5N1 HPAI GLOB OV OC; Forrest Heather L., 2010, Animal Health Research Reviews, V11, P3, DOI 10.1017/S1466252310000071; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henning J., 2012, EPIDEMIOLOGY INFECT, P1, DOI 10.1017/S0950268812001100; Henning J, 2010, EMERG INFECT DIS, V16, P1244, DOI 10.3201/eid1608.091540; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1980, COMP IMMUNOL MICROB, V3, P155, DOI 10.1016/0147-9571(80)90051-X; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jeong OM, 2009, J VET SCI, V10, P53, DOI 10.4142/jvs.2009.10.1.53; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sims LD, 2005, VET REC, V157, P159, DOI 10.1136/vr.157.6.159; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Tumpey TM, 2002, J VIROL, V76, P6344, DOI 10.1128/JVI.76.12.6344-6355.2002; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WHO, 2013, CUM NUMB CONF HUM CA; Wibawa H, 2013, COMP IMMUNOL MICROB, V36, P175, DOI 10.1016/j.cimid.2012.12.001; Wibawa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-117	36	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83417	10.1371/journal.pone.0083417	http://dx.doi.org/10.1371/journal.pone.0083417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392085	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460100009
J	Jeong, J; Park, YU; Kim, DK; Lee, S; Kwak, Y; Lee, SA; Lee, H; Suh, YH; Gho, YS; Hwang, D; Park, SK				Jeong, Jaehoon; Park, Young-Un; Kim, Dae-Kyum; Lee, Saebom; Kwak, Yongdo; Lee, Seol-Ae; Lee, Haeryun; Suh, Yoo-Hun; Gho, Yong Song; Hwang, Daehee; Park, Sang Ki			Cdk5 Phosphorylates Dopamine D2 Receptor and Attenuates Downstream Signaling	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NUCLEUS-ACCUMBENS; CORTICAL-NEURONS; DENDRITIC SPINES; COCAINE REWARD; NMDA RECEPTORS; BETA-CATENIN; BINDING; MORPHOLOGY; BRAIN	The dopamine D2 receptor (DRD2) is a key receptor that mediates dopamine-associated brain functions such as mood, reward, and emotion. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase whose function has been implicated in the brain reward circuit. In this study, we revealed that the serine 321 residue (S321) in the third intracellular loop of DRD2 (D2i3) is a novel regulatory site of Cdk5. Cdk5-dependent phosphorylation of S321 in the D2i3 was observed in in vitro and cell culture systems. We further observed that the phosphorylation of S321 impaired the agonist-stimulated surface expression of DRD2 and decreased G protein coupling to DRD2. Moreover, the downstream cAMP pathway was affected in the heterologous system and in primary neuronal cultures from p35 knockout embryos likely due to the reduced inhibitory activity of DRD2. These results indicate that Cdk5-mediated phosphorylation of S321 inhibits DRD2 function, providing a novel regulatory mechanism for dopamine signaling.	[Jeong, Jaehoon; Park, Young-Un; Kim, Dae-Kyum; Lee, Saebom; Kwak, Yongdo; Lee, Seol-Ae; Gho, Yong Song; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Lee, Haeryun] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Brain Research Institute (KBRI)	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	skpark@postech.ac.kr		Kim, Dae-Kyum/0000-0003-4568-8278	Korean government (MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200]; framework of international cooperation program [2012K2A1A2033117]; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP [2031-415]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards	Korean government (MSIP); framework of international cooperation program; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards	This work was supported by the grants (NRF-2012R1A2A2A01012923 and NRF-2012R1A4A1028200) from the Korean government (MSIP) and also supported under the framework of international cooperation program managed by NRF of Korea (2012K2A1A2033117) and the Korea Brain Research Institute (KBRI) Basic Research Program of MSIP (2031-415). SKP was a recipient of the 2004 and 2006 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2008, INT J NEUROPSYCHOPH, V11, P197, DOI 10.1017/S1461145707007948; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Cho D, 2010, MOL ENDOCRINOL, V24, P574, DOI 10.1210/me.2009-0369; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fu AKY, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4617; Gardner B, 1998, BRIT J PHARMACOL, V124, P978, DOI 10.1038/sj.bjp.0701926; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045618; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; LIST SJ, 1981, P NATL ACAD SCI-BIOL, V78, P2620, DOI 10.1073/pnas.78.4.2620; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NG GYK, 1994, J NEUROCHEM, V63, P1589; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; READER TA, 1992, NEUROCHEM RES, V17, P749, DOI 10.1007/BF00969008; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1997, J NEUROSCI, V17, P8491; Seeman P, 2003, SYNAPSE, V49, P209, DOI 10.1002/syn.10232; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008	49	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84482	10.1371/journal.pone.0084482	http://dx.doi.org/10.1371/journal.pone.0084482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391960	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900103
J	Li, XB; Luo, J; Yan, TL; Xiang, L; Jin, F; Qin, DH; Sun, CB; Xie, M				Li, Xiaobai; Luo, Jie; Yan, Tianlian; Xiang, Lin; Jin, Feng; Qin, Dehui; Sun, Chongbo; Xie, Ming			Deep Sequencing-Based Analysis of the Cymbidium ensifolium Floral Transcriptome	PLOS ONE			English	Article							EST-SSR MARKERS; GENIC MICROSATELLITE MARKERS; MADS-BOX GENES; HEVEA-BRASILIENSIS; FLOWERING TIME; SNP DISCOVERY; GIBBERELLIN 3-BETA-HYDROXYLASE; FUNCTIONAL-ANALYSIS; EXPRESSED GENES; ORCHID	Cymbidium ensifolium is a Chinese Cymbidium with an elegant shape, beautiful appearance, and a fragrant aroma. C. ensifolium has a long history of cultivation in China and it has excellent commercial value as a potted plant and cut flower. The development of C. ensifolium genomic resources has been delayed because of its large genome size. Taking advantage of technical and cost improvement of RNA-Seq, we extracted total mRNA from flower buds and mature flowers and obtained a total of 9.52 Gb of filtered nucleotides comprising 98,819,349 filtered reads. The filtered reads were assembled into 101,423 isotigs, representing 51,696 genes. Of the 101,423 isotigs, 41,873 were putative homologs of annotated sequences in the public databases, of which 158 were associated with floral development and 119 were associated with flowering. The isotigs were categorized according to their putative functions. In total, 10,212 of the isotigs were assigned into 25 eukaryotic orthologous groups (KOGs), 41,690 into 58 gene ontology (GO) terms, and 9,830 into 126 Arabidopsis Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and 9,539 isotigs into 123 rice pathways. Comparison of the isotigs with those of the two related orchid species P. equestris and C. sinense showed that 17,906 isotigs are unique to C. ensifolium. In addition, a total of 7,936 SSRs and 16,676 putative SNPs were identified. To our knowledge, this transcriptome database is the first major genomic resource for C. ensifolium and the most comprehensive transcriptomic resource for genus Cymbidium. These sequences provide valuable information for understanding the molecular mechanisms of floral development and flowering. Sequences predicted to be unique to C. ensifolium would provide more insights into C. ensifolium gene diversity. The numerous SNPs and SSRs identified in the present study will contribute to marker development for C. ensifolium.	[Li, Xiaobai; Luo, Jie; Xiang, Lin; Qin, Dehui; Sun, Chongbo; Xie, Ming] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Yan, Tianlian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Feng] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang University; Hubei University	Xie, M (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	Xieming1957@yahoo.com.cn	Li, Xiaobai/AAB-7604-2021	Li, Xiaobai/0000-0001-9615-3543	National Basic Research Program; Nature Science Foundation of China [31201648]; Postdoctoral Science Foundation of China [2012M521203]; Special Postdoctoral Science Foundation of China [2013T60607]; Foundation for Selected Postdoctoral project of Zhejiang [Bsh1201032]; Qianjiang talents project [2013R10081]; Scientific and technical innovation promotion project of ZAAS [2012R05Y01E04]; New Variety of Flowers Breeding Group Project of Zhejiang Province [2012C12909-10]	National Basic Research Program(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Special Postdoctoral Science Foundation of China; Foundation for Selected Postdoctoral project of Zhejiang; Qianjiang talents project; Scientific and technical innovation promotion project of ZAAS; New Variety of Flowers Breeding Group Project of Zhejiang Province	This research was supported by the National Basic Research Program funded by the Nature Science Foundation of China (No. 31201648), the Postdoctoral Science Foundation of China (No. 2012M521203), the Special Postdoctoral Science Foundation of China (No. 2013T60607), and the Foundation for Selected Postdoctoral project of Zhejiang (Bsh1201032), the Qianjiang talents project (No. 2013R10081), Scientific and technical innovation promotion project of ZAAS (2012R05Y01E04) and the New Variety of Flowers Breeding Group Project of Zhejiang Province (No. 2012C12909-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bus VGM, 2005, MOL BREEDING, V15, P103, DOI 10.1007/s11032-004-3609-5; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chen MK, 2011, PLANT J, V68, P168, DOI 10.1111/j.1365-313X.2011.04677.x; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa F, 2005, EUPHYTICA, V141, P181, DOI 10.1007/s10681-005-6805-4; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; DUPUY D, 2007, GENUS CYMBIDIUM KEW; EMRICH SJ, 2006, GENOME RES, V16, P1; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fan SH, 2003, PROG BIOCHEM BIOPHYS, V30, P221; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Fukai S, 2002, HORTSCIENCE, V37, P1088, DOI 10.21273/HORTSCI.37.7.1088; Gao LF, 2004, THEOR APPL GENET, V108, P1392, DOI 10.1007/s00122-003-1554-z; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Glover B.J., 2007, UNDERSTANDING FLOWER; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gur-Arie R, 2000, GENOME RES, V10, P62; Hsiao YY, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-14; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Itoh H, 1999, PLANT J, V20, P15, DOI 10.1046/j.1365-313X.1999.00568.x; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Li XiaoBai, 2006, Biodiversity Science, V14, P541, DOI 10.1360/biodiv.060148; LIU L, 2012, J BIOMED BIOTECHNOL, V11, P251; LIU ZJ, 2006, CHINESE CYMBIDIUM PL; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Metzger James D., 1995, P617; Mondragon-Palomino M, 2008, TRENDS PLANT SCI, V13, P51, DOI 10.1016/j.tplants.2007.11.007; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; NASH, 1996, ORCHIDS, V9, P972; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rozen S, 2000, BIOINFORMATICS METHO; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; SOOK J, 2005, FUNCT INTEGR GENOMIC, V5, P136, DOI DOI 10.1007/S10142-005-0139-0; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tsai WC, 2006, PLANT SCI, V170, P426, DOI 10.1016/j.plantsci.2005.08.029; Tsai WC, 2013, PLANT CELL PHYSIOL, V54, pE7, DOI 10.1093/pcp/pcs187; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; WU M, 2010, J COTTON SCI, V22, P387; XIANG I, 2011, ACTA HORTICULTURAE S, V38, P143; Xiang L, 2012, PLANT PHYSIOL BIOCH, V58, P98, DOI 10.1016/j.plaphy.2012.06.011; Xiang Lin, 2011, Acta Agriculturae Zhejiangensis, V23, P517; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	96	41	43	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85480	10.1371/journal.pone.0085480	http://dx.doi.org/10.1371/journal.pone.0085480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392013	Green Published, gold, Green Submitted			2022-12-25	WOS:000329323900157
J	Tovo-Rodrigues, L; Rohde, LA; Menezes, AMB; Polanczyk, GV; Kieling, C; Genro, JP; Anselmi, L; Hutz, MH				Tovo-Rodrigues, Luciana; Rohde, Luis A.; Menezes, Ana M. B.; Polanczyk, Guilherme V.; Kieling, Christian; Genro, Julia P.; Anselmi, Luciana; Hutz, Mara H.			DRD4 Rare Variants in Attention-Deficit/Hyperactivity Disorder (ADHD): Further Evidence from a Birth Cohort Study	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; RECEPTOR; GENE; POPULATION; STRENGTHS; CHILDREN; BRAZIL; SUSCEPTIBILITY; PREVALENCE; PREDICTION	The dopamine receptor D4 (DRD4) is one of the most studied candidate genes for Attention-Deficit/Hyperactivity Disorder (ADHD). An excess of rare variants and non-synonymous mutations in the VNTR region of 7R allele in ADHD subjects was observed in previous studies with clinical samples. We hypothesize that genetic heterogeneity in the VNTR is an important factor in the pathophysiology of ADHD. The subjects included in the present study are members of the 1993 Pelotas Birth Cohort Study (N=5,249). We conducted an association study with the 4,101 subjects who had DNA samples collected. The hyperactivity-inattention scores were assessed through the parent version of the Strengths and Difficulties Questionnaire at 11 and 15 years of age. The contribution of allele's length and rare variants to high hyperactivity/inattention scores predisposition was evaluated by multivariate logistic regression. No effect of allele length was observed on high scores of hyperactivity-inattention. By contrast, when resequencing/haplotyping was conducted in a subsample, all 7R rare variants as well as non-synonymous 7R rare variants were associated with high hyperactivity/inattention scores (OR=2.561; P=0.024 and OR=3.216; P=0.008 respectively). A trend for association was observed with 4R rare variants. New coding mutations covered 10 novel motifs and many of them are previously unreported deletions leading to different stop codons. Our findings suggest a contribution of DRD4 7R rare variants to high hyperactivity-inattention scores in a population-based sample from a large birth cohort. These findings provide further evidence for an effect of DRD4 7R rare variants and allelic heterogeneity in ADHD genetic susceptibility.	[Tovo-Rodrigues, Luciana; Genro, Julia P.; Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Rohde, Luis A.; Kieling, Christian; Anselmi, Luciana] Univ Fed Rio Grande do Sul, Child & Adolescent Psychiat Div, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Menezes, Ana M. B.] Univ Fed Pelotas, Grad Program Epidemiol, Pelotas, RS, Brazil; [Polanczyk, Guilherme V.] Univ Sao Paulo, Dept Psychiat, Sch Med, Sao Paulo, Brazil; [Polanczyk, Guilherme V.] Univ Sao Paulo, Res Support Ctr Neurodev & Mental Hlth, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade de Sao Paulo; Universidade de Sao Paulo	Hutz, MH (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	mara.hutz@ufrgs.br	Genro, Julia/J-4795-2015; Polanczyk, Guilherme V./AAF-6142-2021; Hutz, Mara H/I-4070-2012; Tovo-Rodrigues, Luciana/D-4256-2018; Kieling, Christian/U-3905-2019; Polanczyk, Guilherme V/C-2345-2012; Rohde, Luis Augusto P/A-6426-2008; Menezes, Ana MB/G-7266-2012	Polanczyk, Guilherme V./0000-0003-2311-3289; Kieling, Christian/0000-0001-7691-4149; Polanczyk, Guilherme V/0000-0003-2311-3289; Rohde, Luis Augusto P/0000-0002-4552-4188; Menezes, Ana MB/0000-0002-2996-9427; Hutz, Mara/0000-0002-9146-1229	Wellcome Trust; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [470937/2010-6]	Wellcome Trust(Wellcome TrustEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The cohort study follow up is supported by the Wellcome Trust. Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grant no470937/2010-6 Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi L, 2010, CAD SAUDE PUBLICA, V26, P1954, DOI 10.1590/S0102-311X2010001000012; Becker A, 2006, EUR CHILD ADOLES PSY, V15, P56, DOI 10.1007/s00787-006-1008-7; Bidwell LC, 2011, BEHAV GENET, V41, P165, DOI 10.1007/s10519-010-9437-y; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman SH, 1997, J ABNORM PSYCHOL, V106, P3, DOI 10.1037/0021-843X.106.1.3; Grady DL, 2005, AM J MED GENET B, V136B, P33, DOI 10.1002/ajmg.b.30182; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S2; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; King RA, 1997, J AM ACAD CHILD PSY, V36, pS4, DOI 10.1097/00004583-199710001-00002; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; Oldenhof J, 1998, BIOCHEMISTRY-US, V37, P15726, DOI 10.1021/bi981634+; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rohde LA, 1999, J ATTEN DISORD, V3, P91, DOI [DOI 10.1177/108705479900300203, 10.1177/108705479900300203]; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tovo-Rodrigues L, 2012, MOL PSYCHIATR, V17, P520, DOI 10.1038/mp.2011.12; Vacic V, 2012, MOL BIOSYST, V8, P27, DOI 10.1039/c1mb05251a; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 1996, REV SAUDE PUBL, V30, P34, DOI 10.1590/S0034-89101996000100005; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Woods AS, 2010, J RECEPT SIG TRANSD, V30, P331, DOI 10.3109/10799893.2010.513842	40	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85164	10.1371/journal.pone.0085164	http://dx.doi.org/10.1371/journal.pone.0085164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391992	Green Published, Green Submitted, gold			2022-12-25	WOS:000329323900135
J	Vieira, LD; Faoro, H; Fraga, HPD; Rogalski, M; de Souza, EM; Pedrosa, FD; Nodari, RO; Guerra, MP				Vieira, Leila do Nascimento; Faoro, Helisson; de Freitas Fraga, Hugo Pacheco; Rogalski, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Nodari, Rubens Onofre; Guerra, Miguel Pedro			An Improved Protocol for Intact Chloroplasts and cpDNA Isolation in Conifers	PLOS ONE			English	Article							INVERTED REPEAT COPIES; PLASTID GENOME; DNA EXTRACTION; EVOLUTION; NUCLEAR; GENES; SEQUENCE; PROTEIN; BIOTECHNOLOGY; PINACEAE	Background: Performing chloroplast DNA (cpDNA) isolation is considered a major challenge among different plant groups, especially conifers. Isolating chloroplasts in conifers by such conventional methods as sucrose gradient and high salt has not been successful. So far, plastid genome sequencing protocols for conifer species have been based mainly on long-range PCR, which is known to be time-consuming and difficult to implement. Methodology/Principal Findings: We developed a protocol for cpDNA isolation using three different conifer families: Araucaria angustifolia and Araucaria bidwilli (Araucariaceae), Podocarpus lambertii (Podocarpaceae) and Pinus patula (Pinaceae). The present protocol is based on high salt isolation buffer followed by saline Percoll gradient. Combining these two strategies allowed enhanced chloroplast isolation, along with decreased contamination caused by polysaccharides, polyphenols, proteins, and nuclear DNA in cpDNA. Microscopy images confirmed the presence of intact chloroplasts in high abundance. This method was applied to cpDNA isolation and subsequent sequencing by Illumina MiSeq (2x250 bp), using only 50 ng of cpDNA. Reference-guided chloroplast genome mapping showed that high average coverage was achieved for all evaluated species: 24.63 for A. angustifolia, 135.97 for A. bidwilli, 1196.10 for P. lambertii, and 64.68 for P. patula. Conclusion: Results show that this improved protocol is suitable for enhanced quality and yield of chloroplasts and cpDNA isolation from conifers, providing a useful tool for studies that require isolated chloroplasts and/or whole cpDNA sequences.	[Vieira, Leila do Nascimento; de Freitas Fraga, Hugo Pacheco; Nodari, Rubens Onofre; Guerra, Miguel Pedro] Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil; [Faoro, Helisson; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira] Univ Fed Parana, Nucleo Fixacao Biol Nitrogenio, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Rogalski, Marcelo] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal de Vicosa	Guerra, MP (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil.	miguel.guerra@ufsc.br	Faoro, Helisson/F-7163-2012; Pedrosa, Fabio 0/C-1938-2013; Vieira, Leila N/F-9934-2012; ROGALSKI, MARCELO/ABA-3940-2020; Rogalski, Marcelo/AAA-5192-2020; Nodari, Rubens O/B-7006-2014; Fraga, Hugo PF/F-9049-2012; Fraga, Hugo/L-7275-2019	Faoro, Helisson/0000-0002-0146-8639; ROGALSKI, MARCELO/0000-0002-1990-5243; Nodari, Rubens O/0000-0002-8884-2426; Fraga, Hugo PF/0000-0002-7363-5213; Guerra, Miguel/0000-0002-5319-3446; do Nascimento Vieira, Leila/0000-0001-8413-2155	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [14848/2011-2, 3770/2012, 2780/2012-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) with fellowships, and by Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) under project number 14848/2011-2, 3770/2012, and 2780/2012-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; Arif IA, 2010, INT J MOL SCI, V11, P3149, DOI 10.3390/ijms11093149; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Ayliffe MA, 1998, MOL BIOL EVOL, V15, P738, DOI 10.1093/oxfordjournals.molbev.a025977; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Clarke JL, 2011, PLANT MOL BIOL, V76, P207, DOI 10.1007/s11103-011-9792-y; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; Gargano D, 2013, PLANT MOL BIOL, V81, P235, DOI 10.1007/s11103-012-9994-y; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; He ZH, 2013, J PLANT PHYSIOL, V170, P1139, DOI 10.1016/j.jplph.2013.03.016; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kaneko T, 1996, DNA Res, V3, P109; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Mastroberti Alexandra A., 2003, Braz. J. Bot., V26, P343, DOI 10.1590/S0100-84042003000300007; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WALKER DA, 1987, METHOD ENZYMOL, V148, P145; Werner O, 2009, BRYOLOGIST, V112, P315, DOI 10.1639/0007-2745-112.2.315; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Yamamoto S, 2004, J MASS SPECTROM, V39, P1337, DOI 10.1002/jms.726; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042	41	71	74	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84792	10.1371/journal.pone.0084792	http://dx.doi.org/10.1371/journal.pone.0084792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392157	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100080
J	Sun, YY; Chen, LN; Xu, RD; Kong, RQ				Sun, Yuanyuan; Chen, Lina; Xu, Rudan; Kong, Ruiqing			An Image Encryption Algorithm Utilizing Julia Sets and Hilbert Curves	PLOS ONE			English	Article							CRYPTANALYSIS	Image encryption is an important and effective technique to protect image security. In this paper, a novel image encryption algorithm combining Julia sets and Hilbert curves is proposed. The algorithm utilizes Julia sets' parameters to generate a random sequence as the initial keys and gets the final encryption keys by scrambling the initial keys through the Hilbert curve. The final cipher image is obtained by modulo arithmetic and diffuse operation. In this method, it needs only a few parameters for the key generation, which greatly reduces the storage space. Moreover, because of the Julia sets' properties, such as infiniteness and chaotic characteristics, the keys have high sensitivity even to a tiny perturbation. The experimental results indicate that the algorithm has large key space, good statistical property, high sensitivity for the keys, and effective resistance to the chosen-plaintext attack.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Falconer KJ, 2003, FRACTAL MATH FDN APP; Hermassi H, 2010, COMMUN NONLINEAR SCI, V15, P2987, DOI 10.1016/j.cnsns.2009.11.022; Kumar S, 2006, MILCOM 2006, P1, DOI [10.1109/MILCOM.2006.302396, DOI 10.1109/MILCOM.2006.302396]; Li CQ, 2012, NONLINEAR DYNAM, V70, P2383, DOI 10.1007/s11071-012-0626-5; Li CQ, 2011, SIGNAL PROCESS, V91, P949, DOI 10.1016/j.sigpro.2010.09.014; Lin KT, 2012, OPT COMMUN, V285, P2335, DOI 10.1016/j.optcom.2012.01.028; Liu Wen-tao, 2008, Journal of China Academy of Electronics and Information Technology, V3, P580; Lock Abraham Jun Jiang, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P213, DOI 10.1109/ICCRD.2010.40; Rozouvan V, 2009, OPT LASER ENG, V47, P1, DOI 10.1016/j.optlaseng.2008.09.001; Shyu SH, 2007, PATTERN RECOGN, V40, P1014, DOI 10.1016/j.patcog.2006.02.025; Tong XJ, 2009, SIGNAL PROCESS, V89, P480, DOI 10.1016/j.sigpro.2008.09.011; Yuan-yuan Sun, 2010, 2010 International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2010), P170, DOI 10.1109/IWCFTA.2010.70; Yuen CH, 2012, FRACTALS, V20, P41, DOI 10.1142/S0218348X12500041; Yuen CH, 2011, APPL SOFT COMPUT, V11, P5092, DOI 10.1016/j.asoc.2011.05.050	15	95	96	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84655	10.1371/journal.pone.0084655	http://dx.doi.org/10.1371/journal.pone.0084655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404181	Green Published, gold			2022-12-25	WOS:000329460800060
J	Hu, JH; Liu, Y				Hu, Junhua; Liu, Yang			Unveiling the Conservation Biogeography of a Data-Deficient Endangered Bird Species under Climate Change	PLOS ONE			English	Article							HERON GORSACHIUS-MAGNIFICUS; RANGE SHIFTS; COUPLED MODEL; IMPROVE; NICHE; UNCERTAINTIES; DISTRIBUTIONS; PREDICTION; PATTERNS; MAXIMUM	It remains a challenge to identify the geographical patterns and underlying environmental associations of species with unique ecological niches and distinct behaviors. This in turn hinders our understanding of the ecology as well as effective conservation management of threatened species. The white-eared night heron (Gorsachius magnificus) is a non-migratory nocturnal bird species that has a patchy distribution in the mountainous forests of East Asia. It is currently categorized as "Endangered'' on the IUCN Red List, primarily due to its restricted range and fragmented habitat. To improve our knowledge of the biogeography and conservation of this species, we modeled the geographical pattern of its suitable habitat and evaluated the potential impacts of climate change using ecological niche modeling with a maximum entropy approach implemented in Maxent. Our results indicated that the amount of suitable habitat in all of East Asia was about 130 000 km(2), which can be spatially subdivided into several mountain ranges in southern and southwestern China and northern Vietnam. The extent of suitable habitat range may shrink by more than 35% under a predicted changing climate when assuming the most pessimistic condition of dispersal, while some more suitable habitat would be available if the heron could disperse unrestrainedly. The significant future changes in habitat suitability suggested for Gorsachius magnificus urge caution in any downgrading of Red List status that may be considered. Our results also discern potentially suitable areas for future survey efforts on new populations. Overall, this study demonstrates that ecological niche modeling offers an important tool for evaluating the habitat suitability and potential impacts of climate change on an enigmatic and endangered species based on limited presence data.	[Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sun Yat Sen University; Sun Yat Sen University	Liu, Y (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	liuy353@mail.sysu.edu.cn	hu, jh/B-4853-2010	hu, jh/0000-0002-6669-8443	National Natural Science Foundation of China [31270568, 31301875]; Sun Yat-sen University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University, China	This project was supported by the National Natural Science Foundation of China (No. 31270568 to JHH; 31301875 to YL), and the "The One Hundred Talents Project (Bai Ren Ji Hua)" of Sun Yat-sen University, China to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; BirdLife International, 2012, IUCN 2012 IUCN RED L; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; CRETE M, 1991, ARCTIC, V44, P275; Crosby M, 2003, SAVING ASIAS THREATE; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dong L, 2010, CONSERV GENET, V11, P2231, DOI 10.1007/s10592-010-0108-6; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fellowes JR, 2001, BIRD CONSERV INT, V11, P101; Gao Jianyun, 2013, Chinese Birds, V4, P254; Gao Yu-Ren, 2000, Chinese Journal of Zoology, V35, P39; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Gu LY, 2013, MOL PHYLOGENET EVOL, V67, P129, DOI 10.1016/j.ympev.2012.12.013; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; He FQ, 2007, BIRD CONSERV INT, V17, P93, DOI 10.1017/S0959270906000566; He Fen-Qi, 2007, Acta Zootaxonomica Sinica, V32, P802; He Fengqi, 2011, Chinese Birds, V2, P163; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, ECOL MODEL, V246, P86, DOI 10.1016/j.ecolmodel.2012.07.028; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Li BC, 2007, WATERBIRDS, V30, P301, DOI 10.1675/1524-4695(2007)30[301:FBOAAN]2.0.CO;2; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046761; Liu Y, 2008, FORKTAIL, P80; Lu N, 2012, CONDOR, V114, P365, DOI 10.1525/cond.2012.110030; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pilgrim JD, 2009, FORKTAIL, P142; Poncet S, 2006, POLAR BIOL, V29, P772, DOI 10.1007/s00300-006-0114-9; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Richardson DM, 2010, DIVERS DISTRIB, V16, P313, DOI 10.1111/j.1472-4642.2010.00660.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Virkkala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063376; White C.M., 1994, NEW WORLD VULTURES G; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zhou F, 2002, CHINA CRANE NEWS, V6, P30; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106; 李筑眉, 2008, [动物学杂志, Chinese Journal of Zoology], V43, P139	73	66	73	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84529	10.1371/journal.pone.0084529	http://dx.doi.org/10.1371/journal.pone.0084529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404169	gold, Green Submitted, Green Published			2022-12-25	WOS:000329460800048
J	Peng, JX; Jiang, XH; Zhang, JX; Xiao, RX; Song, YY; Feng, X; Zhang, Y; Miao, DM				Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin			The Impact of Psychological Capital on Job Burnout of Chinese Nurses: The Mediator Role of Organizational Commitment	PLOS ONE			English	Article							PERFORMANCE; RESOURCES; WORK	Background: Nursing has a high risk of job burnout, but only a few studies have explored its influencing factors from an organizational perspective. Objective: The present study explores the impact of psychological capital on job burnout by investigating the mediating effect of organizational commitment on this relationship. Methods: A total of 473 female nurses from four large general hospitals in Xi'an City of China were selected as participants. Data were collected via the Psychological Capital Questionnaire, the Maslach Burnout Inventory-General Survey, and the Organizational Commitment Scale. Results: Both psychological capital and organizational commitment were significantly correlated to job burnout. Structural equation modelling indicated that organizational commitment partially mediated the relationship between psychological capital and job burnout. Conclusion: The final model revealed a significant path from psychological capital to job burnout through organizational commitment. These findings extended prior reports and shed some light on the influence of psychological capital on job burnout.	[Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin] Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China	Air Force Military Medical University	Zhang, Y (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China.	zhangyanfmmu@126.com; miaodamin@hotmail.com		su, li/0000-0002-1435-9669				Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Avey J.B., 2006, J LEADERSH ORG STUD, V13, P42, DOI [DOI 10.1177/10717919070130020401, 10.1177/10717919070130020401]; Badri S., 2012, INT C ED MAN INN SIN; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Chang EC, 2000, PERS INDIV DIFFER, V29, P255, DOI 10.1016/S0191-8869(99)00191-9; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DUNHAM RB, 1994, J APPL PSYCHOL, V79, P370, DOI 10.1037/0021-9010.79.3.370; Evers WJG, 2002, BRIT J EDUC PSYCHOL, V72, P227, DOI 10.1348/000709902158865; Fan Y, 2012, J XIAN JIAOTONG U SO, V32, P50; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Hakanen JJ, 2008, J VOCAT BEHAV, V73, P78, DOI 10.1016/j.jvb.2008.01.003; HOBFOLL SE, 1990, J SOC PERS RELAT, V7, P465, DOI 10.1177/0265407590074004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson D, 2007, J ADV NURS, V60, P1, DOI 10.1111/j.1365-2648.2007.04412.x; Judge TA, 2001, PSYCHOL BULL, V127, P376, DOI 10.1037//0033-2909.127.3.376; King RC, 1997, EUR J INFORM SYST, V6, P86, DOI 10.1057/palgrave.ejis.3000259; Kline R.B., 2011, PRINCIPLES PRACTICE; Larson M., 2006, J LEADERSH ORG STUD, V13, P45, DOI [10.1177/10717919070130020601, DOI 10.1177/10717919070130020601, 10.1177/10717919070130010701, DOI 10.1177/10717919070130010701]; [骆宏 Luo Hong], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P933; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F., 2005, MANAGE ORGAN REV, V1, P247, DOI DOI 10.1111/J.1740-8784.2005.00011.X; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Luthans F., 2006, PSYCHOL CAPITAL DEV; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Meyer J. P., 1991, HUM RESOUR MANAGE R, V1, P61, DOI [10.1016/1053-4822(91)90011-Z, DOI 10.1016/1053-4822(91)90011-Z]; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Riolli L., 2003, INT J STRESS MANAGE, V10, P235, DOI DOI 10.1037/1072-5245.10.3.235; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19; SHELDON ME, 1971, ADMIN SCI QUART, V16, P143, DOI 10.2307/2391824; SHERWIN ED, 1992, J SOC CLIN PSYCHOL, V11, P129, DOI 10.1521/jscp.1992.11.2.129; Sivarajasingam V, 2002, J PUBLIC HEALTH MED, V24, P219, DOI 10.1093/pubmed/24.3.219; SNYDER CR, 1995, J COUNS DEV, V73, P355, DOI 10.1002/j.1556-6676.1995.tb01764.x; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; Tan D., 1998, INT J ORGAN ANAL, V6, P310, DOI DOI 10.1108/EB028889; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553; Wright T. A., 2004, J BUSINESS MANAGEMEN, V9, P389, DOI DOI 10.1007/s10869-015-9426-5; Wright TA, 2004, ORGAN DYN, V33, P338, DOI 10.1016/j.orgdyn.2004.09.002; Yan X, 2012, SOCIAL INDICATORS RE, V113, P299; Zhang JF, 2013, COMM COM INF SC, V396, P1; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; [仲理峰 Zhong Lifeng], 2007, [心理学报, Acta Psychologica Sinica], V39, P328	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84193	10.1371/journal.pone.0084193	http://dx.doi.org/10.1371/journal.pone.0084193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24349292	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900084
J	Qin, YW; Peng, J; Liang, BY; Su, L; Chen, Q; Xie, JJ; Gu, L				Qin, Yu-Wang; Peng, Jiao; Liang, Bao-Yun; Su, Li; Chen, Qing; Xie, Juan-Juan; Gu, Lian			The A930G Polymorphism of P22phox (CYBA) Gene but Not C242T Variation Is Associated with Hypertension: A Meta-Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; NAD(P)H OXIDASE; NITRIC-OXIDE; DIABETES-MELLITUS; OXIDATIVE STRESS; NADPH OXIDASE; GLOBAL BURDEN; DISEASE; MORTALITY; PEROXYNITRITE	Background: Recently, it has been reported that the A930G and C242T polymorphisms within p22phox (CYBA) gene are involved in the pathogenesis of hypertension. However, the results remain controversial. Furthermore, no previous meta-analysis has been conducted to evaluate the relationship between the A930G and C242T polymorphisms and hypertension. Therefore, we performed this meta-analysis to clarify these controversies. Objective and Methods: All of the included articles were retrieved from the PubMed and Embase databases, as well as the CNKI, CBM, Chongqing VIP and Wan Fang databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used to assess the strength of the association. Accounting for heterogeneity, a fixed or random effects model was respectively adopted. Heterogeneity was checked using the Q test and the I-2 statistic. A cumulative meta-analysis was conducted to estimate the tendency of pooled OR. Funnel plots and Egger's tests were performed to test for possible publication bias. Results: Five articles on A930G with 2003 cases/2434 controls and eight articles on C242T with 2644 cases/1967 controls were identified. A significant association of A930G polymorphisms with the risk of hypertension was found in the dominant model (OR=0.59, 95% CI: 0.38-0.92, p=0.021) and allelic model (OR=0.66, 95% CI: 0.46-0.95, p=0.024). In the stratified analysis, a significant association could be found among the hospital-based and population-based studies. However, no evidence of a significant association of the C242T polymorphism with hypertension was found in the overall analysis and subgroup analysis. Conclusions: This meta-analysis indicates that the A930G polymorphism, but not the C242T variation, might be a protective factor for hypertension.	[Qin, Yu-Wang; Liang, Bao-Yun; Chen, Qing; Xie, Juan-Juan; Gu, Lian] Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Peng, Jiao] Guangxi Med Univ, Preclin Fac, Nanning, Guangxi, Peoples R China; [Su, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi Medical University	Gu, L (corresponding author), Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	gulian2012@163.com		su, li/0000-0002-1435-9669	National Natural Science Foundation of China [81260594]; Guangxi National Natural Science Foundation [2013GXNSFAA019145]; significant scientific research foundation of the Guangxi health department [2012047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi National Natural Science Foundation(National Natural Science Foundation of Guangxi Province); significant scientific research foundation of the Guangxi health department	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81260594); the Guangxi National Natural Science Foundation (Grant No. 2013GXNSFAA019145); and the significant scientific research foundation of the Guangxi health department (Grant No. 2012047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arima H, 2011, J HYPERTENS, V29, pS3, DOI 10.1097/01.hjh.0000410246.59221.b1; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; [哈黛文 Ha Daiwen], 2004, [中国老年学杂志, Chinese Journal of Gerontology], V24, P1122; Hsueh YM, 2005, J TOXICOL ENV HEAL A, V68, P1471, DOI 10.1080/15287390590967414; Iseki K, 2000, HYPERTENS RES, V23, P143, DOI 10.1291/hypres.23.143; Ji Z LB, 2003, CHIN J GERIATR CARDI, V5, P103; Katsuyama M, 2010, J PHARMACOL SCI, V114, P134, DOI 10.1254/jphs.10R01CR; Kokubo Y, 2005, CIRC J, V69, P138, DOI 10.1253/circj.69.138; Krzesinski J-M, 2012, Rev Med Liege, V67, P279; Kuznetsova TY, 2008, KARDIOLOGIYA, V48, P27; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma CH, 2012, J ADV NURS, V68, P1402, DOI 10.1111/j.1365-2648.2011.05835.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moreno MU, 2007, J HYPERTENS, V25, P1620, DOI 10.1097/HJH.0b013e3281ac211d; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Moreno MU, 2003, FEBS LETT, V542, P27, DOI 10.1016/S0014-5793(03)00331-4; Pang J HD, 2005, ASS NADPH OXIDASE SU; [庞静 Pang Jing], 2004, [高血压杂志, Chinese Journal of Hypertension], V12, P502; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Petrovic D, 2013, CLIN EXP HYPERTENS; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sales ML, 2007, J HUM HYPERTENS, V21, P504, DOI 10.1038/sj.jhh.1002170; Schreiber R, 2012, DIABETIC MED, V29, pE55, DOI 10.1111/j.1464-5491.2012.03594.x; Soccio M, 2005, EUR J CLIN INVEST, V35, P305, DOI 10.1111/j.1365-2362.2005.01500.x; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Wang B WX, 2007, ASS WNK4 GENE CYBA G; Zalba G, 2001, CIRC RES, V88, P217	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82465	10.1371/journal.pone.0082465	http://dx.doi.org/10.1371/journal.pone.0082465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349292	Green Published, Green Submitted, gold			2022-12-25	WOS:000328705200081
J	Wang, WJ; Yan, JQ; Wang, HK; Shi, MM; Zhang, MJ; Yang, WP; Peng, CH; Li, HW				Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun; Yang, Weiping; Peng, Chenghong; Li, Hongwei			Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2	PLOS ONE			English	Article							HEPATIC STELLATE CELL; GROWTH-FACTOR RECEPTOR; LIVER FIBROSIS; HEPATOCYTE PROLIFERATION; INDUCED APOPTOSIS; PATHWAYS; ACTIVATION; EXPRESSION; SURVIVAL; KINASE	Objective: Hepatic stellate cells (HSCs) transdifferentiation and subsequent inflammation are important pathological processes involved in the formation of cirrhotic portal hypertension. This study characterizes the pathogenetic mechanisms leading to cholestatic liver fibrosis and portal hypertension, and focuses on mammalian target of rapamycin (mTOR) pathway as a potential modulator in the early phase of cirrhotic portal hypertension. Methods: Early cirrhotic portal hypertension was induced by bile duct ligation (BDL) for three weeks. One week after operation, sham-operated (SHAM) and BDL rats received rapamycin (2 mg/kg/day) by intraperitoneal injection for fourteen days. Vehicle-treated SHAM and BDL rats served as controls. Fibrosis, inflammation, and portal pressure were evaluated by histology, morphometry, and hemodynamics. Expressions of pro-fibrogenic and pro-inflammatory genes in liver were measured by RT-PCR; alpha smooth muscle actin (alpha-SMA) and antigen Ki67 were detected by immunohistochemistry; expressions of AKT/mTOR signaling molecules, extracellular-signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, and interleukin-1 beta (IL-1 beta) were assessed by western blot. Results: The AKT/mTOR signaling pathway was markedly activated in the early phase of cirrhotic portal hypertension induced by BDL in rats. mTOR blockade by rapamycin profoundly improved liver function by limiting inflammation, fibrosis and portal pressure. Rapamycin significantly inhibited the expressions of phosphorylated 70KD ribosomal protein S6 kinase (p-P70S6K) and phosphorylated ribosomal protein S6 (p-S6) but not p-AKT Ser473 relative to their total proteins in BDL-Ra rats. Those results suggested that mTOR Complex 1 (mTORC1) rather than mTORC2 was inhibited by rapamycin. Interestingly, we also found that the level of p-ERK1/2 to ERK1/2 was significantly increased in BDL rats, which was little affected by rapamycin. Conclusions: The AKT/mTOR signaling pathway played an important role in the early phase of cirrhotic portal hypertension in rats, which could be a potential target for therapeutic intervention in the early phase of such pathophysiological progress.	[Wang, Weijie; Yan, Jiqi; Wang, Huakai; Yang, Weiping; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Digest Surg,Key Lab Syst Biomed Ver, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com	Yang, Wei/HIA-0360-2022	Liang, Ying/0000-0002-4939-8705; Luo, Chunxiong/0000-0001-8974-7693; Fu, Qibin/0000-0002-1419-5676; Peng, Chenghong/0000-0002-5573-7873	Foundation of Shanghai Natural Science [09ZR1418600]; National Natural Science of China [81070358]	Foundation of Shanghai Natural Science; National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the Foundation of Shanghai Natural Science (09ZR1418600) and the National Natural Science (81070358) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804; Chen GQG, 2012, ACTA MATH SCI, V32, P1; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Dixon M, 1999, HEPATOLOGY, V29, P1418, DOI 10.1002/hep.510290516; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Geerts AM, 2008, HEPATOL RES, V38, P1130, DOI 10.1111/j.1872-034X.2008.00369.x; Giron-Gonzalez JA, 2004, LIVER INT, V24, P437, DOI 10.1111/j.1478-3231.2004.0951.x; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mehal WZ, 2007, LIVER IMMUNOLOGY PRI, V9, P111; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Wang Y, 2008, WORLD J GASTROENTERO, V14, P5186, DOI 10.3748/wjg.14.5186; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	44	183	191	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83908	10.1371/journal.pone.0083908	http://dx.doi.org/10.1371/journal.pone.0083908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24416258	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800022
J	Zhao, ZJ; Chi, QS; Liu, QS; Zheng, WH; Liu, JS; Wang, DH				Zhao, Zhi-Jun; Chi, Qing-Sheng; Liu, Quan-Sheng; Zheng, Wei-Hong; Liu, Jin-Song; Wang, De-Hua			The Shift of Thermoneutral Zone in Striped Hamster Acclimated to Different Temperatures	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BASAL METABOLIC-RATE; CYTOCHROME-C-OXIDASE; DJUNGARIAN HAMSTER; ENERGY-METABOLISM; BODY-TEMPERATURE; NONSHIVERING THERMOGENESIS; THERMAL CONDUCTANCE; UNCOUPLING PROTEIN; PHODOPUS-SUNGORUS	Temperature affects all biological functions and will therefore modulate ecologically significant interactions between animals and their environment. Here, we examined the effect of ambient temperature (T-a) on the thermal biology and energy budget in striped hamsters acclimated to cold (5 degrees C), warm (21 degrees C) and hot temperatures (31 degrees C). Thermoneutral zone (TNZ) was 22.5-32.5 degrees C, 25-32.5 degrees C and 30-32.5 degrees C in the cold-, warm- and hot-acclimated hamsters, respectively. The cold acclimation decreased the lower critical temperature and made the TNZ wider, and hot exposure elevated the lower critical temperature, resulting in a narrow TNZ. Within the TNZ, cold-acclimated hamsters showed a significantly higher rate of metabolism and thermogenesis than those acclimated to hot temperature. Digestive enzymes activities, including intestinal sucrase, maltase, L-alanine aminopeptidase-N and leucine aminopeptidase were higher in the cold than in the hot. The changes in metabolic rate and thermogenesis at different temperatures were in parallel with cytochrome c oxidase activity and uncoupling protein 1 gene expression of brown adipose tissue. This suggests that the shift of the lower critical temperature of TNZ is possibly associated with the rate of metabolism and thermogenesis, as well as with the digestive capacity of the gastrointestinal tract at different T-a. The upper critical temperature of TNZ may be independent of the changes in T-a. The changes of lower critical temperature of TNZ are an important strategy in adaption to variations of T-a.	[Zhao, Zhi-Jun; Zheng, Wei-Hong; Liu, Jin-Song] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Zhao, Zhi-Jun; Chi, Qing-Sheng; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Liu, Quan-Sheng] Guangdong Entomol Inst, Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China	Wenzhou University; Chinese Academy of Sciences; Institute of Zoology, CAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zhao, ZJ (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China.	zhao73@foxmail.com	Liu, Quan-Sheng/A-2041-2013	Liu, Quan-Sheng/0000-0002-3001-9170; ji, li li/0000-0001-8483-1554	State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1209]; National Natural Science Foundation of China [31270458, 31070367]	State Key Laboratory of Integrated Management of Pest Insects and Rodents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded the State Key Laboratory of Integrated Management of Pest Insects and Rodents (no. ChineseIPM1209) and also partly supported by grants (no. 31270458 and 31070367) from the National Natural Science Foundation of China to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; BRADLEY SR, 1980, COMP BIOCHEM PHYS A, V65, P465, DOI 10.1016/0300-9629(80)90060-2; Broekman M, 2006, PHYSIOL BEHAV, V89, P750, DOI 10.1016/j.physbeh.2006.08.023; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brzek P, 2009, J EXP BIOL, V212, P1284, DOI 10.1242/jeb.023911; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DELRIO CM, 1990, PHYSIOL ZOOL, V63, P987, DOI 10.1086/physzool.63.5.30152625; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Grodzinski W., 1975, International biol Progm, V5, P173; HAMMOND KA, 1991, PHYSIOL ZOOL, V64, P541, DOI 10.1086/physzool.64.2.30158190; Hammond KA, 2001, J EXP BIOL, V204, P1991; HAMMOND KA, 1995, J MAMMAL, V76, P232, DOI 10.2307/1382331; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HELDMAIER G, 1971, Z VERGL PHYSIOL, V73, P222, DOI 10.1007/BF00304134; HELDMAIER G, 1981, J COMP PHYSIOL, V142, P429, DOI 10.1007/BF00688972; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; HIMMSHAGEN J, 1984, NEW ENGL J MED, V311, P1549, DOI 10.1056/NEJM198412133112407; IUPS Thermal Commission, 2001, JPN J PHYSIOL, V51, P245; Jefimow M, 2004, COMP BIOCHEM PHYS A, V139, P379, DOI 10.1016/j.cbpb.2004.10.007; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kauffman AS, 2003, PHYSIOL BEHAV, V79, P247, DOI 10.1016/S0031-9384(03)00115-X; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Konarzewski M, 1995, EVOLUTION, V49, P1239, DOI 10.2307/2410448; Kronfeld-Schor N, 2000, PHYSIOL BIOCHEM ZOOL, V73, P37, DOI 10.1086/316718; Liu Jin-Song, 2003, Acta Zoologica Sinica, V49, P451; Liu QS, 2007, J COMP PHYSIOL B, V177, P509, DOI 10.1007/s00360-007-0149-4; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA A, 1988, J EXP ZOOL, V248, P133, DOI 10.1002/jez.1402480202; MCDEVITT RM, 1994, PHYSIOL ZOOL, V67, P1117, DOI 10.1086/physzool.67.5.30163885; McNab, 1974, OHIO J SCI, V74, P370; MCNAB BK, 1980, PHYSIOL ZOOL, V53, P145, DOI 10.1086/physzool.53.2.30152577; Naya DE, 2005, J COMP PHYSIOL B, V175, P31, DOI 10.1007/s00360-004-0459-8; Nespolo RF, 2002, J EXP BIOL, V205, P2697; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Schleucher E, 2001, COMP BIOCHEM PHYS A, V129, P821, DOI 10.1016/S1095-6433(01)00356-7; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Song ZG, 2003, J THERM BIOL, V28, P509, DOI 10.1016/S0306-4565(03)00051-2; Song ZG, 2002, ACTA THERIOL, V47, P417, DOI 10.1007/BF03192466; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Sundin U, 1978, AM J PHYSIOL, V252R, P822; Terblanche SE, 2000, COMP BIOCHEM PHYS B, V127, P319, DOI 10.1016/S0305-0491(00)00269-8; TOLOZA EM, 1991, AM J PHYSIOL, V261, pG608, DOI 10.1152/ajpgi.1991.261.4.G608; Wang D, 1999, J COMP PHYSIOL B, V169, P77, DOI 10.1007/s003600050196; Wang D.-H, 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, pS96; WIESINGER H, 1990, CAN J PHYSIOL PHARM, V68, P195, DOI 10.1139/y90-030; WIESINGER H, 1989, PFLUG ARCH EUR J PHY, V413, P667, DOI 10.1007/BF00581818; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wooden KM, 2002, J EXP BIOL, V205, P2099; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]; Zhao ZJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P560, DOI 10.1086/662553; Zhao ZJ, 2010, J THERM BIOL, V35, P401, DOI 10.1016/j.jtherbio.2010.08.005; Zhao ZJ, 2010, J EXP BIOL, V213, P3988, DOI 10.1242/jeb.046821; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008; Zhao ZJ, 2005, PHYSIOL BEHAV, V85, P143, DOI 10.1016/j.physbeh.2005.03.014	68	30	34	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84396	10.1371/journal.pone.0084396	http://dx.doi.org/10.1371/journal.pone.0084396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400087	gold, Green Submitted, Green Published			2022-12-25	WOS:000329462700021
J	Liu, MX; Chen, X; Chen, G; Cui, QH; Yan, GY				Liu, Ming-Xi; Chen, Xing; Chen, Geng; Cui, Qing-Hua; Yan, Gui-Ying			A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DATABASE; GENOME; PROTEIN; INHIBITOR; MOUSE; OVEREXPRESSION; SUSCEPTIBILITY; IDENTIFICATION	As a major class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been implicated in various critical biological processes. Accumulating researches have linked dysregulations and mutations of lncRNAs to a variety of human disorders and diseases. However, to date, only a few human lncRNAs have been associated with diseases. Therefore, it is very important to develop a computational method to globally predict potential associated diseases for human lncRNAs. In this paper, we developed a computational framework to accomplish this by combining human lncRNA expression profiles, gene expression profiles, and human disease-associated gene data. Applying this framework to available human long intergenic noncoding RNAs (lincRNAs) expression data, we showed that the framework has reliable accuracy. As a result, for non-tissue-specific lincRNAs, the AUC of our algorithm is 0.7645, and the prediction accuracy is about 89%. This study will be helpful for identifying novel lncRNAs for human diseases, which will help in understanding the roles of lncRNAs in human diseases and facilitate treatment. The corresponding codes for our method and the predicted results are all available at http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html.	[Liu, Ming-Xi; Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Geng; Cui, Qing-Hua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China [10531070, 10721101, 11301517, 11371355, KJCX-YW-S7]; National Center for Mathematics and Interdisciplinary Sciences, CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10531070, 10721101, 11301517, 11371355, KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haruta N, 2011, P JPN ACAD B-PHYS, V87, P641, DOI 10.2183/pjab.87.641; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 2011, NAT PROD COMMUN, V6, P1801; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshihara C, 2012, ONCOL LETT, V3, P387, DOI 10.3892/ol.2011.467; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara Eiji, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P570; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	51	195	205	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84408	10.1371/journal.pone.0084408	http://dx.doi.org/10.1371/journal.pone.0084408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	25244184	Green Published, gold, Green Submitted			2022-12-25	WOS:000329460100056
